"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT03756649","Mayo Clinic IBD Biobank",,"Enrolling by invitation","No Results Available","Inflammatory Bowel Diseases","Procedure: Blood Draw|Procedure: Urine Collection|Procedure: Stool Collection","Study Participants|Urine Collection|Blood Collection|Stool Collection","Mayo Clinic","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","1000","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","18-007941","November 1, 2018","December 2065","December 2065","November 28, 2018",,"December 17, 2020","Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03756649"
2,"NCT01650311","Investigating Serotonin Signalling in IBD Patients","IBD","Recruiting","No Results Available","Inflammatory Bowel Disease",,"TPH1 and SERT expression|Receptor expressions","McMaster University","All","19 Years to 85 Years   (Adult, Older Adult)",,"60","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","12-239","July 2012","May 2021","May 2021","July 26, 2012",,"September 2, 2020","McMaster University Medical Center, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT01650311"
3,"NCT04205734","Methotrexate Polyglutamate Measurements in Patients With Inflammatory Bowel Disease",,"Recruiting","No Results Available","IBD","Diagnostic Test: MTX Assessment","Methotrexate Polyglutamate Level|The correlation between Methotrexate Polyglutamate Levels and Lab Parameters|The correlation between Methotrexate Polyglutamate Levels and Clinical History","Boston Children's Hospital","All","1 Year to 21 Years   (Child, Adult)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","IRB-P00028947","January 30, 2021","December 31, 2021","December 31, 2021","December 19, 2019",,"March 4, 2021","Boston Children's Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04205734"
4,"NCT02134054","Stavanger IBD Study - Cross Sectional","SUSI-CS","Active, not recruiting","No Results Available","Inflammatory Bowel Disease",,"Clinical remission rate|Symptom scoring|Inflammatory markers|Fatigue scoring","Helse Stavanger HF|Oslo University Hospital","All","16 Years and older   (Child, Adult, Older Adult)",,"210","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","SUSI-CS_1","April 2014","November 2015","December 2021","May 8, 2014",,"February 5, 2020","Stavanger University Hospital, Stavanger, Norway",,"https://ClinicalTrials.gov/show/NCT02134054"
5,"NCT04733456","Brain Activity and Oxygenation Inflammatory Bowel Disease (IBD) Patients",,"Recruiting","No Results Available","IBD|Maladaptive Behavior Associated With Physical Illness","Behavioral: Quality of life questionnaires|Device: NIRS|Other: Stool Collection|Other: Blood and urine collection","a) Clinically: CD (decrease of >3 points in the modified Harvey-Bradshaw Index); UC (decrease of >2 points in the partial Mayo Score)|b) Radiographically: decrease in bowel wall thickness ≥25% in most affected segment with 2 point decrease in color Doppler signal score or normalization|c) Biomarker: decrease in fecal calprotectin >50% from baseline or ≤250 ug/g|d) Endoscopically (where available): CD (decrease in Simple Endoscopic Score for CD ≥50% from baseline); UC (decrease in Mayo endoscopic subscore ≥1 point from baseline)|(i) alterations in markers of bowel (defined by bowel ultrasound) and systemic inflammation.|(ii) reduction from baseline measurement of fecal calprotectin level.|(iii) specific gut microbiome and metabolomics signatures.|(iv) changes in symptom severity in IBD patients that respond (defined as above), or do not respond to anti-TNF therapy.","University of Calgary","All","18 Years to 85 Years   (Adult, Older Adult)",,"40","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","REB20-1873","April 26, 2021","January 5, 2025","January 5, 2026","February 2, 2021",,"April 28, 2021","University of Calgary, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT04733456"
6,"NCT02377258","IBD Cancer and Serious Infection in Europe","I-CARE","Active, not recruiting","No Results Available","IBD","Other: Non Interventional","assess prospectively the presence and the extent of safety concerns (cancers, especially, lymphoma, and serious infections risks) for anti-TNF alone or in combination with thiopurines among IBD patients.|Disease modification|ePRO|Benefit-Risk|Cost Efficacy","Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives","All","18 Years and older   (Adult, Older Adult)",,"13267","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","GETAID 2015-01","March 4, 2016","May 20, 2022","May 20, 2023","March 3, 2015",,"May 21, 2019","Chu Nancy, Vandoeuvre Les Nancy, France",,"https://ClinicalTrials.gov/show/NCT02377258"
7,"NCT04573400","Prevalence of Neuropsychiatric Manifestations in IBD Patients in Upper Egypt",,"Not yet recruiting","No Results Available","IBD","Other: HADS","Identify prevalence of neurological and psychological conditions associated with IBD.","Assiut University","All","18 Years and older   (Adult, Older Adult)",,"90","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","IBD and neuropsychiatry","January 1, 2021","January 1, 2022","May 1, 2022","October 5, 2020",,"October 5, 2020",,,"https://ClinicalTrials.gov/show/NCT04573400"
8,"NCT01551563","Stavanger University Hospital Inflammatory Bowel Disease Trial","SUSI","Recruiting","No Results Available","IBD",,"Clinical efficacy of IBD drug therapy|Fatigue in patients with coeliac disease - substudy|Fatigue in IBD|IBD and the intestinal microbiome","Helse Stavanger HF","All","16 Years to 80 Years   (Child, Adult, Older Adult)",,"600","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","SUSI_1","April 2012","December 2022","December 2027","March 12, 2012",,"March 1, 2021","SUS, Stavanger, Norway",,"https://ClinicalTrials.gov/show/NCT01551563"
9,"NCT04296110","Impact of a Biofeedback Intervention on Microbiome, Metabolome, and Clinical Outcomes in Pediatric IBD (Study 2)",,"Recruiting","No Results Available","IBD","Behavioral: Biofeedback|Other: Music Relaxation Therapy","Disease activity( Fecal calprotectin)|Disease Activity (Crohn's disease)|Stress|Anxiety|Pediatric Quality of Life: scale|Depression|Stress-related changes in the microbiome|Stress-related changes in the metabolome.","Nationwide Children's Hospital","All","8 Years to 17 Years   (Child)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","18-01100","March 12, 2020","March 1, 2022","March 1, 2023","March 5, 2020",,"January 12, 2021","Nationwide Childrens Hospital GI Clinic, Columbus, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT04296110"
10,"NCT04782544","Ganglioside and IBD",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Other: Buttermilk Powder|Other: Anhydrous Milk Fat","Disease activity index|ImproveCareNow Physician Global Assessment|IMPACT-III questionnaire|Intestinal integrity|Calprotectin|C-reactive protein","Children's Hospital of Orange County|Michael Wang|Kenneth Grant","All","9 Years to 21 Years   (Child, Adult)","Not Applicable","48","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","200109","April 15, 2021","June 15, 2022","September 15, 2022","March 4, 2021",,"March 4, 2021",,,"https://ClinicalTrials.gov/show/NCT04782544"
11,"NCT03399188","Fecal Microbiota Transplantation and Analysis of Fecal Microbiome in IBD Patients",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Procedure: Fecal microbiome transplantation","Clinical remission|Microbiome analysis by using relative abundance at phylum and genus level, beta diversity|Clinical response using disease activity index|Endoscopic healing|Adverse events","Yonsei University","All","7 Years to 80 Years   (Child, Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","4-2017-0223","November 15, 2017","November 30, 2023","December 31, 2023","January 16, 2018",,"January 16, 2019","Severance hospital, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT03399188"
12,"NCT04717284","A Self-compassion Intervention for Parents of Children With Inflammatory Bowel Disease (IBD)",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Other: Self-compassion intervention (SCI)|Other: Control condition","State self-compassion.|State shame and distress.|Trait self-compassion.|Parental stress.","University of Sheffield","All","18 Years and older   (Adult, Older Adult)","Not Applicable","154","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","169973","April 20, 2021","December 2021","December 2021","January 22, 2021",,"May 7, 2021","Clinical Psychology Unit, University of Sheffield, Sheffield, South Yorkshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04717284"
13,"NCT04488471","Impact of Isolation in Patients With IBD During the COVID-19 Crisis",,"Recruiting","No Results Available","Inflammatory Bowel Diseases",,"What impact has the isolation of patients during social isolation had in terms of psychological morbidity?|Have levels of psychological morbidity in young people changed from levels prior to the CoViD pandemic?","Sheffield Teaching Hospitals NHS Foundation Trust","All","16 Years and older   (Child, Adult, Older Adult)",,"232","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","STH21414","June 30, 2020","June 30, 2022","June 30, 2022","July 28, 2020",,"July 28, 2020","Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04488471"
14,"NCT03038984","Are Rates of Colectomies, Resections, Mortalities and Cancer Reduced by Home Monitoring of IBD Patients ?",,"Active, not recruiting","No Results Available","Inflammatory Bowel Diseases","Behavioral: At Home Screening procedure On demand|Behavioral: At Home Screening procedure every 3 months","colectomies|resections|mortalities|cancer|Hospitalizations|FC (Fecal Calprotectin) area under the curve (AUC)|Simple clinical colitis activity index (SCCAI): area under the curve (AUC)|Harvey-Bradshaw index (HBI): area under the curve (AUC)|Disease course, Copenhagen IBD Disease course Type","Nordsjaellands Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","H-15005603","August 2016","August 2026","August 2026","February 1, 2017",,"March 3, 2021",,,"https://ClinicalTrials.gov/show/NCT03038984"
15,"NCT04492267","Inflammatory Bowel Disease (IBD) and Covid-19 Infection","MICI-Covid-19","Recruiting","No Results Available","Inflammatory Bowel Disease",,"Retrospective analysis of severity and specific needs in case of SARS-CoV-2 infection in IBD patients","University Hospital, Strasbourg, France","All","18 Years and older   (Adult, Older Adult)",,"700","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","7930","July 7, 2020","January 7, 2021","January 7, 2021","July 30, 2020",,"July 30, 2020","Service Hépato-Gastroentérologie et Assistance Nutritive Hôpitaux Univesitaires de Strasbourg, Strasbourg, France",,"https://ClinicalTrials.gov/show/NCT04492267"
16,"NCT04269720","Biofeedback in Pediatric Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","IBD","Behavioral: Biofeedback","Crohn's disease mucosal healing|Ulcerative Colitis Mucosal healing|Disease activity( Fecal calprotectin)|Disease Activity (Crohn's disease)|Disease Activity ( Ulcerative Colitis)|Stress|Anxiety|Pediatric Quality of life|Depression|Stress-related changes in the microbiome|Stress-related changes in the metabolome.","Ross Maltz|Nationwide Children's Hospital","All","8 Years to 17 Years   (Child)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB18-01100","September 9, 2022","February 1, 2024","February 1, 2025","February 17, 2020",,"January 12, 2021",,,"https://ClinicalTrials.gov/show/NCT04269720"
17,"NCT04180345","Development of a Questionnaire Based on Patients' Messages on an Internet Forum for Flare Detection in IBD","FLARE_IBD","Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Other: Psychometric validation of the questionnaire","Scale calibration of the new developped questionnaire|Construct validity of the new developped questionnaire|Convergence proprieties of the new developped questionnaire|Reproductibility of the new developped questionnaire","Central Hospital, Nancy, France|Association François Aupetit, Paris, France|University of Lorraine","All","18 Years and older   (Adult, Older Adult)",,"260","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","2019-A01520-57","January 2020","July 2020","February 2021","November 27, 2019",,"November 27, 2019",,,"https://ClinicalTrials.gov/show/NCT04180345"
18,"NCT03653481","Treating IBD With Inulin","TII","Recruiting","No Results Available","Inflammatory Bowel Diseases","Dietary Supplement: Oligofructose-enriched Inulin OI|Dietary Supplement: Maltodextrin","Alteration of gut microbiota and metabolome|Change in fecal calprotectin level","Children's Hospital of Philadelphia|Beneo GmbH","All","8 Years to 21 Years   (Child, Adult)","Not Applicable","200","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","18-015331","October 29, 2018","October 2021","October 2022","August 31, 2018",,"July 30, 2020","Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03653481"
19,"NCT04760600","Role of Parasitic Infection in Inflammatory Bowel Disease and Irritable Bowel Syndrome",,"Recruiting","No Results Available","Parasite IBS IBD",,"Detect the prevalence of parasite/s associated with Inflammatory bowel diseases (IBD) and Irritable bowel syndrome (IBS) in comparison with control subjects.|measure the effect of the antiparasitic drugs on the course and prognosis of the diseases","Assiut University","All","17 Years to 69 Years   (Child, Adult, Older Adult)",,"300","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","role of parasites in ibd ibs","June 2021","June 2024","June 2024","February 18, 2021",,"February 18, 2021","Marina Gamil Shwqi, Assiut, Egypt",,"https://ClinicalTrials.gov/show/NCT04760600"
20,"NCT04816812","The IBD-FITT Study - Moderate-intensity Exercise for IBD Patients With Moderate Disease Activity","IBD-FITT","Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Behavioral: Exercise intervention|Behavioral: Lifestyle - online lesson intervention","Inflammatory Bowel Disease Questionnaire (IBDQ)|General health - Waist circumference|General health - blood pressure|General health - Lipid|General health - Clinical disease activity","University of Southern Denmark","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IBD-FITT_1","October 1, 2021","November 1, 2022","December 31, 2022","March 25, 2021",,"March 25, 2021","Hospital of Southwest Jutland, Esbjerg, Denmark|Odense University Hospital, Odense, Denmark",,"https://ClinicalTrials.gov/show/NCT04816812"
21,"NCT03695783","The IBD&me Randomized Controlled Trial",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Other: Online decision aid called IBD&me|Other: Standardized educational material","Patient perceptions of shared decision-making|Patient perceptions of decisional conflict|Patient satisfaction|Disease control and IBD-related quality of life|Initiation or switch of a treatment","Cedars-Sinai Medical Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","152","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research","37998665","March 6, 2019","December 31, 2020","December 31, 2020","October 4, 2018",,"July 22, 2020","Cedars-Sinai Medical Center, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT03695783"
22,"NCT04256538","Identify Specific Peripheral Blood Mononuclear Cell (PBMC) MiRNA as Biomarkers for Inflammatory Bowel Disease (IBD)",,"Recruiting","No Results Available","Inflammatory Bowel Diseases",,"Crohn's Disease Activity Index (CDAI)|Mayo Score","Second Affiliated Hospital, School of Medicine, Zhejiang University","All","14 Years to 75 Years   (Child, Adult, Older Adult)",,"300","Other","Observational","Observational Model: Other|Time Perspective: Prospective","SAHZJU2019-189","August 15, 2019","December 2020","December 2020","February 5, 2020",,"May 19, 2020","2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04256538"
23,"NCT04344249","Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic","IBD-COVID-19","Recruiting","No Results Available","IBD|COVID",,"IgG and IgM anti SARS-CoV-2|Clinical factors and severity of COVID-19 infection|demographic factors and severity of COVID-19 infection|pharmacologic factors and severity of COVID-19 infection","Nantes University Hospital","All","18 Years to 100 Years   (Adult, Older Adult)",,"850","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","RC20_0150","April 10, 2020","September 30, 2020","September 1, 2021","April 14, 2020",,"April 30, 2020","Chu Nantes, Nantes, France",,"https://ClinicalTrials.gov/show/NCT04344249"
24,"NCT03162549","Corrona Inflammatory Bowel Disease (IBD) Registry",,"Enrolling by invitation","No Results Available","Inflammatory Bowel Diseases",,"IBD epidemiology, presentation, natural history, management, and outcomes|Disease burden: Harvey-Bradshaw Index|Disease burden: Fistula History|Disease burden: Disease Location and Behavior|Percentage of patients with history of comorbidities|Physician reported: Pouchitis|Physician reported: Simple Clinical Colitis Activity Index (SCCAI)|Physician reported: Mayo Severity Index|Physician reported: IBD related extraintestinal manifestations|Patient reported: Patient reported: Work productivity and Activity Impairment (WPAI)|Patient reported: PROMIS","CorEvitas","All","18 Years and older   (Adult, Older Adult)",,"2287","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Corrona-IBD-600","March 27, 2017","December 2100","December 2100","May 22, 2017",,"April 19, 2021","Corrona, LLC, Waltham, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT03162549"
25,"NCT04333810","Remote Physiologic Monitoring to Detect Inflammatory Bowel Disease (IBD) Flares: A Feasibility Study",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Device: Whoop strap 3.0","Inflammatory Bowel Disease flares|Change in Sleep (hours per night)|Change in Heart Rate Variability (HRV)|Change in Resting Heart Rate (RHR)","Milton S. Hershey Medical Center","All","18 Years and older   (Adult, Older Adult)",,"12","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","STUDY14888","October 1, 2020","February 1, 2021","March 30, 2021","April 3, 2020",,"September 22, 2020","Penn State Hershey Medical Center, Hershey, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT04333810"
26,"NCT04939948","Multi-factor Analysis of Psychological Disorders in IBD Patients",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases",,"assess the effects of mental disease on risk of IBD-related adverse outcomes|assess the effects of mental disease on drug adherence","Second Affiliated Hospital, School of Medicine, Zhejiang University","All","18 Years to 65 Years   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Other|Time Perspective: Retrospective","2021-0332","July 2021","September 2021","October 2021","June 25, 2021",,"June 25, 2021",,,"https://ClinicalTrials.gov/show/NCT04939948"
27,"NCT03426683","The Effect of Intestinal Microbiota Transplantation for Inflammatory Bowel Diseases","IBD","Recruiting","No Results Available","Inflammatory Bowel Disease(IBD)","Other: Intestinal Microbiota Transplantation","The change of the modified Mayo score|The change of CDAI|Relief of gastrointestinal symptoms|Changes of gut microbiota","Zhongshan Hospital Xiamen University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2017004","November 21, 2017","October 2021","November 2021","February 8, 2018",,"May 25, 2021","Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian, China","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/83/NCT03426683/Prot_001.pdf|""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/83/NCT03426683/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT03426683"
28,"NCT04170192","Multi-center Clinical Study of Cord Blood Stem Cell Transplantation for IBD Caused by IL-10R Gene Deficiency",,"Active, not recruiting","No Results Available","Inflammatory Bowel Diseases","Procedure: Cord Blood Stem Cell Transplantation","Overall survival rate|Disease free survival rate|Successful engraftment","Children's Hospital of Fudan University|Shanghai Children's Hospital|Children's Hospital Of Soochow University|Beijing Children's Hospital|Guangzhou Women and Children's Medical Center|Shenzhen Children's Hospital|Wuhan Women and Children's Medical Center|Children's Hospital of Nanjing Medical University|The First Affiliated Hospital of Zhengzhou University","All","1 Month to 18 Years   (Child, Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CPBMT-IBD-2019","December 1, 2019","October 31, 2022","October 31, 2023","November 20, 2019",,"February 17, 2020","Children's Hospital of Fudan University, Shanghai, Minhang, China",,"https://ClinicalTrials.gov/show/NCT04170192"
29,"NCT03893942","Psychological Predictors in Colorectal IBD Surgery Recovery","MIND-IBD","Active, not recruiting","No Results Available","Inflammatory Bowel Diseases","Other: Questionnaires administration|Other: Langer Mindfulness Scale (LMS)|Other: Mindful Attention Awareness Scale (MAAS)|Other: Cognitive Flexibility Scale (CFS)|Other: Life Orientation Test (LOT)|Other: Mini Locus of Control test (MLS)|Other: Hospital Anxiety and Depression Scale (HADS)|Other: Perceived Stress Scale (PSS)","Correlation between psychological predictors questionnaires outcome and length of hospital stay|Correlation between psychological predictors questionnaires outcome and quality of life","Istituto Clinico Humanitas","All","18 Years and older   (Adult, Older Adult)",,"80","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2214","April 16, 2019","October 25, 2020","April 2021","March 28, 2019",,"February 3, 2021","IRCCS Istituto Clinico Humanitas, Division of Colon and Rectal Surgery, Rozzano, MI, Italy",,"https://ClinicalTrials.gov/show/NCT03893942"
30,"NCT02952131","Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease","ADcSVF-IBD","Enrolling by invitation","No Results Available","Inflammatory Bowel Diseases","Procedure: Lipoaspiration|Procedure: AD-cSVF|Procedure: Normal Saline IV","Safety: Inflammatory Bowel Disease|Efficacy: Quality of life index , Inflammatory Bowel Disease Questionnaire(IBD-QoL)|Change from Baseline in C Reactive Protein (CRP)|Efficacy: Change in Baseline of Modified Truelove-Witts Score (MTW)|Efficacy: Change in Baseline in Lichtiger Index","Healeon Medical Inc|Terry, Glenn C., M.D.","All","18 Years to 85 Years   (Adult, Older Adult)","Phase 1|Phase 2","100","Industry|Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","RGV-GARM3","November 2016","November 2021","March 2022","November 2, 2016",,"November 5, 2020","Regenevita LLC, Stevensville, Montana, United States",,"https://ClinicalTrials.gov/show/NCT02952131"
31,"NCT04867408","Endoscopic Severity Image Recognition to Advance Research and Training in Inflammatory Bowel Disease (EVEREST - IBD)",,"Not yet recruiting","No Results Available","Inflammatory Bowel Disease 1",,"To develop and train a convolutional neural network to detect and characterise disease severity of inflammatory bowel disease during endoscopy|a) To explore whether Artificial Intelligence can predict response to IBD therapies|b) To develop an endoscopic image repository to advance training and standardisation in endoscopic detection and characterisation of IBD.|c) To develop and assess methodologies for training and quality assurance of IBD diagnostic endoscopy|d) To evaluate comparisons in endoscopic image interpretation between endoscopist's|e) To develop deep learning algorithms and computer vision techniques to allow for automated measurement of quality metrics in endoscopy for IBD|f) To create a future robust research platform to ensure the above objectives are continuously developed as novel imaging techniques emerge over time.","Hull University Teaching Hospitals NHS Trust|Wellcome/EPSRC Centre for Interventional and Surgical Sciences, University College London","All","16 Years to 99 Years   (Child, Adult, Older Adult)",,"4000","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","299614","June 2021","June 2031","June 2031","April 30, 2021",,"April 30, 2021",,,"https://ClinicalTrials.gov/show/NCT04867408"
32,"NCT04805749","Osteopathic Approach in Inflammatory Bowel Diseases",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases (IBD)","Other: Manual Therapy: osteopathy","Mean Change from baseline in gut permeability marker|Mean Change from baseline in intestinal inflammation markers|Mean Change from baseline in vagally mediated Heart Rate Variability (HRV)|Mean Change from baseline in Irritable Bowel Syndrome (IBS) like symptoms|Mean Change from baseline in Quality of Life Score|Mean Change from baseline in Anxiety and Depression Score","Ecole Professionnelle des Osteopathes du Quebec","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","OSTEO in subjects with IBD","April 15, 2021","July 1, 2021","September 1, 2021","March 18, 2021",,"March 18, 2021",,,"https://ClinicalTrials.gov/show/NCT04805749"
33,"NCT04794465","Asymptomatic Inflammatory Bowel Disease in Catalonia",,"Enrolling by invitation","No Results Available","Inflammatory Bowel Diseases","Diagnostic Test: Colorectal cancer screening","Time to treatment|Time to symptoms","Corporacion Parc Tauli","All","18 Years and older   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2021/5006","April 1, 2021","July 15, 2021","October 31, 2021","March 12, 2021",,"March 12, 2021","Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain",,"https://ClinicalTrials.gov/show/NCT04794465"
34,"NCT04818892","Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease",,"Recruiting","No Results Available","IBD|Covid19 Vaccine","Diagnostic Test: Serological Assay for SARS-CoV-2","Change in Geometric Mean Titers (GMT) of SARS-CoV-2 Antibody Concentrations following mRNA COVID-19 vaccine series|Sustained antibody concentrations of mRNA COVID-19 vaccines|Incidence of Adverse Events|Patient reported outcome 3 (PRO3) score|Simple Colitis Activity Index (SCAI) Questionnaire Score|Seroconversion: assessed by percentages of participants with ≥4-fold rise in antibody titer|Change in Geometric Mean Titers (GMT) of SARS-CoV-2 Antibody Concentrations following two doses of viral vector COVID-19 vaccine series|Sustained antibody concentration of viral vector COVID-19 vaccines|Percentage of participants with detectable level of T-cell response after mRNA COVID-19 vaccine|Percentage of participants with detectable level of T-cell response after viral vector COVID-19 vaccine|Change in level of T-cell response after mRNA COVID-19 vaccine|Change in level of T-cell response after viral vector COVID-19 vaccine|Presence of SARS-CoV2 anti-nucleocapside antibody : Yes/No","University of Wisconsin, Madison","All","18 Years to 85 Years   (Adult, Older Adult)",,"260","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","2021-0043|A534250|SMPH/MEDICINE/GASTROENT|Protocol Version 3/31/2021|MSN252947","March 26, 2021","October 2021","April 2023","March 26, 2021",,"June 3, 2021","University of Wisconsin, Madison, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT04818892"
35,"NCT04888299","Artificial Intelligence System Based on Raman Spectroscopy in Inflammatory Bowel Disease",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Device: Raman spectroscopy (SPECTRA IMDx)","Feasibility of Raman spectroscopy to identify mucosal healing in IBD and IBD-related dysplasia against the gold standard of histopathology|Diagnostic performance of Raman spectroscopy for assessment of mmucosal healing in IBD and IBD-related dysplasia against the gold standard of histopathology","Changi General Hospital","All","21 Years to 90 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","2021/2000","April 14, 2021","April 2023","April 2023","May 17, 2021",,"May 17, 2021","Changi General Hospital, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT04888299"
36,"NCT01266538","Inflammatory Bowel Disease(IBD)Database","IBD","Not yet recruiting","No Results Available","Inflammatory Bowel Disease",,"flactuations in gastrointestinal inflammation|development of IBD-related morbidity and complications over time","Tel-Aviv Sourasky Medical Center","All","18 Years and older   (Adult, Older Adult)",,"2500","Other","Observational","Time Perspective: Prospective","TASMC-10-ID-467-CTIL","January 2011","December 2026","December 2026","December 24, 2010",,"December 24, 2010","Tel Aviv Sourasky Medical Center, Tel Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT01266538"
37,"NCT04827368","Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease","VOC","Recruiting","No Results Available","IBD|Crohn Disease|Ulcerative Colitis","Other: Breath Test","Breath volatile organic compounds (VOC)s and objective markers of Inflammatory Bowel Disease (IBD) Activity","The Cleveland Clinic|AbbVie","All","18 Years to 70 Years   (Adult, Older Adult)",,"300","Other|Industry","Observational","Observational Model: Other|Time Perspective: Prospective","20-1149|B19-566","March 22, 2021","April 30, 2024","September 30, 2025","April 1, 2021",,"April 5, 2021","Cleveland Clinic, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT04827368"
38,"NCT04100239","A Pilot and Feasibility Trial of a Group Mindfulness and Self-compassion Intervention for Young People Diagnosed With IBD",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Behavioral: Mindfulness-based stress reduction (MBSR)","Change from Baseline Psychological Distress at 6 time points|Change from Baseline Quality of Life at 6 time points|Change from Baseline Disease Activity at 3 time points|Change from Baseline Mindfulness at 6 time points|Change from Baseline Self-Compassion at 6 time points|Change from Baseline Sleep Disturbance at 6 time points|Change from Baseline Fatigue at 6 time points|Change from Baseline Pain Interference and Intensity at 6 time points|Change from Baseline Coping Style at 6 time points|Change from Baseline Self-Efficacy at 6 time points","University of Sheffield|Sheffield Teaching Hospitals NHS Foundation Trust","All","16 Years to 25 Years   (Child, Adult)","Not Applicable","60","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","159047","November 1, 2019","April 30, 2023","September 30, 2023","September 24, 2019",,"April 30, 2021","Department of Clinical Psychology, University of Sheffield, Sheffield, South Yorkshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04100239"
39,"NCT04422171","A 12-month Real Life Study of IBD Patients Switched From Adalimumab Originator Humira® to One of Its Biosimilar","Rhoneswitch","Recruiting","No Results Available","IBD Patients, Originator Treatment, Biosimilar, Switch Back",,"Magnitude of patient's switch back defined as a deterioration of symptoms without objective identification of disease activity, 12 months after the switch from ada originator Humira®.","University Hospital, Grenoble","All","18 Years to 75 Years   (Adult, Older Adult)",,"400","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","38RC19.379|2020-A00494-35","June 19, 2020","June 18, 2021","January 31, 2023","June 9, 2020",,"September 29, 2020","Chu Grenoble Alpes, Grenoble Cedex 9, France",,"https://ClinicalTrials.gov/show/NCT04422171"
40,"NCT03894228","Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Pregnancy",,"To calculate the incide rate of serious infections during pregnancy (evaluated and the end of pregnancy) based on the medications used to treat IBD.|To calculate the incide rate of serious infections for the offspring (at eh age of 4 years) based on the medications used to treat IBD.|To calculate the incide rate of serious adverse events during pregnancy (evaluated at the end of pregnancy) based on the medications used to treat IBD.|To calculate the incide rate of serious adverse events during offspring (at the age of 4 years) based on the medications used to treat IBD.|2. To calculate the Odds ratio of serious adverse events (including abortions) during pregnancy and delivery based on the drugs used for the treatment of IBD.|3. To measure the developmental status of children born from IBD mothers with the ASQ-3 questionnaire during the first 4 years.|4. To calculate the Hazard ratio of serious adverse events in children born from mothers with IBD who have been exposed in utero to different drugs to treat IBD with the risk in children who were not exposed.|5. To calculate the proportion of children with malformations and to compare the proportions between exposure groups (children exposed to biologics with those non exposed to these drugs).|6. To calculate the Hazard ratio of developing neoplasm in children exposed to drugs to treat IBD.","Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa|Spanish Agency of Medicines and Health Products","Female","18 Years and older   (Adult, Older Adult)",,"1750","Other","Observational","Observational Model: Other|Time Perspective: Prospective","GIS-DUMBO-2018","May 21, 2019","March 1, 2024","March 1, 2028","March 28, 2019",,"February 21, 2020","Complejo Hospitalario Santiago de Compostela, Santiago de Compostela, A Coruña, Spain|Hospital Universitario Reina Sofía, Córdoba, Andalucía, Spain|Hospital Clínico Universitario San Cecilio, Granada, Andalucía, Spain|Hospital Infanta Elena, Huelva, Andalucía, Spain|Hospital Universitario Juan Ramón Jimenez, Huelva, Andalucía, Spain|Hospital Regional Universitario de Málaga, Málaga, Andalucía, Spain|Hospital Universitario Virgen de la Victoria, Málaga, Andalucía, Spain|Hospital San Juan de Dios del Aljarafe, Sevilla, Andalucía, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Andalucía, Spain|Hospital San Jorge, Huesca, Aragón, Spain|Hopsital Universitario Miguel Servet, Zaragoza, Aragón, Spain|Hospital Clínico Universitario Lozano Blesa, Zaragoza, Aragón, Spain|Hospital Royo Villanova, Zaragoza, Aragón, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Universitario de Son Espases, Palma De Mallorca, Baleares, Spain|Hospital Doctor Negrin, Las Palmas De Gran Canaria, Canarias, Spain|Hospital Universitario de Canarias, Tenerife, Canarias, Spain|Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Canarias, Spain|Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain|Hospital General de Castellon, Castellon de la Plana, Castellón, Spain|Hospital Alcázar de San Juan, Ciudad Real, Castilla La Mancha, Spain|Hospital General de Tomelloso, Ciudad Real, Castilla La Mancha, Spain|Hospital General Universitario de Ciudad Real, Ciudad Real, Castilla La Mancha, Spain|Hospital Virgen de la Salud, Toledo, Castilla La Mancha, Spain|Hospital Santos Reyes, Burgos, Castilla Y León, Spain|Hospital Universitario de Burgos, Burgos, Castilla Y León, Spain|Hospital Universitario de Salamanca, Salamanca, Castilla Y León, Spain|Hospital Clínico de Valladolid, Valladolid, Castilla Y León, Spain|Hospital Provincial de Zamora, Zamora, Castilla Y León, Spain|Hospital Virgen de la Concha, Zamora, Castilla Y León, Spain|Hospital del Mar, Barcelona, Cataluña, Spain|Hospital Universitario Clinic i Provincial, Barcelona, Cataluña, Spain|Hospital Universitario de Bellvitge, Barcelona, Cataluña, Spain|Hospital Vall d´Hebron, Barcelona, Cataluña, Spain|Hospital Universitari Dr Josep Trueta, Gerona, Cataluña, Spain|Hospital Sant Joan de Déu, Manresa, Cataluña, Spain|Consorci Sanitari de Terrassa, Tarragona, Cataluña, Spain|Hospital Joan XXIII, Tarragona, Cataluña, Spain|Hospital Universitari Sant Joan de Reus, Tarragona, Cataluña, Spain|Hospital General Universitario de Alicante, Alicante, Comunidad Valenciana, Spain|Hospital Marina Baixa de Villajoyosa, Alicante, Comunidad Valenciana, Spain|Hospital Universitario San Juan, Alicante, Comunidad Valenciana, Spain|Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain|Hospital Lluis Alcanyís de Xátiva, Valencia, Comunidad Valenciana, Spain|Hospital Universitàri i Politècnic La Fe, Valencia, Comunidad Valenciana, Spain|Hospital San Pedro Alcántara, Cáceres, Extremadura, Spain|Complejo Hospitalario Universitario de Ferrol, Ferrol, Galicia, Spain|Complexo Hospitalario Universitario de A Coruña, La Coruña, Galicia, Spain|Complexo Hospitalario Universitario de Ourense, Ourense, Galicia, Spain|Hospital Alvaro Cunqueiro, Vigo, Galicia, Spain|Hospital Comaral de Inca, Palma De Mallorca, Islas Baleares, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain|Hosptial Universitario Infanta Cristina, Parla, Madrid, Spain|Hospital del Henares, San Fernando De Henares, Madrid, Spain|Hospital Universitario de Torrejón, Torrejón, Madrid, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital de Galdakao-Usansolo, Galdakao, Pais Vasco, Spain|Hospital Universitario de Álava, Alava, País Vasco, Spain|Hospital Universitario de Donostia, Donostia, País Vasco, Spain|Hospital de Granollers, Barcelona, Spain|Hospital Universitario de La Princesa, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario de La Paz, Madrid, Spain|Hospital Universitario Doce de Octubre, Madrid, Spain|Hospital Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Infanta Sofía, Madrid, Spain|Hospital Universitario Rey Juan Carlos, Madrid, Spain|Hospital Universitario Virgen de la Arrixaca, Murcia, Spain|Hospital Universitario Virgen del Rosell, Murcia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/28/NCT03894228/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03894228"
41,"NCT04411017","Protocol for Optimizing Colonoscopy Preparation in Patients With Inflammatory Bowel Disease","EII_Prep","Recruiting","No Results Available","Inflammatory Bowel Diseases","Procedure: Endoscopy","Bowel cleansing|Treatment related adverse events|Preparation Tolerability: total volume of solution finally taken by the patient","Hospital Universitario La Paz","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","EII_Prep","February 1, 2019","June 30, 2021","October 31, 2021","June 1, 2020",,"May 24, 2021","Hospital Universitario La Paz, Madrid, Madrd, Spain",,"https://ClinicalTrials.gov/show/NCT04411017"
42,"NCT00904878","A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease",,"Recruiting","No Results Available","Inflammatory Bowel Disease",,"Determine whether children born to women with IBD have higher rates of developmental delay compared to their age matched non-IBD peers, as measured by the Ages and Stages Questionnaire (ASQ-3) at ages 12, 24, 36, and 48 months|Determine whether the rate of any adverse pregnancy outcomes in a prospective national sample of women from the United States with IBD differ with respect to exposure to azathioprine/6MP or anti-TNF therapy","University of California, San Francisco|Crohn's and Colitis Foundation","Female","18 Years to 45 Years   (Adult)",,"1500","Other","Observational","Observational Model: Other|Time Perspective: Prospective","CCFA Pregnancy Registry|CCFA pregnancy Registry","August 2007","June 2022","June 2022","May 20, 2009",,"November 18, 2020","Please Contact Jessica Lim For Further Information Regarding Other Sites' Locations, San Francisco, California, United States|University of California San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00904878"
43,"NCT04254614","Mobile Application for IBD Patients With Biologics",,"Enrolling by invitation","No Results Available","Inflammatory Bowel Diseases","Device: Personalised mobile application for IBD patients","Patient satisfaction|Actual use - frequency|Adherence|Satisfaction of care providers|Overall satisfaction of care providers|Number of outpatient visits|Number of telephone contacts|Disease and treatment knowledge","Rijnstate Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","55","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","NL72353.091.19","March 12, 2020","December 2020","February 2021","February 5, 2020",,"March 16, 2020","Rijnstate Hospital, Arnhem, Gelderland, Netherlands",,"https://ClinicalTrials.gov/show/NCT04254614"
44,"NCT04067934","JUMP Inflammatory Bowel Disease Study","JUMP IBD","Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Behavioral: Jumping Exercise programme","Adherence to exercise protocol|Bone metabolism biomarker|Growth hormone axis|Inflammatory cytokines|Muscle function|Disease activity|Health-related quality of life|Fatigue|Bio-electrical impedance as measure of Body composition","NHS Greater Glasgow and Clyde|University of Glasgow","All","10 Years to 17 Years   (Child)","Not Applicable","15","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","GN19GA217P","August 2019","July 2021","July 2021","August 28, 2019",,"August 28, 2019","NHS Greater Glasgow and Clyde, Glasgow, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04067934"
45,"NCT04847401","the Relationship Between Helicobacter Pylori Infection and Irritable Bowel Syndrome",,"Not yet recruiting","No Results Available","Irritable Bowel Syndrome","Diagnostic Test: H. pylori stool antigen","number of irritable bowel syndrome patients who had H.pylori infection","Sohag University","All","18 Years to 50 Years   (Adult)",,"80","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","Soh-Med-21-04-03","May 25, 2021","November 1, 2021","January 1, 2022","April 19, 2021",,"April 19, 2021",,,"https://ClinicalTrials.gov/show/NCT04847401"
46,"NCT02461784","The Effect of Methotrexate on Sperm Quality in Men With Inflammatory Bowel Disease",,"Recruiting","No Results Available","Inflammatory Bowel Disease (IBD)","Procedure: Semen & Data Collection","Compare semen characteristics between male IBD patients on Methotrexate and non-methotrexate exposed males.","University of Wisconsin, Madison","Male","18 Years to 40 Years   (Adult)",,"150","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","2015-0487|MTX/Sperm in IBD|Protocol Version 8/24/2015|A534250|SMPH\MEDICINE\GASTROENT","June 2015","July 2021","July 2022","June 3, 2015",,"August 7, 2020","University of Wisconsin Hospital & Clinics, Madison, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT02461784"
47,"NCT02893670","Tailored Transition for IBD Adolescents","TRANSIT","Active, not recruiting","No Results Available","Inflammatory Bowel Disease","Procedure: Radiologic (MRE) or endoscopic (sigmoidoscopy) evaluation","Change in therapeutic regimen as a result tailored clinical re-evaluation at the end of the transition process|The change in ""self-efficacy"" score at the end of the transition process|Disease activity (evaluated by crohn's disease activity index for crohn's and Mayo Clinic Index of Activity for UC) at 12 months following transition|The rate of flares during the first year following transition|The rate of hospitalizations during the first year following transition|Surgical rate during the first year following transition","Schneider Children's Medical Center, Israel","All","17 Years to 18 Years   (Child, Adult)","Not Applicable","70","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","TRANSIT01","March 1, 2017","March 1, 2021","December 1, 2021","September 8, 2016",,"October 20, 2020","Schenider Children's Medical Center, Petaẖ Tiqwa, Israel",,"https://ClinicalTrials.gov/show/NCT02893670"
48,"NCT03667586","Group Cognitive Behavioral Therapy for IBD Patients",,"Active, not recruiting","No Results Available","Inflammatory Bowel Diseases","Behavioral: Group cognitive behavioral therapy","Health Survey 36 Short Form (SF36)|Hospital Anxiety and Depression Scale (HADS)|Female Sexual Functioning Index (FSFI)|International Index of Erectile Function(IIEF)|Crohn's disease activity index|Truelove and Witts' severity index|Feacal calprotectin|Serum cytokines levels","University Hospital of Patras","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","326/15.05.2018","February 21, 2019","September 1, 2021","October 30, 2021","September 12, 2018",,"May 6, 2021","Department of Gastroenterology, Patras, Greece",,"https://ClinicalTrials.gov/show/NCT03667586"
49,"NCT04769258","Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD)","ESCAPE-IBD","Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Biological: Pfizer Comirnaty vaccine","Quantitative serum titer of IgM and IgG against SARS-CoV-2|Rate of COVID-19 occurrence|Rate of adherence to the vaccination|Rate of adverse events of the different vaccines|Rate of IBD flare-ups|Predictors of effectiveness of COVID-19 vaccine|Differences of effectiveness between patients|Differences of effectiveness between the several vaccines","Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)","All","18 Years and older   (Adult, Older Adult)",,"1380","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","IGIBD001","March 1, 2021","March 1, 2022","June 1, 2022","February 24, 2021",,"February 24, 2021",,,"https://ClinicalTrials.gov/show/NCT04769258"
50,"NCT04879914","Analysis of Microbiota Changes Induced by Microencapsulated Sodium Butyrate in Patients With Inflammatory Bowel Disease","IBDMicro","Enrolling by invitation","No Results Available","Inflammatory Bowel Diseases|Irritable Bowel Syndrome","Dietary Supplement: Butyrate|Dietary Supplement: Placebo","NGS analysis ( 16S rRNA) will be used to highlight the microbiota variation induced by Butyrose/Placebo administration in 160 IBD and 40 IBS-D patients after 8 weeks of treatment.|Treatment effects on clinical activity by fecal calprotectin.|Treatment effects on lifestyle by IBD Questionaire.","University of Padova","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","4049/AO/17","June 1, 2020","December 2022","December 2023","May 10, 2021",,"May 10, 2021","Edoardo Vinvenzo Savarino, Padua, Italy",,"https://ClinicalTrials.gov/show/NCT04879914"
51,"NCT04457934","Effectiveness of PLENVU in the General Screening Population and Patients With IBD",,"Recruiting","No Results Available","IBD|Healthy","Drug: Plenvu","Boston Bowel Preparation Standard (BBPS)|Number of participants with treatment-related adverse events as assessed by CTCAE v4.0|Number of patients with adverse events|Number of patients who are willing to accept repeated examination (surveillance);|Adenoma and Polyp Detection Rate (ADR and PDR)|cecal intubation rate|procedure time","Johannes Gutenberg University Mainz","All","18 Years to 75 Years   (Adult, Older Adult)",,"290","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","001|125","September 2020","January 2021","August 2021","July 7, 2020",,"September 7, 2020","Dr. Helmut Neumann, Bad Salzuflen, Northrine-Westfalia, Germany|Dr. Horst Hohn, Koblenz, Rhenanie-Palatinate, Germany|University Hospital Mainz, Mainz, Germany",,"https://ClinicalTrials.gov/show/NCT04457934"
52,"NCT03841942","Comparison of Trough Level- and Clinical-based Spacing of Infliximab Infusions in Patients With IBD in Deep Remission","SPACIFIX","Recruiting","No Results Available","Inflammatory Bowel Diseases","Other: clinically-based spacing strategy|Other: Trough level-based strategy","Rate of loss of clinical remission|Rate of loss of biological remission","University Hospital, Montpellier","All","18 Years and older   (Adult, Older Adult)","Not Applicable","164","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","RECHMPL18_0024 7596","June 26, 2019","December 26, 2022","April 26, 2023","February 15, 2019",,"January 10, 2020","Amiens University Hospital, Amiens, France|Besançon University Hospital, Besançon, France|Bordeaux University Hospital, Bordeaux, France|Caen University Hospital, Caen, France|Clermont-Ferrand University Hospital, Clermont-Ferrand, France|Lille University Hospital, Lille, France|Pineton de Chambrun, Montpellier, France|CHRU Nancy - Hôpitaux de Brabois, Nancy, France|Nantes University Hospital, Nantes, France|Nice University Hospital, Nice, France|Nîmes University Hospital, Nîmes, France|APHP Beaujon Hospital, Paris, France|APHP Paris Cochin, Paris, France|Rennes University Hospital, Rennes, France|Saint Etienne University Hospital, Saint-Étienne, France|Toulouse University Hospital, Toulouse, France",,"https://ClinicalTrials.gov/show/NCT03841942"
53,"NCT04879810","Plant Exosomes +/- Curcumin to Abrogate Symptoms of Inflammatory Bowel Disease",,"Recruiting","No Results Available","Irritable Bowel Disease","Procedure: Sigmoidoscopy and biopsy, blood work","Change in inflammation on Colonoscopy|Change in Subjective symptoms","University of Louisville","All","18 Years and older   (Adult, Older Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","15.0872","March 1, 2018","January 2, 2022","January 30, 2022","May 10, 2021",,"May 11, 2021","University of Louisville, Louisville, Kentucky, United States",,"https://ClinicalTrials.gov/show/NCT04879810"
54,"NCT04410484","PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic","PREPARE IBD","Active, not recruiting","No Results Available","Inflammatory Bowel Diseases|Coronavirus Infection",,"Flare of IBD needing change in therapy or surgery","Hull University Teaching Hospitals NHS Trust","All","16 Years to 100 Years   (Child, Adult, Older Adult)",,"1500","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","284920","May 22, 2020","August 2020","August 2020","June 1, 2020",,"June 4, 2020","Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust, Hull, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04410484"
55,"NCT04921709","Renal Involvement in Inflammatory Bowel Disease Patients",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Other: Medical tests","correlation between lab, radiological and colonoscopy","Assiut University","All","18 Years to 65 Years   (Adult, Older Adult)",,"60","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IBD impacts on kidney","June 1, 2021","October 1, 2022","January 1, 2023","June 10, 2021",,"June 10, 2021","Hend Hamdy Tawfik, Minya, Egypt",,"https://ClinicalTrials.gov/show/NCT04921709"
56,"NCT02193464","Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk","EPICODE","Recruiting","No Results Available","Idiopathic Chronic Inflammatory Bowel Disease",,"All newly diagnosed cases|All operation cases","Kyungpook National University Hospital|Yeungnam University Hospital|Daegu Catholic University Medical Center|DongGuk University","All","Child, Adult, Older Adult",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","EPICODE","September 2014","December 2025","December 2026","July 17, 2014",,"January 12, 2021","Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT02193464"
57,"NCT03938701","Fluorescence Imaging of Disease Activity in IBD and Rheumatoid Arthritis Using OTL38","AVIATOR","Not yet recruiting","No Results Available","IBD|Rheumatoid Arthritis","Drug: OTL38|Device: Fluorescence Imaging","Safety: number of participants with symptoms or changes in vital signs (blood pressure, heart rate and temperature) that are related to administration of OTL38|Safety: number of participants with (serious) adverse events that are related to the administration of OTL38|Discrimination of inflamed and normal tissue based on in vivo fluorescence measurements from OTL38 gained during fluorescence imaging of the hand of rheumatoid arthritis patients|Discrimination of inflamed and normal tissue based on in vivo and ex vivo fluorescence measurements from OTL38 gained during fluorescence endoscopy in patients with ulcerative colitis (UC).|Discrimination of inflamed and normal tissue based on in vivo and ex vivo fluorescence measurements from OTL38 gained during fluorescence endoscopy in patients with Crohn's disease (CD).|The correlation between the fluorescence intensity and the disease activity measured with the DAS28 in patients with RA.|Calculation of optical properties with MDSFR/SFF spectroscopy in patients with RA|The correlation between fluorescence intensity and the clinical disease activity score in ulcerative colitis using the SCCAI;|The correlation between fluorescence intensity and the endoscopic disease activity score in ulcerative colitis using the Mayo endoscopic subscore;|The correlation between fluorescence intensity and the clinical disease activity score in Crohn's disease using the Crohn's Disease Activity Index (CDAI).|The correlation between fluorescence intensity and the disease activity score in Crohn's disease using the SES-CD score|The correlation and validation of fluorescence signals detected in vivo to the pathology of biopsies for IBD patients;|The feasibility of visualising the fluorescence signal of OTL38 in vivo by confocal laser endomicroscopy for IBD patients;|Quantification of fluorescence signals in vivo and ex vivo of inflamed and normal tissue using multi-diameter single-fiber reflectance, single-fiber fluorescence (MDSFR/SFF) spectroscopy measurements in IBD patients;|Correlation in IBD between fluorescence intensity and biochemical parameters using faecal calprotectin, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR)|Correlation in IBD between the detected fluorescence signals in vivo and the clinical response to induction therapy at week 14.","University Medical Center Groningen|GlaxoSmithKline|On Target Laboratories, LLC|VU University Medical Center","All","18 Years and older   (Adult, Older Adult)","Phase 1","30","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening","NL68577.042.18","September 2021","December 2021","December 2021","May 6, 2019",,"April 28, 2021","University Medical Center Groningen, Groningen, Netherlands",,"https://ClinicalTrials.gov/show/NCT03938701"
58,"NCT04853381","Comparison of the Effects of Different Nutrition Treatments on Patients With Irritable Bowel Syndrome",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Other: dietary treatment (low FODMAP)|Other: dietary treatment (gluten free)|Other: dietary treatment (low FODMAP+gluten free)|Other: dietary treatment (Traditional diet recommendations)","Irritable Bowel Syndrome Severity Scoring Scale (IBS-SSS)|Irritable Bowel Syndrome Quality of Life Scale (IBS-QQL)|Bristol Stool Scale|Food Consumption Frequency Survey including FODMAP Intake|Food Consumption Frequency Survey Including Gluten Intake","University of Gaziantep","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","52","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","nolule","April 21, 2021","July 1, 2021","August 30, 2021","April 21, 2021",,"April 23, 2021","Gaziantep University, Gaziantep, Sehitkamil, Turkey",,"https://ClinicalTrials.gov/show/NCT04853381"
59,"NCT03985800","Specialty Medical Homes to Improve Outcomes for Patients With IBD and Behavioral Health Conditions",,"Recruiting","No Results Available","Inflammatory Bowel Disease|Behavioral Symptoms","Other: TEAM|Other: TECH","Inflammatory Bowel Disease Symptom Severity-PROMIS GI|Inflammatory Bowel Disease Symptom Severity-HBI|Inflammatory Bowel Disease Symptom Severity|Behavioral Health Symptom Severity|Functional Impairment|Health Care Utilization|Self-Efficacy|Inflammatory Bowel Disease- Related Quality of Life","University of Pittsburgh|Mount Sinai Hospital, New York|The Cleveland Clinic|Patient-Centered Outcomes Research Institute","All","18 Years to 60 Years   (Adult)","Not Applicable","990","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","IHS-2017C3-8930","July 1, 2019","February 28, 2023","July 31, 2023","June 14, 2019",,"August 5, 2020","University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03985800"
60,"NCT04304950","Chronotherapy in Inflammatory Bowel Disease",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Drug: Evening Group|Drug: Morning Group","Thioguanine levels in blood|Harvey Bradshaw Activity Index|Short Inflammatory Bowel Disease Questionnaire|6-Methylmercaptopurine levels in blood|Owl and Lark Questionnaire|Munich Chronotype Questionnaire|RU SATED Questionnaire","Rush University Medical Center","All","18 Years and older   (Adult, Older Adult)","Phase 4","128","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","16040505","April 25, 2016","April 2021","April 2021","March 12, 2020",,"December 17, 2020","Rush University Medical Center, Chicago, Illinois, United States","""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/50/NCT04304950/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT04304950"
61,"NCT04291976","Back-to-back Endoscopy Versus Single-pass Endoscopy and Chromoendoscopy in IBD Surveillance","HELIOS","Recruiting","No Results Available","Inflammatory Bowel Diseases|Colorectal Neoplasms","Procedure: Back-to-back high-definition white light endoscopy|Procedure: single-pass high-definition white light endoscopy|Procedure: chromoendoscopy","detection rate of neoplasia for each technique|Number of all lesions for each technique|Number of dysplastic lesions for each technique|Kudo classification for each lesion|Duration|Number of targeted biopsies taken in the different groups.|Percentage of non-interpretable/assessable endoscopies|Location of the lesion|Size of the lesion in mm","Radboud University|UMC Utrecht|Leiden University Medical Center|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","560","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","109344","March 13, 2020","January 2022","March 2022","March 2, 2020",,"January 22, 2021","Radboudumc, Nijmegen, Gelderland, Netherlands|Utrecht University Medical Center, Utrecht, Gelderland, Netherlands|Amsterdam UMC, location AMC, Amsterdam, Noord-Holland, Netherlands|Leiden University Medical Center, Leiden, Zuid Holland, Netherlands",,"https://ClinicalTrials.gov/show/NCT04291976"
62,"NCT04723056","Zemedy Application for Irritable Bowel Syndrome",,"Not yet recruiting","No Results Available","IBS - Irritable Bowel Syndrome","Device: Use of Zemedy Application","IBS-SSS at 8 Weeks|IBS-SSS at 24 Weeks","Stanford University|Bold Health Inc.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","44","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","59209","January 2021","January 2023","January 2023","January 25, 2021",,"January 25, 2021","Stanford University School of Medicine, Redwood City, California, United States",,"https://ClinicalTrials.gov/show/NCT04723056"
63,"NCT03778918","The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Irritable Bowel Syndrome","Other: inflammatory bowel disease|Other: IBS or Normal Control","measurement of blood-based biomarkers to predict disease activity 1|measurement of blood-based biomarkers to predict disease activity 2|measurement of blood-based biomarkers to predict disease activity 3|Age (years)|Gender (M/F)|disease duration (months)|disease onset (years)","Bo-In Lee|Incheon St.Mary's Hospital|St. Vincent's Hospital-Manhattan|Daejeon St. Mary's hospital|Seoul St. Mary's Hospital","All","19 Years to 75 Years   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","XC18TEDI0027","August 1, 2016","June 30, 2020","December 30, 2020","December 19, 2018",,"March 3, 2020","Division of Gastroenterology; Seoul St. Mary's hospital, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT03778918"
64,"NCT01171872","Gene Expression in Inflammatory Bowel Disease",,"Enrolling by invitation","No Results Available","Inflammatory Bowel Disease",,,"Johns Hopkins University|National Institutes of Health (NIH)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Institute of Allergy and Infectious Diseases (NIAID)","All","7 Years and older   (Child, Adult, Older Adult)",,"1100","Other|NIH","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","NA_00038329|U01DK062431|R24DK099803|P01AI125181","November 1999","December 2022","December 2022","July 29, 2010",,"August 25, 2020","Johns Hopkins University School of Medicine, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT01171872"
65,"NCT03889808","Seroprevalence of Anti-bodies Against Clostridium Difficile Toxins and Prevalence of Asymptomatic Carriage of Clostridium Difficile in IBD Patients.",,"Recruiting","No Results Available","Clostridium Difficile|Inflammatory Bowel Diseases","Diagnostic Test: Determination of serum anti-toxin Abs for C. difficile","Prevalence of Clostridium difficile anti-toxin Abs in patients with IBD|Prevalence of asymptomatic carrier of Clostridium difficile in patients with IBD|Study the relationship between the different maintenance therapies for IBD and C. difficile anti-toxin Abs and asymptomatic carriers.","Hospital Universitari de Bellvitge","All","18 Years to 65 Years   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","JGC-INM-2014-01","March 2014","January 2021","December 2021","March 26, 2019",,"April 2, 2019","Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain",,"https://ClinicalTrials.gov/show/NCT03889808"
66,"NCT04507932","Characterizing Inflammatory Bowel Disease With 68Ga-FAPI PET/CT",,"Recruiting","No Results Available","Inflammatory Bowel Disease","Drug: 68Ga-FAPI","Diagnostic value|Metabolic parameters|FAPI expression and SUV|Disease burden assessement|therapy response","Peking Union Medical College Hospital","All","18 Years to 90 Years   (Adult, Older Adult)","Early Phase 1","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","PekingUMCHFAPIIBD","August 1, 2020","January 1, 2022","December 1, 2022","August 11, 2020",,"January 26, 2021","Peking Union Medical College Hospital, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT04507932"
67,"NCT04890405","Clinical Study of Selective Fecal Microbiota Transplantation in the Treatment of Irritable Bowel Syndrome.",,"Not yet recruiting","No Results Available","Irritable Bowel Syndrome Variant of Childhood","Procedure: Standardized FMT|Combination Product: Precision Flora Transplantation","IBS-SSS score|Clinical remission rate|GSRS score|IBS-QoL score|PHQ-9|GAD-7|SAS|SDS|Intestinal flora","Yanling Wei|Third Military Medical University","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","70","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","TMMU-DP-GI-JZ-001","May 20, 2021","October 1, 2021","October 1, 2022","May 18, 2021",,"May 18, 2021",,,"https://ClinicalTrials.gov/show/NCT04890405"
68,"NCT03282786","Comparison of Carbon Dioxide (CO2) to Air Insufflation in Colonoscopy in Patients With Inflammatory Bowel Disease","CO2-IBD","Recruiting","No Results Available","Inflammatory Bowel Diseases","Other: carbon dioxide insufflation during colonoscopy","Comparison of colonoscopy related abdominal pain 1 hour after examination assessed by a visual analogue pain scale in patients with inflammatory bowel disease|Comparison of colonoscopy related abdominal pain 3 hours, 6 hours and 24 hours after examination assessed by a visual analogue pain scale in patients with inflammatory bowel disease","University Hospital Muenster","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","304","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Diagnostic","2017-191-f-S","September 3, 2017","August 1, 2021","January 31, 2022","September 14, 2017",,"June 16, 2020","Unversity Clinic Muenster, Muenster, NRW, Germany",,"https://ClinicalTrials.gov/show/NCT03282786"
69,"NCT04893499","A Study of Chios Mastic Water in Irritable Bowel Syndrome","MASTIQUA","Recruiting","No Results Available","Irritable Bowel Syndrome","Behavioral: Chios mastic water|Behavioral: Placebo water|Behavioral: Chios mastic fruit juice|Behavioral: Placebo fruit juice","Change in IBS symptoms severity assessed through the IBS Symptom Severity Scale (IBS-SSS)|Change in quality of life assessed through the IBS Quality of Life questionnaire (IBS-QOL)|Change in high-sensitivity C-reactive protein|Change in high-sensitivity interleukin-6 levels|Change in malondialdehyde|Change in total serum antioxidant capacity","Rutgers, The State University of New Jersey|Harokopio University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Γ-1038/12-3-2021","June 2021","December 2021","December 2021","May 19, 2021",,"May 27, 2021","Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University, Kallithea, Attica, Greece",,"https://ClinicalTrials.gov/show/NCT04893499"
70,"NCT03422861","Nabilone Use For Acute Pain in Inflammatory Bowel Disease Patients",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Drug: Nabilone|Drug: Placebos","Total amount of opioid consumption postoperatively|Pain scores at rest and movement|Incidence of opioid related side effects|Incidence of nabilone side effects at 24, 48, 72 hours|Ulcerative Colitis (UC) symptom severity|Crohn disease (CD) symptom severity|Time to first flatus|Number of loose stools|Length of hospital stay","Samuel Lunenfeld Research Institute, Mount Sinai Hospital","All","25 Years to 65 Years   (Adult, Older Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","NAB-2017","June 2021","September 2022","December 2022","February 6, 2018",,"February 24, 2021","Mount Sinai Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03422861"
71,"NCT03833310","Novel Biomarkers in Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Diagnostic Test: Osteoprotegerin marker in serum in inflammatory bowel disease","level of Osteoprotegerin and sRANKL in newly diagnosed patients with inflammatory bowel disease","Assiut University","All","15 Years to 40 Years   (Child, Adult)",,"70","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","vosrd","January 1, 2021","December 1, 2023","January 30, 2024","February 7, 2019",,"May 11, 2020","Assuit Medical University, Assiut, Egypt|Assuit Medical University, Assiut, Egypt",,"https://ClinicalTrials.gov/show/NCT03833310"
72,"NCT04504136","Regulation of Mucosal Healing in Inflammatory Bowel Disease",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Procedure: Serial Biopsy","Change in mitochondrial DNA copy number|Change in expression levels of cMyc|Change in expression levels of PGC-1 alpha|Change in expression levels of Ki67|Number of visible ulcers|Change in Mayo Endoscopic Score|Change in Segmental SES-CD Score","Terrence A Barrett|University of Kentucky","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","IMDDN-20-MUCOSALHEALING","April 30, 2021","May 1, 2025","May 1, 2025","August 7, 2020",,"May 4, 2021","University of Kentucky, Lexington, Kentucky, United States",,"https://ClinicalTrials.gov/show/NCT04504136"
73,"NCT01169194","Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)","MAAIS","Recruiting","No Results Available","Inflammatory Bowel Disease",,,"Johns Hopkins University|National Institutes of Health (NIH)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Baylor College of Medicine|Rutgers University|University of Alabama at Birmingham|University of Chicago|University of Louisville|University of Maryland, Baltimore|University of North Carolina, Chapel Hill|Weill Medical College of Cornell University|Virginia Commonwealth University|Meharry Medical College","All","5 Years and older   (Child, Adult, Older Adult)",,"2400","Other|NIH","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","NA_00041578|U01DK062431","June 2003","December 2022","December 2022","July 26, 2010",,"March 26, 2021","University of Alabama at Birmingham, Birmingham, Alabama, United States|University of Chicago, Chicago, Illinois, United States|University of Louisville, Louisville, Kentucky, United States|University of Maryland Baltimore/University of Maryland Medical System, Baltimore, Maryland, United States|Johns Hopkins University School of Medicine, Baltimore, Maryland, United States|Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States|Weill Cornell Medical College, New York, New York, United States|University of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States|Baylor College of Medicine, Houston, Texas, United States|Virginia Commonwealth University, Richmond, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT01169194"
74,"NCT03370614","Pilot Study of the Physiological Effects of an Integrative Medicine Approach in Irritable Bowel Syndrome","IBS","Enrolling by invitation","No Results Available","Irritable Bowel Syndrome","Other: IBS Group|Other: Healthy Control Group","Combined PET/MRI to define IBS activity and inflammation pattern.|Use combined PET/MRI to demonstrate brain and body activity in responders and non-responders.","Thomas Jefferson University","All","18 Years and older   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Other|Time Perspective: Prospective","17D.184","May 4, 2017","June 30, 2021","June 30, 2021","December 12, 2017",,"October 22, 2020","Thomas Jefferson University, Marcus Institute of Integrative Health Centers, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Marcus Institute of Integrative Health Centers, Villanova, Pennsylvania, United States","""Study Protocol and Statistical Analysis Plan: Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/14/NCT03370614/Prot_SAP_002.pdf","https://ClinicalTrials.gov/show/NCT03370614"
75,"NCT04324632","Magnetic Resonance Enterography in Inflammatory Bowel Diseases",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases",,"comparison of magnetic resonance enterography findings with colonoscopic findings and clinical activity scores of IBD","Assiut University","All","Child, Adult, Older Adult",,"30","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","MRE in IBD","April 2020","March 2022","April 2022","March 27, 2020",,"March 27, 2020",,,"https://ClinicalTrials.gov/show/NCT04324632"
76,"NCT04387383","Acupuncture for Irritable Bowel Syndrome Patients",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Device: Acupuncture|Device: Sham-acupuncture","Change on IBS-symptom severity scale|Change on Hamilton Depression Rating Scale (HAMD-17)|Change on Clinical Global Impression-severity (CGI-S)|Change on Self-Rating Depression Scale (SDS)|Change on IBS Quality of Life (IBS-QoL)","Hong Kong Baptist University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","HKBU AcupIBS","May 18, 2020","April 2021","December 2021","May 13, 2020",,"June 18, 2020","Linda Zhong, Kowloon Tong, Kowloon, Hong Kong",,"https://ClinicalTrials.gov/show/NCT04387383"
77,"NCT04558658","Neutrophil to Lymphocyte Ratio in Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Diagnostic Test: Complete Blood Count","Neutrophil to lymphocyte ratio in IBD","Assiut University","All","18 Years to 65 Years   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","N/L ratio in IBD activity","December 2020","December 2021","January 2022","September 22, 2020",,"September 22, 2020",,,"https://ClinicalTrials.gov/show/NCT04558658"
78,"NCT04129619","A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)",,"Recruiting","No Results Available","Irritable Bowel Syndrome With Diarrhea","Drug: ORP-101|Drug: Placebo","Percentage of Participants Who Are Composite Responders Based on Improvements From Baseline in Daily Worst Abdominal Pain and Daily Stool Consistency Scores|Percentage of Participants Who Are Responders in Daily Worst Abdominal Pain Scores|Percentage of Participants Who Are Responders in Daily Stool Consistency Scores|Percentage of Participants Who are Responders in IBS Global Symptom Scores|Percentage of Participants Who are Responders in IBS Adequate Relief Scores|Percentage of Participants Who Are Modified Composite Responders Based on Responder Endpoints|Change from Baseline in Daily Abdominal Discomfort Scores|Change from Baseline in Daily Abdominal Bloating Scores|Number of Bowel Movements Per Day|Number of Bowel Incontinence Free Days","OrphoMed, Inc.|PPD","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","320","Industry","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","OM-201","November 22, 2019","December 2021","December 2021","October 17, 2019",,"May 11, 2021","Achieve Clinical Research (Site 155), Birmingham, Alabama, United States|Synexus Clinical Research US, Inc. - Phoenix Southeast (Site 123), Chandler, Arizona, United States|Elite Clinical Studies - Phoenix (Site 116), Phoenix, Arizona, United States|Del Sol Research Management - BTC (Site 165), Tucson, Arizona, United States|Synexus Clinical Research US, Inc. - Orange Grove Family Practice (Site 118), Tucson, Arizona, United States|Del Sol Research Management - BTC (Site 130), Tucson, Arizona, United States|Preferred Research Partners - ClinEdge (Site 103), Little Rock, Arkansas, United States|Applied Research Center (Site 158), Little Rock, Arkansas, United States|Connecticut Clinical Research Foundation (Site 136), Bristol, Connecticut, United States|Imagine Research of Palm Beach County (Site 187), Boynton Beach, Florida, United States|Meridien Research - Lakeland (Site 167), Lakeland, Florida, United States|Precision Clinical Research LLC (Site 139), Lauderdale Lakes, Florida, United States|Meridien Research, Maitland - Inpatient (Site 141), Maitland, Florida, United States|Oviedo Medical Research (Site 140), Oviedo, Florida, United States|Clinical Research Center of Florida (Site 186), Pompano Beach, Florida, United States|Meridien Research - St. Petersburg (Site 132), Saint Petersburg, Florida, United States|Agile Clinical Research Trials, LLC (Site 163), Atlanta, Georgia, United States|Gastrointestinal Diseases, Inc. Research (Site 137), Columbus, Georgia, United States|In Quest Medical Research (Site 131), Peachtree Corners, Georgia, United States|Meridian Clinical Research (Site 169), Savannah, Georgia, United States|GNP Research (Site 145), Valdosta, Georgia, United States|Northwest Clinical Trials - ClinEdge (Site 133), Boise, Idaho, United States|Synexus Clinical Research US, Inc. - Chicago (Site 120), Chicago, Illinois, United States|Investigators Research Group, LLC (Site 188), Brownsburg, Indiana, United States|Synexus Clinical Research US, Inc. - Allaw (Site 102), Evansville, Indiana, United States|Alliance for Multispecialty Research, LLC (Site 159), Wichita, Kansas, United States|Beth Israel Deaconess Medical Center (Site 115), Boston, Massachusetts, United States|AES-DRS-Synexus Clinical Research US, Inc.-Minneapolis (site 114), Richfield, Minnesota, United States|Sundance Clinical Research (Site 175), Saint Louis, Missouri, United States|Synexus Clinical Research US, Inc. - Omaha (Site 113), Omaha, Nebraska, United States|Synexus Clinical Research US, Inc. - McGill Family Practice, P.C. (Site 126), Papillion, Nebraska, United States|Jubilee Clinical Research - BTC (Site 162), Las Vegas, Nevada, United States|Sierra Clinical Research (Site 179), Las Vegas, Nevada, United States|Lovelace Scientific Resources Inc. (Site 176), Albuquerque, New Mexico, United States|NY Scientific (Site 153), Brooklyn, New York, United States|Long Island Gastrointestinal Research Group LLP (Site 107), Great Neck, New York, United States|Synexus Clinical Research US, Inc. - Queens (Site 119), Jamaica, New York, United States|Mid Hudson Medical Research PLLC (Site 174), Newburgh, New York, United States|Upstate Clinical Research Associates LLC - ClinEdge (Site 164), Williamsville, New York, United States|OnSite Clinical Solutions, LLC - ClinEdge (Site 147), Charlotte, North Carolina, United States|OnSite Clinical Solutions, LLC - ClinEdge (Site 146), Charlotte, North Carolina, United States|Peters Medical Research, LLC - ClinEdge (SIte 111), High Point, North Carolina, United States|PMG Research of Salisbury LLC (Site 110), Salisbury, North Carolina, United States|PMG Research of Wilmington (Site 185), Wilmington, North Carolina, United States|PMG Research of Winston-Salem (Site 124), Winston-Salem, North Carolina, United States|Synexus Clinical Research US, Inc. - Akron (Site 122), Akron, Ohio, United States|Hometown Urgent Care and Research (Site 150), Cincinnati, Ohio, United States|Synexus Clinical Research US, Inc. - Cincinnati (Site 127), Cincinnati, Ohio, United States|Synexus Clinical Research US, Inc. - Columbus (Site 108), Columbus, Ohio, United States|Hometown Urgent Care and Research (Site 149), Columbus, Ohio, United States|Remington Davis Inc (Site 144), Columbus, Ohio, United States|PriMed Clinical Research - ClinEdge (Site 121), Dayton, Ohio, United States|Hometown Urgent Care and Research (Site 151), Dayton, Ohio, United States|Medical Research international (Site 180), Oklahoma City, Oklahoma, United States|Tristar Clinical Investigations, P.C. (Site 168), Philadelphia, Pennsylvania, United States|Frontier Clinical Research, LLC (Site 171), Uniontown, Pennsylvania, United States|Piedmont Research Partners LLC - BTC (Site 157), Fort Mill, South Carolina, United States|Synexus clinical Research US, Inc. - Greer (Site 105), Greer, South Carolina, United States|WR-ClinSearch, LLC (Site 129), Chattanooga, Tennessee, United States|The Jackson Clinic PA - ClinEdge (Site 135), Jackson, Tennessee, United States|New Phase Research & Development (Site 181), Knoxville, Tennessee, United States|Benchmark Research - Austin (Site 178), Austin, Texas, United States|Advanced Medical Trials (SIte 142), Georgetown, Texas, United States|Pioneer Research Solutions (Site 125), Houston, Texas, United States|Synergy Group US, LLC - Missouri City - Hunt (Site 156), Missouri City, Texas, United States|DM Clinical Research - LinQ Research - ERN (Site 109), Pearland, Texas, United States|Synexus Clinical Research US, Inc. - San Antonio (Site 112), San Antonio, Texas, United States|Clinical Trials of Texas Incorporated - ClinEdge (Site 134), San Antonio, Texas, United States|Synexus Clinical Research US, Inc. - Salt Lake City (Site 101), Murray, Utah, United States|Advanced Research Institute (Site 117), Ogden, Utah, United States|Health Research of Hampton Roads Inc. (Site 173), Newport News, Virginia, United States|The Center of Gastrointestinal Health (Site 152), Petersburg, Virginia, United States|Northwest Clinical Research Center - ClinEdge (Site 148), Bellevue, Washington, United States|Exemplar Research, Inc. - Morgantown (Site 172), Morgantown, West Virginia, United States",,"https://ClinicalTrials.gov/show/NCT04129619"
79,"NCT04646785","Mindfulness-based Cognitive Therapy for Patients With Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Behavioral: Mindfulness-based cognitive therapy + TAU|Other: Treatment as usual (TAU)","Psychological distress|Objective sleep quality|Subjective sleep quality|Fatigue|IBD-related quality of life|Perceived control over IBD|Calprotectin|C-reactive protein levels|Clinical disease activity|Repetitive negative thinking|Mindfulness skills|Positive mental health|Self-compassion|Costs|Health-related quality of life","Radboud University|ZonMw: The Netherlands Organisation for Health Research and Development|Jeroen Bosch Ziekenhuis|Rijnstate Hospital|Canisius-Wilhelmina Hospital|Donders Institute for Brain, Cognition and Behaviour","All","18 Years and older   (Adult, Older Adult)","Not Applicable","136","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","MBCT-IBD-2020-2024","May 1, 2021","May 1, 2024","May 1, 2024","November 30, 2020",,"November 30, 2020",,,"https://ClinicalTrials.gov/show/NCT04646785"
80,"NCT04284878","Lymphoid Tyrosine Phosphatase Gene Polymorphisms in Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Genetic: PCR-RFLP","Association between single nucleotide polymorphisms of Lymphoid Tyrosine Phosphatase gene (rs2476601, rs33996649 and rs2488457) and inflammatory bowel disease|To correlate the relation between the studied SNPs and disease activity /response to therapy.","Assiut University","All","18 Years to 60 Years   (Adult)",,"200","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","LYP polymorphisms in IBD","May 1, 2020","May 2021","September 2021","February 26, 2020",,"February 26, 2020",,,"https://ClinicalTrials.gov/show/NCT04284878"
81,"NCT03967236","Impact of Intestinal Virome on Pediatric Inflammatory Bowel Disease","IVOIRE","Recruiting","No Results Available","Inflammatory Bowel Diseases","Other: Collection of stool and blood samples","Evaluation over time of change of the gut virome","Hospices Civils de Lyon","All","6 Years to 17 Years   (Child)",,"20","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","69HCL18_0794","July 10, 2019","July 2021","July 2021","May 30, 2019",,"March 30, 2020","Service de gastroentérologie nutrition, hépatologie pédiatrique - Hôpital Femme Mère Enfant groupement hospitalier Est - HCL, Bron, France",,"https://ClinicalTrials.gov/show/NCT03967236"
82,"NCT04282577","Urinary Biomarkers of Renal Injury in Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Diagnostic Test: urinary nephrin and alpha one microglobulin","Early detection of renal injury in patients diagnosed to have inflammatory bowel disease with normal kidney function","Assiut University","All","18 Years and older   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","Kidney in IBD","March 1, 2020","November 1, 2021","December 1, 2021","February 25, 2020",,"February 25, 2020",,,"https://ClinicalTrials.gov/show/NCT04282577"
83,"NCT04601805","Optical Coherence Tomography Angiography Assessment of Retinal Lesions in Inflammatory Bowel Diseases",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Device: Observation","vascular changes in the posterior segment of patients suffering from inflammatory bowel disease using the optical coherence tomography angiography","Tanta University","All","15 Years to 50 Years   (Child, Adult)",,"30","Other","Observational","Observational Model: Other|Time Perspective: Prospective","34002/8/20","April 13, 2021","July 31, 2021","December 29, 2021","October 26, 2020",,"April 15, 2021","Tanta University Hospital, Tanta, El-Garbeia, Egypt",,"https://ClinicalTrials.gov/show/NCT04601805"
84,"NCT04552158","Nutritional Assessment and Impact of the Mediterranean Diet on Patients With Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Dietary Supplement: Mediterranean diet","Assessment of nutritional status among patients with inflammatory bowel disease using body weight|Assessment of nutritional status among patients with inflammatory bowel disease using body mass index (BMI)|Assessment of nutritional status among patients with inflammatory bowel disease using the anthropometric measures|Assessment of nutritional status among patients with inflammatory bowel disease using prognostic nutritional index (PNI)|Assessment of nutritional status among patients with inflammatory bowel disease using controlling nutritional status(CONUT)|Assessment of the impact of Mediterranean diet on the nutritional status for patients who received the Mediterranean diet after 3 months","Yasmin Ashraf Mahmoud Osman|Assiut University","All","18 Years to 55 Years   (Adult)","Not Applicable","50","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","nutrition and IBD","February 2021","August 2021","October 2021","September 17, 2020",,"September 21, 2020",,,"https://ClinicalTrials.gov/show/NCT04552158"
85,"NCT04286659","Receptor for Advanced Glycation End Products (RAGE) Polymorphisms In Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases",,"Association Of gene polymorphisms -374T/A and -429T/C in IBD patients|To correlate the relation between the studied SNPs , disease activity and the clinical features of the disease","Assiut University","All","Child, Adult, Older Adult",,"180","Other","Observational","Observational Model: Case-Control|Time Perspective: Other","Polymorphisms in IBD","March 1, 2020","March 2023","December 2023","February 27, 2020",,"February 27, 2020",,,"https://ClinicalTrials.gov/show/NCT04286659"
86,"NCT03630146","iPeer2Peer Program for Adolescents With Inflammatory Bowel Disease",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Behavioral: iPeer2Peer program|Other: Waitlist control","TRANSITION-Q (measuring change)|Disease Activity Survey (measuring change)|IBD Self-efficacy Scale for Adolescents and Young Adults (measuring change)|Brief Resiliency Scale (measuring change)|Revised Child Anxiety and Depression Scale (measuring change)|PROMIS Pediatric Item Bank v.1.0 - Peer Relationships - Short Form 8a|IMPACT-III: A Quality of Life Questionnaire for Children with Inflammatory Bowel Disease (measuring change)|Assessment of Quality if Life (AQoL-6D) (measuring change)|Health Services Use and Out-of-Pocket Expense Diary (measuring change)|Mentor Behavior Scale (measuring change)|PROMIS Adult Profile v2.0 (measuring change)|PROMIS Satisfaction with Social Roles and Activities (measuring change)|Chronic Disease Self-Efficacy scale (measuring change)|Mentor Interaction form","The Hospital for Sick Children","All","12 Years to 18 Years   (Child, Adult)","Not Applicable","262","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","1000058684","May 17, 2018","May 2021","May 2021","August 14, 2018",,"October 23, 2020","BC Children's Hospital, Vancouver, British Columbia, Canada|The IWK Health Centre, Halifax, Nova Scotia, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03630146"
87,"NCT04513015","Markers of Oxidative Stress in Inflammatory Bowel Diseases: Risk Factors and Implications for a Dietetic Approach","OxIBDiet","Recruiting","No Results Available","Inflammatory Bowel Diseases","Dietary Supplement: Antioxidant diet|Dietary Supplement: Normal dietetic scheme","Blood levels of ROS and glutathione in patients with IBD and controls|Total antioxidant capacity (Trolox equivalent and ferrous equivalent) in patients with IBD and controls|Antioxidant enzymes pattern (GST, SOD, GPxs, GR enzyme levels, activity and transcripts) in patients with IBD and controls|Plasma hydroperoxides and thiobarbituric acid reactive species in patients with IBD and controls|Urine oxidized guanines (8-OHdG, 8-OHG e guanosine) levels in patients with IBD and controls|Polymorphisms of genes implicated in oxidative stress defense (SOD1, SOD2, SOD3; GPX1, GPX2, GPX3; GPX4; GPX5; GSTA1; GSTA2; GSTM1; GSTM2; GSTM3; GSTP1; GSTO1; NQ01 NQ02; NOX1; NOX3; NOX4 and NOX5 genes) in patients with IBD and controls","Università Politecnica delle Marche","All","6 Years to 80 Years   (Child, Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","OxIBDiet-2020","December 15, 2019","September 10, 2021","December 30, 2022","August 14, 2020",,"August 14, 2020","SOD Clinica Pediatrica, Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona, Italy|SOD Clinica di Gastroenterologia, Epatologia ed Endoscopia Digestiva, Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona, Italy",,"https://ClinicalTrials.gov/show/NCT04513015"
88,"NCT04364750","Biomarkers of Diet-microbiota Interactions in Irritable Bowel Syndrome",,"Not yet recruiting","No Results Available","Irritable Bowel Syndrome","Dietary Supplement: L-Histidine|Dietary Supplement: High-FODMAP beverage|Dietary Supplement: Low-FODMAP beverage|Dietary Supplement: Lactobacillus acidophilus CL1285, L. casei LBC80R and L. rhamnosus CLR2.|Other: Placebo","Metabolites in stool, urine and blood|Expression of hdc gene by stool bacteria|Stool microbiota composition|Worsening of IBS symptoms following High-FODMAP challenge|Changes in IBS symptoms|Changes in general GI symptoms|Levels of anxiety, depression and stress|Changes in dietary intake","McMaster University","All","18 Years to 75 Years   (Adult, Older Adult)","Early Phase 1","30","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","BFIBS","December 2020","November 2021","December 2021","April 28, 2020",,"November 12, 2020","McMaster University Medical Centre, Hamilton, Ontario, Canada|Kingston Health Sciences Centre, Kingston, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04364750"
89,"NCT04349943","Effect of Standardized Nutritional Therapy on Clinical Prognosis and Cost-effectiveness of Inflammatory Bowel Disease",,"Recruiting","No Results Available","Inflammatory Bowel Disease","Other: nutrition therapy","Improvement of nutritional status|Improvement of quality of life","The Third Xiangya Hospital of Central South University","All","Child, Adult, Older Adult","Not Applicable","200","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","YYK-2019001","November 26, 2019","December 30, 2020","December 30, 2021","April 16, 2020",,"April 16, 2020","the Third Xiangya Hospital of Central South University, Changsha, Hunan, China","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/43/NCT04349943/Prot_000.pdf","https://ClinicalTrials.gov/show/NCT04349943"
90,"NCT04880876","A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)",,"Not yet recruiting","No Results Available","Irritable Bowel Syndrome","Drug: 25mg Eluxadoline|Drug: 100mg Eluxadoline","Percentage of Participants with Adverse Events|Percentage of Participants with Clinically Significant Laboratory Values (clinical chemistry, complete blood count, urinalysis) as assessed by the Investigator|Percentage of Participants with Clinically Significant ECGs as assessed by the Investigator|Percentage of Participants with Clinically Significant vital sign measurements as assessed by the Investigator|Percentage of Participants with any new Physical examination abnormality or worsening of change from baseline|Percentage of Participants with any new neurological abnormality post baseline or worsening of change from baseline","Allergan","All","6 Years to 17 Years   (Child)","Phase 3","124","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","3030-302-002","May 28, 2021","December 1, 2027","December 1, 2027","May 11, 2021",,"May 12, 2021",,,"https://ClinicalTrials.gov/show/NCT04880876"
91,"NCT04512898","Helicobacter Pylori Eradication and Irritable Bowel Syndrome: A Prospective Study",,"Not yet recruiting","No Results Available","Irritable Bowel Syndrome","Drug: Triple therapy for H.pylori","Questionnaire for Rome IV criteria|Quality of life questionnaire","Assiut University","All","Child, Adult, Older Adult","Phase 4","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","H. Pylori","August 10, 2020","November 10, 2020","November 10, 2020","August 14, 2020",,"August 14, 2020",,,"https://ClinicalTrials.gov/show/NCT04512898"
92,"NCT03026582","Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease","SPIBDUS","Recruiting","No Results Available","Inflammatory Bowel Diseases","Device: Intestinal ultra-sound monitoring","Change in bowel wall thickness according to therapeutic regimen|Change in bowel wall thickness in comparison to inflammatory markers|Change in bowel wall thickness in comparison to fecal calprotectin|Change in bowel wall thickness in comparison to pediatric Crohn's disease severity index in Crohn's disease|Change in bowel wall thickness in comparison to pediatric ulcerative colitis activity index in ulcerative colitis","Schneider Children's Medical Center, Israel","All","2 Years to 17 Years   (Child)",,"150","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","SchneiderCMCIsrael","July 1, 2017","May 1, 2021","June 30, 2021","January 20, 2017",,"March 17, 2021","Schenider Children's Medical Center, Petaẖ Tiqwa, Israel",,"https://ClinicalTrials.gov/show/NCT03026582"
93,"NCT04276961","Efficacy of Acupuncture in Refractory Irritable Bowel Syndrome",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Other: Acupuncture","The proportion of participants with adequate relief of global IBS symptoms|IBS symptom severity scale|Weekly bowel movements|Work and Social Adjustment Scale|Irritable Bowel Syndrome Quality of Life Instrument|Bristol Stool Form Scale|Self-Rating Anxiety Scale (SAS)|Self-Rating Depression Scale (SDS)","Chengdu University of Traditional Chinese Medicine|Beijing University of Chinese Medicine","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","170","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","2019YFC1709004","October 15, 2020","June 1, 2021","June 1, 2022","February 19, 2020",,"May 10, 2021","Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China",,"https://ClinicalTrials.gov/show/NCT04276961"
94,"NCT04691544","Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Biological: Fecal microbiota transplantation (FMT)","Proportion in the donorFMT (dFMT) versus autologousFMT (aFMT) group with ≥75 points decrease in the Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS) day 90 after treatment when compared to the score 8 days before treatment|Proportion in dFMT versus aFMT group with ≥75 points decrease in the Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS) day 365 after treatment when compared to the score 8 days before treatment|Proportion of patients in dFMT versus aFMT group with a ≥14 points increase in the IBS-Qualiy of Life (IBS-QoL) day 90 after treatment when compared to the score 8 days before treatment|Proportion in the dFMT vs aFMT group with 2 or more weeks with treatment success in Adequate relief by the Global Improvement Scale and Abdominal pain day 69, 76, 83 and 90 after treatment. For treatment success criteria A. and B. have to be fulfilled|Proportion of adverse events and serious adverse events in the dFMT versus aFMT group from treatment and until day 90 after treatment|Change in the dFMT vs aFMT group in mean stool consistency score in the period 8-2 days before treatment, compared to mean stool consistency score in the period 84-90 and 359-365 days after treatment.|Change in the dFMT vs aFMT group in mean number of complete spontaneous bowel movements (CSBM) in the period 8-2 days before treatment, compared to CSBM in the period 84-90 and 359-365 days after treatment|Change in the dFMT vs aFMT group in bowel-related complaints by the item specific and global Irritable Bowel Syndrome Symptom Severity Score score from before and until after treatment.|Change in the dFMT vs aFMT group in quality of life by the global and subdomain specific score in the Irritable Bowel Syndrome-Qualiy of Life from before and until after treatment.|Change in the dFMT vs aFMT group in fatigue by the global and subdomain specific score in the Modified Fatigue Impact Scale from before and until after treatment.|Change in the dFMT vs aFMT group in anxiety and depression (HADS) by the global and subdomain specific score on the Hospital Anxiety and Depression Scale from before and until after treatment.|Proportion of participants identified as treatment success (as defined by the primary endpoint) by a ten species profile generated from a metagenomic dataset from the pilot REFIT trial (unpublished data)|Change in HRV in donor FMT vs placebo FMT group derived from the R-R intervals in continuous ECG recordings. The primary vagal function outcome will be differences in changes from pre-post treatment between groups in High Frequency HRV (HF-HRV; in ms2).|Change in HRV in donor FMT vs placebo FMT group derived from the R-R intervals in continuous ECG recordings. The secondary vagal function outcome will be differences in changes from pre-post treatment between groups in RMSSD (RMSSD; in ms2).|Difference in mean baseline HRV (HF-HRV and RMSSD) between responders' vs non-responders to donor FMT.","University Hospital of North Norway|Oslo University Hospital|Sorlandet Hospital HF|Haukeland University Hospital|Alesund Hospital","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 3","450","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","183984","May 5, 2021","June 1, 2023","December 31, 2026","December 31, 2020",,"June 18, 2021","Ålesund Hospital, Ålesund, Norway",,"https://ClinicalTrials.gov/show/NCT04691544"
95,"NCT04859075","Efficacy and Safety of Alflorex Bei Reizdarm in Patients With Irritable Bowel Syndrome",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Other: Bifidobacterium longum 35624","Relative change in overall IBS symptoms compared to day 1 (sum of abdominal pain, bloating, gas, difficulty in defecating/constipation and urgency/diarrhoea symptom scores)|Relative change in the individual IBS symptoms abdominal pain, gas, bloating, difficulty in defecating/constipation and urgency/diarrhoea compared to day 1|Severity score of irritable bowel syndrome compared to day 1|Efficacy & tolerability by physician|Efficacy & tolerability by participant|Interference of IBS symptoms with general life","Medice Arzneimittel Pütter GmbH & Co KG|BioTeSys GmbH","All","18 Years and older   (Adult, Older Adult)",,"200","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","6630-0280-01","May 5, 2021","December 2021","December 2021","April 26, 2021",,"May 12, 2021","Several General Practicioner and Gastroenterologists (Multicentric), Düsseldorf, Nordrhein-Westfalen, Germany",,"https://ClinicalTrials.gov/show/NCT04859075"
96,"NCT03445624","Abdominal Ultrasound With Doppler and Peripheral Hemogram in Assesment Inflammatory Bowel Disease",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Drug: Infliximab","the role abdominal ultrasound in assessment inflammatory bowel disease","Assiut University","All","15 Years to 60 Years   (Child, Adult)",,"60","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","assiut hospitals university","July 1, 2018","February 1, 2021","October 1, 2021","February 26, 2018",,"July 16, 2020","Hyam Fathy, Assiut, Egypt",,"https://ClinicalTrials.gov/show/NCT03445624"
97,"NCT03615287","Assessing Cardiovascular Dysfunction Pre- & Post-treatment in Inflammatory Bowel Diseases",,"Recruiting","No Results Available","Inflammatory Bowel Diseases",,"Change of CFR","University of Athens","All","18 Years and older   (Adult, Older Adult)",,"120","Other","Observational","Observational Model: Other|Time Perspective: Prospective","42/25-01-18","January 26, 2018","January 2020","January 2022","August 3, 2018",,"August 3, 2018","''Attikon'' University General Hospital, Athens, Attiki, Greece",,"https://ClinicalTrials.gov/show/NCT03615287"
98,"NCT03757533","Health Coaching as a Tool for Improving Medication Adherence in Adult Patients With Inflammatory Bowel Disease",,"Active, not recruiting","No Results Available","Inflammatory Bowel Diseases","Behavioral: Health Coaching|Other: Surveys","Medication Adherence MPR|Medication Adherence PDC","Vanderbilt University Medical Center|AbbVie","All","18 Years and older   (Adult, Older Adult)","Not Applicable","43","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","182030","June 11, 2019","July 2022","July 2022","November 29, 2018",,"March 30, 2021","Vanderbilt University Medical Center Inflammatory Bowel Disease Clinic, Nashville, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT03757533"
99,"NCT03500653","Curcumin Supplementation as an Add on Treatment for Patients With Inflammatory Bowel Diseases Treated With Vedolizumab",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Dietary Supplement: Curcumin|Dietary Supplement: Placebo","Clinical remission- Crohn's disease patients|Clinical remission- ulcerative colitis patients|Disease response- Crohn's disease patients|Disease response- ulcerative colitis patients|Biochemical remission","Henit Yanai|Shaare Zedek Medical Center|Rabin Medical Center","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","RMC-0290-17","June 9, 2020","December 2021","December 2022","April 18, 2018",,"October 9, 2020","Rabin Medical Center, Petah tikva, Israel",,"https://ClinicalTrials.gov/show/NCT03500653"
100,"NCT02686892","An Epidemiological Study of the Incidence of Inflammatory Bowel Disease in Spain","INCIDENCIA","Active, not recruiting","No Results Available","Inflammatory Bowel Disease",,"Number of participants with the incidence of inflammatory bowel disease in Spain|Number of patients with incidece of inflammatory bowel disease in diferent regions of the spanish territory|Characteristics of patients at diagnosis of inflammatory bowel disease|Resourses used in the first year after diagnosis.|Delay from onset of symptoms to diagnosis of the disease","Javier P. Gisbert|Grupo Español de trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)|Fundación de Investigación Biomédica - Hospital Universitario de La Princesa","All","18 Years and older   (Adult, Older Adult)",,"4000","Other","Observational","Observational Model: Cohort|Time Perspective: Other","GIS-2015-INCIDENCIA","January 2017","February 2019","December 2022","February 22, 2016",,"July 28, 2020","Hospital Universitario Reina Sofía, Córdoba, Andalucía, Spain|Hospital Clínico Universitario 'Lozano Blesa', Zaragoza, Aragón, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Son Llatzer, Palma de Mallorca, Baleares, Spain|Hospital Universitari Mutua Terrassa, Terrassa, Barcelona, Spain|Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas, Canarias, Spain|Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain|Hospital General de Ciudad Real, Ciudad Real, Castilla La Mancha, Spain|Hospital Universitario de Burgos, Burgos, Castilla Y León, Spain|Hospital San Pedro de Alcántara, Cáceres, Extremadura, Spain|Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Galicia, Spain|Hospital San Pedro, Logroño, La Rioja, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Galdakao -Usansolo, Usansolo, Vizcaya, Spain|Hospital Universitario Morales Meseguer, Murcia, Spain|Hospital Universitari La Fe, Valencia, Spain",,"https://ClinicalTrials.gov/show/NCT02686892"
101,"NCT03457324","Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Drug: JCM-16021|Drug: Placebo","Global Assessment of Improvement (GAI) score|Pain responder rate in daily worst abdominal pain scores|Stool consistency responder rate In daily stool consistency scores|Efficacy judgement standard of single symptom|Comprehensive efficacy judgement standard of cardinal symptoms|TCM pattern improvement|Quality of life scoring (IBS-QoL)|Irritable Bowel Syndromes-Symptom Severity Score (IBS-SSS)","ZhaoXiang Bian|Chinese University of Hong Kong|Hong Kong Baptist University","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2|Phase 3","392","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","ITS-148-14FP","November 8, 2018","June 30, 2021","June 30, 2021","March 7, 2018",,"August 19, 2020","Chinese Medicine Clinics of Hong Kong Baptist University, Hong Kong, Hong Kong, China|Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China",,"https://ClinicalTrials.gov/show/NCT03457324"
102,"NCT04340661","Effects of a Food Supplement Composed by BIOintestil ® (Bionocol®) on Microbiota and Inflammatory Profile in Irritable Bowel Syndrome Patients",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Dietary Supplement: BIOintestil|Dietary Supplement: PLACEBO","Changes in fecal Microbiota composition|Changes in circulating cytokines and chemokines|Irritable Bowel Syndrome-Visual Analogue Scale (IBS-VAS) score improvement","Targeting Gut Disease S.R.L.","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","108","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","TGD-01","December 5, 2018","September 30, 2020","January 31, 2021","April 9, 2020",,"April 9, 2020","A.O.U Policlinico S.Orsola-Malpighi, Bologna, Italy",,"https://ClinicalTrials.gov/show/NCT04340661"
103,"NCT03201445","Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease","MANTA","Active, not recruiting","No Results Available","Inflammatory Bowel Disease","Drug: Filgotinib|Drug: Placebo|Drug: Standard of Care","Proportion of Participants With a ≥ 50% Decrease From Baseline in Sperm Concentration at Week 13|Proportion of Participants With a ≥ 50% Decrease From Baseline in Sperm Concentration at Week 26|Change From Baseline in Percent Motile Sperm at Week 13|Change From Baseline in Percent Motile Sperm at Week 26|Change From Baseline in Total Sperm Count at Week 13|Change From Baseline in Total Sperm Count at Week 26|Change From Baseline in Sperm Concentration at Week 13|Change From Baseline in Sperm Concentration at Week 26|Change from Baseline in Ejaculate Volume at Week 13|Change from Baseline in Ejaculate Volume at Week 26|Change from Baseline in Percent Normal Sperm Morphology at Week 13|Change from Baseline in Percent Normal Sperm Morphology at Week 26","Gilead Sciences|Galapagos NV","Male","21 Years to 65 Years   (Adult, Older Adult)","Phase 2","250","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","GS-US-418-4279|2017-000402-38","July 11, 2017","July 31, 2020","October 2024","June 28, 2017",,"January 26, 2021","Naval Medical Center San Diego, San Diego, California, United States|Florida Research Institute, Lakewood Ranch, Florida, United States|University of Miami Crohn's and Colitis Center, Miami, Florida, United States|One Health Research Clinic, Inc, Norcross, Georgia, United States|Delta Research Partners, Monroe, Louisiana, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Great Lakes Gastroenterology Research, LLC, Mentor, Ohio, United States|Gastro One, Germantown, Tennessee, United States|Texas Clinical Research Institute, Arlington, Texas, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|Monash Medical Centre, Clayton, Victoria, Australia|AKH Wien - Universitatsklinik fur Innere Medizin III, Vienna, Austria|Medizinische Hochschule Hannover, Hannover, Germany|Surat Institute of Digestive Sciences, Surat, Gujarat, India|Seth GS medical college and KEM hospital, Parel, Mumbai, India|Kaizen Hospital, Ahmedabad, India|SP Medical college & AG Hospitals, Bīkaner, India|Maharaja Agrasen Hospital, Dehli, India|Nizam's Institute of Medical Sciences, Hyderabad, India|SR Kalla Memorial Gastro and General Hospital, Jaipur, India|SMS Medical College and Hospital, Jaipur, India|Om Sai Onco Surgery Center, Kolhapur, India|Institute of Post Graduate Medical Education and Research (IPGMER), Kolkata, India|Radha Krishna Critical Care & General Hospital, Kota, India|Dayanand Medical College & Hospital, Ludhiana, India|Rahate Surgical Hospital, Nagpur, India|Crescent Hospital and Heart Centre, Nagpur, India|All India Institute of Medical Sciences, New Delhi, India|Sir Ganga Ram Hospital, New Delhi, India|Batra Hospital and Medical Research Center, New Delhi, India|Shri Griraj Multispeciality Hospital, Rajkot, India|Gandhi Hospital, Secunderabad, India|Institute of Gastroenterology & Liver Disease, Sunshine Hospitals, Secunderabad, India|BAPS Pramukh Swami Hospital, Surat, India|Sterling Hospital, Vadodara, India|Samvedna Hospital, Varanasi, India|Wellington Hospital, Newtown, New Zealand|Osrodek Badan Klinicznych Cinsante S.C Ewa Galczak-Nowak, Bydgoszcz, Poland|Krakowskie Centrum Medyczne, Kraków, Poland|Endoskopia Sp.z o.o, Sopot, Poland|Bodyclinic Alicja Pasnik, Warsaw, Poland|Santa Familia, Centrum Badan Profilaktyki i Leczenia, Łódź, Poland|S.C. Policlinica Dr. Citu S.R.L - Gastroenterologie, Timisoara, Romania|Olla-Med, Llc, Moscow, Russian Federation|State Budgetary Healthcare Institution, Pensa Regional Clinical Hospital n.a N.N Burdenko, Penza, Russian Federation|State Budgetary Educational Institution of Higher Professional Education ""Rostov State Medical University"" of the Ministry of Health of Russian Fedn., Rostov-on-Don, Russian Federation|Saint Petersburg State Budgetary Healthcare Institution ""City Hospital # 26"", Saint Petersburg, Russian Federation|Municipal Health Care Institution ""Regional Hospital of War Veterans"", Therapeutic Department No. 1, Kharkiv, Ukraine|Kyiv City Clinical Hospital #18, Proctology Department, Kiev, Ukraine|Vinnytsia Regional Clinical Hospital of War Veterans, Therapeutics Department No. 2, Vinnitsa, Ukraine|Vinnytsia Regional Clinical Hospital named after M.I. Pirogov, Gastroenterology Department, Vinnitsya, Ukraine|Medical Center LLC ""Health Clinic"", Medical Clinical Investigational Center, Vinnitsya, Ukraine|Vinnytsia Regional Clinical Hospital of War Veterans, Therapeutics Department No.1, Vinnytsya, Ukraine|Municupal Institution ""Zaporizhzhia City Multidisciplinary Clinic #9"" Gastrointestinal Surgery Department,, Zaporizhzhya, Ukraine|Municipal Non-profit Enterprise ""Zaporizhzhia Regional Clinical Hospital"" of Zaporizhzhia Regional Council,, Zaporizhzhya, Ukraine|Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03201445"
104,"NCT04193501","Frequency of Sleep Abnormalities in Patients With Irritable Bowel Syndrome and Effect of Pharmacological Intervention",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Drug: Melatonin 3 mg|Other: Placebo","Change in levels of 6-Hydroxymelatonin sulphate|Sleep quality index score|Change in IBS symptom severity scores","Sanjay Gandhi Postgraduate Institute of Medical Sciences","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 3","194","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Health Services Research","2018-207-EMP-107","February 1, 2020","February 2021","February 2022","December 10, 2019",,"March 16, 2020","Department of Critical Care Medicine, SGPGIMS, Lucknow, UP, India|Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, Uttar Pradesh, India","""Study Protocol and Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/01/NCT04193501/Prot_ICF_000.pdf","https://ClinicalTrials.gov/show/NCT04193501"
105,"NCT02932111","Irritable Bowel Syndrome and Osteopathic Manipulative Therapy","IBSOMT","Recruiting","No Results Available","Irritable Bowel Syndrome","Procedure: osteopathic session|Procedure: Placebo manipulative session","Changes from baseline of IBSSS at V4.|Clinical improvement (IBSSS)|Percentage of patients with improvement at V4, V5 and V6.|Cardinal signs of IBS measured by visual analogic scales|Shape of the stool|Changes of the severity of IBS|Depression and anxiety quantified using the Beck Depression Inventory II(BDI-II) questionnaires.|Quality of life defined by IBS-QOL.|Depression and anxiety quantified using the STAI questionnaires.","Assistance Publique - Hôpitaux de Paris","All","18 Years and older   (Adult, Older Adult)","Not Applicable","210","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","P150920","May 12, 2017","July 12, 2022","October 12, 2022","October 13, 2016",,"June 30, 2021","Avicenne Hospital, Bobigny, France",,"https://ClinicalTrials.gov/show/NCT02932111"
106,"NCT03339128","Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Drug: Eluxadoline|Drug: Placebo","Change from baseline in stool consistency averaged over the 4-week Treatment Period|Change from baseline in stool consistency for daily daytime and nighttime stool consistency scores|Change from baseline for daytime, nighttime, and 24-hour abdominal pain scores|Change from baseline for daytime, nighttime, and 24-hour bowel movement frequency|Change from baseline for daytime, nighttime, and 24 hour urgency-free days|Change from baseline for daytime, nighttime, and 24 hour number of fecal incontinence-free days","Allergan","All","12 Years to 17 Years   (Child)","Phase 2","120","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","3030-202-002|2017-003770-14","November 15, 2017","January 1, 2023","February 6, 2023","November 13, 2017",,"January 11, 2021","University Of Arizona, Tucson, Arizona, United States|HealthStar Research, LLC, Hot Springs, Arkansas, United States|Applied Research of Arkansas, Little Rock, Arkansas, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, United States|VVCRD Clinical Research, Garden Grove, California, United States|Center for Clinical Trials, LLC, Paramount, California, United States|University of California, San Francisco, San Francisco, California, United States|Wellness Clinical Research, LLC, Hialeah, Florida, United States|Clinical Neuroscience Solutions Inc dba CNS Healthcare, Jacksonville, Florida, United States|Sunrise Research Institute, Miami, Florida, United States|Biotech Pharmaceutical Group, LLC, Miami, Florida, United States|South Miami Medical & Research Group. Inc, Miami, Florida, United States|Valencia Medical and Research Center, Miami, Florida, United States|Florida Research Center, Inc, Miami, Florida, United States|Nemours Children's Clinic, Orlando, Orlando, Florida, United States|Treken Primary Care, Atlanta, Georgia, United States|Children's Center for Digestive Health Care, Atlanta, Georgia, United States|Sleep Care Research Institute/Global Research Associates, Stockbridge, Georgia, United States|Center for Children's Digestive Health, Park Ridge, Illinois, United States|Unity Point Health Pediatric Gastroenterology, Peoria, Illinois, United States|MBAL Sv. Ivan Rilski Kozlodui, Indianapolis, Indiana, United States|Michael W. Simon, MD, PSC, Nicholasville, Kentucky, United States|Willis-Knighton Physician Network, Shreveport, Louisiana, United States|Certified Research Consultants Virgo-Carter Pediatrics, Silver Spring, Maryland, United States|MNGI, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Celen Medical Group, Corp, Marlton, New Jersey, United States|Ubmd Ddnc, Buffalo, New York, United States|UH Rainbow Babies & Children's Hospital, Cleveland, Ohio, United States|IPS Research Company, Oklahoma City, Oklahoma, United States|The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|St. Christopher's Hospital for Children - Drexel University, Philadelphia, Pennsylvania, United States|Preferred Primary Care Physicians Inc., Pittsburgh, Pennsylvania, United States|Coastal Pediatrics Associates, Mount Pleasant, South Carolina, United States|Cook Children's Digestive Health, Fort Worth, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Envision Clinical Research, LLC, Laredo, Texas, United States|Sun Research Institute, San Antonio, Texas, United States|Primary Children's Hospital, Salt Lake City, Utah, United States|Multicare Health Institute for Research and Innovation, Tacoma, Washington, United States|Medical Center-1-Sevlievo EOOD, Sevlievo, Gabrovo, Bulgaria|MHAT Sv.Ivan Rilski, Kozloduy, Vratza, Bulgaria|University Multiprofile Hospital for Active Treatment ""Sveti Georgi"" EAD, Plovdiv, Bulgaria|University Multi-Profile Hospital for Active Treatment-Ruse, Ruse, Bulgaria|University Multiprofile Hospital for Active Treatment-Ruse, Ruse, Bulgaria|UMHAT Sveta Marina, Varna, Bulgaria|Edmonton Clinic Health Academy (ECHA), Edmonton, Alberta, Canada|Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada|Helios Universitätsklinikum Wuppertal, Wuppertal, NRW, Germany|Szent Janos Korhaz Budai Gyermekkórháza, Budapest, Hungary|Soproni Erzsebet Oktato Korhaz es Rehabilitacious Intezet, Sopron, Hungary|Mentahaz Maganorvosi Kozpont, Székesfehérvár, Hungary|Academisch Medisch Centrum Universiteit Van Amsterdam, Amsterdam, Netherlands|Instytut Centrum Zdrowia Matki Polki, Lodz, Lodzkie, Poland|Copertnicus Podmiot Leczniczy Sp. z o.o., Gdansk, Poland|Specjalistyczny Gabinet Naurologiczny Marta Banach, Krakow, Poland|The Children's Memorial Health Institute, Rzeszow, Poland|Riley Hospital for Children at Indiana University Health, Warsaw, Poland|Instytut Pomnik Centrum Zdrowia Dziecka, Warsaw, Poland|Hospital Clinico San Carlos, Madrid, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Blackpool Victoria Hospital, Blackpool, United Kingdom|King's College Hospital, London, United Kingdom|Royal Manchester Children's Hospital, Manchester, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03339128"
107,"NCT03074227","The FAIS-Trial: Faecal Microbiota Transplantation (FMT) in Adolescents With Refractory Irritable Bowel Syndrome (IBS)","FAIS","Recruiting","No Results Available","Irritable Bowel Syndrome","Other: Allogeneic faecal transplantation|Other: Autologous faecal transplantation","The proportion of patients with > 50% reduction of their abdominal pain intensity and pain frequency at t=12 weeks after the first faecal transplantation|Intra-individual changes in faecal gut microbiota composition|Adverse events|The proportion of patients with > 50% reduction of their abdominal pain intensity and pain frequency|Total IBS-SSS score|Health related quality of life|Depression and anxiety|Absence of school or work, health care resources and costs|Adequate relief|Number of participants with treatment-related adverse events as assessed by CRP, liver profile and renal profile","Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","All","16 Years to 21 Years   (Child, Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","FAIS2016","November 23, 2017","December 1, 2021","December 1, 2022","March 8, 2017",,"January 14, 2021","AMC, Amsterdam, Noord Holland, Netherlands",,"https://ClinicalTrials.gov/show/NCT03074227"
108,"NCT04105348","Diabetes Mellitus and Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Diagnostic Test: HbA1c","effect of IBD on DM","Assiut University","All","Child, Adult, Older Adult",,"100","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","DM and IBD","October 1, 2019","June 2021","October 2021","September 26, 2019",,"October 1, 2019",,,"https://ClinicalTrials.gov/show/NCT04105348"
109,"NCT03899779","Face-to-face Versus Online Hypnotherapy for the Treatment of Irritable Bowel Syndrome","FORTITUDE","Recruiting","No Results Available","Irritable Bowel Syndrome","Other: Face-to-face hypnotherapy|Other: Online hypnotherapy|Other: Online psychoeducation","Abdominal pain response rate after 12 weeks of treatment|Degree of relief response rate after 12 weeks of treatment|Improvement of symptom severity|Indirect costs|Direct costs|General Quality of life (by EQ-5D)|IBS related Quality of life (by IBS-QoL)|Use of over the counter medication and rescue medication|Number and severity of side effects|Expectation|Response rates in relation to comorbid anxiety|Response rates in relation to comorbid depression","Maastricht University Medical Center|ZonMw: The Netherlands Organisation for Health Research and Development","All","16 Years to 65 Years   (Child, Adult, Older Adult)","Not Applicable","285","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","NL67607.068.18|852001924|METC18-037","July 8, 2019","August 2022","August 2022","April 2, 2019",,"September 3, 2020","Medisch Centrum Leeuwarden, Leeuwarden, Friesland, Netherlands|Gelderse Vallei, Ede, Gelderland, Netherlands|Maastricht University Medical Center, Maastricht, Limburg, Netherlands|Jeroen Bosch Ziekenhuis, Den Bosch, Noord-Brabant, Netherlands|Bernhoven, Uden, Noord-Brabant, Netherlands|Martini Ziekenhuis, Groningen, Netherlands",,"https://ClinicalTrials.gov/show/NCT03899779"
110,"NCT04072991","A Study Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS)",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Other: dietary therapy","Change in Irritable bowel syndrome Severity Scoring System questionnaire","Sheffield Teaching Hospitals NHS Foundation Trust","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","105","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","STH20655","April 18, 2019","November 30, 2021","November 30, 2021","August 28, 2019",,"October 22, 2020","Royal Hallamshire Hospital, Sheffield, South Yorkshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04072991"
111,"NCT02249169","Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome",,"Active, not recruiting","No Results Available","Irritable Bowel Syndrome",,"Change in gut microbiome in patients with IBS compared to healthy individuals measured over 6 months","Mayo Clinic|University of Minnesota","All","18 Years to 65 Years   (Adult, Older Adult)",,"84","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","14-000305","May 2014","December 2021","December 2021","September 25, 2014",,"February 21, 2021","Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT02249169"
112,"NCT02970591","A Comparison of Three Different Treatment Options for Irritable Bowel Syndrome","Car-IBS","Recruiting","No Results Available","Irritable Bowel Syndrome","Other: Traditional dietary advice and low FODMAP content|Other: Low carbohydrate diet|Other: Optimized Medical treatment","Change in IBS-SSS|Change in metabolic profile|Change in microbiota content","Sahlgrenska University Hospital, Sweden","All","18 Years and older   (Adult, Older Adult)","Not Applicable","300","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","Car-IBS 1511-01","January 2017","December 2021","June 2022","November 22, 2016",,"October 22, 2020","Magnus Simren, Gothenburg, Non-US/Non-Canadian, Sweden",,"https://ClinicalTrials.gov/show/NCT02970591"
113,"NCT04095988","Allogeneic Microbiota-reconstitution (AMR) in Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)","AMIRA","Active, not recruiting","No Results Available","Diarrhea-predominant Irritable Bowel Syndrome","Procedure: Allogeneic microbiota reconstitution|Procedure: Placebo-Allogeneic microbiota reconstitution","Decrease of the IBS-SSS questionnaire > 105 Points compared to baseline|Improvement of IBS-QOL using IBS-QOL-questionnaire compared to baseline|Changes and acceptance of donor microbiome (16S rDNA-analysis)|Number of participants with treatment related adverse events","University of Ulm|Klinikum Ludwigsburg|Helios Klinikum Krefeld|Charite University, Berlin, Germany|Assign International, Berlin, Germany","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","42","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","AMIRA|2016-002550-20","September 2016","December 2020","May 2021","September 19, 2019",,"January 31, 2020","Helios Klinikum Krefeld, Krefeld, Germany|Ulm University Hospital, Ulm, Germany",,"https://ClinicalTrials.gov/show/NCT04095988"
114,"NCT04136587","The Bacterial Secretome in IBD",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Other: Colonic fluid collection during endoscopy for analysis of the bacterial secretome","Concentration of proinflammatory cytokines of bacterial fractions in IBD compared to healthy controls|Concentration of proinflammatory cytokines of bacterial fractions in relation to disease activity|Concentration of proinflammatory cytokines of bacterial fractions in relation to disease type|Concentration of proinflammatory cytokines of bacterial fractions in other colonic diseases","Medical University of Graz","All","18 Years and older   (Adult, Older Adult)","Not Applicable","90","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","17-199 ex 05/06","June 1, 2019","June 2021","June 2021","October 23, 2019",,"March 2, 2021","Medical University of Graz, Graz, Austria",,"https://ClinicalTrials.gov/show/NCT04136587"
115,"NCT03983434","Irritable Bowel Syndrome and Control Volunteers: Diet Challenge",,"Recruiting","No Results Available","IBS - Irritable Bowel Syndrome","Dietary Supplement: Inulin","Total fecal bile acids|Total fecal short chain fatty acids|Individual fecal short chain fatty acids|Fecal microbial population|Fecal inulin|Percent primary fecal bile acids|Stool characteristics","Indiana University|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","All","18 Years to 65 Years   (Adult, Older Adult)","Early Phase 1","72","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","1903209172|K23DK122015","August 13, 2019","May 31, 2022","September 30, 2022","June 12, 2019",,"May 20, 2021","Indiana University, Indianapolis, Indiana, United States",,"https://ClinicalTrials.gov/show/NCT03983434"
116,"NCT04083157","Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients",,"Active, not recruiting","No Results Available","Inflammatory Bowel Diseases|Hepatitis B","Biological: Intradermal hepatitis B vaccine with imiquimod|Biological: Intramuscular hepatitis B vaccine with aqueous cream","Sero-protection rate to HBV|Injection site adverse effect of intradermal hepatitis B vaccine in IBD patients|Systemic adverse effect of intradermal hepatitis B vaccine in IBD patients|Sero-protection rate to HBV at 1 and 6 months after dose of vaccine|Percentage of good responder defined as anti-HBs ≥ 100 IU/L|Geometric mean concentration of anti-HBs at 1, 6 and 12 months after first dose of vaccine","The University of Hong Kong","All","18 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","IBDHepBVaccine","August 12, 2019","December 30, 2020","December 30, 2021","September 10, 2019",,"April 29, 2021","Queen Mary Hospital, Hong Kong, China",,"https://ClinicalTrials.gov/show/NCT04083157"
117,"NCT03948854","Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients",,"Enrolling by invitation","No Results Available","IBS - Irritable Bowel Syndrome","Other: Registered dietitian|Other: On-line video program|Other: Printed handout|Other: Dietitian-led group","Improvement in IBS symptoms","Mayo Clinic","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","18-011391","May 22, 2019","May 22, 2021","May 22, 2021","May 14, 2019",,"November 27, 2020","Mayo Clinic in Florida, Jacksonville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT03948854"
118,"NCT03116568","Bacterial Transmission In Utero and IBD Risk",,"Recruiting","No Results Available","IBD|Pregnancy Related|Microbiota",,"Relation of microbiota in the gut between mother and new-borns","Chinese University of Hong Kong","All","up to 100 Years   (Child, Adult, Older Adult)",,"180","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","The Meconium Study","April 24, 2017","April 14, 2022","September 27, 2027","April 17, 2017",,"June 28, 2018","The Chinese University of Hong Kong, Sha Tin, Hong Kong",,"https://ClinicalTrials.gov/show/NCT03116568"
119,"NCT00880594","Irritable Bowel Syndrome (IBS) Functional Magnetic Resonance Imaging (fMRI) With Desipramine",,"Active, not recruiting","No Results Available","Irritable Bowel Syndrome","Drug: Desipramine","Changes in brain activations using functional MR following desipramine therapy in IBS populations.","Washington University School of Medicine","Female","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","09-0013","February 2009","May 2021","May 2021","April 14, 2009",,"July 16, 2020","Washington University School of Medicine, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT00880594"
120,"NCT04380922","Prevalence of Periodontal Diseases in IBD","MICIMaP","Recruiting","No Results Available","Inflammatory Bowel Diseases|Periodontal Diseases","Other: Periodontal screening","Prevalence of Periodontal Disease|Gingivitis|Oral mucosa dermatological manifestations secondary to IBD|Oral Health Quality of Life|Oral treatment need","CHU de Reims","All","18 Years to 70 Years   (Adult, Older Adult)",,"60","Other","Observational","Observational Model: Other|Time Perspective: Prospective","PO20062*","June 19, 2020","December 19, 2021","December 2022","May 8, 2020",,"June 8, 2021","Chu Reims, Reims, France",,"https://ClinicalTrials.gov/show/NCT04380922"
121,"NCT04757493","The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Drug: Prucalopride 2mg","Assess the Change of IBS symptoms from baseline by using IBS-Symptom Severity Score|Assess the change of quality of life from baseline by using IBS- Quality of life questionnaire","Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2|Phase 3","160","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","BSMMU/2021/394","March 10, 2021","June 2021","June 2021","February 17, 2021",,"March 11, 2021","Shahbag, Dhaka, Bangladesh",,"https://ClinicalTrials.gov/show/NCT04757493"
122,"NCT04808271","The Effects of Bifidobacterium Breve Bif195 for Diarrhea-predominant Irritable Bowel Syndrome",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Dietary Supplement: Bifidobacterium breve Bif195|Dietary Supplement: Placebo","Change in IBS symptoms from baseline measured by IBS-severity scoring system (IBS-SSS) at 8 weeks|Change in quality of life from baseline measured by Irritable Bowel Syndrome-Quality of Life (IBS-QOL) Questionnaire Scores at 8 weeks|Changes from baseline in bowel habits at 8 weeks|Change from baseline in abdominal pain at 8 weeks|Adverse events","Hvidovre University Hospital|Chr Hansen","All","18 Years to 60 Years   (Adult)","Not Applicable","60","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","H-20060730","April 16, 2021","April 30, 2024","November 30, 2030","March 22, 2021",,"April 22, 2021","Hvidovre Hospital, Copenhagen University, Hvidovre, Copenhagen, Denmark|Copenhagen University Hospital Hvidovre, Hvidovre, Denmark",,"https://ClinicalTrials.gov/show/NCT04808271"
123,"NCT04542018","Effects of Low FODMAP Diet on Colonic Epithelial Physiology in Diarrhea-predominant Irritable Bowel Syndrome",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Other: a low FODMAP diet for 4 weeks","Lactulose Mannitol excretion|Changes in epithelial permeability|Changes in stool microbiome","University of Michigan","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","HUM00166423","August 3, 2020","September 2023","September 2023","September 9, 2020",,"September 9, 2020","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT04542018"
124,"NCT03449628","L. Casei DG® in Patients With Irritable Bowel Syndrome.","PROBE2","Active, not recruiting","No Results Available","IBS - Irritable Bowel Syndrome","Dietary Supplement: L.casei DG|Dietary Supplement: PLACEBO","Proportion of patients who have a response in pain|Proportion of patients who have a response in stool consistencies|Evaluation of Pain relief|Evaluation of global symptom score|Relief of IBS symptoms|IBS-SSS score questionnaire (Severity Scoring System )|Improvement in stool consistency|Satisfaction with treatment|Quality of life|Intake of rescue medication|gut microbiota composition|Short Chain Fatty Acids (SCFA)|Free Aminoacids|Biogenic Amines|Gut permeability for zonulin|Gut permeability for citrulline|Gut permeability for PV-1 (Plasmalemma vesicle-associated) protein|L. casei DG® strain in the feces","SOFAR S.p.A.|1Med","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","264","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","PSC-DS PROBE2-IBS/17","November 6, 2017","May 4, 2021","June 30, 2021","February 28, 2018",,"April 27, 2021","A.O. Bolognini, Seriate, BG, Italy|A.O. ""G. Brotzu""- Ospedale San Michele, Cagliari, CA, Italy|AOU di Cagliari - Policlinico di Monserrato, Cagliari, CA, Italy|Ospedale Valduce, Como, CO, Italy|ASST-FTB-Sacco, Milano, MI, Italy|Policlinico San Donato, San Donato Milanese, MI, Italy|Ospedale Sant'Andrea, Vercelli, VC, Italy|Gastroenterologia Universitaria Policlinico Giovanni XXIII, Bari, Italy|Azienda ULSS 1, Belluno, Italy|Azienda Ospedaliero-Universitaria S. Orsola Malpighi, Bologna, Italy|Ospedale SS. Annunziata, Chieti, Italy|Fondazione IRCCS Policlinico, Milano, Italy|Policlinico, Napoli, Italy|Policlinico Federico II, Napoli, Italy|Azienda Ospedaliera di Padova, Padova, Italy|Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy|U.O. Gastroenterologia Universitaria, Pisa, Italy|Policlinico Universitario Campus Biomedico, Roma, Italy|A.O. San Camillo-Forlanini, Roma, Italy|Ospedale Sant'Andrea, Roma, Italy",,"https://ClinicalTrials.gov/show/NCT03449628"
125,"NCT04053790","Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)",,"Active, not recruiting","No Results Available","Irritable Bowel Syndrome With Diarrhea","Drug: lactobacillus LB|Other: placebo","decrease in the number of stools per day|improvement in the consistency of the stools according to Bristol scale.|improvement in bloating measured by a Likert scale (0-4)|improvement in abdominal pain measured by a Likert scale (0-4)","Hospital General de Mexico","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 4","177","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","DI/18/107/03/080","January 15, 2019","August 2021","December 2021","August 13, 2019",,"February 11, 2021","Hospital General de Mexico, Mexico City, Mexico",,"https://ClinicalTrials.gov/show/NCT04053790"
126,"NCT04899869","Faecal Microbiota Transplantation in Irritable Bowel Syndrome","MISCEAT","Recruiting","No Results Available","Irritable Bowel Syndrome With Diarrhea|Irritable Bowel Syndrome Mixed","Other: Faecal microbiota transplantation with active study microbiota first|Other: Faecal microbiota transplantation with inactive autoclaved study microbiota first|Other: Faecal microbiota transplantation with inactive autoclaved study microbiota only","Change in the IBS severity symptom score (IBS-SSS)|The acute change in the IBS severity symptom score|The long-term change in the IBS severity symptom score","Thomayer University Hospital|Charles University, Czech Republic","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","INT_TN_001","June 8, 2021","June 30, 2023","December 31, 2023","May 25, 2021",,"June 9, 2021","Thomayer University Hospital, Prague, Czechia",,"https://ClinicalTrials.gov/show/NCT04899869"
127,"NCT03432078","Individual vs. Group Hypnotherapy in Patients With Irritable Bowel Syndrome",,"Active, not recruiting","No Results Available","IBS - Irritable Bowel Syndrome","Other: Hypnotherapy","Change of Gastrointestinal symptom severity","Sahlgrenska University Hospital, Sweden","All","18 Years to 67 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","686-11","August 15, 2011","December 31, 2019","December 31, 2025","February 13, 2018",,"October 22, 2020",,,"https://ClinicalTrials.gov/show/NCT03432078"
128,"NCT03245645","FODMAP Reintroduction in Irritable Bowel Syndrome",,"Enrolling by invitation","No Results Available","Irritable Bowel Syndrome With Diarrhea|Irritable Bowel Syndrome With Mixed Bowel Habits","Other: Dietary Intervention","Adequate relief of IBS symptoms in past 7 days|Highest amount of grams of sugar in solutions that do not significantly increase IBS symptoms|Change in IBS-symptom severity scale|Change in Visceral Sensitivity Index (VSI)|Change in Personal Health Questionnaire (PHQ-15)|Change in abdominal pain severity|Change in overall severity of gastrointestinal symptoms|Change in severity of the sensation of bloating, abdominal fullness or visible distension|Change in intestinal microbiota|Change in visceral sensitivity index score","University of California, Los Angeles","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","16-000934","March 24, 2017","June 30, 2021","June 30, 2021","August 10, 2017",,"January 28, 2021","UCLA, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT03245645"
129,"NCT04748627","Global IBD Visualization of Epidemiology Studies (GIVES) in the 21st Century","GIVES-21","Not yet recruiting","No Results Available","Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease",,"Incidence of IBD|Geographical effect","Chinese University of Hong Kong|University of Calgary","All","18 Years and older   (Adult, Older Adult)",,"400","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","GIVES-21","June 2021","November 2022","November 2023","February 10, 2021",,"May 6, 2021",,,"https://ClinicalTrials.gov/show/NCT04748627"
130,"NCT04613479","Frequency of Hepatobilliary Manifestations in Patients With Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Hepatobilliary Manifestations in Inflammatory Bowel Disease Patients",,"The prevelance of hepatobilliary manifestations in IBD patients","Assiut University","All","18 Years to 60 Years   (Adult)",,"60","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Inflammatory bowel disease","December 1, 2020","December 1, 2021","June 1, 2022","November 3, 2020",,"November 13, 2020",,,"https://ClinicalTrials.gov/show/NCT04613479"
131,"NCT04830410","The Effects of Carbohydrates in Irritable Bowel Syndrome","FIBS","Recruiting","No Results Available","Irritable Bowel Syndrome With Diarrhea","Dietary Supplement: Fructan reintroduction|Dietary Supplement: Placebo reintroduction","IBS-SSS|visceral sensitivity|change in intestinal gas production|change in gas production|change in microbiota|Change in metabolomics profiles|change in stool form and frequency|GSRS-IBS|HAD|VSI|IBSQOL|PHQ12|CSI","Sahlgrenska University Hospital, Sweden|Atmo Biosciences|Beneo-Institute","All","18 Years to 50 Years   (Adult)","Not Applicable","70","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","FIBS 2020-03644","March 30, 2021","June 2022","June 2022","April 5, 2021",,"April 5, 2021","Sahlgrenska University Hospital, Göteborg, Sweden",,"https://ClinicalTrials.gov/show/NCT04830410"
132,"NCT04067778","IBD Neoplasia Surveillance Pilot RCT","IBDDysplasia","Recruiting","No Results Available","Inflammatory Bowel Diseases|Colonic Neoplasms|Dysplasia","Diagnostic Test: Intervention Group|Diagnostic Test: Control Group","Overall Number of Participants Enrolled|Rate of Protocol Adherence|Rate of overall neoplasia detection|Adverse Events occurrence|Rate of Study Variables|Rate of Missed 2-Week Post-Procedural Assessment for Complications","Ottawa Hospital Research Institute|Health Sciences Centre, Winnipeg, Manitoba|Western University, Canada|University of Toronto|Hamilton Health Sciences Corporation|Hotel Dieu Hospital|Thunder Bay Regional Health Sciences Centre|Eastern Health|McGill University Health Centre/Research Institute of the McGill University Health Centre|Providence Health & Services|Royal Jubilee Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","400","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","20190428-01T","November 6, 2020","October 31, 2022","October 31, 2022","August 26, 2019",,"February 3, 2021","Eastern Regional Health Authority, St. John's, NFLD, Canada|Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada|Ottawa Hospital Research Institute, Ottawa, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04067778"
133,"NCT04898530","Diet Patterns in IBD in Central Texas",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis","Other: NO INTERVENTION","diet patterns|diet preferences|diet impact","University of Texas at Austin","All","18 Years and older   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","STUDY00000439","May 15, 2021","May 15, 2024","May 15, 2024","May 24, 2021",,"May 24, 2021","Dell Medical School, UT Austin, Austin, Texas, United States",,"https://ClinicalTrials.gov/show/NCT04898530"
134,"NCT03177044","Behavioural Treatment for Functional Bowel Symptoms in Inflammatory Bowel Disease","LIBERATE","Active, not recruiting","No Results Available","Inflammatory Bowel Diseases|Functional Gastrointestinal Disorders","Behavioral: Behavioural treatment","Patient rating of improvement in symptoms|Change in Personal assessment of Constipation Symptoms (PAC-SYM) score|Change in St Marks Faecal Incontinence Score|Change in Inflammatory Bowel disease questionnaire (IBDQ) score|Change in Short Form -36 (SF-36) score|Change in Hospital Anxiety and Depression Score (HADS)|Change in Brief Illness Perception Questionnaire score|Change in Brief Cope score|Change in Inflammatory Bowel Disease Self-efficacy scale (IBD-SES)|Change in Euro-Qol (EQ-5D)","St Vincent's Hospital Melbourne","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","35","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","HREC/17/SVHM/92","June 1, 2017","July 30, 2021","December 31, 2021","June 6, 2017",,"March 19, 2021","St Vincent's Hospital, Fitzroy, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT03177044"
135,"NCT04613466","The Prevelance of Pulmonary Manifestation in Patients With Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","The Prevelance and Complications of Pulmonary Manifestations in Patients With Inflammatory Bowel Disease",,"The presence of pulmonary manifestations in IBD patients","Assiut University","All","18 Years to 60 Years   (Adult)",,"60","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Gateroentrolgy unit","December 1, 2020","December 1, 2021","June 1, 2022","November 3, 2020",,"November 13, 2020",,,"https://ClinicalTrials.gov/show/NCT04613466"
136,"NCT04168047","Are Sleeping Disorders Associated With Visceral Hypersensitivity in Irritable Bowel Syndrome Patients ?","S3i","Not yet recruiting","No Results Available","Irritable Bowel Syndrome","Procedure: Barostat procedure|Other: Anxiety and Depression Evaluation|Other: Assessment of sleep quality","Pressure threshold measured during the barostat procedure|Score at HAD anxiety and depression scale|Score at Pittsburg sleep quality index","University Hospital, Rouen","All","18 Years and older   (Adult, Older Adult)","Not Applicable","77","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","2016/381/HP","July 2020","August 2023","August 2023","November 19, 2019",,"June 29, 2020","Rouen University Hospital, Rouen, France",,"https://ClinicalTrials.gov/show/NCT04168047"
137,"NCT04492787","Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)",,"Recruiting","No Results Available","Irritable Bowel Syndrome With Diarrhea","Drug: Changkang Granule|Drug: Changkang Placebo Granule","Percentage of Participants Who Are Composite Responders Consistency Scores|Percentage of Participants Who Are Responders in Abdominal Pain Scores|Percentage of Participants Who Are Responders in Stool Consistency Scores|Change from baseline to each week during follow up for IBS-symptoms abdominal pain；|Change from baseline to each week during follow up for IBS-symptoms stool consistency;|Change from baseline to each week during follow up for IBS-symptoms bloating|Change from baseline to each week during follow up for IBS-symptoms urgency|Change from baseline to each week during follow up for IBS-symptoms Defecation frequency|Disappearance rate of traditional Chinese Medicine（TCM）symptom","Tasly Pharmaceutical Group Co., Ltd","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","240","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","TSL-TCM-CKKL-Ⅱ","June 6, 2020","June 30, 2022","October 30, 2022","July 30, 2020",,"July 30, 2020","Xiyuan Hospital, China Academy of Traditional Chinese Medicine, Beijing, China|Shengjing Hospital of China Medical University, Dalian, China|Gansu Provincial Hospital of TCM, Gansu, China|The first affiliated Hospital of Hunan University of Traditional Chinese Medicine, Hunan, China|Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China|West China Hospital of Sichuan University, Sichuan, China|Wenzhou Hospital of Traditional Chinese Medicine, Wenzhou, China|Xiamen Hospital of Traditional Chinese Medicine, Xiamen, China",,"https://ClinicalTrials.gov/show/NCT04492787"
138,"NCT03827109","Peer Mentoring to Improve Self-management in Youth With IBD",,"Recruiting","No Results Available","Pediatric Crohns Disease|Pediatric Ulcerative Colitis|Inflammatory Bowel Diseases","Behavioral: Group educational activities|Behavioral: IBD educational website|Behavioral: Monthly check-in calls from program coordinator|Behavioral: Mentor|Behavioral: Fun group activities|Behavioral: Parent support group","12 month youth quality of life: PedsQL|18 month youth quality of life: PedsQL|12 month change from baseline Youth quality of life: PedsQL|18 month change from baseline Youth quality of life: PedsQL|12 month youth functional disability|18 month youth functional disability|12 month change from baseline youth functional disability|18 month change from baseline youth functional disability|12 month Youth disease outcomes - Crohn's Disease severity|12 month Youth disease outcomes - Ulcerative Colitis severity|18 month Youth disease outcomes - Crohn's Disease severity|18 month Youth disease outcomes - Ulcerative Colitis severity|12 month number of hospital admissions in previous 6 months|18 month number of hospital admissions in previous 6 months|12 month number of clinic appointments in previous 6 months|18 month number of clinic appointments in previous 6 months|12 month number of missed appointments in previous 6 months|18 month number of missed appointments in previous 6 months|12 month number of procedures in previous 6 months|18 month number of procedures in previous 6 months|12 months Mentor QOL|18 months Mentor QOL|12 month change from baseline Mentor QOL|12 month Parent QOL|12 month change from baseline Parent QOL","Laura Mackner|Children's Hospital Medical Center, Cincinnati|Rosalind Franklin University of Medicine and Science|Nationwide Children's Hospital","All","10 Years to 17 Years   (Child)","Not Applicable","300","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","R01NR017533","June 12, 2019","February 23, 2023","February 23, 2023","February 1, 2019",,"January 20, 2021","Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/09/NCT03827109/Prot_SAP_000.pdf|""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/09/NCT03827109/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT03827109"
139,"NCT04217733","Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome",,"Recruiting","No Results Available","IBS - Irritable Bowel Syndrome","Drug: pentoxyifylline|Drug: Mebeverine|Drug: ethosuximide","Number of patients with improved Visual analog scales (VAS) for assessment of pain in IBS","Tanta University","All","18 Years and older   (Adult, Older Adult)","Phase 3","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","Sherief Protocol","November 1, 2019","December 1, 2030","December 30, 2030","January 3, 2020",,"January 3, 2020","Sherief Abd-Elsalam, Tanta, Egypt",,"https://ClinicalTrials.gov/show/NCT04217733"
140,"NCT04521205","A Multicenter Clinical Trial: Efficacy, Safety of Fecal Microbiota Transplantation for Inflammatory Bowel Disease",,"Recruiting","No Results Available","Inflammatory Bowel Disease, Ulcerative Colitis Type","Drug: fecal microbiota capsule","Clinical remission: the modified Mayo score and endoscopy","Zhongshan Hospital Xiamen University","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","XMZSYY-AF-SC-12-03","September 2020","September 2023","April 2024","August 20, 2020",,"August 20, 2020","Yanyun Fan, Xiamen, China",,"https://ClinicalTrials.gov/show/NCT04521205"
141,"NCT03923322","Botanical Tincture for Symptoms of Irritable Bowel Syndrome",,"Not yet recruiting","No Results Available","Irritable Bowel Syndrome Characterized by Constipation","Drug: Botanical Tincture|Other: Placebo","Number of subjects recruited|Proportion of subjects who complete the study|Proportion of dosages of drug/placebo that are taken by participants|Abdominal Pain Intensity: weekly average of worst daily (in past 24 hours) abdominal pain score scale of 0 (No pain) -10 (Worst imaginable pain)|Abdominal Bloating Intensity: weekly average of worst daily (in past 24 hours) abdominal bloating rating on a scale of 0 (absent) - 4 (very severe)|Bowel movement frequency: Number of Complete Spontaneous Bowel Movements (CSBMs) each week","Stamford Hospital","All","18 Years and older   (Adult, Older Adult)","Phase 2","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","TSH_Family Medicine_2018001","September 2020","September 2022","January 2023","April 22, 2019",,"March 18, 2020","Stamford Health, Stamford, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT03923322"
142,"NCT03596905","Efficacy and Safety of Plecanatide in Children 6 to <18 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C)","(IBS-C)","Recruiting","No Results Available","Irritable Bowel Syndrome With Constipation","Drug: Plecanatide|Drug: Matching placebo","Change from baseline in weekly SBM frequency over the 4 Week Treatment Period compared to placebo and across treatment groups|Change from baseline in frequency and severity of abdominal pain/discomfort|Change from baseline in frequency of BMs and CSBMs|Change from baseline in stool consistency (BSFS or mBSFS-C)","Bausch Health Americas, Inc.","All","6 Years to 17 Years   (Child)","Phase 2","210","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","SP304202-14","June 30, 2018","December 2022","December 2022","July 24, 2018",,"January 20, 2021","Synergy Research Site, Corona, California, United States|Synergy Research Site, Doral, Florida, United States|Synergy Research Site, Hialeah, Florida, United States|Synergy Research Site, Miami, Florida, United States|Synergy Research Site, Miami, Florida, United States|Synergy Research Site, Miami, Florida, United States|Synergy Research Site, Tampa, Florida, United States|Synergy Research Site, Crowley, Louisiana, United States|Synergy Research Site, Houston, Texas, United States|Synergy Research Site, San Antonio, Texas, United States|Synergy Research Site, Newport News, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT03596905"
143,"NCT03687814","Low FODMAP Plus PEG 3350 for the Treatment of Patients With Irritable Bowel Syndrome-Constipation",,"Recruiting","No Results Available","Irritable Bowel Syndrome Characterized by Constipation","Other: Low FODMAP diet/PEG 3350|Other: sham diet/PEG 3350","Improvement of abdominal pain as measured by 11-point numerical rating scale|Bloating|abdominal discomfort|Mean number of SBMs per day|Mean weekly number of spontaneous complete bowel movements|Composite endpoint: Full responder was defined as a patient with >3 SBM per week, an increase of ≥1 SBM per week and >30% pain reduction.|stool consistency|Straining|IBS-QOL|HADS score|WPAI questionnaire|Sleep Assessment questionnaire","University of Michigan","All","18 Years and older   (Adult, Older Adult)","Early Phase 1","78","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","HUM00139784","November 8, 2018","November 3, 2022","November 3, 2022","September 27, 2018",,"December 23, 2020","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT03687814"
144,"NCT04904224","Diagnosis of Inflammatory Bowel Disease by Examining the Entire Bowel by Pan-intestinal Capsule Endoscopy","PEC","Recruiting","No Results Available","Inflammatory Bowel Diseases|Morbus Crohn","Device: Panintestinal video capsule endoscopy|Device: Colonoscopy","Number of Participants with Evidence of inflammatory Alterations in the Gastrointestinal Tract|Number of Diagnosis of a Chronic Inflammatory Bowel Disease|Number of Participants with Indication for a Therapy because of the Examination findings","Robert Bosch Medical Center|Medtronic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","150","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","KKF-06-2019","March 7, 2021","March 31, 2022","March 31, 2023","May 27, 2021",,"May 27, 2021","Praxis Gersemann, Ditzingen, Baden-Württemberg, Germany|Praxis Escher, Leonberg, Baden-Württemberg, Germany|Gastroenterologische Schwerpunktpraxis, Stuttgart, Baden-Württemberg, Germany|Robert Bosch Medical Center, Stuttgart, Baden-Württemberg, Germany|Gastroenterologie am Pragsattel, Stuttgart, Baden-Württemberg, Germany|Ambulante Gastroenterologie, Stuttgart, Baden-Württemberg, Germany",,"https://ClinicalTrials.gov/show/NCT04904224"
145,"NCT04138186","G-PUR® for Symptomatic Treatment in Irritable Bowel Syndrome With Diarrhea",,"Recruiting","No Results Available","Irritable Bowel Syndrome With Diarrhea (IBS-D)","Device: 2.0g G-PUR®, oral administration|Device: Placebo, oral administration","The rate of responders for the patient's global assessment of relief using the last four assessments in the treatment period.|Patient's global assessment of symptom relief measured on a 5-point Likert scale (1= very good and 5= very poor)|Incidence of adverse (and serious) events|Daily intensity of bloating using a 11-point numerical rating scale (NRS) where 0 represents no bloating discomfort and 10 represents very severe bloating discomfort|Daily urgency using a 11-point numerical rating scale (NRS) where 0 represents no defecation urgency and 10 represents worst imaginable urgency|Daily stool frequency|Patient compliance with daily diary reporting|ePRO usability using a paper questionnaire|Worst daily abdominal pain using a 11-point NRS|Daily stool consistency using the Bristol Stool Form Scale (Type 1 separate hard lumps, like nuts (hard to pass); Type 7 watery, no solid pieces, entirely liquid)|Responder rate (ie weekly and daily) of the combined endpoint: worst daily abdominal pain and daily stool consistency|Additional responder analyses (i.e. weekly and daily) of IBS symptoms listed all above evaluating different change in symptom intensity with treatment (i.e., greater than or equal to 30, 40 and 50 percent change in intensity compared with baseline)|Number of pain-free days|Assessment of gastrointestinal symptoms using the IBS-SSS during each onsite visit;|Quality of Life using validated generic SF12 questionnaire|Hospital anxiety and depression scale (HADS)|Stress response using the perceived stress questionnaire|Use of rescue medication (to be assessed daily)|Exploratory endpoint: bile acid in stool|Exploratory endpoint: zonulin in stool|Exploratory endpoint: microbiome in stool|Exploratory endpoint: HBD2 in stool|Exploratory endpoint: gluten in stool|Exploratory endpoint: IDO in blood|Exploratory endpoint: zonulin in blood","Glock Health, Science and Research GmbH","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","30","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","G-IBS_01","October 2, 2019","February 2021","February 2021","October 24, 2019",,"November 13, 2020","Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria",,"https://ClinicalTrials.gov/show/NCT04138186"
146,"NCT03487926","Microglial Activation in Inflammatory Bowel Disease",,"Active, not recruiting","No Results Available","Major Depressive Episode|Inflammatory Bowel Diseases","Radiation: [18F]FEPPA","TSPO VT in prefrontal cortex, anterior cingulate cortex, and insula|change in TSPO VT in prefrontal cortex, anterior cingulate cortex, and insula before and after 3 to 6 months|MAO-B VT in prefrontal cortex, anterior cingulate cortex, insula in IBD compared to controls|TSPO VT in prefrontal cortex, anterior cingulate cortex, insula compared between Crohns disease and ulcerative colitis|TSPO VT in prefrontal cortex, anterior cingulate cortex, insula compared between IBD with MDE compared to MDE controls|change in TSPO VT in prefrontal cortex, anterior cingulate cortex, insula compared between naturalistic treatment with sulfasalazine/5-aminosalicylates versus other interventions like biologics or fecal transplantation","Centre for Addiction and Mental Health|McMaster University","All","19 Years to 65 Years   (Adult, Older Adult)",,"135","Other","Observational","Observational Model: Other|Time Perspective: Prospective","102-2016","January 1, 2019","December 31, 2021","December 31, 2021","April 4, 2018",,"July 17, 2020","Centre for Addiction and Mental Health, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03487926"
147,"NCT03847467","Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy","PRIME","Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis","Drug: 2'-Fucosyllactose|Other: Placebo","Mean Gastrointestinal Symptom Rating Scale (GSRS) in participants who receive 2'-fucosyllactose (2'FL) or dextrose placebo|Mean fecal Bifidobacterium abundance in participants who receive 2'-fucosyllactose (2'FL) or dextrose placebo","Children's Hospital Medical Center, Cincinnati|Broad Institute|University of Cincinnati|Connecticut Children's Medical Center","All","11 Years to 25 Years   (Child, Adult)","Phase 1|Phase 2","216","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","2017-6667","September 20, 2019","March 2023","March 2023","February 20, 2019",,"February 1, 2021","Connecticut Children's Medical Center, Hartford, Connecticut, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT03847467"
148,"NCT04290156","The Effect of Joint Transition Visits on Quality of Life in Inflammatory Bowel Diseases (TRANS-IBD)","TRANS-IBD","Not yet recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn's Disease|Ulcerative Colitis","Other: joint visits","Change in patient reported health-related quality of life (HRQoL) one year after transfer|The number of patients not lost to follow-up|Medication adherence|Self-efficacy: IBDSES-A|Patient's satisfaction: CACHE|Transition readiness (1)|Transition readiness (2)|The number of flare-ups|The number of patients who needed the initiation of corticosteroid treatment|The number of patients who needed the initiation of biological treatment|Stool calprotectin level|Disease activity (1)|Disease activity (2)|Disease activity (3)|Disease activity (4)|Disease activity (5)|Laboratory parameter refers to inflammation: C-reactive protein (CRP)|Laboratory parameter refers to inflammation: White blood cell count (WBC)|Laboratory parameter refers to inflammation: Erythrocyte sedimentation rate (ESR)|The number of unplanned visits at the caregiver gastroenterologist|The number of visits at the emergency department|The number of scheduled imaging performed|The number of urgent imaging performed|The number of scheduled endoscopies performed|The number of urgent endoscopies performed|The number of IBD-related surgical interventions performed|The number of IBD related hospital admissions|The length of IBD-related hospitalization","University of Pecs","All","16 Years to 17 Years   (Child)","Not Applicable","160","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","50457-2/2019/EKU","April 1, 2020","April 1, 2024","November 1, 2024","February 28, 2020",,"February 28, 2020",,,"https://ClinicalTrials.gov/show/NCT04290156"
149,"NCT04589338","Impact of Different Types of Physical Activity in Patients With Chronic Inflammatory Bowel Disease","ACHILLE","Recruiting","No Results Available","Inflammatory Bowel Diseases|Exercise Therapy","Other: Endurance training|Other: Resistance training","Progressive effort test on bicycle ergometer (VO2 max)|Progressive effort test on bicycle ergometer (Heart rate)|Progressive effort test on bicycle ergometer (Power)|Maximum force test (N/m)|Blood sample|Saddle analysis|IBD-F|Godin Leisure Time exercise questionnaire|Metabolic Equivalent Task questionnaire|Short Food Frequency Questionnaire|EQ5D questionnaire|Short health scale questionnaire","University of Liege","All","20 Years to 50 Years   (Adult)","Not Applicable","72","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","20202021","January 5, 2021","January 2022","February 2022","October 19, 2020",,"April 28, 2021","Université de Liège, Liège, Belgium",,"https://ClinicalTrials.gov/show/NCT04589338"
150,"NCT04373304","The Effect of a Low FODMAP Diet in Irritable Bowel Syndrome Patients","FIBS","Recruiting","No Results Available","Irritable Bowel Syndrome|FODMAP","Other: low FODMAP diet","Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS)","Universitaire Ziekenhuizen Leuven","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","45","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","s63269","November 25, 2019","July 1, 2021","July 1, 2021","May 4, 2020",,"May 8, 2020","KU Leuven, Leuven, Vlaams-Brabant, Belgium",,"https://ClinicalTrials.gov/show/NCT04373304"
151,"NCT03613545","Fecal Microbiota Transplantation for Irritable Bowel Syndrome",,"Recruiting","No Results Available","Irritable Bowel Syndrome|Fecal Microbiota Transplantation","Procedure: fecal microbiota transplantation|Procedure: Infusion of sham|Drug: probiotics, antibiotics or antidepressants","Change in Irritable Bowel Syndrome assessed by Symptom Severity Score (IBS-SSS)|Change in Irritable Bowel Syndrome assessed by Quality of Life (IBS-QOL) Questionnaire Scores|Change in Depression and Anxiety assessed by Hamilton Depression Rating Scale (HAMD) and Hamilton Anxiety Rating Scale(HAMA)","Guangzhou First People's Hospital","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2|Phase 3","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","K-2017-078-02","August 10, 2018","December 31, 2028","December 31, 2030","August 3, 2018",,"November 14, 2018","Guangzhou First People's Hospital, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03613545"
152,"NCT03576027","Hyperbaric Oxygen Therapy in Children With Inflammatory Bowel Diseases",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Children, Only","Other: Hyperbaric Oxygen Therapy","Change of the ulcerative colitis activity|Change of the Crohn's disease activity|Number of participants with treatment-related adverse events|Concentration of proinflammatory cytokines|Maintaining remission of the ulcerative colitis|Maintaining remission of the Crohn's disease","Medical University of Warsaw|Military Institute of Medicine, Poland","All","5 Years to 18 Years   (Child, Adult)","Not Applicable","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Dembinski2018","May 21, 2018","December 31, 2021","December 31, 2021","July 3, 2018",,"May 20, 2020","Medical University of Warsaw, Warsaw, Poland",,"https://ClinicalTrials.gov/show/NCT03576027"
153,"NCT03375424","Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany","VEDOibdI","Recruiting","No Results Available","Inflammatory Bowel Diseases|Treatment","Biological: vedolizumab","safety index (Chronic steroid-use ≥ 20 mg for ≥ 6 months, New secreting fistula, Op caused by stenosis, Mortality (all), Hospitalization > 14 days, Long-term-illness (with > 30 days off work), Early retirement)|Comparison of the disease course in IBD-patients on Vedolizumab/anti-TNF therapy with IBD-patients with an early-stage disease|Development of a multifactorial model to predict a favorable course of disease|Online documentation of effectiveness in induction and maintenance therapy including the occurrence of serious side effects|Efficacy (remission and response) of induction therapy (week 14)|Generation of health economic data in IBD-patients on biologicals|Generation of follow-up data on IBD-patients with early disease|Formation of a large-scaled patient-collective of IBD-patients with an early course of disease|Efficacy (remission and response) of maintenance therapy (month 6 and 12)|Efficacy (remission and response) of effectiveness in different subpopulations","Ced Service GmbH","All","18 Years to 80 Years   (Adult, Older Adult)",,"2500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Version 1.4","October 2, 2017","April 30, 2019","April 30, 2024","December 18, 2017",,"December 18, 2017","Gastroenterologische Gemeinschaftspraxis Minden, Minden, Niedersachsen, Germany",,"https://ClinicalTrials.gov/show/NCT03375424"
154,"NCT01464151","Risk Factors for Colorectal Cancer in Patients With Inflammatory Bowel Disease Undergoing Surveillance: a Prospective Cohort Study",,"Active, not recruiting","No Results Available","Inflammatory Bowel Disease|Colorectal Cancer",,"low- or high grade dysplasia or colorectal cancer during follow-up","UMC Utrecht|Merck Sharp & Dohme Corp.|Ferring Pharmaceuticals","All","18 Years to 70 Years   (Adult, Older Adult)",,"700","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","11-050","July 2011","May 2021","December 2021","November 3, 2011",,"May 3, 2021","AMC, Amsterdam, Netherlands|LUMC, Leiden, Netherlands|Radboud UMC, Nijmegen, Netherlands|UMC Utrecht, Utrecht, Netherlands",,"https://ClinicalTrials.gov/show/NCT01464151"
155,"NCT04329481","The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD Patients",,"Recruiting","No Results Available","Ulcerative Colitis|Crohn Disease|Inflammatory Bowel Diseases","Dietary Supplement: Mycodigest supplement","efficacy of ""Mycodigest"" supplementation to inflammatory bowel disease (IBD) patients on clinical response and remission rates|efficacy of ""Mycodigest"" supplementation to inflammatory bowel disease (IBD) patients on inflammatory markers|efficacy of ""Mycodigest"" supplementation to inflammatory bowel disease (IBD) patients on quality of life|effect of ""Mycodigest"" supplementation to inflammatory bowel disease (IBD) patients on 4. Fecal microbiome composition and diversity","Tel-Aviv Sourasky Medical Center","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Supportive Care","TASMC-17-0643-TLV","June 12, 2018","June 12, 2022","June 12, 2024","April 1, 2020",,"April 7, 2020","Department of Gastroentherology, Tel Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT04329481"
156,"NCT03825900","Transcranial Direct Current Stimulation and the Interaction Between Chronic Pain and the Intestinal Epithelial Barrier in Patients With Chronic Inflammatory Bowel Diseases (IBD)",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Device: Sham OR active Transcranial direct current stimulation","Functional changes in the brain measured with cerebral MRI|Structural changes in the brain measured with cerebral MRI|Functional and/or structural changes in the Intestinal Epithelial Barrier measured with endoscopy of the rectum with sample-taking|Changes in pain measured with visual analogue scale|Changes in perception of pain measured with an algometer (pain pressure threshold)|Changes in questionnaire ""quality of life""|Changes in functional symptoms using IBS-SSS|Changes in activity indices using HWI questionnaire or SCCAI questionnaire|Changes in pain catastrophizing scale questionnaire|Changes in inflammation biomarker (blood - C-reactive protein)|Changes in inflammation biomarker (stool - calprotectin)","Charite University, Berlin, Germany|German Research Foundation","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 3","84","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","EA4/221/17","June 1, 2018","December 30, 2022","December 30, 2022","February 1, 2019",,"July 28, 2020","Charite University Medicine, Berlin, Germany",,"https://ClinicalTrials.gov/show/NCT03825900"
157,"NCT04328259","Prevalance of non_ Alcoholic Fatty Liver Diseases in Patient With Inflammatory Bowel Diseases Attending Assiut University Hospitals",,"Not yet recruiting","No Results Available","Inflammatory Bowel Disease Patients",,"the prevalance of non-alcoholic fatty liver in inflammatory bowel disease participants|the Correlation between immunosuppressive drugs and prevalance of non-alcoholic fatty liver affection in inflammatory bowel disease participants","Assiut University","All","Child, Adult, Older Adult",,"30","Other","Observational","Observational Model: Other|Time Perspective: Prospective","NAFLD in patient of IBD","October 1, 2020","October 1, 2021","April 1, 2022","March 31, 2020",,"May 20, 2020",,,"https://ClinicalTrials.gov/show/NCT04328259"
158,"NCT03414580","Analysis of Volatile Organic Compounds in the Exhaled Air in Inflammatory Bowel Disease",,"Recruiting","No Results Available","Volatile Organic Compounds|Inflammatory Bowel Disease","Procedure: Breath sampling for volatile organic compounds","Volatile organic compounds differentiating the study groups|Volatile organic compounds differentiating the disease activity","Keimyung University Dongsan Medical Center","All","18 Years to 80 Years   (Adult, Older Adult)",,"90","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2017-08-003","February 20, 2018","June 1, 2021","June 1, 2021","January 30, 2018",,"September 3, 2020","KeimyungUniversity, Daegu, Jung-gu, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT03414580"
159,"NCT04700917","Internet-Based Cognitive Behavioural Program for Managing Stress With IBD: An RCT","iCBT","Recruiting","No Results Available","Inflammatory Bowel Diseases|Anxiety|Depression|Stress","Behavioral: Cognitive Behavioural Therapy","PSS-4|HADS|PROMIS-29|WSAS|IBDSI-SF|CGI","University of Manitoba","All","18 Years and older   (Adult, Older Adult)","Not Applicable","352","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","H2020:430","March 16, 2021","June 2022","December 2022","January 8, 2021",,"March 29, 2021","University of Manitoba, Winnipeg, Manitoba, Canada",,"https://ClinicalTrials.gov/show/NCT04700917"
160,"NCT02389075","The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis",,"Active, not recruiting","No Results Available","Inflammatory Bowel Diseases (IBD)|Ankylosing Spondylitis (AS)","Procedure: Pinch biopsies|Procedure: Flexible sigmoidoscopy","IEL characteristics in IBD, AS, and healthy controls|Microbiome Differences in IBD, AS, and healthy controls|Microbiome changes are reflected in IELs","University of Colorado, Denver","All","18 Years to 70 Years   (Adult, Older Adult)",,"129","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","14-1507|UL1TR001082","March 2015","October 2022","October 2022","March 17, 2015",,"October 22, 2020","Denver, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT02389075"
161,"NCT04885920","A Study on Administration Choices of Vedolizumab and Outcomes for Adults With Inflammatory Bowel Disease (IBD) (VARIETY - CROATIA AND SLOVENIA)",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases|Crohns Disease|Colitis, Ulcerative",,"Percentage of Participants Persisting to Treatment With Vedolizumab IV Compared to Participants With Treatment Change at 12 Months|Time to any Treatment Change|Number of Participants With Reason for Treatment Change|Number of Participants With Change in Vedolizumab Dosing Frequency|Number of Participants Who Discontinued the Vedolizumab Treatment|Number of Participants Who Changed to Another Treatment","Takeda","All","18 Years and older   (Adult, Older Adult)",,"120","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","Vedolizumab-4036","September 30, 2021","September 30, 2023","December 1, 2023","May 13, 2021",,"May 19, 2021",,,"https://ClinicalTrials.gov/show/NCT04885920"
162,"NCT04026113","Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)",,"Recruiting","No Results Available","Functional Constipation|Irritable Bowel Syndrome With Constipation","Drug: Linaclotide 72 μg (FC Participants)|Drug: Placebo (FC Participants)|Drug: Linaclotide 145 μg (IBS-C Participants)|Drug: Linaclotide 290 μg (IBS-C Participants)","Functional Constipation (FC) Participants: Change from baseline in 12-week SBM (spontaneous bowel movement) frequency rate (SBMs/week) during the study intervention period|Irritable Bowel Syndrome with Constipation (IBS-C) Participants: 6/12 weeks APS (abdominal pain and SBM) + 2 responder|Functional Constipation (FC) Participants: Change from baseline in 12-week stool consistency during the study intervention period|Irritable Bowel Syndrome with Constipation (IBS-C) Participants: Change from baseline in 12-week SBM frequency rate (SBMs/week) during the study intervention period|Irritable Bowel Syndrome with Constipation (IBS-C) Participants: Change from baseline in 12-week abdominal pain during the study intervention period|Irritable Bowel Syndrome with Constipation (IBS-C) Participants: Change from baseline in 12-week stool consistency during the study intervention period|Irritable Bowel Syndrome with Constipation (IBS-C) Participants: 6/12 weeks SBM + 2 responder|Irritable Bowel Syndrome with Constipation (IBS-C) Participants: 6/12 weeks abdominal pain responder","Allergan|Ironwood Pharmaceuticals, Inc.","All","6 Years to 17 Years   (Child)","Phase 3","426","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","LIN-MD-64","October 1, 2019","December 14, 2022","December 14, 2022","July 19, 2019",,"May 28, 2021","Central Research Associates, Inc, Birmingham, Alabama, United States|Southeastern Pediatrics Associates, Dothan, Alabama, United States|G & L Research, LLC, Foley, Alabama, United States|HealthStar Research, Hot Springs, Arkansas, United States|Preferred Clinical Research Partners, Little Rock, Arkansas, United States|Applied Research Center of Arkansas, Little Rock, Arkansas, United States|Advanced Research Center, Anaheim, California, United States|Alliance Research Institute, Bell Gardens, California, United States|Alliance Research Institute, Canoga Park, California, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, United States|Center for Clinical Trials, LLC, Paramount, California, United States|Medical Center for Clinical Research, San Diego, California, United States|Paragon Rx Clinical, Inc, Santa Ana, California, United States|Lynn Institute of Denver, Aurora, Colorado, United States|Children's National Medical Center, Washington, District of Columbia, United States|Prohealth Research Center, Doral, Florida, United States|Dolphin Medical Research, Doral, Florida, United States|Amedica Research Institute, Inc, Hialeah, Florida, United States|Nemours Children's Specialty Care, Jacksonville, Florida, United States|Elite Clinical Research, Miami, Florida, United States|Biotech Pharmaceuticals Group LLC, Miami, Florida, United States|South Miami Medical & Research Group, Inc., Miami, Florida, United States|Valencia Medical & Research Center, Miami, Florida, United States|Advanced Research for Health Improvement,LLC, Naples, Florida, United States|Pediatric & Adult Research Center, Orlando, Florida, United States|Nemours Children's Hospital, Orlando, Florida, United States|Oviedo Medical Research, Oviedo, Florida, United States|Treken Primary Care, Atlanta, Georgia, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Childrens Center for Digestive Health Care, Atlanta, Georgia, United States|River Birch Research Alliance, LLC, Blue Ridge, Georgia, United States|Clinical Trials Specialist, Inc., Doraville, Georgia, United States|Clinical Research Institute, Stockbridge, Georgia, United States|SleepCare Research Institute, Inc., Stockbridge, Georgia, United States|SKY Clinical Research Network Group, Union City, Georgia, United States|The University of Chicago, Chicago, Illinois, United States|Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana, United States|Alliance for Multispecialty Research, LLC, Newton, Kansas, United States|KU Wichita Center for Clinical Research, Wichita, Kansas, United States|Private Practice - Dr. Michael W. Simon, Lexington, Kentucky, United States|Meridian Clinical Research, Baton Rouge, Louisiana, United States|LSU Health Science Center - Shreveport, Shreveport, Louisiana, United States|Virgo Carter Pediatrics, Silver Spring, Maryland, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Minnesota Gastroenterology PA, Minneapolis, Minnesota, United States|The Center for Clinical Trials, Biloxi, Mississippi, United States|Gastrointestinal Associates and Endoscopy Center, Flowood, Mississippi, United States|David M. Headley, MD, P.A., Port Gibson, Mississippi, United States|Private Practice - Dr. Craig Spiegel, Bridgeton, Missouri, United States|Foundation Pediatrics Med Clinical Research Partners, LLC, East Orange, New Jersey, United States|University of New Mexico, Albuquerque, New Mexico, United States|The Children's Hospital at Montefiore, Bronx, New York, United States|Advantage Clinical Trials, Bronx, New York, United States|Columbia University Medical Center, New York, New York, United States|Brody School of Medicine at East Carolina University, Greenville, North Carolina, United States|PMG Research, Inc. dba PMG Research of Piedmont Healthcare, Statesville, North Carolina, United States|IPS Research Company, Oklahoma City, Oklahoma, United States|University of Oklahoma Health Sciences Center/Children's Hospital at OU Medical Center, Oklahoma City, Oklahoma, United States|Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Frontier Clinical Research, LLC, Scottdale, Pennsylvania, United States|Frontier Clinical Research, LLC, Smithfield, Pennsylvania, United States|Coastal Pediatric Research, Charleston, South Carolina, United States|Coastal Pediatric Research, Summerville, South Carolina, United States|The Jackson Clinic, P.A., Jackson, Tennessee, United States|PMG Research of Knoxville, LLC, Jefferson City, Tennessee, United States|GI for Kids, PLLC, Knoxville, Tennessee, United States|Vanderbilt Children's Hospital, Nashville, Tennessee, United States|Hasbro Children's Hospital/Rhode Island Hospital, Providence, Tennessee, United States|Oak Cliff Research Company, LLC, Dallas, Texas, United States|UT Southwestern Medical Center, Dallas, Texas, United States|Cook Childrens Health Care System, Fort Worth, Texas, United States|Capital Area Primary Care, PLLC dba San Gabriel Clinical Research, Georgetown, Texas, United States|Valley Institute of Research, Harlingen, Texas, United States|Vilo Research Group, Houston, Texas, United States|Cullen Research, Houston, Texas, United States|Synergy Group US LLC, Houston, Texas, United States|Pioneer Research Solutions Inc, Houston, Texas, United States|Synergy Group US LLC, Missouri City, Texas, United States|AIM Trials, LLC, Plano, Texas, United States|Sun Research Institute, San Antonio, Texas, United States|UT Health San Antonio, San Antonio, Texas, United States|ClinPoint Trials, Waxahachie, Texas, United States|Chrysalis Clinical Research, Saint George, Utah, United States|University of Utah and Primary Children's Hospital, Salt Lake City, Utah, United States|Private Practice - Office of Maria Ona, Franklin, Virginia, United States|Health Research of Hampton Roads, Inc., Newport News, Virginia, United States|Clinical Research Partners, LLC, Richmond, Virginia, United States|Carilion Medical Center, Roanoke, Virginia, United States|MultiCare Institute for Research and Innovation, Tacoma, Washington, United States|Marshall Health, Huntington, West Virginia, United States|The Medical College of Wisconsin, Milwaukee, Wisconsin, United States|UZ Brussel, Brussels, Belgium|Universitair Ziekenhuis, Ghent, Belgium|KU Leuven, Leuven, Belgium|Medical Center-1-Sevlievo EOOD, Sevlievo, Gabrovo, Bulgaria|MBAL Sv.Ivan Rilski Kozlodui, Kiril I Metodii, Bulgaria|Multi-Profile Hospital for Active Treatment - Ruse JSC MHAT-Ruse, Ruse, Bulgaria|Medical Center-1-Sevlievo EOOD, Sevlievo, Bulgaria|University Hospital Plovdiv, Tsentar, Bulgaria|UMHAT Sveta Marina, Varna, Bulgaria|Stollery Children's Hospital, Edmonton, Alberta, Canada|DSMED, Lower Sackville, Nova Scotia, Canada|Victoria Hospital - London Health Sciences Centre/Lawson Health Research Institute, London, Ontario, Canada|SKDS Research Inc, Newmarket, Ontario, Canada|Bluewater Clinical Research Group Inc, Sarnia, Ontario, Canada|Stouffville Medical Centre, Stouffville, Ontario, Canada|Al Mare Perearstikeskus, Harjumaa, Estonia|Merelahe Family Doctors Centre, Tallinn, Estonia|Kiliiniliste Uuringute Keskus, Tartu, Estonia|Kindergastroenterologie, Uni-Kinderklinik Leipzig, Leipzig, Saxony-Anhalt, Germany|Klinikum Kassel GmbH, Kassel, Germany|Svabhegy Pediatric Clinic, Budapest, Hungary|Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak, Budapest, Hungary|Soproni Erzsebet Oktato Korhaz es Rehabilitacious Intezet, Sopron, Hungary|Szent Borbala Korhaz, Tatabanya, Hungary|Rambam Health Care Campus, Ruth Rappaport Children's Hospital, Haifa, Israel|Wolfson Medical Center, Holon, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah University Hospital, Jerusalem, Israel|The Baruch Padeh Medical Center Poriya, Lower Galilee, Israel|Schneider Children's Medical Center of Israel, Petah Tikva, Israel|Sheba Medical Center, Tel Hashomer, Israel|Azienda Ospedaliera Sant' Andrea, Naples, Italy|IRCCS Ospedale Pediatrico Bambino Gesu, Roma, Italy|Academisch Medisch Centrum Universiteit Van Amsterdam, Amsterdam, Netherlands|Maasstad Hospital Rotterdam, Rotterdam, Netherlands|Isala Zwolle, Zwolle, Netherlands|Szpital Uniwersytecki ""r. A. Jurasza"", Bydgoszcz, Poland|Klinika Pediatrii Gastroenterologii Hepatologii Zywienia Dzieci Szpiatl, Gdansk, Poland|Wojewódzki Specjalistyczny Szpital Dzieciecy, Olsztyn, Poland|Korczowski Bartosz, Gabinet Lekarski, Rzeszow, Poland|Centrum Zdrowia MDM, Warsaw, Poland|University Children's Hospital - Tirsova, Belgrade, Serbia|University Children's Hospital, Belgrade, Serbia|Children's Hospital, Clinical Center Nis, Nis, Serbia|GI for Kids, PLLC, Novi Sad, Serbia|Hospital San Joan de Deu, Barcelona, Spain|Hospital Regional Universitario de Malaga, Malaga, Spain|Instituto Hispalense Pediatria, Sevilla, Spain|MMI ""Regional children's clinical hospital"", Chernivtsi, Chernivets'ka Oblast', Ukraine|Municipal Nonprofit Enterprise ""Lviv City Children's Clinical Hospital"", Lviv, L'vivs'ka Oblast', Ukraine|State Institution ""Dnipropetrovsk medical academy"", Dnipro, Ukraine|Kharkiv National Medical University, Kharkiv, Ukraine|Vinnytsya National Medical University, Vinnytsya, Ukraine|Birmingham Children's Hospital, Birmingham, United Kingdom|Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom|Barts Health NHS Trust - The Royal London Hospital, London, United Kingdom|King's College Hospital, London, United Kingdom|Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom|William Harvey Hospital, Willesborough, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04026113"
163,"NCT02131168","Epidemiology of IBD in Hong Kong: An Inception Cohort and Follow up Study","ACCESS","Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis",,"Number of new cases of IBD","Chinese University of Hong Kong","All","Child, Adult, Older Adult",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IBD EPI","January 2011","March 2021","September 2021","May 6, 2014",,"April 29, 2020","Prince of Wales Hospital, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT02131168"
164,"NCT04760353","The Effect of a Probiotic Mixture in Obese Patients With Irritable Bowel Syndrome",,"Not yet recruiting","No Results Available","IBS - Irritable Bowel Syndrome|Obesity","Dietary Supplement: Probiotic mixture (OMNi-BiOTiC STRESS)|Other: Placebo","Adequate relief|The fecal flora compositions","University Hospital Rijeka|Institute AllergoSan","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Omni Stress 1.1","August 1, 2021","August 1, 2022","December 1, 2022","February 18, 2021",,"April 22, 2021","Clinical Hospital Centre, Rijeka, Kresimirova 42, Croatia|University Hospital Rijeka, Rijeka, Croatia",,"https://ClinicalTrials.gov/show/NCT04760353"
165,"NCT04225819","Adjunctive Treatment With Vitamin D3 in Patients With Active IBD","ACTIVATED","Recruiting","No Results Available","IBD|Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis|Vitamin D3 Deficiency","Dietary Supplement: Vitamin D3|Other: Placebo","Short Inflammatory Bowel Disease Questionnaire (SIBDQ) outcome|stool microbiome in IBD patients|serum cathelicidin levels|HBI|SCCAI|fecal calprotectin|plasma 25(OH)D levels.","Massachusetts General Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","2019P003843","October 1, 2020","April 1, 2023","April 1, 2024","January 13, 2020",,"February 24, 2021","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04225819"
166,"NCT03729271","Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea",,"Recruiting","No Results Available","Irritable Bowel Syndrome|Irritable Bowel Syndrome With Diarrhea","Drug: Rifaximin|Device: Glucose and lactulose hydrogen breath testing","Number of treatment responders|Severity of abdominal pain by numeric rating scale (0-10)|Stool consistency by Bristol Stool Form Scale (1-7)|Severity of bloating by numeric rating scale (0-10)|Severity of bowel urgency by rating scale (0-10)|Compare the predictive value of a pre-treatment glucose vs. lactulose hydrogen breath test for symptomatic response to rifaximin in IBS-D patients.|Irritable Bowel Syndrome - Quality of Life Measure responder|Compare the predictive value of a pre-treatment glucose or lactulose hydrogen breath test","University of Michigan|Commonwealth Diagnostics International, Inc.","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 4","110","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","HUM00142925","January 9, 2020","January 1, 2023","January 1, 2023","November 2, 2018",,"December 24, 2020","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT03729271"
167,"NCT03983837","Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease",,"Enrolling by invitation","No Results Available","Chronic Granulomatous Disease|Inflammatory Bowel Disease","Other: Neocate Splash","Change in the relative abundance of proteobacteria in stool samples obtained after elemental diet.|Unexpected AEs possibly, probably, or definitely related to the elemental diet.|Ability to tolerate 4 weeks of elemental diet as measured by > 75% of caloric intake via elemental diet over the 4-week period.|Weight loss.|Initiation of antibiotics.|Changes in fecal calprotectin, ESR, and CRP.|Changes in the HBI at completion of the elemental diet and at 4 weeks after completion.|Change in alpha and beta diversity after diet","National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC)","All","8 Years to 40 Years   (Child, Adult)","Phase 2","10","NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","190108|19-I-0108","July 7, 2021","May 31, 2022","March 19, 2024","June 12, 2019",,"July 2, 2021","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT03983837"
168,"NCT03715673","Von Willebrand Antigen and Activity as Novel Biomarkers of Hemostasis in Inflammatory Bowel Disease",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Von Willebrand Diseases","Diagnostic Test: von willebrand antigen and activity","comparison of von willebrand antigen and activity between the two groups|detection of arterial or venous thrombosis|detection of acquired von willebrand syndrome|Estimation of the prevalence of IBD patients attending our clinic (Assiut University Experience).","Assiut University","All","18 Years and older   (Adult, Older Adult)",,"46","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","vWF in IBD","October 1, 2019","October 2020","December 2020","October 23, 2018",,"January 13, 2020","Assiut University, Assiut, Egypt",,"https://ClinicalTrials.gov/show/NCT03715673"
169,"NCT03829475","ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI","ICON-2","Recruiting","No Results Available","Inflammatory Bowel Diseases|Clostridium Difficile Infection","Drug: Bezlotoxumab|Drug: Placebo|Drug: Fecal Microbiota Transplantation","Clostridium difficile recurrence|Diarrheal symptoms|Rectal bleeding|Abdominal Pain","Brigham and Women's Hospital","All","18 Years and older   (Adult, Older Adult)","Phase 2","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","2018","January 1, 2020","June 1, 2021","December 30, 2021","February 4, 2019",,"January 26, 2021","Brigham and Women's Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT03829475"
170,"NCT02880722","Experience Sampling Method for Symptom Assessment in Irritable Bowel Syndrome",,"Recruiting","No Results Available","Irritable Bowel Syndrome",,"Abdominal pain scores as measured by the ESM tool.|Abdominal pain scores as measured by the end-of-day diary.|Abdominal pain scores as measured by the Gastrointestinal Symptom Rating Scale - IBS.|Symptom scores (other than abdominal pain) as measured using the ESM-tool.|Gastrointestinal symptom scores (other than abdominal pain) as measured using the end-of-day diary.|Gastrointestinal symptom scores (other than abdominal pain) as measured using the GSRS-IBS.|Psychological symptom scores as measured using the PHQ-9.|Psychological symptom scores as measured using the GAD-7.|Quality of life scores as measured using SF-36.","Maastricht University Medical Center|Grünenthal GmbH","All","18 Years to 70 Years   (Adult, Older Adult)",,"216","Other|Industry","Observational","Observational Model: Other|Time Perspective: Prospective","NL57473.068.16","October 2016","January 2022","January 2022","August 26, 2016",,"March 3, 2021","Maastricht University Medical Center, Maastricht, Netherlands",,"https://ClinicalTrials.gov/show/NCT02880722"
171,"NCT04692194","Study ""HEMORROIDAL SURGERY AND Chronic Inflammatory Bowel Disease""","CHRMICI","Active, not recruiting","No Results Available","Hemorrhoids|Chronic Inflammatory Bowel Disease",,"Morbidity from hemorrhoidal surgery","Groupe Hospitalier Paris Saint Joseph","All","18 Years and older   (Adult, Older Adult)",,"25","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","CHRMICI","December 28, 2020","January 31, 2021","June 30, 2021","December 31, 2020",,"April 27, 2021","Groupe Hospitalier Paris Saint-Joseph, Paris, Groupe Hospitalier Paris Saint-Joseph, France",,"https://ClinicalTrials.gov/show/NCT04692194"
172,"NCT04302623","Meditation and Yoga for Irritable Bowel Syndrome","MY-IBS","Recruiting","No Results Available","Yoga|Meditation|Irritable Bowel Syndrome","Behavioral: Yoga","IBS-Symptom Severity Scale|Fecal Microbiota Sequencing|IBS-Quality of Life|Generalized Anxiety Disorder|Patient Health Questionnaire|Perceived Stress Scale|Modified Fatigue Impact Scale-21|Scores range from 0 to 30. scores of 5, 10, and 15 represent cut points for low, medium, and high somatic symptom severity. Patient Health Questionnaire-15|Recruitment rates|Attrition rates|Adherence|Program preferences|Program satisfaction|Adverse event outcomes","University of Calgary","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research","REB20-0084","March 1, 2021","December 2021","June 2022","March 10, 2020",,"May 11, 2021","University of Calgary, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT04302623"
173,"NCT03471728","Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)",,"Active, not recruiting","No Results Available","Chronic Constipation (CC) (Excluding Constipation Due to Organic Diseases)|Irritable Bowel Syndrome With Constipation (IBS-C)","Drug: linaclotide","Incidence of diarrhea|Safety assessed by incidence of adverse drug reactions|Efficacy assessed by Global assessment of relief of IBS and constipation symptoms","Astellas Pharma Inc","All","Child, Adult, Older Adult",,"2475","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","0456-MA-3141","October 2, 2017","December 31, 2021","December 31, 2021","March 21, 2018",,"June 8, 2021","Site JP00023, Aichi, Japan|Site JP00005, Akita, Japan|Site JP00002, Aomori, Japan|Site JP00012, Chiba, Japan|Site JP00038, Ehime, Japan|Site JP00018, Fukui, Japan|Site JP00040, Fukuoka, Japan|Site JP00007, Fukushima, Japan|Site JP00021, Gifu, Japan|Site JP00010, Gunma, Japan|Site JP00034, Hiroshima, Japan|Site JP00001, Hokkaido, Japan|Site JP00028, Hyogo, Japan|Site JP00008, Ibaraki, Japan|Site JP00017, Ishikawa, Japan|Site JP00003, Iwate, Japan|Site JP00037, Kagawa, Japan|Site JP00046, Kagoshima, Japan|Site JP00014, Kanagawa, Japan|Site JP00039, Kochi, Japan|Site JP00043, Kumamoto, Japan|Site JP00026, Kyoto, Japan|Site JP00024, Mie, Japan|Site JP00004, Miyagi, Japan|Site JP00045, Miyazaki, Japan|Site JP00020, Nagano, Japan|Site JP00042, Nagasaki, Japan|Site JP00029, Nara, Japan|Site JP00015, Niigata, Japan|Site JP00044, Oita, Japan|Site JP00033, Okayama, Japan|Site JP00047, Okinawa, Japan|Site JP00027, Osaka, Japan|Site JP00041, Saga, Japan|Site JP00011, Saitama, Japan|Site JP00025, Shiga, Japan|Site JP00032, Shimane, Japan|Site JP00022, Shizuoka, Japan|Site JP00009, Tochigi, Japan|Site JP00036, Tokushima, Japan|Site JP00013, Tokyo, Japan|Site JP00031, Tottori, Japan|Site JP00016, Toyama, Japan|Site JP00030, Wakayama, Japan|Site JP00006, Yamagata, Japan|Site JP00035, Yamaguchi, Japan|Site JP00019, Yamanashi, Japan",,"https://ClinicalTrials.gov/show/NCT03471728"
174,"NCT02877654","Is There Any Correlation Between Plasmatic Zonulin and Expression of Intestinal Tight Junction Proteins in IBS Patients?","BISII","Recruiting","No Results Available","Irritable Bowel Syndrome","Procedure: colonoscopy with biopsies in the left colon to assess intestinal permeability","occludin level expression in left colonic biopsies|plasmatic zonulin expression|Claudin and ZO-1 level expression in left colonic biopsies|Faecal calprotectin level|Quality of life (GIQLI)|Abdominal symptoms|Anxiety and depression levels","University Hospital, Rouen","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","112","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening","2015/174/HP","February 2, 2017","February 2021","February 2021","August 24, 2016",,"June 29, 2020","Rouen University Hospital, Rouen, France",,"https://ClinicalTrials.gov/show/NCT02877654"
175,"NCT04835727","Effect of Semi-vegetarian Diet in Inflammatory Bowel Disease Patients With Clinical Remission",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Calprotectin|Fecal Microbiota|Vegetarian Diet","Other: Semi-vegetarian diet and increase fiber consumption","Rate of participants with clinical relapses|C-Reactive Protein (CRP)|fecal calprotectin level|Fecal microbiota|Quality of life score of SIBDQ|Quality of life score of EQ5D3L","Mahidol University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","Si 063/2020","January 21, 2020","October 1, 2021","October 1, 2021","April 8, 2021",,"April 13, 2021","Gastroenterology division, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand",,"https://ClinicalTrials.gov/show/NCT04835727"
176,"NCT04650867","Non Invasive Characterization of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography","PED_MSOT_IBD","Recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis|IBD","Device: Multispectral Optoacoustic Tomography (MSOT)","Quantitative amount of oxygenated/deoxygenated hemoglobin in a.u.|Quantitative amount of fibrosis/collagen signal in a.u.|Quantitative amount of single wavelength signal in a.u.|Optoacoustic spectrum in a.u.|Endoscopic extent of inflammation|Histological extent of inflammation and fibrosis|Clinical evaluation|Ultrasound|Laboratory parameters (blood - c-reaktive protein (CrP))|Laboratory parameters (stool - Calprotectin)|MRI","University of Erlangen-Nürnberg Medical School","All","2 Years to 18 Years   (Child, Adult)",,"30","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","351_20B","March 22, 2021","December 31, 2023","December 31, 2023","December 3, 2020",,"April 29, 2021","University Hospital Erlangen, Erlangen, Bavaria, Germany",,"https://ClinicalTrials.gov/show/NCT04650867"
177,"NCT04178408","IBD Registry in a Sub-Saharan African Population",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease","Other: No intervention","Demographic and phenotypic features of inflammatory bowel disease|Risk factors of inflammatory bowel disease in Zimbabwe|Dietary risk factors of inflammatory bowel disease in Zimbabwe|Incidence and prevalence of inflammatory bowel disease in Zimbabwe","University of Zimbabwe|IBDnet|University of Bern","All","Child, Adult, Older Adult",,"100","Other","Observational","Observational Model: Other|Time Perspective: Prospective","IBDZIM","January 2, 2020","December 31, 2021","December 31, 2025","November 26, 2019",,"December 4, 2019","Parirenyatwa Hospital, Harare, Zimbabwe",,"https://ClinicalTrials.gov/show/NCT04178408"
178,"NCT04388865","Patient Automated Text Hovering for IBD","PATH-IBD","Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis","Behavioral: Control|Behavioral: Text-based Clinical Hovering","Short Inflammatory Bowel Disease Questionnaire (SIBDQ) response|Patient Satisfaction|Medication Adherence","University of Pennsylvania","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research","842733","February 23, 2021","November 1, 2021","November 1, 2021","May 14, 2020",,"March 2, 2021","University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT04388865"
179,"NCT04345393","Translating Scientific Evidence Into Practice Using Digital Medicine and Electronic Patient Reported Outcomes",,"Not yet recruiting","No Results Available","Inflammatory Bowel Disease (IBD)","Behavioral: Digital Transformation Network (DTN) Program","Number of Participants in Disease Control|Change in Number of Unplanned Acute Care|Northstar Digital Literacy Assessment|Digital Disparities Module|Overall Health Numeric Rating Scale [OHNRS]|PROMIS Global scales|Patient Health Questionnaire (PHQ-4)|Patient Health Questionnaire (PHQ-9)|Generalized Anxiety Disorder scale (GAD-7)|Number of participants with improvement in mucosal healing|Visual Analog Scale (VAS)|Proportion of patients meeting eligible quality metrics|System Usability Scale (SUS)|Net Promoter Score","Icahn School of Medicine at Mount Sinai|The Cleveland Clinic|Northwestern University|Responsive Health","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1578","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","GCO 18-2481","January 2021","March 2024","March 2024","April 14, 2020",,"April 14, 2020","Northwestern University, Chicago, Illinois, United States|Responsive Health, Secaucus, New Jersey, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Cleveland Clinic, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT04345393"
180,"NCT03852745","Managing Stress With Inflammatory Bowel Disease",,"Active, not recruiting","No Results Available","Inflammatory Bowel Disease|Anxiety|Depression","Behavioral: Cognitive Behavioral Therapy","Change in Hospital Anxiety and Depression Scale (HADS)|Change in Perceived Stress Scale 4 (PSS-4)|Change in Patient-Reported Outcomes Measurement Information System - 29 (PROMIS-29)|Change in Clinical Global Impression - Improvement scale (CGI-I)|Change in the Work and Social Adjustment Scale (WSAS)|Change in Inflammatory Bowel Disease Symptom Inventory - Short Form (IBDSI)","University of Manitoba","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","H2018:333|H2017:228","April 18, 2019","May 31, 2021","October 30, 2021","February 25, 2019",,"March 29, 2021","University of Manitoba - College of Medicine, Winnipeg, Manitoba, Canada",,"https://ClinicalTrials.gov/show/NCT03852745"
181,"NCT04617184","Registry and Biorepository for IBD in Central Texas",,"Recruiting","No Results Available","Crohn Disease|Ulcerative Colitis|Inflammatory Bowel Diseases","Other: NO INTERVENTION","Number of patients with inflammatory bowel disease","University of Texas at Austin","All","18 Years to 100 Years   (Adult, Older Adult)",,"1000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2019-07-0137","June 1, 2021","December 31, 2030","December 31, 2030","November 5, 2020",,"May 18, 2021","Dell Medical School, UT Austin, Austin, Texas, United States",,"https://ClinicalTrials.gov/show/NCT04617184"
182,"NCT04598529","Impact of A2 Milk Versus Conventional Milk on Intestinal Health: a Proof-of-concept Study in IBS-patients",,"Not yet recruiting","No Results Available","Irritable Bowel Syndrome","Other: A2 milk|Other: Conventional milk","The acute effects of A2 milk versus conventional milk on overall gastrointestinal discomfort in separate groups of individuals with IBS-C and IBS-D.|The mid-term effects of A2 milk versus conventional milk on overall gastrointestinal discomfort in separate groups of individuals with IBS-C and IBS-D.|The acute and mid-term effects of A2 milk versus conventional milk on single gastrointestinal symptoms and stool characteristics in separate groups of individuals with IBS-C and IBS-D.|The mid-term effects of A2 milk versus conventional milk on single gastrointestinal symptoms and stool characteristics in separate groups of individuals with IBS-C and IBS-D.|The mid-term effects of A2 milk versus conventional milk on gastrointestinal immune and defense markers in separate groups of individuals with IBS-C and IBS-D.","Maastricht University Medical Center","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","NL73898.068.20|METC 20-032","October 2020","December 2022","December 2022","October 22, 2020",,"October 22, 2020",,,"https://ClinicalTrials.gov/show/NCT04598529"
183,"NCT04223518","Serum Bovine Immunoglobulin (SBI) in Children and Young Adults With Inflammatory Bowel Disease (IBD)",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease","Dietary Supplement: Serum bovine immunoglobulin|Dietary Supplement: Placebo","Effects of Serum Bovine Immunoglobulin (SBI) on nutrition of pediatric patients with inflammatory Bowel Disease|Effects of SBI on nutritional marker: Vitamin D|Effects of SBI on nutritional marker: pre-albumin|Effects of SBI on nutritional markers: transferrin and iron saturation|Effects of SBI on weight|Effects of SBI on Body Mass Index (BMI)|Safety assessment for kidney function|Safety assessment for liver function|Effect of SBI on symptom of diarrhea for ulcerative colitis|Effect of SBI on symptom of diarrhea for Crohn's disease|Effect of SBI on disease activity (ESR)|Effect of SBI on disease activity (CRP)|Effect of SBI on disease activity (calprotectin)|Effect of SBI on stool microbiota","Monisha Hitesh Shah|The University of Texas Health Science Center, Houston","All","6 Years to 30 Years   (Child, Adult)","Early Phase 1","43","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","HSC-MS-19-0998","September 20, 2020","May 31, 2021","June 25, 2021","January 10, 2020",,"November 13, 2020","University of Texas Health Science Center at Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT04223518"
184,"NCT04626947","Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease|C. Diff. Infections","Biological: Bezlotoxumab","Number of participants with recurrent C. Diff infection at 90 days|Number of participants with recurrent C. Diff infection at 12 months|Number of participants with recurrent C. Diff infection at 24 months|Change from baseline in inflammatory markers after Bezlotoxumab at 90 days|Change from 90 days in inflammatory markers after Bezlotoxumab at 12 months|Change from 12 months in inflammatory markers after Bezlotoxumab at 24 months|Change from baseline in disease activity scores after Bezlotoxumab at 90 days|Change from 90 days in disease activity scores after Bezlotoxumab at 12 months|Change from 12 months in disease activity scores after Bezlotoxumab at 24 months|Change from baseline in disease related quality of life after Bezlotoxumab at 90 days|Change from 90 days in disease related quality of life after Bezlotoxumab at 12 months|Change from 12 months in disease related quality of life after Bezlotoxumab at 24 months|Change from 90 days in healthcare utilization after Bezlotoxumab at 12 months|Change from 12 months in healthcare utilization after Bezlotoxumab at 24 months|Change from 90 days in healthcare associated charges after Bezlotoxumab at 12 months|Change from 12 months in healthcare associated charges after Bezlotoxumab at 24 months","David Binion, MD|Merck Sharp & Dohme Corp.|University of Pittsburgh","All","18 Years and older   (Adult, Older Adult)","Phase 4","50","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","STUDY19100301","May 30, 2021","December 30, 2023","December 30, 2025","November 13, 2020",,"April 12, 2021","University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT04626947"
185,"NCT04079335","A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease",,"Clinical relapse for CD patients|Clinical relapse for UC patients","Chinese University of Hong Kong","All","18 Years and older   (Adult, Older Adult)",,"40","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IBD MiREL","January 28, 2019","January 28, 2021","January 28, 2021","September 6, 2019",,"September 6, 2019","Chinese University of Hong Kong, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT04079335"
186,"NCT04191655","High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Colon Dysplasia|Ulcerative Colitis|Crohn Colitis|Indeterminate Colitis","Device: High Definition Colonoscopy|Device: Dye Spraying Chromocolonoscopy","Detection rate of dysplastic lesions in High Definition White Light Colonoscopy versus Dye Spraying Chromo-colonoscopy|Detection rate of Adenoma in both groups.|Detection rate of high-grade dysplasia in both groups.|Numbers of detected adenomas per patient.|Difference in withdrawal time to perform the procedure in both groups.|Difference in adverse event, mild (e.g.; nausea, vomiting, or abdominal pain that necessitate phone call from the patient to the provider, or sever (e.g.; GI bleeding, perforation, hospitalization after the procedure) for each arm.|Number of targeted chromoendoscopies|Appropriateness of reported follow up recommendations per standard guideline recommendations","Beth Israel Deaconess Medical Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","500","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Screening","2018P000795","April 3, 2019","October 2021","December 2021","December 10, 2019",,"June 29, 2020","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04191655"
187,"NCT03338894","A Trial of Yoga in Pediatric Inflammatory Bowel Disease",,"Active, not recruiting","Has Results","Inflammatory Bowel Disease|Crohn's Disease|Ulcerative Colitis","Behavioral: Yoga","Pediatric Quality of Life Inventory|General Perceived Self Efficacy Scale","Atlantic Health System","All","10 Years to 17 Years   (Child)","Not Applicable","66","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","YOGAL","December 13, 2017","March 18, 2020","December 31, 2021","November 9, 2017","June 8, 2021","June 8, 2021","Morristown Memorial Hospital/Goyerb Children's Hospital, Morristown, New Jersey, United States|Children's Hospital of Philadelphia/Roberts Center for Pediatric Research, Philadelphia, Pennsylvania, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/94/NCT03338894/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03338894"
188,"NCT04179201","Study on Clostridium Difficile Infection in Chinese Patients With Inflammatory Bowel Disease",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Clostridium Infections",,"Prevalence rate of IBD with CDI in Chinese adults|Risk factors of IBD with CDI in China|Gut microbiota in patients with IBD-CDI，IBD and healthy volunteers by 16S rDNA sequencing","Xijing Hospital","All","Child, Adult, Older Adult",,"1000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","ChiECRCT20190106","September 13, 2017","January 2020","September 2020","November 27, 2019",,"November 27, 2019","The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China|The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China|Xijing Hospital, Xi'an, Shaanxi, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China|Peking Union Medical College Hospital, Beijing, China|Renji Hospital, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT04179201"
189,"NCT02931799","Prevention of Readmissions at IBD Centres of Excellence","PRICE","Not yet recruiting","No Results Available","Colitis, Ulcerative|Crohn Disease|Inflammatory Bowel Diseases","Behavioral: Nurse Follow-Up|Other: Electronic Monitoring|Other: Post-Discharge Questionnaire|Other: Standard of Care","Post-Discharge Readmission|Post-Discharge Occurrence of Venous Thromboembolism|Patient Satisfaction with Health Care in IBD|IBD related Quality of Life|Disease Activity|Patient Satisfaction with 'Health Promise'","Mount Sinai Hospital, Canada|Crohn's and Colitis Canada","All","18 Years and older   (Adult, Older Adult)","Not Applicable","400","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","PRICE","October 1, 2018","September 2021","December 2021","October 13, 2016",,"September 10, 2018","Mount Sinai Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02931799"
190,"NCT04612803","Prevalence of Antihistamine Responsive Irritable Bowel Syndrome With Diarrhea",,"Not yet recruiting","No Results Available","Irritable Bowel Syndrome|Dermatographism|Post-prandial Diarrhea","Drug: Antihistamine","IBS symptomy severity score|IBS quality of life","University of Cincinnati","All","18 Years and older   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","2020-0193","November 15, 2020","August 1, 2021","August 1, 2021","November 3, 2020",,"November 3, 2020",,,"https://ClinicalTrials.gov/show/NCT04612803"
191,"NCT04646187","De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease","FREE","Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Colitis, Ulcerative","Biological: Infliximab|Biological: Adalimumab","cumulative incidence of out-of-range fecal calprotectin results at 48 weeks follow-up|Time to get out-of-range fecal calprotectin results|Cumulative incidence of anti-TNF-associated respiratory infections and dermatological adverse effects at 48 weeks follow-up|Evolution of FC and anti-TNF trough levels in the first 16 weeks after reverting to previous dosing interval|Proportion of patients developing loss-of-response in the first 16 weeks after reverting to the previous dosing interval|Identification of predictors of successful de-escalation.","University Medical Center Groningen|European Crohn´s and Colitis Organisation|Bühlmann Laboratories AG","All","12 Years to 25 Years   (Child, Adult)","Phase 4","148","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","202000261|2020-001811-26","March 11, 2021","April 2022","April 2022","November 27, 2020",,"March 17, 2021","Universitair Ziekenhuis Gent, Gent, Belgium|Centre hospitalier universitaire de Liège, Liège, Belgium|University Medical Center Groningen, Groningen, Netherlands|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Spain",,"https://ClinicalTrials.gov/show/NCT04646187"
192,"NCT02308917","Canadian Children Inflammatory Bowel Disease Network (CIDsCANN)","CIDsCaNN","Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn's|Ulcerative Colitis",,"Sustained Clinical Remission|Other Clinical Outcomes (combination of Pediatric Crohn's Disease Activity Index, Pediatric Ulcerative Colitis Activity Index, physician global assessment of disease activity, serologic inflammatory markers and fecal calprotectin results)","The Hospital for Sick Children|Children's Hospital of Eastern Ontario|British Columbia Children's Hospital|Alberta Children's Hospital|Stollery Children's Hospital|IWK Health Centre|Montreal Children's Hospital of the MUHC|St. Justine's Hospital|Health Sciences Centre, Winnipeg, Manitoba|Eastern Health|Children's Hospital of Western Ontario|McMaster Children's Hospital","All","2 Years to 17 Years   (Child)",,"2400","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","1000039604","September 2013","April 1, 2026","April 1, 2026","December 5, 2014",,"February 8, 2021","Alberta Children'S Hospital, Calgary, Alberta, Canada|Stollery Children'S Hospital, Edmonton, Alberta, Canada|Children'S Hospital of Bc, Vancouver, British Columbia, Canada|Winnipeg Children'S Hospital, Winnipeg, Manitoba, Canada|Janeway Children'S Health & Rehabilitation Centre, St. John's, Newfoundland and Labrador, Canada|Izaak Walton Killam Hospital (Iwk), Halifax, Nova Scotia, Canada|William Osler Health System, Brampton, Ontario, Canada|Hamilton Health Sciences, Hamilton, Ontario, Canada|CHILDRENS HOSPITAL OF WESTERN ONTARIO, Lawson Health Research Institute, London, Ontario, Canada|Children's Hospital of Eastern Ontario (CHEO), Ottawa, Ontario, Canada|SickKids Hospital, Toronto, Ontario, Canada|Montreal Children'S Hospital, Montreal, Quebec, Canada|Hopital Ste. Justine, Montreal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT02308917"
193,"NCT03855657","Biobank - Investigating the Gut Microbiota, Genetics, Epigenetics and Metabolites",,"Recruiting","No Results Available","Inflammatory Bowel Diseases",,"Setup a large scale biobank|Intestinal microbiota of IBD patient|Genetics and epigenetic markers in IBD|Therapeutic drug monitoring|Biomarker of IBD|Pathobionts of IBD|Microbiota-induced molecular mechanisms|Disease pathogenesis","Chinese University of Hong Kong","All","18 Years and older   (Adult, Older Adult)",,"6000","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","IBD Biobank Study","March 2014","February 2034","July 2034","February 27, 2019",,"April 29, 2020","Prince of Wales Hospital, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT03855657"
194,"NCT04905524","Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)",,"Recruiting","No Results Available","Depression, Anxiety|IBS - Irritable Bowel Syndrome","Dietary Supplement: VIOME Precision Nutrition Program","Disease activity changes for IBS|Disease activity changes depression|Disease activity changes anxiety","Viome","All","18 Years and older   (Adult, Older Adult)","Not Applicable","10000","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","V216 (VIOME-001 v5.0)","May 19, 2021","December 31, 2023","December 31, 2023","May 27, 2021",,"June 8, 2021","Viome Research Institute, Bothell, Washington, United States",,"https://ClinicalTrials.gov/show/NCT04905524"
195,"NCT04526808","Effects of Low FODMAP Diet on Leaky Gut",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Other: FODMAP diet","colonic permeability|colonic immune cells|colonic microbiome","Beth Israel Deaconess Medical Center","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2019P000149","May 20, 2019","June 2021","December 2021","August 26, 2020",,"August 26, 2020","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT04526808"
196,"NCT03532932","A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice","INTENT","Recruiting","No Results Available","Colitis, Ulcerative|Crohn Disease|Inflammatory Bowel Diseases",,"Percentage of UC and CD Participants Treated with Biologics Observed for Treatment Patterns|Percentage of UC and CD Participants Treated with Non-biological Treatment Observed for Treatment Patterns|Percentage of Participants Based on Usage of Methods for Documentation of Disease Activity in Routine Practice|Percentage of Participants Based on Objective UC and CD Disease Activity Assessment Using Different Methods|Percentage of Participants who Achieved Clinical and Combined Clinical and Endoscopic Remission|Percentage of Participants with at least one Episode of Failure of Biological or Non-biological Therapy|Number of Participants Based on Treatment Decisions or Actions made after Making the Clinical Patterns of Treatment Decisions or Actions made after Assessment of IBD Activity Depending on Scenario of Achievement or Non-achievement of T2T Treatment Goals|Percentage of Participants Based on Challenges of Implementing a T2T Strategy in UC and CD Participants in Real Clinical Practice|Percentage of Participants with Hospitalizations due to Complications, IBD related Surgeries, and Disability Determination|Percentage of Participants with Surgical Treatment Based on Indications, Types of Surgeries and Complications","Takeda","All","18 Years and older   (Adult, Older Adult)",,"2000","Industry","Observational","Observational Model: Cohort|Time Perspective: Other","IBD-5005|U1111-1207-6263","July 20, 2018","July 15, 2021","July 15, 2021","May 22, 2018",,"July 21, 2020","Republican Gastroenterology Center, City Clinical Hospital # 10, Minsk, Minsk Region, Belarus|Vitebsk regional clinical specialized center, Vitebsk, Vitebsk Region, Belarus|Scientific-Research Institute of Cardiology and Internal Diseases, Gastroentorology department, Almaty, Almaty Region, Kazakhstan|The Centre of Coloproctology based at City Hospital 1, Astana, Astana Region, Kazakhstan|Regional clinical hospital, Shymkent, Shymkent Region, Kazakhstan|Regional Clinical Hospital, Barnaul, Altai Territory, Russian Federation|State Budgetary Healthcare Institution ""Chelyabinsk Regional Clinical hospital"", Chelyabinsk, Chelyabinsk Region, Russian Federation|State Budgetary Healthcare Institution Irkutsk Order of the Badge of Honor Regional Clinical Hospital, Irkutsk, Irkutsk Region, Russian Federation|State Autonomous Healthcare Institution of Kemerovo region ""Kemerovo regional clinical hospital n. a. S.V. Belyaev"", Kemerovo, Kemerovo Region, Russian Federation|Regional State Budgetary Healthcare Institution ""Regional Clinical Hospital # 1 n. a. S.I. Sergeev"", Khabarovsk, Khabarovsk Territory, Russian Federation|Budgetary Institution ""Surgut District Clinical Hospital"", Surgut, Khanty-Mansi Autonomous Okrug-Yugra, Russian Federation|State Budgetary Institution ""Regional Clinical Hospital No. 1 named after Professor S.V. Ochapovsky""., Krasnodar, Krasnodar Region, Russian Federation|Krasnoyarsk Interdistrict Clinical Hospital No. 20 named after IS Berzon, Krasnoyarsk, Krasnoyarsk Region, Russian Federation|Federal State Budget Military Educational Institution of Higher Education ""Military Medical Academy named after S.Kirov"" of the Ministry of Defense of the Russian Federation, Saint-Petersburg, Leningrad Region, Russian Federation|Scientific and Research Center ""Eco-safety"", LLC, Saint-Petersburg, Leningrad Region, Russian Federation|St. Petersburg State Budgetary Healthcare Institution ""City Clinical Hospital No. 31"", Saint-Petersburg, Leningrad Region, Russian Federation|MEDSI Clinical Hospital, Krasnogorsk, Moscow Region, Russian Federation|Moscow Clinical Scientific Center, Moscow, Moscow Region, Russian Federation|State Scientific Center of Coloproctology, Moscow, Moscow Region, Russian Federation|State Budgetary Healthcare Institution Moscow Regional Research and Clinical Institute (MONIKI) n. a. M. F. Vladimirskiy, Moscow, Moscow Region, Russian Federation|Regional Clinical Hospital, Omsk, Omsk Region, Russian Federation|Perm regional clinical hospital, Perm, Perm Region,, Russian Federation|Medical Academy n. a. S. I. Georgievksiy Federal State Autonomous Educational Institution of Higher Education ""Crimean State University n. a. V.I. Vernadskiy, Simferopol, Republic Crimea, Russian Federation|State Budgetary Healthcare Institution Republic of Crimea ""Republican clinical hospital n.a. N.A.Semashko"", Simferopol, Republic Crimea, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""Bashkir State Medical University"" of the Ministry of Health of the Russian Federation, Ufa, Republic Of Bashkortostan, Russian Federation|Federal State Budget Educational Institution of Higher Education ""Petrozavodsk State University"", Petrozavodsk, Republic Of Karelia, Russian Federation|Health Care Unit # 1 of Yoshkar-Ola city, Yoshkar-Ola, Republic Of Maruy El, Russian Federation|Budgetary Institution of Health in the Republic of Udmurtia First Republican Clinical Hospital under the Ministry of Health, the Republic of Udmurtia, Izhevsk, Republic Of Udmurtia, Russian Federation|State Budgetary Institution of Ryazan Region ""City Clinical Hospital #4"", Ryazan, Ryazan Region, Russian Federation|Society with limited liability ""Medical Association"" New Hospital "", Ekaterinburg, Sverdlovsk Region, Russian Federation|Republican Clinical Hospital Ministry of health Republic of Tatarstan, Kazan, Tatarstan Republic, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""Chita state medical academy"" of the Ministry of Health of the Russian Federation, Chita, Transbaikal Region, Russian Federation|State Budgetary Healthcare Institution RB Regional Clinical Hospital G.G Kuvatov, Ufa, Ufa Region, Russian Federation|State Budgetary Healthcare Institution City Clinical Hospital 21, Ufa, Ufa Region, Russian Federation|State Healthcare Institution Ulyanovsk Regional Clinical Hospital, Ulyanovsk, Ulyanovsk Region, Russian Federation|Regional Clinical Hospital, Vladimir, Vladimir Region, Russian Federation",,"https://ClinicalTrials.gov/show/NCT03532932"
197,"NCT02874365","Intestinal Stem Cells Characterization","BIODIGE","Recruiting","No Results Available","Inflammatory Bowel Diseases","Procedure: Endoscopic biopsies","number of organoids|mean size of organoids|percentage of different types of organoids","University Hospital, Toulouse","All","3 Years and older   (Child, Adult, Older Adult)","Not Applicable","120","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","RC31/15/7816","September 2016","December 2020","December 2021","August 22, 2016",,"November 10, 2020","Hopital des Enfants, Toulouse, France",,"https://ClinicalTrials.gov/show/NCT02874365"
198,"NCT04236843","Faecal Microbiota Transplantation (FMT) in Patients With IBSmechanism(s) of Action",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Dietary Supplement: Feces","Change in IBS-SSS total score|Change in the Dysbiosis index","Helse Fonna|University of Bergen","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Helse Fonna","January 1, 2020","December 31, 2020","December 31, 2021","January 22, 2020",,"May 21, 2020","Helse Fonna, Haugesund, Norway",,"https://ClinicalTrials.gov/show/NCT04236843"
199,"NCT03664531","Dietary Triggers of Gastrointestinal Symptoms in IBS Patients",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Other: Purified gluten|Other: Non-purified gluten (containing ATIs)|Other: Nocebo","Irritable Bowel Syndrome (IBS) symptoms|General gastrointestinal symptoms|Orocecal transit|Anti-gliadin antibody (AGA) levels|Gut microbiota profiles|Genetic predisposition for celiac disease|Depression, anxiety and stress|Somatic symptoms|Stool consistency|Gluten levels in stool|Diet assessment|IBS symptom duration|Systemic immune reactivity","McMaster University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","34","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","Diet in IBS","January 1, 2019","August 2021","February 2022","September 10, 2018",,"September 29, 2020","McMaster University Medical Centre, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03664531"
200,"NCT03269032","Mediterranean Diet and the Gut Microbiome",,"Active, not recruiting","No Results Available","Irritable Bowel Syndrome","Other: American Diet|Other: Mediterranean-style Diet","Phase 1- Change in predominant enterotypes and diversity of fecal microbiota|Phase 2-Change in predominant enterotypes and diversity of fecal microbiota|Changes in plasma inflammatory marker - Erythrocyte sedimentation rate (ESR)|Changes in plasma inflammatory marker - C-reactive protein (CPR)|Changes in IBS Symptom Severity Scores|Changes in Hospital Anxiety and Depression Scores","Wake Forest University Health Sciences","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","IRB00039422","October 10, 2017","December 2021","December 2021","August 31, 2017",,"November 20, 2020","Wake Forest Baptist Heath, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03269032"
201,"NCT02550704","Association Between High Faecal Calprotectin, Increased Intestinal Permeability and Visceral Hypersensitivity in IBS-D Patients","SIIMPA","Recruiting","No Results Available","Irritable Bowel Syndrome","Procedure: Colonoscopy with eleven biopsies in the left colon to assess intestinal permeability","Occludin level expression in left colonic biopsies|Faecal calprotectin level|Claudin level expression in left colonic biopsies|Zonula Occludens (ZO)-1 level expression|Pression pain threshold by rectal barostat|Quality of life by GIQLI|Abdominal symptoms|Anxiety and depression level","University Hospital, Rouen|Société Nationale Française de Gastroentérologie","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","68","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening","2015/079/HP","May 20, 2016","October 2020","October 20, 2020","September 15, 2015",,"June 30, 2020","Rouen University Hospital, Rouen, France",,"https://ClinicalTrials.gov/show/NCT02550704"
202,"NCT03459482","Endpoint Determination Study Protocol",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Other: Food Elimination Diet","Change in the IBS-API - Abdominal Pain Intensity. The IBS-API is being assessed daily from enrollment (baseline) to study completion; total 10 weeks","Biomerica","All","21 Years and older   (Adult, Older Adult)","Not Applicable","180","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","EPT-InF24-001","June 21, 2018","April 2021","April 2021","March 9, 2018",,"January 28, 2021","Mayo Clinic, Scottsdale, Arizona, United States|Mayo Clinic, Jacksonville, Florida, United States|Family Medicine Specialists, Wauconda, Illinois, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Michigan Health System, Ann Arbor, Michigan, United States|Houston Methodist Research Institute, Houston, Texas, United States|UT Health, Houston, Texas, United States|Gastroenterology Research of San Antonio, San Antonio, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03459482"
203,"NCT04916067","Stoma Closure and Reinforcement Trial ll","SCAR-ll","Not yet recruiting","No Results Available","Ileostomy - Stoma|Inflammatory Bowel Diseases","Device: Mesh Implantation","Incidence of wound occurrences|Incidence of hernia formation|Quality of Life after mesh implantation|Bowel Function after mesh implantation","Dartmouth-Hitchcock Medical Center|Becton, Dickinson and Company","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","STUDY02000875","June 15, 2021","June 15, 2023","June 15, 2024","June 7, 2021",,"June 7, 2021","Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States",,"https://ClinicalTrials.gov/show/NCT04916067"
204,"NCT04196920","Methotrexate-associated Anti-TNF Combination Therapy, the Neglected One !","MTX","Active, not recruiting","No Results Available","Chronic Inflammatory Bowel Disease",,"Evaluation of the efficacy of anti-TNF alpha and methotrexate combination therapy|Tolerance assessment of anti-TNF alpha and methotrexate combination therapy","University Hospital, Montpellier|Rennes University Hospital - CHU Pontchaillou","All","18 Years and older   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Other|Time Perspective: Retrospective","RECHMPL19_0580","December 20, 2019","May 1, 2020","November 30, 2020","December 12, 2019",,"June 5, 2020","Uhmontpellier, Montpellier, France",,"https://ClinicalTrials.gov/show/NCT04196920"
205,"NCT04151420","Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported Assessment",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis|IBD|Digestive System Disease|Patient Reported Outcome Measures","Other: Remote monitoring tool (infections questionnaire) validation","Remote monitoring tool validation|Relative risk of all infections|Relation between mild/moderate and serious infectious complications","Maastricht University Medical Center|Takeda","All","18 Years to 70 Years   (Adult, Older Adult)",,"492","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","MEC 2019-1115","June 15, 2020","November 2021","April 2022","November 5, 2019",,"October 19, 2020","Maastricht University Medical Centrer, Maastricht, Netherlands|Zuyderland Medical Centre, Sittard, Netherlands",,"https://ClinicalTrials.gov/show/NCT04151420"
206,"NCT04428619","Percutaneous Electrical Nerve Field Stimulation for Adults With Irritable Bowel Syndrome",,"Recruiting","No Results Available","Irritable Bowel Syndrome|Abdominal Pain|Autonomic Nervous System Imbalance","Device: Peripheral Electrical Nerve Field Stimulation (PENFS) Device|Device: Sham Device","Mean change in IBS symptom severity from baseline|IBS symptom severity responder rate|Daily worst abdominal pain responder rate|Mean change in average daily worst abdominal pain from baseline|Change in average weekly abdominal pain symptoms from baseline|Change in average daily stool consistency from baseline|Change in average weekly bowel habits from baseline|Change in average weekly bloating symptoms from baseline|Change in quality of life from baseline|Change in heart rate variability from baseline|Incidence of treatment-related adverse events as assessed by a weekly adverse events questionnaire","University of California, Los Angeles|Innovative Health Solutions","All","18 Years to 60 Years   (Adult)","Not Applicable","54","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","IRB# 19-001796","August 1, 2020","May 1, 2022","November 30, 2022","June 11, 2020",,"January 29, 2021","UCLA, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT04428619"
207,"NCT00775060","Maastricht IBS Cohort",,"Recruiting","No Results Available","Irritable Bowel Syndrome",,,"Maastricht University Medical Center","All","18 Years to 75 Years   (Adult, Older Adult)",,"600","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","MEC 08-3-066","September 2009","September 2024","September 2024","October 17, 2008",,"April 7, 2016","Maastricht University Medical Center, Maastricht, Netherlands",,"https://ClinicalTrials.gov/show/NCT00775060"
208,"NCT04225650","Prevalence of Respiratory Impairment During IBD","PARAMICI","Not yet recruiting","No Results Available","Chronic Obstructive Pulmonary Disease|Asthma|Bronchiectasis|Inflammatory Bowel Diseases","Other: Pulmonology consultation","Frequency of functional respiratory signs|Chronic respiratory diseases|Exacerbations|Drugs","Central Hospital, Nancy, France|University of Lorraine","All","18 Years and older   (Adult, Older Adult)",,"480","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2019PI164","May 1, 2020","July 2020","August 2020","January 13, 2020",,"April 15, 2020",,,"https://ClinicalTrials.gov/show/NCT04225650"
209,"NCT04557215","Efficacy and Safety of Rifaximin With NAC in IBS-D",,"Recruiting","No Results Available","Irritable Bowel Syndrome With Diarrhea","Drug: Rifaximin|Drug: N-acetylcysteine|Drug: Placebo","Change in stool form and in stool frequency|Change in abdominal pain|Change in urgency|Changes in bloating|Changes of Hydrogen on lactulose hydrogen breath test","Cedars-Sinai Medical Center|Bausch Health Ireland Limited","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1|Phase 2","45","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","550","November 13, 2020","February 2021","June 2021","September 21, 2020",,"December 4, 2020","Cedars-Sinai Medical Center, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT04557215"
210,"NCT04637399","Circadian Misalignment in Inflammatory Bowel Disease",,"Active, not recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis",,"Harvey Bradshaw Activity Index|Beck's Depression Index|International Restless Leg Syndrome Scale|Berlin OSA Questionnaire|Short Inflammatory Bowel Disease Questionnaire|Munich Chronotype Questionnaire|Owl and Lark Questionnaire|ActiWatch|Food Timing Questionnaire|Sleep Diary|Urine Samples|C-Reactive Protein|Left Sided Colon Tissue Samples","Rush University Medical Center","All","18 Years to 70 Years   (Adult, Older Adult)",,"68","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","16080305","November 22, 2016","November 2021","November 2021","November 19, 2020",,"November 19, 2020","Rush University Medical Center, Chicago, Illinois, United States","""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/99/NCT04637399/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT04637399"
211,"NCT04082559","Biomarker-based Multidisciplinary Team (Bio-MDT) Approach to Personalized Microbial-targeted Treatment of Pouchitis and Crohn's Disease","Bio-MDT","Recruiting","No Results Available","Inflammatory Bowel Diseases","Other: Arm 1- Antibiotics treatment|Other: Arm 2- Antibiotics treatment|Other: Arm 1- Combination therapy (Antibiotics + diet)|Other: Arm 2- Combination therapy (Antibiotics + diet)|Other: Arm 1- Nutritional prevention|Other: Arm 2- Nutritional prevention|Other: Arm 3- Nutritional prevention","Time interval to response|Time interval to remission","Rabin Medical Center|The Leona M. and Harry B. Helmsley Charitable Trust|Tel Aviv University","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","170","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","0129-19-RMC","June 11, 2019","June 11, 2021","June 11, 2023","September 9, 2019",,"October 8, 2020","Rabin Medical Center, Petah Tikva, Israel",,"https://ClinicalTrials.gov/show/NCT04082559"
212,"NCT03369353","Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)","PREDICT","Enrolling by invitation","No Results Available","Graft Vs Host Disease|Inflammatory Bowel Diseases|Functional Gastrointestinal Disorders",,"Perform flow cytometry, TCR deep sequencing and whole transcriptome analysis on T cells purified from GI endoscopy samples taken for presumed GI GVHD, inflammatory bowel disease (IBD), and functional gastrointestinal disease (FGID).|Perform flow cytometry, TCR deep sequencing and transcriptome analysis on T cells from the peripheral blood in patients diagnosed with GI GVHD, IBD and FGID and patients receiving cellular therapies.|Perform longitudinal immune analysis on T cells and B cells purified from patients with allo- and auto-immune diseases and those receiving cellular immunotherapies.|Perform microbiome analysis longitudinally in patients with auto- and allo-immune diseases.","Boston Children's Hospital","All","Child, Adult, Older Adult",,"550","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","P00030890","May 1, 2017","January 2022","January 2026","December 12, 2017",,"October 14, 2020","Boston Children's Hospital, Boston, Massachusetts, United States|Seattle Children's Hospital, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT03369353"
213,"NCT02862132","Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases",,"Recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis|Inflammatory Bowel Disease","Drug: Vedolizumab","Complete remission at week 14|Complete remission at week 30|Complete remission at week 54|Complete remission at week 108|Complete remission at week 162|Steroid and EEN free clinical remission (without the need for normal CRP) using PCDAI or PUCAI score and concomitant medication list.|Steroid and EEN free clinical response (without the need for normal CRP) using PCDAI or PUCAI score and concomitant medication list.|Fecal calprotectin levels|serum CRP levels|Rate of loss of response including drug levels|Steroid dependency (defined as cumulative use of >4 months in a year with at least one need to increase dose while weaning)|Adverse events|Measures of mucosal inflammation as available as part of clinical care using endoscopy, imaging or capsule endoscopy.|Time to induction of remission|Longitudinal Physician Global Assessment (PGA)|Height velocity as compared with the year prior to commencing VDZ|Need for surgical interventions (including resections, colectomy, and dilatations)","Shaare Zedek Medical Center","All","up to 18 Years   (Child, Adult)","Not Applicable","120","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","VEDOKIDS","January 2017","January 2022","July 2022","August 10, 2016",,"March 17, 2021","Cohen Children's Medical Center of NY, Northwell, New York, New York, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Hvidovre University Hospital, Copenhagen, Denmark|Hospital for Children and Adolescents Helsinki University Hospital, Helsinki, Finland|Our Lady's Children's Hospital Crumlin, Dublin, Ireland|Rambam Medical Cener, Haifa, Israel|Wolfson Medical Center, Holon, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Schneider Medical Center, Petach Tikva, Israel|Sheba Medical Center, Ramat Gan, Israel|Ichilov, Tel Aviv, Israel|Assaf Harofeh, Tzrifin, Israel|University Children's Hospital Ljubljana, Ljubljana, Slovenia|The Royal Hospital for Children Glasgow, Glasgow, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02862132"
214,"NCT04133519","Efficacy and Safety of IBS Digital Behavioral Treatment","EASITx","Active, not recruiting","No Results Available","Irritable Bowel Syndrome","Device: Arm 1 - Active behavioral Treatment Arm (Regulora; Gut-Directed Hypnotherapy Software as a Medical Device - SaMD)|Device: Arm 2 - Active Comparator behavioral treatment arm (MR-1; Muscle Relaxation, Software as a Medical Device - SaMD)","Abdominal Pain Intensity Responder|Abdominal Pain Intensity|Abdominal Pain Frequency|Daily Stool Consistency|Daily Stool Frequency|Health-related Quality of Life using the IBS Quality of Life (QOL) Instrument|Work Productivity and Absenteeism by the Work Productivity and Activity Impairment (WPAI) Questionnaire","metaMe Health","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","378","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","MM001","October 23, 2019","October 28, 2020","December 30, 2021","October 21, 2019",,"June 29, 2021","Curebase, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT04133519"
215,"NCT04790825","Periodontal Therapy on the Gut Microbiome of Inflammatory Bowel Disease",,"Recruiting","No Results Available","Periodontal Diseases|IBD|Dysbiosis|Inflammation","Procedure: Full mouth scaling and root planing (FMSRP)","Changes in microbiome alpha diversity measured from stool samples at 3 months|Changes in microbiome alpha diversity measured from saliva samples at 3 months|Change of the inflammatory markers levels in plasma|Changes in mean clinical attachment level (CAL) at 3 months|Changes in periodontal pocket depth (PPD) at 3 months|Changes in full mouth bleeding score (FMBS) at 3 months","University of Turin, Italy","All","18 Years to 60 Years   (Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","IBD-perio project","May 2, 2021","May 15, 2023","May 15, 2023","March 10, 2021",,"May 27, 2021","CIR Dental School, Turin, Italy",,"https://ClinicalTrials.gov/show/NCT04790825"
216,"NCT04893928","Role of Information and Communication Technologies for Health Support in Inflammatory Bowel Diseases: The DAMASCO Trial","DAMASCO","Recruiting","No Results Available","Inflammatory Bowel Diseases|Knowledge, Attitudes, Practice|Quality of Life|Treatment Adherence and Compliance","Other: QUECOMIICAT survey|Other: Self-Efficacy for Appropriate Medication Use Scale|Other: ICTs preferences and barriers survey|Other: Focus group and IBD mobile App for health support (MAHS) development and validation","IBD-related knowledge level|Treatment adherence and compliance|Information and communication technologies preferences and barriers","Hospital Nacional Profesor Alejandro Posadas|Hospital Nacional Cayetano Heredia|Instituto Ecuatoriano de Enfermedades Digestivas","All","15 Years to 79 Years   (Child, Adult, Older Adult)",,"351","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","446 LMiPeS0/21","May 3, 2021","November 1, 2021","April 30, 2022","May 20, 2021",,"May 21, 2021","Miguel Angel Puga Tejada, Buenos Aires, Argentina",,"https://ClinicalTrials.gov/show/NCT04893928"
217,"NCT04520594","OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial",,"Recruiting","No Results Available","Crohn Disease|Ulcerative Colitis|Inflammatory Bowel Diseases","Other: Resistant Starch|Other: Placebo","Increased potential of butyrate production following the use of individualized resistant starch, as assessed by meta-omics analysis.|Sustained potential for butyrate production following 6 months use of individualized resistant starch post randomization as assessed by meta-omics analysis.|Change in microbiome composition of cases towards the microbiome of controls as assessed by meta-omics analysis.|Changes in patient reported disability outcomes as measured by the IBD Disability Index Questionnaire.|Changes in patient, parent/caregiver reported quality of life outcomes as measured by the IMPACT III Questionnaires.|Changes in intestinal mucosal inflammation by measuring fecal calprotectin through stool samples.|Change in clinical disease activity as measured by the wPCDAI for Crohn's Disease.|Change in clinical disease activity as measured by the PUCAI for Ulcerative Colitis.|Change in clinical disease activity as measured by the Partial Mayo Score for Ulcerative Colitis.|Change in clinical disease activity as measured by the PGA for both Crohn's Disease and Ulcerative Colitis.","Children's Hospital of Eastern Ontario","All","5 Years to 17 Years   (Child)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","20/16E","March 3, 2021","August 2023","February 2024","August 20, 2020",,"June 9, 2021","Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04520594"
218,"NCT04828031","Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease","Drug: Vitamin D","Reduction in α4β7+ B cells by 20%|Reduction in immunoglobulin coating of commensal gut bacteria by 20%.|Increase in serum vitamin D (25(OH)D levels by 10 ng/mL|Decrease in disease activity index scores by 50%|Decrease cohort mean fecal calprotectin or C-reactive protein (CRP) by 50%.","Stanford University","All","18 Years and older   (Adult, Older Adult)","Phase 1","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB-60958","July 1, 2021","July 1, 2023","July 1, 2024","April 1, 2021",,"April 1, 2021",,,"https://ClinicalTrials.gov/show/NCT04828031"
219,"NCT04663971","Fertility and Pregnancy IBD Audit","FertilIBD","Not yet recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis|Fertility Disorders|Pregnancy Complications|Delivery Problem","Procedure: Any surgery|Procedure: Any medical treatment","Fertility|Pregnancy|In-vitro fertilization|Abortion/s|Complications, surgical|Complications, medical|Surgical approach","University of Campania ""Luigi Vanvitelli""|University of Bologna|University of Rome Tor Vergata","Female","18 Years to 35 Years   (Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","FertilIBD","June 1, 2021","November 30, 2021","November 30, 2021","December 11, 2020",,"April 23, 2021","Policlinico S.Orsola-Malpighi, Bologna, Italy|Rho Memorial Hospital, Milano, Italy|Universitá degli Studi della Campania Luigi Vanvitelli, Napoli, Italy|Policlinico Tor Vergata, Roma, Italy",,"https://ClinicalTrials.gov/show/NCT04663971"
220,"NCT03809728","IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE","i-BANK","Not yet recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis","Procedure: endoscopic biopsy|Procedure: samples of the oral cavity|Procedure: Samples of the resected specimen","Proportion of patients who have lost response to biotherapies (anti-TNF, ustekinumab, vedolizumab).|Proportion of patients who underwent surgery|Post-operative morbidity rates in IBD|Surgical recurrent rate in Crohn's disease|Propotion of patients with a destruction of the intestinal wall in CD (abscess, fistula)|Proportion of patients developing a cancer|Readmission rates for acute severe colitis or ileitis","Central Hospital, Nancy, France","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1000","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","PSS 2018 / I-BANK-GERMAIN / MS","April 2, 2019","April 2, 2021","April 2, 2029","January 18, 2019",,"January 18, 2019","CHRU Nancy, Vandœuvre-lès-Nancy, France",,"https://ClinicalTrials.gov/show/NCT03809728"
221,"NCT04109300","Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease","INHERIT","Not yet recruiting","No Results Available","Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease","Genetic: HLADQA1*05A>G screening|Other: Standard of Care","incidence of infliximab anti-drug antibodies|incidence of infliximab loss of response|incidence of infliximab discontinuation|incidence of infliximab-related adverse drug events|incidence of immunomodulator-related adverse drug events|incidence of combination therapy (infliximab and one of methotrexate or azathioprine) -related adverse drug events|time to infliximab anti-drug antibody formation|time to infliximab loss of response|time to infliximab discontinuation","Western University, Canada","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","162","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Other","HLAADA1","September 1, 2020","September 1, 2023","September 1, 2023","September 30, 2019",,"September 30, 2019","Western University, London, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04109300"
222,"NCT03640637","The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases","PEDICAD","Enrolling by invitation","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis",,"Sensitivity, specificity, accuracy and predictive value of PET/MRI at diagnosis of IBD and in differentiating Crohn's disease and Ulcerous colitis.|Sensitivity, specificity and accuracy of PET/MRI in diagnosing disease flare in Crohn's disease and to evaluate inflammatory response to anti-TNF treatment.","Odense University Hospital|University of Southern Denmark","All","8 Years to 25 Years   (Child, Adult)",,"75","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","OUH-HCA-003","October 18, 2018","December 2020","August 2021","August 21, 2018",,"April 27, 2020","Steffen Husby, Odense, Denmark",,"https://ClinicalTrials.gov/show/NCT03640637"
223,"NCT04859972","How Well do Primary Care Doctors in Region Örebro County, Sweden Follow Diagnostic Guidelines of IBS?",,"Not yet recruiting","No Results Available","Irritable Bowel Syndrome","Diagnostic Test: Diagnosis of IBS","Adherence to guidelines of making a positive diagnosis of IBS within primary care.|Prevalence of diarrhea-predominant IBS and IBS without diarrhea.|The proportion of IBS patients that have one or more comorbidities.|The proportion of IBS patients with post-infectious IBS.|The proportion of IBS patients with substance abuse.","Region Örebro County","All","18 Years to 40 Years   (Adult)",,"3000","Other","Observational","Observational Model: Other|Time Perspective: Retrospective","252661","September 2021","August 2022","May 2023","April 26, 2021",,"April 26, 2021",,,"https://ClinicalTrials.gov/show/NCT04859972"
224,"NCT02791854","Improving the Quality of Care for Adults With Inflammatory Bowel Disease","IBD:QORUS","Enrolling by invitation","No Results Available","Crohn's Disease|Ulcerative Colitis|Inflammatory Bowel Diseases",,"Number of patients enrolled|Proportion of patients in remission|Proportion of patients on steroids|Proportion of patients admitted into the Emergency Room|Proportion of patients hospitalized|Proportion of patients with anemia|Proportion of patients with malnutrition","Dartmouth-Hitchcock Medical Center|Crohn's and Colitis Foundation|Cedars-Sinai Medical Center|Dartmouth College","All","18 Years and older   (Adult, Older Adult)",,"10000","Other","Observational","Observational Model: Other|Time Perspective: Prospective","OSP#510516 D16124|Award#P01193","February 26, 2016","December 2030","December 2030","June 7, 2016",,"June 4, 2021","Keck Medical Center at University of Southern California Digestive Health Center (USC/Keck), Los Angeles, California, United States|Cedars-Sinai Inflammatory Bowel Disease Center, Los Angeles, California, United States|Hoag Digestive Health, Newport Beach, California, United States|UC San Diego Health Inflammatory Bowel Disease Center, San Diego, California, United States|University of Colorado Health, Denver, Colorado, United States|Yale School of Medicine IBD Program, New Haven, Connecticut, United States|MedStar Georgetown University Hospital Center for Inflammatory Bowel Disease, Washington, District of Columbia, United States|Gastro Health LLC, Miami, Florida, United States|University of South Florida, Tampa, Florida, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Northwestern Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, United States|University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, United States|Digestive Care Center, Evansville, Indiana, United States|University of Kansas Health System, Kansas City, Kansas, United States|GastroIntestinal Specialists, A.M.C., Shreveport, Louisiana, United States|Boston University Medical Center, Boston, Massachusetts, United States|Spectrum Health-Michigan State, Grand Rapids, Michigan, United States|The Henry Ford Center for Inflammatory Bowel Disease, Novi, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Midwest Gastrointestinal Associates, Omaha, Nebraska, United States|Dartmouth-Hitchcock Inflammatory Bowel Disease Center, Lebanon, New Hampshire, United States|Saratoga Schenectady Gastroenterology Associates, Burnt Hills, New York, United States|NYU Winthrop- Inflammatory Bowel Disease Center, Mineola, New York, United States|New York University Langone Medical Center, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|University of Rochester, Rochester, New York, United States|The Oregon Clinic - Gastroenterology, Portland, Oregon, United States|Penn State Hershey Inflammatory Bowel Disease Center, Hershey, Pennsylvania, United States|Regional GI, Lancaster, Pennsylvania, United States|Gastroenterology Associates, Providence, Rhode Island, United States|Gastro One, Germantown, Tennessee, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor College of Medicine IBD Center, Houston, Texas, United States|University of Utah Health Care, Salt Lake City, Utah, United States|University of Virginia, Charlottesville, Virginia, United States|The University of Washington Inflammatory Bowel Disease Center, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT02791854"
225,"NCT02463305","Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)",,"Recruiting","No Results Available","Colitis, Ulcerative","Drug: Creatine monohydrate|Other: Placebo","Improvement in endoscopic assessment of mucosal inflammation in ulcerative colitis.|Clinical response in ulcerative colitis disease activity.|Intestinal permeability|Patient symptom severity|Colonic inflammation|Creatine kinase modulation|Clinical remission of ulcerative colitis disease activity.|Creatine modulation","University of Colorado, Denver","All","18 Years to 70 Years   (Adult, Older Adult)","Early Phase 1","12","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","13-3054|UL1TR001082","April 2016","December 2021","December 2021","June 4, 2015",,"January 19, 2021","University of Colorado Hospital, Denver, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT02463305"
226,"NCT03885713","Identification of Predictive Biomarkers for Response to Biologic Therapies in Inflammatory Bowel Disease","BioIBD","Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis","Biological: Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab","Identify predictive tissue and blood biomarkers for response to biologic therapies in Crohn´s disease and ulcerative colitis|Identify non-invasive blood biomarkers of endoscopical inflammation|Evaluate the effect of the treatment on the immune subsets and study the signaling pathways specifically modulated|Generate a collection of biological simple (Blood sample, urine sample, stool sample, biopsy simple)","Fundación de Investigación Biomédica - Hospital Universitario de La Princesa","All","18 Years and older   (Adult, Older Adult)","Phase 4","180","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","GIS-2018-BioIBD","September 10, 2019","August 31, 2021","August 31, 2022","March 22, 2019",,"May 22, 2020","Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Universitario Parc Taulí, Sabadell, Barcelona, Spain|Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain|Hospital Público General de Tomelloso, Tomelloso, Ciudad Real, Spain|Hospital Clínico de Santiago, Santiago De Compostela, La Coruña, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitario de Torrejón, Torrejón De Ardoz, Madrid, Spain|Hospital de Galdakao, Galdakao, Vizcaya, Spain|Hospital General Universitario de Alicante, Alicante, Spain|Hospital Universitario Reina Sofía, Córdoba, Spain|Hospital Universitario Donostia, Donostia, Spain|Hospital Universitario Dr. Josep Trueta, Gerona, Spain|Hospital Juan Ramón Jiménez, Huelva, Spain|Hospital San Jorge, Huesca, Spain|Hospital Universitario de La Princesa, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Hospital Universitario y Politécnico La Fe, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain",,"https://ClinicalTrials.gov/show/NCT03885713"
227,"NCT03589183","Gut Microbiome in Inflammatory Bowel Disease",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease",,"Composition and diversity of gut microbiome|Taxonomic profiling of gut microbiome|Finding of single nucleotide polymorphisms (SNPs)|Finding of serologic biomarkers|Correlation between host genotyping and gut microbiome|Liquid biopsy biosignatures assessed by single cell RNA-Seq","Kyunghee University Medical Center","All","Child, Adult, Older Adult",,"1500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IBD library_2018","April 1, 2018","March 31, 2028","March 31, 2028","July 17, 2018",,"September 2, 2020","Kyung Hee University Hospital, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT03589183"
228,"NCT03336034","Assessment of Responsiveness to Treatment by Experience Sampling Method",,"Recruiting","No Results Available","Constipation-predominant Irritable Bowel Syndrome",,"Mean abdominal pain scores as measured by the ESM tool.|Maximum abdominal pain scores as measured by the ESM tool.|Number of bowel movements.|Symptom scores for other symptoms than abdominal pain, as measured by the ESM tool.","Maastricht University Medical Center","All","18 Years to 75 Years   (Adult, Older Adult)",,"30","Other","Observational","Observational Model: Other|Time Perspective: Prospective","METC 173007|NL60925.068.17","January 1, 2018","January 2022","March 2022","November 8, 2017",,"March 3, 2021","Maastricht University Medical Center, Maastricht, Netherlands",,"https://ClinicalTrials.gov/show/NCT03336034"
229,"NCT04896203","Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel Disease","EDGAR","Recruiting","No Results Available","Inflammatory Bowel Diseases|Thrombosis|Blood Coagulation Disorder","Procedure: rotational thromboelastometry","Platelet Function|Protein expression on Platelets Surface|Thromboembolic Events","Hospital Universitario La Paz","All","18 Years and older   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","PI-4182","November 18, 2020","June 15, 2021","February 15, 2022","May 21, 2021",,"May 21, 2021","Hospital Universitario La Paz, Madrid, Madrd, Spain",,"https://ClinicalTrials.gov/show/NCT04896203"
230,"NCT03266484","Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis","Dietary Supplement: Probiotic Mixture|Dietary Supplement: Placebo","Change in gut microbiome|Change in serum inflammatory cytokines levels|Change in metabolomic profiles|Change in fatigue symptoms","Massachusetts General Hospital|Winclove Bio Industries BV","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","100","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Diagnostic","2017P001489","November 13, 2017","December 2021","December 2022","August 30, 2017",,"February 23, 2021","Crohn's and Colitis Center, MGH, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT03266484"
231,"NCT03219528","A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Drug: Rifaximin 550 MG|Other: Low FODMAP Diet","Improvement in Mean Daily Pain and/or Bloating|IBS Symptom Severity Scale","University of Michigan|Michigan Institute for Clinical and Health Research (MICHR)","All","18 Years and older   (Adult, Older Adult)","Phase 4","64","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","HUM129427","February 13, 2018","December 2021","December 2021","July 17, 2017",,"January 19, 2021","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT03219528"
232,"NCT04243525","Inflammatory Bowel Disease (IBD) Research Registry",,"Recruiting","No Results Available","Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)",,"Number of patients with IBD","University of Pittsburgh","All","18 Years and older   (Adult, Older Adult)",,"4216","Other","Observational","Observational Model: Other|Time Perspective: Other","STUDY19060285","May 2009","May 2030","May 2030","January 28, 2020",,"February 9, 2021","University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT04243525"
233,"NCT04672161","Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) Patients",,"Enrolling by invitation","No Results Available","Crohn Disease (CD)|Ulcerative Colitis (UC)|Indeterminate Colitis","Other: Vaccine Education","Mean Change in Vaccination Adherence in Patients|Change in qualitative attitude assessment on vaccination adherence and non-adherence as measured by self-reported 6-month questionnaire.","Weill Medical College of Cornell University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","20-06022242","March 4, 2021","May 2021","May 2021","December 17, 2020",,"May 28, 2021","Weill Cornell Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04672161"
234,"NCT04841980","Rifaximin Therapy vs Low FODMAP Diet In IBS",,"Recruiting","No Results Available","Irritable Bowel Syndrome|Small Intestinal Bacterial Overgrowth","Drug: Rifaximin|Other: Low FODMAP diet","Proportion of subjects with adequate relief of composite of abdominal symptom (pain/discomfort) and stool symptom (frequency/ consistency) after treatment.|Proportion of patients who had relief was determined from the patients' weekly assessments of global IBS symptoms, bloating, abdominal pain/ discomfort, and stool consistency/ frequency after treatment with Rifaximin or low FODMAP diet|Symptom severity score improvement|Proportion of patients with SIBO who had eradication of SIBO after treatment|Assessment of factors that were associated with treatment response|Change in Health-Related Quality of Life (HRQOL) score","University of Malaya","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 4","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","2021001","April 22, 2021","April 2023","June 2023","April 12, 2021",,"May 5, 2021","University Malaya Medical Centre, Kuala Lumpur, Malaysia",,"https://ClinicalTrials.gov/show/NCT04841980"
235,"NCT04873700","A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)","RISE-MX","Not yet recruiting","No Results Available","Inflammatory Bowel Diseases|Colitis, Ulcerative|Crohn Disease",,"Percentage of Participants with Active CD at Day 1|Percentage of Participants with Active UC at Day 1|Number of Participants With UC or CD Based on Clinical Presentation|Number of Participants With UC or CD Based on Inflammatory Bowel Disease (IBD) Therapies|Duration of IBD Therapies|Percentage of Participants With UC or CD Based on Biologic-experience|Percentage of Participants With UC or CD who Have not Responded Previously to Biologic Therapies|Percentage of Participants With UC or CD Based on Reasons for Non-response to Previous Biologic Therapies|Number of Participants With UC or CD Introduced With IBD Treatment at Day 1|Number of Participants With HBI >=8 or CDAI >=220 Points Versus HBI <8 or CDAI <220 Points Categorized Based on Socio-demographic, Clinical and Treatment-related Variables in CD Participants|Number of Participants With pMayo Score >=5 Versus pMayo Score <5 Categorized Based on Socio-demographic, Clinical and Treatment-related Variables in UC Participants|Mean Score of Components of 36-item Short Form health Survey (SF-36) of UC or CD Participants|Mean Total Score of Inflammatory Bowel Disease Questionnaire (IBDQ) of UC or CD Participants|Mean Total Percentage of Work Impairment Assessed by Work Productivity and Activity Impairment questionnaire (WPAI) in UC or CD Participants|Mean Work Time Missed Assessed by WPAI in UC or CD Participants|Mean Impairment While Working Assessed by WPAI in UC or CD Participants|Mean Total Activity Impairment Assessed by WPAI in UC or CD Participants|Percentage of Participants With UC or CD Who Quit Their Job due to IBD and Unable to Return to Work|Percentage of Participants With UC or CD Categorized Based on Healthcare Resources|Number of Participants With UC or CD Based on Direct Medical Cost|Number of Participants With UC or CD Based on Indirect Cost","Takeda","All","18 Years and older   (Adult, Older Adult)",,"335","Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","IBD-5010|U1111-1262-1609","August 31, 2021","November 30, 2021","November 30, 2021","May 5, 2021",,"June 30, 2021","Unidad de Enfermedades Reumaticas y Cronico dgenerativas, Torreon, Coahuila, Mexico|Centro De Investigacion Clinica De Alta Especialidad ""Cicae"", Torreon, Coahuila, Mexico|Hospital Medica Sur Tlalpan, Ciudad de Mexico, Distrito Federal, Mexico|Instituto Nacional de Ciencias Medicas Y Nutricion Salvador Zubiran, Ciudad de Mexico, Distrito Federal, Mexico|Endoamer S.C., Guadalajara, Jalisco, Mexico|CIMESAP Sociedad de Responsabilidad Limitada de Capital Variable, Zapopan, Jalisco, Mexico|Fundacion Santos y de la Garza Evia, Monterrey, Nuevo Leon, Mexico|Hospital Zambrano Hellion TecSalud, San Pedro Garza Garcia, Nuevo Leon, Mexico|Centro de Investigacion Clinica de Oaxaca, Oaxaca de Juarez, Oaxaca, Mexico|Torre Medica Sanatorio Toluca, Toluca, Mexico|Arke SMO S.A. De C.V, Veracruz, Mexico",,"https://ClinicalTrials.gov/show/NCT04873700"
236,"NCT04881370","Quality of Life for Patients With Chronic Paediatric Onset Inflammatory Bowel Disease (IBD)","QALY-ECOPED","Recruiting","No Results Available","Crohn Disease|Ulcerative Colitis",,"Quality of life according to age and disease activity|Correlation between EQ5D-5L and SIBDQ questionnaire in adults|Correlation between EQ5D-5L and IMPACT III questionnaire in adolescents|Quality of life according to previous surgery occurence|Correlation between quality of life and perceived health|Quality of life according to profession and academic degree (adults only)","University Hospital, Lille|Ministry of Health, France","All","12 Years to 24 Years   (Child, Adult)",,"430","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","2020_70|2020-A00464-35|PRME-15-0464","October 9, 2020","August 9, 2021","November 9, 2021","May 11, 2021",,"May 11, 2021","Hop Jeanne de Flandre Chu Lille, Lille, France",,"https://ClinicalTrials.gov/show/NCT04881370"
237,"NCT04316806","Effect of a Probiotic Formula on Reducing SIBO in IBS Patients",,"Recruiting","No Results Available","Irritable Bowel Syndrome|Small Intestinal Bacterial Overgrowth","Dietary Supplement: Probiotic|Drug: Rifaximin","SIBO|Gut microbiota|IBS severity|Intestinal related anxiety|Global improvement after treatment","AB Biotics, SA","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","40","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","Probiotic_IBS+SIBO","November 20, 2020","April 1, 2022","July 1, 2022","March 20, 2020",,"December 1, 2020","Dr. Bofill Clinic, Girona, Spain",,"https://ClinicalTrials.gov/show/NCT04316806"
238,"NCT04887428","Occupational Insertion and Educational Level of Adult Patients With Pediatric Early Inflammatory Bowel Disease (IBD)","PROMICI","Recruiting","No Results Available","Crohn Disease|Ulcerative Colitis",,"Rate of active workers in employment|Educational level|Association between occupational insertion and disease variables|Association between occupational insertion and quality of life|Association between educational level and disease variables|Association between educational level and quality of life|Percentage of patients for whom the disease had an influence on the choice of studies|Percentage of patients for whom the disease had an influence on the course of the studies|Percentage of patients for whom the disease had an influence on the choice of profession|Quality of life as measured by EQ5D-5L questionnaire|Disease activity for Crohn's patients|Disease activity for Ulcerative Colitis patients|Disability in 200 patients","University Hospital, Lille|Ministry of Health, France","All","25 Years and older   (Adult, Older Adult)",,"460","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","2017_19|2017-A03397-46","November 28, 2019","October 2021","October 2021","May 14, 2021",,"May 14, 2021","Hop Jeanne de Flandre Chu Lille, Lille, France",,"https://ClinicalTrials.gov/show/NCT04887428"
239,"NCT03920410","Effect of Serotonergic Stimulation on the Gut-brain Axis",,"Recruiting","No Results Available","Healthy|Irritable Bowel Syndrome","Other: serotonergic stimulation|Other: no serotonergic stimulation","Differences in functional brain response pattern to the barostat in stimulated compared to unstimulated serotonergic activity|Differences in functional brain response pattern to the Montreal Imaging Stress Task between stimulated and unstimulated serotonergic activity|Differences in functional brain response pattern to the Emotional Attention Task between stimulated and unstimulated serotonergic activity|Differences in functional brain response pattern to the barostat stimulus paradigm between irritable bowel syndrome patients and healthy controls for stimulated and unstimulated serotonergic activity|Differences in functional brain response pattern to the Montreal imaging stress task (MIST) between irritable bowel syndrome patients and healthy controls for stimulated and unstimulated serotonergic activity|Differences in functional brain response pattern to the emotional attention task (EAT) between irritable bowel syndrome patients and healthy controls for stimulated and unstimulated serotonergic activity","Örebro University, Sweden|Region Örebro County","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","5HT","April 24, 2019","January 2022","December 2022","April 18, 2019",,"February 24, 2021","Örebro University, Region Örebro County, Örebro, Sweden",,"https://ClinicalTrials.gov/show/NCT03920410"
240,"NCT03125564","FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment",,"Recruiting","No Results Available","Irritable Bowel Syndrome|Fecal Microbiota Transplantation","Procedure: Fecal Microbiota Transplantation|Procedure: Sham|Procedure: Fecal and Mucosal Microbiota Assessment","The proportion of responder|The proportion of patients who had adequate relief of global IBS symptoms|Assess the onset and duration of relief of IBS symptoms|The proportion of patients who had improvement on worst abdominal bloating|Assess the onset and duration of worst abdominal bloating|The proportion of patients who had improvement of abdominal discomfort|Assess the onset and duration of abdominal discomfort|IBS-d global symptoms score","Chinese University of Hong Kong","All","18 Years and older   (Adult, Older Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","FMT-IBS study","April 12, 2017","December 31, 2021","July 31, 2022","April 24, 2017",,"April 23, 2021","The Chinese University of Hong Kong, Sha Tin, Hong Kong",,"https://ClinicalTrials.gov/show/NCT03125564"
241,"NCT04189692","Evolution of Fatigue in Patients With Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Fatigue|Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis",,"Evaluate the evolution of fatigue in patients with Inflammatory Bowel Disease at 3 years|Assess the biological factors associated with the persistence of fatigue|Assess the psychological factors associated with the persistence of fatigue","Corporacion Parc Tauli","All","18 Years and older   (Adult, Older Adult)",,"202","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","HMT3","January 7, 2020","December 7, 2020","December 7, 2020","December 6, 2019",,"December 6, 2019",,,"https://ClinicalTrials.gov/show/NCT04189692"
242,"NCT04693780","Randomized Controlled Trial of Citizen-targeted Evidence-based Resources",,"Active, not recruiting","No Results Available","Inflammatory Bowel Diseases|Irritable Bowel Syndrome","Other: Structured guide|Other: List","Website logins|Self-reported change in information usage|Clicks on resources|Time on website","McMaster University|Canadian Institutes of Health Research (CIHR)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research","8180","April 19, 2021","October 18, 2021","October 18, 2021","January 5, 2021",,"May 27, 2021","McMaster Health Forum Impact Lab, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04693780"
243,"NCT04404517","Correlation of Serum Adalimumab Levels at an Administration of 40 mg Weekly vs 80 mg Every Two Weeks","IntnsificADA","Recruiting","No Results Available","Inflammatory Bowel Diseases","Drug: Adalimumab","Adalimumab trough level|Antibodies to Adalimumab (ADA)|Clinical response for Ulcerative Colitis|Clinical response for Ulcerative colitis|Clinical response for Crohn´s Disease|Fecal calprotectin|Blood acute phase reactants|QOL|Treatment Satisfaction","Hospital Universitario La Paz","All","18 Years and older   (Adult, Older Adult)","Phase 3","20","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IntnsificADA","October 1, 2019","June 30, 2020","October 30, 2020","May 27, 2020",,"May 27, 2020","Hospital Universitario La Paz, Madrid, Madrd, Spain",,"https://ClinicalTrials.gov/show/NCT04404517"
244,"NCT04794335","Visceral Afferents",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases",,"Single unit activity in afferents innervating intestine specimen|The ability to identify receptive fields of visceral afferents in the intestine|Pharmacological characterization of isolated visceral afferent|Changes in threshold of action potential generation in response to inflammatory mediators and/or GABAA agonists or agonist/antagonist combinations.|Biochemical characterization of GABAA receptor signaling molecules in human intestine|Anatomical characterization of GABAA receptor signaling molecules in human intestine|Molecular biological characterization of GABAA receptor signaling molecules in human intestine","University of Pittsburgh|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","All","18 Years to 85 Years   (Adult, Older Adult)",,"224","Other|NIH","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","STUDY20070343|R01DK107966","July 1, 2021","January 31, 2025","January 31, 2025","March 12, 2021",,"June 7, 2021","University of Pittsburgh Medical Center (UPMC) Presbyterian, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT04794335"
245,"NCT04924543","OPtical Diagnosis Training to Improve Dysplasia Characterisation in IBD","OPTIC-IBD","Not yet recruiting","No Results Available","Inflammatory Bowel Diseases|Dysplasia Colon|Dysplasia, Crohn Disease-Associated|Polyp of Colon|Ulcerative Colitis|Crohn Colitis|Crohn Disease","Other: Online self-learning training module|Other: Refresher training","Change in percentage of participants who accurately characterized endoscopic lesions of the intestine in patients with inflammatory bowel disease - impact of training module|Change in percentage of participants who accurately characterized endoscopic lesions of the intestine in patients with inflammatory bowel disease - impact of training module, impact of short refresher training|Change in percentage of participants who accurately characterized endoscopic lesions of the intestine in patients with inflammatory bowel disease - retention between participants randomized to receive or not receive refresher training|Change in participant assessment of confidence of prediction for each video (High vs. Low) - impact of training module|Change in participant assessment of confidence of prediction for each video (High vs. Low) - impact of training module, impact of short refresher training|Change in participant assessment of confidence of prediction for each video (High vs. Low) - at re-assessment between participants randomized to receive or not receive short refresher training|Participant assessment of overall confidence in characterization of endoscopic lesions in patients with inflammatory bowel disease - impact of training module|Participant assessment of impact of training module on overall confidence in characterization of endoscopic lesions in patients with inflammatory bowel disease - impact of training module|Participant assessment of impact of training program on overall confidence in characterization of endoscopic lesions in patients with inflammatory bowel disease - impact of training module with or without brief refresher training","University of Birmingham|University of Calgary|University of Milan|Federico II University|University of Bari Aldo Moro","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","ERN-18-0222A|REB21-0409","June 2021","October 2021","December 2021","June 14, 2021",,"June 24, 2021","University of Calgary, Calgary, Alberta, Canada|University Aldo Moro, Bari, Italy|University of Milan, Milano, Italy|University Federico II, Napoli, Italy|University of Birmingham, Birmingham, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04924543"
246,"NCT03787771","The Fecal Microbiota Transplantation Registry",,"Recruiting","No Results Available","Inflammatory Bowel Diseases",,"Set up a FMT registry|Patient outcome of FMT|Factors associated with successful FMT|Characterize FMT stool donors and other gut-related microbiota products|FMT in Asia|Promoting scientific investigation in FMT|Future research studies|Developing Biobank of FMT","Chinese University of Hong Kong","All","18 Years and older   (Adult, Older Adult)",,"3000","Other","Observational","Observational Model: Cohort|Time Perspective: Other","FMTR","July 2, 2017","May 2046","November 2046","December 26, 2018",,"April 29, 2020","Prince of Wales Hospital, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT03787771"
247,"NCT04074421","Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D",,"Recruiting","No Results Available","IBS - Irritable Bowel Syndrome|Gut Microbiota","Drug: Rifaximin|Drug: Probiotic Formula|Drug: Placebo oral tablet","the IBS symptom grade score|the quality of life score|16 S rRNA (ribosomal ribonucleic acid) to detect gut microbiota","Second Affiliated Hospital, School of Medicine, Zhejiang University|Sir Run Run Shaw Hospital|The First Affiliated Hospital of Zhejiang Chinese Medical University|RenJi Hospital|Peking Union Medical College Hospital|First Affiliated Hospital of Wenzhou Medical University|The Central Hospital of Lishui City","All","18 Years to 85 Years   (Adult, Older Adult)","Phase 4","240","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","(2019) Study No. 413","May 10, 2020","June 2022","December 2022","August 30, 2019",,"July 28, 2020","The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04074421"
248,"NCT02614911","Characterization of Phenotype and Genotype of Early Onset Enteropathies","IMMUNOBIOTA","Recruiting","No Results Available","Inflammatory Bowel Disease","Other: Biological sampling","Increasing the current rate (20%) of genetic characterization of early onset entheropathies","Imagine Institute","All","Child, Adult, Older Adult",,"599","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IMIS2014-01","June 2014","June 2029","June 2029","November 25, 2015",,"October 11, 2018","Centre Hospitalier Pellegrin-Enfants, Bordeaux, France|Hôpital pédiatrique de Lyon, Bron, France|Hôpital Jeanne de Flandre, CHRU de Lille, Lille, France|Hôpital d'enfants de la Timone, Marseille, France|Hôpital Saint Antoine, Paris, France|Necker - Enfants Malades Hospital, Paris, France|Hôpital Robert Debré, Paris, France|Hôpital Trousseau, Paris, France|Hôpital Sud, Rennes, France|CHU Hautepierre, Strasbourg, France|Hôpital des Enfants, Toulouse, France|Hôpital Clocheville, CHU de Tours, Tours, France",,"https://ClinicalTrials.gov/show/NCT02614911"
249,"NCT04790422","Nutrition to Relieve IBS Symptoms by Targeting the Microbiota","NUTRIMI","Recruiting","No Results Available","Irritable Bowel Syndrome","Dietary Supplement: Dietary fiber supplement|Dietary Supplement: Caseine protein hydrolisate|Dietary Supplement: Maltrodextrine","Abundance of feceal Bifidobacterium|fecal microbiota composition|fecal microbiota metabolite levels|Stool frequency|Stool consistency|gastro-intestinal complaints|Irritable Bowel Syndrome severity|Irritable Bowel Syndrome related quality of life|mental wellbeing|dietary intake","Wageningen University and Research|Ministery of Economic affairs|Nexira|Wecare|Roquette Freres|Ingredion Incorporated|Ingredia S.A.|Naturex|Winclove|Bioiberica|Darling Ingredients","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","70","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","NL75824.041.20","May 11, 2021","August 1, 2021","August 1, 2021","March 10, 2021",,"May 18, 2021","Stichting Wageningen Research, Wageningen, Gelderland, Netherlands",,"https://ClinicalTrials.gov/show/NCT04790422"
250,"NCT04665271","Acceptability and Efficacy of Zemedy App Versus Education and Relaxation Training App for IBS",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Behavioral: Zemedy App","Irritable Bowel Syndrome Quality of Life (IBSQoL)|Gastrointestinal Symptom Rating Scale (GSRS)|GI-Cognitions Questionnaire (GICog)|Visceral Sensitivity Index (VSI)|Fear of Food Questionnaire (FFQ)|Beck Depression Inventory (BDI)|Work Productivity and Activity Impairment (WPAI)","University of Pennsylvania|Bold Health Inc.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","300","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","844160","March 1, 2021","February 16, 2023","May 28, 2023","December 11, 2020",,"April 8, 2021","University of Pennsylvania, Philadelphia, Pennsylvania, United States","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/71/NCT04665271/Prot_001.pdf|""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/71/NCT04665271/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT04665271"
251,"NCT04598295","SH-DS01 on Fecal Metagenomic Stability",,"Recruiting","No Results Available","Irritable Bowel Syndrome","Drug: DS-01","Maintenance or increase of diversity within the DS-01 treatment group [baseline-Day 84]|Percentage of responders|Improvement by ≥ 15% in one or more individual IBS symptoms: abdominal pain, bloating, bowel movement difficulty, or stool consistency.|Abdominal pain responder|CSBM Responder|Global Improvement in IBS|Adequate Relief|VSI responder","Beth Israel Deaconess Medical Center|Seed Health","All","18 Years and older   (Adult, Older Adult)","Phase 2","100","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","2019P-000274","October 20, 2020","September 30, 2021","December 31, 2021","October 22, 2020",,"November 3, 2020","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04598295"
252,"NCT04587141","Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial","RIDARTII","Recruiting","No Results Available","Iron Deficiency Anemia|Inflammatory Bowel Diseases","Drug: Sucrosomial iron|Drug: Ferric Gluconate|Drug: Ferric carboxymaltose","Relative efficacy of the three iron supplementation regimens|Safety evaluation: Adverse events|Influence of anemia and its treatment on fatigue|Evaluation of quality of life|Number of hospitalizations, additional outpatient visits, number of endoscopic examinations, further treatments","IRCCS Policlinico S. Matteo|Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)","All","18 Years and older   (Adult, Older Adult)","Phase 3","300","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRCCSPSM 2","January 1, 2020","June 30, 2023","June 30, 2023","October 14, 2020",,"October 19, 2020","Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",,"https://ClinicalTrials.gov/show/NCT04587141"
253,"NCT04770883","Psychological and Dietary Treatment in IBS","ROLIBS","Not yet recruiting","No Results Available","Irritable Bowel Syndrome","Behavioral: Internet based cognitive behavioral therapy.|Dietary Supplement: Low FODMAP diet therapy","Gastrointestinal Symptom Rating Scale-IBS (GSRS-IBS)|The IBS quality of life questionnaire (IBS-QoL)|Patient Health Questionnaire Anxiety module (GAD-7)|Patient Health Questionnaire Depression Module (PHQ-9)|Patient Health Questionnaire Somatic symptom severity ('somatization') module (PHQ-12)|Visceral Sensitivity Index (VSI) questionnaire|The Irritable Bowel Syndrome-Behavioural Responses Questionnaire (IBSBRQ)|Nepean Dyspepsia Index (NDI)|IBS severity scoring system (IBS-SSS)|Rome IV diagnostic questionnaire|The Neuroticism-Extraversion-Openness Five Factor Inventory-3 (NEO-FFI-3) questionnaire|Bristol Stool Form Scale","Region Örebro County","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","261771","March 1, 2021","March 31, 2024","May 31, 2026","February 25, 2021",,"March 2, 2021","Skebäck primary health care center, Örebro, Sweden",,"https://ClinicalTrials.gov/show/NCT04770883"
254,"NCT04849936","A Diagnostic Accuracy Study Testing Fecal Biomarkers In Comparison To Endoscopic Examination",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Diagnostic Test: Testing Fecal Biomarkers In Comparison To Endoscopic Examination With Confocal Laser Endomicroscopy","correlation analyses","Universität Duisburg-Essen|Sozialstiftung Bamberg|Enterosan Labor LS SE & Co.KG","All","18 Years and older   (Adult, Older Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","20025","July 13, 2020","July 2023","August 2023","April 19, 2021",,"April 19, 2021","Sozialstiftung Bamberg, Klinik für Intergrative Medizin, Bamberg, Bayern, Germany",,"https://ClinicalTrials.gov/show/NCT04849936"
255,"NCT03462966","Rifaximin on Visceral Hypersensitivity",,"Recruiting","No Results Available","Visceral Hypersensitivity|Irritable Bowel Syndrome","Drug: Rifaximin","Mean change in the balloon volume (measured in mL) that leads to first urge to defecate.|Association of urgency symptom and rectal sensitivity testing.|Normalization of lactulose breath test as a potential predictor of improvement of rectal hypersensitivity.","Cedars-Sinai Medical Center|Bausch Health Americas, Inc.","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","40","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","49509","July 1, 2018","July 2021","July 2021","March 13, 2018",,"December 29, 2020","Cedars-Sinai Medical Center, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT03462966"
256,"NCT04462900","Evaluate the Safety of Linaclotide in IBS-C Patients in China","Liberty","Recruiting","No Results Available","Irritable Bowel Syndrome-IBS",,"Demonstrate the safety of linaclotide therapy|Assess the treatment satisfaction|Assess the impact of linaclotide treatment in patient's quality of life.","AstraZeneca","All","18 Years and older   (Adult, Older Adult)",,"3000","Industry","Observational","Observational Model: Other|Time Perspective: Prospective","D5630R00001","September 18, 2020","March 30, 2023","March 30, 2023","July 8, 2020",,"June 23, 2021","Research Site, Baotou, China|Research Site, Beijing, China|Research Site, Beijing, China|Research Site, Bin Zhou, China|Research Site, Chengdu, China|Research Site, Guang Zhou, China|Research Site, Guang Zhou, China|Research Site, Guang Zhou, China|Research Site, Ji Nan, China|Research Site, Leshan, China|Research Site, Nanchang, China|Research Site, Nanjing, China|Research Site, Nanjing, China|Research Site, Shanghai, China|Research Site, Shanghai, China|Research Site, Shenyang, China|Research Site, Shenzhen, China|Research Site, Taiyuan, China|Research Site, Tianjin, China|Research Site, Wuhan, China|Research Site, Xi'an, China|Research Site, Zheng Zhou, China",,"https://ClinicalTrials.gov/show/NCT04462900"
257,"NCT04331639","High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy",,"Recruiting","No Results Available","Inflammatory Bowel Disease|Crohn Disease|Ulcerative Colitis|Vitamin D Deficiency","Dietary Supplement: vitamin D3","vitamin D target|change in vitamin D level|vitamin D binding protein|parathyroid hormone|serum safety parameter|urine safety parameter|bone mineral density|markers of bone turnover|inflammatory bowel disease treatment parameters|cytokine measurements|c-reactive protein|erythrocyte sedimentation rate|health-related quality of life questionnaire for inflammatory bowel disease|baseline questionnaire on overall health|fracture history questionnaire|food frequency questionnaire|physical activity questionnaire|sun exposure questionnaire|follow-up questionnaire on overall health","Boston Children's Hospital","All","5 Years to 25 Years   (Child, Adult)","Phase 2","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","P00033424","November 1, 2020","September 2023","September 2024","April 2, 2020",,"June 10, 2021","Boston Children's Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04331639"
258,"NCT03342287","Cognitive and Psychiatric Effects of Linaclotide on Patients With Constipation",,"Active, not recruiting","No Results Available","Constipation|Irritable Bowel Syndrome","Other: questionnaires|Other: cognitive evaluation|Other: Blood|Other: Fecal sample","To measure anxiety and depression using the Depression, Anxiety and Stress Scale (DASS) in patients with IBS-C and CIC before and after treatment with Linaclotide|To measure neuropsychological performance in Patients with IBS-C and CIC using a standardized neuropsychological assessment in patients (CNS vital signs) before and after treatment with Linaclotide|To determine changes in fecal microbiome profile before and after treatment with Linaclotide and whether these changes correlate with changes in psychiatric symptoms and cognition.|To determine changes in inflammatory biomarker profile before and after treatment with Linaclotide and whether these changes correlate with changes in psychiatric symptoms and cognition.","McMaster University","All","18 Years to 65 Years   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","1088","March 2016","December 2020","March 2021","November 14, 2017",,"February 19, 2020","McMaster University Medical Centre, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03342287"
259,"NCT03798691","Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis|Herpes Zoster","Biological: Shingrix","Change in cell mediated immunity|Percent of participants with sustained cell mediated immunity measured via ELISPOT after immunization.|Percent of participants with a change in antibody concentration post immunization|Percent of participants with a change in antibody concentration that is sustained at 6 months|Incidence of Vaccine related adverse effects|Incidence of change in disease activity post immunization","University of Wisconsin, Madison|Boston Medical Center","All","50 Years to 70 Years   (Adult, Older Adult)","Phase 4","30","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2018-1037|SMPH/MEDICINE/GASTROENT|A534250|Protocol Version 10/10/2018","May 28, 2019","May 2022","December 2022","January 10, 2019",,"March 11, 2021","University of Wisconsin Digestive Health Center, Madison, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT03798691"
260,"NCT04301297","Renal Manifestations of IBD",,"Recruiting","No Results Available","Kidney Diseases",,"Renal manifestations of IBD","Assiut University","All","18 Years to 70 Years   (Adult, Older Adult)",,"194","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","Renal manifestations of IBD","February 1, 2020","April 2021","May 2021","March 10, 2020",,"January 28, 2021","Egypt, Assiut, Egypt",,"https://ClinicalTrials.gov/show/NCT04301297"
261,"NCT03096717","Dysplasia in Inflammatory Chronic Idiopathic Colitis Long-standing",,"Recruiting","No Results Available","Dysplasia in IBD","Diagnostic Test: colonoscopy and histology","incidence of dysplasia in relation to therapy performed","Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis","All","30 Years to 75 Years   (Adult, Older Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","7","January 1, 2017","May 30, 2020","January 21, 2021","March 30, 2017",,"March 19, 2020","Alba Panarese, Castellana Grotte, Puglia, Italy",,"https://ClinicalTrials.gov/show/NCT03096717"
262,"NCT04297852","The Function of Nutrition Rich Vegan Drink on Inflammatory Bowel Disease",,"Recruiting","No Results Available","Recovery","Dietary Supplement: Vegan drink|Dietary Supplement: Control","Inflammatory factors","Per Bendix Jeppesen|Future Food Innovation|University of Aarhus","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","50","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","VEGJUICE","March 3, 2020","December 20, 2020","December 1, 2021","March 6, 2020",,"March 6, 2020","Aarhus university, Aarhus N, Denmark",,"https://ClinicalTrials.gov/show/NCT04297852"
263,"NCT04582071","Assessing Efficacy of Psychotherapy Intervention With Inflammatory Bowel Disease Surgery Patients",,"Not yet recruiting","No Results Available","Anxiety Depression","Behavioral: Psychotherapy","Change in State - based anxiety|Change in participant's level of depression|Change in Quality of life of participants|Increase ability to function|Improved self efficacy in participants|Change in social support of participants|Improvement in coping strategies|Change in the participants perception of body image|Change in the participants' perception of illness|Change in pain perception","NYU Langone Health","All","18 Years to 100 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","20-00275","January 2021","August 2021","August 2022","October 9, 2020",,"October 12, 2020",,,"https://ClinicalTrials.gov/show/NCT04582071"
264,"NCT04166058","Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C",,"Enrolling by invitation","No Results Available","Irritable Bowel Syndrome With Constipation|Functional Constipation","Drug: Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 completers)|Drug: Functional Constipation (FC) participants (LIN-MD-62 and LIN-MD-64 completers):","Incidence of Treatment Emergent Adverse Events.","Allergan|Ironwood Pharmaceuticals, Inc.","All","6 Years to 18 Years   (Child, Adult)","Phase 3","120","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","LIN-MD-66","November 19, 2019","December 14, 2023","December 14, 2023","November 18, 2019",,"May 28, 2021","Central Research Associates, Inc, Birmingham, Alabama, United States|G & L Research, LLC, Foley, Alabama, United States|HealthStar Research, Hot Springs, Arkansas, United States|Preferred Clinical Research Partners, Little Rock, Arkansas, United States|Applied Research Center of Arkansas, Little Rock, Arkansas, United States|Advanced Research Center, Anaheim, California, United States|Alliance Research Institute, Bell Gardens, California, United States|Alliance Research Institute, Canoga Park, California, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, United States|Children's Hospital of Orange County, Orange, California, United States|Center for Clinical Trials, LLC, Paramount, California, United States|Medical Center for Clinical Research, San Diego, California, United States|Paragon Rx Clinical, Inc, Santa Ana, California, United States|Lynn Institute of Denver, Aurora, Colorado, United States|Children's National Medical Center, Washington, District of Columbia, United States|Prohealth Research Center, Doral, Florida, United States|Dolphin Medical Research, Doral, Florida, United States|Amedica Research Institute, Inc, Hialeah, Florida, United States|Nemours Children's Specialty Care, Jacksonville, Florida, United States|Elite Clinical Research, Miami, Florida, United States|Biotech Pharmaceuticals Group LLC, Miami, Florida, United States|South Miami Medical & Research Group, Inc., Miami, Florida, United States|Valencia Medical & Research Center, Miami, Florida, United States|Advanced Research for Health Improvement,LLC, Naples, Florida, United States|Pediatric & Adult Research Center, Orlando, Florida, United States|Nemours Children's Hospital, Orlando, Florida, United States|Oviedo Medical Research, Oviedo, Florida, United States|Treken Primary Care, Atlanta, Georgia, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Childrens Center for Digestive Health Care, Atlanta, Georgia, United States|River Birch Research Alliance, LLC, Blue Ridge, Georgia, United States|Clinical Trials Specialist, Inc., Doraville, Georgia, United States|Clinical Research Institute, Stockbridge, Georgia, United States|SleepCare Research Institute, Inc., Stockbridge, Georgia, United States|SKY Clinical Research Network Group, Union City, Georgia, United States|Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana, United States|Alliance for Multispecialty Research, LLC, Newton, Kansas, United States|KU Wichita Center for Clinical Research, Wichita, Kansas, United States|Private Practice - Dr. Michael W. Simon, Lexington, Kentucky, United States|Meridian Clinical Research, Baton Rouge, Louisiana, United States|Virgo Carter Pediatrics, Silver Spring, Maryland, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Minnesota Gastroenterology PA, Minneapolis, Minnesota, United States|The Center for Clinical Trials, Biloxi, Mississippi, United States|Gastrointestinal Associates and Endoscopy Center, Flowood, Mississippi, United States|David M. Headley, MD, P.A., Port Gibson, Mississippi, United States|Private Practice - Dr. Craig Spiegel, Bridgeton, Missouri, United States|Foundation Pediatrics Med Clinical Research Partners, LLC, East Orange, New Jersey, United States|University of New Mexico, Albuquerque, New Mexico, United States|Biomedical Research Alliance of New York/ Montefiore Medical Center, Bronx, New York, United States|Advantage Clinical Trials, Bronx, New York, United States|Columbia University Medical Center and Morgan Stanley Children's Hospital of New York, New York, New York, United States|Brody School of Medicine at East Carolina University, Greenville, North Carolina, United States|UNC Physicians Network (Capitol Pediatrics & Adolescent Center), Raleigh, North Carolina, United States|PMG Research, Inc. dba PMG Research of Piedmont Healthcare, Statesville, North Carolina, United States|University of Oklahoma Health Sciences Center/Children's Hospital at OU Medical Center, Oklahoma City, Oklahoma, United States|IPS Research Company, Oklahoma City, Oklahoma, United States|Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Frontier Clinical Research, LLC, Scottdale, Pennsylvania, United States|Frontier Clinical Research, LLC, Smithfield, Pennsylvania, United States|Hasbro Children's Hospital/Rhode Island Hospital, Providence, Rhode Island, United States|Coastal Pediatric Research, Charleston, South Carolina, United States|Coastal Pediatric Research, Mount Pleasant, South Carolina, United States|The Jackson Clinic, P.A., Jackson, Tennessee, United States|PMG Research of Knoxville, LLC, Jefferson City, Tennessee, United States|Vanderbilt Children's Hospital, Nashville, Tennessee, United States|Cook Childrens Health Care System, Fort Worth, Texas, United States|Valley Institute of Research, Harlingen, Texas, United States|Vilo Research Group, Houston, Texas, United States|Cullen Research, Houston, Texas, United States|Pioneer Research Solutions Inc, Houston, Texas, United States|AIM Trials, LLC, Plano, Texas, United States|Sun Research Institute, San Antonio, Texas, United States|Ace Clinical Research, Sugar Land, Texas, United States|ClinPoint Trials, Waxahachie, Texas, United States|Chrysalis Clinical Research, Saint George, Utah, United States|Office of Maria Ona, Franklin, Virginia, United States|Health Research of Hampton Roads, Inc., Newport News, Virginia, United States|Clinical Research Partners, LLC, Richmond, Virginia, United States|Carilion Medical Center, Roanoke, Virginia, United States|MultiCare Institute for Research and Innovation, Tacoma, Washington, United States|Marshall Health, Huntington, West Virginia, United States|The Medical College of Wisconsin, Milwaukee, Wisconsin, United States|UZ Brussel, Brussels, Belgium|Universitair Ziekenhuis, Ghent, Belgium|KU Leuven, Leuven, Belgium|Medical Center-1-Sevlievo EOOD, Sevlievo, Gabrovo, Bulgaria|MBAL Sv.Ivan Rilski Kozlodui, Kiril I Metodiy, Bulgaria|University Hospital Plovdiv, Plovdiv, Bulgaria|Multi-Profile Hospital for Active Treatment - Ruse JSC MHAT-Ruse, Ruse, Bulgaria|Medical Center-1-Sevlievo EOOD, Sevlievo, Bulgaria|DSMED, Lower Sackville, Nova Scotia, Canada|London Health Sciences Centre, London, Ontario, Canada|SKDS Research Inc, Newmarket, Ontario, Canada|Bluewater Clinical Research Group Inc, Sarnia, Ontario, Canada|Stouffville Medical Centre, Stouffville, Ontario, Canada|Stollery Children's Hospital, Edmonton, Canada|Al Mare Perearstikeskus, Harjumaa, Estonia|Merelahe PAK, Tallinn, Estonia|Kiliiniliste Uuringute Keskus, Tartu, Estonia|Kindergastroenterologie, Uni-Kinderklinik Leipzig, Leipzig, Saxony-Anhalt, Germany|Klinikum Kassel GmbH, Kassel, Germany|Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak, Budapest, Hungary|Soproni Erzsebet Oktato Korhaz es Rehabilitacious Intezet, Sopron, Hungary|Rambam Health Care Campus, Ruth Rappaport Children's Hospital, Haifa, Israel|Wolfson Medical Center, Holon, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah University Hospital, Jerusalem, Israel|The Baruch Padeh Medical Center Poriya, Lower Galilee, Israel|Schneider Children's Medical Center of Israel, Petah Tikva, Israel|Sheba medical center, Tel Hashomer, Israel|Azienda Ospedaliera Sant' Andrea, Naples, Italy|IRCCS Ospedale Pediatrico Bambino Gesu, Roma, Italy|Academisch Medisch Centrum Universiteit Van Amsterdam, Amsterdam, Netherlands|Maasstad Hospital Rotterdam, Rotterdam, Netherlands|Isala Zwolle, Zwolle, Netherlands|Szpital Uniwersytecki ""r. A. Jurasza"", Bydgoszcz, Poland|Klinika Pediatrii Gastroenterologii Hepatologii Zywienia Dzieci Szpiatl, Gdansk, Poland|Wojew dzki Specjalistyczny Szpital Dzieciecy, Olsztyn, Poland|Korczowski Bartosz, Gabinet Lekarski, Rzeszów, Poland|Centrum Zdrowia MDM, Warsaw, Poland|University Children's Hospital, Belgrade, Serbia|University Children's Hospital - Tirsova, Belgrad, Serbia|Institute for Child and Youth Health Care of Vojvodina, Novi Sad, Serbia|Hospital Regional Universitario de Malaga, Malaga, Spain|Instituto Hispalense Pediatria, Sevilla, Spain|MMI ""Regional children's clinical hospital"", Chernivtsi, Chernivets'ka Oblast', Ukraine|Municipal Nonprofit Enterprise ""Lviv City Children's Clinical Hospital"", Lviv, L'vivs'ka Oblast', Ukraine|State Institution ""Dnipropetrovsk medical academy"", Dnipro, Ukraine|Kharkiv National Medical University, Kharkiv, Ukraine|Vinnytsya National Medical University, Vinnytsya, Ukraine|Birmingham Children's Hospital, Birmingham, United Kingdom|Barts Health NHS Trust - The Royal London Hospital, London, United Kingdom|King's College Hospital, London, United Kingdom|Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom|William Harvey Hospital, Willesborough, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04166058"
265,"NCT03251118","A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease","TARGET-IBD","Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn's Disease|Ulcerative Colitis|Indeterminate Colitis",,"Natural history of Inflammatory Bowel Disease: Characteristics of IBD|Natural history of Inflammatory Bowel Disease: Participant demographics|Natural history of Inflammatory Bowel Disease: Treatment use|Natural history of Inflammatory Bowel Disease: Treatment response|Natural history of Inflammatory Bowel Disease: Disease progression|Endoscopic measures of mucosal healing|Adverse event frequency and severity|Timepoint of clinical response|Timepoint of endoscopic response|Reasons for treatment discontinuation|Self-reported patient health measures: EQ-5D|Self-reported patient health measures: PRO-2 for Crohn's Disease|Self-reported patient health measures: PRO-2 for Ulcerative colitis|Self-reported patient health measures: 2-question Adherence Measure|Self-reported patient health measures: Manitoba IBD Index (MIBDI)|Self-reported patient health measures: Pediatric Ulcerative colitis Activity Index (PUCAI)|Timepoint of endoscopic remission","Target PharmaSolutions, Inc.","All","2 Years and older   (Child, Adult, Older Adult)",,"15000","Industry","Observational","Observational Model: Cohort|Time Perspective: Other","TARGET-IBD","July 24, 2017","July 2025","July 2025","August 16, 2017",,"June 8, 2021","Om Research, Lancaster, California, United States|FACEY Medical Foundation, Mission Hills, California, United States|University of California - Davis, Sacramento, California, United States|Stanford University, Stanford, California, United States|University of Colorado Denver, Aurora, Colorado, United States|Gastro Florida, Clearwater, Florida, United States|University of Florida Health Jacksonville-Gastroenterology, Jacksonville, Florida, United States|Advanced Gastroenterology Associates, LLC, Palm Harbor, Florida, United States|Atlanta Gastro, Atlanta, Georgia, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|Indianapolis Gastroenterology Research Foundation, Indianapolis, Indiana, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|Gastroenterology Associates, Baton Rouge, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|University of Michigan Medical Center, Ann Arbor, Michigan, United States|University of Minnesota, Minneapolis, Minnesota, United States|Saint Louis University, Saint Louis, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Rutgers, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States|The Children's Hospital at Montefiore, Bronx, New York, United States|NYU Langone Health, New York, New York, United States|Mount Sinai, Icahn School of Medicine, New York, New York, United States|Premier Medical Group of the Hudson Valley, Poughkeepsie, New York, United States|Cary Gastroenterology Associates, Cary, North Carolina, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Carolinas Healthcare System-Center for Digestive Health, Charlotte, North Carolina, United States|Digestive Health Specialists, PA, Winston-Salem, North Carolina, United States|Cleveland Clinic/DIgestive Disease and Surgery Institute, Cleveland, Ohio, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|UT Southwestern, Dallas, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Swedish Medical Center, Seattle, Washington, United States|MultiCare Institute for Research and Innovation, Tacoma, Washington, United States|University of Wisconsin Hospital & Clinics, Madison, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT03251118"
266,"NCT04919252","Efficacy and Safety of Vedolizumab in Biologic-naïve Korean Patients With Moderate to Severe Inflammatory Bowel Disease","VEDOKO-IIT","Not yet recruiting","No Results Available","Crohn's Disease and Ulcerative Colitis","Drug: Vedolizumab","Clinical remission rate (%) at 14 weeks after commencement of vedolizumab treatment in induction phase|Clinical remission rate (%) at 54 weeks in maintenance phase|Response rate of dose intensification at 54 weeks in inadequate responders at 6 weeks|Mucosal healing rate at 14 weeks and 54 weeks|Steroid free remission rate at 54 weeks|Transmural healing rate at 14 weeks and 54 weeks for Crohn's Disease|Correlation of CRP(C-reactive protein) level with clinical remission at 54 weeks.|Correlation of fecal calprotectin level with clinical remission at 54 weeks|Correlation of endoscopic severity with clinical remission at 54 weeks|Correlation of radiologic severity with clinical remission at 54 weeks|Correlation of CDAI(Crohn's Disease Activity Index) score with clinical remission at 54 weeks|Correlation of Mayo score with clinical remission at 54 weeks|Changes in fecal microbiota after vedolizumab treatment: Microbiota change will be compared with baseline status using α diversity and β diversity.|QoL(Quality of Life): IBDQ(Inflammatory Bowel Disease Questionnaire)","Yonsei University","All","19 Years to 70 Years   (Adult, Older Adult)","Phase 3","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","4-2020-1365","June 1, 2021","December 31, 2022","January 31, 2023","June 9, 2021",,"June 9, 2021","Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT04919252"
267,"NCT04670250","The Validity of Novel Non-invasive Inflammatory Markers for Monitoring of Patients With Ulcerative Colitis",,"Not yet recruiting","No Results Available","IBD, Non Invasive Markers,IL6,Lactoferrin,Ferritin","Diagnostic Test: non invasive markers","The Validity of Novel Noninvasive Inflammatory Markers for Monitoring of Patients with Ulcerative Colitis.","Assiut University","All","18 Years to 80 Years   (Adult, Older Adult)",,"160","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","non invasive markers in IBD","June 2021","October 2022","December 2022","December 17, 2020",,"December 17, 2020",,,"https://ClinicalTrials.gov/show/NCT04670250"
268,"NCT04387279","The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease",,"Recruiting","No Results Available","COVID-19|Perception, Self|Facilities and Services Utilization","Other: Interview","Patient's perception of COVID-19 and medical use patterns|Exacerbation of symptoms","Keimyung University Dongsan Medical Center|Yeungnam University College of Medicine","All","18 Years and older   (Adult, Older Adult)",,"800","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","2020-04-070","April 24, 2020","March 30, 2021","March 30, 2021","May 13, 2020",,"May 13, 2020","KeimyungUniversity, Daegu, Jung-gu, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT04387279"
269,"NCT04403997","Virtual Chromoendoscopy With Second Generation NBI (HQ190) vs Chromoendoscopy in Inflammatory Bowel Disease",,"Recruiting","No Results Available","Chromoendoscopy","Procedure: Chromoendoscopy","Lesions detected|Detection rate of dysplastic lesions|Non-dysplastic lesions|Ratio of neoplastic lesions/total lesions|Total endoscopy time|Removal time|Near Focus ability|Number of biopsies","Hospital Universitario La Paz","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","175","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic","NBICromo","October 1, 2019","December 30, 2020","February 25, 2021","May 27, 2020",,"June 1, 2020","Hospital Universitario La Paz, Madrid, Spain",,"https://ClinicalTrials.gov/show/NCT04403997"
270,"NCT04330105","Subclinical Cardiac Involvement in Patients With Inflamatory Bowel Disease",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases","Device: ECG, HolterECG ,Echocardiography","determine the prevelance of cardiac involvement in inflamatory bowel disease","Hossam Eldin Mohammed Essam Abdelhafez|Assiut University","All","18 Years to 80 Years   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","inflamatory bowel disease","May 1, 2020","May 1, 2022","July 30, 2022","April 1, 2020",,"April 3, 2020",,,"https://ClinicalTrials.gov/show/NCT04330105"
271,"NCT04436874","Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease","FMT-IBD","Enrolling by invitation","No Results Available","Fecal Microbiota Transplantation","Device: endoscopy","steroid-free clinical remission and endoscopic remission|Steroid-free clinical remission|Steroid-free clinical response|Steroid-free endoscopic response|microbiological change|Change in microbiome of stool|Difference in microbiome compared between subjects in different treatment arm|Proportion of microbiome|Difference in microbiome compared between subjects who have weight loss and those do not have weight loss|Microbial factors that are associated with percentage of body weight loss|Trans-kingdom correlation of microbial engraftment after FMT between bacteriome, virome and fungome","The First Affiliated Hospital of Kunming Medical College|Chinese University of Hong Kong","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","240","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","FMT-IBD-190923","September 23, 2019","December 23, 2021","December 23, 2022","June 18, 2020",,"June 19, 2020","Endoscopy, Kunming, Yunnan, China",,"https://ClinicalTrials.gov/show/NCT04436874"
272,"NCT04566679","Butyrate in Children With IBS: Double Blind Placebo Controlled Randomized Clinical Trial","BUZIR","Recruiting","No Results Available","Irritable Bowel Syndrome (IBS)|Children, Only","Dietary Supplement: Dibuzin|Dietary Supplement: placebo","butyrate on GI symptoms|butyrate on inflammation","University of Bari","All","4 Years to 16 Years   (Child)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","BUZIR2020","April 21, 2021","January 1, 2023","January 1, 2023","September 28, 2020",,"April 23, 2021","Pediatric Department ""B Trambusti"" Ospedale Giovanni XXIII Via Amendola 270, Bari, Ba, Italy|Clinica Pediatrica, Bari, Puglia, Italy",,"https://ClinicalTrials.gov/show/NCT04566679"
273,"NCT04647578","Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified Colitis","MICI-FIT","Not yet recruiting","No Results Available","Crohn's Enteritis|Crohn Disease|Inflammatory Bowel Diseases|Colitis, Ulcerative|Granulomatous Enteritis|Granulomatous Colitis|Ileocolitis|Proctocolitis","Device: GT3X Actigraph accelerometer.","Difference in cardiorespiratory fitness (expressed in ml/kg/min) between children and adolescents with IBD and age-, BMI and sex-matched healthy controls.|Difference in muscular endurance, strength, speed/agility, flexibility, strength between children and adolescents with IBD and age-, BMI and sex-matched healthy controls|Disease activity according to PCDAI scores|Disease activity according to PUCAI scores|Percentage of IBD children and adolescents with a cardiovascular risk disease|Correlation between quality of life and physical fitness in children and adolescent with IBD|Correlation between fatigue and physical fitness in children and adolescent with IBD|Correlation between daily physical activity and physical fitness in children and adolescent with IBD","University Hospital, Lille|Groupement Interrégional de Recherche Clinique et d'Innovation","All","10 Years to 17 Years   (Child)",,"100","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","2019_03|2019-A02651-56","December 2020","July 2022","July 2022","December 1, 2020",,"December 1, 2020",,,"https://ClinicalTrials.gov/show/NCT04647578"
274,"NCT00606346","A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease","DEVELOP","Active, not recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis|Indeterminate Colitis|Inflammatory Bowel Diseases","Biological: Anti TNF therapy including infliximab|Drug: No Biologics","Obtain long-term safety and clinical status information on pediatric patients with IBD (ie, CD, UC, or indeterminate colitis [IC]).","Janssen Biotech, Inc.","All","1 Month to 17 Years   (Child)",,"4970","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","CR013912|C0168Z02|REMICADEPIB4002|REMICADEPIB4003","May 31, 2007","November 15, 2037","June 30, 2038","February 1, 2008",,"April 12, 2021","Mobile, Alabama, United States|Phoenix, Arizona, United States|Beverly Hills, California, United States|Los Angeles, California, United States|Oakland, California, United States|Sacramento, California, United States|San Diego, California, United States|San Francisco, California, United States|Aurora, Colorado, United States|Hartford, Connecticut, United States|New Haven, Connecticut, United States|Gainesville, Florida, United States|Miami, Florida, United States|Orlando, Florida, United States|Atlanta, Georgia, United States|Boise, Idaho, United States|Chicago, Illinois, United States|Lexington, Kentucky, United States|New Orleans, Louisiana, United States|Portland, Maine, United States|Boston, Massachusetts, United States|Newton, Massachusetts, United States|Worcester, Massachusetts, United States|Detroit, Michigan, United States|Southfield, Michigan, United States|Minneapolis, Minnesota, United States|Rochester, Minnesota, United States|Boys Town, Nebraska, United States|Las Vegas, Nevada, United States|Manchester, New Hampshire, United States|Mays Landing, New Jersey, United States|Morristown, New Jersey, United States|Bronx, New York, United States|Brooklyn, New York, United States|Buffalo, New York, United States|Lake Success, New York, United States|Mineola, New York, United States|New York, New York, United States|Stony Brook, New York, United States|Syracuse, New York, United States|Williamsville, New York, United States|Chapel Hill, North Carolina, United States|Durham, North Carolina, United States|Oklahoma City, Oklahoma, United States|Danville, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Greenville, South Carolina, United States|Knoxville, Tennessee, United States|Memphis, Tennessee, United States|Dallas, Texas, United States|Fort Worth, Texas, United States|San Antonio, Texas, United States|Burlington, Vermont, United States|Charlottesville, Virginia, United States|Fairfax, Virginia, United States|Norfolk, Virginia, United States|Seattle, Washington, United States|Madison, Wisconsin, United States|Milwaukee, Wisconsin, United States|Edmonton, Alberta, Canada|Halifax, Nova Scotia, Canada|Dundas, Ontario, Canada|Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT00606346"
275,"NCT04115722","Coagulation Parameters in IBD Patients",,"Not yet recruiting","No Results Available","Coagulopathy","Other: IBD ACTIVIT","Percentage of IBD patients in activity with DVT","Assiut University","All","18 Years to 75 Years   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","Coagulation parameters in IBD","November 2019","November 2020","December 2020","October 4, 2019",,"October 4, 2019",,,"https://ClinicalTrials.gov/show/NCT04115722"
276,"NCT00001184","Immune Regulation in Ulcerative Colitis or Crohn s Disease",,"Recruiting","No Results Available","Inflammatory Bowel Disease|Ulcerative Colitis|Chrohn's Disease",,"To identify the molecular abnormalities that result in inflammatory bowel diseases and develop novel therapies based on these discoveries.","National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC)","All","up to 75 Years   (Child, Adult, Older Adult)",,"1000","NIH","Observational","Observational Model: Cohort|Time Perspective: Prospective","820183|82-I-0183","August 7, 1998",,,"November 4, 1999",,"June 24, 2021","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT00001184"
277,"NCT03986476","The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel Syndrome",,"Active, not recruiting","No Results Available","IBS","Dietary Supplement: Probiotics|Other: Placebo","Change in small intestinal permeability after 6 weeks (urinary lactulose/rhamnose ratio, 0-5h)|Change in small intestinal permeability after 3 weeks (urinary lactulose/rhamnose ratio, 0-5h)|Change in whole gut permeability after 6 weeks (urinary sucralose/erythritol ratio, 0-24h)|Change in whole gut permeability after 3 weeks (urinary sucralose/erythritol excretion ratio, 0-24h)|Change in colonic permeability after 6 weeks (urinary sucralose/erythritol ratio, 5-24h)|Change in colonic permeability after 3 weeks (urinary sucralose/erythritol ratio, 5-24hrs)|Change in gastroduodenal permeability after 6 weeks (urinary sucrose excretion, 0-5hrs)|Change in gastroduodenal permeability after 3 weeks (urinary sucrose excretion, 0-5hrs)|Change in inflammatory status after 3 weeks|Change in inflammatory status after 6 weeks","Örebro University, Sweden","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","65","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","2018/450","March 26, 2019","May 11, 2021","May 11, 2021","June 14, 2019",,"April 20, 2021","Örebro University, Örebro, Örebro Län, Sweden",,"https://ClinicalTrials.gov/show/NCT03986476"
278,"NCT03266471","Cytokines and Genes in Therapeutic Response in Crohn's Disease",,"Active, not recruiting","No Results Available","Inflammatory Bowel Diseases","Diagnostic Test: Baseline blood sample|Diagnostic Test: Baseline intestinal biopsies|Other: Crohn's disease activity index (CDAI)|Diagnostic Test: Post treatment blood sample|Diagnostic Test: Post treatment intestinal biopsies|Diagnostic Test: Baseline stool sample|Diagnostic Test: Post treatment stool sample","Compare longitudinal cytokine measurements in treatment responders versus nonresponders.|Compare serum and tissue pro-inflammatory cytokines in CD patients and healthy subjects.|To assess whether gene variants are associated with treatment response.","Vanderbilt University Medical Center","All","18 Years and older   (Adult, Older Adult)",,"96","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","171198","October 13, 2017","April 2022","April 2022","August 30, 2017",,"May 17, 2021","Inflammatory Bowel Disease Clinic, Vanderbilt University Medical Center, Nashville, Tennessee, United States|Vanderbilt University Medical Center Endoscopy Laboratory, Nashville, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT03266471"
279,"NCT04431700","Study of Dietary Composition in Crohn's Disease","CD","Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease","Other: Anti-inflammatory diet|Other: Regular diet","Efficacy of the anti-inflammatory whole food diet for the induction of remission in Crohn's Disease","University of California, Los Angeles","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","116","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","20-001120","October 5, 2020","January 31, 2023","May 1, 2023","June 16, 2020",,"October 8, 2020","UCLA Center for Human Nutrition, 1000 Veteran Ave., Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT04431700"
280,"NCT04122586","Mechanism of PERK - eIF2a Pathways in Intestinal Mucosal Barrier of IBS-D and the Role ""Metabolism Ingredients"" of Tongxieyaofang",,"Recruiting","No Results Available","IBS (Irritable Bowel Syndrome)","Drug: Tongxieyaofang(granule)","Irritable Bowel Syndrome Symptom Severity(IBS-SSS) scale|Bristol stool form scale（BSFS）|IBS-D PRO( patient reported outcomes) Scale|SF-36(the MOS item short from health survey)Scale","Xiyuan Hospital of China Academy of Chinese Medical Sciences","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","81774304","August 1, 2018","December 31, 2020","December 31, 2021","October 10, 2019",,"January 2, 2020","Xiyuan hospital, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT04122586"
281,"NCT04861597","Digital Behavioral Interventions in Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Crohn Disease|Ulcerative Colitis|Inflammatory Bowel Diseases|Stress, Psychological|Depression, Anxiety","Behavioral: Internet based cognitive behavioral therapy|Behavioral: Digital mood tracking","Anxiety and/or depression|Perceived Stress Score|Health-related Quality-of-Life|Crohn's Disease Activity|Ulcerative Colitis Disease Activity","Montefiore Medical Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","2021-12896","July 2021","June 2022","June 2022","April 27, 2021",,"April 27, 2021",,,"https://ClinicalTrials.gov/show/NCT04861597"
282,"NCT02981888","Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome","IBS","Recruiting","No Results Available","IBS","Radiation: X-Ray","Total and individual fecal bile acid excretion|Total fecal excretion of short chain fatty acids|Fecal microbial population and community from stool collection|Fecal excretion of individual short chain fatty acids|Stool characteristics","Indiana University","All","18 Years to 65 Years   (Adult, Older Adult)",,"90","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","1606244063","July 2016","July 2021","July 2021","December 5, 2016",,"February 9, 2021","Indiana University Hospital, Indianapolis, Indiana, United States",,"https://ClinicalTrials.gov/show/NCT02981888"
283,"NCT04296552","Brain-Gut-Microbiota Interaction in IBS",,"Recruiting","No Results Available","Irritable Bowel Syndrome|Functional Gastrointestinal Disorders","Other: Dietary lowFODMAP intervention","Short-term dietary lowFODMAP responder will be measured using IBS-symptom severity score|Long-term dietary lowFODMAP responder will be measured using the IBS-symptom severity score","Haukeland University Hospital|National Research Council, Spain|Genetic Analysis AS|Lovisenberg Diakonale Hospital|University of Bergen","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2015-01621","May 20, 2019","December 31, 2021","December 31, 2023","March 5, 2020",,"June 30, 2020","Haukeland University Hospital, Bergen, Vestlandet, Norway",,"https://ClinicalTrials.gov/show/NCT04296552"
284,"NCT04232228","A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers",,"Recruiting","No Results Available","Crohn Disease","Other: No intervention","Crohn's Disease Related Secondary Health Related Utilization (HRU) in the 6 Months Pre-Activation of Care4Today® Inflammatory Bowel Disease (C4T IBD) Application (Pre-Index)|Crohn's Disease Related Secondary HRU in the 12 Months Post-Activation of C4T IBD Application (post-index)|Crohn's Disease (CD)-Related Primary Healthcare Resource Utilization|Number of Participants with Characteristics Including Duration of Disease, Current Treatments and Previous Treatments|Disease Activity of Participants Measured Using the Harvey-Bradshaw Index (HBI) or Modified HBI|Disease Activity of Participants Measured Using Markers of Systemic Inflammation|Disease Progression of Participants Measured Using the Fatigue Severity Scale (FSS)|Disease Progression of Participants Measured Using Number of Bowel Movements|Disease Progression of Participants Measured by Level of Abdominal Pain|Impact of C4T IBD on Health Related Quality of Life (HRQoL, General and Inflammatory Bowel Disease [IBD] Specific) and Productivity|Impact of C4T IBD on Participant's Level of Engagement with Their Disease Measured Using the Patient Activation Measure (PAM)|Patient- and HCP-Reported Satisfaction","Janssen-Cilag Ltd.","All","18 Years and older   (Adult, Older Adult)",,"100","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","CR108721|CNTO1275CRD4033","February 7, 2020","April 30, 2021","July 31, 2022","January 18, 2020",,"March 17, 2021","Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04232228"
285,"NCT02421705","Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)",,"Recruiting","No Results Available","IBS|Ulcerative Colitis, Active|Ulcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms)|Healthy Controls|Crohn's Disease, Active|Crohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)","Other: Sample collection","differences in visceral sensitivity in different study groups (Visceral sensitivity will me measured by performing a rectal barostat test)|immune activity (measuring release of mest cell mediators in rectal biopsies, measuring parameters of immune activity in blood)","KU Leuven","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","99999999","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","S51573","February 2010","January 2099","January 2099","April 21, 2015",,"February 8, 2017","University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium",,"https://ClinicalTrials.gov/show/NCT02421705"
286,"NCT02997293","An Analysis of the Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery at the University of Arkansas for Medical Sciences",,"Active, not recruiting","No Results Available","ColoRectal Cancer and Inflammatory Bowel Disease","Other: Enhanced Recovery protocol","Hospital length of stay","University of Arkansas","All","18 Years and older   (Adult, Older Adult)",,"120","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","206240","March 1, 2017","June 2021","July 2021","December 20, 2016",,"September 17, 2020","University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States",,"https://ClinicalTrials.gov/show/NCT02997293"
287,"NCT03223077","Mucosal and Microbiota Changes During Acute Campylobacteriosis",,"Recruiting","No Results Available","Irritable Bowel Syndrome",,"Development of IBS is the endpoint.","Mayo Clinic","All","18 Years to 80 Years   (Adult, Older Adult)",,"150","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","14-006180","October 31, 2014","June 30, 2022","June 30, 2022","July 19, 2017",,"August 18, 2020","Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03223077"
288,"NCT04656015","Cardiovascular Manifestation of Inflamatory Bowel Disease Patient ( Tissue Doppler Echocardiography and Cardiac MRI )",,"Not yet recruiting","No Results Available","Cardiac MRI in IBD Patient","Device: MRI","Incidence of cardiovascular affection in IBD patients","Assiut University","All","18 Years and older   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Other|Time Perspective: Prospective","cardiac MRI in IBD patient","December 1, 2020","November 30, 2021","November 30, 2021","December 7, 2020",,"December 7, 2020",,,"https://ClinicalTrials.gov/show/NCT04656015"
289,"NCT04921670","Infliximab Proactive Drug Monitoring in the Pediatric IBD Population",,"Recruiting","No Results Available","Inflammatory Bone Disease","Diagnostic Test: Infliximab Assay","Number of relapses","Cares, Kristen, M.D.","All","5 Years to 21 Years   (Child, Adult)",,"60","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","INFLIXIMAB-2019","March 12, 2021","March 30, 2022","March 30, 2022","June 10, 2021",,"June 10, 2021","Children's Hospital of Michigan, Detroit, Michigan, United States","""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/70/NCT04921670/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT04921670"
290,"NCT04488198","Acupuncture in Pediatrics and Adolescents With Chronic Inflammatory Bowel Diseases",,"Recruiting","No Results Available","Morbus Crohn|Colitis, Ulcerative","Other: Acupuncture|Other: Placebo-Acupuncture","Disease Activity Index|Quality of Life in Children and Adolescents measured by KINDL(R)|Quality of Life in Children and Adolescents measured by ILK|Pain assessment|C reactive protein|Leukocytes|Erythrocyte sedimentation rate","Medical University of Vienna","All","10 Years to 17 Years   (Child)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","1773/2018","March 1, 2019","December 31, 2021","December 31, 2021","July 27, 2020",,"July 27, 2020","Department of Anesthesia, General Intensive Care and Pain Management,Medical University of Vienna, Vienna, Austria",,"https://ClinicalTrials.gov/show/NCT04488198"
291,"NCT04112212","NIR FME of Labelled Vedolizumab to Elucidate the Mechanism of Action and Predicting Response in IBD Patients.","VISION","Recruiting","No Results Available","Crohn Disease|Colitis, Ulcerative","Drug: Vedolizumab-800CW|Device: Fluorescence endoscopy and spectroscopy","Fluorescent signal in patients with IBD|Safety of Vedolizumab-800CW in patients with IBD|Quantifying fluorescent signals in patients with IBD|FME Ex Vivo analysis to detect target cells|Distribution of Vedolizumab in the inflamed gut|Elucidate vedolizumab target cells","University Medical Center Groningen","All","18 Years and older   (Adult, Older Adult)","Phase 1","35","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","NL69572.042.19","November 4, 2020","December 1, 2021","December 30, 2021","October 2, 2019",,"April 28, 2021","University Medical Center Groningen, Groningen, Netherlands",,"https://ClinicalTrials.gov/show/NCT04112212"
292,"NCT03997708","A Mediterranean Approach to Low FODMAP Diet (MED-LFD) for Managing IBS Symptoms",,"Recruiting","No Results Available","Irritable Bowel Syndrome With Diarrhea","Other: Med-LFD|Other: Nutritional Guidelines of the British National Institute for Health and Care Excellence (NICE) Managing IBS","Change of symptoms severity pre and post intervention using a specialized questionnaire.|Assessment of IBS related quality of life with a specialized questionnaire pre and post intervention between groups.|Assessment of general quality of life pre and post intervention between groups|Adequate relief of symptoms after the intervention.|Assessment of symptoms burden any in general pre and post intervention.","Attikon Hospital|Department of Gastroenterology, Central Clinical School, Monash University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","108","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","ΕΒΔ435/19-06-2018","September 1, 2019","June 3, 2021","June 3, 2022","June 25, 2019",,"December 18, 2019","Attikon University General Hospital, Athens, Greece",,"https://ClinicalTrials.gov/show/NCT03997708"
293,"NCT04132804","Effect of Tai Chi as Treatment for IBS-C",,"Active, not recruiting","No Results Available","Irritable Bowel Syndrome With Constipation","Behavioral: Tai Chi","IBS Severity Scoring System|Likelihood of continuing treatment|Treatment satisfaction|IBS Quality of Life (IBS-QOL)|Bowel movement frequency|Bloating Scale|Abdominal Discomfort Scale|Constipation Severity Scale|Hospital Anxiety and Depression Scale (HADS)|Visceral Sensitivity Index (VSI)|Stool microbiome|Global Assessment of Relief","Massachusetts General Hospital","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","23","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2019P000361","July 21, 2020","August 1, 2021","August 1, 2021","October 21, 2019",,"March 9, 2021","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04132804"
294,"NCT03935451","Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease","EXPAND","Not yet recruiting","No Results Available","IBD|Venous Thromboembolism|Crohn Disease|Ulcerative Colitis|Pulmonary Embolism|Colorectal Disorders","Drug: Apixaban 2.5 milligram|Drug: Placebo Oral Tablet","Incidence of post operative venous thromboembolism events (DVT/PE) in in patients with Inflammatory Bowel Disease|Incidence of bleeding while undergoing treatment with oral anticoagulant or placebo.|Incidence of surgical complications related to post operative anticoagulation","McMaster University","All","18 Years and older   (Adult, Older Adult)","Early Phase 1","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","7043","April 1, 2021","October 30, 2021","August 30, 2022","May 2, 2019",,"February 24, 2021",,,"https://ClinicalTrials.gov/show/NCT03935451"
295,"NCT04749576","Saffron as Anti Inflammatory Agent In Patients With Inflammatory Bowel Disease",,"Recruiting","No Results Available","Ulcerative Colitis","Dietary Supplement: saffron supplement for IBD","inflammatory markers assessment|stool frequency assessment|stool consistency assessment|fecal calprotectin assessment|C reactive protein assessment|erythrocyte sedimentation rate assessment|Serum Pro-inflammatory assessment|Serum Anti-inflammatory assessment|The Ulcerative Colitis Colonoscopic Index of Severity scores|endoscopy colitis assessment","Howard University","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","HowardU","December 15, 2020","December 10, 2021","December 10, 2023","February 11, 2021",,"February 11, 2021","Howard University Hospital, Washington, District of Columbia, United States",,"https://ClinicalTrials.gov/show/NCT04749576"
296,"NCT04740541","Threonine Requirement in Adult Males With Crohn's Disease Using IAAO",,"Not yet recruiting","No Results Available","Crohn Disease|IBD","Other: Dietary Intakes (Reference protein drinks (Scandishake, Solcarb, Beneprotein) and cookies)","Requirement of Threonine in Adult Males with Crohn's Disease","The Hospital for Sick Children|MOUNT SINAI HOSPITAL","Male","18 Years to 49 Years   (Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","1000062867","August 1, 2021","January 1, 2022","January 1, 2022","February 5, 2021",,"March 18, 2021","The Hospital for Sick Children, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04740541"
297,"NCT04123990","Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Intestinal Disease","Diagnostic Test: Iron status testing","Ferritinemia according to inflammatory status","VIFORFRANCE","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1100","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","CARENFER MICI","November 2, 2019","February 28, 2020","March 30, 2020","October 11, 2019",,"October 11, 2019",,,"https://ClinicalTrials.gov/show/NCT04123990"
298,"NCT02617927","The Safety Assessment of Vedolizumab During Pregnancy in IBD Patient",,"Recruiting","No Results Available","Pregnancy Complications",,"Major body measurements defects of the infant|Minor body measurements defects of the infant","Ariella Shitrit|Shaare Zedek Medical Center","Female","18 Years to 50 Years   (Adult)",,"200","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","szmc 2015-001","October 2015","March 2021","December 2021","December 1, 2015",,"May 2, 2019","Shaarey Zedek MC, Jerusalem, Israel","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/27/NCT02617927/Prot_000.pdf","https://ClinicalTrials.gov/show/NCT02617927"
299,"NCT04890262","A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice","VARIETY-AUT","Not yet recruiting","No Results Available","Inflammatory Bowel Diseases|Crohns Disease|Colitis, Ulcerative",,"Percentage of Participants Persisting on Treatment With Vedolizumab IV Compared to Participants With Treatment Change up to 12 Months|Time to any Treatment Change|Number of Participants With Reason for Treatment Change|Number of Participants With Change in Vedolizumab Dosing Frequency|Number of Participants Who Discontinued Vedolizumab Treatment|Number of Participants Who Changed to Another Treatment","Takeda","All","18 Years and older   (Adult, Older Adult)",,"100","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","Vedolizumab-4035","July 15, 2021","April 14, 2023","April 14, 2023","May 18, 2021",,"June 11, 2021",,,"https://ClinicalTrials.gov/show/NCT04890262"
300,"NCT04131504","Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION)","ENvISION","Recruiting","No Results Available","Crohn's Disease|IBD","Drug: Infliximab|Drug: Adalimumab","Sustained Deep Remission|End of Induction Outcomes: Clinical Response|End of Induction Outcomes: Clinical Remission|End of Induction Outcomes: Steroid Free Clinical Remission|End of Induction Outcomes: Fecal Biochemical Response|End of Induction Outcomes: Fecal Biochemical Remission|End of Induction Outcomes: Blood CRP Biochemical Remission|End of Induction Outcomes: Blood CD64 Biochemical Remission|Week 52 Outcomes: Endoscopic Response|Week 52 Outcomes: Endoscopic Remission|Week 52 Outcomes: Minimal Endoscopic Activity|Week 52 Outcomes: Complete Intestinal Healing|Week 52 Outcomes: Sustained, Steroid-free Clinical Remission|Week 52 Outcomes: Clinical Remission|Week 52 Outcomes: Clinical Remission and Endoscopic Response|Week 52 Outcomes: Clinical Remission and Minimal Endoscopic Activity|Week 52 Outcomes: Treatment Response|Week 52 Outcomes: Transmural ileal healing|Week 52 Outcomes: Transmural colonic healing|Week 52 Outcomes: Total Bowel Transmural healing|Week 52 Outcomes: Fecal Biochemical Remission|Week 52 Outcomes: Deep Fecal Biochemical Remission|Week 52 Outcomes: CRP Biochemical Remission|Week 52 Outcomes: CD64 Biochemical Remission|Week 52 Outcomes: PGA Remission","Children's Hospital Medical Center, Cincinnati|The Leona M. and Harry B. Helmsley Charitable Trust","All","1 Year to 22 Years   (Child, Adult)",,"240","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2019-0730","October 16, 2019","February 2022","August 2022","October 18, 2019",,"June 23, 2021","Connecticut Children's Medical Center, Hartford, Connecticut, United States|Cincinnati Children's Hospital, Cincinnati, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT04131504"
301,"NCT03591770","Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib",,"Recruiting","No Results Available","Inflammatory Bowel Diseases","Biological: SHINGRIX","Change in the immunogenicity of the herpes zoster subunit vaccine in UC patients|Sustained T cell response|Change in antibody response|Sustained antibody response|Vaccine adverse effects at 1 month|Vaccine adverse effects at 2 months|Vaccine adverse effects at 3 months (1 month post-immunization)|Vaccine adverse effects at 8 months (6 months post-immunization)|Change in disease activity","Boston Medical Center","All","50 Years and older   (Adult, Older Adult)","Phase 4","100","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","H-37673","July 31, 2019","December 2021","December 2021","July 19, 2018",,"January 26, 2021","Boston Medical Center, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT03591770"
302,"NCT03759288","An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease","Intrepid","Active, not recruiting","No Results Available","Crohn's Disease|IBD","Drug: Brazikumab low dose|Drug: Brazikumab high dose|Drug: Humira®|Drug: Placebo","Stage 1. Percentage of participants with endoscopic response and clinical remission at Week 12|Stage 2. Percentage of participants with endoscopic response and clinical remission at Week 52|Stage 1. Percentage of participants with endoscopic response and clinical remission at both Weeks 12 and 52|Stage 1. Percentage of participants with endoscopic remission and clinical remission at Week 52|Stage 1. Percentage of participants with endoscopic response at Week 12 and endoscopic remission at Week 52 and clinical remission at both Weeks 12 and 52|Stage 2. Percentage of participants with endoscopic response and clinical remission at both Weeks 12 and 52|Stage 2. Percentage of participants with endoscopic remission and clinical remission at Week 52|Stage 2. Percentage of participants with corticosteriod-free endoscopic remission and clinical remission at Week 52","AstraZeneca","All","16 Years to 80 Years   (Child, Adult, Older Adult)","Phase 2|Phase 3","1140","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","D5271C00001|2018-004346-42","December 7, 2018","November 17, 2022","December 1, 2023","November 29, 2018",,"February 15, 2021","Research Site, Little Rock, Arkansas, United States|Research Site, Chula Vista, California, United States|Research Site, Lancaster, California, United States|Research Site, Lincoln, California, United States|Research Site, Newport Beach, California, United States|Research Site, Poway, California, United States|Research Site, San Bernardino, California, United States|Research Site, San Diego, California, United States|Research Site, Colorado Springs, Colorado, United States|Research Site, Boca Raton, Florida, United States|Research Site, Clearwater, Florida, United States|Research Site, Cutler Bay, Florida, United States|Research Site, Kissimmee, Florida, United States|Research Site, Lakeland, Florida, United States|Research Site, Miami Lakes, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, New Port Richey, Florida, United States|Research Site, Saint Petersburg, Florida, United States|Research Site, Tampa, Florida, United States|Research Site, Tampa, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Atlanta, Georgia, United States|Research Site, Decatur, Georgia, United States|Research Site, Springfield, Illinois, United States|Research Site, Brownsburg, Indiana, United States|Research Site, Topeka, Kansas, United States|Research Site, Marrero, Louisiana, United States|Research Site, Glen Burnie, Maryland, United States|Research Site, Rockville, Maryland, United States|Research Site, Chesterfield, Michigan, United States|Research Site, Saint Louis, Missouri, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Albuquerque, New Mexico, United States|Research Site, Morehead City, North Carolina, United States|Research Site, Beachwood, Ohio, United States|Research Site, Springfield, Ohio, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Uniontown, Pennsylvania, United States|Research Site, Carrollton, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, McAllen, Texas, United States|Research Site, Pflugerville, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Spring, Texas, United States|Research Site, Richmond, Virginia, United States|Research Site, Spokane, Washington, United States|Research Site, Huntington, West Virginia, United States|Research Site, Steyr, Austria|Research Site, Vaughan, Ontario, Canada|Research Site, Wardha, India|Research Site, Bologna, Italy|Research Site, Busan, Korea, Republic of|Research Site, Daegu, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Wonju-si, Korea, Republic of|Research Site, Białystok, Poland|Research Site, Bydgoszcz, Poland|Research Site, Bydgoszcz, Poland|Research Site, Chojnice, Poland|Research Site, Częstochowa, Poland|Research Site, Gdańsk, Poland|Research Site, Katowice, Poland|Research Site, Kielce, Poland|Research Site, Krakow, Poland|Research Site, Mysłowice, Poland|Research Site, Nowa Sól, Poland|Research Site, Rzeszow, Poland|Research Site, Sopot, Poland|Research Site, Szczecin, Poland|Research Site, Toruń, Poland|Research Site, Warszawa, Poland|Research Site, Warszawa, Poland|Research Site, Wrocław, Poland|Research Site, Łódź, Poland|Research Site, San Juan, Puerto Rico|Research Site, Bucharest, Romania|Research Site, Bucharest, Romania|Research Site, Cluj Napoca, Romania|Research Site, Timisoara, Romania|Research Site, Kaohsiung, Taiwan|Research Site, Taichung, Taiwan|Research Site, Taichung, Taiwan|Research Site, Taipei City, Taiwan|Research Site, Coventry, United Kingdom|Research Site, Epsom, United Kingdom|Research Site, West Bromwich, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03759288"
303,"NCT02770599","Improving the Health Care in Inflammatory Bowel Disease.",,"Active, not recruiting","No Results Available","Crohn Disease|Colitis, Ulcerative","Other: IBD multidisciplinary team model including IBD nurse","Health related quality of life|Quality of care","University Hospital of North Norway|University of Tromso","All","18 Years to 80 Years   (Adult, Older Adult)",,"304","Other","Observational","Observational Model: Other|Time Perspective: Retrospective","2013/1397(REK)","May 15, 2016","March 20, 2022","July 20, 2022","May 12, 2016",,"November 27, 2020","University Hospital of North Norway, Harstad, Norway",,"https://ClinicalTrials.gov/show/NCT02770599"
304,"NCT04129762","Effect of a Diet Without Non-caloric Sweeteners on Gastrointestinal Symptoms in Patients With IBS and Dyspepsia","IBS","Recruiting","No Results Available","IBS - Irritable Bowel Syndrome|Functional Gastrointestinal Disorders","Other: Diet without NCS|Other: Diet with NCS","The diet without NCS will change the frequency of gastrointestinal symptoms in patients with IBS.|The diet without NCS will change the frequency of gastrointestinal symptoms in patients with dyspepsia.|The changes in the weight of the patients with irritable bowel syndrome, from the beginning of the diet, at 6 weeks and at 12 weeks|The changes in the weight of the patients with dyspepsia, from the beginning of the diet, at 6 weeks and at 12 weeks|The changes in the body composition in patients with irritable bowel syndrome, from the beginning of the diet, at 6 weeks and at 12 weeks|The changes in the body composition in patients with dyspepsia, from the beginning of the diet, at 6 weeks and at 12 weeks|The changes in the waist circumference in patients with irritable bowel syndrome, from the beginning of the diet, at 6 weeks and at 12 weeks|The changes in the waist circumference in patients with dyspepsia, from the beginning of the diet, at 6 weeks and at 12 weeks|The changes in glucose in the patients with irritable bowel syndrome, from the beginning and end of the diet|The changes in glucose in the patients with dyspepsia, from the beginning and end of the diet|The changes insulin in the patients with irritable bowel syndrome, at the beginning and end of the diet|The changes insulin in the patients with dyspepsia, at the beginning and end of the diet|The changes in the lipids profile in the patients with irritable bowel syndrome, at the beginning and end of the diet|The changes in the lipids profile in the patients with dyspepsia, at the beginning and end of the diet.|Effect of the diet without NCS in gut microbiota in patients with irritable bowel syndrome at the beginning and end of the diet|Effect of the diet without NCS in gut microbiota in patients with dyspepsia at the beginning and end of the diet","Hospital General de Mexico","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","140","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","DI/19/301/03/020","July 17, 2019","August 31, 2020","December 31, 2020","October 17, 2019",,"October 17, 2019","Nallely Hernandez Bueno, Mexico City, Cuauhtemoc, Mexico",,"https://ClinicalTrials.gov/show/NCT04129762"
305,"NCT03774329","Impact of a Physical Activity Program on Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel Disease","PROPHYSICOS","Recruiting","No Results Available","Crohn's Enteritis|Crohn Disease|Ulcerative Colitis|Chronic; Colitis (Noninfective)","Other: Usual care|Other: adapted physical activity","Change in total (whole body) Bone Mineral Density|Change in vertebral BMD|Change in femoral body BMD|Change in time spent (minutes / day) in moderate to vigorous physical activity measured by accelerometry for 7 days|Change in in fat mass measured by two-photon absorptiometry (%)|Change in lean mass measured by two-photon absorptiometry (kg)|Change IMPACT score III|Change in pediatrics crohn's disease activity index or pediatric ulcerative colitis activity index|Change in biologic inflammatory parameters by decrease or increase C-reactive protein","University Hospital, Lille","All","6 Years to 18 Years   (Child, Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","2017_04|2018-A00423-52","March 2, 2020","March 2022","March 2022","December 12, 2018",,"September 11, 2020","Chu Amiens Picardie, Amiens, France|Hop Jeanne de Flandre Chu Lille, Lille, France",,"https://ClinicalTrials.gov/show/NCT03774329"
306,"NCT03881436","Assessment of MRI Tractography for Pelvic Floor Sphincter Analysis","TractoCA","Recruiting","No Results Available","Inflammatory Bowel Disease|Neoplastic Pathology","Diagnostic Test: MRI with DTI sequence","The ability of MRI tractography to visualize the muscular architecture of pelvic sphincters evaluated with a Likert score.|Evaluation of the sphincter orientation based on a color gradient.|Thickness of the sphincters evaluated in millimetres|Fractional Anisotropy (FA) Values in Sphincter Fibres|Apparent Diffusion Coefficient (ADC) Values in Sphincter Fibres","IHU Strasbourg","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","18-005","August 12, 2019","August 2021","August 2021","March 19, 2019",,"February 10, 2021","Service de Radiologie et d'Echographie, NHC Strasbourg, Strasbourg, France",,"https://ClinicalTrials.gov/show/NCT03881436"
307,"NCT03415919","Collection of Gastrointestinal Malignant and Non-malignant Human Samples",,"Enrolling by invitation","No Results Available","Inflammatory Bowel Diseases|Colo-rectal Cancer","Other: no intervention will be given to patients.","confirmation of diagnosis by pathologist","University of Texas at Austin","All","18 Years to 99 Years   (Adult, Older Adult)",,"300","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","IRB 2017-06-0114","July 13, 2018","July 2022","July 2022","January 30, 2018",,"June 16, 2021","The University of Texas, Austin, Texas, United States","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/19/NCT03415919/Prot_001.pdf","https://ClinicalTrials.gov/show/NCT03415919"
308,"NCT04912999","Inflammatory Bowel Diseases Remission Registry",,"Recruiting","No Results Available","Crohn Disease|Ulcerative Colitis|Pouchitis",,"Disease exacerbation for CD patients|Disease exacerbation in UC patients|Disease exacerbation in UC-Pouch patients|nutritional factors as a risk of disease exacerbation|o Circadian rhythm as a risk factor for relapse|o Stress as a risk factor for relapse","Tel-Aviv Sourasky Medical Center","All","18 Years to 80 Years   (Adult, Older Adult)",,"1000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","0268-19-TLV","August 1, 2019","December 1, 2022","May 1, 2023","June 3, 2021",,"June 3, 2021","Tel Aviv Medical Center; ,, Tel Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT04912999"
309,"NCT04182048","Remote Study of an Electronic Means to Characterize Bowel Movements in Adult Populations",,"Active, not recruiting","No Results Available","Irritable Bowel Syndrome|Healthy",,"Dataset completeness|Daily bowel movement characteristics and fluctuation|Usability of the application","HealthMode Inc.","All","18 Years and older   (Adult, Older Adult)",,"569","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","HM102001","September 14, 2019","December 2021","December 2021","December 2, 2019",,"March 27, 2020","Virtual Facility, Bronx, New York, United States",,"https://ClinicalTrials.gov/show/NCT04182048"
310,"NCT03863704","Transcutaneous VNS to Treat Pediatric IBD","STIMIBD","Recruiting","No Results Available","Crohn Disease|Ulcerative Colitis","Device: Transcutaneous Electrical Nerve Stimulation (TENS)","Fecal Calprotectin|Change in Whole blood stimulated cytokine levels over time|Patient Reported Outcome (PRO)|Pediatric Ulcerative colitis activity index (PUCAI)|Weighted Pediatric Crohn Disease activity index (wPCDAI)|Physician Global Assessment (PGA) Score|Heart Rate Variability (HRV)","Northwell Health","All","10 Years to 21 Years   (Child, Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","18-0945","February 14, 2019","December 31, 2021","December 31, 2021","March 5, 2019",,"July 13, 2020","Steven & Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York, United States",,"https://ClinicalTrials.gov/show/NCT03863704"
311,"NCT03594435","Ibudilast for the Treatment of Alcohol Use Disorder",,"Recruiting","No Results Available","Alcohol Use Disorder","Drug: Ibudilast|Drug: Placebo oral capsule","Percent heavy drinking days|Drinks per day|Drinks per drinking day|Percent days abstinent|Percent subjects with no heavy drinking days|Percent subjects abstinent","University of California, Los Angeles|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|MediciNova","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","132","Other|NIH|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","18-000963|R01AA026190","October 1, 2018","September 2022","September 2022","July 20, 2018",,"May 24, 2021","UCLA Addictions Laboratory, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT03594435"
312,"NCT04303260","Special Physical Exercises as a Therapeutic Intervention for Inflammatory Bowel Disease",,"Recruiting","No Results Available","Crohn Disease|Ulcerative Colitis","Behavioral: Physical exercises","Clinical response assessed by a change in HBI|Clinical response as assessed by a decrease in SCCAI|Clinical response as assessed by a decrease in PROMIS questionnaire|Clinical response as assessed by a decrease in QOL questionnaire","Tel-Aviv Sourasky Medical Center","All","18 Years to 60 Years   (Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","0277-18-TLV","July 8, 2019","December 2022","December 2025","March 11, 2020",,"March 11, 2020","Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT04303260"
313,"NCT04716738","Visceral Sensitivity in Women With BS and Sexual Dysfunction","IBS","Not yet recruiting","No Results Available","Irritable Bowel Syndrome|Sexual Dysfunction","Diagnostic Test: Blood analyses and coprological","Change on barostat study during menstrual cycle|General Quality of Life questionnaire (SF-36, Short Form-36)|Specific Quality of Life questionnaire (IBS-QOL, Irritable Bowel Syndrome-Quality of Life)","Hospital General de Mexico|Miguel Motola Kuba|María de Fátima Higuera de la Tijera|Hector Batalla Casimiro|Yoshua Flores Bravo","Female","18 Years and older   (Adult, Older Adult)",,"20","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","DI/19/107/03/080","February 1, 2021","April 30, 2021","June 1, 2021","January 20, 2021",,"February 2, 2021",,,"https://ClinicalTrials.gov/show/NCT04716738"
314,"NCT02745457","Body Composition in Children With Inflammatory Bowel Disease",,"Active, not recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis",,"To evaluate the change in body composition accorging to treatment treatment is children with IBD over the course of 2 years|To assess the accuracy of ADP in comparison to DEXA based measurement of body composition in children with IBD|To evaluate the correlation of body composition to skin fold and mid arm circumference measurements in children with IBD|To evaluate the correlation of body composition with BMI|To evaluate the correlation of body composition with disease activity|To evaluate the correlation of body composition with physical activity","Schneider Children's Medical Center, Israel","All","6 Years to 17 Years   (Child)",,"75","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","BodPod IBD","April 2016","February 28, 2021","April 30, 2021","April 20, 2016",,"October 20, 2020","Schenider Children's Medical Center, Petach Tikva, Israel",,"https://ClinicalTrials.gov/show/NCT02745457"
315,"NCT02994836","GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )",,"Active, not recruiting","No Results Available","Crohn's Disease|Inflammatory Bowel Disease|Ulcerative Colitis","Biological: Anti-TNF: Infliximab (Infusion)|Drug: Anti-TNF discontinuation: Physiological saline solution|Biological: Anti-TNF:Adalimumab (Subcutaneus)","Sustained clinical remission after one year of follow-up (after discontinuing or continuing treatment with anti-TNF).|Clinical activity assessment|Endoscopic activity assessment|Radiologic activity assessment|Quality of life assessment|The Work productivity and activity assessment","Fundación de Investigación Biomédica - Hospital Universitario de La Princesa","All","18 Years and older   (Adult, Older Adult)","Phase 4","194","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","GIS-SUSANTI-TNF-2015","April 21, 2017","December 31, 2021","December 31, 2022","December 16, 2016",,"January 15, 2021","Hospital Universitario de La Princesa, Madrid, Spain",,"https://ClinicalTrials.gov/show/NCT02994836"
316,"NCT01169207","Johns Hopkins Crohn's Disease and Ulcerative Colitis Study",,"Active, not recruiting","No Results Available","Inflammatory Bowel Disease",,,"Johns Hopkins University","All","5 Years and older   (Child, Adult, Older Adult)",,"2500","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","NA_00041583","July 1996","December 2022","December 2022","July 26, 2010",,"August 25, 2020","Johns Hopkins University, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT01169207"
317,"NCT03648398","Pilot Study of an Online Therapeutic Education Program for Patients With Inflammatory Bowel Disease","EDUMICILOR","Recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis","Other: EDUMICILOR","Frequency of participation in the online therapeutic education program|Score of the Crohn and Colitis Knowledge Score|Score of the short Inflammatory Bowel Disease Questionnaire (short-IBDQ)|Score of the Inflammatory Bowel Disease Disability Index (IBD Disability Index)|Score of the Hospital Anxiety and Depression Scale|Score of the Girerd Scale|Score of a satisfaction survey on the online therapeutic education program","Central Hospital, Nancy, France","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","APPARA2018/EDUMICILOR-VELTIN","January 29, 2021","April 1, 2023","April 1, 2023","August 27, 2018",,"March 18, 2021","CHRU Nancy, Nancy, France",,"https://ClinicalTrials.gov/show/NCT03648398"
318,"NCT04759378","Comorbid Esophageal Disorders in IBS Patients",,"Not yet recruiting","No Results Available","GERD|Non-erosive Reflux Disease|Functional Esophageal Disorders|Irritable Bowel Syndrome","Diagnostic Test: Upper endoscopy, esophageal manometry, 24-hour pH monitoring","Incidence of GERD in IBS patients who have upper GIT symptoms|Incidence of Functional esophageal disorders in IBS patient who have upper GIT symptoms.","Assiut University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening","esophageal disorders and IBS","February 25, 2021","September 1, 2021","October 1, 2021","February 18, 2021",,"February 18, 2021",,,"https://ClinicalTrials.gov/show/NCT04759378"
319,"NCT04315714","Impact of a Yoga Intervention on Pain and Multiomics in Participants With IBS",,"Recruiting","No Results Available","Irritable Bowel Syndrome|Abdominal Pain","Other: Yoga Program","Changes in Abdominal Pain|Baseline Metagenomics|Baseline Metabolomics|Changes in Metagenomics|Changes in Metabolomics","University of Maryland, Baltimore|National Institute of Nursing Research (NINR)","All","18 Years to 55 Years   (Adult)","Not Applicable","40","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","HP-00089815|1P30NR016579-01","March 4, 2021","March 2022","March 2022","March 19, 2020",,"March 29, 2021","University of Maryland, Baltimore, School of Nursing, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT04315714"
320,"NCT03571373","PIBD-SETQuality; the PIBD-NET Inception Cohort and Safety Registry",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis","Other: No intervention","Predictors for outcome and treatment response or non-response|New biomarkers as classifiers of response or non-response to therapy|Identification of patients with rare and serious complications","PIBD-Net|European Commission","All","up to 19 Years   (Child, Adult)",,"1000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","PIBD-Net 2016-02","January 3, 2017","December 31, 2020","December 31, 2020","June 27, 2018",,"March 6, 2020","Erasmus MC - Sophia Children's Hospital, Rotterdam, Netherlands|Royal Hospital London, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03571373"
321,"NCT04060303","ENhancing Recovery in CHildren Undergoing Surgery","ENRICH-US","Recruiting","No Results Available","Inflammatory Bowel Disease|Crohn's Disease|Ulcerative Colitis","Procedure: Perioperative surgical care","Length of stay (LOS)|Intraoperative fluid use|Surgical Complications|Hospital readmission|Intraoperative opioid use|Postoperative opioid use|Post-discharge opioid prescribed|Time to regular diet|Preoperative Quality of Life assessment|Immediate post-operative Quality of Life assessment|Long-term post-operative Quality of Life assessment","Northwestern University","All","10 Years to 18 Years   (Child, Adult)","Not Applicable","1260","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","ENRICH-US 2019","September 1, 2019","December 1, 2023","May 1, 2024","August 19, 2019",,"July 10, 2020","Northwestern University, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT04060303"
322,"NCT01140789","GWA Study in Patients With Inflammatory Bowel Disease",,"Recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis",,"To identify genetic variation among three study groups","Chinese University of Hong Kong","All","18 Years and older   (Adult, Older Adult)",,"3600","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","IBD GWA","April 2010","April 2037","April 2037","June 10, 2010",,"April 29, 2020","Prince of Wales Hospital, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT01140789"
323,"NCT04896684","Chronic Intestinal Pathologies Analytical Cohort at TouLouse","CAPITOL","Recruiting","No Results Available","Inflammatory Bowel Diseases|Colon Cancer","Biological: blood and intestinal biopsy sampling","Biological collection associated with clinical data|Identify new potential therapeutic molecules|Optimize treatment success rates for IBD","University Hospital, Toulouse","All","18 Years to 99 Years   (Adult, Older Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","RC31/21/0038","April 29, 2021","May 3, 2022","April 12, 2023","May 21, 2021",,"May 21, 2021","Rangueil University Hospital, Toulouse, France",,"https://ClinicalTrials.gov/show/NCT04896684"
324,"NCT03277703","Flu Vaccine Response in Patients on Biologic Therapies",,"Recruiting","No Results Available","Rheumatologic Disorder|Inflammatory Bowel Diseases|Immune Complex Diseases","Biological: Influenza vaccine","Influenza hemagglutination inhibition (HAI) titer|Clinical efficacy of vaccine","Stony Brook University|University of North Carolina, Chapel Hill","All","3 Years to 22 Years   (Child, Adult)","Phase 2","54","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","1077651","November 3, 2017","April 2020","August 2020","September 11, 2017",,"September 30, 2019","Clinical Research Center, East Setauket, New York, United States",,"https://ClinicalTrials.gov/show/NCT03277703"
325,"NCT02358564","Gut Permeability, Sensitivity and Symptomatology","GPSS","Active, not recruiting","No Results Available","Irritable Bowel Syndrome|Visceral Hypersensitivity","Procedure: Gastrointestinal Permeability Test|Procedure: Upper Endoscopy|Procedure: Rectal Barostat and Infusion of Fats","Mean Percent of complete epithelial cell loss","Mayo Clinic|University of Erlangen-Nürnberg|Heidelberg University|University of Leeds","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","39","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","14-000837|UL1TR000135","February 2015","August 2021","September 2021","February 9, 2015",,"October 29, 2020","Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT02358564"
326,"NCT01765439","The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease",,"Active, not recruiting","No Results Available","Crohn Disease|Ulcerative Colitis","Dietary Supplement: VSL#3 (Original De Simone formulation)","Alteration in the rate of bile acid synthesis|Change of the spectrum of bile acids in stools and plasma|Change of a metabolomic profile in urine","Charles University, Czech Republic|Iscare i.v.f., Czech Republic|CD Investments srl|University Of Perugia|University of Roma La Sapienza","All","Child, Adult, Older Adult","Not Applicable","79","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","VSL#3-2013-CR","February 2014","August 2021","February 2022","January 10, 2013",,"January 28, 2020","Iscare I.V.F., Prague, Czechia",,"https://ClinicalTrials.gov/show/NCT01765439"
327,"NCT03359642","Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy","MIST","Recruiting","No Results Available","Spondyloarthritis|Crohn Disease|Ulcerative Colitis","Other: blood sample|Other: stool samples|Other: food questionnaire|Other: colonoscopy|Other: VOCs profile","Change from Baseline fecal microbiota profile by DNA 16S sequencing at 3 months|Clinical response for Crohn Disease|Clinical response for ulcerative colitis (UC)|Clinical response for spondyloarthritis (SpA)|Ratio of circulating Th17 / Treg lymphocytes|Only for UC group : Analysis of endoscopic activity|Only for UC group : Analysis of histological activity|Change from Baseline Volatile Organic Compounds (VOCs) profile at 3 months","University Hospital, Bordeaux","All","18 Years and older   (Adult, Older Adult)","Not Applicable","72","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","CHUBX 2017/28","June 5, 2018","June 2022","June 2022","December 2, 2017",,"April 19, 2021","CHU de Bordeaux - service d'Hépato-gastroentérologie, Pessac, France",,"https://ClinicalTrials.gov/show/NCT03359642"
328,"NCT04508088","Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescent Girls With Crohn Disease",,"Recruiting","No Results Available","Inflammatory Bowel Disease|Crohn Disease","Diagnostic Test: Coronal T1 weighted spin echo images|Diagnostic Test: Spin-lattice relaxation (T1)|Diagnostic Test: Magnetic resonance spectroscopy","Bone marrow adiposity by magnetic resonance imaging (MRI)|Magnetic resonance spectroscopy (MRS)|Total body bone mineral density Z-score by Dual-energy X-ray absorptiometry (DXA)|Spine BMD Z-score by DXA|Spine apparent density Z-score by DXA|Volumetric bone mineral density (vBMD)|Bone strength by quantitative computed tomography pQCT|Current Crohn's Disease Activity|Physical Activity|Dietary Calcium Intake","Boston Children's Hospital","Female","13 Years to 20 Years   (Child, Adult)",,"20","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","IRB-P00034878","September 10, 2020","August 2022","August 2022","August 11, 2020",,"October 5, 2020","Boston Children's Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04508088"
329,"NCT04198831","Effect of Acupuncture on Quiescent Crohn's Disease",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease","Other: acupuncture|Other: Sham acupuncture","The proportion of clinical recurrences|Mean time of recurrence|The mean change of CDAI from baseline|The mean change of Inflammatory Bowel Disease Questionnaire (IBDQ)|The mean change of the Hospital anxiety and depression scale (HADS)|The mean change of Crohn's disease endoscopic index of severity (CDEIS)","Shanghai Institute of Acupuncture, Moxibustion and Meridian|Fudan University|Shanghai University of Traditional Chinese Medicine|Ruijin Hospital|Indiana University School of Medicine","All","16 Years to 70 Years   (Child, Adult, Older Adult)","Not Applicable","76","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","ZYS2015-03","April 1, 2015","December 31, 2021","December 31, 2021","December 13, 2019",,"March 22, 2021","Shanghai Research Institute of Acupuncture and Meridian, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT04198831"
330,"NCT04848649","Shortening Treatments Of Chronic Inflammatory Conditions","STOIC","Not yet recruiting","No Results Available","Psoriasis|Inflammatory Bowel Diseases","Other: Study arm","Presence and activation of tissue-resident memory [TRM] lymphocytes","Centre Hospitalier Universitaire de Besancon","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2020/534","April 2021","November 2022","April 2024","April 19, 2021",,"April 19, 2021",,,"https://ClinicalTrials.gov/show/NCT04848649"
331,"NCT04094324","Mental Health in Children and Youth Within Pediatric Care","PHU","Enrolling by invitation","No Results Available","Mental Health Impairment|Obesity, Adolescent|IBD","Behavioral: Questionnaires","The Eating Disorder Examination-Questionnaire for children (ChEDE-Q8)|The psychic health questionnaire 8 items (PHQ-8)|General anxiety scale 7 items (GAD-7)|Pediatric quality of Life scale (PedsQL) 23 items|Changes in ISO-BMI|Changes in F-kalprotectin levels","Region Skane","All","11 Years to 18 Years   (Child, Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","HBG/MMÖ PED2019","October 1, 2020","December 31, 2021","December 31, 2022","September 18, 2019",,"October 12, 2020","Helsingborgs lasarett BUM, Helsingborg, Sweden|BÖE SUS, Malmö, Sweden",,"https://ClinicalTrials.gov/show/NCT04094324"
332,"NCT04211129","Effect of Acupuncture on Patients With Crohn's Disease in Remission",,"Recruiting","No Results Available","Crohn Disease|Inflammatory Bowel Diseases","Other: acupuncture|Other: Sham acupuncture","Brief Fatigue Inventory (BFI-C)|The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F)|Crohn's disease activity index （CDAI）score|Inflammatory bowel disease questionnaire (IBDQ)|Hospital anxiety and depression scale (HADS)|Patient Health Questionnaire Depression Scale (PHQ-9)|Generalized Anxiety Disorder (GAD-7)|The proportion of recurrences|Brain functional and structural changes|Colonoscopy or small bowel MR evaluation|Laboratory tests","Shanghai Institute of Acupuncture, Moxibustion and Meridian|Fudan University|Ruijin Hospital|Shanghai Mental Health Center|Indiana University School of Medicine","All","16 Years to 70 Years   (Child, Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","ZYS2019-02","July 1, 2019","December 2022","December 2023","December 26, 2019",,"March 22, 2021","Shanghai Research Institute of Acupuncture and Meridian, Shanghai, China|Yueyang Hospital of Integrated Traditional Chinese and Western medicine, Shanghai university of traditional Chinese medicine, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT04211129"
333,"NCT04798417","Nutrition to Relieve IBS Constipation","NUTRIC","Recruiting","No Results Available","Irritable Bowel Syndrome|Constipation","Dietary Supplement: Probiotic supplement|Dietary Supplement: Prebiotic supplement|Dietary Supplement: Maltodextrin","Stool frequency|Stool consistency|stool volume|Constipation severity|Irritable Bowel Syndrome severity|Constipation related quality of life|Dietary intake|Mental wellbeing|gastro-intestinal complaints","Wageningen University and Research|Ministery of Economic affairs|Nexira|Wecare|Roquette Freres|Ingredion Incorporated|Ingredia S.A.|Naturex|Winclove|Bioiberica|Darling Ingredients","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","180","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","NL76449.041.21","March 8, 2021","August 1, 2021","August 1, 2021","March 15, 2021",,"June 25, 2021","Stichting Wageningen Research, Wageningen, Gelderland, Netherlands",,"https://ClinicalTrials.gov/show/NCT04798417"
334,"NCT04522271","Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)",,"Recruiting","No Results Available","Crohn Disease|Ulcerative Colitis|Inflammatory Bowel Diseases","Other: Resistant Starch|Other: Placebo","Increased potential for butyrate production and its level at the mucosal luminal interface following ingestion of an individualized resistant starch as assessed by meta-omics analysis.|Sustained increased potential of butyrate production 6 months following cessation of the use of individualized resistant starch as assessed by meta-omics analysis of stools.|The percentage of eligible inflammatory bowel disease (IBD) patients who will enter a resistant starch-based ingestion trial.|Compliance of resistant starch intake by patient report.|Compliance of resistant starch intake by product reconciliation.|Change in microbiome composition of cases towards the microbiome of controls as assessed by meta-omics analysis.|Changes in mitochondrial function due to ingestion of resistant starch as assessed by host proteomics of biopsy sampling.|Change in clinical disease activity as measured by the wPCDAI for Crohn's Disease, the PUCAI and Partial Mayo Score for Ulcerative Colitis, and the PGA for both Crohn's Disease and Ulcerative Colitis.|Changes in patient reported disability outcomes as measured by the IBD Disability Index Questionnaire.|Changes in patient, parent/caregiver reported quality of life outcomes as measured by the IMPACT III Questionnaires.|Changes in intestinal mucosal inflammation by measuring fecal calprotectin through stool samples.|Change in endoscopic disease activity measured during colonoscopies using the SES-CD for Crohn's Disease and the Mayo Endoscopic Sub Score and UCEIS for Ulcerative Colitis.|Change in histological scoring of acute and chronic inflammation collected through biopsies during colonoscopies and assessed using Naini and Cortina score for Crohn's disease and the Robarts Histopathological Index (RHI) for Ulcerative Colitis.","Children's Hospital of Eastern Ontario","All","5 Years to 17 Years   (Child)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","20/04E","August 25, 2020","August 2023","February 2024","August 21, 2020",,"June 9, 2021","Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04522271"
335,"NCT04656730","Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas",,"Recruiting","No Results Available","Irritable Bowel Syndrome|Functional Dyspepsia","Drug: Iberogast® and Iberogast® N","Transit and evacuation of intestinal gas|Perception of abdominal symptoms|Objective abdominal distension|Adverse events","Fundació Institut Germans Trias i Pujol|Bayer Hispania, S.L","All","18 Years and older   (Adult, Older Adult)","Phase 4","68","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","IBO","September 3, 2020","April 2023","April 2023","December 7, 2020",,"December 7, 2020","Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain",,"https://ClinicalTrials.gov/show/NCT04656730"
336,"NCT03917303","Control Crohn Safe Trial","CoCroS","Recruiting","No Results Available","Crohn Disease|Inflammatory Bowel Diseases","Drug: Adalimumab|Drug: standard step-up care","Number of yearly-quarters of corticosteroid free remission as a measure of treatment efficacy|Cumulative structural bowel damage as a measure of disease progression|Incidence of drug related serious adverse events|Incidence of serious disease related adverse events|Integer amount of direct health care costs (in €)|Integer amount of indirect health care costs (in €)|Corticosteroid use|Endoscopic remission as assessed by SES-CD|Time to remission|Quality of life as assessed by QoL EQ-5D-5L questionnaire","Maastricht University Medical Center|Maastricht University|ZonMw: The Netherlands Organisation for Health Research and Development","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 4","158","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","NL64005.068.18","December 23, 2019","May 2024","September 2024","April 17, 2019",,"May 19, 2021","Maastricht University Medical Centre+, Maastricht, Netherlands|Laurentius Ziekenhuis, Roermond, Netherlands|Zuyderland Medical Center, Sittard, Netherlands|Máxima Medisch Centrum, Veldhoven, Netherlands|VieCuri, Venlo, Netherlands",,"https://ClinicalTrials.gov/show/NCT03917303"
337,"NCT03397108","Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease",,"Recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis|Healthy Controls",,"Levels of TNFα and its downstream chemokines (CCL2, CCL4, CCL7, and CXCL10) in breast milk of women with IBD and healthy controls by Multiplex assay|Milk concentration of TNFα inhibitors (infliximab, adalimumab) at different time-points between two doses of medication, in lactating women with IBD by ELISA assay|Scores on cognitive subset of Bayley Scales of Infant and Toddler development- Third Version (Bayley-III) in infants of healthy controls and women with IBD|Scores on the ""Problem-solving"" and ""Communication"" subscales of The Ages and Stages Questionnaire (ASQ®-3) in infants of healthy controls and women with IBD|Simulated/predicted profiles of TNFα inhibitors (infliximab, adalimumab) in breast milk in a large population of lactating women with IBD by population pharmacokinetic modelling","The Hospital for Sick Children|MOUNT SINAI HOSPITAL|Crohn's and Colitis Foundation","Female","18 Years and older   (Adult, Older Adult)",,"160","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","1000056982","July 4, 2017","June 30, 2021","June 30, 2021","January 11, 2018",,"October 8, 2020","Mount Sinai Hospital, Toronto, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03397108"
338,"NCT04760964","Mitochondrial DAMPs as Mechanistic Biomarkers of Mucosal Inflammation in Crohn's Disease and Ulcerative Colitis","MUSIC","Recruiting","No Results Available","Inflammatory Bowel Diseases",,"The role of mitochondrial DAMPs as an indicator of gut inflammation and mucosal healing","University of Edinburgh","All","Child, Adult, Older Adult",,"250","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","AC19037","January 27, 2021","February 28, 2023","February 28, 2023","February 18, 2021",,"February 26, 2021","Ninewells Hospital, Dundee, United Kingdom|Western General Hospital, Edinburgh, United Kingdom|NHS Greater Glasgow & Clyde, Glasgow, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04760964"
339,"NCT04454996","Study on the Rule and Mechanism of Treating Functional Gastrointestinal Diseases From the Perspective of Liver and Spleen",,"Recruiting","No Results Available","Non-erosive Reflux Disease/Diarrheal Irritable Bowel Syndrome","Drug: tong-jiang granules|Drug: Chang 'an II Recipe|Drug: The placebo of tong-jiang granules|Drug: The placebo of Chang 'an II Recipe","Changes in 7 point Likert scale scores|Changes in irritable bowel syndrome symptom severity scale scores","Xiyuan Hospital of China Academy of Chinese Medical Sciences","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 4","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","ZZ13-ZD-02","June 25, 2020","September 30, 2021","March 30, 2022","July 2, 2020",,"July 2, 2020","Xiyuan Hospital of China Academy of Chinese Medical Science, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT04454996"
340,"NCT03266068","Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders",,"Active, not recruiting","No Results Available","Campylobacter Infections|Irritable Bowel Syndrome","Genetic: DNA Analysis of Blood Sample|Procedure: Flexible sigmoidoscopy with colonic biopsies|Procedure: Small bowel and colonic gastrointestinal permeability|Diagnostic Test: Stool sample analysis","Colonic geometric center at 24 hours","Mayo Clinic|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","All","18 Years to 80 Years   (Adult, Older Adult)",,"150","Other|NIH","Observational","Observational Model: Case-Control|Time Perspective: Prospective","12-006529|K23DK103911|P30DK084567|UL1TR000135","September 2016","December 2022","December 2022","August 29, 2017",,"January 5, 2021","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03266068"
341,"NCT04734496","Evaluation of the Mechanisms of Sarcopenia in Chronic Inflammatory Disease: Protocol for a Prospective Cohort Study",,"Active, not recruiting","No Results Available","Chronic Liver Disease|Rheumatoid Arthritis|Inflammatory Bowel Diseases","Other: National Healthcare System Standard of care for each disease type (National Institute for Health and Care Excellence guidelines)","Sarcopenia (Muscle Area) using Magnetic Resonance Imaging|Sarcopenia (Muscle Area) using ultrasound|Quality of Life questionnaire|Muscle biopsy of the Vastus lateralis|Leg (Quadricep/Hamstring) strength|Handgrip strength","University of Birmingham|National Institute for Health Research, United Kingdom","All","18 Years and older   (Adult, Older Adult)",,"170","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","RG 18-053|238190","January 1, 2019","April 1, 2020","September 1, 2021","February 2, 2021",,"February 2, 2021","Institute of Inflammation and Ageing (IIA) University of Birmingham Research Laboratories, Birmingham, West Midlands, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04734496"
342,"NCT03291743","The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives",,"Recruiting","No Results Available","Crohn Disease|Genetic Predisposition|IBD","Device: Capsule endoscopy","Prevalence of Crohn's Disease in First Degree Relatives by capsule endoscopy screening|Correlation of capsule endoscopy with ileocolonoscopy; characterization of disease state","Dario Sorrentino|Carilion Clinic","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","144","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","RTDB-2201","February 10, 2017","May 30, 2021","May 30, 2021","September 25, 2017",,"April 28, 2021","Carilion Clinic, Roanoke, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT03291743"
343,"NCT01793831","Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases",,"Recruiting","No Results Available","Crohn's Diseases|Inflammatory Bowel Disease","Procedure: FMT","Clinical remission|Costs|Adverse events","The Second Hospital of Nanjing Medical University|Air Force Military Medical University, China","All","6 Years to 80 Years   (Child, Adult, Older Adult)","Phase 4","200","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","FMC-CN-121101","November 2012","December 2022","December 2032","February 18, 2013",,"September 19, 2018","Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China",,"https://ClinicalTrials.gov/show/NCT01793831"
344,"NCT04882566","Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel Disease",,"Not yet recruiting","No Results Available","Ulcerative Colitis|Crohn Disease|Nutrition","Other: Paleolithic Diet","Evaluation of nutritional knowledge among IBD patients","Assiut University","All","18 Years to 60 Years   (Adult)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Nutrition in IBD patients","July 2021","March 2022","April 2022","May 12, 2021",,"June 3, 2021",,,"https://ClinicalTrials.gov/show/NCT04882566"
345,"NCT03341078","Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users","Ibudilast","Recruiting","No Results Available","Methamphetamine-dependence","Drug: Ibudilast|Drug: Placebo Oral Tablet","Effects of ibudilast on neuroinflammation as assessed by positron emission tomography (PET)|Effects of ibudilast on brain function as assessed by magnetic resonance imaging (MRI)|Effects of ibudilast on overall cognitive battery score.","VA Office of Research and Development|Portland VA Medical Center|Oregon Health and Science University","All","18 Years to 55 Years   (Adult)","Phase 2","65","U.S. Fed|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","NURA-001-17F|16768|18176|20053","May 1, 2019","January 1, 2022","January 1, 2022","November 14, 2017",,"May 24, 2021","VA Portland Health Care System, Portland, OR, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT03341078"
346,"NCT02407236","A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis","UNIFI","Active, not recruiting","Has Results","Colitis, Ulcerative|Inflammatory Bowel Diseases","Drug: Placebo IV|Drug: Placebo SC|Drug: Ustekinumab IV|Drug: Ustekinumab SC","Induction Study - Number of Participants With Clinical Remission at Week 8 (As Per Global Definition)|Induction Study - Number of Participants With Clinical Remission at Week 8 (As Per US Definition)|Maintenance Study: Number of Participants With Clinical Remission at Week 44 (As Per Global Definition)|Maintenance Study: Number of Participants With Clinical Remission at Week 44 (as Per US Definition)|Induction Study: Number of Participants With Endoscopic Healing at Week 8|Induction Study: Number of Participants With Clinical Response at Week 8|Induction Study - Change From Baseline in Total Inflammatory Bowel Disease Questionnaire (IBDQ) Score at Week 8|Maintenance Study: Number of Participants With Clinical Response up to Week 44|Maintenance Study: Number of Participants With Endoscopic Healing at Week 44|Maintenance Study: Number of Participants With Clinical Remission and Not Receiving Concomitant Corticosteroids (Corticosteroid-free Clinical Remission) at Week 44 (As Per Global Definition)|Maintenance Study: Number of Participants With Clinical Remission and Not Receiving Concomitant Corticosteroids (Corticosteroid-free Clinical Remission) at Week 44 (As Per US Definition)|Maintenance Study: Number of Participants With Clinical Remission up to Week 44 Among Participants Who Achieved Clinical Remission at Maintenance Study Baseline (As Per Global Definition)|Maintenance Study: Number of Participants With Clinical Remission up to Week 44 Among Participants Who Achieved Clinical Remission at Maintenance Study Baseline (As Per US Definition)|Induction Study - Number of Participants With Mucosal Healing at Week 8|Induction Study - Number of Participants in Clinical Remission With a Rectal Bleeding Subscore of 0 at Week 8 (As Per Global Definition)|Induction Study - Number of Participants in Symptomatic Remission at Week 8|Induction Study - Number of Participants in With Normal or Inactive Mucosal Disease at Week 8|Induction Study - Change From Baseline in Mayo Score at Week 8|Induction Study - Change From Baseline in Partial Mayo Score Through Week 8|Induction Study - Number of Participants With Individual Mayo Subscore (Stool Frequency) up to Week 8|Induction Study - Number of Participants With Individual Mayo Subscore (Rectal Bleeding) up to Week 8|Induction Study - Number of Participants With Individual Mayo Subscore (Endoscopy Findings) at Week 8|Induction Study - Number of Participants With Individual Mayo Subscore (Physician's Global Assessment) up to Week 8|Induction Study - Number of Participants With Clinical Remission at Week 8 by Biologic Failure (BF) Status (As Per Global Definition)|Induction Study - Number of Participants With Clinical Remission at Week 8 by Biologic Failure (BF) Status (As Per US Definition)|Induction Study - Number of Participants With Endoscopic Healing at Week 8 by Biologic Failure Status|Induction Study - Number of Participants With Clinical Response at Week 8 by Biologic Failure Status|Induction Study: Number of Participants in Remission Based on Stool Frequency Subscore of 0 or 1, Rectal Bleeding Subscore of 0, and Endoscopy Subscore of 0 or 1 at Week 8 (US Specific)|Induction Study: Number of Participants in Remission Based on Stool Frequency Subscore of 0, Rectal Bleeding Subscore of 0, and Endoscopy Subscore of 0 or 1 at Week 8 (US Specific)|Induction Study - Change From Baseline in C-reactive Protein (CRP) Concentration Through Week 8|Induction Study - Number of Participants With Normalized CRP (<=3 mg/L) up to Week 8 Among Participants With Abnormal CRP (>3 mg/L) at Baseline|Induction Study - Change From Baseline in Fecal Lactoferrin Concentration Through Week 8|Induction Study - Number of Participants With Normalized Fecal Lactoferrin (<=7.24 mcg/g) up to Week 8 Among Participants With Abnormal Fecal Lactoferrin (>7.24 mcg/g) at Baseline|Induction Study - Change From Baseline in Fecal Calprotectin Concentration Through Week 8|Induction Study - Number of Participants With Normalized Fecal Calprotectin (<=250 mg/kg) up to Week 8 Among Participants With Abnormal Fecal Calprotectin (>250 mg/kg) at Baseline|Induction Study - Number of Participants With a >20-point Improvement From Baseline in Total Inflammatory Bowel Disease Questionnaire (IBDQ) Score at Week 8|Induction Study - Change From Baseline in IBDQ Dimension Scores at Week 8|Induction Study - Change From Baseline in 36-Item Short-Form (SF-36) Physical Component Score (PCS) and Mental Component Score (MCS) at Week 8|Induction Study - Change From Baseline in Individual Subscales of 36-Item Short-Form (SF-36) at Week 8|Induction Study - Change From Baseline in EuroQOL-5 Dimensions (EQ-5D) Health Questionnaire Index Score at Week 8|Induction Study - Change From Baseline in EuroQOL-5 Dimensions (EQ-5D) Health State Visual Analog Scale (VAS) Score at Week 8|Induction Study - Percentage of Participants With Change From Baseline in EuroQOL-5 Dimensions (EQ-5D) Score at Week 8|Maintenance Study - Change From Maintenance Baseline in Mayo Score at Week 44|Maintenance Study - Change From Induction Baseline in Mayo Score at Week 44|Maintenance Study - Number of Participants With Individual Mayo Subscore (Stool Frequency) up to Week 44|Maintenance Study - Number of Participants With Individual Mayo Subscore (Rectal Bleeding) up to Week 44|Maintenance Study - Number of Participants With Individual Mayo Subscore (Endoscopy Findings) at Week 44|Maintenance Study - Number of Participants With Individual Mayo Subscore (Physician's Global Assessment) up to Week 44|Maintenance Study - Change From Maintenance Baseline in Partial Mayo Score Through Week 44|Maintenance Study - Change From Induction Baseline in Partial Mayo Score Through Week 44|Maintenance Study: Number of Participants in Remission Based on Stool Frequency Subscore of 0 or 1, Rectal Bleeding Subscore of 0, and Endoscopy Subscore of 0 or 1 at Week 44|Maintenance Study: Number of Participants in Remission Based on Stool Frequency Subscore of 0, Rectal Bleeding Subscore of 0, and Endoscopy Subscore of 0 or 1 at Week 44|Maintenance Study: Number of Participants in Symptomatic Remission at Week 44|Maintenance Study: Number of Participants With Clinical Remission at Week 44 by Biologic Failure Status (As Per Global Definition)|Maintenance Study: Number of Participants With Clinical Remission at Week 44 by Biologic Failure Status (As Per US Definition)|Maintenance Study: Number of Participants With Clinical Response up to Week 44 by Biologic Failure Status|Maintenance Study: Number of Participants With Endoscopic Healing at Week 44 by Biologic Failure Status|Maintenance Study: Number of Participants With Endoscopic Healing at Week 44 Among Participants Who Had Achieved Endoscopic Healing at Maintenance Baseline|Maintenance Study: Number of Participants With Normal or Inactive Mucosal Disease at Week 44|Maintenance Study: Number of Participants With Clinical Remission at Week 44 and Not Receiving Concomitant Corticosteroids at Week 44 Among Participants Who Received Concomitant Corticosteroids at Maintenance Baseline (Per Global Definition)|Maintenance Study: Number of Participants With Clinical Remission at Week 44 and Not Receiving Concomitant Corticosteroids at Week 44 Among Participants Who Received Concomitant Corticosteroids at Maintenance Baseline (Per US Definition)|MS: Change From Maintenance Baseline in Average Daily P.Eq Corticosteroid Dose Through Week 44 Among Participants Who Received Corticosteroids Other Than Budesonide and Beclomethasone Dipropionate at Maintenance Baseline|Maintenance Study: Number of Participants Not Receiving Concomitant Corticosteroids at Week 44 Among Participants Who Received Concomitant Corticosteroids at Maintenance Baseline|Maintenance Study: Number of Participants Who Maintained 20-point Improvement From Induction Baseline in IBDQ up to Week 44 Among Participants With a >20-point Improvement in IBDQ at Maintenance Baseline|Maintenance Study: Change From Maintenance Baseline in the IBDQ Score at Week 20 and 44|Maintenance Study: Change From Maintenance Baseline in the IBDQ Dimension Scores at Week 20 and 44|Maintenance Study: Change From Maintenance Baseline in 36-Item Short-Form (SF-36) Physical Component Score (PCS) and Mental Component Score (MCS) at Weeks 20 and 44|Maintenance Study: Change From Maintenance Baseline in Individual Subscales of 36-Item Short-Form (SF-36) at Weeks 20 and 44|Maintenance Study: Change From Maintenance Baseline in EuroQOL-5 Dimensions (EQ-5D) Health Questionnaire Index Score at Weeks 20 and 44|Maintenance Study: Change From Maintenance Baseline in EuroQOL-5 (EQ-5D) Health State Visual Analog Scale (VAS) Score at Weeks 20 and 44|Maintenance Study: Percentage of Participants With Change From Maintenance Baseline in EuroQOL-5 (EQ-5D) Dimensions Score at Weeks 20 and 44|Maintenance Study: Number of Participants With Mucosal Healing at Week 44|Maintenance Study: Change From Maintenance Baseline in C-reactive Protein (CRP) Concentration at Weeks 8, 24, and 44|Maintenance Study: Change From Maintenance Baseline in Fecal Lactoferrin Concentration at Weeks 8, 24, and 44|Maintenance Study: Change From Maintenance Baseline in Fecal Calprotectin Concentration at Weeks 8, 24, and 44","Janssen Research & Development, LLC","All","18 Years and older   (Adult, Older Adult)","Phase 3","961","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)","CR106920|2014-005606-38|CNTO1275UCO3001","July 10, 2015","August 10, 2018","November 26, 2021","April 2, 2015","December 23, 2019","June 9, 2021","Birmingham, Alabama, United States|La Mirada, California, United States|Los Angeles, California, United States|Newport Beach, California, United States|Torrance, California, United States|Vallejo, California, United States|Lone Tree, Colorado, United States|Farmington, Connecticut, United States|Washington, District of Columbia, United States|Gainesville, Florida, United States|Largo, Florida, United States|Miami, Florida, United States|Port Orange, Florida, United States|Tampa, Florida, United States|Winter Park, Florida, United States|Zephyrhills, Florida, United States|Atlanta, Georgia, United States|Decatur, Georgia, United States|Macon, Georgia, United States|Suwanee, Georgia, United States|Idaho Falls, Idaho, United States|Chicago, Illinois, United States|Evanston, Illinois, United States|Urbana, Illinois, United States|Indianapolis, Indiana, United States|Pratt, Kansas, United States|Crestview Hills, Kentucky, United States|Lexington, Kentucky, United States|Louisville, Kentucky, United States|Houma, Louisiana, United States|Shreveport, Louisiana, United States|Columbia, Maryland, United States|Boston, Massachusetts, United States|Ann Arbor, Michigan, United States|Chesterfield, Michigan, United States|Troy, Michigan, United States|Ypsilanti, Michigan, United States|Rochester, Minnesota, United States|Jackson, Mississippi, United States|Marlton, New Jersey, United States|Morristown, New Jersey, United States|Bronx, New York, United States|Brooklyn, New York, United States|Mineola, New York, United States|New York, New York, United States|Poughkeepsie, New York, United States|Rochester, New York, United States|Cincinnati, Ohio, United States|Mentor, Ohio, United States|Portland, Oregon, United States|Doylestown, Pennsylvania, United States|Hershey, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Sayre, Pennsylvania, United States|Germantown, Tennessee, United States|Nashville, Tennessee, United States|Dallas, Texas, United States|Houston, Texas, United States|Irving, Texas, United States|San Antonio, Texas, United States|Southlake, Texas, United States|Tyler, Texas, United States|Salt Lake City, Utah, United States|West Jordan, Utah, United States|Chesapeake, Virginia, United States|Fairfax, Virginia, United States|Roanoke, Virginia, United States|Seattle, Washington, United States|Bedford, Australia|Clayton, Australia|Concord N/a, Australia|Fitzroy, Australia|Five Dock, Australia|Garran, Australia|Heidelberg, Australia|Liverpool, Australia|Melbourne, Australia|South Brisbane, Australia|Salzburg, Austria|Wien, Austria|Antwerpen, Belgium|Gent, Belgium|Kortrijk, Belgium|Leuven, Belgium|Liege, Belgium|Liège, Belgium|Roeselaere, Belgium|Pleven, Bulgaria|Rousse, Bulgaria|Sevlievo, Bulgaria|Sofia, Bulgaria|Varna, Bulgaria|Vancouver, British Columbia, Canada|Victoria, British Columbia, Canada|Brandon, Manitoba, Canada|Winnipeg, Manitoba, Canada|London, Ontario, Canada|Sudbury, Ontario, Canada|Montreal, Quebec, Canada|Hradec Kralove, Czechia|Plzen, Czechia|Prague 4, Czechia|Praha 5, Czechia|Praha 7, Czechia|Praha 9, Czechia|Aarhus, Denmark|Odense, Denmark|Amiens, France|Bordeaux, France|Lille, France|Lyon, France|Marseille, France|Montpellier, France|Pierre-Benite, France|Reims, France|Rennes, France|Saint-Etienne, France|Toulouse, France|Berlin, Germany|Essen, Germany|Freiburg, Germany|Hannover, Germany|Kiel, Germany|Leipzig, Germany|Lüneburg, Germany|Mannheim, Germany|Minden, Germany|Münster, Germany|Balatonfüred, Hungary|Budapest, Hungary|Békéscsaba, Hungary|Debrecen, Hungary|Miskolc, Hungary|Mosonmagyarovar, Hungary|Szekszárd, Hungary|Szombathely, Hungary|Székesfehérvár, Hungary|Vac, Hungary|Beersheba, Israel|Haifa, Israel|Holon, Israel|Jerusalem, Israel|Kfar-Saba, Israel|Nahariya, Israel|Petach Tikvah, Israel|Tel Aviv, Israel|Tel Hashomer, Israel|Ageo-shi, Japan|Asahikawa, Japan|Bunkyo-Ku, Japan|Chiba, Japan|Chikushinoshi, Japan|Fujiidera, Japan|Fukuoka-ken, Japan|Higashi-Ibaraki, Japan|Hirosaki, Japan|Hiroshima, Japan|Isesaki, Japan|Iwate, Japan|Izumo, Japan|Kagawa, Japan|Kagoshima, Japan|Kahoku, Japan|Kobe-shi, Japan|Kochi, Japan|Kurume, Japan|Kyoto, Japan|Midori-ku, Japan|Nagasaki, Japan|Nara, Japan|Nishinomiya, Japan|Oita, Japan|Osaka, Japan|Saga-ken, Japan|Saga, Japan|Saitama, Japan|Sakura, Japan|Sapporo, Japan|Sendai, Japan|Shizuoka, Japan|Sunto-gun, Japan|Takamatsu, Japan|Tokorozawa, Japan|Tokyo, Japan|Toyama, Japan|Toyota, Japan|Tsuchiura, Japan|Tsu, Japan|Wakayama, Japan|Yamanashi, Japan|Daegu, Korea, Republic of|Guri-si, Korea, Republic of|Seoul, Korea, Republic of|Suwon-si, Korea, Republic of|Amsterdam, Netherlands|Maastricht, Netherlands|Auckland, New Zealand|Christchurch, New Zealand|Dunedin, New Zealand|Lower Hutt, New Zealand|Milford, New Zealand|Gdansk, Poland|Krakow, Poland|Lodz, Poland|Pulawy, Poland|Sopot, Poland|Szczecin, Poland|Warszawa, Poland|Wroclaw, Poland|Bucuresti, Romania|Oradea, Romania|Romania, Romania|Timisoara, Romania|Irkutsk, Russian Federation|Karzan, Russian Federation|Moscow, Russian Federation|Novosibirsk, Russian Federation|Rostov-on-Don, Russian Federation|Ryazan, Russian Federation|Saint Petersburg, Russian Federation|St Petersburg, Russian Federation|St.-Petersburg, Russian Federation|Stavropol, Russian Federation|Ufa, Russian Federation|Belgrade, Serbia|Kragujevac, Serbia|Nis, Serbia|Vojvodina, Serbia|Bratislava, Slovakia|Presov, Slovakia|Chernivtsi, Ukraine|Dnipropetrovsk, Ukraine|Ivano-Frankivsk, Ukraine|Kharkiv, Ukraine|Kiyv, Ukraine|Kyiv, Ukraine|Lviv, Ukraine|Odessa, Ukraine|Sumy, Ukraine|Uzhgorod, Ukraine|Vinnytsia, Ukraine|Zaporizhzhia, Ukraine|Zhaporozhia, Ukraine|Birmingham, United Kingdom|Cambridge, United Kingdom|Coventry, United Kingdom|Doncaster, United Kingdom|Edinburgh, United Kingdom|Liverpool, United Kingdom|London, United Kingdom|Salford, United Kingdom|Southampton, United Kingdom|Sutton In Ashfield, United Kingdom","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/36/NCT02407236/Prot_000.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/36/NCT02407236/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT02407236"
347,"NCT04057898","Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS","COMBAT-ALS","Recruiting","No Results Available","Amyotrophic Lateral Sclerosis","Drug: MN-166|Drug: placebo","Change from baseline in ALSFRS-R score at Month 12 (or last measurement before death in case of censoring) and survival time.|Mean change from baseline of muscle strength measured by hand-held dynamometry|Mean change from baseline on quality of life assessed by ALSAQ-5 at Month 12|Mean change from baseline of functional activity measured by ALSFRS-R at Month 12|Responders, measured in percent of subjects overall, whose ALSFRS-R total score was stable or improved|Time to survival|Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v4.0|Changes from Baseline in Laboratory Values","MediciNova","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2|Phase 3","230","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","MN-166-ALS-2301","May 28, 2020","December 2023","December 2024","August 15, 2019",,"June 1, 2021","University of California, Orange, California, United States|Mayo Clinic, Jacksonville, Florida, United States|Augusta University, Augusta, Georgia, United States|Indiana University IU Health Neuroscience Center, Indianapolis, Indiana, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Johns Hopkins University, Baltimore, Maryland, United States|Hennepin Healthcare Research Institute, Minneapolis, Minnesota, United States|Mayo Clinic / Rochester, Rochester, Minnesota, United States|Hospital for Special Surgery, New York, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|Duke University, Durham, North Carolina, United States|Providence Brain and Spine Institute, Portland, Oregon, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, United States|Allegheny Health Network, Allegheny Neurological Associates, Pittsburgh, Pennsylvania, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Swedish Neuroscience Institute, Seattle, Washington, United States|McMaster University Medical Center, Hamilton, Ontario, Canada|Sunnybrook Research Institute, Toronto, Ontario, Canada|Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT04057898"
348,"NCT02508012","Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases","ATAIM","Active, not recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis","Other: Immuno monitoring","cost-utility analysis of the immunomonitoring strategy|quality of life","University Hospital, Montpellier|Department of the medical information of Montpellier","All","18 Years and older   (Adult, Older Adult)","Not Applicable","260","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","UF 9535","September 24, 2015","September 23, 2020","June 23, 2021","July 24, 2015",,"January 10, 2020","University hospital, Montpellier, France",,"https://ClinicalTrials.gov/show/NCT02508012"
349,"NCT03998488","Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis","MINDFUL","Recruiting","No Results Available","Ulcerative Colitis|Inflammatory Bowel Diseases","Drug: Fecal Microbiota Transplantation|Dietary Supplement: Psyllium Husk Powder","Clinical Response|Clinical Remission|Endoscopic Response or Remission|Number and type of treatment related adverse events.|Change in Number of disease-related complications such as hospitalizations, surgeries and endoscopies, medical complications, and mortality","Weill Medical College of Cornell University|Crohn's and Colitis Foundation","All","18 Years to 89 Years   (Adult, Older Adult)","Phase 2","135","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","19-04020045","January 31, 2020","January 2023","January 2025","June 26, 2019",,"May 17, 2021","Weill Cornell Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03998488"
350,"NCT01731665","Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.",,"Recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis|Epidemiology|Korea",,"Incidence rate and prevalence rate of IBD|Clinical features of patients with IBD","Asan Medical Center|Kyung Hee University Hospital at Gangdong|Seoul National University Hospital|Seoul National University Bundang Hospital|Samsung Medical Center|Konkuk University Medical Center|National Police Hospital|Seoul Veterans Hospital|hansol hospital|Kangdong Seoul Clinic|Jamsil Seoul Surgical Clinic|Song Do Colorectal Hospital|Yang Hospital|Daehang Hospital|Kangdong Sacred Heart Hospital","All","Child, Adult, Older Adult",,"2000","Other","Observational","Observational Model: Cohort|Time Perspective: Other","2012-0634","December 2012","June 2029","June 2029","November 22, 2012",,"January 13, 2021","Asan Medical Center, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT01731665"
351,"NCT04456400","Enhancing Ultrasound & Photoacoustic for Recognition of Intestinal Abnormalities","EUPHORIA","Recruiting","No Results Available","Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease","Diagnostic Test: Multispectral Optoacoustic Tomography (MSOT)","Derivation Cohort: derive optimum diagnostic MSOT thresholds|Validation cohort: re-assess the diagnostic accuracy of MSOT|Derivation Cohort: MSOT thresholds|Derivation Cohort: MSOT performance, diagnostic accuracy measures|Derivation Cohort: MSOT performance, diagnostic accuracy|Validation Cohort: MSOT performance, diagnostic accuracy measures|Validation Cohort: MSOT performance, diagnostic accuracy|Both cohorts: diagnostic accuracy|Both cohorts: performance of other non-invasive diagnostic modalities|Both cohorts: likelihood ratios and predictive values for active inflammation|Both cohorts: performance of MSOT in combination with other modalities|Both cohorts: discriminate different grades of disease activity|Both cohorts: interobserver variability|Both cohorts: patient preference|Derivation cohort: MSOT thresholds using clinical scores as a reference","iThera Medical GmbH|European Commission","All","18 Years and older   (Adult, Older Adult)",,"540","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","cMSOT-2","February 3, 2021","December 2021","December 2021","July 2, 2020",,"February 4, 2021","Universitätsklinikum Erlangen Medizinische Klinik 1, Erlangen, Germany",,"https://ClinicalTrials.gov/show/NCT04456400"
352,"NCT04369963","The Healthy Endoscopy Study",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Functional Gastrointestinal Disorders","Procedure: Esophagogastroduodenoscopy and Colonoscopy with Biopsies","To create a single-cell RNA atlas of healthy gastrointestinal tract from healthy participants","Seattle Children's Hospital|Boston Children's Hospital","All","18 Years to 25 Years   (Adult)",,"10","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","STUDY00001638","March 14, 2019","February 5, 2021","February 5, 2022","April 30, 2020",,"May 6, 2020","Seattle Children's Hospital, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT04369963"
353,"NCT04202211","FMT for Remission of Active Ulcerative Colitis in Adults",,"Not yet recruiting","No Results Available","Ulcerative Colitis|Inflammatory Bowel Diseases","Biological: FMT oral|Biological: FMT enema|Other: Placebo oral|Other: Placebo enema","Remission of UC|Incidence/absence of adverse events upon treatment with LYO-FMT [safety and tolerability]|UC disease progression","University of British Columbia|Crohn's and Colitis Canada|Vancouver Island Health Authority","All","18 Years and older   (Adult, Older Adult)","Phase 2","145","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","H19-03882","February 2020","May 2023","February 2025","December 17, 2019",,"December 18, 2019","University of Alberta Hospital, Edmonton, Alberta, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|Royal Jubilee Hospital, Victoria, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT04202211"
354,"NCT04666155","Cost-effectiveness of ICE With MOWOOT",,"Not yet recruiting","No Results Available","Constipation - Functional|Constipation-predominant Irritable Bowel Syndrome","Device: Intermittent Colonic Exoperistalsis with MOWOOT device|Combination Product: Standard of care","Changes in quality of life|Changes in Constipation symptoms|Economic outcome","usMIMA S.L.|County Durham and Darlington NHS Foundation Trust|University of York|EIT Health","All","18 Years to 99 Years   (Adult, Older Adult)","Phase 4","90","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Other","MOW-06-2020","May 1, 2021","August 1, 2022","October 31, 2022","December 14, 2020",,"December 14, 2020",,,"https://ClinicalTrials.gov/show/NCT04666155"
355,"NCT04411784","PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis","PROTECT-ASUC","Active, not recruiting","No Results Available","Inflammatory Bowel Diseases|COVID",,"Primary outcome measure: The need for in-hospital colectomy or rescue therapy|2.1: Duration and type/route of steroid use|2.2: 30 day colectomy free survival rates|2.3: Covid-19 infection rates|2.4: Rate of Rescue therapy use|2.5: Duration of hospital stay|2.6: Admission severity scoring|2.7: Readmission rates","Hull University Teaching Hospitals NHS Trust","All","16 Years to 100 Years   (Child, Adult, Older Adult)",,"200","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","284030","May 20, 2020","July 2020","July 2020","June 2, 2020",,"June 2, 2020","Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust, Hull, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04411784"
356,"NCT03861689","Tight Control Management in Perianal Crohn's Disease","PLACE-PCD","Enrolling by invitation","No Results Available","Inflammatory Bowel Diseases|Perianal Fistula","Diagnostic Test: MRI pelvis","Change in the disease activity in patients with perianal Crohn's disease|Number of pCD patients achieving closure of external fistula opening with FiLAC|Proportion of pCD patients requiring proctectomy, defunctioning surgery|Number of surgeries required for perianal Crohn's disease|Side effects profile","Chinese University of Hong Kong","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","PLACE-PCD_Protocol_20200909 v6","July 1, 2019","October 30, 2021","October 30, 2023","March 4, 2019",,"May 11, 2021","The Chinese University of Hong Kong, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT03861689"
357,"NCT03278912","Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations",,"Recruiting","No Results Available","Chronic Granulomatous Disease|Inflammatory Bowel Disease",,"Disease-specific intestinal microbiome signatures, and related localized and systemic immune responses.|Changes in microbiome signatures. Changes in metabolomic and transcriptomic signatures.|Changes in systemic and tissue-specific markers of innate and adaptive immunity.|Disease-specific differences in relative quantity and function of peripheral blood and tissue immune cells (includes hematopoietic and stromal cells).","National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC)","All","3 Years and older   (Child, Adult, Older Adult)",,"339","NIH","Observational","Observational Model: Cohort|Time Perspective: Prospective","170163|17-I-0163","September 28, 2020","July 1, 2030","July 1, 2030","September 12, 2017",,"March 5, 2021","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT03278912"
358,"NCT04456517","Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy","REACT","Enrolling by invitation","No Results Available","Crohn's Disease|Inflammatory Bowel Disease","Drug: Ranolazine|Drug: Placebo","Mean change in daily number of loose stools from baseline|Mean change in Crohn's Disease Activity Index (CDAI) score|Mean change in Harvey Bradshaw Index (HBI) score|Short Inflammatory Bowel Disease Questionnaire (SIBDQ) score|Patient Health Questionnaire (PHQ-9) score","Vanderbilt University Medical Center","All","18 Years and older   (Adult, Older Adult)","Phase 2","16","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","200640","June 15, 2021","June 2023","December 2023","July 2, 2020",,"May 14, 2021","Vanderbilt University Medical Center, Nashville, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT04456517"
359,"NCT04046913","The ADDapt Diet in Reducing Crohn's Disease Inflammation",,"Recruiting","No Results Available","Crohn Disease|Inflammatory Bowel Diseases","Behavioral: Dietary education","Crohn's Disease Activity Index|Faecal calprotectin|Serum C-reactive protein|Mucosal immune cell gene expression|Crohn's Disease Activity Index (CDAI)|Perceived Crohn's disease control|Health related quality of life|Faecal microbiota composition|Faecal microbial gene expression|Mucosal microbiota composition|Gastrointestinal permeability|Dietary intake|Dietary adherence|Diet feasibility and acceptability","King's College London","All","18 Years and older   (Adult, Older Adult)","Not Applicable","154","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","IRAS 260196","September 9, 2019","August 2021","August 2021","August 6, 2019",,"September 9, 2020","King's College London, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04046913"
360,"NCT03606499","Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases","TENOR","Recruiting","No Results Available","Crohn Disease|Colitis, Ulcerative","Drug: Ustekinumab","Percentage of Participants Achieving a Clinical Response (CR) on at Least one Extra-intestinal Manifestation/Immune-mediated Inflammatory Disease (EIM/IMID) Associated with Inflammatory Bowel Disease (IBD) at Week 24|Percentage of Participants with Change from Baseline in Clinical Response for Crohn's Disease (CD) as Measured by Harvey-Bradshaw Index (HBI)|Percentage of Participants Achieving Remission for CD as Measured by HBI|Change from Baseline in Partial Mayo Score|Percentage of Participants Achieving Remission for UC as Measured by Partial Mayo Score (Score of <=2)|Change from Baseline in the Presence of Extra Intestinal Manifestations (EIMS) or Immune-Mediated Inflammatory Diseases (IMIDs)|Work Productivity and Activity Impairment (WPAI) Questionnaire|Short Inflammatory Bowel Disease Questionnaire Score (Short IBDQ)|Functional Assessment of Chronic Illness Therapy Scale (FACIT)|Inflammatory Bowel Disease-Disability Index (IBD-DI)|Number of Participants with Adverse Events|Number of IBD Related Medical Visits|Number of Days of IBD Related Hospitalization with Surgery|Number of Days of IBD Related Hospitalization Without Surgery|Number of IBD Related Emergency Visits","Janssen Cilag S.A.S.","All","18 Years and older   (Adult, Older Adult)",,"214","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","CR108498|CNTO1275CRD4012","September 26, 2018","October 30, 2022","October 30, 2022","July 31, 2018",,"May 24, 2021","CHU de Nancy - Hôpital de Brabois, Vandoeuvre les Nancy, France",,"https://ClinicalTrials.gov/show/NCT03606499"
361,"NCT04231279","Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency",,"Not yet recruiting","No Results Available","Abdominal Pain|Irritable Bowel Syndrome","Drug: synthetic human secretin","Prevalence of pancreatic insufficiency in Pediatric cases undergoing upper endoscopy for Abdominal Pain|Secondary biomarkers for exocrine pancreatic insufficiency in blood and pancreatic fluid will be measured to explore mechanisms involved leading to abdominal pain and become potential tests in future.","Orlando Health, Inc.|ChiRhoClin, Inc.","All","6 Months to 18 Years   (Child, Adult)","Phase 3","800","Other|Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","RAP and EPI|1804804","January 2020","December 2023","December 2023","January 18, 2020",,"January 18, 2020",,,"https://ClinicalTrials.gov/show/NCT04231279"
362,"NCT04838834","Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children","RECONN","Active, not recruiting","No Results Available","COVID-19|SARS-CoV-2|Inflammatory Bowel Diseases",,"Presence of anti-SARS-CoV-2 Immunoglobulin G (IgG)|Presence of anti-SARS-CoV-2 IgG neutralizing antibodies","Connecticut Children's Medical Center|The Jackson Laboratory","All","2 Years to 27 Years   (Child, Adult)",,"472","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","20-073","May 15, 2020","December 31, 2024","December 31, 2024","April 9, 2021",,"April 9, 2021","Connecticut Children's Medical Center, Hartford, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT04838834"
363,"NCT04159311","Osteopathy on IBS Symptoms in Patients With Ulcerative Colitis in Remission","OSTEOMIC","Recruiting","No Results Available","Irritable Bowel Syndrome|Ulcerative Colitis","Other: Osteopathy","Evaluate the score change of Irritable Bowel Syndrome Severity Scoring System (IBS SSS)|IBDQol : Inflammatory Bowel Disease Questionnaire|FACIT-F : Functional Assessment of Chronic Illness Therapy-Fatigue|Evaluation of osteopathic dysfunctions|Questionnaire for use of medication for Irritable Bowel Syndrome","Clinique Paris-Bercy","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","CParisBercy","November 14, 2019","November 2, 2021","November 2, 2021","November 12, 2019",,"January 2, 2020","Clinique Paris Bercy, Charenton Le Pont, France",,"https://ClinicalTrials.gov/show/NCT04159311"
364,"NCT04138225","The Ecological Role of Yeasts in the Human Gut","YIG","Recruiting","No Results Available","Irritable Bowel Syndrome|Inflammatory Bowel Diseases|Gastrointestinal Disease",,"Yeast species in gut|Metabolic profile|Calprotectin|Lactorferrin","Grace Ward|Guy's and St Thomas' NHS Foundation Trust|Royal Berkshire Hospital|University of Reading","All","20 Years to 60 Years   (Adult)",,"120","Other","Observational","Observational Model: Cohort|Time Perspective: Other","YIGV1","September 23, 2018","May 23, 2020","September 23, 2021","October 24, 2019",,"October 28, 2019","University of Reading, Reading, Berkshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04138225"
365,"NCT03782415","Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma",,"Active, not recruiting","No Results Available","Glioblastoma|Recurrent Glioblastoma|GBM|Recurrent GBM","Drug: MN-166|Drug: Temozolomide","Evaluate safety and tolerability of ibudilast and temozolomide combination treatment|Evaluate efficacy of ibudilast and TMZ combination treatment|Evaluate Tmax|Cmax|AUC|Terminal rate constant|Terminal half-life|Maximum tolerated dose determination|Evaluate the safety of fixed-dose ibudilast in combination with TMZ|Evaluate overall survival, response rate, and median 6-month progression-free survival (PFS6)","MediciNova","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","50","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","MN-166-GBM-1201","December 29, 2018","December 2021","December 2022","December 20, 2018",,"June 7, 2021","Dana-Farber Cancer Institute, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT03782415"
366,"NCT04147585","Effects of an Intermittent Reduced Calorie Diet on Crohn's Disease",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Diet Modification","Other: Intermittent Reduced Calorie Diet (IRCD)","Number of Participants with Clinical response as per CDAI (70 points)|Number of Participants with Clinical remission as per CDAI|Number of Participants with Clinical response as per CDAI (100 points)|Change in C-reactive protein (CRP) at baseline versus after 3rd cycle of IRCD (or control at corresponding time point) in both IRCD and control group.|Change in Erythrocyte Sedimentation Rate (ESR) at baseline versus after 3rd cycle of IRCD (or control at corresponding time point) in both IRCD and control group.|Change in fecal calprotectin at baseline versus after 3rd cycle of IRCD (or control at corresponding time point) in both IRCD and control group.|Number of Participants with Clinical remission as per Patient Reported Outcome (PRO) score|Patient global assessment|Effect of IRCD on endoscopic outcomes|Effect of IRCD on patient quality of life: Short Inflammatory Bowel Disease questionnaire (SIBDQ)","Stanford University","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","75","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB 53161","December 18, 2019","July 14, 2022","October 14, 2022","November 1, 2019",,"May 4, 2021","Stanford University, Palo Alto, California, United States",,"https://ClinicalTrials.gov/show/NCT04147585"
367,"NCT04806386","The Role of Fiber in the Prevention and Treatment of Fecal Incontinence",,"Not yet recruiting","No Results Available","Fecal Incontinence|Irritable Bowel Syndrome With Diarrhea","Dietary Supplement: Psyllium","Stool metagenomics|Stool microbiome|Fecal incontinence severity index (FISI)|Fecal Incontinence quality of life (FIQL)|Anorectal manometry parameters|Translumbosacral anorectal magnetic stimulation|Global assessment of relief|Bloating scale|Urgency scale|Flatus scale|Waist circumference measurement (cm)","Massachusetts General Hospital","Female","55 Years to 85 Years   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2021P000691","May 10, 2021","August 15, 2023","August 15, 2023","March 19, 2021",,"April 28, 2021","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04806386"
368,"NCT04060121","Efficacy of Psychological Therapies in Patients With Functional Bowel Disorders","PTSD","Recruiting","No Results Available","IBS - Irritable Bowel Syndrome|Constipation",,"Early adverse life events (EALS)|Post-traumatic Stress Disorder (PTSD)|Change in weekly number of complete spontaneous bowel movements|Change in abdominal pain|IBS or functional constipation (FC)|Psychological comorbidities|Health-related quality of life: Short Form-12 (SF-12)|Constipation-related symptoms|Constipation-related quality of life","Indiana University|Indiana University Health|Indiana Clinical and Translational Sciences Institute","All","18 Years and older   (Adult, Older Adult)",,"370","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","1802270023|UL1TR002529","June 1, 2018","December 31, 2021","December 31, 2022","August 16, 2019",,"December 9, 2020","Indiana University Hospital, Indianapolis, Indiana, United States",,"https://ClinicalTrials.gov/show/NCT04060121"
369,"NCT02693730","Phenotyping IBS: Perceptions and Modulations of Visceral Sensations","PMVS-P","Active, not recruiting","No Results Available","Irritable Bowel Syndrome|Ulcerative Colitis|Inflammatory Bowel Disease",,"Classifying patients with IBS and Ulcerative Colitis (UC) based on their brain ""signatures"" obtained from structural and functional MRI scanning.|Global and regional brain network alterations in IBS.|Possible biological mediators of observed IBS related brain network alterations","University of California, Los Angeles|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","All","18 Years to 60 Years   (Adult)",,"290","Other|NIH","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","2R01DK048351-15A1","January 2016","June 2021","June 2021","February 29, 2016",,"June 14, 2021","Oppenheimer Center for Neurobiology of Stress and Resilience, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT02693730"
370,"NCT03604536","Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Ulcerative Colitis",,"Change in Total Inflammation Burden Scoring (TIBS)|Disease course type|Compliance with medication|Short Inflammatory Bowel Disease Questionnaire|Disability|Fatigue","Nordsjaellands Hospital|Ferring Pharmaceuticals","All","18 Years to 75 Years   (Adult, Older Adult)",,"20","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","H-17038710","December 2, 2019","August 31, 2021","December 31, 2021","July 27, 2018",,"August 25, 2020","North zealand university hospital, Frederikssund, Denmark",,"https://ClinicalTrials.gov/show/NCT03604536"
371,"NCT03678935","Effect of FODMAP Restriction on Persistent GI-symptoms in Coeliac Patients",,"Active, not recruiting","No Results Available","Celiac Disease|Irritable Bowel Syndrome|Diet Modification|Gluten Sensitivity","Other: Low FODMAP diet","Change in gastrointestinal symptoms|Changes in biomarkers like faecal microbiota|Quality of Life in patients with coeliac disease: Short form- 36 (SF-36)","Oslo University Hospital","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2018/1055","October 1, 2018","June 1, 2021","October 1, 2023","September 20, 2018",,"July 14, 2020","Rikshospitalet-Radiumhospitalet HF, Oslo University Hospital, Oslo, Postboks PB 4950 Nydalen, Norway","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/35/NCT03678935/Prot_002.pdf","https://ClinicalTrials.gov/show/NCT03678935"
372,"NCT04750135","Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis",,"Not yet recruiting","No Results Available","Ulcerative Colitis|Inflammatory Bowel Diseases","Drug: metformin 500 mg TID Oral Tablet|Drug: Placebo","Difference between the two groups in the expression of colonic (NF)-κB proteins.","National Hepatology & Tropical Medicine Research Institute","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","21-2019","February 7, 2021","June 1, 2021","June 1, 2021","February 11, 2021",,"February 11, 2021","Tanta University Hospitals, Tanta, الغربية, Egypt",,"https://ClinicalTrials.gov/show/NCT04750135"
373,"NCT04241029","Boosting Biologics in UC",,"Recruiting","No Results Available","Ulcerative Colitis|Inflammatory Bowel Diseases","Dietary Supplement: IDOFORM®Travel","Adverse events|Total Mayo Score for Ulcerative Colitis|Change in Fecal Calprotectin|Alterations in mucosa-adherent microbial composition|Alterations in epithelial gene expression|Alterations in markers of chronic inflammation / immune activation","Oslo University Hospital|Helse Sor-Ost","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1","20","Other","Interventional","Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2016/2269","February 25, 2020","June 30, 2021","June 30, 2023","January 27, 2020",,"March 4, 2020","Oslo University Hospital, Oslo, Norway",,"https://ClinicalTrials.gov/show/NCT04241029"
374,"NCT03947931","Russian Extremely Severe Ulcerative Colitis Study","REXs_UC","Recruiting","No Results Available","Ulcerative Colitis|Inflammatory Bowel Diseases",,"Inpatient colectomy rate|Long-term colectomy rate|Total mortality|Postoperative complications","State Scientific Centre of Coloproctology, Russian Federation","All","18 Years and older   (Adult, Older Adult)",,"140","Other","Observational","Observational Model: Other|Time Perspective: Prospective","127","June 20, 2019","June 20, 2021","June 20, 2022","May 13, 2019",,"October 22, 2020","State Scientific Centre of Coloproctology, Russian Federation, Moscow, Russian Federation",,"https://ClinicalTrials.gov/show/NCT03947931"
375,"NCT03843385","Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis","FRESCO","Not yet recruiting","No Results Available","Ulcerative Colitis|Inflammatory Bowel Diseases","Drug: encapsulated faecal microbiota filtrate|Drug: encapsulated faecal microbiota|Drug: Placebo","clinical remission|steroid-free clinical remission|clinical response|change in quality of life","Jena University Hospital|German Federal Ministry of Education and Research","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2|Phase 3","174","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","KS2017-114","May 2019","December 2020","September 2021","February 18, 2019",,"February 21, 2019",,,"https://ClinicalTrials.gov/show/NCT03843385"
376,"NCT03586622","One Year Home Monitoring and Treatment of IBS Patients",,"Active, not recruiting","No Results Available","eHealth|Dietary Modification|Probiotics|Microbiome|Irritable Bowel Syndrome","Dietary Supplement: Low FODMAP diet (LFD)|Dietary Supplement: VSL#3®","Symptom Severity (5-Item visual analogue scale, IBS-SSS)|Symptom Severity (IBS-SSS) area under the curve (AUC)|Disease course, Copenhagen IBS Disease course Type|Compliance, FODMAP adherence Report scale (FARS)|Compliance, Medication Adherence Report Scale (MARS)|Stool consistency, Bristol Stool Chart|Low grade inflammation measured by Fecal calprotectin (FC) on any smart phone|Microbiome|Symptom Severity (Time to and time in symptom remission, IBS-SSS)|Quality of life, IBS-QOL|Food registration|Patients feedback for improvement of the ehealth platform","Nordsjaellands Hospital|Colitis-Crohn Foreningen|Ferring Pharmaceuticals|Calpro AS|Muusmann forlag|Statens Serum Institut|Genetic Analysis AS","All","18 Years and older   (Adult, Older Adult)","Not Applicable","124","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","H16023499","September 23, 2018","December 20, 2020","December 20, 2020","July 13, 2018",,"October 19, 2020","North Zealand university hospital, Gastro unit, Frederikssund, Capital Region, Denmark",,"https://ClinicalTrials.gov/show/NCT03586622"
377,"NCT03952364","The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United States",,"Recruiting","No Results Available","Crohn Disease|Ulcerative Colitis|IBD|Inflammatory Bowel Diseases","Other: PredictSURE IBD™","To stratify patients at diagnosis into high and low- risk cohorts","PredictImmune Ltd|The Crohn's and Colitis Foundation","All","16 Years to 80 Years   (Child, Adult, Older Adult)",,"200","Industry|Other","Observational","Observational Model: Ecologic or Community|Time Perspective: Prospective","The Precious Study","October 10, 2019","June 2021","June 2021","May 16, 2019",,"March 19, 2021","University of Miami Crohn's and Colitis Center, Miami, Florida, United States|Washington University in St. Louis, Saint Louis, Missouri, United States|Rutgers Robert Wood Johnson Medical School (Adult), New Brunswick, New Jersey, United States|Rutgers Robert Wood Johnson Medical School (Prediatric), New Brunswick, New Jersey, United States|Manhattan Clinical Research, LLC., New York, New York, United States|NYU Langone Health, New York, New York, United States|Weill Cornell Medical Center, New York, New York, United States|ClinSearch, Chattanooga, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT03952364"
378,"NCT04946448","COmbinAtion Therapy of dieT With biologicalS for Crohn's Disease: the OATS Study","OATS","Not yet recruiting","No Results Available","Crohn Disease|Inflammatory Bowel Diseases|Diet, Healthy","Other: FIT diet","Steroid-free clinical and biochemical remission|Clinical response|Clinical remission|Steroid-free clinical remission|Endoscopic remission|Endoscopic improvement|CRP improvement|Fecal calprotectin improvement|Number of participants without nutritional deficiencies|Fatigue|Health-related quality of life","Universitaire Ziekenhuizen Leuven","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","144","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","S64746","July 1, 2021","September 30, 2023","September 30, 2023","June 30, 2021",,"June 30, 2021","University Hospital of Leuven, Leuven, Belgium",,"https://ClinicalTrials.gov/show/NCT04946448"
379,"NCT04722757","Randomized Trial Comparing Functional Outcome Between Transanal and Laparoscopic or Open Ileal Pouch-Anal Anastomosis","FUNCTIon","Active, not recruiting","No Results Available","Ulcerative Colitis|Inflammatory Bowel Diseases|Ileal Pouch","Procedure: ta-IPAA|Procedure: tabd-IPAA","Pouch function|anastomotic leak rate|postoperative morbidity|Readmission|Patient's Quality of Life|Sexual function|urinary function|fecal incontinence","Mount Sinai Hospital, Canada|Mantaj S. Brar|Philip Fleshner|Karen Zaghiyan|Janindra Warusavitarne","All","18 Years to 60 Years   (Adult)","Not Applicable","48","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","20-0260-A","January 1, 2021","December 31, 2023","June 30, 2025","January 25, 2021",,"January 25, 2021","Mount Sinai Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04722757"
380,"NCT03351972","Differences in Preparation for Small Bowel Capsule Endoscopy",,"Recruiting","No Results Available","Capsule Endoscopy|Inflammatory Bowel Diseases|Celiac Disease","Drug: Klean Prep|Other: Clear liquids only","Clinician assessed Visual Quality of small bowel|clinician assessed Diagnostic yield during capsule endoscopy","Sheffield Teaching Hospitals NHS Foundation Trust|Hotel Dieu Hospital","All","18 Years and older   (Adult, Older Adult)","Phase 4","230","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Other","STH20061","November 23, 2017","November 1, 2021","December 1, 2021","November 24, 2017",,"October 22, 2020","Hotel Dieu Hospital, Kingston,, Ontario, Canada|Royal Hallamshire Hospital, Sheffield, South Yorkshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03351972"
381,"NCT04214470","A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS",,"Recruiting","No Results Available","Irritable Bowel|Irritable Bowel Syndrome|Irritable Bowel Syndrome With Diarrhea|Irritable Bowel Syndrome Mixed|Irritable Bowel Syndrome With Constipation|Irritable Bowel Syndrome Without Diarrhea|Irritable Bowel Syndrome Aggravated|Irritable Bowel Syndrome Characterized by Constipation|Irritable Bowel Syndrome Characterised by Alternating Bowel Habit","Other: No intervention","Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing","ProgenaBiome","All","Child, Adult, Older Adult",,"100","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","ProgenaBiome-036","March 2, 2020","March 2023","July 2023","January 2, 2020",,"April 8, 2021","ProgenaBiome, Ventura, California, United States",,"https://ClinicalTrials.gov/show/NCT04214470"
382,"NCT04429555","Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS",,"Recruiting","No Results Available","Pneumonia, Viral","Drug: Ibudilast|Drug: Placebo","Proportion of subjects free from respiratory failure|Mean change from baseline in clinical status using the NIAID 8-point ordinal scale at Day 7|Percentage of patients with improvement in clinical status|Change in cytokine levels from baseline|Adverse event Incidence, severity, relationship to study drug, and study discontinuations|Changes in laboratory values from baseline|Proportion of subjects free from respiratory failure as defined by the need for decreased oxygen requirement (invasive mechanical ventilation, non-invasive ventilation, high-flow oxygen, or ECMO, CPAP, BiPAP, nasal cannula) at Day 14|Mean change from baseline in clinical status|Incidence of mechanical ventilation or intubation|Intensive care unit admission|Plasma concentrations of Ibudilast|All cause mortality","MediciNova","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","40","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","MN-166-COVID-19-201","January 11, 2021","June 30, 2021","December 1, 2021","June 12, 2020",,"February 23, 2021","Denver Health and Hospital Authority, Denver, Colorado, United States|Yale University School of Medicine, New Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT04429555"
383,"NCT03222011","Stricture Definition and Treatment (STRIDENT) Endoscopic Therapy Study","STRIDENT","Recruiting","No Results Available","Crohn Disease|Inflammatory Bowel Diseases|Stricture; Bowel","Procedure: Standard (single) endoscopic stricture dilatation|Procedure: Intensive endoscopic stricture dilatation","Improvement in obstructive symptoms using the Obstructive Symptom Score (OSS).|Improvement in imaging parameters|Improvement in endoscopic features|Avoidance of surgery|Improvement in patient reported outcomes (PROs)|Technical success of procedure","St Vincent's Hospital Melbourne|Australasian Gastro Intestinal Research Foundation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","StVincentsMelbourneSTRIDENT2","October 9, 2017","February 2021","February 2021","July 19, 2017",,"October 23, 2020","St. Vincent's Hospital Melbourne, Melbourne, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT03222011"
384,"NCT03220841","Stricture Definition and Treatment (STRIDENT) Drug Therapy Study","STRIDENT","Active, not recruiting","No Results Available","Crohn Disease|Inflammatory Bowel Diseases|Stricture; Bowel","Drug: Adalimumab Injection|Drug: Thiopurine|Procedure: Endoscopic balloon dilatation","Improvement in obstructive symptoms.|Improvement in symptoms|Improvement in biochemical inflammatory parameters|Improvement in imaging parameters (Intestinal ultrasound)|Improvement in imaging parameters|Surgery|Improvement in patient reported outcomes (PROs)","St Vincent's Hospital Melbourne|Australasian Gastro Intestinal Research Foundation|AbbVie","All","18 Years and older   (Adult, Older Adult)","Phase 4","78","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","StVincentsMelbourneSTRIDENT1","October 9, 2017","September 18, 2020","September 2021","July 18, 2017",,"October 23, 2020","St. Vincent's Hospital Melbourne, Melbourne, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT03220841"
385,"NCT03869372","Cerebral Cortical Influences on Autonomic Function",,"Recruiting","No Results Available","Healthy Subjects|Functional Dyspepsia|Irritable Bowel Syndrome","Device: rTMS","Electrogastrogram (EGG)|Volume threshold to satiety|Colonic motility|MEP responses|Heart rate variability|Cardiac Impedance","David Levinthal|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|University of Pittsburgh","All","18 Years to 60 Years   (Adult)","Not Applicable","224","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","STUDY19010027|5K08DK101756-05","April 5, 2019","January 2024","January 2024","March 11, 2019",,"June 28, 2021","University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03869372"
386,"NCT03220711","Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon",,"Recruiting","No Results Available","Colonic Dysplasia|Adenomatous Polyps|Irritable Bowel Disease","Device: confocal endomicroscope|Drug: Fluorescein","Depth-imaging capability of the confocal endomicroscope using an imaging contrast agent, fluorescein","University of Michigan","All","18 Years to 100 Years   (Adult, Older Adult)","Phase 1","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","HUM00124968","July 28, 2017","December 2021","December 2021","July 18, 2017",,"December 3, 2020","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT03220711"
387,"NCT04401605","Fermented Food-Supplemented Diet in Ulcerative Colitis",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Diet Modification|Ulcerative Colitis","Other: Fermented Food-supplemented Diet|Other: Regular Diet","Change in the clinical disease activity inflammatory marker fecal calprotectin|Clinical response as per partial Mayo score.|Clinical remission as per partial Mayo score.|Symptomatic remission as per Patient Reported Outcome (PRO2) score|Patient global assessment|Effect of Fermented Food-Supplemented Diet on patient quality of life|Changes in cytokines/chemokines and immune cell profiles|Changes in gut microbiome profiles","Stanford University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","21","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB 55558","September 14, 2020","September 2022","December 2022","May 26, 2020",,"May 4, 2021","Stanford University, Palo Alto, California, United States",,"https://ClinicalTrials.gov/show/NCT04401605"
388,"NCT03615690","The Influence of a Fasting Mimicking Diet on Ulcerative Colitis",,"Recruiting","No Results Available","Inflammatory Bowel Disease|Diet Modification|Ulcerative Colitis","Other: Fasting Mimicking Diet|Other: Regular Diet","Clinical response as per partial Mayo score|Clinical remission as per partial Mayo score|Clinical remission as per modified Mayo (mMayo) score|Clinical response as per mMayo score|Patient global assessment|Change in C-Reactive Protein (CRP).|Change in Erythrocyte Sedimentation Rate (ESR).|Change in Fecal Calprotectin.|Effect of FMD on endoscopic outcomes|Symptomatic remission as per Patient Reported Outcome (PRO2) score|Change in Short Inflammatory Bowel Disease questionnaire (SIBDQ) score","Stanford University","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","75","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB 47075","December 15, 2020","December 2021","May 2022","August 6, 2018",,"May 4, 2021","Stanford University, Palo Alto, California, United States",,"https://ClinicalTrials.gov/show/NCT03615690"
389,"NCT04820413","Faecal Microbiota Transplantation From Normal Pouch Function Donor in the Treatment of Chronic Pouchitis",,"Enrolling by invitation","No Results Available","Pouchitis|Inflammatory Bowel Diseases|Ulcerative Colitis","Other: Faecal microbiota transplantation","Number of patients achieving clinical remission assessed by PDAI|Number of patients achieving clinical response assessed by PDAI|Engraftment of the donor microbiota in the patients","Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery|Aalborg University Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","3","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","MicroPouch-NP","March 1, 2021","December 31, 2021","June 1, 2022","March 29, 2021",,"March 29, 2021","Department of Gastrointestinal Surgery, Aalborg University Hospital, Aalborg, Denmark",,"https://ClinicalTrials.gov/show/NCT04820413"
390,"NCT04100291","Faecal Microbiota Transplantation in the Treatment of Chronic Pouchitis","MicroPouch","Recruiting","No Results Available","Pouchitis|Inflammatory Bowel Diseases|Ulcerative Colitis","Other: Faecal microbiota transplantation|Other: Placebo","Number of patients achieving clinical remission assessed by PDAI|Number of patients achieving clinical response assessed by PDAI|Number of patients experience improvement in quality of life assessed by the patient-reported questionnaire SIBDQ|Number of patients relapsing|Number of patients with treatment-related adverse events in the FMT group compared to the placebo group|Increase of the faecal microbiota biodiversity assessed by alpha-diversity|Engraftment of the donor microbiota in the patients assessed by beta-diversity","Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery|Aalborg University Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","MicroPouch","July 1, 2019","September 30, 2021","December 31, 2021","September 24, 2019",,"February 15, 2021","Department of Gastrointestinal Surgery, Aalborg University Hospital, Aalborg, Denmark|Department of Medical Gastroenterology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark",,"https://ClinicalTrials.gov/show/NCT04100291"
391,"NCT04755673","Atrantil for Intestinal Bacterial Overgrowth",,"Recruiting","No Results Available","Irritable Bowel Syndrome|Bacterial Overgrowth Syndrome|SIBO","Other: Atrantil (Medical Food)","Change in clinical symptoms of Intestinal Methane Overgrowth as measured by daily Numeric Rating Scale (NRS) measuring pain, bloating, distention, and discomfort.|Change in clinical symptoms of Intestinal Methane Overgrowth as measured by Patient Reported Outcome Measures Information Systems Gastrointestinal Symptoms Scale (PROMIS-GI)|Change in clinical symptoms of Intestinal Methane Overgrowth as measured by the Bristol Stool Scale (BSS)|Change in quality of life as measured by Short Form- 12.|Change in Quality of life as measured by the PROMIS-Global Health (PROMIS-GH)|Change in methane as measured by hydrogen methane breath-test pre and post-treatment.","Northwestern University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","STU00212557","September 18, 2020","October 31, 2022","December 31, 2023","February 16, 2021",,"February 16, 2021","Northwestern Medicine Digestive Health Center, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT04755673"
392,"NCT04272307","MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach.","ITAC","Recruiting","No Results Available","Inflammatory Bowel Diseases|Colitis|Ulcerative","Biological: Blood samples|Procedure: Stool samples|Procedure: Colorectal biopsies","Analysis of the faecal microbiota in each group.|Diagnosis of Clostridium difficile infections|Diagnosis of Cytomegalovirus (CMV) infections","University Hospital, Bordeaux|McGill University Health Centre/Research Institute of the McGill University Health Centre","All","18 Years and older   (Adult, Older Adult)",,"40","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","CHUBX 2019/28","May 14, 2020","February 2021","February 2022","February 17, 2020",,"May 26, 2020","Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France",,"https://ClinicalTrials.gov/show/NCT04272307"
393,"NCT04187820","Effect of Acupuncture on Mild to Moderate Active Crohn's Disease",,"Recruiting","No Results Available","Intestinal Disorder|Inflammatory Bowel Diseases|Crohn Disease","Other: acupuncture","Clinical remission|Clinical response|Crohn's disease activity index （CDAI）score|laboratory test|Inflammatory bowel disease questionnaire (IBDQ)|Crohn's disease endoscopic index of severity (CDEIS)|Hospital anxiety and depression scale (HADS)|The proportion of recurrences|Brain functional and structural changes|Plasma and intestinal TRP-KYN metabolism level","Shanghai Institute of Acupuncture, Moxibustion and Meridian|Fudan University|Shanghai University of Traditional Chinese Medicine|Shanghai Jiao Tong University School of Medicine|Indiana University School of Medicine","All","16 Years to 70 Years   (Child, Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","ZYS2019-01","June 1, 2019","December 31, 2021","December 31, 2022","December 5, 2019",,"March 18, 2021","Shanghai Research Institute of Acupuncture and Meridian, Shanghai, Shanghai, China|Guona Li, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT04187820"
394,"NCT03000296","Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease","AutoChron","Active, not recruiting","No Results Available","Crohn's Disease|Inflammatory Bowel Diseases|Gastroenteritis","Procedure: Autologous Hematopoietic Stem Cell Transplantation","Safety of unselected autologous HSCT in refractory Crohn´s disease patients|Crohn´s Disease Activity Index (CDAI)|CRAIG Crohn´s Severity Score (CSS)|Inflammatory Bowel Disease Questionnaire (IBDQ)|Short Form-36 Health Survey (SF-36)|Simple Endoscopic Activity Score (SES)|Crohn's Disease Endoscopic Index of Severity (CDEIS)|Rutgeerts endoscopic score|Harvey & Bradshaw Index (HBI)","Beneficência Portuguesa de São Paulo","All","14 Years to 70 Years   (Child, Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","autocrohnproject1","October 2013","December 2017","December 2024","December 22, 2016",,"January 15, 2021","Beneficencia Portuguesa, Sao Jose do Rio Preto, SP, Brazil",,"https://ClinicalTrials.gov/show/NCT03000296"
395,"NCT04280510","Pathogenic Study of Adult Immune Enteropathies","ENTEROPAH","Recruiting","No Results Available","Celiac Disease|Autoimmune Enteropathy|Inflammatory Bowel Diseases","Genetic: Blood sample collection; gastrointestinal biopsy","Intestinal Lymphocytes count|DNA sequencing","Institut National de la Santé Et de la Recherche Médicale, France|Imagine Institute","All","18 Years and older   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","C19-07|2019-A01594-53","February 27, 2020","February 27, 2028","February 27, 2028","February 21, 2020",,"July 29, 2020","Hôpital Beaujon, Clichy, France|Hôpital Henri Mondor, Créteil, France|Hôpital Bicêtre, Le Kremlin Bicêtre, France|Hôpital Saint Louis, Paris, France|Hôpital Saint Antoine, Paris, France|Hôpital Cochin, Paris, France",,"https://ClinicalTrials.gov/show/NCT04280510"
396,"NCT03142321","Defining Predictors of RT Response to Vedolizumab in IBD",,"Recruiting","No Results Available","Crohn Disease of Small Intestine","Drug: Vedolizumab 300 MG Injection [Entyvio]","Radiological response","Washington University School of Medicine","All","18 Years and older   (Adult, Older Adult)","Phase 4","80","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","17-001","June 8, 2018","June 2021","June 2022","May 5, 2017",,"July 16, 2020","Washington University School of Medicine, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT03142321"
397,"NCT04696458","Effects of a Multispecies Probiotic on Migraine",,"Not yet recruiting","No Results Available","Migraine|Irritable Bowel Syndrome|Headache, Migraine","Dietary Supplement: Lactobacillus plantarum (CECT7484 and CECT7485)/ Pediococcus acidilactici (CECT7483)|Other: Placebo Comparator: Placebo","Reduction in Migraine-induced Disability as measured by the Migraine Induced Disability Assessment Score (MIDAS) total score|Improved Quality of Life (QoL) and reduced depressive symptoms (per Patient Health Questionnaire (PHQ-9))|Reduced severity of Gastrointestinal (GI) symptoms (per Irritable Bowel Syndrome Severity Scoring System (IBS -SSS))|Reduced generalized anxiety (per Generalized Anxiety Disorder (GAD-7))|Reduce headache parameters (headache episodes, headache days, intensity, duration) based on MIDAS subcomponents and journal/diary|Change in acute medication requirements","Scripps Health|Kaneka Corporation","Female","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","60","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","IP","April 1, 2021","December 31, 2022","April 1, 2023","January 6, 2021",,"January 6, 2021",,,"https://ClinicalTrials.gov/show/NCT04696458"
398,"NCT04654494","Colorectal Cancer in Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease|Colorectal Cancer|Inflammatory Bowel Diseases","Procedure: Total proctocolectomy|Procedure: Total colectomy|Procedure: Segmental colectomy","Overall Survival|disease free survival","University of Rome Tor Vergata","All","18 Years and older   (Adult, Older Adult)",,"70","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","REGISTROSPERIMENTAZIONI120/20","July 1, 2020","January 2021","January 2021","December 4, 2020",,"December 8, 2020","Policlinico Tor Vergata, Roma, RM, Italy",,"https://ClinicalTrials.gov/show/NCT04654494"
399,"NCT04807933","Neurovegetative Decoupling in Somatoform Disorders : Biofeedback Interest","BIOFEESOMATO","Not yet recruiting","No Results Available","Somatoform Disorders|Irritable Bowel Syndrome|Psychogenic Non-Epileptic Seizure","Behavioral: Heart rate variability Biofeedback [HRV-BFB]","High frequency [HF] (0.15-0.40 Hz)|Root mean square of successive RR interval differences [RMSSD]|Low frequency [LF] (0.04-0.15 Hz)|Low frequency [LF] 0.1 Hertz (0.075-0.108Hz)|Total power (0-0.40 Hz)|Ratio Low frequency / High frequency [LF / HF]|Standard deviation of all NN intervals [SDNN]|Skin conductance responses [SCR] frequency|Skin conductance responses [SCR] amplitude|Integrated skin conductance responses [ISCR]|Pulsatility index variation [PI]|Breathing rate|Dominant power (0-0.15Hz)|Total power (0-0.15Hz)|Slow-waves frequency (physiological outcome)|Delta frequency (0-4Hz)|Theta frequency (4-7Hz)|Alpha frequency (8-12Hz)|Beta frequency (13-30Hz)|Gamma frequency (>30Hz)|Alexithymia score|Neuroticism score|Trait and state anxiety scores|Style of coping|Positive affectivity score|Depressive symptoms score|Perceived-stress level|Coping flexibility|Metacoping|Social support score|Interceptive sensitivity score|Life satisfaction score|Negative impact scores|Frequency, severity and intensity scores|Child Abuse scores|Acceptance score","University Hospital, Grenoble|Laboratoire de Psychologie et NeuroCognition|Laboratoire interuniversitaire de psychologie : personnalité, cognition et changement social - LIP-PC2S","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","2020-A02155-34","March 2021","October 2022","October 2022","March 19, 2021",,"March 19, 2021","University Hospital, Grenoble Alpes, Grenoble, Isère, France","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/33/NCT04807933/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT04807933"
400,"NCT04653259","Digital Nutrition Therapy for Patients With IBD","LYFEMD","Not yet recruiting","No Results Available","Crohn Disease|Ulcerative Colitis","Other: LYFE MD app","Short-form 12-items (SF-12): Change is being assessed.|Perceived stress score 10-item measure (PSS-10): Change is being assessed.|Pittsburgh sleep quality index a validated 10-item sleep score (PSQI): Change is being assessed.|Godin, a validated 4-item tool: Change is being assessed.|24-item tool from the National Institute for Neurological Disorders and Stroke: Change is being assessed.|Generalized anxiety disorder 7-item (GAD-7) tool: Change is being assessed.|Patient health questionnaire 9-item (PHQ-9) tool: Change is being assessed.|Behaviour compliance: Change is being assessed.|24 hour ASA food recalls: Change is being assessed.|Fecal calprotectin: Change is being assessed.|Harvey Bradshaw Index (HBI) fro Crohn's disease: Change is being assessed.|Partial-Mayo score for ulcerative colitis: Change is being assessed.","University of Calgary|Pfizer","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","44","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","REB20-1534","May 15, 2021","October 15, 2022","October 15, 2022","December 4, 2020",,"April 27, 2021","TRW building, Foothills, University of Calgary, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT04653259"
401,"NCT04852666","Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD)","COMPARE","Enrolling by invitation","No Results Available","Crohn's Disease|Ulcerative Colitis",,"PROMIS measures of pain interference|PROMIS measures of fatigue","University of North Carolina, Chapel Hill|Patient-Centered Outcomes Research Institute|Crohn's & Colitis Foundation","All","18 Years and older   (Adult, Older Adult)",,"900","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","19-0273|PaCR-2017C2-8172-IC","July 25, 2019","December 2021","December 2021","April 21, 2021",,"April 21, 2021","Crohn's & Colitis Foundation, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT04852666"
402,"NCT04761952","N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's Disease",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Polyunsaturated Acid Lipidosis","Drug: azathioprine|Drug: infliximab|Drug: N-3 Polyunsaturated Fatty Acids","1 year postoperative anastomotic recurrence rate|3 months postoperative anastomotic recurrence rate|clinical recurrence rate|Inflammatory load|Life quality SF-36","Sixth Affiliated Hospital, Sun Yat-sen University","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","236","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","2020ZSLYEC-292","February 13, 2021","December 31, 2022","December 31, 2023","February 21, 2021",,"February 21, 2021",,,"https://ClinicalTrials.gov/show/NCT04761952"
403,"NCT02255227","Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD","PneumoMICI","Active, not recruiting","No Results Available","Infections, Pneumococcal|Bowel Diseases, Inflammatory","Biological: Prevenar 13|Biological: Pneumo 23","number of patients with anti-pneumococcal immunogenicity|Number of patients with local and/or general reaction|Number of patients with inflammatory disease activity|Factors implicated in anti-pneumococcal vaccination efficacy|number of patients with serotype coverage of PSV-23","Centre Hospitalier Universitaire de Saint Etienne|Pfizer","All","18 Years and older   (Adult, Older Adult)","Phase 2","104","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","1308162|2013-004609-19","April 13, 2015","August 6, 2019","July 2022","October 2, 2014",,"February 4, 2021","CHU Amiens-Picardie, Amiens, France|Hôpital Jean Minjoz, Besançon, France|Hôpital Saint-Eloi, Montpellier, France|Hôpital de l'Archet II, Nice, France|APHP - Hôpital Cochin, Paris, France|Centre Hospitalier Lyon Sud, Pierre Bénite, France|Hôpital Charles Nicolle, Rouen, France|CHU de Saint-Etienne, Saint-Etienne, France",,"https://ClinicalTrials.gov/show/NCT02255227"
404,"NCT03282903","The PRognostic Effect of Environmental Factors in Crohn's and Colitis","PREdiCCt","Recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis",,"Clinical flare|Hard clinical flare","University of Edinburgh|University of Aberdeen|The Wellcome Trust Sanger Institute|NHS Lothian|Chief Scientist Office of the Scottish Government|Crohn's and Colitis in Childhood|Cure Crohn's and Colitis|Edinburgh and Lothain Health Fund (Lothian Health Board)","All","6 Years and older   (Child, Adult, Older Adult)",,"3100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","16/WM/0152|IRAS183889","November 1, 2016","March 16, 2021","March 16, 2021","September 14, 2017",,"December 19, 2020","Aberdeen Royal Infirmary, Aberdeen, United Kingdom|Bronglais General Hospital, Aberystwyth, United Kingdom|NHS Lanarkshire, Airdrie, United Kingdom|Ulster Hospital, Belfast, United Kingdom|Bristol Royal Infirmary, Bristol, United Kingdom|West Suffolk NHS Foundation Trust, Bury Saint Edmunds, United Kingdom|Cambridge Addenbrooke's Hospital, Cambridge, United Kingdom|Glangwili General Hospital, Carmarthen, United Kingdom|University Hospital Coventry & Warwickshire, Coventry, United Kingdom|Darlington Memorial Hospital, Darlington, United Kingdom|Ninewells Hospital, Dundee, United Kingdom|Eastbourne General Hospital, Eastbourne, United Kingdom|Western General Hospital, Edinburgh, United Kingdom|Royal Hospital for Sick Children,Edinburgh, Edinburgh, United Kingdom|Royal Devon and Exeter Hospital, Exeter, United Kingdom|Queen Elizabeth Hospital, Gateshead, United Kingdom|Glasgow Royal Infirmary, Glasgow, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom|Royal Hospital for Children, Glasgow, Glasgow, United Kingdom|Withybush General Hospital, Haverfordwest, United Kingdom|Raigmore Hospital, Inverness, United Kingdom|Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom|Queen Elizabeth King's Lynn, King's Lynn, United Kingdom|Kingston Hospital, Kingston Upon Thames, United Kingdom|NHS Fife, Kirkcaldy, United Kingdom|NHS Forth Valley, Larbert, United Kingdom|Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom|St John's Hospital, Livingston, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|Royal Free Hospital, London, United Kingdom|Royal London Hospital (Barts Health), London, United Kingdom|Newcastle Royal Victoria Hospital, Newcastle, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom|Royal Berkshire Hospital, Reading, United Kingdom|Salford Royal Hospital, Salford, United Kingdom|Sandwell and West Birmingham Hospitals NHS Trust, Sandwell, United Kingdom|Buckinghamshire Healthcare NHS Trust, Stoke Mandeville, United Kingdom|Musgrove Park Hospital, Taunton, United Kingdom|Pinderfield General Hospital, Wakefield, United Kingdom|Warrington and Halton NHS FT, Warrington, United Kingdom|Royal Hampshire Hospital, Winchester, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03282903"
405,"NCT04799496","A Study of Vedolizumab in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Colitis, Ulcerative|Crohn Disease",,"Percentage of Participants With Serious Adverse Events (SAEs)|Percentage of Participants With Adverse Drug Reactions (ADRs)|Percentage of Participants With Serious Adverse Drug Reactions (SADRs)|Percentage of Participants With Adverse Events of Special Interest (AESIs)|Percentage of Participants With Unexpected Adverse Events (AEs)|Percentage of Participants With Unexpected ADRs|Percentage of Participants With Clinical Response|Percentage of Participants With Clinical Remission|Percentage of Participants With Mucosal Healing","Takeda","All","18 Years and older   (Adult, Older Adult)",,"600","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","Vedolizumab-4023","June 1, 2020","June 1, 2025","January 31, 2026","March 16, 2021",,"March 29, 2021","Gangnam Severance Hospital, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT04799496"
406,"NCT04535882","Effectiveness of Serum Leucine-rich Alpha-2 Glycoprotein Levels on IBD",,"Recruiting","No Results Available","LRG Levels","Diagnostic Test: serum leucine-rich alpha-2 glycoprotein (LRG) levels","Serum LRG measurement","Showa Inan General Hospital","All","Child, Adult, Older Adult",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","LRG","October 1, 2020","August 31, 2021","August 31, 2021","September 2, 2020",,"October 22, 2020","Showa Inan General Hospital, Komagane, Nagano, Japan",,"https://ClinicalTrials.gov/show/NCT04535882"
407,"NCT03378167","PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial","PediCRaFT","Recruiting","No Results Available","Crohn Disease|Pediatric Crohns Disease|Inflammatory Bowel Diseases|Colitis","Biological: MICROBIOTA|Biological: PLACEBO","Monthly Recruitment Rate|Dropout Rate Post Enrolment|Rate of Patient Protocol Adherence|Rate of Adverse Events|Clinical: Improvement in Disease Symptoms|Clinical: Remission in Disease Symptoms|Clinical: Improvement in Serum Inflammatory Markers|Clinical: Improvement in Mucosal Inflammatory Markers|Clinical: Change in Urine Metabolomics|Clinical: Change in Fecal Microbiome","McMaster Children's Hospital|Hamilton Health Sciences Corporation|McMaster University","All","3 Years to 17 Years   (Child)","Phase 1","45","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","0000","December 1, 2018","July 31, 2022","December 31, 2022","December 19, 2017",,"March 23, 2021","McMaster Children's Hospital, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03378167"
408,"NCT04318405","Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).","Real-CHOICE","Recruiting","No Results Available","Iron-Deficiency Anemia|Iron-Deficiency","Drug: Iron isomaltoside 1000","Attitude of patients towards IV iron treatment evaluated with questionnaire.|Effectiveness of treatment with IIM.|Attitude of patients towards IIM treatment evaluated with questionnaire.|Attitude of physicians towards IIM and IV iron treatment evaluated with questionnaire.|Patient and disease profiles at baseline.|Calculation of iron need based on IIM simplified dosing scheme.|Treatment sequence before IIM.|Reason(s) for selection of IIM.|Treatment with IIM.|Treatment satisfaction of physician and patient upon treatment.|Effectiveness of treatment with IIM: whole blood count changes.|Effectiveness of treatment with IIM: total Hb increase.|Effectiveness of treatment with IIM: serum ferritin increase.|Effectiveness of treatment with IIM: CRP (C-reactive protein) status.|Safety and tolerability of treatment with IIM, including frequency and severity of treatment-emergent AEs (Adverse Events) / ADRs (Adverse Drug Reactions).","Pierre Fabre Pharma AG","All","18 Years and older   (Adult, Older Adult)",,"450","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","NIS-PFM-2019-2654","June 2, 2020","November 2021","November 2022","March 24, 2020",,"March 26, 2021","9, Basel, Switzerland|1, Bern, Switzerland|11, Kreuzlingen, Switzerland|12, Kreuzlingen, Switzerland|8, Kreuzlingen, Switzerland|5, Liestal, Switzerland|13, Sankt Gallen, Switzerland|7, Sion, Switzerland|6, Spreitenbach, Switzerland|14, Steinach, Switzerland|10, Wettingen, Switzerland|3, Zollikon, Switzerland|2, Zürich, Switzerland|4, Zürich, Switzerland",,"https://ClinicalTrials.gov/show/NCT04318405"
409,"NCT03000101","Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Disease","POME2016","Active, not recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis","Other: 100% pomegranate juice|Other: placebo beverage","Changes in fecal calprotectin|Changes in plasma concentration of ellagitannin metabolites|Changes in circulating cytokines levels|Changes in circulating trimethylamine-N-oxide (TMAO) levels|Changes in gene expression levels in peripheral blood mononuclear cells (PBMC)|Changes in gene expression levels in intestinal biopsies|Changes in urinary ellagitannin metabolite excretion","IRCCS Azienda Ospedaliero-Universitaria di Bologna|University of Bologna|Conserve Italia|GAT Foods","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","18","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","RBSI14LHMB|SIR Programme no. RBSI14LHMB","January 19, 2017","July 2021","January 2022","December 21, 2016",,"January 15, 2021","U.O. Gastroenterologia - Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy",,"https://ClinicalTrials.gov/show/NCT03000101"
410,"NCT04810572","Nutraceutical Composition Containing Natural Products Derivatives on the Modulation of the Endocrine Neuroimmune Axis","NCCNPDMENA","Not yet recruiting","No Results Available","Insulin Resistance|Inflammatory Bowel Diseases|Overweight and Obesity|Healthy","Dietary Supplement: Composition with Silymarin|Dietary Supplement: Low-mineral composition without Silymarin","Change Lipid Profile Baseline after 4 and 12 weeks of intervention.|Change Lymphocyte Phenotype at 4 and 12 weeks after intervention.|Change Serum Cortisol Level Baseline after 4 and 12 Weeks of Intervention.|Change Gut Microbiota Baseline after 4 and 12 Weeks of Intervention.|Change Haemogram Parameters Baseline after 4 and 12 Weeks of Intervention.|Change Leucogram Parameters Baseline after 4 and 12 Weeks of Intervention.|Change Circadian Rhythms Over time of Intervention.|Change Quality of Life Assessments Over time of Intervention.|Change Sleep Patterns Over time of Intervention.|Change Sleep Quality Over Time of Intervention.|Change Sleepiness Patterns Over time of Intervention.|Change Body Mass Index (BMI) Over time of Intervention.","University of Sao Paulo General Hospital|University of Sao Paulo","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","39984320.5.0000.0068","May 2021","May 2022","December 2022","March 23, 2021",,"March 23, 2021",,,"https://ClinicalTrials.gov/show/NCT04810572"
411,"NCT04923100","Therapeutic Effect of New Biologics in Crohn's Disease",,"Not yet recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis|Treatment Side Effects",,"endoscopic remission|clinical remission|clinical response|endoscopic response","Sixth Affiliated Hospital, Sun Yat-sen University","All","17 Years to 80 Years   (Child, Adult, Older Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","2021ZSLYEC-066","June 10, 2021","March 29, 2022","March 29, 2022","June 11, 2021",,"June 11, 2021","the Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04923100"
412,"NCT02849717","Pre-Habilitation Exercise Intervention",,"Recruiting","No Results Available","Inflammatory Bowel Diseases|Colon Cancer|Rectal Cancer|Diverticular Disease","Behavioral: Exercise for Cancer Patients","The primary outcome measure for this study is fatigue assessed by the FACIT-F fatigue subscale..|Aerobic Capacity via VO2 maximum testing|Skeletal Muscle Mass will be assessed using bio-electrical impedance assessment of muscle mass|Skeletal Muscle Mass will be assessed using CT assessment of muscle mass|Circulating Levels of Pro-Inflammatory Cytokines will be measured by standard Complete Blood Count (CBC) differential procedures.|Post-operative Complications will be extracted from patient charts and will be classified for severity using the Clavien-Dindo classification of surgical complications.|Quality of Life (QOL) on self reported psychological distress questionnaires: Profile of Mood States (POMS).|Quality of Life (QOL) on self reported psychological distress questionnaires: Spielberg State/Trait Anxiety Inventory (STAI Form Y-1).","University of Rochester","All","18 Years and older   (Adult, Older Adult)","Not Applicable","83","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","59142","March 2016","March 2022","April 2022","July 29, 2016",,"November 4, 2020","University of Rochester, Rochester, New York, United States",,"https://ClinicalTrials.gov/show/NCT02849717"
413,"NCT04230603","Tissue Characterization With Hyperspectral Imaging (HSI)","HSIT","Recruiting","No Results Available","Tissue Perfusion|Tumor|Inflammation|Inflammatory Bowel Diseases","Procedure: Hyperspectral imaging|Diagnostic Test: Lactate acid measurement|Diagnostic Test: pathological examination","Tumor detection with HSI|Tissue recognition with HSI|Inflammatory classification with HSI|Tissue perfusion","University of Leipzig","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1000","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","201905","June 6, 2019","January 2, 2022","June 2, 2022","January 18, 2020",,"September 16, 2020","Universitätsklinikum Leipzig - AöR, Leipzig, Sachsen, Germany",,"https://ClinicalTrials.gov/show/NCT04230603"
414,"NCT02636517","Fecal Microbiome Transplant",,"Active, not recruiting","No Results Available","Clostridium Difficile|Inflammatory Bowel Disease|Crohn's Disease|Ulcerative Colitis","Biological: Fecal Microbiota Transplant","Number of subjects with a recurrence of C. difficile (CDI)","Children's Hospital of Philadelphia","All","3 Years to 21 Years   (Child, Adult)","Not Applicable","250","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","13-010531","December 2015","December 2023","December 2023","December 21, 2015",,"April 6, 2021","Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT02636517"
415,"NCT04774042","Probiotic Supplementation in the Dysbiosis of Bowel Preparation",,"Not yet recruiting","No Results Available","Microbial Colonization|Irritable Bowel Syndrome|Metabolic Syndrome","Dietary Supplement: Infloran probiotic|Dietary Supplement: HAC probiotic|Dietary Supplement: Infloran placebo|Dietary Supplement: HAC placebo","Alpha diversity|Beta diversity|Bacterial species abundance|Incidence of functional bowel symptoms|BMI|Insulin resistance|Dyslipidemia|Total cholesterol|LDL|HDL|TG|Weight|Waist|Fatty liver (grade)|Fatty liver (CAP)","National Taiwan University Hospital","All","20 Years and older   (Adult, Older Adult)","Not Applicable","300","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","202006016MIPB","March 2021","January 2023","January 2023","February 26, 2021",,"February 26, 2021",,,"https://ClinicalTrials.gov/show/NCT04774042"
416,"NCT04565821","Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe",,"Recruiting","No Results Available","Inflammatory Disease|Permeability; Increased|Crohn Disease|Inflammatory Bowel Diseases|Environmental Enteropathy","Device: IPD Probe via TNIT","Baseline IPD readings|IPD readings after Glucose/Galactose infusion|Image Quality","Massachusetts General Hospital","All","18 Years to 60 Years   (Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","2020P000158","October 31, 2020","December 31, 2021","December 31, 2022","September 25, 2020",,"September 25, 2020","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04565821"
417,"NCT03616821","An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis","Expedition","Active, not recruiting","No Results Available","Ulcerative Colitis|Colitis|Ulcerative|IBD","Drug: Brazikumab|Drug: Vedolizumab|Drug: Placebo","Clinical remission based on modified Mayo score (mMS)|Sustained clinical remission based on mMS|Corticosteroid-free (CS-free) clinical remission based on mMS|Maximum serum concentration of brazikumab (Cmax)|Presence of antibrazikumab antibodies|Area under the serum concentration time curve (AUC) of brazikumab","AstraZeneca","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","225","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","D5272C00001|2018-001605-93","August 7, 2018","December 13, 2022","January 23, 2024","August 6, 2018",,"May 21, 2021","Research Site, Tucson, Arizona, United States|Research Site, Little Rock, Arkansas, United States|Research Site, Chula Vista, California, United States|Research Site, Lancaster, California, United States|Research Site, Lincoln, California, United States|Research Site, Los Angeles, California, United States|Research Site, Newport Beach, California, United States|Research Site, Poway, California, United States|Research Site, San Diego, California, United States|Research Site, Colorado Springs, Colorado, United States|Research Site, Clearwater, Florida, United States|Research Site, Cutler Bay, Florida, United States|Research Site, Kissimmee, Florida, United States|Research Site, Lakeland, Florida, United States|Research Site, Miami Lakes, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, New Port Richey, Florida, United States|Research Site, Ocoee, Florida, United States|Research Site, Saint Petersburg, Florida, United States|Research Site, Tampa, Florida, United States|Research Site, Tampa, Florida, United States|Research Site, Tampa, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Atlanta, Georgia, United States|Research Site, Decatur, Georgia, United States|Research Site, Gurnee, Illinois, United States|Research Site, Moline, Illinois, United States|Research Site, Springfield, Illinois, United States|Research Site, Brownsburg, Indiana, United States|Research Site, Evansville, Indiana, United States|Research Site, Iowa City, Iowa, United States|Research Site, Shawnee Mission, Kansas, United States|Research Site, Topeka, Kansas, United States|Research Site, Baton Rouge, Louisiana, United States|Research Site, Marrero, Louisiana, United States|Research Site, Shreveport, Louisiana, United States|Research Site, Wyoming, Michigan, United States|Research Site, Biloxi, Mississippi, United States|Research Site, Biloxi, Mississippi, United States|Research Site, Flowood, Mississippi, United States|Research Site, Saint Louis, Missouri, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Brooklyn, New York, United States|Research Site, Brooklyn, New York, United States|Research Site, New York, New York, United States|Research Site, Sunnyside, New York, United States|Research Site, Greenville, North Carolina, United States|Research Site, Morehead City, North Carolina, United States|Research Site, Beachwood, Ohio, United States|Research Site, Springfield, Ohio, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Uniontown, Pennsylvania, United States|Research Site, Orangeburg, South Carolina, United States|Research Site, Amarillo, Texas, United States|Research Site, Carrollton, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Pflugerville, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Spring, Texas, United States|Research Site, Bountiful, Utah, United States|Research Site, Salt Lake City, Utah, United States|Research Site, Salt Lake City, Utah, United States|Research Site, North Chesterfield, Virginia, United States|Research Site, Spokane, Washington, United States|Research Site, Huntington, West Virginia, United States|Research Site, Vaughan, Ontario, Canada|Research Site, Amiens Cedex 1, France|Research Site, Grenoble, France|Research Site, Montpellier CEDEX 5, France|Research Site, Pessac, France|Research Site, Saint Priest en Jarez, France|Research Site, Augsburg, Germany|Research Site, Kiel, Germany|Research Site, Ulm, Germany|Research Site, Ahemdabad, India|Research Site, Ahmedabad, India|Research Site, Ahmedabad, India|Research Site, Assam, India|Research Site, Bangalore, India|Research Site, Gandhinagar, India|Research Site, Hyderabad, India|Research Site, Hyderabad, India|Research Site, Jaipur, India|Research Site, Jaipur, India|Research Site, Kolkatta, India|Research Site, Nagpur, India|Research Site, New Dehli, India|Research Site, New Delhi, India|Research Site, New Delhi, India|Research Site, Pune, India|Research Site, Rajkot, India|Research Site, Secunderabad, India|Research Site, Surat, India|Research Site, Wardha, India|Research Site, Bologna, Italy|Research Site, Castellana Grotte, Italy|Research Site, Catania, Italy|Research Site, Chieti, Italy|Research Site, Foggia, Italy|Research Site, L Aquila, Italy|Research Site, Milano, Italy|Research Site, Napoli, Italy|Research Site, Napoli, Italy|Research Site, Negrar, Italy|Research Site, Padova, Italy|Research Site, Rho, Italy|Research Site, Roma, Italy|Research Site, Roma, Italy|Research Site, Rozzano, Italy|Research Site, Salerno, Italy|Research Site, Busan, Korea, Republic of|Research Site, Daegu, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Wonju-si, Korea, Republic of|Research Site, Białystok, Poland|Research Site, Bydgoszcz, Poland|Research Site, Bydgoszcz, Poland|Research Site, Chojnice, Poland|Research Site, Częstochowa, Poland|Research Site, Gdańsk, Poland|Research Site, Katowice, Poland|Research Site, Krakow, Poland|Research Site, Kraków, Poland|Research Site, Ksawerów, Poland|Research Site, Mysłowice, Poland|Research Site, Nowa Sól, Poland|Research Site, Piaseczno, Poland|Research Site, Poznań, Poland|Research Site, Rzeszow, Poland|Research Site, Sopot, Poland|Research Site, Szczecin, Poland|Research Site, Toruń, Poland|Research Site, Warszawa, Poland|Research Site, Warszawa, Poland|Research Site, Warszawa, Poland|Research Site, Wrocław, Poland|Research Site, Łódź, Poland|Research Site, Łódź, Poland|Research Site, San Juan, Puerto Rico|Research Site, Cluj Napoca, Romania|Research Site, Saint-Petersburg, Russian Federation|Research Site, Kaohsiung, Taiwan|Research Site, Taichung, Taiwan|Research Site, Taichung, Taiwan|Research Site, Taipei City, Taiwan|Research Site, Taipei, Taiwan|Research Site, Taipei, Taiwan|Research Site, Chernivtsi, Ukraine|Research Site, Kyiv, Ukraine|Research Site, Kyiv, Ukraine|Research Site, Lviv, Ukraine|Research Site, Zaporizhzhia, Ukraine|Research Site, Cardiff, United Kingdom|Research Site, Chorley, United Kingdom|Research Site, Coventry, United Kingdom|Research Site, Edgbaston, United Kingdom|Research Site, Epsom, United Kingdom|Research Site, Glasgow, United Kingdom|Research Site, Hexham, United Kingdom|Research Site, Liverpool, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Reading, United Kingdom|Research Site, Stockton, United Kingdom|Research Site, West Bromwich, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03616821"
418,"NCT03131414","The IMAGINE-SPOR CIHR Chronic Disease Network","IMAGINE","Recruiting","No Results Available","IBS - Irritable Bowel Syndrome|Ulcerative Colitis|Crohn Disease|Healthy","Other: Diet|Other: Gastrointestinal microbiome","IMAGINE microbiome and diet|IMAGINE metabolomics|IMAGINE anxiety|IMAGINE depression|IMAGINE health related costs","Hamilton Health Sciences Corporation|Canadian Institutes of Health Research (CIHR)","All","4 Years to 99 Years   (Child, Adult, Older Adult)",,"8000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","REB#3000","October 1, 2017","December 1, 2022","June 1, 2023","April 27, 2017",,"February 9, 2021","Hamilton Health Sciences / McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03131414"
419,"NCT04924686","Changes of Muramyl Dipeptide in Intestinal and Extra-intestinal Diseases",,"Recruiting","No Results Available","Colorectal Cancer|Inflammatory Bowel Disease|Atherosclerotic Cardiovascular Disease|Type2 Diabetes Mellitus","Other: Observational studies, no intervention","NOD2 ligands in fecal and plasma","Zhujiang Hospital|National Natural Science Foundation of China","All","18 Years to 70 Years   (Adult, Older Adult)",,"600","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","ZhujiangH-1","May 10, 2020","June 10, 2023","August 15, 2023","June 14, 2021",,"June 14, 2021","Zhujiang hospital, Guangzhou, Guang Dong, China",,"https://ClinicalTrials.gov/show/NCT04924686"
420,"NCT03953768","VNS Prospective Neuromodulation of Autonomic, Immune and Gastrointestinal Systems","VNSAIG","Recruiting","No Results Available","Autoimmune Diseases|Epilepsy|Autonomic Dysfunction|Inflammatory Bowel Diseases","Device: Vagal nerve stimulation (VNS)","Metagenomic microbiome profile|Bowel movement frequency|Abdominal pain|Immune Profile 1 - Flow cytometric profiling of cell populations|Immune Profile 2 - Ex vivo stimulation of cells in whole blood|Inflammatory Profile 1 - Meso Scale Discovery (or MSD) analysis for pro-inflammatory cytokines/chemokines|Inflammatory Profile 2 - Meso Scale Discovery (or MSD) analysis for metabolic hormones|Inflammatory Profile 3 - Metabolomics for Short Chain Fatty acids (SCFAs)|Inflammatory Profile 4 - Intestinal inflammation and permeability markers|Epilepsy severity","University of Louisville","All","up to 60 Years   (Child, Adult)","Not Applicable","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","19.0330","April 1, 2021","December 14, 2023","December 14, 2023","May 17, 2019",,"April 30, 2021","Norton Healthcare, Louisville, Kentucky, United States|University of Louisville, Louisville, Kentucky, United States",,"https://ClinicalTrials.gov/show/NCT03953768"
421,"NCT03185000","Treg Immunotherapy in Crohn's Disease","TRIBUTE","Not yet recruiting","No Results Available","Crohn Disease","Drug: TR004 (Treg immunotherapy)|Other: Placebo","Rate of dose limiting toxicities (DLTs)|Determination of Maximum Tolerated Dose (MTD)|Disease Activity Score (CDAI / PRO-2) calculated by evaluation of patient's diary completion and colonoscopy findings|Biomarkers analysis (CRP, FCP) measured by blood test and stool sample analysis|Mucosal Healing Score (CDEIS / SES-CD) calculated by evaluation of colonoscopy findings","King's College London|Guy's and St Thomas' NHS Foundation Trust|Medical Research Council|Imperial College London|St. George's Hospital, London|Miltenyi biotech","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 1|Phase 2","24","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","TRIBUTE","February 2018","September 2020","September 2021","June 14, 2017",,"June 14, 2017",,,"https://ClinicalTrials.gov/show/NCT03185000"
422,"NCT04918329","Functional Digestive Disorders Observatory","OTFI","Recruiting","No Results Available","Irritable Bowel Syndrome|Dyspepsia|Functional Constipation|Faecal Incontinence","Other: Observational study","Correlation between Rectal sensitivity and intestinal permeability|Correlation betwenne rectal sensitivity and fecal concentration of zonuline","University Hospital, Rouen","All","18 Years to 90 Years   (Adult, Older Adult)",,"600","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2019/120/OB","October 9, 2020","October 9, 2030","October 9, 2030","June 8, 2021",,"June 8, 2021","Physiology Unit, Hopital Charles Nicolle, 1 rue de Germont, Rouen, France",,"https://ClinicalTrials.gov/show/NCT04918329"
423,"NCT03301311","Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease","PRODUCE","Active, not recruiting","No Results Available","Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis|Indeterminate Colitis","Other: Specific Carbohydrate Diet (SCD)|Other: Modified Specific Carbohydrate Diet (MSCD)","Stool frequency|Stool Consistency|Pain Interference|Gastrointestinal Symptoms|Fecal Calprotectin|Provider measured disease activity|Laboratory markers of disease activity and inflammation|Growth|Short Crohn's Disease Activity Index (sCDAI)|Pediatric Ulcerative Colitis Activity Index (PUCAI)","Children's Hospital Medical Center, Cincinnati|University of California, San Francisco|Seattle Children's Hospital|Dayton Children's Hospital|Brown University","All","7 Years to 18 Years   (Child, Adult)","Not Applicable","54","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CIN001-PRODUCE","April 10, 2018","December 2, 2020","December 2, 2020","October 4, 2017",,"October 6, 2020","Arkansas Children's Hospital, Little Rock, Arkansas, United States|Children's Hospital of Los Angeles, Los Angeles, California, United States|UCSF Benioff Children's Hospital Oakland, Oakland, California, United States|Lucile Packard Children's Hospital, Palo Alto, California, United States|University of California San Francisco Benioff Children's Hospita;, San Francisco, California, United States|Nemours, Alfred I duPont Hospital for Children, Wilmington, Delaware, United States|Nemours Children's Speciality Care, Jacksonville, Florida, United States|Nemours Children's Hospital, Orlando, Florida, United States|GI Care for Kids, Atlanta, Georgia, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Children's Mercy Hospital, Kansas City, Missouri, United States|Levine Children's Hospital, Charlotte, North Carolina, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Oregon Health Sciences University, Portland, Oregon, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, United States|UT Soutwestern Medical Center, Dallas, Texas, United States|Pediatric Specialists of Virginia, Fairfax, Virginia, United States|Children's Hospital of the King's Daughters, Norfolk, Virginia, United States|Seattle Children's, Seattle, Washington, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/11/NCT03301311/Prot_SAP_006.pdf","https://ClinicalTrials.gov/show/NCT03301311"
424,"NCT04844606","A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)","SHINE-ON","Not yet recruiting","No Results Available","Ulcerative Colitis|Ulcerative Colitis Chronic|Inflammatory Bowel Diseases|Crohn's Disease","Drug: Mirikizumab","Percentage of Participants in Modified Mayo Score (MMS) Clinical Remission|Percentage of Participants in MMS Clinical Remission|Percentage of Participants in MMS Clinical Response|Percentage of Participants in Pediatric Ulcerative Colitis Activity Index (PUCAI) Clinical Response|Percentage of Participants in PUCAI Clinical Remission|Percentage of Participants in Endoscopic Remission|Percentage of Participants in Endoscopic Response|Percentage of Participants in Endoscopic Subscore|Percentage of Participants Experiencing Histologic Remission|Percentage of Participants in Corticosteroid-free Remission Without Surgery|Change from baseline in Body Weight|Height Velocity (in Centimeters/Year)|Change from Baseline in Hormone levels at approximate 6-month intervals until growth is complete","Eli Lilly and Company","All","2 Years to 19 Years   (Child, Adult)","Phase 3","185","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","16633|I6T-MC-AMAZ|2020-005311-49","May 26, 2021","September 23, 2027","September 23, 2027","April 14, 2021",,"May 19, 2021","UCSF Medical Center at Mission Bay, San Francisco, California, United States|Cook Children's Medical Center, Fort Worth, Texas, United States|Tokyo Medical And Dental University Medical Hospital, Bunkyō, Tokyo, Japan",,"https://ClinicalTrials.gov/show/NCT04844606"
425,"NCT04698148","Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases","BIOMIS-Gastr","Recruiting","No Results Available","Clostridium Difficile Infection|Multi Drug Resistant Organisms|Chronic Inflammatory Bowel Disease|Irritable Bowel Syndrome|Hepatic Encephalopathy","Other: Biological sample collection|Other: Questionnaire|Other: Medical examination","Biological samples collection for establishment of the first National Microbiome Biobank","Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari|Istituti Tumori Giovanni Paolo II|University of Bari Aldo Moro|University of Salento|Università degli Studi di Perugia|Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies|Catholic University of the Sacred Heart","All","18 Years to 60 Years   (Adult)",,"225","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","BIOMIS-Gastr","February 8, 2021","December 2021","January 2022","January 6, 2021",,"April 13, 2021","Azienda Ospedaliera Universitaria Policlinico di Bari - Sezione di Malattie dell'Apparato Digerente, Endoscopia e Trapianto di Fegato (D.E.T.O.), Bari, Italy|Università degli Studi di Perugia - Dipartimento di Medicina, Perugia, Italy|Centro Malattie Apparato Digerente - CEMAD, Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore, Roma, Italy",,"https://ClinicalTrials.gov/show/NCT04698148"
426,"NCT04102163","Health-Related Quality of Life in Crohn's Disease Participants With Complex Perianal Fistula Before and After Treatment","CALYPSO","Recruiting","No Results Available","Crohn Disease|Inflammatory Bowel Disease|Gastrointestinal Diseases|Intestinal Diseases",,"Number of Participants With Change From Baseline in QoLAF-Q Scores at Month 12 After Treatment Initiation for CPF|Number of Participants With Change From Baseline in QoLAF-Q Scores at Month 6 After Treatment Initiation for CPF|Percentage of Participants With Clinically Significant Change From Baseline in QoLAF-Q Score at Months 6 and 12 After Treatment for CPF|Change From Baseline in EuroQoL-Five Dimensions, Five Levels (EQ-5D-5L) Scores at Months 6 and 12 After Treatment for CPF|Change From Baseline in Faecal Incontinence Quality of Life Scale (FIQOL) Scores at Months 6 and 12 After Treatment for CPF|Change From Baseline in Perceived Stress Scale (PSS) Scores at Months 6 and 12 After Treatment for CPF|Change From Baseline in International Index of Erectile Function (IIEF) Scores at Months 6 and 12 After Treatment for CPF|Change From Baseline in Female Sexual Function Index (FSFI) Scores at Months 6 and 12 After Treatment for CPF|Number of Participants Based on Type of Treatment, Dose, Dose Frequency and Date of Initiation|Number of Participants Based on Biological Data|Number of Participants With Comorbidities Based on Charlson Comorbidity Index|Number of Participants With Comedications for Treatment of CD and Fistula|Number of Participants With Target CPF|Number of Participants With the Presence of new CPF at Months 6 and 12|Montreal Classification Assessed at Baseline|Number of Participants With Clinical characteristics Based on Harvey Bradshaw Index (HBI)|Number of Participants With Clinical Characteristics Based on Perianal Crohn´s Disease Activity Index (PDAI) or Fistula Drainage Assessment (FDA)|Number of Occurrences of Treatment Switching or Dose Change|Relation Between Participants QoLAF-Q Score and Clinical Variables|Number of Participants Based on Methods Used to Evaluate the Response to Different Treatments for CPF in Routine Clinical Practice|Number of Participants Based on Effectiveness of Different Treatment Options for CPF Grouped According to Therapeutic Class|Health Care Resources Utilization (HCRU)|Correlation Between the Change in CD Participant's Scores in the QoLAF-Q, the EQ-5D-5L and Rapid Assessment Faecal Incontinence Score (RAFIS)","Takeda","All","18 Years and older   (Adult, Older Adult)",,"300","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","IBD-5008|U1111-1232-1975","January 26, 2021","September 1, 2021","September 1, 2021","September 25, 2019",,"April 2, 2021","Hospital Reina Sofia, Cordoba, Andalucia, Spain|Hospital San Cecilio, Granada, Andalucia, Spain|Hospital Universiario Juan Ramon Jimenez, Huelva, Andalucia, Spain|Hospital Regional de Malaga, Malaga, Andalucia, Spain|Hospital Virgen del Rocio, Sevilla, Andalucia, Spain|Hospital Nuestra Senora de la Candelaria, Santa Cruz de Tenerife, Canarias, Spain|Hospital Universitario de Salamanca, Salamanca, Castilla Y Leon, Spain|Hospital Universitario Rio Hortega, Valladolid, Castilla Y Leon, Spain|Hospital Santa creu i Sant Pau, Barcelona, Cataluna, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Cataluna, Spain|Hospital Parc Tauli, Barcelona, Cataluna, Spain|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Cataluna, Spain|Hospital La Princesa, Madrid, Comunidad De Madrid, Spain|Hospital Gregorio Maranon, Madrid, Comunidad De Madrid, Spain|Fundacion Jimenez Diaz, Madrid, Comunidad De Madrid, Spain|Hospital Clinico San Carlos, Madrid, Comunidad De Madrid, Spain|Hospital La Paz, Madrid, Comunidad De Madrid, Spain|Complejo Hospitalario Universitario de Ferrol, A Coruna, Galicia, Spain|Complejo Hospitalario de Pontevedra, Pontevedra, Galicia, Spain|Hospital de Fuenlabrada, Fuenlabrada, Madrid, Spain",,"https://ClinicalTrials.gov/show/NCT04102163"
427,"NCT04055662","A Comparison of Post-Operative Analgesia Requirements In Recreational Cannabis Users Versus Cannabis Naïve Inflammatory Bowel Disease Patients",,"Recruiting","No Results Available","Cannabis Use, Opioid Consumption",,"Opioid consumption","Mount Sinai Hospital, Canada","All","18 Years to 70 Years   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","2108.2.7","August 1, 2019","March 2020","March 2020","August 14, 2019",,"August 14, 2019","Sinai Health System, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04055662"
428,"NCT03042091","Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery",,"Recruiting","No Results Available","Colorectal Neoplasms|Diverticulitis|Inflammatory Bowel Diseases|Surgical Site Infection","Drug: Polyethylene Glycol|Drug: Neomycin|Drug: Metronidazole Hydrochloride|Procedure: Therapeutic Conventional Surgery","Incidence of post-operative surgical site infection (SSI) including superficial/incisional, deep, and organ space, anastomotic dehiscence and leak|Incidence of post-operative clostridium difficile infection|Incidence of adynamic ileus|Incidence of cardiopulmonary complications|Incidence of urinary tract infection|Length of hospital stay|Incidence of mortality","Thomas Jefferson University","All","19 Years and older   (Adult, Older Adult)","Early Phase 1","224","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","16D.204","September 2016","October 2020","October 2021","February 3, 2017",,"August 22, 2018","Thomas Jefferson University, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03042091"
429,"NCT03669237","RCT on Postoperative Bowel Function Following SPS by Different Reconstruction Methods",,"Not yet recruiting","No Results Available","Bowel; Functional Syndrome","Procedure: different reconstruction methods","LARS score","YE Yingjiang|Peking University People's Hospital","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","630","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","FPOCS-1705","January 1, 2019","December 31, 2020","December 31, 2021","September 13, 2018",,"September 13, 2018",,,"https://ClinicalTrials.gov/show/NCT03669237"
430,"NCT03434639","Fluorescence Spectroscopy for Gut Permeability Assessment","GutPerm","Recruiting","No Results Available","Development and Validation of Gut Permeability Sensor|Permeability; Increased|Celiac Disease|Inflammatory Bowel Diseases|Liver Diseases|HIV/AIDS","Diagnostic Test: Spectroscopic gut permeability test","Blood concentration from intravenous injection|Blood concentration from samples|PEG permeability assay|Histology","Imperial College London","All","18 Years and older   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","18SM4374","March 29, 2019","September 30, 2021","September 30, 2021","February 15, 2018",,"February 12, 2020","IMPERIAL COLLEGE Healthcare Trust, London, United Kingdom","""Informed Consent Form: ICF for ophthalmology patients"", https://ClinicalTrials.gov/ProvidedDocs/39/NCT03434639/ICF_007.pdf|""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/39/NCT03434639/Prot_SAP_008.pdf|""Informed Consent Form: ICF for GI, liver and HIV patients"", https://ClinicalTrials.gov/ProvidedDocs/39/NCT03434639/ICF_009.pdf|""Informed Consent Form: ICF for healthy volunteers (Group 2a)"", https://ClinicalTrials.gov/ProvidedDocs/39/NCT03434639/ICF_010.pdf|""Informed Consent Form: ICF for healthy volunteers (Group 2b)"", https://ClinicalTrials.gov/ProvidedDocs/39/NCT03434639/ICF_011.pdf","https://ClinicalTrials.gov/show/NCT03434639"
431,"NCT03913962","Health and Exercise Response in Children With Chronic and Auto-immune Pathologies","HERCCULE","Recruiting","No Results Available","Juvenile Idiopathic Arthritis|Diabetes|Inflammatory Bowel Disease|Cancer Survivor|Anorexia Nervosa","Other: indirect calorimetry","Maximal lipid oxidation rate during submaximal incremental exercise|Maximal strength during isometric contraction|Muscle architecture|Body composition|Maximal muscular strength|Muscular fatigue|Blood sample IL-17|Blood sample CRP|Blood sample IL-6|Blood sample TNF - a|Blood sample IL-10|Blood sample INF|Blood sample calprotectin","University Hospital, Clermont-Ferrand|Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques|INSERM CIC 1405","All","6 Years to 18 Years   (Child, Adult)","Not Applicable","300","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","CHU-409|2018-A03247-48","May 2, 2019","December 31, 2028","December 31, 2028","April 12, 2019",,"May 8, 2019","Chu Clermont-Ferrand, Clermont-Ferrand, France",,"https://ClinicalTrials.gov/show/NCT03913962"
432,"NCT01790061","Standardized Fecal Microbiota Transplantation for Ulcerative Colitis",,"Recruiting","No Results Available","Bacteria|Microbiota|Fecal Microbiota Transplantation|Inflammatory Bowel Disease|Ulcerative Colitis","Procedure: Standardized FMT|Drug: Traditional treatments","Efficacy of FMT|Adverse events","The Second Hospital of Nanjing Medical University|Air Force Military Medical University, China","All","6 Years to 80 Years   (Child, Adult, Older Adult)","Phase 2|Phase 3","500","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","FMT-CN-121123","November 2012","December 2022","December 2032","February 13, 2013",,"January 9, 2018","Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China",,"https://ClinicalTrials.gov/show/NCT01790061"
433,"NCT02425865","Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET","In-TARGET","Active, not recruiting","No Results Available","ULCERATIVE COLITIS","Drug: GOLIMUMAB","Continuous Clinical Response and Endoscopic Remission|Continuous Clinical Response and Endoscopic Remission after discontinuation or de- escalation of golimumab|Efficacy of dose optimization in patients who loose response between week 10 and 54|Clinical remission at week 54|Clinical remission at week 108|PRO2 (Partial Mayo minus PGA) at week 54 and 108|CCR between study inclusion and week 54 and 108|Steroid-free clinical remission at week 54 and 108|MH (endoscopic score MAYO 0-1) at week 54 and 108|Changes in faecal calprotectin levels from baseline at week 54 and 108|Colectomy between W0 and W54 and 108|UC-related hospitalizations throughout the trial|Histological remission at W54 and 108|PRO: Fatigue (FACIT), disability (IBD Disability index), QoL (SHS-IBD VAS)|PK data (golimumab trough levels and antibodies against golimumab)|Late responders being in Clinical Response from week 18 to week 54 and with MH at week 54 following treatment intensification in Maintenance Phase","Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 4","202","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","GETAID 2015-05","December 2016","October 2021","October 2022","April 24, 2015",,"June 30, 2021","CHU LIEGE - Sart Tilman, Liege, Belgium|CHU Dinant Godinne UCL Namur, NAmur, Belgium|CHU Amiens, Amiens, France|Chu Besancon, Besançon, France|Caen Unversity Hospital, Caen, France|CHU Clermont Ferrand, Clermont-Ferrand, France|APHP- Hopital BEAUJON, Clichy, France|CHU de Colmar- Hopital Trousseau Medecine A, Colmar, France|CHRU Lille, Lille, France|CHU de Montpellier- Hopital saint Eloi, Montpellier, France|CHU NANTES - Hôpital Hôtel Dieu, Nantes, France|CHU de NICE- Hopital Archet 2, Nice, France|CHU de Nimes- Hopital Carémeau, Nîmes, France|APHP- Hopital BICHAT, Paris, France|CHU Bordeaux- Hopital Haut Levèque, Pessac, France|CHU LYON- Hopital Lyon Sud, Pierre-Bénite, France|Chu Reims, Reims, France|CHU RENNES - Hopital Pontchaillou, Rennes, France|CHU de Saint Etienne- Hopital Nord, Saint-Priest-en-Jarez, France|Chu Strasbourg, Strasbourg, France|CHU de TOULOUSE, Toulouse, France|CHU de Tours - Hopital Trousseau, Tours, France|CHU NANCY - Hopital Brabois, Vandoeuvre Les Nancy, France",,"https://ClinicalTrials.gov/show/NCT02425865"
434,"NCT04377061","Anemia in Non-celiac Wheat Sensitivity",,"Recruiting","No Results Available","Non-celiac Gluten Sensitivity|Anemia","Diagnostic Test: Evaluation of anemia","Presence, severity and morphologic characteristic of anemia|Possible pathogenic mechanisms","University of Palermo","All","18 Years to 65 Years   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","ACPM25","January 1, 2020","January 1, 2021","January 1, 2022","May 6, 2020",,"February 23, 2021","Department of Internal Medicine, Giovanni Paolo II Hospital of Sciacca, Sciacca, Agrigento, Italy|Internal Medicine Division of the ""Cervello-Villa Sofia"" Hospital, Palermo, PA, Italy|Department of Internal Medicine, University Hospital of Palermo, Palermo, Italy",,"https://ClinicalTrials.gov/show/NCT04377061"
435,"NCT04184986","Screening of Fabry Disease in Patients With GI Symptoms","GiFD","Recruiting","No Results Available","Fabry Disease","Diagnostic Test: dry blood test","prevalence of Fabry disease in GI symptomatic patients","General University Hospital, Prague|Charles University, Czech Republic|Klinické centrum ISCARE|Amicus Therapeutics","All","18 Years to 60 Years   (Adult)",,"200","Other|Industry","Observational","Observational Model: Other|Time Perspective: Prospective","1","September 1, 2019","September 1, 2020","December 1, 2020","December 4, 2019",,"February 6, 2020","General Teaching Hospital, Prague, Czechia",,"https://ClinicalTrials.gov/show/NCT04184986"
436,"NCT04631471","Regeneration in Cervical Degenerative Myelopathy","RECEDE","Not yet recruiting","No Results Available","Myelopathy|Spinal Cord Diseases","Drug: Ibudilast|Procedure: Cervical decompressive surgery|Drug: Matching placebo","Change in modified Japanese Orthopaedic Association (mJOA) scale|Change in Visual Analogue Scale (VAS) neck pain|PCS-SF36|MCS-SF36","Cambridge University Hospitals NHS Foundation Trust","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 3","400","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","CCTU0178|2017-004856-41|213009","December 1, 2020","September 1, 2026","September 1, 2026","November 17, 2020",,"November 19, 2020",,,"https://ClinicalTrials.gov/show/NCT04631471"
437,"NCT04504383","PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)",,"Recruiting","No Results Available","Ulcerative Colitis Chronic Moderate|Ulcerative Colitis Chronic Severe","Drug: PN-943|Drug: Placebo","Proportion of subjects achieving clinical remission at Week 12 compared to placebo.|Comparison between PN-943 high-dose and low-dose individually to placebo.","Protagonist Therapeutics, Inc.","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","150","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","PN-943-03","August 5, 2020","June 1, 2022","June 1, 2023","August 7, 2020",,"June 15, 2021","Protagonist Investigational Site, Tucson, Arizona, United States|Protagonist Investigational Site, Garden Grove, California, United States|Protagonist Investigational Site, Los Angeles, California, United States|Protagonist Investigational Site, Murrieta, California, United States|Protagonist Investigational Site, San Francisco, California, United States|Protagonist Investigational Site, Colorado Springs, Colorado, United States|Protagonist Investigational Site, Miami, Florida, United States|Protagonist Investigational Site, Miami, Florida, United States|Protagonist Investigational site, Orlando, Florida, United States|Protagonist Investigational Site, Saint Augustine, Florida, United States|Protagonist Investigational Site, Wesley Chapel, Florida, United States|Protagonist Investigational Site, Metairie, Louisiana, United States|Protagonist Investigational Site, Chesterfield, Michigan, United States|Protagonist Investigational Site, Troy, Michigan, United States|Protagonist Investigational Site, Jackson, Mississippi, United States|Protagonist Investigational Site, Saint Louis, Missouri, United States|Protagonist Investigational Site, Charlotte, North Carolina, United States|Protagonist Investigational Site, Norman, Oklahoma, United States|Protagonist Investigational Site, Oklahoma City, Oklahoma, United States|Protagonist Investigational Site, Orangeburg, South Carolina, United States|Protagonist Investigational Site, Austin, Texas, United States|Protagonist Investigational site, Garland, Texas, United States|Protagonist Investigational Site, Pasadena, Texas, United States|Protagonist Investigational Site, Spring, Texas, United States|Protagonist Investigational site, Lynchburg, Virginia, United States|Protagonist Investigational Site, Innsbruck, Austria|Protagonist Investigational Site, Salzburg, Austria|Protagonist Investigational Site, Sofia, Bulgaria|Protagonist Investigational Site, Kelowna, British Columbia, Canada|Protagonist Investigational Site, Vancouver, British Columbia, Canada|Protagonist Investigational Site, West Vancouver, British Columbia, Canada|Protagonist Investigational Site, North Bay, Ontario, Canada|Protagonist Investigational Site, Tbilisi, Georgia|Protagonist Investigational Site, Tbilisi, Georgia|Protagonist Investigational Site, Tbilisi, Georgia|Protagonist Investigational Site, Berlin, Germany|Protagonist Investigational Site, Kiel, Germany|Protagonist Investigational Site, Budapest, Hungary|Protagonist Investigational Site, Debrecen, Hungary|Protagonist Investigational Site, Székesfehérvár, Hungary|Protagonist Investigational Site, Castellana Grotte, Italy|Protagonist Investigational Site, Modena, Italy|Protagonist Investigational Site, Negrar, Italy|Protagonist Investigational Site, Padova, Italy|Protagonist Investigational Site, Roma, Italy|Protagonist Investigational Site, Roma, Italy|Protagonist Investigational Site, San Giovanni Rotondo, Italy|Protagonist Investigational Site, Busan, Korea, Republic of|Protagonist Investigational Site, Busan, Korea, Republic of|Protagonist Investigational Site, Daegu, Korea, Republic of|Protagonist Investigational Site, Daegu, Korea, Republic of|Protagonist Investigational Site, Daejeon, Korea, Republic of|Protagonist Investigational Site, Seoul, Korea, Republic of|Protagonist Investigational Site, Seoul, Korea, Republic of|Protagonist Investigational site, Seoul, Korea, Republic of|Protagonist Investigational Site, Poznań, Wielkopolskie, Poland|Protagonist Investigational Site, Bydgoszcz, Poland|Protagonist Investigational Site, Bydgoszcz, Poland|Protagonist Investigational Site, Czestochowa, Poland|Protagonist Investigational Site, Czestochowa, Poland|Protagonist Investigational Site, Katowice, Poland|Protagonist Investigational Site, Kraków, Poland|Protagonist Investigational Site, Ksawerów, Poland|Protagonist Investigational Site, Lublin, Poland|Protagonist Investigational Site, Nowy Targ, Poland|Protagonist Investigational Site, Piotrków Trybunalski, Poland|Protagonist Investigational Site, Poznań, Poland|Protagonist Investigational Site, Poznań, Poland|Protagonist Investigational Site, Rzeszów, Poland|Protagonist Investigational Site, Sopot, Poland|Protagonist Investigational Site, Swidnica, Poland|Protagonist Investigational Site, Toruń, Poland|Protagonist Investigational Site, Tychy, Poland|Protagonist Investigational Site, Warsaw, Poland|Protagonist Investigational Site, Warsaw, Poland|Protagonist Investigational Site, Warszawa, Poland|Protagonist Investigational Site, Wrocław, Poland|Protagonist Investigational Site, Wrocław, Poland|Protagonist Investigational Site, Wrocław, Poland|Protagonist Investigational Site, Wrocław, Poland|Protagonist Investigational Site, Włocławek, Poland|Protagonist Investigational Site, Łódź, Poland|Protagonist Investigational Site, Łódź, Poland|Protagonist Investigational Site, Chelyabinsk, Russian Federation|Protagonist Investigational Site, Moscow, Russian Federation|Protagonist Investigational Site, Novosibirsk, Russian Federation|Protagonist Investigational Site, Novosibirsk, Russian Federation|Protagonist Investigational Site, Perm, Russian Federation|Protagonist Investigational Site, Pyatigorsk, Russian Federation|Protagonist Investigational Site, Saint Petersburg, Russian Federation|Protagonist Investigational Site, Saint Petersburg, Russian Federation|Protagonist Investigational Site, Samara, Russian Federation|Protagonist Investigational Site, Stavropol', Russian Federation|Protagonist Investigational Site, Tomsk, Russian Federation|Protagonist Investigational Site, Tyumen, Russian Federation|Protagonist Investigational Site, Kyiv, Ukraine|Protagonist Investigational Site, Kyiv, Ukraine",,"https://ClinicalTrials.gov/show/NCT04504383"
438,"NCT01762579","Bio-markers of Not-celiac Wheat Sensitivity",,"Recruiting","No Results Available","Not-celiac Wheat Sensitivity","Dietary Supplement: wheat flour|Dietary Supplement: Xylose","Symptoms/signs evaluation|Bio-Markers evaluation","University of Palermo","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic","ACPM03","January 1, 2012","January 1, 2016","January 1, 2022","January 7, 2013",,"April 27, 2021","Internal Medicine, ""Giovanni Paolo II"" Hospital, Sciacca, Agrigento, Italy|Internal Medicine, University Hospital, Palermo, Italy",,"https://ClinicalTrials.gov/show/NCT01762579"
439,"NCT04183608","A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab","CONTROL","Recruiting","No Results Available","Ulcerative Colitis","Drug: Adalimumab|Diagnostic Test: Calprotectin|Other: e-Monitoring|Other: Therapy Education","Endoscopic Remission|Efficacy of adalimumab treatment on clinical remission (at Week 48)|Efficacy of adalimumab treatment on endoscopic Healing (at Week 48)|Efficacy of adalimumab treatment on endoscopic mucosal healing|Efficacy of adalimumab treatment on histological Healing (at Week 48)|Efficacy of adalimumab treatment on patient quality of life (at Week 48)|Patient satisfaction|Treatment compliance|Patient adhesion|Disability score evolution|Medico-economic analysis|Continuous Clinical Response (CCR)|Loss of clinical response|Number of visits in trial|Colectomies at Week 48|UC related Hospitalizations at Week 48","Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives|AbbVie","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 4","238","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","GETAID-2018-01","January 14, 2020","January 2022","May 2024","December 3, 2019",,"June 30, 2021","Centre hospitalier de Cholet, Cholet, Maine Et Loire, France|CHU Amiens- Picardie (site Sud), Amiens, France|CHU Caen Hôpital Côte de Nacre, Caen, France|CHU Estaing, Clermont-Ferrand, France|APHP - Hôpital Beaujon, Clichy, France|CH Colmar - Hôpital Pasteur, Colmar, France|CHRU Lille Hôpital Claude Huriez, Lille, France|APHM - Hôpital Nord, Marseille, France|GHI Le Raincy-Montfermeil, Montfermeil, France|CHU Montpellier - Hôpital Saint Eloi, Montpellier, France|CHU Nantes - Hôpital Hotel Dieu, Nantes, France|CHU Nice- Hopital l'Archet, Nice, France|Chu nimes - Hôpital Universitaire Caremeau, Nîmes, France|CHU Bordeaux - Hôpital Haut Lévêque, Pessac, France|CHU Lyon Sud, Pierre-Bénite, France|CHU Rennes Hôpital Pontchaillou, Rennes, France|CH Saint Etienne Hopital Nord, Saint-Priest-en-Jarez, France|CH Toulon - CHITS CH Sainte Musse, Toulon, France|CHU Toulouse - Hôpital Rangueil, Toulouse, France|CH Tourcoing - Hôpital Gustave Dron, Tourcoing, France|CHU Nancy - Hôpital de Brabois, Vandœuvre-lès-Nancy, France|Franck CARBONNEL, Le Kremlin-Bicêtre, Île-de-France, France",,"https://ClinicalTrials.gov/show/NCT04183608"
440,"NCT04633512","Safety and Feasibility of ActivSightTM in Human",,"Enrolling by invitation","No Results Available","Acute Cholecystitis|Colorectal Cancer|Diverticulitis, Colonic|Obesity, Morbid|Inflammatory Bowel Diseases","Device: ActivSight","Incidence of Adverse Events in 28 days following use of ActivSightTM|Preparation time of ActivSightTM.|Latency of display of ActivSightTM.|Resolution of display of ActivSightTM.|Specificity of display of ActivSightTM.|Usability of ActivSightTM by surgeon, as quantified by Likert scale.|Support personnel satisfaction with ActivSightTM, as quantified by Likert scale.|Ability of ActivSightTM to display perfusion.|Ability of ActivSightTM to display blood vessels.|Ability of ActivSightTM to display biliary tree.","Activ Surgical|The University of Texas Health Science Center, Houston|University of Buffalo, Buffalo General Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Industry|Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","ACF0012020","November 17, 2020","January 2024","January 2024","November 18, 2020",,"May 4, 2021","Kaleida Health, University of Buffalo, Buffalo, New York, United States|Memorial Hermann Texas Medical Center, Houston, Texas, United States|Memorial Hermann Sugar Land Hospital, Sugar Land, Texas, United States","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/12/NCT04633512/Prot_000.pdf","https://ClinicalTrials.gov/show/NCT04633512"
441,"NCT04870476","Feasibility and Acceptability of the Internet-delivered Treatment ""One Step at the Time"" for Bodily Distress Syndrome",,"Not yet recruiting","No Results Available","Bodily Distress Disorder Moderate|Fibromyalgia|Chronic Fatigue Syndrome|Irritable Bowel Syndrome|Somatization Disorder","Behavioral: Internet-delivered treatment: ""One step at the time""","Changes in physical Health|SF-36 physical health|5-point clinical global improvement scale (CGI)|The Numeric Rating Scale|Relevant subscores of the 92-item Danish version of the Symptom Checklist (SCL-92)|The BDS Checklist|Whiteley-7|Brief-Illness perception questionnaire|The Behavioural Responses to Illness Questionnaire (BRIQ) Changes in illness behaviour|The credibility/expectancy questionnaire|Costs associated with Psychiatric Illness (TiC-P)|The inventory for the assessment of negative effects of psychotherapy (INEP)|The Internet Evaluation and Utility Questionnaire|The Sources of Meaning and Meaning in Life Questionnaire (SoMe short version)","University of Aarhus","All","18 Years to 60 Years   (Adult)","Not Applicable","35","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","OneStep 1.0","September 19, 2021","March 15, 2022","October 27, 2022","May 3, 2021",,"May 3, 2021",,,"https://ClinicalTrials.gov/show/NCT04870476"
442,"NCT04085211","Image-Enhanced Endoscopy in the Gastrointestinal Tract",,"Recruiting","No Results Available","Gastro-Intestinal Disorder|Inflammatory Bowel Diseases|Gastro Esophageal Reflux|Atrophic Gastritis|Neuroendocrine Tumors",,"Sensitivity, specificity, positive predictive value of specific endoscopic image enhancement findings to diagnose or stage the severity of different gastrointestinal conditions|Specific image enhancement findings to predict relapse for patients with inactive inflammatory bowel disease.|median duration for image enhanced endoscopy procedures","King's College Hospital NHS Trust","All","18 Years to 90 Years   (Adult, Older Adult)",,"260","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","KCH19-069","July 1, 2019","February 2022","May 2022","September 11, 2019",,"November 30, 2020","Department of Gastroenterology, King's College Hospital, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04085211"
443,"NCT04556383","A Study With GB004 in Adult Subjects With Active Ulcerative Colitis (UC)",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: GB004|Drug: Placebo","Proportion of Participants With Clinical Remission at Week 12|Proportion of Participants with Clinical Response at Week 12|Proportion of Participants with Histologic Remission at Week 12|Proportion of Participants with Endoscopic Improvement at Week 12|Proportion of Participants with Mucosal Healing at Week 12|Proportion of Participants with Clinical Remission at Week 36|Proportion of Participants with Clinical Response at Week 36|Proportion of Participants with Histologic Remission at Week 36|Proportion of Participants with Endoscopic Improvement at Week 36|Proportion of Patients with Mucosal Healing at Week 36","GB004, Inc.|Gossamer Bio Inc.","All","18 Years and older   (Adult, Older Adult)","Phase 2","195","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","GB004-2101|2020-002306-12","October 19, 2020","March 2022","February 2023","September 21, 2020",,"June 28, 2021","B G Clinical Research, Inc., Encinitas, California, United States|Gastro Care Institute, Lancaster, California, United States|Texas Digestive Disease Consultants, Baton Rouge, Louisiana, United States|Gastroenterology Clinic of Acadiana, Lafayette, Louisiana, United States|Delta Research Partners, Monroe, Louisiana, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|Freehold Endoscopy Associates, LLC d/b/a/ Endoscopy Center of Monmouth County, Freehold, New Jersey, United States|Great Lakes Gastroenterology Research, LLC, Mentor, Ohio, United States|Susquehanna Research Group, LLC, Harrisburg, Pennsylvania, United States|Texas Digestive Disease Consultant, Southlake, Texas, United States|Coral Sea Clinical Research Institute, North Mackay, Queensland, Australia|University of the Sunshine Coast Clinical Trials Centre, Sippy Downs, Queensland, Australia|JSC Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia|LTD Aversi Clinic, Tbilisi, Georgia|LTD Central University Clinic After Academic N. Kipshidze, Tbilisi, Georgia|LTD Coloproctological Center of Georgia, Tbilisi, Georgia|Malkhaz Katsiashvili Multiprofile Emergency Medicine Center LTD, Tbilisi, Georgia|Inje University Heaundae Paik Hospital, Busan, Korea, Republic of|Dong-A University Hospital, Busan, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|PMSI Republican Clinical Hospital ""Timofei Mosneaga"", Chisinau, Moldova, Republic of|CLINSANTE Clinical Research Center Civil Law Partnership Ewa Galczak-Nowak, Malgorzata Trzaska, Bydgoszcz, Poland|Clinical Research Center of Karkonosze - Lexmedica Limited Liability Company, KCBK - LEXMEDICA, Jelenia Gora, Poland|Professor K. Gibinski University Clinical Centre of the Medical University of Silesia in Katowice, Katowice, Poland|""LANDA"" Katarzyna Agata Landa, Landa"" Specialist Doctor's Offices, Krakow, Poland|Medicome Limited Liability Company, Oswiecim Clinical Trial Centre, Oswiecim, Poland|Marek Horynski, MD, Ph.D. Individual Specialist Medical Practice [Specjialistyczna Praktyka Lekarska Dr med. Marek Horynski], Sopot, Poland|""NOWE ZDROWIE-CK"" Kieltucki and Partners General Partnership, NOWE ZDROWIE-CK, Staszow, Poland|""Gastromed"" Torun Gastrology Centre [Torunskie Centrum Gastrologiczne ""Gastromed""], Toruń, Poland|EB GROUP Limited Liability Company, MDM Health Centre, Warsaw, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warsaw, Poland|Reuma Park Clinic Limited Liability Company Limited Partnership, Reuma Park Medical Center, Warsaw, Poland|VIVAMED Non-Public Healthcare Facility, Warsaw, Poland|Clinical Research Center Piotr Napora Medical Doctors Professional Partnership, Wroclaw, Poland|Limited Liability Company Joint Venture Diagnostic Center ""Biotherm"", Barnaul, Russian Federation|""Myod"" Ltd., Bataysk, Russian Federation|Chita State Medical Academy under the Ministry of Healthcare of the Russian Federation, Chita, Russian Federation|Belyayev Regional Clinical Hospital of the Kuzbass, Kemerovo, Russian Federation|Federal Siberian Research Clinical Center under the Federal Medical Biological Agency, Krasnoyarsk, Russian Federation|Moscow State-Funded Healthcare Institution City Clinical Hospital n.a. V.M. Buyanov under Moscow Healthcare Department, Moscow, Russian Federation|Private Healthcare Institution: RZD Medicine Nizhniy Novgorod Clinical Hospital, Nizhniy Novgorod, Russian Federation|Medical Center SibNovoMed, Limited Liability Company, Novosibirsk, Russian Federation|Novosibirskiy Gastrocenter, LLC, Novosibirsk, Russian Federation|Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russian Federation|Medical Diagnostic Center, Limited Liability Company, Orenburg, Russian Federation|Penza Regional Clinical Hospital named after N.N. Burdenko, Penza, Russian Federation|Clinic UZI 4D, Limited Liability Company, Pyatigorsk, Russian Federation|S.M. Kirov Miltiary Medical Academy, St Petersburg, Russian Federation|St. Petersburg State-Funded Healthcare Institution: City Outpatient Care Unit No. 38, St. Petersburg, Russian Federation|St. Petersburg State-Funded Healthcare Institution: Holy Martyr Elizabeth City Hospital, St. Petersburg, Russian Federation|Consultation and Diagnostics Center and Outpatient Care Unit under the Department of Presidential Affairs, St. Petersburg, Russian Federation|Regional State-Funded Healthcare Institution: Novgorod Regional Clinic Hospital, Veliky Novgorod, Russian Federation|Clinical Hospital Center ""Dr Dragisa Misovic Dedinje'' local lab, Belgrade, Serbia|Clinical Hospital Center Zemun, Belgrade, Serbia|Zvezdara University Medical Center-local lab, Belgrade, Serbia|General Hospital ""Djordje Joanovic"", Zrenjanin, Serbia|Communal Nonprofit Enterprise ""Cherkasy Regional Hospital of Cherkasy Oblast Council"", Cherkasy, Ukraine|Public Non-Profit Enterprise ""Regional Clinical Hospital under Ivano-Frankivsk Regional Council"", Ivano-Frankivsk, Ukraine|PNPE ""Prof. O.O. Shalimov City Clinical Hospital #2"" under Kharkiv City Council, Kharkiv, Ukraine|Public Non-Profit Enterprise under Kharkiv Regional Council ""Regional Clinical Hospital"", Kharkiv, Ukraine|Medical Center of the Limited Liability Company ""Harmoniia Krasy"", Kyiv, Ukraine|Medical Center ""OK!Clinic+"" of the Company with Limited Liability ""International Institute of Clinical Research"", Kyiv, Ukraine|Medical Center of the Limited Liability Company ""Medical Center ""CONSILIUM MEDICAL"", Kyiv, Ukraine|Public Non-Profit Enterprise under Kyiv Regional Council ""Kyiv Regional Hospital"", Kyiv, Ukraine|The Municipal Enterprise ""Volyn Regional Clinical Hospital"" of the Volyn Regional Council, Lutsk, Ukraine|Communal Noncommercial Enterprise of Lviv Regional Council ""Lviv Regional Clinical Hospital"", Lviv, Ukraine|Public Non-Profit Enterprise ""Odesa Regional Clinical Hospital"" under Odesa Regional Council, Odesa, Ukraine|Communal Non-Commercial Enterprise ""Vinnytsia City Clinical Hospital #1, Vinnytsia, Ukraine|PNPE ""City Hospital of Urgent and Emergency Medical Care under Zaporizhia City Council"", Zaporizhia, Ukraine|MNPE ""Zaporizhia Regional Clinical Hospital"" of Zaporizhia Regional Council, Zaporizhia, Ukraine|Limited Liability Company ""Medibor"", Zhytomyr, Ukraine",,"https://ClinicalTrials.gov/show/NCT04556383"
444,"NCT04583358","Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: AMT-101 (oral)|Other: Placebo (oral)","Change in Mayo Score|Endoscopic Remission Rate|Mucosal Healing Rate|Histologic Remission Rate|Clinical Remission Rate","Applied Molecular Transport","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","102","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","AMT-101-202","August 26, 2020","February 2022","March 2022","October 12, 2020",,"June 8, 2021","Advanced Medical Research Center, Port Orange, Florida, United States|Gwinnett Research Institute, LLC, Buford, Georgia, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Huron Gastroenterology Associates, Ypsilanti, Michigan, United States|Carolina Research, Greenville, North Carolina, United States|Gastro One, Germantown, Tennessee, United States|GIA Clinical Trials, LLC, Knoxville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Caprock Gastro Research, Lubbock, Texas, United States|Tyler Research Institute, Tyler, Texas, United States|University of Utah Hospitals and Clinics, Salt Lake City, Utah, United States|Washington Gastroenterology, PLLC, Tacoma, Washington, United States|GI Research Institute, Vancouver, British Columbia, Canada|London Health Sciences Centre - Victoria Hospital, London, Ontario, Canada|Toronto Digestive Disease Associates Inc., Vaughan, Ontario, Canada|CHU Saint-Etienne - Hospital Nord Gastroenteroloy, Saint-Priest-en-Jarez, France|ARENSIA Exploratory Medicine, Tbilisi, Georgia|University Hospital Schleswig-Holstein, Kiel, Germany|Clinexpert Kft., Budapest, Hungary|Semmelweis Egyetem Altalanos Orvostudomanyi Kar, Budapest, Hungary|Javorszky Odon Korhaz, Gasztroenterologiai Osztaly, Vác, Hungary|ARENSIA Exploratory Medicine, Chisinau, Moldova, Republic of|Vitamed Gałaj i Cichomski S.J., Bydgoszcz, Poland|Centrum Opieki Zdrowotnej ORKAN-MED Stec-Michalska, Ksawerów, Poland|Centrum Medyczne Medyk, Rzeszów, Poland|Nowe Zdrowie CK Kieltucki I Wspólnicy sp.j., Staszów, Poland|Gastromed Kopon, Zmudziski I Wspolnicy Sp.j., Toruń, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland",,"https://ClinicalTrials.gov/show/NCT04583358"
445,"NCT03519945","A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Mirikizumab","Percentage of Participants in Clinical Remission|Percentage of Participants in Endoscopic Remission|Percentage of Participants in Corticosteroid-free Remission|Percentage of Participants with Histologic-Endoscopic Mucosal Remission at Week 52|Health Related Quality of Life: Inflammatory Bowel Disease Questionnaire (IBDQ) Score|UC Symptoms: Numeric Rating Score|Percentage of Participants Who are Hospitalized Due to UC|Percentage of Participants Who Undergo UC Surgeries Including Colectomy","Eli Lilly and Company","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 3","960","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","16596|I6T-MC-AMAP|2017 004092 31","July 18, 2018","August 23, 2023","July 1, 2025","May 9, 2018",,"June 18, 2021","Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|Research Solutions of Arizona, Litchfield Park, Arizona, United States|Valleywise Health, Phoenix, Arizona, United States|inSite Digestive Health Care, Arcadia, California, United States|Care Access Research, Berkeley, California, United States|Om Research, LLC, Lancaster, California, United States|California Medical Research Group, Northridge, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Clinical Applications Laboratories, Inc., San Diego, California, United States|Direct Helpers Medical Center, Hialeah, Florida, United States|Borland Groover Clinic, Jacksonville, Florida, United States|Wellness Clinical Research, Miami Lakes, Florida, United States|Research Associates of South Florida, LLC, Miami, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Clintheory Healthcare, Orlando, Florida, United States|Gastroenterology Associates of Pensacola, PA, Pensacola, Florida, United States|Florida Medical Clinic LLC, Zephyrhills, Florida, United States|Digestive Healthcare of Georgia, Atlanta, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Indiana University School of Medicine, Indianapolis, Indiana, United States|Cotton-O'Neil Clinical Research Center, Digestive Health, Topeka, Kansas, United States|GI Alliance Research Baton Rouge, Baton Rouge, Louisiana, United States|Delta Research Partners LLC, Monroe, Louisiana, United States|Nola Research Works, LLC, New Orleans, Louisiana, United States|University of Michigan, Ann Arbor, Michigan, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Henry Ford Health System, Novi, Michigan, United States|Gastroenterology Associates of Western Michigan, P.L.C., Wyoming, Michigan, United States|Minnesota Gastroenterology, P.A., Plymouth, Minnesota, United States|Lee Memorial Hospital, Great Neck, New York, United States|Weill Cornell Medical College, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|University of North Carolina Center for Inflammatory Bowel Disease, Chapel Hill, North Carolina, United States|Carolina Digestive Diseases, Greenville, North Carolina, United States|Care Access Research - Youngstown, Poland, Ohio, United States|Central Sooner Research, Norman, Oklahoma, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Care Access Research LLC, Pottsville, Pennsylvania, United States|Digestive Disease Associates, Ltd., Wyomissing, Pennsylvania, United States|Midwest Medical Care, Sioux Falls, South Dakota, United States|Digestive Health Associates of Texas, Garland, Texas, United States|Biopharma Informatic, Inc., Houston, Texas, United States|Gastroenterology Research of San Antonio, San Antonio, Texas, United States|Southern Star Research Institute, LLC, San Antonio, Texas, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|Care Access Research LLC - Salt Lake City, Ogden, Utah, United States|Care Access Research LLC - Salt Lake City, Salt Lake City, Utah, United States|The Gastroenterology Group, P.C., Reston, Virginia, United States|Carilion Clinic, Roanoke, Virginia, United States|Washington Gastroenterology, PLLC, Tacoma, Washington, United States|Wisconsin Center for Advanced Research, Milwaukee, Wisconsin, United States|Mautalen Salud e Investigación, Caba, Buenos Aires, Argentina|CER Instituto Medico, Quilmes, Buenos Aires, Argentina|Fundación de Estudios Clínicos, Rosario, Santa Fe, Argentina|Sanatorio 9 de Julio SA, San Miguel de Tucuman, Tucuman, Argentina|Centro Medico Privado de Reumatologia, SAN M. DE Tucuman, Tucumán, Argentina|Princess Alexandra Hospital, Brisbane, Queensland, Australia|Coastal Digestive Health, Maroochydore, Queensland, Australia|Mater University Hospital, South Brisbane, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Box Hill Hospital, Box Hill, Victoria, Australia|St Vincents Hospital Melbourne, Fitzroy, Victoria, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|The Royal Melbourne Hospital, Parkville, Victoria, Australia|AKH - Gastroenterologie und Hepatologie - Interne Medizin III, Wien, Vienna, Austria|Medizinische Universität Innsbruck, Innsbruck, Austria|Universitätsklinikum Salzburg, Salzburg, Austria|Universitair Ziekenhuis Gent, Gent, Belgium|Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium|Centre Hospitalier de Wallonie picarde - CHwapi A.S.B.L., Tournai, Belgium|West Edmonton Diabetes Center, Edmonton, Alberta, Canada|The Gordon and Leslie Diamond Health Care Centre, Vancouver, British Columbia, Canada|GI Research Institute, Vancouver, British Columbia, Canada|PerCuro Clinical Research Ltd., Victoria, British Columbia, Canada|London Health Sciences Centre, London, Ontario, Canada|Victoria Hospital, London, Ontario, Canada|CIUSS-de-L'Est-de-l'île-de-Montréal-Hôpital, Montreal, Quebec, Canada|McGill University, Montreal, Quebec, Canada|The First Affiliated Hospital of Anhui Medical University, HefeiCity, Anhui, China|The Affiliated 2nd Hosp. of Third Military Med. Univ. of PLA, Chongqing, Chongqing, China|The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China|Tongji Hosp Tongji Med Col Huazhong Univ of Sci & Tech, Wu Han, Hubei, China|Qilu Hospital of Shandong University, Jinan, Shandong, China|Liaocheng People's hospital, Liaocheng, Shandong, China|Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai/China, China|Renji Hospital Affliated to Shanghai Jiaotong University, Shanghai, Shanghai, China|West China Hospital Sichuan University, Cheng Du, Sichuan, China|West China Hospital Sichuan University, Chengdu, Sichuan, China|The First People's Hospital of Yunnan Province, Kunming, Yunnan, China|The Second Affiliated Hospital of Zhejiang University School of Med, Hangzhou, Zhejiang, China|First Affiliated Hosp of College of Med, Zhejiang University, Hangzhou, Zhejiang, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China|Vojenska nemocnice Brno, Brno, Czechia|Fakultni Nemocnice U svate Anny, Brno, Czechia|Hepato-gastroenterologie HK, s.r.o., Hradec Kralove, Czechia|Gregar s.r.o., Olomouc, Czechia|PreventaMed, s.r.o., Olomouc, Czechia|A-Shine s.r.o., Plzen, Czechia|Fakultni nemocnice Kralovske Vinohrady, Praha 10, Czechia|Mediendo s.r.o., Praha 8 - Karlin, Czechia|ISCARE Clinical Centre, Praha 9, Czechia|Herlev and Gentofte Hospital, Herlev, Denmark|Zealand University Hospital Køge, Køge, Denmark|Nyborg Sygehus - OUH, Nyborg, Denmark|Hôpital de HautePierre, Strasbourg Cedex, Bas Rhin, France|CHU Amiens Picardie Site Sud - Service d'Hepato-gastro-entérologie, Amiens, France|Hôpital Trousseau, CHRU de Tours, Chambray-lès-Tours, France|Hopital Beaujon, Clichy, France|Hôpital C. HURIEZ, Lille, France|CHRU de Montpellier-Hopital St Eloi, Montpellier, France|CHU de Nice Hopital de L'Archet, Nice cedex 3, France|Hopital Saint-Louis, Paris, France|CH Francois Mitterand, PAU, France|Centre hospitalier universitaire de Haut Leveque, Pessac Cedex, France|Centre Hospitalier Lyon Sud, Pierre Benite Cedex, France|CHU St Etienne Hopital Nord, Saint Etienne Cedex 2, France|CHRU Nancy Brabois - Hôpital d'Enfants, Vandoeuvre les Nancy, France|LLC ARENSIA Exploratory Medicine, Tbilisi, Georgia|Staedisches Klinikum Brandenburg, Brandenburg an der Havel, Brandenburg, Germany|Medizinische Hochschule Hanover, Hannover, Niedersachsen, Germany|Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Sachsen-Anhalt, Germany|Gastroenterologische Praxis Dres Behrens, Steudel, Fechner, Halle (Saale), Saxony-Anhalt, Germany|Charité Universitätsmedizin Berlin Campus Buch, Berlin, Germany|Krankenhaus Waldfriede e. V., Berlin, Germany|Hamburgisches Forschungsinstitut fuer Chronisch Entzuendliche Darmerkrankungen, Hamburg, Germany|INLUGA im Haus der Gesundheit, Ludwigshafen, Germany|SZTE AOK Belgyogyaszati Klinika, Szeged, Csongrad, Hungary|DRC Gyogyszervizsgalo Kozpont Kft., Balatonfüred, EU, Hungary|Debreceni Egyetem Klinikai Kozpont Belgyogyaszati Intezet, Debrecen, Hajdu-Bihar, Hungary|Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaz IV. Belgyogyaszat, Bekescsaba, Hungary|SE Belgyogyaszati és Hematologiai Klinika, Budapest, Hungary|Eszak-Kozep-budai Centrum, Uj Szent Janos Korhaz es Szakrendelo I. Belgyogyaszat, Budapest, Hungary|Endomedix Diagnosztikai Kozpont, Miskolc, Hungary|Karolina Korhaz-Rendelointezet, Mosonmagyarovar, Hungary|Clinfan Szolgaltato Kft., Szekszard, Hungary|Javorszky Odon Hospital, Vac, Hungary|Centre for Liver Research & Diagnostics, Deccan College of Medical Sciences, Owaisi Hospital & Research Centre, Hyderabad, Andhra Pradesh, India|Apollo Research and Innovations, Apollo Hospitals International Ltd, Gandhinagar, Gujarat, India|Shree Giriraj Hospital, Rajkot, Gujarat, India|Nirmal Hospital Private Limited, Surat, Gujarat, India|M S Ramaiah Medical College Hospital, Bangalore, Karnataka, India|Poona Medical Foundation. Ruby Hall Clinic, Pune, Maharashtra, India|Datta Meghe Institute of Medical Sciences (DU), Acharya Vinoba Bhave Rural Hospital, Wardha, Maharashtra, India|Midas Multispecilaity Hopsital Pvt Ltd, Ramdaspeth, Nagpur, India|Dayanand Medical College, Ludhiana, Punjab, India|S.R. Kalla Hospital, Jaipur, Rajasthan, India|King George Medical University, Lucknow, Uttar Pradesh, India|Fortis Hospital, Noida, Uttar Pradesh, India|Gandhi Hospital, Telangana, India|Beaumont Hospital, Dublin, Ireland|Soroka Medical Center, Beer Sheva, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Galilee Medical Center Department of Internal Medicine A, Nahariya, Israel|Kaplan Medical Center, Rehovot, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Assaf Harofeh Medical Center, Zerifin, Israel|Policlinico Univ. Agostino Gemelli, Roma, Lazio, Italy|Presidio di Rho, Rho, Milano, Italy|Istituto Clinico Humanitas, Rozzano, Milano, Italy|Istituto Mangiagalli, Milano, MI, Italy|Ospedale Sandro Pertini, Roma, RM, Italy|Policlinico Mater Domini, Catanzaro, Italy|IRCCS Ospedale Policlinico San Martino, Genova, Italy|Azienda Ospedaliera Universitaria Policlinico de Modena, Modena, Italy|Azienda Ospedlaliero-Univeristaria Pisana - Ospedale di Cisanello - Gastroenterologia, Pisa, Italy|Policlinico di Tor Vergata, Roma, Italy|Ospedale Mauriziano Umberto I, Torino, Italy|NHO Hirosaki National Hospital, Hirosaki-shi, Aomori-Ken, Japan|Toho University School of Medicine, Sakura Hospital, Sakura, Chiba, Japan|Kitakyushu Municipal Medical Center, Kitakyusyu-shi, Fukoka, Japan|Hidaka Coloproctology Clinic, Kurume-shi, Fukuoka-Ken, Japan|Gunma University Hosptial, Maebashi, Gunma, Japan|Takasaki General Medical Center, Takasaki, Gunma, Japan|NHO Mito Medical Center, Ibaraki-machi, HigaShiibaraki-Gun, Japan|Asahikawa City Hospital, Asahikawa, Hokkaido, Japan|Tokushukai Sapporo Tokushukai Hospital, Sapporo-shi, Hokkaido, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital, Sapporo-shi, Hokkaido, Japan|Tokushukai Sapporo Higashi Tokushukai Hospital, Sapporo-shi, Hokkaido, Japan|Aoyama Clinic GI Endoscopy & IBD Center, Kobe-shi, Hyogo-Ken, Japan|Hyogo College of Medicine, Nishinomiya, Hyogo, Japan|Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan|Sameshima Hospital, Kagoshima-shi, Kagoshima, Japan|Gokeikai Ofuna Chuo Hospital, Kamakura-shi, Kanagawa, Japan|Kawasaki Municipal Kawasaki Hospital, Kawasaki, Kanagawa, Japan|Matsushima Clinic, Yokohama, Kanagawa, Japan|Showa University Northern Yokohama Hospital, Yokohama, Kanagawa, Japan|Yokohama City University Medical Center, Yokohama, Kanagawa, Japan|NHO Kyoto Medical Center, Kyoto-shi, Kyoto, Japan|Mie University Hospital, Tsu, Mie, Japan|Takagi Clinic, Sendai-shi, Miyagi-Ken, Japan|Nagaoka Chuo General Hospital, Nagaoka-shi, Niigata, Japan|Ishida Clinic of IBD and Gastroenterology, Oita-shi, Oita-Ken, Japan|Shinseikai Sai Gastroenterology, proctology, Fujiidera-shi, Osaka Fu, Japan|Kinshukai Infusion Clinic, Osaka-shi, Osaka, Japan|NHO Osaka National Hospital, Osaka-shi, Osaka, Japan|Saga-Ken Medical Center Koseikan, Saga-shi, Saga, Japan|Kumagaya General Hospital, Kumagaya-shi, Saitama-Ken, Japan|Tokitokai Tokito Clinic, Saitama-shi, Saitama-Ken, Japan|Matsuaikai Matsuda Hospital, Hamamatsu-shi, Shizuoka-Ken, Japan|Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan|Center Hospital of the National Center for Global Health and Medicine, Shinjuku-ku, Tokyo-To, Japan|Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan|Tokyo Medical And Dental University Medical Hospital, Bunkyō, Tokyo, Japan|Mitsui Memorial Hospital, Chiyoda-ku, Tokyo, Japan|Showa University Koto Toyosu Hospital, Koto-ku, Tokyo, Japan|Kitasato University Kitasato Institute Hospital, Minato-Ku, Tokyo, Japan|Kyorin University Hospital, Mitaka, Tokyo, Japan|JHCO Tokyo Yamate Medical Center, Shinjuku-ku, Tokyo, Japan|Toyama Prefectural Central Hospital, Toyama-Shi, Toyama, Japan|Fukuoka University Hospital, Fukuoka, Japan|Okayama University Hospital, Okayama, Japan|The Catholic University of Daejeon St. Mary's Hospital, Jung-gu, Daejeon, Korea, Republic of|Yeungnam Univeristy Medical Center, Gyeongsan-si, Korea, Korea, Republic of|Kyung Hee University Hospital, Seoul, Korea, Korea, Republic of|Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of|Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Dong-A University Hospital, Busan, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Gangwon-do, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Digestive Diseases Center ""Gastro"", Riga, Latvia|Pauls Stradins Kliniska Universitates Slimnica, Riga, Latvia|Riga Eastern Clinical University Hospital, Riga, Latvia|Hospital of Lithuanian University of Health Sciences Kaunas, Kaunas, Lithuania|Republic Hospital of Klaipeda, Klaipeda, Lithuania|Klaipeda Seamen's Hospital, Klaipeda, Lithuania|Respublikine Panevezio Ligonine, Panevezys, Lithuania|Vilniaus Universiteto Ligonines Santariskiu Klinikos, Vilnius, Lithuania|Hospital Sultanah Bahiyah, Alor Star, Kedah, Malaysia|Hospital Raja Perempuan Zainab II, Kota Bahru, Kelantan, Malaysia|Pusat Perubatan University Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia|Hospital Universiti Sains Malaysia, Kelantan, Malaysia|University Malaya Medical Centre, Kuala Lumpur, Malaysia|University Malaya Medical Centre, Kuala Lumpur, Malaysia|Hospital Serdang, Selangor, Malaysia|Clinicos Asociados BOCM, S.C., Mexico, DF, Mexico|Centro de Investigación Clínica Acelerada, Mexico City, Distrito Federal, Mexico|Clinical Research Institute S C, Tlalnepantla, Edo De Mex, Mexico|Investigación Biomédica para el Desarrollo de Fármacos S.A. de C.V., Zapopan, Jalisco, Mexico|Christus Muguerza Sur S.A. de C.V., Monterrey, Nuevo León, Mexico|Centro Para el Desarrollo de la Medicina y de Asistencia Med, Culiacan, Sinaloa, Mexico|Scientia Investigacion Clinica S.C., Chihuahua, Mexico|Sociedad de Metabolismo y Corazon S.C., Veracruz, Mexico|Republican Clinical Hospital, Chisinau, Moldova, Republic of|ETZ Elisabeth Tilburg, Tilburg, North Brabant, Netherlands|Academisch Medisch Centrum, Amsterdam, Netherlands|Bernhoven Uden, Uden, Netherlands|Universitair Medisch Centrum Utrecht, Utrecht, Netherlands|Szpital Uniwersytecki Nr 2 w Bydgoszczy, Klinika Reumatologii i Ukladowych Chorob Tkanki Lacznej, Bydgoszcz, Kujawsko-pomorskie, Poland|Promedica S.C, Bedzin, Poland|Centrum Medyczne Pratia Bydgoszcz, Bydgoszcz, Poland|Szpital Miejski Sw. Jana Pawla II, Elblag, Poland|NZOZ ALL-MEDICUS, Zaklad Gastroenterologii, Katowice, Poland|Topolowa Medicenter, Krakow, Poland|Gabinet Endoskopii Przewodu Pokarmowego, Krakow, Poland|GASTROMED Zakład Opieki Zdrowotnej, Lublin, Poland|Samodzielny Publiczny Szpital Kliniczny nr 4, Lublin, Poland|Medicenter Nowy Targ, Nowy Targ, Poland|Wojewodzki Specjalistyczny Szpital w Olsztynie, Olsztyn, Poland|Centrum Medyczne Lux Med Poradnia Gastroenterologii, Rzeszow, Poland|Endoskopia sp z o. o, Sopot, Poland|KO-MED Centra Kliniczne Staszow, Staszow, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Niepubliczny Zaklad Opieki Zdrowotnej SONOMED, Szczecin, Poland|Gastromed Kopoń Zmudziński I Wspólnicy Spółka Jawna Specjalistyczne Centrum Gastrologii I Endoskopii, Torun, Poland|Nzoz Formed, Wadowice, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Centrum Zdrowia Matki, Dziecka i Młodzieży (CZMDM) Przychodnie, Warszawa, Poland|Centralny Szpital Kliniczny MSWiA, Warszawa, Poland|Vivamed, Warszawa, Poland|PlanetMed Sp.z o.o., Wroclaw, Poland|LexMedica Osrodek Badan Klinicznych, Wroclaw, Poland|ETG Zamosc, Zamosc, Poland|SC Pelican SRL, Oradea, Bihor, Romania|SC Med Life SA, Bucuresti, Romania|S.C. Centrul Medical Medicum SRL, Bucuresti, Romania|Spitalul Clinic Colentina, Bucuresti, Romania|CCBR Clinical Research, Bucuresti, Romania|Multidisciplinary Medical Clinic ""Anthurium"", Barnaul, Russian Federation|LLC MA New Hospital, Ekaterinburg, Russian Federation|Irkutsk State Medical Academy of Continuing Education, Irkutsk, Russian Federation|LLC Alliance Biomedical - Ural Group, Izhevsk, Russian Federation|Kazan State Medical University, Kazan, Russian Federation|SIH Kemerovo Regional Clinical Hosptial, Kemerovo, Russian Federation|Nizhegorodskiy Regional Clinical Hospital N.A.Semashko, Nizhniy Novgorod, Russian Federation|Private Healthcare Institution Clinical Hospital Russian Railways - Medicine of Nizhniy Novgorod, Nizhniy Novgorod, Russian Federation|LLC ""Medicine Center SibNovoMed"", Novosibirsk, Russian Federation|LLC Novosibirsk GastroCenter, Novosibirsk, Russian Federation|Ultramed, Omsk, Russian Federation|Karelia Republican Hospital V.A. Baranova, Petrozavodsk, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|SPb SBIH ""City Mariinskaya Hospital"", Saint-Petersburg, Russian Federation|SBIH City Clinical Hospital #31, Saint-Petersburg, Russian Federation|Academician I.P. Pavlov First St-Petersburg State Medical University, St-Petersburg, Russian Federation|GOU VPO St-Petersburg SMA n/a Mechnikov Fed. Agen of Health, St. Petersburg, Russian Federation|Railway clinical hospital, St. Petersburg, Russian Federation|LLC Scientific Research Centre EKO-Bezopasnost, St. Petersburg, Russian Federation|Stavropol State Medical Academy, Stavropol, Russian Federation|SHI of Yaroslavl Region Clinical Hospital #8, Yaroslavl, Russian Federation|Clinical Center Bezanijska Kosa, Belgrade, NAP, Serbia|Clinical Center Zvezdara, Belgrade, Serbia|Clinical Center Kragujevac Gastroenterohepatology Clinic, Kragujevac, Serbia|General Hospital Dr Radivoj Simonovic, Sombor, Serbia|General Hospital Sremska Mitrovica, Sremska Mitrovica, Serbia|General Hospital ""Djordje Joanovic"", Zrenjanin, Serbia|Fakultna nemocnica s poliklinikou Roosevelta Banska Bystrica, Banska Bystrica, Slovakia|Univerzitna nemocnica Bratislava, Bratislava, Slovakia|KM Management spol. s r.o. Gastroenterologicke a hepatologicke centrum, Nitra, Slovakia|GASTRO I., s.r.o., Presova, Slovakia|Endomed, s.r.o.- Gastroenterologicka ambulancia, Vranov N. Toplou, Slovakia|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Universitario Marques De Valdecilla, Santander, Cantabria, Spain|Hospital De Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital de Sagunto, Port De Sagunto, Valencia, Spain|Instituto de Ciencias Médicas, Alicante, Spain|Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain|Hospital General Juan Ramón Jiménez, Huelva, Spain|Hospital De Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain|Hospital Universitario La Paz, Madrid, Spain|Cantonal Hospital St.Gallen, St. Gallen, Sankt Gallen, Switzerland|Inselspital Bern, Bern, Switzerland|Praxis Balsiger, Seibold & Partner und Crohn-Colitis-Zentrum, Bern, Switzerland|Universitätsspital Zürich USZ Zürich, Zürich, Switzerland|Taipei Medical University- Shuang Ho Hospital, New Taipei, Taiwan|China Medical University Hospital, Taichung, Taiwan|National Taiwan University Hospital, Taipei City, Taiwan|Antalya Training and Research Hospital, Muratpasa, Antayla, Turkey|Ege University Medicine of Faculty, Izmir, Turkey|Kocaeli University Medical Faculty Hospital, Izmit, Turkey|Mersin University, Mersin, Turkey|Ivano-Frankivsk State Medical University, Ivano-Frankivsk, Ukraine|CHI Prof.O.O.Shalimov Kharkiv City Clinical Hospital #2, Kharkiv, Ukraine|GI L.T. Malaya TI Namsu, Kharkiv, Ukraine|CI Kherson CCH, Kherson, Ukraine|ACINUS Medical and Diagnostic Center, Kropyvnytskyi, Ukraine|International Institute of Clinical Trials LLC, Kyiv, Ukraine|Medical Centre CONSILIUM MEDICAL, Kyiv, Ukraine|Communal institution of the Kyiv Regional Council ""Kyiv Regional Clinical Oncology Dispensary"", Kyiv, Ukraine|Communal institution of the Kyiv Regional Council ""Kyiv Regional Clinical Oncology Dispensary"", Kyiv, Ukraine|Communal Non-Commercial Enterprise of Lviv Regional Council Lviv Regional Clinical Hospital, Liviv, Ukraine|Lviv Clinical Hospital at Railway Transport of Division Healthcare Center PJSC Ukrainian Railway Sta, Lviv, Ukraine|Communal City Clinical Emergency Hospital, Danylo Galytskyy Lviv National Medical University, Lviv, Ukraine|Communal Enterprise ""Odesa Regional Clinical Hospital"", Odesa, Ukraine|Communal Institution ""Poltava Reg.Cl.H. n.a.M.V.Sklifosovskogo"", Poltava, Ukraine|A. Novak Transcarpathian Regional Clinical Hospital, Uzhgorod, Ukraine|Medical Center ""Health Clinic"" LLC, Vinnitsa, Ukraine|Vinnytsia RCH of Veterans of War Dept of Therapy#1 Vinnytsia M.I.Pyrogov NMU, Vinnytsia, Ukraine|Vinnytsia M.I. Pyrogov NMU Ch of internal medicine #1, Vinnytsia, Ukraine|Diaservis Ltd, Zaporizhzhia, Ukraine|Diacenter LLC, Zaporizhzhia, Ukraine|Fairfield General Hospital, Bury, Lancashire, United Kingdom|Whipps Cross University Hospital, Leytonstone, London, United Kingdom|John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom|Guys/St. Thomas Hospital, London, Surrey, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03519945"
446,"NCT04247100","A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders",,"Recruiting","No Results Available","Functional Gastrointestinal Disorders|Vagus Nerve Autonomic Disorder|Irritable Bowel Syndrome|Nausea|Dyspepsia","Device: Transcutaneous Electrical Nerve Stimulation (TENS)|Device: Sham Transcutaneous Electrical Nerve Stimulation","Change in Heart Rate Variability at 4 weeks|Change in Heart Rate Variability at 8 weeks|Change in Mitochondrial Bioenergetics measured by cellular Oxygen Consumption Rate (OCR) at 4 weeks|Change in Mitochondrial Bioenergetics measured by cellular Oxygen Consumption Rate (OCR) at 8 weeks|Change in Blood Cytokines measured by TNF α levels at 4 weeks|Change in Blood Cytokines measured by TNF α levels at 8 weeks|Functional Disability Inventory (Child and Adolescent)|Symptom Intensity Questionnaire|Pain Catastrophizing Scale (Child)|Revised Child Anxiety and Depression Scale|Functional Disability Inventory (Parent)|Pain Catastrophizing Scale (Parent)","Chelimsky, Gisela Grotewold|Medical College of Wisconsin","Female","12 Years to 18 Years   (Child, Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","1473783","September 1, 2020","September 30, 2021","September 30, 2021","January 29, 2020",,"September 16, 2020","Medical College of Wisconsin, Milwaukee, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT04247100"
447,"NCT04306939","Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study","GREAT1","Recruiting","No Results Available","Chronic Pancreatitis|Inflammatory Bowel Diseases|Hepatitis|NASH - Nonalcoholic Steatohepatitis|Acute Pancreatitis|Rheumatoid Arthritis|Diabetes Mellitus|Dyslipidemias|Multiple Sclerosis|Irritable Bowel Syndrome|Chronic Pain|Chronic Disease|Chronic Kidney Diseases|Crohn Disease|Celiac Disease|Biliary Cirrhosis|Bile Acid Synthesis Defect|Gastritis|Cholecystitis|Cholelithiases|IPMN|Cyst Pancreas|Cystic Fibrosis|Pancreatic Exocrine Insufficiency|Diarrhea Chronic|Constipation - Functional|Constipation Chronic Idiopathic","Other: venipuncture|Behavioral: Questionnaires|Other: Additional Sample Collections","Define the molecular disorders contributing to clinicopathological disease definitions for common complex disorders|Define risk factors for disease progression, severity, complications and poor quality of life.|Common disease mechanisms and repurposing of medications.|Pain profile|Patient Reported Global Health Assessment","University of Pittsburgh","All","12 Years and older   (Child, Adult, Older Adult)",,"120000","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","STUDY19020035","November 1, 2014","December 1, 2025","December 1, 2025","March 13, 2020",,"March 5, 2021","University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT04306939"
448,"NCT03078803","Fecal Transplant for Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Biological: Fecal Microbiota Transplant (FMT)|Biological: Placebo","Clinical and Endoscopic Remission|Clinical response|Clinical remission|Endoscopic response|Endoscopic remission|Quality of Life 1|Quality of Life 2|Quality of Life 3","University of Alberta|University of Calgary|McMaster University","All","18 Years and older   (Adult, Older Adult)","Phase 2","126","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","66218","March 28, 2017","March 2022","March 2023","March 13, 2017",,"May 12, 2020","Foothills Hospital, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada|McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03078803"
449,"NCT03972956","Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease",,"Recruiting","No Results Available","Colorectal Cancer|Gastric Cancer|Inflammatory Bowel Diseases|Gastric Ulcer|Hemorrhoids|Hernia","Other: No intervention will be given to patients.","Confirmation of diagnosis by pathologist","Renmin Hospital of Wuhan University","All","18 Years to 80 Years   (Adult, Older Adult)",,"1000","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","SAMPGICUS","December 23, 2020","December 23, 2023","December 23, 2026","June 4, 2019",,"March 23, 2021","Department of Gastrointestinal Surgery II, Renmin Hospital of Wuhan University, Wuhan, Hubei, China",,"https://ClinicalTrials.gov/show/NCT03972956"
450,"NCT03729674","Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs",,"Recruiting","No Results Available","Rheumatoid Arthritis|Ankylosing Spondylitis|Ulcerative Colitis|Crohn's Disease","Drug: Biosimilar|Drug: Originator (legacy) drug","Persistence on the initial treatment, measured as time in months to drug discontinuation.|Proportion of participants discontinuing/switching the initial treatment due to treatment failure or adverse events.|Time in months from cohort entry to treatment discontinuation/switching due to treatment failure or adverse events.|Proportion of participants who modified therapy during follow-up.|In RA participants, change from baseline in the Health Assessment Questionnaire-Disability Index (HAQ-DI) score at months 12, 24, and 48.|Change from baseline in the European Quality of Life-5 Dimensions (EQ-5D) score at months 12 and 24.|Proportion of RA participants achieving disease remission assessed using the Disease Activity Score 28 (DAS28).|Proportion of RA participants achieving sustained disease remission assessed using the DAS28.|Proportion of RA participants achieving low disease activity (LDA) assessed using DAS28.|Proportion of AS participants achieving an ASAS20 response|Proportion of AS participants achieving sustained remission using the Ankylosing Spondylitis Disease Activity Score (ASDAS)|Proportion of UC participants with induction of response within 3 months of initiation of treatment using the partial Mayo Score (PMS)|Proportion of UC participants with sustained response after initiation of treatment using the PMS.|Proportion of UC participants achieving clinical remission using the PMS.|Proportion of UC participants with sustained clinical remission using the PMS.|Proportion of UC participants with of loss of clinical response among responders using the PMS.|Proportion of CD participants with induction of response within 3 months of initiation of treatment using the Harvey-Bradshaw Index (HBI)|Proportion of CD participants with sustained response after initiation of treatment using the HBI.|Proportion of CD participants achieving clinical remission using the HBI.|Proportion of CD participants with sustained clinical remission using the HBI.|Proportion of CD participants with of loss of clinical response among responders using the HBI.|Change from baseline in the Short Inflammatory Bowel Disease Questionnaire (SIBDQ) score at months 12, 24, and 48 in UC and CD participants.","McGill University Health Centre/Research Institute of the McGill University Health Centre|Université de Sherbrooke|Institut de rhumatologie de Montréal|Hospital for Special Surgery, New York|University of Manitoba|University of Toronto|University of Alberta|University of British Columbia|Alberta Health Services|McMaster University|The Arthritis Program Research Group","All","18 Years and older   (Adult, Older Adult)",,"800","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","MP-37-2019-4560","November 26, 2018","March 30, 2021","December 31, 2022","November 5, 2018",,"June 2, 2020","McGill University Health Centre at Montreal General Hospital, Montreal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT03729674"
451,"NCT04014413","Safety and Efficacy of Fecal Microbiota Transplantation",,"Recruiting","No Results Available","Crohn Disease|Ulcerative Colitis|Celiac Disease|Irritable Bowel Syndrome|Functional Dysphonia|Constipation|Clostridium Difficile Infection|Diabetes Mellitus|Obesity|Multidrug -Resistant Infection|Hepatic Encephalopathy|Multiple Sclerosis|Pseudo-Obstruction|Carbapenem-Resistant Enterobacteriaceae Infection|Vancomycin Resistant Enterococci Infection|Multiple Organ Dysfunction Syndrome|Dysbiotic Bowel Syndrome|MRSA Enteritis|Pseudomembranous Enterocolitis|Alopecia|Autism|Graft-versus-host Disease|Idiopathic Thrombocytopenic Purpura|Atopy or Allergy|Liver Disease|Alcohol Dependence|Psoriatic Arthropathy","Procedure: Fecal Microbiota Transplantation","The efficacy of FMT in treating dysbiosis-associated disorder will be assessed by number of patients who have improvement in clinical symptoms (depends on each disease as stated in outcome)|Number of Participants With Treatment-Related Adverse Events as Assessed by CTCAE v4.0","Chinese University of Hong Kong","All","Child, Adult, Older Adult","Not Applicable","450","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","FMT-Pilot","July 15, 2019","October 31, 2023","October 31, 2024","July 10, 2019",,"April 22, 2020","The Chinese University of Hong Kong, Hong Kong, Shatin, Hong Kong",,"https://ClinicalTrials.gov/show/NCT04014413"
452,"NCT03700593","Feasibility and Safety of Single Port Robot in Colorectal Procedures",,"Enrolling by invitation","No Results Available","Colon Cancer|Colon Polyp|Rectal Cancer|Diverticulitis|Prolapse, Rectal|Rectal Polyp|Inflammatory Bowel Diseases","Device: Single Port Robotic Colorectal Surgery","Feasibility of the SP robot|Rate of postoperative complications and mortality of the SP robot|Assessment of patients quality of life using validated questionnaires.|Assessment of patients' satisfaction with their surgical scars using validated questionnaires.|Assessment of patient's quality of recovery|Assessment of patients' postoperative body image satisfaction","Marks Colorectal Surgical Associates","All","18 Years to 95 Years   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","F/N-R19-3864L","October 15, 2018","October 1, 2020","December 31, 2020","October 9, 2018",,"February 19, 2020","Lankenau Medical Center, Marks Colorectal Surgical Associates, Wynnewood, Pennsylvania, United States","""Study Protocol and Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/93/NCT03700593/Prot_ICF_000.pdf","https://ClinicalTrials.gov/show/NCT03700593"
453,"NCT03669822","Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC)","MASCC","Recruiting","No Results Available","Ulcerative Colitis","Other: Standard of care","Inpatient response to medical management|Long-term response to medical management","Johns Hopkins University|Massachusetts General Hospital|University of Maryland, College Park|University of North Carolina, Chapel Hill|Icahn School of Medicine at Mount Sinai","All","18 Years to 80 Years   (Adult, Older Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IRB00174643","November 10, 2018","December 31, 2021","December 31, 2022","September 13, 2018",,"December 11, 2020","Joanna Melia, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT03669822"
454,"NCT03281304","A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission",,"Active, not recruiting","Has Results","Ulcerative Colitis","Drug: CP-690,500 5 mg|Drug: CP-690,550 10 mg","Number of Participants With Remission Based on Modified Mayo Score at Month 6|Kaplan-Meier Estimated Rate at Month 6 for Time to Loss of Remission Based on Modified Mayo Score|Number of Participants With Remission Based on Modified Partial Mayo Score at Months 1, 3 and 6|Number of Participants With Remission Based on Total Mayo Score at Month 6|Number of Participants With Remission Based on Partial Mayo Score at Months 1, 3 and 6|Change From Baseline in Modified Mayo Score at Month 6|Change From Baseline in Modified Partial Mayo Score at Months 1, 3 and 6|Change From Baseline in Total Mayo Score at Month 6|Change From Baseline in Partial Mayo Score at Months 1, 3 and 6|Number of Participants With Mucosal Healing at Month 6|Number of Participants With Clinical Response Based on Mayo Score at Month 6|Change From Baseline in Fecal Calprotectin at Months 1, 3 and 6|Change From Baseline in High Sensitivity C-Reactive Protein (Hs-CRP) Level at Months 1, 3 and 6|Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)|Number of Participants With Serious Infections|Number of Participants With Clinical Laboratory Abnormalities|Number of Participants With Vital Sign Abnormalities|Number of Participants With Clinically Significant Physical Examinations Abnormalities|Number of Participants With Opportunistic Infections, All Malignancy, Gastrointestinal Perforation and Cardiovascular Events Adjudicated by Adjudication Committee","Pfizer","All","18 Years and older   (Adult, Older Adult)","Phase 4","141","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","A3921288|RIVETING STUDY|2017-002274-39","November 16, 2017","February 14, 2020","March 8, 2023","September 13, 2017","April 15, 2021","April 27, 2021","Surgicare of Mobile, Mobile, Alabama, United States|Alabama Medical Group, P.C., Mobile, Alabama, United States|Clinical Applications Laboratories, Inc., San Diego, California, United States|Bristol Hospital, Bristol, Connecticut, United States|Connecticut Clinical Research Institute, Bristol, Connecticut, United States|Central Connecticut Endoscopy Center, Plainville, Connecticut, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Florida Medical Clinic, P.A., Zephyrhills, Florida, United States|Cotton-O'Neil Clinical Research Center, Digestive Health, Topeka, Kansas, United States|Chevy Chase Endoscopy Center, Chevy Chase, Maryland, United States|MGG Group Co., Inc., Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Eastside Endoscopy Center, Macomb, Michigan, United States|Center for Digestive Health, Troy, Michigan, United States|Surgical Centers of Michigan, Troy, Michigan, United States|NYU Langone Long Island Clinical Research Associates, Lake Success, New York, United States|Columbia University Irving Medical Center, New York, New York, United States|Columbia University Medical Center Research Pharmacy/ Milstein Hospital, New York, New York, United States|Great Lakes Gastroenterology Research, LLC, Mentor, Ohio, United States|Memorial Hermann Hospital, Houston, Texas, United States|The University of Texas Health Science Center at Houston (UTHealth)- McGovern Medical School, Houston, Texas, United States|Christus Trinity Mother Frances Endoscopy Center, Tyler, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Wasatch Clinical Research, LLC, Salt Lake City, Utah, United States|Alpine Medical Group, Salt Lake City, Utah, United States|UZ Leuven (University Hospital Leuven), Campus Gasthuisberg, Leuven, Belgium|London Health Sciences Centre - University Hospital, London, Ontario, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada|Ustavni lekarna Nemocnice Strakonice, a.s., Strakonice, Czechia|CHU de Nantes - Hotel Dieu-Service d'Hepato-Gastroenterologie, Nantes, France|CHU de Bordeaux Hopital Haut Leveque, Pessac, France|Universitaetsklinikum Schleswig-Holstein, Kiel, Germany|Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz Endoszkopos Laboratorium, Gyula, Bekes, Hungary|Szent Janos Korhaz és Eszak-budai Egyesitett Korhazak, Budapest, Hungary|Pannonia Maganorvosi Centrum Kft., Budapest, Hungary|Università ""Magna Graecia"" di Catanzaro, Catanzaro, CZ, Italy|Aichi Medical University Hospital, Nagakute, Aichi, Japan|Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan|Kurume University Hospital, Kurume, Fukuoka, Japan|Hokkaido P.W.F.A.C Sapporo-Kosei General Hospital, Sapporo, Hokkaido, Japan|Osaka Medical and Pharmaceutical University Hospital, Takatsuki-shi, Osaka, Japan|Shiga University of Medical Science Hospital, Otsu, Shiga, Japan|Tokyo Medical And Dental University Hospital, Faculty of Medicine, Bunkyo-ku, Tokyo, Japan|Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan|Kitasato University Kitasato Institute Hospital, Minato-ku, Tokyo, Japan|Showa University Hospital, Shinagawa-ku, Tokyo, Japan|Toho University Sakura Medical Center, Chiba, Japan|Hiroshima University Hospital, Hiroshima, Japan|Osaka City University Hospital, Osaka, Japan|Keio University Hospital, Tokyo, Japan|Hanyang University Guri Hospital, Gyeonggi-do, Korea, Republic of|Kyung Hee University Hospital, Seoul, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of|Academic Medical Centre, Amsterdam, Netherlands|North Shore Hospital (Waitemata District Health Board), Auckland, New Zealand|Christchurch Hospital (Canterbury District Health Board), Christchurch, New Zealand|Southern District Health Board, Dunedin, New Zealand|Endoskopia Sp. z o.o., Sopot, Poland|Lexmedica, Wroclaw, Poland|Federal State Budgetary Institution ""State Scientific Centre of Coloproctology, Moscow, Russian Federation|LLC Novosibirskiy Gastrocenter, Novosibirsk, Russian Federation|Federal State Budgetary Scientific Institution ""Scientific Research Institute of Physiology, Novosibirsk, Russian Federation|Clinical Centre of Serbia, Clinic for Gastroenterology and Hepatology, Belgrade, Serbia|Clinical Hospital Centre Zvezdara, Belgrade, Serbia|Military Medical Academy, Clinic for Gastroenterology and Hepatology, Belgrade, Serbia|Clinical Centre of Kragujevac, Kragujevac, Serbia|General Hospital ""Djordje Joanovic"", Zrenjanin, Serbia|Medak s.r.o., Bratislava, Slovakia|KM Management spol. s.r.o., Nitra, Slovakia|Gastro I., s.r.o., Gastroenterologicka ambulancia, Presov, Slovakia|Kingsbury Hospital, Claremont, Cape Town, South Africa|Wits Clinical Research (WCR) Bara Site, Chris Hani Baragwanath Academic Hospital, Soweto, Johannesburg, Gauteng, South Africa|Chris Hani Baragwanath Academic Hospital, Soweto, Johannesburg, South Africa|Endocare Research Centre, Paarl, Western CAPE, South Africa|Panorama Mediclinic, Panorama, Western CAPE, South Africa|Hospital Clinic de Barcelona, Barcelona, Spain|Regional Municipal Non-Profit Enterprise ""Chernivtsi Regional Clinical Hospital"" Surgery Departm, Chernivtsi, Ukraine|Kyiv Municipal Clinical Hospital #18, Kyiv, Ukraine|MI Uzhgorod Regional Hospital, Uzhgorod, Ukraine|Vinnytsia Regional Clinical Hospital for War Veterans,, Vinnytsia, Ukraine|University Hospitals Bristol NHS Foundation Trust, Bristol, Avon, United Kingdom","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/04/NCT03281304/Prot_001.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/04/NCT03281304/SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03281304"
455,"NCT04741087","Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis","FILLMORE","Recruiting","No Results Available","Pouchitis","Drug: AMT-101 (oral)-Dose A|Drug: AMT-101 (oral)-Dose B","Stool Frequency Response|Histologic Healing|Histologic Response|Change in Endoscopic Score|Change in Stool Frequency","Applied Molecular Transport","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","20","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","AMT-101-201","February 5, 2021","March 31, 2022","June 30, 2022","February 5, 2021",,"July 2, 2021","Connecticut Clinical Research Institute, Bristol, Connecticut, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Mayo Clinic, Rochester, Minnesota, United States|Gastrointestinal Associates - Jackson, Flowood, Mississippi, United States|University of North Carolina GI, Chapel Hill, North Carolina, United States|Gastro One, Germantown, Tennessee, United States|Gastrointestinal Asssociates- GIA Clinical Trials, LLC, Knoxville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|University of Utah Health Sciences Center, Salt Lake City, Utah, United States|Washington Gastroenterology, Tacoma, Tacoma, Washington, United States|UZ Leuven - University Hospital Gasthuisberg, Leuven, Belgium|Groupe santé CHC / Clinique du MontLégia, Liege, Liège, Belgium|GI Research Institute, Vancouver, British Columbia, Canada|CHU Saint Etienne - Hopital Nord, St Priest en Jarez, France|CHU de Toulouse - Hôpital Rangueil, Toulouse, France|CHRU Nancy - Hopital de Brabois, Vandœuvre-lès-Nancy, France|Praxis fur Gastroenterologie am Bayerischen Platz, Berlin, Germany|Klinik für Innere Medizin KIM IV, Jena, Germany|UKSH Universitätsklinikum Schleswig-Holstein, Kiel, Germany|Semmelweis Egyetem I. sz Belgyogyaszati Klinika, Budapest, Hungary|ETZ - Elisabeth, Tilburg, Netherlands|Hospital Universitario y Politecnico La Fe de Valencia, Valencia, Spain|Clarunis Bauchzentrum, Basel, Switzerland|MAC Clinical Research - Blackpool, Blackpool, Lancashire, United Kingdom|MAC Clinical Research - Liverpool, Prescot, Liverpool, United Kingdom|MAC Clinical Research - Cannock, Cannock, South Staffordshire, United Kingdom|MAC Clinical Research - Leeds, Leeds, West Yorkshire, United Kingdom|MAC Clinical Research - Manchester, Manchester, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04741087"
456,"NCT00790543","Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease","RS","Active, not recruiting","No Results Available","Crohn's Disease",,"Identify demographic, clinical, microbial, genetic, and/or immunologic risk factors influencing the likelihood of rapid development of complicated disease phenotypes manifested as penetrating or stricturing disease and need for surgery.|Develop and validate risk stratification by stratifying patients into different levels of risk at diagnosis based on clinical, demographic, host microbial ecology, immune, and genetic determinants.","Emory University|Crohn's and Colitis Foundation","All","up to 16 Years   (Child)",,"1813","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IRB00012206","November 2008","December 2020","December 2020","November 13, 2008",,"July 23, 2020","Cedars-Sinai Medical Center, Los Angeles, California, United States|UCLA Medical Center, Los Angeles, California, United States|University of California at San Francisco, San Francisco, California, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Nemours Children's Clinic, Jacksonville, Florida, United States|Emory-Children's Center - Emory University School of Medicine, Atlanta, Georgia, United States|Children's Center for Digestive Healthcare, Atlanta, Georgia, United States|The University of Chicago, Chicago, Illinois, United States|Riley Children's Hospital - Indiana University School of Medicine, Indianapolis, Indiana, United States|Johns Hopkins Children's Center, Baltimore, Maryland, United States|Children's Hospital Boston - Harvard Medical School, Boston, Massachusetts, United States|Goryeb Children's Hospital - Atlantic Health System, Morristown, New Jersey, United States|The Research Foundation of SUNY on behalf of the University at Buffalo, Buffalo, New York, United States|Cohens (Schneider) Children's Hospital, New Hyde Park, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh - University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States|Children's Medical Center, Dallas, Texas, United States|BCM Texas Children's Hospital - Houston, Houston, Texas, United States|Primary Children's Medical Center - University of Utah, Salt Lake City, Utah, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|IWK Health Centre, Halifax, Nova Scotia, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|The Hospital for Sick Children - Sickkids, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT00790543"
457,"NCT04191395","Evolution and Treatments of Chronic Inflammatory Systemic Diseases","MISTIC","Recruiting","No Results Available","Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease|Arthritis, Rheumatoid|Spondyloarthritis|Psoriatic Arthritis",,"Diagnosis of a second inflammatory disease","Centre Hospitalier Universitaire de Besancon","All","18 Years and older   (Adult, Older Adult)",,"3000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","P/2019/433","December 11, 2019","December 2029","December 2029","December 9, 2019",,"January 27, 2020","Charline Vauchy, Besançon, France",,"https://ClinicalTrials.gov/show/NCT04191395"
458,"NCT03823742","Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?",,"Recruiting","No Results Available","Irritable Bowel Syndrome|Functional Abdominal Pain Syndrome|Functional Gastrointestinal Disorders|Functional Bowel Disorder|Functional Abdominal Pain|Functional Abdominal Pain Disorders","Other: Cognitive Behavioral Therapy|Other: Low FODMAP Diet","Symptom Improvement|Improvement in quality of life","Baylor College of Medicine|University of Washington","All","7 Years to 12 Years   (Child)","Not Applicable","250","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","H-43391","February 22, 2019","September 2022","March 2023","January 30, 2019",,"December 9, 2020","Children's Nutrition Research Center, Houston, Texas, United States|Texas Children's Hospital, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03823742"
459,"NCT04263831","LOW DOSE IL-2 FOR THE TREATMENT OF CROHN'S DISEASE",,"Recruiting","No Results Available","Crohn Disease","Drug: Interleukin-2 (aldesleukin).","Number of subjects with serious and non-serious adverse events.|Maximum effective dose|Clinical Response|Immunological Response","Boston Children's Hospital","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 1|Phase 2","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB-P00032653","March 11, 2021","December 31, 2023","December 31, 2024","February 11, 2020",,"April 5, 2021","Boston Children's Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04263831"
460,"NCT03747718","Randomized Trial Comparing Single vs. Maintenance Fecal Microbiota Transplant for Refractory Crohn's Disease in Children",,"Not yet recruiting","No Results Available","Crohn Disease","Biological: Fecal Microbiota Transplantation|Other: Placebo","Safety as assessed by Adverse events|Efficacy as assessed by Physician Global Assessment (PGA)|Efficacy as assessed by PCDAI (Pediatric crohn's disease Activity Index)analysis|Response as assessed by fecal calprotectin|Response as assessed by fecal microbiota changes","Stanford University","All","2 Years to 25 Years   (Child, Adult)","Phase 1","30","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","CMH-17010048","December 1, 2022","December 1, 2024","December 1, 2025","November 20, 2018",,"March 17, 2021","Stanford University, Palo Alto, California, United States",,"https://ClinicalTrials.gov/show/NCT03747718"
461,"NCT04065048","A Dietary Intervention Study on the Microbiome in Crohn's Disease Patients",,"Recruiting","No Results Available","Crohn Disease","Other: Soy based diet|Other: Non-soy based diet","Maintenance of Symptomatic Remission, without worsening of any existing disease activity during study period|Changes to Functional Composition of Gut Microbiota|Proportion of subjects who continue diet following completion of study","Case Western Reserve University|University of California, Davis|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|University Hospitals Cleveland Medical Center","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","60","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","09411|1P30DK097948","November 1, 2019","December 30, 2021","February 15, 2022","August 22, 2019",,"December 17, 2020","University Hospitals Digestive Health Institute, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT04065048"
462,"NCT03508193","Reverse Engineering of Exclusive Enteral Nutrition","RE-EEN","Recruiting","No Results Available","Crohn Disease","Other: Nutritional therapy","Fecal calprotectin <250 micrograms/gram|Quality of life as measured by IMPACT III Questionnaire","Dale Lee|Seattle Children's Hospital","All","8 Years to 21 Years   (Child, Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","STUDY00000619","November 4, 2017","December 2021","December 2021","April 25, 2018",,"November 4, 2020","Seattle Children's Hospital, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT03508193"
463,"NCT03938324","Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions","PiCASO","Recruiting","No Results Available","Sickle Cell Disease|Chronic Kidney Diseases|Systemic Lupus Erythematosus|Childhood Cancer|Inflammatory Bowel Diseases|Asthma|Stem Cell Transplant|Organ Transplant|Diabetes Mellitus, Type 1","Behavioral: PiCASO Intervention Group|Behavioral: Sham Comparator: Attention Control Group","Change in Self-management as measured by the Partners in Health Scale|Change in Patient activation as measured by the Patient Activation Measure (PAM-13)|Change in Transition Readiness as measured by the Transition Readiness Questionnaire (TRAQ 20)|Change in Health-related Quality of Life as measured by the Short Form Health Survey (SF12)|Change in Emotional Health as measured by the Brief Symptom Inventory (BSI 18)","Duke University|National Institutes of Health (NIH)|National Institute of Nursing Research (NINR)","All","16 Years to 22 Years   (Child, Adult)","Not Applicable","225","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","Pro00102191|1R01NR018379-01","October 29, 2019","February 29, 2024","February 29, 2024","May 6, 2019",,"June 24, 2021","Duke University, Durham, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03938324"
464,"NCT04667611","Patient-reported Outcome Measures (PROMs) in Patients With Bodily Stress Syndrome: Protocol for a Prospective Cohort Study","SYMPA","Recruiting","No Results Available","Fibromyalgia|Irritable Bowel Syndrome|Somatic Symptom|Chronic Fatigue Syndrome|Fatigue|Dysphagia|Exhaustion; Syndrome","Behavioral: Psychosocial interventions","Self-rated global health improvement|Functional ability|PHQ-9|GAD-7|EUROHIS-QOL-8|15D|SSD-12|RS-14","Helsinki University Central Hospital","All","18 Years to 80 Years   (Adult, Older Adult)",,"400","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","1159007","March 9, 2020","December 2022","December 2023","December 16, 2020",,"December 16, 2020","Clinic for Functional Disorders, Helsinki University Hospital, Helsinki, Finland",,"https://ClinicalTrials.gov/show/NCT04667611"
465,"NCT04188990","Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition",,"Recruiting","No Results Available","Pancreatitis, Acute|Crohn Disease|Ulcerative Colitis|Inflammatory Bowel Diseases|Pancreatic Cancer|Esophagus Cancer|Gastric Cancer|Colorectal Cancer","Dietary Supplement: Nutritional dietary intervention|Dietary Supplement: By demand|Dietary Supplement: Usual current care","Mean weight changes|Mean length of stay|Mortality rate|Number of Participants with complications|Number of Participants with Hospital readmissions|Other health care resources use|Number of Participants with Adverse effects of the nutrition program|Costs|Health-related quality of life (HRQoL) changes|Patient's functional status","Hospital Galdakao-Usansolo","All","18 Years and older   (Adult, Older Adult)","Not Applicable","900","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","PI18/00698","June 15, 2020","June 30, 2022","December 31, 2022","December 6, 2019",,"February 16, 2021","Hospital Universitario Donostia, Donostia / San Sebastián, Spain|Hospital Galdakao-Usansolo, Galdakao, Spain",,"https://ClinicalTrials.gov/show/NCT04188990"
466,"NCT01280825","The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing",,"Recruiting","No Results Available","Patients Undergoing Routine Health Care|Heart Diseases|Inflammatory Bowel Diseases|Autoimmune Disease|Inflammatory Disease|Blood Coagulation Disorders|Hepatitis C|Non-Metastatic Neoplasm",,"Feasibility of incorporating pharmacogenomic testing into routine medical care|Find out whether availability of pharmacogenomic information impacts drug decision making in the health care setting","University of Chicago","All","18 Years and older   (Adult, Older Adult)",,"1200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","10-487-A","January 14, 2011","November 14, 2022","December 14, 2022","January 21, 2011",,"January 7, 2021","University of Chicago Medical Center, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT01280825"
467,"NCT03456206","Chronic Inflammatory Disease, Lifestyle and Risk of Disease","PROCID-DCH","Active, not recruiting","No Results Available","Autoimmune Diseases|Inflammatory Bowel Diseases|Crohn Disease (CD)|Ulcerative Colitis (UC)|Arthritis, Rheumatoid (RA)|Spondylarthropathies|Arthritis, Psoriatic (PsA)|Psoriasis (PsO)|Multiple Sclerosis (MS)","Other: Intake of red and processed meat and fibres|Other: Lifestyle factors independently or combined","CID diagnosis","University of Southern Denmark|Hospital of Southern Jutland|Odense Patient Data Explorative Network|University of Aarhus|Danish Cancer Society","All","50 Years to 64 Years   (Adult)",,"57053","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","PROCID-DCH","November 10, 2018","September 1, 2020","May 1, 2023","March 7, 2018",,"November 10, 2020","University of Southern Denmark, Odense, Denmark",,"https://ClinicalTrials.gov/show/NCT03456206"
468,"NCT03813862","Observational Pharmaco-Epidemiology Research & Analysis","OPERA","Recruiting","No Results Available","Chronic Disease|HIV/AIDS|Liver Diseases|Inflammatory Bowel Diseases|Cardiovascular Diseases|Rheumatic Diseases|Neurodegenerative Diseases","Other: Non-interventional (observational only)","Virologic response to therapy","Epividian","All","Child, Adult, Older Adult",,"2000000","Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","Pro00023648","December 1, 2013","November 2027","November 2027","January 23, 2019",,"January 24, 2019","Epividian, Durham, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03813862"
469,"NCT04631965","Healthcare Transition of Adolescents With Chronic Health Conditions",,"Active, not recruiting","No Results Available","Transition|Diabetes|Kidney Diseases|Liver Diseases|Inflammatory Bowel Diseases|Rheumatic Diseases|Congenital Heart Disease|Neurologic Disorder","Behavioral: Transition support service","Change in 16D health-related quality of life|Change in PedsQL health-related quality of life|Change in health status|Change in anxiety related to transition of care|Missed appointments|Emergency admissions|Change in educational status|Change in employment status","University of Helsinki|Pediatric Research Center|Foundation for Medical Research|Foundation for Paediatric Research, Finland|The Paulo Foundation|Royal Children's Hospital|Murdoch Childrens Research Institute|University of Melbourne","All","15 Years to 20 Years   (Child, Adult)",,"503","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","U1011SILTA","September 1, 2017","December 2021","December 2023","November 17, 2020",,"November 17, 2020","Royal Children's Hospital, Melbourne, Victoria, Australia|Pediatric Research Center, Helsinki, Uusimaa, Finland",,"https://ClinicalTrials.gov/show/NCT04631965"
470,"NCT04751396","Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors",,"Not yet recruiting","No Results Available","Ankylosing Spondylitis|Autoimmune Disease|Crohn Disease|Enteropathic Arthritis|Enteropathic Spondylitis|Inflammatory Bowel Disease|Melanoma|Psoriasis|Psoriatic Arthritis|Reactive Arthritis|Rheumatoid Arthritis|Systemic Lupus Erythematosus|Ulcerative Colitis","Other: Best Practice|Other: Educational Intervention|Other: Interview|Other: Questionnaire Administration|Other: Survey Administration","Decisional conflict scale|Knowledge|Acceptability|Usability|Depression|Anxiety|Stress|CollaboRATE measure|Shared decision-making process survey|Patient's perception of usefulness of the tool","M.D. Anderson Cancer Center|National Cancer Institute (NCI)","All","18 Years and older   (Adult, Older Adult)",,"125","Other|NIH","Observational","Observational Model: Cohort|Time Perspective: Prospective","2020-0843|NCI-2021-00565|K08CA237619","May 30, 2021","April 15, 2025","April 15, 2025","February 12, 2021",,"March 10, 2021","M D Anderson Cancer Center, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT04751396"
471,"NCT03816345","Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer",,"Recruiting","No Results Available","Advanced Malignant Solid Neoplasm|Autoimmune Disease|Crohn Disease|Dermatomyositis|Hematopoietic and Lymphoid Cell Neoplasm|Inflammatory Bowel Disease|Metastatic Malignant Solid Neoplasm|Multiple Sclerosis|Rheumatoid Arthritis|Sjogren Syndrome|Systemic Lupus Erythematosus|Systemic Scleroderma|Ulcerative Colitis|Unresectable Malignant Solid Neoplasm","Biological: Nivolumab","Incidence of adverse events|Change in disease assessments|Overall response rate|Changes in serum chemokines and circulating immune cells over time|Gene expression in normal tissues|Clinical measures of interest","National Cancer Institute (NCI)","All","18 Years and older   (Adult, Older Adult)","Phase 1","312","NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","NCI-2019-00241|10204|UM1CA186688","April 4, 2019","August 31, 2022","August 31, 2022","January 25, 2019",,"June 25, 2021","Stanford Cancer Institute Palo Alto, Palo Alto, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Smilow Cancer Center/Yale-New Haven Hospital, New Haven, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|University of Kansas Clinical Research Center, Fairway, Kansas, United States|HaysMed University of Kansas Health System, Hays, Kansas, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Olathe Health Cancer Center, Olathe, Kansas, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States|University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas, United States|Ascension Via Christi - Pittsburg, Pittsburg, Kansas, United States|Salina Regional Health Center, Salina, Kansas, United States|University of Kansas Health System Saint Francis Campus, Topeka, Kansas, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|Truman Medical Centers, Kansas City, Missouri, United States|University of Kansas Cancer Center - North, Kansas City, Missouri, United States|University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States|University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, United States|Siteman Cancer Center at Christian Hospital, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT03816345"
472,"NCT03285230","The French E3N Prospective Cohort Study","E3N","Active, not recruiting","No Results Available","Breast Cancer|Colo-rectal Cancer|Parkinson Disease|Asthma|Diabetes|Inflammatory Bowel Diseases|Melanoma|Endometriosis|Thyroid Cancer|Hypertension|Endometrial Cancer|Crohn Disease|Depression|Cardiovascular Diseases",,"Anthropometric measurements|Educational level|Professional activity|Age at cessation of activity|Menstrual factors|Reproductive history|Menopause|Hormonal Treatments|Tobacco consumption|Alcohol consumption|Physical activity|Diet questionnaire|Family history of diseases|Medication use|Medical and surgical history|Mental Health|Health outcomes","Institut National de la Santé Et de la Recherche Médicale, France|Université Paris-Sud|Gustave Roussy, Cancer Campus, Grand Paris|Ligue contre le cancer, France","Female","40 Years and older   (Adult, Older Adult)",,"100000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","C 95-01","June 15, 1990","November 15, 1991","December 15, 2025","September 15, 2017",,"September 19, 2017",,,"https://ClinicalTrials.gov/show/NCT03285230"
473,"NCT03944447","Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19","OMNI-Can","Recruiting","No Results Available","Chronic Pain|Chronic Pain Syndrome|Chronic Pain Due to Injury|Chronic Pain Due to Trauma|Fibromyalgia|Seizures|Hepatitis C|Cancer|Crohn Disease|HIV/AIDS|Multiple Sclerosis|Traumatic Brain Injury|Sickle Cell Disease|Post Traumatic Stress Disorder|Tourette Syndrome|Ulcerative Colitis|Glaucoma|Epilepsy|Inflammatory Bowel Diseases|Parkinson Disease|Amyotrophic Lateral Sclerosis|Chronic Traumatic Encephalopathy|Anxiety|Depression|Insomnia|Autism|Opioid-use Disorder|Bipolar Disorder|Covid19|SARS-CoV Infection|COVID-19|Corona Virus Infection|Coronavirus","Drug: Cannabis, Medical","Prevention of COVID-19|Treatment of COVID-19|Treatment of Symptoms|Cannabis Impact on Quality of Life|Cannabis Route and Dosing|Monitoring Adverse Events","OMNI Medical Services, LLC|OMNI Medical Services Inc","All","7 Years and older   (Child, Adult, Older Adult)","Phase 2","200000","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Pro00033337","December 1, 2018","December 31, 2025","December 31, 2025","May 9, 2019",,"December 9, 2020","OMNI Medical Services, Boca Raton, Florida, United States|OMNI Medical Services, Bradenton, Florida, United States|OMNI Medical Services, Fort Lauderdale, Florida, United States|OMNI Medical Services, Fort Myers, Florida, United States|OMNI Medical Services, Gainesville, Florida, United States|OMNI Medical Services, Merritt Island, Florida, United States|OMNI Medical Services, Miami, Florida, United States|OMNI Medical Services, Ocoee, Florida, United States|OMNI Medical Services, Pensacola, Florida, United States|OMNI Medical Services, Pompano Beach, Florida, United States|OMNI Medical Services, Tampa, Florida, United States|OMNI Medical Services, Wesley Chapel, Florida, United States|OMNI Medical Services, Beechwood, Ohio, United States|OMNI Medical Services, Bowling Green, Ohio, United States|OMNI Medical Services, Sandusky, Ohio, United States|OMNI Medical Services, Toledo, Ohio, United States|OMNI Medical Services, Toledo, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT03944447"
474,"NCT03228095","Volatiles in Breath and Headspace Analysis - Diagnostic Markers","Volatolome","Enrolling by invitation","No Results Available","Tuberculosis|Gastric Cancer|Peptic Ulcer|Atrophic Gastritis|Intestinal Metaplasia|Gastric Dysplasia|Colorectal Cancer|Colorectal Polyp|Colorectal Adenoma|Pancreatic Cancer|Pancreatitis, Chronic|Liver Cancer|Liver Cirrhosis|Flu, Human|Other Infectious Diseases|Inflammatory Bowel Diseases","Diagnostic Test: VOC detection in breath and in skin headspace|Diagnostic Test: Breath sampling|Procedure: Upper endoscopy with biopsies|Procedure: Colonoscopy with biopsies|Procedure: Whole blood/ Plasma / serum sampling|Diagnostic Test: Faecal sampling|Procedure: Histological examination of surgical specimen|Diagnostic Test: Headspace analysis for biological material","Specific VOC detected|Performance of nanoarray sensor testing to detect target lesions and diseases|Specific VOC patterns for target disease or lesion and risk groups|VOC pattern changes following treatment|VOC pattern changes in relapse of disease for early recognition and treatment|Groups of gastrointestinal microbiota correlating to VOCs","University of Latvia|Technion, Israel Institute of Technology|Riga East University Hospital|JLM Innovation GmbH","All","18 Years and older   (Adult, Older Adult)",,"3000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2017/20329","July 24, 2017","December 20, 2019","December 31, 2025","July 24, 2017",,"August 21, 2018","University of Latvia, Riga, Latvia",,"https://ClinicalTrials.gov/show/NCT03228095"
475,"NCT03844412","Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments",,"Recruiting","No Results Available","Vestibulodynia|Temporomandibular Disorder|Fibromyalgia Syndrome|Irritable Bowel Syndrome|Migraines|Tension Headache|Endometriosis|Interstitial Cystitis|Back Pain|Chronic Fatigue Syndrome","Drug: 5% lidocaine/5 mg/ml 0.02% estradiol compound cream|Drug: Nortriptyline|Drug: Placebo cream|Drug: Placebo pill","Change in pain score during the tampon test|Change in self-reported pain via the Short Form- McGill Pain Questionnaire (SF-MPQ)|Change in self-reported physical/mental health via SF-12 Health Survey (SF12v2)|Change in sexual health via Patient-Reported Outcomes Measurement Information System (PROMIS)|Change in inflammation as measured by cytokine expression levels|Change in regulators of pro-pain and pro-inflammatory genes, as measured by microRNA expression levels|Change in pain level as measured by Vaginal Vestibule Pressure Pain Intensities (PPI)|Levator Muscle Complex Pressure Pain Thresholds (PPTs)|Change in pain level as measured by Remote Bodily PPTs|Change in degree of overlapping pain, as measured by COPC follow-up survey|Change in mood as measured by the Symptom Checklist-27 (SCL-27)|Change in somatic awareness via Pennebaker Index of Limbic Languidness (PILL)|Change in perceived stress via Perceived Stress Scale (PSS)|Change in sleep as measured by the sleep scale|Change in in pain score during the tampon test at other time points|Change in in pain score via the SF-MPQ at other time points|Change in self-reported health on the SF12v2 at other time points|Change in self-reported health on the PROMIS at other time points|Change in cytokine biomarkers at other time points|Change in microRNA biomarkers at other time points","Duke University|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","Female","18 Years to 50 Years   (Adult)","Phase 2","400","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Pro00100678|1R01HD096331-01","November 4, 2019","October 1, 2022","December 1, 2022","February 18, 2019",,"November 5, 2020","University of California, Los Angeles, Los Angeles, California, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03844412"
476,"NCT04014517","Effect of Peri-operative Immunonutrition on Recurrence and Infections in Crohn's Disease Patients","EPIRIC","Not yet recruiting","No Results Available","Crohn Disease","Other: Standard of Care|Dietary Supplement: Immunonutrition","Post-operative infective complications rate|6 months endoscopic recurrence|6 months nutritional status|30 days quality of life|90 days quality of life|6 months quality of life","Istituto Clinico Humanitas","All","18 Years and older   (Adult, Older Adult)","Not Applicable","350","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","2019-001","March 1, 2020","March 1, 2022","October 1, 2022","July 10, 2019",,"November 27, 2019",,,"https://ClinicalTrials.gov/show/NCT04014517"
477,"NCT02868983","Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems","IBHPC","Active, not recruiting","No Results Available","Arthritis|Asthma|Chronic Obstructive Lung Disease|Diabetes|Heart Failure|Hypertension|Anxiety|Chronic Pain|Depression|Fibromyalgia|Insomnia|Irritable Bowel Syndrome|Problem Drinking|Substance Use Disorder","Other: Integration","PROMIS-29 v2|CAHPS 12-Month PCMH Adult Questionnaire 2.0|Consultation and Relational Empathy measure|Patient Activation Measure-13|Modified Self-reported Medication-taking Scale|Patient Report of Utilization|Restricted Activity Days|Duke Activity Status Index|Hgb A1C|30-day use|Global Appraisal of Individual Needs - Short Screener|Systolic blood pressure|Asthma Symptom Utility Index","University of Vermont|Arizona State University|State University of New York at Buffalo|Case Western Reserve University|DARTNet|National Committee for Quality Assurance|University of Massachusetts, Worcester","All","18 Years and older   (Adult, Older Adult)","Not Applicable","4025","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","WLPS-1409-24372","April 2016","April 2021","April 2021","August 16, 2016",,"January 29, 2021","University of Vermont, Burlington, Vermont, United States",,"https://ClinicalTrials.gov/show/NCT02868983"
478,"NCT04506593","Indiana University Gastrointestinal Motility Diagnosis Registry",,"Recruiting","No Results Available","Eosinophilic Esophagitis|Gastroesophageal Reflux Disease (GERD)|Gastroparesis|Functional Vomiting|Irritable Bowel Syndrome (IBS)|Constipation|Chronic Intestinal Pseudo-obstruction|Fecal Incontinence|Small Intestinal Bacterial Overgrowth","Other: no intervention","Identification of patients by accurate motility diagnosis|Patient Reported Outcome (PRO) Measurements in Patients with Small Intestinal Bacterial Overgrowth (SIBO)|Patient Reported Outcome (PRO) Measurements in Patients with Gastroparesis","Indiana University","All","Child, Adult, Older Adult",,"5000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","GI Database|1403899260","November 2014","November 2024","November 2024","August 10, 2020",,"August 10, 2020","Indiana University Hospital, Indianapolis, Indiana, United States",,"https://ClinicalTrials.gov/show/NCT04506593"
479,"NCT04173273","A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease","CULTIVATE","Recruiting","No Results Available","Crohn's Disease","Drug: Etrasimod|Drug: Placebo","Number and Severity of Adverse Events [Substudy A]|Proportion of Participants With Endoscopic Response [Substudy 1]|Proportion of Participants With Endoscopic Response [Substudy 2]|Proportion of Participants With Clinical Remission Crohn's Disease Activity Index (CDAI) [Substudy 2]|Proportion of Participants With Clinical Remission CDAI [Substudy 3]|Proportion of Participants With Endoscopic Response [Substudy 3]|Proportion of Participants With Endoscopic Response [Substudy A]|Proportion of Participants With Clinical Remission CDAI [Substudy A]|Change From Baseline in Simple Endoscopic Score in Crohn's Disease (SES-CD) Score [Substudy A]|Change From Baseline in CDAI Score [Substudy A]|Proportion of Participants With Clinical Remission CDAI [Substudy 1]|Proportion of Participants With Clinical Remission Patient Reported Outcome 2 (PRO2) [Substudy 2]|Proportion of Participants With Clinical Response CDAI [Substudy 2]|Proportion of Participants With Endoscopic Response and Clinical Remission CDAI [Substudy 2]|Proportion of Participants With Endoscopic Remission [Substudy 2]|Proportion of Participants With Clinical Remission CDAI Among Participants In Clinical Remission CDAI at Substudy 3 Baseline [Substudy 3]|Proportion of Participants With Endoscopic Response Among Participants in Endoscopic Response at Substudy 3 Baseline [Substudy 3]|Proportion of Participants With Corticosteroid-Free Clinical Remission CDAI Among Participants Receiving Corticosteroids at Substudy 3 Baseline [Substudy 3]|Proportion of Participants With Endoscopic Remission [Substudy 3]|Proportion of Participants With Clinical Remission PRO2 [Substudy 3]|Proportion of Participants With Clinical Remission CDAI by Visit up to the End Of Treatment [Substudy 4]|Proportion of Participants With Clinical Remission PRO2 by Visit up to the End Of Treatment [Substudy 4]|Number and Severity of Adverse Events","Arena Pharmaceuticals","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2|Phase 3","1265","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","APD334-202|2019-002895-14","February 12, 2020","December 2021","December 2029","November 21, 2019",,"June 11, 2021","East View Medical Research, LLC, Mobile, Alabama, United States|Arizona Digestive Health, Sun City, Arizona, United States|VVCRD Research, Garden Grove, California, United States|University of California San Diego Medical Center, La Jolla, California, United States|Om Research, LLC, Lancaster, California, United States|United Medical Doctors, Los Alamitos, California, United States|Entertainment Medical Group, Inc., Los Angeles, California, United States|United Medical Doctors, Murrieta, California, United States|San Diego Gastroenterology Medical Associates, San Diego, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Xera Med Research, Boca Raton, Florida, United States|Gastro Florida, Clearwater, Florida, United States|Gastro Florida, Clearwater, Florida, United States|Hollywood Research Center, Hollywood, Florida, United States|UF Health Jacksonville Gastroenterology-Emerson, Jacksonville, Florida, United States|Latashia Hundley, CCRC, Jacksonville, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|Infinite Clinical Research, Miami, Florida, United States|La Salud Research Clinic, Miami, Florida, United States|Anchor Medical Research LLC, Miami, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|Pharma Research International, Inc., Naples, Florida, United States|Sarkis Clinical Trials, Ocala, Florida, United States|Endoscopic Research, Inc., Orlando, Florida, United States|Pediatric & Adult Research Center, Orlando, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Gastro Florida, Pinellas Park, Florida, United States|BRCR Medical Center Inc., Plantation, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Theia Clinical Research, LLC, Saint Petersburg, Florida, United States|Advanced Research Institute, Inc, Saint Petersburg, Florida, United States|GCP Clinical Research, Tampa, Florida, United States|Digestive Healthcare of Georgia, Atlanta, Georgia, United States|AGA, LLC, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Illinois Gastroenterology Group - Arlington Heights, Arlington Heights, Illinois, United States|Illinois Gastroenterology Group, Gurnee, Illinois, United States|CroNOLA, LLC, Houma, Louisiana, United States|Gastro Center of Maryland, LLC, Columbia, Maryland, United States|Flint Clinical Research, Flint, Michigan, United States|Southern Therapy and Advanced Research, LLC, Jackson, Mississippi, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Sierra Clinical Research, Las Vegas, Nevada, United States|Allied Health Clinical Research Organization, Freehold, New Jersey, United States|Carolinas Research Center, Charlotte, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Clinical Research of Gastonia, Gastonia, North Carolina, United States|Carolina Research, Greenville, North Carolina, United States|Great Lakes Gastroenterology Research, LLC, Mentor, Ohio, United States|Care Access Research, Poland, Ohio, United States|Great Lakes Medical Research, LLC, Warren, Ohio, United States|Digestive Disease Specialists, Inc., Oklahoma City, Oklahoma, United States|Central Sooner Research, Oklahoma City, Oklahoma, United States|Guthrie Clinical Research/Guthrie Foundation, Sayre, Pennsylvania, United States|Clinical Research of Rock Hill, Rock Hill, South Carolina, United States|Tri-Cities Gastroenterology, Kingsport, Tennessee, United States|The University of Texas at Austin Dell Medical School, Austin, Texas, United States|Texas Gastroenterology Associates, PA, Cypress, Texas, United States|Digestive Health Associates, Houston, Texas, United States|Invesclinic US LLC, McAllen, Texas, United States|Spring Gastroenterology, Spring, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Victoria Gastroenterology, Victoria, Texas, United States|Care Access Research LLC, Ogden, Utah, United States|Blue Ridge Medical Research, Lynchburg, Virginia, United States|Marshall University Department of Clinical Research, Huntington, West Virginia, United States|Medical College of Wisconsin Clinical Trials Office, Milwaukee, Wisconsin, United States|Instituto Medico de la Fundacion Estudios Clinicos, Rosario, Santa Fe, Argentina|The Royal Melbourne Hospital, Parkville, Victoria, Australia|Brest Regional Clinical Hospital, Brest, Belarus|Gomel Regional Clinical Hospital, Gomel, Belarus|Mogilev Hospital #1, Mogilev, Belarus|Vitebsk Regional Clinical Hospital, Vitebsk, Belarus|Vitebsk Regional Clinical Specialized Center, Vitebsk, Belarus|M y F Estudios Clínicos/MIRES, Santiago, Chile|Centro de Investigacion del Maule, Talca, Chile|Clinical Research Chile SpA, Valdivia, Chile|Fundación Cardiomet Cequin, Armenia, Colombia|Clinica de la Mujer S.A.S, Bogota, Colombia|Centro de Investigaciones Clínicas S.A.S, Cali, Colombia|LLC Vivamedi, Tbilisi, Georgia|LTD Institute of Clinical Cardiology, Tbilisi, Georgia|JSC Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia|LTD Aversi Clinic, Tbilisi, Georgia|LTD Central University Clinic After Academic N. Kipshidze, Tbilisi, Georgia|Malkhaz Katsiashvili Multiprofile Emergency Medicine Center LTD, Tbilisi, Georgia|Krishna Institute of Medical Sciences Limited (KIMS Hospital), Secunderabad, Andhra Pradesh, India|Yashoda Hospital, Secunderabad, Andhra Pradesh, India|Maharaja Agrasen Hospital, New Delhi, Delhi, India|Surat Institute of Digestive Sciences, Surat, Gujarat, India|Gujarat Hospital, Surat, Gujarat, India|Isha Multispeciality Hospital, Vadodara, Gujarat, India|Fortis Memorial Research Institute, Gurgaon, Haryana, India|Aster DM Healthcare LTD, Kochi, Kerala, India|Midas Multispeciality Hospital Pvt. Ltd., Nagpur, Maharashtra, India|S. R. Kalla Memorial Gastro & General Hospital, Jaipur, Rajasthan, India|HaEmek Medical Center, Afula, Israel|Wolfson Medical Center, Holon, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Galilee Medical Center, Nahariya, Israel|Ziv Medical Center, Safed, Israel|Korea University Ansan Hospital, Ansan-si, Gyeonggi-do, Korea, Republic of|Dong-A University Hospital, Busan, Korea, Republic of|Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of|Keimyung University Dongsan Hospital, Daegu, Korea, Republic of|Kyungpook National University Hospital, Daegu, Korea, Republic of|Inje University Seoul Paik Hospital, Seoul, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of|Saint George University Hospital Medical Center, Beirut, Lebanon|Hotel Dieu de France Hospital, Beirut, Lebanon|Hammoud Hospital University Medical Center, Sidon, Lebanon|PMSI ""Timofei Mosneaga"" Republican Clinical Hospital, Chisinau, Moldova, Republic of|PMSI Republican Clinical Hospital ""Timofei Mosneaga"", Department of Colorectal Surgery, Chisinau, Moldova, Republic of|PMSI Republican Clinical Hospital ""Timofei Mosneaga"", Outpatient Department, Chisinau, Moldova, Republic of|FARMOVS (Pty) Ltd, Bloemfontein, Free State, South Africa|JOHESE Clinical Research, Centurion, Gauteng, South Africa|Worthwhile Clinical Trials, Johannesburg, Gauteng, South Africa|Hacettepe University Medical Faculty, Ankara, Turkey|Gazi Universitesi Tip Fakultesi, Ankara, Turkey|T.C. Saglik Bakanligi Ankara Sehir Hastanesi, Ankara, Turkey|Antalya Training and Research Hospital, Antalya, Turkey|Kocaeli University Research and Training Hospital, Kocaeli, Turkey|Karadeniz Tecnical Uni. Med. Fac., Trabzon, Turkey",,"https://ClinicalTrials.gov/show/NCT04173273"
480,"NCT03772145","Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study","TOUR","Enrolling by invitation","No Results Available","Ulcerative Colitis",,"Change in clinical response from baseline|Change in clinical remission from baseline|Persistence of the initial tofacitinib dose","University of North Carolina, Chapel Hill|Pfizer","All","18 Years to 80 Years   (Adult, Older Adult)",,"100","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","18-2435","November 27, 2018","December 31, 2023","December 31, 2024","December 11, 2018",,"January 20, 2021","Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03772145"
481,"NCT03483246","Impact of Fecal Microbiota Transplantation in Ulcerative Colitis","REBALANCE-UC","Recruiting","No Results Available","Ulcerative Colitis","Drug: Fecal Microbiota Transplantation (FMT)|Drug: Sham-transplantation Placebo","Steroid-free clinical and endoscopic remission|Steroid-free clinical remission|Steroid-free endoscopic response|Steroid-free endoscopic remission|Microbiota composition and diversity|Proportion of adverse events in each group|Inflammatory biological parameter 1|Inflammatory biological parameter 2|Inflammatory biological parameter 3|Endoscopic lesions","Assistance Publique - Hôpitaux de Paris|CRB-HUEP|Institut National de la Santé Et de la Recherche Médicale, France","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 3","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","P 160931J|2017-003802-42","June 18, 2019","September 2021","December 2023","March 30, 2018",,"September 30, 2019","Service de Gastroentérologie et Nutrition Hôpital Saint Antoine, Paris, France",,"https://ClinicalTrials.gov/show/NCT03483246"
482,"NCT04898348","A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis",,"Not yet recruiting","No Results Available","Ulcerative Colitis","Drug: Vancomycin Pre-Treatment|Drug: KBL697|Drug: Placebo","Proportion of Patients with Clinical Remission|Change from baseline in Partial Mayo Score|Portion of patients with Endoscopic subscore change|Change from baseline in C-reactive Protein|Change from baseline in Fecal Calprotectin|Changes from baseline in Inflammatory Bowel Disease Questionnaire score|Change from baseline in Histologic Disease Activity|Safety measure through incidence of treatment-emergent adverse events (TEAEs)","KoBioLabs","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","30","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","KBL-CURE-2020-03","August 2021","August 2022","September 2022","May 24, 2021",,"May 26, 2021",,,"https://ClinicalTrials.gov/show/NCT04898348"
483,"NCT01793168","Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford","CoRDS","Recruiting","No Results Available","Rare Disorders|Undiagnosed Disorders|Disorders of Unknown Prevalence|Cornelia De Lange Syndrome|Prenatal Benign Hypophosphatasia|Perinatal Lethal Hypophosphatasia|Odontohypophosphatasia|Adult Hypophosphatasia|Childhood-onset Hypophosphatasia|Infantile Hypophosphatasia|Hypophosphatasia|Kabuki Syndrome|Bohring-Opitz Syndrome|Narcolepsy Without Cataplexy|Narcolepsy-cataplexy|Hypersomnolence Disorder|Idiopathic Hypersomnia Without Long Sleep Time|Idiopathic Hypersomnia With Long Sleep Time|Idiopathic Hypersomnia|Kleine-Levin Syndrome|Kawasaki Disease|Leiomyosarcoma|Leiomyosarcoma of the Corpus Uteri|Leiomyosarcoma of the Cervix Uteri|Leiomyosarcoma of Small Intestine|Acquired Myasthenia Gravis|Addison Disease|Hyperacusis (Hyperacousis)|Juvenile Myasthenia Gravis|Transient Neonatal Myasthenia Gravis|Williams Syndrome|Lyme Disease|Myasthenia Gravis|Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome)|Isolated Klippel-Feil Syndrome|Frasier Syndrome|Denys-Drash Syndrome|Beckwith-Wiedemann Syndrome|Emanuel Syndrome|Isolated Aniridia|Axenfeld-Rieger Syndrome|Aniridia-intellectual Disability Syndrome|Aniridia - Renal Agenesis - Psychomotor Retardation|Aniridia - Ptosis - Intellectual Disability - Familial Obesity|Aniridia - Cerebellar Ataxia - Intellectual Disability|Aniridia - Absent Patella|Aniridia|Peters Anomaly - Cataract|Peters Anomaly|Potocki-Shaffer Syndrome|Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11|Silver-Russell Syndrome Due to Imprinting Defect of 11p15|Silver-Russell Syndrome Due to 11p15 Microduplication|Syndromic Aniridia|WAGR Syndrome|Wolf-Hirschhorn Syndrome|4p16.3 Microduplication Syndrome|4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome|Autosomal Recessive Stickler Syndrome|Stickler Syndrome Type 2|Stickler Syndrome Type 1|Stickler Syndrome|Mucolipidosis Type 4|X-linked Spinocerebellar Ataxia Type 4|X-linked Spinocerebellar Ataxia Type 3|X-linked Intellectual Disability - Ataxia - Apraxia|X-linked Progressive Cerebellar Ataxia|X-linked Non Progressive Cerebellar Ataxia|X-linked Cerebellar Ataxia|Vitamin B12 Deficiency Ataxia|Toxic Exposure Ataxia|Unclassified Autosomal Dominant Spinocerebellar Ataxia|Thyroid Antibody Ataxia|Sporadic Adult-onset Ataxia of Unknown Etiology|Spinocerebellar Ataxia With Oculomotor Anomaly|Spinocerebellar Ataxia With Epilepsy|Spinocerebellar Ataxia With Axonal Neuropathy Type 2|Spinocerebellar Ataxia Type 8|Spinocerebellar Ataxia Type 7|Spinocerebellar Ataxia Type 6|Spinocerebellar Ataxia Type 5|Spinocerebellar Ataxia Type 4|Spinocerebellar Ataxia Type 37|Spinocerebellar Ataxia Type 36|Spinocerebellar Ataxia Type 35|Spinocerebellar Ataxia Type 34|Spinocerebellar Ataxia Type 32|Spinocerebellar Ataxia Type 31|Spinocerebellar Ataxia Type 30|Spinocerebellar Ataxia Type 3|Spinocerebellar Ataxia Type 29|Spinocerebellar Ataxia Type 28|Spinocerebellar Ataxia Type 27|Spinocerebellar Ataxia Type 26|Spinocerebellar Ataxia Type 25|Spinocerebellar Ataxia Type 23|Spinocerebellar Ataxia Type 22|Spinocerebellar Ataxia Type 21|Spinocerebellar Ataxia Type 20|Spinocerebellar Ataxia Type 2|Spinocerebellar Ataxia Type 19/22|Spinocerebellar Ataxia Type 18|Spinocerebellar Ataxia Type 17|Spinocerebellar Ataxia Type 16|Spinocerebellar Ataxia Type 15/16|Spinocerebellar Ataxia Type 14|Spinocerebellar Ataxia Type 13|Spinocerebellar Ataxia Type 12|Spinocerebellar Ataxia Type 11|Spinocerebellar Ataxia Type 10|Spinocerebellar Ataxia Type 1 With Axonal Neuropathy|Spinocerebellar Ataxia Type 1|Spinocerebellar Ataxia - Unknown|Spinocerebellar Ataxia - Dysmorphism|Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature|Spasticity-ataxia-gait Anomalies Syndrome|Spastic Ataxia With Congenital Miosis|Spastic Ataxia - Corneal Dystrophy|Spastic Ataxia|Rare Hereditary Ataxia|Rare Ataxia|Recessive Mitochondrial Ataxia Syndrome|Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature|Posterior Column Ataxia - Retinitis Pigmentosa|Post-Stroke Ataxia|Post-Head Injury Ataxia|Post Vaccination Ataxia|Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract|Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus|Non-hereditary Degenerative Ataxia|Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity|Olivopontocerebellar Atrophy - Deafness|NARP Syndrome|Myoclonus - Cerebellar Ataxia - Deafness|Multiple System Atrophy, Parkinsonian Type|Multiple System Atrophy, Cerebellar Type|Multiple System Atrophy|Maternally-inherited Leigh Syndrome|Machado-Joseph Disease Type 3|Machado-Joseph Disease Type 2|Machado-Joseph Disease Type 1|Leigh Syndrome|Late-onset Ataxia With Dementia|Infection or Post Infection Ataxia|GAD Ataxia|Hereditary Episodic Ataxia|Gliadin/Gluten Ataxia|Friedreich Ataxia|Fragile X-associated Tremor/Ataxia Syndrome|Familial Paroxysmal Ataxia|Exposure to Medications Ataxia|Episodic Ataxia With Slurred Speech|Episodic Ataxia Unknown Type|Episodic Ataxia Type 7|Episodic Ataxia Type 6|Episodic Ataxia Type 5|Episodic Ataxia Type 4|Episodic Ataxia Type 3|Episodic Ataxia Type 1|Epilepsy and/or Ataxia With Myoclonus as Major Feature|Early-onset Spastic Ataxia-neuropathy Syndrome|Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity|Early-onset Cerebellar Ataxia With Retained Tendon Reflexes|Early-onset Ataxia With Dementia|Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia|Dilated Cardiomyopathy With Ataxia|Cataract - Ataxia - Deafness|Cerebellar Ataxia, Cayman Type|Cerebellar Ataxia With Peripheral Neuropathy|Cerebellar Ataxia - Hypogonadism|Cerebellar Ataxia - Ectodermal Dysplasia|Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss|Brain Tumor Ataxia|Brachydactyly - Nystagmus - Cerebellar Ataxia|Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia|Autosomal Recessive Syndromic Cerebellar Ataxia|Autosomal Recessive Spastic Ataxia With Leukoencephalopathy|Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay|Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria|Autosomal Recessive Spastic Ataxia|Autosomal Recessive Metabolic Cerebellar Ataxia|Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine|Autosomal Recessive Ataxia, Beauce Type|Autosomal Recessive Ataxia Due to Ubiquinone Deficiency|Autosomal Recessive Ataxia Due to PEX10 Deficiency|Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia|Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency|Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency|Autosomal Recessive Congenital Cerebellar Ataxia|Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome|Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency|Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency|Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency|Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome|Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity|Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency|Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect|Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion|Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation|Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness|Autosomal Recessive Cerebellar Ataxia|Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly|Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation|Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy|Autosomal Dominant Spastic Ataxia Type 1|Autosomal Dominant Spastic Ataxia|Autosomal Dominant Optic Atrophy|Ataxia-telangiectasia Variant|Ataxia-telangiectasia|Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy|Autosomal Dominant Cerebellar Ataxia Type 4|Autosomal Dominant Cerebellar Ataxia Type 3|Autosomal Dominant Cerebellar Ataxia Type 2|Autosomal Dominant Cerebellar Ataxia Type 1|Autosomal Dominant Cerebellar Ataxia|Ataxia-telangiectasia-like Disorder|Ataxia With Vitamin E Deficiency|Ataxia With Dementia|Ataxia - Oculomotor Apraxia Type 1|Ataxia - Other|Ataxia - Genetic Diagnosis - Unknown|Acquired Ataxia|Adult-onset Autosomal Recessive Cerebellar Ataxia|Alcohol Related Ataxia|Multiple Endocrine Neoplasia|Multiple Endocrine Neoplasia Type II|Multiple Endocrine Neoplasia Type 1|Multiple Endocrine Neoplasia Type 2|Multiple Endocrine Neoplasia, Type IV|Multiple Endocrine Neoplasia, Type 3|Multiple Endocrine Neoplasia (MEN) Syndrome|Multiple Endocrine Neoplasia Type 2B|Multiple Endocrine Neoplasia Type 2A|Atypical Hemolytic Uremic Syndrome|Atypical HUS|Wiedemann-Steiner Syndrome|Breast Implant-Associated Anaplastic Large Cell Lymphoma|Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA)|Hemophagocytic Lymphohistiocytosis|Behcet's Disease|Alagille Syndrome|Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD)|Lowe Syndrome|Pitt Hopkins Syndrome|1p36 Deletion Syndrome|Jansen Type Metaphyseal Chondrodysplasia|Cockayne Syndrome|Chronic Recurrent Multifocal Osteomyelitis|CRMO|Malan Syndrome|Hereditary Sensory and Autonomic Neuropathy Type Ie|VCP Disease|Hypnic Jerking|Sleep Myoclonus|Mollaret Meningitis|Recurrent Viral Meningitis|CRB1|Leber Congenital Amaurosis|Retinitis Pigmentosa|Rare Retinal Disorder|KCNMA1-Channelopathy|Primary Biliary Cirrhosis|ZMYND11|Transient Global Amnesia|Glycogen Storage Disease|Alstrom Syndrome|White Sutton Syndrome|DNM1|EIEE31|Myhre Syndrome|Recurrent Respiratory Papillomatosis|Laryngeal Papillomatosis|Tracheal Papillomatosis|Refsum Disease|Nicolaides Baraitser Syndrome|Leukodystrophy|Tango2|Cauda Equina Syndrome|Rare Gastrointestinal Disorders|Achalasia-Addisonian Syndrome|Achalasia Cardia|Achalasia Icrocephaly Syndrome|Anal Fistula|Congenital Sucrase-Isomaltase Deficiency|Eosinophilic Gastroenteritis|Idiopathic Gastroparesis|Hirschsprung Disease|Rare Inflammatory Bowel Disease|Intestinal Pseudo-Obstruction|Scleroderma|Short Bowel Syndrome|Sacral Agenesis|Sacral Agenesis Syndrome|Caudal Regression|Scheuermann Disease|SMC1A Loss of Function Epilepsy",,"To accelerate research into rare disorders by connecting individuals who are interested in research and who have been diagnosed with a rare disorder (or a disorder of unknown prevalence, or who are undiagnosed) with researchers who study rare diseases.","Sanford Health|National Ataxia Foundation|International WAGR Syndrome Association|4p- Support Group|ML4 Foundation|Cornelia de Lange Syndrome Foundation|Stickler Involved People|Kawasaki Disease Foundation|Klippel-Feil Syndrome Alliance|Klippel-Feil Syndrome Freedom|Hyperacusis Research Limited|Hypersomnia Foundation|Kabuki Syndrome Network|Kleine-Levin Syndrome Foundation|Leiomyosarcoma Direct Research Foundation|Marinesco-Sjogren Syndrome Support Group - NORD|Mucolipidosis Type IV (ML4) Foundation|People with Narcolepsy 4 People with Narcolepsy (PWN4PWN)|Soft Bones Incorporated|American Multiple Endocrine Neoplasia Support|Atypical Hemolytic Uremic Syndrome Foundation|All Things Kabuki|Wiedemann-Steiner Syndrome Foundation|Breast Implant Victim Advocates|PROS Foundation|American Behcet's Disease Association|Alstrom United Kingdom|Athymia|Curing Retinal Blindness Foundation|HSAN1E Society|1p36 Deletion Support and Awareness|The Alagille Syndrome Alliance|Autoinflammatory Alliance|Beyond Batten|Bohring-Opitz Syndrome Foundation, INC|Cockayne Syndrome Network (Share and Care)|CRMO Foundation|Cure VCP Disease,INC|FOD Support|Cystinosis Research Foundation|Global DARE Foundation|Hypnic Jerk-Sleep Myoclonus Support Group|Jansen's Foundation|KCNMA1 Channelopathy International Advocacy Foundation|Kawasaki Disease Foundation Australia|Life with LEMS Foundation|Lowe Syndrome Association|The Malan Syndrome Foundation|Maple Syrup Urine Disease Family Support Group|International Association for Muscle Glycogen Storage Disease (IamGSD)|Myhre Syndrome Foundation|DNM1 Families|Nicolaides Baraitser Syndrome (NCBRS) Worldwide Foundation|The PBCers Organization|Pitt Hopkins Research Foundation|Progressive Familial Intrahepatic Cholestasis Advocacy and Resource Network, Inc|Recurrent Meningitis Association|Recurrent Respiratory Papillomatosis Foundation|Remember the Girls|Smith-Kingsmore Syndrome Foundation|SPG Research Foundation|Team Telomere|Transient Global Amnesia Project|The Charlotte & Gwenyth Gray Foundation|The Cute Syndrome Foundation|The Maddi Foundation|White Sutton Syndrome Foundation|Zmynd11 Gene Disorder|Cauda Equina Foundation, Inc|Tango2 Research Foundation|Noah's Hope - Hope4Bridget Foundation|Project Sebastian|SMC1A Epilepsy Foundation|International Foundation for Gastrointestinal Disorders|Endosalpingiosis Foundation, Inc|International Sacral Agenesis/Caudal Regression Association (ISACRA)|Scheuermann's Disease Fund","All","Child, Adult, Older Adult",,"20000","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","03-10-014|Hypersomnia Foundation|National Ataxia Foundation|4p- Support Group|CdLS Foundation|Hyperacusis Research Limited|Kabuki Syndrome Network|Kawasaki Disease Foundation|Klippel-Feil Syndrome Freedom|Leiomyosarcoma Direct Research|MSS Support Group|ML4 Foundation|Stickler Involved People|IWSA|Soft Bones|PWN4PWN|aHUS|Klippel-Feil Syndrome Alliance|American MEN Support|Kleine-Levin Syndrome|All Things Kabuki|WSS Foundation|BIVA|ABDA|PROS Foundation (HLH)|Alagille Syndrome Association|Cure VCP Disease, Inc.|Lowe Syndrome Association|Pitt Hopkins|Cure Batten Disease|Hypnic Jerk/Sleep Myoclonus|1p36 DSA|Jansen Foundation|Share and Care Network|CRMO|The Malan Syndrome Foundation|HSAN1E Society|Alstrom United Kingdomg|Athymia|CRB1 Foundation|Cystinosis Research Foundation|DNM1 Families|Global DARE Foundation|KCIAF|MSUD FSG|IamGSD|Myhre Syndrome Foundation|NCBRS|PBCers Organization|DBA - PFIC Network|Remember the Girls|RRPF|SKS Foundation|SPG15 Research Foundation|Team Telomere|TGA Project|The Cute Syndrome Foundation|Zmynd11 Gene Disorder|SPG11 and SPG15|Endosalpingiosis Foundation|Cauda Equina Foundation|Tango2 Research Foundation|SMC1A Epilepsy|IFFGD|Noah's Hope - Hope4Bridget|Project Sebastian|ISACRA|Scheuermann's Disease Fund","July 2010","December 2100","December 2100","February 15, 2013",,"December 10, 2020","Sanford Health, Sioux Falls, South Dakota, United States|Online Patient Enrollment System, Sydney, Australia",,"https://ClinicalTrials.gov/show/NCT01793168"
484,"NCT03524092","A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis","LUCENT 2","Recruiting","No Results Available","Ulcerative Colitis","Drug: Mirikizumab|Drug: Placebo","Percentage of Participants in Clinical Remission|Percentage of Participants in Endoscopic Remission|Percentage of Participants with Histologic Remission|Percentage of Participants in Symptomatic Remission|Percentage of Participants in Endoscopic Response|Percentage of Participants in Clinical Response|Change from Baseline to Week 40 in Health Related Quality of Life|Change from Baseline to Week 40 in Fecal Calprotectin|Change from Baseline to Week 40 in Ulcerative Colitis (UC) Symptoms: Numeric Rating Score (NRS)|Percentage of Participants Hospitalized for UC|Pharmacokinetics (PK): Clearance of Mirikizumab","Eli Lilly and Company","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 3","1044","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","16823|I6T-MC-AMBG|2017-003238-96","October 19, 2018","November 24, 2021","August 27, 2023","May 14, 2018",,"June 18, 2021","Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|Dcr-Pi, Pc, Litchfield Park, Arizona, United States|Maricopa Integrated Health System, Phoenix, Arizona, United States|Physicians Research Group, Tempe, Arizona, United States|Valley Gastroenterology Cnslts, Arcadia, California, United States|Care Access Research, Berkeley, California, United States|Om Research, LLC, Lancaster, California, United States|California Medical Research Group, Northridge, California, United States|Clinical Applications Laboratories, Inc., San Diego, California, United States|UCSF Medical Center at Mission Bay, San Francisco, California, United States|Direct Helpers Medical Center, Hialeah, Florida, United States|Wellness Clinical Research, Hialeah, Florida, United States|Nature Coast Clinical Research, LLC, Inverness, Florida, United States|SIH Research, LLC, Kissimmee, Florida, United States|Columbus Clinical Services, LLC, Miami, Florida, United States|Research Associates of South Florida, LLC, Miami, Florida, United States|Center for Interventional Endoscopy, Orlando, Florida, United States|Clintheory Healthcare, Orlando, Florida, United States|Gastroenterology Associates of Pensacola, PA, Pensacola, Florida, United States|Florida Digestive Specialist, Saint Petersburg, Florida, United States|Florida Medical Clinic LLC, Zephyrhills, Florida, United States|Digestive Healthcare of Georgia, Atlanta, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Indiana University School of Medicine, Indianapolis, Indiana, United States|Cotton-O'Neil Clinical Research Center, Digestive Health, Topeka, Kansas, United States|Texas Digestive Disease Consultants, Baton Rouge, Louisiana, United States|Delta Research Partners LLC, Monroe, Louisiana, United States|Nola Research Works, LLC, New Orleans, Louisiana, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Henry Ford Health System, Novi, Michigan, United States|Gastroenterology Associates of Western Michigan, P.L.C., Wyoming, Michigan, United States|Huron Gastroenterology Associates, Ypsilanti, Michigan, United States|Minnesota Gastroenterology, P.A., Plymouth, Minnesota, United States|Northwell Health, Great Neck, New York, United States|Weill Cornell Medical College, New York, New York, United States|University of North Carolina Center for Inflammatory Bowel Disease, Chapel Hill, North Carolina, United States|Carolina Digestive Diseases, Greenville, North Carolina, United States|Paramount Medical Research, Middleburg Heights, Ohio, United States|Care Access Research - Youngstown, Poland, Ohio, United States|Central Sooner Research, Norman, Oklahoma, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Care Access Research LLC, Pottsville, Pennsylvania, United States|Digestive Disease Associates, Ltd., Wyomissing, Pennsylvania, United States|Midwest Medical Care, Sioux Falls, South Dakota, United States|Gastro One, Germantown, Tennessee, United States|Galen Medical Group, Hixson, Tennessee, United States|Digestive Health Associates of Texas, Garland, Texas, United States|Houston Methodist Research Ins, Houston, Texas, United States|Biopharma Informatic, Inc., Houston, Texas, United States|Gastroenterology Research of San Antonio, San Antonio, Texas, United States|Southern Star Research Institute, LLC, San Antonio, Texas, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|Care Access Research LLC - Salt Lake City, Ogden, Utah, United States|Emeritas Research Group, Leesburg, Virginia, United States|The Gastroenterology Group, P.C., Reston, Virginia, United States|Carilion Clinic, Roanoke, Virginia, United States|Digestive Health Specialists, Tacoma, Washington, United States|Wisconsin Center for Advanced Research, Milwaukee, Wisconsin, United States|Centro de Investigaciones Metabólicas (CINME), Caba, Buenos Aires, Argentina|Mautalen Salud e Investigacion-Centro de Osteopatías Médicas, Ciudad Autonoma De Buenos Air, Buenos Aires, Argentina|CER Instituto Medico, Quilmes, Buenos Aires, Argentina|Fundación de Estudios Clínicos, Rosario, Santa Fe, Argentina|Sanatorio 9 de Julio SA, San Miguel de Tucuman, Tucuman, Argentina|Centro Medico Privado de Reumatologia, SAN M. DE Tucuman, Tucumán, Argentina|Hospital Privado Centro Medico de Cordoba SA, Cordoba, Argentina|Princess Alexandra Hospital, Brisbane, Queensland, Australia|Coastal Digestive Health, Maroochydore, Queensland, Australia|Mater University Hospital, South Brisbane, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Box Hill Hospital, Box Hill, Victoria, Australia|Melbourne Gastrointestinal Investigation Unit (MGIU), Malvern, Victoria, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|The Royal Melbourne Hospital, Parkville, Victoria, Australia|Medizinische Universität Innsbruck, Innsbruck, Austria|Universitätsklinikum Salzburg, Salzburg, Austria|Medical University of Vienna, Vienna, Austria|Universitair Ziekenhuis Gent, Gent, Oost-Vlaanderen, Belgium|AZ Klina, Brasschaat, Belgium|Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium|Centre Hospitalier de Wallonie picarde - CHwapi A.S.B.L., Tournai, Belgium|West Edmonton Diabetes Center, Edmonton, Alberta, Canada|The Gordon and Leslie Diamond Health Care Centre, Vancouver, British Columbia, Canada|GI Research Institute, Vancouver, British Columbia, Canada|PerCuro Clinical Research Ltd., Victoria, British Columbia, Canada|Victoria Hospital, London, Ontario, Canada|University of Western Ontario, London, Ontario, Canada|Centre de santé et de services sociaux Champlain-Charles-Le Moyne, Greenfield Park, Quebec, Canada|Hopital Maisonneure-Rosemount, Montreal, Quebec, Canada|Inflammatory Bowel Disease Centre Montreal General Hospital - MUHC, Montreal, Quebec, Canada|Anhui Provincial Hospital, Hefei City, Anhui, China|The First Affiliated Hospital of Anhui Medical University, HefeiCity, Anhui, China|Beijing Friendship Hospital, Beijing, Beijing, China|Xiangya Hospital Central South University, Kaifu District, Changsha City, China|The Affiliated 2nd Hosp. of Third Military Med. Univ. of PLA, Chongqing, Chongqing, China|The First Hospital Affiliated to AMU (Southwest Hospital), Chongqing, Chongqing, China|Fujian Province Hospital, Fuzhou, Fujian, China|The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China|The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China|Hainan General Hospital, Haikou, Hainan, China|Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China|The Affiliated Drum Tower Hospital of Nanjing University, Nanjing, Jiangsu, China|Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China|Jiangsu Province Hospital, Nanjing, Jiangsu, China|Zhongda Hospital Southeast University, Nanjing, Jiangsu, China|Nanjing Medical University - Nanjing Jiangning Hospital, Nanjing, Jiangsu, China|Jiangxi Pingxiang People's Hospital, Pingxiang, Jiangxi, China|Jilin Central General Hospital, Jilin, Jilin, China|The Second Hospital of Dalian Medical University, Dalian, Lianing, China|Qilu Hospital of Shandong University, Jinan, Shandong, China|Liaocheng People's hospital, Liaocheng, Shandong, China|Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China|Renji Hospital Affliated to Shanghai Jiaotong University, Shanghai, Shanghai, China|West China Hospital Sichuan University, Chengdu, Sichuan, China|No.1 Hospital Affiliated to Xinjiang Medical University, Urumchi, Urumchi, China|Kunming Medical College Affiliated First Hospital, Kunming, Yunnan, China|The First People's Hospital of Yunnan Province, Kunming, Yunnan, China|The Second Affiliated Hospital of Zhejiang University School of Med, Hangzhou, Zhejiang, China|First Affiliated Hosp of College of Med, Zhejiang University, Hangzhou, Zhejiang, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China|The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou, Zhejiang, China|Tongji Hospital of Tongji University, Wuhan, China|Fakultni nemocnice Kralovske Vinohrady, Praha 10, Hl. M. Praha, Czechia|Vojenska nemocnice Brno, Brno, Czechia|Fakultni nemocnice u sv. Anny v Brne, Brno, Czechia|Hepato-gastroenterologie HK, s.r.o., Hradec Kralove, Czechia|Gregar s.r.o., Olomouc, Czechia|PreventaMed, s.r.o., Olomouc, Czechia|A-Shine s.r.o., Plzen, Czechia|Mediendo s.r.o., Praha 8 - Karlin, Czechia|ISCARE Clinical Centre, Praha 9, Czechia|Herlev and Gentofte Hospital, Herlev, Denmark|Zealand University Hospital Køge, Køge, Denmark|Hopital de Hautepierre - Service d'Hépatogastroentérolgie, Strasbourg Cedex, Bas Rhin, France|Hopital Saint-Louis, Paris, Cedex 10, France|CHU Lille - Hôpital Claude Huriez, Lille cedex, Nord, France|Hospices Civils de Lyon - Centre Hospitalier Lyon Sud -, Pierre Benite cedex, Rhone, France|CHU Amiens Picardie-Site Sud - RDC Service Hépato gastro, Amiens Cedex, Somme, France|CHU Tours - Hôpital Trousseau, Chambray les Tours, France|Hopital Beaujon, Clichy, France|Hopital Nord de Marseille, Marseille Cedex 20, France|CHRU de Montpellier-Hopital St Eloi, Montpellier Cedex 5, France|Hopital L'Archet 2, Nice Cedex, France|Centre Hospitalier de Pau, Pau CEDEX, France|CHU Bordeaux - Hôpital Haut-Lévêque, Pessac Cedex, France|Robert Debre Hospital, Reims, France|CHU de Saint Etienne Hopital Nord, Saint Priest en Jarez, France|CHRU Nancy Brabois - Hôpital d'Enfants, Vandoeuvre les Nancy, France|Staedisches Klinikum Brandenburg, Brandenburg an der Havel, Brandenburg, Germany|Medizinische Hochschule Hanover, Hannover, Niedersachsen, Germany|Gemeinschaftspraxis Dr. Peter Uebel, Ludwigshafen am Rhein, Rheinland-Pfalz, Germany|Studiengesellschaft BSF Unternehmergesellschaft haftungsbeschraenkt, Halle (Saale),, Sachsen Anhalt, Germany|Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Sachsen-Anhalt, Germany|Charité Universitätsmedizin Berlin Campus Buch, Berlin, Germany|Krankenhaus Waldfriede e. V., Berlin, Germany|Hamburgisches Forschungsinstitut fuer Chronisch Entzuendliche Darmerkrankungen, Hamburg, Germany|Internistische Praxisgemeinschaft, Weyhe, Germany|DRC Gyogyszervizsgalo Kozpont Kft., Balatonfüred, EU, Hungary|Obudai Egeszsegugyi Centrum Kft, Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Endomedix Diagnosztikai Kozpont, Miskolc, Hungary|Karolina Korhaz-Rendelointezet, Mosonmagyarovar, Hungary|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont I. Belgyogyaszati Klinika, Szeged, Hungary|Clinfan Szolgaltato Kft., Szekszard, Hungary|Javorszky Odon Hospital, Vac, Hungary|Centre for Liver Research & Diagnostics, Deccan College of Medical Sciences, Owaisi Hospital & Research Centre, Hyderabad, Andhra Pradesh, India|Escorts Heart Institute and Research Centre Ltd, New Delhi, Delhi, India|Apollo Research and Innovations, Apollo Hospitals International Ltd, Gandhinagar, Gujarat, India|Shree Giriraj Hospital, Rajkot, Gujarat, India|Nirmal Hospital Private Limited, Surat, Gujarat, India|Bangalore Medical College and Research Institute, Bangalore, Karnataka, India|M S Ramaiah Medical College Hospital, Bangalore, Karnataka, India|Poona Medical Foundation. Ruby Hall Clinic, Pune, Maharashtra, India|Datta Meghe Institute of Medical Sciences (DU), Acharya Vinoba Bhave Rural Hospital, Wardha, Maharashtra, India|Midas Multispecilaity Hopsital Pvt Ltd, Ramdaspeth, Nagpur, India|Dayanand Medical College, Ludhiana, Punjab, India|S.R. Kalla Hospital, Jaipur, Rajasthan, India|King George Medical University, Lucknow, Uttar Pradesh, India|Fortis Hospital, Noida, Uttar Pradesh, India|Gandhi Hospital, Telangana, India|Beaumont Hospital, Dublin, Ireland|Shaare Zedek Medical Center, Bait Vagan, Jerusalem, Israel|Soroka Medical Center - Pediatric Outpatient Clinic, Beer-Sheva, Israel|Galilee Medical Center Department of Internal Medicine A, Nahariya, Israel|Kaplan Medical Center, Rehovot, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Assaf Harofeh Medical Center, Zerifin, Israel|Presidio di Rho, Rho, Milano, Italy|Istituto Clinico Humanitas, Rozzano, Milano, Italy|Istituti di Ricovero e Cura a Carattere Scientifico Policlinico San Donato Gastroenterologia, San Donato Milanese, Milano, Italy|Ospedale Sandro Pertini, Roma, RM, Italy|Azienda Ospedaliera Universitaria Policlinico Tor Vergata, Torre, Roma, Italy|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili), Brescia, Italy|Azienda ospedaliero-universitaria Mater Domini, Catanzaro, Italy|Azienda Ospedaliero Universitaria San Martino, Genova, Italy|Gastroenterology and Endoscopy Unit IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation, Milano, Italy|Azienda Ospedaliera Universitaria Policlinico de Modena, Modena, Italy|Azienda Ospedaliera Universitaria Pisana, Pisa, Italy|Policlinico Univ. Agostino Gemelli, Roma, Italy|Ospedale Mauriziano Umberto I, Torino, Italy|Azienda Ospedaliero-Universitaria Santa Maria della Misericordia Gastroenterologia, Udine, Italy|Aichi Medical University Hospital, Nagakute-shi, Aichi-ken, Japan|Fujita Health University Hospital, Toyoake-shi, Aichi-ken, Japan|NHO Hirosaki National Hospital, Hirosaki-shi, Aomori-Ken, Japan|Toho University School of Medicine, Sakura Hospital, Sakura, Chiba, Japan|Kitakyushu Municipal Medical Center, Kitakyusyu-shi, Fukoka, Japan|Fukuoka University Chikushi Hospital, Chikushino-shi, Fukuoka-Ken, Japan|Hidaka Coloproctology Clinic, Kurume-shi, Fukuoka-Ken, Japan|Gunma University Hosptial, Maebashi, Gunma, Japan|Takasaki General Medical Center, Takasaki, Gunma, Japan|NHO Mito Medical Center, Ibaraki-machi, HigaShiibaraki-Gun, Japan|Hiroshima University Hospital, Hiroshima-shi, Hiroshima-ken, Japan|Asahikawa City Hospital, Asahikawa, Hokkaido, Japan|Tokushukai Sapporo Tokushukai Hospital, Sapporo-shi, Hokkaido, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital, Sapporo-shi, Hokkaido, Japan|Tokushukai Sapporo Higashi Tokushukai Hospital, Sapporo-shi, Hokkaido, Japan|Aoyama Clinic GI Endoscopy & IBD Center, Kobe-shi, Hyogo-Ken, Japan|Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan|Sameshima Hospital, Kagoshima-shi, Kagoshima, Japan|Sankikai Yokohama Shin midori General Hospital, Yokohama-shi, Kanagawa-Ken, Japan|Gokeikai Ofuna Chuo Hospital, Kamakura-shi, Kanagawa, Japan|Kawasaki Municipal Kawasaki Hospital, Kawasaki, Kanagawa, Japan|Showa University Northern Yokohama Hospital, Yokohama, Kanagawa, Japan|Yokohama City University Medical Center, Yokohama, Kanagawa, Japan|Kumamoto University Hospital, Kumamoto-shi, Kumamoto, Japan|NHO Kyoto Medical Center, Kyoto-shi, Kyoto, Japan|Mie University Hospital, Tsu, Mie, Japan|Takagi Clinic, Sendai-shi, Miyagi-Ken, Japan|Nagaoka Chuo General Hospital, Nagaoka-shi, Niigata, Japan|Ishida Clinic of IBD and Gastroenterology, Oita-shi, Oita-Ken, Japan|Shinseikai Sai Gastroenterology, proctology, Fujiidera-shi, Osaka Fu, Japan|Kinshukai Infusion Clinic, Osaka-shi, Osaka, Japan|NHO Osaka National Hospital, Osaka-shi, Osaka, Japan|Saga-Ken Medical Center Koseikan, Saga-Shi, Saga-Ken, Japan|Kumagaya General Hospital, Kumagaya-shi, Saitama-Ken, Japan|Tokitokai Tokito Clinic, Saitama-shi, Saitama-Ken, Japan|Matsuaikai Matsuda Hospital, Hamamatsu-shi, Shizuoka-Ken, Japan|Jichi Medical University Hospital, Shimotsuke-shi, Tochigi-Ken, Japan|Mitsui Memorial Hospital, Chiyoda-ku, Tokyo-To, Japan|Center Hospital of the National Center for Global Health and Medicine, Shinjuku-ku, Tokyo-To, Japan|Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan|Tokyo Medical And Dental University Medical Hospital, Bunkyō, Tokyo, Japan|Showa University Koto Toyosu Hospital, Koto-ku, Tokyo, Japan|Kitasato University Kitasato Institute Hospital, Minato-Ku, Tokyo, Japan|Kyorin University Hospital, Mitaka, Tokyo, Japan|JHCO Tokyo Yamate Medical Center, Shinjuku-ku, Tokyo, Japan|Toyama Prefectural Central Hospital, Toyama-Shi, Toyama, Japan|Fukuoka University Hospital, Fukuoka, Japan|Okayama University Hospital, Okayama, Japan|The Catholic University of Daejeon St. Mary's Hospital, Jung-gu, Daejeon, Korea, Republic of|Severance Hospital, Wonju-si, Gangwon-do, Korea, Republic of|Kyung Hee University Hospital, Seoul, Korea, Korea, Republic of|Dong-A University Hospital, Busan, Pusan-Kwangyǒkshi, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of|Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of|Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Yeungnam Univeristy Medical Center, Daegu, Korea, Republic of|Digestive Diseases Center ""Gastro"", Riga, Latvia|Pauls Stradins Kliniska Universitates Slimnica, Riga, Latvia|Riga Eastern Clinical University Hospital, Riga, Latvia|Hospital of Lithuanian University of Health Sciences Kaunas, Kaunas, Lithuania|Republic Hospital of Klaipeda, Klaipeda, Lithuania|Klaipeda Seamen's Hospital, Klaipeda, Lithuania|Respublikine Panevezio Ligonine, Panevezys, Lithuania|Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania|Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia|University Malaya Medical Centre, Lembah Pantai, Kuala Lumpur, Malaysia|Hospital Ampang, Ampang, Selangor, Malaysia|Centro de Investigación Clínica Acelerada, Mexico City, Distrito Federal, Mexico|Investigación Biomédica para el Desarrollo de Fármacos S.A. de C.V., Zapopan, Jalisco, Mexico|Centro Para el Desarrollo de la Medicina y de Asistencia Med, Culiacan, Sinaloa, Mexico|Scientia Investigacion Clinica S.C., Chihuahua, Mexico|Sociedad de Metabolismo y Corazon S.C., Veracruz, Mexico|St Elisabeth Ziekenhuis, Tilburg, Noord Brabant, Netherlands|Academisch Medisch Centrum, Amsterdam, Noord-Holland, Netherlands|Bernhoven Ziekenhuis, Uden, Netherlands|UMC Utrecht, Dept. of Internal Medicine, MDL, Utrecht, Netherlands|Szpital Uniwersytecki Nr 2 w Bydgoszczy, Klinika Reumatologii i Ukladowych Chorob Tkanki Lacznej, Bydgoszcz, Kujawsko-pomorskie, Poland|Promedica S.C, Bedzin, Poland|Centrum Medyczne Pratia Bydgoszcz, Bydgoszcz, Poland|NZOZ ALL-MEDICUS, Zaklad Gastroenterologii, Katowice, Poland|Topolowa Medicenter, Krakow, Poland|GASTROMED Zakład Opieki Zdrowotnej, Lublin, Poland|Samodzielny Publiczny Szpital Kliniczny nr 4, Lublin, Poland|Medicenter Nowy Targ, Nowy Targ, Poland|Wojewodzki Specjalistyczny Szpital w Olsztynie, Olsztyn, Poland|Endoskopia sp z o. o, Sopot, Poland|KO-MED Centra Kliniczne Staszow, Staszow, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Niepubliczny Zaklad Opieki Zdrowotnej SONOMED, Szczecin, Poland|Gastromed Kopoń Zmudziński I Wspólnicy Spółka Jawna Specjalistyczne Centrum Gastrologii I Endoskopii, Torun, Poland|Nzoz Formed, Wadowice, Poland|Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Centrum Zdrowia Matki, Dziecka i Młodzieży (CZMDM) Przychodnie, Warszawa, Poland|Centrum Medyczne NeuroProtect, Warszawa, Poland|Vivamed, Warszawa, Poland|PlanetMed Sp.z o.o., Wroclaw, Poland|LexMedica Osrodek Badan Klinicznych, Wroclaw, Poland|ETG Zamosc, Zamosc, Poland|CCBR Clinical Research, Bucharest, București, Romania|MedLife Grivita, Bucuresti, Romania|Spitalul Clinic Colentina, Bucuresti, Romania|Institutul Clinic Fundeni, Bucuresti, Romania|Hifu Terramed Conformal SRL, Bucuresti, Romania|Spital Pelican Oradea, Oradea, Romania|Multidisciplinary Medical Clinic ""Anthurium"", Barnaul, Russian Federation|Medical and Sanitary Division of Severstal, Cherepovets, Russian Federation|LLC MA New Hospital, Ekaterinburg, Russian Federation|Irkutsk State Medical Academy of Continuing Education, Irkutsk, Russian Federation|LLC Alliance Biomedical - Ural Group, Izhevsk, Russian Federation|Clinical Trials Center of Medical Institute, Kaliningrad, Russian Federation|State Autonomous Institution of Healthcare ""Republican Clinical Hospital of the Ministry of Healthcare of Republic Tatarstan"", Kazan, Russian Federation|SIH Kemerovo Regional Clinical Hosptial, Kemerovo, Russian Federation|Medical rehabilitation center, Moscow, Russian Federation|Nizhegorodskiy Regional Clinical Hospital N.A.Semashko, Nizhniy Novgorod, Russian Federation|Private Healthcare Institution Clinical Hospital Russian Railways - Medicine of Nizhniy Novgorod, Nizhniy Novgorod, Russian Federation|LLC ""Medicine Center SibNovoMed"", Novosibirsk, Russian Federation|LLC Novosibirsk GastroCenter, Novosibirsk, Russian Federation|Clinical Diagnostic Center Ultramed, Omsk, Russian Federation|Karelia Republican Hospital V.A. Baranova, Petrozavodsk, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|Saint Petersburg State Medical University n.a. Pavlov I.P., Saint Petersburg, Russian Federation|Pokrovskaya Municipal Hospital, Saint-Petersburg, Russian Federation|Non-state Healthcare Institution ""Roadway Clinical Hospital of OJSC Russian Railways"", Saint-Petersburg, Russian Federation|SBIH City Clinical Hospital #31, Saint-Petersburg, Russian Federation|Medical Institute REAVIZ, Samara, Russian Federation|City Mariinskaya Hospital, St. Petersburg, Russian Federation|LLC Scientific Research Centre EKO-Bezopasnost, St. Petersburg, Russian Federation|Stavropol State Medical Academy, Stavropol, Russian Federation|Yaroslavl Municipal HI Clinical Hospital #8, Yaroslavl, Russian Federation|Clinical Center Bezanijska Kosa, Belgrade, NAP, Serbia|Clinical Center Zvezdara, Belgrade, Serbia|Clinical Center Kragujevac Gastroenterohepatology Clinic, Kragujevac, Serbia|General Hospital Dr Radivoj Simonovic, Sombor, Serbia|General Hospital Sremska Mitrovica, Sremska Mitrovica, Serbia|General Hospital ""Djordje Joanovic"", Zrenjanin, Serbia|Fakultna nemocnica s poliklinikou Roosevelta Banska Bystrica, Banska Bystrica, Slovakia|Univerzitna nemocnica Bratislava, Bratislava, Slovakia|KM Management spol. s r.o. Gastroenterologicke a hepatologicke centrum, Nitra, Slovakia|Gastro I s.r.o., Gastroenterologická ambulancia, Prešov, Slovakia|Endomed, s.r.o.- Gastroenterologicka ambulancia, Vranov N. Toplou, Slovakia|Hospital Universitario Virgen Del Rocio, Sevilla, Andalucía, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Universitari Son Espases, Palma de Mallorca, Baleares Islands, Spain|Hospital Universitario Marques De Valdecilla, Santander, Cantabria, Spain|Hospital De Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Gen. Juan Ramon Jimenez - Depto de Digestivo, Sagunto, Valencia, Spain|Instituto de Ciencias Médicas, Alicante, Spain|Hospital Universitari de Girona, Girona, Spain|Hospital General Juan Ramón Jiménez, Huelva, Spain|Complexo Hospitalario Universitario A Coruña, CHUAC, La Coruña, Spain|Hospital De Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain|Hospital Universitario La Paz, Madrid, Spain|Inselspital Bern, Bern, Switzerland|Praxis Balsiger, Seibold & Partner und Crohn-Colitis-Zentrum, Bern, Switzerland|Kantonsspital St.Gallen, St.Gallen, Switzerland|Universitätsspital Zürich USZ Zürich, Zürich, Switzerland|China Medical University Hospital, Taichung City, Taiwan|Health management center, Taipei, Taiwan|Antalya Training and Research Hospital, Muratpasa, Antayla, Turkey|Acibadem Universitesi - Acibadem Kozyatagi Hastanesi, Kadıkoy, Istanbul, Turkey|Kocaeli University Medical Faculty Hospital, Izmit, Kocaeli, Turkey|Mersin University Medical Faculty, Yenişehir, Mersin, Turkey|Ege University Medicine of Faculty, Izmir, Turkey|Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, Ivano-Frankivsk Region, Ukraine|Kharkiv City Student Hospital, Kharkiv, Ukraine|CHI Prof.O.O.Shalimov Kharkiv City Clinical Hospital #2, Kharkiv, Ukraine|GI L.T. Malaya TI Namsu, Kharkiv, Ukraine|CI Kherson CCH, Kherson, Ukraine|Treatment-Diagnostic Center of Private Enterprise of PPC Atsynus, Kropyvnytskyi, Ukraine|Kyiv Municipal Clinical Hospital #1, Kyiv, Ukraine|Medical Centre CONSILIUM MEDICAL, Kyiv, Ukraine|Communal institution of the Kyiv Regional Council ""Kyiv Regional Clinical Oncology Dispensary"", Kyiv, Ukraine|Communal institution of the Kyiv Regional Council ""Kyiv Regional Clinical Oncology Dispensary"", Kyiv, Ukraine|Communal Non-Commercial Enterprise of Lviv Regional Council Lviv Regional Clinical Hospital, Liviv, Ukraine|Lviv Clinical Hospital at Railway Transport of Division Healthcare Center PJSC Ukrainian Railway Sta, Lviv, Ukraine|Communal City Clinical Hospital of Ambulance, Lviv, Ukraine|Communal Enterprise ""Odesa Regional Clinical Hospital"", Odesa, Ukraine|Communal Institution ""Poltava Reg.Cl.H. n.a.M.V.Sklifosovskogo"", Poltava, Ukraine|A. Novak Transcarpathian Regional Clinical Hospital, Uzhgorod, Ukraine|Vinnytsia RCH of Veterans of War Dept of Therapy#1 Vinnytsia M.I.Pyrogov NMU, Vinnytsia, Ukraine|MCIC MC LLC Health Clinic, Vinnytsia, Ukraine|CCH #1 Vinnytsia M.I. Pyrogov NMU Ch of Propaedeutics of IM, Vinnytsia, Ukraine|M.I. Pyrogov Regional Clinical Hospital, Vinnytsya, Ukraine|Diaservis Ltd, Zaporizhzhia, Ukraine|Communal Institution of Kyiv Regional Council Kyiv Regional Hospital #2, Zaporizhzhia, Ukraine|Queens Hospital, Romford, Essex, United Kingdom|Fairfield General Hospital, Bury, Lancashire, United Kingdom|St Thomas' Hospital, Great Maze Pond, London, United Kingdom|Whipps Cross University Hospital, London, Surrey, United Kingdom|St James's University Hospital, Leeds, Vinnytsia, United Kingdom|Morriston Hospital, Swansea, Wales, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03524092"
485,"NCT04271748","The Impact of Time Restricted Feeding in Crohn's Disease","TRF-CD","Recruiting","No Results Available","Crohn's Disease (CD)","Other: Time Restricted Feeding","Change in patient reported outcomes as measured by Patient Recorded Outcome 2 (PRO2) scores.|Change in Inflammatory Markers as measured by blood C-reactive protein (CRP).|Change in inflammatory markers as measured by fecal calprotectin lab results|Change in taxonomic composition of the gut microbiome as measured by Polymerase Chain Reaction (PCR) analysis.|Markers of systemic peripheral blood immunity as measured by Mass Cytometry by Time-Of-Flight (CyTOF) analysis.","Weill Medical College of Cornell University|The Kenneth Rainin Foundation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","19-11021081","January 14, 2021","June 2021","June 2021","February 17, 2020",,"February 2, 2021","Weill Cornell Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04271748"
486,"NCT03219359","Autologous Stem Cell Transplant for Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Procedure: Autologous stem cell transplant|Drug: Cyclophosphamide|Drug: Thymoglobulin|Drug: Methylprednisolone|Drug: Vedolizumab","Change in Crohn's Disease Activity Index (CDAI)|Change in endoscopic activity indices","Icahn School of Medicine at Mount Sinai","All","18 Years and older   (Adult, Older Adult)","Phase 2","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","GCO 17-0378","July 12, 2017","August 2022","August 2022","July 17, 2017",,"August 25, 2020","Icahn School of Medicine at Mount Sinai, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03219359"
487,"NCT04590508","A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease","XMaS","Recruiting","No Results Available","Crohn Disease","Drug: Xanthohumol|Other: Placebo","Change from Baseline: Aspartate aminotransferase (AST)|Change from Baseline:Alanine aminotransferase (ALT)|Change from Baseline: gamma-Glutamyl transferase (GGT)|Change from Baseline: Estimated glomerular filtration rate|Change from Baseline: Blood urea nitrogen to creatinine ratio|Change from Baseline: Complete blood count|Change from Baseline: Composite Symptoms: Crohn's Disease Activity Index (CDAI)|Change from Baseline: Change in fecal calprotectin levels|Change from Baseline: Change in plasma inflammatory markers (pg/mL)","National University of Natural Medicine|Oregon State University|Pacific Northwest National Laboratory","All","21 Years to 50 Years   (Adult)","Phase 2","32","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Placeholder","October 1, 2020","June 30, 2022","December 31, 2022","October 19, 2020",,"May 21, 2021","National University of Natural Medicine, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT04590508"
488,"NCT02742597","Patient-Centred Innovations for Persons With Multimorbidity - Ontario","PACEinMM-ON","Active, not recruiting","No Results Available","Hypertension|Depression|Anxiety|Musculoskeletal Pain|Arthritis|Rheumatoid Arthritis|Osteoporosis|Chronic Obstructive Pulmonary Disease (COPD)|Asthma|Chronic Bronchitis|Cardiovascular Disease|Heart Failure|Stroke|Transient Ischemic Attacks|Ulcer|Gastroesophageal Reflux|Irritable Bowel|Crohn's Disease|Ulcerative Colitis|Diverticulosis|Chronic Hepatitis|Diabetes|Thyroid Disorder|Cancer|Kidney Disease|Urinary Tract Problem|Dementia|Alzheimer's Disease|Hyperlipidemia|HIV|Multimorbidity","Behavioral: TIP / IMPACT Plus Care Coordination","Evaluation of Intervention Effectiveness - Change in Self-Management outcomes|Evaluation of Intervention Effectiveness - Change in Transitions of Care|Evaluation of Intervention Effectiveness - Change in Self-Efficacy|Evaluation of Intervention Effectiveness - Change in Patient-Centredness|Evaluation of Intervention Effectiveness - Change in Chronic Diseases|Evaluation of Intervention Effectiveness - Change in Health Status|Evaluation of Intervention Effectiveness - Change in Quality of Life|Evaluation of Intervention Effectiveness - Change in Psychological Well-being|Evaluation of Intervention Effectiveness - Change in Lifestyle/Health Behaviours|Evaluation of Intervention Effectiveness - Change in Equity|Evaluation of Intervention Effectiveness - Change in Demographics","Lawson Health Research Institute|Western University, Canada|Université de Sherbrooke|Canadian Institutes of Health Research (CIHR)|Sunnybrook Health Sciences Centre|Unity Health Toronto|University Health Network, Toronto|Michael Garron Hospital|Providence Healthcare|Mount Sinai Hospital, Canada|Toronto Central Community Care Access Centre|Women's College Hospital","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","175","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","104191","January 12, 2016","April 7, 2019","March 30, 2021","April 19, 2016",,"March 1, 2021","Western University, London, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Providence Healthcare, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Toronto Central Community Care Access Centre, Toronto, Ontario, Canada|Toronto East General Hospital, Toronto, Ontario, Canada|University Hospital Network, Toronto, Ontario, Canada|Women's College Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02742597"
489,"NCT04685200","Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach",,"Not yet recruiting","No Results Available","Primary Sclerosing Cholangitis",,"The ultimate goal of this study is to generate understanding of how factors driving pathogenesis in PSC interact by capturing and integrating collated datasets from across relevant biologic systems and interpreting those in the context of phenot...|To collect comprehensive data on distinct patterns of disease expression, through single cell sequencing and microRNA and transcriptome profiling.|To conduct extensive phenotypic characterization of cellular and humoral immune responses as well as microbiome signatures at multiple anatomic sites|To evaluate metabolic signatures or biomarkers for PSC diagnosis and prognostication|To generate a humanized mouse model of each subject s disease by obtaining bone marrow aspirate","National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Institutes of Health Clinical Center (CC)","All","18 Years and older   (Adult, Older Adult)",,"143","NIH","Observational","Observational Model: Cohort|Time Perspective: Prospective","10000130|000130-DK","July 7, 2021","October 31, 2022","October 31, 2022","December 28, 2020",,"July 2, 2021","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT04685200"
490,"NCT04902807","Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation","ATRACTion","Not yet recruiting","No Results Available","Autoimmune Lymphoproliferative Syndrome|Autoimmune Cytopenia|Autoimmune Diseases|Autoimmune Anemia|Autoimmune Thrombocytopenia|Autoimmune Hepatitis|Autoimmune Diabetes|Autoimmune Rheumatologic Disease|Systemic Lupus Erythematosus|Juvenile Idiopathic Arthritis|Hemophagocytic Lymphohistiocytoses|EBV Lymphoproliferation|RAS-Associated Autoimmune Leucoproliferative Disease|Primary Immunodeficiency|APECED|IPEX|BENTA|Enteropathy, Autoimmune|Combined Immunodeficiency|IBD","Biological: Collection of samples","Generate a diagnosis and therapeutic-decision tools|1- Development of an atlas of molecular interactions leading to autoimmunity and inflammation|2 - To develop an artificial intelligent online application|3- Ancillary study (pilot study)","Institut National de la Santé Et de la Recherche Médicale, France","All","1 Year to 18 Years   (Child, Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","C20-59","June 2021","December 2024","December 2024","May 26, 2021",,"May 28, 2021",,,"https://ClinicalTrials.gov/show/NCT04902807"
491,"NCT01090154","Study of Cimzia for the Treatment of Ulcerative Colitis","UC CIMZIA","Active, not recruiting","No Results Available","Ulcerative Colitis","Drug: Cimzia","To determine the proportion of patients achieving clinical response determined by patient reported symptoms and investigator's assessment of mucosal healing via endoscopy measured by Total Mayo Score at Week 14 compared to Week 0.|To determine the proportion of patients achieving clinical remission determined by patient reported symptoms and investigator's assessment of mucosal healing via endoscopy measured by Total Mayo Score at Week 14 compared to Week 0.|To determine the proportion of patients achieving clinical response or clinical remission at week 54 per the same criteria as listed above.|To determine the proportion of patients achieving mucosal healing at weeks 14 and 54 defined as a Mayo endoscopic subscore less than 2.|To determine the corticosteroid-sparing effects of certolizumab pegol over a years treatment time.|To determine the colectomy rate between week 0 and week 54|To determine the change in mean or median total or partial Mayo score between week 0 and week 54|To determine the change in mean or median serum CRP levels between week 0 and week 54|To determine the change in mean or median IBDQ or SIBDQ scores between week 0 and week 54|To determine all adverse events, serious adverse events, opportunistic infections, and injection site reactions between week 0 and week 64","University of Washington|UCB Pharma|University of Pennsylvania","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","25","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","37823|CZP-UC-001","December 1, 2010","December 31, 2021","December 31, 2021","March 19, 2010",,"March 3, 2021","University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Washington, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT01090154"
492,"NCT04247737","Gluten Free Diet in IBS",,"Recruiting","No Results Available","Gluten Sensitivity","Other: gluten free diet","Determination of inflammatory Stimulation of monocytes after gluten exposure|Differences in Stimulation of inflammatory Parameters between healthy controls and patients with irritable bowel disease (IBD)|Effect of a gluten free diet on improvement of gastrointestinal symptoms|Effect of the gluten free diet on Quality of life|Determination of a subgroup of Patients with NCGS in IBS cohorte","University of Erlangen-Nürnberg Medical School","All","18 Years and older   (Adult, Older Adult)","Not Applicable","150","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","IBS GFD","October 1, 2019","December 31, 2021","December 31, 2021","January 30, 2020",,"January 27, 2021","Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany",,"https://ClinicalTrials.gov/show/NCT04247737"
493,"NCT04839315","COVID-19 Vaccination in Rheumatic Disease Patients",,"Recruiting","No Results Available","Systemic Lupus Erythematosus|Sjogren's Syndrome|Inflammatory Myositis|Psoriatic Arthritis|Gout|Ankylosing Spondylitis|Arthritis of Multiple Sites Associated With Inflammatory Bowel Disease (Diagnosis)|Osteoarthritis","Biological: mRNA COVD19 vaccine","Humoral responses towards mRNA COVID-19 vaccines|Cellular immune responses towards mRNA COVID-19 vaccines","Mayo Clinic","All","18 Years and older   (Adult, Older Adult)","Early Phase 1","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","21-000501","February 15, 2021","December 2021","December 2021","April 9, 2021",,"April 9, 2021","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT04839315"
494,"NCT04213729","Diet Intervention for Crohn's Disease Patient",,"Recruiting","No Results Available","Crohn Disease","Behavioral: Diet Counseling|Other: CD LFD|Behavioral: Dyadic Psychological Support (DPS)","Change in fat intake|Rate of adherence to fat intake|Change in clinical symptoms as assessed by Patient Reported Outcomes (PRO2).|Change in clinical symptoms as assessed by the Harvey Bradshaw Index (HBI)|Change in clinical symptoms as assessed by the Short Crohn's Disease Activity Index (sCDAI).|Change in quality of life (QoL) as assessed by the Short Inflammation Bowel Disease Questionnaire (sIBDQ).|Change in quality of life (QoL) as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS-29).|Change in the expression of cytokine high-sensitivity C-reactive protein (hsCRP).|Change in the expression of Serum Amyloid A (SAA).","University of Miami|The Leona M. and Harry B. Helmsley Charitable Trust","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","300","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","20190548","November 26, 2019","October 14, 2022","October 14, 2022","December 30, 2019",,"November 13, 2020","University of Miami, Miami, Florida, United States",,"https://ClinicalTrials.gov/show/NCT04213729"
495,"NCT04913467","Effect of Ileocolonic Delivered Vitamins and an Anti-Inflammatory Diet on Crohn's Disease and Healthy Volunteers","Vita-GrAID","Not yet recruiting","No Results Available","Crohn Disease","Other: Groningen Anti-Inflammatory Diet (GrAID)|Dietary Supplement: ColoVit capsule|Other: ColoPulse-placebo capsule","Change in faecal calprotectin|Change in microbiome composition measured by metagenomic sequencing- based profiles|The number of flares (defined as faecal calprotectin >200 μg/g and Crohn's Disease Activity Index (CDAI) ≥220 points)|Improvements of Quality of life scores as assessed by Inflammatory Bowel Disease Questionnaire (Score range of 32-224, The higher the score the higher the Quality of Life)|Improvements of Quality of life scores as assessed Food Related Quality of Life Questionnaire (Score range of 29-145, The higher the score the higher the Food related-Quality of Life)|Adherence to the dietary interventions as assessed by a Dietary Compliance Questionnaire","University Medical Center Groningen","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","510","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","NL66008.056.20|202000683","July 1, 2021","July 1, 2024","July 1, 2025","June 4, 2021",,"June 4, 2021",,,"https://ClinicalTrials.gov/show/NCT04913467"
496,"NCT03635112","Efficacy and Safety of TD-1473 in Crohn's Disease","DIONE","Recruiting","No Results Available","Crohn's Disease","Drug: Placebo|Drug: TD-1473","Improvement in Crohn's Disease Activity Index (CDAI) score from Baseline to Week 12 (PRIMARY)|Clinical response measured by CDAI|CDAI clinical remission|SES-CD (Simple Endoscopic Score for Crohn's Disease) change from baseline to Week 12|Endoscopic response|Stool Frequency and Abdominal Pain (SFAP) clinical remission","Theravance Biopharma","All","18 Years and older   (Adult, Older Adult)","Phase 2","160","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","0173|2018-001272-37","November 19, 2018","August 2021","August 2022","August 17, 2018",,"January 20, 2021","Theravance Biopharma Investigational Site, Birmingham, Alabama, United States|Theravance Biopharma Investigational Site, Mobile, Alabama, United States|Theravance Biopharma Investigational Site, Scottsdale, Arizona, United States|Theravance Biopharma Investigational Site, La Jolla, California, United States|Theravance Biopharma Investigational Site, Los Angeles, California, United States|Theravance Biopharma Investigational Site, Aventura, Florida, United States|Theravance Biopharma Investigational Site, Clearwater, Florida, United States|Theravance Biopharma Investigational Site, Hialeah, Florida, United States|Theravance Biopharma Investigational Site, Hollywood, Florida, United States|Theravance Biopharma Investigational Site, Largo, Florida, United States|Theravance Biopharma Investigational Site, Miami, Florida, United States|Theravance Biopharma Investigational Site, New Port Richey, Florida, United States|Theravance Biopharma Investigational Site, Saint Petersburg, Florida, United States|Theravance Biopharma Investigational Site, Tampa, Florida, United States|Theravance Biopharma Investigational Site, Tampa, Florida, United States|Theravance Biopharma Investigational Site, New Lenox, Illinois, United States|Theravance Biopharma Investigational Site, Kansas City, Kansas, United States|Theravance Biopharma Investigational Site, Louisville, Kentucky, United States|Theravance Biopharma Investigational Site, Rockville, Maryland, United States|Theravance Biopharma Investigational Site, Brockton, Massachusetts, United States|Theravance Biopharma Investigational Site, Wyoming, Michigan, United States|Theravance Biopharma Investigational Site, Saint Louis, Missouri, United States|Theravance Biopharma Investigational Site, Gastonia, North Carolina, United States|Theravance Biopharma Investigational Site, Greenville, North Carolina, United States|PMG Research of Salisbury, Salisbury, North Carolina, United States|Theravance Biopharma Investigational Site, Tulsa, Oklahoma, United States|Theravance Biopharma Investigational Site, Pittsburgh, Pennsylvania, United States|Theravance Biopharma Investigational Site, Uniontown, Pennsylvania, United States|Theravance Biopharma Investigational Site, Orangeburg, South Carolina, United States|Theravance Biopharma Investigational Site, Rock Hill, South Carolina, United States|Theravance Biopharma Investigational Site, Garland, Texas, United States|Theravance Biopharma Investigational Site, Houston, Texas, United States|Theravance Biopharma Investigational Site, San Antonio, Texas, United States|Theravance Biopharma Investigational Site, Spring, Texas, United States|Theravance Biopharma Investigational Site, Lansdowne Town Center, Virginia, United States|Theravance Biopharma Investigational Site, Bankstown, New South Wales, Australia|Theravance Biopharma Investigational Site, Elizabeth Vale, South Australia, Australia|Theravance Biopharma Investigational Site, Perth, Western Australia, Australia|Theravance Biopharma Investigational Site, Klagenfurt am Wörthersee, Carinthia, Austria|Theravance Biopharma Investigational Site, Innsbruck, Tyrol, Austria|Theravance Biopharma Investigational Site, Wien, Vienna, Austria|Theravance Biopharma Investigational Site, Sofia, Sofiya, Bulgaria|Theravance Biopharma Investigational Site, Sofia, Sofiya, Bulgaria|Theravance Biopharma Investigational Site, Sofia, Sofiya, Bulgaria|Theravance Biopharma Investigational Site, Sofia, Sofiya, Bulgaria|Theravance Biopharma Investigational Site, Sofia, Sofiya, Bulgaria|Theravance Biopharma Investigational Site, Targovishte, Turgovishte, Bulgaria|Theravance Biopharma Investigational Site, Dobrich, Bulgaria|Theravance Biopharma Investigational Site, Plovdiv, Bulgaria|Theravance Biopharma Investigational Site, Sliven, Bulgaria|Theravance Biopharma Investigational Site, Stara Zagora, Bulgaria|Theravance Biopharma Investigational Site, Stara Zagora, Bulgaria|Theravance Biopharma Investigational Site, Veliko Tarnovo, Bulgaria|Theravance Biopharma Investigational Site, Osijek, Osijek-baranja, Croatia|Theravance Biopharma Investigational Site, Rijeka, Croatia|Theravance Biopharma Investigational Site, Split, Croatia|Theravance Biopharma Investigational Site, Zagreb, Croatia|Theravance Biopharma Investigational Site, Saint Etienne, Auvergne, France|Theravance Biopharma Investigational Site, Reims, Champagne-ardenne, France|Theravance Biopharma Investigational Site, Colombes, Ile-de-france, France|Theravance Biopharma Investigational Site, Toulouse, Midi-pyrenees, France|Theravance Biopharma Investigational Site, Nice, Provence Alpes COTE D'azur, France|Theravance Biopharma Investigational Site, Pierre-Bénite, Rhone-alpes, France|Theravance Biopharma Investigational Site, Clichy, France|Theravance Biopharma Investigational Site, Vandœuvre-lès-Nancy, France|Theravance Biopharma Investigational Site, Tbilisi, Georgia|Theravance Biopharma Investigational Site, Tbilisi, Georgia|Theravance Biopharma Investigational Site, München, Bayern, Germany|Theravance Biopharma Investigational Site, München, Bayern, Germany|Theravance Biopharma Investigational Site, Hannover, Niedersachsen, Germany|Theravance Biopharma Investigational Site, Kiel, Schleswig-holstein, Germany|Theravance Biopharma Investigational Site, Berlin, Germany|Theravance Biopharma Investigational Site, Hamburg, Germany|Theravance Biopharma Investigational Site, Athens, Attica, Greece|Theravance Biopharma Investigational Site, Heraklion, Crete, Greece|Theravance Biopharma Investigational Site, Baja, Bacs-kiskun, Hungary|Theravance Biopharma Investigational Site, Debrecen, Hajdu-bihar, Hungary|Theravance Biopharma Investigational Site, Gyöngyös, Heves, Hungary|Theravance Biopharma Investigational Site, Budapest, Hungary|Theravance Biopharma Investigational Site, Be'er Ya'aqov, Rehoboth, Israel|Theravance Biopharma Investigational Site, Rehovot, Rehoboth, Israel|Theravance Biopharma Investigational Site, Kfar Saba, Sharon, Israel|Theravance Biopharma Investigational Site, Haifa, Israel|Theravance Biopharma Investigational Site, Holon, Israel|Theravance Biopharma Investigational Site, Jerusalem, Israel|Theravance Biopharma Investigational Site, Nahariya, Israel|Theravance Biopharma Investigational Site, Petah Tikva, Israel|Theravance Biopharma Investigational Site, Tel Aviv, Israel|Theravance Biopharma Investigational Site, Wŏnju, Gangwon-Do, Korea, Republic of|Theravance Biopharma Investigational Site, Guri-si, Gyeonggi-do, Korea, Republic of|Theravance Biopharma Investigational Site, Seongnam-si, Gyeonggi-Do, Korea, Republic of|Theravance Biopharma Investigational Site, Busan, Korea, Republic of|Theravance Biopharma Investigational Site, Daegu, Korea, Republic of|Theravance Biopharma Investigational Site, Seoul, Korea, Republic of|Theravance Biopharma Investigational Site, Seoul, Korea, Republic of|Theravance Biopharma Investigational Site, Hamilton, Waikato, New Zealand|Theravance Biopharma Investigational Site, Lower Hutt, Wellington, New Zealand|Theravance Biopharma Investigational Site, Wroclaw, Dolnoslaskie, Poland|Theravance Biopharma Investigational Site, Wrocław, Dolnoslaskie, Poland|Theravance Biopharma Investigational Site, Włocławek, Kujawsko-Pomorskie, Poland|Theravance Biopharma Investigational Site, Lodz, Lodzkie, Poland|Theravance Biopharma Investigational Site, Lodz, Lodzkie, Poland|Theravance Biopharma Investigational Site, Łódź, Lodzkie, Poland|Theravance Biopharma Investigational Site, Kraków, Malopolskie, Poland|Theravance Biopharma Investigational Site, Warszawa, Masovian, Poland|Theravance Biopharma Investigational Site, Warszawa, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Warszawa, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Warszawa, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Warszawa, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Rzeszow, Podkarpackie, Poland|Theravance Biopharma Investigational Site, Sopot, Pomorskie, Poland|Theravance Biopharma Investigational Site, Tychy, Slaskie, Poland|Theravance Biopharma Investigational Site, Poznań, Wielkopolskie, Poland|Theravance Biopharma Investigational Site, Szczecin, Zachodnio-Pomorskie, Poland|Theravance Biopharma Investigational Site, Braga, Portugal|Theravance Biopharma Investigational Site, Guimarães, Portugal|Theravance Biopharma Investigational Site, Leiria, Portugal|Theravance Biopharma Investigational Site, Lisboa, Portugal|Theravance Biopharma Investigational Site, Santa Maria da Feira, Portugal|Theravance Biopharma Investigational Site, Setúbal, Portugal|Theravance Biopharma Investigational Site, Vila Nova De Gaia, Portugal|Theravance Biopharma Investigational Site, Oradea, Bihor, Romania|Theravance Biopharma Investigational Site, Bucharest, Bucuresti, Romania|Theravance Biopharma Investigational Site, Cluj-Napoca, Cluj, Romania|Theravance Biopharma Investigational Site, Timisoara, Timis, Romania|Theravance Biopharma Investigational Site, Timişoara, Timis, Romania|Theravance Biopharma Investigational Site, Bucuresti, Romania|Theravance Biopharma Investigational Site, Cluj, Romania|Theravance Biopharma Investigational Site, Moscow, Moscow City, Russian Federation|Theravance Biopharma Investigational Site, Rostov-on-Don, Rostov, Russian Federation|Theravance Biopharma Investigational Site, Samara, Samarskaya Oblast, Russian Federation|Theravance Biopharma Investigational Site, Novosibirsk, Russian Federation|Theravance Biopharma Investigational Site, Novosibirsk, Russian Federation|Theravance Biopharma Investigational Site, Saint Petersburg, Russian Federation|Theravance Biopharma Investigational Site, Saint-Petersburg, Russian Federation|Theravance Biopharma Investigational Site, Saratov, Russian Federation|Theravance Biopharma Investigational Site, Belgrade, Serbia|Theravance Biopharma Investigational Site, Belgrade, Serbia|Theravance Biopharma Investigational Site, Kragujevac, Serbia|Theravance Biopharma Investigational Site, Niš, Serbia|Theravance Biopharma Investigational Site, Subotica, Serbia|Theravance Biopharma Investigational Site, Zrenjanin, Serbia|Theravance Biopharma Investigational Site, Johannesburg, Gauteng, South Africa|Theravance Biopharma Investigational Site, Johannesburg, Gauteng, South Africa|Theravance Biopharma Investigational Site, Lenasia, Gauteng, South Africa|Theravance Biopharma Investigational Site, Claremont, Western Cape, South Africa|Theravance Biopharma Investigational Site, Las Palmas De Gran Canaria, Las Palmas, Spain|Theravance Biopharma Investigational Site, Barcelona, Spain|Theravance Biopharma Investigational Site, Barcelona, Spain|Theravance Biopharma Investigational Site, Huelva, Spain|Theravance Biopharma Investigational Site, Madrid, Spain|Theravance Biopharma Investigational Site, Valencia, Spain|Theravance Biopharma Investigational Site, Kiev, Kiev City, Ukraine|Theravance Biopharma Investigational Site, Kyiv, Kiev City, Ukraine|Theravance Biopharma Investigational Site, Kyiv, Kiev, Ukraine|Theravance Biopharma Investigational Site, Kremenchuk, Poltava, Ukraine|Theravance Biopharma Investigational Site, Úzhgorod, Transcarpathian, Ukraine|Theravance Biopharma Investigational Site, Úzhgorod, Transcarpathia, Ukraine|Theravance Biopharma Investigational Site, Chernivtsi, Ukraine|Theravance Biopharma Investigational Site, Kharkiv, Ukraine|Theravance Biopharma Investigational Site, Kharkiv, Ukraine|Theravance Biopharma Investigational Site, Kharkiv, Ukraine|Theravance Biopharma Investigational Site, Lviv, Ukraine|Theravance Biopharma Investigational Site, Vinnytsia, Ukraine|Theravance Biopharma Investigational Site, Zaporizhzhya, Ukraine|Theravance Biopharma Investigational Site, Zaporizhzhya, Ukraine|Theravance Biopharma Investigational Site, Blackpool, England, United Kingdom|Theravance Biopharma Investigational Site, London, England, United Kingdom|Theravance Biopharma Investigational Site, Glasgow, Scotland, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03635112"
497,"NCT04859088","Biologics and Partial Enteral Nutrition Study","BIOPIC","Not yet recruiting","No Results Available","Crohn Disease","Dietary Supplement: Partial Enteral Nutrition","Crohn's Disease Activity Index|Harvey-Bradshaw Index|Faecal Calprotectin|Blood C-Reactive Protein|Blood Erythrocyte Sedimentation Rate|Blood Albumin|Blood Haemoglobin|Steroid-free remission|Dosage of biologics|Blood anti-drug antibodies|Blood adalimumab|Micronutrient status|Blood immunophenotype|Self-Administered Inflammatory Bowel Disease Questionnaire|Body Mass Index|Body weight|Body fat mass|Body fat-free mass|Handgrip strength","NHS Greater Glasgow and Clyde|University of Glasgow","All","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","GN21RH169","July 2021","July 2026","July 2026","April 26, 2021",,"May 14, 2021","Gartnavel Royal Hospital, Glasgow, Scotland, United Kingdom|Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom|Queen Elizabeth University Hospital, Glasgow, Scotland, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04859088"
498,"NCT03733314","A Study of E6011 in Participants With Active Crohn's Disease",,"Recruiting","No Results Available","Crohn's Disease","Drug: E6011|Drug: Placebo","Percentage of Participants with Clinical Response (CR) 100 (CR100)|Percentage of Participants with CR70 and CR100|Percentage of Participants with Reduction below 150 (CDAI Remission Rate)|Percentage of Participants with at Least 5-point and 8-point Reduction from Baseline in Patient Reported Outcome 2 (PRO2)|Percentage of Participants with Reduction below 8 Points (PRO2-remission Rate)|Percentage of Participants with Endoscopic Response based on Simple Endoscopic Score for Crohn's Disease (SES-CD) Score|Percentage of Participants with Endoscopic Remission based on SES-CD Score|Change from Baseline in CDAI Score|Percent Change from Baseline in CDAI score|Change from Baseline in PRO2|Percent Change from Baseline in PRO2|Change from Baseline in SES-CD Score|Percent Change from Baseline in SES-CD Score|Percentage of Participants who Achieved Steroid-free Remission|Percentage of Participants who Achieved Steroid-Free Improvement|Percent Change From Baseline in Steroid Dosage in Participants Concomitantly Using Adrenocorticosteroids","EA Pharma Co., Ltd.|Eisai Inc.","All","18 Years to 64 Years   (Adult)","Phase 2","40","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","E6011-ET2|2018-002109-70|184139","April 25, 2019","January 2022","December 2024","November 7, 2018",,"March 29, 2021","E6011-ET2 Trial Site 2, Hradec Králové, Czechia|E6011-ET2 Trial Site 1, Prague, Czechia|E6011-ET2 Trial Site 1, Debrecen, Hungary|E6011-ET2 Trial Site 2, Győr, Hungary|E6011-ET2 Trial Site 4, Nagoya, Aichi, Japan|E6011-ET2 Trial Site 12, Toyota, Aichi, Japan|E6011-ET2 Trial Site 10, Kashiwa, Chiba, Japan|Eisai Trial Site #20, Kashiwa, Chiba, Japan|Eisai Trial Site #16, Kitakyushu, Fukuoka, Japan|Eisai Trial Site #18, Kasamatsu, Gifu, Japan|E6011-ET2 Trial Site 9, Ogaki, Gifu, Japan|Eisai Trial Site #15, Sapporo, Hokkaido, Japan|E6011-ET2 Trial Site 7, Nishinomiya, Hyogo, Japan|Eisai Trial Site #21, Kanazawa, Ishikawa, Japan|E6011-ET2 Trial Site 8, Takamatsu, Kagawa, Japan|Eisai Trial SIte #19, Ōiso, Kanagawa, Japan|Eisai Trial Site #17, Urazoe, Okinawa, Japan|E6011-ET2 Trial Site 2, Bunkyo, Tokyo, Japan|Eisai Trial Site #22, Hachiōji, Tokyo, Japan|Eisai Trial Site #23, Kodatra, Tokyo, Japan|E6011-ET2 Trial Site 3, Minato, Tokyo, Japan|E6011-ET2 Trial Site 6, Mitakashi, Tokyo, Japan|E6011-ET2 Trial Site 1, Shinjuku, Tokyo, Japan|Eisai Trial Site #14, Fukuoka, Japan|Eisai Trial Site #25, Fukuoka, Japan|E6011-ET2 Trial Site 11, Gifu, Japan|E6011-ET2 Trial Site 5, Kagoshima, Japan|Eisai Trial Site #13, Osaka, Japan|Eisai Trial Site #5, Bydgoszcz, Poland|Eisai Trial Site #6, Katowice, Poland|E6011-ET2 Trial Site 2, Kraków, Poland|Eisai Trial Site #4, Poznań, Poland|E6011-ET2 Trial Site 1, Wadowice, Poland|E6011-ET2 Trial Site 3, Warsaw, Poland|Eisai Trial Site #7, Wrocław, Poland",,"https://ClinicalTrials.gov/show/NCT03733314"
499,"NCT04882007","Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis","CoTikiS","Recruiting","No Results Available","Ulcerative Colitis","Drug: OSE-127|Drug: Placebo","Change in modified Mayo Score|Clinical Remission|Clinical efficacy of OSE-127 vs placebo|Efficacy of OSE-127 vs placebo on endoscopic remission|Efficacy of OSE-127 vs placebo on endoscopic improvement|Overall safety and tolerability of OSE-127 in patients with moderate to severe UC","OSE Immunotherapeutics","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","150","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","OSE-127-C201|2020-001398-59","October 2, 2020","December 2021","March 2023","May 11, 2021",,"June 28, 2021","Brest Regional Hospital, Brest, Belarus|Gomel Regional Clinical Hospital, Gomel, Belarus|Grodno University Hospital, Grodno, Belarus|City Clinical Emergency Hospital, Minsk, Belarus|Vitebsk Regional Clinical Hospital, Vitebsk, Belarus|UZ Leuven - Department of Gastroenterology and Hepatology, Leuven, Belgium|CHU Liège, Liège, Belgium|Groupe Santé CHC - Clinique du Mont Légia, Liège, Belgium|Medical Center Medconsult Pleven - OOD, Pleven, Bulgaria|Medical Center Medconsult Pleven, Pleven, Bulgaria|Acibadem City Clinic University Multiprofile Hospital for Active Treatment - EOOD, Clinic of Gastroenterology, Sofia, Bulgaria|Medical Center Asklepion - Researches in humane medicine (EOOD), Sofia, Bulgaria|Medical Center Asklepion, Sofia, Bulgaria|Medical Center Hera EOOD, Sofia, Bulgaria|Medical Center Hera, Sofia, Bulgaria|UMHAT Tsaritsa Yoanna - ISUL - EAD, Sofia, Bulgaria|Medical center VIP Clinic - OOD, Varna, Bulgaria|Medical Center VIP Clinic, Varna, Bulgaria|University Hospital Center Split, Split, Croatia|EVEX Hospitals JSC, Kutaisi, Georgia|West Regional Center of Modern Medical Technologies Ltd, Kutaisi, Georgia|Institute of Clinical Cardiology, Tbilisi, Georgia|Israel-Georgia Medical Research Clinic Helsicore Ltd, Tbilisi, Georgia|JSC Clinic Jerarsi, Tbilisi, Georgia|Multiprofile Clinic Consilium Medulla Ltd, Tbilisi, Georgia|Clinexpert SMO, Budapest, Hungary|II. Sz. Belgyogyaszati Klinika, Semmelweis Egyetem, Budapest, Hungary|II. Sz Belgyogyasztai Intezet, Gasztroenterologia Debreceni Egyetem, Debrecen, Hungary|Polana-D, Daugavpils, Latvia|Liepāja Regional Hospital, Liepāja, Latvia|Digestive Diseases Centre GASTRO, Riga, Latvia|Pauls Stradins Clinical University Hospital, Riga, Latvia|Centrum Opieki Zdrowotnej Orkan-med, Ksawerów, Poland|Medicome Sp. z o.o., Oświęcim, Poland|Centrum Medyczne Medyk, Rzeszów, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Melita Medical, Wrocław, Poland|Centrum Medyczne Med-Gastr, Łódź, Poland|Oddział Kliniczny Gastroenterologii Ogólnej i Onkologicznej, Łódź, Poland|Ekaterinburg City Clinical Hospital No. 14, Ekaterinburg, Russian Federation|Prof. S.V. Ochapovskiy Regional Clinical Hospital No.1, Krasnodar, Russian Federation|Ryzhikh State Coloproctology Research Center, Moscow, Russian Federation|LLC Novosibirskiy Gastrocenter, Novosibirsk, Russian Federation|Medical Center Healthy Family LLC, Novosibirsk, Russian Federation|State Budgetary Healthcare Institution of the Stavropol Region - Pyatigorsk Oncology Dispensary, Pyatigorsk, Russian Federation|Saratov State Medical University, Saratov, Russian Federation|301 Fairfield Medical Suite, Cape Town, South Africa|Dnipropetrovsk I.I. Mechnikov Regional Clinical Hospital - Dnipropetrovsk Regional Council, Dnipro, Ukraine|Prof. O.O. Salimov City Clinical Hospital #2 - Kharkiv City Council, Kharkiv, Ukraine|Kryvyi Rih City Clinical Hospital #2, Kryvyi Rih, Ukraine|Kyiv Regional Clinical Hospital - Kyiv Regional Council, Kyiv, Ukraine|Medical Center OK!Clinic+ of International Institute of Clinical Studies LLC, Kyiv, Ukraine|Ternopil University Hospital - Ternopil Regional Council, Ternopil, Ukraine|Andrii Novak Transcarpathian Regional Clinical Hospital, Uzhhorod, Ukraine|Municipal Institution City Clinical Hospital #6 - Therapeutic Department, Zaporizhzhya, Ukraine",,"https://ClinicalTrials.gov/show/NCT04882007"
500,"NCT03863886","Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative Colitis","EUSIBD","Recruiting","No Results Available","Crohn Disease|Ulcerative Colitis","Procedure: Endoscopic ultrasound catheter (UM-2R/3R, Olympus)","Active Crohn's disease has significantly thicker submucosa layer compared to patients with active ulcerative colitis and non-inflammatory bowel disease controls.|The thickness of the submucosa layer in Crohn's disease patients correlates to the degree of disease activity as measured by the Harvey-Bradshaw clinical index and Simple Endoscopic Score index.|The thickness of the mucosa layer in ulcerative colitis patients correlates to the degree of disease activity as measured by the Mayo score index.","Carilion Clinic","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","2694","January 4, 2019","January 2022","June 2022","March 5, 2019",,"April 29, 2021","Carilion Clinic, Roanoke, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT03863886"
501,"NCT04259060","Hydroxocobalamin Approach to Reduction of Calprotectin With Butyrate for Ulcerative Colitis Research","HARBOUR","Not yet recruiting","No Results Available","Ulcerative Colitis","Drug: Hydroxocobalamin with Butyrate|Drug: Placebo with Butyrate","Change from Baseline calprotectin at week 4|Incidence of Treatment-Emergent Adverse Events (AE) as assessed by Common Terminology Criteria for Adverse Events (CTCAE)|Clinical Symptoms assessed by Simple Clinical Colitis Activity Index (SCCAI)|Assessment of urinary nitrate levels and plasma nitrite, nitrate levels and nitrosothiol levels|Normalization of fecal calprotectin below the upper limit of normal|Reduction of Mayo Score (Phase 2)|Correlation between urinary, plasma nitrite, nitrate or nitrosothiol levels and fecal calprotectin","Joshua Korzenik|Brigham and Women's Hospital","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","42","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","2019P003412","June 2020","June 2022","December 2022","February 6, 2020",,"February 11, 2020","Brigham and Women's Hospital, Chestnut Hill, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04259060"
502,"NCT03718182","Can Vitamin D Supplementation in People With Crohn's Disease Improve Symptoms as an Adjunct Therapy?","D-CODE","Recruiting","No Results Available","Crohn Disease|Vitamin D Deficiency","Dietary Supplement: Cholecalciferol","Inflammatory Bowel Disease Questionnaire (IBDQ)|Euroquol EQ-5D-5L","University Hospital Birmingham NHS Foundation Trust|National Institute for Health Research, United Kingdom|University of Birmingham|Clinical Trials Research Centre","All","18 Years and older   (Adult, Older Adult)","Phase 4","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","RRK6542","September 17, 2019","November 30, 2020","December 31, 2020","October 24, 2018",,"March 26, 2020","University Hospitals Birmingham NHS Trust, Birmingham, West Midlands, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03718182"
503,"NCT03531892","A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis",,"Active, not recruiting","No Results Available","Colitis, Ulcerative","Drug: AJM300|Drug: Placebo","Clinical Response Rate Based on Mayo Score|Clinical Remission Rate Based on Mayo Score|Mucosal Healing Rate|Complete Mucosal Healing Rate|Clinical Response Rate Based on Partial Mayo Score|Clinical Remission Rate Based on Partial Mayo Score|Modified Clinical Remission Rate 1|Modified Clinical Remission Rate 2|Percentage of Rectal Bleeding Subscore of 0|Change From Baseline in Mayo score|Change From Baseline in Partial Mayo Score|Change From Baseline in Fecal Calprotectin|Change From Baseline in Peripheral Blood White Blood Cell (WBC) Differentiation (Neutrophil, Eosinophil, Basophil, Lymphocyte, and Monocyte Counts)","EA Pharma Co., Ltd.|Kissei Pharmaceutical Co., Ltd.|Eisai Inc.","All","16 Years to 74 Years   (Child, Adult, Older Adult)","Phase 3","198","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","AJM300/CT3|JapicCTI-183924","June 6, 2018","December 16, 2020","March 31, 2023","May 22, 2018",,"May 19, 2021","AJM300/CT3 trial site 41, Nagoya, Aichi, Japan|AJM300/CT3 trial site 57, Nagoya, Aichi, Japan|AJM300/CT3 trial site 63, Nagoya, Aichi, Japan|AJM300/CT3 trial site 9, Toyoake, Aichi, Japan|AJM300/CT3 trial site 33, Toyohashi, Aichi, Japan|AJM300/CT3 trial site 42, Toyota, Aichi, Japan|AJM300/CT3 trial site 39, Hirosaki, Aomori, Japan|AJM300/CT3 trial site 49, Hirosaki, Aomori, Japan|AJM300/CT3 trial site 11, Kashiwa, Chiba, Japan|AJM300/CT3 trial site 51, Kashiwa, Chiba, Japan|AJM300/CT3 trial site 73, Sakura, Chiba, Japan|AJM300/CT3 trial site 54, Urayasu, Chiba, Japan|AJM300/CT3 trial site 81, Matsuyama, Ehime, Japan|AJM300/CT3 trial site 53, Kurume, Fukuoka, Japan|AJM300/CT3 trial site 24, Tikushino, Fukuoka, Japan|AJM300/CT3 trial site 55, Isesaki, Gunma, Japan|AJM300/CT3 trial site 35, Fukuyama, Hiroshima, Japan|AJM300/CT3 trial site 18, Asahikawa, Hokkaido, Japan|AJM300/CT3 trial site 26, Asahikawa, Hokkaido, Japan|AJM300/CT3 trial site 2, Sapporo, Hokkaido, Japan|AJM300/CT3 trial site 3, Sapporo, Hokkaido, Japan|AJM300/CT3 trial site 4, Sapporo, Hokkaido, Japan|AJM300/CT3 trial site 79, Akashi, Hyogo, Japan|AJM300/CT3 trial site 34, Kobe, Hyogo, Japan|AJM300/CT3 trial site 64, Nishinomiya, Hyogo, Japan|AJM300/CT3 trial site 82, Kasama, Ibaraki, Japan|AJM300/CT3 trial site 75, Tsukuba, Ibaraki, Japan|AJM300/CT3 trial site 19, Morioka, Iwate, Japan|AJM300/CT3 trial site 16, Takamatsu, Kagawa, Japan|AJM300/CT3 trial site 12, Kamakura, Kanagawa, Japan|AJM300/CT3 trial site 14, Sagamihara, Kanagawa, Japan|AJM300/CT3 trial site 32, Sagamihara, Kanagawa, Japan|AJM300/CT3 trial site 13, Yokohama, Kanagawa, Japan|AJM300/CT3 trial site 6, Yokohama, Kanagawa, Japan|AJM300/CT3 trial site 47, Tsu, Mie, Japan|AJM300/CT3 trial site 46, Yokkaichi, Mie, Japan|AJM300/CT3 trial site 45, Sendai, Miyagi, Japan|AJM300/CT3 trial site 50, Sendai, Miyagi, Japan|AJM300/CT3 trial site 78, Sendai, Miyagi, Japan|AJM300/CT3 trial site 22, Nagaoka, Nigata, Japan|AJM300/CT3 trial site 15, Kurashiki, Okayama, Japan|AJM300/CT3 trial site 70, Kurashiki, Okayama, Japan|AJM300/CT3 trial site 77, Higashiosaka, Osaka, Japan|AJM300/CT3 trial site 76, Osakasayama, Osaka, Japan|AJM300/CT3 trial site 10, Takatsuki, Osaka, Japan|AJM300/CT3 trial site 40, Ageo, Saitama, Japan|AJM300/CT3 trial site 5, Ageo, Saitama, Japan|AJM300/CT3 trial site 72, Tokorozawa, Saitama, Japan|AJM300/CT3 trial site 17, Hamamatsu, Shizuoka, Japan|AJM300/CT3 trial site 60, Ashikaga, Tochigi, Japan|AJM300/CT3 trial site 29, Shimotsuga, Tochigi, Japan|AJM300/CT3 trial site 71, Utsunomiya, Tochigi, Japan|AJM300/CT3 trial site 61, Bunkyo, Tokyo, Japan|AJM300/CT3 trial site 68, Bunkyo, Tokyo, Japan|AJM300/CT3 trial site 59, Chiyoda, Tokyo, Japan|AJM300/CT3 trial site 30, Chuo, Tokyo, Japan|AJM300/CT3 trial site 31, Hachioji, Tokyo, Japan|AJM300/CT3 trial site 56, Minato, Tokyo, Japan|AJM300/CT3 trial site 66, Minato, Tokyo, Japan|AJM300/CT3 trial site 80, Mitaka, Tokyo, Japan|AJM300/CT3 trial site 38, Shinagawa, Tokyo, Japan|AJM300/CT3 trial site 21, Shinjuku, Tokyo, Japan|AJM300/CT3 trial site 52, Shinjuku, Tokyo, Japan|AJM300/CT3 trial site 8, Shūnan, Yamaguchi, Japan|AJM300/CT3 trial site 23, Kofu, Yamanashi, Japan|AJM300/CT3 trial site 44, Chiba, Japan|AJM300/CT3 trial site 43, Fukuoka, Japan|AJM300/CT3 trial site 58, Fukuoka, Japan|AJM300/CT3 trial site 69, Fukuoka, Japan|AJM300/CT3 trial site 67, Gifu, Japan|AJM300/CT3 trial site 28, Hiroshima, Japan|AJM300/CT3 trial site 36, Hiroshima, Japan|AJM300/CT3 trial site 74, Hiroshima, Japan|AJM300/CT3 trial site 62, Kyoto, Japan|AJM300/CT3 trial site 7, Kyoto, Japan|AJM300/CT3 trial site 48, Nagasaki, Japan|AJM300/CT3 trial site 37, Oita, Japan|AJM300/CT3 trial site 65, Okayama, Japan|AJM300/CT3 trial site 1, Osaka, Japan|AJM300/CT3 trial site 20, Saga, Japan|AJM300/CT3 trial site 25, Saga, Japan|AJM300/CT3 trial site 27, Toyama, Japan",,"https://ClinicalTrials.gov/show/NCT03531892"
504,"NCT02130362","A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)","CAPE","Active, not recruiting","No Results Available","Crohn's Disease",,"Number of treatment-emergent AESI per 100 PYs of infections and malignancies|Percentage of subjects with SAEs|Number of treatment-emergent other AESI per 100 PYs|Percentage of subjects with other AESI|Number of subjects with Adverse Events of Special Interest (AESI) of infections, malignancies, and pregnancies|Number of subjects with other AESI|Number of treatment-emergent SAEs per 100 patient years (PYs)|Number of subjects with Serious Adverse Events (SAEs)|Percentage of subjects with AESI of infections, malignancies, and pregnancies|Short Pediatric Crohn's Disease Activity Index (sh-PCDAI)|Short Quality of Life in Inflammatory Bowel Disease Questionnaire (SIBDQ)|Work Productivity and Activity Impairment (WPAI) questionnaire|Physician's Global Assessment of Disease Activity (PGA)|IMPACT III","AbbVie","All","6 Years to 17 Years   (Child)",,"1446","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","P11-292","August 28, 2014","March 2, 2028","March 2, 2028","May 5, 2014",,"July 2, 2021","Univ Alabama, Birmingham CCC /ID# 146060, Birmingham, Alabama, United States|University of South Alabama /ID# 137255, Mobile, Alabama, United States|Phoenix Children's Hospital /ID# 141336, Phoenix, Arizona, United States|Childrens Hospital LA /ID# 141551, Los Angeles, California, United States|Private practice: Dr. Shervin Rabizadeh /ID# 137269, Los Angeles, California, United States|Rady Children's Hospital San Diego /ID# 140883, San Diego, California, United States|Univ California, San Francisco /ID# 141312, San Francisco, California, United States|Children's Hospital Colorado /ID# 137261, Aurora, Colorado, United States|CT Childrens Medical Ctr, US /ID# 137265, Hartford, Connecticut, United States|Yale University /ID# 137257, New Haven, Connecticut, United States|Nemours Children's Specilaity Clinic-Jacksonville /ID# 148498, Jacksonville, Florida, United States|University of Miami /ID# 140893, Miami, Florida, United States|Winship Cancer Institute of Emory University /ID# 144274, Atlanta, Georgia, United States|Children's Ctr Digestive, US /ID# 144625, Atlanta, Georgia, United States|Children's Hosp New Orleans /ID# 144477, New Orleans, Louisiana, United States|Maine Medical Partners /ID# 147685, Portland, Maine, United States|Tufts Medical Center /ID# 143581, Boston, Massachusetts, United States|Massachusetts General Hospital /ID# 141552, Boston, Massachusetts, United States|Boston Childrens Hospital /ID# 164102, Boston, Massachusetts, United States|University of Massachusetts Medical Center /ID# 148325, Worcester, Massachusetts, United States|University of Minnesota /ID# 137238, Minneapolis, Minnesota, United States|Univ of Mississippi Med Ctr,US /ID# 137239, Jackson, Mississippi, United States|Goryeb Chidlren's Hospital /ID# 144275, Morristown, New Jersey, United States|Women and Childrens Hosp /ID# 143778, Buffalo, New York, United States|CCMC - Steven and Alexandra Cohen Children's Medical Center of New York /ID# 137266, New Hyde Park, New York, United States|Columbia Univ Medical Center /ID# 144440, New York, New York, United States|Columbia Univ Medical Center /ID# 144475, New York, New York, United States|Univ Med Ctr at Stony Brook /ID# 140913, Stony Brook, New York, United States|SUNY Upstate Medical University /ID# 148437, Syracuse, New York, United States|Univ NC Chapel Hill /ID# 137236, Chapel Hill, North Carolina, United States|Duke Cancer Center /ID# 137268, Durham, North Carolina, United States|Children's Hospital Oklahoma /ID# 144047, Oklahoma City, Oklahoma, United States|Geisinger Medical Center /ID# 149910, Danville, Pennsylvania, United States|Penn State Child Hosp.Hersh,PA /ID# 144476, Hershey, Pennsylvania, United States|Medical University of South Carolina /ID# 144473, Charleston, South Carolina, United States|Children's Medical Center /ID# 149256, Dallas, Texas, United States|Cook Children's Med. Center /ID# 144474, Fort Worth, Texas, United States|Texas Children's Hospital /ID# 148211, Houston, Texas, United States|University Of Vermont Medical /ID# 137263, Burlington, Vermont, United States|Pediatric Specialty of VA /ID# 142831, Fairfax, Virginia, United States|Swedish Medical Center /ID# 137258, Seattle, Washington, United States|Seattle Children's Hospital /ID# 140879, Seattle, Washington, United States|Multicare Institute for Research and Innovation /ID# 152120, Tacoma, Washington, United States|Children's Hospital Wisconsin - Milwaukee Campus /ID# 137259, Milwaukee, Wisconsin, United States|University Clinical Center Tuzla /ID# 130638, Tuzla, Tuzlanski, Bosnia and Herzegovina|SHAT Hematologic Diseases /ID# 143572, Sofia, Bulgaria|Alberta Health Services /ID# 128717, Edmonton, Alberta, Canada|University of Manitoba /ID# 141310, Winnipeg, Manitoba, Canada|IWK Health Center /ID# 127912, Halifax, Nova Scotia, Canada|The Univ of Western Ontario /ID# 137962, London, Ontario, Canada|Hospital for Sick Children /ID# 127910, Toronto, Ontario, Canada|Klinicki bolnicki centar Sestre milosrdnice /ID# 128256, Zagreb, Grad Zagreb, Croatia|Zadar General Hospital /ID# 129830, Zadar, Croatia|FN Hradec Kralove /ID# 128521, Hradec Kralove, Czechia|Fakultni nemocnice Olomouc /ID# 127437, Olomouc, Czechia|Univ Hosp Ostrava-Poruba /ID# 127913, Ostrava, Czechia|Fakult Nem Kralovske Vinohrady /ID# 127697, Prague, Czechia|Krajska zdravotni a.s. Masarykova nemocnice v Usti nad Labem o.z. /ID# 129829, Usti Nad Labem, Czechia|Kobenhavns Universitet - Hvidovre Hospital (HH) /ID# 146013, Hvidovre, Denmark|Tallinn Children's Hospital /ID# 126974, Tallinn, Estonia|Children's Clinic Of Tartu Uni /ID# 146017, Tartu, Estonia|Hospices Civils de Lyon /ID# 128193, Bron, France|Necker Hopital, FR /ID# 147702, Paris, France|Universitaetsklinikum Ulm /ID# 148444, Ulm, Baden-Wuerttemberg, Germany|Universitaetsklinikum Erlangen /ID# 137274, Erlangen, Bayern, Germany|Universitatsklinikum Munster /ID# 148441, Munster, Niedersachsen, Germany|Universitaetsklinikum Aachen /ID# 126591, Aachen, Nordrhein-Westfalen, Germany|Universitaetsklinikum Carl Gustav Carus an der TU Dresden /ID# 127696, Dresden, Sachsen, Germany|Froehlich Gemeinschaftspraxis /ID# 127975, Forchheim, Germany|Duplicate_Universitaetsklinikum Freiburg /ID# 130010, Freiburg, Germany|Kinderarztpraxis Neuhausen /ID# 144402, Munich, Germany|Christliches Kinderhospital Osnabrueck /ID# 136629, Osnabrueck, Germany|Universitaetsklinikum Regensburg /ID# 137140, Regensburg, Germany|Agia Sofia Hospital /ID# 134349, Athens, Attiki, Greece|General Hospital of Chest Diseases of Athens SOTIRIA /ID# 147690, Athens, Attiki, Greece|Iatriko Kentro Athinon /ID# 130639, Marousi, Attiki, Greece|Venizeleio General Hospital /ID# 147335, Heraklion, Greece|Duplicate_Duplicate_GENERAL HOSPITAL OF THESSALONIKI GENNIMATAS /ID# 163658, Thessaloniki, Greece|Our Lady's Hospital /ID# 127438, Manorhamilton, Ireland|Duplicate_Ha'Emek Medical Center /ID# 156316, Afula, Israel|Assaf Harofeh Medical Center /ID# 157182, Be'Er Ya'Akov, Israel|Rambam Health Care Campus /ID# 162061, Haifa, Israel|Carmel Medical Center /ID# 151519, Haifa, Israel|Shaare Zedek Medical Center /ID# 144277, Jerusalem, Israel|Schneider Children's Medical Center /ID# 152683, Petah Tikva, Israel|Edmond And Lily Safra Children /ID# 148730, Ramat Gan, Israel|Kaplan Medical Center /ID# 152945, Rehovot, Israel|Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 141962, Rome, Lazio, Italy|Duplicate_POLICLINICO PAOLO GIACCONE /ID# 138410, Palermo, Sicilia, Italy|Ospedale Maggiore Carlo Alberto Pizzardi /ID# 147347, Bologna, Italy|A.O.U. Policlinico G. Martino /ID# 141683, Messina, Italy|ASST Fatebenefratelli Sacco - Ospedale Fatebenefratelli e Oftalmico /ID# 144279, Milano, Italy|ASST Fatebenefratelli Sacco/Ospedale dei Bambini Vittore Buzzi /ID# 141679, Milan, Italy|Duplicate_Universita di Napoli Federico II /ID# 144280, Naples, Italy|A.O. Ospedali Riuniti Villa Sofia - Cervello /ID# 152684, Palermo, Italy|Azienda Ospedaliero-Universitaria di Parma /ID# 147441, Parma, Italy|Azienda Sanitaria Locale di Pescara /ID# 141307, Pescara, Italy|Hospital of Lithuanian University of Health Sciences Kaunas Clinics /ID# 127809, Kaunas, Lithuania|Vilnius University Hospital /ID# 127810, Vilnius, Lithuania|Erasmus Medisch Centrum /ID# 141841, Rotterdam, Zuid-Holland, Netherlands|Academisch Medisch Centrum /ID# 141843, Amsterdam, Netherlands|CCA Braga - Hospital de Braga /ID# 138269, Braga, Portugal|Centro Hospitalar Universitario de Sao Joao, EPE /ID# 138146, Porto, Portugal|Ctr. Gastroenterologia Ped Oes /ID# 140875, Mayaguez, Puerto Rico|Spitalul Clinic de Urgenta pentru Copii- Pediatrie II-Nefrologie Pediatrica /ID# 131297, Cluj-Napoca, Cluj, Romania|Spitalul Clinic de Urgenta pentru Copii Louis Turcanu /ID# 130251, Timisoara, Timis, Romania|Spitalul Clinic de Urgenta Pentru Copii Grigore Alexandrescu /Id# 130358, Bucharest, Romania|Spitalul Clinic Judetean de Urgenta Targu Mures /ID# 137014, Targu Mures, Romania|Hospital Arquitecto Marcide - Complejo Hospitalario Universitario de Ferrol /ID# 138462, Ferrol, A Coruna, Spain|Hospital Clínico Universitario de Santiago-CHUS /ID# 141667, Santiago de Compostela, A Coruna, Spain|Hospital Universitario Central de Asturias /ID# 163053, Oviedo, Asturias, Spain|Hospital Universitario Germans Trias i Pujol /ID# 139400, Badalona, Barcelona, Spain|Hospital Sant Joan de Deu /ID# 152059, Esplugues de Llobregat, Barcelona, Spain|Consorci Corporacio Sanitaria Parc Tauli Sabadell /ID# 149029, Sabadell, Barcelona, Spain|Hospital Universitari Son Espases /ID# 147446, Palma de Mallorca, Illes Balears, Spain|Hospital Universitario Severo Ochoa /ID# 141545, Leganes, Madrid, Spain|Hospital Universitario Puerta de Hierro, Majadahonda /ID# 157872, Majadahonda, Madrid, Spain|Hospital Regional de Malaga /ID# 144289, Málaga, Malaga, Spain|Hospital Clinico Universitario Virgen de la Arrixaca /ID# 138460, El Palmar, Murcia, Spain|OSI Ezkerraldea-Enkarterri-Cruces /ID# 141781, Barakaldo, Vizcaya, Spain|Hospital Universitario A Coruna - CHUAC /ID# 137235, A Coruna, Spain|Hospital Universitario Vall d'Hebron /ID# 141778, Barcelona, Spain|Hospital Universitario Vall d'Hebron /ID# 146015, Barcelona, Spain|Hospital General de Granollers /ID# 140882, Barcelona, Spain|Hospital Universitario de Girona Doctor Josep Trueta /ID# 147572, Girona, Spain|Hospital Infantil Universitario Nino Jesus /ID# 165738, Madrid, Spain|Hospital Universitario 12 de Octubre /ID# 136998, Madrid, Spain|Hospital Universitario La Paz /ID# 161152, Madrid, Spain|Compl Hospital Univer de Vigo /ID# 136999, Pontevedra, Spain|Hospital Universitario Dr. Peset /ID# 159484, Valencia, Spain|Hospital Universitario y Politecnico La Fe /ID# 141847, Valencia, Spain|Karolinska University Hospital Solna /ID# 129045, Solna, Stockholms Lan, Sweden|University Hospital Southampton NHS Foundation Trust /ID# 147538, Southampton, Hampshire, United Kingdom|The Royal London Hospital /ID# 128471, London, London, City Of, United Kingdom|Royal Aberdeen Childrens Hosp /ID# 131296, Aberdeen, United Kingdom|Birmingham Childrens Hospital /ID# 136631, Birmingham, United Kingdom|Addenbrookes Hospital /ID# 143779, Cambridge, United Kingdom|Epsom & St Helier University Hospital NHS Trust /ID# 150097, Carshalton, United Kingdom|University of Dundee - NHS Tayside /ID# 131592, Derby, United Kingdom|Glasgow West Ambulatory Care Hospital /ID# 127436, Glasgow, United Kingdom|Alder Hey Children's Hospital /ID# 138013, Liverpool, United Kingdom|St. George's Healthcare NHS /ID# 131590, London, United Kingdom|Manchester University NHS Foundation Trust, Royal Manchester Children's Hospital /ID# 128476, Manchester, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 147438, Newcastle Upon Tyne, United Kingdom|Sheffield Children's Hospital /ID# 130370, Sheffield, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02130362"
505,"NCT02926300","Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)",,"Recruiting","No Results Available","Crohn's Disease","Biological: stem cells","all kinds of adverse events which occur during the clinical sutdy|ratio of patients who is applicable to CDAI<150|ratio of patients who reduce CDAI over 70 as contrasted witd baseline(V7)","Kang Stem Biotech Co., Ltd.","All","19 Years to 70 Years   (Adult, Older Adult)",,"24","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","KSTHD_FURESTEM-CD-EXT","November 2015","October 2021","November 2021","October 6, 2016",,"September 6, 2017","Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Yeungnam University Medical Center, Daegu, Korea, Republic of|Seoul National Universtiy Bundang Hospital, Seongnam-si, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Soeul National University Hospital, Soeul, Korea, Republic of|The Catholic University of Korea, St. Vincent'S Hospital., Suwon-si, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT02926300"
506,"NCT03172377","Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients","LADI","Active, not recruiting","No Results Available","Crohn Disease in Remission|Crohn Disease","Other: Lengthening adalimumab dosing interval","Cumulative incidence of persistent disease flares.|Cumulative incidence of transient disease flares.|(Serious) adverse event rate|Whether adalimumab drug level is associated with successful interval lengthening|Whether biochemic FC or CRP are associated with successful interval lengthening|Whether co-medication use is associated with successful interval lengthening|The decremental cost effectiveness ratio of this interval lengthening strategy","Radboud University|Erasmus Medical Center","All","18 Years and older   (Adult, Older Adult)","Phase 4","174","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","NL58948.091.16|848015002|2016-003321-42","May 3, 2017","January 2022","July 2022","June 1, 2017",,"September 16, 2020","Radboud university medical center, Nijmegen, Gelderland, Netherlands|Jeroen Bosch Ziekenhuis, 's Hertogenbosch, Noord-Brabant, Netherlands|Amphia Ziekenhuis, Breda, Noord-Brabant, Netherlands|Bernhoven, Uden, Noord-Brabant, Netherlands|VU Medisch Centrum, Amsterdam, Noord-Holland, Netherlands|Albert Schweitzer Ziekenhuis, Dordrecht, Zuid-Holland, Netherlands|Franciscus Gasthuis & Vlietland, Rotterdam, Zuid-Holland, Netherlands|Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands|Ikazia Ziekenhuis, Rotterdam, Zuid-Holland, Netherlands|Flevoziekenhuis, Almere, Netherlands|AmsterdamUMC - location AMC, Amsterdam, Netherlands|Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, Netherlands|Reinier de Graaf, Delft, Netherlands|Maxima Medisch Centrum, Eindhoven, Netherlands|Medisch Spectrum Twente, Enschede, Netherlands|Zuyderland ziekenhuis, Geleen, Netherlands|Spaarne Gasthuis, Haarlem, Netherlands|Leids Universitair Medisch Centrum, Leiden, Netherlands|Maastricht UMC+, Maastricht, Netherlands|Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands|Elisabeth-TweeSteden Ziekenhuis, Tilburg, Netherlands|UMC Utrecht, Utrecht, Netherlands",,"https://ClinicalTrials.gov/show/NCT03172377"
507,"NCT04528914","Low-FODMAP Diet for FAPD in Children.",,"Not yet recruiting","No Results Available","Functional Abdominal Pain Disorder","Other: Low-FODMAP diet","Change in abdominal pain intensity|Change in stool consistency|Change in abdominal pain frequency|Change in Gastrointestinal Symptom Rating Scale (GSRS) total score|Change in KIDSCREEN-10 index total score|Change in World Health Organization Five Well-Being Index (WHO-5) total score|Change in percentage of school attendance associated with IBS symptoms|Change in percentage of parents' work absenteeism associated with IBS symptoms in child|Change in BMI-for-age z-score|Percentage of compliant participants|Percentage of tolerability of the low-FODMAP diet|Adverse events","Medical University of Warsaw|Nutricia Foundation","All","8 Years to 18 Years   (Child, Adult)","Not Applicable","74","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","1W44/5FNUT13/20","September 2020","August 2022","August 2022","August 27, 2020",,"August 27, 2020","Department of Paediatrics, The Medical University of Warsaw, Warsaw, Poland",,"https://ClinicalTrials.gov/show/NCT04528914"
508,"NCT03920254","TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study",,"Recruiting","No Results Available","Ulcerative Colitis (UC)","Drug: TD-1473 Dose A|Drug: TD-1473 Dose B|Drug: TD-1473 Dose C","Adverse Events|Laboratory Safety tests|ECGs|Vital Signs","Theravance Biopharma","All","18 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","500","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","0164|2018-002135-19","July 23, 2020","September 2028","September 2028","April 18, 2019",,"January 7, 2021","Theravance Biopharma Investigational Site, Chula Vista, California, United States|Theravance Biopharma Investigational Site, Lancaster, California, United States|Theravance Biopharma Investigational Site, Orange, California, United States|Theravance Biopharma Investigational Site, Colorado Springs, Colorado, United States|Theravance Biopharma Investigational Site, Aventura, Florida, United States|Theravance Biopharma Investigational Site, Clearwater, Florida, United States|Theravance Biopharma Investigational Site, Hialeah, Florida, United States|Theravance Biopharma Investigational Site, Largo, Florida, United States|Theravance Biopharma Investigational Site, Miami, Florida, United States|Theravance Biopharma Investigational Site, Miami, Florida, United States|Theravance Biopharma Investigational Site, New Port Richey, Florida, United States|Theravance Biopharma Investigational Site, New Smyrna Beach, Florida, United States|Theravance Biopharma Investigational Site, Orlando, Florida, United States|Theravance Biopharma Investigational Site, Pembroke Pines, Florida, United States|Theravance Biopharma Investigational Site, Atlanta, Georgia, United States|Theravance Biopharma Investigational Site, Suwanee, Georgia, United States|Theravance Biopharma Investigational Site, Idaho Falls, Idaho, United States|Theravance Biopharma Investigational Site, Kansas City, Kansas, United States|Theravance Biopharma Investigational Site, Louisville, Kentucky, United States|Theravance Biopharma Investigational Site, Monroe, Louisiana, United States|Theravance Biopharma Investigational Site, Baltimore, Maryland, United States|Theravance Biopharma Investigational Site, Brockton, Massachusetts, United States|Theravance Biopharma Investigational Site, Troy, Michigan, United States|Theravance Biopharma Investigational Site, Wyoming, Michigan, United States|Theravance Biopharma Investigational Site, Rochester, Minnesota, United States|Theravance Biopharma Investigational Site, Kansas City, Missouri, United States|Theravance Biopharma Investigational Site, Las Vegas, Nevada, United States|Theravance Biopharma Investigational Site, New York, New York, United States|Theravance Biopharma Investigational Site, Charlotte, North Carolina, United States|Theravance Biopharma Investigational Site, Gastonia, North Carolina, United States|Theravance Biopharma Investigational Site, Greenville, North Carolina, United States|Theravance Biopharma Investigational Site, Tulsa, Oklahoma, United States|Theravance Biopharma Investigational Site, Pittsburgh, Pennsylvania, United States|Theravance Biopharma Investigational Site, Smithfield, Pennsylvania, United States|Theravance Biopharma Investigational Site, Greenville, South Carolina, United States|Theravance Biopharma Investigational Site, Rock Hill, South Carolina, United States|Theravance Biopharma Investigational Site, Jackson, Tennessee, United States|Theravance Biopharma Investigational Site, Nashville, Tennessee, United States|Theravance Biopharma Investigational Site, Garland, Texas, United States|Theravance Biopharma Investigational Site, Houston, Texas, United States|Theravance Biopharma Investigational Site, San Antonio, Texas, United States|Theravance Biopharma Investigational Site, South Brisbane, Queensland, Australia|Theravance Biopharma Investigational Site, Woolloongabba, Queensland, Australia|Theravance Biopharma Investigational Site, Malvern, Victoria, Australia|Theravance Biopharma Investigational Site, Murdoch, Western Australia, Australia|Theravance Biopharma Investigational Site, Sofia, Sofiya, Bulgaria|Theravance Biopharma Investigational Site, Sofia, Sofiya, Bulgaria|Theravance Biopharma Investigational Site, Sofia, Sofiya, Bulgaria|Theravance Biopharma Investigational Site #2, Pleven, Bulgaria|Theravance Biopharma Investigational Site, Pleven, Bulgaria|Theravance Biopharma Investigational Site, Plovdiv, Bulgaria|Theravance Biopharma Investigational Site, Plovdiv, Bulgaria|Theravance Biopharma Investigational Site, Ruse, Bulgaria|Theravance Biopharma Investigational Site, Sliven, Bulgaria|Theravance Biopharma Investigational Site, Sofia, Bulgaria|Theravance Biopharma Investigational Site, Stara Zagora, Bulgaria|Theravance Biopharma Investigational Site, Stara Zagora, Bulgaria|Theravance Biopharma Investigational Site, Veliko Tarnovo, Bulgaria|Theravance Biopharma Investigational Site, Kingston, Ontario, Canada|Theravance Biopharma Investigational Site, Reims, Champagne-ardenne, France|Theravance Biopharma Investigational Site, Montpellier Cedex 5, Languedoc-roussillon, France|Theravance Biopharma Investigational Site, Vandœuvre-lès-Nancy Cedex, Limousin, France|Theravance Biopharma Investigational Site, Toulouse Cedex 9, Midi-pyrenees, France|Theravance Biopharma Investigational Site, Lille Cedex, NORD Pas-de-calais, France|Theravance Biopharma Investigational Site, Nantes, PAYS DE LA Loire, France|Theravance Biopharma Investigational Site, Amiens Cedex 1, Picardie, France|Theravance Biopharma Investigational Site, Pierre-Bénite, Rhone-alpes, France|Theravance Biopharma Investigational Site, Saint-Étienne, Rhone-alpes, France|Theravance Biopharma Investigational Site, Batumi, Georgia|Theravance Biopharma Investigational Site, Tbilisi, Georgia|Theravance Biopharma Investigational Site, Tbilisi, Georgia|Theravance Biopharma Investigational Site, Heidelberg, Baden Wuerttemberg, Germany|Theravance Biopharma Investigational Site, Kiel, Schleswig-holstein, Germany|Theravance Biopharma Investigational Site, Berlin, Germany|Theravance Biopharma Investigational Site, Berlin, Germany|Theravance Biopharma Investigational Site, Athens, Attica, Greece|Theravance Biopharma Investigational Site #2, Athens, Attica, Greece|Theravance Biopharma Investigational Site, Heraklion, Crete, Greece|Theravance Biopharma Investigational Site, Patra, Peloponnese, Greece|Theravance Biopharma Investigational Site, Szekesfehervar, Fejer, Hungary|Theravance Biopharma Investigational Site, Debrecen, Hajdu-bihar, Hungary|Theravance Biopharma Investigational Site, Szekszárd, Tolna, Hungary|Theravance Biopharma Investigational Site, Budapest, Hungary|Theravance Biopharma Investigational Site, Budapest, Hungary|Theravance Biopharma Investigational Site, Budapest, Hungary|Theravance Biopharma Investigational Site, Zerifin, Rehoboth, Israel|Theravance Biopharma Investigational Site, Haifa, Israel|Theravance Biopharma Investigational Site, H̱olon, Israel|Theravance Biopharma Investigational Site, Jerusalem, Israel|Theravance Biopharma Investigational Site, Nahariya, Israel|Theravance Biopharma Investigational Site, Pethah Tiqvā, Israel|Theravance Biopharma Investigational Site, Reẖovot, Israel|Theravance Biopharma Investigational Site, Rozzano, Milano, Italy|Theravance Biopharma Investigational Site, Catanzaro, Italy|Theravance Biopharma Investigational Site, Pavia, Italy|Theravance Biopharma Investigational Site, Nagoya, Aichi, Japan|Theravance Biopharma Investigational Site, Abiko, Chiba, Japan|Theravance Biopharma Investigational Site, Sakura, Chiba, Japan|Theravance Biopharma Investigational Site, Kurume, Fukuoka, Japan|Theravance Biopharma Investigational Site, Ōgaki, Gifu, Japan|Theravance Biopharma Investigational Site, Isesaki, Gunma, Japan|Theravance Biopharma Investigational Site, Hiroshima, Hiroshima-ken, Japan|Theravance Biopharma Investigational Site, Hatsukaichi, Hiroshima, Japan|Theravance Biopharma Investigational Site, Kawasaki, Kanagawa, Japan|Theravance Biopharma Investigational Site, Sendai, Miyagi, Japan|Theravance Biopharma Investigational Site, Suwa, Nagano, Japan|Theravance Biopharma Investigational Site, Ōita, Oita, Japan|Theravance Biopharma Investigational Site, Fujiidera, Osaka, Japan|Theravance Biopharma Investigational Site, Izumiotsu, Osaka, Japan|Theravance Biopharma Investigational Site, Ageo Shi, Saitama Ken, Japan|Theravance Biopharma Investigational Site, Tokorozawa, Saitama, Japan|Theravance Biopharma Investigational Site, Kurobe, Toyama, Japan|Theravance Biopharma Investigational Site, Chiba, Japan|Theravance Biopharma Investigational Site, Fukuoka, Japan|Theravance Biopharma Investigational Site, Kumamoto, Japan|Theravance Biopharma Investigational Site, Tokyo, Japan|Theravance Biopharma Investigational Site, Tokyo, Japan|Theravance Biopharma Investigational Site, Tokyo, Japan|Theravance Biopharma Investigational Site, Wŏnju, Gangwon-do, Korea, Republic of|Theravance Biopharma Investigational Site, Suwon, Gyeonggi-do, Korea, Republic of|Theravance Biopharma Investigational Site, Daegu, Korea, Republic of|Theravance Biopharma Investigational Site, Seoul, Korea, Republic of|Theravance Biopharma Investigational Site, Seoul, Korea, Republic of|Theravance Biopharma Investigational Site, Seoul, Korea, Republic of|Theravance Biopharma Investigational Site, Seoul, Korea, Republic of|Theravance Biopharma Investigational Site, Wrocław, Dolnoslaskie, Poland|Theravance Biopharma Investigational Site, Wrocław, Dolnoslaskie, Poland|Theravance Biopharma Investigational Site, Toruń, Kujawsko-Pomorskie, Poland|Theravance Biopharma Investigational Site, Włocławek, Kujawsko-Pomorskie, Poland|Theravance Biopharma Investigational Site, Ksawerów, Lodzkie, Poland|Theravance Biopharma Investigational Site, Łódź, Lodzkie, Poland|Theravance Biopharma Investigational Site, Łódź, Lodzkie, Poland|Theravance Biopharma Investigational Site, Kraków, Malopolskie, Poland|Theravance Biopharma Investigational Site, Piaseczno, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Warszawa, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Warszawa, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Warszawa, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Warszawa, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Sopot, Pomorskie, Poland|Theravance Biopharma Investigational Site, Tychy, Slaskie, Poland|Theravance Biopharma Investigational Site, Poznań, Wielkopolskie, Poland|Theravance Biopharma Investigational Site, Poznań, Wielkopolskie, Poland|Theravance Biopharma Investigational Site, Szczecin, Zachodniopomorskie, Poland|Theravance Biopharma Investigational Site, Szczecin, Zachodniopomorskie, Poland|Theravance Biopharma Investigational Site, Świętokrzyskie, Poland|Theravance Biopharma Investigational Site, Coimbra, Portugal|Theravance Biopharma Investigational Site, Guimarães, Portugal|Theravance Biopharma Investigational Site, Leiria, Portugal|Theravance Biopharma Investigational Site, Lisboa, Portugal|Theravance Biopharma Investigational Site, Santa Maria Da Feira, Portugal|Theravance Biopharma Investigational Site, Senhora Da Hora, Portugal|Theravance Biopharma Investigational Site, Viana Do Castelo, Portugal|Theravance Biopharma Investigational Site, Vila Nova de Gaia, Portugal|Theravance Biopharma Investigational Site, Timişoara, Timis, Romania|Theravance Biopharma Investigational Site, Bucuresti, Romania|Theravance Biopharma Investigational Site, Belgrade, Serbia|Theravance Biopharma Investigational Site, Belgrade, Serbia|Theravance Biopharma Investigational Site, Kragujevac, Serbia|Theravance Biopharma Investigational Site, Nis, Serbia|Theravance Biopharma Investigational Site, Subotica, Serbia|Theravance Biopharma Investigational Site, Zrenjanin, Serbia|Theravance Biopharma Investigational Site, Prešov, Prešovsky, Slovakia|Theravance Biopharma Investigational Site, Nitra, Slovakia|Theravance Biopharma Investigational Site, Šahy, Slovakia|Theravance Biopharma Investigational Site, Johannesburg, Gauteng, South Africa|Theravance Biopharma Investigational Site, Johannesburg, South Africa|Theravance Biopharma Investigational Site, Barcelona, Spain|Theravance Biopharma Investigational Site, Madrid, Spain|Theravance Biopharma Investigational Site, Sevilla, Spain|Theravance Biopharma Investigational Site, Valencia, Spain|Theravance Biopharma Investigational Site, Kaohsiung, Kaohsiung City, Taiwan|Theravance Biopharma Investigational Site, Taichung, Taiwan|Theravance Biopharma Investigational Site, Tainan, Taiwan|Theravance Biopharma Investigational Site, Taipei, Taiwan|Theravance Biopharma Investigational Site, Kiev, Kiev City, Ukraine|Theravance Biopharma Investigational Site, Kyiv, Kiev, Ukraine|Theravance Biopharma Investigational Site, Kyiv, Kiev, Ukraine|Theravance Biopharma Investigational Site, Kremenchuk, Poltava, Ukraine|Theravance Biopharma Investigational Site, Úzhgorod, Transcarpathian, Ukraine|Theravance Biopharma Investigational Site, Úzhgorod, Transcarpathia, Ukraine|Theravance Biopharma Investigational Site #2, Vinnytsia, Vinnytsya, Ukraine|Theravance Biopharma Investigational Site, Vinnytsia, Vinnytsya, Ukraine|Theravance Biopharma Investigational Site, Vinnytsia, Vinnytsya, Ukraine|Theravance Biopharma Investigational Site, Chernivtsi, Ukraine|Theravance Biopharma Investigational Site, Kharkiv, Ukraine|Theravance Biopharma Investigational Site #2, Lviv, Ukraine|Theravance Biopharma Investigational Site, Lviv, Ukraine|Theravance Biopharma Investigational Site, Ternopil, Ukraine|Theravance Biopharma Investigational Site, Vinnytsia, Ukraine|Theravance Biopharma Investigational Site, Zaporizhzhya, Ukraine|Theravance Biopharma Investigational Site, Zaporizhzhya, Ukraine",,"https://ClinicalTrials.gov/show/NCT03920254"
509,"NCT03758443","Efficacy & Safety of TD-1473 in Ulcerative Colitis","RHEA","Recruiting","No Results Available","Ulcerative Colitis (UC)","Drug: TD-1473 Dose A|Drug: TD-1473 Dose B|Drug: TD-1473 Dose C|Drug: Placebo","Phase 2b Induction: Change from baseline in total Mayo score (tMS) at Week 8|Phase 3 Induction: Clinical remission by adapted Mayo score components at Week 8|Phase 3 Maintenance: Clinical remission by adapted Mayo score components at Maintenance (m) Week 44|Clinical remission by adapted Mayo Score Components at Week 8|Endoscopic healing at Week 8|Symptomatic remission at Week 8|Clinical response by Adapted Mayo score (aMS response) at Week 8|Mucosal healing at Week 8|Maintenance of clinical response at mWeek 44|Endoscopic healing at mWeek 44|Symptomatic remission at mWeek 44|Corticosteroid-free remission at mWeek 44|Maintenance of clinical remission at mWeek 44 in those who were in remission at mWeek 0|Mucosal healing at mWeek 44","Theravance Biopharma","All","18 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","880","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","0157","March 11, 2019","June 2025","July 2025","November 29, 2018",,"February 2, 2021","Theravance Biopharma Investigational Site, Chula Vista, California, United States|Theravance Biopharma Investigational Site, La Jolla, California, United States|Theravance Biopharma Investigational Site, Lancaster, California, United States|Theravance Biopharma Investigational Site, Orange, California, United States|Theravance Biopharma Investigational Site, Colorado Springs, Colorado, United States|Theravance Biopharma Investigational Site, Aventura, Florida, United States|Theravance Biopharma Investigational Site, Clearwater, Florida, United States|Theravance Biopharma Investigational Site, Hialeah, Florida, United States|Theravance Biopharma Investigational Site, Largo, Florida, United States|Theravance Biopharma Investigational Site, Miami, Florida, United States|Theravance Biopharma Investigational Site, Miami, Florida, United States|Theravance Biopharma Investigational Site, New Port Richey, Florida, United States|Theravance Biopharma Investigational Site, New Smyrna Beach, Florida, United States|Theravance Biopharma Investigational Site, Orlando, Florida, United States|Theravance Biopharma Investigational Site, Pembroke Pines, Florida, United States|Theravance Biopharma Investigational Site, Atlanta, Georgia, United States|Theravance Biopharma Investigational Site, Suwanee, Georgia, United States|Theravance Biopharma Investigational Site, Idaho Falls, Idaho, United States|Theravance Biopharma Investigational Site, Kansas City, Kansas, United States|Theravance Biopharma Investigational Site, Louisville, Kentucky, United States|Theravance Biopharma Investigational Site, Monroe, Louisiana, United States|Theravance Biopharma Investigational Site, Baltimore, Maryland, United States|Theravance Biopharma Investigational Site, Brockton, Massachusetts, United States|Theravance Biopharma Investigational Site, Troy, Michigan, United States|Theravance Biopharma Investigational Site, Wyoming, Michigan, United States|Theravance Biopharma Investigational Site, Rochester, Minnesota, United States|Theravance Biopharma Investigational Site, Kansas City, Missouri, United States|Theravance Biopharma Investigational Site, Las Vegas, Nevada, United States|Theravance Biopharma Investigational Site, New York, New York, United States|Theravance Biopharma Investigational Site, Charlotte, North Carolina, United States|Theravance Biopharma Investigational Site, Gastonia, North Carolina, United States|Theravance Biopharma Investigational Site, Greenville, North Carolina, United States|Theravance Biopharma Investigational Site, Tulsa, Oklahoma, United States|Theravance Biopharma Investigational Site, Pittsburgh, Pennsylvania, United States|Theravance Biopharma Investigational Site, Smithfield, Pennsylvania, United States|Theravance Biopharma Investigational Site, Greenville, South Carolina, United States|Theravance Biopharma Investigational Site, Rock Hill, South Carolina, United States|Theravance Biopharma Investigational Site, Jackson, Tennessee, United States|Theravance Biopharma Investigational Site, Nashville, Tennessee, United States|Theravance Biopharma Investigational Site, Garland, Texas, United States|Theravance Biopharma Investigational Site, Houston, Texas, United States|Theravance Biopharma Investigational Site, San Antonio, Texas, United States|Theravance Biopharma Investigational Site, South Brisbane, Queensland, Australia|Theravance Biopharma Investigational Site, Woolloongabba, Queensland, Australia|Theravance Biopharma Investigational Site, Malvern, Victoria, Australia|Theravance Biopharma Investigational Site, Murdoch, Western Australia, Australia|Theravance Biopharma Investigational Site, Sofia, Sofiya, Bulgaria|Theravance Biopharma Investigational Site, Sofia, Sofiya, Bulgaria|Theravance Biopharma Investigational Site, Sofia, Sofiya, Bulgaria|Theravance Biopharma Investigational Site (2), Pleven, Bulgaria|Theravance Biopharma Investigational Site, Pleven, Bulgaria|Theravance Biopharma Investigational Site, Plovdiv, Bulgaria|Theravance Biopharma Investigational Site, Plovdiv, Bulgaria|Theravance Biopharma Investigational Site, Ruse, Bulgaria|Theravance Biopharma Investigational Site, Sliven, Bulgaria|Theravance Biopharma Investigational Site, Sofia, Bulgaria|Theravance Biopharma Investigational Site, Stara Zagora, Bulgaria|Theravance Biopharma Investigational Site, Stara Zagora, Bulgaria|Theravance Biopharma Investigational Site, Veliko Tarnovo, Bulgaria|Theravance Biopharma Investigational Site, Kingston, Ontario, Canada|Theravance Biopharma Investigational Site, Reims, Champagne-ardenne, France|Theravance Biopharma Investigational Site, Montpellier Cedex 5, Languedoc-roussillon, France|Theravance Biopharma Investigational Site, Vandœuvre-lès-Nancy Cedex, Limousin, France|Theravance Biopharma Investigational Site, Toulouse Cedex 9, Midi-pyrenees, France|Theravance Biopharma Investigational Site, Lille Cedex, NORD Pas-de-calais, France|Theravance Biopharma Investigational Site, Nantes, PAYS DE LA Loire, France|Theravance Biopharma Investigational Site, Amiens Cedex 1, Picardie, France|Theravance Biopharma Investigational Site, Pierre Bénite, Rhone-alpes, France|Theravance Biopharma Investigational Site, Saint-Etienne, Rhone-alpes, France|Theravance Biopharma Investigational Site, Batumi, Georgia|Theravance Biopharma Investigational Site, Tbilisi, Georgia|Theravance Biopharma Investigational Site, Tbilisi, Georgia|Theravance Biopharma Investigational Site, Heidelberg, Baden-wuerttemberg, Germany|Theravance Biopharma Investigational Site, Kiel, Schleswig-holstein, Germany|Theravance Biopharma Investigational Site, Berlin, Germany|Theravance Biopharma Investigational Site, Berlin, Germany|Theravance Biopharma Investigational Site, Athens, Attica, Greece|Theravance Biopharma Investigational Site #2, Athens, Attica, Greece|Theravance Biopharma Investigational Site, Heraklion, Crete, Greece|Theravance Biopharma Investigational Site, Patra, Peloponnese, Greece|Theravance Biopharma Investigational Site, Székesfehérvár, Fejer, Hungary|Theravance Biopharma Investigational Site, Debrecen, Hajdu-bihar, Hungary|Theravance Biopharma Investigational Site, Szekszard, Tolna, Hungary|Theravance Biopharma Investigational Site, Budapest, Hungary|Theravance Biopharma Investigational Site, Budapest, Hungary|Theravance Biopharma Investigational Site, Budapest, Hungary|Theravance Biopharma Investigational Site, Zerifin, Rehoboth, Israel|Theravance Biopharma Investigational Site, Haifa, Israel|Theravance Biopharma Investigational Site, Holon, Israel|Theravance Biopharma Investigational Site, Jerusalem, Israel|Theravance Biopharma Investigational Site, Nahariya, Israel|Theravance Biopharma Investigational Site, Petah Tikva, Israel|Theravance Biopharma Investigational Site, Rehovot, Israel|Theravance Biopharma Investigational Site, Rozzano, Milano, Italy|Theravance Biopharma Investigational Site, Catanzaro, Italy|Theravance Biopharma Investigational Site, Pavia, Italy|Theravance Biopharma Investigational Site, Nagoya, Aichi, Japan|Theravance Biopharma Investigational Site, Abiko, Chiba, Japan|Theravance Biopharma Investigational Site, Sakura, Chiba, Japan|Theravance Biopharma Investigational Site, Kurume, Fukuoka, Japan|Theravance Biopharma Investigational Site, Ōgaki, Gifu, Japan|Theravance Biopharma Investigational Site, Isesaki, Gunma, Japan|Theravance Biopharma Investigational Site, Fukuyama-Shi, Hiroshima-ken, Japan|Theravance Biopharma Investigational Site, Hatsukaichi, Hiroshima, Japan|Theravance Biopharma Investigational Site, Kawasaki, Kanagawa, Japan|Theravance Biopharma Investigational Site, Sendai, Miyagi, Japan|Theravance Biopharma Investigational Site, Suwa, Nagano, Japan|Theravance Biopharma Investigational Site, Ōita, Oita, Japan|Theravance Biopharma Investigational Site, Fujiidera, Osaka Fu, Japan|Theravance Biopharma Investigational Site, Izumiotsu, Osaka, Japan|Theravance Biopharma Investigational Site, Ageo, Saitama Ken, Japan|Theravance Biopharma Investigational Site, Tokorozawa, Saitama, Japan|Theravance Biopharma Investigational Site, Kurobe, Toyama, Japan|Theravance Biopharma Investigational Site, Chiba, Japan|Theravance Biopharma Investigational Site, Fukuoka, Japan|Theravance Biopharma Investigational Site, Kumamoto, Japan|Theravance Biopharma Investigational Site, Tokyo, Japan|Theravance Biopharma Investigational Site, Tokyo, Japan|Theravance Biopharma Investigational Site, Tokyo, Japan|Theravance Biopharma Investigational Site, Wŏnju, Gangwon-do, Korea, Republic of|Theravance Biopharma Investigational Site, Suwon, Gyeonggi-do, Korea, Republic of|Theravance Biopharma Investigational Site, Daegu, Korea, Republic of|Theravance Biopharma Investigational Site, Seoul, Korea, Republic of|Theravance Biopharma Investigational Site, Seoul, Korea, Republic of|Theravance Biopharma Investigational Site, Seoul, Korea, Republic of|Theravance Biopharma Investigational Site, Seoul, Korea, Republic of|Theravance Biopharma Investigational Site, Wrocław, Dolnoslaskie, Poland|Theravance Biopharma Investigational Site, Wrocław, Dolnoslaskie, Poland|Theravance Biopharma Investigational Site, Toruń, Kujawsko-Pomorskie, Poland|Theravance Biopharma Investigational Site, Włocławek, Kujawsko-Pomorskie, Poland|Theravance Biopharma Investigational Site, Ksawerów, Lodzkie, Poland|Theravance Biopharma Investigational Site, Łódź, Lodzkie, Poland|Theravance Biopharma Investigational Site, Łódź, Lodzki, Poland|Theravance Biopharma Investigational Site, Kraków, Malopolskie, Poland|Theravance Biopharma Investigational Site, Piaseczno, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Warszawa, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Warszawa, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Warszawa, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Warszawa, Mazowieckie, Poland|Theravance Biopharma Investigational Site, Sopot, Pomorskie, Poland|Theravance Biopharma Investigational Site, Tychy, Slaskie, Poland|Theravance Biopharma Investigational Site, Staszów, Swietokrzyskie, Poland|Theravance Biopharma Investigational Site, Poznań, Wielkopolskie, Poland|Theravance Biopharma Investigational Site, Poznań, Wielkopolskie, Poland|Theravance Biopharma Investigational Site, Szczecin, Zachodniopomorskie, Poland|Theravance Biopharma Investigational Site, Szczecin, Poland|Theravance Biopharma Investigational Site, Coimbra, Portugal|Theravance Biopharma Investigational Site, Guimarães, Portugal|Theravance Biopharma Investigational Site, Leiria, Portugal|Theravance Biopharma Investigational Site, Lisboa, Portugal|Theravance Biopharma Investigational Site, Santa Maria Da Feira, Portugal|Theravance Biopharma Investigational Site, Senhora da Hora, Portugal|Theravance Biopharma Investigational Site, Viana Do Castelo, Portugal|Theravance Biopharma Investigational Site, Vila Nova De Gaia, Portugal|Theravance Biopharma Investigational Site, Timişoara, Timis, Romania|Theravance Biopharma Investigational Site, Bucuresti, Romania|Theravance Biopharma Investigational Site, Belgrade, Serbia|Theravance Biopharma Investigational Site, Belgrade, Serbia|Theravance Biopharma Investigational Site, Kragujevac, Serbia|Theravance Biopharma Investigational Site, Nis, Serbia|Theravance Biopharma Investigational Site, Subotica, Serbia|Theravance Biopharma Investigational Site, Zrenjanin, Serbia|Theravance Biopharma Investigational Site, Prešov, Prešovsky, Slovakia|Theravance Biopharma Investigational Site, Nitra, Slovakia|Theravance Biopharma Investigational Site, Šahy, Slovakia|Theravance Biopharma Investigational Site, Johannesburg, Gauteng, South Africa|Theravance Biopharma Investigational Site, Johannesburg, Gauteng, South Africa|Theravance Biopharma Investigational Site, Barcelona, Spain|Theravance Biopharma Investigational Site, Madrid, Spain|Theravance Biopharma Investigational Site, Sevilla, Spain|Theravance Biopharma Investigational Site, Valencia, Spain|Theravance Biopharma Investigational Site, Kaohsiung, Taiwan|Theravance Biopharma Investigational Site, Taichung, Taiwan|Theravance Biopharma Investigational Site, Tainan, Taiwan|Theravance Biopharma Investigational Site, Taipei, Taiwan|Theravance Biopharma Investigational Site, Kiev, Kiev City, Ukraine|Theravance Biopharma Investigational Site, Kyiv, Kiev, Ukraine|Theravance Biopharma Investigational Site, Kyiv, Kiev, Ukraine|Theravance Biopharma Investigational Site, Kremenchuk, Poltava, Ukraine|Theravance Biopharma Investigational Site, Úzhgorod, Transcarpathian, Ukraine|Theravance Biopharma Investigational Site, Vinnytsia, Vinnytsya, Ukraine|Theravance Biopharma Investigational Site, Vinnytsia, Vinnytsya, Ukraine|Theravance Biopharma Investigational Site, Chernivtsi, Ukraine|Theravance Biopharma Investigational Site, Kharkiv, Ukraine|Theravance Biopharma Investigational Site #2, Lviv, Ukraine|Theravance Biopharma Investigational Site, Lviv, Ukraine|Theravance Biopharma Investigational Site, Ternopil, Ukraine|Theravance Biopharma Investigational Site, Vinnytsia, Ukraine|Theravance Biopharma Investigational Site, Vinnytsia, Ukraine|Theravance Biopharma Investigational Site, Zaporizhzhya, Ukraine|Theravance Biopharma Investigational Site, Zaporizhzhya, Ukraine|Theravance Biopharma Investigational Site, Úzhgorod, Ukraine",,"https://ClinicalTrials.gov/show/NCT03758443"
510,"NCT03565939","Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO)","PROCTO","Recruiting","No Results Available","Ulcerative Colitis Chronic Moderate","Biological: Trichuris suis ova|Biological: Placebo","Response (Full MAYO)|Remission (Full MAYO)|Reduction in use of steroid","ParaTech A/S","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","120","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","PROCTO|2017-004772-65","May 4, 2018","December 2021","December 2021","June 21, 2018",,"September 22, 2020","Hvidovre Hospital, Hvidovre, Denmark",,"https://ClinicalTrials.gov/show/NCT03565939"
511,"NCT04408703","PRognOstiC valuE of rEd Density in Ulcerative Colitis","PROCEED-UC","Not yet recruiting","No Results Available","Ulcerative Colitis","Diagnostic Test: Red Density","sustained clinical remission|endoscopic remission Mayo|endoscopic remission UCEIS","Universitaire Ziekenhuizen Leuven|Sapporo Medical University|Imelda GI Clinical Research Center","All","16 Years and older   (Child, Adult, Older Adult)",,"243","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","s63012","June 2020","June 2021","June 2022","May 29, 2020",,"May 29, 2020","Imelda GI clinical research center, Bonheiden, Belgium|UZ Leuven, Leuven, Belgium",,"https://ClinicalTrials.gov/show/NCT04408703"
512,"NCT03582969","Capsulized Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis Patients","FMT UC","Recruiting","No Results Available","Ulcerative Colitis","Other: Fecal transplantation|Other: Placebo","UC remission|Improvement in UC symptoms|markers of inflammation|Improvement in UC endoscopic score|change in gut microbiome|use of treatments for UC|Extra-intestinal disease manifestations","Assaf-Harofeh Medical Center","All","12 Years to 18 Years   (Child, Adult)","Phase 2","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","0134-17-ASF","August 2018","July 2021","July 2022","July 11, 2018",,"July 11, 2018","Assaf-HarofehMC, Zerifin, Israel",,"https://ClinicalTrials.gov/show/NCT03582969"
513,"NCT02193685","Identification Genetic, Immunologic and Microbial Markers of Hirschsprung Associated Enterocolitis in Children With Hirschsprung Disease","HAEC","Recruiting","No Results Available","Hirschsprung Disease|Enterocolitis",,"To identify genetic associations in HD patients who display HAEC phenotype|To identify immunological markers in HD patients who display HAEC phenotype","Cedars-Sinai Medical Center|Karolinska University Hospital|Children's Hospital Los Angeles|UCSF Benioff Children's Hospital Oakland|University of Michigan|The University of Texas Health Science Center, Houston","All","up to 17 Years   (Child)",,"400","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Biomarkers of HAEC","February 2010","December 2022","December 2025","July 18, 2014",,"August 12, 2016","Cedars-Sinai Medical Center 8723 Alden Drive, Suite 240, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT02193685"
514,"NCT04032756","Tofacitinib Registry of Patients With Ulcerative Colitis in Germany","TOFA-UC","Recruiting","No Results Available","Colitis, Ulcerative|Biologics|Tofacitiniib|Chronic Inflammatory Small Bowel Disease|Bowel Diseases, Inflammatory|Bowel Disease|CED",,"partial Mayo score ≤ 1 plus a bleeding subscore of 0) in the inductionphase (week 16)|occurrence of serious side effects (e.g., death, tumor, tuberculosis, severe infections, or side effects leading to hospitalization)|response: partial Mayo Score reduction of ≥ 3 accompanied by a decrease of at least 30% from baseline and remission: partial Mayo score ≤ 1 plus a bleeding subscore of 0 - Efficacy|hospitalization days via question in questionnaire|psychosocial impairments - EQ-5D|EQ-5D quality of life|early retirement via question in questionnaire","Ced Service GmbH|Pfizer","All","18 Years to 80 Years   (Adult, Older Adult)",,"480","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","Protocol V1.4 31.05.2019","August 1, 2019","March 31, 2023","September 30, 2023","July 25, 2019",,"February 18, 2020","Gastroenterologische Gemeinschaftspraxis Minden, Minden, Niedersachsen, Germany","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/56/NCT04032756/Prot_000.pdf","https://ClinicalTrials.gov/show/NCT04032756"
515,"NCT04877990","A Study to Evaluate the Long-term Safety and Efficacy of BMS-986165 in Participants With Crohn's Disease or Ulcerative Colitis",,"Not yet recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis","Drug: BMS-986165","Number of adverse events (AEs)|Number of serious adverse events (SAEs)|Number of AEs leading to study discontinuation|Number of clinically significant abnormalities in vital signs: Blood pressure|Number of clinically significant abnormalities in vital signs: Heart rate|Number of clinically significant abnormalities in vital signs: Temperature|Number of clinically significant abnormalities in electrocardiogram (ECG) parameters: PR interval|Number of clinically significant abnormalities in electrocardiogram (ECG) parameters: QRS interval|Number of clinically significant abnormalities in electrocardiogram (ECG) parameters: QT interval|Number of clinically significant abnormalities in electrocardiogram (ECG) parameters: QTc interval|Number of clinically significant abnormalities in clinical laboratory results: Hematology tests|Number of clinically significant abnormalities in clinical laboratory results: Clinical Chemistry test|Number of clinically significant abnormalities in clinical laboratory results: Coagulation tests","Bristol-Myers Squibb","All","18 Years and older   (Adult, Older Adult)","Phase 2","300","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IM011-077|2020-004461-40|U1111-1258-3838","May 7, 2021","June 3, 2027","June 4, 2027","May 7, 2021",,"May 7, 2021","Local Institution, Wyoming, Michigan, United States|Local Institution, Salvador, Bahia, Brazil|Local Institution, Porto Alegre, RIO Grande DO SUL, Brazil|Local Institution, Sao Bernardo do Campo, SAO Paulo, Brazil|Local Institution, Rio de Janeiro, Brazil|Local Institution, Bydgoszcz, Poland|Local Institution, Krakow, Poland|Local Institution, Warszawa, Poland|Local Institution, Bucharest, Romania",,"https://ClinicalTrials.gov/show/NCT04877990"
516,"NCT03053713","The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative Colitis",,"Enrolling by invitation","No Results Available","Ulcerative Colitis","Behavioral: Mediterranean diet pattern|Behavioral: Habitual diet (control)","Simple Clinical Colitis Activity Index (SCCAI)|Short Inflammatory Bowel Disease Questionnaire (SIBDQ)|Fecal microbiota|Change in mucosal inflammation measured by fecal calprotectin|Change in serum marker of inflammation (serum CRP)|Change in serum marker of inflammation (serum ferritin)","University of British Columbia|Canadian Foundation for Dietetic Research (CFDR)","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","102","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","H16-03300","April 4, 2017","September 1, 2021","January 1, 2022","February 15, 2017",,"November 23, 2020","University of British Columbia - Okanagan, Kelowna, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT03053713"
517,"NCT04165265","The Use of Web-app Constant-Care in Patients With Acute Severe Ulcerative Colitis Treated With Rescue Therapy",,"Recruiting","No Results Available","Ulcerative Colitis|Telemedicine","Device: Constant-Care","Change in length of hospitalization due to the use of Constant-Care|Quality of Life (S-IBDQ)|Disability index (WEB-DI), The IBD Disk|Fecal calprotectin level|Time to clinical decision-making (days)|Colectomy rate (at week 52)|Disease course types","Nordsjaellands Hospital|Calpro AS","All","18 Years and older   (Adult, Older Adult)","Not Applicable","28","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","H-19047104","December 3, 2019","June 30, 2021","December 31, 2021","November 15, 2019",,"December 5, 2019","North Zealand University Hospital, Frederikssund, Denmark",,"https://ClinicalTrials.gov/show/NCT04165265"
518,"NCT03942861","Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol.","SUCCES","Recruiting","No Results Available","Ulcerative Colitis|Ultrasound Therapy; Complications","Drug: Solu-Medrol","Changes in GIUS parameters 48 hours after intravenous corticosteroid treatment.|Changes in GIUS parameters ability to predict treatment outcome.|Interrater variability compared to central reading with regards to GIUS parameters.|Time since last meal correlated to feasibility of GIUS.|GIUS disease extent assessment compared to endoscopy and CT (if present).|Calculate the best cutoff value for GIUS parameters for optimal sensitivity, specificity and accuracy compared to treatment outcome and endoscopy results.|Change in GIUS parameters correlation with change in endoscopic scores and fecal calprotectin within 3 months compared to baseline.|Change in GIUS parameters correlation with change clinical scores and biochemistry on 48 ± 24 hours, 6 ± 1 days and after 3 months compared to baseline.","Copenhagen University Hospital at Herlev","All","18 Years to 70 Years   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CopenhagenUHH","February 21, 2019","September 21, 2021","February 21, 2022","May 8, 2019",,"January 27, 2021","Herlev University Hospital, Copenhagen, Herlev, Denmark",,"https://ClinicalTrials.gov/show/NCT03942861"
519,"NCT02200445","Low Dose IL-2 for Ulcerative Colitis",,"Active, not recruiting","Has Results","Ulcerative Colitis","Drug: Interleukin-2 (aldesleukin).","Number of Subjects With Serious and Non-serious Adverse Events.|Number of Participants With Clinical Response|Number of Participants With Clinical Remission","Scott Snapper|Boston Children's Hospital","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 1","26","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB-P00009599|2015P000016","February 2015","October 1, 2020","January 2021","July 25, 2014","December 19, 2020","December 19, 2020","Boston Children's Hospital, Boston, Massachusetts, United States|Brigham & Women's Hospital, Boston, Massachusetts, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/45/NCT02200445/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02200445"
520,"NCT04621006","The Contact Activation System and Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Diagnostic Test: Consecutively assessment of the disease activity","Coagulation Factor XII (FXII)|Prekallikrein (PK)|Plasma kallikrein (PKa) generation|Native high-molecular-weight-kininogen (HK)|PKa cleaved High-molecular-weight-kininogen (HK)|Tissue kallikrein (TKa) cleaved High-molecular-weight-kininogen (HK)|C1-esterase inhibitor (C1 Inh)|Polymerized alpha-1-antitrypsin (AAT)|Elastase|Thrombin generation|Simple Clinical Colitis Activity Index questionnaire (SCCAI)|Patient Reported Outcome 2 questionnaire (PRO2)|Short Inflammatory Bowel Disease Questionnaire (SIBDQ)|Mayo score|Nancy Index|C reactive peptide (CRP)|Calprotectin","Sydvestjysk Hospital|University of Southern Denmark|UMC Utrecht|Odense University Hospital|Sygehus Lillebaelt","All","18 Years and older   (Adult, Older Adult)",,"102","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CAS UC","May 1, 2021","October 31, 2022","February 29, 2024","November 9, 2020",,"May 18, 2021","Department of Medical Gastroenterology, University Hospital of Southern Denmark, Esbjerg, Denmark",,"https://ClinicalTrials.gov/show/NCT04621006"
521,"NCT04156984","Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis",,"Not yet recruiting","No Results Available","Ulcerative Colitis","Drug: Golimumab Prefilled Syringe","Endoscopic outcome|Clinical outcome|Association of golimumab through levels and Anti-golimumab antibodies development on endoscopic and clinical outcome.","David Drobne|University Medical Centre Ljubljana","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 4","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2019-001G","May 2020","November 2022","November 2022","November 8, 2019",,"March 25, 2020","General hospital Celje, Department of Gastoenterology, Celje, Slovenia|General hospital Izola, Department of Internal medicine, Izola, Slovenia|University Medical Centre Ljubljana, Department of Gastroenterology, Ljubljana, Slovenia|University Medical Centre Maribor, Department of Gastoenterology, Maribor, Slovenia",,"https://ClinicalTrials.gov/show/NCT04156984"
522,"NCT01848561","A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)",,"Active, not recruiting","No Results Available","Ulcerative Colitis (UC)",,"Evaluation of long term safety of Adalimumab in patients with moderately to severely active UC|Evaluation of long term effectiveness of Adalimumab in patients with moderately to severely active UC who have had an inadequate response to conventional therapy","AbbVie","All","18 Years to 99 Years   (Adult, Older Adult)",,"8250","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","P11-282","April 29, 2013","April 6, 2027","June 24, 2030","May 7, 2013",,"January 7, 2021","Birmingham Gastroenterology Associates O.C /ID# 102063, Birmingham, Alabama, United States|University of Alabama at Birmingham - Main /ID# 131646, Birmingham, Alabama, United States|Longwood Research /ID# 118662, Huntsville, Alabama, United States|Alabama Medical Group, PC /ID# 116259, Mobile, Alabama, United States|Mobile Med & Diag Ctr.,AL /ID# 102064, Mobile, Alabama, United States|HOPE Research Institute /ID# 127947, Phoenix, Arizona, United States|University of Arizona Cancer Center - North Campus /ID# 140387, Tucson, Arizona, United States|University of Arizona /ID# 117836, Tucson, Arizona, United States|Arkansas Gastroenterology /ID# 113898, North Little Rock, Arkansas, United States|Southern California Res. Ctr. /ID# 116898, Coronado, California, United States|Moore UC San Diego Cancer Center /ID# 133722, La Jolla, California, United States|McGuire, Jr. La Mirada, CA /ID# 116257, La Mirada, California, United States|Atay, Los Alamitos, CA /ID# 110175, Los Alamitos, California, United States|Temecula Valley Endoscopy Ctr /ID# 118660, Murrieta, California, United States|Community Clinical Trials, CA /ID# 117335, Orange, California, United States|Digestive Care Medical Center /ID# 122075, San Carlos, California, United States|Precision Research Institute - San Diego /ID# 103638, San Diego, California, United States|Precision Research Institute - San Diego /ID# 113445, San Diego, California, United States|Santa Monica Research Institut /ID# 118675, Santa Monica, California, United States|St. Joseph Heritage Group /ID# 133721, Yorba Linda, California, United States|Western States Clinical Research, Inc. /ID# 116237, Wheat Ridge, Colorado, United States|Gastro Assoc of Fair County /ID# 113443, Bridgeport, Connecticut, United States|Medical Research Ctr CT /ID# 102057, Hamden, Connecticut, United States|Middlesex Hospital /ID# 122077, Middletown, Connecticut, United States|Yale Univ Digestive Diseases /ID# 141987, New Haven, Connecticut, United States|Georgetown University Hospital /ID# 113437, Washington, District of Columbia, United States|Brandon Premier Health Care, PA /ID# 148230, Brandon, Florida, United States|Sarkis Clinical Trials /ID# 137948, Gainesville, Florida, United States|Hollywood Research Center /Id# 214723, Hollywood, Florida, United States|Ctr for Advanced Gastroenterol /ID# 116236, Maitland, Florida, United States|Paradise Clnical Research, LLC /ID# 212027, Miami, Florida, United States|Research Associates of South Florida,LLC /ID# 148212, Miami, Florida, United States|Abel & Buchheim, P.R., Inc. /ID# 143863, Miami, Florida, United States|Gastroenterology Group Naples /ID# 105837, Naples, Florida, United States|Advanced Research Institute /ID# 211335, New Port Richey, Florida, United States|North Florida Gastro Research /ID# 128538, Orange Park, Florida, United States|Combined Res. Orlando Ph I-IV /ID# 141660, Orlando, Florida, United States|Endoscopic Research, Inc. /ID# 136883, Orlando, Florida, United States|Florida Hospital /ID# 145705, Orlando, Florida, United States|Digestive Diseases Center /ID# 118116, Panama City, Florida, United States|Palekar. Parkland, FL /ID# 108202, Parkland, Florida, United States|BRCR Medical Center Inc /ID# 152015, Plantation, Florida, United States|Advanced Medical Research Ctr. /ID# 116235, Port Orange, Florida, United States|Precision Clinical Research /ID# 127849, Sunrise, Florida, United States|Digestive Disease Clinic /ID# 107162, Tallahassee, Florida, United States|University of South Florida /ID# 213305, Tampa, Florida, United States|Guardian Angels Health Center /ID# 209706, Tampa, Florida, United States|South Florida Ctr Gastro, P.A. /ID# 166784, Wellington, Florida, United States|Shafran Gastroenterology Ctr /ID# 117839, Winter Park, Florida, United States|Winship Cancer Institute of Emory University /ID# 133724, Atlanta, Georgia, United States|Atlanta Gastro Assoc /ID# 107164, Atlanta, Georgia, United States|Gastroenterology Associates of Central Georgia, LLC /ID# 117838, Macon, Georgia, United States|Atlanta Gastroenterology Spec /ID# 103619, Suwanee, Georgia, United States|Grand Teton Research Group /ID# 108197, Idaho Falls, Idaho, United States|Northwest Gastro, S.C. /ID# 103620, Arlington Heights, Illinois, United States|Northwest Gastro, S.C. /ID# 145707, Arlington Heights, Illinois, United States|Christie Clinic, LLC /ID# 116258, Champaign, Illinois, United States|Northwestern University Feinberg School of Medicine /ID# 126760, Chicago, Illinois, United States|Rush University Medical Center /ID# 132979, Chicago, Illinois, United States|University of Chicago DCAM /ID# 114115, Chicago, Illinois, United States|NorthShore University HealthSystem - Evanston Hospital /ID# 107165, Evanston, Illinois, United States|DM Clinical Research/Southwest /ID# 120635, Oak Lawn, Illinois, United States|North Suburban Gastro Assoc /ID# 134437, Park Ridge, Illinois, United States|Carle Foundation Hospital Digestive Health Research Center /ID# 117417, Urbana, Illinois, United States|Iowa Digestive Disease Center /ID# 107159, Clive, Iowa, United States|University of Iowa Hospitals and Clinics /ID# 134432, Iowa City, Iowa, United States|University of Kansas Health Sy /ID# 134436, Kansas City, Kansas, United States|Univ Kansas Med Ctr /ID# 120917, Kansas City, Kansas, United States|Kansas Gasteroenterology /ID# 214827, Wichita, Kansas, United States|Houma Digestive Health Special /ID# 125711, Houma, Louisiana, United States|Gastro Clinic of Acadiana, LA /ID# 119155, Lafayette, Louisiana, United States|Louisana Research Center, LLC /ID# 102055, Shreveport, Louisiana, United States|Investigative Clinical Research /ID# 102056, Annapolis, Maryland, United States|Univ Maryland School Medicine /ID# 116897, Baltimore, Maryland, United States|John Hopkins Medicine /ID# 212398, Baltimore, Maryland, United States|MGG Group Co, Inc.Chevy Chase Clinical Research /ID# 107157, Chevy Chase, Maryland, United States|Gastro Center of Maryland /ID# 126969, Columbia, Maryland, United States|Endoscopic Microsurgery Assoc /ID# 102065, Towson, Maryland, United States|Attleboro Gastroenterology, PC /ID# 113899, Attleboro, Massachusetts, United States|Commonwealth Clinical Studies /ID# 118597, Brockton, Massachusetts, United States|UMass Memorial Medical Center /ID# 212924, Worcester, Massachusetts, United States|University of Michigan Health Systems /ID# 105836, Ann Arbor, Michigan, United States|Huron Gastroenterology Assoc /ID# 132484, Ann Arbor, Michigan, United States|Henry Ford Health System /ID# 103617, Detroit, Michigan, United States|Detroit Clinical Research Ctr /ID# 123235, Farmington Hills, Michigan, United States|Mayo Clinic /ID# 116899, Rochester, Minnesota, United States|Univ of Mississippi Med Ctr,US /ID# 132981, Jackson, Mississippi, United States|Saint Louis University School of Medicine /ID# 163794, Saint Louis, Missouri, United States|Washington University-School of Medicine /ID# 107156, Saint Louis, Missouri, United States|CHI Health Research Center /ID# 116255, Omaha, Nebraska, United States|Cooper Digestive Health Instit /ID# 103615, Mount Laurel, New Jersey, United States|The Gastro Group of S. Jersey /ID# 129902, Vineland, New Jersey, United States|Allied Gastrointestinal Associ /ID# 107158, Voorhees, New Jersey, United States|NYU Langone Long Island Clinical Research Associates /ID# 107163, Great Neck, New York, United States|Orlin & Cohen /ID# 117895, Lynbrook, New York, United States|Progressive Gastro Consultants /ID# 105835, Mineola, New York, United States|Digestive Dis Care/Excel Med /ID# 133489, New Hyde Park, New York, United States|North Shore University Hospital /ID# 127948, New Hyde Park, New York, United States|Premier Medical Group /ID# 140388, New Windsor, New York, United States|Manhattan Clinical Research, LLC /ID# 113442, New York, New York, United States|Weill Cornell Medical College /ID# 135052, New York, New York, United States|Westside Gastroenterology /ID# 133689, New York, New York, United States|The Mount Sinai Hospital /ID# 108201, New York, New York, United States|Premier Medical Group /ID# 140384, Poughkeepsie, New York, United States|Gastro Group of Rochester /ID# 113438, Rochester, New York, United States|Univ Rochester Med Ctr /ID# 126152, Rochester, New York, United States|Ctr Digest, Allergic & Imm Dis /ID# 125502, Williamsville, New York, United States|Asheville Gastro Assoc /ID# 144367, Asheville, North Carolina, United States|Cary Gastroenterology Assoc PA /ID# 108198, Cary, North Carolina, United States|Univ NC Chapel Hill /ID# 102059, Chapel Hill, North Carolina, United States|Atrium Health Carolinas Medical Center /ID# 126970, Charlotte, North Carolina, United States|Charlotte Gastroenterology and Hepatology, PLLC /ID# 102058, Charlotte, North Carolina, United States|Carolina Digest Health Assoc /ID# 108199, Charlotte, North Carolina, United States|Carolinas Research center /ID# 211288, Charlotte, North Carolina, United States|Atlantic Gastroenterology, PA /ID# 135536, Greenville, North Carolina, United States|Carolina Research, Greenville, NC /ID# 134133, Greenville, North Carolina, United States|Boice-Willis Clinic, P.A. /ID# 103618, Rocky Mount, North Carolina, United States|Trial Management Associates /ID# 138459, Wilmington, North Carolina, United States|Wake Forest Univ HS /ID# 113436, Winston-Salem, North Carolina, United States|Cleveland Clinic Main Campus /ID# 108055, Cleveland, Ohio, United States|Clinical Research Solutions /ID# 207698, Middleburg Heights, Ohio, United States|ProMedica Physicians Digestive Healthcare /ID# 156529, Sylvania, Ohio, United States|Avamar Center for Endoscopy /ID# 113440, Warren, Ohio, United States|Southwoods Surgical Hospital /ID# 133038, Youngstown, Ohio, United States|Northwest Gastroenterology Cli /ID# 116896, Portland, Oregon, United States|Penn State University and Milton S. Hershey Medical Center /ID# 133688, Hershey, Pennsylvania, United States|Main Line Gastro Assoc /ID# 113446, Malvern, Pennsylvania, United States|Drexel Univ College of Med /ID# 126968, Philadelphia, Pennsylvania, United States|Temple University Hospital /ID# 108203, Philadelphia, Pennsylvania, United States|Methodist Hospital /ID# 129461, Philadelphia, Pennsylvania, United States|Guthrie Medical Group, PC /ID# 105838, Sayre, Pennsylvania, United States|Bierwirth, Cranston, RI /ID# 113435, Cranston, Rhode Island, United States|Medical University of South Carolina /ID# 113439, Charleston, South Carolina, United States|Cons Gastro & S. Carolina Endo /ID# 126517, Columbia, South Carolina, United States|Greenville Endoscopy Center /ID# 129900, Greenville, South Carolina, United States|Invocare Med Research and Healthcar Center-W Columbia /ID# 213980, West Columbia, South Carolina, United States|Rapid City Medical Center /ID# 201191, Rapid City, South Dakota, United States|Singaram Gastroenterology /ID# 113447, Sioux Falls, South Dakota, United States|Erlanger Institute for Clinical Research /ID# 126151, Chattanooga, Tennessee, United States|Franklin Endoscopy Center /ID# 113444, Franklin, Tennessee, United States|Clinical Research Solutions /ID# 154153, Jackson, Tennessee, United States|Mid-State Gastroenterology /ID# 125457, Murfreesboro, Tennessee, United States|Baylor College of Medicine /ID# 103636, Houston, Texas, United States|Kelsey-Seybold Clinic /ID# 125942, Houston, Texas, United States|University of Texas MD Anderson Cancer Center /ID# 144198, Houston, Texas, United States|Precision Research Institute - Houston /ID# 211340, Houston, Texas, United States|Houston Endoscopy and Research Center /ID# 206978, Houston, Texas, United States|Houston Digestive Dis Clinic /ID# 102076, Houston, Texas, United States|Rio Grande Gastroenterology /ID# 210218, McAllen, Texas, United States|Digestive Health Center /ID# 113897, Pasadena, Texas, United States|Digestive Health Assoc of TX /ID# 116215, Plano, Texas, United States|Gastroenterology Clinic of San /ID# 113441, San Antonio, Texas, United States|San Antonio Gastro Assoc /ID# 143435, San Antonio, Texas, United States|Scott & White Mem Hosp & Clin /ID# 103639, Temple, Texas, United States|Digestive Health Spec of Tyler /ID# 138144, Tyler, Texas, United States|Care Access Research-Ogden /ID# 213432, Ogden, Utah, United States|Granger Medical Clinic /ID# 122896, West Valley City, Utah, United States|University of Vermont Medical Center /ID# 102075, Burlington, Vermont, United States|Gastro Assoc of Tidewater /ID# 102061, Chesapeake, Virginia, United States|Gastro Assoc. of N. Va. /ID# 125495, Fairfax, Virginia, United States|Emeritas Research Group, LLC /ID# 135537, Leesburg, Virginia, United States|Digestive and Liver Disease Sp /ID# 125943, Norfolk, Virginia, United States|Gastroenterology Ltd. /ID# 103640, Virginia Beach, Virginia, United States|University of Washington /ID# 122076, Seattle, Washington, United States|Wenatchee Valley Hosp & Clinic /ID# 118661, Wenatchee, Washington, United States|Morgantown Surgical Associates /ID# 123082, Morgantown, West Virginia, United States|St. Mary's Hospital /ID# 116915, Madison, Wisconsin, United States|Univ of Wisconsin Hosp/Clinics /ID# 103637, Madison, Wisconsin, United States|Wisconsin Center for Advanced Research, a division of GI Associates, LLC /ID# 103616, Milwaukee, Wisconsin, United States|Froedtert Memorial Lutheran Hospital /ID# 102066, Milwaukee, Wisconsin, United States|Reach /Id# 116256, Monroe, Wisconsin, United States|The Canberra Hospital /ID# 157980, Garran, Australian Capital Territory, Australia|Royal Prince Alfred Hospital /ID# 157986, Camperdown, New South Wales, Australia|Concord Repatriation General /ID# 157983, Concord, New South Wales, Australia|St. Vincents Hospital /ID# 157978, East Lismore, New South Wales, Australia|Hunter New England Local Healt /ID# 157999, New Lambton, New South Wales, Australia|Royal Brisbane and Women's Hospital /ID# 158086, Herston, Queensland, Australia|Mater Misericordiae /ID# 164171, South Brisbane, Queensland, Australia|Royal Adelaide Hospital /ID# 158026, Adelaide, South Australia, Australia|Flinders Centre for Innovation /ID# 157979, Bedford Park, South Australia, Australia|Austin Hospital /ID# 157998, Heidelberg, Victoria, Australia|Alfred Health /ID# 159261, Melbourne, Victoria, Australia|Box Hill Hospital /ID# 157987, Melbourne, Victoria, Australia|Royal Melbourne Hospital /ID# 157993, Parkville, Victoria, Australia|Fiona Stanley Hospital /ID# 157992, Murdoch, Western Australia, Australia|KH der Elisabethinen Linz GmbH /ID# 98555, Linz, Oberoesterreich, Austria|Krankenanstalt Rudolfstiftung /ID# 121615, Vienna, Wien, Austria|Medizinische Universitat Innsbruck,Universitatsklinik fur Innere Medizin 1 /ID# 120775, Innsbruck, Austria|Krankenhaus/Barmherzigen Brued /ID# 120776, Salzburg, Austria|LKH Salzburg and Paracelsus /ID# 127897, Salzburg, Austria|UZ Gent /ID# 127985, Gent, Oost-Vlaanderen, Belgium|Onze Lieve Vrouw Hospital /ID# 127986, Aalst, Belgium|GZA St. Vincentiusziekenhuis /ID# 127398, Antwerp, Belgium|ZNA Middelheim /ID# 129116, Antwerp, Belgium|Imelda Ziekenhuis /ID# 127497, Bonheiden, Belgium|UZ Antwerp /ID# 142757, Edegem, Belgium|AZ Maria Middelares /ID# 127489, Ghent, Belgium|AZ Sint-Lucas /ID# 127000, Ghent, Belgium|A.Z. Herentals /ID# 127135, Herentals, Belgium|UZ Leuven /ID# 127984, Leuven, Belgium|CHU de Liege /ID# 127983, Liege, Belgium|Clinique St Joseph /ID# 127988, Liege, Belgium|Clinique Saint Luc /ID# 127987, Namur, Belgium|AZ Nikolaas /ID# 141601, Sint-Niklaas, Belgium|Regionaal Ziekenhuis Sint-Trud /ID# 127136, Sint-truiden, Belgium|GI Research /ID# 133723, Edmonton, Alberta, Canada|University of Alberta /ID# 144673, Edmonton, Alberta, Canada|Columbia Gastro Mgmnt Ltd /ID# 128719, New Westminster, British Columbia, Canada|Dr. M. Prest Inc. /ID# 134309, Surrey, British Columbia, Canada|Univ British Columbia /ID# 129995, Vancouver, British Columbia, Canada|GIRI Gastrointestinal Research Institute /ID# 129095, Vancouver, British Columbia, Canada|Percuro Clinical Research, Ltd /ID# 129996, Victoria, British Columbia, Canada|Dr. Everett Chalmers Reg Hosp. /ID# 135408, Fredericton, New Brunswick, Canada|Qe Ii Hsc /Id# 128916, Halifax, Nova Scotia, Canada|Scope Clinic /ID# 145706, Brampton, Ontario, Canada|Guelph GI and Surgery Clinic /ID# 128917, Guelph, Ontario, Canada|Charlton Medical Centre /ID# 135390, Hamilton, Ontario, Canada|London Health Sciences Centre - University Hospital /ID# 128915, London, Ontario, Canada|Lakeridge Health /ID# 128275, Oshawa, Ontario, Canada|The Ottawa Hospital /ID# 128918, Ottawa, Ontario, Canada|Hospital Montfort /ID# 151588, Ottawa, Ontario, Canada|Kensington Screening Clinic /ID# 133720, Toronto, Ontario, Canada|Hospital Maisonneuve-Rosemont /ID# 130321, Montreal, Quebec, Canada|CHUM - Notre-Dame Hospital /ID# 151379, Montréal, Quebec, Canada|CHUS - Hopital Fleurimont /ID# 133031, Sherbrooke, Quebec, Canada|Royal Univ. Hosp, Saskatoon,CA /ID# 128720, Saskatoon, Saskatchewan, Canada|Klinicki bolnicki centar Osijek /ID# 127980, Osijek, Osjecko-baranjska Zupanija, Croatia|Klinicki bolnicki centar Rijeka /ID# 127979, Rijeka, Primorsko-goranska Zupanija, Croatia|Official Universtiy Hospital S /ID# 127978, Split, Croatia|Clinical Hospital Dubrava /ID# 127982, Zagreb, Croatia|General Hospital Sveti Duh /ID# 127977, Zagreb, Croatia|Herlev Hospital /ID# 98239, Herlev, Hovedstaden, Denmark|Aalborg University Hospital /ID# 119215, Aalborg, Nordjylland, Denmark|Rigshospitalet, Finsen Centre /ID# 98238, Copenhagen, Denmark|Hvidovre Hospital /ID# 120557, Hvidovre, Denmark|Centre Hospitalier Lyon Sud /ID# 98718, Pierre Benite CEDEX, Auvergne-Rhone-Alpes, France|CHU Hopital Nord /ID# 98639, Marseille, Bouches-du-Rhone, France|Hopital Universitaire Purpan /ID# 148183, Toulouse, Haute-Garonne, France|CHRU Lille - Hopital Claude Huriez /ID# 98737, Lille CEDEX, Hauts-de-France, France|Hopital Saint Eloi /ID# 217142, Montpellier CEDEX 5, Herault, France|Hopital Beaujon /ID# 127395, Clichy, Ile-de-France, France|CHU NANCY - Hopital Brabois Adultes /ID# 127394, Vandoeuvre les Nancy CEDEX, Meurthe-et-Moselle, France|Charles Nicolle CHU Rouen /ID# 98721, Rouen CEDEX, Seine-Maritime, France|CHU Amiens-Picardie Site Sud /ID# 98637, Amiens CEDEX 1, Somme, France|Hospitalier Germon et Gauthier /ID# 137874, Bethune, France|CHU Estaing /ID# 98735, Clermont Ferrand, France|Centre Hospitalier Universitaire de Grenoble - Hopital Michallon /ID# 98638, Grenoble, France|Hospital Edouard Herriot /ID# 155711, Lyon, France|Ctr Consultations La Sauvegard /ID# 98719, Lyon, France|Private Practice /ID# 161671, Metz, France|Ctr Hosp Inter Le Raincy Montf /ID# 98642, Montfermeil, France|Hopital l'Archet 2 /ID# 98645, Nice, France|APHP - Groupe Hospitalier 1 /ID# 98736, Paris, France|Hopital Saint Antoine /ID# 141611, Paris, France|Groupe Hospitalier Cochin /ID# 98717, Paris, France|Hopital Bichat Claude Bernard /ID# 98641, Paris, France|Hopital Robert Debre /ID# 98640, Reims, France|Thevenin, Saint Quentin, FR /ID# 98720, Saint Quentin, France|CHU de Saint-Etienne, Hopital Nord /ID# 130978, SAINT-ETIENNE Cedex 1, France|Hopital de Rangueil /ID# 147755, Toulouse, France|Hopital Trousseau /ID# 98716, Tours, France|Groupe Hosp Les Portes Au Sud /ID# 98722, Venissieux, France|Universitaetsklinik Heidelberg /ID# 98120, Heidelberg, Baden-Wuerttemberg, Germany|Universitatsklinikum Mannheim /ID# 129279, Mannheim, Baden-Wuerttemberg, Germany|Universitaetsklinikum Erlangen /ID# 128179, Erlangen, Bayern, Germany|KH Martha-Maria Halle Dolau /ID# 122935, Halle (Saale), Sachsen-Anhalt, Germany|Universitaetsklinikum Leipzig /ID# 98116, Leipzig, Sachsen, Germany|Universitaetsklinikum Ulm /ID# 98202, Ulm, Thueringen, Germany|Klinikum Altenburger Land /ID# 131748, Altenburg, Germany|Prax. Dres. Roesler und Lachma /ID# 128466, Bayreuth, Germany|Charite Universitaetsmedizin Berlin /ID# 129115, Berlin, Germany|Charite Universitaetsmedizin Berlin /ID# 129117, Berlin, Germany|Charite Universitaetsmedizin Berlin /ID# 98124, Berlin, Germany|Private Practice - Dr. Michael R. MroB Dipl. med. S. Schache /ID# 98117, Berlin, Germany|Charite-Univ. Berlin, Benjamin-Franklin /ID# 130318, Berlin, Germany|DRK-Kliniken Westend /ID# 98179, Berlin, Germany|Krankenhaus Waldfriede /ID# 98200, Berlin, Germany|Klinikum Ruhr Univ Bochum /ID# 148107, Bochum, Germany|Stadtisches Klinikum Braunschw /ID# 98123, Braunschweig, Germany|Klinikum Dortmund gGmbH /ID# 127061, Dortmund, Germany|Kliniken Essen Sued /ID# 98196, Essen, Germany|Universitaetsklinikum Freiburg /ID# 98176, Freiburg, Germany|Klinikum Garmisch-Partenkirchen /ID# 127915, Garmisch-partenkirchen, Germany|Dr. Zeisler, Halle, DE /ID# 98218, Halle, Germany|Asklepios Klinik St. Georg /ID# 125216, Hamburg, Germany|Gastroenterologie Rothenbaum /ID# 98195, Hamburg, Germany|Forstep /ID# 125206, Hamburg, Germany|Magen-Darm-Zentrum /ID# 141610, Hamburg, Germany|Israelitisches Krankenhaus Hamburg /ID# 98197, Hamburg, Germany|Asklepios Westklinikum Hamburg /ID# 127492, Hamburg, Germany|Gastroenterologie Studien -CED /ID# 98205, Hamburg, Germany|Graefin v.Waldersee&Partner, H /ID# 141607, Hamburg, Germany|Mueller/Mueller-Ziehm, Hanover /ID# 130490, Hannover, Germany|Ehehalt/Helmstadter, Heidelber /ID# 125211, Heidelberg, Germany|Group Practice Gastroenterolog /ID# 98121, Herne, Germany|Hoffstadt, Iserlohn, DE /ID# 98208, Iserlohn, Germany|Universitaetsklinikum Jena /ID# 127496, Jena, Germany|Leberstudienzentrum Kiel /ID# 127798, Kiel, Germany|Benner, Luetke & Weismueller /ID# 129119, Koblenz, Germany|EUGASTRO GmbH /ID# 98178, Leipzig, Germany|Borkenhagen & Teich, Leipzig /ID# 98119, Leipzig, Germany|St. Marien- und Anastiftskrane /ID# 98235, Ludwigshafen, Germany|Otto von Guericke Universitaet /ID# 129227, Magdeburg, Germany|Internistisches Fachzentrum /ID# 123255, Memmingen, Germany|Gastro Gemeinschaftspraxis /ID# 98115, Minden, Germany|Isar Medizin Zentrum /ID# 125213, Munich, Germany|LMU Klinikum der Universitat Munchen /ID# 98198, Munich, Germany|Gastroenterologie Im Josephinu /ID# 123496, Munich, Germany|Medizinisches Versorgungszentrum Portal 10 /ID# 98122, Munster, Germany|Gastro Campus Research GbR /ID# 125558, Munster, Germany|Klinikum Neumarkt /ID# 123016, Neumarkt, Germany|Innere Am Stadtpark /ID# 123015, Nuremberg, Germany|Klinikum Nuremberg /ID# 134976, Nuremberg, Germany|Helwig, Oldenburg, DE /ID# 129120, Oldenburg, Germany|Klinikum Univ. Regensburg /ID# 141606, Regensburg, Germany|Praxiszentrum Altemalzerei /ID# 129001, Regensburg, Germany|Universitaetsklinikum Rostock /ID# 128396, Rostock, Germany|Biewer/Mohl, Saarbruecken, DE /ID# 98204, Saarbruecken, Germany|Ambulanzzentrum Schweinfurt /ID# 123238, Schweinfurt, Germany|Bank, Schwerin, DE /ID# 125215, Schwerin, Germany|Clinics of Sigmaringen /ID# 98216, Sigmaringen, Germany|Ctr Gastro & Hepatology Stade /ID# 98206, Stade, Germany|Kardalinos, Stuhr, DE /ID# 98201, Stuhr, Germany|Internistische Praxisgemeinsch /ID# 129000, Weyhe, Germany|Loehr, Wiesbaden, DE /ID# 98217, Wiesbaden, Germany|General Hospital of Athens Laiko /ID# 129280, Athens, Attiki, Greece|Gen Univ Hosp Alexandroupolis /ID# 128636, Alexandroupolis, Greece|General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 98756, Athens, Greece|General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 98761, Athens, Greece|General Hospital of Athens Ippokratio /ID# 128638, Athens, Greece|HYGEIA Hospital /ID# 128637, Athens, Greece|Venizeleio General Hospital /ID# 98757, Heraklion, Greece|University General Hospital of Ioannina /ID# 127390, Ioannina, Greece|Iatriko Kentro Athinon Hospita /ID# 98762, Marousi, Greece|Theageneio Anticancer Hospital /ID# 141670, Thessaloniki, Greece|General Hospital of Thessaloniki Hippokrateio /ID# 127400, Thessaloniki, Greece|Adelaide and Meath Hosp,IE /ID# 117947, Dublin 24, Ireland|Trinity College Dublin - St. J /ID# 149406, Dublin, Ireland|St Vincent's University Hosp /ID# 116835, Dublin, Ireland|Mater Misericordiae Univ Hosp /ID# 119054, Dublin, Ireland|Beaumont Hospital /ID# 98775, Dublin, Ireland|Connolly Hospital /ID# 98895, Dublin, Ireland|Galway University Hospital /ID# 98763, Galway, Ireland|Assaf Harofeh Medical Center /ID# 128996, Be'er Ya'akov, Israel|Hillel Jafe Medical Center /ID# 129047, Hadera, Israel|Rambam Health Care Campus /ID# 129282, Haifa, Israel|Shaare Zedek Medical Center /ID# 126638, Jerusalem, Israel|Gastroenterology Institute, Division of Medicine /ID# 132530, Jerusalem, Israel|Clalit Health Services /ID# 129237, Jerusalem, Israel|Meir Medical Center /ID# 129238, Kfar Saba, Israel|Zavulun Medical Centre /ID# 129048, Kiriat Bialik, Israel|Baruch-Padeh Poriya Medical /ID# 141671, Lower Galilee, Israel|Sheba Medical Center /ID# 129281, Ramat Gan, Israel|A.O.U. Policlinico S.Orsola-Malpighi /ID# 137945, Bologna, Emilia-Romagna, Italy|Policlinico Universitario Campus Bio-Medico /ID# 141393, Rome, Lazio, Italy|UOSD - Azienda Ospedaliera San Camillo Forlanini /ID# 144211, Rome, Lazio, Italy|AOU Policlinico Umberto I /ID# 144080, Rome, Lazio, Italy|IBD Center - IRCCS Istituto Clinico Humanitas /ID# 141382, Rozzano, Milano, Italy|A.O. Per L'Emergenza Cannizzaro /ID# 138142, Catania, Sicilia, Italy|Policlinico Paolo Giaccone /Id# 141397, Palermo, Sicilia, Italy|A.O. Univ Consorziale Policlin /ID# 144213, Bari, Italy|ASST Spedali civili di Brescia /ID# 137943, Brescia, Italy|Fondazione Poliambulanza /ID# 141593, Brescia, Italy|Ospedale Valduce /ID# 155712, Como, Italy|A.O. Universitaria Careggi /ID# 137946, Florence, Italy|Azienda Ospedaliera Univ San M /ID# 137947, Genoa, Italy|A.O.U. Policlinico G. Martino /ID# 144212, Messina, Italy|Policlinico San Donato /ID# 141383, Milan, Italy|Ospedale S Giuseppe /ID# 141395, Milan, Italy|Azienda Ospedaliera Luigi Sacc /ID# 137944, Milan, Italy|Azienda Ospedaliera Luigi Sacc /ID# 141716, Milan, Italy|Universita di Napoli Federico II /ID# 141381, Naples, Italy|Seconda Universita' di Napoli /ID# 141717, Naples, Italy|Azienda Ospedaliero Universitaria Maggiore della Carita di Novara /ID# 144084, Novara, Italy|Universita di Padova /ID# 137941, Padova, Italy|Ospedali Riuniti Villa Sofia-C /ID# 141392, Palermo, Italy|Policlinico Tor Vergata /ID# 145912, Rome, Italy|AO Univ Policlinico Gemelli /ID# 141396, Rome, Italy|Fondazione di Religione e di Culto Casa Sollievo della Sofferenza /ID# 137939, San Giovanni Rotondo, Italy|ASO Ordine Mauriziano, Umberto /ID# 137942, Turin, Italy|A.O. Circolo e Fondazione Macc /ID# 141394, Varese, Italy|Morales Vargas Centro de Investigacion S.C. /ID# 131390, Leon, Guanajuato, Mexico|Clinica de Investigacion en Reumatologia y Obesidad S.C. /ID# 129318, Guadalajara, Jalisco, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez /ID# 128375, Monterrey, Nuevo Leon, Mexico|Invest y Biomed de Chihuahua /ID# 150115, Chihuahua, Mexico|Clinica de Higado & Gastro Int /ID# 128376, Cuernavaca, Mexico|Asoc Mex Para la Invest Clinic /ID# 128387, Guadalajara, Jalisco, Mexico|Instituto de Salud Digestiva /ID# 157435, Guadalajara, Jalisco, Mexico|Issste /Id# 128386, Guadalajara, Jalisco, Mexico|Torre de Especialidades Medica /ID# 154276, Metepec, Mexico|Centro Especializado en Diabetes, Obesidad y Prevención de Enfermedades Cardiova /ID# 138113, Mexico City, Mexico|Ruiz Flores, Monterrey, MX /ID# 128379, Monterrey, NL, Mexico|Vega Fonseca, San Luis Potosi /ID# 128380, San Luis Potosi, Mexico|Meander Medisch Centrum /ID# 98338, Amersfoort, Netherlands|Onze Lieve Vrouwe Gasthuis /ID# 98336, Amsterdam, Netherlands|Rijnstate /ID# 127397, Arnhem, Netherlands|Leids Universitair Medisch Centrum /ID# 127402, Leiden, Netherlands|Erasmus Medisch Centrum /ID# 98337, Rotterdam, Netherlands|Sint Franciscus Gasthuis /ID# 127904, Rotterdam, Netherlands|Orbis Medisch Centrum /ID# 98241, Sittard Geleen, Netherlands|Isala /ID# 98317, Zwolle, Netherlands|Christchurch Hospital /ID# 164265, Christchurch, Canterbury, New Zealand|Akershus Universitetssykehus_MAIN /ID# 127159, Lorenskog, Akershus, Norway|Perez Jimenz Gastroenterologo /ID# 110135, Mayaguez, Puerto Rico|Gastro-Hepato & Geriatric Ctr /ID# 113135, Ponce, Puerto Rico|Rodriguez-Ginorio, San Juan /ID# 113448, San Juan, Puerto Rico|School of Medicine University of Puerto Rico-Medical Science Campus /ID# 102067, San Juan, Puerto Rico|Hospital Universitario A Coruña - CHUAC /ID# 129002, A Coruña, A Coruna, Spain|Hospital Arquitecto Marcide - Complejo Hospitalario Universitario de Ferrol /ID# 129124, Ferrol, A Coruna, Spain|Hospital Clínico Universitario de Santiago-CHUS /ID# 98619, Santiago de Compostela, A Coruna, Spain|Hospital General Universitario de Elche /ID# 129121, Elche, Alicante, Spain|Hospital Universitario San Juan de Alicante /ID# 130167, San Juan de Alicante, Alicante, Spain|Hospital de Cabuenes /ID# 141998, Gijon, Asturias, Spain|Hospital Universitario Central de Asturias /ID# 98617, Oviedo, Asturias, Spain|Hospital de Manacor /ID# 128348, Manacor, Balears, Spain|Hospital Universitario Germans Trias i Pujol /ID# 98592, Badalona, Barcelona, Spain|Hospital Sant Joan de Deu /ID# 151342, Esplugues de Llobregat, Barcelona, Spain|Hospital Sant Joan de Deu /ID# 155774, Esplugues de Llobregat, Barcelona, Spain|Hospital Universitario de Bellvitge /ID# 98584, L'Hospitalet de Llobregat, Barcelona, Spain|Hospital Parc Tauli de Sabadell /ID# 98585, Sabadell, Barcelona, Spain|Hospital de Viladecans /ID# 155500, Viladecans, Barcelona, Spain|Hospital Universitario de Jerez de la Frontera /ID# 128345, Jerez de la Frontera, Cadiz, Spain|Hospital Unversitario Marques de Valdecilla /ID# 98581, Santander, Cantabria, Spain|Hospital General de Castellon /ID# 128351, Castellon de la Plana, Castellon, Spain|Hospital General La Mancha Centro /ID# 98588, Alcazar de San Juan, Ciudad Real, Spain|Hospital Comarcal Santa Ana de Motril /ID# 129040, Motril, Granada, Spain|Hospital Alto Guadalquivir /ID# 129006, Andujar, Jaen, Spain|Hospital Universitario Principe de Asturias /ID# 131751, Alcala de Henares, Madrid, Spain|Hospital General de Mostoles /ID# 130319, Mostoles, Madrid, Spain|Hospital Universitario Infanta Cristina /ID# 98635, Parla, Madrid, Spain|Hospital Infanta Sofia /ID# 98615, San Sebastián de Los Reyes, Madrid, Spain|Hospital de Antequera /ID# 129041, Antequera, Malaga, Spain|Hospital General Universitario Santa Lucia /ID# 129125, Cartagena, Murcia, Spain|Complejo Hospitalario Universitario Ourense /ID# 128349, Orense, Ourense, Spain|Hospital Xeral Cies (CHUVI) /ID# 129515, Vigo, Pontevedra, Spain|Hospital Meixoeiro (CHUVI) /ID# 128355, Vigo, Pontevedra, Spain|Hospital Universitario Canarias /ID# 129037, La Cuesta, Santa Cruz De Tenerife, Spain|Hospital de Sagunto /ID# 98587, Sagunto, Valencia, Spain|Hospital Universitario Fundacion Alcorcon /ID# 98576, Alcorcon, Spain|Hospital General Universitario Alicante /ID# 128467, Alicante, Spain|Hospital San Eloy /ID# 147830, Barakaldo, Spain|Hospital Parc de Salut del Mar /ID# 126637, Barcelona, Spain|Hospital de Sant Joan Despí Moisès Broggi /ID# 128347, Barcelona, Spain|Hospital Universitario Basurto /ID# 129123, Bilbao, Spain|Hospital San Pedro de Alcantara /ID# 98579, Caceres, Spain|Hospital Universitario Reina Sofia /ID# 98586, Cordoba, Spain|Hospital Universitario de Fuenlabrada /ID# 98591, Fuenlabrada, Spain|Hospital Universitario de Galdakao /ID# 98618, Galdakao, Spain|Hospital Universitario de Girona Doctor Josep Trueta /ID# 130049, Girona, Spain|Hospital San Jorge Huesca /ID# 149628, Huesca, Spain|Hospital Universitario de Jaen /ID# 129035, Jaen, Spain|Hospital Universitario Dr. Negrin /ID# 98578, Las Palmas de Gran Canaria, Spain|Hospital de Leon /ID# 131750, Leon, Spain|Hospital Universitario de la Princesa /ID# 98580, Madrid, Spain|Hospital General Universitario Gregorio Maranon /ID# 98558, Madrid, Spain|Hospital Universitario Ramon y Cajal /ID# 98596, Madrid, Spain|Hospital Clinico Universitario San Carlos /ID# 98577, Madrid, Spain|Hospital Universitario 12 de Octubre /ID# 98575, Madrid, Spain|Hospital Universitario La Paz /ID# 98582, Madrid, Spain|Hospital Universitario Virgen de la Victoria /ID# 129038, Malaga, Spain|Hospital Universitari Son Espases /ID# 148214, Palma de Mallorca, Spain|Complejo Hospitalario Universitario de Pontevedra /ID# 128354, Pontevedra, Spain|Hospital Clinico Universitario de Salamanca /ID# 98589, Salamanca, Spain|Hospital General de Segovia /ID# 148926, Segovia, Spain|Hospital Universitario Virgen Macarena /ID# 128346, Sevilla, Spain|Hospital Universitario Virgen del Rocio /ID# 98557, Sevilla, Spain|Hospital Universitario Virgen de Valme /ID# 129036, Sevilla, Spain|Hospital Unide Tarragona /ID# 129122, Tarragona, Spain|Hospital Virgen de la Salud /ID# 98595, Toledo, Spain|Hospital Clinico Universitario de Valencia /ID# 131749, Valencia, Spain|Hospital General Universitario de Valencia /ID# 98616, Valencia, Spain|Hospital Universitario y Politecnico La Fe /ID# 98597, Valencia, Spain|Hospital Rio Hortega /ID# 98590, Valladolid, Spain|Hospital Clinico Universitario Lozano Blesa /ID# 98556, Zaragoza, Spain|Hospital Universitario Miguel Servet /ID# 131188, Zaragoza, Spain|Hospital Royo Villanova /ID# 149850, Zaragoza, Spain|Sahlgrenska University Hosp /ID# 141672, Goteborg, Sweden|Skaraborgs Sjukhus Skovde /ID# 98898, Skövde, Sweden|Capio St Gorans Sjukhus /ID# 126123, Stockholm, Sweden|Sodersjukhuset /ID# 124158, Stockholm, Sweden|Danderyd Hospital /ID# 98897, Stockholm, Sweden|Karolinska University Hospital /ID# 171247, Stockholm, Sweden|Uppsala University Hospital /ID# 120558, Uppsala, Sweden|Kingston Hosp NHS Foundation /ID# 164109, Kingston upon Thames, England, United Kingdom|Royal Hampshire County Hosp /ID# 98900, Winchester, Hampshire, United Kingdom|County Durham & Darlington NHS /ID# 145914, Bishop Auckland, United Kingdom|Blackpool Teaching Hosp NHS /ID# 164213, Blackpool, United Kingdom|The Royal Bournemouth Hospital /ID# 164108, Bournemouth, United Kingdom|Southmead Hospital /ID# 146043, Bristol, United Kingdom|Addenbrookes Hospital /ID# 145704, Cambridge, United Kingdom|UH Coventry & Warwickshire /ID# 145680, Coventry, United Kingdom|Russells Hall Hospital, Dudley /ID# 164119, Dudley, United Kingdom|Queen Elizabeth University Hos /ID# 153818, Glasgow, United Kingdom|James Paget University Hosp /ID# 164106, Great Yarmouth, United Kingdom|London North West Healthcare N /ID# 145953, Harrow, United Kingdom|Hull University Teaching Hospitals NHS Trust /ID# 98899, Hull, United Kingdom|West Suffolk Hospital /ID# 164105, Ipswich, United Kingdom|Isle of Wight NHS Trust /ID# 168166, ISLE OF Wight, United Kingdom|St. James University Hospital /ID# 157949, Leeds, United Kingdom|King's College Hospital NHS /ID# 145698, London, United Kingdom|Imperial College Healthcare /ID# 145916, London, United Kingdom|Manchester Royal Infirmary, Ma /ID# 145702, Manchester, United Kingdom|Queen Elizabeth Hospital Kings /ID# 145937, Norfolk, United Kingdom|Nottingham Univ Hospitals NHS /ID# 145678, Nottingham, United Kingdom|Plymouth Hospitals NHS Trust /ID# 157432, Plymouth, United Kingdom|Plymouth Hospitals NHS Trust /ID# 203182, Plymouth, United Kingdom|St. Helens and Knowsley Teach /ID# 144089, Prescot, United Kingdom|Royal Shrewsbury Hospital /ID# 98901, Shrewsbury, United Kingdom|University Hospital Southampton NHS Fundation Trust /ID# 145676, Southampton, United Kingdom|Stepping Hill Hospital /ID# 144090, Stockport, United Kingdom|Barts and the London NHS Trust /ID# 145703, Whitechapel, United Kingdom|The Royal Wolverhampton NHS Tr /ID# 164209, Wolverhampton, United Kingdom|Yeovil District Hospital NHS /ID# 146042, Yeovil, United Kingdom",,"https://ClinicalTrials.gov/show/NCT01848561"
523,"NCT04933214","Adherence to Exclusive Enteral Nutrition in Patients With Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease",,"Adherence","Second Affiliated Hospital, School of Medicine, Zhejiang University","All","14 Years and older   (Child, Adult, Older Adult)",,"131","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","2021-0324","May 12, 2021","December 12, 2021","December 12, 2021","June 21, 2021",,"June 21, 2021","2ndAffiliated Hospital, School of Medicine, Zhejiang University, China, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04933214"
524,"NCT04921033","Exclusive Enteral Nutrition in Patients With Ileocaecal Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease|Nutrient; Excess|Remission/Regression","Dietary Supplement: EEN (Nestle Modulen®)|Drug: Standart of care","Percentage of participants with mucosal healing|Percentage of patients that tolerate the EEN by week 12|Endoscopic response|Mean change from baseline in SES-CD at 12 weeks after randomization|Mean change from baseline in CDAI over time (Time Frame: Baseline, 4, 8 and 12 weeks after randomization)|Time to clinical remission (Time frame: from randomization through 12 weeks after randomization)|Time to clinical response (Time frame: from randomization through 12 weeks after randomization)|Mean change from baseline in C-reactive protein (CRP) over time (Time Frame: 4, 8 and 12 weeks after randomization)|Mean change from baseline in fecal calprotectin (FC) over time (Time Frame: 4, 8 and 12 weeks after randomization)|Mean change from baseline in PRO-2 (Time Frame: Baseline and 12 weeks after randomization)|Change from baseline in SIBDQ total score (Time Frame: Baseline and 12 weeks after randomization)|Change in Robarts Histopathology Index (RHI) (Time Frame: Baseline and 12 weeks after randomization)|Number of Crohn's disease-related hospitalizations after randomization (Time Frame: From randomization through 12 weeks after randomization)","Duzce University","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 3","256","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","EEN in ileocaecal Crohn's","March 1, 2021","January 1, 2026","January 1, 2026","June 10, 2021",,"June 30, 2021","Duzce University School of Medicine, Duzce, Turkey",,"https://ClinicalTrials.gov/show/NCT04921033"
525,"NCT04915911","Nutritional Status and Body Composition of Adult Patients With Crohn's Disease",,"Not yet recruiting","No Results Available","Crohn Disease","Other: cross-sectional study","Appendicular skeletal mass index|Body composition|Nutritional risk screening|Nutritional assessment|Grip strength","Second Affiliated Hospital, School of Medicine, Zhejiang University","All","18 Years and older   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","2020-1109","June 1, 2021","May 1, 2023","May 1, 2023","June 7, 2021",,"June 7, 2021",,,"https://ClinicalTrials.gov/show/NCT04915911"
526,"NCT04865484","Prospective Randomized Comparative Study of the Treatment of Multisegmental Fibrostenosing Crohn's Disease.","SUREST","Recruiting","No Results Available","Crohn Disease|Stricture; Bowel","Procedure: Surgical resection|Procedure: Endoscopic stricturotomy|Procedure: Strictureplasty","Intervention-free survival|Surgery-free survival|Obstructive score reduction|CDAI score reduction|IBDQ score reduction|Adverse event rate|Total cost for intervention","Sixth Affiliated Hospital, Sun Yat-sen University","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2021ZSLYEC-020","March 12, 2021","December 31, 2023","December 31, 2023","April 29, 2021",,"April 29, 2021","The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04865484"
527,"NCT04842149","The Effects of Bifidobacterium Breve Bif195 for Small Intestinal Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Dietary Supplement: Bif195 capsules|Dietary Supplement: Placebo capsules","Change in Bowel Wall Thickness (BWT) from baseline measured by intestinal ultrasound (IUS) at 8 weeks|Change in fecal calprotectin level from baseline at 8 weeks|Change in severity of symptoms from baseline measured by Harvey-Bradshaw index (HBI) at 8 weeks|Change in quality of life from baseline measured by Inflammatory Bowel Disease Questionnaire (IBDQ) Questionnaire Scores at 8 weeks|The change from baseline on Color Doppler Imaging Score (0-3) including inflammatory fat and ulceration (yes/no) at 8 weeks|Adverse and severe adverse events","Hvidovre University Hospital|Chr Hansen","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","60","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","H-20068527","May 21, 2021","April 30, 2024","November 30, 2030","April 13, 2021",,"June 4, 2021","Gastrounit, Copenhagen University Hospital Hvidovre, Hvidovre, Copenhagen, Denmark",,"https://ClinicalTrials.gov/show/NCT04842149"
528,"NCT04835506","The OPTIMIZE Trial",,"Not yet recruiting","No Results Available","Crohn Disease","Drug: Infliximab","clinical remission|deep remission|composite biological and endoscopic remission|sustained CS-free clinical remission|primary non-responders|biological remission|endoscopic remission|hs-CRP normalization|hs-CRP change from baseline|endoscopic response|fecal calprotectin|fecal calprotectin change","Beth Israel Deaconess Medical Center|The Leona M. and Harry B. Helmsley Charitable Trust|Icahn School of Medicine at Mount Sinai","All","16 Years and older   (Child, Adult, Older Adult)","Phase 4","196","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2021P","July 1, 2021","December 31, 2022","December 31, 2022","April 8, 2021",,"April 8, 2021","Mount Sinai, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04835506"
529,"NCT04809363","A Study of CDPATH™ to Help Manage and Treat Crohn's Disease","COMPASS-CD","Recruiting","No Results Available","Crohn's Disease","Other: CDPATH™|Other: Blood Draw","Percentage of Participants in Real-world Practice in Each Risk Category at Baseline Based on the CDPATH™ Tool Results|Percentage of Participants with Specific Treatment Path and Choice Based on CDPATH™ Tool, Stratified According to Risk Category|Change From Baseline in Decisional Conflict Scale (DCS) Score|Change From Baseline in Work Productivity and Activity Impairment Questionnaire - CD Version (WPAI-CD) Score|Change From Baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health Scale Score|Patient-Reported Satisfaction and Experience Score with the CDPATH™ Tool|Number of Participants with Clinical Outcomes|Percentage of Participants with Healthcare Resource Utilization|Change from First Assessment in Health Care Provider (HCP)-reported Assessment of the Feasibility and Usability of the CDPATH™ Tool","Takeda","All","18 Years and older   (Adult, Older Adult)","Phase 4","200","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","Vedolizumab-4015","June 25, 2021","May 26, 2023","May 26, 2026","March 22, 2021",,"July 1, 2021","Care Access Research LLC, Berkeley, California, United States|University of Southern California Medical Center, Irvine, California, United States|United Medical Doctors, Los Alamitos, California, United States|University of California at Irvine Medical Center, Orange, California, United States|Kaiser Permanate of Colorado, Englewood, Colorado, United States|Medical Research Center of Connecticut, LLC, Hamden, Connecticut, United States|Gastroenterology Associates of Pensacola, PA, Pensacola, Florida, United States|Grand Teton Research Group, PLL, Idaho Falls, Idaho, United States|University of Chicago Medical Center, Chicago, Illinois, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Indiana University, Indianapolis, Indiana, United States|Iowa Digestive Disease Center, Clive, Iowa, United States|University Of Iowa Hospital and Clinics, Iowa City, Iowa, United States|University of Kansas Medical Center Research Institute, Inc., Kansas City, Kansas, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|University of Michigan, Ann Arbor, Michigan, United States|Atlantic Digestive Health Institute at Morristown, Morristown, New Jersey, United States|University of New Mexico, Albuquerque, New Mexico, United States|Options Health Research, LLC, Tulsa, Oklahoma, United States|Gastroenterology Associates, PA, Greenville, South Carolina, United States|The University of Texas at Austin, Austin, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Pinnacle Clinical Research, PLLC, San Antonio, Texas, United States|Texas Digestive Disease Consultants - Southlake, Southlake, Texas, United States|University of Utah, Salt Lake City, Utah, United States|Gastroenterology Associates, Lynchburg, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT04809363"
530,"NCT04809194","Stress in Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease",,"Study Retention|Daily survey/task adherence|Oura adherence|Empatica adherence|Bodyport adherence","4YouandMe|Evidation Health|Vector Institute of Artificial Intelligence|Icahn School of Medicine at Mount Sinai|Oxford University Hospitals NHS Trust","All","18 Years to 65 Years   (Adult, Older Adult)",,"200","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","4UCROHNS01","February 22, 2021","March 2023","March 2023","March 22, 2021",,"March 23, 2021","Mount Sinai, New York, New York, United States|Nuffield Department of Population Health of Oxford University, Oxford, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04809194"
531,"NCT04804046","Synbiotics and Post-op Crohn's Disease",,"Not yet recruiting","No Results Available","Crohn's Disease","Dietary Supplement: Synbiotic|Other: Digestible Maltodextrin","The percentage of participants who experience treatment emergent adverse and serious adverse events|Changes in quality of life (1)|Changes in quality of life (2)|Prevention of clinical recurrence|Prevention of endoscopic recurrence|Changes in systemic inflammation|Changes in intestinal inflammation|Changes in intestinal barrier function|Changes in the fecal microbiota composition|Changes in fecal short chain fatty acids|Changes in fecal bile acids|Time to first bowel movement|Time to hospital discharge","University of Alberta|W. Garfield Weston Foundation","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","36","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","Pro00092967","April 15, 2021","December 30, 2022","June 30, 2023","March 18, 2021",,"March 29, 2021","Royal Alexandra Hospital, Edmonton, Alberta, Canada|Misericordia Community Hospital, Edmonton, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|University of Alberta Human Nutrition Research Unit, Edmonton, Alberta, Canada|Grey Nuns Community Hospital, Edmonton, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT04804046"
532,"NCT04795960","Microbiome Modification to Enhance Stelara Response in Crohn's Disease","MIM-TESRIC","Recruiting","No Results Available","Crohn Disease","Dietary Supplement: Low serine diet|Dietary Supplement: High serine diet","The mean simple endoscopic subscore Crohn's disease (SES-CD) score at week 25 between the two treatment groups.|The mean stool flagellin content at week 2 will be compared between the two groups with Student's t test.|The mean lamina propria mucosa (LPM) response in stool at week 2 will be compared between the two groups with Student's t test.|The mean C-reactive protein (CRP) at week 2 will be compared between the two groups with Student's t test.|The mean Fecal Calprotectin (FCP) at week 2 will be compared between the two groups with Student's t test.|The mean lactulose to mannitol ratio (L/M) at week 2 will be compared between the two groups with Student's t test.|The mean Crohn's disease patient report outcomes (CD-PRO) score at week 2 will be compared between the two groups with Student's t test|The mean CRP at week 25 will be compared between the two groups with Student's t test.|The mean FCP at week 25 will be compared between the two groups with Student's t test.|The mean L/M ratio at week 25 will be compared between the two groups with Student's t test.|The mean CD-PRO scores calculated by study team at week 25 will be compared between the two groups with Student's t test.|The mean Crohn's Disease Activity Index (CDAI) scores calculated by study team at week 25 will be compared between the two groups with Student's t test","University of Michigan|Kenneth Rainin Foundation","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","10","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","HUM00185677","March 18, 2021","March 2023","March 2023","March 12, 2021",,"May 24, 2021","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT04795960"
533,"NCT04779762","Stelara and Diet Trial for Crohn""s Disease",,"Not yet recruiting","No Results Available","Crohn Disease","Other: Crohn's disease exclusion diet (CDED)|Drug: Ustekinumab Injection [Stelara]","ITT, steroid free remission|Median calprotectin|Intestinal bowel wall thickness|UST trough level|CDAI between groups","Wolfson Medical Center|Sheba Medical Center, Israel","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","STEDI","January 2022","January 2025","January 2026","March 3, 2021",,"March 3, 2021","Sheba Medical Center, Ramat Gan, Israel",,"https://ClinicalTrials.gov/show/NCT04779762"
534,"NCT04779320","A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease",,"Not yet recruiting","No Results Available","Crohn's Disease (CD)","Drug: Vedolizumab IV","Percentage of Participants With Clinical Remission at Week 54 Based on Pediatric Crohn's Disease Activity Index (PCDAI) Score ≤10|Percentage of Participants With Endoscopic Response at Week 54 Based on Simple Endoscopic Score for Crohn's Disease [SES-CD] Score|Percentage of Participants with Clinical and Endoscopic Remission at Week 14 Based on Both PCDAI Score and SES-CD Score|Percentage of Participants with Clinical and Endoscopic Remission at Week 54 Based on Both PCDAI Score and SES-CD Score|Percentage of Participants with Sustained Clinical and Endoscopic Remission at Week 54|Percentage of Participants with Corticosteroid-free Remission at Week 54 Based on PCDAI Score|Percentage of Participants with Sustained Endoscopic Remission Based on SES-CD Score|Percentage of Participants with Sustained Clinical Remission at Week 54 Based on PCDAI Score|Serum Trough Concentrations of Vedolizumab Over Time|Percentage of Participants With Positive Antivedolizumab Antibodies|Percentage of Participants With Positive Neutralizing Antivedolizumab Antibodies|Sustained Clinical Response at Week 54 Based on PCDAI Score|Percentage of Participants with Clinical Remission at Weeks 2, 6, 10, 14, 22, 30, 38, 46, and 54|Percentage of Participants with Clinical Response at Weeks 2, 6, 10, 14, 22, 30, 38, 46, and 54|Percentage of Participants with at Least One Adverse Event (AE), Serious Adverse Event (SAE), and AE of special interest (AESI)|Change from Baseline in Weight|Change from Baseline in Linear Growth Z-score|Percentage of Participants with Tanner Stage V at Week 54","Takeda","All","2 Years to 17 Years   (Child)","Phase 3","120","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","MLN0002-3025|2020-004301-31","May 5, 2021","November 30, 2024","November 30, 2024","March 3, 2021",,"April 29, 2021",,,"https://ClinicalTrials.gov/show/NCT04779320"
535,"NCT04777656","Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients.","ASCENSION","Not yet recruiting","No Results Available","Crohn's Disease","Dietary Supplement: Phase1 : CDED/Modulen™IBD® + Maintenance therapy|Dietary Supplement: Phase2 and 3 :","Relapse from randomization until M12|Change of wPCDAI from baseline to M2|Change of fecal calprotectin values from baseline to M2|Clinical remission at M2|Deep remission at M2|Physician global assessment (PGA) from baseline to M2|Mucosal healing at M2|Endoscopic response at M2|Change of MRI from baseline to M2|CDED tolerance rate at M2|CDED compliance rate at M2|Change of intestinal microbiome composition from baseline to M2|Clinical remission|Deep remission|Relapse|Physician global assessment (PGA)|Mucosal Healing at M12|Endoscopic response at M12|Change of MRI from M2 to M12|CDED tolerance rate at M12|CDED compliance rate at M12|Change of Intestinal microbiome composition|Change of quality of life IMPACT-3 from inclusion until 12 months","Assistance Publique - Hôpitaux de Paris|URC-CIC Paris Descartes Necker Cochin|MICALIS Institute","All","6 Years to 17 Years   (Child)","Phase 3","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","APHP200010|2020-A02569-30","July 2021","September 2025","September 2025","March 2, 2021",,"June 24, 2021","Hôpital Femme mère enfant, CHU Lyon - Service Hépato-gastroentérologie et Nutrition pédiatrique, Bron, France|CHU Caen Normandie - Service de Gastroentérologie pédiatrique, Caen, France|Hôpital de la Timone, AP-HM - Service de Gastroentérologie pédiatrique, Marseille, France|Hôpital Necker-Enfants malades - Service de Gastroentérologie pédiatrique, Paris, France",,"https://ClinicalTrials.gov/show/NCT04777656"
536,"NCT04736368","Effect of EDIP Based Diet on CD Activity",,"Not yet recruiting","No Results Available","Crohn Disease","Other: EDIP Diet Suggestions|Other: diet guidance","Chron's Disease Activity Index|Mucosal Changes|Cerebrovascular Function","First Affiliated Hospital of Zhejiang University","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","EDIPstudy","January 26, 2021","May 31, 2021","July 31, 2021","February 3, 2021",,"February 3, 2021",,,"https://ClinicalTrials.gov/show/NCT04736368"
537,"NCT04713631","Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease",,"Not yet recruiting","No Results Available","Crohn's Disease","Drug: Artesunate|Drug: Curcumin|Drug: Placebo A|Drug: Placebo C","Remission of disease|Effect of artesunate and curcumin on azathioprine metabolites|Change in tumor necrosis factor-alpha|Change in C-reactive protein|Change in fecal calprotectin","Sanjay Gandhi Postgraduate Institute of Medical Sciences|St George's University of London, London, UK","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","40","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","2020-37-EMP-114","January 2021","January 2022","January 2024","January 19, 2021",,"January 22, 2021","Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, Uttar Pradesh, India",,"https://ClinicalTrials.gov/show/NCT04713631"
538,"NCT04682522","Flagyl Microbiome in Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Drug: Metronidazole Oral","Change in bacteria in the gut","University of Louisville","All","20 Years to 80 Years   (Adult, Older Adult)","Phase 4","36","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","20.1054","March 21, 2021","September 2021","September 2021","December 23, 2020",,"March 26, 2021","University Surgical Associates, Louisville, Kentucky, United States",,"https://ClinicalTrials.gov/show/NCT04682522"
539,"NCT04673357","A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease","UNITI Jr","Recruiting","No Results Available","Crohn Disease","Drug: Ustekinumab|Drug: Placebo","Number of Participants with Clinical Remission at Induction Week 8|Number of Participants with Adverse Events (AEs)|Number of Participants with Serious Adverse Events (SAEs)|Number of Participants with AEs leading to Discontinuation of Study Intervention|Number of Participants with AEs of Interest|Number of Participants with Abnormalities in Clinical Laboratory Parameters|Number of Participants with Reactions Temporally Associated with Intravenous (IV) Infusion (Induction Period)|Number of Participants with Subcutaneous (SC) Injection-Site Reactions (Maintenance Period)|Serum Ustekinumab Concentrations|Number of Participants with Clinical Remission at Maintenance Week 44|Number of Participants with Clinical Remission|Number of Participants with Clinical Response|Number of Participants with Endoscopic Response|Number of Participants with Corticosteroid-free Clinical Remission|Number of Participants with Corticosteroid-free Clinical Response|Number of Participants with Durable Clinical Remission","Janssen Research & Development, LLC","All","2 Years to 17 Years   (Child)","Phase 3","90","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","CR108864|2019-004225-24|CNTO1275CRD3004","March 26, 2021","July 24, 2025","July 25, 2025","December 17, 2020",,"June 21, 2021","Nemours DuPont Hospital for Children, Wilmington, Delaware, United States|Children's Center for Digestive Health Care, Atlanta, Georgia, United States|Mayo Clinic, Rochester, Minnesota, United States|Morristown Memorial Hospital, Morristown, New Jersey, United States|Cohen Children's Medical Center, Lake Success, New York, United States|Levine Children's at Atrium Health, Charlotte, North Carolina, United States|University Hospitals Case Medical Center Rainbow Babies and Childrens Hospital, Cleveland, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|Penn State Hershey Children's Hospital, Hershey, Pennsylvania, United States|Center For Digestive Health Systems-Greenville, Greenville, South Carolina, United States|Children's Medical Center of Dallas, Dallas, Texas, United States|Pediatric Specialists Of Virginia, Fairfax, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Universitair Kinderziekenhuis Koningin Fabiola, Brussel, Belgium|Cliniques Universitaires Saint-Luc, Brussel, Belgium|UZ Gent, Gent, Belgium|UZ Brussel, Jette, Belgium|UZ Leuven, Leuven, Belgium|Universitätsklinikum Aachen, Aachen, Germany|Charite-Universitätsmedizin Berlin - Berlin, Berlin, Germany|Universitatsklinikum Essen, Essen, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Dr. von Haunersches Kinderspital, Munich, Germany|KUNO Klinik St. Hedwig, Regensburg, Germany|Universitätsklinikum Ulm, Ulm, Germany|Semmelweis Egyetem, Budapest, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz, Miskolc, Hungary|Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz, Josa Andras Oktatokorhaz, Nyiregyhaza, Hungary|Szegedi Tudományegyetem, Gyermekgyógyászati Klinika és Gyermekegészségügyi Centrum, Szeged, Hungary|Juntendo University Hospital, Bunkyo-Ku, Japan|Gunma University Hospital, Gunma, Japan|Kindai University Nara Hospital, Ikoma, Japan|Kurume University Hospital, Kurume, Japan|Saitama Children's Medical Center, Saitama-shi, Japan|Miyagi Children'S Hospital, Sendai-shi, Japan|National Center for Child Health and Development, Setagaya-ku, Japan|Jichi Medical University Hospital, Shimotsuke, Japan|Mie University Hospital, Tsu, Japan|Szpital im. M. Kopernika, Gdansk, Poland|Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow, Poland|Gabinet Lekarski Bartosz Korczowski, Rzeszow, Poland|Szpital Pomnik Centrum Zdrowia Dziecka, Warszawa, Poland|Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw, Poland|Kazan State Medical University, Kazan, Russian Federation|Kemerovo Regional Clinical Hospital, Kemerovo, Russian Federation|Russian National Research Medical University named after N.I.Pirogov, Moscow, Russian Federation|FSBI 'Scientific Centre of Children Health' of the Russian Academy of Medical Sciences, Moscow, Russian Federation|Privolzhsky Research Medical University of Ministry of Health of Russian Federation, Nizhny Novgorod, Russian Federation|Saratov State Medical University, Saratov, Russian Federation|Yaroslavl Regional Children's Clinical Hospital, Yaroslavl, Russian Federation|Birmingham Children's Hospital, Birmingham, United Kingdom|Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom|Royal Hospital for Children and Young People, Edinburgh, United Kingdom|Royal London Hospital, London, United Kingdom|King's College Hospital, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04673357"
540,"NCT04660136","Usefulness of Contrast-enhanced Ultrasound (CEUS) in Crohn's Disease Pediatric Patients",,"Recruiting","No Results Available","Crohn's Disease in Pediatric Patient","Biological: contrast enhanced ultrasound","feasibility of Contrast Enhanced Ultrasound (CEUS) in the assessment of Crohn's disease (CD) using endoscopy as a reference standard","Yonsei University","All","2 Years to 18 Years   (Child, Adult)","Phase 4","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","4-2020-1010","December 1, 2020","March 2023","March 2023","December 9, 2020",,"December 10, 2020","Severance Hospital, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT04660136"
541,"NCT04655729","Biomarkers to Predict and Monitor Response to Infliximab",,"Recruiting","No Results Available","Crohn Disease","Drug: Infliximab","Define pretreatment serum protein biomarkers that predict and monitor response to TNF inhibitors (Discovery Cohort)|Identify pathophysiological mechanisms associated with response or lack of response in patients receiving IFX using SOMAscan.|Use systems biology to map out pathways activated in those patients at week 14 that have clinical and laboratory response to infliximab","Massachusetts General Hospital|The Crohn's and Colitis Foundation","All","3 Years to 20 Years   (Child, Adult)",,"120","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2019p002322","November 18, 2019","November 30, 2021","June 1, 2022","December 7, 2020",,"December 7, 2020","MassGeneral for Children, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04655729"
542,"NCT04637438","Fecal Microbiota Transplantation in Postoperative Crohn's Disease",,"Not yet recruiting","No Results Available","Crohn Disease","Other: Fecal Microbiota Transplantation|Other: Placebo","Change in endoscopic Rutgeerts score between first and second colonoscopy|Safety of FMT using FinFMT-Questionnaire|Clinical activity of Crohn's disease using Harwey-Bradshaw Index|Histologic activity of Crohn's Disease using modified Global Histological Activity Score|Change of microbiota in stool samples and in intestinal biopsies|Patient reported outcome|Change in inflammatory marker CRP mg/l|Need for hospitalization|Need for treatment escalation|F-calpro microg/g|Hb mg/l","Tampere University Hospital|Turku University Hospital|Joint Authority for Päijät-Häme Social and Health Care|Kuopio University Hospital|Helsinki University Central Hospital|Tampere University","All","18 Years to 120 Years   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","R20041","November 2020","December 2023","December 2027","November 19, 2020",,"November 19, 2020",,,"https://ClinicalTrials.gov/show/NCT04637438"
543,"NCT04629196","Induction Optimization With Stelara for Crohn's Disease",,"Not yet recruiting","No Results Available","Crohn Disease","Drug: Ustekinumab","Number of patients with clinical remission|Number of patients with a clinical response|Number of patients with a composite clinical and biomarker response|Number of patients with a composite clinical and biomarker remission|Change in Crohn's Disease Activity Index (CDAI) Score|Number of patients with improvement in health-related quality of life","NYU Langone Health","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 4","113","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","19-01401","January 2021","March 2022","May 2022","November 16, 2020",,"November 16, 2020","University of Maryland, Baltimore, Maryland, United States|NYU Langone Health, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04629196"
544,"NCT04623476","PAtophysiological, Nodal-based Approach for Crohn's Disease Excision","PANACEAPILOT","Recruiting","No Results Available","Crohn Disease|Crohn's Ileocolitis","Procedure: Pathophysiological Excision for Crohn's disease","Rate of endoscopic CD recurrence|Rate of overall postoperative complications|Rate of major postoperative complications|Overall and Disease specific Quality of life","University of Rome Tor Vergata","All","18 Years and older   (Adult, Older Adult)","Not Applicable","12","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","112/20","November 16, 2020","April 30, 2021","April 30, 2021","November 10, 2020",,"December 28, 2020","Policlinico Tor Vergata, Roma, RM, Italy",,"https://ClinicalTrials.gov/show/NCT04623476"
545,"NCT04612621","MILESTONE-CD -A Prospective Multiomic Inception Real -Life Study To Evaluate Predictors of Disease Outcomes & respoNse to Biologic Treatment in Crohn's Disease","MILESTONE-CD","Recruiting","No Results Available","Crohn Disease of Intestine","Diagnostic Test: combination of diagnostic tests","failure of first biologic","Sheba Medical Center","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","149","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","SHEBA-20-7346-UK-CTIL","November 1, 2020","November 1, 2023","November 1, 2023","November 3, 2020",,"March 17, 2021","Sheba Medical Center, Ramat Gan, Israel",,"https://ClinicalTrials.gov/show/NCT04612621"
546,"NCT04596566","Modeling Patient Response to a Therapeutic Diet in Crohn's Disease","TDI","Active, not recruiting","No Results Available","Crohn Disease","Other: Therapeutic diet Intervention","Fecal calprotectin: Change is being assessed.|Harvey Bradshaw Index (HBI): Change is being assessed|Bowel wall thickness on sonographic findings and Fecal calprotectin: Change is being assessed.|Fecal Microbiota Sequencing: change is being assessed.|Short chain fatty acids: Change is being assessed|Health related quality of life: Change is being assessed.|Subjective global assessment: Change is being assessed|Dietary intake: Change is being assessed|Sedentary time: Change is being assessed|CRP: Change is being assessed|Ferritin: Change is being assessed|Albumin: Change is being assessed|Vitamin D: Change is being assessed|Cr: Change is being assessed|Electrolytes: Change is being assessed|Hb: Change is being assessed|Platelet: Change is being assessed|WBC: Change is being assessed","University of Calgary|Crohn's and Colitis Foundation|University of Alberta|University of Guelph|University of British Columbia|Alphabiomics|University of Birmingham","All","18 Years and older   (Adult, Older Adult)","Not Applicable","102","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","REB19-0402","February 20, 2020","February 12, 2023","June 12, 2023","October 22, 2020",,"October 22, 2020","TRW building, Foothills, University of Calgary, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT04596566"
547,"NCT04578392","MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)","SPARES","Recruiting","No Results Available","Crohn Disease","Procedure: high ligation of ileocolic artery|Procedure: mesenteric sparing","Endoscopic recurrence based on Rutgeert scoring at the time of colonoscopy|Clinical Recurrence - Crohn's Disease Activity Index (CDAI)|Endoscopic Recurrence - Rutgeert score|Surgical Recurrence","The Cleveland Clinic","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","181","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","20-139","July 28, 2020","December 31, 2021","December 31, 2027","October 8, 2020",,"December 3, 2020","Cedars-Sinai Hospital System, Los Angeles, California, United States|Cleveland Clinic, Cleveland, Ohio, United States|Mt. Sinai, Toronto, Ontario, Canada|Humanitas, Rozzano, Milano, Italy|St Mark's Hospital and Academic Institution, Harrow, Middlesex, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04578392"
548,"NCT04530877","Exclusive Enteral Nutrition vs. Infliximab in Chinese CD Patients",,"Not yet recruiting","No Results Available","Crohn's Disease|Exclusive Enteral Nutrition|Infliximab|Mucosal Healing","Biological: Infliximab|Dietary Supplement: Exclusive Enteral Nutrition","the number of patients who reach mucosal healing at the end of treatment in Exclusive enteral nutrition group|the number of patients who reach mucosal healing at the end of treatment in Infliximab group","Children's Hospital of Fudan University","All","1 Year to 18 Years   (Child, Adult)","Phase 4","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","twj01","June 1, 2021","September 30, 2024","September 30, 2024","August 28, 2020",,"March 11, 2021",,,"https://ClinicalTrials.gov/show/NCT04530877"
549,"NCT04524611","Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)",,"Recruiting","No Results Available","Crohn's Disease (CD)","Drug: Risankizumab|Drug: Ustekinumab","Percentage of Participants Achieving Clinical Remission at Week 24|Percentage of Participants Achieving Clinical Remission at Week 48|Percentage of Participants Achieving Endoscopic Response at Week 48|Percentage of Participants Achieving Endoscopic Remission|Percentage of Participants Achieving Clinical Remission (Patient Reported Outcome [PRO]-2)|Percentage of Participants Achieving Endoscopic Response at Week 24|Percentage of Participants Achieving Steroid-Free Remission","AbbVie","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 3","508","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","M20-259|2020-002674-26","September 30, 2020","March 3, 2023","June 11, 2023","August 24, 2020",,"June 24, 2021","Advanced Gastroenterology, P.C /ID# 224396, Chandler, Arizona, United States|Southern California Res. Ctr. /ID# 223484, Coronado, California, United States|United Medical Doctors /ID# 223486, Los Alamitos, California, United States|TLC Clinical Research Inc /ID# 223467, Los Angeles, California, United States|Hoag Memorial Hosp Presbyterian /ID# 224373, Newport Beach, California, United States|UC Davis Medical Center /ID# 225700, Sacramento, California, United States|University of California, San Francisco /ID# 223621, San Francisco, California, United States|Western Connecticut Medical Group /ID# 223478, Danbury, Connecticut, United States|Medical Research Center of CT /ID# 223540, Hamden, Connecticut, United States|Yale Univ Digestive Diseases /ID# 224463, New Haven, Connecticut, United States|Omega Research Maitland, LLC /ID# 223463, DeBary, Florida, United States|Nature Coast Clinical Research - Inverness /ID# 223600, Inverness, Florida, United States|University of Miami /ID# 223496, Miami, Florida, United States|Gastroenterology Group Naples /ID# 223516, Naples, Florida, United States|Advanced Research Institute, Inc /ID# 223470, New Port Richey, Florida, United States|Endoscopic Research, Inc. /ID# 223505, Orlando, Florida, United States|University of South Florida /ID# 224733, Tampa, Florida, United States|Atlanta Gastro Assoc /ID# 223537, Atlanta, Georgia, United States|Gastroenterology Associates of Central Georgia, LLC /ID# 223525, Macon, Georgia, United States|University of Chicago /ID# 223520, Chicago, Illinois, United States|NorthShore University HealthSystem /ID# 223538, Evanston, Illinois, United States|Southwest Gastroenterology /ID# 223509, Oak Lawn, Illinois, United States|University of Louisville /ID# 223471, Louisville, Kentucky, United States|Gastroenterology Associates LLC - Jefferson Hwy /ID# 223508, Baton Rouge, Louisiana, United States|Nola Research Works, LLC /ID# 223489, New Orleans, Louisiana, United States|Louisana Research Center, LLC /ID# 223503, Shreveport, Louisiana, United States|MGG Group Co, Inc.Chevy Chase Clinical Research /ID# 223499, Chevy Chase, Maryland, United States|Gastro Center of Maryland /ID# 223518, Columbia, Maryland, United States|Massachusetts General Hospital /Id# 224335, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center /ID# 228094, Boston, Massachusetts, United States|University of Michigan Health Systems /ID# 223597, Ann Arbor, Michigan, United States|AA Medical Research Center /ID# 224384, Grand Blanc, Michigan, United States|Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinic /ID# 223465, Wyoming, Michigan, United States|Las Vegas Medical Research /ID# 223533, Las Vegas, Nevada, United States|University of New Mexico Department of Internal Medicine /ID# 223515, Albuquerque, New Mexico, United States|NY Scientific /ID# 223479, Brooklyn, New York, United States|Saratoga Schenectady Gastroenterology Associates - Burnt Hills /ID# 224048, Burnt Hills, New York, United States|Intercity Advanced Gastroentertology Center /ID# 224313, Fresh Meadows, New York, United States|North Shore University Hospital /ID# 224356, New Hyde Park, New York, United States|The Mount Sinai Hospital /ID# 223687, New York, New York, United States|Columbia Univ Medical Center /ID# 224215, New York, New York, United States|Lenox Hill Hospital /ID# 223534, New York, New York, United States|Univ NC Chapel Hill /ID# 224405, Chapel Hill, North Carolina, United States|Wake Forest Baptist Medical Center /ID# 224406, Winston-Salem, North Carolina, United States|Plains Clinical Research Center, LLC /ID# 223522, Fargo, North Dakota, United States|University of Cincinnati /ID# 224614, Cincinnati, Ohio, United States|Cleveland Clinic Main Campus /ID# 223691, Cleveland, Ohio, United States|SSM Health Medical Group - OKC /ID# 223566, Oklahoma City, Oklahoma, United States|Digestive Disease Specialists /ID# 223528, Oklahoma City, Oklahoma, United States|Penn State Milton S. Hershey Medical Center /ID# 224216, Hershey, Pennsylvania, United States|Guthrie Medical Group, PC /ID# 223910, Sayre, Pennsylvania, United States|Digestive Disease Associates, LTD /ID# 223462, Wyomissing, Pennsylvania, United States|Medical University of South Carolina /ID# 223485, Charleston, South Carolina, United States|Consultants in Gastroenterology - Columbia NE /ID# 224263, Columbia, South Carolina, United States|Gastroenterology Associates, P.A. of Greenville /ID# 223497, Greenville, South Carolina, United States|Gastro One /ID# 223539, Germantown, Tennessee, United States|Vanderbilt University Medical Center /ID# 224610, Nashville, Tennessee, United States|Baylor Scott & White Center for Inflammatory Bowel Diseases /ID# 223512, Dallas, Texas, United States|DHAT Research Institute /ID# 223521, Garland, Texas, United States|Vilo Research Group Inc /ID# 223513, Houston, Texas, United States|Baylor College of Medicine - Baylor Medical Center /ID# 223488, Houston, Texas, United States|Clinical Associates in Research Therapeutics of America, LLC /ID# 223510, San Antonio, Texas, United States|Southern Star Research Institute, LLC /ID# 223598, San Antonio, Texas, United States|Texas Digestive Disease Consultants - Southlake /ID# 224264, Southlake, Texas, United States|Tyler Research Institute, LLC /ID# 223469, Tyler, Texas, United States|University of Vermont Medical Center /ID# 224047, Burlington, Vermont, United States|Hunter Holmes McGuire VA Medical Center /ID# 223586, Richmond, Virginia, United States|Virginia Mason - Seattle Orthapedics /ID# 224253, Seattle, Washington, United States|Harborview Medical Center /ID# 224464, Seattle, Washington, United States|West Virginia University Hospitals /ID# 223501, Morgantown, West Virginia, United States|Cemic /Id# 223670, Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina|CINME Centro de Investigaciones Metabolicas /ID# 223447, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina|Hospital Italiano de Buenos Aires /ID# 224550, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina|Hospital Britanico de Buenos Aires /ID# 223432, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina|Gedyt /ID# 224698, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina|Sanatorio 9 de Julio /ID# 226086, San Miguel de Tucuman, Tucuman, Argentina|Hospital Privado Univesitario /ID# 223433, Cordoba, Argentina|Wollongong Hospital /ID# 224688, Wollongong, New South Wales, Australia|Mater Misericordiae Limited /ID# 223642, South Brisbane, Queensland, Australia|Griffith University /ID# 223641, Southport, Queensland, Australia|Lyell McEwin Hospital /ID# 223643, Elizabeth Vale, South Australia, Australia|Monash Medical Centre /ID# 224599, Clayton, Victoria, Australia|Universitaetsklinikum St. Poelten /ID# 223437, Sankt Poelten, Niederoesterreich, Austria|Ordensklinikum Linz GmbH Barmherzige Schwestern /ID# 223440, Linz, Oberoesterreich, Austria|Medizinische Universitat Wien /ID# 223438, Vienna, Wien, Austria|ULB Hospital Erasme /ID# 223902, Brussels, Bruxelles-Capitale, Belgium|UCL Saint-Luc /ID# 223900, Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium|CHU UCL Namur - site Godinne /ID# 223905, Godinne, Namur, Belgium|UZ Gent /ID# 223899, Gent, Oost-Vlaanderen, Belgium|Universitair Ziekenhuis Leuven /ID# 223901, Leuven, Vlaams-Brabant, Belgium|AZ Maria Middelares /ID# 223908, Gent, Belgium|CHU de Liege /ID# 223904, Liege, Belgium|Groupe Sante CHC - Clinique du MontLegia /ID# 223898, Liege, Belgium|ZNA - Jan Palfijn /ID# 223907, Merksem, Belgium|AZ-Delta /ID# 223896, Roeselare, Belgium|AZ Nikolaas /ID# 224511, Sint-Niklaas, Belgium|Upeclin Fmb - Unesp /Id# 223234, Botucatu, Sao Paulo, Brazil|Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP /ID# 223233, Ribeirão Preto, Sao Paulo, Brazil|Faculdade de Medicina do ABC /ID# 223231, Santo André, Sao Paulo, Brazil|Kaiser Clinica e Hospital Dia /ID# 223232, Sao Jose Do Rio Preto, Sao Paulo, Brazil|UMHAT Kaspela EOOD /ID# 223415, Plovdiv, Bulgaria|Second MHAT Sofia /ID# 223425, Sofia, Bulgaria|Acibadem City Clinic UMHAT Tokuda /ID# 223757, Sofia, Bulgaria|UMHAT Tsaritsa Joanna - ISUL /ID# 223822, Sofia, Bulgaria|University of Calgary - Cumming School of Medicine - Adult Cystic Fibrosis Clini /ID# 223750, Calgary, Alberta, Canada|Allen Whey Khye Lim Professional Corporation /ID# 223755, Edmonton, Alberta, Canada|Covenant Health /ID# 223753, Edmonton, Alberta, Canada|Fraser Clinical Trials Inc /ID# 223742, New Westminster, British Columbia, Canada|Percuro Clinical Research, Ltd /ID# 223747, Victoria, British Columbia, Canada|QEII - Health Sciences Centre /ID# 223748, Halifax, Nova Scotia, Canada|London Health Sciences Center /ID# 223741, London, Ontario, Canada|Scott Shulman Medicine Professional Corporation /ID# 223754, North Bay, Ontario, Canada|Mount Sinai Hospital /ID# 223752, Toronto, Ontario, Canada|Axler, Toronto, ON. Canada /ID# 223740, Toronto, Ontario, Canada|CISSS de la Monteregie /ID# 224399, Greenfield Park, Quebec, Canada|Montreal General Hospital /ID# 223743, Montréal, Quebec, Canada|CSSS Alphonse-Desjardins, CHAU de Levis /ID# 223744, Quebec City, Quebec, Canada|CHUS - Hopital Fleurimont /ID# 224819, Sherbrooke, Quebec, Canada|Sociedad de Servicios Médicos Walsen Galmez Ltda. /ID# 224032, Santiago, Region Metropolitana De Santiago, Chile|Hospital Guillermo Grant Benavente de Concepción /ID# 223668, Concepción, Chile|Hospital Las Higueras /ID# 223669, Talcahuano, Chile|Zhongshan Hospital Xiamen University /ID# 224663, Fujian, Anhui, China|Anhui Provincial Hospital /ID# 224832, Hefei, Anhui, China|Zhujiang hospital,southern medical university /ID# 224524, Guangzhou, Guangdong, China|The Sixth Affiliated Hosp Sun /ID# 224416, Guangzhou, Guangdong, China|The Second Hospital of Hebei Medical University /ID# 224544, Shijiazhuang, Hebei, China|The Second Affiliated Hospital of Zhengzhou University /ID# 224528, Zhengzhou, Henan, China|Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 224545, Wuhan, Hubei, China|Renmin Hospital of Wuhan University /ID# 224525, Wuhan, Hubei, China|The Third Xiangya Hospital of Central South University /ID# 224754, Changsha, Hunan, China|Wuxi People's Hospital /ID# 224426, Wuxi, Jiangsu, China|The First Affiliated Hospital of Nanchang University /ID# 224507, Nanchang, Jiangxi, China|Renji Hospital, Shanghai Jiaotong University School of Medicine /ID# 224420, Shanghai, Shanghai, China|The second Affiliated hospital of Zhejiang University school of Medicine /ID# 224662, Hangzhou, Zhejiang, China|Sir Run Run Shaw Hospital /ID# 224421, Hangzhou, Zhejiang, China|Peking University Third Hospital /ID# 224479, Beijing, China|2nd Xiangya Hosp South Univ /ID# 224684, Changsha, China|West China Hospital, Sichuan University /ID# 224786, Chengdu, China|Nanjing Drum Tower Hospital /ID# 224746, Nanjing Jiangsu, China|Shengjing Hospital of China Medical University /ID# 224478, Shenyang, China|Tongji Hospital Tongji Medical College Huazhong University of Science and Techno /ID# 224428, Wuhan, China|Nemocnice Ceske Budejovice a.s. /ID# 224219, Ceske Budejovice, Czechia|Hepato-Gastroenterologie HK, s.r.o. /ID# 223277, Hradec Kralove, Czechia|Nemocnice Pardubickeho kraje, a.s. /ID# 223256, Pardubice, Czechia|Axon Clinical, s.r.o. /ID# 223260, Praha, Czechia|NH Hospital a.s. /ID# 223276, Praha, Czechia|ISCARE a.s. /ID# 223279, Praha, Czechia|Chu de Nice-Hopital L'Archet Ii /Id# 223763, Nice CEDEX 3, Alpes-Maritimes, France|Hopital Haut-Leveque /ID# 223764, Pessac CEDEX, Gironde, France|CHRU Lille - Hopital Claude Huriez /ID# 223765, Lille CEDEX, Hauts-de-France, France|Hopital Beaujon /ID# 223863, Clichy, Ile-de-France, France|CHU NANCY - Hopital Brabois Adultes /ID# 223767, Vandoeuvre les Nancy CEDEX, Meurthe-et-Moselle, France|Assis.Publique-Hopital Nord /ID# 223869, Marseille, Provence-Alpes-Cote-d Azur, France|CHU Estaing /ID# 224529, Clermont Ferrand, France|CHU Grenoble Alpes - Hopital /ID# 224091, Grenoble, France|CHU Saint ELOI /ID# 223860, Montpellier Cedex 5, France|Clinique Jules Verne /ID# 223870, Nantes, France|Polyclinique Grand Sud /ID# 224092, Nimes Cedex, France|Hopital Robert Debre /ID# 224530, Reims, France|CHU de Saint-Etienne, Hopital Nord /ID# 223768, SAINT-ETIENNE Cedex 1, France|Universitaetsklinikum Freiburg /ID# 223406, Freiburg, Baden-Wuerttemberg, Germany|Universitatsklinikum Mannheim /ID# 223410, Mannheim, Baden-Wuerttemberg, Germany|Universitaetsklinikum Ulm /ID# 223400, Ulm, Baden-Wuerttemberg, Germany|Universitaetsklinikum Erlangen /ID# 223404, Erlangen, Bayern, Germany|Universitatsklinik Regensburg /ID# 223407, Ratisbon, Bayern, Germany|Universitaetsklinikum Frankfurt /ID# 223396, Frankfurt am Main, Hessen, Germany|Praxiszentrum fuer Gastroenterologie /ID# 223409, Grevenbroich, Nordrhein-Westfalen, Germany|Zentrum für Gastroenterologie Saar MVZ GmbH /ID# 223482, Saarbrücken, Saarland, Germany|Universitaetsklinikum Carl Gustav Carus an der TU Dresden /ID# 223403, Dresden, Sachsen, Germany|Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 223395, Kiel, Schleswig-Holstein, Germany|Krankenhaus Waldfriede /ID# 223397, Berlin-Zehlendorf, Germany|Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 223405, Berlin, Germany|Praxis Dr. Michael Mross /ID# 229110, Berlin, Germany|MVZ fuer Gastroenterlogie am Bayerischen Platz /ID# 223411, Berlin, Germany|DRK Kliniken Berlin Westend /ID# 223412, Berlin, Germany|Agaplesion Markus Krankenhaus /ID# 223673, Frankfurt am Main, Germany|Medizinische Hochschule Hannover /ID# 223402, Hannover, Germany|EUGASTRO GmbH /ID# 223401, Leipzig, Germany|Klinikum Lueneburg /ID# 223408, Lueneburg, Germany|Otto-von-Guericke-Universitaet /ID# 223413, Magdeburg, Germany|Medizinisches Versorgungszentrum Portal 10 /ID# 224552, Muenster, Germany|General Hospital of Athens Ippokratio /ID# 223344, Athens, Attiki, Greece|General Hospital of Chest Diseases of Athens SOTIRIA /ID# 223342, Athens, Attiki, Greece|University General Hospital of Heraklion PA.G.N.I /ID# 223336, Heraklion, Kriti, Greece|General Hospital of Athens, Ev /ID# 223338, Athens, Greece|University General Hospital of Ioannina /ID# 223339, Ioannina, Greece|General Hospital of Nikaia-Piraeus ""Agios Panteleimon""- general hospital dytikis /ID# 223340, Pireaus, Greece|Genl Hosp Thess Ippokrateio /ID# 223887, Thessaloniki, Greece|Clinexpert Kft. /ID# 223775, Budapest, Hungary|Semmelweis Egyetem /ID# 223772, Budapest, Hungary|Debreceni Egyetem Klinikai Kozpont /ID# 223773, Debrecen, Hungary|University of Szeged /ID# 223774, Szeged, Hungary|Clinfan Szolgaltato Kft. /ID# 224751, Szekszárd, Hungary|Tel Aviv Sourasky Medical Center /ID# 223551, Tel Aviv-Yafo, Tel-Aviv, Israel|Soroka University Medical Center /ID# 223556, Be'er Sheva, Israel|The Edith Wolfson Medical Center /ID# 227652, Holon, Israel|Shaare Zedek Medical Center /ID# 223549, Jerusalem, Israel|Rabin Medical Center /ID# 223558, Petakh Tikva, Israel|Sheba Medical Center /ID# 223557, Ramat Gan, Israel|Assaf Harofeh Medical Center /ID# 224686, Zerifin, Israel|University of Catanzaro /ID# 223331, Catanzaro, Calabria, Italy|A.O.U. Policlinico S.Orsola-Malpighi /ID# 223330, Bologna, Emilia-Romagna, Italy|Azienda Ospedaliera San Camillo Forlanini /ID# 223325, Rome, Lazio, Italy|Policlinico Agostino Gemelli /ID# 223323, Rome, Lazio, Italy|Ospedale Policlinico San Martino/ Università Degli Studi Di Genova /ID# 223329, Genoa, Liguria, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 223324, Milan, Lombardia, Italy|ASST Rhodense /ID# 223335, Rho, Lombardia, Italy|Istituto Clinico Humanitas /ID# 223326, Rozzano, Milano, Italy|A.O. Per L'Emergenza Cannizzaro /ID# 223334, Catania, Sicilia, Italy|Ospedale Classificato Equiparato Sacro Cuore-Don Calabria /ID# 223327, Negrar, Verona, Italy|Azienda Ospedaliero-Universitaria di Cagliari /ID# 223474, Cagliari, Italy|Policlinico Tor Vergata /ID# 223332, Messina, Italy|ASST Fatebenefratelli Sacco-Ospedale Sacco /ID# 223322, Milano, Italy|Ospedali Riuniti Villa Sofia-C /ID# 223333, Palermo, Italy|Kangbuk Samsung Hospital /ID# 223452, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Dong-A University Hospital /ID# 223455, Busan, Korea, Republic of|The Catholic University of Korea, Daejeon St.Mary's Hospital /ID# 223456, Daejeon, Korea, Republic of|Samsung Medical Center /ID# 223453, Seoul, Korea, Republic of|Centro de Investigacion en Artritis y Osteoporosis S.C. /ID# 227179, Mexicali, Baja California, Mexico|BRCR Global México /ID# 223970, Guadalajara, Jalisco, Mexico|Centro Medico Zambrano Hellion /ID# 224025, San Pedro Garza Garcia, Nuevo Leon, Mexico|Medical Care & Research SA de CV /ID# 223974, Mérida, Yucatan, Mexico|Faicic S de Rl de Cv /Id# 226990, Veracruz, Mexico|Academisch Medisch Centrum /ID# 223228, Amsterdam, Noord-Holland, Netherlands|Elisabeth Tweesteden Ziekenhuis /ID# 223229, Tilburg, Netherlands|Universitair Medisch Centrum Utrecht /ID# 223696, Utrecht, Netherlands|Gastromed /Id# 223705, Torun, Kujawsko-pomorskie, Poland|Malopolskie Centrum Kliniczne /ID# 223708, Krakow, Malopolskie, Poland|NZOZ Vivamed /ID# 223706, Warszawa, Mazowieckie, Poland|Institutul Clinic Fundeni /ID# 223914, Sector 2, Bucuresti, Romania|Strada dr. Sergiu Dumitru Nr 5 /ID# 223682, Bucharest, Romania|Spitalul Clinic Colentina /ID# 223680, Bucharest, Romania|Univ Emergency Hosp Bucharest /ID# 223579, Bucuresti, Romania|Spitalul Clinic Judetean Mures /ID# 223613, Targu Mures, Romania|Spitalul Clinic Judetean de Urgenta Targu Mures /ID# 224017, Targu Mures, Romania|Centrul de Gastroenterologie Dr.Goldis /ID# 223578, Timisoara, Romania|Immanuel Kant Baltic Federal University /ID# 224224, Kaliningrad, Kaliningradskaya Oblast, Russian Federation|National Medical Research Center of Coloproctology n.a. A. N. Ryzhikh /ID# 224222, Moscow, Russian Federation|City Clinical Hospital No. 31 /ID# 224223, St. Petersburg, Russian Federation|Fakultna nemocnica s poliklinikou F.D. Roosevelta Banska Bystrica /ID# 223302, Banska Bystrica, Slovakia|KM Management s.r.o. /ID# 223304, Nitra, Slovakia|Fakultna nemocnica s poliklini /ID# 224580, Nove Zamky, Slovakia|GASTRO I., s.r.o. /ID# 223303, Presov, Slovakia|Lenasia Clinical Trial Centre /ID# 224306, Johannesburg, Gauteng, South Africa|Wits Clinical Research Site /ID# 223807, Johannesburg, Gauteng, South Africa|Spoke Research Inc /ID# 223803, Cape Town,Milnerton, Western Cape, South Africa|Dr MJ Prins /ID# 224304, Cape Town, Western Cape, South Africa|Mediclinic Constantiaberg /ID# 223805, Cape Town, Western Cape, South Africa|Hospital Arquitecto Marcide - Complejo Hospitalario Universitario de Ferrol /ID# 223356, Ferrol, A Coruna, Spain|Hospital Clínico Universitario de Santiago-CHUS /ID# 226554, Santiago de Compostela, A Coruna, Spain|Hospital Universitario Central de Asturias /ID# 223368, Oviedo, Asturias, Spain|Hospital Universitario Germans Trias i Pujol /ID# 223436, Badalona, Barcelona, Spain|Hospital Universitario de Bellvitge /ID# 225719, L'Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario de Fuenlabrada /ID# 223371, Fuenlabrada, Madrid, Spain|Hospital Universitario Puerta de Hierro, Majadahonda /ID# 223319, Majadahonda, Madrid, Spain|Hospital General Universitario Alicante /ID# 223552, Alicante, Spain|Hospital Clinic de Barcelona /ID# 223355, Barcelona, Spain|Hospital General Universitario Gregorio Maranon /ID# 223317, Madrid, Spain|Hospital Clinico Universitario San Carlos /ID# 223367, Madrid, Spain|Hospital Universitario La Paz /ID# 223318, Madrid, Spain|Hospital Universitario Virgen Macarena /ID# 223315, Sevilla, Spain|Hospital Universitario Virgen del Rocio /ID# 223476, Sevilla, Spain|Hospital Clinico Universitario de Valencia /ID# 223321, Valencia, Spain|Hospital Universitario y Politecnico La Fe /ID# 223314, Valencia, Spain|GHP Stockholm Gastro Center /ID# 223420, Stockholm, Stockholms Lan, Sweden|Falu Lasarett /ID# 227222, Falun, Sweden|Karolinska Univ Sjukhuset /ID# 223423, Solna, Sweden|Danderyds sjukhus AB /ID# 223363, Stockholm, Sweden|Universitaetsspital Basel /ID# 223711, Basel, Switzerland|Inselspital, Universitaetsklinik /ID# 223590, Bern, Switzerland|Universitatsspital Zurich /ID# 223712, Zurich, Switzerland|Gazi Universitesi Tip Fakultes /ID# 223386, Ankara, Turkey|Ankara Univ Medical Faculty /ID# 223388, Ankara, Turkey|Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty /ID# 223387, Istanbul, Turkey|Mersin University Medical /ID# 223385, Mersin, Turkey|MNE Kyiv City Clinical Hospital no.18 /ID# 223700, Kyiv, Ukraine|Lviv Regional Clinical Hospital /ID# 223661, Lviv, Ukraine|Medical Center of LLC DIASERVIS /ID# 224249, Zaporizhzhia, Ukraine|Queen Elizabeth University Hos /ID# 223653, Glasgow, Glasgow City, United Kingdom|East and North Hertfordshire NHS Trust /ID# 224607, Stevenage, Hertfordshire, United Kingdom|The Royal London Hospital /ID# 223651, London, London, City Of, United Kingdom|Guy's and St Thomas' NHS Found /ID# 223647, London, London, City Of, United Kingdom|Forth Valley Royal Hospital /ID# 224657, Larbert, Stirling, United Kingdom|Royal Victoria Hospital /ID# 224023, Belfast, United Kingdom|Fairfield General Hospital /ID# 223650, Bury, United Kingdom|Addenbrookes Hospital /ID# 223648, Cambridge, United Kingdom|Western General Hospital /ID# 223646, Edinburgh, United Kingdom|Royal Devon and Exeter NHS Fou /ID# 223644, Exeter, United Kingdom|Huddersfield Royal Infirmary /ID# 223654, Huddersfield, United Kingdom|King's College Hospital NHS Foundation Trust /ID# 223649, London, United Kingdom|St. George's Healthcare NHS /ID# 223656, London, United Kingdom|Manchester Royal Infirmary /ID# 224573, Manchester, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 223655, Newcastle Upon Tyne, United Kingdom|Nottingham Univ Hospitals NHS /ID# 224179, Nottingham, United Kingdom|Oxford University Hospitals NHS Foundation Trust The John Radcliffe Hospital /ID# 223645, Oxford, United Kingdom|Univ Hosp Southampton NHS /ID# 224351, Southampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04524611"
550,"NCT04502303","18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease",,"Not yet recruiting","No Results Available","Crohn Disease","Diagnostic Test: 18F-FDG and 68Ga-FAPI PET/CT","SUVmax of stenotic intestine|MV of stenotic intestine|TMI of stenotic intestine|Histological findings","Peking Union Medical College Hospital","All","18 Years and older   (Adult, Older Adult)","Phase 2","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","FAPICD","September 2020","September 2021","September 2021","August 6, 2020",,"August 7, 2020",,,"https://ClinicalTrials.gov/show/NCT04502303"
551,"NCT04496063","USTekinumab in Fistulising Perianal Crohn's Disease (USTAP)","USTAP","Recruiting","No Results Available","Crohn's Disease","Drug: Ustekinumab|Drug: Placebo","Combined clinical and radiological remission|Clinical response|MAGNIFI-CD26|PDAI|IBDQ scores|UST trough levels and antidrug|Clinical response of UST optimization|Clinical response of UST introduction at week 12|CDAI","Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives|Janssen, LP","All","18 Years and older   (Adult, Older Adult)","Phase 4","146","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","GT-2019-01","November 16, 2020","December 2, 2022","September 2, 2023","August 3, 2020",,"January 20, 2021","CHU Rennes, Rennes, Bretagne, France|Chu Amiens, Amiens, France|Chu Besancon, Besançon, France|CHU Clermont Ferrand, Clermont-Ferrand, France|APHP- Hopital Beaujon, Clichy, France|Hôpital Louis Mourier, Colombes, France|Hôpital Kremlin Bicêtre, Le Kremlin Bicêtre, France|CHRU Lille, Lille, France|CHU Montpellier - St Eloi, Montpellier, France|Hôpital Hôtel Dieu, Nantes, France|CHU Nice- Hopital l'Archet, Nice, France|CHU Nîmes - Hôpital Universitaire Caremeau, Nîmes, France|Hôpital St Louis, Paris, France|Hôpital Saint-Antoine, Paris, France|Hôpital Bichat, Paris, France|CHU LYON- Hopital Lyon Sud, Pierre-Bénite, France|CHU Roubaix, Roubaix, France|CHU Saint-Etienne, Saint-Priest-en-Jarez, France|CHU de Tours - Hopital Trousseau, Tours, France|CHU Nancy - Hôpital de Brabois, Vandœuvre-lès-Nancy, France",,"https://ClinicalTrials.gov/show/NCT04496063"
552,"NCT04488146","Pain in Patients With Crohn Disease (PAINCD)","PAINCD","Not yet recruiting","No Results Available","Crohn Disease|Pain|Depression, Anxiety",,"Pain intensity in patients with Crohn Disease (CD)|Presence of hyperalgesia|Search for a neuropathic component of pain|Investigation of the impact of pain on depression and anxietey","University of Liege","All","18 Years and older   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","PAINCD","October 2020","January 2021","February 2021","July 27, 2020",,"July 27, 2020",,,"https://ClinicalTrials.gov/show/NCT04488146"
553,"NCT04397263","A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease",,"Recruiting","No Results Available","Crohns Disease","Drug: Guselkumab","Number of Participants with Adverse Events as a Measure of Safety and Tolerability|Change from Baseline in the Crohn's Disease Activity Index (CDAI) Score|Change from Baseline in Patient-Reported Outcome (PRO)-2 Score|Change from Baseline in Simplified Endoscopic Score for Crohn's disease (SES-CD) Score|Serum Concentation of Guselkumab|Number of Participants with Anti-Guselkumab Antibodies|Change from Baseline in C-reactive protein (CRP)|Change from Baseline in Fecal Calprotectin (FC) Levels","Janssen Pharmaceutical K.K.","All","18 Years and older   (Adult, Older Adult)","Phase 3","25","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CR108801|CNTO1959CRD3003","June 10, 2020","September 30, 2024","September 30, 2024","May 21, 2020",,"May 12, 2021","KOKIKAI Tokatsu Tsujinaka Hospital, Abiko, Japan|Hitachi General Hospital, Hitachi, Japan|Asahikawa Medical University Hospital, Hokkaido, Japan|Ofuna Chuo Hospital, Kamakura, Japan|Kishiwada Tokushukai Hospital, Kishiwada, Japan|Kumamoto University Hospital, Kumamoto, Japan|Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan|Sendai Kosei Hospital, Miyagi, Japan|Kenseikai Dongo Hospital, Nara, Japan|Ishida Clinic of IBD and Gastroenterology, Oita, Japan|Okayama University Hospital, Okayama-shi, Japan|Kitasato University Hospital, Sagamihara, Japan|Saga University Hospital, Saga, Japan|Saitama Medical Center, Saitama, Japan|Sapporo Tokushukai Hospital, Sapporo, Japan|Jichi Medical University Hospital, Shimotsuke, Japan|Tokyo Women's Medical University Hospital, Shinjuku-ku, Japan|Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Japan|Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan|National Center for Global Health and Medicine, Tokyo, Japan|Toyama Prefectural Central Hospital, Toyama, Japan|NHO Toyohashi Medical Center, Toyohashi, Japan",,"https://ClinicalTrials.gov/show/NCT04397263"
554,"NCT04372108","A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Drug: Ustekinumab|Drug: Other Biologic Therapies","Incidence Rate for Malignancy|Opportunistic Infection (OI)|Serious Infection","Janssen Scientific Affairs, LLC","All","18 Years and older   (Adult, Older Adult)",,"1536","Industry","Observational","Observational Model: Cohort|Time Perspective: Other","CR108561|RRA-18896","May 14, 2020","August 31, 2029","August 30, 2030","May 1, 2020",,"July 2, 2020","NMCP, Portsmouth, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT04372108"
555,"NCT04370535","PMA-Zeolite-Clinoptilolite Effects in Crohn Disease",,"Recruiting","No Results Available","Crohn Disease","Device: cellulose|Device: PMA-zeolite","Zonulin concentration in stool (ng/ml)|Bacterial diversity in the marbus crohn patients","Ciim Plus, d.o.o.|University of Rijeka","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","40","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","crohn-disease ver. 1.3_17","October 17, 2018","November 28, 2019","May 15, 2020","May 1, 2020",,"May 20, 2020","University Clinical Centre Ljubljana, Ljubljana, Slovenia|Medical Thermal Centre Fontana, Maribor, Slovenia|Slovenj Gradec General Hospital, Slovenj Gradec, Slovenia",,"https://ClinicalTrials.gov/show/NCT04370535"
556,"NCT04362735","Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological Therapy",,"Not yet recruiting","No Results Available","Crohn Disease","Drug: Vedolizumab","Clinical remission|Clinical response|Mucosal healing|Need for major surgery during treatment","Pontifícia Universidade Católica do Paraná|Takeda","All","18 Years and older   (Adult, Older Adult)",,"100","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","IISR-2020-103104","August 1, 2020","January 20, 2021","April 1, 2021","April 27, 2020",,"April 27, 2020",,,"https://ClinicalTrials.gov/show/NCT04362735"
557,"NCT04362254","A Study to Test Long-term Treatment With Spesolimab in Patients With Fistulising Crohn's Disease Who Took Part in Previous Trials",,"Recruiting","No Results Available","Crohn Disease","Drug: Spesolimab","Exposure adjusted rate of patients reporting a treatment emergent adverse event (TEAE)|Proportion of patients with perianal fistula remission|Proportion of patients with perianal fistula response","Boehringer Ingelheim","All","18 Years and older   (Adult, Older Adult)","Phase 2","20","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","1368-0007|2019-001673-93","May 15, 2020","May 14, 2030","August 15, 2030","April 24, 2020",,"June 7, 2021","AKH - Medical University of Vienna, Wien, Austria|Universitätsklinikum Erlangen, Erlangen, Germany",,"https://ClinicalTrials.gov/show/NCT04362254"
558,"NCT04330846","Prospective Multicenter Randomized Comparative Study of the Treatment of de Novo Stenosis in Chron's Disease.","ENDOCIR","Not yet recruiting","No Results Available","Crohn Disease","Procedure: Surgical resection","Quality of life of patients|Percentage of patients with clinical recurrence|Percentage of complications","Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","ENDOCIR","April 1, 2021","April 1, 2023","April 1, 2026","April 2, 2020",,"February 4, 2021","Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Althaia, xarxa assistencial universitaria de Manresa, Manresa, Barcelona, Spain|Consorci Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain|Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain|Hospital Mutua de Terrassa, Terrassa, Barcelona, Spain|Hospital Universitario de Cáceres, Cáceres, Spain|Clínica Girona, Girona, Spain|Hospital Josep Trueta, Girona, Spain|Hospital de Inca, Inca, Spain|Hospital Universitari Arnau de Vilanova, Lleida, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital de Terrassa, Terrassa, Spain|Hospital Clínico de Valencia, Valencia, Spain|Hospital Universitari La Fe, Valencia, Spain",,"https://ClinicalTrials.gov/show/NCT04330846"
559,"NCT04328922","Fecal Microbial Transplantation and Vedolizumab Treatment of Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease|Microbial Substitution","Other: Fecal microbial transplantation|Other: Placebo capsuls","safety of FMT pre vedolizumab treatment in CD patients|safety of FMT pre vedolizumab treatment in CD patients: measured by disease exacerbations, hospitalizations and surgery rate in treatment versus placebo group|efficacy of FMT pre vedolizumab treatment in CD patients that results in higher remission rate|efficacy of FMT pre vedolizumab treatment in CD patients that results in clinical response rate|efficacy of FMT pre vedolizumab treatment in CD patients that results in endoscopic response|efficacy of FMT pre vedolizumab treatment in CD patients that results in endoscopic remission|efficacy of FMT pre vedolizumab treatment in CD patients that results in histological healing|efficacy of FMT pre vedolizumab treatment in CD patients that results in biological remission|safety of FMT pre vedolizumab treatment in CD patients that results in low adverse events rate","Tel-Aviv Sourasky Medical Center","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","TASMC-16-NH-0123-CTIL","July 3, 2018","April 2022","January 2023","April 1, 2020",,"April 1, 2020","Department of Gastroentherology, Tel Aviv, Israel|Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT04328922"
560,"NCT04321941","Trial Evaluating the Diagnostic Usefulness of Lumentin® 44 When Used as Contrast Agent",,"Recruiting","No Results Available","Crohn Disease","Diagnostic Test: Lumentin|Diagnostic Test: Movprep","RCDAS score","Lument AB|LINK Medical Research","All","18 Years and older   (Adult, Older Adult)","Phase 2","55","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","LUM-002|2019-002093-32","January 29, 2020","December 31, 2020","December 31, 2020","March 25, 2020",,"March 27, 2020","Department of medical imaging and function, Malmö, Sweden",,"https://ClinicalTrials.gov/show/NCT04321941"
561,"NCT04321863","Stratifying Crohn's Using Biomarker Assessment","SCUBA","Recruiting","No Results Available","Crohn Disease in Remission","Other: Faecal calprotectin (FC)|Other: quantitative Faecal Immunochemical Testing (qFIT)|Other: Serum and faecal zinc","qFIT and FC|Serum/faecal zinc","NHS Greater Glasgow and Clyde","All","18 Years to 50 Years   (Adult)",,"315","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","20/WS/0028|246230","August 13, 2020","July 1, 2021","July 1, 2022","March 25, 2020",,"October 8, 2020","Glasgow Royal Infirmary, Glasgow, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04321863"
562,"NCT04312659","A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Drug: Infliximab","Percentage of Participants with Clinical Response at Week 14|Number of Participants with Adverse Events (AE) as a Measure of Safety and Tolerability|Percentage of Participants with Clinical Remission at Week 14|Percentage of Participants with Clinical Remission at Week 30|Percentage of Participants with Clinical Response at Week 30|Percentage of Participants with Endoscopic Remission at Week 30|Change from Baseline in Height Z-Scores at Week 30|Change from Baseline in Body Mass Index (BMI) Z-Scores at Week 30|Change from Baseline in Acute Response Indicators at Week 14|Change from Baseline in White Blood Cells Countat Week 14|Change from Baseline in Hemoglobin Levels at Week 14|Change from Baseline in Platelet Count at Week 14|Change from Baseline in Albumin Levels at Week 14","Johnson & Johnson (China) Investment Ltd.","All","6 Years to 17 Years   (Child)",,"30","Industry","Observational","Observational Model: Case-Only|Time Perspective: Prospective","CR108748|C0168CRD4020","July 15, 2020","August 14, 2023","August 14, 2023","March 18, 2020",,"April 14, 2021","Beijing Children's Hospital, Capital Medical University, Beijing, China|Guangzhou Women And Children's Medical Center, Guangzhou, China|The Children's Hospital, Zhejiang University School Of Medicine, Hangzhou, China|Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, China|Children's Hospital of Fudan University, Shanghai, China|Henan Children's Hospital, Zhengzhou Children's Hospital, ZhengZhou, China",,"https://ClinicalTrials.gov/show/NCT04312659"
563,"NCT04283864","Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease",,"Personalised nutrition Algorithm based on microbiome.","Weizmann Institute of Science|The Leona M. and Harry B. Helmsley Charitable Trust","All","6 Years to 18 Years   (Child, Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","0722-19 -RMC","November 29, 2020","December 2021","December 2024","February 25, 2020",,"December 17, 2020","Schneider children's medical center, Petah tikva, Israel",,"https://ClinicalTrials.gov/show/NCT04283864"
564,"NCT04274010","PANenteric Crohn's Capsule Versus Ileo-Colonoscopy and Scan Study","PAN-ICS","Not yet recruiting","No Results Available","Crohn Disease","Diagnostic Test: PillCamTM Crohn's capsule|Diagnostic Test: Magnetic resonance enterography|Procedure: Ileo-colonoscopy","Positive yields in Crohn's capsule vs ileo-colonoscopy and magnetic resonance enterography.|Correlation between small bowel scoring systems.|Correlation between colonic scoring systems.|Positive diagnostic yield of Crohn's capsule with clinical severity of Crohn's disease.|Positive diagnostic yield of Crohn's capsule with patient quality of life.|Patient experience in each modality.","South Tyneside and Sunderland NHS Foundation Trust|County Durham and Darlington NHS Foundation Trust|Sheffield Teaching Hospitals NHS Foundation Trust|Newcastle University|Durham University","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","125","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","275854","November 2, 2020","November 3, 2021","June 30, 2022","February 18, 2020",,"October 20, 2020",,,"https://ClinicalTrials.gov/show/NCT04274010"
565,"NCT04273399","High-impact Exercise in Adults With Crohn's Disease","IMPACT CD","Not yet recruiting","No Results Available","Crohn Disease","Other: High-impact exercise intervention|Other: Acute response to high-impact exercise","Feasibility of participation in high-impact exercise: proportion of exercise sessions completed, and proportion of repetitions completed across intervention|Change in Tibia Bone Density & Geometry|Change in Whole Body Bone Density & Composition|Change in Inflammatory Cytokines|Change in Bone Formation Marker|Change in Bone Resorption Marker|Change in Disease Specific Health related quality of life|Change in Health related quality of life|Change in disease related Fatigue|Change in Fatigue|Change in Lower limb muscle function|Habitual physical activity|Self-efficacy for exercise: questionnaire|Change in Disease activity|Change in Dietary Intake|Change in Body composition|Changes in Inflammatory marker in stool sample","NHS Greater Glasgow and Clyde|University of Glasgow","All","18 Years to 40 Years   (Adult)","Not Applicable","30","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","GN19GA462","March 2020","October 2021","October 2021","February 18, 2020",,"February 18, 2020","Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04273399"
566,"NCT04245215","Loss of RESponse to Ustekinumab Treated by Dose Escalation","REScUE","Recruiting","No Results Available","Crohn Disease","Drug: Ustekinumab","Proportion of patients with steroid free clinical remission and fecal calprotectin<250µg/g at week 48|Proportion of patients with complete endoscopic remission at week 48|Proportion of patients with endoscopic remission at week 48|Proportion of patients with endoscopic response at week 48|Proportion of patients with clinical remission at week 48|Proportion of patients with biomarker remission at week 48|Proportion of patients with at all time points after baseline ustekinumab trough concentration > 1.4 μg/mL|Proportion of patients with serious adverse events at week 48","Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW|Janssen Cilag N.V./S.A.","All","18 Years and older   (Adult, Older Adult)","Phase 3","108","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","BIRD2018001","February 13, 2020","October 2022","October 2022","January 28, 2020",,"March 16, 2020","Saskia Appelmans, Deinze, Belgium",,"https://ClinicalTrials.gov/show/NCT04245215"
567,"NCT04239248","""Tasty&Healthy"" Dietary Approach for Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Dietary Supplement: Tasty&Healthy intervention group|Dietary Supplement: EEN intervention group","ACTIVE-RCT-I: patient's tolerance to the diet by week 8.|MH-RCT-II: Rate of mucosal healing (MH).|Percent of patients achieving MH rate at Week 8 assessed with panenteric capsule endoscopy (i.e. Crohn's capsule) at the end of both trials as the major secondary outcome.|Percent of patients achieving clinical remission rate|Response rate defined as percent of patients achieving clinical remission and either reduction of FC levels.","Shaare Zedek Medical Center","All","6 Years to 24 Years   (Child, Adult)","Not Applicable","192","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","Tasty&Healthy","April 1, 2020","November 2021","November 2022","January 27, 2020",,"May 25, 2021","Shaare Zedek Medical Center, Jerusalem, Israel",,"https://ClinicalTrials.gov/show/NCT04239248"
568,"NCT04233463","The Effect of Oral Polymeric Diet Enriched With TGF-beta 2 (Modulen) on Clinical Response and Mucosal Healing in Adult Patients With Newly Diagnosed Crohn's Disease",,"Not yet recruiting","No Results Available","Crohn Disease","Dietary Supplement: Modulen|Drug: Budesonide","Efficacy of Modulen Diet","Hillel Yaffe Medical Center","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","0128-18-HYMC","January 2020","January 2021","June 2021","January 18, 2020",,"January 18, 2020","Hillel Yaffe Medical Center, Hadera, Israel",,"https://ClinicalTrials.gov/show/NCT04233463"
569,"NCT04232553","A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease","VIVID-2","Recruiting","No Results Available","Crohn's Disease","Drug: Mirikizumab","Percentage of Participants Achieving Endoscopic Response|Percentage of Participants Achieving Clinical Remission|Percentage of Participants Achieving Endoscopic Remission|Percentage of Participants Achieving Clinical Response|Change from Baseline in C-Reactive Protein|Change from Baseline in Fecal Calprotectin|Change from Baseline on the Inflammatory Bowel Disease Questionnaire (IBDQ)","Eli Lilly and Company","All","18 Years and older   (Adult, Older Adult)","Phase 3","778","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","16628|I6T-MC-AMAX|2019-002687-27","June 22, 2020","June 15, 2024","June 15, 2024","January 18, 2020",,"June 18, 2021","California Medical Research Group, Northridge, California, United States|UCSF Medical Center at Mission Bay, San Francisco, California, United States|Gastro Florida, Clearwater, Florida, United States|Clinical Research of West Florida, Inc. (Clearwater), Clearwater, Florida, United States|Midland Florida Clinical Research Center, LLC, DeLand, Florida, United States|C2 Research Center, LLC, Jacksonville, Florida, United States|I.H.S. Health, LLC, Kissimmee, Florida, United States|Wellness Clinical Research, Lehigh Acres, Florida, United States|Center for Interventional Endoscopy, Orlando, Florida, United States|Clintheory Healthcare, Orlando, Florida, United States|Care Access Research - Orlando, Orlando, Florida, United States|Gastroenterology Associates of Pensacola, PA, Pensacola, Florida, United States|Synexus Clinical Research - St. Petersburg, Pinellas Park, Florida, United States|Precision Clinical Research, Sunrise, Florida, United States|University of South Florida, Tampa, Florida, United States|Alliance Clinical Research, LLC, Tampa, Florida, United States|Digestive Healthcare of Georgia, Atlanta, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|Qualmedica Research, LLC, Evansville, Indiana, United States|Qualmedica Research, LLC, Evansville, Indiana, United States|Indiana University Health, Indianapolis, Indiana, United States|Robley Rex VAMC, Louisville, Kentucky, United States|Delta Research Partners LLC, Bastrop, Louisiana, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Robert Ferguson, MD PC, West Bloomfield, Michigan, United States|Minnesota Gastroenterology, P.A., Plymouth, Minnesota, United States|Washington University Medical School, Saint Louis, Missouri, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|University of North Carolina Center for Inflammatory Bowel Disease, Chapel Hill, North Carolina, United States|Carolina Research, Greenville, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Paramount Medical Research, Middleburg Heights, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Gastroenterology Associates of Orangeburg, Orangeburg, South Carolina, United States|Gastro One, Germantown, Tennessee, United States|HD Research, Bellaire, Texas, United States|Caprock Gastro Research, LLC, Lubbock, Texas, United States|Southern Star Research Institute, LLC, San Antonio, Texas, United States|Care Access Research LLC - Salt Lake City, Salt Lake City, Utah, United States|Virginia Mason Medical Center, Seattle, Washington, United States|DOM- Centro de Reumatologia, Caba, Buenos Aires, Argentina|Instituto Medico Elsa Perez SRL (IMEP), Ciudadela, Buenos Aires, Argentina|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, Australia|AKH - Gastroenterologie und Hepatologie - Interne Medizin III, Wien, Vienna, Austria|Medizinische Universität Innsbruck, Innsbruck, Austria|Universitätsklinikum Salzburg, Salzburg, Austria|Krankenhaus der Barmherzigen Schwestern, Wien, Austria|Imelda General Hospital, Bonheiden, Antwerpen, Belgium|Université Libre de Bruxelles - Hôpital Erasme, Brussel, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|Cliagen - Clinica de Atencao em Gastroenterologia, Especialidades e Nutricao, Salvador, Bahia, Brazil|HUWC - UFC - Hospital Universitário Walter Cantídio - Universidade Federal do Ceará, Fortaleza, Ceara, Brazil|L2IP - Instituto de Pesquisas Clinicas Ltda., Brasília, Distrito Federal, Brazil|Chronos Pesquisa Clínica, Brasília, Distrito Federal, Brazil|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Ltda, Goiania, GO, Brazil|Hospital Felício Rocho, Belo Horizonte, Minas Gerais, Brazil|Eurolatino Pesquisas Medicas Ltda., Uberlandia, Minas Gerais, Brazil|Associacao Paranaense de Cultura - PUCPR, Curitiba, Parana, Brazil|Instituto de Pesquisa em Saúde - Fundação Universidade de Caxias do Sul, Caxias do Sul, Rio Grande Do Sul, Brazil|Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Ernesto Dornelles, Porto Alegre, Rio Grande Do Sul, Brazil|Nucleo de Pesquisa Clínica do Rio Grande do Sul-NPCRS, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Moinhos de Vento - Instituto de Educação e Pesquisa, Porto Alegre, Rio Grande Do Sul, Brazil|Loema Instituto de Pesquisa Clinica e Consultores Ltda, Campinas, Sao Paulo, Brazil|HMCP - Hospital e Maternidade Celso Pierro - PUC-Campinas, Campinas, Sao Paulo, Brazil|Pesquisare, Santo Andre, Sao Paulo, Brazil|Praxis Pesquisa Medica, Santo André, Sao Paulo, Brazil|Faculdade de Medicina do ABC, Santo Andre, SP, Brazil|Instituto de Assistencia Medica ao Servidor Publico Estudo Estadual, Sao Paulo, SP, Brazil|Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP, Botucatu, São Paulo, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clinicos EPP Ltda, São Bernardo do Campo, São Paulo, Brazil|Hospital Gloria Dor, Rio de Janeiro, Brazil|Hospital Sirio-Libanes, Sao Paulo, Brazil|Hepatogastro, Sao Paulo, Brazil|CPQuali Pesquisa Clínica, São Paulo, Brazil|Clinica Onco Star, São Paulo, Brazil|GI Research Institute, Vancouver, British Columbia, Canada|Victoria Hospital, London, Ontario, Canada|Krajska zdravotni a.s. - Masarykova nemocnice v Usti nad Labem, o.z., Usti nad Labem, Czech Republic, Czechia|Vojenska nemocnice Brno, Brno, Czechia|Fakultni nemocnice u sv. Anny v Brne, Brno, Czechia|Hepato-gastroenterologie HK, s.r.o., Hradec Kralove, Czechia|Gregar s.r.o., Olomouc, Czechia|PreventaMed, s.r.o., Olomouc, Czechia|A-Shine s.r.o., Plzen, Czechia|Thomayerova nemocnice, Praha 4 - Krc, Czechia|Fakultni Nemocnice v Motole, Praha 5, Czechia|Mediendo s.r.o., Praha 8 - Karlin, Czechia|Krajska nemocnice T. Bati a.s., Zlin, Czechia|Siloah St. Trudpert Klinikum-Zentrum für Innere Medizin, Pforzheim, Baden-Württemberg, Germany|Synexus Clinical Research GmbH, Frankfurt am Main, Hessen, Germany|Medizinische Hochschule Hanover, Hannover, Niedersachsen, Germany|Knappschaftskrankenhaus Bottrop, Bottrop, Nordrhein Westfalen, Germany|Johanna-Etienne-Krankenhaus, Neuss, Nordrhein Westfalen, Germany|Magen-Darm-Zentrum Remscheid, Remscheid, North Rhine-Westphalia, Germany|Gemeinschaftspraxis Jakobeit, Wipperfurth, North Rhine-Westphalia, Germany|St. Marienkrankenhaus-Medizinische Klinik I, Ludwigshafen, Rhineland-Palatinate, Germany|Practice Dr.med. Denger and Dr.med. Pfitzner, Friedrichsthal, Saarland, Germany|Studiengesellschaft BSF Unternehmergesellschaft haftungsbeschraenkt, Halle (Saale),, Sachsen Anhalt, Germany|Synexus Clinical Research GmbH, Leipzig, Sachsen, Germany|Charité Universitätsmedizin Berlin Campus Buch, Berlin, Germany|Synexus Clinical Research GmbH, Berlin, Germany|Gastroenterologische Gemeinschaftspraxis Mainz, Mainz, Germany|Tumorzentrum Nordthüringen, Uslar, Germany|Dr. Rethy Pal Korhaz es Rendelointezet, Bekescsaba, Bekes, Hungary|Synexus Gyula, Gyula, Bekes, Hungary|DRC Gyogyszervizsgalo Kozpont Kft., Balatonfüred, EU, Hungary|Clinexpert Tatabánya Ltd., Tatabánya, Komarom-Esztergom, Hungary|Clinexpert SMO, Budapest, Hungary|Synexus Magyarorszag Kft., Budapest, Hungary|Pannonia Maganorvosi Centrum, Budapest, Hungary|Bugát Pál Kórház, Gyöngyös, Hungary|Endomedix Diagnosztikai Kozpont, Miskolc, Hungary|Karolina Korhaz-Rendelointezet, Mosonmagyarovar, Hungary|SZTE AOK Belgyogyaszati Klinika, Szeged, Hungary|Clinfan Szolgaltato Kft., Szekszard, Hungary|Javorszky Odon Hospital, Vac, Hungary|Soroka Medical Center, Beer Sheva, Israel|Bnai Zion Medical Center, Haifa, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Galilee Medical Center Department of Internal Medicine A, Nahariya, Israel|Kaplan Medical Center, Rehovot, Israel|Assaf Harofeh Medical Center, Zerifin, Israel|Ospedale di Rho, Rho, Milano, Italy|Istituto Clinico Humanitas, Rozzano, Milano, Italy|Istituto Mangiagalli, Milano, MI, Italy|Policlinico Mater Domini, Catanzaro, Italy|Policlinico di Modena, Modena, Italy|Policlinico Gemelli - Università Cattolica del Sacro Cuore, Roma, Italy|Kitakyushu Municipal Medical Center, Kitakyusyu-shi, Fukoka, Japan|Fukuoka University Chikushi Hospital, Chikushino-shi, Fukuoka-Ken, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital, Chuo-ku, Sapporo-shi, Hokkaido, Japan|Tokushukai Sapporo Tokushukai Hospital, Sapporo-shi, Hokkaido, Japan|Ibaraki Prefectural Central Hp, Kasama, Ibaraki, Japan|Sameshima Hospital, Kagoshima-shi, Kagoshima, Japan|Gokeikai Ofuna Chuo Hospital, Kamakura-shi, Kanagawa, Japan|Mie University Hospital, Tsu, Mie, Japan|Takagi Clinic, Sendai-shi, Miyagi-Ken, Japan|Tokyo Medical And Dental University Medical Hospital, Bunkyō, Tokyo, Japan|Kyorin University Hospital, Mitaka, Tokyo, Japan|JHCO Tokyo Yamate Medical Center, Shinjuku-ku, Tokyo, Japan|Toyama Prefectural Central Hospital, Toyama-Shi, Toyama, Japan|Fukuoka University Hospital, Fukuoka, Japan|Kagoshima University Hospital, Kagoshima, Japan|Ajou University Hospital, Suwon-si, Gyeonggi-do, Korea, Republic of|Kyung Pook National University Hospital, Daegu, Korea, Korea, Republic of|Yeungnam Univeristy Medical Center, Gyeongsan-si, Korea, Korea, Republic of|Kyung Hee University Hospital, Seoul, Korea, Korea, Republic of|Asan Medical Center, Seoul, Korea, Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Keimyung University Dongsan Hospital, Daegu, Korea, Republic of|The Catholic University of Daejeon St. Mary's Hospital, Daejeon, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Pauls Stradins Kliniska Universitates Slimnica, Riga, Latvia|Grupo Medico Camino Sc, Mexico City, Distrito Federal, Mexico|Health Pharma Professional Research, S.A. de C.V., Mexico City, Federal District, Mexico|PanAmerican Clinical Research S.A.de C.V. Guadalajara, Guadalajara, Jalisco, Mexico|Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"" Depto Gastroenterología, Monterrey, Nuevo León, Mexico|Christus Muguerza Sur S.A. de C.V., Monterrey, Nuevo León, Mexico|PanAmerican Clinical Research Mexico S.A. de C.V., Santiago de Queretaro, Queretaro, Mexico|Centro de Alta Especialidad en Reumatologia e Investigación del Potosi,S.C, San Luis Potosi, San Luis Potosí, Mexico|Scientia Investigacion Clinica S.C., Chihuahua, Mexico|Instituto de Investigaciones Clínicas para la Salud, Durango, Mexico|Unidad de Atención Médica e Investigación en Salud (UNAMIS), Merida, Mexico|ETZ Elisabeth Tilburg, Tilburg, North Brabant, Netherlands|Academisch Medisch Centrum, Amsterdam, Netherlands|Synexus Polska Sp. z o.o. Oddzial w Gdyni, Gdynia, Pomeranian, Poland|Synexus Polska Sp. z o.o. Oddzial w Katowicach, Katowice, Silesian, Poland|Szpital Uniwersytecki Nr 2 w Bydgoszczy, Klinika Reumatologii i Ukladowych Chorob Tkanki Lacznej, Bydgoszcz, Poland|GASTROMED Zakład Opieki Zdrowotnej, Lublin, Poland|Korczowski Bartosz, Gabinet Lekarski, Rzeszow, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Nzoz Formed, Wadowice, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Centrum Zdrowia Matki, Dziecka i Młodzieży (CZMDM) Przychodnie, Warszawa, Poland|Synexus Polska Sp. z o.o. Oddzial we Wroclawiu, Wroclaw, Poland|Melita Medical Sp. Z O. O., Wroclaw, Poland|ETG Zamosc, Zamosc, Poland|SC Pelican SRL, Oradea, Bihor, Romania|Sc Tvm Med Serv, Cluj-Napoca, Cluj, Romania|Spitalul Universitar de Urgenta Bucuresti, Bucuresti, Sector 5, Romania|Arensia Exploratory Medicine Colentina Clinical Hospital, Bucharest, Romania|SC Med Life SA, Bucuresti, Romania|Spitalul Clinic CF 2 Bucuresti, Bucuresti, Romania|S.C. Centrul Medical Medicum SRL, Bucuresti, Romania|Institutul Clinic Fundeni, Bucuresti, Romania|Centrul Medical Unirea SRL, Bucuresti, Romania|CCBR Clinical Research, Bucuresti, Romania|Affidea Medical Research Center, Constanta, Romania|Spitalul Clinic Judetean Targu Mures, Targu Mures, Romania|S.C Centrul de Gastroenterologie Dr. Goldis S.R.L, Timisoara, Romania|S.C. Materna Care S.R.L., Timisoara, Romania|LLC Multidisciplinary Medical Clinic Anthurium, Barnaul, Russian Federation|LLC MA New Hospital, Ekaterinburg, Russian Federation|Irkutsk State Medical Academy of Continuing Education, Irkutsk, Russian Federation|LLC Olla-Med, Moscow, Russian Federation|Nizhegorodskiy Regional Clinical Hospital N.A.Semashko, Nizhniy Novgorod, Russian Federation|LLC ""Medicine Center SibNovoMed"", Novosibirsk, Russian Federation|LLC Novosibirsk GastroCenter, Novosibirsk, Russian Federation|Karelia Republican Hospital V.A. Baranova, Petrozavodsk, Russian Federation|LLC Medical Center Reavita Med SPb, Saint Petersburg, Russian Federation|Saint-Petersburg City Hospital of Saint Elizabeth, Saint Petersburg, Russian Federation|Saint Petersburg State Medical University n.a. Pavlov I.P., Saint Petersburg, Russian Federation|SBIH City Clinical Hospital #31, Saint-Petersburg, Russian Federation|NonState Healthcare Institution Central Clinical Hospital, Samara, Russian Federation|GOU VPO St-Petersburg SMA n/a Mechnikov Fed. Agen of Health, St. Petersburg, Russian Federation|LLC Scientific Research Centre EKO-Bezopasnost, St. Petersburg, Russian Federation|FNsP FDRoosevelta Banska Bystrica, Banska Bystrica, Slovakia|ENDOMED s.r.o., Kosice, Slovakia|Gastromedic, Nove Zamky, Slovakia|Gastro LM s.r.o., Presov, Slovakia|Instituto de Ciencias Médicas, Alicante, Spain|Antalya Training and Research Hospital, Muratpasa, Antayla, Turkey|Kocaeli University Medical Faculty Hospital, Izmit, Kocaeli, Turkey|Mersin University Medical Faculty, Yenişehir, Mersin, Turkey|Hacettepe University Faculty of Medicine, Ankara, Turkey|Ankara City Hospital, Ankara, Turkey|Gazi University Faculty of Medicine, Ankara, Turkey|Uludag University Medical Faculty, Bursa, Turkey|Trakya University, Edirne, Turkey|Gaziantep University Medical Faculty, Gaziantep, Turkey|Acibadem Fulya Hospital, Istanbuk, Turkey|Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey|Acibadem Kozyatagi Hospital, Istanbul, Turkey|Marmara University Pendik Research and Training Hospital, İstanbul, Turkey|Medical Park Pendik Hospital, Istanbul, Turkey|Dokuz Eylul University Hospital, Izmir, Turkey|Erciyes University Hospital, Kayseri, Turkey|Medical Center of Limited Liability Company Medical Center Clinic of Family Medicine, Dnipro, Ukraine|CHI Prof.O.O.Shalimov Kharkiv City Clinical Hospital #2, Kharkiv, Ukraine|Kharkiv Regional Council Regional Clinical Hospital, Kharkiv, Ukraine|Medical Center Ok!Clinic of Intl Inst of Clinical Trials LLC, Kyiv, Ukraine|Communal institution of the Kyiv Regional Council ""Kyiv Regional Clinical Oncology Dispensary"", Kyiv, Ukraine|Lviv Clinical Hospital at Railway Transport of Division Healthcare Center PJSC Ukrainian Railway Sta, Lviv, Ukraine|Communal Enterprise ""Odesa Regional Clinical Hospital"", Odesa, Ukraine|A. Novak Transcarpathian Regional Clinical Hospital, Uzhgorod, Ukraine|Vinnytsia RCH of Veterans of War Dept of Therapy#1 Vinnytsia M.I.Pyrogov NMU, Vinnytsia, Ukraine|MCIC MC LLC Health Clinic, Vinnytsia, Ukraine|SRI of Invalid Rehabil.,Educ.Scient.Med.Complex, Vinnytsia, Ukraine|Diacenter LLC, Zaporizhzhia, Ukraine",,"https://ClinicalTrials.gov/show/NCT04232553"
570,"NCT04225689","The Intensive Post Exclusive Enteral Nutrition Study","iPENS","Recruiting","No Results Available","Crohn Disease","Other: CD-TREAT diet","Colonic inflammation|Diet and faecal microbiome|Diet and faecal metabolome|Crohn's Disease activity score|Blood inflammatory markers|Quality of life","NHS Greater Glasgow and Clyde|University of Glasgow","All","6 Years to 17 Years   (Child)","Not Applicable","58","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","GN19GA433P","January 10, 2020","January 2023","February 2024","January 13, 2020",,"July 21, 2020","University Hospital Crosshouse, Crosshouse, United Kingdom|Royal Hospital for Sick Children, Edinburgh, United Kingdom|Royal Hospital for Children, Glasgow, United Kingdom|Forth Valley Royal Hospital, Larbert, United Kingdom|University Hospital Wishaw, Wishaw, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04225689"
571,"NCT04224558","Stem Cell Transplantation in Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Drug: Mesna|Drug: Cyclophosphamide|Drug: Filgrastim|Procedure: Apheresis catheter placement|Procedure: Leukapheresis|Drug: Fludarabine|Drug: Methylprednisolone|Drug: Diphenhydramine|Drug: Acetaminophen|Drug: anti-thymocyte globulin (rabbit)|Drug: lymphocyte immune globulin|Biological: Peripheral Blood Stem Cell Infusion|Drug: Cytoxan","Change in mucosal healing|Change in erythrocyte sedimentation rate (SED rate)|Change in fecal calprotectin concentration|Change in C reactive protein (CRP)|Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]|Incidence of HSCT Related Complications|Change in clinical measures of sustained remission|Change in quality of life|Change in school and work productivity|Change in thymopoiesis after HSCT|Change in T-cell repertoire after HSCT using spectratyping","Cedars-Sinai Medical Center","All","13 Years to 28 Years   (Child, Adult)","Phase 1|Phase 2","15","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Pro00051458","December 15, 2020","January 1, 2023","January 1, 2024","January 13, 2020",,"February 18, 2021","Cedars-Sinai Medical Center, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT04224558"
572,"NCT04200547","Interest of the Dosage of Adalimumab Serum Levels in Crohn's Disease Patients for Prevention of Postoperative Recurrence","ADAPT","Recruiting","No Results Available","Crohn Disease","Other: Immunomonitoring-based follow-up|Other: Standard follow-up","Percentage of patients with a Rutgeerts score ≥ i2|Percentage of patients with clinical recurrence|Percentage of patients with biological recurrence|Percentage of patients with adverse effects|Rate of adalimumab in the serum|Rate of anti-adalimumab antibodies in the serum","University Hospital, Montpellier","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","84","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other","RECHMPL19_0071|UF 7772","January 29, 2020","January 29, 2022","September 1, 2022","December 16, 2019",,"April 30, 2020","CHU de Montpellier, Montpellier, France",,"https://ClinicalTrials.gov/show/NCT04200547"
573,"NCT04186247","Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)","PAZAZ","Not yet recruiting","No Results Available","Crohn Disease|Pediatric Crohns Disease","Drug: Azithromycin|Drug: Metronidazole|Other: Standard of Care","Percent of Subjects with Sustained Remission|Change in Pediatric Crohn's Disease Activity Index (PCDAI) Score over Baseline to Week 52|Change in Fecal Calprotectin Levels in Stool over Baseline to Week 52|Change in C-Reactive Protein (CRP) Levels in Blood over Baseline to Week 52|Change in IMPACT-III Score over Baseline to Week 52","University of North Carolina, Chapel Hill|Crohn's and Colitis Foundation|University of Amsterdam","All","3 Years to 17 Years   (Child)","Phase 2","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","19-3100|585718","December 2021","June 2023","June 2023","December 4, 2019",,"July 2, 2021","UCSF Benioff Children's Hospital, San Francisco, California, United States|North Carolina Children's Hospital, Chapel Hill, North Carolina, United States|Children's Hospital Pittsburgh, Pittsburgh, Pennsylvania, United States|IWK Health Centre, Halifax, Canada|Sheba Medical Centre, Tel Aviv, Israel|Wolfson Medical Centre, Tel Aviv, Israel|Amsterdam UMC, Amsterdam, Netherlands",,"https://ClinicalTrials.gov/show/NCT04186247"
574,"NCT04164849","Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid",,"Recruiting","No Results Available","Crohn Disease","Drug: 5-aminolevulinic acid|Procedure: Blue light photopheresis|Procedure: Transfusion|Procedure: Continuous Mononuclear Cell Collection (CMNC)|Procedure: Red light photopheresis","Clinical response|Safety and tolerability adverse events|Safety and tolerability Electrocardiogram-PR interval|Safety and tolerability Electrocardiogram-PR segment|Safety and tolerability Electrocardiogram-QT interval|Safety and tolerability Electrocardiogram-ST segment|Safety and tolerability Electrocardiogram-T wave|Safety and tolerability Electrocardiogram-QRS complex|Safety and tolerability vital signs|Safety and tolerability blood pressure|Alkaline phosphatase|Aspartate transferase|Alanine aminotransferase|Albumin|Bilirubin|Gamma glutamyltransferase|White cell count|Neutrophil granulocytes|Lymphocytes|Monocytes|Eosinophile granulocytes|Basophile granulocytes|Platelet count|Mean Cell Volume|Mean Cell hemoglobin|International Normalized Ratio|Hemoglobin|Calcium|Potassium|Sodium|Creatinin|Lactate Dehydrogenase|Cholesterol|Total Protein|Carbamide|CD4+ and CD8+ T cell subpopulations|Apoptosis and necrosis|Clinical remission|Endoscopic efficacy|Faecal calprotectin|Concentration of C reactive protein in blood|Quality of life questionnaire Short-Form 36 (SF-36)|Quality of life questionnaire Inflammatory Bowel Disease Questionnaire (IBDQ)","University Hospital, Akershus|Oslo University Hospital","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","twostepala","November 22, 2019","February 28, 2022","February 28, 2022","November 15, 2019",,"January 15, 2021","Akershus University Hospital, Lorenskog, Akershus, Norway",,"https://ClinicalTrials.gov/show/NCT04164849"
575,"NCT04160325","Effect of the Exclusive Enteral Nutrition Combined With Azathioprine for Remission of Crohn's Diseases After Surgery",,"Recruiting","No Results Available","Crohn Disease","Dietary Supplement: postoperative 3-month exclusive enteral nutrition|Drug: azathioprine|Other: normal diet","the 1 year postoperative anastomotic recurrence","Zhu Weiming|Sixth Affiliated Hospital, Sun Yat-sen University|Sir Run Run Shaw Hospital|The First Affiliated Hospital of Anhui Medical University|Beijing Tsinghua Changgeng Hospital|Jinling Hospital, China","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","198","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","jinlingH201709","May 14, 2018","December 2023","December 2023","November 13, 2019",,"November 13, 2019","Department of General Surgery, Jinling hosptal,Medical School of Nanjing University, Nanjing, Jiangsu, China",,"https://ClinicalTrials.gov/show/NCT04160325"
576,"NCT04135027","Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease Patients",,"Recruiting","No Results Available","Crohn Disease","Other: no interventions","time to first treatment escalation","Second Affiliated Hospital, School of Medicine, Zhejiang University","All","18 Years and older   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IR2019001055","July 1, 2019","December 2020","September 2021","October 22, 2019",,"October 22, 2019","2nd Affiliated Hospital, School of Medicine, Hangzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04135027"
577,"NCT04129723","Stopping Biological Therapy in PCD Study",,"Not yet recruiting","No Results Available","Perianal Crohn Disease|MRI|Biological Therapy","Other: Stopping biological therapy","Rate of perianal Crohn's disease relapse within 12 months after stopping|Rate of luminal Crohn's disease relapse within 12 months after stopping biological therapy|Efficacy of re-treatment with biological therapy after luminal Crohn's disease relapse|Factors associated with relapse of perianal Crohn's disease after stopping biological therapy|Factors associated with relapse of luminal Crohn's disease after stopping biological therapy","Chinese University of Hong Kong","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","STOP-PCD","January 1, 2022","December 31, 2023","December 31, 2025","October 17, 2019",,"May 11, 2021","The Chinese University of Hong Kong, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT04129723"
578,"NCT04113733","Combinatorial Single Cell Strategies for a Crohn's Disease Gut Cell Atlas",,"Enrolling by invitation","No Results Available","Crohn Disease","Other: Sample Collection","The change in cellular composition (i.e., percentage of cell types) between Crohn's disease and control patients as assessed by single-cell RNA sequencing analysis, RNA-fluorescence in situ hybridization, and multiplex immunofluorescence.","Vanderbilt University Medical Center|The Leona M. and Harry B. Helmsley Charitable Trust","All","18 Years and older   (Adult, Older Adult)",,"160","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","191738","December 17, 2019","December 2022","December 2022","October 3, 2019",,"December 2, 2020","Vanderbilt University Medical Center, Nashville, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT04113733"
579,"NCT04102111","A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease","PRISM","Recruiting","No Results Available","Crohn Disease","Drug: JNJ-67864238|Drug: Placebo","Change from Baseline in the Crohn's Disease Activity Index (CDAI) Score at Week 12|Change From Baseline in Simplified Endoscopic Score for Crohn's disease (SES-CD) at Week 12|Percentage of Participants with Clinical Response at Week 12|Percentage of Participants with Clinical Remission at Week 12|Percentage of Participants with Patient-reported Outcome (PRO)-2 Remission at Week 12|Percentage of Participants with Endoscopic Response at Week 12|Percentage of Participants with Endoscopic Remission at Week 12","Janssen Research & Development, LLC","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","90","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","CR108455|2018-000649-38|67864238PACRD2001|PLATFORMPACRD2001|2019-003335-37","September 23, 2019","December 27, 2021","March 25, 2022","September 25, 2019",,"June 14, 2021","Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Gastro Florida, Clearwater, Florida, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Gastroenterology Associates of Central GA, Macon, Georgia, United States|CroNOLA, LLC, Houma, Louisiana, United States|Washington University, Saint Louis, Missouri, United States|NYU Langone Long Island Clinical Research Associates, Lake Success, New York, United States|Columbia University Medical Center, New York, New York, United States|Great Lakes Medical Research, LLC, Beachwood, Ohio, United States|Great Lakes Gastroenterology Research, LLC, Mentor, Ohio, United States|Great Lakes Medical Research, LLC, Westlake, Ohio, United States|Digestive Disease Specialists Inc, Oklahoma City, Oklahoma, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Gastroenterology Research of San Antonio, San Antonio, Texas, United States|University of Washington Medical Center, Seattle, Washington, United States|CEMIC (Centro de Educación Médica e Investigaciones Clínicas), Buenos Aires, Argentina|Cer Instituto Medico, Buenos Aires, Argentina|Clinica Privada Dim, Buenos Aires, Argentina|Fundacion Favaloro, Buenos Aires, Argentina|Hospital Aleman, Buenos Aires, Argentina|Hospital Italiano de Buenos Aires, Buenos Aires, Argentina|Cinme - Centro De Investigaciones Metabolicas, Caba, Argentina|Cinme - Centro De Investigaciones Metabolicas, Caba, Argentina|Clínica Adventista Belgrano, Ciudad De Buenos Aires, Argentina|Instituto Médico Elsa Pérez I.M.E.P, Ciudadela, Argentina|Sanatorio Duarte Quiroz, Cordoba, Argentina|Clinica Universitaria Reina Fabiola, Cordoba, Argentina|Centro de Investigaciones Medicas Mar Del Plata, Mar Del Plata, Argentina|Fundación de Estudios Clínicos, Rosario, Argentina|Sanatorio de la Mujer, Rosario, Argentina|Sanatorio 9 de Julio, San Miguel de Tucuman, Argentina|Sanatorio Vicente Lopez - La Torre, Vicente Lopez, Argentina|CHU Amiens, Amiens, France|Hôpital Beaujon, Clichy, France|Hopital Henri Mondor, Creteil, France|CHRU de Lille - Hôpital Claude Huriez, Lille, France|Hopital Saint-Louis, Paris, France|Hospices Civils de Lyon HCL, Pierre Bénite, France|Hôpital Robert Debré, Reims, France|CHU Nancy Brabois, Vandoeuvre-Les -nancy, France|Universitaetsklinikum Charite, Campus Virchow Klinikum, Berlin, Germany|Universitatsklinikum Schleswig-Holstein - Kiel, Kiel, Germany|Eugastro GmbH, Leipzig, Germany|Universitatsklinikum Leipzig, Leipzig, Germany|Universitatsklinikum Mannheim, Mannheim, Germany|Universitätsklinikum Ulm, Klinik für Innere Medizin II, Ulm, Germany|Policlinico di Bari Ospedale Giovanni XXIII, Bari, Italy|Policlinico Sant'Orsola Malpighi, Bologna, Italy|Azienda Ospedaliera G. Brotzu, Cagliari, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, Italy|Ospedale Policlinico San Martino IRCCS, Genova, Italy|AOU Policlinico di Modena, Modena, Italy|Ospedale Classificato Equiparato Sacro Cuore Don Calabria di Negrar, Negrar ( Ve), Italy|Ospedale Maggiore della Carità, Novara, Italy|Azienda Ospedaliera di Padova, Padova, Italy|IRCCS Policlinico San Matteo, Università degli studi di Pavi, Pavia, Italy|Azienda Ospedaliera Universitaria Pisana, Pisa, Italy|Azienda Ospedaliera G.Salvini Ospedale di Rho, RHO, Italy|Policinico A Gemelli, Roma, Italy|Istituto Clinico Humanitas, Rozzano, Italy|A.O.Citta della Salute e della Scienza di Torino, Torino, Italy|AO Ordine Mauriziano, Torino, Italy|AOU di Circolo -Fondazione Macchi, Varese, Italy|Gastromed Kralisz Romatowski Stachurska Sp. j., Bialystok, Poland|SP ZOZ MSWiA Gdansk, Gdansk, Poland|Malopolskie Centrum Medyczne, Krakow, Poland|Uniwersytecki Szpital Kliniczny nr 1 im. N. Barlickiego, Lodz, Poland|SANTA FAMILIA Centrum Badan, Profilaktyki i Leczenia, Lodz, Poland|Centrum Medyczne AMED oddzial w Lodzi, Lodz, Poland|Gastromed Spotka Z Ograniczona Odpowiedzialnoscia Sp. K., Lublin, Poland|Endoskopia Sp z o.o., Sopot, Poland|Pomorski Uniwersytet Medyczny w Szczecinie, Szczecin, Poland|Centralny Szpital Kliniczny Mswia, Warsaw, Poland|NZOZ Vivamed Zespol Lekarzy Specjalistow, Warsaw, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Centrum Badawcze Wspolczesnej Terapii, Warszawa, Poland|Centrum Onkologii Klinika Gastroenterologii Onkologicznej, Warszawa, Poland|Wojskowy Instytut Medyczny, Warszawa, Poland|Melita Medical Sp. z o.o., Wroclaw, Poland|LLC Evimed, Chelyabinsk, Russian Federation|Medical Center Meditsinskie Tekhnologii, Ekaterinburg, Russian Federation|Immanuel Kant Baltic Federal University, Kaliningrad, Russian Federation|Kemerovo Region Clinical Hospital, Kemerovo, Russian Federation|City Hospital #13 of Avtozavodsky, Nizhniy Novgorod, Russian Federation|Medical Center SibNovoMed LLC, Novosibirsk, Russian Federation|Republican Hospital n.a.V.A.Baranov, Petrozavodsk, Russian Federation|Rostov State Medical University, Rostov-On-Don, Russian Federation|Rostov State Medical University (RSMU) based on City Hospital No. 20, Rostov-on-Don, Russian Federation|City Hospital named after St. Martyr Elizabeth, Saint-Petersburg, Russian Federation|Non State Healthcare Inst. Railway Clinical Hospital at Samara station JSC 'Russian Railways', Samara, Russian Federation|International Medical Centre SOGAZ, St-Petersburg, Russian Federation|Consultative and Diagnostic Center 'Endos', Tyumen, Russian Federation|GBUZ Respublican Clinical Hospital n.a. GG Kuvatova, Ufa, Russian Federation|Ulyanovsk Regional Clinical Hospital, Ul'yanovsk, Russian Federation|Primorskaya Regional Clinical Hospital#1, Vladivostok, Russian Federation|Medical diagnostic centre LTD 'MDC', Yaroslavl, Russian Federation|Bukovinian State Medical University, Chernivtsi, Ukraine|MNCE'City Clinical Hospital №2 named after prof. O.O. Shalimov' of the Kharkiv City Council, Kharkiv, Ukraine|GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine, Kharkiv, Ukraine|KZ Khersonska Miska Klinichna Likarnia Im. Ye.Ie.Karabelesha, Kherson, Ukraine|Kyivska miska klinichna likarnia 18, Kyiv, Ukraine|Medical Center 'Ok Clinic' of International Institute of Clinical Research LLC, Kyiv, Ukraine|Kyiv City Clinical Hospital #6, Kyiv, Ukraine|Danylo Halytsky Lviv National Medical University, Lviv, Ukraine|Municipal Non-profit Enterprise 'Odesa Regional Clinical Hospital' Odesa Regional Council, Odesa, Ukraine|Municipal Non-commercial Enterprise 'Ternopil University Hospital' of Ternopil Regional Council, Ternopil, Ukraine|MNCE Zakarpatska Regional Clinical Hospital named after A Novak of Zakarpatska Regional Council, Uzhgorod, Ukraine|Medical Center Ltd 'Health Clinic', Vinnytsya, Ukraine|VNMUn.af.Pyrogova,CNE Vinnytsia Regional Clinical Hospital n.af.Pyrogova Vinnytsia Regional Council, Vinnytsya, Ukraine",,"https://ClinicalTrials.gov/show/NCT04102111"
580,"NCT04088773","Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Diagnostic Test: blood biomarkers|Diagnostic Test: stool biomarkers|Diagnostic Test: MRI imaging","Magnetization transfer ratio (MTR)|Correlation between MTR values and bowel wall collagen measurements","Children's Hospital Medical Center, Cincinnati|The Leona M. and Harry B. Helmsley Charitable Trust","All","8 Years to 70 Years   (Child, Adult, Older Adult)",,"232","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","2019-0677","November 1, 2019","September 2022","September 2022","September 13, 2019",,"May 12, 2021","Emory/Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Michigan Medicine, Ann Arbor, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT04088773"
581,"NCT04056442","A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients",,"Recruiting","No Results Available","Steroid Dependent Crohn's Disease","Drug: Cannabidiol , synthetic form|Drug: Placebo","Assessment of the safety and tolerability of up to 300 mg CBD/day measured by Adverse Events|Efficacy will be mesursed by precentegae of reduction in dose of steroids without flares|Percentage of patients without flares|Percent of patients who did not demonstrate an increase in inflammatory activity","Stero Biotechs Ltd.","All","18 Years and older   (Adult, Older Adult)","Phase 2","28","Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","ST-SDCD-01","July 7, 2019","July 7, 2021","July 7, 2021","August 14, 2019",,"June 30, 2020","Soroka Medical Center, Beer Sheva, Israel|Meir Medical Center, Kfar Saba, Israel|Shamir Medical Center, Tzrifin, Israel",,"https://ClinicalTrials.gov/show/NCT04056442"
582,"NCT04031482","TARGET Registry A Project of the German Network for Intestinal Diseases in Cooperation With Other Corporate Partners","TARGET","Not yet recruiting","No Results Available","Crohn Disease|Ulcerative Colitis|Indeterminate Colitis","Other: No intervention, only standard care","Disease activity","Ced Service GmbH","All","18 Years to 80 Years   (Adult, Older Adult)",,"4400","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Version 1.2","October 2019","September 2022","September 2023","July 24, 2019",,"July 29, 2019",,,"https://ClinicalTrials.gov/show/NCT04031482"
583,"NCT04002180","Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]",,"Recruiting","No Results Available","Crohn's Disease","Drug: Vedolizumab (Genetical Recombination)","Number of Participants who have One or More Adverse Events|Number of Participants who have One or More Adverse Drug Reactions|Change from Baseline in Crohn's Disease Activity Index (CDAI) Score|Percentage of Participants with CDAI-100 Response|Percentage of Participants with CDAI-70 Response|Percentage of Participants with Clinical Remission|Change from Baseline in Quality of Life (QOL) Assessment using Short Inflammatory Bowel Disease Questionnaire (SIBDQ)|Change from Baseline in White Blood Cell Count|Change from Baseline in Lymphocytes|Change from Baseline in Hemoglobin|Change from Baseline in Hematocrit|Change from Baseline in Albumin|Change from Baseline in C-reactive protein (CRP)","Takeda","All","Child, Adult, Older Adult",,"300","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","Vedolizumab-4021|JapicCTI-194830","July 1, 2019","October 31, 2023","October 31, 2023","June 28, 2019",,"December 23, 2020","Takeda Selected Site, Tokyo, Japan",,"https://ClinicalTrials.gov/show/NCT04002180"
584,"NCT03999580","The Vitamin D in Pediatric Crohn's Disease ( ViDiPeC-2 )","ViDiPeC-2","Recruiting","No Results Available","Crohn Disease","Drug: vitamin D3","Relapse|Lapse of time from randomization to first relapse|Number of relapses per patient per year|Number of hospitalizations per year|Improvement of the Quality of life","Jantchou Prevost|St. Justine's Hospital","All","4 Years to 18 Years   (Child, Adult)","Phase 3","316","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","MP-21-2019-2095","February 7, 2020","December 2023","December 2024","June 26, 2019",,"September 23, 2020","Stollery Children's Hospital, Edmonton, Alberta, Canada|BC Children's Hospital, Vancouver, British Columbia, Canada|Children's Hospital, Winnipeg, Manitoba, Canada|McMaster University, Hamilton, Ontario, Canada|London Health Sciences Centre, London, Ontario, Canada|Montreal Children's Hospital, Montréal, Quebec, Canada|CHU Sainte-Justine, Montréal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT03999580"
585,"NCT03992469","Study to Evaluate Safety, Tolerability and Efficacy of Oral B-FAHF-2 in Mild-to-Moderate Crohn's Disease",,"Not yet recruiting","No Results Available","Crohn's Disease","Drug: BFAHF-2|Drug: Placebo","Number of grades of adverse events|Number of participants requiring an escalation in therapy.|Fecal Calprotectin|PROMIS Profile 29|Self Efficacy Scale: IBDSES|Immunologic Changes in PBMC cytokine levels","Icahn School of Medicine at Mount Sinai","All","18 Years to 30 Years   (Adult)","Phase 1","28","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","GCO 19-0125|0266-3308","September 2021","December 2023","December 2023","June 20, 2019",,"July 2, 2021","Icahn School of Medicine at Mount Sinai, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03992469"
586,"NCT03962998","Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability",,"Recruiting","No Results Available","Crohn Disease","Drug: Lactulose/Rhamnose solution|Drug: MB-102","Mean urine concentration of MB-102 over time in normal participants and in those with Crohn's disease|Correlation between MB-102 excretion and the results of dual sugar testing in normal participants and in those with Crohn's disease","MediBeacon","All","18 Years and older   (Adult, Older Adult)","Early Phase 1","20","Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","MB-300-01","October 27, 2019","April 2021","April 2021","May 24, 2019",,"November 25, 2020","Washington University in St. Louis, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT03962998"
587,"NCT03961815","Open-label Extension Study of Brazikumab in Crohn's Disease","Intrepid","Enrolling by invitation","No Results Available","Crohn's Disease","Drug: Brazikumab","To assess the safety of long-term treatment with Brazikumab in patients with Crohn's disease (CD) based on the number of patients who experience one or more Treatment Emergent Adverse Events (TEAE)|Percentage of participants with potentially clinically significant vital sign measurements|Percentage of participants with potentially clinically significant laboratory values|Percentage of participants with potentially clinically significant electrocardiograms","AstraZeneca","All","16 Years to 80 Years   (Child, Adult, Older Adult)","Phase 3","1000","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","D5271C00002|2019-001866-14","May 20, 2019","April 14, 2025","April 14, 2025","May 23, 2019",,"May 7, 2021","Research Site, Lincoln, California, United States|Research Site, Clearwater, Florida, United States|Research Site, Kissimmee, Florida, United States|Research Site, Lakeland, Florida, United States|Research Site, Miami Lakes, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Tampa, Florida, United States|Research Site, Brownsburg, Indiana, United States|Research Site, Farmington Hills, Michigan, United States|Research Site, Albuquerque, New Mexico, United States|Research Site, Beachwood, Ohio, United States|Research Site, Houston, Texas, United States|Research Site, Innsbruck, Austria|Research Site, Steyr, Austria|Research Site, Wels, Austria",,"https://ClinicalTrials.gov/show/NCT03961815"
588,"NCT03950336","Prebiotics and Diet to Reduce ""Leaky"" Gut in First Degree Relatives of Crohn's Disease Patients",,"Recruiting","No Results Available","Healthy First Degree Relatives of Crohn's Disease Patients","Dietary Supplement: Prebiotics|Other: Low n-6 PUFA Diet|Dietary Supplement: Maltodextrin|Other: Control Diet","Change in small intestinal permeability over 12 weeks|Changes in serum/plasma markers for intestinal permeability|Changes in fecal microbiota and their metabolic activity","University of Alberta","All","15 Years to 50 Years   (Child, Adult)","Not Applicable","32","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","Pro00090125","February 4, 2020","September 2020","December 2020","May 15, 2019",,"March 31, 2020","University of Alberta, Edmonton, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT03950336"
589,"NCT03945019","CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease",,"Recruiting","No Results Available","Crohn's Disease","Biological: CT-P13 SC (Infliximab)|Other: Placebo SC","Clinical remission","Celltrion","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 3","600","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","CT-P13 3.8|2019-001087-30","October 28, 2019","June 2021","June 2022","May 10, 2019",,"May 4, 2021","GC GA DBA Consultants for Clinical Research, Cincinnati, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT03945019"
590,"NCT03942120","Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)","STELARA CD PMS","Recruiting","No Results Available","Crohn Disease","Drug: Ustekinumab","Number of Participants with Adverse Events|Change from Baseline in Crohn's Disease Activity Index (CDAI) Score|Change from Baseline in C-reactive Protein (CRP) Concentration|Change from Baseline in Harvey-Bradshaw Index (HBI) Score|Change from Baseline in Fecal Calprotectin Level|Change from Baseline in Simple Endoscopic Score for Crohn's Disease (SES-CD)|Change from Baseline in Short Inflammatory Bowel Disease Questionnaire (SIBDQ) Score","Janssen Korea, Ltd., Korea","All","18 Years and older   (Adult, Older Adult)",,"70","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","CR108610|CNTO1275CRD4029","April 8, 2019","November 30, 2021","January 31, 2022","May 8, 2019",,"June 9, 2021","Korea University Ansan Hospital, Ansan-si, Korea, Republic of|Inje University Busan Paik Hospital, Busan, Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Kosin University Gospel Hospital, Busan, Korea, Republic of|Good Gangan Hospital, Busan, Korea, Republic of|Pusan National University Hospital, Busan, Korea, Republic of|Dong-A University Hospital, Busan, Korea, Republic of|Changwon Kyunngsang University Hospital, Changwonsi, Korea, Republic of|Samsung ChangWon Hospital, ChangWon, Korea, Republic of|Dankook University Hospital, Cheonan-si, Korea, Republic of|Soonchunhyang University Cheonan Hospital, Cheonan, Korea, Republic of|Hallym University Chuncehon Medical Center, ChunCheon, Korea, Republic of|Kangwon National University Hospital, Chuncheon, Korea, Republic of|Daegu Fatima Hospital, Daegu, Korea, Republic of|Kyongpook national university Medical center, Daegu, Korea, Republic of|Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of|Kyungpook National University Hospital, Daegu, Korea, Republic of|Yeungnam University Medical Center, Daegu, Korea, Republic of|Koo Hospital, Daegu, Korea, Republic of|Keimyung University Dongsan Hospital, Daegu, Korea, Republic of|Chungnam National University Hospital, Daejeon, Korea, Republic of|Chunnam National University Hospital, Gwangju, Korea, Republic of|Jeju National University Hospital, JeJu, Korea, Republic of|GyeongSang National University Hospital, Jinju, Korea, Republic of|Bucheon Soonchunhyang Hospital, Kyunggido, Korea, Republic of|The Catholic Univ. of Korea, DaeJeon St. Mary's Hospital, Seongnam, Korea, Republic of|CHA Bundang Medical center, CHA University, Seongnam, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam, Korea, Republic of|Pusan National University Yangsan Hospital, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Soonchunhyang University Seoul Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Hallym University Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of|Chung-Ang University Hospital, Seoul, Korea, Republic of|KyungHee University Hospital, Seoul, Korea, Republic of|Yonsei University Severance Hospital - Dept.of Internal Medicine, Seoul, Korea, Republic of|Gangnam Severance Hospital, Seoul, Korea, Republic of|Ewha Woman's University Hospital, Seoul, Korea, Republic of|Pusan National University Yangsan Hospital, Yangsan, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT03942120"
591,"NCT03926130","A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease","VIVID-1","Recruiting","No Results Available","Crohn's Disease","Drug: Mirikizumab|Drug: Ustekinumab|Drug: Placebo","Percentage of Participants Achieving Endoscopic Response|Percentage of Participants Achieving Clinical Remission|Percentage of Participants Achieving Endoscopic Remission|Percentage of Participants Achieving Clinical Remission or Endoscopic Remission who were Corticosteroid Free|Change from Baseline in C-Reactive Protein|Change from Baseline in Fecal Calprotectin|Percentage of Participants with Extraintestinal Manifestations (EIMs) of Crohn's Disease|Percentage of Participants with Fistulae Response|Pharmacokinetics (PK): Area Under the Concentration Time Curve (AUC) of Mirikizumab|Change from Baseline in Health Related Quality of Life","Eli Lilly and Company","All","15 Years to 80 Years   (Child, Adult, Older Adult)","Phase 3","1150","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","16590|I6T-MC-AMAM|2018-004614-18","July 23, 2019","December 23, 2022","April 21, 2023","April 24, 2019",,"June 18, 2021","University of Alabama-The Kirklin Clinic, Birmingham, Alabama, United States|Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|Lakeview Clinical Research, Guntersville, Alabama, United States|Care Access Research - Tuscaloosa, Tuscaloosa, Alabama, United States|Research Solutions of Arizona, Litchfield Park, Arizona, United States|Central Arizona Medical Associates, PC, Mesa, Arizona, United States|Phoenix Childrens Hospital, Phoenix, Arizona, United States|Arizona Arthritis & Rheumatology Research, PLLC, Phoenix, Arizona, United States|Synexus Site Network, Tempe, Arizona, United States|inSite Digestive Health Care, Arcadia, California, United States|B G Clinical Research, Inc., Encinitas, California, United States|Care Access - Gilroy, Gilroy, California, United States|Newport Huntington Med Grp, Huntington Beach, California, United States|Om Research, LLC, Lancaster, California, United States|VA Long Beach Healthcare System, Long Beach, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|GastroIntestinal Biosciences Clinical Trials, Los Angeles, California, United States|Care Access Research - Los Gatos, Los Gatos, California, United States|California Medical Research Group, Northridge, California, United States|Childrens Hospital of Orange County, Orange, California, United States|University of CA, Irvine, Orange, California, United States|inSite Digestive Health Care, Pasadena, California, United States|Precision Research Institute, LLC, San Diego, California, United States|UCSF Medical Center at Mission Bay, San Francisco, California, United States|Wolverine Clinical Trials, LLC, Santa Ana, California, United States|Fomat Medical Research, Inc., Thousand Oaks, California, United States|Care Access - Ygnacio Valley, Walnut Creek, California, United States|Synexus - Colorado Springs Family Practice, Colorado Springs, Colorado, United States|Medical Research Center of Connecticut, Hamden, Connecticut, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Nemours Childrens Clinic - Delaware Valley of The Nemours Foundation, Wilmington, Delaware, United States|MedStar Research Institute, Washington, District of Columbia, United States|IMR of South Florida, Aventura, Florida, United States|Renaissance Research and Medical Group, Inc., Cape Coral, Florida, United States|Gastro Florida, Clearwater, Florida, United States|West Central Gastroenterology d/b/a Gastro Florida, Clearwater, Florida, United States|Advanced Research, Coral Springs, Florida, United States|Doral Medical Research, Doral, Florida, United States|Inpatient Research Clinic, LLC, Hialeah, Florida, United States|C2 Research Center, LLC, Jacksonville, Florida, United States|I.H.S. Health, LLC, Kissimmee, Florida, United States|Central Florida Gastro Research, Kissimmee, Florida, United States|Florida Research Institute, Lakewood Ranch, Florida, United States|Wellness Clinical Research, Lehigh Acres, Florida, United States|Apollo Surgery Center, Melbourne, Florida, United States|Goji Group - Research Trials Group, Miami Lakes, Florida, United States|Wellness Clinical Research, Miami Lakes, Florida, United States|Columbus Clinical Services, LLC, Miami, Florida, United States|Infinite Clinical Research, Miami, Florida, United States|Nickalus Children's Hospital Research Institute, Miami, Florida, United States|Research Associates of South Florida, LLC, Miami, Florida, United States|SaludMax Medical Corp, Miami, Florida, United States|Ezy Medical Research, Miami, Florida, United States|Coral Research Clinic Corp, Miami, Florida, United States|Clintheory Healthcare, North Miami Beach, Florida, United States|Endoscopic Research Inc, Orlando, Florida, United States|Center for Interventional Endoscopy, Orlando, Florida, United States|Synexus Clinical Research US, Inc - Orlando, Orlando, Florida, United States|Clintheory Healthcare, Orlando, Florida, United States|Care Access Research - Orlando, Orlando, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Gastroenterology Associates of Pensacola, PA, Pensacola, Florida, United States|Synexus Clinical Research - St. Petersburg, Pinellas Park, Florida, United States|USPA Advance Concept Medical Research Group LLC., South Miami, Florida, United States|Precision Clinical Research, Sunrise, Florida, United States|University of South Florida, Tampa, Florida, United States|Alliance Clinical Research, LLC, Tampa, Florida, United States|Digestive Healthcare of Georgia, Atlanta, Georgia, United States|Morehouse School of Medicine, Atlanta, Georgia, United States|Emory University, Atlanta, Georgia, United States|Children's Center for Digestive Health Care, LLC, Atlanta, Georgia, United States|Columbus Regional Research Institute, Columbus, Georgia, United States|Medical Center of Conyers, Conyers, Georgia, United States|Gastrointestinal Specialists of Georgia, Marietta, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|Northwestern University, Chicago, Illinois, United States|Care Access Research - Chicago, Chicago, Illinois, United States|Eagle Clinical Research, Chicago, Illinois, United States|Care Access Research LLC, Fairview Heights, Illinois, United States|Qualmedica Research, LLC, Evansville, Indiana, United States|Indiana University Health, Indianapolis, Indiana, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Care Access Research - Terre Haute, Terre Haute, Indiana, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|BVL Clinical Research, Leawood, Kansas, United States|Robley Rex VAMC, Louisville, Kentucky, United States|Qualmedica Research, LLC, Owensboro, Kentucky, United States|CroNola LLC, Houma, Louisiana, United States|Delta Research Partners LLC, Monroe, Louisiana, United States|Nola Research Works, LLC, New Orleans, Louisiana, United States|Louisiana Clinical Research, LLC, Shreveport, Louisiana, United States|MGG Group, Inc.., Co., Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Woodholme Gastroenterology Associates PA, Glen Burnie, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Boston Children's Hospital, Boston, Massachusetts, United States|MGH for Children - Waltham, Waltham, Massachusetts, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Revive Research Institute, Farmington Hills, Michigan, United States|Infusion Associates, Grand Rapids, Michigan, United States|Robert Ferguson, MD PC, West Bloomfield, Michigan, United States|MNGI Digestive Health, P.A., Plymouth, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Gastrointestinal Associates, Flowood, Mississippi, United States|University of Mississippi School of Medicine, Jackson, Mississippi, United States|Southern Therapy and Advanced Research (STAR) LLC, Jackson, Mississippi, United States|Washington University Medical School, Saint Louis, Missouri, United States|Rita B. Chuang, MD LLC, Henderson, Nevada, United States|Advanced Biomedical Research of America, Las Vegas, Nevada, United States|Care Access - Las Vegas, Las Vegas, Nevada, United States|Atlantic Children's Health--Pediatric Gastroenterology, Morristown, New Jersey, United States|Lovelace Scientific Resources, Albuquerque, New Mexico, United States|NYU Langone Long Island Clinical Research Associates, Lake Success, New York, United States|Columbia Presbyterian Medical, New York, New York, United States|Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, New York, New York, United States|Care Access Research - Manhattan, New York, New York, United States|Care Access Research - Yonkers, Yonkers, New York, United States|UNC Children's Hospital, Chapel Hill, North Carolina, United States|Unc Hospitals, Chapel Hill, North Carolina, United States|Javara, Charlotte, North Carolina, United States|Medication Management, LLC, Greensboro, North Carolina, United States|Peters Medical Research, High Point, North Carolina, United States|Care Access Research-Kinston, Kinston, North Carolina, United States|Care Access Research-Lumberton, Lumberton, North Carolina, United States|Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Nationwide Children's Hosp, Columbus, Ohio, United States|Ohio State University Hospital, Columbus, Ohio, United States|Paramount Medical Research, Middleburg Heights, Ohio, United States|Care Access Research - Youngstown, Poland, Ohio, United States|Northshore Gastroenterology Research, LLC, Westlake, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Philadelphia Gastroenterology Consultants, Philadelphia, Pennsylvania, United States|Care Access Research LLC, Pottsville, Pennsylvania, United States|Care Access Research - Scranton, Scranton, Pennsylvania, United States|Radiant Research, Anderson, South Carolina, United States|Gastroenterology Associates of Orangeburg, Orangeburg, South Carolina, United States|Invocare Clinical Research Center, West Columbia, South Carolina, United States|Midwest Medical Care, Sioux Falls, South Dakota, United States|Gastro One, Germantown, Tennessee, United States|The Jackson Clinic PA, Jackson, Tennessee, United States|Tri-Cities Gastroenterology, Kingsport, Tennessee, United States|GIA Clinical Trials, LLC, Knoxville, Tennessee, United States|Mesa Research LLC, Austin, Texas, United States|Synexus - US, Dallas, Texas, United States|The University of Texas Southwestern Children's Medical Center, Dallas, Texas, United States|Baylor Scott & White Center for Inflammatory Bowel Diseases, Dallas, Texas, United States|Advanced Gastroenterology Associates, Decatur, Texas, United States|Cook Children's Hospital, Fort Worth, Texas, United States|University of Texas Medical Branch at Galveston, Galveston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Texas Childrens Hospital, Houston, Texas, United States|University of Texas Health Services Center - Houston, Houston, Texas, United States|Biopharma Informatic, Inc., Houston, Texas, United States|Katy Gastro Health & Nutrition, Katy, Texas, United States|Caprock Gastro Research, LLC, Lubbock, Texas, United States|Rio Grande Gastroenterology, McAllen, Texas, United States|Digestive System Healthcare, Pasadena, Texas, United States|Synexus - US, Plano, Texas, United States|Sun Research Institute, San Antonio, Texas, United States|Southern Star Research Institute, LLC, San Antonio, Texas, United States|VIP Trials, San Antonio, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Care Access Research LLC - Salt Lake City, Ogden, Utah, United States|Care Access Research LLC - Salt Lake City, Salt Lake City, Utah, United States|Advanced Clinical Research, West Jordan, Utah, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Pediatrics Specialists of Virginia, Fairfax, Virginia, United States|Children's Specialty Group, PPLC, Norfolk, Virginia, United States|The Center for Gastrointestinal Health, Petersburg, Virginia, United States|The Gastroenterology Group, P.C., Reston, Virginia, United States|Clinical Research Partners, LLC, Richmond, Virginia, United States|Maithili Chitnavis, MD, Roanoke, Virginia, United States|Virginia Gastroenterology Institute, Suffolk, Virginia, United States|TPMG Clinical Research Williamsburg, Williamsburg, Virginia, United States|Washington Gastroenterology, PLLC, Bellevue, Washington, United States|Seattle Children's Hospital Research Foundation, Seattle, Washington, United States|University of Washington School Medicine, Seattle, Washington, United States|Advanced Clinical Research-Spokane Gastroenterology, Spokane, Washington, United States|Washington Gastroenterology, PLLC, Tacoma, Washington, United States|Marshall University School of Medicine, Huntington, West Virginia, United States|Care Access Research - Wyoming, Casper, Wyoming, United States|DOM- Centro de Reumatologia, Caba, Buenos Aires, Argentina|CIPREC-Centro de Investigacion y Prevencion Cardiovascular-, Caba, Buenos Aires, Argentina|Mautalen Salud e Investigación, Caba, Buenos Aires, Argentina|CEMIC- Servicio de Reumatología, Caba, Buenos Aires, Argentina|Instituto Medico Elsa Perez SRL (IMEP), Ciudadela, Buenos Aires, Argentina|Instituto de Especialidades de la Salud Rosario, Rosario, Santa Fe, Argentina|Centro Medico Privado de Reumatologia, SAN M. DE Tucuman, Tucumán, Argentina|Centro de Investigaciones Metabólicas (CINME), Buenos Aires, Argentina|Centro Medico Dra. De Salvo, Capital Federal, Argentina|Concord Repatriation General Hospital, Concord, New South Wales, Australia|St. Vincents Hospital Sydney, Darlinghurst, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|Liverpool Hospital, Liverpool, New South Wales, Australia|Royal Brisbane and Womens Hospital, Herston, Queensland, Australia|Coastal Digestive Health, Maroochydore, Queensland, Australia|Coral Sea Clinical Research Institute, North Mackay, Queensland, Australia|Emeritus Research, Camberwell, Victoria, Australia|The Northern Hospital, Epping, Victoria, Australia|The Royal Melbourne Hospital, Parkville, Victoria, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, Australia|Medizinische Universität Innsbruck, Innsbruck, Austria|Universitätsklinikum Salzburg, Salzburg, Austria|Krankenhaus der Barmherzigen Schwestern, Wien, Austria|AKH, Wien, Austria|Imelda General Hospital, Bonheiden, Antwerpen, Belgium|Cliniques Universitaires Saint-Luc, Bruxelles, Brussel, Belgium|UZ Brussel, Brussel, Belgium|UZ Brussel, Brussel, Belgium|AZ Groeninge, Kortrijk, Belgium|Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium|Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium|Cliagen - Clinica de Atencao em Gastroenterologia, Especialidades e Nutricao, Salvador, Bahia, Brazil|HUWC - UFC - Hospital Universitário Walter Cantídio - Universidade Federal do Ceará, Fortaleza, Ceara, Brazil|L2IP - Instituto de Pesquisas Clinicas Ltda., Brasília, Distrito Federal, Brazil|Chronos Pesquisa Clínica, Brasília, Distrito Federal, Brazil|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Ltda, Goiania, GO, Brazil|Hospital Felício Rocho, Belo Horizonte, MG, Brazil|Eurolatino Pesquisas Medicas Ltda., Uberlandia, Minas Gerais, Brazil|Associacao Paranaense de Cultura - PUCPR, Curitiba, Parana, Brazil|Instituto de Pesquisa em Saúde - Fundação Universidade de Caxias do Sul, Caxias do Sul, Rio Grande Do Sul, Brazil|Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Ernesto Dornelles, Porto Alegre, Rio Grande Do Sul, Brazil|Nucleo de Pesquisa Clínica do Rio Grande do Sul-NPCRS, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Moinhos de Vento - Instituto de Educação e Pesquisa, Porto Alegre, Rio Grande Do Sul, Brazil|Loema Instituto de Pesquisa Clinica e Consultores Ltda, Campinas, Sao Paulo, Brazil|HMCP - Hospital e Maternidade Celso Pierro - PUC-Campinas, Campinas, Sao Paulo, Brazil|Pesquisare, Santo Andre, Sao Paulo, Brazil|Praxis Pesquisa Medica, Santo André, Sao Paulo, Brazil|Faculdade de Medicina de Botucatu, Botucatu, SP, Brazil|Faculdade de Medicina do ABC, Santo Andre, SP, Brazil|Instituto de Assistencia Medica ao Servidor Publico Estudo Estadual, Sao Paulo, SP, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clinicos EPP Ltda, São Bernardo do Campo, São Paulo, Brazil|Hospital Gloria Dor, Rio de Janeiro, Brazil|Hospital Sirio-Libanes, Sao Paulo, Brazil|Hepatogastro, Sao Paulo, Brazil|CPQuali Pesquisa Clínica, São Paulo, Brazil|Clinica Onco Star, São Paulo, Brazil|Allen Whey Khye Lim Professional Corporation, Edmonton, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|Fraser Clinical Trials, Inc., New Westminster, British Columbia, Canada|The Medical Arts Health Research Group, North Vancouver, British Columbia, Canada|BC Children's Hospital, Vancouver, British Columbia, Canada|GI Research Institute, Vancouver, British Columbia, Canada|Milestone Clinical, Dartmouth, Nova Scotia, Canada|K&M Medical, Kentville, Nova Scotia, Canada|London Health Science Centre - Victoria Hospital, London, Ontario, Canada|Victoria Hospital, London, Ontario, Canada|Digestive Health Clinic, Richmond Hill, Ontario, Canada|Viable Clinical Research, Sudbury, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada|CIUSS-de-L'Est-de-l'île-de-Montréal-Hôpital, Montreal, Quebec, Canada|Anhui Provincial Hospital, Hefei, Anhui, China|Peking University First Hospital, Beijing, Beijing, China|Peking University Third Hospital, Beijing, Beijing, China|The Affiliated 2nd Hosp. of Third Military Med. Univ. of PLA, Chongqing, Chongqing, China|The First Hospital Affiliated to AMU (Southwest Hospital), Chongqing, Chongqing, China|The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou, China|The First People's Hospital of Foshan, Foshan, Guangdong, China|First affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China|Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China|The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China|Hainan General Hospital, Haikou, Hainan, China|Tongji Hosp Tongji Med Col Huazhong Univ of Sci & Tech, Wu Han, Hubei, China|Xiangya Hospital, Central South University, Changsha, Hunan, China|The Second Xiangya Hospital of Central South University, Changsha, Hunan, China|The Third Xiangya Hospital of Central South University, Changsha, Hunan, China|The First People's Hospital of Changzhou, Changzhou, Jiangsu, China|Changzhou No.2 People's Hospital, Changzhou, Jiangsu, China|Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China|Jiangsu Province Hospital, Nanjing, Jiangsu, China|The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China|The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China|Wuxi People's Hospital, Wuxi, Jiangsu, China|Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China|The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China|The First Hospital of China Medical University, Shenyang, Liaoning, China|Shanghai East Hospital, Shanghai, Pudong District, China|Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai/China, China|Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China|Shanghai 6th people's hospital, Shanghai, Shanghai, China|West China Hospital Sichuan University, Cheng Du, Sichuan, China|Tianjin Medical University General Hospital, Tianjin, Tianjin, China|First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China|The First People's Hospital of Yunnan Province, Kunming, Yunnan, China|First Affiliated Hosp of College of Med, Zhejiang University, Hangzhou, Zhejiang, China|The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China|The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou, Zhejiang, China|Zhongshan Hospital Xiamen University, Xiamen, China|Clinical Medical Centre Osijek, Osijek, Croatia|CHC Zagreb, Zagreb, Croatia|Krajska zdravotni a.s. - Masarykova nemocnice v Usti nad Labem, o.z., Usti nad Labem, Czech Republic, Czechia|Institute klinicke a experimentalni mediciny - IKEM, Praha 4, Prague, Czechia|Thomayerova nemocnice, Prague, Praha 4, Czechia|MUDr. Michal Konecny, Ph.D. s.r.o., Budovatelu, Prerov, Czechia|Vojenska nemocnice Brno, Brno, Czechia|Fakultni Nemocnice U svate Anny, Brno, Czechia|Hepato-gastroenterologie HK, s.r.o., Hradec Kralove, Czechia|Oblastni nemocnice Nachod-Endoskopicke centrum, Nachod, Czechia|Gregar s.r.o., Olomouc, Czechia|PreventaMed, s.r.o., Olomouc, Czechia|MUDr. Radka Koskova, s.r.o., Gastroenterologicka ambulance, Ostrava, Czechia|A-Shine s.r.o., Plzen, Czechia|Synexus Czech s.r.o., Praha 2, Czechia|Axon Clinical, s.r.o., Praha 5, Czechia|Mediendo, s.r.o., Praha 8, Czechia|ISCARE Clinical Centre, Praha 9, Czechia|Krajska nemocnice T. Bati a.s., Zlin, Czechia|Aalborg Hospital, Aalborg, Denmark|Aarhus Universitetshospital, Skejby, Aarhus, Denmark|Hopital de Hautepierre - Service d'Hépatogastroentérolgie, Strasbourg Cedex, Bas Rhin, France|Hôpital Saint Antoine - Service d'Hépato-gastro-entérologie, Paris, Cedex 12, France|Centre Hospitalier du Pays dAix - Centre Hospitalier Intercommunal Aix-Pertuis - Site d'Aix en Provence, Aix en Provence, Cedex 1, France|Hospices Civils de Lyon - Centre Hospitalier Lyon Sud -, Pierre Benite cedex, Rhone, France|CHU Amiens Picardie Site Sud - Service d'Hepato-gastro-entérologie, Amiens, France|Hopital Beaujon, Clichy, France|Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre, France|Centre Hospitalier du Mans, Le Mans, France|Hopital Européen, Marseille, France|CHRU de Montpellier-Hopital St Eloi, Montpellier Cedex 5, France|GH Necker - Enfants Malades, Paris, France|CHU Bordeaux - Hôpital Haut-Lévêque, Pessac Cedex, France|CHU de Poitiers- Service d'Hépato-gastro-entérologie,, Poitiers Cedex, France|Chu de Rouen Hopital Charles Nicolle, Rouen cedex, France|CHU St Etienne Hopital Nord, Saint Etienne Cedex 2, France|CHRU de Nancy, Vand?uvre-lès-Nancy, France|Siloah St. Trudpert Klinikum-Zentrum für Innere Medizin, Pforzheim, Baden-Württemberg, Germany|Universitätsklinikum Würzburg A. ö. R., Würzburg, Bayern, Germany|Synexus Clinical Research GmbH, Frankfurt am Main, Hessen, Germany|Krankenhaus Eichhof, Lauterbach, Hessen, Germany|Medizinische Hochschule Hanover, Hannover, Niedersachsen, Germany|Knappschaftskrankenhaus Bottrop, Bottrop, Nordrhein Westfalen, Germany|Universitätsklinikum Essen, Essen, North Rhine-Westphalia, Germany|Johanna Etienne Krankenhaus-Klinik für Allgemeine Innere Medizin, Neuss, North Rhine-Westphalia, Germany|Magen-Darm-Zentrum Remscheid, Remscheid, North Rhine-Westphalia, Germany|Gemeinschaftspraxis Jakobeit, Wipperfurth, North Rhine-Westphalia, Germany|St. Marienkrankenhaus-Medizinische Klinik I, Ludwigshafen, Rhineland-Palatinate, Germany|Practice Dr.med. Denger and Dr.med. Pfitzner, Friedrichsthal, Saarland, Germany|Gastroenterologische Praxis Dres Behrens, Steudel, Fechner, Halle (Saale), Saxony-Anhalt, Germany|Synexus Clinical Research GmbH-Leipzig Research Centre, Leipzig, Saxony-Anhalt, Germany|Universitätsklinikum Schleswig-Holstein, Kiel, Schleswig-Holstein, Germany|RED-Institut GmbH, Oldenburg, Schleswig-Holstein, Germany|Charité Universitätsmedizin Berlin Campus Buch, Berlin, Germany|Synexus Clinical Research GmbH, Berlin, Germany|Florence Nightingale Krankenhaus, Düsseldorf, Germany|Gastroenterologische Gemeinschaftspraxis Mainz, Mainz, Germany|Gastroenterologische Praxis Minden, Minden, Germany|Tumorzentrum Nordthüringen, Uslar, Germany|Dr. Rethy Pal Korhaz es Rendelointezet, Bekescsaba, Bekes, Hungary|Synexus Gyula, Gyula, Bekes, Hungary|SZTE AOK Belgyogyaszati Klinika, Szeged, Csongrad, Hungary|DRC Gyogyszervizsgalo Kozpont Kft., Balatonfüred, EU, Hungary|Clinexpert Tatabánya Ltd., Tatabánya, Komarom-Esztergom, Hungary|Clinexpert SMO, Budapest, Hungary|Synexus Magyarorszag Kft., Budapest, Hungary|Pannonia Maganorvosi Centrum, Budapest, Hungary|Bugát Pál Kórház, Gyöngyös, Hungary|Endomedix Diagnosztikai Kozpont, Miskolc, Hungary|Karolina Korhaz-Rendelointezet, Mosonmagyarovar, Hungary|Clinfan Szolgaltato Kft., Szekszard, Hungary|Javorszky Odon Hospital, Vac, Hungary|All India Institute of Medical Sciences, New Delhi, Delhi, India|Sir Ganga Ram Hospital, New Delhi, Delhi, India|International Gastro Institute, Vadodara, Gujarat, India|Ruby Hall Clinic and Grant Medical Foundation, Pune, Maharashtra, India|Midas Multispecilaity Hopsital Pvt Ltd, Ramdaspeth, Nagpur, India|Dayanand Medical College, Ludhiana, Punjab, India|S.R. Kalla Hospital, Jaipur, Rajasthan, India|Asian Institute of Gastroenterology, Hyderabad, Telangana, India|Post Graduate Institute of Medical Education & Research, Chandigarh, India|Apollo Speciality Hospital, Chennai, India|Gujarat Hospital - Gastro and Vascular Centre, Gujarat, India|Aakash Healthcare Super Speciality Hospital, New Delhi, India|Gandhi Hospital, Telangana, India|Yashoda Super Speciality Hospital, Telangana, India|Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel|Soroka Medical Center, Beer Sheva, Israel|Soroka Medical Center, Beer Sheva, Israel|Shamir Medical Center (Asaf Harofe)-Pediatric Endocrinology Unit, Beer Yaakov, Israel|Bnai Zion Medical Center, Haifa, Israel|Rambam Medical Center, Haifa, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|The Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition; Shaare Zedek Medical Center, Jerusalem, Israel|Galilee Medical Center Department of Internal Medicine A, Nahariya, Israel|Schneider Med Center Pediatric Gastro Hepatology, Petach-Tikva, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Kaplan Medical Center, Rehovot, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Assaf Harofeh Medical Center, Zerifin, Israel|Azienda Ospedaliera Saverio De Bellis, Castellana Grotte, Bari, Italy|Università di Cagliari - Presidio Policlinico Monserrato, Monserrato, Cagliari, Italy|Azienda ospedaliero-universitaria Mater Domini, Germaneto, Catanzaro, Italy|Policlinico Univ. Agostino Gemelli, Roma, Lazio, Italy|Presidio di Rho, Rho, Milano, Italy|Istituto Clinico Humanitas, Rozzano, Milano, Italy|Ospedale Clinicizzato San Donato, San Donato Milanese, Milan, Italy|Istituto Mangiagalli, Milano, MI, Italy|Azienda Ospedaliera Policlinico Consorziale, Bari, Italy|Università degli Studi c/o Spedali Civili, Brescia, Italy|Azienda Ospedaliera Giuseppe Brotzu, Cagliari, Italy|Ospedale Luigi Sacco, Milano, Italy|Azienda Ospedaliera Universitaria Policlinico de Modena, Modena, Italy|Azienda Ospedaliera Cardarelli, Napoli, Italy|Azienda Ospedaliera Universitaria Federico II, Napoli, Italy|Arcispedale Santa Maria Nuova Azienda Ospedaliera di Reggio Emilia, Reggio Emilia, Italy|Polic.Umberto I -Univ. La Sapienza, Roma, Italy|Azienda Ospedaliera Santa Maria Della Misericordia, Udine, Italy|Fujita Health University Hospital, Toyoake-shi, Aichi-ken, Japan|Kojunkai Daido Clinic, Nagoya, Aichi, Japan|NHO Hirosaki National Hospital, Hirosaki-shi, Aomori-Ken, Japan|Tsujinaka Hospital, Kashiwa, Chiba, Japan|Fukuoka University Chikushi Hospital, Chikushino-shi, Fukuoka-Ken, Japan|Hoshi General Hospital, Koriyama, Fukushima, Japan|Isesaki Municipal Hospital, Isesaki, Gunma, Japan|Kiryu Kosei Hospital, Kiryu, Gunma, Japan|Maebashi Red-Cross Hospital, Maebashi, Gunma, Japan|National Hospital Organization Fukuyama Medical Center, Fukuyama, Hiroshima, Japan|Asahikawa Medical College Hospital, Asahikawa, Hokkaido, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital, Chuo-ku, Sapporo-shi, Hokkaido, Japan|Tokushukai Sapporo Tokushukai Hospital, Sapporo-shi, Hokkaido, Japan|Tokushukai Sapporo Higashi Tokushukai Hospital, Sapporo-shi, Hokkaido, Japan|Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan|Hyogo College of Medicine, Nishinomiya, Hyogo, Japan|Ibaraki Prefectural Central Hp, Kasama, Ibaraki, Japan|Kanazawa University Hospital, Kanazawa, Ishikawa, Japan|Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan|Sameshima Hospital, Kagoshima-shi, Kagoshima, Japan|Kitasato University Hospital, Sagamihara-shi, Kanagawa-ken, Japan|Gokeikai Ofuna Chuo Hospital, Kamakura-shi, Kanagawa, Japan|Matsushima Clinic, Yokohama, Kanagawa, Japan|Mie University Hospital, Tsu, Mie, Japan|Takagi Clinic, Sendai-shi, Miyagi-Ken, Japan|IMS Meirikai Sendai General Hospital, Sendai, Miyagi, Japan|Nagasaki Harbor Medical Center, Nagasaki City, Nagasaki, Japan|Nagaoka Chuo General Hospital, Nagaoka, Niigata, Japan|Kinshukai Infusion Clinic, Osaka-shi, Osaka-Fu, Japan|Saga-Ken Medical Center Koseikan, Saga-shi, Saga, Japan|Tokitokai Tokito Clinic, Saitama-shi, Saitama-Ken, Japan|Matsuaikai Matsuda Hospital, Hamamatsu-shi, Shizuoka-Ken, Japan|Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan|Tokyo Medical And Dental University Medical Hospital, Bunkyō, Tokyo, Japan|Showa University Koto Toyosu Hospital, Koto-ku, Tokyo, Japan|National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan|JHCO Tokyo Yamate Medical Center, Shinjuku-ku, Tokyo, Japan|Tottori University Hospital, Yonago, Tottori, Japan|Toyama Prefectural Central Hospital, Toyama-Shi, Toyama, Japan|Fukuoka University Hospital, Fukuoka, Japan|Kagoshima University Hospital, Kagoshima, Japan|Kumamoto University Hospital, Kumamoto, Japan|Kyoto Furitsu Medical University Hospital, Kyoto, Japan|Okayama Saiseikai General Hospital Outpatient Center, Okayama, Japan|Okayama University Hospital, Okayama, Japan|Yamagata University Hospital, Yamagata, Japan|The Catholic University of Daejeon St. Mary's Hospital, Jung-gu, Daejeon, Korea, Republic of|Ajou University Hospital, Suwon, Gyeonggi-do, Korea, Republic of|Hanyang University Guri Hospital, Guri-si, Gyeonggido, Korea, Republic of|Kyung Pook National University Hospital, Daegu, Korea, Korea, Republic of|Yeungnam Univeristy Medical Center, Gyeongsan-si, Korea, Korea, Republic of|Kyung Hee University Hospital, Seoul, Korea, Korea, Republic of|Seoul St. Mary's Hospital, Seoul, Korea, Korea, Republic of|Kyunghee University Hospital at Gangdong, Seoul, Korea, Korea, Republic of|Seoul National University Hospital, Seoul, Seoul, Korea, Korea, Republic of|Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Dong-A University Hospital, Busan, Korea, Republic of|Kyungpook National University Medical Center Chilgok Hospital, Daegu, Korea, Republic of|Keimyung University Dongsan Hospital, Daegu, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Gangwon-do, Korea, Republic of|Korea University Ansan Hospital, Gyeonggi-do, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Chungang University Hospital, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Pauls Stradins Kliniska Universitates Slimnica, Riga, Latvia|Hospital of Lithuanian University of Health Sciences Kaunas, Kaunas, Lithuania|Centro de Investigación Clínica Acelerada, Mexico City, Distrito Federal, Mexico|Grupo Medico Camino Sc, México City, Distrito Federal, Mexico|Health Pharma Professional Research, S.A. de C.V., Mexico City, Federal District, Mexico|PanAmerican Clinical Research S.A.de C.V. Guadalajara, Guadalajara, Jalisco, Mexico|Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"", Monterrey, Nuevo Leon, Mexico|Christus Muguerza Sur S.A. de C.V., Monterrey, Nuevo León, Mexico|PanAmerican Clinical Research Mexico S.A. de C.V., Santiago de Queretaro, Queretaro, Mexico|Scientia Investigacion Clinica S.C., Chihuahua, Mexico|Instituto de Investigaciones Clínicas para la Salud, Durango, Mexico|Unidad de Atención Médica e Investigación en Salud (UNAMIS), Merida, Mexico|Centro de Alta Especialidad Reumatologia Inv del Potosi SC, San Luis Potosi, Mexico|Sociedad de Metabolismo y Corazon S.C., Veracruz, Mexico|ETZ Elisabeth Tilburg, Tilburg, North Brabant, Netherlands|Erasmus Medisch Centrum, South Holland, Netherlands|Bernhoven Uden, Uden, Netherlands|Synexus Polska Sp. z o.o. Oddzial w Poznaniu, Poznan, Greater Poland, Poland|Nzoz Med-Roz, Karwiany, Lower Silesian, Poland|Dc-Med. Sp. z o.o., Swidnica, Lower Silesian, Poland|M. Sklodowskiej-Curie 12, Wroclaw, Lower Silesian, Poland|Reuma Clinic, Bialystok, Podlaskie, Poland|Synexus Polska Sp. z o.o. Oddzial w Gdansku, Gdansk, Pomeranian, Poland|Synexus Polska Sp. z o.o. Oddzial w Gdyni, Gdynia, Pomeranian, Poland|Synexus Polska Sp. z o.o. Oddzial w Czestochowie, Czestochowa, Silesian, Poland|Synexus Polska Sp. z o.o. Oddzial w Katowicach, Katowice, Silesian, Poland|Kiepury Clinic, Sosnowiec, Silesian, Poland|Centrum Medyczne Medyk, Rzeszow, Subcarpathian, Poland|Sonomed Sp. z o.o., Szczecin, West Pomeranian, Poland|Instytut Pomnik-Centrum Zdrowia Dziecka, Warszawa, Woj Mazowieckie, Poland|Szpital Uniwersytecki Nr 2 w Bydgoszczy, Klinika Reumatologii i Ukladowych Chorob Tkanki Lacznej, Bydgoszcz, Poland|Topolowa Medicenter, Krakow, Poland|Synexus Polska Sp. z o.o. Oddzial w Lodzi, Lodz, Poland|GASTROMED Zakład Opieki Zdrowotnej, Lublin, Poland|Medicenter Nowy Targ, Nowy Targ, Poland|Korczowski Bartosz, Gabinet Lekarski, Rzeszow, Poland|Endoskopia sp z o. o, Sopot, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Gastromed Kopoń Zmudziński I Wspólnicy Spółka Jawna Specjalistyczne Centrum Gastrologii I Endoskopii, Torun, Poland|Nzoz Formed, Wadowice, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Vivamed, Warszawa, Poland|Melita Medical Sp. Z O. O., Wroclaw, Poland|ETG Zamosc, Zamosc, Poland|Caguas Gastroenterology and Hepatology Center, LLC, Caguas, Puerto Rico|Clinical Research Management Group, Inc., Ponce, Puerto Rico|Pan American Center for Oncology Trials, LLC, Rio Piedras, Puerto Rico|Latin Clinical Trial Center, San Juan, Puerto Rico|Wellness clinical Research Vega Baja, Vega Baja, Puerto Rico|SC Pelican SRL, Oradea, Bihor, Romania|Sc Tvm Med Serv, Cluj-Napoca, Cluj, Romania|Spitalul Universitar de Urgenta Bucuresti, Bucuresti, Sector 5, Romania|SC Med Life SA, Bucuresti, Romania|Spitalul Clinic CF 2 Bucuresti, Bucuresti, Romania|S.C. Centrul Medical Medicum SRL, Bucuresti, Romania|Institutul Clinic Fundeni, Bucuresti, Romania|Spitalul Clinic Colentina, Bucuresti, Romania|CCBR Clinical Research, Bucuresti, Romania|Spitalul Euroclinic, Bucureti, Romania|Gastromed S.R.L., Constanta, Romania|Affidea Medical Research Center, Constanta, Romania|Spitalul Clinic Judetean Targu Mures, Targu Mures, Romania|S.C. Materna Care S.R.L., Timisoara, Romania|Multidisciplinary Medical Clinic ""Anthurium"", Barnaul, Russian Federation|Medical and Sanitary Division of Severstal, Cherepovets, Russian Federation|LLC MA New Hospital, Ekaterinburg, Russian Federation|Irkutsk State Medical Academy of Continuing Education, Irkutsk, Russian Federation|Clinical Trials Center of Medical Institute, Kaliningrad, Russian Federation|Kazan State Medical University, Kazan, Russian Federation|SIH Kemerovo Regional Clinical Hosptial, Kemerovo, Russian Federation|LLC Olla-Med, Moscow, Russian Federation|LLC ?Medsanchast No 14?, Moscow, Russian Federation|State Scientific Centre of Coloproctology, Moscow, Russian Federation|Treatment and Rehabilitation Center of the Ministry of Health of the RF, Moscow, Russian Federation|Nizhegorodskiy Regional Clinical Hospital N.A.Semashko, Nizhniy Novgorod, Russian Federation|LLC ""Medicine Center SibNovoMed"", Novosibirsk, Russian Federation|LLC Novosibirsk GastroCenter, Novosibirsk, Russian Federation|The University Clinic of OSMU, Omsk, Russian Federation|Karelia Republican Hospital V.A. Baranova, Petrozavodsk, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|LLC Medical Center Reavita Med SPb, Saint Petersburg, Russian Federation|Saint-Petersburg City Hospital of Saint Elizabeth, Saint Petersburg, Russian Federation|LLC X7Clinical Research, Saint-Petersburg, Russian Federation|Pokrovskaya Municipal Hospital, Saint-Petersburg, Russian Federation|LLC Gastroenterology Centre Expert, Saint-Petersburg, Russian Federation|SBIH City Clinical Hospital #31, Saint-Petersburg, Russian Federation|SPb SBIH ""City Polyclinic # 106"", Saint-Petersburg, Russian Federation|NonState Healthcare Institution Central Clinical Hospital, Samara, Russian Federation|Academician I.P. Pavlov First St-Petersburg State Medical University, St-Petersburg, Russian Federation|LLC Scientific Research Centre EKO-Bezopasnost, St. Petersburg, Russian Federation|Clinical Center Bezanijska Kosa, Belgrade, NAP, Serbia|Clinical Center "" Dr Dragisa Misovic Dedinje"", Belgrade, Serbia|Clinical Center Zvezdara, Belgrade, Serbia|Clinical Center Kragujevac Gastroenterohepatology Clinic, Kragujevac, Serbia|Clinical Center Nis, Nis, Serbia|General Hospital Sremska Mitrovica, Sremska Mitrovica, Serbia|Clinical Center Zemun, Zemun, Serbia|General Hospital ""Djordje Joanovic"", Zrenjanin, Serbia|FNsP FDRoosevelta Banska Bystrica, Banska Bystrica, Slovakia|Univerzitna nemocnica Bratislava, Bratislava, Slovakia|Cliniq s.r.o, Bratislava, Slovakia|Gastromedic, Nove Zamky, Slovakia|Gastro LM s.r.o., Presov, Slovakia|Gastro I s.r.o., Gastroenterologická ambulancia, Prešov, Slovakia|Endomed, s.r.o.- Gastroenterologicka ambulancia, Vranov N. Toplou, Slovakia|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain|Hospital Universitari de Girona Dr. Josep Trueta, Girona, Barcelona, Spain|Hospital Universitario Marques De Valdecilla, Santander, Cantabria, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|Complejo Hospitalario de Navarra NAVARRABIOMED UNIDAD EC, Pamplona, Navarra, Spain|Instituto de Ciencias Médicas, Alicante, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Centro Medico Teknon - DIGESTIVO, Barcelona, Spain|Hospital Reina Sofia, Cordoba, Spain|Complexo Hospitalario Universitario A Coruña, CHUAC, La Coruña, Spain|Hospital De Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain|Complejo Hospitalario Ruber Juan Bravo, Madrid, Spain|Hospital De La Princesa, Madrid, Spain|Hospital Infantil Universitario Niño Jesús, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain|Clínica Gaias - Santiago, Santiago de Compostela, Spain|Hospital Universitario Virgen Del Rocio, Sevilla, Spain|Cantonal Hospital St.Gallen, St. Gallen, Sankt Gallen, Switzerland|Inselspital Bern, Bern, Switzerland|Gastroenterologische Praxis Balsiger, Seibold & Partner, Bern, Switzerland|Antalya Training and Research Hospital, Muratpasa, Antayla, Turkey|Acibadem Universitesi - Acibadem Kozyatagi Hastanesi, Kadıkoy, Istanbul, Turkey|Mersin University Medical Faculty, Yenişehir, Mersin, Turkey|Hacettepe University Faculty of Medicine, Ankara, Turkey|Ankara City Hospital, Ankara, Turkey|Gazi University Faculty of Medicine, Ankara, Turkey|Uludag University Medical Faculty, Bursa, Turkey|Trakya University, Edirne, Turkey|Eskisehir Osmangazi University Gastroenterology, Eskisehir, Turkey|Gaziantep University Medical Faculty, Gaziantep, Turkey|Mustafa Kemal Universitesi Tayfur Ata Sokmen Tip Fakultesi, Hatay, Turkey|Acibadem Fulya Hospital, Istanbuk, Turkey|Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey|Marmara University Pendik Research and Training Hospital, Istanbul, Turkey|Medical Park Pendik Hospital, Istanbul, Turkey|Dokuz Eylul University Hospital, Izmir, Turkey|Kocaeli University Medical Faculty Hospital, Izmit, Turkey|Erciyes University Hospital, Kayseri, Turkey|Konya Necmettin Erbakan Gastroenterology, Konya, Turkey|Inonu University Medical Faculty, Malatya, Turkey|RCI Chernivtsi Regional Clinical Hospital, Chernivtsi, Ukraine|Medical Center of Limited Liability Company Medical Center Clinic of Family Medicine, Dnipro, Ukraine|Ivano-Frankivsk State Medical University, Ivano-Frankivsk, Ukraine|CHI Prof.O.O.Shalimov Kharkiv City Clinical Hospital #2, Kharkiv, Ukraine|Kharkiv Regional Council Regional Clinical Hospital, Kharkiv, Ukraine|Medical Centre of Ukrainian German Antiulcer Gastroenterology Centre BYK-KYIV, Kyiv, Ukraine|International Institute of Clinical Trials LLC, Kyiv, Ukraine|LLC Medbud-Clinic Medical Center, Kyiv, Ukraine|Kyiv Railway Clinical Hospital 2 of branch Health Center of the JSC Ukrainian Railway, Kyiv, Ukraine|Medical Centre CONSILIUM MEDICAL, Kyiv, Ukraine|Communal institution of the Kyiv Regional Council ""Kyiv Regional Clinical Oncology Dispensary"", Kyiv, Ukraine|Communal institution of the Kyiv Regional Council ""Kyiv Regional Clinical Oncology Dispensary"", Kyiv, Ukraine|Communal Non-Commercial Enterprise of Lviv Regional Council Lviv Regional Clinical Hospital, Liviv, Ukraine|Lviv Clinical Hospital at Railway Transport of Division Healthcare Center PJSC Ukrainian Railway Sta, Lviv, Ukraine|Communal Enterprise ""Odesa Regional Clinical Hospital"", Odesa, Ukraine|A. Novak Transcarpathian Regional Clinical Hospital, Uzhgorod, Ukraine|Medical Center ""Health Clinic"" LLC, Vinnitsa, Ukraine|Vinnytsia RCH of Veterans of War Dept of Therapy#1 Vinnytsia M.I.Pyrogov NMU, Vinnytsia, Ukraine|CCH #1 Vinnytsia M.I. Pyrogov NMU Ch of Propaedeutics of IM, Vinnytsia, Ukraine|Vinnytsya Regional Clinical Hospital, Vinnytsya, Ukraine|Zaporozhye City Clinical Hospital #6, Zaporizhzhia, Ukraine|CNCE ""City Hospital 9"" Zaporizhzhia CC, Zaporizhzhia, Ukraine|Diacenter LLC, Zaporizhzhia, Ukraine|Addenbrookes Hospital, Cambridge, Cambridgeshire, United Kingdom|Synexus Manchester Clinical Research Centre, Manchester, Greater Manchester, United Kingdom|Chelsea and Westminster Hospital, Fulham, London, United Kingdom|Royal London Hospital, Whitechapel, London, United Kingdom|Synexus Wales Clinical Research Centre, Cardiff, South Glamorgan, United Kingdom|Whipps Cross University Hospital, London, Surrey, United Kingdom|Synexus Midlands Clinical Research Center, Birmingham, Wstmid, United Kingdom|Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, United Kingdom|Paediatric Clinical Research Facility Royal Hospital for Children and Young People, Edinburgh, United Kingdom|Synexus North East Clinical Research Centre, Hexham, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03926130"
592,"NCT03905109","Safety Evaluation of ABX464 in Patients With Moderate to Severe Active Crohn's Disease",,"Not yet recruiting","No Results Available","Crohn Disease","Drug: ABX464|Drug: Placebo","Incidence of Treatment-Emergent Adverse Events of ABX464|Proportion of patients with a clinical response|Proportion of patients with a clinical remission|Time to clinical response|Time to clinical remission|Evaluation of the effect of ABX464 50mg on Clinical Response and Remission assessed by 2-item Patient Reporting Outcome versus placebo;|Proportion of patients with endoscopic response|Proportion of patients with endoscopic remission|Evaluation of the effect of ABX464 on the histopathology of the Crohn's disease|Proportion of patients with both clinical response and endoscopic response|Evaluation of the effect of ABX464 50mg on C-reactive protein levels and fecal calprotectin at week 8 and week 16 versus placebo;|Evaluation of the effect of ABX464 50mg on patients' quality of life measured by Inflammatory Bowel Disease Questionnaire|Evaluation of treatment-emergent serious adverse events|Evaluation of adverse events leading to investigational product discontinuation|Change from baseline of the micro RNA-124 expression in whole blood and in tissue in the ABX464 treatment group vs placebo;|Assessment of ABX464 pharmacokinetics and its main active metabolite N-Glu-ABX464 after oral administration of a 50 mg dose of ABX464","Abivax S.A.","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","30","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","ABX464-201","April 15, 2020","July 1, 2021","October 30, 2021","April 5, 2019",,"December 20, 2019","University Hospitals Leuven - campus Gasthuisberg, Leuven, Belgium",,"https://ClinicalTrials.gov/show/NCT03905109"
593,"NCT03901235","MSC Intratissular Injection in Crohn Disease Patients","MSC","Recruiting","No Results Available","Efficacy and Safety","Biological: Mesenchymal Stromal Cells","Proportion of patients with deep ulcer healing|Proportion of patients with stricture healing|Proportion of patients with complex perianal fistula healing|Safety assessed by the incidence of treatment-emergent adverse events during the study period|Evolution of clinical disease activity index|Evolution of Short health scale (quality of life)|Evolution of the Lemann Index (measuring cumulated intestinal damage in Crohn's disease)|Evolution of the "" Group of Therapeutic Study of Inflammatory Disorders of the Digestive Tube"" obstructive score for Crohn Disease strictures","University of Liege|Centre Hospitalier Universitaire de Liège","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","TJT1707P1","January 15, 2018","December 31, 2021","December 31, 2022","April 3, 2019",,"February 17, 2021","CHU de Liège, Liège, Belgium",,"https://ClinicalTrials.gov/show/NCT03901235"
594,"NCT03889613","Pillcam Crohn's Capsule for Monitoring of Panenteric Mucosal Healing in Crohn's Disease Patients With Vedolizumab",,"Recruiting","No Results Available","Crohn Disease","Other: prospective follow-up with videocapsule","Panenteric mucosal healing","Sheba Medical Center|Takeda|Medtronic","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","60","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","SHEBA-18-4710-UK-CTIL","April 3, 2019","March 2022","March 2022","March 26, 2019",,"May 12, 2020","Sheba Medical Center, Ramat Gan, Israel",,"https://ClinicalTrials.gov/show/NCT03889613"
595,"NCT03870334","Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease",,"Recruiting","No Results Available","Crohn's Disease","Drug: BT-11 1,000 mg|Drug: Placebo","Clinical remission rate|Clinical response|Endoscopic remission|Histologic Remission|Endoscopic Response","Landos Biopharma Inc.","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","150","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","BT-11-202","May 5, 2021","November 2021","January 2022","March 12, 2019",,"June 30, 2021","I.H.S Health LLC, Kissimmee, Florida, United States",,"https://ClinicalTrials.gov/show/NCT03870334"
596,"NCT03850600","Modulating Early Life Microbiome Through Dietary Intervention in Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease|Pregnancy","Other: Diet-CD","Change in overall number of proteobacteria|Calprotectin level|Harvey Bradshaw index (HBI)|SF-12|The Rome IV Criteria|The Center for Epidemiologic Studies Depression Scale-Revised (CESD-R)|The Bristol Stool Form Scale|Alternative Healthy Eating Index","Icahn School of Medicine at Mount Sinai|The Leona M. and Harry B. Helmsley Charitable Trust|University of Massachusetts, Worcester","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","396","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","GCO 18-2246","January 30, 2019","January 1, 2023","January 1, 2023","February 22, 2019",,"July 2, 2021","University of Massachusetts Medical School, Worcester, Massachusetts, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03850600"
597,"NCT03808103","Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Biological: Placebo|Biological: Bacteriophage preparation","Incidence of adverse events|Severity of adverse events|Effect on Harvey Bradshaw Index (HBI)|Effect on inflammation, as indicated by C-reactive protein (CRP)|Effect on inflammation, as indicated by fecal calprotectin|Effect on the incidence and levels of AIEC","Intralytix, Inc.|MOUNT SINAI HOSPITAL","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","30","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","ITX/EA-002","May 1, 2019","December 2020","June 2021","January 17, 2019",,"July 28, 2020","The Mount Sinai Hospital, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03808103"
598,"NCT03782376","A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease","POWER","Recruiting","No Results Available","Crohn Disease","Drug: Ustekinumab approximately 6 mg/kg (IV)|Drug: Placebo (SC)|Drug: Placebo (IV)|Drug: Ustekinumab 90 mg (SC) Group 1|Drug: Ustekinumab 90 mg (SC) Group 2","Percentage of Participants with Clinical Response at Week 16|Percentage of Participants with Clinical Remission at Week 16|Percentage of Participants with Clinical Response at Week 8|Percentage of Participants with Clinical Remission at Week 8|Percentage of Participants with Normalization of CRP at Week 16|Percentage of Participants with Normalization of Fecal Calprotectin Concentration at Week 16|Percentage of Participants with Clinical Remission at Week 24|Percentage of Participants with Clinical Response at Week 24|Percentage of Participants with Normalization of CRP at Week 24|Percentage of Participants with Normalization of Fecal Calprotectin Concentration at Week 24|Percentage of Participants with Adverse Events (AEs) and Serious Adverse Events (SAEs)|Percentage of Participants with Infections and Serious Infections|Number of Participants with Clinical Laboratory Abnormalities","Janssen-Cilag Ltd.","All","18 Years and older   (Adult, Older Adult)","Phase 3","200","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","CR108533|2018-002629-51|CNTO1275CRD3008","December 20, 2018","June 28, 2022","November 30, 2022","December 20, 2018",,"June 9, 2021","Premier Gastroenterology Associates, Little Rock, Arkansas, United States|University of California, San Diego, La Jolla, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Medical Research Center of Connecticut, Hamden, Connecticut, United States|Florida Research Network, LLC, Gainesville, Florida, United States|Mayo Clinic Jacksonville, Jacksonville, Florida, United States|Advent Health, Orlando, Florida, United States|Florida Hospital Tampa, Tampa, Florida, United States|Emory University, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, (AGA) LLC - Emory Saint Joseph's, Atlanta, Georgia, United States|Atlanta Gastroenterology Specialists, Suwanee, Georgia, United States|The University Of Chicago Medicine, Chicago, Illinois, United States|University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Brigham & Women's Hospital, Boston, Massachusetts, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mount Sinai School of Medicine, New York, New York, United States|Ohio State University Hospital, Hilliard, Ohio, United States|Great Lakes Medical Research, LLC, Westlake, Ohio, United States|Oklahoma Digestive Disease Specialists, Oklahoma City, Oklahoma, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Digestive Disease Consultants, Cedar Park, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Gastroenterology Research of America, LLC, San Antonio, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Texas Digestive Disease Consultants, Webster, Texas, United States|Virginia Mason Medical Center, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States|Medizinische Universität Innsbruck, Innsbruck, Austria|Klinikum Klagenfurt am Worthersee, Klagenfurt, Austria|Krankenhaus der Barmherzigen Brüder, Wien, Austria|Medizinische Universität Wien, Wien, Austria|Hepato-gastroenterologie HK, s.r.o., Hradec Kralove, Czechia|Klinicke centrum ISCARE, Praha 9, Czechia|Hôpital Beaujon, Clichy, France|CHRU de Lille - Hôpital Claude Huriez, Lille, France|CHRU Montpellier - Hopital Saint-Eloi, Montpellier, France|CHU Hôpital Saint Antoine, Paris cedex 12, France|Hospices Civils de Lyon HCL, Pierre Bénite, France|CHRU Hôpital de Pontchaillou, Rennes, France|CHU de Nancy_ Hôpital Brabois, Vandoeuvre-les-Nancy, France|Klinikum Augsburg, Augsburg, Germany|Gastroenterologische Spezialpraxis - Berlin-Karlshorst, Berlin-Karlshorst, Germany|GASTRO-Studien, Berlin, Germany|Charite - Universitatsmedizin Berlin (CCM), Berlin, Germany|Medizinisches Versorgungszentrum (MVZ) Dachau, Dachau, Germany|University Hospital Dresden, Dresden, Germany|Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus, Frankfurt, Germany|Universitätsklinikum Frankfurt/ Medizinische Klinik 1, Frankfurt, Germany|Universitatsklinikum Freiburg, Freiburg, Germany|Städtisches Krankenhaus Martha-Maria Halle-Dölau gGmbH, Halle, Germany|Hamburgisches Forschungsinstitut fuer CED, HaFCED e.K., Hamburg, Germany|Asklepios Westklinikum, Hamburg, Germany|Gastroenterologie Opernstraße, Kassel, Germany|Universitatsklinikum Schleswig-Holstein - Kiel, Kiel, Germany|Internistische Gemeinschaftspraxis Für Verdauungs- Und Stoffwechselkrankheiten, Leipzig, Germany|Städtisches Klinikum Lüneburg, Lueneburg, Germany|Universitätsklinikum Otto-von-Guericke-Universität Magdeburg, Magdeburg, Germany|Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany|Gastroenterologische Gemeinschaftspraxis Minden, Minden, Germany|Klinikum der Universität München, München, Germany|Praxis Dr. med. Ulf Helwig, Oldenburg, Germany|Zentrum für Gastroenterologie Saar MVZ GmbH, Saarbrücken, Germany|Universitaetsklinik Tuebingen, Tübingen, Germany|Universitätsklinikum Ulm, Klinik für Innere Medizin II, Ulm, Germany|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy|Ospedale Villa Sofia-Cervello, Palermo, Italy|Azienda Ospedaliera G.Salvini Ospedale di Rho, RHO, Italy|Fondazione Policlinico Gemelli Università Cattolica, Roma, Italy|Istituto Clinico Humanitas, Rozzano, Italy|AO Ordine Mauriziano, Torino, Italy|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|KyungHee University Hospital, Seoul, Korea, Republic of|Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands|Amphia Ziekenhuis, Breda, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Maastricht Universitair Medisch Centrum, Maastricht, Netherlands|Radboudumc, Nijmegen, Netherlands|Erasmus MC, Rotterdam, Netherlands|Sint Franciscus Gasthuis, Rotterdam, Netherlands|Hosp. Univ. Fundacion Alcorcon, Alcorcón, Spain|Hosp. Arquitecto Marcide, Ferrol, Spain|Hosp. Gral. Univ. Gregorio Marañon, Madrid, Spain|Hosp. Univ. La Paz, Madrid, Spain|Hosp. Univ. Virgen de La Arrixaca, Murcia, Spain|Hosp. Virgen de La Victoria, Málaga, Spain|Hosp. de Navarra, Pamplona, Spain|Hosp. Montecelo, Pontevedra, Spain|Corporacio Sanitari Parc Tauli, Sabadell, Spain|Hosp. Clinico Univ. de Salamanca, Salamanca, Spain|Hosp. Univ. Marques de Valdecilla, Santander, Spain|Hosp. Clinico Univ. de Valencia, Valencia, Spain|Hosp. Gral. Univ. Valencia, Valencia, Spain|Hosp. Alvaro Cunqueiro, Vigo, Spain|Hosp. Clinico Univ. Lozano Blesa, Zaragoza, Spain|Hosp. Univ. Miguel Servet, Zaragoza, Spain|Gastromottagningen, Malmö, Sweden|Gastromottagningen, Stockholm, Sweden|Pennine Acute Hospitals-Fairfield General Hospital, Bury, United Kingdom|Gloucestershire Hospitals NHS Foundation Trust - Cheltenham, Cheltenham, United Kingdom|Royal Devon & Exeter Hospital, Exeter, United Kingdom|St. Mark's Hospital, Harrow, United Kingdom|King's College Hospital NHS Foundation Trust, London, United Kingdom|St George's Hospital, London, United Kingdom|Southampton University Hospitals NHS Trust, Southampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03782376"
599,"NCT03774485","Myoelectric GutPrint-Crohn's Disease","Gutcheck-CD","Recruiting","No Results Available","Crohn Disease","Device: G-Tech Gutcheck Myoelectric recording device","Myoelectric activity pattern (physiological parameters)|Number of anticipated Adverse Events|Number of unanticipated adverse device effects","Stanford University|The Leona M. and Harry B. Helmsley Charitable Trust|G-Tech Corporation","All","18 Years to 75 Years   (Adult, Older Adult)",,"90","Other|Industry","Observational","Observational Model: Case-Control|Time Perspective: Prospective","IRB48539","January 1, 2019","June 30, 2021","June 30, 2021","December 13, 2018",,"February 21, 2021","Stanford University, Palo Alto, California, United States",,"https://ClinicalTrials.gov/show/NCT03774485"
600,"NCT03752970","A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Drug: Spesolimab|Drug: Placebo","Total number of deregulated genes|Proportion of patients with perianal fistula response|Proportion of patients with perianal fistula remission|Proportion of patients with combined perianal fistula remission","Boehringer Ingelheim","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","28","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","1368-0008|2017-003090-34","February 5, 2019","April 30, 2022","April 30, 2022","November 26, 2018",,"June 7, 2021","AKH - Medical University of Vienna, Wien, Austria|UZ Leuven, Leuven, Belgium|Centre Hospitalier Universitaire de Liège, Liège, Belgium|Herlev and Gentofte Hospital, Herlev, Denmark|Odense University Hospital, Odense, Denmark|Charité - Universitätsmedizin Berlin, Berlin, Germany|Universitätsklinikum Erlangen, Erlangen, Germany|Universitätsklinikum Ulm, Ulm, Germany|Semmelweis University, Budapest, Hungary|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Yeungnam University Medical Center, Daegu, Korea, Republic of|Amsterdam UMC, Locatie AMC, Amsterdam, Netherlands|Erasmus Medisch Centrum, Rotterdam, Netherlands|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain|Hospital Politècnic La Fe, Valencia, Spain",,"https://ClinicalTrials.gov/show/NCT03752970"
601,"NCT03735355","Endoscopic Balloon Dilation vs Surgery to Treat Short Strictures in Fibrostenosing Crohns Disease: An RCT",,"Not yet recruiting","No Results Available","Crohn Disease","Procedure: Surgery|Procedure: TTS balloon dilation","Surgery-free period in patients with fibrostenotic Crohns disease","McMaster University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","TTS Surgery Crohns Stricture","April 1, 2019","June 30, 2021","February 28, 2022","November 8, 2018",,"November 8, 2018",,,"https://ClinicalTrials.gov/show/NCT03735355"
602,"NCT03706664","Small Bowel Deep Learning Algorithm Project",,"Active, not recruiting","No Results Available","Crohn Disease","Other: Machine learning algorithm","Machine learning algorithm's ability to accurately localize the terminal ileum.|Data processing time until a diagnosis reported by algorithm.|Machine learning algorithm's ability to accurately distinguish abnormal and normal terminal ileum.","London North West Healthcare NHS Trust|Imperial College London","All","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","226","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","IRAS No:238924","March 1, 2019","November 2020","January 2021","October 16, 2018",,"February 27, 2020","St Mark's Hospital, London, Harrow, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03706664"
603,"NCT03706196","Comparison of Environmental Factors Between the Areas of Over- and Under-incidence of Crohn's Disease in the Haut de France Region, by the Study of Dental Exposomes","EXPOSOMES","Recruiting","No Results Available","Environmental Exposure",,"comparison of aluminum rate using metabolomic method in teeth between subjects living in high and low incidence crohn's disease areas.|comparison of environmental exposomes using metabolomic method in teeth between subjects living in high and low incidence crohn's disease areas.","University Hospital, Lille","All","18 Years and older   (Adult, Older Adult)",,"20","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2017_44|2018-A00195-50","April 2, 2019","December 2020","December 2020","October 15, 2018",,"September 16, 2020","CHU lille, Lille, France",,"https://ClinicalTrials.gov/show/NCT03706196"
604,"NCT03681652","Post-Operative Crohn's Disease Outcome in Children","POPCORN","Recruiting","No Results Available","Crohn Disease","Drug: Azathioprine|Drug: Anti-TNF Drug","Endoscopic recurrence (Rutgeerts score ≥ i2b)|Clinical recurrence according to PCDAI: ≥10|Re-operation rate|Exacerbation free quartiles","Schneider Children's Medical Center, Israel","All","6 Years to 18 Years   (Child, Adult)",,"100","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","POPCORN","February 11, 2019","December 31, 2022","March 1, 2023","September 24, 2018",,"March 18, 2020","Schneider Children's Hospital, Petach Tikva, Israel",,"https://ClinicalTrials.gov/show/NCT03681652"
605,"NCT03677648","A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease",,"Recruiting","No Results Available","Crohn's Disease","Drug: SHR0302|Drug: Placebos","The percentage of subjects achieving clinical remission at week 12.|The percentage of subjects achieving clinical remission defined as mean daily stool frequency (SF) ≤2.5, and abdominal pain (AP) ≤ 1 using the Patient Reported Outcome from CDAI at week 1, 4, 8, 12, 13, 16, and 24.|The percentage of subjects achieving clinical remission defined as PRO2 < 8 at week 1, 4, 8, 12, 13, 16, and 24.|The percentage of subjects achieving clinical response defined as a CDAI decrease from baseline of ≥ 100 points at week 1, 4, 8, 12, 13, 16, and 24.","Reistone Biopharma Company Limited","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","144","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","RSJ10201","May 14, 2019","June 2021","October 2021","September 19, 2018",,"December 2, 2020","West Central Gastroenterology d/b/a Gastro Florida, Clearwater, Florida, United States|Wellness Clinical Research, LLLC-Central Florida, Lake Wales, Florida, United States|West Central Gastroenterology d/b/a Gastro Florida, Tampa, Florida, United States|NECCR Primacare Research, LLC, Fall River, Massachusetts, United States|Wilmington Health, Wilmington, North Carolina, United States|Digestive Disease Specialists, Inc., Oklahoma City, Oklahoma, United States|The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China|Yijishan Hospital of Wannan Medical College, Yingshan, Anhul, China|Peking University Third Hospital, Beijing, Beijing, China|Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China|The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China|The First Affiliated Hospital of Nanchang University, Guangzhou, Guangzhou, China|The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangzhou, China|Henan Provincial People's Hospital, Zhengzhou, Henan, China|Tongji Hospital Affiliated to Tongji Medicine College, Huazhong University of Science & Technology, Wuhan, Hubei, China|Renmin Hospital of Wuhan University, Wuhan, Hubei, China|Henan Provincial People's Hospital, Pingxiang, Hunan, China|The First People's Hospital of Changzhou, Changzhou, Jiangsu, China|Zhongda Hospital Southeast University, Nanjing, Jiangsu, China|Wuxi People's Hospital, Wuxi, Jiangsu, China|Yangzhou First People's Hospital, Yangzhou, Jiangsu, China|The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China|Ruijin Hospital, Shanghai Jiaotong University, School of Medicne, Shanghai, Shanghai, China|Shanghai Xinhua Hospital, Shanghai, Shanghai, China|Shanghai East Hospital, Shanghai, Shanghai, China|Shanghai Changhai Hospital, Shanghai, Shanghai, China|Tianjin Union Medical Center, Tianjin, Tianjin, China|Sir Run Run Shaw Hospital, Affiliated with the Zhejiang University School of Medicine, Hangzhou, Zheijiang, China|Huzhou Central Hospital, Huzhou, Zheijiang, China|Nanfang Hospital of Southern Medical University, Changchun, China|Xiangya Hospital Central South University, Changsha, China|st China Hospital Sichuan University, Chengdu, China|Fujian Provincial Hospital, Fuzhou, China|Qilu Hospital of Shandong University, Jinan, China|Jiangsu Province Hospital, Nanjing, China|Nanjing First Hospital, Nanjing, China|The Affiliated Hospital of Nanjing University School, Nanjing, China|Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China|The University of Hong Kong-Shenzhen Hospital, Shenzhen, China|Shanxi Provincial People's Hospital, Taiyuan, China|Second hospital of Shanxi Medical university, Taiyuan, China|Indywidualma Specjalistyczna Praktyka Lekarska Maciej Zymla, Knurów, Poland|Nzoz Allmedica Badania, Nowy Targ, Poland|Provita Profamilia, Piotrków Trybunalski, Poland|SOLUMED Centrum Medyczne, Poznań, Poland|KO-MED Central Kliniczne Plulawy, Puławy, Poland|Gabinet Lekarski Bartosz Korczowski, Rzeszów, Poland|Specjalistyczna Praktyka Lekarska dr med. Marek Horynski, Sopot, Poland|KO-MED Centra Kliniczne Staszow, Staszów, Poland|Centrum Zdrowia MDM, Warszawa, Poland|Centralny Szpital Kliniczny MSW, Warszawa, Poland|Nzoz Vivamed, Warszawa, Poland|PlanetMed sp. z o.o., Wrocław, Poland|Amicare Sp. z o.o. Sp.k, Łódź, Poland|SALVE Zakład Opieki Zdrowotnej Sp. zo.o., Łódź, Poland|EZ-MED Centrum Medyczne, Świdnica, Poland|RCI Chernivtsi Regional Clinical Hospital Dept of Gastroenterology Bukovinsky SMU, Chernivtsi, Ukraine|I.I.Mechnykov Dnipropetrovsk Regional Clinical Hospital, Dnipro, Ukraine|I.I.Mechnykov Dnipropetrovsk, Dnipro, Ukraine|Ivano-Frankivsk Hospital, Ivano-Frankivs'k, Ukraine|Ivano-Frankivsk Med. University, Ivano-Frankivs'k, Ukraine|CHI Kharkiv City Clinical Hospital #13, Kharkiv, Ukraine|Public nonprofit enterprise, Kharkiv, Ukraine|Kherson City Clinical Hospital, Kherson, Ukraine|Khmelnyski Regional Hospital, Khmelnytskyi, Ukraine|Tx-Dx Center Adonis Plus Ltd, Kiev, Ukraine|Healthy and Happy, Kyiv, Ukraine|Kyiv City Clinical Hospital, Kyiv, Ukraine|Kyiv Clin Hospital on Railway St. 2, Kyiv, Ukraine|Med. Cen.of Limited Liability, Kyiv, Ukraine|Kyiv Regional Hospital #2, Kyiv, Ukraine|Lviv Regional Clinical Hosp, Lviv, Ukraine|Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU, Lviv, Ukraine|Medical Center Pulse, Vinnytsia, Ukraine|RCH Vinnytsia, Dept. Therapy, Vinnytsia, Ukraine|Vinnytsia M I Pyrogov, Vinnytsia, Ukraine|CCH #1 Vinnytsia M.I. Pyrogov NMU Ch of Propaedeutics of IM, Vinnytsia, Ukraine|Communal Institution Center of the Primary Medical- Sanitary Care#2, Vinnytsia, Ukraine|Center of primary health care, Vinnytsia, Ukraine|City Clinical Hospital, Zaporizhzhya, Ukraine|O.F. Herbachevskiyi Zhytomyr Regional Clinical Hospital, Zhytomyr, Ukraine",,"https://ClinicalTrials.gov/show/NCT03677648"
606,"NCT03646708","Response Assessment in SB CD",,"Recruiting","No Results Available","Small Bowel Crohn's Disease",,"Corticosteroid free remission (CFR)|Mucosal healing (MH)","Washington University School of Medicine|American College of Gastroenterology","All","18 Years and older   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","201805058","May 9, 2018","May 30, 2023","May 30, 2023","August 24, 2018",,"October 6, 2020","Washington University School of Medicine, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT03646708"
607,"NCT03627091","Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)","CARMEN CD 307","Active, not recruiting","No Results Available","Crohn's Disease","Drug: Ontamalimab|Other: Placebo","Number of Participants With Clinical Remission at Week 52|Number of Participants With Enhanced Endoscopic Response at Week 52|Number of Participants With Clinical Remission as Measured by Crohn's Disease Activity Index (CDAI) Less Than (<) 150 at Week 52|Number of Participants With Glucocorticoid-free Clinical Remission at Week 52|Number of Participants With Clinical Remission as Defined by Crohn's Disease (CD) e-diary Subscores at Week 52|Number of Participants With Sustained Clinical Remission at Week 52|Number of Participants With Sustained Enhanced Endoscopic Response at Week 52|Number of Participants With Clinical Remission and Enhanced Endoscopic Response at Week 52|Number of Participants With Complete Endoscopic Healing at Week 52","Shire|Takeda","All","16 Years to 80 Years   (Child, Adult, Older Adult)","Phase 3","40","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","SHP647-307","February 6, 2019","November 1, 2021","November 1, 2021","August 13, 2018",,"June 8, 2021","Arizona Digestive Health Mesa - East, Mesa, Arizona, United States|Elite Clinical Studies - Phoenix - Clinedge - PPDS, Phoenix, Arizona, United States|CATS Research Center - University of Arizona, Tucson, Arizona, United States|Atria Clinical Research - Clinedge - PPDS, Little Rock, Arkansas, United States|Advanced Research Center, Anaheim, California, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, United States|OM Research LLC - Lancaster - ClinEdge - PPDS, Lancaster, California, United States|Alliance Clinical Research-(Vestavia Hills), Poway, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Care Access Research, San Pablo, San Pablo, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Asthma and Allergy Associates PC - CRN - PPDS, Colorado Springs, Colorado, United States|Renaissance Research Medical Group, INC, Cape Coral, Florida, United States|Gastro Florida, Clearwater, Florida, United States|Advanced Clinical Research Network, Coral Gables, Florida, United States|Alliance Medical Research LLC, Coral Springs, Florida, United States|SIH Research, Kissimmee, Florida, United States|Crystal Biomedical Research, Miami Lakes, Florida, United States|Hi Tech and Global Research, LLc, Miami, Florida, United States|Sanchez Clinical Research, Inc, Miami, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|Pharma Research International Inc, Naples, Florida, United States|Omega Research Consultants LLC - Clinedge - PPDS, Orlando, Florida, United States|Accel Research Sites - St. Petersburg - ERN - PPDS, Pinellas Park, Florida, United States|East Coast Institute for Research, LLC, Saint Augustine, Florida, United States|DBC Research, Tamarac, Florida, United States|Bayside Clinical Research - New Port Richey, Tampa, Florida, United States|Atlanta Gastroenterology Specialists, PC, Atlanta, Georgia, United States|Infinite Clinical Trials, Atlanta, Georgia, United States|Atlanta Center For Gastroenterology PC, Decatur, Georgia, United States|Loretto Hospital, Chicago, Illinois, United States|IL Gastroenterology Group, Gurnee, Illinois, United States|Laporte County Institute For Clinical Research, Michigan City, Indiana, United States|Cotton O'Neil Clinical Research Center, Topeka, Kansas, United States|Gastroenterology Associates of Hazard, Hazard, Kentucky, United States|CroNOLA, LLC., Houma, Louisiana, United States|Clinical Trials of SWLA, LLC, Lake Charles, Louisiana, United States|DelRicht Clinical Research, LLC - ClinEdge - PPDS, New Orleans, Louisiana, United States|Louisiana Research Center LLC, Shreveport, Louisiana, United States|Commonwealth Clinical Studies LLC, Brockton, Massachusetts, United States|Winchester Gastroenterology Associates, Winchester, Massachusetts, United States|UMass Memorial Medical Center, Worcester, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Clinical Research Institute of Michigan, Chesterfield, Michigan, United States|National Clinical, LLC, Hamtramck, Michigan, United States|Gastroenterology Associates of Western Michigan, PLC, Wyoming, Michigan, United States|Mayo Clinic Health System - PPDS, Duluth, Minnesota, United States|Minnesota Gastroenterology PA, Saint Paul, Minnesota, United States|Washington University in St. Louis, Saint Louis, Missouri, United States|Advanced Biomedical Research of America, Las Vegas, Nevada, United States|Encompass Care, North Las Vegas, Nevada, United States|New York Total Medical Care PC, Brooklyn, New York, United States|NYU Langone Long Island Clinical Research Associates, Great Neck, New York, United States|Southtowns Gastroenterology, PLLC, Orchard Park, New York, United States|Piedmont Healthcare, Statesville, North Carolina, United States|Consultants For Clinical Research Inc, Cincinnati, Ohio, United States|Consultants For Clinical Research Inc, Cincinnati, Ohio, United States|Consultants For Clinical Research Inc, Fairfield, Ohio, United States|Penn State Hershey Medical Group, State College, Pennsylvania, United States|Digestive Disease Associates, Wyomissing, Pennsylvania, United States|Gastro One, Germantown, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Advanced Gastroenterology-Union City, Union City, Tennessee, United States|Northside Gastroenterology, Cypress, Texas, United States|Digestive Health Associates of Texas, P.A.dba DHAT Research Institute, Garland, Texas, United States|Precision Research Institute, LLC, Houston, Texas, United States|Biopharma Informatic Inc., Houston, Texas, United States|Southwest Clinical Trials, Houston, Texas, United States|BI Research Center, Houston, Texas, United States|Southern Star Research Institute LLC, San Antonio, Texas, United States|Inquest Clinical Research/Coastal Gastroenterology Associates, PA - TDDC - PPDS, Webster, Texas, United States|HP Clinical Research, Bountiful, Utah, United States|Mid Atlantic Health Specialists, Galax, Virginia, United States|Fundación Favaloro, Buenos Aires, Argentina|Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Liverpool Hospital, Liverpool, New South Wales, Australia|Mater Hospital Brisbane, South Brisbane, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|St Vincents Hospital Melbourne - PPDS, Fitzroy, Victoria, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|LKH-Universitätsklinikum Klinikum Graz, Graz, Steiermark, Austria|Klinikum Wels-Grieskirchen GmbH, Vienna, Wien, Austria|Salzburger Landeskliniken, Salzburg, Austria|Medizinische Universitat Wien (Medical University of Vienna), Wien, Austria|Academisch Medisch Centrum Amsterdam, Bonheiden, Antwerpen, Belgium|UZ Gent, Gent, Oost-Vlaanderen, Belgium|AZ Groeninge, Kortrijk, West-Vlaanderen, Belgium|CHU Mouscron, Mouscron, Belgium|Clinical Center Banja Luka, Banja Luka, Bosnia and Herzegovina|Acibadem City Clinic University Multiprofile Hospital for Active Treatment EOOD, Sofia, Sofia-Grad, Bulgaria|Multiprofile Hospital for Active Treatment Eurohospital, Plovdiv, Bulgaria|Second Multiprofile Hospital for Active Treatment Sofia, Sofia, Bulgaria|Diagnostic and Consulting Center Aleksandrovska EOOD, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Sv Ivan Rilski EAD, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna - ISUL EAD, Sofia, Bulgaria|Medical Center Excelsior OOD - PPDS, Sofia, Bulgaria|Medical Center Convex EOOD, Sofia, Bulgaria|Diagnostic Consultative Centre Mladost - M OOD, Varna, Bulgaria|Fundación Valle Del Lili, Cali, Valle Del Cauca, Colombia|IPS Centro Médico Julián Coronel S.A.S. - PPDS, Cali, Colombia|University Hospital Center Zagreb, Zagreb, Grad Zagreb, Croatia|Opca bolnica Bjelovar, Bjelovar, Croatia|Clinical Hospital Centre Osijek, Osijek, Croatia|General Hospital Virovitica, Virovitica, Croatia|OÜ LV Venter, Parnu, Estonia|West Tallinn Central Hospital, Tallinn, Estonia|Klinikum rechts der Isa der Technischen Universitaet Muenchen, Munich, Bayern, Germany|Universitätsklinikum der RWTH Aachen, Aachen, Nordrhein-Westfalen, Germany|Uniklinik Köln, Köln, Nordrhein-Westfalen, Germany|Gastro Campus Research GbR, Münster, Nordrhein-Westfalen, Germany|Universitatsklinikum Schleswig-Holstein, Kiel, Schleswig-Holstein, Germany|Universitatsklinikum Jena, Jena, Thüringen, Germany|Gastroenterologische Facharztpraxis am Mexikoplatz, Berlin-Zehlendorf, Germany|Charité - Universitätsmedizin Berlin, Berlin, Germany|Sana Klinikum Biberach, Biberach an der Riss, Germany|Universitätsklinikum Frankfurt, Frankfurt, Germany|Ippokrateio General Hospital of Athens, Athens, Attiki, Greece|University General Hospital of Heraklion, Heraklion, Greece|Iatriko Palaiou Falirou, Paliao Faliro, Greece|University General Hospital of Patras, Patras, Greece|Euromedica - PPDS, Thessaloniki, Greece|Bekes Megyei Kozponti Korhaz, Bekescsaba, Hungary|Magyar Honvédség Egészségügyi Központ, Budapest, Hungary|Pannónia Magánorvosi Centrum Kft, Budapest, Hungary|ENDOMEDIX Kft., Budapest, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Mohacsi Korhaz, Mohacs, Hungary|Tolna Megyei Balassa János Kórház, Szekszard, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Székesfehérvár, Hungary|St Vincent's University Hospital, Dublin, Ireland|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah Medical Center - PPDS, Jerusalem, Israel|Galilee Medical Center, Nahariya, Israel|Baruch Padeh Poriya Medical Center, Tiberias, Israel|Azienda Ospedaliera Mater Domini Di Catanzaro, Catanzaro, Calabria, Italy|Azienda Ospedaliero Universitaria Di Modena Policlinico, Modena, Emilia-Romagna, Italy|Fondazione Policlinico Universitario A Gemelli, Roma, Lazio, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, Toscana, Italy|IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Veneto, Italy|A.O.U. Maggiore della Carità, Novara, Italy|Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia, Italy|La Sapienza-Università di Roma-Policlinico Umberto I, Roma, Italy|Istituto Clinico Humanitas, Rozzano (MI), Italy|Ospedale Casa Sollievo Della Sofferenza IRCCS, San Giovanni Rotondo, Italy|Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy|Sapporo Medical University Hospital, Sapporo, Hokkaidô, Japan|Medical Corporation Aoyama Clinic, Kobe-shi, Hyôgo, Japan|Hyogo College of Medicine, Nishinomiya-shi, Hyôgo, Japan|Jikei University Hospital, Minato-ku, Tokyo, Japan|Ome Municipal General Hospital, Ome, Tokyo, Japan|Kunimoto Hospital, Asahikawa, Japan|Hidaka Coloproctology Clinic, Kurume-shi, Japan|Aichi Medical University Hospital, Nagakute, Japan|Nishinomiya Municipal Central Hospital, Nishinomiya, Japan|Onomichi General Hospital, Onomichi, Japan|Kinshukai Infusion Clinic, Osaka-shi, Japan|Chiinkai Dojima General & Gastroenterology Clinic, Osaka, Japan|Yodogawa Christian Hospital, Osaka, Japan|Shiga University of Medical Science Hospital, Otsu-Shi, Japan|Toho University Sakura Medical Center, Sakura, Japan|Sapporo Tokushukai Hospital, Sapporo-shi, Japan|Sapporo Higashi Tokushukai Hospital, Sapporo, Japan|Dokkyo Medical University Hospital, Shimotsuga-gun, Japan|Nihonbashi Egawa Clinic, Tokyo, Japan|Colo-Proctology Center Matsushima Clinic, Yokohama, Japan|Ishida Clinic of IBD and Gastroenterology, Oita-city, Ôita, Japan|Yonsei University Wonju Severance Christian Hospital, Wonju, Gang'weondo, Korea, Republic of|CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggido, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital, Suwon, Gyeonggido, Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Pusan National University Hospital, Busan, Korea, Republic of|Kyungpook National University Hospital, Daegu, Korea, Republic of|Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of|Gachon University Gil Medical Center, Incheon, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Inje University Seoul Paik Hospital, Seoul, Korea, Republic of|Al Zahraa University Hospital, Beirut, Lebanon|Hammoud Hospital University Medical Center, Saida, Lebanon|Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania|Vilnius City Clinical Hospital, Vilnius, Lithuania|Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V., Zapopan, Jalisco, Mexico|Clinica de Higado y Gastroenterologia Integral, S.C., Cuernavaca, Morelos, Mexico|JM Research S.C, Cuernavaca, Morelos, Mexico|Accelerium, S. de R.L. de C.V., Monterrey, Nuevo León, Mexico|Unidad de Atencion Medica e Investigacion en Salud, Merida, Yucatán, Mexico|Centro de Investigacion Clinica Acelerada, S.C., Distrito Federal, Mexico|Instituto de Investigaciones Aplicadas a la Neurociencia A.C., Durango, Mexico|ETZ-Elisabeth, Tilburg, Noord-Brabant, Netherlands|NWZ, location Alkmaar, Den Helder, Noord-Holland, Netherlands|Dunedin Hospital, Dunedin, South Island, New Zealand|Wellington Hospital, Newtown, Wellington, New Zealand|Waikato Hospital, Hamilton, New Zealand|Melita Medical, Wroclaw, Dolnoslaskie, Poland|Lexmedica, Wroclaw, Dolnoslaskie, Poland|Vitamed Galaj i Cichomski sp.j., Bydgoszcz, Kujawsko-pomorskie, Poland|Gastromed Kopon Zmudzinski i Wspolnicy Sp.j.Specjalistyczne Centrum Gastrologii i Endoskopii Specj, Torun, Kujawsko-pomorskie, Poland|Centrum Diagnostyczno - Lecznicze Barska sp. z o.o., Wloclawek, Kujawsko-pomorskie, Poland|Niepubliczny Zaklad Opieki Zdrowotnej CENTRUM MEDYCZNE Szpital Swietej Rodziny, Lódz, Lódzkie, Poland|Centrum Opieki Zdrowotnej Orkan-Med Stec-Michalska Sp. J., Lódz, Lódzkie, Poland|Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Warszawa, Mazowieckie, Poland|Niepubliczny Zakład Opieki Zdrowotnej VIVAMED, Warszawa, Mazowieckie, Poland|Miedzyleski Szpital Specjalistyczny w Warszawie, Warszawa, Mazowieckie, Poland|Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok, Podlaskie, Poland|Endoskopia Sp. z o.o., Sopot, Pomorskie, Poland|Szpital Specjalistyczny sw Lukasza - Oddzial Gastroenterologii, Konskie, Swietokrzyskie, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, Zachodniopomorskie, Poland|Szpital Uniwersytecki Nr 2 im. Dr Jana Biziela w Bydgoszczy, Bydgoszcz, Poland|Centrum Medyczne Czestochowa - PRATIA - PPDS, Czestochowa, Poland|Centrum Medyczne Gdynia - PRATIA - PPDS, Gdynia, Poland|NZOZ All Medicus, Katowice, Poland|Med Gastr Sp.z.o.o Sp.k, Lodz, Poland|Instytut Centrum Zdrowia Matki Polki, Lodz, Poland|Twoja Przychodnia - Centrum Medyczne Nowa Sol, Nowa Sól, Poland|Clinical Research Center Spółka z Ograniczoną Odpowiedzialnością, Medic-R Spółka Komandytowa, Poznan, Poland|Centrum Medyczne Warszawa - PRATIA - PPDS, Rzeszow, Poland|Korczowski Bartosz, Gabinet Lekarski, Rzeszow, Poland|Sonomed Sp. z o.o., Szczecin, Poland|Centrum Zdrowia M D M, Warszawa, Poland|Centralny Szpital Kliniczny MSW, Warszawa, Poland|BioVirtus Centrum Medyczne, Warszawa, Poland|Samodzielny Publiczny Szpital Wojewodzki im. Papieza Jana Pawla II, Zamosc, Poland|Hospital Senhora da Oliveira - Guimaraes, E.P.E, Guimarães, Portugal|Hospital da Luz, Lisboa, Portugal|Centro Hospitalar do Algarve - Hospital de Portimao, Portimão, Portugal|Sana Monitoring SRL, Bucharest, Bucuresti, Romania|Cluj-Napoca Emergency Clinical County Hospital, Cluj-Napoca, Cluj, Romania|Dr.Carol Davila Emergency University Central Military Hospital, Bucharest, Romania|Colentina Clinical Hospital, Bucharest, Romania|Prof. Dr. Matei Bals Institute of Infectious Diseases, Bucharest, Romania|Fundeni Clinical Institute, Bucharest, Romania|Emergency University Hospital, Bucharest, Romania|Centrul Medical Hifu Terramed Conformal S.R.L., Bucuresti, Romania|Affidea Romania SRL, Constanta, Romania|Gastromedica SRL, Iasi, Romania|Dr. Tirnaveanu Amelita Private Practice, Oradea, Romania|Dr. Goldis Gastroenterology Center SRL, Timisoara, Romania|Rostov State Medical University, Rostov-on-Don, Russian Federation|Russian Medical Military Academy n.a. S.M. Kirov, Saint Petersburg, Russian Federation|Medical University Reaviz, Samara, Russian Federation|Private Healthcare Institution Clinical Hospital RZD-Medicina of Samara city, Samara, Russian Federation|SHI Regional Clinical Hospital, Saratov, Russian Federation|St. Elizabeth Municipal Clinical Hospital, St. Petersburg, Russian Federation|Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia|University Clinical Center Nis, Nis, Serbia|General Hospital Vrsac, Vrsac, Serbia|Clinical Hospital Center Zemun, Zemun, Serbia|University Clinical Center Kragujevac, Kragujevac, Šumadijski Okrug, Serbia|KM Management, spol. s r.o., Nitra, Slovakia|Gastro LM, s.r.o., Presov, Slovakia|CLINRESCO, ARWYP Medical Suites, Johannesburg, Gauteng, South Africa|Dr. J Breedt, Pretoria, Gauteng, South Africa|Dr JP Wright, Claremont, Western Cape, South Africa|C.H. Regional Reina Sofia - PPDS, Cordoba, Córdoba, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Madrid, Communidad Delaware, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|CHUVI - H.U. Alvaro Cunqueiro, Vigo, Pontevedra, Spain|Centro Medico Teknon - Grupo Quironsalud, Barcelona, Spain|Hospital Universitario Juan Ramon Jimenez, Huelva, Spain|Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain|Hospital Universitario La Paz - PPDS, Madrid, Spain|Hospital Universitario Virgen del Rocio - PPDS, Sevilla, Spain|Mersin University Medical Faculty, Mersin, Turkey|Regional Municipal Non-profit Enterprise ""Chernivtsi Regional Clinical Hospital"", Chernivtsi, Chernivets'ka Oblast, Ukraine|Municipal Nonprofit Enterprise CCH #2 n.a. prof. O.O. Shalimov of Kharkiv City Council, Kharkiv, Kharkivs'ka Oblast, Ukraine|Municipal Non-profit Enterprise of Kyiv Regional Council Kyiv Regional Clinical Hospital, Kyiv, Kyïv, Ukraine|LLC Medical Center Family Medicine Clinic, Dnipro, Ukraine|Communal Non-Commercial Enterprize of Kharkiv Regional Council Regional Clinical Hospital, Kharkiv, Ukraine|Municipal Non-profit Enterprise Kherson City Clinical Hospital named after Ye.Ye. Karabelesh, Kherson, Ukraine|Medical Center of LLC Medical Clinic Blagomed, Kyiv, Ukraine|Medical Center OK!Clinic+LLC International Institute of Clinical Research, Kyiv, Ukraine|Medical Center of LLC Medical Center Dopomoga-Plus, Kyiv, Ukraine|Municipal Institution of KRC Kyiv Regional Hospital #2, Kyiv, Ukraine|Municipal Nonprofit Enterprise Lviv Clinical Emergency Care Hospital, Lviv, Ukraine|Communal Non-Commercial Enterprise Vinnytsia City Clinical Hospital 1, Vinnytsia, Ukraine|MNPE City Hospital No. 6 of Zaporizhzhia City Council, Zaporizhzhia, Ukraine|North Tyneside General Hospital, North Shields, Northumberland, United Kingdom|Aberdeen Royal Infirmary - PPDS, Aberdeen, United Kingdom|Royal Gwent Hospital - PPDS, Newport, United Kingdom|New Cross Hospital, Wolverhampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03627091"
608,"NCT03623932","Contribution of a Non Medicamentous Approach by Hypnosis on Quality of Life in Crohn Disease","HYPNOCROHN","Recruiting","No Results Available","Crohn Disease","Drug: immunosuppressor/TNFalpha|Behavioral: Hypnosis","Mid term hypnosis efficacy with IBDQ|Short term hypnosis efficacy with IBDQ|Disease acceptance with ICQ-18|Clinical score with Harvey-Bradshaw Index short and mid term|Vagal tonus with electrocardiogram|Inflammatory status with C Reactive Protein|Stress with Perceived Stress Scale|Fatigue with Multidimensional Fatigue Inventory|Long term hypnosis efficacy|Clinical score with Harvey-Bradshaw Index long term","University Hospital, Grenoble","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","38RC17.298","November 13, 2018","November 12, 2021","November 13, 2021","August 9, 2018",,"March 23, 2020","University Hospital, Grenoble, France",,"https://ClinicalTrials.gov/show/NCT03623932"
609,"NCT03599622","An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease",,"Recruiting","No Results Available","Granulomatous Colitis|Crohn's Disease|Crohn's Enteritis|Granulomatous Enteritis","Drug: BMS-986165|Other: Placebo","Proportion of participants achieving clinical remission at Week 12|Proportion of participants achieving endoscopic response at Week 12|Proportion of participants who achieve a clinical response at Week 12|Proportion of participants who achieve PRO2 [Participant reported outcome based on the stool frequency and abdominal pain components of the Crohn's Disease Activity Index (CDAI)] remission at Week 12|Change from baseline in SES-CD (Simple Endoscopic Score for Crohn's Disease) at Week 12|Proportion of participants achieving endoscopic normalization at Week 12|Proportion of participants achieving endoscopic remission at Week 12|Proportion of participants achieving deep remission at Week 12","Bristol-Myers Squibb","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","240","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","IM011-023|2017-001976-48","July 16, 2018","May 9, 2022","March 12, 2024","July 26, 2018",,"May 24, 2021","Local Institution, Los Angeles, California, United States|Local Institution, Los Angeles, California, United States|Local Institution, San Diego, California, United States|Kaiser Permanente Colorado Institute for Health Research, Aurora, Colorado, United States|The Medical Research Center of Connecticut, Hamden, Connecticut, United States|Gastro Florida, Clearwater, Florida, United States|University of Florida Health - Jacksonville, Jacksonville, Florida, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Local Institution, Lakewood Ranch, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|University of Miami Miller School of Medicine, Miami, Florida, United States|Advanced Research Institute - New Port Richey, New Port Richey, Florida, United States|Omega Research Consultants - Maitland, Orlando, Florida, United States|Florida Hospital Orlando, Orlando, Florida, United States|Local Institution, Palmetto Bay, Florida, United States|Clinical Research of West Florida - Tampa, Tampa, Florida, United States|Florida Medical Clinic - Clinical Research Division, Zephyrhills, Florida, United States|Atlanta Gastroenterology Specialists, Suwanee, Georgia, United States|Local Institution, Chicago, Illinois, United States|Local Institution, Evansville, Indiana, United States|Local Institution, Indianapolis, Indiana, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|Local Institution, Topeka, Kansas, United States|Louisiana Research Center, Shreveport, Louisiana, United States|Local Institution, Chevy Chase, Maryland, United States|Clinical Research Institute of Michigan, Chesterfield, Michigan, United States|Troy Gastroenterology, Troy, Michigan, United States|Gastroenterology Associates of Western Michigan, Wyoming, Michigan, United States|Huron Gastroenterology Associates, Ypsilanti, Michigan, United States|The University of Mississippi Medical Center, Jackson, Mississippi, United States|Digestive Health Center - Ocean Springs, Ocean Springs, Mississippi, United States|Advanced Biomedical Research of America, Las Vegas, Nevada, United States|Local Institution, New Brunswick, New Jersey, United States|New York Langone Long Island Clinical Research Associates, Lake Success, New York, United States|Local Institution, New York, New York, United States|Local Institution, New York, New York, United States|Local Institution, Chapel Hill, North Carolina, United States|Atrium Health, Charlotte, North Carolina, United States|Local Institution, Oklahoma City, Oklahoma, United States|Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Donald Guthrie Foundation for Education and Research, Sayre, Pennsylvania, United States|Clinical Trials of South Carolina, Charleston, South Carolina, United States|Local Institution, Jackson, Tennessee, United States|Vanderbilt Inflammatory Bowel Disease Clinic, Nashville, Tennessee, United States|Texas Clinical Research Institute, Arlington, Texas, United States|Digestive Health Associates of Texas - Richardson, Garland, Texas, United States|Local Institution, Houston, Texas, United States|Gastroenterology Research of San Antonio, San Antonio, Texas, United States|Southern Star Research Institute - Medical Center Office, San Antonio, Texas, United States|Local Institution, Southlake, Texas, United States|Spring Gastroenterology Associates - Houston, Spring, Texas, United States|Tyler Research Institute, Tyler, Texas, United States|Local Institution, Ogden, Utah, United States|Local Institution, Salt Lake City, Utah, United States|Local Institution, Lynchburg, Virginia, United States|Hunter Holmes McGuire Veterans Administration Medical Center, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Swedish First Hill Campus, Seattle, Washington, United States|Local Institution, Seattle, Washington, United States|The Vancouver Clinic, Vancouver, Washington, United States|Local Institution, Herston, Queensland, Australia|Mater Hospital Brisbane, South Brisbane, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Ballarat Base Hospital, Ballarat, Victoria, Australia|Local Institution, Camberwell, Victoria, Australia|Monash Medical Centre, Clayton, Victoria, Australia|Local Institution, Melbourne, Victoria, Australia|St Vincents Hospital Melbourne, Melbourne, Victoria, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, Australia|GZA Ziekenhuizen campus Sint-Vincentius, Antwerpen, Belgium|Universitair Ziekenhuis Antwerpen, Edegem, Belgium|Algemeen Ziekenhuis Maria Middelares, Gent, Belgium|Centre Hospitalier Universitaire Universite Catholique de Louvain Site Godinne, Yvoir, Belgium|Local Institution, Salvador, Bahia, Brazil|SER - Servicos Especializados em Reumatologia da Bahia, Salvador, Bahia, Brazil|Eurolatino Juiz de Fora Pesquisas Medicas, Juiz de Fora, Minas Gerais, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, RIO Grande DO SUL, Brazil|Hospital das Clinicas da Faculdade de Medicina de Botucatu, Botucato, SAO Paulo, Brazil|Faculdade De Medicina Do Abc, Santo Andre, SAO Paulo, Brazil|Centro Multidisciplinar de Estudos Clinicos, Sao Bernardo do Campo, SAO Paulo, Brazil|Faculdade de Medicina de Sao Jose do Rio Preto Hospital de Base, Sao Jose do Rio Preto, SAO Paulo, Brazil|Hospital Universitario Clementino Fraga Filho, Rio de Janeiro, Brazil|University of Calgary, Calgary, Alberta, Canada|Local Institution, Edmonton, Alberta, Canada|South Edmonton Gastroenterology Research Clinic, Edmonton, Alberta, Canada|Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada|Local Institution, Winnipeg, Manitoba, Canada|Local Institution, Etobicoke, Ontario, Canada|Local Institution, London, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Local Institution, Toronto, Ontario, Canada|Toronto Digestive Diseases Associates, Vaughan, Ontario, Canada|Local Institution, Montreal, Quebec, Canada|Local Institution, Montreal, Quebec, Canada|Local Institution, XIamen, Fujian, China|Local Institution, Guangzhou, Guangdong, China|Local Institution, Guangzhou, Guangdong, China|Local Institution, Wuhan, Hubei, China|Local Institution, Changsha, Hunan, China|Local Institution, Nanjing, Jiangsu, China|Local Institution, Nanjing, Jiangsu, China|Local Institution, Nanjing, Jiangsu, China|Local Institution, Changchun Shi, Jilin, China|Local Institution, Shenyang, Liaoning, China|Local Institution, Shanghai, Shanghai, China|Local Institution, Shanghai, Shanghai, China|Local Institution, Shanghai, Shanghai, China|Local Institution, Hangzhou, Zhejiang, China|Local Institution, Osijek, Croatia|Local Institution, Rijeka, Croatia|Local Institution, Zagreb, Croatia|Local Institution, Brno, Czechia|Hepato-Gastroenterology HK, Hradec Kralove, Czechia|Local Institution, Olomouc, Czechia|Fakultni Nemocnice Ostrava, Ostrava, Czechia|Local Institution, Plzen, Czechia|Local Institution, Prague 4, Czechia|Klinicke centrum ISCARE IVF a.s., Praha 9, Czechia|Local Institution, Usti nad Orlici, Czechia|Aalborg Universitetshospital, Aalborg, Denmark|Bispebjerg Hospital, Copenhagen NV, Denmark|Odense University Hospital, Odense, Denmark|Local Institution, Silkeborg, Denmark|Local Institution, Amiens Cedex 1, France|Hopital Beaujon, Clichy Cedex, France|Hopital Louis Mourier Colombes, Colombes, France|Local Institution, Lille Cedex, France|Centre Hospitalier Universitaire de Montpellier, Montpellier cedex 5, France|Local Institution, Nantes, France|Local Institution, Nice Cedex 3, France|Local Institution, Paris cedex 12, France|Local Institution, Saint-Etienne, France|Hopital Rangueil, Toulouse Cedex 9, France|Centre Hospitalier Universitaire de Toulouse - Hopital Rangueil, Toulouse, France|Local Institution, Tours cedex, France|Charite Universitatsmedizin Berlin, Berlin, Germany|Local Institution, Berlin, Germany|Local Institution, Berlin, Germany|Charite Universitatsmedizin Berlin, Berlin, Germany|Local Institution, Brandenburg An Der Havel, Germany|Universitatsklinikum Frankfurt, Frankfurt am Main, Germany|Local Institution, Freiburg, Germany|Studiengesellschaft BSF UG, Halle, Germany|Local Institution, Halle, Germany|Local Institution, Hamburg, Germany|Local Institution, Hamburg, Germany|Local Institution, Hannover, Germany|Universitatsklinikum Jena, Jena, Germany|Universitaetsklinikum Schleswig-Holstein - Campus Kiel, Kiel, Germany|Local Institution, Mannheim, Germany|Local Institution, Munchen, Germany|Gastroenterologische Gemeinschaftspraxis am Germania Campus, Munster, Germany|Universitaetsklinikum Regensburg, Regensburg, Germany|Local Institution, Stuttgart, Germany|Local Institution, Tubingen, Germany|Universitatsklinikum Ulm, Ulm, Germany|Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaz, Bekescsaba, Hungary|Szent Margit Korhaz, Budapest, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary|Semmelweis Egyetem I.sz. Belgyogyaszati Klinika, Budapest, Hungary|Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Budapest, Hungary|Pannonia Maganorvosi Centrum, Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Bugat Pal Korhaz, Gyongyos, Hungary|Local Institution, Gyula, Hungary|Mohacsi Korhaz, Mohacs, Hungary|Local Institution, Szeged, Hungary|Szegedi Tudomanyegyetem - Altalanos Orvostudomanyi Kar, Szeged, Hungary|Javorszky Odon Korhaz, Vac, Hungary|Local Institution, Veszprem, Hungary|Local Institution, Tallaght, Dublin, Ireland|Local Institution, Ballinasloe, Galway, Ireland|Local Institution, Drogheda, Louth, Ireland|Local Institution, Dublin, Ireland|Local Institution, Galway, Ireland|Local Institution, Beer Sheva, Israel|Local Institution, Nahariya, Israel|Local Institution, Petah Tikva, Israel|Local Institution, Rehovot, Israel|Local Institution, Bologna, Italy|Local Institution, Castellana Grotte, Italy|Azienda Ospedaliero-Universitaria Mater Domini, Catanzaro, Italy|Local Institution, Firenza, Italy|Clinica Medica Azienda Ospedaliera Universitaria, Messina, Italy|ASST Santi Paolo e Carlo - Ospedale San Paolo Polo Universitario, Milano, Italy|Local Institution, Milano, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milano, Italy|Local Institution, Monserrato, Italy|Ospedale Sacro Cuore Don Calabria, Negrar, Italy|Azienda Ospedaliera di Padova, Padova, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|Local Institution, Roma, Italy|Local Institution, Roma, Italy|Fondazione Policlinico Universitario Agostino Gemelli - Presidio Columbus, Roma, Italy|Istituto Clinico Humanitas Humanitas Cancer Center, Rozzano, Italy|Ospedale Mauriziano Umberto I di Torino, Torino, Italy|Fujita Health University, Toyoake, Aichi, Japan|National Hospital Organization Hirosaki National Hospital, Hirosaki, Aomori, Japan|Toho University Sakura Medical Center, Sakura-shi, Chiba, Japan|Ehime University Hospital, Toon, Ehime, Japan|Fukui Prefectural Hospital, Fukui-shi, Fukui, Japan|Local Institution, Chikushino-shi, Fukuoka, Japan|Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan|Kurume University Hospital, Kurume-shi, Fukuoka, Japan|Sapporo-Kosei General Hospital, Sapporo-Shi, Hokkaido, Japan|Local Institution, Sapporo, Hokkaido, Japan|Sapporo Higashi Tokushukai Hospital, Sapporo, Hokkaido, Japan|Hyogo College of Medicine Hospital, Nishinomiya, Hyogo, Japan|Kitasato University Hospital, Sagamihara-shi, Kanagawa, Japan|National Hospital Organization Sendai Medical Center, Sendai, Miyagi, Japan|National Hospital Organization Nagasaki Medical Center, Omura-shi, Nagasaki, Japan|Urasoe General Hospital, Urasoe-Shi, Okinawa, Japan|Osaka University Hospital, Suita, Osaka, Japan|Shiga University of Medical Science Hospital, Otsu, Shiga, Japan|Hamamatsu University Hospital, Hamamatsu, Shizuoka, Japan|Tokyo Medical and Dental University, Medical Hospital, Bunkyo-ku, Tokyo, Japan|The Jikei University Hospital, Minato-ku, Tokyo, Japan|Hiroshima University Hospital, Hiroshima, Japan|National Hospital Organization Kyoto Medical Center, Kyoto, Japan|University of Miyazaki Hospital, Miyazaki, Japan|Saga University Hospital, Saga, Japan|Local Institution, Ansan-si, Korea, Republic of|Local Institution, Busan, Korea, Republic of|Local Institution, Daegu, Korea, Republic of|Local Institution, Daegu, Korea, Republic of|Local Institution, Incheon, Korea, Republic of|Local Institution, Seongnam-si, Korea, Republic of|Local Institution, Seoul, Korea, Republic of|Local Institution, Seoul, Korea, Republic of|Local Institution, Seoul, Korea, Republic of|Local Institution, Wonju-si, Korea, Republic of|Local Institution, Yangsan-si, Korea, Republic of|Centro de Investigacion en Gastroenterologia, Mexico, Distrito Federal, Mexico|Local Institution, Cuautitlan Izcalli, Estado DE Mexico, Mexico|Desarrollo Etico en Investigacion Clinica, Guadalajara, Jalisco, Mexico|JM Research - Cuernavaca, Cuernavaca, Morelos, Mexico|Cardiolink Clin Trials, Monterrey, Nuevo LEON, Mexico|SMIQ, Queretaro, Mexico|Local Institution, Amsterdam, Netherlands|Local Institution, Amsterdam, Netherlands|Local Institution, Groningen, Netherlands|Local Institution, Utrecht, Netherlands|NZOZ Centrum Medyczne KERmed, Bydgoszcz, Poland|Osrodek Badan Klinicznych Clinsante, Bydgoszcz, Poland|Krakowskie Centrum Medyczne, Krak, Poland|Uniwersytecki Szpital Kliniczny Number 1 im. Norberta Barlickiego, Lodz, Poland|Centrum Medyczne Szpital Swietej Rodziny, Lodz, Poland|Gastromed, Lublin, Poland|Osrodek Badan Klinicznych Allmedica, Nowy Targ, Poland|ETYKA Osrodek Badan Klinicznych, Olsztyn, Poland|Endoskopia, Sopot, Poland|Local Institution, Szczecin, Poland|H-T. Centrum Medyczne Spolka z Ograniczona Odpowiedzialnoscia, Tychy, Poland|Local Institution, Warszawa, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych i Administracji w Warszawie, Warszawa, Poland|Niepubliczny Zaklad Opieki Zdrowotnej VIVAMED Jadwiga Miecz, Warszawa, Poland|Wojskowy Instytut Medyczny, Warszawa, Poland|PlanetMed sp.z o.o., Wroclaw, Poland|Centrum Medyczne Oporow, Wroclaw, Poland|Local Institution, Wroclaw, Poland|Hospital da Senhora da Oliveira - Guimaraes, Guimaraes, Portugal|Centro Hospitalar de Entre o Douro e Vouga, Santa Maria da Feira, Portugal|Spitalul Universitar de Urgenta Bucuresti, Bucharest, Romania|Hyperclinica MedLife Grivita, Bucuresti, Romania|Local Institution, Bucuresti, Romania|Spitalul Clinic Colentina, Bucuresti, Romania|Centrul Medical Sana, Bucuresti, Romania|Cabinet Particular Policlinic Algomed, Timisoara, Romania|Centrul Medical Tuculanu, Timisoara, Romania|Local Institution, Barnaul, Russian Federation|Irkutsk Scientific Center, Irkutsk, Russian Federation|Local Institution, Kazan, Russian Federation|Republican Clinical Hospital Ministry of Health Republic of Tatarstan, Kazan, Russian Federation|Local Institution, Kemerovo, Russian Federation|City Clinical Hospital Number 24, Moscow, Russian Federation|Medical Center SibNovoMed, Novosibirsk, Russian Federation|Novosibirsk Gastrocenter, Novosibirsk, Russian Federation|Novosibirsk State Regional Clinical Hospital, Novosibirsk, Russian Federation|Medical Center Healthy Family, Novosibirsk, Russian Federation|Local Institution, Novosibirsk, Russian Federation|Local Institution, Omsk, Russian Federation|Local Institution, Pyatigorsk, Russian Federation|Local Institution, Rostov-on-Don, Russian Federation|Local Institution, Saint-Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Health City Hospital of the Holy Martyr Elizabeth, Saint-Petersburg, Russian Federation|Saratov Regional Clinical Hospital, Saratov, Russian Federation|Tomsk Regional Clinical Hospital, Tomsk, Russian Federation|Multidisciplinary Consultative and Diagnostic Center, Tyumen, Russian Federation|Local Institution, Velikij Novgorod, Russian Federation|Local Institution, Nitra, Slovakia|Local Institution, Sahy, Slovakia|Local Institution, Alicante, Spain|Local Institution, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain|Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain|Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain|Local Institution, LHospitalet de Llobregat, Spain|Local Institution, Manises, Spain|Local Institution, Sabadell, Spain|Hospital Universitario Marques de Valdecilla, Santander, Spain|Clinica Gaias-Santiago, Santiago De Compostelle, Spain|Local Institution, Sevilla, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Clinico Universitario de Valencia, Valencia, Spain|Local Institution, Lulea, Sweden|Local Institution, Stockholm, Sweden|Gastroenterologische Praxis Balsiger, Seibold & Partner Crohn-Colitis-Zentrum, Bern, Switzerland|Local Institution, Sankt Gallen, Switzerland|Local Institution, Kaohsiung, Taiwan|Local Institution, Taichung, Taiwan|Local Institution, Taipei City, Taiwan|Local Institution, Taipei, Taiwan|Local Institution, Taoyuan, Taiwan|Local Institution, Taoyuan, Taiwan|Local Institution, Kharkiv, Ukraine|Local Institution, Kiev, Ukraine|Local Institution, Kiyv, Ukraine|Local Institution, Lviv, Ukraine|Local Institution, Odesa, Ukraine|Local Institution, Sumy, Ukraine|Local Institution, Vinnytsia, Ukraine|Local Institution, Vinnytsya, Ukraine|Local Institution, Zaporozhzhya, Ukraine|Local Institution, Belfast, United Kingdom|Queen Elizabeth Hospital, Birmingham, United Kingdom|Local Institution, Birmingham, United Kingdom|Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom|Local Institution, Bury, United Kingdom|Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom|Warrington and Halton Hospitals NHS Foundation Trust, Cheshire, United Kingdom|Local Institution, Derby, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom|Local Institution, Harrow, United Kingdom|Local Institution, London, United Kingdom|Abertawe Bro Morgannwg University Health Board, Swansea, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03599622"
610,"NCT03555058","The CURE - CD Trial",,"Recruiting","No Results Available","CD - Crohn's Disease","Other: Treatment escalation","Rate of disease flares/complications in high-risk patients|Rate of disease flares/complications in low-risk patients|Rate of mucosal healing|Rate of disease flares/complications compared to a previous similar study","Sheba Medical Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","4945-18-SMC","July 3, 2018","July 2021","August 2023","June 13, 2018",,"October 22, 2020","Sheba_Medical_Center, Tel-Hashomer, Israel",,"https://ClinicalTrials.gov/show/NCT03555058"
611,"NCT03498625","Crohn's Disease Endoscopic REmission Definition in an Objective Way","CREDO1","Recruiting","No Results Available","CD","Diagnostic Test: Colonoscopy","Building an objective definition of the depth or grade of endoscopic remission in relation to what is observed during endoscopy in CD patients presenting with clinical remission|Intra- and inter-observer variability of what is observed during endoscopy in CD|Intra- and inter-observer variability of depth and grade of endoscopic remission in CD","Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives|AbbVie|Biogen|Celgene|Gilead Sciences|Roche Pharma AG|Takeda","All","18 Years and older   (Adult, Older Adult)","Not Applicable","240","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","GETAID 2017-001|2017-003345-15","March 13, 2018","December 31, 2021","December 31, 2021","April 17, 2018",,"June 30, 2021","Leuven University Hospital, Leuven, Belgium|APHP- Hopital BEAUJON, Clichy, France",,"https://ClinicalTrials.gov/show/NCT03498625"
612,"NCT03492944","Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason",,"Recruiting","No Results Available","Crohn Disease","Drug: Ultrasound Microbubble Contrast Agent|Device: Ultrasound Imaging","Degree of bowel wall enhancement|Overall Disease Status for imaged section|Degree of mesenteric inflammation|Maximum Bowel Wall Thickness","Children's Hospital Medical Center, Cincinnati","All","10 Years to 18 Years   (Child, Adult)",,"25","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CIN_Lumason Crohns_001","March 6, 2020","January 2022","June 2022","April 10, 2018",,"June 11, 2021","Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT03492944"
613,"NCT03481751","Validation and Interobserver Reliability of a Simple Ultrasound Score for Crohn's Disease",,"Active, not recruiting","No Results Available","Crohn Disease|Ultrasound","Diagnostic Test: Diagnostic test: Ultrasound","Remission","Haukeland University Hospital|Alesund Hospital|University Hospital of North Norway","All","18 Years to 75 Years   (Adult, Older Adult)",,"124","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2017/1750","January 8, 2018","December 20, 2020","December 20, 2020","March 29, 2018",,"April 7, 2020","Department of Medicine, Haukeland University Hospital, Bergen, Hordaland, Norway|Ålesund Hospital, Ålesund, Møre Og Romsdal, Norway|University Hospital of North Norway Tromsø, Tromsø, Troms, Norway",,"https://ClinicalTrials.gov/show/NCT03481751"
614,"NCT03467958","An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Drug: Ozanimod","Proportion of subjects with a CDAI score of < 150|Proportion of subjects with a simple endoscopy score (SES-CD) decrease from baseline of ≥ 50%|Proportion of subjects with average daily abdominal pain score ≤ 1 point, and average daily stool frequency ≤ 3 points with abdominal pain and stool frequency no worse than baseline|Proportion of subjects with CDAI reduction from baseline of ≥ 100 points or CDAI score of < 150|Proportion of subjects with absence of ulcers ≥ 0.5 cm with no segment with any ulcerated surface ≥ 10%|Proportion of subjects with CDAI reduction from baseline of ≥ 70 points|Change from baseline in CDAI|Proportion of subjects with CDAI reduction from baseline of ≥ 100 points or CDAI score of < 150 and SES-CD decrease from baseline of ≥ 50%|Proportion of subjects with CDAI score of < 150 and SES-CD ≤ 4 points and a SES-CD decrease ≥ 2 points|Proportion of subjects with average daily abdominal pain score ≤ 1 point and average daily stool frequency ≤ 3 points with abdominal pain and stool frequency no worse than baseline and SES-CD ≤ 4 points and a SES-CD decrease ≥ 2 points|Proportion of subjects with SES-CD ≤ 4 points and a SES-CD decrease ≥ 2 points|Proportion of subjects with a CDAI score < 150 in subjects off corticosteroids|Proportion of subjects with a Crohn's Disease Endoscopic Index of Severity (CDEIS) decrease from baseline of ≥ 50%|Proportion of subjects with a PCDAI score of ≤ 10 points","Celgene","All","12 Years to 75 Years   (Child, Adult, Older Adult)","Phase 3","1200","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","RPC01-3204|U1111-1203-8203|2017-004295-55","August 22, 2018","June 26, 2026","September 24, 2026","March 16, 2018",,"February 15, 2021","Holland Center for Family Health, Peoria, Arizona, United States|Elite Clinical Studies, LLC, Phoenix, Arizona, United States|HonorHealth Research Institute, Scottsdale, Arizona, United States|Arkansas Gastroenterology, P.A., North Little Rock, Arkansas, United States|Sharp Chula Vista Medical Center, Chula Vista, California, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, United States|Valley View Internal Medicine, Garden Grove, California, United States|UCSD Medical Center, La Jolla, California, United States|San Diego Clinical Trials, La Mesa, California, United States|OM Research, Lancaster, California, United States|Children's Hospital of Los Angeles, Los Angeles, California, United States|Southern California Research Institute Medical Group, Inc., Los Angeles, California, United States|Matrix Clinical Research Inc, Los Angeles, California, United States|Gastrointestinal Biosciences, Los Angeles, California, United States|VA Northern California Health Care System, Mather, California, United States|Facey Medical Foundation (Parent), Mission Hills, California, United States|ABS Health, LLC, Mission Viejo, California, United States|Alliance Clinical Research, Oceanside, California, United States|Palo Alto Center-Palo Alto Medical Foundation Research Institute, Palo Alto, California, United States|Havana Research Institute LLC, Pasadena, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Sutter Medical Group, Roseville, California, United States|UC Davis Health - Gastroenterology and Hepatology Clinical Trials Unit, Sacramento, California, United States|Medical Associates Research Group, San Diego, California, United States|University of California at San Francisco, San Francisco, California, United States|New Hope Research Development, West Covina, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Connecticut Clinical Research Foundation, Bristol, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Gastro Florida, Clearwater, Florida, United States|Clinical Research of West Florida, Clearwater, Florida, United States|South Lake Pain Institute, Clermont, Florida, United States|American Research Institute Inc, Cutler Bay, Florida, United States|Universal Axon Clinical Research, Doral, Florida, United States|Riverside Clinical Research, Edgewater, Florida, United States|University of Florida Health Endocrinology - Medical Specialties - Medical Plaza, Gainesville, Florida, United States|Qway Research LLC, Hialeah, Florida, United States|Floridian Clinical Research LLC, Hialeah, Florida, United States|Harmony Medical Research Institute, Hialeah, Florida, United States|The Center for Gastrointestinal Disorders, Hollywood, Florida, United States|Vista Health Research, Homestead, Florida, United States|SIH Research, Kissimmee, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|Pioneer Clinical Research, Lighthouse Point, Florida, United States|Center For Advanced Gastroenterology, Maitland, Florida, United States|Galiz Research LLC, Miami Springs, Florida, United States|LMG Research, Miami, Florida, United States|Nova Clinical Research Center LLC, Miami, Florida, United States|LCC Medical Research Institute, LLC, Miami, Florida, United States|Research Associates of South Florida LLC, Miami, Florida, United States|Life Medical Center & Research, Inc., Miami, Florida, United States|Vista Health Research, Miami, Florida, United States|Advanced Research for Health Improvement, Naples, Florida, United States|Bayside Clinical Research, New Port Richey, Florida, United States|NSB Research, New Smyrna Beach, Florida, United States|Omega Research Maitland, LLC, Orlando, Florida, United States|HMD Research LLC, Orlando, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Theia Clinical Research, LLC, Pinellas Park, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Precision Clinical Research, LLC., Sunrise, Florida, United States|University of South Florida, Tampa, Florida, United States|Apex Clinical Research, Tampa, Florida, United States|Guardian Angel Health Svcs Inc, Tampa, Florida, United States|Asclepes Research Centers, Weeki Wachee, Florida, United States|Consultative Gastroenterology, Atlanta, Georgia, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Emory Clinic, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, LLC, Atlanta, Georgia, United States|Children's Center for Digestive Healthcare, Atlanta, Georgia, United States|Gastrointestinal Disease Research, Columbus, Georgia, United States|Atlanta Center For Gastroenterology, P.C., Decatur, Georgia, United States|Gastroenterology Associates Of Central Georgia LLC, Macon, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|Rush University Medical Center - University Cardiovascular Surgeons, Chicago, Illinois, United States|Northwestern University, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|DM Clinical Research, Oak Lawn, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|MediSphere Medical Research Center, LLC, Evansville, Indiana, United States|Indiana University, Indianapolis, Indiana, United States|Iowa Digestive Disease Center, Clive, Iowa, United States|Cotton ONeil Clinical Research Center Digestive Health, Topeka, Kansas, United States|University of Kentucky Health Care, Lexington, Kentucky, United States|Gastroenterology Associates, LLC, Baton Rouge, Louisiana, United States|CroNOLA LLC, Houma, Louisiana, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Clinical Trials of SW Louisiana LLC, Lake Charles, Louisiana, United States|Tandem Clinical Research, LLC, Marrero, Louisiana, United States|Nola Research Works, New Orleans, Louisiana, United States|LSU Health Sciences Center Shreveport, Shreveport, Louisiana, United States|Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|Digestive Disease Associates, PA, Catonsville, Maryland, United States|Woodholme Gastroenterology Associates, Glen Burnie, Maryland, United States|Harvard Medical School - Boston Children's Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital - Crohn's and Colitis Center, Chestnut Hill, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States|Medex Research Institute, Caro, Michigan, United States|Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, United States|Henry Ford Medical Center - New Center One, Novi, Michigan, United States|Revive Research Institute, Southfield, Michigan, United States|University of Minnesota Medical Center, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Southern Therapy and Advanced Research, Jackson, Mississippi, United States|Mid America Gastrointestinal Consultants, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Internal Medicine Specialists, Las Vegas, Nevada, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Englewood Hospital and Medical Center, Englewood, New Jersey, United States|University of New Mexico Hospital, Albuquerque, New Mexico, United States|Advantage Clinical Trials, Bronx, New York, United States|NY Scientific, Brooklyn, New York, United States|Adirondack Medical Research Center, Glens Falls, New York, United States|Northwell Health, Great Neck, New York, United States|Drug Trials America, Hartsdale, New York, United States|Weill Cornell Medical College, New York, New York, United States|Concorde Medical Group, New York, New York, United States|Cornell University, New York, New York, United States|TrialSpark, New York, New York, United States|Lenox Hill Hospital, New York, New York, United States|DiGiovanna Institute for Medical Education And Research, North Massapequa, New York, United States|Circuit Clinical, Orchard Park, New York, United States|Asheville Gastroenterology Associates, P.A., Asheville, North Carolina, United States|Carolinas HealthCare System Digestive Health, Charlotte, North Carolina, United States|Internal Medicine Research, Charlotte, North Carolina, United States|PMG Research of Charlotte LLC, Charlotte, North Carolina, United States|Carolina Research Center, Greenville, North Carolina, United States|PMG Research of Winston-Salem LLC, Winston-Salem, North Carolina, United States|Great Lakes Medical Research, LLC, Beachwood, Ohio, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Cleveland Clinic - Taussig Cancer Institute, Cleveland, Ohio, United States|Advance Clinical Research - Dayton Internal Medicine, Dayton, Ohio, United States|Ohio State University Wexner Medical Center, Hilliard, Ohio, United States|Great Lakes Gastroenterology, Mentor, Ohio, United States|Paramount Medical Research & Consulting, LLC, Middleburg Heights, Ohio, United States|Great Lakes Medical Research, LLC, Warren, Ohio, United States|Cancer Care Associates of OK-N PorterAvenue, Norman, Oklahoma, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Digestive Disease Specialists, Oklahoma City, Oklahoma, United States|Allergy, Asthma and Immunology Center, PC, Tulsa, Oklahoma, United States|Central States Research, LLC, Tulsa, Oklahoma, United States|Oregon Health & Science University, Portland, Oregon, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|Penn State University Milton S Hershey Medical Center, State College, Pennsylvania, United States|Gastroenterology Associates of Orangeburg, Orangeburg, South Carolina, United States|Quality Medical Research, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Advanced Gastroenterology, Union City, Tennessee, United States|Avant Research Associates, LLC - Austin, Austin, Texas, United States|San Antonio Military Medical Center, Fort Sam Houston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Biopharma Informatic Inc. Research Center, Houston, Texas, United States|Centex Studies, Inc., Houston, Texas, United States|GI Specialists of Houston, Houston, Texas, United States|Premier Vein and Vascular Center, Houston, Texas, United States|The Coastal Medical Group, Houston, Texas, United States|Gulf Coast Research Group LLC, Houston, Texas, United States|Accurate Clinical Research Inc, Pasadena, Texas, United States|DHAT Research Institute, Richardson, Texas, United States|Sun Research Institute, San Antonio, Texas, United States|San Antonio Gastroenterology, San Antonio, Texas, United States|Texas Digestive Disease Consultants - Southlake, Southlake, Texas, United States|Baylor Scott and White Health, Temple, Texas, United States|Digestive Health Specialists of Tyler, Tyler, Texas, United States|University of Utah School of Medicine, Salt Lake City, Utah, United States|Gastroenterology Associates, PC, Gainesville, Virginia, United States|Blue Ridge Medical Research, Lynchburg, Virginia, United States|Summit Clinical Research, LLC, Petersburg, Virginia, United States|The Gastroenterology Group, Reston, Virginia, United States|McGuire Veterans Affairs Medical Center, Richmond, Virginia, United States|Carilion Clinic, Roanoke, Virginia, United States|Virginia Gastroenterology Institute PC, Suffolk, Virginia, United States|University of Washington Medical Center, Seattle, Washington, United States|Dermatologist Specialists of Spokane, Spokane, Washington, United States|Aurora Health Care Aurora Research, Grafton, Wisconsin, United States|Franciscan Skemp Healthcare, La Crosse, Wisconsin, United States|Sanatorio Guemes, Ciudad Autonoma de Buenos Aires, Argentina|Hospital Privado Centro Medico de Cordoba, Cordoba, Argentina|Instituto Medico de la Fundacion Estudios Clinicos, Rosario, Argentina|Universidad Nacional De Rosario - Hospital Provincial Del Centenario, Rosario, Argentina|Sanatorio 9 de Julio - CICE 9 de Julio, San Miguel de Tucuman, Argentina|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|Liverpool Hospital, Liverpool, New South Wales, Australia|John Hunter Hospital and Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia|Wollongong Hospital, Wollongong, New South Wales, Australia|Coastal Digestive Health, Maroorchydore, Queensland, Australia|University of the Sunshine Coast, North Mackay, Queensland, Australia|Mater Hospital Brisbane, South Brisbane, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|The Queen Elizabeth Hospital, Woodville South, South Australia, Australia|Monash Medical Centre, Clayton, Victoria, Australia|St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|Harry Perkins Medical Research Institute, Fiona Stanley Hospital, Murdoch, Western Australia, Australia|St John of God Subiaco Hospital, Subiaco, Western Australia, Australia|Ballarat Base Hospital, Ballarat, Australia|Medical University Innsbruck, Innsbruck, Austria|University Hospital St. Poelten, St Polten, Austria|Medical University Vienna, Vienna, Austria|Grodno City Clinical Hospital #4, Grodno, Belarus|Vitebsk Regional Clinical Specialized Center, Vitebsk, Belarus|Algemeen Ziekenhuis Klina, Brasschaat, Belgium|Universitair Ziekenhuis Brussel, Brussels, Belgium|University Hospital Brussels, Brussels, Belgium|CHU Saint-Luc, Brussels, Belgium|Queen Fabiola Children's University Hospital, Brussels, Belgium|Universitair Ziehenhuis Antwerpen, Edegem, Belgium|Universitair Ziekenhuis Gent, Ghent, Belgium|Universitair Ziekenhuis Leuven, Campus Gasthuisberg, Leuven, Belgium|Clinique du Montlegia, Liege, Belgium|Sart Tilman Hospital Department of Gastroenterology and Hepatology, Seraing, Belgium|Hospital Centre of Walloon Picarde, Tournai, Belgium|University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina|University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina|Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina|General Hospital ""Prim.dr. Abdulah Nakas"", Sarajevo, Bosnia and Herzegovina|Multiprofile Hospital for Active Treatment Medline, Plovdiv, Bulgaria|MHAT Ruse AD, Ruse, Bulgaria|Second MHAT Sofia AD, Sofia, Bulgaria|Excelsior Medical Center, Sofia, Bulgaria|Multiprofile Hospital for Active Treatment Tokuda Hospital Sofia, Sofia, Bulgaria|Diagnostic and Consulting Center Alexandrovska, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Sveti Ivan Rilski EAD, Sofia, Bulgaria|Diagnostic-Consultative Center Sveta Anna, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment ACIBADEM City Clinic Sofia, Sofia, Bulgaria|ACIBADEM City Clinic Medical Center Bregalnitsa, Varna, Bulgaria|University of Calgary Health - The Gastrointestinal Research Group (GIRG), Calgary, Alberta, Canada|West Edmonton Gastroenterology Consultants, Edmonton, Alberta, Canada|Okanagan Clinical Trials Ltd, Kelowna, British Columbia, Canada|Fraser Clinical Trials Inc., New Westminister, British Columbia, Canada|Vancouver Hospital Gastrointestinal Research Unit The Gordon and Leslie Diamond Centre, Vancouver, British Columbia, Canada|GI Research Institute, Vancouver, British Columbia, Canada|Brandon Medical Arts Clinic, Brandon, Manitoba, Canada|Winnipeg Clinic Dermatology Research, Winnipeg, Manitoba, Canada|Viable Clinical Research, Bridgewater, Nova Scotia, Canada|IWK Health Center, Halifax, Nova Scotia, Canada|London Health Sciences Centre, University Hospital, London, Ontario, Canada|LHSC Victoria Hospital, London, Ontario, Canada|Dr.Garisa Jagan Mohan Reddy MD, Sudbury, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Kensington Screening Clinic, Toronto, Ontario, Canada|Toronto Digestive Disease Associates Inc, Vaughan, Ontario, Canada|Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada|The Ottawa Hospital - General Campus, Ottawa, Quebec, Canada|Peking University First Hospital, Beijing, China|Peking University People's Hospital, Beijing, China|Beijing YouYi Hospital-Beijing Friendship Hospital Capital Medical University, Beijing, China|The Seventh Medical Center of PLA General Hospital, Beijing, China|First Hospital of Jilin University, Changchun, China|Guangzhou First People's Hospital, Guangzhou Shi, China|Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China|Anhui Provincial Hospital, Hefei, China|The First Affiliated Hospital of Nanchang University, Nanchang, China|Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China|Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China|China Medical University Hospital, Taichung City, China|Wuhan Union Hospital, Wuhan, China|Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China|Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou, China|The Second Affiliated Hospital Of Zhengzhou University, Zhengzhou, China|Clinical Hospital Center Osijek, Osijek, Croatia|Clinical Hospital Centre Rijeka, Rijeka, Croatia|Clinical Hospital Center Split, Split, Croatia|Clinical Hospital Center Sestre milosrdnice Clinic of Internal Diseases, Zagreb, Croatia|Clinical Hospital Dubrava, Zagreb, Croatia|University Hospital Centre Zagreb, Clinic of Internal Diseases, Zagreb, Croatia|Military Hospital Brno, Brno, Czechia|St. Anne's University Hospital Brno, Brno, Czechia|Hepato-Gastroenterologie HK, s. r. o., Hradec Králové, Czechia|Soukroma Gastroenterologicka ambulance a endoskopie, Most, Czechia|PreventaMed, Olomouc, Czechia|Krajská nemocnice Pardubice, Kožní oddelení, Pardubice, Czechia|University Hospital Pilsen, Plzen, Czechia|University Hospital Motol, Prague 5, Czechia|ISCARE, a.s., Prague 9, Czechia|Institut klinicke a experimentalni mediciny, Praha 4, Czechia|Bispebjerg Hospital, Copenhagen, Denmark|Holbaek Hospital, Holbaek, Denmark|Nykobing F Hospital, Nykobing F, Denmark|Helsinki University Central Hospital (HUCH), Helsinki, Finland|Turku University Hospital, Turku, Finland|CHU Amiens Picardie - Site Sud, Amiens cedex 1, France|Centre Hospitalier de Blois, Blois Cedex, France|Beziers Hospital, Béziers, France|University Hospital Center Caen, Caen, France|Assistance Publique - Hopitaux de Paris - Hopital Beaujon, Clichy, France|Louis Mourier Hospital, Colombes, France|Centre Hospitalier Intercommunal de Creteil, Creteil Cedex, France|CHU de Dijon Bourgogne - Hopital Francois Mitterand, Dijon Cedex, France|CHU de Grenoble Alpes, Grenoble Cedex 9, France|CHRU de Lille - Hopital Claude Huriez, Lillie Cedex, France|Hopital Nord, Marseille cedex 20, France|CHU Nantes University Hospital - Hotel Dieu Hospital, Nantes, France|South Lyon Hospital Center, Pierre-Benite, France|Hospital Pontchaillou, Rennes, France|CHU de Rouen Hopital Charles Nicolle, Rouen Cedex, France|Saint-Etienne University Hospital Center, Saint Priest en Jarez, France|CHU de Toulouse Hopital Rangueil, Toulouse Cedex 09, France|JSC Evex Medical Corporation - Batumi Referral Hospital, Batumi, Georgia|JSC Evex Medical Corporation - Oncology Center, Kutaisi, Georgia|Helsicore - Israeli Georgian Medical Research Clinic, Tbilisi, Georgia|LLC Vivamedi, Tbilisi, Georgia|Tbilisi State Medical University, Tbilisi, Georgia|LTD Institute of Clinical Cardiology, Tbilisi, Georgia|JSC Infectious Disease, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia|LTD Academician N.Kipshidze Central University Clinic, Tbilisi, Georgia|LTD Aversi Clinic, Tbilisi, Georgia|LTD MediClub Georgia, Tbilisi, Georgia|David Tatishvili Medical Center, Tbilisi, Georgia|JSC Evex Medical Corporation - Telavi Referral Hospital, Telavi, Georgia|Charite - Universitaetsmedizin Berlin, Berlin, Germany|Gastroenterological Special Practice at Wittenbergplatz, Berlin, Germany|Gastroenterology Am Bayerischen Platz, Berlin, Germany|Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany|Charite - Universitätsmedizin Berlin, Berlin, Germany|DRK Clinics Berlin, Berlin, Germany|Hospital Waldfriede e.V., Berlin, Germany|Brandenburg City Hospital, Brandenburg an der Havel, Germany|Medical Care Unit Dachau, Dachau, Germany|Klinikum Darmstadt, Darmstadt, Germany|Kliniken Essen-Mitte, Essen, Germany|Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany|Agaplesion Markus Krankenhaus, Frankfurt, Germany|Interdisciplinary Crohn Colitis Center Rhein Main, Frankfurt, Germany|Studiengesellschaft BSF, Halle, Germany|University Hospital Halle (Saale), Halle, Germany|University Hospital Hamburg-Eppendorf, Hamburg, Germany|Asklepios Klinik Hamburg, Hamburg, Germany|Universitatsklinikum Schleswig-Holstein, Keil, Germany|Universitaetsklinikum Leipzig AoeR, Leipzig, Germany|Practice for Gastroenterology and Internal Medicine, Ludwigshafen am Rhein, Germany|St Marien und St Annastiftskrankenhaus, Ludwigshafen am Rhein, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, Germany|University Hospital Muenster, Muenster, Germany|Synesis Research Center, Munich, Germany|Universitaetsklinikum Charite - Ruppiner Kliniken GmbH, Neuruppin, Germany|Robert-Bosch-Hospital, Stuttgart, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Germany|Universitaetsklinikum Ulm, Ulm, Germany|Laiko General Hospital of Athens, Athens, Greece|Sotiria Chest Diseases Hospital of Athens, Athens, Greece|Tzanio General Hospital of Piraeus, Athens, Greece|PAGNI University Hospital, Heraklion, Greece|General Hospital of Thessaloniki Hippokration, Thessaloniki, Greece|424th Army General Hospital, Thessaloniki, Greece|Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaz, Bekescsaba, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary|Semmelweis Egyetem - Altalanos Orvostudomanyi Kar, Budapest, Hungary|Petz Aladar Megyei Oktato Korhaz,II. Belgyogyaszat, Gyor, Hungary|CRU Hungary Kft, Miskolc, Hungary|Kanizsai Dorottya Hospital, Nagykanizsa, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Szekesfehervar, Hungary|Clinfan Ltd, Szekszárd, Hungary|Csongrad County Dr. Bugyi Istvan Hospital, Szentes, Hungary|Zala Megyei KorhazHaematologia, Zalaegerszeg, Hungary|St Vincent's University Hospital, Dublin 4, Dublin, Ireland|Beaumont Hospital, Dublin 9, Ireland|Institute of Gastroenterology and Hepatology at Ha'Emek Medical Center, Afula, Israel|Bat Yamon Medical Center, Clalit Medical Services, Bat Yam, Israel|Asaf Harofeh Medical Center, Beer Jacob, Israel|Rambam Health Care Campus, Haifa, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Clalit Health Services, Jerusalem, Israel|Meir Medical Center, Kfar-Saba, Israel|Galilee Medical Center, Nahariya, Israel|Rabin Medical Center, Petah Tikva, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Kaplan Medical Center, Rechovot, Israel|Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel|University Polyclinic Hospital of Bari, Bari, Italy|Polyclinic S. Orsola-Malpighi, Bologna, Italy|Civil Hospital of Brescia, Brescia, Italy|Poliambulanza Hospital, Brescia, Italy|IRCCS ""Savario De Bellis"", Castellana Grotte, Italy|University Hospital Mater Domini, Catanzaro, Italy|""Ss. Annunziata"" Policlinic of Chieti, Chieti, Italy|University Polyclinic Hospital G. Martino, Messina, Italy|Maggiore Polyclinic Hospital, IRCCS Ca' Granda, Milano, Italy|Humanitas Research Hospital - Humanitas Mirasole S.p.A, Milan, Italy|Azienda Socio Sanitaria Territoriale (ASST) di Monza, Monza, Italy|Hospital of Di Padova, Padova, Italy|United Hospitals Villa Sofia Cervello, Palermo, Italy|Polyclinic San Matteo IRCCS, Pavia, Italy|Polyclinic Tor Vergata, Roma, Italy|Univerisity Polyclinic Foundation Agostino Gemelli, Roma, Italy|Azienda Ospedaliera San Camillo Forlanini, Rome, Italy|Integrated University Hospital Santa Maria della Misericordia of Udine, Udine, Italy|A.O. Universitaria Fondazione Macchi, Varese, Italy|Sacred Heart Don Calabria, Verona, Italy|Korea University Medical Center - Korea University Ansan Hospital, Ansan, Korea, Republic of|Pusan National University Hospital, Busan, Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Yeungnam University Medical Center, Daegu, Korea, Republic of|Hanyang University Guri Hospital, Guri-si, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of|St. Vincent's Hospital, Suwon, Korea, Republic of|P. Stradins Clinical University Hospital, Riga, Latvia|Digestive Diseases Center Gastro, Riga, Latvia|Riga East Clinical University Hospital clinic Gailezers, Riga, Latvia|Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania|Klaipeda University Hospital, Klaipeda, Lithuania|Vilnius University Hospital Santariskes Clinics, Vilnius, Lithuania|Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania|Vilnius City Clinical Hospital, Vilnius, Lithuania|Investigacion Biomedica para el desarrollo de Farmacos, S.A. de C.V., Zapapan, Jalisco, Mexico|Centro Regiomontano de Estudios Clinicos Roma SC., Monterrey, Nuevo León, Mexico|Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Nuevo León, Mexico|SMIQ, Santiago de Queretaro, Querétaro, Mexico|Hospital Christus Muquerza del Parque S.A. de C.V., Chihuahua, Mexico|Centro de Investigacion Clinica Acelerada (CICA) S.C., Mexico, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Tlalpan, Mexico|""Sfanta Treime"" Clinical Municipal Hospital, Chisinau, Moldova, Republic of|Clinical Hospital of the Ministry of Health, Department of Endoscopic Surgery, Chisinau, Moldova, Republic of|""Sf. Arhanghel Mihail"" Municipal Clinical Hospital, Chisinau, Moldova, Republic of|Republican Clinical Hospital, Department of Colorectal Surgery, Chisinau, Moldova, Republic of|Republican Clinical Hospital, Chisinau, Moldova, Republic of|Vrije Universiteit Medisch Centrum (VUMC), Amsterdam, Netherlands|Academisch Medisch Centrum, Amsterdam, Netherlands|UMC Groningen, Groningen, Netherlands|Radboud University Medical Center, Nijmegen, Netherlands|Zuyderland Medisch Centrum, Sittard-Geleen, Netherlands|St. Elisabeth Ziekenhuis, Tilburg, Netherlands|Akershus University Hospital, Lørenskog, Norway|Lovisenberg Diakonale Sykehus, Oslo, Norway|SP ZOZ Wojewodzki Szpital Zespolony im. J. Sniadeckiego, Bialystok, Poland|Medical Services Center MaxMed, Bochnia, Poland|St. John Paul 2nd Municipal Hospital in Elblag, Elblag, Poland|Nicolaus Copernicus Hospital, Gdansk, Poland|Private Medical Practice Miroslaw Fic, Jelenia Gora, Poland|BioVirtus Medical Centre, Jozefow, Poland|Nzoz All-Medicus, Katowice, Poland|Kornel Gibinski Independent Public Central Clinical Hospital in Katowice, Katowice, Poland|GLOBE Clinical Research Sp. z o.o. LLC, Klodzko, Poland|PLEJADY Sp. z o.o. (LLC) Medical Centre, Krakow, Poland|Landa Specialist Doctor's Offices, Krakow, Poland|Krakow Medical Center LLC, Krakow, Poland|Centrum Opieki Zdrowotnej Orkan Med, Ksawerow, Poland|Santa Familia Centrum Badan, Profilaktyki i Leczenia, Lodz, Poland|Salve Limited Liability Company Limited Partnership, Outpatient Clinic, Lodz, Poland|LUX MED Centrum Medyczne - Lodz, Lodz, Poland|Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland|1 Military Clinical Hospital in Lublin, Lublin, Poland|Non-Public Healthcare Facility Allmedica Clinical Trials, Nowy Targ, Poland|Provincial Specialist Hospital in Olsztyn, Olsztyn, Poland|SOLUMED Medical Center, Poznan, Poland|Office of Bartosz Korczowski, MD, Rzeszow, Poland|Endoskopia Sp. z o.o., Sopot, Poland|TWOJA PRZYCHODNIA Medical Centre of Szczecin LLC, Szczecin, Poland|GASTROMED Kopon, Zmudzinski and Partners Specialist Centre for Gastroenterology and Endoscopy, Spe, Torun, Poland|H-T. Medical Center Sp. z o.o. LLC Limited Partnership, Tychy, Poland|Polimedica, Ul. Piotrkowska 177, Poland|Maternal Pediatric and Adolescent Healthcare Centre, Warsaw, Poland|WIP Warsaw IBD Point, Warsaw, Poland|PRIMA LCC Specialist Clinics, Warsaw, Poland|Children's Memorial Health Institute, Warsaw, Poland|Endoterapia PFG LLC, Endotherapy PFG Outpatient Clinic Branch No 1, Warszawa, Poland|Niepubliczny Zaklad Opieki Zdrowotnej VIVAMED, Warszawa, Poland|Health Centre Metabolic Diseases Outpatient Clinic in Wierzchoslawice, Wierzchoslawice, Poland|LUX MED Centrum Medyczne - Wroclaw, Wroclaw, Poland|Wroclaw Medical University, Wroclaw, Poland|Jan Mikulicz Radecki University Hospital, Wroclaw, Poland|Clinical Research Center Early-Phase Research Facility, Wroclaw, Poland|LexMedica, Wroclaw, Poland|Ars Medica, Wroclaw, Poland|EMC Medical Institute S.A, Wroclaw, Poland|Hospital Universitario de Coimbra- Hospitais de Universidade de Coimbra, Coimbra, Portugal|Centro Hospitalar do Alto Ave, Hospital da Senhora da Oliveira Guimaraes, Guimaraes, Portugal|Hospital Beatriz Angelo, Loures, Portugal|Centro Hospitalar do Alto Minho - Unidade Local de Saúde do Alto Minho, EPE, Viana do Castelo, Portugal|Hyperclinica MedLife Grivita, Bucharest, Romania|Center of Diagnosis and Treatment Provita, Bucharest, Romania|Fundeni Clinical Institute, Bucharest, Romania|Bucharest University Emergency Hospital, Department of Internal Medicine II, Bucharest, Romania|Dr. Carol Davila Central Military Emergency Clinical Hospital, Bucharest, Romania|Craiova County Emergency Clinical Hospital, Craiova, Romania|Colentina Clinical Hospital, Napoca, Romania|Targu Mures County Emergency Clinical Hospital, Targu Mures, Romania|Joint Venture Company Diagnostic Center, Bioterm Ltd., Barnaul, Russian Federation|Territorial Clinical Hospital, Barnaul, Russian Federation|Regional Clinical Hospital #3, Chelyabinsk, Russian Federation|Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russian Federation|Chita State Medical Academy, Chita, Russian Federation|Ural State Medical Academy - Medical Association Novaya Bolnitsa, Ekaterinburg, Russian Federation|Irkutsk State Medical Academy of Postgraduate Education, Irkutsk, Russian Federation|Immanuel Kant Baltic Federal University, Kaliningrad, Russian Federation|Kaluga Regional Hospital, Kaluga, Russian Federation|City Clinical Hospital No 7 - Kazan, Kazan, Russian Federation|S.V. Beliaev Kemerovo Regional Clinical Hospital, Kemerovo, Russian Federation|Regional Clinical Hospital, Khanty-mansiysk, Russian Federation|Federal Siberian Research and Clinical Center, Krasnoyarsk, Russian Federation|Moscow Clinical Scientific and Practical Center, Moscow, Russian Federation|City Clinical Hospital n.a. V.M. Buyanov, Moscow, Russian Federation|City Clinical Hospital 24, Moscow, Russian Federation|CJSC Nasledniki, Moscow, Russian Federation|A.N. Ryzhikh State Research Center for Coloproctology, Moscow, Russian Federation|Railway Station Clinical Hospital, Nizhny Novgorod, Russian Federation|Novosibirskiy Gastrocenter, Novosibirsk, Russian Federation|Medical Center Sibnovomed LLC, Novosibirsk, Russian Federation|Scientific Research Institute of Physiology and Basic Medicine, Novosibirsk, Russian Federation|Euromed Multi-Specialty Center for Contemporary Medicine LLC, Omsk, Russian Federation|Medical Diagnostic Center LLC, Orenburg, Russian Federation|N.N. Burdenko Penza Regional Clinical Hospital, Penza, Russian Federation|Republican Hospital na VA Baranov, Petrozavodsk, Russian Federation|Evromedservis, Pushkin, Russian Federation|Clinic UZI 4D, LLC, Pyatigorsk, Russian Federation|Pyatigorsk City Hospital 2, Pyatigorsk, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|Medical Center Reavita Med Spb LLC, Saint Petersburg, Russian Federation|City Clinical Hospital No 31 - St. Petersburg, Saint Petersburg, Russian Federation|S.M. Kirov Military Medical Academy, Saint-Petersburg, Russian Federation|Medical University REAVIZ, Samara, Russian Federation|Samara Station Railway Clinical Hospital under OAO Russian Railways, Samara, Russian Federation|Regional Clinical Hospital, Saratov, Russian Federation|Sochi City Hospital No 5, Sochi, Russian Federation|S.M. Kirov Military Medical Academy, St Petersburg, Russian Federation|Oncology Center of Moskovskiy District, St Petersburg, Russian Federation|City Outpatient Care Unit No 38, St. Petersburg, Russian Federation|I.I. Mechnikov North-Western State Medical University, St. Petersburg, Russian Federation|State Unitary Enterprise Passengeravtotrans, St. Petersburg, Russian Federation|Clinical and Diagnostic Center with an outpatient department under the Presidential Executive Office, St. Petersburg, Russian Federation|SPb SBIH City Hospital of Saint Martyr Elizaveta, St. Petersburg, Russian Federation|Medical Center Eko-Bezopasnost LLC, St. Petersburg, Russian Federation|Budget Institution of the Khanty-Mansiysk Autonomous Okrug - Ugra Surgut Regional Clinical Hospital, Surgut, Russian Federation|Tomsk Regional Clinical Hospital, Tomsk, Russian Federation|Tula Regional Clinical Hospital, Tula, Russian Federation|G.G. Kuvatov Republican Clinical Hospital, Ufa, Russian Federation|City Clinical Hospital #21, Ufa, Russian Federation|Ulyanovsk Regional Clinical Hospital, Ulyanovsk, Russian Federation|Novgorod Regional Clinical Hospital, Veliky Novgorod, Russian Federation|Regional Clinical Hospital, Vladimir, Russian Federation|Primorsky Regional Clinical Hospital No.1, Vladivostok, Russian Federation|Medical Center of Far-Eastern Federal University, Vladivostok, Russian Federation|Medical Scientific Manufacturing Association Dvizheniye Clinic, Volgograd, Russian Federation|King Fahad Specialist Hospital, Dammam, Saudi Arabia|King Abdul Aziz University Hospital, Jeddah, Saudi Arabia|King Saud Medical Complex, Riyadh, Saudi Arabia|King Fahad National Guard Hospital, Riyadh, Saudi Arabia|Clinical Hospital Center Bezanijska Kosa, Clinic of Internal Medicine, Belgrade, Serbia|Clinical Hospital Center - Dr. Dragisa Misovic-Dedinje, Belgrade, Serbia|Clinical Hospital Center Zvezdara Clinic of Internal Diseases, Belgrade, Serbia|Military Medical Academy, Clinic of Gastroenterology and Hepatology, Belgrade, Serbia|Clinical Center Kragujevac, Kragujevac, Serbia|Clinical Center of Vojvodina, Clinic of Gastroenterology and Hepatology, Novi Sad, Serbia|General Hospital Pancevo, Pancevo, Serbia|General Hospital Djordje Jovanovic Zrenjanin, Zrenjanin, Serbia|Cliniq, s.r.o., Bratislava, Slovakia|Univerzitna nemocnica Bratislava, Nemocnica Ruzinov, Bratislava, Slovakia|Brezno gastroenterology center s.r.o., Brezno, Slovakia|KM Management, spol. s r.o., Nitra, Slovakia|Gastromedic s.r.o., Nove Zamky, Slovakia|GASTRO I., s.r.o., Presov, Slovakia|World of the Health Inc. General Hospital Rimavska Sobota, Rimavska Sobota, Slovakia|General Hospital Celje, Celje, Slovenia|Ahmed Kathrada Private Hospital, Gauteng, South Africa|Emmed Research, Pretoria, South Africa|General University Hospital of Alicante, Alicante, Spain|University Hospital Germans Trias i Pujol, Badalona, Spain|Teknon Medical Center, Barcelona, Spain|University Hospital Reina Sofia, Cordoba, Spain|University Hospital of Girona Dr. Josep Trueta, Girona, Spain|University Hospital of the Canary Islands (HUC) La Laguna, La Laguna, Spain|Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain|University Hospital de La Princesa, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|University Hospital La Paz, Madrid, Spain|University Hospital Puerta de Hierro Majadajonda, Majadahonda, Madrid, Spain|University Hospital Marques de Valdecilla (HUMV), Santander, Spain|University Hospital Virgen Macarena, Sevilla, Spain|University Hospital Virgen del Rocio, Sevilla, Spain|University Clinical Hospital of Valencia, Valencia, Spain|Viladecans Hospital, Viladecans, Spain|University Hospital Miguel Servet, Zaragoza, Spain|Saint Goran Hospital, Stockholm, Sweden|Ersta Hospital, Stockholm, Sweden|Lindenhofspital, Bern, Switzerland|Cantonal Hospital Saint Gallen, St.Gallen, Switzerland|University Hospital Zurich, Zurich, Switzerland|Kaohsiung Medical University Hospital, Kaohsiung, San Ming Dist., Taiwan|E-DA Hospital, Kaohsiung, Taiwan|Bulent Ecevit Universitesi Uygulama ve Arastirma Hastanesi, Kozlu, Taiwan|Chang Gung Medical Foundation, Kaohsiung Memorial Hospital, Niao-Sung Hsiang Kaohsiung County, Taiwan|National Cheng Kung University Hospital, Tainan, Taiana, Taiwan|Chang Gung Memorial Hospital- Linkou, Taoyuan City, Taiwan|Taipei Veterans General Hospital, Tapei, Beitou Dist., Taiwan|National Taiwan University Hospital, Tapei, Taiwan|Hacettepe Universitesi, Ankara, Turkey|Ankara University Medical Faculty Cebeci Hospital, Ankara, Turkey|Uludag Universitesi Tip Fakultesi, Bursa, Turkey|Firat University Medical Faculty, Elazig, Turkey|Bezmialem Foundation University Medical Faculty, Istanbul, Turkey|Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey|Sultan Abdulhamid Han Egitim ve Arastirma Hastanesi, Istanbul, Turkey|Marmara University, Istanbul, Turkey|Istanbul Medeniyet Uni Goztepe Training&Res Hosp, Istanbul, Turkey|Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Kadiköy/Istanbul, Turkey|Karadeniz Teknik Universitesi Tip Fakultesi Farabi Hastanesi, Trabzon, Turkey|Chernivtsi Regional Clinical Hospital, Chernivtsi, Ukraine|Chernivtsi Regional Clinical Hospital, Chernivtsi, Ukraine|Dnipropetrovsk II Mechnykov Regional Clinical Hospital Surgery Department 2, Dnipropetrovsk, Ukraine|Si Institute Of Gastroenterology Of Namsu Dept Of Stomach And Duodenum Diseases, Dnipropetrovsk, Ukraine|Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, Ukraine|Ivano-Frankivsk Central City Clinical Hospital, Ivano-Frankivsk, Ukraine|V.T. Zaitsev Institute of General and Emergency Surgery, Kharkiv, Ukraine|Kharkiv City Clinical Hospital 2, Kharkiv, Ukraine|Khmelnytskyi Regional Hospital, Khmelnytskyi, Ukraine|Medical and Diagnostic Center Acinus, Kropyvnytskyi, Ukraine|Medical Center Medical Clinic Blagomed LLC, Kyiv, Ukraine|Kyiv City Clinical Hospital #18, Kyiv, Ukraine|Kyiv City Clinical Hospital #18, Kyiv, Ukraine|BIK-KYIV Ukrainian German Gastroenterology Center, Kyiv, Ukraine|Medical Center Consilium Medical, Kyiv, Ukraine|Ok Clinic Medical Center within International Institute of Clinical Trials, LLC, Kyiv, Ukraine|Kyiv Regional Hospital #2, Kyiv, Ukraine|Kyiv Regional Clinical Hospital, Kyiv, Ukraine|Volyn Regional Clinical Hospital, Lutsk, Ukraine|Lviv Regional Clinical Hospital, Lviv, Ukraine|Public City Clinical Hospital of Emergency Medical Care, Lviv, Ukraine|Odesa Regional Clinical Hospital Regional Gastroenterology Center Surgery Department, Odesa, Ukraine|Poltava M.V. Sklifosovskyi Regional Clinical Hospital under Poltava Regional Council, Poltava, Ukraine|Ternopil City Public Emergency Medical Care Hospital, Ternopil, Ukraine|Vinnytsia City Clinical Hospital #1, Vinnytsia, Ukraine|Vinnytsia M.I. Pyrohov Regional Clinical Hospital, Vinnytsia, Ukraine|Health Clinic, LLC, Vinnytsya, Ukraine|Multidisciplinary Clinic of the St. Nicholas, LLC, Zaporizhia, Ukraine|Zaporizhzhya Regional, Zaporizhzhya, Ukraine|First Private Clinic, Zhytomyr, Ukraine|Bristol Royal Infirmary, Bristol, United Kingdom|Ulster Hospital, Dundonald, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom|Victoria Hospital Blackpool, Lancashire Blackpool, United Kingdom|Royal London Hospital, London, United Kingdom|University College London Hospitals NHS Foundation Trust - University College Hospital, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital, London, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom|Royal Shrewsbury Hospital, Shrewsbury, United Kingdom|University Hospital Southampton NHS Foundation Trust - Southampton General Hospital, Southampton, United Kingdom|Torbay Hospital, Torquay, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03467958"
615,"NCT03466411","A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease","GALAXI","Recruiting","No Results Available","Crohn's Disease","Drug: Guselkumab Dose 1|Drug: Guselkumab Dose 2|Drug: Guselkumab Dose 3|Drug: Guselkumab Dose 4|Drug: Guselkumab Dose 5|Drug: Guselkumab|Drug: Ustekinumab|Drug: Placebo","Phase 2: Change from Baseline in the Crohn's Disease Activity Index (CDAI) Score at Week 12|Phase 3: Clinical Remission at Week 12|Phase 3: Endoscopic Response at Week 12|Phase 2: Clinical Remission at Week 12|Phase 2: Clinical Response at Week 12|Phase 2 and Phase 3: Patient-Reported Outcome (PRO)-2 Remission at Week 12|Phase 2: Clinical-Biomarker Response at Week 12|Phase 2: Endoscopic Response at Week 12|Phase 3: Clinical Remission at Week 48|Phase 3: Endoscopic Response at Week 48|Phase 3: Durable Clinical Remission at Week 48|Phase 3: Corticosteroid-Free Clinical Remission at Week 48|Phase 3: PRO-2 Remission at Week 48|Phase 3: Endoscopic Remission at Week 12|Phase 3: Endoscopic Remission at Week 48|Phase 3: Fatigue Response at Week 12","Janssen Research & Development, LLC","All","18 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","2000","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","CR108387|2017-002195-13|CNTO1959CRD3001","April 13, 2018","June 3, 2022","February 28, 2025","March 15, 2018",,"June 9, 2021","University of Arizona, Tucson, Arizona, United States|Advanced Research Center Inc, Anaheim, California, United States|University Of California San Diego, La Jolla, California, United States|Om Research LLC, Lancaster, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|UC Davis Medical Center, Sacramento, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|InvesClinic, LLC, Fort Lauderdale, Florida, United States|Harmony Medical Research Institute, Inc., Hialeah, Florida, United States|Elite Research Network - Nature Coast Clinical Research, LLC, Inverness, Florida, United States|University of Florida, Jacksonville, Florida, United States|SIH Research, Kissimmee, Florida, United States|Visionary Investigators Network, Miami, Florida, United States|Florida Hospital, Orlando, Florida, United States|Synexus Clinical Research US, Inc, Orlando, Florida, United States|Synexus Clinical Research US, Inc, Pinellas Park, Florida, United States|Theia Clincial Research, LLC, Pinellas Park, Florida, United States|Clinical Research of West Florida, Tampa, Florida, United States|Florida Hospital Tampa, Tampa, Florida, United States|Cleveland Clinic Florida, Weston, Florida, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Atlanta Center For Gastroenterology, Decatur, Georgia, United States|Gastrointestinal Specialists of Georgia, Marietta, Georgia, United States|Gastroenterology Consultants, Roswell, Georgia, United States|Atlanta Gastroenterology Specialists PC, Suwanee, Georgia, United States|Carle Foundation Hospital, Urbana, Illinois, United States|IU Health University Hospital, Indianapolis, Indiana, United States|Health Science Research Center, Pratt, Kansas, United States|Robley Rex VAMC, Louisville, Kentucky, United States|Gastroenterology Associates, Baton Rouge, Louisiana, United States|Gastroenterology Clinic of Acadiana, Lafayette, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|DelRicht Research, New Orleans, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Harvard Medical School-Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Associated cardiology, Saginaw, Michigan, United States|Huron Gastroenterology Associates Center for Digestive Care, Ypsilanti, Michigan, United States|Minnesota Gastroenterology, P.A, Minneapolis, Minnesota, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|Atlantic Digestive Health Institute/ Atlantic IBD Center, Morristown, New Jersey, United States|A1 Clinical Research, Jackson Heights, New York, United States|Weill Cornell Medical College, New York, New York, United States|NYU Langone Medical Center, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Syracuse VA Medical Center, Syracuse, New York, United States|Asheville Gastroenterology Associates, Asheville, North Carolina, United States|University North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Cumberland Research Associates, Fayetteville, North Carolina, United States|Carolina Research, Greenville, North Carolina, United States|PMG Research of Winston-Salem, Winston-Salem, North Carolina, United States|Wexner Medical Center at the Ohio State University, Columbus, Ohio, United States|Synexus Clinical Research US, Inc, Columbus, Ohio, United States|Integris Baptist Office, Oklahoma City, Oklahoma, United States|Drexel University College of Medicine, Philadelphia, Pennsylvania, United States|Guthrie Medical Group, PC, Sayre, Pennsylvania, United States|LifeSpan Hospital System, Providence, Rhode Island, United States|Synexus Clinical Research US, Inc, Anderson, South Carolina, United States|Clinical Trials of South Carolina, Charleston, South Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Aztec Clinical Research, Inc., Channelview, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Memorial Hermann Hospital - TMC, Houston, Texas, United States|Biopharma Informatic Research Center, Houston, Texas, United States|CliniCore Houston, Houston, Texas, United States|BI Research Center, Houston, Texas, United States|DHAT Research Institute, Richardson, Texas, United States|Gastroenterology Research of America, LLC, San Antonio, Texas, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|Baylor Scott & White Research Institute, Temple, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Victoria Gastroenterology, Victoria, Texas, United States|Val Hansen, Bountiful, Utah, United States|University of Virginia, Charlottesville, Virginia, United States|Gastroenterology Associates of Tidewater, Chesapeake, Virginia, United States|Center for Gastrointestinal Health, Petersburg, Virginia, United States|Clinical Research Partners, LLC, Richmond, Virginia, United States|Gastroenterology Consultants of Southwest Virginia, Roanoke, Virginia, United States|University of Washington, Seattle, Washington, United States|The Queen Elizabeth Hospital, Adelaide, Australia|Monash Health, Monash Medical Centre, Clayton, Australia|Concord Hospital, Concord, Australia|Austin Hospital, Heidelberg, Australia|Royal Brisbane and Women's Hospital, Herston, Australia|Sir Charles Gairdner Hospital, Nedlands, Australia|Royal Adelaide Hospital, North Terrace, Australia|Royal Melbourne Hospital, Parkville, Australia|Nepean Hospital, Penrith, Australia|The Alfred Hospital, Prahran, Australia|Mater Hospital Brisbane, South Brisbane, Australia|Princess Alexandra Hospital, Woolloongabba, Australia|Krankenhaus der Elisabethinen Linz, Linz, Austria|Universitätsklinikum Salzburg - Landeskrankenhaus, Salzburg, Austria|Akh Wien, Wien, Austria|Gomel Regional Clinical Hospital, Gomel, Belarus|Republican Research Centre of Radiation Medicine and Human E, Gomel, Belarus|Grodno University Hospital, Grodno, Belarus|BelMAPE, Minsk, Belarus|City Clinical Hospital #9, Minsk, Belarus|Vitebsk Regional Clinical Hospital, Vitebsk, Belarus|GZA Ziekenhuizen, Antwerpen, Belgium|CHU Saint-Pierre, Bruxelles, Belgium|Hopital Erasme, Bruxelles, Belgium|UZ Gent, Gent, Belgium|Az Groeninge, Kortrijk, Belgium|Centre Hospitalier De Mouscron, Mouscron, Belgium|Algemeen Ziekenhuis Delta, Roeselare, Belgium|CHwapi, Tournai, Belgium|University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina|Clinical hospital Mostar, Mostar, Bosnia and Herzegovina|Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina|Polyclinic Dr. Al-Tawil, Sarajevo, Bosnia and Herzegovina|Kantonalna bolnica Zenica, Zenica, Bosnia and Herzegovina|MK Blumenau Pesquisa Clínica, Blumenau, Brazil|Universidade Estadual Paulista 'Julio De Mesquita Filho', Botucatu, Brazil|L2IP - Instituto de Pesquisas Clínicas, Brasília, Brazil|Centro Digestivo de Curitiba - Instituto de Pesquisa Clínica, Curitiba, Brazil|Hospital Nossa Senhora Das Gracas, Curitiba, Brazil|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva, Goiania, Brazil|Hospital Universitrio Santa Terezinha, Joaaba, Brazil|Hospital de Clínicas de Porto Alegre/ HCPA / UFRGS, Porto Alegre, Brazil|Hospital Ernesto Dornelles, Porto Alegre, Brazil|UFRJ-Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil|Bioclinica Inc. Research Network, Rio de Janeiro, Brazil|Pesquisare Saude, Santo Andre, Brazil|Praxis pesquisa médica, Santo André, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clínicos, Santo André, Brazil|Fundacao Faculdade Regional De Medicina De Sao Jose Do Rio Preto, Sao Jose do Rio Preto, Brazil|Hemomed, Sao Paulo, Brazil|CEP - Hospital das Clinicas da FMUSP, Sao Paulo, Brazil|Kaiser Hospta, São José Do Rio Preto, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil|University of Calgary, Calgary, Alberta, Canada|Gastroenterology and Internal Medicine Research Institute (GIRI), Edmonton, Alberta, Canada|Columbia Gastroenterology, New Westminster, British Columbia, Canada|Health Sciences Centre, Winnipeg, Manitoba, Canada|QEII Health Sciences Centre, Helifax, Nova Scotia, Canada|London Health Sciences Centre, London, Ontario, Canada|Ottawa Hospital, Ottawa, Ontario, Canada|Mount Sinai Hospital-Toronto, Toronto, Ontario, Canada|Toronto Digestive Disease Associates Inc, Vaughan, Ontario, Canada|MUHC Center for Applied Ethics, Montreal, Quebec, Canada|GI Research Institute (G.I.R.I.), Edmonton, Canada|University of Alberta- Ziedler Ledcor Centre, Edmonton, Canada|Instituto Oncologico Viña del Mar, Viña del Mar, Chile|Peking University First Hospital, Beijing, China|Peking University People's Hospital, Beijing, China|Beijing Friendship Hospital, Beijing, China|Peking University Third Hospital, Beijing, China|The Military General Hospital of Beijing PLA, Beijing, China|The second Xiangya Hospital of Central South University, Changsha, China|West China Hospital, Sichuan University, Chengdu, China|The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China|First Affiliated Hospital of Gannan Medical University, Ganzhou, China|Chongqing Qijiang People Hospital, Guangzhou, China|Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China|ZhuJiang Hospital of Southern Medical University, Guangzhou, China|Sun Yat-sen University - The Sixth Affiliated Hospital Guangdong Gastrointestinal Hospital, Guangzhou, China|The Second Affiliated Hospital of Zhejiang University, Hangzhou, China|Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China|The 1st affiliated hospital of Anhui Medical University, Hefei, China|First Affiliated Hospital of Kunming Medical Unversity, Kunming, China|The First Affiliated Hospital of NanChang University, Nanchang, China|Nanjing Drum Tower Hospital, Nanjing, China|Zhongda Hospital,Southeast University, Nanjing, China|Shanghai Ninth People's Hospital, Shanghai, China|Huashan Hospital Fudan University, Shanghai, China|Shanghai 10th Peoples Hospital, Shanghai, China|Shanghai General Hospital, Shanghai, China|Shanghai East Hospital, Shanghai, China|Shanghai Renji Hospital, Shanghai, China|Second Military Medical University (SMMU), Shanghai, China|Tongji Hospital of Tongji University, Shanghai, China|Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, China|The first hospital of China medical university, Shenyang, China|Peking University Shenzhen Hospital, Shenzhen, China|University of Hong Kong-Shenzhen Hospital, Shenzhen, China|The first affiliated hospital of suzhou University, Suzhou, China|The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China|Wuhan Union Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Zhongshan Hospital, Xiamen University, Xiamen, China|Yangzhou First People's Hospital, Yangzhou, China|Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou, China|Medplus Medicina Prepagada S.A., Bogota, Colombia|Clinica de la Mujer, Bogota, Colombia|Endocare Ltda., Bogota, Colombia|Centro Médico Imbanaco, Cali, Colombia|Corporacion para Estudios en Salud Clinica CES - Gastroenterology, Medellin, Colombia|Hospital Pablo Tobon Uribe, Medellin, Colombia|Instituto De Coloproctologia Ico S.A.S, Medellin, Colombia|Klinički bolnički centar Osijek, Osijek, Croatia|Opca bolnica Zadar, Zadar, Croatia|CH Sestre Milosrdnice, Zagreb, Croatia|University Hospital Center Zagreb, Zagreb, Croatia|University Hospital Dubrava, Zagreb, Croatia|NH Hospital, a.s., Horovice, Czechia|FN Hradec Kralove, Hradec Kralove, Czechia|Hepato-gastroenterologie HK, s.r.o., Hradec Kralove, Czechia|Fakultni nemocnice Ostrava, Ostrava - Poruba, Czechia|Synexus Czech s.r.o., Prague 2, Czechia|Fakultni nemocnice Kralovske Vinohrady, Praha 10, Czechia|Klinicke centrum ISCARE, Praha 7, Czechia|CHU Amiens, Amiens, France|Hôpital Besançon, Besançon, France|Centre Hospitalier Universitaire (CHU) de Caen, Caen, France|CHRU de Tours - Hopital Trousseau, Chambray Les Tours Centre, France|CHU Clermont-Ferrant-Hopital Hotel Dieu, Clermont-Ferrand Cedex 3, France|Hopitaux Universitaires Paris Nord Val de Seine - Hopital Beaujon, Clichy-Sous-Bois, France|Hopital Louis Mourier, Colombes Cedex, France|CHRU de Lille - Hôpital Claude Huriez, Lille, France|Aphm - Hopital Nord, Marseille, France|APHM Hopital Timone, Marseille, France|CHRU Montpellier - Hopital Saint-Eloi, Montpellier Cedex 5, France|CHU de Nantes hôtel-Dieu, Nantes, France|CHU de Nice Hopital de l Archet, Nice cedex 03, France|Hôpital Saint Louis, Paris, France|Groupement Hospitalier Universitaire Ouest, Paris, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, France|Hôpital Robert Debré, Reims, Cedex, France|CHU Saint-etienne, Saint Etienne, France|Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre, Strasbourg Cedex, France|CHU Rangueil, Toulouse, France|Hopital Purpan, Toulouse, France|CHU de Nancy_ Hôpital Brabois, Vandoeuvre-les-Nancy, France|LTD 'Aversi Clinic', T'bilisi, Georgia|TSMU The First University Clinic, Tbilisi, Georgia|Institute of Clinical Cardiology, Ltd., Tbilisi, Georgia|LTD 'Georgia Archangel St. Michael Multiprofile Clinical Hospital', Tbilisi, Georgia|Ltd Central University Clinic by Academician N.Kipshidze, Tbilisi, Georgia|Ltd Medison Holding, Tbilisi, Georgia|Israel Georgian medical research clinic Helsicore, Tbilisi, Georgia|LTD Unimed Kakheti- Telavi Referral Hospital, Telavi, Georgia|Klinikum Augsburg, Augsburg, Germany|Gastroenterologische Spezialpraxis - Berlin-Karlshorst, Berlin-Karlshorst, Germany|Charité - Campus Mitte, Berlin, Germany|Universitaetsklinikum Charite, Campus Virchow Klinikum, Berlin, Germany|Vivantes Klinikum Spandau, Berlin, Germany|Krankenhaus Waldfriede Mitte, Berlin, Germany|Universitatsklinikum Bonn, Bonn, Germany|Klinikum Dresden, Dresden, Germany|Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus, Frankfurt/Main, Germany|Synexus Clinical Research GmbH, Frankfurt, Germany|JWG-University Hospital, Frankfurt, Germany|Martin-Luther-Universitaet Halle-Wittenberg - Universitaetsk, Halle, Germany|Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf Urologie, Hamburg, Germany|Asklepios Westklinikum, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitaetsklinikum Heidelberg, Heidelberg, Germany|Universitatsklinikum Schleswig-Holstein - Kiel, Kiel, Germany|Eugastro GmbH, Leipzig, Germany|Gastroenterologie und Hepatologie am Johannisplatz, Leipzig, Germany|Gemeinschaftspraxis Germania-Campus, Münster, Germany|Praxiszentrum Alte Mälzerei, Regensburg, Germany|Universitätsklinikum Ulm, Ulm, Germany|Laiko General Hospital of Athens, Athens, Greece|University Hospital of Heraklion, Heraklion, Greece|University General Hospital of Ioannina, Ioannina, Greece|Obudai Egeszsegugyi Centrum Kft., Budapest, Hungary|Synexus Magyarorszag Kft., Budapest, Hungary|Észak-Közép-budai Centrum, Új Szent János Kórház és Szakrendelő Budai Családközpontú, Budapest, Hungary|Meddica Centre Hungarian Defence Froces, Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Réthy Pál Kórház - Rendelőintézet, Békéscsaba, Hungary|Synexus Magyarorszag Kft, Gyula, Hungary|Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz, Gyula, Hungary|Kaposi Mór Oktató Kórház, Kardiológiai Részleg, Kaposvár, Hungary|Karolina Hospital, Mosonmagyarovár, Hungary|Szegedi Tud.Egyetem Szent-Gyorgyi Albert Klin. Közp., Szeged, Hungary|Tolna Megyei Balassa János Kórház, Szekszárd, Hungary|Ha'Emek Medical Center, Afula, Israel|Barzilai Medical Center, Ashkelon, Israel|Hillel Yaffe Medical Center, Hadera, Israel|Bnai Zion Medical Center, Haifa, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah Medical Organization Ein Kerem, Jerusalem, Israel|Meir Medical Center, Kfar Saba, Israel|Galilee Medical Center, Nahariya, Israel|Rabin Med Ctr Beilinson Hosp, Petah Tikva, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Assaf Harofeh Medical Center, Zerifin, Israel|Policlinico S.Orsola Malpighi, AOU di Bologna, Bologna, Italy|Azienda Ospedaliero Universitaria di Cagliari - Policlinico Duilio Casula di Monserrato, Cagliari, Italy|Ospedale Santissima Annunziata, Cento, Italy|AOU Careggi, Firenze, Italy|AOU Policlinico G.Martino, Messina, Italy|Gruppo Ospedaliero San Donato - Istituto di Ricovero e Cura, Milano, Italy|Ospedale L.Sacco, PU, ASST Fatebenefratelli Sacco, Milano, Italy|AOU Policlinico di Modena, Modena, Italy|Universita degli Studi di Padova - Azienda Ospedaliera di Padova, Padova, Italy|Università Campus Biomedico di Roma, Roma, Italy|IBD Unit- Sandro Pertini Hospital, Roma, Italy|Catholic University of Sacred Hearth, Roma, Italy|Complesso Integrato Columbus, Rome, Italy|Istituto Clinico Humanitas Rozzano, IRCCS, Rozzano, Italy|Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy|Ospedale Molinette, AO Città della Salute e della Scienza di, Torino, Italy|S.C. Gastroenterologia, Torino, Italy|Azienda Ospedaliero Universitaria S.Maria Della Misericordia, Udine, Italy|Policlinico G.B.Rossi, Verona, Italy|Asahikawa City Hospital, Asahikawa, Japan|Juntendo University Hospital, Bunkyo-ku, Japan|Chiba University Hospital, Chiba, Japan|Fukuoka University Chikushi Hospital, Chikushino, Japan|Saiseikai Fukuoka General Hospital, Fukuoka-shi, Japan|Fukuoka University Hospital, Fukuoka-shi, Japan|Gifu University Hospital, Gifu, Japan|Matsuda Hospital, Hamamatsu-shi, Japan|National Hospital Organization Mito Medical Center, Higashiibaraki-gun, Japan|Hirosaki National Hospital, Hirosaki, Japan|Hiroshima University Hospital, Hiroshima, Japan|Tokai University Hospital, Isehara, Japan|Izumiotsu Municipal Hospital, Izumiotsu, Japan|Shimane University Hospital, Izumo, Japan|Sameshima Hospital, Kagoshima, Japan|Nanpuh Hospital, Kagoshima, Japan|Kanazawa University Hospital, Kanazawa, Japan|The Jikei University Hospital, Kashiwa, Japan|Aoyama Naika Clinic, Kobe, Japan|Kobe University Hospital, Kobe, Japan|Kochi National Hospital, Kochi, Japan|Yamanashi Prefectural Central Hospital, Kofu, Japan|Showa University Kouto Toyosu Hospital, Koto-ku, Japan|National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan|Kurume University Hospital, Kurume, Japan|University Hospital Kyoto Perfectural University of Medicine, Kyoto, Japan|JRC Kyoto Daiichi Hospital, Kyoto, Japan|Kyoto University Hospital, Kyoto, Japan|National Hospital Organization Kyoto Medical Center, Kyoto, Japan|Kitasato University Kitasato Institute Hospital, Minato-ku, Japan|Kyorin University Hospital, Mitaka, Japan|Osaki Citizen Hospital, Miyagi, Japan|Iwate Medical University Hospital, Morioka, Japan|Aichi Medical University Hospital, Nagakute, Japan|Nagaoka Red Cross Hospital, Nagaoka, Japan|Nagasaki University Hospital, Nagasaki, Japan|Nagoya University Hospital, Nagoya, Japan|Nagoya City University Hospital, Nagoya, Japan|Niigata University Medical & Dental Hospital, Niigata, Japan|The Hospital of Hyogo College of Medicine, Nishinomiya, Japan|JA Obihiro Kosei Hospital, Obihiro, Japan|Oita Red Cross Hospital, Oita, Japan|Okayama Saiseikai General Hospital, Okayama, Japan|Keiaikai Chibana Clinic, Okinawa, Japan|Kindai University Hospital, Osaka-Sayama, Japan|Kinshukai Infusion Clinic, Osaka, Japan|Kitano Hospital, Osaka, Japan|Osaka City University Hospital, Osaka, Japan|National Hospital Organization Higashi Ohmi General Medical Center, Otsu-shi, Japan|Shiga University of Medical Science Hospital, Otsu, Japan|Japan Community Health Care Organization Saitama Medical Center, Saitama, Japan|Tokitokai Tokito Clinic Coloproctology Center, Saitama, Japan|Saitama Medical University Hospital, Saitama, Japan|Toho University Sakura Medical Center, Sakura, Japan|Sapporo IBD Clinic, Sapporo Chuo-ku, Japan|Hokkaido University Hospital, Sapporo-shi, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital, Sapporo, Japan|Sapporo Higashi Tokushukai Hospital, Sapporo, Japan|Keio University Hospital, Shinjuku-ku, Japan|Tokyo Yamate Medical Center, Shinjuku-ku, Japan|Osaka University Hospital, Suita, Japan|Takamatsu Red Cross Hospital, Takamatsu, Japan|Kagawa Prefectural Central Hospital, Takamatsu, Japan|Tokushima University Hospital, Tokushima, Japan|The Jikei University Hospital, Tokyo, Japan|Yuaikai Tomishiro Central Hospital, Tomishiro, Japan|Ehime University Hospital, Toon, Japan|Toyama City Hospital, Toyama-shi, Japan|Fujita Health University Hospital, Toyoake, Japan|Mie University Hospital, Tsu, Japan|Wakayama Medical University Hospital, Wakayama, Japan|Khalidi Hospital and Medical Center, Amman, Jordan|Prince Hamza Hospital, Amman, Jordan|Jordan University Hospital, Amman, Jordan|King Abdullah University Hospital, Irbid, Jordan|Korea University Ansan Hospital, Ansan-si, Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Dong-A University Hospital, Busan, Korea, Republic of|Kyungpook National University Hospital, Daegu, Korea, Republic of|CHA Bundang Medical center, CHA University, Seongnam, Korea, Republic of|Kyung Hee University Medical Center, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Yonsei University College of Medicine, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Gangnam Severance Hospital, Seoul, Korea, Republic of|Chung-Ang University Hospital, Seoul, Korea, Republic of|The Catholic University of Korea St. Vincent's Hospital, Suwon-si, Korea, Republic of|Ewha Womans University Mokdong Hospital, YangCheon-Gu, Korea, Republic of|Pauls Stradins Clinical University Hospital, Riga, Latvia|Riga East Clinical University Hospital, Riga, Latvia|Alda Pukisa arsta prakse, Riga, Latvia|American Universitty of Beirut Medical Center, Beirut, Lebanon|St Georges Hospital university medical centre, Beirut, Lebanon|Hotel Dieu de France Hospital, Beirut, Lebanon|Bellevue Medical Center, Beirut, Lebanon|Mount Lebanon Hospital, Beirut, Lebanon|Rafik Hariri University Hospital, Beirut, Lebanon|Notre Dame De Secours, Jbeil, Lebanon|Hammoud Hospital, Saida, Lebanon|Lietuvos sveikatos mokslų universiteto ligoninė Kauno klinik, Kaunas, Lithuania|Vilnius University Hospital Santaros Klinikos, Public Institution, Vilnius, Lithuania|Hospital Ampang, Ampang, Malaysia|Hospital Raja Perempuan Zainab Ii, Kota Bahru, Malaysia|University Malaya Medical Centre, Kuala Lumpur, Malaysia|Academisch Medisch Centrum Universiteit van Amsterdam, Amsterdam, Netherlands|Academisch Ziekenhuis Maastricht, Maastricht, Netherlands|Stichting Zuyderland Medisch Centrum, Sittard-Geleen, Netherlands|Auckland City Hospital, Auckland, New Zealand|Christchurch Hospital, Christchurch, New Zealand|Dunedin Hospital, Dunedin, New Zealand|Waikato Hospital, Hamilton, New Zealand|General City Hospital 8mi Septemvri, Skopje, North Macedonia|University Clinic of Gastroenterohepatology, Skopje, North Macedonia|NZOZ Centrum Medyczne KERmed, Bydgoszcz, Poland|Synexus Polska Sp. z o.o. Oddzial w Czestochowie, Czestochowa, Poland|Synexus Polska Sp. z o.o. Oddzial w Gdansku, Gdansk, Poland|Synexus Scm Sp. Z o.o. Oddzial Gdynia, Gdynia, Poland|Synexus Polska Sp. z o.o. Oddzial w Katowicach, Katowice, Poland|Centrum medyczne plejady, Krakow, Poland|Centrum Medyczne Pratia Krakow, Krakow, Poland|Centrum Medyczne Promed, Krakow, Poland|Synexus Polska Sp. z o.o., Lodz, Poland|Gastromed Spotka Z Ograniczona Odpowiedzialnoscia Sp. K., Lublin, Poland|Wojewodzki Szpital Specjalistyczny w Olsztynie, Olsztyn, Poland|Oswiecimskie Centrum Badan Klinicznych, Oswiecim, Poland|Synexus Polska Sp. z.o.o. Oddzial w Poznaniu, Poznan, Poland|Centrum Medyczne 'Medyk' Sp. z o.o. K., Rzeszow, Poland|Endoskopia Sp z o.o., Sopot, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, Poland|Toruńskie Centrum Gastrologiczne, Toruń, Poland|H-T Centrum Medyczne Endoterapia, Tychy, Poland|NZOZ Vivamed Zespol Lekarzy Specjalistow, Warsaw, Poland|Wojskowy Instytut Medyczny, Warszawa, Poland|Centrum Medyczne Pratia Warszawa, Warszawa, Poland|Centrum Badawcze Wspolczesnej Terapii, Warszawa, Poland|Szpital Pomnik Centrum Zdrowia Dziecka, Warszawa, Poland|Synexus Polska Sp. z o.o. Oddzial w Warszawie, Warszawa, Poland|Centrum Zdrowia Tuchow, Wierzchoslawice, Poland|Centrum Diagnostyczno - Lecznicze Barska sp. z o.o. Szpital Specjalistyczny Barska, Wloclawek, Poland|Melita Medical Sp. z o.o., Wroclaw, Poland|Przychodnia Vistamed, Wroclaw, Poland|ARS MEDICA Rybak Maria, Rybak Zbigniew, s.c., Wroclaw, Poland|Synexus Polska Sp. z o.o. Oddzial we Wroclawiu, Wrocław, Poland|ETG Zamosc, Zamosc, Poland|Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal|Hospital da Senhora da Oliveira, Guimarães, Portugal|Centro Hospitalar Lisboa Norte EPE - Hospital Pulido Valente, Lisbon, Portugal|H. Santo António - Centro Hospitalar do Porto, Porto, Portugal|Centro Hospitalar de Entre o Douro e Vouga, E.P.E, Santa Maria da Feira, Portugal|San Juan Bautista School of Medicine, Caguas, Puerto Rico|Hopital San Cristobal, Ponce, Puerto Rico|VA Caribbean Healthcare System - San Juan VA Medical Center, San Juan, Puerto Rico|Kazan State Medical University, Kazan, Russian Federation|KGBUZ 'Regional Clinical Hospital', Krasnoyarsk, Russian Federation|State Scientific Centre of Coloproctology, Moscow, Russian Federation|State Scientific Centre of Coloproctology, Moscow, Russian Federation|Novgorod Regional Clinical Hospital n.a. N.A. Semashko, Nizhny Novgorod, Russian Federation|Novosibirsk Region Clinical Hospital, Novosibirsk, Russian Federation|City Clinical Hospital #12, Novosibirsk, Russian Federation|Federal State Budgetary Institution 'Scientific Research In, Novosibirsk, Russian Federation|FSBI 'Scientific Research Institute of Clinical and Experimental Lymphology' of Siberian Branch, Novosibirsk, Russian Federation|Clinical Diagnostic Center 'Ultramed', Omsk, Russian Federation|GBUZ of Moscow Region City Clinical Hospital #3, Podolsk, Russian Federation|GBOU VPO Rostov State Medical University, Rostov-na-Donu, Russian Federation|City Hospital #20, Rostov-on-Don, Russian Federation|Clinical Hospital #122 n.a. after L.G. Sokolov, Saint Petersburg, Russian Federation|City Hospital #9, Saint Petersburg, Russian Federation|City Hospital named after St. Martyr Elizabeth, Saint-Petersburg, Russian Federation|City Clinical Hospital # 26, Saint-Petersburg, Russian Federation|Medical University Reaviz, Samara, Russian Federation|NUZ 'Railway Clinical Hospital on Samara station of LLC 'Russian Railways', Samara, Russian Federation|Saratov City Hospital #5, Saratov, Russian Federation|City Hospital# 40, Sestroretsk, Russian Federation|St.Petersburg State Medical University n.a.Pavlov, St Petersburg, Russian Federation|City Clinical Hospital #31, St. Petersburg, Russian Federation|LLC PoliClinic EXPERT, St. Petersburg, Russian Federation|Tomsk Regional Clinical Hospital, Tomsk, Russian Federation|Ulyanovsk Regional Clinical Hospital, Ulyanovsk, Russian Federation|GUZ Novgorod Regional Clinical Hospital, Velikiy Novgorod, Russian Federation|King Abdullah Medical City in Holy Capital, Makkah, Saudi Arabia|King Abdul Aziz Medical City for National Guard Health Affairs, Riyadh, Saudi Arabia|King Khalid Hospital, Riyadh, Saudi Arabia|Special hospital for Internal diseases, Oncomed system, Belgrade, Serbia|University Clinical Center of Serbia, Belgrade, Serbia|Zvezdara University Medical Center, Belgrade, Serbia|Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia|University Clinical Center Kragujevac, Kragujevac, Serbia|General Hospital Dr Djordje Joanovic, Zrenjanin, Serbia|FNsP F.D.R. Banska Bystrica, Banska Bystrica, Slovakia|ENDOMED s.r.o, Kosice, Slovakia|GASTRO I. s.r.o., Presov, Slovakia|Complejo Hosp Univ. de Ferrol, Ferrol, Spain|Hosp. Univ. Fuenlabrada, Fuenlabrada, Spain|Hosp. Univ. Dr. Josep Trueta, Girona, Spain|Hosp. Gral. Juan Ramon Jimenez, Huelva, Spain|Hosp. Univ. Ramon Y Cajal, Madrid, Spain|Hosp. Clinico San Carlos, Madrid, Spain|Hosp. Univ. Pta. de Hierro Majadahonda, Majadahonda, Spain|Hosp. Univ. Central de Asturias, Oviedo, Spain|Hosp. Provincial de Pontevedra, Pontevedra, Spain|Hosp. Univ. de Torrejon, Torrejón de Ardoz, Spain|Hosp. Alvaro Cunqueiro, Vigo, Spain|Gastroenterologische Praxis Balsiger und Seibold, Bern, Switzerland|Chang-Hua Christian Hospital, Changhua, Taiwan|China Medical University Hospital, Taichung, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Chang-Gung Memorial Hospital-Linkou, Taoyuan, Taiwan|Hopital Regional Mohamed Tahar El Maamouri, Nabul, Tunisia|Hopital Universitaire Sahloul, Sousse, Tunisia|Hospital La Rabta, Tunis Jebbari, Tunisia|Hopital Habib Thameur, Tunis, Tunisia|Military Hospital of Instruction of Tunis, Tunis, Tunisia|Cukurova University Medical Faculty Balcali Hospital, Adana, Turkey|Hacettepe University Medical Faculty, Ankara, Turkey|Gulhane Egitim ve Arastirma Hastanesi, Ankara, Turkey|Ankara University Medical Faculty, Ankara, Turkey|Acibadem Fulya Hospital, D:14/4 Nisantasi, Turkey|Firat University Hospital, Elazig, Turkey|Gaziantep University School of Medicine, Gaziantep, Turkey|Mustafa Kemal University Research and Practise Hospital, Hatay, Turkey|Bezmialem University Medical Faculty, İstanbul, Turkey|Sisli Etfal Egitim ve Arastirma Hospital, Istanbul, Turkey|Marmara University Medical Faculty, Istanbul, Turkey|Dokuz Eylul Universitesi Tip Fakultesi, Izmir, Turkey|Istanbul Medeniyet University Goztepe Training and Research Hospital, Kadikoy, Turkey|Kocaeli University Medical Faculty, Kocaeli, Turkey|Inonu Universitesi Turgut Ozal Tip Merkezi, Ic Hastaliklari, Malatya, Turkey|Mersin University Medical Faculty, Mersin, Turkey|MNCE'City Clinical Hospital №2 named after prof. O.O. Shalimov' of the Kharkiv City Council, Kharkiv, Ukraine|SE 'National institute therapy named L.T. Maloi NAMS of Ukraine', Kharkiv, Ukraine|KZ Khersonska Miska Klinichna Likarnia Im. Ye.Ie.Karabelesha, Kherson, Ukraine|O.O.Bogomolets National Medical University, Kyiv City Clinical Hospital #18,, Kyiv, Ukraine|LLC Treatment and Diagnostic Center Adonis Plus, Kyiv, Ukraine|Medical Centre 'IBN SINA+', Kyiv, Ukraine|Kyiv Railway Clinical Hospital #2 Of Branch 'Health Center' Of The Company 'Ukrainian Railway', Kyiv, Ukraine|Kyiv Regional Clinical Hospital, Kyiv, Ukraine|Odeska oblasna klinichna likarnia, Odesa, Ukraine|Sumska oblasna klinichna likarnia, Sumy, Ukraine|Ternopil municipal hospital #1, Ternopil, Ukraine|MNCE Zakarpatska Regional Clinical Hospital named after A Novak of Zakarpatska Regional Council, Uzhgorod, Ukraine|Health Clinic Limited Liability Company, Vinnytsia, Ukraine|Komunalna ustanova 'Miska likarnia №1', Zaporizhzhia, Ukraine|Zaporizka oblasna klinichna likarnia, Zaporizhzhia, Ukraine|KU 6 miska klinichna likarnia ZMR, Zaporozhye, Ukraine|Barnsley District General Hospital, Barnsley, United Kingdom|Royal Victoria Hospital, Belfast, United Kingdom|Addenbrooke's Hospital, Cambridge, United Kingdom|Leighton Hospital, Crewe, United Kingdom|Whipps Cross University Hospital, London, United Kingdom|St George's Healthcare NHS Trust, London, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom|Sandwell and West Birmingham Hospitals NHS Trust-Sandwell Gene, West Bromwich, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03466411"
616,"NCT03464097","A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Drug: Ozanimod|Other: Placebo","Proportion of subjects with a CDAI score of < 150|Proportion of subjects with a Simple Endoscopic Score for Crohn's Disease (SESCD) score decrease from baseline of ≥ 50%|Proportion of subjects with average daily abdominal pain score ≤ 1 point and average daily stool frequency ≤ 3 points with abdominal pain and stool frequency no worse than baseline|Proportion of subjects with CDAI reduction from baseline of ≥ 100 points or CDAI score of < 150|Proportion of subjects with a CDAI score < 150 at Week 52, while remaining corticosteroid-free in the prior 12 weeks|Proportion of subjects with a CDAI score of < 150 in subjects with a CDAI score < 150 at pre-randomization|Proportion of subjects with a CDAI score of < 150 at Week 52 and at ≥ 80% of visits between Week 8 and Week 52, inclusive, in subjects with a CDAI score <150 at pre-randomization|Proportion of subjects with absence of ulcers ≥ 0.5 cm with no segment with any ulcerated surface ≥10%|Histologic improvement based on differences between ozanimod and placebo in histologic disease activity scores (ie, Global Histologic Disease Activity Score [GHAS] changes (Geboes, 2000))|Proportion of subjects with average daily abdominal pain score ≤ 1 point, and average daily stool frequency score ≤ 3 points with abdominal pain and stool frequency no worse than baseline and an SES-CD decrease from baseline of ≥ 50%|Proportion of subjects with CDAI score of < 150 and SES-CD decrease from baseline of ≥ 50%|Proportion of subjects with average daily abdominal pain score ≤ 1 point, and average daily stool frequency score ≤ 3 points with abdominal pain and stool frequency no worse than baseline and an SES-CD ≤ 4 points and a SES-CD decrease ≥2 points|Proportion of subjects with CDAI reduction from baseline of ≥ 100 points or CDAI score < 150 and SES-CD decrease from baseline of ≥ 50%|Proportion of subjects with CDAI score < 150 at Week 12 and SES-CD decrease from baseline of ≥ 50%|Proportion of subjects with CDAI reduction from baseline of ≥ 70 points|Proportion of subjects with mucosal healing (SES-CD ≤ 4 points and a SES-CD decrease ≥ 2 points) and histologic improvement by GHAS or Robarts Histologic Index (RHI)|Time to relapse and exclusion of other causes of an increase in disease activity unrelated to underlying CD (eg, infections, change in medication)|Proportion of subjects with a Crohn's Disease Endoscopic Index of Severity (CDEIS) decrease from baseline of ≥ 50%|Proportion of adolescent subjects with Pediatric Crohn's Disease Activity Index (PCDAI) ≤ 10 points|Proportion of adolescent subjects with decrease from baseline in PCDAI score ≥15 points|Change from baseline (Induction) in Inflammatory Bowel Disease Questionnaire (IBDQ) scores (adult subjects only)|Change from baseline (Induction) in 36-Item Short Form-36 Survey (SF-36) scores (adult subjects only)|Change from baseline (Induction) in Work Productivity and Activity Impairment questionnaire for Crohn's disease (WPAI-CD) scores (adult subjects only)|Change from baseline (Induction) in EuroQol 5 dimensions questionnaire (EQ-5D) scores|Patient Global Impression of Change (PGIC) scores (adult subjects only)|Differences in CD-related hospitalizations, procedures, and surgery|Assessment of circulating lymphocyte concentration|Assessment of gene expression|Assessment of protein biomarker concentration|Assessment of pharmacogenetics|Assessment of impact of SARS-CoV-2 serologic status on subjects receiving ozanimod and CD","Celgene","All","12 Years to 75 Years   (Child, Adult, Older Adult)","Phase 3","485","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","RPC01-3203|U1111-1203-8002|2017-004294-14","June 27, 2018","June 26, 2024","September 24, 2024","March 13, 2018",,"February 15, 2021","Holland Center for Family Health, Peoria, Arizona, United States|Elite Clinical Studies, LLC, Phoenix, Arizona, United States|HonorHealth Research Institute, Scottsdale, Arizona, United States|Arkansas Gastroenterology, P.A., North Little Rock, Arkansas, United States|Sharp Chula Vista Medical Center, Chula Vista, California, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, United States|Valley View Internal Medicine, Garden Grove, California, United States|UCSD Medical Center, La Jolla, California, United States|San Diego Clinical Trials, La Mesa, California, United States|OM Research, Lancaster, California, United States|Children's Hospital of Los Angeles, Los Angeles, California, United States|Southern California Research Institute Medical Group, Inc., Los Angeles, California, United States|Matrix Clinical Research Inc, Los Angeles, California, United States|Gastrointestinal Biosciences, Los Angeles, California, United States|VA Northern California Health Care System, Mather, California, United States|Facey Medical Foundation (Parent), Mission Hills, California, United States|ABS Health, LLC, Mission Viejo, California, United States|Alliance Clinical Research, Oceanside, California, United States|Palo Alto Center-Palo Alto Medical Foundation Research Institute, Palo Alto, California, United States|Havana Research Institute LLC, Pasadena, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Sutter Medical Group, Roseville, California, United States|UC Davis Health - Gastroenterology and Hepatology Clinical Trials Unit, Sacramento, California, United States|Medical Associates Research Group, San Diego, California, United States|University of California at San Francisco, San Francisco, California, United States|New Hope Research Development, West Covina, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Connecticut Clinical Research Foundation, Bristol, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Gastro Florida, Clearwater, Florida, United States|Clinical Research of West Florida, Clearwater, Florida, United States|South Lake Pain Institute, Clermont, Florida, United States|American Research Institute Inc, Cutler Bay, Florida, United States|Universal Axon Clinical Research, Doral, Florida, United States|Riverside Clinical Research, Edgewater, Florida, United States|University of Florida Health Endocrinology - Medical Specialties - Medical Plaza, Gainesville, Florida, United States|Qway Research LLC, Hialeah, Florida, United States|Floridian Clinical Research LLC, Hialeah, Florida, United States|Harmony Medical Research Institute, Hialeah, Florida, United States|The Center for Gastrointestinal Disorders, Hollywood, Florida, United States|Vista Health Research, Homestead, Florida, United States|SIH Research, Kissimmee, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|Pioneer Clinical Research, Lighthouse Point, Florida, United States|Center For Advanced Gastroenterology, Maitland, Florida, United States|Galiz Research LLC, Miami Springs, Florida, United States|LMG Research, Miami, Florida, United States|Nova Clinical Research Center LLC, Miami, Florida, United States|LCC Medical Research Institute, LLC, Miami, Florida, United States|Research Associates of South Florida LLC, Miami, Florida, United States|Life Medical Center & Research, Inc., Miami, Florida, United States|Vista Health Research, Miami, Florida, United States|Advanced Research for Health Improvement, Naples, Florida, United States|Bayside Clinical Research, New Port Richey, Florida, United States|NSB Research, New Smyrna Beach, Florida, United States|Omega Research Maitland, LLC, Orlando, Florida, United States|HMD Research LLC, Orlando, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Theia Clinical Research, LLC, Pinellas Park, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Precision Clinical Research, LLC., Sunrise, Florida, United States|University of South Florida, Tampa, Florida, United States|Apex Clinical Research, Tampa, Florida, United States|Guardian Angel Health Svcs Inc, Tampa, Florida, United States|Asclepes Research Centers, Weeki Wachee, Florida, United States|Consultative Gastroenterology, Atlanta, Georgia, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Emory Clinic, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, LLC, Atlanta, Georgia, United States|Children's Center for Digestive Healthcare, Atlanta, Georgia, United States|Gastrointestinal Disease Research, Columbus, Georgia, United States|Atlanta Center For Gastroenterology, P.C., Decatur, Georgia, United States|Gastroenterology Associates Of Central Georgia LLC, Macon, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|Rush University Medical Center - University Cardiovascular Surgeons, Chicago, Illinois, United States|Northwestern University, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|DM Clinical Research, Oak Lawn, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|MediSphere Medical Research Center, LLC, Evansville, Indiana, United States|Indiana University, Indianapolis, Indiana, United States|Iowa Digestive Disease Center, Clive, Iowa, United States|Cotton ONeil Clinical Research Center Digestive Health, Topeka, Kansas, United States|University of Kentucky Health Care, Lexington, Kentucky, United States|Gastroenterology Associates, LLC, Baton Rouge, Louisiana, United States|CroNOLA LLC, Houma, Louisiana, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Clinical Trials of SW Louisiana LLC, Lake Charles, Louisiana, United States|Tandem Clinical Research, LLC, Marrero, Louisiana, United States|Nola Research Works, New Orleans, Louisiana, United States|LSU Health Sciences Center Shreveport, Shreveport, Louisiana, United States|Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|Digestive Disease Associates, PA, Catonsville, Maryland, United States|Woodholme Gastroenterology Associates, Glen Burnie, Maryland, United States|Harvard Medical School - Boston Children's Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital - Crohn's and Colitis Center, Chestnut Hill, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States|Medex Research Institute, Caro, Michigan, United States|Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, United States|Henry Ford Medical Center - New Center One, Novi, Michigan, United States|Revive Research Institute, Southfield, Michigan, United States|University of Minnesota Medical Center, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Southern Therapy and Advanced Research, Jackson, Mississippi, United States|Mid America Gastrointestinal Consultants, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Internal Medicine Specialists, Las Vegas, Nevada, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Englewood Hospital and Medical Center, Englewood, New Jersey, United States|University of New Mexico Hospital, Albuquerque, New Mexico, United States|Advantage Clinical Trials, Bronx, New York, United States|NY Scientific, Brooklyn, New York, United States|Adirondack Medical Research Center, Glens Falls, New York, United States|Northwell Health, Great Neck, New York, United States|Drug Trials America, Hartsdale, New York, United States|Weill Cornell Medical College, New York, New York, United States|Concorde Medical Group, New York, New York, United States|Cornell University, New York, New York, United States|TrialSpark, New York, New York, United States|Lenox Hill Hospital, New York, New York, United States|DiGiovanna Institute for Medical Education And Research, North Massapequa, New York, United States|Circuit Clinical, Orchard Park, New York, United States|Asheville Gastroenterology Associates, P.A., Asheville, North Carolina, United States|Carolinas HealthCare System Digestive Health, Charlotte, North Carolina, United States|Internal Medicine Research, Charlotte, North Carolina, United States|PMG Research of Charlotte LLC, Charlotte, North Carolina, United States|Carolina Research Center, Greenville, North Carolina, United States|PMG Research of Winston-Salem LLC, Winston-Salem, North Carolina, United States|Great Lakes Medical Research, LLC, Beachwood, Ohio, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Cleveland Clinic - Taussig Cancer Institute, Cleveland, Ohio, United States|Advance Clinical Research - Dayton Internal Medicine, Dayton, Ohio, United States|Ohio State University Wexner Medical Center, Hilliard, Ohio, United States|Great Lakes Gastroenterology, Mentor, Ohio, United States|Paramount Medical Research & Consulting, LLC, Middleburg Heights, Ohio, United States|Great Lakes Medical Research, LLC, Warren, Ohio, United States|Cancer Care Associates of OK-N PorterAvenue, Norman, Oklahoma, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Digestive Disease Specialists, Oklahoma City, Oklahoma, United States|Allergy, Asthma and Immunology Center, PC, Tulsa, Oklahoma, United States|Central States Research, LLC, Tulsa, Oklahoma, United States|Oregon Health & Science University, Portland, Oregon, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|Penn State University Milton S Hershey Medical Center, State College, Pennsylvania, United States|Quality Medical Research, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Advanced Gastroenterology, Union City, Tennessee, United States|Avant Research Associates, LLC - Austin, Austin, Texas, United States|San Antonio Military Medical Center, Fort Sam Houston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Biopharma Informatic Inc. Research Center, Houston, Texas, United States|Centex Studies, Inc., Houston, Texas, United States|GI Specialists of Houston, Houston, Texas, United States|Premier Vein and Vascular Center, Houston, Texas, United States|The Coastal Medical Group, Houston, Texas, United States|Gulf Coast Research Group LLC, Houston, Texas, United States|Accurate Clinical Research Inc, Pasadena, Texas, United States|DHAT Research Institute, Richardson, Texas, United States|Sun Research Institute, San Antonio, Texas, United States|San Antonio Gastroenterology, San Antonio, Texas, United States|Texas Digestive Disease Consultants - Southlake, Southlake, Texas, United States|Baylor Scott and White Health, Temple, Texas, United States|Digestive Health Specialists of Tyler, Tyler, Texas, United States|University of Utah School of Medicine, Salt Lake City, Utah, United States|Gastroenterology Associates, PC, Gainesville, Virginia, United States|Blue Ridge Medical Research, Lynchburg, Virginia, United States|Summit Clinical Research, LLC, Petersburg, Virginia, United States|The Gastroenterology Group, Reston, Virginia, United States|McGuire Veterans Affairs Medical Center, Richmond, Virginia, United States|Carilion Clinic, Roanoke, Virginia, United States|Virginia Gastroenterology Institute PC, Suffolk, Virginia, United States|University of Washington Medical Center, Seattle, Washington, United States|Dermatologist Specialists of Spokane, Spokane, Washington, United States|Aurora Health Care Aurora Research, Grafton, Wisconsin, United States|Franciscan Skemp Healthcare, La Crosse, Wisconsin, United States|Sanatorio Guemes, Ciudad Autonoma de Buenos Aires, Argentina|Hospital Privado Centro Medico de Cordoba, Cordoba, Argentina|Instituto Medico de la Fundacion Estudios Clinicos, Rosario, Argentina|Universidad Nacional De Rosario - Hospital Provincial Del Centenario, Rosario, Argentina|Sanatorio 9 de Julio - CICE 9 de Julio, San Miguel de Tucuman, Argentina|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|Liverpool Hospital, Liverpool, New South Wales, Australia|John Hunter Hospital and Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia|Wollongong Hospital, Wollongong, New South Wales, Australia|Coastal Digestive Health, Maroorchydore, Queensland, Australia|University of the Sunshine Coast, North Mackay, Queensland, Australia|Mater Hospital Brisbane, South Brisbane, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|The Queen Elizabeth Hospital, Woodville South, South Australia, Australia|Monash Medical Centre, Clayton, Victoria, Australia|St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|Harry Perkins Medical Research Institute, Fiona Stanley Hospital, Murdoch, Western Australia, Australia|St John of God Subiaco Hospital, Subiaco, Western Australia, Australia|Ballarat Base Hospital, Ballarat, Australia|Medical University Innsbruck, Innsbruck, Austria|University Hospital St. Poelten, St Polten, Austria|Medical University Vienna, Vienna, Austria|Grodno City Clinical Hospital #4, Grodno, Belarus|Vitebsk Regional Clinical Specialized Center, Vitebsk, Belarus|Algemeen Ziekenhuis Klina, Brasschaat, Belgium|Universitair Ziekenhuis Brussel, Brussels, Belgium|University Hospital Brussels, Brussels, Belgium|CHU Saint-Luc, Brussels, Belgium|Queen Fabiola Children's University Hospital, Brussels, Belgium|Universitair Ziehenhuis Antwerpen, Edegem, Belgium|Universitair Ziekenhuis Gent, Ghent, Belgium|Universitair Ziekenhuis Leuven, Campus Gasthuisberg, Leuven, Belgium|Clinique du Montlegia, Liege, Belgium|Sart Tilman Hospital Department of Gastroenterology and Hepatology, Seraing, Belgium|Hospital Centre of Walloon Picarde, Tournai, Belgium|University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina|University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina|Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina|General Hospital ""Prim.dr. Abdulah Nakas"", Sarajevo, Bosnia and Herzegovina|Multiprofile Hospital for Active Treatment Medline, Plovdiv, Bulgaria|MHAT Ruse AD, Ruse, Bulgaria|Second MHAT Sofia AD, Sofia, Bulgaria|Excelsior Medical Center, Sofia, Bulgaria|Multiprofile Hospital for Active Treatment Tokuda Hospital Sofia, Sofia, Bulgaria|Diagnostic and Consulting Center Alexandrovska, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Sveti Ivan Rilski EAD, Sofia, Bulgaria|Diagnostic-Consultative Center Sveta Anna, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment ACIBADEM City Clinic Sofia, Sofia, Bulgaria|ACIBADEM City Clinic Medical Center Bregalnitsa, Varna, Bulgaria|University of Calgary Health - The Gastrointestinal Research Group (GIRG), Calgary, Alberta, Canada|West Edmonton Gastroenterology Consultants, Edmonton, Alberta, Canada|Okanagan Clinical Trials Ltd, Kelowna, British Columbia, Canada|Fraser Clinical Trials Inc., New Westminister, British Columbia, Canada|Vancouver Hospital Gastrointestinal Research Unit The Gordon and Leslie Diamond Centre, Vancouver, British Columbia, Canada|GI Research Institute, Vancouver, British Columbia, Canada|Brandon Medical Arts Clinic, Brandon, Manitoba, Canada|Winnipeg Clinic Dermatology Research, Winnipeg, Manitoba, Canada|Viable Clinical Research, Bridgewater, Nova Scotia, Canada|IWK Health Center, Halifax, Nova Scotia, Canada|London Health Sciences Centre, University Hospital, London, Ontario, Canada|LHSC Victoria Hospital, London, Ontario, Canada|Dr.Garisa Jagan Mohan Reddy MD, Sudbury, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Kensington Screening Clinic, Toronto, Ontario, Canada|Toronto Digestive Disease Associates Inc, Vaughan, Ontario, Canada|Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada|The Ottawa Hospital - General Campus, Ottawa, Quebec, Canada|Peking University First Hospital, Beijing, China|Peking University People's Hospital, Beijing, China|Beijing YouYi Hospital-Beijing Friendship Hospital Capital Medical University, Beijing, China|The Seventh Medical Center of PLA General Hospital, Beijing, China|First Hospital of Jilin University, Changchun, China|Guangzhou First People's Hospital, Guangzhou Shi, China|Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China|Anhui Provincial Hospital, Hefei, China|The First Affiliated Hospital of Nanchang University, Nanchang, China|Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China|Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China|China Medical University Hospital, Taichung City, China|Wuhan Union Hospital, Wuhan, China|Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China|Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou, China|The Second Affiliated Hospital Of Zhengzhou University, Zhengzhou, China|Clinical Hospital Center Osijek, Osijek, Croatia|Clinical Hospital Centre Rijeka, Rijeka, Croatia|Clinical Hospital Center Split, Split, Croatia|Clinical Hospital Center Sestre milosrdnice Clinic of Internal Diseases, Zagreb, Croatia|Clinical Hospital Dubrava, Zagreb, Croatia|University Hospital Centre Zagreb, Clinic of Internal Diseases, Zagreb, Croatia|Military Hospital Brno, Brno, Czechia|St. Anne's University Hospital Brno, Brno, Czechia|Hepato-Gastroenterologie HK, s. r. o., Hradec Králové, Czechia|Soukroma Gastroenterologicka ambulance a endoskopie, Most, Czechia|PreventaMed, Olomouc, Czechia|Krajská nemocnice Pardubice, Kožní oddelení, Pardubice, Czechia|University Hospital Pilsen, Plzen, Czechia|University Hospital Motol, Prague 5, Czechia|ISCARE, a.s., Prague 9, Czechia|Institut klinicke a experimentalni mediciny, Praha 4, Czechia|Bispebjerg Hospital, Copenhagen, Denmark|Holbaek Hospital, Holbaek, Denmark|Nykobing F Hospital, Nykobing F, Denmark|Helsinki University Central Hospital (HUCH), Helsinki, Finland|Turku University Hospital, Turku, Finland|CHU Amiens Picardie - Site Sud, Amiens cedex 1, France|Centre Hospitalier de Blois, Blois Cedex, France|Beziers Hospital, Béziers, France|University Hospital Center Caen, Caen, France|Assistance Publique - Hopitaux de Paris - Hopital Beaujon, Clichy, France|Louis Mourier Hospital, Colombes, France|Centre Hospitalier Intercommunal de Creteil, Creteil Cedex, France|CHU de Dijon Bourgogne - Hopital Francois Mitterand, Dijon Cedex, France|CHU de Grenoble Alpes, Grenoble Cedex 9, France|CHRU de Lille - Hopital Claude Huriez, Lillie Cedex, France|Hopital Nord, Marseille cedex 20, France|CHU Nantes University Hospital - Hotel Dieu Hospital, Nantes, France|South Lyon Hospital Center, Pierre-Benite, France|Hospital Pontchaillou, Rennes, France|CHU de Rouen Hopital Charles Nicolle, Rouen Cedex, France|Saint-Etienne University Hospital Center, Saint Priest en Jarez, France|CHU de Toulouse Hopital Rangueil, Toulouse Cedex 09, France|JSC Evex Medical Corporation - Batumi Referral Hospital, Batumi, Georgia|JSC Evex Medical Corporation - Oncology Center, Kutaisi, Georgia|Helsicore - Israeli Georgian Medical Research Clinic, Tbilisi, Georgia|LLC Vivamedi, Tbilisi, Georgia|Tbilisi State Medical University, Tbilisi, Georgia|LTD Institute of Clinical Cardiology, Tbilisi, Georgia|JSC Infectious Disease, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia|LTD Academician N.Kipshidze Central University Clinic, Tbilisi, Georgia|LTD Aversi Clinic, Tbilisi, Georgia|LTD MediClub Georgia, Tbilisi, Georgia|David Tatishvili Medical Center, Tbilisi, Georgia|JSC Evex Medical Corporation - Telavi Referral Hospital, Telavi, Georgia|Charite - Universitaetsmedizin Berlin, Berlin, Germany|Gastroenterological Special Practice at Wittenbergplatz, Berlin, Germany|Gastroenterology Am Bayerischen Platz, Berlin, Germany|Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany|Charite - Universitätsmedizin Berlin, Berlin, Germany|DRK Clinics Berlin, Berlin, Germany|Hospital Waldfriede e.V., Berlin, Germany|Brandenburg City Hospital, Brandenburg an der Havel, Germany|Medical Care Unit Dachau, Dachau, Germany|Klinikum Darmstadt, Darmstadt, Germany|Kliniken Essen-Mitte, Essen, Germany|Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany|Agaplesion Markus Krankenhaus, Frankfurt, Germany|Interdisciplinary Crohn Colitis Center Rhein Main, Frankfurt, Germany|Studiengesellschaft BSF, Halle, Germany|University Hospital Halle (Saale), Halle, Germany|University Hospital Hamburg-Eppendorf, Hamburg, Germany|Asklepios Klinik Hamburg, Hamburg, Germany|Universitatsklinikum Schleswig-Holstein, Keil, Germany|Universitaetsklinikum Leipzig AoeR, Leipzig, Germany|Practice for Gastroenterology and Internal Medicine, Ludwigshafen am Rhein, Germany|St Marien und St Annastiftskrankenhaus, Ludwigshafen am Rhein, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, Germany|University Hospital Muenster, Muenster, Germany|Synesis Research Center, Munich, Germany|Universitaetsklinikum Charite - Ruppiner Kliniken GmbH, Neuruppin, Germany|Robert-Bosch-Hospital, Stuttgart, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Germany|Universitaetsklinikum Ulm, Ulm, Germany|Laiko General Hospital of Athens, Athens, Greece|Sotiria Chest Diseases Hospital of Athens, Athens, Greece|Tzanio General Hospital of Piraeus, Athens, Greece|PAGNI University Hospital, Heraklion, Greece|General Hospital of Thessaloniki Hippokration, Thessaloniki, Greece|424th Army General Hospital, Thessaloniki, Greece|Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaz, Bekescsaba, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary|Semmelweis Egyetem - Altalanos Orvostudomanyi Kar, Budapest, Hungary|Petz Aladar Megyei Oktato Korhaz,II. Belgyogyaszat, Gyor, Hungary|CRU Hungary Kft, Miskolc, Hungary|Kanizsai Dorottya Hospital, Nagykanizsa, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Szekesfehervar, Hungary|Clinfan Ltd, Szekszárd, Hungary|Csongrad County Dr. Bugyi Istvan Hospital, Szentes, Hungary|Zala Megyei KorhazHaematologia, Zalaegerszeg, Hungary|St Vincent's University Hospital, Dublin 4, Dublin, Ireland|Beaumont Hospital, Dublin 9, Ireland|Institute of Gastroenterology and Hepatology at Ha'Emek Medical Center, Afula, Israel|Bat Yamon Medical Center, Clalit Medical Services, Bat Yam, Israel|Asaf Harofeh Medical Center, Beer Jacob, Israel|Rambam Health Care Campus, Haifa, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Clalit Health Services, Jerusalem, Israel|Meir Medical Center, Kfar-Saba, Israel|Galilee Medical Center, Nahariya, Israel|Rabin Medical Center, Petah Tikva, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Kaplan Medical Center, Rechovot, Israel|Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel|University Polyclinic Hospital of Bari, Bari, Italy|Polyclinic S. Orsola-Malpighi, Bologna, Italy|Civil Hospital of Brescia, Brescia, Italy|Poliambulanza Hospital, Brescia, Italy|IRCCS ""Savario De Bellis"", Castellana Grotte, Italy|University Hospital Mater Domini, Catanzaro, Italy|""Ss. Annunziata"" Policlinic of Chieti, Chieti, Italy|University Polyclinic Hospital G. Martino, Messina, Italy|Maggiore Polyclinic Hospital, IRCCS Ca' Granda, Milano, Italy|Humanitas Research Hospital - Humanitas Mirasole S.p.A, Milan, Italy|Azienda Socio Sanitaria Territoriale (ASST) di Monza, Monza, Italy|Hospital of Di Padova, Padova, Italy|United Hospitals Villa Sofia Cervello, Palermo, Italy|Polyclinic San Matteo IRCCS, Pavia, Italy|Polyclinic Tor Vergata, Roma, Italy|Univerisity Polyclinic Foundation Agostino Gemelli, Roma, Italy|Azienda Ospedaliera San Camillo Forlanini, Rome, Italy|Integrated University Hospital Santa Maria della Misericordia of Udine, Udine, Italy|A.O. Universitaria Fondazione Macchi, Varese, Italy|Sacred Heart Don Calabria, Verona, Italy|Korea University Medical Center - Korea University Ansan Hospital, Ansan, Korea, Republic of|Pusan National University Hospital, Busan, Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Yeungnam University Medical Center, Daegu, Korea, Republic of|Hanyang University Guri Hospital, Guri-si, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of|St. Vincent's Hospital, Suwon, Korea, Republic of|P. Stradins Clinical University Hospital, Riga, Latvia|Digestive Diseases Center Gastro, Riga, Latvia|Riga East Clinical University Hospital clinic Gailezers, Riga, Latvia|Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania|Klaipeda University Hospital, Klaipeda, Lithuania|Vilnius University Hospital Santariskes Clinics, Vilnius, Lithuania|Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania|Vilnius City Clinical Hospital, Vilnius, Lithuania|Investigacion Biomedica para el desarrollo de Farmacos, S.A. de C.V., Zapapan, Jalisco, Mexico|Centro Regiomontano de Estudios Clinicos Roma SC., Monterrey, Nuevo León, Mexico|Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Nuevo León, Mexico|SMIQ, Santiago de Queretaro, Querétaro, Mexico|Hospital Christus Muquerza del Parque S.A. de C.V., Chihuahua, Mexico|Centro de Investigacion Clinica Acelerada (CICA) S.C., Mexico, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Tlalpan, Mexico|""Sfanta Treime"" Clinical Municipal Hospital, Chisinau, Moldova, Republic of|Clinical Hospital of the Ministry of Health, Department of Endoscopic Surgery, Chisinau, Moldova, Republic of|""Sf. Arhanghel Mihail"" Municipal Clinical Hospital, Chisinau, Moldova, Republic of|Republican Clinical Hospital, Department of Colorectal Surgery, Chisinau, Moldova, Republic of|Republican Clinical Hospital, Chisinau, Moldova, Republic of|Vrije Universiteit Medisch Centrum (VUMC), Amsterdam, Netherlands|Academisch Medisch Centrum, Amsterdam, Netherlands|UMC Groningen, Groningen, Netherlands|Radboud University Medical Center, Nijmegen, Netherlands|Zuyderland Medisch Centrum, Sittard-Geleen, Netherlands|St. Elisabeth Ziekenhuis, Tilburg, Netherlands|Akershus University Hospital, Lørenskog, Norway|Lovisenberg Diakonale Sykehus, Oslo, Norway|SP ZOZ Wojewodzki Szpital Zespolony im. J. Sniadeckiego, Bialystok, Poland|Medical Services Center MaxMed, Bochnia, Poland|St. John Paul 2nd Municipal Hospital in Elblag, Elblag, Poland|Nicolaus Copernicus Hospital, Gdansk, Poland|Private Medical Practice Miroslaw Fic, Jelenia Gora, Poland|BioVirtus Medical Centre, Jozefow, Poland|Nzoz All-Medicus, Katowice, Poland|Kornel Gibinski Independent Public Central Clinical Hospital in Katowice, Katowice, Poland|GLOBE Clinical Research Sp. z o.o. LLC, Klodzko, Poland|PLEJADY Sp. z o.o. (LLC) Medical Centre, Krakow, Poland|Landa Specialist Doctor's Offices, Krakow, Poland|Krakow Medical Center LLC, Krakow, Poland|Centrum Opieki Zdrowotnej Orkan Med, Ksawerow, Poland|Santa Familia Centrum Badan, Profilaktyki i Leczenia, Lodz, Poland|Salve Limited Liability Company Limited Partnership, Outpatient Clinic, Lodz, Poland|LUX MED Centrum Medyczne - Lodz, Lodz, Poland|Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland|1 Military Clinical Hospital in Lublin, Lublin, Poland|Non-Public Healthcare Facility Allmedica Clinical Trials, Nowy Targ, Poland|Provincial Specialist Hospital in Olsztyn, Olsztyn, Poland|SOLUMED Medical Center, Poznan, Poland|Office of Bartosz Korczowski, MD, Rzeszow, Poland|Endoskopia Sp. z o.o., Sopot, Poland|TWOJA PRZYCHODNIA Medical Centre of Szczecin LLC, Szczecin, Poland|GASTROMED Kopon, Zmudzinski and Partners Specialist Centre for Gastroenterology and Endoscopy, Spe, Torun, Poland|H-T. Medical Center Sp. z o.o. LLC Limited Partnership, Tychy, Poland|Polimedica, Ul. Piotrkowska 177, Poland|Maternal Pediatric and Adolescent Healthcare Centre, Warsaw, Poland|WIP Warsaw IBD Point, Warsaw, Poland|PRIMA LCC Specialist Clinics, Warsaw, Poland|Children's Memorial Health Institute, Warsaw, Poland|Endoterapia PFG LLC, Endotherapy PFG Outpatient Clinic Branch No 1, Warszawa, Poland|Niepubliczny Zaklad Opieki Zdrowotnej VIVAMED, Warszawa, Poland|Health Centre Metabolic Diseases Outpatient Clinic in Wierzchoslawice, Wierzchoslawice, Poland|LUX MED Centrum Medyczne - Wroclaw, Wroclaw, Poland|Wroclaw Medical University, Wroclaw, Poland|Jan Mikulicz Radecki University Hospital, Wroclaw, Poland|Clinical Research Center Early-Phase Research Facility, Wroclaw, Poland|LexMedica, Wroclaw, Poland|Ars Medica, Wroclaw, Poland|EMC Medical Institute S.A, Wroclaw, Poland|Hospital Universitario de Coimbra- Hospitais de Universidade de Coimbra, Coimbra, Portugal|Centro Hospitalar do Alto Ave, Hospital da Senhora da Oliveira Guimaraes, Guimaraes, Portugal|Hospital Beatriz Angelo, Loures, Portugal|Centro Hospitalar do Alto Minho - Unidade Local de Saúde do Alto Minho, EPE, Viana do Castelo, Portugal|Hyperclinica MedLife Grivita, Bucharest, Romania|Center of Diagnosis and Treatment Provita, Bucharest, Romania|Fundeni Clinical Institute, Bucharest, Romania|Bucharest University Emergency Hospital, Department of Internal Medicine II, Bucharest, Romania|Dr. Carol Davila Central Military Emergency Clinical Hospital, Bucharest, Romania|Craiova County Emergency Clinical Hospital, Craiova, Romania|Colentina Clinical Hospital, Napoca, Romania|Targu Mures County Emergency Clinical Hospital, Targu Mures, Romania|Joint Venture Company Diagnostic Center, Bioterm Ltd., Barnaul, Russian Federation|Territorial Clinical Hospital, Barnaul, Russian Federation|Regional Clinical Hospital #3, Chelyabinsk, Russian Federation|Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russian Federation|Chita State Medical Academy, Chita, Russian Federation|Ural State Medical Academy - Medical Association Novaya Bolnitsa, Ekaterinburg, Russian Federation|Irkutsk State Medical Academy of Postgraduate Education, Irkutsk, Russian Federation|Immanuel Kant Baltic Federal University, Kaliningrad, Russian Federation|Kaluga Regional Hospital, Kaluga, Russian Federation|City Clinical Hospital No 7 - Kazan, Kazan, Russian Federation|S.V. Beliaev Kemerovo Regional Clinical Hospital, Kemerovo, Russian Federation|Regional Clinical Hospital, Khanty-mansiysk, Russian Federation|Federal Siberian Research and Clinical Center, Krasnoyarsk, Russian Federation|Moscow Clinical Scientific and Practical Center, Moscow, Russian Federation|City Clinical Hospital n.a. V.M. Buyanov, Moscow, Russian Federation|City Clinical Hospital 24, Moscow, Russian Federation|CJSC Nasledniki, Moscow, Russian Federation|A.N. Ryzhikh State Research Center for Coloproctology, Moscow, Russian Federation|Railway Station Clinical Hospital, Nizhny Novgorod, Russian Federation|Novosibirskiy Gastrocenter, Novosibirsk, Russian Federation|Medical Center Sibnovomed LLC, Novosibirsk, Russian Federation|Scientific Research Institute of Physiology and Basic Medicine, Novosibirsk, Russian Federation|Euromed Multi-Specialty Center for Contemporary Medicine LLC, Omsk, Russian Federation|Medical Diagnostic Center LLC, Orenburg, Russian Federation|N.N. Burdenko Penza Regional Clinical Hospital, Penza, Russian Federation|Republican Hospital na VA Baranov, Petrozavodsk, Russian Federation|Evromedservis, Pushkin, Russian Federation|Clinic UZI 4D, LLC, Pyatigorsk, Russian Federation|Pyatigorsk City Hospital 2, Pyatigorsk, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|Medical Center Reavita Med Spb LLC, Saint Petersburg, Russian Federation|City Clinical Hospital No 31 - St. Petersburg, Saint Petersburg, Russian Federation|S.M. Kirov Military Medical Academy, Saint-Petersburg, Russian Federation|Medical University REAVIZ, Samara, Russian Federation|Samara Station Railway Clinical Hospital under OAO Russian Railways, Samara, Russian Federation|Regional Clinical Hospital, Saratov, Russian Federation|Sochi City Hospital No 5, Sochi, Russian Federation|S.M. Kirov Military Medical Academy, St Petersburg, Russian Federation|Oncology Center of Moskovskiy District, St Petersburg, Russian Federation|City Outpatient Care Unit No 38, St. Petersburg, Russian Federation|I.I. Mechnikov North-Western State Medical University, St. Petersburg, Russian Federation|State Unitary Enterprise Passengeravtotrans, St. Petersburg, Russian Federation|Clinical and Diagnostic Center with an outpatient department under the Presidential Executive Office, St. Petersburg, Russian Federation|SPb SBIH City Hospital of Saint Martyr Elizaveta, St. Petersburg, Russian Federation|Medical Center Eko-Bezopasnost LLC, St. Petersburg, Russian Federation|Budget Institution of the Khanty-Mansiysk Autonomous Okrug - Ugra Surgut Regional Clinical Hospital, Surgut, Russian Federation|Tomsk Regional Clinical Hospital, Tomsk, Russian Federation|Tula Regional Clinical Hospital, Tula, Russian Federation|G.G. Kuvatov Republican Clinical Hospital, Ufa, Russian Federation|City Clinical Hospital #21, Ufa, Russian Federation|Ulyanovsk Regional Clinical Hospital, Ulyanovsk, Russian Federation|Novgorod Regional Clinical Hospital, Veliky Novgorod, Russian Federation|Regional Clinical Hospital, Vladimir, Russian Federation|Primorsky Regional Clinical Hospital No.1, Vladivostok, Russian Federation|Medical Center of Far-Eastern Federal University, Vladivostok, Russian Federation|Medical Scientific Manufacturing Association Dvizheniye Clinic, Volgograd, Russian Federation|King Fahad Specialist Hospital, Dammam, Saudi Arabia|King Abdul Aziz University Hospital, Jeddah, Saudi Arabia|King Saud Medical Complex, Riyadh, Saudi Arabia|King Fahad National Guard Hospital, Riyadh, Saudi Arabia|Clinical Hospital Center Bezanijska Kosa, Clinic of Internal Medicine, Belgrade, Serbia|Clinical Hospital Center - Dr. Dragisa Misovic-Dedinje, Belgrade, Serbia|Clinical Hospital Center Zvezdara Clinic of Internal Diseases, Belgrade, Serbia|Military Medical Academy, Clinic of Gastroenterology and Hepatology, Belgrade, Serbia|Clinical Center Kragujevac, Kragujevac, Serbia|Clinical Center of Vojvodina, Clinic of Gastroenterology and Hepatology, Novi Sad, Serbia|General Hospital Pancevo, Pancevo, Serbia|General Hospital Djordje Jovanovic Zrenjanin, Zrenjanin, Serbia|Cliniq, s.r.o., Bratislava, Slovakia|Univerzitna nemocnica Bratislava, Nemocnica Ruzinov, Bratislava, Slovakia|Brezno gastroenterology center s.r.o., Brezno, Slovakia|KM Management, spol. s r.o., Nitra, Slovakia|Gastromedic s.r.o., Nove Zamky, Slovakia|GASTRO I., s.r.o., Presov, Slovakia|World of the Health Inc. General Hospital Rimavska Sobota, Rimavska Sobota, Slovakia|General Hospital Celje, Celje, Slovenia|Ahmed Kathrada Private Hospital, Gauteng, South Africa|Emmed Research, Pretoria, South Africa|General University Hospital of Alicante, Alicante, Spain|University Hospital Germans Trias i Pujol, Badalona, Spain|Teknon Medical Center, Barcelona, Spain|University Hospital Reina Sofia, Cordoba, Spain|University Hospital of Girona Dr. Josep Trueta, Girona, Spain|University Hospital of the Canary Islands (HUC) La Laguna, La Laguna, Spain|Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain|University Hospital de La Princesa, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|University Hospital La Paz, Madrid, Spain|University Hospital Puerta de Hierro Majadajonda, Majadahonda, Madrid, Spain|University Hospital Marques de Valdecilla (HUMV), Santander, Spain|University Hospital Virgen Macarena, Sevilla, Spain|University Hospital Virgen del Rocio, Sevilla, Spain|University Clinical Hospital of Valencia, Valencia, Spain|Viladecans Hospital, Viladecans, Spain|University Hospital Miguel Servet, Zaragoza, Spain|Saint Goran Hospital, Stockholm, Sweden|Ersta Hospital, Stockholm, Sweden|Lindenhofspital, Bern, Switzerland|Cantonal Hospital Saint Gallen, St.Gallen, Switzerland|University Hospital Zurich, Zurich, Switzerland|Kaohsiung Medical University Hospital, Kaohsiung, San Ming Dist., Taiwan|E-DA Hospital, Kaohsiung, Taiwan|Bulent Ecevit Universitesi Uygulama ve Arastirma Hastanesi, Kozlu, Taiwan|Chang Gung Medical Foundation, Kaohsiung Memorial Hospital, Niao-Sung Hsiang Kaohsiung County, Taiwan|National Cheng Kung University Hospital, Tainan, Taiana, Taiwan|Chang Gung Memorial Hospital- Linkou, Taoyuan City, Taiwan|Taipei Veterans General Hospital, Tapei, Beitou Dist., Taiwan|National Taiwan University Hospital, Tapei, Taiwan|Hacettepe Universitesi, Ankara, Turkey|Ankara University Medical Faculty Cebeci Hospital, Ankara, Turkey|Uludag Universitesi Tip Fakultesi, Bursa, Turkey|Firat University Medical Faculty, Elazig, Turkey|Bezmialem Foundation University Medical Faculty, Istanbul, Turkey|Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey|Sultan Abdulhamid Han Egitim ve Arastirma Hastanesi, Istanbul, Turkey|Marmara University, Istanbul, Turkey|Istanbul Medeniyet Uni Goztepe Training&Res Hosp, Istanbul, Turkey|Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Kadiköy/Istanbul, Turkey|Karadeniz Teknik Universitesi Tip Fakultesi Farabi Hastanesi, Trabzon, Turkey|Chernivtsi Regional Clinical Hospital, Chernivtsi, Ukraine|Chernivtsi Regional Clinical Hospital, Chernivtsi, Ukraine|Dnipropetrovsk II Mechnykov Regional Clinical Hospital Surgery Department 2, Dnipropetrovsk, Ukraine|Si Institute Of Gastroenterology Of Namsu Dept Of Stomach And Duodenum Diseases, Dnipropetrovsk, Ukraine|Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, Ukraine|Ivano-Frankivsk Central City Clinical Hospital, Ivano-Frankivsk, Ukraine|V.T. Zaitsev Institute of General and Emergency Surgery, Kharkiv, Ukraine|Kharkiv City Clinical Hospital 2, Kharkiv, Ukraine|Khmelnytskyi Regional Hospital, Khmelnytskyi, Ukraine|Medical and Diagnostic Center Acinus, Kropyvnytskyi, Ukraine|Medical Center Medical Clinic Blagomed LLC, Kyiv, Ukraine|Kyiv City Clinical Hospital #18, Kyiv, Ukraine|Kyiv City Clinical Hospital #18, Kyiv, Ukraine|BIK-KYIV Ukrainian German Gastroenterology Center, Kyiv, Ukraine|Medical Center Consilium Medical, Kyiv, Ukraine|Ok Clinic Medical Center within International Institute of Clinical Trials, LLC, Kyiv, Ukraine|Kyiv Regional Hospital #2, Kyiv, Ukraine|Kyiv Regional Clinical Hospital, Kyiv, Ukraine|Volyn Regional Clinical Hospital, Lutsk, Ukraine|Lviv Regional Clinical Hospital, Lviv, Ukraine|Public City Clinical Hospital of Emergency Medical Care, Lviv, Ukraine|Odesa Regional Clinical Hospital Regional Gastroenterology Center Surgery Department, Odesa, Ukraine|Poltava M.V. Sklifosovskyi Regional Clinical Hospital under Poltava Regional Council, Poltava, Ukraine|Ternopil City Public Emergency Medical Care Hospital, Ternopil, Ukraine|Vinnytsia City Clinical Hospital #1, Vinnytsia, Ukraine|Vinnytsia M.I. Pyrohov Regional Clinical Hospital, Vinnytsia, Ukraine|Health Clinic, LLC, Vinnytsya, Ukraine|Multidisciplinary Clinic of the St. Nicholas, LLC, Zaporizhia, Ukraine|Zaporizhzhya Regional, Zaporizhzhya, Ukraine|First Private Clinic, Zhytomyr, Ukraine|Bristol Royal Infirmary, Bristol, United Kingdom|Ulster Hospital, Dundonald, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom|Victoria Hospital Blackpool, Lancashire Blackpool, United Kingdom|Royal London Hospital, London, United Kingdom|University College London Hospitals NHS Foundation Trust - University College Hospital, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital, London, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom|Royal Shrewsbury Hospital, Shrewsbury, United Kingdom|University Hospital Southampton NHS Foundation Trust - Southampton General Hospital, Southampton, United Kingdom|Torbay Hospital, Torquay, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03464097"
617,"NCT03458195","Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group","POP-REMIND","Recruiting","No Results Available","Crohn Disease","Other: bio-banking collection","Ileal Crohn's disease classification|Postoperative recurrence study|Study of Treatments efficacy to prevent recurrence|Identification of biomarkers which could predict postoperative recurrence and response to treatments","Saint-Louis Hospital, Paris, France","All","18 Years to 100 Years   (Adult, Older Adult)","Not Applicable","575","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","POP STUDY - REMIND","December 10, 2009","December 2025","December 2026","March 8, 2018",,"March 17, 2021","SART Tilman Hospital, Liège, Belgium|Amiens Hospital, Amiens, France|Haut-levêque Hospital, Bordeaux, France|Clermont-Ferrand Hospital, Clermont-Ferrand, France|Beaujon Hospital, Clichy, France|Henri Mondor Hospital, Créteil, France|Kremlin-Bicêtre Hospital, Le Kremlin-Bicêtre, France|Lille Hospital, Lille, France|Hôpital Nord, CHU Marseille, Marseille, France|Montpellier Hospital, Montpellier, France|Brabois Hospital, Nancy, France|Nantes Hospital, Nantes, France|Archet 2 Hospital, Nice, France|Saint Louis Hospital, Paris, France|Saint Antoine Hospital, Paris, France|South Lyon Hospital, Pierre-Bénite, France|Strasbourg Hospital, Strasbourg, France",,"https://ClinicalTrials.gov/show/NCT03458195"
618,"NCT03440385","Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Drug: Ozanimod|Other: Placebo","Proportion of subjects with a CDAI score < 150|Proportion of subjects with average daily abdominal pain score ≤ 1 point, and average daily stool frequency score ≤ 3 points with abdominal pain and stool frequency no worse than baseline|Proportion of subjects with a Simple Endoscopic Score for Crohn's Disease (SES-CD) score decrease from baseline of ≥ 50%|Proportion of subjects with CDAI reduction from baseline of ≥ 100 points or CDAI score < 150|Proportion of subjects with CDAI reduction from baseline of ≥ 100 points or CDAI score < 150 and SES-CD decrease from baseline of ≥ 50%|Proportion of subjects with CDAI score < 150 at Week 12 and SES-CD decrease from baseline of ≥ 50%|Proportion of subjects with an average daily abdominal pain score ≤ 1 point, and average daily stool frequency score ≤ 3 points and both no worse than baseline AND an SES-CD ≤ 4 points and decrease ≥2 points|Proportion of subjects with an average daily abdominal pain score ≤ 1 point, and average daily stool frequency score ≤ 3 points and both no worse than baseline AND an SES-CD decrease from baseline of ≥ 50%|Histologic Improvement based on differences between ozanimod and placebo in histologic disease activity scores (ie, Global Histologic Disease Activity Score changes (Geboes, 2000)|Proportion of subjects with CDAI reduction from baseline of ≥ 70 points|Proportion of subjects with absence of ulcers ≥ 0.5 cm with no segment with any ulcerated surface ≥ 10%|Proportion of subjects with a Crohn's Disease Endoscopic Index of Severity (CDEIS) decrease from baseline of ≥ 50%|Proportion of adolescent subjects with clinical remission, defined as Pediatric Crohn's Disease Activity Index (PCDAI) ≤ 10 points|Proportion of adolescent subjects with clinical response, defined as a decrease in PCDAI ≥ 15 points from baseline|Assessment of circulating lymphocyte concentration|Assessment of gene expression|Assessment of protein biomarker concentration|Assessment of pharmacogenetics|Assessment of impact of SARS-CoV-2 serologic status on subjects receiving ozanimod and CD","Celgene","All","12 Years to 75 Years   (Child, Adult, Older Adult)","Phase 3","600","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","RPC01-3202|U1111-1203-7949|2017-004293-33","March 7, 2018","April 11, 2023","July 10, 2023","February 22, 2018",,"March 3, 2021","HonorHealth Research Institute, Scottsdale, Arizona, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, United States|UCSD Medical Center, La Jolla, California, United States|OM Research, Lancaster, California, United States|Southern California Research Institute Medical Group, Inc., Los Angeles, California, United States|Matrix Clinical Research Inc, Los Angeles, California, United States|Facey Medical Foundation (Parent), Mission Hills, California, United States|Havana Research Institute LLC, Pasadena, California, United States|Sutter Medical Group, Roseville, California, United States|UC Davis Health - Gastroenterology and Hepatology Clinical Trials Unit, Sacramento, California, United States|University of California at San Francisco, San Francisco, California, United States|New Hope Research Development, West Covina, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Connecticut Clinical Research Foundation, Bristol, Connecticut, United States|Clinical Research of West Florida, Clearwater, Florida, United States|South Lake Pain Institute, Clermont, Florida, United States|American Research Institute Inc, Cutler Bay, Florida, United States|Universal Axon Clinical Research, Doral, Florida, United States|Riverside Clinical Research, Edgewater, Florida, United States|SIH Research, Kissimmee, Florida, United States|Pioneer Clinical Research, Lighthouse Point, Florida, United States|Center For Advanced Gastroenterology, Maitland, Florida, United States|Galiz Research LLC, Miami Springs, Florida, United States|LMG Research, Miami, Florida, United States|Life Medical Center & Research, Inc., Miami, Florida, United States|Vista Health Research, Miami, Florida, United States|Bayside Clinical Research, New Port Richey, Florida, United States|Omega Research Maitland, LLC, Orlando, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Theia Clinical Research, LLC, Pinellas Park, Florida, United States|Precision Clinical Research, LLC., Sunrise, Florida, United States|University of South Florida, Tampa, Florida, United States|Apex Clinical Research, Tampa, Florida, United States|Guardian Angel Health Svcs Inc, Tampa, Florida, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Emory Clinic, Atlanta, Georgia, United States|Atlanta Center For Gastroenterology, P.C., Decatur, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|University of Chicago, Chicago, Illinois, United States|MediSphere Medical Research Center, LLC, Evansville, Indiana, United States|Indiana University, Indianapolis, Indiana, United States|Cotton ONeil Clinical Research Center Digestive Health, Topeka, Kansas, United States|Gastroenterology Associates, LLC, Baton Rouge, Louisiana, United States|Clinical Trials of SW Louisiana LLC, Lake Charles, Louisiana, United States|Tandem Clinical Research, LLC, Marrero, Louisiana, United States|Harvard Medical School - Boston Children's Hospital, Boston, Massachusetts, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States|Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, United States|Henry Ford Medical Center - New Center One, Novi, Michigan, United States|University of Minnesota Medical Center, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Mid America Gastrointestinal Consultants, Kansas City, Missouri, United States|Internal Medicine Specialists, Las Vegas, Nevada, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Drug Trials America, Hartsdale, New York, United States|Weill Cornell Medical College, New York, New York, United States|Concorde Medical Group, New York, New York, United States|TrialSpark, New York, New York, United States|DiGiovanna Institute for Medical Education And Research, North Massapequa, New York, United States|PMG Research of Charlotte LLC, Charlotte, North Carolina, United States|PMG Research of Winston-Salem LLC, Winston-Salem, North Carolina, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Advance Clinical Research - Dayton Internal Medicine, Dayton, Ohio, United States|Ohio State University Wexner Medical Center, Hilliard, Ohio, United States|Paramount Medical Research & Consulting, LLC, Middleburg Heights, Ohio, United States|Cancer Care Associates of OK-N PorterAvenue, Norman, Oklahoma, United States|Allergy, Asthma and Immunology Center, PC, Tulsa, Oklahoma, United States|Central States Research, LLC, Tulsa, Oklahoma, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|San Antonio Military Medical Center, Fort Sam Houston, Texas, United States|Centex Studies, Inc., Houston, Texas, United States|The Coastal Medical Group, Houston, Texas, United States|Gulf Coast Research Group LLC, Houston, Texas, United States|Accurate Clinical Research Inc, Pasadena, Texas, United States|DHAT Research Institute, Richardson, Texas, United States|San Antonio Gastroenterology, San Antonio, Texas, United States|Baylor Scott and White Health, Temple, Texas, United States|Blue Ridge Medical Research, Lynchburg, Virginia, United States|The Gastroenterology Group, Reston, Virginia, United States|McGuire Veterans Affairs Medical Center, Richmond, Virginia, United States|Carilion Clinic, Roanoke, Virginia, United States|Franciscan Skemp Healthcare, La Crosse, Wisconsin, United States|Liverpool Hospital, Liverpool, New South Wales, Australia|John Hunter Hospital and Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia|Coastal Digestive Health, Maroorchydore, Queensland, Australia|University of the Sunshine Coast, North Mackay, Queensland, Australia|Mater Hospital Brisbane, South Brisbane, Queensland, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|Monash Medical Centre, Clayton, Victoria, Australia|St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|St John of God Subiaco Hospital, Subiaco, Western Australia, Australia|Medical University Innsbruck, Innsbruck, Austria|University Hospital St. Poelten, St Polten, Austria|Medical University Vienna, Vienna, Austria|MHAT Ruse AD, Ruse, Bulgaria|Excelsior Medical Center, Sofia, Bulgaria|Multiprofile Hospital for Active Treatment Tokuda Hospital Sofia, Sofia, Bulgaria|Diagnostic and Consulting Center Alexandrovska, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD, Sofia, Bulgaria|West Edmonton Gastroenterology Consultants, Edmonton, Alberta, Canada|Fraser Clinical Trials Inc., New Westminister, British Columbia, Canada|GI Research Institute, Vancouver, British Columbia, Canada|Brandon Medical Arts Clinic, Brandon, Manitoba, Canada|IWK Health Center, Halifax, Nova Scotia, Canada|Dr.Garisa Jagan Mohan Reddy MD, Sudbury, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Kensington Screening Clinic, Toronto, Ontario, Canada|Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada|The Ottawa Hospital - General Campus, Ottawa, Quebec, Canada|Peking University First Hospital, Beijing, China|Peking University People's Hospital, Beijing, China|Beijing YouYi Hospital-Beijing Friendship Hospital Capital Medical University, Beijing, China|The Seventh Medical Center of PLA General Hospital, Beijing, China|First Hospital of Jilin University, Changchun, China|Guangzhou First People's Hospital, Guangzhou Shi, China|Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China|Anhui Provincial Hospital, Hefei, China|The First Affiliated Hospital of Nanchang University, Nanchang, China|Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China|Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China|China Medical University Hospital, Taichung City, China|Wuhan Union Hospital, Wuhan, China|Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China|Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou, China|The Second Affiliated Hospital Of Zhengzhou University, Zhengzhou, China|Helsinki University Central Hospital (HUCH), Helsinki, Finland|Centre Hospitalier de Blois, Blois Cedex, France|Beziers Hospital, Béziers, France|University Hospital Center Caen, Caen, France|Assistance Publique - Hopitaux de Paris - Hopital Beaujon, Clichy, France|Louis Mourier Hospital, Colombes, France|CHU Nantes University Hospital - Hotel Dieu Hospital, Nantes, France|South Lyon Hospital Center, Pierre-Benite, France|Saint-Etienne University Hospital Center, Saint Priest en Jarez, France|JSC Evex Medical Corporation - Batumi Referral Hospital, Batumi, Georgia|JSC Evex Medical Corporation - Oncology Center, Kutaisi, Georgia|Helsicore - Israeli Georgian Medical Research Clinic, Tbilisi, Georgia|LLC Vivamedi, Tbilisi, Georgia|Tbilisi State Medical University, Tbilisi, Georgia|LTD Institute of Clinical Cardiology, Tbilisi, Georgia|JSC Infectious Disease, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia|LTD Academician N.Kipshidze Central University Clinic, Tbilisi, Georgia|LTD Aversi Clinic, Tbilisi, Georgia|LTD MediClub Georgia, Tbilisi, Georgia|David Tatishvili Medical Center, Tbilisi, Georgia|JSC Evex Medical Corporation - Telavi Referral Hospital, Telavi, Georgia|Gastroenterological Special Practice at Wittenbergplatz, Berlin, Germany|Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany|Charite - Universitätsmedizin Berlin, Berlin, Germany|Hospital Waldfriede e.V., Berlin, Germany|Brandenburg City Hospital, Brandenburg an der Havel, Germany|Medical Care Unit Dachau, Dachau, Germany|Klinikum Darmstadt, Darmstadt, Germany|Kliniken Essen-Mitte, Essen, Germany|Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany|Studiengesellschaft BSF, Halle, Germany|University Hospital Halle (Saale), Halle, Germany|Asklepios Klinik Hamburg, Hamburg, Germany|Universitatsklinikum Schleswig-Holstein, Keil, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, Germany|University Hospital Muenster, Muenster, Germany|Universitaetsklinikum Charite - Ruppiner Kliniken GmbH, Neuruppin, Germany|Robert-Bosch-Hospital, Stuttgart, Germany|Laiko General Hospital of Athens, Athens, Greece|Sotiria Chest Diseases Hospital of Athens, Athens, Greece|Tzanio General Hospital of Piraeus, Athens, Greece|PAGNI University Hospital, Heraklion, Greece|General Hospital of Thessaloniki Hippokration, Thessaloniki, Greece|424th Army General Hospital, Thessaloniki, Greece|Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaz, Bekescsaba, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary|Semmelweis Egyetem - Altalanos Orvostudomanyi Kar, Budapest, Hungary|Petz Aladar Megyei Oktato Korhaz,II. Belgyogyaszat, Gyor, Hungary|CRU Hungary Kft, Miskolc, Hungary|Kanizsai Dorottya Hospital, Nagykanizsa, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Szekesfehervar, Hungary|Clinfan Ltd, Szekszárd, Hungary|Csongrad County Dr. Bugyi Istvan Hospital, Szentes, Hungary|Zala Megyei KorhazHaematologia, Zalaegerszeg, Hungary|Institute of Gastroenterology and Hepatology at Ha'Emek Medical Center, Afula, Israel|Asaf Harofeh Medical Center, Beer Jacob, Israel|Rambam Health Care Campus, Haifa, Israel|Clalit Health Services, Jerusalem, Israel|Meir Medical Center, Kfar-Saba, Israel|Rabin Medical Center, Petah Tikva, Israel|Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel|Pusan National University Hospital, Busan, Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Yeungnam University Medical Center, Daegu, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|St. Vincent's Hospital, Suwon, Korea, Republic of|Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania|Klaipeda University Hospital, Klaipeda, Lithuania|Vilnius University Hospital Santariskes Clinics, Vilnius, Lithuania|Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania|Vilnius City Clinical Hospital, Vilnius, Lithuania|Vrije Universiteit Medisch Centrum (VUMC), Amsterdam, Netherlands|Academisch Medisch Centrum, Amsterdam, Netherlands|UMC Groningen, Groningen, Netherlands|Radboud University Medical Center, Nijmegen, Netherlands|Zuyderland Medisch Centrum, Sittard-Geleen, Netherlands|St. Elisabeth Ziekenhuis, Tilburg, Netherlands|St. John Paul 2nd Municipal Hospital in Elblag, Elblag, Poland|Nicolaus Copernicus Hospital, Gdansk, Poland|Private Medical Practice Miroslaw Fic, Jelenia Gora, Poland|BioVirtus Medical Centre, Jozefow, Poland|Centrum Opieki Zdrowotnej Orkan Med, Ksawerow, Poland|LUX MED Centrum Medyczne - Lodz, Lodz, Poland|Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland|Non-Public Healthcare Facility Allmedica Clinical Trials, Nowy Targ, Poland|Office of Bartosz Korczowski, MD, Rzeszow, Poland|Endoskopia Sp. z o.o., Sopot, Poland|TWOJA PRZYCHODNIA Medical Centre of Szczecin LLC, Szczecin, Poland|WIP Warsaw IBD Point, Warsaw, Poland|PRIMA LCC Specialist Clinics, Warsaw, Poland|Children's Memorial Health Institute, Warsaw, Poland|Endoterapia PFG LLC, Endotherapy PFG Outpatient Clinic Branch No 1, Warszawa, Poland|Health Centre Metabolic Diseases Outpatient Clinic in Wierzchoslawice, Wierzchoslawice, Poland|LUX MED Centrum Medyczne - Wroclaw, Wroclaw, Poland|Wroclaw Medical University, Wroclaw, Poland|Jan Mikulicz Radecki University Hospital, Wroclaw, Poland|Clinical Research Center Early-Phase Research Facility, Wroclaw, Poland|LexMedica, Wroclaw, Poland|Ars Medica, Wroclaw, Poland|EMC Medical Institute S.A, Wroclaw, Poland|Hospital Universitario de Coimbra- Hospitais de Universidade de Coimbra, Coimbra, Portugal|Centro Hospitalar do Alto Ave, Hospital da Senhora da Oliveira Guimaraes, Guimaraes, Portugal|Hospital Beatriz Angelo, Loures, Portugal|Centro Hospitalar do Alto Minho - Unidade Local de Saúde do Alto Minho, EPE, Viana do Castelo, Portugal|Joint Venture Company Diagnostic Center, Bioterm Ltd., Barnaul, Russian Federation|Territorial Clinical Hospital, Barnaul, Russian Federation|Regional Clinical Hospital #3, Chelyabinsk, Russian Federation|Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russian Federation|Ural State Medical Academy - Medical Association Novaya Bolnitsa, Ekaterinburg, Russian Federation|Immanuel Kant Baltic Federal University, Kaliningrad, Russian Federation|Kaluga Regional Hospital, Kaluga, Russian Federation|S.V. Beliaev Kemerovo Regional Clinical Hospital, Kemerovo, Russian Federation|City Clinical Hospital n.a. V.M. Buyanov, Moscow, Russian Federation|City Clinical Hospital 24, Moscow, Russian Federation|CJSC Nasledniki, Moscow, Russian Federation|A.N. Ryzhikh State Research Center for Coloproctology, Moscow, Russian Federation|Railway Station Clinical Hospital, Nizhny Novgorod, Russian Federation|Medical Center Sibnovomed LLC, Novosibirsk, Russian Federation|Scientific Research Institute of Physiology and Basic Medicine, Novosibirsk, Russian Federation|Euromed Multi-Specialty Center for Contemporary Medicine LLC, Omsk, Russian Federation|Medical Diagnostic Center LLC, Orenburg, Russian Federation|N.N. Burdenko Penza Regional Clinical Hospital, Penza, Russian Federation|City Clinical Hospital No 31 - St. Petersburg, Saint Petersburg, Russian Federation|S.M. Kirov Military Medical Academy, Saint-Petersburg, Russian Federation|Medical University REAVIZ, Samara, Russian Federation|Regional Clinical Hospital, Saratov, Russian Federation|Sochi City Hospital No 5, Sochi, Russian Federation|Oncology Center of Moskovskiy District, St Petersburg, Russian Federation|City Outpatient Care Unit No 38, St. Petersburg, Russian Federation|I.I. Mechnikov North-Western State Medical University, St. Petersburg, Russian Federation|State Unitary Enterprise Passengeravtotrans, St. Petersburg, Russian Federation|Medical Center Eko-Bezopasnost LLC, St. Petersburg, Russian Federation|Tomsk Regional Clinical Hospital, Tomsk, Russian Federation|G.G. Kuvatov Republican Clinical Hospital, Ufa, Russian Federation|Medical Scientific Manufacturing Association Dvizheniye Clinic, Volgograd, Russian Federation|Clinical Hospital Center Bezanijska Kosa, Clinic of Internal Medicine, Belgrade, Serbia|Clinical Hospital Center - Dr. Dragisa Misovic-Dedinje, Belgrade, Serbia|Clinical Hospital Center Zvezdara Clinic of Internal Diseases, Belgrade, Serbia|Military Medical Academy, Clinic of Gastroenterology and Hepatology, Belgrade, Serbia|Clinical Center Kragujevac, Kragujevac, Serbia|Clinical Center of Vojvodina, Clinic of Gastroenterology and Hepatology, Novi Sad, Serbia|General Hospital Pancevo, Pancevo, Serbia|General Hospital Djordje Jovanovic Zrenjanin, Zrenjanin, Serbia|Cliniq, s.r.o., Bratislava, Slovakia|Univerzitna nemocnica Bratislava, Nemocnica Ruzinov, Bratislava, Slovakia|Brezno gastroenterology center s.r.o., Brezno, Slovakia|KM Management, spol. s r.o., Nitra, Slovakia|Gastromedic s.r.o., Nove Zamky, Slovakia|GASTRO I., s.r.o., Presov, Slovakia|World of the Health Inc. General Hospital Rimavska Sobota, Rimavska Sobota, Slovakia|General Hospital Celje, Celje, Slovenia|Ahmed Kathrada Private Hospital, Gauteng, South Africa|Emmed Research, Pretoria, South Africa|Teknon Medical Center, Barcelona, Spain|University Hospital Reina Sofia, Cordoba, Spain|University Hospital of Girona Dr. Josep Trueta, Girona, Spain|Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain|Hospital Clinico San Carlos, Madrid, Spain|University Hospital Puerta de Hierro Majadajonda, Majadahonda, Madrid, Spain|University Hospital Marques de Valdecilla (HUMV), Santander, Spain|University Clinical Hospital of Valencia, Valencia, Spain|University Hospital Miguel Servet, Zaragoza, Spain|Saint Goran Hospital, Stockholm, Sweden|Ersta Hospital, Stockholm, Sweden|Kaohsiung Medical University Hospital, Kaohsiung, San Ming Dist., Taiwan|E-DA Hospital, Kaohsiung, Taiwan|Chang Gung Medical Foundation, Kaohsiung Memorial Hospital, Niao-Sung Hsiang Kaohsiung County, Taiwan|National Cheng Kung University Hospital, Tainan, Taiana, Taiwan|Chang Gung Memorial Hospital- Linkou, Taoyuan City, Taiwan|Taipei Veterans General Hospital, Tapei, Beitou Dist., Taiwan|National Taiwan University Hospital, Tapei, Taiwan|Hacettepe Universitesi, Ankara, Turkey|Firat University Medical Faculty, Elazig, Turkey|Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey|Sultan Abdulhamid Han Egitim ve Arastirma Hastanesi, Istanbul, Turkey|Istanbul Medeniyet Uni Goztepe Training&Res Hosp, Istanbul, Turkey|Chernivtsi Regional Clinical Hospital, Chernivtsi, Ukraine|Dnipropetrovsk II Mechnykov Regional Clinical Hospital Surgery Department 2, Dnipropetrovsk, Ukraine|Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, Ukraine|Kharkiv City Clinical Hospital 2, Kharkiv, Ukraine|Khmelnytskyi Regional Hospital, Khmelnytskyi, Ukraine|Medical and Diagnostic Center Acinus, Kropyvnytskyi, Ukraine|Medical Center Medical Clinic Blagomed LLC, Kyiv, Ukraine|Kyiv City Clinical Hospital #18, Kyiv, Ukraine|BIK-KYIV Ukrainian German Gastroenterology Center, Kyiv, Ukraine|Kyiv Regional Clinical Hospital, Kyiv, Ukraine|Volyn Regional Clinical Hospital, Lutsk, Ukraine|Lviv Regional Clinical Hospital, Lviv, Ukraine|Odesa Regional Clinical Hospital Regional Gastroenterology Center Surgery Department, Odesa, Ukraine|Vinnytsia M.I. Pyrohov Regional Clinical Hospital, Vinnytsia, Ukraine|Health Clinic, LLC, Vinnytsya, Ukraine|Multidisciplinary Clinic of the St. Nicholas, LLC, Zaporizhia, Ukraine|Zaporizhzhya Regional, Zaporizhzhya, Ukraine",,"https://ClinicalTrials.gov/show/NCT03440385"
619,"NCT03440372","Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Drug: Ozanimod|Other: Placebo","Proportion of subjects with a CDAI score < 150|Proportion of subjects with average daily abdominal pain score ≤ 1 point, and average daily stool frequency score ≤ 3 points with abdominal pain and stool frequency no worse than baseline|Proportion of subjects with a Simple Endoscopic Score for Crohn's Disease (SES-CD) score decrease from baseline of ≥ 50%|Proportion of subjects with CDAI reduction from baseline of ≥ 100 points or CDAI score < 150|Proportion of subjects with CDAI reduction from baseline of ≥ 100 points or CDAI score < 150 and SES-CD decrease from baseline of ≥ 50%|Proportion of subjects with CDAI score < 150 at Week 12 and SES-CD decrease from baseline of ≥ 50%|Proportion of subjects with an average daily abdominal pain score ≤ 1 point, and average daily stool frequency score ≤ 3 points and both no worse than baseline AND an SES-CD ≤ 4 points and decrease ≥2 points at week 12|Proportion of subjects with an average daily abdominal pain score ≤ 1 point, and average daily stool frequency score ≤ 3 points and both no worse than baseline AND an SES-CD decrease from baseline of ≥ 50% at week 12.|Histologic Improvement based on differences between ozanimod and placebo in histologic disease activity scores (ie, Global Histologic Disease Activity Score changes (Geboes, 2000)|Proportion of subjects with CDAI reduction from baseline of ≥ 70 points|Proportion of subjects with absence of ulcers ≥ 0.5 cm with no segment with any ulcerated surface ≥ 10%|Proportion of subjects with a Crohn's Disease Endoscopic Index of Severity (CDEIS) decrease from baseline of ≥ 50%|Proportion of adolescent subjects with clinical remission, defined as Pediatric Crohn's Disease Activity Index (PCDAI) ≤ 10 points at week 12|Proportion of adolescent subjects with clinical response, defined as a decrease in PCDAI ≥ 15 points from baseline|Assessment of circulating lymphocyte concentration|Assessment of gene expression|Assessment of protein biomarker concentration|Assessment of pharmacogenetics|Assessment of impact of SARS-CoV-2 serologic status on subjects receiving ozanimod and CD","Celgene","All","12 Years to 75 Years   (Child, Adult, Older Adult)","Phase 3","600","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","RPC01-3201|U1111-1203-7225|2017-004292-31","February 27, 2018","June 27, 2023","September 25, 2023","February 22, 2018",,"March 2, 2021","Holland Center for Family Health, Peoria, Arizona, United States|Elite Clinical Studies, LLC, Phoenix, Arizona, United States|Arkansas Gastroenterology, P.A., North Little Rock, Arkansas, United States|Sharp Chula Vista Medical Center, Chula Vista, California, United States|Valley View Internal Medicine, Garden Grove, California, United States|San Diego Clinical Trials, La Mesa, California, United States|Children's Hospital of Los Angeles, Los Angeles, California, United States|Gastrointestinal Biosciences, Los Angeles, California, United States|VA Northern California Health Care System, Mather, California, United States|ABS Health, LLC, Mission Viejo, California, United States|Alliance Clinical Research, Oceanside, California, United States|Palo Alto Center-Palo Alto Medical Foundation Research Institute, Palo Alto, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Medical Associates Research Group, San Diego, California, United States|Childrens Hospital Colorado, Aurora, Colorado, United States|Yale University, New Haven, Connecticut, United States|Gastro Florida, Clearwater, Florida, United States|University of Florida Health Endocrinology - Medical Specialties - Medical Plaza, Gainesville, Florida, United States|Qway Research LLC, Hialeah, Florida, United States|Floridian Clinical Research LLC, Hialeah, Florida, United States|Harmony Medical Research Institute, Hialeah, Florida, United States|The Center for Gastrointestinal Disorders, Hollywood, Florida, United States|Vista Health Research, Homestead, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|Nova Clinical Research Center LLC, Miami, Florida, United States|LCC Medical Research Institute, LLC, Miami, Florida, United States|Research Associates of South Florida LLC, Miami, Florida, United States|Advanced Research for Health Improvement, Naples, Florida, United States|NSB Research, New Smyrna Beach, Florida, United States|HMD Research LLC, Orlando, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Asclepes Research Centers, Weeki Wachee, Florida, United States|Consultative Gastroenterology, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, LLC, Atlanta, Georgia, United States|Children's Center for Digestive Healthcare, Atlanta, Georgia, United States|Gastrointestinal Disease Research, Columbus, Georgia, United States|Gastroenterology Associates Of Central Georgia LLC, Macon, Georgia, United States|Rush University Medical Center - University Cardiovascular Surgeons, Chicago, Illinois, United States|Northwestern University, Chicago, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|Iowa Digestive Disease Center, Clive, Iowa, United States|University of Kentucky Health Care, Lexington, Kentucky, United States|CroNOLA LLC, Houma, Louisiana, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Nola Research Works, New Orleans, Louisiana, United States|LSU Health Sciences Center Shreveport, Shreveport, Louisiana, United States|Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|Digestive Disease Associates, PA, Catonsville, Maryland, United States|Woodholme Gastroenterology Associates, Glen Burnie, Maryland, United States|Brigham and Women's Hospital - Crohn's and Colitis Center, Chestnut Hill, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Medex Research Institute, Caro, Michigan, United States|Revive Research Institute, Southfield, Michigan, United States|Southern Therapy and Advanced Research, Jackson, Mississippi, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Englewood Hospital and Medical Center, Englewood, New Jersey, United States|University of New Mexico Hospital, Albuquerque, New Mexico, United States|Advantage Clinical Trials, Bronx, New York, United States|NY Scientific, Brooklyn, New York, United States|Adirondack Medical Research Center, Glens Falls, New York, United States|Northwell Health, Great Neck, New York, United States|Cornell University, New York, New York, United States|Lenox Hill Hospital, New York, New York, United States|Circuit Clinical, Orchard Park, New York, United States|Asheville Gastroenterology Associates, P.A., Asheville, North Carolina, United States|Carolinas HealthCare System Digestive Health, Charlotte, North Carolina, United States|Internal Medicine Research, Charlotte, North Carolina, United States|Carolina Research Center, Greenville, North Carolina, United States|Great Lakes Medical Research, LLC, Beachwood, Ohio, United States|Cleveland Clinic - Taussig Cancer Institute, Cleveland, Ohio, United States|Great Lakes Gastroenterology, Mentor, Ohio, United States|Great Lakes Medical Research, LLC, Warren, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Digestive Disease Specialists, Oklahoma City, Oklahoma, United States|Oregon Health & Science University, Portland, Oregon, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|Penn State University Milton S Hershey Medical Center, State College, Pennsylvania, United States|Quality Medical Research, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Advanced Gastroenterology, Union City, Tennessee, United States|Avant Research Associates, LLC - Austin, Austin, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Biopharma Informatic Inc. Research Center, Houston, Texas, United States|GI Specialists of Houston, Houston, Texas, United States|Premier Vein and Vascular Center, Houston, Texas, United States|Sun Research Institute, San Antonio, Texas, United States|Texas Digestive Disease Consultants - Southlake, Southlake, Texas, United States|Digestive Health Specialists of Tyler, Tyler, Texas, United States|University of Utah School of Medicine, Salt Lake City, Utah, United States|Gastroenterology Associates, PC, Gainesville, Virginia, United States|Summit Clinical Research, LLC, Petersburg, Virginia, United States|Virginia Gastroenterology Institute PC, Suffolk, Virginia, United States|University of Washington Medical Center, Seattle, Washington, United States|Dermatologist Specialists of Spokane, Spokane, Washington, United States|Aurora Health Care Aurora Research, Grafton, Wisconsin, United States|Sanatorio Guemes, Ciudad Autonoma de Buenos Aires, Argentina|Hospital Privado Centro Medico de Cordoba, Cordoba, Argentina|Instituto Medico de la Fundacion Estudios Clinicos, Rosario, Argentina|Universidad Nacional De Rosario - Hospital Provincial Del Centenario, Rosario, Argentina|Sanatorio 9 de Julio - CICE 9 de Julio, San Miguel de Tucuman, Argentina|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|Wollongong Hospital, Wollongong, New South Wales, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|The Queen Elizabeth Hospital, Woodville South, South Australia, Australia|Harry Perkins Medical Research Institute, Fiona Stanley Hospital, Murdoch, Western Australia, Australia|Ballarat Base Hospital, Ballarat, Australia|Grodno City Clinical Hospital #4, Grodno, Belarus|Vitebsk Regional Clinical Specialized Center, Vitebsk, Belarus|Algemeen Ziekenhuis Klina, Brasschaat, Belgium|Universitair Ziekenhuis Brussel, Brussels, Belgium|University Hospital Brussels, Brussels, Belgium|CHU Saint-Luc, Brussels, Belgium|Queen Fabiola Children's University Hospital, Brussels, Belgium|Universitair Ziehenhuis Antwerpen, Edegem, Belgium|Universitair Ziekenhuis Gent, Ghent, Belgium|Universitair Ziekenhuis Leuven, Campus Gasthuisberg, Leuven, Belgium|Clinique du Montlegia, Liege, Belgium|Sart Tilman Hospital Department of Gastroenterology and Hepatology, Seraing, Belgium|Hospital Centre of Walloon Picarde, Tournai, Belgium|University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina|University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina|Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina|General Hospital ""Prim.dr. Abdulah Nakas"", Sarajevo, Bosnia and Herzegovina|Multiprofile Hospital for Active Treatment Medline, Plovdiv, Bulgaria|Second MHAT Sofia AD, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Sveti Ivan Rilski EAD, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment ACIBADEM City Clinic Sofia, Sofia, Bulgaria|ACIBADEM City Clinic Medical Center Bregalnitsa, Varna, Bulgaria|University of Calgary Health - The Gastrointestinal Research Group (GIRG), Calgary, Alberta, Canada|Okanagan Clinical Trials Ltd, Kelowna, British Columbia, Canada|Vancouver Hospital Gastrointestinal Research Unit The Gordon and Leslie Diamond Centre, Vancouver, British Columbia, Canada|Winnipeg Clinic Dermatology Research, Winnipeg, Manitoba, Canada|Viable Clinical Research, Bridgewater, Nova Scotia, Canada|London Health Sciences Centre, University Hospital, London, Ontario, Canada|LHSC Victoria Hospital, London, Ontario, Canada|Toronto Digestive Disease Associates Inc, Vaughan, Ontario, Canada|Clinical Hospital Center Osijek, Osijek, Croatia|Clinical Hospital Centre Rijeka, Rijeka, Croatia|Clinical Hospital Center Split, Split, Croatia|Clinical Hospital Center Sestre milosrdnice Clinic of Internal Diseases, Zagreb, Croatia|Clinical Hospital Dubrava, Zagreb, Croatia|University Hospital Centre Zagreb, Clinic of Internal Diseases, Zagreb, Croatia|Military Hospital Brno, Brno, Czechia|St. Anne's University Hospital Brno, Brno, Czechia|Hepato-Gastroenterologie HK, s. r. o., Hradec Králové, Czechia|Soukroma Gastroenterologicka ambulance a endoskopie, Most, Czechia|PreventaMed, Olomouc, Czechia|Krajská nemocnice Pardubice, Kožní oddelení, Pardubice, Czechia|University Hospital Pilsen, Plzen, Czechia|University Hospital Motol, Prague 5, Czechia|ISCARE, a.s., Prague 9, Czechia|Institut klinicke a experimentalni mediciny, Praha 4, Czechia|Bispebjerg Hospital, Copenhagen, Denmark|Holbaek Hospital, Holbaek, Denmark|Nykobing F Hospital, Nykobing F, Denmark|Turku University Hospital, Turku, Finland|CHU Amiens Picardie - Site Sud, Amiens cedex 1, France|Centre Hospitalier Intercommunal de Creteil, Creteil Cedex, France|CHU de Dijon Bourgogne - Hopital Francois Mitterand, Dijon Cedex, France|CHU de Grenoble Alpes, Grenoble Cedex 9, France|CHRU de Lille - Hopital Claude Huriez, Lillie Cedex, France|Hopital Nord, Marseille cedex 20, France|Hospital Pontchaillou, Rennes, France|CHU de Rouen Hopital Charles Nicolle, Rouen Cedex, France|CHU de Toulouse Hopital Rangueil, Toulouse Cedex 09, France|Charite - Universitaetsmedizin Berlin, Berlin, Germany|Gastroenterology Am Bayerischen Platz, Berlin, Germany|DRK Clinics Berlin, Berlin, Germany|Agaplesion Markus Krankenhaus, Frankfurt, Germany|Interdisciplinary Crohn Colitis Center Rhein Main, Frankfurt, Germany|University Hospital Hamburg-Eppendorf, Hamburg, Germany|Universitaetsklinikum Leipzig AoeR, Leipzig, Germany|Practice for Gastroenterology and Internal Medicine, Ludwigshafen am Rhein, Germany|St Marien und St Annastiftskrankenhaus, Ludwigshafen am Rhein, Germany|Synesis Research Center, Munich, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Germany|Universitaetsklinikum Ulm, Ulm, Germany|St Vincent's University Hospital, Dublin 4, Dublin, Ireland|Beaumont Hospital, Dublin 9, Ireland|Bat Yamon Medical Center, Clalit Medical Services, Bat Yam, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Galilee Medical Center, Nahariya, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Kaplan Medical Center, Rechovot, Israel|University Polyclinic Hospital of Bari, Bari, Italy|Polyclinic S. Orsola-Malpighi, Bologna, Italy|Civil Hospital of Brescia, Brescia, Italy|Poliambulanza Hospital, Brescia, Italy|IRCCS ""Savario De Bellis"", Castellana Grotte, Italy|University Hospital Mater Domini, Catanzaro, Italy|""Ss. Annunziata"" Policlinic of Chieti, Chieti, Italy|University Polyclinic Hospital G. Martino, Messina, Italy|Maggiore Polyclinic Hospital, IRCCS Ca' Granda, Milano, Italy|Humanitas Research Hospital - Humanitas Mirasole S.p.A, Milan, Italy|Azienda Socio Sanitaria Territoriale (ASST) di Monza, Monza, Italy|Hospital of Di Padova, Padova, Italy|United Hospitals Villa Sofia Cervello, Palermo, Italy|Polyclinic San Matteo IRCCS, Pavia, Italy|Polyclinic Tor Vergata, Roma, Italy|Univerisity Polyclinic Foundation Agostino Gemelli, Roma, Italy|Azienda Ospedaliera San Camillo Forlanini, Rome, Italy|Integrated University Hospital Santa Maria della Misericordia of Udine, Udine, Italy|A.O. Universitaria Fondazione Macchi, Varese, Italy|Sacred Heart Don Calabria, Verona, Italy|Korea University Medical Center - Korea University Ansan Hospital, Ansan, Korea, Republic of|Hanyang University Guri Hospital, Guri-si, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of|P. Stradins Clinical University Hospital, Riga, Latvia|Digestive Diseases Center Gastro, Riga, Latvia|Riga East Clinical University Hospital clinic Gailezers, Riga, Latvia|Investigacion Biomedica para el desarrollo de Farmacos, S.A. de C.V., Zapapan, Jalisco, Mexico|Centro Regiomontano de Estudios Clinicos Roma SC., Monterrey, Nuevo León, Mexico|Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Nuevo León, Mexico|SMIQ, Santiago de Queretaro, Querétaro, Mexico|Hospital Christus Muquerza del Parque S.A. de C.V., Chihuahua, Mexico|Centro de Investigacion Clinica Acelerada (CICA) S.C., Mexico, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Tlalpan, Mexico|""Sfanta Treime"" Clinical Municipal Hospital, Chisinau, Moldova, Republic of|Clinical Hospital of the Ministry of Health, Department of Endoscopic Surgery, Chisinau, Moldova, Republic of|""Sf. Arhanghel Mihail"" Municipal Clinical Hospital, Chisinau, Moldova, Republic of|Republican Clinical Hospital, Department of Colorectal Surgery, Chisinau, Moldova, Republic of|Republican Clinical Hospital, Chisinau, Moldova, Republic of|Akershus University Hospital, Lørenskog, Norway|Lovisenberg Diakonale Sykehus, Oslo, Norway|SP ZOZ Wojewodzki Szpital Zespolony im. J. Sniadeckiego, Bialystok, Poland|Medical Services Center MaxMed, Bochnia, Poland|Nzoz All-Medicus, Katowice, Poland|Kornel Gibinski Independent Public Central Clinical Hospital in Katowice, Katowice, Poland|GLOBE Clinical Research Sp. z o.o. LLC, Klodzko, Poland|PLEJADY Sp. z o.o. (LLC) Medical Centre, Krakow, Poland|Landa Specialist Doctor's Offices, Krakow, Poland|Krakow Medical Center LLC, Krakow, Poland|Santa Familia Centrum Badan, Profilaktyki i Leczenia, Lodz, Poland|Salve Limited Liability Company Limited Partnership, Outpatient Clinic, Lodz, Poland|1 Military Clinical Hospital in Lublin, Lublin, Poland|Provincial Specialist Hospital in Olsztyn, Olsztyn, Poland|SOLUMED Medical Center, Poznan, Poland|GASTROMED Kopon, Zmudzinski and Partners Specialist Centre for Gastroenterology and Endoscopy, Spe, Torun, Poland|H-T. Medical Center Sp. z o.o. LLC Limited Partnership, Tychy, Poland|Polimedica, Ul. Piotrkowska 177, Poland|Maternal Pediatric and Adolescent Healthcare Centre, Warsaw, Poland|Niepubliczny Zaklad Opieki Zdrowotnej VIVAMED, Warszawa, Poland|Hyperclinica MedLife Grivita, Bucharest, Romania|Center of Diagnosis and Treatment Provita, Bucharest, Romania|Fundeni Clinical Institute, Bucharest, Romania|Bucharest University Emergency Hospital, Department of Internal Medicine II, Bucharest, Romania|Dr. Carol Davila Central Military Emergency Clinical Hospital, Bucharest, Romania|Craiova County Emergency Clinical Hospital, Craiova, Romania|Colentina Clinical Hospital, Napoca, Romania|Targu Mures County Emergency Clinical Hospital, Targu Mures, Romania|Chita State Medical Academy, Chita, Russian Federation|Irkutsk State Medical Academy of Postgraduate Education, Irkutsk, Russian Federation|City Clinical Hospital No 7 - Kazan, Kazan, Russian Federation|Regional Clinical Hospital, Khanty-mansiysk, Russian Federation|Federal Siberian Research and Clinical Center, Krasnoyarsk, Russian Federation|Moscow Clinical Scientific and Practical Center, Moscow, Russian Federation|Novosibirskiy Gastrocenter, Novosibirsk, Russian Federation|Republican Hospital na VA Baranov, Petrozavodsk, Russian Federation|Evromedservis, Pushkin, Russian Federation|Clinic UZI 4D, LLC, Pyatigorsk, Russian Federation|Pyatigorsk City Hospital 2, Pyatigorsk, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|Medical Center Reavita Med Spb LLC, Saint Petersburg, Russian Federation|Samara Station Railway Clinical Hospital under OAO Russian Railways, Samara, Russian Federation|S.M. Kirov Military Medical Academy, St Petersburg, Russian Federation|Clinical and Diagnostic Center with an outpatient department under the Presidential Executive Office, St. Petersburg, Russian Federation|SPb SBIH City Hospital of Saint Martyr Elizaveta, St. Petersburg, Russian Federation|Budget Institution of the Khanty-Mansiysk Autonomous Okrug - Ugra Surgut Regional Clinical Hospital, Surgut, Russian Federation|Tula Regional Clinical Hospital, Tula, Russian Federation|City Clinical Hospital #21, Ufa, Russian Federation|Ulyanovsk Regional Clinical Hospital, Ulyanovsk, Russian Federation|Novgorod Regional Clinical Hospital, Veliky Novgorod, Russian Federation|Regional Clinical Hospital, Vladimir, Russian Federation|Primorsky Regional Clinical Hospital No.1, Vladivostok, Russian Federation|Medical Center of Far-Eastern Federal University, Vladivostok, Russian Federation|King Fahad Specialist Hospital, Dammam, Saudi Arabia|King Abdul Aziz University Hospital, Jeddah, Saudi Arabia|King Saud Medical Complex, Riyadh, Saudi Arabia|King Fahad National Guard Hospital, Riyadh, Saudi Arabia|General University Hospital of Alicante, Alicante, Spain|University Hospital Germans Trias i Pujol, Badalona, Spain|University Hospital of the Canary Islands (HUC) La Laguna, La Laguna, Spain|University Hospital de La Princesa, Madrid, Spain|University Hospital La Paz, Madrid, Spain|University Hospital Virgen Macarena, Sevilla, Spain|University Hospital Virgen del Rocio, Sevilla, Spain|Viladecans Hospital, Viladecans, Spain|Lindenhofspital, Bern, Switzerland|Cantonal Hospital Saint Gallen, St.Gallen, Switzerland|University Hospital Zurich, Zurich, Switzerland|Bulent Ecevit Universitesi Uygulama ve Arastirma Hastanesi, Kozlu, Taiwan|Ankara University Medical Faculty Cebeci Hospital, Ankara, Turkey|Uludag Universitesi Tip Fakultesi, Bursa, Turkey|Bezmialem Foundation University Medical Faculty, Istanbul, Turkey|Marmara University, Istanbul, Turkey|Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Kadiköy/Istanbul, Turkey|Karadeniz Teknik Universitesi Tip Fakultesi Farabi Hastanesi, Trabzon, Turkey|Chernivtsi Regional Clinical Hospital, Chernivtsi, Ukraine|Si Institute Of Gastroenterology Of Namsu Dept Of Stomach And Duodenum Diseases, Dnipropetrovsk, Ukraine|Ivano-Frankivsk Central City Clinical Hospital, Ivano-Frankivsk, Ukraine|V.T. Zaitsev Institute of General and Emergency Surgery, Kharkiv, Ukraine|Kyiv City Clinical Hospital #18, Kyiv, Ukraine|Medical Center Consilium Medical, Kyiv, Ukraine|Ok Clinic Medical Center within International Institute of Clinical Trials, LLC, Kyiv, Ukraine|Kyiv Regional Hospital #2, Kyiv, Ukraine|Kyiv Regional Clinical Hospital, Kyiv, Ukraine|Public City Clinical Hospital of Emergency Medical Care, Lviv, Ukraine|Poltava M.V. Sklifosovskyi Regional Clinical Hospital under Poltava Regional Council, Poltava, Ukraine|Ternopil City Public Emergency Medical Care Hospital, Ternopil, Ukraine|Vinnytsia City Clinical Hospital #1, Vinnytsia, Ukraine|Vinnytsia M.I. Pyrohov Regional Clinical Hospital, Vinnytsia, Ukraine|First Private Clinic, Zhytomyr, Ukraine|Bristol Royal Infirmary, Bristol, United Kingdom|Ulster Hospital, Dundonald, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom|Victoria Hospital Blackpool, Lancashire Blackpool, United Kingdom|Royal London Hospital, London, United Kingdom|University College London Hospitals NHS Foundation Trust - University College Hospital, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital, London, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom|Royal Shrewsbury Hospital, Shrewsbury, United Kingdom|University Hospital Southampton NHS Foundation Trust - Southampton General Hospital, Southampton, United Kingdom|Torbay Hospital, Torquay, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03440372"
620,"NCT03435016","A Comparative Study of MRI, US and CE for Assessing Treatment Response in Known Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease","Diagnostic Test: Diagnostic work-up","Diagnostic accuracy|Diagnostic accuracy fCal|Diagnostic accuracy CRP|Bowel wall thickening|Elastography|Ultrasound activity index","Sygehus Lillebaelt|Odense University Hospital|Sydvestjysk Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","75","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","ANDI-2","February 1, 2018","March 1, 2023","March 1, 2023","February 15, 2018",,"March 23, 2020","Sygehus Lillebaelt, Vejle, Denmark",,"https://ClinicalTrials.gov/show/NCT03435016"
621,"NCT03395184","Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease",,"Recruiting","No Results Available","Crohn's Disease","Drug: Placebo PF-06651600|Drug: Placebo PF-06700841|Drug: PF-06651600|Drug: PF-06700841","Proportion of subjects achieving clinically meaningful endoscopic improvement (reduction of more than or equal to 3 points from baseline in Simplified Endoscopic Activity Score for Crohn's Disease (SES-CD) at Week 12|Number of subjects with adverse events|Number of subjects with serious adverse events|Number of subjects with electrocardiogram findings of potential clinical importance|Number of subjects with laboratory tests findings of potential clinical importance|Number of subjects withdrawal due to adverse events|Number of subjects with vital signs findings of potential clinical importance|Number of participants with potentially clinically important serious infections findings|Mean change from baseline in SES-CD score at Week 12.|Proportion of subjects achieving SES-CD 25 and SES-CD 50 at Week 12.|Proportion of subjects achieving endoscopic remission (SES-CD less than or equal to 2) at Week 12.|Proportion of subjects achieving mucosal healing at Week 12.|Number of subjects with electrocardiogram findings of potential clinical importance.|Number of subjects with vital signs findings of potential clinical importance.|Number of subjects with laboratory tests findings of potential clinical importance.|Proportion of subjects achieving SES CD 25 and SES CD 50 at Week 64 among subjects who achieved SES CD 25 and SES CD 50 at week 12 respectively.|Proportion of subjects achieving clinically meaningful endoscopic improvement (CMEI response) at week 64 among subjects who achieved CMEI response at Week 12.","Pfizer","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","250","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","B7981007|2017-003359-43|PIZZICATO","February 2, 2018","November 30, 2022","November 30, 2022","January 10, 2018",,"June 21, 2021","Dothan Surgery Center, Dothan, Alabama, United States|Gut P.C., dba Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|Brighton Surgical Center, Beverly Hills, California, United States|Entertainment Medical Group, Los Angeles, California, United States|Gastrointestinal Biosciences Clinical Trials, LLC, Los Angeles, California, United States|Stanford Medicine Outpatient Center - Digestive Health Center, Redwood City, California, United States|Front Range Endoscopy Center, Colorado Springs, Colorado, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Gastro Florida, Clearwater, Florida, United States|West Coast Endoscopy Center, Clearwater, Florida, United States|Gastro Florida, Clearwater, Florida, United States|UF Health Jacksonville - Gastroenterology Emerson, Jacksonville, Florida, United States|UF Health Jacksonville - Faculty Clinic, Jacksonville, Florida, United States|Homestead Associates in Research, Miami, Florida, United States|Millenia Surgery Center, Orlando, Florida, United States|HMD Research LLC, Orlando, Florida, United States|Treasure Valley Medical Research, Boise, Idaho, United States|WestGlen Gastrointestinal Consultants, P.A., Shawnee Mission, Kansas, United States|Chevy Chase Endoscopy Center, Chevy Chase, Maryland, United States|MGG Group Co., Inc., Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Capitol Research, Rockville, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Mass Eye and Ear, Longwood, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Chestnut Hill, Massachusetts, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Eastside Endoscopy Center, Macomb, Michigan, United States|Digestive Health Center, Ocean Springs, Mississippi, United States|Weill Cornell Medical College - New York Presbyterian Hospital, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|New York Presbyterian Hospital - Weill Cornell Medical College (Colonoscopy), New York, New York, United States|New York Presbyterian Hospital - Weill Cornell Medical College Investigational Pharmacy, New York, New York, United States|Weill Cornell Medical College - New York Presbyterian Hospital (Endoscopy Suite), New York, New York, United States|Weill Cornell Medical College - New York Presbyterian Hospital, New York, New York, United States|DiGiovanna Institute for Medical Education And Research, North Massapequa, New York, United States|UNC Hospitals, Chapel Hill, North Carolina, United States|UNC Hospitals Endoscopy Center at Meadowmont, Chapel Hill, North Carolina, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Gastroenterology Associates of the Piedmont, PA, Winston-Salem, North Carolina, United States|PMG Research of Winston-Salem, LLC, Winston-Salem, North Carolina, United States|Holston Medical Group, Kingsport, Tennessee, United States|Holston Valley Surgery Center, Kingsport, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Cross Timbers Surgery Center L.P. (Colonoscopy), Arlington, Texas, United States|Envision Imaging (CXR), Arlington, Texas, United States|Texas Clinical Research Institiute, LLC, Arlington, Texas, United States|First Street Hospital, Bellaire, Texas, United States|First Street Surgical Center, Bellaire, Texas, United States|Pearland Surgery Center, Houston, Texas, United States|Lonestar Endoscopy, LLP, Southlake, Texas, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|Verity Research, Inc., Fairfax, Virginia, United States|Blue Ridge Medical Research, Lynchburg, Virginia, United States|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Mater Misericordiae Ltd, South Brisbane, Queensland, Australia|Ballarat Base Hospital, Ballarat, Victoria, Australia|Saint John of God Health Care Inc., Subiaco, Western Australia, Australia|AKH Wien Universitaetsklinik fuer Innere Medizin III, Wien, Austria|University Hospital Brussels, Jette, Belgium|University Hospitals Leuven, Leuven, Belgium|CHC MontLégia, Liège, Belgium|Javna zdravstvena ustanova Univerzitetski klinicki centar Republike Srpske,, Banja Luka, Bosnia and Herzegovina|Winnipeg Regional Health Authority - Health Sciences Centre, Winnipeg, Winnipeg, Manitoba, Canada|CIUSSS de l'Est-de-l'Ile-de-Montreal Installation Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada|Klinicki bolnicki centar Rijeka, Odjel za gastroenterologiju, Rijeka, Croatia|Klinicki Bolnicki centar Split, Zavod za gastroenterologiju, Split, Croatia|Opca bolnica Zadar, Odjel za gastroenterologiju, Zadar, Croatia|Klinicka bolnica Dubrava Zagreb, Zagreb, Croatia|Klinicki bolnicki centar Zagreb, Zavod za gastroenterologiju i hepatologiju, Zagreb, Croatia|Lekarna Altea, Bilina, Czechia|Nemocnice Horovice, a.s., Horovice, Czechia|Hepato-Gastroenterologie HK s.r.o., Hradec Kralove, Czechia|Medialpharma s.r.o., Hradec Kralove, Czechia|Gastroenterologicka ambulance a endoskopie, Most, Czechia|MUDr. GREGAR s.r.o., Olomouc, Czechia|Vseobecna fakultni nemocnice, Praha 2, Czechia|Všeobecná fakultní nemocnice v Praze, Praha 2, Czechia|Libera Scientia s.r.o., Praha 3, Czechia|Axon Clinical s.r.o., Praha 5, Czechia|Lekarna Benu, Praha 5, Czechia|Fakultni nemocnice v Motole, Praha 5, Czechia|Fakultní Nemocnice v Motole, Praha 5, Czechia|Nemocnice Strakonice, a.s., Interni oddeleni, Strakonice, Czechia|Nemocnice Strakonice, a.s., Strakonice, Czechia|LTD ""Acad. F. Todua Medical Center - LTD Research Institute of Clinical Medicine"", Tbilisi, Georgia|The First University Clinic of TSMU, Tbilisi, Georgia|Institute of Clinical Cardiology, Ltd., Tbilisi, Georgia|Paian MED Research GmbH, Berlin, Germany|Krankenhaus Waldfriede e.V.,, Berlin, Germany|Universitaetsklinikum Bonn, Bonn, Germany|Universitaetsklinikum Schleswig-Holstein, Kiel, Germany|Universitätsklinikum Giessen und Marburg GmbH, Marburg, Germany|Bekes Megyei Kozponti Korhaz, Rethy Pal Tagkorhaz, Bekescsaba, Hungary|Semmelweis Egyetem, II. Belgyogyaszati Klinika, Budapest, Hungary|Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak, Budapest, Hungary|Clinfan Szolgaltato Kft., Szekszard, Hungary|IRCCS Saverio de Bellis, Castellana Grotte, Bari, Italy|A.O.Spedali Civili, Brescia, BS, Italy|Univ. ""Magna Graecia"" di Catanzaro, Catanzaro, CZ, Italy|ASST Monza, Monza, MB, Italy|Istituto Clinico Humanitas IRCCS - IBD Center, Rozzano, Milan, Italy|A.O.U. Policlinico G. Martino, Messina, Italy|Azienda Ospedaliera di Padova, Padova, Italy|Policlinico Universitario Campus Bio-Medico, Roma, Italy|Kyungpook National University Hospital, Daegu, Korea, Korea, Republic of|Kyung Hee University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of|Hôtel Dieu de France Hospital, Achrafieh, Beirut, Lebanon|Saint George Hospital University Medical Center, Achrafieh, Lebanon|American University of Beirut Medical Center, Beirut, Lebanon|Ain Wazein Medical Village, El Chouf, Lebanon|Hammoud Hospital University Medical Center, Saida, Lebanon|DC-MED Sp. z o.o. Sp.k., Swidnica, Other, Poland|H-T. Centrum Medyczne-Endoterapia, Tychy, Silesia, Poland|Niepubliczny Zaklad Opieki Zdrowotnej All-Medicus, Katowice, Poland|ETG Kielce, Kielce, Poland|Indywidualna Specjalistyczna Praktyka Lekarska Maciej Zymla, Knurow, Poland|Szpital w Knurowie Sp. z o.o., Knurow, Poland|Samodzielny Publiczny Zespół Opieki Zdrowotnej, Pracownia Endoskopii, Koscian, Poland|Centrum Medyczne Szpital Swietej Rodziny Sp z o.o., Lodz, Poland|Pracownia Endoskopii Centrum Medyczne Szpital Swietej Rodziny Sp z o.o., Lodz, Poland|Osrodek Badan Klinicznych AppleTreeClinics, Lodz, Poland|Medical Magnus Clinic, Lodz, Poland|Wojewodzki Szpital Specjalistyczny im. Bieganskiego w Lodzi, Lodz, Poland|SALVE, Lodz, Poland|Gastromed Sp. z o.o., Lublin, Poland|IRMED, Piotrkow Trybunalski, Poland|Samodzielny Szpital Wojewodzki im. M. Kopemika w Piotrkowie Trybunalskim, Piotrkow Tryunalski, Poland|PRZYCHODNIA SPECJALISTYCZNA MEDIC-R Clinical Research Center Spolka z ograniczona odpowiedzialnoscia, Poznan, Poland|AM-MEDIC Sp, Poznan, Poland|Ai Centrum Medyczne Sp. Z O.O. Sp.K., Poznan, Poland|Gabinety Lekarskie Rivermed, Poznan, Poland|ENDOSKOPIA Sp. z o. o., Sopot, Poland|Szpital Sredzki Serca Jezusowego sp. z o.o., Sroda Wielkopolska, Poland|Pracownia Endoskopii Szpital MSW, Szczecin, Poland|Twoja Przychodnia Szczecinskie Centrum Medyczne, Szczecin, Poland|SONOMED, Szczecin, Poland|Centrum Zdrowia MDM, Warszawa, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Endoterapia PFG Sp. z o.o., Warszawa, Poland|Centrum Diagnostyczno-Lecznicze Barska Sp. z o. o., Wloclawek, Poland|Futuremeds, Wroclaw, Poland|Melita Medical Sp. z o.o., Wroclaw, Poland|Centrum Gastrologiczno Hepatologiczne, Wroclaw, Poland|Lexmedica, Wroclaw, Poland|Golden Care, Wroclaw, Poland|EuroMediCare Szpital Specjalistyczny we Wroclawiu, Wroclaw, Poland|SPb SBIH ""City Hospital #40 of the Kurortnyi region"", Saint-Petersburg, Sestroretsk, Russian Federation|Polyclinic Ultrasound 4D LLC, Pyatigorsk, Stavropol Region, Russian Federation|LLC ""Alliance Biomedical-Ural Group"", Izhevsk, Russian Federation|LLC ""Olla-Med"", Moscow, Russian Federation|Sechenov University on the base of Institute of Translational Medicine and Biotechnology, Moscow, Russian Federation|Limited Liability Company ""Medical Center SibNovoMed"", Novosibirsk, Russian Federation|Novosibirskiy Gastrocenter, Novosibirsk, Russian Federation|Clinic at FSBEI HE ""Omsk State Medical University"" MoH RF, Omsk, Russian Federation|LLC ""New Clinic"", Pyatigorsk, Russian Federation|Limited Liability Company ""Medical Center ""Reavita Med SPb"" (OOO ""MC ""RM SPb""), Saint-Petersburg, Russian Federation|Limited Liability Company ""RIAT"", Saint-Petersburg, Russian Federation|The Limited Liability Company ""Research center Eco-safety"" (Research center Eco-safety, LLC), Saint-Petersburg, Russian Federation|Private Institution Educational Organization of Higher Education, Samara, Russian Federation|Non-state Healthcare Institution 'Railway Clinical Hospital at Samara Station of Open Joint Stock, Samara, Russian Federation|Limited Liability Company Medical Company ""Hepatolog"", Samara, Russian Federation|Saint-Petersburg State Budgetary Healthcare Institution ""City Clinical Hospital of the Righteous, St. Petersburg, Russian Federation|State Budgetary Healthcare Institution of the Stavropol Region, Stavropol, Russian Federation|King Abdulaziz Medical City, Jeddah, Saudi Arabia|King AbdulAziz Medical City, Riyadh, Saudi Arabia|King Khalid University Hospital, Riyadh, Saudi Arabia|Klinicko Bolnicki Centar ""Bezanijska Kosa"", Zemun, Beograd, Serbia|Klinicki Centar Srbije, Klinika za gastroenterohepatologiju, Beograd, Srbija, Serbia|Klinicki Centar Kragujevac, Kragujevac, Srbija, Serbia|Klinicki Centar Nis, Nis, Srbija, Serbia|Opsta bolnica Subotica, Subotica, Srbija, Serbia|Opsta Bolnica ""Djordje Joanovic"", Odeljenje Interno, Odsek Gastroenterologija, Zrenjanin, Srbija, Serbia|Klinicko Bolnicki Centar Zvezdara, Klinika za Interne bolesti,, Beograd, Serbia|Vojnomedicinska akademija, Klinika za gastroenterologiju i hepatologiju, Beograd, Serbia|KBC ""Dr Dragisa Misovic-Dedinje"", Beograd, Serbia|Klinicko Bolnicki Centar Zemun, klinika za Internu medicinu,, Zemun, Beograd, Serbia|Fakultna nemocnica s poliklinikou F.D. Roosevelta Banska Bystrica, Banska Bystrica, Slovakia|Breznianske centrum gastroenterologie s.r.o., Brezno, Slovakia|KM Management spol. s.r.o., Nitra, Slovakia|Accout Center s.r.o. Gastroenterologicka ambulancia, Sahy, Slovakia|ENDOMED, s.r.o., Vranov nad Toplou, Slovakia|Lenasia Clinical Trial Centre, Lenasia, Gauteng, South Africa|Wits Clinical Research Trial Site, Parktown, Gauteng, South Africa|Dr Wright Private Practice, Claremont, Western CAPE, South Africa|Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain|Hospital Universitario Fundacion Alcorcon, Alcorcon, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Spain|Universitätsspital Zürich, Zürich, Switzerland|La Rabta Hospital, Tunis, Tunisia|Habib Thameur Hospital, Tunis, Tunisia|Hacettepe Universitesi Tip Fakultesi, Ankara, Turkey|Bezmialem Vakif Universitesi Tip Fakultesi Hastanesi, Istanbul, Turkey|Erciyes Universitesi Tip Fakultesi, Kayseri, Turkey|Kocaeli Universitesi Tip Fakultesi, Kocaeli, Turkey|Mersin Universitesi Tip Fakultesi Hastanesi, Ic Hastaliklari, Mersin, Turkey|Mersin Universitesi Tip Fakultesi Hastanesi, Mersin, Turkey|Karadeniz Teknik Universitesi Tip Fakultesi, Ic Hastaliklari, Trabzon, Turkey|Karadeniz Teknik Universitesi Tip Fakultesi, Trabzon, Turkey|Bulent Ecevit Universitesi Tip Fakultesi, Zonguldak, Turkey|Regional Municipal Non-profit Enterprise ""Chernivtsi Regional Clinical Hospital"", Surgery Depart, Chernivtsi, Ukraine|Municipal Healthcare Institution Kharkiv City Clinical Hospital #2 n.a. prof. O.O. Shalimov, Kharkiv, Ukraine|Medical Centre Medical Clinic Blagomed LLC, Kyiv, Ukraine|Medical Center ""OK Clinic+"" of International Institute of Clinical Trials, Kyiv, Ukraine|Medical Center ""Universal clinic Oberig"" of ""Kapital"" LLC, Gastro center, Kyiv, Ukraine|Municipal Non-profit enterprise of Kyiv Regional Council ""Kyiv regional hospital"", Kyiv, Ukraine|Municipal non-profit enterprise of Kyiv regional council ""Kyiv regional clinical hospital"", Kyiv, Ukraine|Lviv clinical hospital on Railway Transport of Health Care Center branch of PJSC Ukrainian Railway, Lviv, Ukraine|Vinnytsia City Clinical Hospital No.1, Vinnytsia, Ukraine|Private Small-Scale Enterprise Medical Center ""Pulse"", Vinnytsia, Ukraine|Vinnytsia Regional Clinical Hospital for War Veterans, Vinnytsia, Ukraine|Vinnytsia Regional Clinical Hospital n.a. M.I.Pyrohov, Vinnytsia, Ukraine|Medical Center ""DIACENTER""LLC, Zaporizhzhia, Ukraine|Cleveland Clinica Abu Dhabi, Department of Gastroenterology and Hepatology, Abu Dhabi, United Arab Emirates|Al Kuwait Hospital - Dubai, Dubai, United Arab Emirates|Emirates Specialty Hospital, Dubai, United Arab Emirates",,"https://ClinicalTrials.gov/show/NCT03395184"
622,"NCT03345849","A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies",,"Recruiting","No Results Available","Crohn's Disease","Drug: Upadacitinib|Drug: Placebo for Upadacitinib","Percentage of Participants with Clinical Remission per Crohn's Disease Activity Index (CDAI)|Percentage of Participants with Endoscopic Response|Percentage of Participants with Clinical Remission per Patient-Reported Outcomes (PROs)|Percentage of Participants with Endoscopic Remission|Percentage of Participants who Discontinue Corticosteroid Use for Crohn's Disease (CD) and Achieve Clinical Remission per per Crohn's Disease Activity Index (CDAI), in Participants Taking Corticosteroids at Baseline.|Change in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F)|Change in Inflammatory Bowel Disease Questionnaire (IBDQ)|Percentage of Participants Achieving Clinical Response 100 (CR-100)|Percentage of Participants with Hospitalizations due to Crohn's Disease (CD)|Percentage of Participants with Resolution of Extra-Intestinal Manifestation (EIMs) , in Participants with EIMs at Baseline","AbbVie","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 3","501","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","M14-433|2017-001240-35","December 7, 2017","September 14, 2021","February 2, 2022","November 17, 2017",,"July 2, 2021","East View Medical Research, LLC /ID# 171176, Mobile, Alabama, United States|CB Flock Research Corporation /ID# 166185, Mobile, Alabama, United States|Delsol Research Management, Ll /Id# 170145, Chandler, Arizona, United States|HonorHealth Research Institute - Shea /ID# 164821, Scottsdale, Arizona, United States|Arizona Arthritis & Rheumatology Research, PLLC /ID# 164803, Sun City, Arizona, United States|Southern California Res. Ctr. /ID# 169655, Coronado, California, United States|Citrus Valley Gastroenterology /ID# 166173, Covina, California, United States|Hoag Memorial Hosp Presbyterian /ID# 222540, Irvine, California, United States|United Medical Doctors /ID# 207449, Los Alamitos, California, United States|Gastrointestinal Biosciences Clinical Trials, LLC /ID# 164762, Los Angeles, California, United States|Facey Medical Foundation /ID# 203136, Mission Hills, California, United States|United Medical Doctors - Murrieta /ID# 164945, Murrieta, California, United States|Ucsd /Id# 164910, San Diego, California, United States|Medical Assoc Research Grp /ID# 169706, San Diego, California, United States|Univ of California San Francis /ID# 164944, San Francisco, California, United States|Care Access Research /ID# 167767, San Pablo, California, United States|Peak Gastroenterology Associates, PC /ID# 170143, Colorado Springs, Colorado, United States|Delta Waves, Inc. /ID# 164776, Colorado Springs, Colorado, United States|Western States Clinical Res /ID# 164760, Wheat Ridge, Colorado, United States|Medical Research Center of CT /ID# 164926, Hamden, Connecticut, United States|Clinical Research of West Florida, Inc /ID# 205827, Clearwater, Florida, United States|Clinical Research of West Florida, Inc /ID# 208118, Clearwater, Florida, United States|Advanced Research - Coral Springs /ID# 218021, Coral Springs, Florida, United States|Encore Borland-Groover Clinical Research /Id# 203499, Jacksonville, Florida, United States|Ctr for Advanced Gastroenterol /ID# 165353, Maitland, Florida, United States|Crystal Pharmacology Research /ID# 166081, Miami, Florida, United States|Coral Research Clinic /ID# 164890, Miami, Florida, United States|Advanced Research Institute, Inc /ID# 164921, New Port Richey, Florida, United States|Endoscopic Research, Inc. /ID# 206136, Orlando, Florida, United States|Omega Research Consultants /ID# 203481, Orlando, Florida, United States|Clinical Research Trials of Florida, Inc. /ID# 203485, Tampa, Florida, United States|AdventHealth Tampa /ID# 171167, Tampa, Florida, United States|Gastroenterology Associates of Central Georgia, LLC /ID# 165478, Macon, Georgia, United States|Gastroenterology Consultants PC - Roswell /ID# 218220, Roswell, Georgia, United States|Atlanta Gastroenterology Spec /ID# 164799, Suwanee, Georgia, United States|Treasure Valley Medical Research /ID# 215032, Boise, Idaho, United States|Rush University Medical Center /ID# 165497, Chicago, Illinois, United States|University of Chicago /ID# 165503, Chicago, Illinois, United States|DuPage Medical Group /ID# 205328, Downers Grove, Illinois, United States|MediSphere Medical Research Center /ID# 166175, Evansville, Indiana, United States|Indianapolis Gastroenterology /ID# 164938, Indianapolis, Indiana, United States|University of Iowa Hospitals and Clinics /ID# 165436, Iowa City, Iowa, United States|Tri-State Gastroenterology /ID# 165496, Crestview Hills, Kentucky, United States|University of Louisville /ID# 165366, Louisville, Kentucky, United States|University of Louisville /ID# 168572, Louisville, Kentucky, United States|CroNOLA, LLC /ID# 164823, Houma, Louisiana, United States|Nola Research Works, LLC /ID# 164759, New Orleans, Louisiana, United States|Louisana Research Center, LLC /ID# 164894, Shreveport, Louisiana, United States|Johns Hopkins University School of Medicine /ID# 211941, Baltimore, Maryland, United States|MGG Group Co, Inc.Chevy Chase Clinical Research /ID# 164935, Chevy Chase, Maryland, United States|Gastro Center of Maryland /ID# 171161, Columbia, Maryland, United States|Lahey Hospital and Medical Center /ID# 214726, Burlington, Massachusetts, United States|University of Michigan Health Systems /ID# 164943, Ann Arbor, Michigan, United States|Clin Res Inst of Michigan, LLC /ID# 170133, Chesterfield, Michigan, United States|Digestive Health Associates (DHA) - Farmington Hills /ID# 205793, Farmington Hills, Michigan, United States|Center for Digestive Health /ID# 164822, Troy, Michigan, United States|Mayo Clinic /ID# 164783, Rochester, Minnesota, United States|Southern Therapy and Advanced Research (STAR) LLC /ID# 165343, Jackson, Mississippi, United States|Quality Clinical Research, Inc /ID# 170137, Omaha, Nebraska, United States|CHI Nebraska d/b/a CHI Health /ID# 168578, Omaha, Nebraska, United States|Las Vegas Medical Research /ID# 168588, Las Vegas, Nevada, United States|AGA Clinical Research Associates, LLC /ID# 164769, Egg Harbor Township, New Jersey, United States|Rutgers Robert Wood Johnson /ID# 166073, New Brunswick, New Jersey, United States|Montefiore Medical Center - Moses Campus /ID# 166193, Bronx, New York, United States|Advantage Clinical Trials /ID# 168546, Bronx, New York, United States|NY Scientific /ID# 164931, Brooklyn, New York, United States|United Health Services Hospitals, Inc /ID# 217485, Johnson City, New York, United States|NYU Langone Long Island Clinical Research Associates /ID# 164927, Lake Success, New York, United States|The Mount Sinai Hospital /ID# 170257, New York, New York, United States|Columbia Univ Medical Center /ID# 164782, New York, New York, United States|Gastro Group of Rochester /ID# 166177, Rochester, New York, United States|Richmond University Medical Center /ID# 201857, Staten Island, New York, United States|Atrium Health Carolinas Medical Center /ID# 164932, Charlotte, North Carolina, United States|PMG Research of Charlotte /ID# 171160, Charlotte, North Carolina, United States|Wake Radiology UNC REX Healthcare - Raleigh Office /ID# 164904, Raleigh, North Carolina, United States|Wake Forest Baptist Medical Center /ID# 164908, Winston-Salem, North Carolina, United States|Plains Clinical Research Center, LLC /ID# 170140, Fargo, North Dakota, United States|Consultants for Clinical Res /ID# 164791, Cincinnati, Ohio, United States|University of Cincinnati /ID# 164825, Cincinnati, Ohio, United States|Cleveland Clinic Main Campus /ID# 209231, Cleveland, Ohio, United States|The Ohio State University /ID# 170141, Columbus, Ohio, United States|Optimed Research, Ltd. /ID# 205624, Columbus, Ohio, United States|Hometown Urgent Care and Resea /ID# 201291, Dayton, Ohio, United States|Dayton Gastroenterology, Inc. /ID# 167627, Englewood, Ohio, United States|Great Lakes Gastroenterology Research LLC /ID# 202010, Mentor, Ohio, United States|Digestive Disease Specialists /ID# 201064, Oklahoma City, Oklahoma, United States|Options Health Research, LLC /ID# 164820, Tulsa, Oklahoma, United States|Healthcare Research Consultant /ID# 166195, Tulsa, Oklahoma, United States|University of Pennsylvania /ID# 168430, Philadelphia, Pennsylvania, United States|Pharmacorp Clinical Trials /ID# 164916, Charleston, South Carolina, United States|Gastroenterology Associates, P.A. of Greenville /ID# 164771, Greenville, South Carolina, United States|Rapid City Medical Center - GI Research /ID# 201735, Rapid City, South Dakota, United States|Gastro One /ID# 164826, Germantown, Tennessee, United States|East Tennessee Research Institute /ID# 203613, Johnson City, Tennessee, United States|Quality Medical Research /ID# 205263, Nashville, Tennessee, United States|Vanderbilt University Medical Center /ID# 164946, Nashville, Tennessee, United States|TX Clinical Research Institute /ID# 164896, Arlington, Texas, United States|Quest Clinical Research /ID# 164785, Baytown, Texas, United States|Texas Digestive Disease Consultants /ID# 209801, Cedar Park, Texas, United States|Texas Digestive Disease Consultants /ID# 209953, Cedar Park, Texas, United States|Baylor Scott & White Center for Inflammatory Bowel Diseases /ID# 170144, Dallas, Texas, United States|CliniCore International, LLC /ID# 164902, Houston, Texas, United States|Baylor College of Medicine - Baylor Medical Center /ID# 164947, Houston, Texas, United States|Centex Studies, Inc. - Houston /ID# 201214, Houston, Texas, United States|GI Specialists of Houston /ID# 202339, Houston, Texas, United States|Caprock Gastro Research /ID# 215438, Lubbock, Texas, United States|Clinical Associates in Research Therapeutics of America, LLC /ID# 164786, San Antonio, Texas, United States|Southern Star Research Institute, LLC /ID# 169755, San Antonio, Texas, United States|Carl R. Meisner Medical Clinic /ID# 201061, Sugar Land, Texas, United States|Tyler Research Institute, LLC /ID# 168687, Tyler, Texas, United States|Gastro Health & Nutrition - Victoria /ID# 167812, Victoria, Texas, United States|HP Clinical Research /ID# 164933, Bountiful, Utah, United States|Advanced Research Institute /ID# 164784, Ogden, Utah, United States|Care Access Research /ID# 164794, Salt Lake City, Utah, United States|Velocity Clinical Research/ Gut Whisperer /ID# 166076, West Jordan, Utah, United States|Washington Gastroenterology Associates /ID# 164824, Bellevue, Washington, United States|Virginia Mason - Seattle Orthapedics /ID# 164913, Seattle, Washington, United States|The Vancouver Clinic, INC. PS /ID# 164918, Vancouver, Washington, United States|Allegiance Research Specialist /ID# 165346, Wauwatosa, Wisconsin, United States|Cemic /Id# 169182, Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina|Cardio Alem /ID# 211285, San Isidro, Buenos Aires, Argentina|Hospital Italiano de Buenos Aires /ID# 215541, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina|Gedyt /ID# 210020, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina|Hospital Centenario /Id# 171252, Rosario, Santa Fe, Argentina|Hospital Privado Univesitario /ID# 169230, Cordoba, Argentina|Concord Repatriation General Hospital /ID# 171512, Concord, New South Wales, Australia|Coral Sea Clinical Research institute /ID# 212988, North Mackay, Queensland, Australia|Mater Misericordiae Limited /ID# 204909, South Brisbane, Queensland, Australia|Royal Adelaide Hospital /ID# 171514, Adelaide, South Australia, Australia|Box Hill Hospital /ID# 203736, Box Hill, Victoria, Australia|Fiona Stanley Hospital /ID# 171513, Murdoch, Western Australia, Australia|Medical University of Vienna /ID# 169465, Vienna, Wien, Austria|LKH Salzburg and Paracelsus /ID# 214470, Salzburg, Austria|UCL Saint-Luc /ID# 200303, Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium|CHU de Liege Sart Tilman /ID# 217534, Liège, Liege, Belgium|AZ Sint-Lucas /ID# 200302, Gent, Belgium|University Clinical Centre of the Republic of Srpska /ID# 208051, Banja Luka, Republika Srpska, Bosnia and Herzegovina|University Clinical Center Tuzla /ID# 210325, Tuzla, Tuzlanski, Bosnia and Herzegovina|Clinical Center University of Sarajevo /ID# 203887, Sarajevo, Bosnia and Herzegovina|Polyclinic and Daily Hospital Dr. Al-Tawil /ID# 217842, Sarajevo, Bosnia and Herzegovina|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva /ID# 166852, Goiania, Goias, Brazil|Hospital Nossa Senhora das Graças /ID# 166863, Curitiba, Parana, Brazil|Hospital de Clinicas de Porto Alegre /ID# 166862, Porto Alegre, Rio Grande Do Sul, Brazil|Upeclin Fmb - Unesp /Id# 166867, Botucatu, Sao Paulo, Brazil|Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP /ID# 166866, Ribeirão Preto, Sao Paulo, Brazil|Faculdade de Medicina do ABC /ID# 208323, Santo André, Sao Paulo, Brazil|Kaiser Clinica e Hospital Dia /ID# 166865, Sao Jose Do Rio Preto, Sao Paulo, Brazil|UMHAT Kaspela EOOD /ID# 167613, Plovdiv, Bulgaria|Second MHAT Sofia /ID# 167614, Sofia, Bulgaria|MHAT Trakia /ID# 201679, Stara Zagora, Bulgaria|University of Calgary - Cumming School of Medicine - Adult Cystic Fibrosis Clini /ID# 166974, Calgary, Alberta, Canada|Allen Whey Khye Lim Professional Corporation /ID# 168044, Edmonton, Alberta, Canada|University of Alberta - Zeidler Ledcor Centre /ID# 166971, Edmonton, Alberta, Canada|Covenant Health /ID# 166978, Edmonton, Alberta, Canada|Fraser Clinical Trials Inc /ID# 166968, New Westminster, British Columbia, Canada|GIRI Gastrointestinal Research Institute /ID# 166975, Vancouver, British Columbia, Canada|QEII - Health Sciences Centre /ID# 169307, Halifax, Nova Scotia, Canada|London Health Sciences Center /ID# 221038, London, Ontario, Canada|Scott Shulman Medicine Professional Corporation /ID# 169066, North Bay, Ontario, Canada|Taunton Surgical Centre /ID# 168043, Oshawa, Ontario, Canada|The Ottawa Hospital /ID# 212414, Ottawa, Ontario, Canada|Medicor Research Inc /ID# 166979, Sudbury, Ontario, Canada|Toronto Digestive Disease Asso /ID# 166972, Vaughan, Ontario, Canada|CHAU- Hotel-Dieu de Levis /ID# 166969, Levis, Quebec, Canada|Crchum /Id# 170120, Montreal, Quebec, Canada|Montreal General Hospital - McGill University Health Center /ID# 170119, Montreal, Quebec, Canada|CIUSSS de l'Estrie - CHUS /ID# 170940, Sherbrooke, Quebec, Canada|Research Group /ID# 203179, Santiago, Region Metropolitana De Santiago, Chile|M y F Estudios Clínicos /ID# 169984, Santiago, Region Metropolitana De Santiago, Chile|Hospital Guillermo Grant Benavente de Concepción /ID# 212423, Concepción, Chile|CTR Estudios Clinicos /ID# 203941, Providencia, Chile|Hospital Clinico Universidad De Los Andes /ID# 207466, Santiago, Chile|Zhongshan Hospital Xiamen University /ID# 204984, Fujian, Anhui, China|Sun Yat-sen Memorial Hospital of Sun Yat-sen University /ID# 205228, Guangzhou, Guangdong, China|The Sixth Affiliated Hosp Sun /ID# 204077, Guangzhou, Guangdong, China|Tongji Medical College Huazhong Univ of Science and Techno /ID# 204081, Wuhan, Hubei, China|The First Affiliated Hospital of Nanchang University /ID# 204092, Nanchang, Jiangxi, China|The First Hospital of Jilin University /ID# 206868, Changchun, Jilin, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 204091, Shanghai, Shanghai, China|The second Affiliated hospital of Zhejiang University school of Medicine /ID# 204073, Hangzhou, Zhejiang, China|Sir Run Run Shaw Hospital /ID# 204076, Hangzhou, Zhejiang, China|Beijing Friendship Hospital /ID# 204173, Beijing, China|The Second Hospital Central South University /ID# 204082, Changsha, China|Nanfang Hospital of Southern Medical University /ID# 204083, Guangzhou, China|Nanjing Drum Tower Hospital /ID# 204900, Nanjing Jiangsu, China|Duplicate_Tianjin Med Univ General Hosp /ID# 206994, Tianjin, China|Tongji Hospital Tongji Medical College Huazhong University of Science and Techno /ID# 204088, Wuhan, China|Hospital Pablo Tobon Uribe /ID# 202404, Medellín, Antioquia, Colombia|Hospital Universitario San Vic /ID# 200029, Medellin, Colombia|Poliklinika Solmed /ID# 211519, Zagreb, Grad Zagreb, Croatia|UHC Split /ID# 171191, Split, Croatia|Zadar General Hospital /ID# 205536, Zadar, Croatia|CH Dubrava /ID# 171185, Zagreb, Croatia|UHC Sestre Milosrdnice /ID# 205535, Zagreb, Croatia|UHC Zagreb /ID# 171203, Zagreb, Croatia|Nemocnice Ceske Budejovice a.s. /ID# 224389, Ceske Budejovice, Czechia|Hepato-Gastroenterologie HK, s.r.o. /ID# 171401, Hradec Kralove, Czechia|Artroscan s.r.o. /ID# 200790, Ostrava, Czechia|ResTrial s.r.o. /ID# 208653, Praha, Czechia|Nordsjallands Hospital /ID# 202424, Frederikssund, Hovedstaden, Denmark|Herlev Hospital /ID# 202423, Herlev, Hovedstaden, Denmark|Sjaellands Universitets Hospital /ID# 209445, Roskilde, Sjælland, Denmark|Hvidovre Hospital /ID# 202425, Hvidovre, Denmark|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 171012, Alexandria, Egypt|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 171013, Alexandria, Egypt|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 209564, Alexandria, Egypt|National Hepatology and Tropical Medicine Research Institute /ID# 170989, Cairo, Egypt|Air Force Specialized Hospital /ID# 170996, Cairo, Egypt|National Liver Institute /ID# 170988, Menoufiya, Egypt|West Tallinn Central Hospital /ID# 202785, Tallinn, Estonia|CHU Grenoble Alpes - Hopital /ID# 219034, Grenoble, France|Clinique Jules Verne /ID# 219073, Nantes, France|CH Valenciennes /ID# 219035, Valenciennes, France|Universitatsklinikum Mannheim /ID# 168759, Mannheim, Baden-Wuerttemberg, Germany|Universitaetsklinikum Ulm /ID# 203560, Ulm, Baden-Wuerttemberg, Germany|Universitaetsklinikum Erlangen /ID# 203552, Erlangen, Bayern, Germany|Universitaetsklinikum Frankfurt /ID# 203566, Frankfurt am Main, Hessen, Germany|Zentrum für Gastroenterologie Saar MVZ GmbH /ID# 206741, Saarbrücken, Saarland, Germany|Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 168757, Kiel, Schleswig-Holstein, Germany|Gastroenterologie am Mexikoplatz /ID# 203575, Berlin, Germany|Universitaetsmedizin Essen St. Josef Krankenhaus Werden /ID# 203570, Essen, Germany|Agaplesion Markus Krankenhaus /ID# 168758, Frankfurt am Main, Germany|Universitaetsklinikum Halle (Saale) /ID# 207455, Halle (Saale), Germany|Medizinisches Versorgungszentrum Portal 10 /ID# 200214, Muenster, Germany|General Hospital of Athens Ippokratio /ID# 167045, Athens, Attiki, Greece|General Hospital of Chest Diseases of Athens SOTIRIA /ID# 202104, Athens, Attiki, Greece|Tzaneio general hospital of Piraeus /ID# 206433, Piraeus, Attiki, Greece|University General Hospital of Heraklion PA.G.N.I /ID# 167044, Heraklion, Kriti, Greece|Genl Hosp Thess Ippokrateio /ID# 208825, Thessaloniki, Greece|Tuen Mun Hospital /ID# 171218, Tuen Mun, Hong Kong|Mohacsi Korhaz /ID# 209441, Mohács, Baranya, Hungary|CRU Hungary Egeszsegugyi és Szolgaltato Kft. /ID# 205547, Miskolc, Borsod-Abauj-Zemplen, Hungary|Bugat Pal Korhaz /ID# 201893, Gyöngyös, Heves, Hungary|Obudai Egeszsegugyi Centrum Kft. /ID# 201892, Budapest, Hungary|MH Honvedkorhaz /ID# 201724, Budapest, Hungary|Semmelweis Egyetem /ID# 210167, Budapest, Hungary|Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz /ID# 201723, Debrecen, Hungary|Debreceni Egyetem Klinikai Kozpont /ID# 216419, Debrecen, Hungary|Pest Megyei Flor Ferenc Korhaz /ID# 206154, Kistarcsa, Hungary|Mentahaz Maganorvosi Kozpont /ID# 201895, Szekesfehervar, Hungary|Szent Borbala Korhaz /ID# 209897, Tatabánya, Hungary|Mercy University Hospital /ID# 206511, Cork, Ireland|Soroka Medical Center /ID# 169913, Be'er Sheva, HaDarom, Israel|Tel Aviv Sourasky Medical Center /ID# 204877, Tel Aviv-Yafo, Tel-Aviv, Israel|Hadassah Medical Center-Hebrew University /ID# 169928, Jerusalem, Yerushalayim, Israel|Assaf Harofeh Medical Center /ID# 204872, Be'Er Ya'Akov, Israel|Rabin Medical Center /ID# 202636, Petakh Tikva, Israel|Kaplan Medical Center /ID# 170276, Rehovot, Israel|AOU Policlinico S. Orsola Malpighi /ID# 168187, Bologna, Emilia-Romagna, Italy|Policlinico Universitario Campus Bio-Medico /ID# 168183, Rome, Lazio, Italy|Azienda Ospedaliera San Camillo Forlanini /ID# 168184, Rome, Lazio, Italy|Istituto Clinico Humanitas /ID# 168185, Rozzano, Milano, Italy|Fondazione PTV Policlinico Tor Vergata /ID# 168188, Rome, Roma, Italy|Presidio Columbus-Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Un /ID# 168182, Rome, Roma, Italy|IRCCS Ospedale Sacro Cuore Don Calabria /ID# 168186, Negrar, Verona, Italy|A.O. Per L'Emergenza Cannizzaro /ID# 168190, Catania, Italy|Policlinico San Martino/Univer /ID# 168191, Genova, Italy|ASST Fatebenefratelli Sacco - Ospedale Fatebenefratelli e Oftalmico /ID# 168181, Milano, Italy|ASST Grande Ospedale Metropolitano Niguarda /ID# 170849, Milano, Italy|Azienda Ospedaliero-Universitaria di Modena /ID# 201897, Modena, Italy|Ospedali Riuniti Villa Sofia-C /ID# 168189, Palermo, Italy|AOU Pisana /ID# 202421, Pisa, Italy|Aichi Medical University Hospital /ID# 165971, Nagakute-shi, Aichi, Japan|Nagoya City University Hospital /ID# 165970, Nagoya shi, Aichi, Japan|Japanese Red Cross Nagoya Daiichi Hospital /ID# 165969, Nagoya-shi, Aichi, Japan|Toyohashi Municipal Hospital /ID# 200175, Toyohashi-shi, Aichi, Japan|Hirosaki National Hospital /ID# 165961, Hirosaki-shi, Aomori, Japan|Toho University Medical Center Sakura Hospital /ID# 165963, Sakura-shi, Chiba, Japan|Kurume University Hospital /ID# 166012, Kurume-shi, Fukuoka, Japan|National Hospital Organization Takasaki General Medical Center /ID# 167127, Takasaki-shi, Gunma, Japan|NHO Fukuyama Medical Center /ID# 167131, Fukuyama-shi, Hiroshima, Japan|Duplicate_Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital /ID# 166014, Hiroshima-shi, Hiroshima, Japan|Asahikawa Medical University Hospital /ID# 167120, Midorigaokahiga-shi, Hokkaido, Japan|Sapporo IBD Clinic /ID# 223561, Sapporo-shi, Hokkaido, Japan|Duplicate_Sapporo Higashi Tokushukai Hospital /ID# 165960, Sapporo-shi, Hokkaido, Japan|Duplicate_Sapporo Higashi Tokushukai Hospital /ID# 167124, Sapporo-shi, Hokkaido, Japan|Kobe Home Clinic of Neurology /ID# 166009, Kobe-shi, Hyogo, Japan|Hyogo College of Medicine College Hospital /Id# 165973, Nishinomiya-shi, Hyogo, Japan|Kanazawa University Hospital /ID# 169218, Kanazawa-shi, Ishikawa, Japan|Sameshima Hospital /ID# 206675, Kagoshima-shi, Kagoshima, Japan|Shin-Yurigaoka General Hospital /ID# 206654, Kawasaki City, Kanagawa, Japan|Shin-Yurigaoka General Hospital /ID# 227137, Kawasaki City, Kanagawa, Japan|Yokohama City University Medical Center /ID# 167128, Yokohama shi, Kanagawa, Japan|Japanese Red Cross Kyoto Daiichi Hosital /ID# 165972, Kyoto-shi, Kyoto, Japan|Duplicate_Duplicate_Duplicate_Kyoto University Hospital /ID# 169889, Kyoto-shi, Kyoto, Japan|Yokkaichi Hazu Medical Center /ID# 167196, Yokkaichi-shi, Mie, Japan|Tohoku Rosai Hospital /ID# 167122, Sendai-shi, Miyagi, Japan|Nara Medical University Hospital /ID# 169219, Kashihara-shi, Nara, Japan|Kenseikai Dongo Hospital /ID# 208104, Yamatotakada-shi, Nara, Japan|Niigata Cancer Center Hospital /ID# 170045, Niigata-shi, Niigata, Japan|Ishida Clinic of IBD and Gastroenterology /ID# 167121, Oita-shi, Oita, Japan|Chikuba Hospital for Proctological and Gastrointestinal Diseases /ID# 166010, Kurashiki-shi, Okayama, Japan|Duplicate_Japanese Red Cross Okayama Hospital /ID# 167356, Okayama-shi, Okayama, Japan|National Hospital Organization Osaka Minami Medical Center /ID# 206326, Kawachinagano Shi, Osaka, Japan|Shimizu-Clinic /ID# 218872, Osaka-shi, Osaka, Japan|Osaka City University Hospital /ID# 166015, Osaka-shi, Osaka, Japan|Osaka University Hospital /ID# 169663, Suita-shi, Osaka, Japan|Tokitokai Tokito clinic /ID# 165962, Saitama-shi, Saitama, Japan|Shiga University of Medical Science Hospital /ID# 167129, Otsu-shi, Shiga, Japan|Hamamatsu University Hospital /ID# 224352, Hamamatsu-shi, Shizuoka, Japan|Shizuoka Medical Centre /ID# 167125, Sunto-shi, Shizuoka, Japan|Duplicate_Tokai University Hachioji Hospital /ID# 165967, Hachioji-shi, Tokyo, Japan|Kyorin University Hospital /ID# 165966, Mitaka-shi, Tokyo, Japan|Tokyo Medical University Hospital /ID# 165965, Shinjuku-ku, Tokyo, Japan|Tokyo Medical University Hospital /ID# 167130, Shinjuku-ku, Tokyo, Japan|Tokyo Medical University Hospital /ID# 205980, Shinjuku-ku, Tokyo, Japan|Toyama Prefectural Central Hospital /ID# 217834, Toyama-shi, Toyama, Japan|Japanese Red Cross Wakayama Medical Center /ID# 200643, Wakayama-shi, Wakayama, Japan|Wakayama Medical University Hospital /ID# 169482, Wakayama-shi, Wakayama, Japan|Yamagata University Hospital /ID# 200157, Yamagata-shi, Yamagata, Japan|Shunan Memorial Hospital /ID# 214404, Kudamatsu-shi, Yamaguchi, Japan|Yamanashi Prefectural Central Hospital /ID# 202464, Kofu-shi, Yamanashi, Japan|Hanyang University Guri Hospital /ID# 167587, Guri, Gyeonggido, Korea, Republic of|CHA Bundang Medical center CHA University /ID# 167592, Seongnam si, Gyeonggido, Korea, Republic of|Kangbuk Samsung Hospital /ID# 167586, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Yonsei University Health System Severance Hospital /ID# 167590, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Inje University Haeundae Hospital /ID# 202630, Busan, Korea, Republic of|Dong-A University Hospital /ID# 167591, Busan, Korea, Republic of|Pusan National University Hospital /ID# 167589, Busan, Korea, Republic of|Kyungpook National Univ Hosp /ID# 207019, Daegu, Korea, Republic of|Samsung Medical Center /ID# 167588, Seoul, Korea, Republic of|Chung-Ang University Hostipal /ID# 207018, Seoul, Korea, Republic of|Riga East Clinical Univ Hosp /ID# 169498, Riga, Latvia|P. Stradins Clinical Univ Hosp /ID# 169519, Riga, Latvia|Digestive Diseases Ctr Gastro /ID# 169508, Riga, Latvia|Duplicate_LUHS hospital Kauno Klinikos /ID# 206936, Kovno, Lithuania|Vilnius University Hospital /ID# 203286, Vilnius, Lithuania|Hospital Sultanah Bahiyah /ID# 202626, Alor Setar, Kedah, Malaysia|Universiti Kebangsaan Malaysia (UKM) Medical Centre /ID# 170773, Kuala Lumpur, Selangor, Malaysia|Universiti Sains Malaysia /ID# 200102, Kelantan, Malaysia|Instituto de Investigaciones Aplicadas a la Neurociencias A.C. /ID# 207579, Victoria de Durango, Durango, Mexico|Morales Vargas Centro de Investigacion S.C. /ID# 203494, Leon, Guanajuato, Mexico|Clinica de Investigacion en Reumatologia y Obesidad S.C. /ID# 207238, Guadalajara, Jalisco, Mexico|Radboud Universitair Medisch Centrum /ID# 166928, Nijmegen, Gelderland, Netherlands|Onze Lieve Vrouwe Gasthuis /ID# 166929, Amsterdam, Netherlands|Academisch Medisch Centrum /ID# 166927, Amsterdam, Netherlands|Medisch Spectrum Twente /ID# 170298, Enschede, Netherlands|Zuyderland Medisch Centrum /ID# 169700, Heerlen, Netherlands|Vistamed /ID# 208572, Wroclaw, Dolnoslaskie, Poland|Malopolskie Centrum Kliniczne /ID# 202167, Krakow, Malopolskie, Poland|WIP Warsaw IBD Point Profesor Kierkus /ID# 224301, Warsaw, Mazowieckie, Poland|Centrum Medyczne Reuma Park w Warszawie /ID# 200490, Warsaw, Mazowieckie, Poland|Centrum Zdrowia MDM /ID# 200491, Warszawa, Mazowieckie, Poland|Hospital da Senhora da Oliveira Guimaraes, EPE /ID# 170245, Guimaraes, Braga, Portugal|Hospital Egas Moniz /ID# 170253, Lisbon, Porto, Portugal|Unidade Local de Saúde do Alto Minho, EPE - Hospital Conde de Bertiandos /ID# 200607, Ponte de Lima, Viana Do Castelo, Portugal|Hospital Garcia de Orta, EPE /ID# 170241, Almada, Portugal|Centro Hospitalar Universitario de Sao Joao, EPE /ID# 170248, Porto, Portugal|Mindful Medical Research /ID# 203358, San Juan, Puerto Rico|School of Medicine University of Puerto Rico-Medical Science Campus /ID# 166771, San Juan, Puerto Rico|Institutul Clinic Fundeni /ID# 167817, Sector 2, Bucuresti, Romania|Clinica GASTRO MED SRL /ID# 206369, Cluj-Napoca, Cluj, Romania|Cabinet Particular Policlinic Algomed /ID# 167818, Timisoara, Romania|Immanuel Kant Baltic Federal University /ID# 203811, Kaliningrad, Kaliningradskaya Oblast, Russian Federation|Perm Clinical Center of the Federal Medical and Biological Agency /ID# 202990, Perm, Permskiy Kray, Russian Federation|LLC Novaya Klinika /ID# 206616, Pyatigorsk, Stavropol Skiy Kray, Russian Federation|Professor Pasechnikov Gastroenterology and Pankreatology clinic /ID# 202997, Stavropol, Stavropol Skiy Kray, Russian Federation|Kazan State Medical University /ID# 169638, Kazan, Tatarstan, Respublika, Russian Federation|Olla-Med Clinic /ID# 208720, Moscow, Russian Federation|P.A. Bayandin Murmansk Regiona /ID# 169639, Murmansk, Russian Federation|Medical Center Zdorovaya Semya /ID# 209236, Novosibirsk, Russian Federation|Republican hospital named after V.A. Baranov /ID# 206488, Petrozavodsk, Russian Federation|Euromedservice /ID# 206610, Pushkin, Russian Federation|X7 Clinical Research Center /ID# 216350, Saint Petersburg, Russian Federation|City Clinical Hospital No. 31 /ID# 208868, St. Petersburg, Russian Federation|Clinical Hosp Center Zvezdara /ID# 168214, Belgrade, Beograd, Serbia|Military Medical Academy /ID# 168783, Belgrade, Beograd, Serbia|University Clinical Center Serbia /ID# 168215, Belgrade, Beograd, Serbia|Clin Hosp Ctr Bezanijska Kosa /ID# 168750, Belgrade, Beograd, Serbia|University Clinical Center Kragujevac /ID# 205859, Kragujevac, Sumadijski Okrug, Serbia|Clinical Center Vojvodina /ID# 168213, Novi Sad, Vojvodina, Serbia|KL Ling Gastroenterology and Liver Clinic /ID# 217962, Singapore, Singapore|Gleneagles Medical Centre /ID# 206531, Singapore, Singapore|Tan Tock Seng Hospital /ID# 203160, Singapore, Singapore|FNsP F.D.Roosevelta Banska Bystrica /ID# 169958, Banska Bystrica, Banskobystricky Kraj, Slovakia|KM Management s.r.o. /ID# 170201, Nitra, Slovakia|Univ Medical Ctr Ljubljana /ID# 217795, Ljubljana, Slovenia|Farmovs (Pty) Ltd /Id# 207535, Bloemfontein, Free State, South Africa|Lenasia Clinical Trial Centre /ID# 205145, Johannesburg, Gauteng, South Africa|Wits Clinical Research Site /ID# 170852, Johannesburg, Gauteng, South Africa|Allergy & Immunology (AIU) /ID# 171431, Cape Town, Western Cape, South Africa|Dr JP Wright /ID# 170887, Cape Town, Western Cape, South Africa|Private Practice Dr MN Rajabally /ID# 169853, Cape Town, Western Cape, South Africa|Hospital Universitari Son Espases /ID# 201998, Palma de Mallorca, Illes Balears, Spain|Complejo Hospitalario de Navarra /ID# 202355, Pamplona, Navarra, Spain|Hospital Universitario A Coruna - CHUAC /ID# 203910, A Coruna, Spain|Hospital Clinic de Barcelona /ID# 201990, Barcelona, Spain|Hospital Universitario de Girona Doctor Josep Trueta /ID# 202645, Girona, Spain|Hospital Juan Ramon Jimenez /ID# 201995, Huelva, Spain|Hospital Universitario La Paz /ID# 201994, Madrid, Spain|Hospital Clinico Universitario de Salamanca /ID# 206358, Salamanca, Spain|Hospital Universitario Virgen Macarena /ID# 201993, Sevilla, Spain|Hospital Clinico Universitario de Valencia /ID# 209657, Valencia, Spain|Hospital Universitario y Politecnico La Fe /ID# 201992, Valencia, Spain|Karolinska University Hospital Solna /ID# 224488, Solna, Stockholms Lan, Sweden|Alingsås lasarett /ID# 170826, Alingsås, Vastra Gotalands Lan, Sweden|Sodra Alvsborgs sjukhus /ID# 203077, Boras, Vastra Gotalands Lan, Sweden|Sahlgrenska US Gbg /ID# 169171, Göteborg, Vastra Gotalands Lan, Sweden|Hallands sjukhus Halmstad /ID# 170828, Halmstad, Sweden|Inselspital, Universitätsspital Bern /ID# 170997, Bern, Switzerland|Universitatsspital Zurich /ID# 170998, Zurich, Switzerland|China Medical University Hosp /ID# 169791, Taichung City, Taichung, Taiwan|Taichung Veterans General Hosp /ID# 169790, Taichung City, Taiwan|National Taiwan University Hospital /ID# 169792, Taipei City, Taiwan|Acibadem Kozyatagi Hospital /ID# 209406, Kadikoy, Istanbul, Turkey|Erciyes University Medical Fac /ID# 171331, Melikgazi, Kayseri, Turkey|Ankara Univ Medical Faculty /ID# 206409, Ankara, Turkey|Inonu Universitesi Turgut Ozal /ID# 201268, Battalgazi/malatya, Turkey|Mustafa Kemal University Medic /ID# 171336, Hatay, Turkey|Istanbul University Istanbul Medical Faculty /ID# 171364, Istanbul, Turkey|Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi /ID# 171332, Istanbul, Turkey|Mersin University Medical /ID# 171338, Mersin, Turkey|Sisli Etfal Train & Res Hosp /ID# 171334, Sisli, Turkey|Gazi Universitesi Tip Fakultes /ID# 217444, Yenimahalle, Turkey|Medical Centre of ""Ukrainian German Antiulcer Gastroenterology Centre BYK-KYIV"" /ID# 203738, Kyiv, Kyivska Oblast, Ukraine|Kharkiv City Clinical Hospital No.2 n.a. Prof. O.O. Shalimov /ID# 167907, Kharkiv, Ukraine|MNE Kyiv City Clinical Hospital no.18 /ID# 207889, Kyiv, Ukraine|MI of Kyiv Regional Rada Kyiv Regional Clinical Hospital /ID# 202454, Kyiv, Ukraine|Lviv Railway Clinical Hospital of branch Healthcare Centers of Public Joint Stoc /ID# 167908, Lviv, Ukraine|MNPE Vinnytsia Regional Clinical Hospital n.a. M.I. Pyrohov /ID# 222110, Vinnytsia, Ukraine|South Eastern Health and Social Care Trust /ID# 205323, Belfast, Antrim, United Kingdom|Warrington and Halton Hospitals NHS Foundation Trust /ID# 171383, Warrington, Cheshire West And Chester, United Kingdom|Royal United Hospitals Bath /ID# 169074, Bath, United Kingdom|Queen Elizabeth Hospital - BIRMINGHAM /ID# 169070, Birmingham, United Kingdom|Russells Hall Hospital, Dudley /ID# 169069, Dudley, United Kingdom|King's College Hospital NHS Foundation Trust /ID# 169072, London, United Kingdom|St. George's Healthcare NHS /ID# 205552, London, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 169075, Newcastle Upon Tyne, United Kingdom|St. Helens and Knowsley Teach /ID# 209086, Prescot, United Kingdom|Stockport NHS foundation trust /ID# 208719, Stockport, United Kingdom|Taunton and Somerset NHS Found /ID# 209665, Tauntojn, United Kingdom|New Cross Hospital, Royal Wolv /ID# 171382, Wolverhampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03345849"
623,"NCT03345836","A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy",,"Active, not recruiting","No Results Available","Crohn's Disease","Other: Matching placebo for upadacitinib|Drug: upadacitinib","Percentage of Participants with Clinical Remission per Crohn's Disease Activity Index (CDAI)|Percentage of Participants with Endoscopic Response|Percentage of Participants with Clinical Remission per Patient-Reported Outcomes (PROs)|Percentage of Participants with Endoscopic Remission|Percentage of Participants who Discontinue Corticosteroid Use for Crohn's Disease (CD) and Achieve Clinical Remission|Change in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F)|Change in Inflammatory Bowel Disease Questionnaire (IBDQ)|Percentage of Participants Achieving Clinical Response 100 (CR-100)|Percentage of Participants with Hospitalizations due to Crohn's Disease (CD)|Percentage of Participants with Resolution of Extra-Intestinal Manifestation (EIM) , in Participants with EIM at Baseline","AbbVie","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 3","645","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","M14-431|2017-001226-18","November 29, 2017","October 7, 2021","October 7, 2021","November 17, 2017",,"May 24, 2021","East View Medical Research, LLC /ID# 171133, Mobile, Alabama, United States|CB Flock Research Corporation /ID# 166220, Mobile, Alabama, United States|Delsol Research Management, Ll /Id# 170179, Chandler, Arizona, United States|HonorHealth Research Institute - Shea /ID# 164734, Scottsdale, Arizona, United States|Arizona Arthritis & Rheumatology Research, PLLC /ID# 203891, Sun City, Arizona, United States|Southern California Res. Ctr. /ID# 169654, Coronado, California, United States|Citrus Valley Gastroenterology /ID# 166201, Covina, California, United States|United Medical Doctors /ID# 207452, Los Alamitos, California, United States|Gastrointestinal Biosciences /ID# 164887, Los Angeles, California, United States|Facey Medical Foundation /ID# 203137, Mission Hills, California, United States|United Medical Doctors - Murrieta /ID# 164845, Murrieta, California, United States|Ucsd /Id# 164679, San Diego, California, United States|Medical Assoc Research Grp /ID# 169705, San Diego, California, United States|UCSF Center for Colitis and Crohn's Disease /ID# 202373, San Francisco, California, United States|Univ of California San Francis /ID# 164843, San Francisco, California, United States|Care Access Research /ID# 167766, San Pablo, California, United States|Peak Gastroenterology Associat /ID# 170181, Colorado Springs, Colorado, United States|Delta Waves, Inc. /ID# 164872, Colorado Springs, Colorado, United States|Western States Clinical Research, Inc. /ID# 164895, Wheat Ridge, Colorado, United States|Medical Research Ctr CT /ID# 164829, Hamden, Connecticut, United States|Clinical Research of West Florida - Clearwater /ID# 205825, Clearwater, Florida, United States|Clinical Research of West Florida - Clearwater /ID# 208117, Clearwater, Florida, United States|Advanced Research - Coral Springs /ID# 218020, Coral Springs, Florida, United States|Encore Borland-Groover Clinical Research /Id# 203498, Jacksonville, Florida, United States|Ctr for Advanced Gastroenterol /ID# 165332, Maitland, Florida, United States|Crystal Pharmacology Research /ID# 166101, Miami, Florida, United States|Coral Research Clinic /ID# 164657, Miami, Florida, United States|Advanced Research Institute /ID# 164814, New Port Richey, Florida, United States|Endoscopic Research, Inc. /ID# 205893, Orlando, Florida, United States|Omega Research Consultants /ID# 203480, Orlando, Florida, United States|Clinical Research Trials of Florida, Inc. /ID# 203484, Tampa, Florida, United States|AdventHealth Tampa /ID# 171175, Tampa, Florida, United States|Gastroenterology Associates of Central Georgia, LLC /ID# 165460, Macon, Georgia, United States|Gastroenterology Consultants PC - Roswell /ID# 218219, Roswell, Georgia, United States|Atlanta Gastroenterology Spec /ID# 164780, Suwanee, Georgia, United States|University of Chicago /ID# 165472, Chicago, Illinois, United States|DuPage Medical Group /ID# 205303, Downers Grove, Illinois, United States|MediSphere Medical Research Center /ID# 166209, Evansville, Indiana, United States|Indianapolis Gastroenterology /ID# 164837, Indianapolis, Indiana, United States|Aquiant Research /ID# 205504, New Albany, Indiana, United States|University of Iowa Hospitals and Clinics /ID# 165330, Iowa City, Iowa, United States|Tri-State Gastroenterology /ID# 165484, Crestview Hills, Kentucky, United States|University of Louisville /ID# 168536, Louisville, Kentucky, United States|University of Louisville /ID# 208093, Louisville, Kentucky, United States|CroNOLA, LLC /ID# 164722, Houma, Louisiana, United States|Nola Research Works, LLC /ID# 164897, New Orleans, Louisiana, United States|Louisana Research Center, LLC /ID# 164659, Shreveport, Louisiana, United States|Johns Hopkins University School of Medicine /ID# 211940, Baltimore, Maryland, United States|MGG Group Co, Inc.Chevy Chase Clinical Research /ID# 164835, Chevy Chase, Maryland, United States|Gastro Center of Maryland /ID# 171171, Columbia, Maryland, United States|Lahey Hospital and Medical Center /ID# 214725, Burlington, Massachusetts, United States|University of Michigan Health Systems /ID# 164844, Ann Arbor, Michigan, United States|Clin Res Inst of Michigan, LLC /ID# 170178, Chesterfield, Michigan, United States|Digestive Health Associates (DHA) - Farmington Hills /ID# 206099, Farmington Hills, Michigan, United States|Center for Digestive Health /ID# 164733, Troy, Michigan, United States|Mayo Clinic /ID# 164868, Rochester, Minnesota, United States|Southern Therapy and Advanced Research (STAR) LLC /ID# 165318, Jackson, Mississippi, United States|Quality Clinical Research, Inc /ID# 170177, Omaha, Nebraska, United States|CHI Nebraska d/b/a CHI Health /ID# 168545, Omaha, Nebraska, United States|Las Vegas Medical Research /ID# 168562, Las Vegas, Nevada, United States|AGA Clinical Research Associates, LLC /ID# 164883, Egg Harbor Township, New Jersey, United States|Rutgers, The State University /ID# 166092, New Brunswick, New Jersey, United States|Montefiore Medical Center - Moses Campus /ID# 166226, Bronx, New York, United States|Advantage Clinical Trials /ID# 168557, Bronx, New York, United States|NY Scientific /ID# 164833, Brooklyn, New York, United States|NYU Langone Long Island Clinical Research Associates /ID# 164830, Lake Success, New York, United States|The Mount Sinai Hospital /ID# 170172, New York, New York, United States|Columbia Univ Medical Center /ID# 164870, New York, New York, United States|Gastro Group of Rochester /ID# 166216, Rochester, New York, United States|Richmond University Medical Center /ID# 201855, Staten Island, New York, United States|Atrium Health Carolinas Medical Center /ID# 164834, Charlotte, North Carolina, United States|PMG Research of Charlotte /ID# 171170, Charlotte, North Carolina, United States|Wake Radiology UNC REX Healthcare - Raleigh Office /ID# 164663, Raleigh, North Carolina, United States|Wake Forest Baptist Medical Center /ID# 201225, Winston-Salem, North Carolina, United States|Plains Clinical Research Center, LLC /ID# 170184, Fargo, North Dakota, United States|Consultants for Clinical Res /ID# 164855, Cincinnati, Ohio, United States|University of Cincinnati /ID# 164720, Cincinnati, Ohio, United States|Cleveland Clinic Main Campus /ID# 208220, Cleveland, Ohio, United States|The Ohio State University /ID# 170174, Columbus, Ohio, United States|Optimed Research, Ltd. /ID# 205618, Columbus, Ohio, United States|Hometown Urgent Care and Resea /ID# 201290, Dayton, Ohio, United States|Dayton Gastroenterology, Inc. /ID# 167624, Englewood, Ohio, United States|Great Lakes Gastroenterology Research LLC /ID# 202007, Mentor, Ohio, United States|Digestive Disease Specialists /ID# 201062, Oklahoma City, Oklahoma, United States|Options Health Research, LLC /ID# 164737, Tulsa, Oklahoma, United States|Healthcare Research Consultant /ID# 166228, Tulsa, Oklahoma, United States|University of Pennsylvania /ID# 168402, Philadelphia, Pennsylvania, United States|Thomas Jefferson University /ID# 168014, Philadelphia, Pennsylvania, United States|Pharmacorp Clinical Trials /ID# 164809, Charleston, South Carolina, United States|Gastroenterology Associates, P.A. of Greenville /ID# 164880, Greenville, South Carolina, United States|Rapid City Medical Center /ID# 201734, Rapid City, South Dakota, United States|Gastro One /ID# 164718, Germantown, Tennessee, United States|East Tennessee Research Instit /ID# 203612, Johnson City, Tennessee, United States|Quality Medical Research, PLLC /ID# 205262, Nashville, Tennessee, United States|Vanderbilt University Medical Center /ID# 164846, Nashville, Tennessee, United States|TX Clinical Research Institute /ID# 164848, Arlington, Texas, United States|Quest Clinical Research /ID# 164865, Baytown, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209802, Cedar Park, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209952, Cedar Park, Texas, United States|DHAT Research Institute /ID# 164777, Garland, Texas, United States|CliniCore International, LLC /ID# 164662, Houston, Texas, United States|Baylor College of Medicine /ID# 164847, Houston, Texas, United States|Centex Studies, Inc. - Houston /ID# 201213, Houston, Texas, United States|GI Specialists of Houston /ID# 202338, Houston, Texas, United States|Caprock Gastro Research /ID# 215437, Lubbock, Texas, United States|Clinical Associates in Researc /ID# 164863, San Antonio, Texas, United States|Southern Star Research Institute, LLC /ID# 169754, San Antonio, Texas, United States|Carl R. Meisner Medical Clinic /ID# 201060, Sugar Land, Texas, United States|Tyler Research Institute, LLC /ID# 168681, Tyler, Texas, United States|Gastro Health & Nutrition - Victoria /ID# 167813, Victoria, Texas, United States|HP Clinical Research /ID# 164929, Bountiful, Utah, United States|Advanced Research Institute /ID# 164866, Ogden, Utah, United States|Care Access Research /ID# 164853, Salt Lake City, Utah, United States|Velocity Clinical Research - Salt Lake City /ID# 166095, West Jordan, Utah, United States|Washington Gastroenterology Associates /ID# 164721, Bellevue, Washington, United States|Virginia Mason - Seattle Orthapedics /ID# 164680, Seattle, Washington, United States|University of Washington /ID# 164875, Seattle, Washington, United States|The Vancouver Clinic, INC. PS /ID# 164811, Vancouver, Washington, United States|Froedtert Memorial Lutheran Hospital /ID# 202286, Milwaukee, Wisconsin, United States|Allegiance Research Specialist /ID# 165321, Wauwatosa, Wisconsin, United States|Hospital Italiano de Buenos Aires /ID# 215543, Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina|Cemic /Id# 169184, Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina|Cardio Alem /ID# 211284, San Isidro, Buenos Aires, Argentina|GEDyT /ID# 210019, Ciudad Autonoma Buenos Aires, Ciuadad Autonoma De Buenos Aires, Argentina|Hospital Centenario /Id# 171254, Rosario, Santa Fe, Argentina|Hospital Privado Univesitario /ID# 169228, Cordoba, Argentina|Concord Repatriation General Hospital /ID# 171509, Concord, New South Wales, Australia|Coral Sea Clinical Research institute /ID# 212987, North Mackay, Queensland, Australia|Mater Misericordiae /ID# 204908, South Brisbane, Queensland, Australia|Royal Adelaide Hospital /ID# 171511, Adelaide, South Australia, Australia|Box Hill Hospital /ID# 203734, Box Hill, Victoria, Australia|Fiona Stanley Hospital /ID# 171510, Murdoch, Western Australia, Australia|Klinik Landstrasse /ID# 203437, Vienna, Wien, Austria|Medical University of Vienna /ID# 169462, Vienna, Wien, Austria|LKH Salzburg and Paracelsus /ID# 214467, Salzburg, Austria|UCL Saint-Luc /ID# 200297, Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium|Universitair Ziekenhuis Leuven /ID# 200298, Leuven, Vlaams-Brabant, Belgium|AZ Sint-Lucas /ID# 200301, Gent, Belgium|CHU de Liege Sart Tilman /ID# 200299, Liege, Belgium|CHU Dinant Godinne - UCL Namur /ID# 200300, Yvoir, Belgium|University Clinical Centre of the Republic of Srpska /ID# 208050, Banja Luka, Republika Srpska, Bosnia and Herzegovina|University Clinical Center Tuzla /ID# 210324, Tuzla, Tuzlanski, Bosnia and Herzegovina|Clinical Center University of Sarajevo /ID# 203885, Sarajevo, Bosnia and Herzegovina|Polyclinic and Daily Hospital Dr. Al-Tawil /ID# 217841, Sarajevo, Bosnia and Herzegovina|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Ltda /ID# 166870, Goiania, Goias, Brazil|Hospital Nossa Senhora das Graças /ID# 166869, Curitiba, Parana, Brazil|Hospital de Clinicas de Porto Alegre /ID# 166872, Porto Alegre, Rio Grande Do Sul, Brazil|Upeclin Fmb - Unesp /Id# 166876, Botucatu, Sao Paulo, Brazil|Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP /ID# 166874, Ribeirao Preto, Sao Paulo, Brazil|Faculdade de Medicina do ABC /ID# 208327, Santo André, Sao Paulo, Brazil|Kaiser Clinica e Hospital Dia /ID# 166873, Sao Jose Do Rio Preto, Sao Paulo, Brazil|UMHAT Kaspela EOOD /ID# 167617, Plovdiv, Bulgaria|II MHAT - Sofia /ID# 167618, Sofia, Bulgaria|MHAT Trakia /ID# 201678, Stara Zagora, Bulgaria|University of Calgary Cumming School of Medicine Adult Cystic Fibrosis Clinic /ID# 166963, Calgary, Alberta, Canada|Allen Whey Khye Lim Professional Corporation /ID# 168041, Edmonton, Alberta, Canada|Covenant Health /ID# 166966, Edmonton, Alberta, Canada|Fraser Clinical Trials Inc /ID# 166957, New Westminster, British Columbia, Canada|GIRI Gastrointestinal Research Institute /ID# 166964, Vancouver, British Columbia, Canada|QEII - Victoria Building /ID# 169306, Halifax, Nova Scotia, Canada|Scott Schulman medicine profes /ID# 169064, North Bay, Ontario, Canada|Taunton surgical centre /ID# 168039, Oshawa, Ontario, Canada|The Ottawa Hospital /ID# 212413, Ottawa, Ontario, Canada|Medicor Research Inc /ID# 166967, Sudbury, Ontario, Canada|Toronto Digestive Disease Asso /ID# 166961, Vaughan, Ontario, Canada|Hopital Hotel-Dieu de Levis /ID# 166958, Levis, Quebec, Canada|Crchum /Id# 170121, Montreal, Quebec, Canada|Montreal General Hospital - McGill University Health Centre /ID# 170010, Montréal, Quebec, Canada|CRCHUS Hotel-Dieu /ID# 170935, Sherbrooke, Quebec, Canada|Research Group Ltda /ID# 203180, Santiago, Region Metropolitana De Santiago, Chile|M y F Estudios Clínicos Ltda. /ID# 169995, Ñuñoa, Region Metropolitana De Santiago, Chile|Hospital Guillermo Grant Benavente de Concepción /ID# 212422, Concepción, Chile|CTR Estudios SpA /ID# 200650, Providencia, Chile|Hospital Clinico Universidad De Los Andes /ID# 207465, Santiago, Chile|The First Affiliated Hosp, Sun /ID# 205226, Guangzhou, Anhui, China|Zhongshan Hospital Xiamen Univ /ID# 204985, Xiamen, Anhui, China|Nanfang Hospital of Southern Medical University /ID# 204074, Guangzhou, Guangdong, China|The Sixth Affiliated Hosp Sun /ID# 204049, Guangzhou, Guangdong, China|The First Affiliated Hospital of Nanchang University /ID# 204070, Nanchang, Jiangxi, China|The First Hosp of Jilin Univ /ID# 206867, Changchun, Jilin, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 204072, Shanghai, Shanghai, China|'The Second Affiliated Hospital of Zhejiang University School of Medicine /ID# 204078, Hangzhou, Zhejiang, China|Sir Run Run Shaw Hospital /ID# 204068, Jianggan Hangzhou, Zhejiang, China|Beijing Friendship Hospital /ID# 204536, Beijing, China|The Second Xiangya Hospital of Central South University /ID# 204075, Changsha, China|Nanjing Drum Tower Hospital /ID# 204869, Nanjing Jiangsu, China|Tianjin Med Univ General Hosp /ID# 206993, Tianjin, China|Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 204096, Wuhan, China|Tongji Hospital Tongji Medical College Huazhong University of Science and Techno /ID# 204069, Wuhan, China|Hospital San Vicente de Paul /ID# 200028, Medellin, Antioquia, Colombia|Hospital Pablo Tobon Uribe /ID# 202405, Medellín, Colombia|Poliklinika Solmed /ID# 211518, Zagreb, Grad Zagreb, Croatia|UHC Split /ID# 171206, Split, Croatia|Zadar General Hospital /ID# 205534, Zadar, Croatia|CH Dubrava /ID# 171186, Zagreb, Croatia|UHC Sestre Milosrdnice /ID# 171190, Zagreb, Croatia|UHC Zagreb /ID# 171201, Zagreb, Croatia|Hepato-Gastroenterologie HK, s.r.o. /ID# 171566, Hradec Kralove, Czechia|ARTROSCAN s.r.o. /ID# 171592, Ostrava, Czechia|ResTrial s.r.o. /ID# 208652, Praha, Czechia|Nordsjallands Hospital /ID# 200613, Frederikssund, Hovedstaden, Denmark|Herlev Hospital /ID# 200782, Herlev, Hovedstaden, Denmark|Sjaellands Universitets Hospit /ID# 200783, Roskilde, Sjælland, Denmark|Hvidovre Hospital /ID# 200611, Hvidovre, Denmark|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 171010, Alexandria, Egypt|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 171015, Alexandria, Egypt|University of Alexandria /ID# 224412, Alexandria, Egypt|Nat Hep & Trop Med Res Inst /ID# 170990, Cairo, Egypt|Clinical Research Center, Faculty of Medicine, Cairo university /ID# 209557, Cairo, Egypt|Faculty of Medicine Ain Shams Research Institute- Clinical Research Centre /ID# 209565, Cairo, Egypt|Air Force Specialized Hospital /ID# 170995, Cairo, Egypt|Tartu University Hospital /ID# 203140, Tartu, Estonia|Chu de Nice-Hopital L'Archet Ii /Id# 171009, Nice CEDEX 3, Alpes-Maritimes, France|Hopital Haut-Leveque /ID# 207414, Pessac CEDEX, Gironde, France|CHRU Lille - Hopital Claude Huriez /ID# 206539, Lille CEDEX, Hauts-de-France, France|Hopital Saint Eloi /ID# 170646, Montpellier CEDEX 5, Herault, France|Hopital Beaujon /ID# 171011, Clichy, Ile-de-France, France|CHU de SAINT ETIENNE - Hopital Nord /ID# 171018, St. Priest En Jarez, Loire, France|Centre Hospitalier Lyon Sud /ID# 171014, Pierre Benite CEDEX, Rhone, France|Chu Amiens Picardie - Hopital /Id# 171016, Amiens Cedex 01, France|Chru Trousseau /Id# 169786, Chambray-les-tours, France|CHU Henri Mondor /ID# 169787, Creteil, France|Polyclinique Grand Sud /ID# 170649, Nimes Cedex, France|Hopital Rangueil /ID# 169785, Toulouse, France|Duplicate_CHRU de NANCY /ID# 170985, Vandoeuvre-les-nancy Cedex, France|Universitatsklinikum Mannheim /ID# 168778, Mannheim, Baden-Wuerttemberg, Germany|Universitaetsklinikum Erlangen /ID# 203551, Erlangen, Bayern, Germany|Universitaetsmedizin St. Josef Krankenhaus Werden /ID# 203571, Essen, Nordrhein-Westfalen, Germany|Zentrum für Gastroenterologie Saar MVZ GmbH /ID# 206740, Saarbrücken, Saarland, Germany|Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 168779, Kiel, Schleswig-Holstein, Germany|Universitaetsklinikum Ulm /ID# 203563, Ulm, Thueringen, Germany|Charite; Campus Benjamin Frank /ID# 169067, Berlin, Germany|Gastroenterologie am Mexikoplatz /ID# 203573, Berlin, Germany|Agaplesion Markus Krankenhaus /ID# 168777, Frankfurt, Germany|Universitaetsklinikum Frankfurt /ID# 203565, Frankfurt, Germany|Universitaetsklinikum Halle (Saale) /ID# 207454, Halle, Germany|Medizinisches Versorgungszentrum Portal 10 /ID# 200213, Muenster, Germany|General Hospital of Chest Diseases of Athens SOTIRIA /ID# 202103, Athens, Attiki, Greece|Tzaneio general hospital of Piraeus /ID# 206432, Piraeus, Attiki, Greece|General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 167037, Athens, Greece|General Hospital of Athens Ippokratio /ID# 167036, Athens, Greece|University General Hospital of Heraklion PA.G.N.I /ID# 167035, Heraklion, Greece|General Hospital of Thessaloniki Hippokrateio /ID# 208824, Thessaloniki, Greece|Queen Mary Hospital /ID# 171217, Hong Kong, Hong Kong|CRU Hungary Egeszsegugyi és Szolgaltato Kft. /ID# 205546, Miskolc, Borsod-Abauj-Zemplen, Hungary|Bugat Pal Korhaz /ID# 201889, Gyöngyös, Heves, Hungary|Obudai Egeszsegugyi Centrum Kft. /ID# 201891, Budapest, Hungary|MH Honvedkorhaz /ID# 201719, Budapest, Hungary|Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz /ID# 201720, Debrecen, Hungary|Mentahaz Maganorvosi Kozpont /ID# 201890, Szekesfehervar, Hungary|Mercy University Hospital /ID# 206510, Cork, Ireland|Soroka Medical Center /ID# 169912, Be'er Sheva, HaDarom, Israel|Tel Aviv Sourasky Medical Center /ID# 204876, Tel Aviv-Yafo, Tel-Aviv, Israel|Hadassah Medical Center-Hebrew University /ID# 169927, Jerusalem, Yerushalayim, Israel|Barzilai Medical Center /ID# 223372, Ashkelon, Israel|Assaf Harofeh Medical Center /ID# 204870, Be'er Ya'akov, Israel|Rabin Medical Center /ID# 202635, Petakh Tikva, Israel|Kaplan Medical Center /ID# 170277, Rehovot, Israel|Universita di Catanzaro Magna Graecia /ID# 201920, Catanzaro, Calabria, Italy|AOU Policlinico S. Orsola Malpighi /ID# 168173, Bologna, Emilia-Romagna, Italy|Azienda Ospedaliero-Universitaria Policlinico di Modena /ID# 200008, Modena, Emilia-Romagna, Italy|Policlinico Universitario Campus Bio-Medico /ID# 168169, Rome, Lazio, Italy|Azienda Ospedaliera San Camillo Forlanini /ID# 168170, Rome, Lazio, Italy|IBD Center - IRCCS Istituto Clinico Humanitas /ID# 168171, Rozzano, Milano, Italy|Presidio Columbus, Fondazione Policlinico Gemelli Universita Cattolica S. Cuore /ID# 168168, Rome, Roma, Italy|A.O. Per L'Emergenza Cannizzaro /ID# 168176, Catania, Sicilia, Italy|Ospedale Classificato Equiparato Sacro Cuore-Don Calabria /ID# 168172, Negrar, Verona, Italy|Policlinico San Martino/Univer /ID# 168177, Genova, Italy|ASST Fatebenefratelli Sacco- O /ID# 168167, Milano, Italy|Ospedali Riuniti Villa Sofia-C /ID# 168175, Palermo, Italy|AOU Pisana /ID# 202420, Pisa, Italy|Policlinico Tor Vergata /ID# 168174, Rome, Italy|Aichi Medical University Hospital /ID# 165957, Nagakute-shi, Aichi, Japan|Nagoya City University Hospital /ID# 165956, Nagoya shi, Aichi, Japan|Nagoya University Hospital /ID# 165955, Nagoya-shi, Aichi, Japan|Toyohashi Municipal Hospital /ID# 200174, Toyohashi-shi, Aichi, Japan|Hirosaki National Hospital /ID# 165944, Hirosaki-shi, Aomori, Japan|Toho University Medical Center Sakura Hospital /ID# 165949, Sakura-shi, Chiba, Japan|Kurume University Hospital /ID# 166004, Kurume-shi, Fukuoka, Japan|National Hospital Organization Takasaki General Medical Center /ID# 167136, Takasaki-shi, Gunma, Japan|NHO Fukuyama Medical Center /ID# 167139, Fukuyama-shi, Hiroshima, Japan|Hiroshima University Hospital /ID# 166006, Hiroshima-shi, Hiroshima, Japan|Asahikawa Medical University Hospital /ID# 167133, Asahikawa-shi, Hokkaido, Japan|Sapporo Medical University Hospital /ID# 167137, Sapporo shi, Hokkaido, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital /ID# 165943, Sapporo-shi, Hokkaido, Japan|Aoyama Clinic /ID# 166001, Kobe-shi, Hyogo, Japan|Hyogo College of Medicine College Hospital /Id# 200173, Nishinomiya-shi, Hyogo, Japan|Kanazawa University Hospital /ID# 169215, Kanazawa-shi, Ishikawa, Japan|Iwate Medical University Uchimaru Medical Center /ID# 202407, Morioka-shi, Iwate, Japan|Imamura General Hospital /ID# 227136, Kagoshima-shi, Kagoshima, Japan|Idzuro Imamura Hospital /ID# 206651, Kagoshima-shi, Kagoshima, Japan|Sameshima Hospital /ID# 206674, Kagoshima-shi, Kagoshima, Japan|Japanese Red Cross Kyoto Daiichi Hosital /ID# 165958, Kyoto-shi, Kyoto, Japan|Kyoto University Hospital /ID# 169888, Kyoto-shi, Kyoto, Japan|Yokkaichi Hazu Medical Center /ID# 167191, Yokkaichi-shi, Mie, Japan|Tohoku University Hospital /ID# 167135, Sendai-shi, Miyagi, Japan|Nara Medical University Hospital /ID# 169216, Kashihara-shi, Nara, Japan|Kenseikai Dongo Hospital /ID# 208103, Yamatotakada-shi, Nara, Japan|Niigata University Medical & Dental Hospital /ID# 170044, Niigata-shi, Niigata, Japan|Ishida Clinic of IBD and Gastroenterology /ID# 167134, Oita-shi, Oita, Japan|Chikuba Hospital for Proctological and Gastrointestinal Diseases /ID# 166002, Kurashiki-shi, Okayama, Japan|Okayama University Hospital /ID# 167355, Okayama-shi, Okayama, Japan|Kinshukai Infusion Clinic /ID# 218871, Osaka-shi, Osaka, Japan|Osaka City University Hospital /ID# 166007, Osaka-shi, Osaka, Japan|Osaka University Hospital /ID# 169662, Suita-shi, Osaka, Japan|Osaka Medical College Hospital /ID# 206324, Takatsuki-shi, Osaka, Japan|Tokitokai Tokito clinic /ID# 165945, Saitama-shi, Saitama, Japan|Shiga University of Medical Science Hospital /ID# 167141, Otsu-shi, Shiga, Japan|NHO Shizuoka Medical Center /ID# 167138, Sunto-gun, Shizuoka, Japan|Tokyo Medical And Dental University, Medical Hospital /ID# 165948, Bunkyo-ku, Tokyo, Japan|Tokai University Hachioji Hospital /ID# 165951, Hachioji-shi, Tokyo, Japan|The Jikei University Hospital /ID# 167142, Minato-ku, Tokyo, Japan|Kyorin University Hospital /ID# 165950, Mitaka-shi, Tokyo, Japan|Tokyo Women's Medical University Hospital /ID# 205981, Shinjuku-ku, Tokyo, Japan|Toyama Prefectural Central Hospital /ID# 217833, Toyama-shi, Toyama, Japan|Wakayama Medical University /ID# 169481, Wakayama-shi, Wakayama, Japan|Yamagata University Hospital /ID# 200156, Yamagata-shi, Yamagata, Japan|JP Red Cross Wakayama Med Ctr /ID# 200638, Wakayama, Japan|Kyungpook National Univ Hosp /ID# 207015, Daegu, Daegu Gwang Yeogsi, Korea, Republic of|Hanyang University Guri Hospital /ID# 167578, Guri, Gyeonggido, Korea, Republic of|CHA Bundang Medical center CHA University /ID# 167583, Seongnam si, Gyeonggido, Korea, Republic of|Yonsei University Health System, Severance Hospital /ID# 167581, Seodaemun-gu, Seoul Teugbyeolsi, Korea, Republic of|Kangbuk Samsung Hospital /ID# 167577, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Inje University Haeundae Hospital /ID# 202629, Busan, Korea, Republic of|Dong-A University Hospital /ID# 167582, Busan, Korea, Republic of|Pusan National University Hospital /ID# 167580, Busan, Korea, Republic of|Samsung Medical Center /ID# 167579, Seoul, Korea, Republic of|Chung-Ang University Hostipal /ID# 207017, Seoul, Korea, Republic of|Riga East Clinical Univ Hosp /ID# 169496, Riga, Latvia|P. Stradins Clinical Univ Hosp /ID# 169493, Riga, Latvia|Digestive Diseases Ctr Gastro /ID# 169517, Riga, Latvia|Hospital of lithuanian university of Health Science Kauno Klinikos /ID# 207263, Kaunas, Lithuania|Vilnius University Hospital /ID# 203285, Vilnius, Lithuania|Hospital Sultanah Bahiyah /ID# 202627, Alor Setar, Kedah, Malaysia|UKM Medical Centre /ID# 170778, Kuala Lumpur, Selangor, Malaysia|Instituto de Investigaciones Aplicadas a la Neurociencias A.C. /ID# 207143, Victoria de Durango, Durango, Mexico|Morales Vargas Centro de Investigacion S.C. /ID# 203495, Leon, Guanajuato, Mexico|Clinica de Investigacion en Reumatologia y Obesidad S.C. /ID# 206779, Guadalajara, Jalisco, Mexico|Radboud Universitair Medisch Centrum /ID# 166925, Nijmegen, Gelderland, Netherlands|Academisch Medisch Centrum /ID# 166924, Amsterdam, Noord-Holland, Netherlands|Medisch Spectrum Twente /ID# 170297, Enschede, Netherlands|Zuyderland Medisch Centrum /ID# 169698, Heerlen, Netherlands|Vistamed /ID# 208570, Wroclaw, Dolnoslaskie, Poland|Malopolskie Centrum Kliniczne /ID# 202166, Krakow, Malopolskie, Poland|WIP Warsaw IBD Point Profesor Kierkus /ID# 224300, Warsaw, Mazowieckie, Poland|Centrum Zdrowia MDM /ID# 200486, Warszawa, Mazowieckie, Poland|Centrum Medyczne Reuma Park w Warszawie /ID# 200488, Warsaw, Poland|Hospital Egas Moniz /ID# 170249, Lisbon, Porto, Portugal|Unidade Local de Saúde do Alto Minho, EPE - Hospital Conde de Bertiandos /ID# 200606, Ponte de Lima, Viana Do Castelo, Portugal|Hospital Garcia de Orta, EPE /ID# 170234, Almada, Portugal|Hospital da Senhora da Oliveira Guimarães, EPE /ID# 170225, Guimarães, Portugal|Centro Hospitalar de Sao Joao /ID# 170231, Porto, Portugal|Mindful Medical Research /ID# 203357, San Juan, Puerto Rico|School of Medicine University of Puerto Rico-Medical Science Campus /ID# 166770, San Juan, Puerto Rico|Institutul Clinic Fundeni /ID# 167826, Sector 2, Bucuresti, Romania|Clinica GASTRO MED SRL /ID# 206367, Cluj-Napoca, Cluj, Romania|Cabinet Particular Policlinic Algomed /ID# 167827, Timisoara, Romania|Immanuel Kant Baltic Federal University /ID# 202128, Kaliningrad, Kaliningradskaya Oblast, Russian Federation|Perm Clinical Center of FMBA /ID# 202988, Perm, Permskiy Kray, Russian Federation|Private institution Center of educational and clinical gastroenterology, hepatol /ID# 202995, Stavropol, Stavropol Skiy Kray, Russian Federation|Kazan State Medical University /ID# 169574, Kazan, Tatarstan, Respublika, Russian Federation|Llc Olla-Med /Id# 208721, Moscow, Russian Federation|P.A. Bayandin Murmansk Regiona /ID# 169575, Murmansk, Russian Federation|Medical Center Zdorovaya Semya /ID# 209233, Novosibirsk, Russian Federation|Republican Clin Hos n.a. Baran /ID# 206487, Petrozavodsk, Russian Federation|PMI Euromedservice /ID# 206609, Pushkin, Russian Federation|LLC Novaya Clinica /ID# 206615, Pyatigorsk, Russian Federation|X7 Clinical Research Center /ID# 216349, Saint-Petersburg, Russian Federation|City Clinical Hospital No. 31 /ID# 208870, St. Petersburg, Russian Federation|Clinical Hosp Center Zvezdara /ID# 168221, Belgrade, Beograd, Serbia|Military Medical Academy /ID# 168784, Belgrade, Beograd, Serbia|University Clinical Center Serbia /ID# 168220, Belgrade, Beograd, Serbia|Clin Hosp Ctr Bezanijska Kosa /ID# 168799, Belgrade, Beograd, Serbia|University Clinical Center Kragujevac /ID# 205858, Kragujevac, Sumadijski Okrug, Serbia|Clinical Center Vojvodina /ID# 168222, Novi Sad, Vojvodina, Serbia|KL Ling Gastroenterology and Liver Clinic /ID# 217963, Singapore, Singapore|Gleneagles Medical Centre /ID# 206530, Singapore, Singapore|Tan Tock Seng Hospital /ID# 203159, Singapore, Singapore|FNsP F.D.Roosevelta Banska Bystrica /ID# 169952, Banska Bystrica, Banskobystricky Kraj, Slovakia|KM Management s.r.o. /ID# 170199, Nitra, Slovakia|Univ Medical Ctr Ljubljana /ID# 211042, Ljubljana, Slovenia|Farmovs (Pty) Ltd /Id# 207536, Bloemfontein, Free State, South Africa|Lenasia Clinical Trial Centre /ID# 205144, Johannesburg, Gauteng, South Africa|Wits Clinical Research Site /ID# 170851, Johannesburg, Gauteng, South Africa|Mediclinic Constantiaberg /ID# 169852, Cape Town, Western Cape, South Africa|Dr JP Wright /ID# 170885, Cape Town, South Africa|Hospital Universitario A Coruña - CHUAC /ID# 203908, A Coruña, A Coruna, Spain|Hospital Unversitario Marques de Valdecilla /ID# 202039, Santander, Cantabria, Spain|Hospital Universitari Son Espases /ID# 201997, Palma de Mallorca, Illes Balears, Spain|Hospital Universitario Dr. Negrin /ID# 171238, Las Palmas de Gran Canaria, Las Palmas, Spain|Complejo Hospitalario de Navarra /ID# 202038, Pamplona, Navarra, Spain|Hospital Universitario Vall d'Hebron /ID# 171237, Barcelona, Spain|Hospital Clinic de Barcelona /ID# 171242, Barcelona, Spain|Hospital Universitario de Girona Doctor Josep Trueta /ID# 202040, Girona, Spain|Hospital Juan Ramon Jimenez /ID# 171243, Huelva, Spain|Hospital Universitario La Paz /ID# 171241, Madrid, Spain|Hospital Universitario Virgen Macarena /ID# 171240, Sevilla, Spain|Hospital Universitario y Politecnico La Fe /ID# 201988, Valencia, Spain|Alingsås lasarett /ID# 170838, Alingsås, Vastra Gotalands Lan, Sweden|Sodra Alvsborgs sjukhus /ID# 202889, Boras, Vastra Gotalands Lan, Sweden|Sahlgrenska US Gbg /ID# 169031, Göteborg, Vastra Gotalands Lan, Sweden|Hallands sjukhus Halmstad /ID# 170840, Halmstad, Sweden|Inselspital, Universitaetsklinik /ID# 171006, Bern, Switzerland|Universitatsspital Zurich /ID# 170999, Zurich, Switzerland|National Taiwan University Hospital /ID# 169789, Taipei City, Taiwan|Chang Gung Memorial Hospital /ID# 169788, Taoyuan, Taiwan|Acibadem Kozyatagi Hospital /ID# 209405, Kadikoy, Istanbul, Turkey|Erciyes University Medical Fac /ID# 171321, Melikgazi, Kayseri, Turkey|Gazi Universitesi Tip Fakultes /ID# 217443, Ankara, Turkey|Ankara Univ Medical Faculty /ID# 206412, Ankara, Turkey|Inonu Universitesi Turgut Ozal /ID# 201267, Battalgazi/malatya, Turkey|Mustafa Kemal University Medic /ID# 171318, Hatay, Turkey|Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty /ID# 200280, Istanbul, Turkey|Marmara University Medical Fac /ID# 171316, Istanbul, Turkey|Mersin University Medical /ID# 171320, Mersin, Turkey|Sisli Etfal Train & Res Hosp /ID# 171317, Sisli, Turkey|MNE Kyiv City Clinical Hospital no.18 /ID# 207870, Kyiv, Ukraine|Vinnytsia Regional Clinical Hospital n.a. M.I.Pyrogov /ID# 222109, Vinnytsia, Ukraine|South Eastern Health and Social Care Trust /ID# 205322, Belfast, Antrim, United Kingdom|Warrington and Halton Hospitals NHS Foundation Trust /ID# 171388, Warrington, Cheshire West And Chester, United Kingdom|Royal United Hospitals Bath /ID# 169084, Bath, United Kingdom|Queen Elizabeth Hospital - BIRMINGHAM /ID# 169080, Birmingham, United Kingdom|Russells Hall Hospital, Dudley /ID# 169079, Dudley, United Kingdom|London North West Healthcare N /ID# 169078, Harrow, United Kingdom|King's College Hospital NHS Foundation Trust /ID# 169082, London, United Kingdom|St. George's Healthcare NHS /ID# 205551, London, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 169085, Newcastle Upon Tyne, United Kingdom|St. Helens and Knowsley Teach /ID# 209085, Prescot, United Kingdom|Stockport NHS foundation trust /ID# 208718, Stockport, United Kingdom|Taunton and Somerset NHS Found /ID# 209664, Tauntojn, United Kingdom|Barts and the London NHS Trust /ID# 218829, Whitechapel, United Kingdom|New Cross Hospital, Royal Wolv /ID# 171387, Wolverhampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03345836"
624,"NCT03345823","A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433",,"Enrolling by invitation","No Results Available","Crohn's Disease","Drug: Upadacitinib|Drug: Placebo for Upadacitinib","Sub-Study 1: Percentage of Participants with Clinical Remission per Crohn's Disease Activity Index (CDAI)|Sub-Study 1: Percentage of Participants with Endoscopic Response|Sub-Study 2: Number of Participants with Adverse Events|Sub-Study 1: Percentage of Participants with Clinical Remission per Patient-Reported Outcomes (PROs)|Sub-Study 1: Percentage of Participants Achieving Clinical Response 100 (CR-100)|Sub-Study 1: Percentage of Participants with Endoscopic Remission|Sub-Study 1: Percentage of Participants who Discontinue Corticosteroid Use for Crohn's Disease at Least 90 Days Prior to Week 52 and Achieve Clinical Remission, in Participants Taking Corticosteroids at Baseline.|Sub-Study 1: Percentage of Participants with Clinical Remission per CDAI and Endoscopic Remission|Sub-Study 1: Change in Inflammatory Bowel Disease Questionnaire (IBDQ)|Sub-Study 1: Change in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F)|Sub-Study 1: Percentage of Participants with Hospitalizations due to Crohn's Disease (CD)|Sub-Study 1: Percentage of Participants with Resolution of Extra-Intestinal Manifestation (EIMs), in Participants with EIMs at Baseline","AbbVie","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 3","747","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","M14-430|2017-001225-41","March 21, 2018","August 15, 2027","August 15, 2027","November 17, 2017",,"March 23, 2021","East View Medical Research, LLC /ID# 171132, Mobile, Alabama, United States|CB Flock Research Corporation /ID# 166239, Mobile, Alabama, United States|Delsol Research Management, Ll /Id# 170164, Chandler, Arizona, United States|AZ Arthritis and Rheumotology Research, PLLC /ID# 164702, Phoenix, Arizona, United States|HonorHealth Research Institute - Shea /ID# 164725, Scottsdale, Arizona, United States|Southern California Res. Ctr. /ID# 169653, Coronado, California, United States|Citrus Valley Gastroenterology /ID# 166230, Covina, California, United States|United Medical Doctors /ID# 207458, Los Alamitos, California, United States|Gastrointestinal Biosciences /ID# 164640, Los Angeles, California, United States|Facey Medical Foundation /ID# 203138, Mission Hills, California, United States|United Medical Doctors - Murrieta /ID# 164602, Murrieta, California, United States|Hoag Memorial Hosp Presbyterian /ID# 222538, Newport Beach, California, United States|Ucsd /Id# 164763, San Diego, California, United States|Medical Assoc Research Grp /ID# 169704, San Diego, California, United States|UCSF Center for Colitis and Crohn's Disease /ID# 202372, San Francisco, California, United States|Univ of California San Francis /ID# 164653, San Francisco, California, United States|Care Access Research /ID# 167765, San Pablo, California, United States|Peak Gastroenterology Associat /ID# 170166, Colorado Springs, Colorado, United States|Delta Waves, Inc. /ID# 164656, Colorado Springs, Colorado, United States|Duplicate_Western States Clinical Res /ID# 164625, Wheat Ridge, Colorado, United States|Medical Research Ctr CT /ID# 164614, Hamden, Connecticut, United States|Clinical Research of West Florida - Clearwater /ID# 205828, Clearwater, Florida, United States|Clinical Research of West Florida - Clearwater /ID# 208119, Clearwater, Florida, United States|Advanced Research - Coral Springs /ID# 218019, Coral Springs, Florida, United States|Encore Borland-Groover Clinical Research /Id# 203500, Jacksonville, Florida, United States|Ctr for Advanced Gastroenterol /ID# 165306, Maitland, Florida, United States|Crystal Pharmacology Research /ID# 166118, Miami, Florida, United States|Coral Research Clinic /ID# 164604, Miami, Florida, United States|Advanced Research Institute /ID# 164601, New Port Richey, Florida, United States|Endoscopic Research, Inc. /ID# 206139, Orlando, Florida, United States|Omega Research Consultants /ID# 203482, Orlando, Florida, United States|Clinical Research Trials of Florida, Inc. /ID# 203486, Tampa, Florida, United States|Florida Hospital Tampa /ID# 171181, Tampa, Florida, United States|Gastroenterology Associates of Central Georgia, LLC /ID# 165492, Macon, Georgia, United States|Gastroenterology Consultants PC - Roswell /ID# 218218, Roswell, Georgia, United States|Atlanta Gastroenterology Spec /ID# 164698, Suwanee, Georgia, United States|Treasure Valley Medical Research /ID# 215030, Boise, Idaho, United States|Northwestern University Feinberg School of Medicine /ID# 165297, Chicago, Illinois, United States|Rush University Medical Center /ID# 165470, Chicago, Illinois, United States|University of Chicago /ID# 165509, Chicago, Illinois, United States|DuPage Medical Group /ID# 205320, Downers Grove, Illinois, United States|MediSphere Medical Research Center /ID# 166233, Evansville, Indiana, United States|Indianapolis Gastroenterology /ID# 164649, Indianapolis, Indiana, United States|Aquiant Research /ID# 205505, New Albany, Indiana, United States|University of Iowa Hospitals and Clinics /ID# 165405, Iowa City, Iowa, United States|Tri-State Gastroenterology /ID# 165469, Crestview Hills, Kentucky, United States|University of Louisville /ID# 165391, Louisville, Kentucky, United States|University of Louisville /ID# 168520, Louisville, Kentucky, United States|Houma Digestive Health Special /ID# 164727, Houma, Louisiana, United States|Nola Research Works, LLC /ID# 164612, New Orleans, Louisiana, United States|Louisana Research Center, LLC /ID# 164694, Shreveport, Louisiana, United States|Johns Hopkins University School of Medicine /ID# 211939, Baltimore, Maryland, United States|MGG Group Co, Inc.Chevy Chase Clinical Research /ID# 164647, Chevy Chase, Maryland, United States|Gastro Center of Maryland /ID# 171180, Columbia, Maryland, United States|Lahey Hospital and Medical Center /ID# 214724, Burlington, Massachusetts, United States|University of Michigan Health Systems /ID# 164654, Ann Arbor, Michigan, United States|Clin Res Inst of Michigan, LLC /ID# 170163, Chesterfield, Michigan, United States|Digestive Health Associates (DHA) - Farmington Hills /ID# 206101, Farmington Hills, Michigan, United States|Center for Digestive Health /ID# 164726, Troy, Michigan, United States|Minneapolis VA Medical Center /ID# 204623, Minneapolis, Minnesota, United States|Mayo Clinic /ID# 164691, Rochester, Minnesota, United States|Southern Therapy and Advanced Research (STAR) LLC /ID# 165295, Jackson, Mississippi, United States|Quality Clinical Research, Inc /ID# 170162, Omaha, Nebraska, United States|CHI Nebraska d/b/a CHI Health /ID# 168513, Omaha, Nebraska, United States|Las Vegas Medical Research /ID# 168551, Las Vegas, Nevada, United States|AGA Clinical Research Associates, LLC /ID# 164641, Egg Harbor Township, New Jersey, United States|Rutgers, The State University /ID# 166110, New Brunswick, New Jersey, United States|Montefiore Medical Center - Moses Campus /ID# 166242, Bronx, New York, United States|Advantage Clinical Trials /ID# 168582, Bronx, New York, United States|NY Scientific /ID# 164630, Brooklyn, New York, United States|NYU Langone Long Island Clinical Research Associates /ID# 164627, Great Neck, New York, United States|United Health Services Hospitals, Inc /ID# 217483, Johnson City, New York, United States|The Mount Sinai Hospital /ID# 170256, New York, New York, United States|Columbia Univ Medical Center /ID# 164692, New York, New York, United States|Gastro Group of Rochester /ID# 166235, Rochester, New York, United States|Richmond University Medical Center /ID# 201858, Staten Island, New York, United States|Atrium Health Carolinas Medical Center /ID# 164632, Charlotte, North Carolina, United States|PMG Research of Charlotte /ID# 171178, Charlotte, North Carolina, United States|Wake Research Associates, LLC /ID# 164752, Raleigh, North Carolina, United States|Wake Forest Baptist Medical Center /ID# 164755, Winston-Salem, North Carolina, United States|Plains Clinical Research Center, LLC /ID# 170169, Fargo, North Dakota, United States|Consultants for Clinical Res /ID# 164668, Cincinnati, Ohio, United States|University of Cincinnati /ID# 164729, Cincinnati, Ohio, United States|Cleveland Clinic Main Campus /ID# 209230, Cleveland, Ohio, United States|Ohio State University/ Gastroe /ID# 170159, Columbus, Ohio, United States|Optimed Research, Ltd. /ID# 205625, Columbus, Ohio, United States|Hometown Urgent Care and Resea /ID# 201289, Dayton, Ohio, United States|Dayton Gastroenterology, Inc. /ID# 167623, Englewood, Ohio, United States|Great Lakes Gastroenterology Research LLC /ID# 202006, Mentor, Ohio, United States|Digestive Disease Specialists /ID# 201063, Oklahoma City, Oklahoma, United States|Options Health Research, LLC /ID# 164704, Tulsa, Oklahoma, United States|Healthcare Research Consultant /ID# 166244, Tulsa, Oklahoma, United States|University of Pennsylvania /ID# 168406, Philadelphia, Pennsylvania, United States|Thomas Jefferson University /ID# 168003, Philadelphia, Pennsylvania, United States|Pharmacorp Clinical Trials /ID# 165008, Charleston, South Carolina, United States|Gastroenterology Associates, P.A. /ID# 164643, Greenville, South Carolina, United States|Rapid City Medical Center /ID# 201733, Rapid City, South Dakota, United States|Gastro One /ID# 164730, Germantown, Tennessee, United States|East Tennessee Research Instit /ID# 203614, Johnson City, Tennessee, United States|Quality Medical Research, PLLC /ID# 205264, Nashville, Tennessee, United States|Vanderbilt Univ Med Ctr /ID# 164607, Nashville, Tennessee, United States|TX Clinical Research Institute /ID# 164719, Arlington, Texas, United States|Inquest Clinical Research /ID# 164676, Baytown, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209803, Cedar Park, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209954, Cedar Park, Texas, United States|Baylor Scott & White Research /ID# 170161, Dallas, Texas, United States|DHAT Research Institute /ID# 164699, Garland, Texas, United States|Baylor College of Medicine /ID# 164609, Houston, Texas, United States|Centex Studies, Inc. - Houston /ID# 201212, Houston, Texas, United States|GI Specialists of Houston /ID# 202340, Houston, Texas, United States|Caprock Gastro Research /ID# 215436, Lubbock, Texas, United States|Clinical Associates in Researc /ID# 164675, San Antonio, Texas, United States|Southern Star Research Institute, LLC /ID# 169756, San Antonio, Texas, United States|Carl R. Meisner Medical Clinic /ID# 171057, Sugar Land, Texas, United States|Tyler Research Institute, LLC /ID# 168679, Tyler, Texas, United States|Victoria gastroenterology /ID# 167810, Victoria, Texas, United States|HP Clinical Research /ID# 164631, Bountiful, Utah, United States|Advanced Research Institute /ID# 164689, Ogden, Utah, United States|Care Access Research /ID# 164685, Salt Lake City, Utah, United States|Velocity Clinical Research - Salt Lake City /ID# 166113, West Jordan, Utah, United States|Washington Gastroenterology /ID# 164728, Bellevue, Washington, United States|Virginia Mason Medical Center /ID# 164862, Seattle, Washington, United States|University of Washington /ID# 164646, Seattle, Washington, United States|The Vancouver Clinic, INC. PS /ID# 164874, Vancouver, Washington, United States|Froedtert Memorial Lutheran Hospital /ID# 202285, Milwaukee, Wisconsin, United States|Allegiance Research Specialist /ID# 165298, Wauwatosa, Wisconsin, United States|Hospital Italiano de Buenos Aires /ID# 215542, Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina|Cemic /Id# 169183, Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina|Cardio Alem /ID# 211283, San Isidro, Buenos Aires, Argentina|Hospital Centenario /Id# 171251, Rosario, Santa Fe, Argentina|Gedyt /ID# 210018, Ciudad Autonoma Buenos Aires, Argentina|Hospital Privado Univesitario /ID# 169229, Cordoba, Argentina|Concord Repatriation & Gen Hos /ID# 171506, Concord, New South Wales, Australia|Coral Sea Clinical Research /ID# 212989, North Mackay, Queensland, Australia|Mater Misericordiae /ID# 204910, South Brisbane, Queensland, Australia|Royal Adelaide Hospital /ID# 171508, Adelaide, South Australia, Australia|Box Hill Hospital /ID# 203735, Melbourne, Victoria, Australia|Fiona Stanley Hospital /ID# 171507, Murdoch, Western Australia, Australia|Krankenanstalt Rudolfstiftung /ID# 203438, Vienna, Wien, Austria|Medical University of Vienna /ID# 169459, Vienna, Wien, Austria|LKH Salzburg and Paracelsus /ID# 214468, Salzburg, Austria|Cliniques Universitaires Saint Luc /ID# 200293, Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium|AZ Sint-Lucas /ID# 200296, Ghent, Belgium|UZ Leuven /ID# 200031, Leuven, Belgium|CHU de Liege Sart Tilman /ID# 200294, Liege, Belgium|CHU Dinant Godinne - UCL Namur /ID# 200295, Yvoir, Belgium|University Clinical Centre of the Republic of Srpska /ID# 200743, Banja Luka, Republika Srpska, Bosnia and Herzegovina|University Clinical Center Tuzla /ID# 210323, Tuzla, Tuzlanski, Bosnia and Herzegovina|Clinical Center University of Sarajevo /ID# 201346, Sarajevo, Bosnia and Herzegovina|Polyclinic and Daily Hospital Dr. Al-Tawil /ID# 217843, Sarajevo, Bosnia and Herzegovina|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Ltda /ID# 166853, Goiania, Goias, Brazil|Hospital Nossa Senhora das Graças /ID# 166856, Curitiba, Parana, Brazil|Hospital de Clinicas de Porto Alegre /ID# 166855, Porto Alegre, Rio Grande Do Sul, Brazil|Upeclin Fmb - Unesp /Id# 166860, Botucatu, Sao Paulo, Brazil|Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP /ID# 166859, Ribeirao Preto, Sao Paulo, Brazil|Faculdade de Medicina do ABC /ID# 166854, Santo André, Sao Paulo, Brazil|Kaiser Clinica e Hospital Dia /ID# 166858, Sao Jose Do Rio Preto, Sao Paulo, Brazil|UMHAT Kaspela EOOD /ID# 167615, Plovdiv, Bulgaria|II MHAT - Sofia /ID# 167616, Sofia, Bulgaria|MHAT Trakia /ID# 201677, Stara Zagora, Bulgaria|University Multiprofile Hospit /ID# 167566, Varna, Bulgaria|University of Calgary Cumming School of Medicine Adult Cystic Fibrosis Clinic /ID# 166990, Calgary, Alberta, Canada|Allen Whey Khye Lim Professional Corporation /ID# 168047, Edmonton, Alberta, Canada|University of Alberta /ID# 166987, Edmonton, Alberta, Canada|Covenant Health /ID# 166996, Edmonton, Alberta, Canada|Fraser Clinical Trials Inc /ID# 166984, New Westminster, British Columbia, Canada|GIRI Gastrointestinal Research Institute /ID# 166994, Vancouver, British Columbia, Canada|QEII - Victoria Building /ID# 169308, Halifax, Nova Scotia, Canada|London Health Sciences Centre - University Hospital /ID# 221039, London, Ontario, Canada|Scott Schulman medicine profes /ID# 169065, North Bay, Ontario, Canada|Taunton surgical centre /ID# 168045, Oshawa, Ontario, Canada|The Ottawa Hospital /ID# 212412, Ottawa, Ontario, Canada|Medicor Research Inc /ID# 166997, Sudbury, Ontario, Canada|Toronto Digestive Disease Asso /ID# 166988, Vaughan, Ontario, Canada|Hopital Hotel-Dieu de Levis /ID# 166985, Levis, Quebec, Canada|Crchum /Id# 170122, Montreal, Quebec, Canada|Montreal General Hospital - McGill University Health Centre /ID# 170011, Montréal, Quebec, Canada|CRCHUS Hotel-Dieu /ID# 170936, Sherbrooke, Quebec, Canada|Research Group Ltda /ID# 203178, Santiago, Region Metropolitana De Santiago, Chile|M y F Estudios Clínicos Ltda. /ID# 169872, Ñuñoa, Region Metropolitana De Santiago, Chile|Hospital Guillermo Grant Benavente de Concepción /ID# 212421, Concepción, Chile|CTR Estudios SpA /ID# 203940, Providencia, Chile|Hospital Clinico Universidad De Los Andes /ID# 207463, Santiago, Chile|The First Affiliated Hosp, Sun /ID# 205227, Guangzhou, Anhui, China|Zhongshan Hospital Xiamen Univ /ID# 204986, Xiamen, Anhui, China|Nanfang Hospital of Southern Medical University /ID# 204056, Guangzhou, Guangdong, China|The Sixth Affiliated Hosp Sun /ID# 204054, Guangzhou, Guangdong, China|The First Affiliated Hospital of Nanchang University /ID# 204052, Nanchang, Jiangxi, China|The First Hosp of Jilin Univ /ID# 206865, Changchun, Jilin, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 204055, Shanghai, Shanghai, China|'The Second Affiliated Hospital of Zhejiang University School of Medicine /ID# 204058, Hangzhou, Zhejiang, China|Sir Run Run Shaw Hospital /ID# 204050, Jianggan Hangzhou, Zhejiang, China|Beijing Friendship Hospital /ID# 204175, Beijing, China|The Second Xiangya Hospital of Central South University /ID# 204057, Changsha, China|Nanjing Drum Tower Hospital /ID# 204899, Nanjing Jiangsu, China|Tianjin Med Univ General Hosp /ID# 206979, Tianjin, China|Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 204065, Wuhan, China|Tongji Hosp Tongji Med College /ID# 204051, Wuhan, China|Hospital San Vicente de Paul /ID# 200020, Medellin, Antioquia, Colombia|Hospital Pablo Tobon Uribe /ID# 202403, Medellín, Colombia|Poliklinika Solmed /ID# 211517, Zagreb, Grad Zagreb, Croatia|UHC Split /ID# 171205, Split, Croatia|Zadar General Hospital /ID# 205533, Zadar, Croatia|Clinical Hospital Dubrava /ID# 171165, Zagreb, Croatia|UHC Sestre Milosrdnice /ID# 171194, Zagreb, Croatia|UHC Zagreb /ID# 171168, Zagreb, Croatia|Nemocnice Ceske Budejovice a.s. /ID# 224390, Ceske Budejovice 1, Czechia|Nemocnice Horovice, NH Hospita /ID# 209867, Horovice, Czechia|Hepato-Gastroenterologie HK s.r.o. /ID# 171564, Hradec Kralove, Czechia|Artroscan , s.r.o. /ID# 171575, Ostrava, Czechia|Restrial /ID# 208651, Prague 412, Czechia|Nordsjallands Hospital /ID# 200788, Frederikssund, Hovedstaden, Denmark|Herlev Hospital /ID# 200785, Herlev, Hovedstaden, Denmark|Sjaellands Universitets Hospit /ID# 200786, Roskilde, Sjælland, Denmark|Hvidovre Hospital /ID# 200787, Hvidovre, Denmark|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 171008, Alexandria, Egypt|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 171017, Alexandria, Egypt|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 209561, Alexandria, Egypt|Nat Hep & Trop Med Res Inst /ID# 170991, Cairo, Egypt|Clinical Research Center, Faculty of Medicine, Cairo university /ID# 209559, Cairo, Egypt|Faculty of Medicine Ain Shams Research Institute- Clinical Research Centre /ID# 209566, Cairo, Egypt|Air Force Specialized Hospital /ID# 170993, Cairo, Egypt|National Liver Institute /ID# 170987, Menoufiya, Egypt|West Tallinn Central Hospital /ID# 202787, Tallinn, Estonia|Tartu University Hospital /ID# 203141, Tartu, Estonia|Chu de Nice-Hopital L'Archet Ii /Id# 171004, Nice CEDEX 3, Alpes-Maritimes, France|Hopital Haut-Leveque /ID# 207812, Pessac CEDEX, Gironde, France|CHRU Lille - Hopital Claude Huriez /ID# 206653, Lille CEDEX, Hauts-de-France, France|Hopital Saint Eloi /ID# 170039, Montpellier CEDEX 5, Herault, France|Hopital Beaujon /ID# 171007, Clichy, Ile-de-France, France|CHU de SAINT ETIENNE - Hopital Nord /ID# 171027, St. Priest En Jarez, Loire, France|Centre Hospitalier Lyon Sud /ID# 171030, Pierre Benite CEDEX, Rhone, France|Chu Amiens Picardie - Hopital /Id# 171023, Amiens Cedex 01, France|Chru Trousseau /Id# 169783, Chambray-les-tours, France|CHU Henri Mondor /ID# 169782, Creteil, France|CHU Grenoble Alpes - Hopital /ID# 222403, Grenoble, France|Clinique Jules Verne /ID# 222240, Nantes, France|Polyclinique Grand Sud /ID# 170037, Nimes Cedex, France|Hopital Rangueil /ID# 169784, Toulouse, France|CH Valenciennes /ID# 222399, Valenciennes, France|Duplicate_CHRU de NANCY /ID# 170970, Vandoeuvre-les-nancy Cedex, France|Universitatsklinikum Mannheim /ID# 168754, Mannheim, Baden-Wuerttemberg, Germany|Universitaetsklinikum Erlangen /ID# 203550, Erlangen, Bayern, Germany|Universitaetsmedizin St. Josef Krankenhaus Werden /ID# 203569, Essen, Nordrhein-Westfalen, Germany|Zentrum für Gastroenterologie Saar MVZ GmbH /ID# 206739, Saarbrücken, Saarland, Germany|Universitaetsklinikum Schleswig-Holstein /ID# 168755, Kiel, Schleswig-Holstein, Germany|Universitaetsklinikum Ulm /ID# 203554, Ulm, Thueringen, Germany|Charite; Campus Benjamin Frank /ID# 169271, Berlin, Germany|Gastroenterologie am Mexikoplatz /ID# 203574, Berlin, Germany|Agaplesion Markus Krankenhaus /ID# 168753, Frankfurt, Germany|Universitaetsklinikum Frankfurt /ID# 203567, Frankfurt, Germany|Universitaetsklinikum Halle (S /ID# 207453, Halle, Germany|Medizinisches Versorgungszentrum Portal 10 /ID# 200212, Munster, Germany|Tzaneio general hospital of Piraeus /ID# 206435, Piraeus, Attiki, Greece|General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 167033, Athens, Greece|General Hospital of Athens Ippokratio /ID# 167032, Athens, Greece|General Hospital of Chest Diseases of Athens SOTIRIA /ID# 202102, Athens, Greece|University General Hospital of Heraklion PA.G.N.I /ID# 167031, Heraklion, Greece|General Hospital of Thessaloniki Hippokrateio /ID# 208823, Thessaloniki, Greece|Queen Mary Hospital /ID# 171214, Hong Kong, Hong Kong|Tuen Mun Hospital /ID# 171213, Tuen Mun, Hong Kong|Mohacsi Korhaz /ID# 209440, Mohács, Baranya, Hungary|CRU Hungary Egeszsegugyi és Szolgaltato Kft. /ID# 205549, Miskolc, Borsod-Abauj-Zemplen, Hungary|Bugat Pal Korhaz /ID# 201885, Gyöngyös, Heves, Hungary|Obudai Egeszsegugyi Centrum Kft. /ID# 201886, Budapest, Hungary|MH Honvedkorhaz /ID# 200888, Budapest, Hungary|Semmelweis Egyetem /ID# 210166, Budapest, Hungary|Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz /ID# 200887, Debrecen, Hungary|Debreceni Egyetem Klinikai Kozpont /ID# 216420, Debrecen, Hungary|Pest Megyei Flor Ferenc Korhaz /ID# 206153, Kistarcsa, Hungary|Mentahaz Maganorvosi Kozpont /ID# 201888, Szekesfehervar, Hungary|Szent Borbala Korhaz /ID# 209896, Tatabánya, Hungary|Mercy University Hospital /ID# 206512, Cork, Ireland|Soroka Medical Center /ID# 169911, Be'er Sheva, HaDarom, Israel|Rabin Medical Center /ID# 202634, Petakh Tikva, Tel-Aviv, Israel|Tel Aviv Sourasky Medical Center /ID# 206450, Tel Aviv-Yafo, Tel-Aviv, Israel|Hadassah Medical Center-Hebrew University /ID# 169926, Jerusalem, Yerushalayim, Israel|Barzilai Medical Center /ID# 223374, Ashkelon, Israel|Assaf Harofeh Medical Center /ID# 206449, Be'er Ya'akov, Israel|Kaplan Medical Center /ID# 170275, Rehovot, Israel|Universita di Catanzaro Magna Graecia /ID# 201986, Catanzaro, Calabria, Italy|AOU Policlinico S. Orsola Malpighi /ID# 168155, Bologna, Emilia-Romagna, Italy|Azienda Ospedaliero-Universitaria Policlinico di Modena /ID# 200009, Modena, Emilia-Romagna, Italy|Policlinico Universitario Campus Bio-Medico /ID# 168151, Rome, Lazio, Italy|Azienda Ospedaliera San Camillo Forlanini /ID# 168152, Rome, Lazio, Italy|IBD Center - IRCCS Istituto Clinico Humanitas /ID# 168153, Rozzano, Milano, Italy|Presidio Columbus, Fondazione Policlinico Gemelli Universita Cattolica S. Cuore /ID# 168150, Rome, Roma, Italy|A.O. Per L'Emergenza Cannizzaro /ID# 168161, Catania, Sicilia, Italy|Ospedale Classificato Equiparato Sacro Cuore-Don Calabria /ID# 168154, Negrar, Verona, Italy|Policlinico San Martino/Univer /ID# 168162, Genova, Italy|ASST Fatebenefratelli Sacco- O /ID# 168149, Milano, Italy|Azienda Ospedaliera Ospedale N /ID# 170906, Milano, Italy|Ospedali Riuniti Villa Sofia-C /ID# 168157, Palermo, Italy|AOU Pisana /ID# 202419, Pisa, Italy|Policlinico Tor Vergata /ID# 168156, Rome, Italy|Aichi Medical University Hospital /ID# 165989, Nagakute shi, Aichi, Japan|Nagoya University Hospital /ID# 165987, Nagoya shi, Aichi, Japan|Nagoya City University Hospital /ID# 165988, Nagoya-shi, Aichi, Japan|Toyohashi Municipal Hospital /ID# 200176, Toyohashi-shi, Aichi, Japan|Hirosaki National Hospital /ID# 165976, Hirosaki-shi, Aomori, Japan|Toho University Sakura Medical Center /ID# 165978, Sakura-shi, Chiba, Japan|Fukuoka University Chikushi Hospital /ID# 214402, Chikushino shi, Fukuoka, Japan|Kurume University Hospital /ID# 165996, Kurume-shi, Fukuoka, Japan|National Hospital Organization Takasaki General Medical Center /ID# 167151, Takasaki-shi, Gunma, Japan|NHO Fukuyama Medical Center /ID# 167155, Fukuyama-shi, Hiroshima, Japan|Hiroshima University Hospital /ID# 165998, Hiroshima-shi, Hiroshima, Japan|Asahikawa Medical University Hospital /ID# 167148, Asahikawa-shi, Hokkaido, Japan|Sapporo Medical University Hospital /ID# 167152, Sapporo shi, Hokkaido, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital /ID# 165975, Sapporo-shi, Hokkaido, Japan|Sapporo IBD Clinic /ID# 223559, Sapporo-shi, Hokkaido, Japan|Aoyama Clinic /ID# 165993, Kobe-shi, Hyogo, Japan|Hyogo College of Medicine College Hospital /Id# 165991, Nishinomiya-shi, Hyogo, Japan|Kanazawa University Hospital /ID# 169212, Kanazawa-shi, Ishikawa, Japan|Iwate Medical University Uchimaru Medical Center /ID# 202465, Morioka-shi, Iwate, Japan|Imamura General Hospital /ID# 227135, Kagoshima-shi, Kagoshima, Japan|Idzuro Imamura Hospital /ID# 206655, Kagoshima-shi, Kagoshima, Japan|Sameshima Hospital /ID# 206677, Kagoshima-shi, Kagoshima, Japan|Yokohama City University Medical Center /ID# 167156, Yokohama shi, Kanagawa, Japan|Japanese Red Cross Kyoto Daiichi Hosital /ID# 165990, Kyoto-shi, Kyoto, Japan|Kyoto University Hospital /ID# 169887, Kyoto-shi, Kyoto, Japan|Yokkaichi Hazu Medical Center /ID# 167201, Yokkaichi-shi, Mie, Japan|Tohoku University Hospital /ID# 167150, Sendai-shi, Miyagi, Japan|Nara Medical University Hospital /ID# 169213, Kashihara-shi, Nara, Japan|Kenseikai Dongo Hospital /ID# 208105, Yamatotakada-shi, Nara, Japan|Niigata University Medical & Dental Hospital /ID# 170042, Niigata-shi, Niigata, Japan|Ishida Clinic of IBD and Gastroenterology /ID# 167149, Oita-shi, Oita, Japan|Chikuba Hospital for Proctological and Gastrointestinal Diseases /ID# 165994, Kurashiki-shi, Okayama, Japan|Okayama University Hospital /ID# 167354, Okayama-shi, Okayama, Japan|Kinshukai Infusion Clinic /ID# 218873, Osaka-shi, Osaka, Japan|Osaka City University Hospital /ID# 165999, Osaka-shi, Osaka, Japan|Osaka University Hospital /ID# 169661, Suita-shi, Osaka, Japan|Osaka Medical College Hospital /ID# 206323, Takatsuki-shi, Osaka, Japan|Tokitokai Tokito clinic /ID# 165977, Saitama-shi, Saitama, Japan|Shiga University of Medical Science Hospital /ID# 167157, Otsu-shi, Shiga, Japan|Hamamatsu University Hospital /ID# 224402, Hamamatsu-shi, Shizuoka, Japan|NHO Shizuoka Medical Center /ID# 167153, Sunto-gun, Shizuoka, Japan|Tokyo Medical And Dental University, Medical Hospital /ID# 165982, Bunkyo-ku, Tokyo, Japan|Tokai University Hachioji Hospital /ID# 165984, Hachioji-shi, Tokyo, Japan|The Jikei University Hospital /ID# 167154, Minato-ku, Tokyo, Japan|Kyorin University Hospital /ID# 165983, Mitaka-shi, Tokyo, Japan|Tokyo Women's Medical University Hospital /ID# 205979, Shinjuku-ku, Tokyo, Japan|Toyama Prefectural Central Hospital /ID# 217836, Toyama-shi, Toyama, Japan|Wakayama Medical University /ID# 169480, Wakayama-shi, Wakayama, Japan|Yamagata University Hospital /ID# 200158, Yamagata-shi, Yamagata, Japan|JP Red Cross Wakayama Med Ctr /ID# 200641, Wakayama, Japan|Dong-A University Hospital /ID# 167568, Busan, Busan Gwang Yeogsi, Korea, Republic of|Pusan National University Hosp /ID# 167565, Busan, Busan Gwang Yeogsi, Korea, Republic of|Kyungpook National Univ Hosp /ID# 207020, Daegu, Daegu Gwang Yeogsi, Korea, Republic of|CHA Bundang Medical center CHA University /ID# 167569, Seongnam si, Gyeonggido, Korea, Republic of|Kangbuk Samsung Hospital /ID# 167562, Jongno-Gu, Seoul Teugbyeolsi, Korea, Republic of|Yonsei University Health System, Severance Hospital /ID# 167567, Seodaemun-gu, Seoul Teugbyeolsi, Korea, Republic of|Samsung Medical Center /ID# 167564, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Haeundae Paik Hospital /ID# 202631, Busan, Korea, Republic of|Hanyang University Guri Hosp /ID# 167563, Guri-si, Korea, Republic of|Chung-Ang University Hostipal /ID# 207021, Seoul, Korea, Republic of|Riga East Clinical Univ Hosp /ID# 169499, Riga, Latvia|P. Stradins Clinical Univ Hosp /ID# 169494, Riga, Latvia|Digestive Diseases Ctr Gastro /ID# 169518, Riga, Latvia|Hospital of lithuanian university of Health Science Kauno Klinikos /ID# 207030, Kaunas, Lithuania|Vilnius University Hospital /ID# 203269, Vilnius, Lithuania|Hospital Sultanah Bahiyah /ID# 201317, Alor Setar, Kedah, Malaysia|UKM Medical Centre /ID# 170780, Kuala Lumpur, Selangor, Malaysia|Universiti Sains Malaysia /ID# 200101, Kelantan, Malaysia|Instituto de Investigaciones Aplicadas a la Neurociencias A.C. /ID# 207681, Victoria de Durango, Durango, Mexico|Morales Vargas Centro de Investigacion S.C. /ID# 203496, Leon, Guanajuato, Mexico|Clinica de Investigacion en Reumatologia y Obesidad S.C. /ID# 206843, Guadalajara, Jalisco, Mexico|Radboud Universitair Medisch Centrum /ID# 166931, Nijmegen, Gelderland, Netherlands|Academisch Medical center Amsterdam /ID# 166930, Amsterdam, Noord-Holland, Netherlands|Onze Lieve Vrouwe Gasthuis /ID# 166932, Amsterdam, Netherlands|Medisch Spectrum Twente /ID# 170299, Enschede, Netherlands|Atrium-Orbis Zuyderland Medisch Centrum /ID# 169699, Heerlen, Netherlands|Vistamed /ID# 208571, Wrocław, Dolnoslaskie, Poland|Malopolskie Centrum Kliniczne /ID# 202169, Krakow, Malopolskie, Poland|Centrum Zdrowia MDM /ID# 200493, Warsaw, Mazowieckie, Poland|WIP Warsaw IBD Point Profesor Kierkus /ID# 224302, Warsaw, Mazowieckie, Poland|Reumatika - Centrum Reumatologii NZOZ /ID# 200489, Warsaw, Poland|Hospital Egas Moniz /ID# 170232, Lisbon, Porto, Portugal|HGO - Hospital Garcia de Orta /ID# 170209, Almada, Portugal|HSOG - Hospital Senhora da Oli /ID# 170204, Guimaraes, Portugal|Centro Hospitalar de Sao Joao /ID# 170211, Porto, Portugal|Unidade Local De Saude Alto Minho, EPE /ID# 200608, Viana Do Castelo, Portugal|Mindful Medical Research /ID# 203356, San Juan, Puerto Rico|School of Medicine University of Puerto Rico-Medical Science Campus /ID# 166769, San Juan, Puerto Rico|Institutul Clinic Fundeni /ID# 167831, Sector 2, Bucuresti, Romania|Clinica GASTRO MED SRL /ID# 206363, Cluj-Napoca, Cluj, Romania|Cabinet Particular Policlinic Algomed /ID# 167832, Timisoara, Romania|Immanuel Kant Baltic Federal University /ID# 203810, Kaliningrad, Kaliningradskaya Oblast, Russian Federation|Perm Clinical Center of FMBA /ID# 202989, Perm, Permskiy Kray, Russian Federation|LLC Novaya Klinika /ID# 206613, Pyatigorsk, Stavropol Skiy Kray, Russian Federation|Private institution Center of educational and clinical gastroenterology, hepatol /ID# 202996, Stavropol, Stavropol Skiy Kray, Russian Federation|Kazan State Medical University /ID# 169589, Kazan, Tatarstan, Respublika, Russian Federation|Llc Olla-Med /Id# 208723, Moscow, Russian Federation|P.A. Bayandin Murmansk Regiona /ID# 169590, Murmansk, Russian Federation|LLC Medical center Zdorovaya s /ID# 209234, Novosibirsk, Russian Federation|Republican Clin Hos n.a. Baran /ID# 206497, Petrozavodsk, Russian Federation|PMI Euromedservice /ID# 206608, Pushkin, Russian Federation|X7 Clinical Research Center /ID# 216348, Saint-Petersburg, Russian Federation|City Clinical Hospital No. 31 /ID# 208871, St. Petersburg, Russian Federation|Clinical Center Serbia /ID# 168217, Belgrade, Beograd, Serbia|Clinical Hosp Center Zvezdara /ID# 168216, Belgrade, Beograd, Serbia|Military Medical Academy /ID# 168785, Belgrade, Beograd, Serbia|Clin Hosp Ctr Bezanijska Kosa /ID# 168787, Belgrade, Beograd, Serbia|Clinical Center Kragujevac /ID# 205856, Kragujevac, Sumadijski Okrug, Serbia|Clinical Center Vojvodina /ID# 168196, Novi Sad, Vojvodina, Serbia|KL Ling Gastroenterology and Liver Clinic /ID# 205739, Singapore, Singapore|Gleneagles Medical Centre /ID# 206019, Singapore, Singapore|Tan Tock Seng Hospital /ID# 203158, Singapore, Singapore|FNsP F.D.Roosevelta Banska Bys /ID# 169960, Banska Bystrica, Banskobystricky Kraj, Slovakia|KM Management s.r.o. /ID# 170202, Nitra, Slovakia|Univ Medical Ctr Ljubljana /ID# 211041, Ljubljana, Slovenia|Farmovs (Pty) Ltd /Id# 207534, Bloemfontein, Free State, South Africa|Lenasia Clinical Trial Centre /ID# 205143, Johannesburg, Gauteng, South Africa|Wits Clinical Research Site /ID# 170850, Johannesburg, Gauteng, South Africa|Allergy & Immunology (AIU) /ID# 171427, Cape Town, Western Cape, South Africa|Mediclinic Constantiaberg /ID# 169851, Cape Town, Western Cape, South Africa|Dr JP Wright /ID# 170882, Cape Town, South Africa|Hospital Universitario A Coruña - CHUAC /ID# 203909, A Coruña, A Coruna, Spain|Hospital Unversitario Marques de Valdecilla /ID# 202495, Santander, Cantabria, Spain|Hospital Universitari Son Espases /ID# 201969, Palma de Mallorca, Illes Balears, Spain|Hospital Universitario Dr. Negrin /ID# 202723, Las Palmas de Gran Canaria, Las Palmas, Spain|Complejo Hospitalario de Navarra /ID# 202354, Pamplona, Navarra, Spain|Hospital Universitario Vall d'Hebron /ID# 202721, Barcelona, Spain|Hospital Clinic de Barcelona /ID# 202726, Barcelona, Spain|Hospital Universitario de Girona Doctor Josep Trueta /ID# 202644, Girona, Spain|Hospital Juan Ramon Jimenez /ID# 202727, Huelva, Spain|Hospital Universitario La Paz /ID# 202725, Madrid, Spain|Hospital Clinico Universitario de Salamanca /ID# 206359, Salamanca, Spain|Hospital Universitario Virgen Macarena /ID# 202722, Sevilla, Spain|Hospital Clinico Universitario de Valencia /ID# 209658, Valencia, Spain|Hospital Universitario y Politecnico La Fe /ID# 202720, Valencia, Spain|Alingsås lasarett /ID# 170814, Alingsås, Vastra Gotalands Lan, Sweden|Sodra Alvsborgs sjukhus /ID# 203078, Boras, Vastra Gotalands Lan, Sweden|Sahlgrenska US Gbg /ID# 169032, Göteborg, Vastra Gotalands Lan, Sweden|Sahlgrenska US Gbg /ID# 169170, Göteborg, Vastra Gotalands Lan, Sweden|Hallands sjukhus Halmstad /ID# 170815, Halmstad, Sweden|Karolinska Univ Sjukhuset /ID# 224489, Solna, Sweden|Inselspital, Universitaetsklinik /ID# 170994, Bern, Switzerland|Universitatsspital Zurich /ID# 171000, Zurich, Switzerland|China Medical University Hosp /ID# 169803, Taichung City, Taichung, Taiwan|Taichung Veterans General Hosp /ID# 169802, Taichung City, Taiwan|National Taiwan University Hospital /ID# 169805, Taipei City, Taiwan|Chang Gung Memorial Hospital /ID# 169804, Taoyuan, Taiwan|Acibadem Kozyatagi Hospital /ID# 209404, Kadikoy, Istanbul, Turkey|Erciyes University Medical Fac /ID# 171325, Melikgazi, Kayseri, Turkey|Gazi Universitesi Tip Fakultes /ID# 217445, Ankara, Turkey|Ankara Univ Medical Faculty /ID# 206408, Ankara, Turkey|Inonu Universitesi Turgut Ozal /ID# 201266, Battalgazi/malatya, Turkey|Mustafa Kemal University Medic /ID# 171328, Hatay, Turkey|Istanbul University Istanbul Medical Faculty /ID# 171365, Istanbul, Turkey|Marmara University Medical Fac /ID# 171326, Istanbul, Turkey|Mersin University Medical /ID# 171330, Mersin, Turkey|Sisli Etfal Train & Res Hosp /ID# 171327, Sisli, Turkey|Medical Centre of ""Ukrainian German Antiulcer Gastroenterology Centre BYK-KYIV"" /ID# 203739, Kyiv, Kyivska Oblast, Ukraine|MNE Kyiv City Clinical Hospital no.18 /ID# 207890, Kyiv, Ukraine|MI of Kyiv Regional Rada Kyiv Regional Clinical Hospital /ID# 202456, Kyiv, Ukraine|Lviv Railway Clinical Hospital /ID# 167917, Lviv, Ukraine|Vinnytsia Regional Clinical Hospital n.a. M.I.Pyrogov /ID# 222111, Vinnytsia, Ukraine|Kharkiv City Clinical Hospital /ID# 167918, Харків, Ukraine|South Eastern Health and Social Care Trust /ID# 205324, Belfast, Antrim, United Kingdom|Warrington and Halton Hospitals NHS Foundation Trust /ID# 171396, Warrington, Cheshire West And Chester, United Kingdom|Royal United Hospitals Bath /ID# 169062, Bath, United Kingdom|Queen Elizabeth Hospital - BIRMINGHAM /ID# 169058, Birmingham, United Kingdom|Russells Hall Hospital, Dudley /ID# 169057, Dudley, United Kingdom|London North West Healthcare N /ID# 169056, Harrow, United Kingdom|King's College Hospital NHS /ID# 169060, London, United Kingdom|St. George's Healthcare NHS /ID# 205550, London, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 169063, Newcastle Upon Tyne, United Kingdom|St. Helens and Knowsley Teach /ID# 209087, Prescot, United Kingdom|Stockport NHS foundation trust /ID# 208717, Stockport, United Kingdom|Taunton and Somerset NHS Found /ID# 209666, Tauntojn, United Kingdom|Barts and the London NHS Trust /ID# 218830, Whitechapel, United Kingdom|New Cross Hospital, Royal Wolv /ID# 171395, Wolverhampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03345823"
625,"NCT03340519","Early MRI Prediction of Crohns",,"Active, not recruiting","No Results Available","Crohn Disease","Device: MR Imaging","Prediction of therapeutic response in patients with Crohns disease","Children's Hospital Medical Center, Cincinnati","All","11 Years to 25 Years   (Child, Adult)",,"35","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","CIN_EarlyMRCrohns","December 17, 2018","October 2021","October 2021","November 13, 2017",,"May 12, 2021","Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT03340519"
626,"NCT03306446","Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab","CURE","Active, not recruiting","No Results Available","CD","Drug: Start adalimumab in monotherapy","Sustained deep remission rate|2-year deep remission rate","Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 4","203","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","GETAID 2013-1","March 17, 2015","March 2021","March 2025","October 11, 2017",,"January 20, 2021","Chu Liege, Liège, Belgium|Chu Amiens, Amiens, France|Chu Besancon, Besançon, France|CHU de Caen- Hopital de la Cote de Nacre, Caen, France|CHU de CLERMONT FERRAND- Hopital Estain, Clermont-Ferrand, France|APHP- Hopital BEAUJON, Clichy, France|CHU de Colmar- Hopital Trousseau Medecine A, Colmar, France|Chu Lille, Lille, France|CHU de Montpellier- Hopital saint Eloi, Montpellier, France|CHU NANTES - Hôpital Hôtel Dieu, Nantes, France|CHU de NICE- Hopital Archet 2, Nice, France|CHU de Nimes- Hopital Carémeau, Nîmes, France|APHP- Hopital COCHIN, Paris, France|APHP- Hopital BICHAT, Paris, France|IMM, Paris, France|CHU Bordeaux- Hopital Haut Levèque, Pessac, France|CHU LYON- Hopital Lyon Sud, Pierre-Bénite, France|CHU RENNES - Hopital Pontchaillou, Rennes, France|CHU de Saint Etienne- Hopital Nord, Saint-Priest-en-Jarez, France|CHU de TOULOUSE, Toulouse, France|CHU de Tours - Hopital Trousseau, Tours, France|CH Valenciennes, Valenciennes, France|CHU NANCY - Hopital Brabois, Vandoeuvre Les Nancy, France",,"https://ClinicalTrials.gov/show/NCT03306446"
627,"NCT03267238","Fecal Microbial Transplantation in Patients With Crohn's Disease",,"Active, not recruiting","No Results Available","Crohn Disease","Biological: Fecal Microbial Transplantation","Number of participants with treatment-related adverse events as assessed by CTCAE v4.0.|To measure the effect of fecal microbial transplantation on microbial diversity in healthy donor stools compared to pre-FMT, 1 week post FMT, and 12 weeks post-FMT recipient stools.|To measure the effect of fecal microbial transplantation on microbial composition in healthy donor stools compared to pre-FMT, 1 week post FMT, and 12 weeks post-FMT recipient stools.|To measure the effect of fecal microbial transplantation on microbial function using shotgun DNA metagenomic in healthy donor stools compared to pre-FMT, 1 week post FMT, and 12 weeks post-FMT recipient stools.|To measure the effect of fecal microbial transplantation on microbial function using bacterial metatranscriptomic sequencing|To measure the effect of fecal microbial transplantation on microbial function using targeted metabolomic assays.|Determine if FMT causes a statistically significant change in recipient fecal calprotectin levels","Stony Brook University","All","7 Years and older   (Child, Adult, Older Adult)","Early Phase 1","9","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","973349","June 16, 2017","June 30, 2022","June 30, 2023","August 30, 2017",,"March 18, 2021","Stony Brook University Hospital, Stony Brook, New York, United States","""Study Protocol and Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/38/NCT03267238/Prot_ICF_002.pdf","https://ClinicalTrials.gov/show/NCT03267238"
628,"NCT03261206","Stopping Aminosalicylate Therapy in Inactive Crohn's Disease","STATIC","Recruiting","No Results Available","Crohn Disease|Remission","Other: 5-ASA Withdrawal","CD-related complications at 2 years|CD-related complications at 1 year|CD-related or CD-treatment related surgeries at 1 year|CD-related or CD-treatment related surgeries at 2 years|CD-related or CD-treatment related hospitalizations at 1 year|CD-related or CD-treatment related hospitalizations at 2 years|Other CD-related or CD-treatment related complications at 1 year|Other CD-related or CD-treatment related complications at 2 years|Proportion of patients who require the use of systemic corticosteroids for treatment of CD flares at 1 year|Proportion of patients who require the use of systemic corticosteroids for treatment of CD flares at 2 years|Time to first CD-related complication|Change in disease activity at 6 months|Change in disease activity at 12 months|Change in disease activity at 24 months|Change in self-assessed quality of life at 6 months|Change in self-assessed quality of life at 1 year|Change in self-assessed quality of life at 2 years|Change in C-reactive protein concentration at 6 months|Change in C-reactive protein concentration at 1 year|Change in C-reactive protein concentration at 2 years|Change in fecal calprotectin concentration at 1 year|Change in fecal calprotectin concentration at 2 years|Change in CD-related drug treatment costs at 2 years|Change in CD-related and total healthcare costs at 2 years","Alimentiv Inc.|Academic Medical Organization of Southwestern Ontario","All","18 Years and older   (Adult, Older Adult)","Phase 4","1580","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","RP1610","November 20, 2017","October 2023","October 2023","August 24, 2017",,"April 5, 2021","University of Calgary, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada|Dr. Jesse Siffledeen Professional Medical Corporation, Edmonton, Alberta, Canada|(G.I.R.I.) GI Research Institute, Vancouver, British Columbia, Canada|Discovery Clinical Services Ltd., Victoria, British Columbia, Canada|PerCuro Clinical Research Ltd., Victoria, British Columbia, Canada|University of Manitoba - Health Sciences Centre, Winnipeg, Manitoba, Canada|McMaster University, Hamilton, Ontario, Canada|London Health Sciences Centre - University Hospital, London, Ontario, Canada|Scott Shulman Medical Professional Corporation, North Bay, Ontario, Canada|Taunton Surgical Center, Oshawa, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Dr. O. Tarabain Medicine Professional Corporation, Windsor, Ontario, Canada|McGill University Healthcare, Montréal, Quebec, Canada|IRCCS Policlinico San Donato, San Donato Milanese, Milan Italy, Italy|UOC Gastroenterologic UOS Malattie Infiammatorie Intestinali, Ospedali, Roma, Rome, Italy|IRCCA De Bellis, Castellana Grotte, Via Turi, Italy|Luigi Vanvitelli of Campania, Catania, Italy|Intituto Clinico Humanitas, Milano, Italy|Azienda Ospedale-Universita Padova, Padova, Italy|Campus Bio-Medico University of Rome, Roma, Italy|BYK - Kyiv, Kyiv, Ukraine|Danylo Halytsky Lviv National Medical University, Lviv, Ukraine|Odesa Regional Clinical Hospital, Odesa, Ukraine|Ternopil University Hospital, Ternopil, Ukraine|Vinnytsia Nation Medical University N.I. Pirogov, Vinnytsia, Ukraine|Warrington and Halton Hospitals NHS Foundation Trust, Warrington, Cheshire, United Kingdom|Darlington Memorial Hospital, Darlington, Durham, United Kingdom|Basildon and Thurrock University Hospitals NHS Foundation Trust, Basildon, Essex, United Kingdom|Royal Blackburn Hospital, Blackburn, Lancashire, United Kingdom|St. Marks Hospital, Harrow, Middlesex, United Kingdom|Sherwood Forest Hospitals NHS Foundation Trust - Kings Mill Hospital, Sutton In Ashfield, Nottinghamshire, United Kingdom|Barnsley Hospital NHS Trust, Barnsley, Yorkshire, United Kingdom|Bedford Hospital NHS Trust, Bedford, United Kingdom|West Suffolk Hospital, Bury St Edmunds, United Kingdom|Northern Care Alliance NHS Group - Fairfield General Hospital, Bury, United Kingdom|Addenbrooke's NHS, Cambridge, United Kingdom|Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom|Royal Free Hospital, London, United Kingdom|Guy's and St. Thomas' Hospitals NHS Trust, London, United Kingdom|Luton and Dustable Hospital Foundation Trust, Luton, United Kingdom|Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, United Kingdom|Royal Berkshire NHS Foundation Trust, Reading, United Kingdom|Salford Ryal NHS Foundation Trust, Salford, United Kingdom|Airedale NHS Foundation Trust, Steeton, United Kingdom|Royal Hampshire County Hospital, Winchester, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03261206"
629,"NCT03256240","Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis",,"Recruiting","No Results Available","Crohn's Disease","Other: side-to-side functional end anastomosis|Other: Kono-S analstomosis","Post-operative remission of Crohn's disease between 3 and 6 months after surgery|Post-operative remission of Crohn's disease between 12 and 18 months after surgery|Number of subjects with surgical recurrence at 60 months","Weill Medical College of Cornell University|Crohn's and Colitis Foundation","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","88","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","1303013645","March 12, 2014","July 31, 2022","December 31, 2026","August 21, 2017",,"March 16, 2021","Massachusetts General Hospital, Boston, Massachusetts, United States|Weill Cornell Medical College, New York, New York, United States|Baylor Scott & White Research Institute, Dallas, Texas, United States|University of Washington Medical Center, Seattle, Washington, United States|University Clinics Gasthuisberg Herestraat, Leuven, Belgium|Helsinki University Hospital, Helsinki, Finland|Theresien Hospital and St. Hedwigs Clinic gGmbH, Mannheim, Germany|Humanitas University Hospital, Rozzano, Milan, Italy|Policlinico University Hospital, Naples, Italy",,"https://ClinicalTrials.gov/show/NCT03256240"
630,"NCT03235180","Ultrasound Evaluation of Crohn's Disease",,"Enrolling by invitation","No Results Available","Crohn Disease","Drug: Sulfur Hexafluoride|Device: Ultrasound Elastography|Device: Ultrasound Vascularity|Device: Magnetic Resonance Enterography (MRE)","Change in shear wave speed|Change in vessel density","Mayo Clinic","All","18 Years and older   (Adult, Older Adult)","Phase 4","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","17-001175","June 16, 2017","August 31, 2022","August 31, 2023","August 1, 2017",,"October 5, 2020","Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03235180"
631,"NCT03167437","An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab",,"Recruiting","No Results Available","Crohn's Disease","Drug: Vorinostat|Drug: Ustekinumab","To evaluate the safety and tolerability of vorinostat in patients with moderate to severe CD as measured by the rate, frequency, and severity of adverse events (AEs) after 12 weeks of treatment.|170 or greater score on IBDQ|Determine safety and tolerability of ustekinumab maintenance|Mucosal healing from use of Vorinostat|Changes in CDAI score equal to or greater than 70|Acheive clinical remission|Mucosal healing after ustekinumab maintenance|Achieve continued remission with ustekinumab","National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC)","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1|Phase 2","35","NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","170101|17-I-0101","October 30, 2017","June 30, 2021","June 30, 2022","May 30, 2017",,"April 5, 2021","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT03167437"
632,"NCT03108326","Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease","RUN-CD","Recruiting","No Results Available","Crohn Disease","Biological: Stelara, Remicade, Entyvio, Humira, Remsima, Flixabi, Inflectra","Effectiveness of induction therapy in CD-patients treated with Ustekinumab.|Effectiveness of induction therapy at week 8 in CD-patients treated with Ustekinumab vs. anti-TNF/Vedolizumab.|Effectiveness of maintenance therapy up to 3 years in CD-patients treated with Ustekinumab vs. anti-TNF/Vedolizumab.|Effectiveness of Ustekinumab in different subpopulations|Measurement of disease activity with HBI|Measurement of Quality of Life with EQ-5D questionnaire|Measurement of disease activity with CDAI","Ced Service GmbH","All","18 Years to 80 Years   (Adult, Older Adult)",,"900","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","bio101","April 15, 2017","March 31, 2023","March 31, 2023","April 11, 2017",,"July 13, 2018","Gastroenterologische Gemeinschaftspraxis Minden, Minden, Niedersachsen, Germany",,"https://ClinicalTrials.gov/show/NCT03108326"
633,"NCT03107793","Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab","STARDUST","Active, not recruiting","Has Results","Crohn Disease","Drug: Ustekinumab","Percentage of Participants With Endoscopic Response at Week 48|Percentage of Participants With Endoscopic Response at Week 48 (Premature Drop-outs Excluded)|Percentage of Participants With Endoscopic Response at Week 48 (Last Observation Carried Forward [LOCF])|Percentage of Participants With Clinical Response at Week 8, Week 16, Week 48|Percentage of Participants With Clinical Remission at Week 8, Week 16, Week 48","Janssen-Cilag Ltd.","All","18 Years and older   (Adult, Older Adult)","Phase 3","500","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CR108276|2016-002918-43|CNTO1275CRD3005","April 19, 2017","April 30, 2020","July 24, 2021","April 11, 2017","May 19, 2021","June 9, 2021","GZA Ziekenhuizen, Antwerpen, Belgium|Imelda Ziekenhuis, Bonheiden, Belgium|UZ Brussel, Brussel, Belgium|Cliniques Universitaires Saint-Luc, Brussel, Belgium|Universitair Ziekenhuis Antwerpen, Edegem, Belgium|AZ Maria Middelares, Gent, Belgium|UZ Gent, Gent, Belgium|Az Groeninge, Kortrijk, Belgium|UZ Leuven, Leuven, Belgium|CHC MontLegia, Liège, Belgium|CHU de Liège, Liège, Belgium|Algemeen Ziekenhuis Jan Palfijn Merksem, Merksem, Belgium|AZ Damiaan, Oostende, Belgium|Fakultni nemocnice Hradec Kralove, Hradec Kralove, Czechia|Hepato-gastroenterologie HK, s.r.o., Hradec Kralove, Czechia|EGK s.r.o. - Sanatorium sv. Anny, Prague, Czechia|AXON Clinical s.r.o., Prague, Czechia|MEDIENDO s.r.o., Prague, Czechia|Klinicke centrum ISCARE, Praha 9, Czechia|Aalborg University Hospital, Aalborg, Denmark|Aarhus Kommunehospital, Aarhus C., Denmark|Abdominalcenter K, København NV, Denmark|Odense Universitetshospital, Odense, Denmark|Silkeborg Hospital, Silkeborg, Denmark|Vejle Sygehus, Vejle, Denmark|Hôpital Beaujon, Clichy, France|CHU Grenoble, La Tronche, France|Hopital de Bicetre, Le Kremlin Bicêtre, France|Hopital Claude Huriez, Lille, France|CHU Saint Eloi, Montpellier, France|CHU de Nice Hopital de l Archet, Nice, France|Hopital Saint-Louis, Paris, France|CHU Bordeaux, Pessac, France|Hospices Civils de Lyon HCL, Pierre Bénite, France|CHU Saint-etienne, Saint Priest en jarez, France|CHU Rangueil, Toulouse, France|CHU-Nancy, Vandoeuvre les Nancy, France|Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany|Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus, Frankfurt, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Städtisches Klinikum Lüneburg, Lueneburg, Germany|Universitatsklinikum Mannheim, Mannheim, Germany|MVZ Portal10, Muenster, Germany|Policlinico di Bari Ospedale Giovanni XXIII, Bari, Italy|Policlinico Sant'Orsola Malpighi, Bologna, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy|ASST Fatebenefratelli Sacco, Milano, Italy|Ospedale Classificato Equiparato Sacro Cuore Don Calabria di Negrar, Negrar (VR), Italy|Ospedale Villa Sofia-Cervello, Palermo, Italy|Azienda Ospedaliera G.Salvini Ospedale di Rho, RHO, Italy|Azienda Ospedaliera San Camillo - Roma, Roma, Italy|Fondazione Policlinico Gemelli Università Cattolica, Roma, Italy|Istituto Clinico Humanitas, Rozzano, Italy|IRCCS Policlinico San Donato, San Donato Milanese, Italy|AO Ordine Mauriziano, Torino, Italy|Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy|Meander Medisch Centrum, Amersfoort, Netherlands|AMC, Amsterdam, Netherlands|Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands|Rivas Zorggroep, Beatrixziekenhuis, Gorinchem, Netherlands|UMCG, Groningen, Netherlands|Erasmus MC, Rotterdam, Netherlands|Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal|Centro Hospitalar e Universitário do Algarve, Faro, Portugal|Centro Hospitalar Lisboa Central, EPE - Hospital Santo Antonio dos Capuchos, Lisboa, Portugal|Centro Hospitalar Lisboa Norte, EPE/Hosp. Santa Maria, Lisboa, Portugal|Centro Hospitalar do Porto, EPE, Porto, Portugal|Centro Hospitalar de São João, EPE, Porto, Portugal|Centro Hospitalar de Tondela Viseu, EPE, Viseu, Portugal|FNsP F.D.R. Banska Bystrica, Banska Bystrica, Slovakia|Gastroenterology Department GASTROMART s.r.o., Bardejov, Slovakia|Gastroenterology Center ASSIDUO, Bratislava, Slovakia|University Hospital in Bratislava, St. Cyril and Method Hospital, Bratislava, Slovakia|Gastroenterology and Hepatology Center Nitra, KM Management spol. s r.o., Nitra, Slovakia|GASTRO I. s.r.o., Presov, Slovakia|Gastroenterology Department ENDOMED, s.r.o., Vranov nad Toplou, Slovakia|Hosp. Gral. Univ. de Alicante, Alicante, Spain|Hosp. Univ. Germans Trias I Pujol, Badalona, Spain|Hosp. Clinic I Provincial de Barcelona, Barcelona, Spain|Hosp. Reina Sofia, Córdoba, Spain|Hosp. Arquitecto Marcide, El Ferrol, Spain|Hosp. Univ. de Bellvitge, L'Hospitalet de Llobregat, Spain|Hosp. Univ. de La Princesa, Madrid, Spain|Hosp. Gral. Univ. Gregorio Marañon, Madrid, Spain|Hosp. Univ. La Paz, Madrid, Spain|Hosp. de Manises, Manises, Spain|Hosp. Univ. Son Espases, Palma de Mallorca, Spain|Hosp. Virgen Del Rocio, Sevilla, Spain|Hosp. Clinico Univ. de Valencia, Valencia, Spain|Hosp. Univ. I Politecni La Fe, Valencia, Spain|Hosp. Clinico Univ. Lozano Blesa, Zaragoza, Spain|Skane University Hospital, Lund, Sweden|Karolinska University Hospital, Solna, Sweden|Medicinkliniken, Stockholm, Sweden|Danderyd Hospital, Stockholm, Sweden|Royal Victoria Hospital, Belfast, United Kingdom|County Durham and Darlington NHS Foundation Trust, Darlington, United Kingdom|Ninewells Hospital, Dundee, United Kingdom|Glasgow Royal Infirmary, Glasgow, United Kingdom|Royal London Hospital, London, United Kingdom|Guy's & St Thomas Hospital, London, United Kingdom|Kings College Hospital NHS Trust, London, United Kingdom|St George's University Hosptial NHS Foundation Trust, London, United Kingdom|Whiston Hospital, Prescot, United Kingdom|Salford Royal NHS Foundation Trust, Salford, United Kingdom|Southampton University Hospital, Southampton, United Kingdom|Musgrove Park Hospital, Taunton, United Kingdom","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/93/NCT03107793/Prot_000.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/93/NCT03107793/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT03107793"
634,"NCT03105102","A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease",,"Active, not recruiting","No Results Available","Crohn's Disease","Drug: Placebo for Risankizumab SC|Drug: Risankizumab IV|Drug: Placebo for Risankizumab IV|Drug: Risankizumab SC|Drug: Risankizumab On-Body Injector (OBI)","Sub-Study 1 and Sub-Study 2: Percentage of Participants With Crohn's Disease Activity Index (CDAI) Clinical Remission|Sub-Study 1 and Sub-Study 2: Percentage of Participants With Endoscopic Response|Sub-Study 3: Number of Participants With Adverse Events|Sub-Study 4: Percentage of Participants With an Observer Rating of Successful Participant Self Administration|Sub-Study 4: Percentage of Participants who had no Potential Hazards|Sub-Study 4: Percentage of Participants Rating of Acceptability Using Self-Injection Assessment Questionnaire (SIAQ) at Weeks 0, 8, 16|Sub-Study 4: Percentage of Participants in CDAI Clinical Remission at Week 0, 16|Sub-Study 1: Percentage of Participants With Clinical Remission|Sub-Study 1: Percentage of Participants With CDAI Clinical Remission Among Participants With CDAI Clinical Remission in Week 0|Sub-Study 1: Percentage of Participants With Ulcer-Free Endoscopy|Sub-Study 1: Percentage of Participants With Endoscopic Remission|Sub-Study 1: Change From Baseline of Induction in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue)|Sub-Study 1: Percentage of Participants Who Discontinued Corticosteroid Use for 90 Days and Achieved Clinical Remission in Participants Taking Steroids at Baseline|Sub-Study 1: Percentage of Participants With Crohn's Disease Activity Index (CDAI) Clinical Response|Sub-Study 1: Percentage of Participants With Stool Frequency (SF) Remission|Sub-Study 1: Percentage of Participants With Abdominal Pain (AP) Remission|Sub-Study 1: Percentage of Participants With CDAI Clinical Remission and Endoscopic Response|Sub-Study 1: Percentage of Participants With Deep Remission|Sub-Study 1 and Sub-Study 2: Percentage of Participants With Exposure Adjusted Occurrence of CD-related Hospitalizations From Week 0 Through Week 52","AbbVie","All","16 Years to 80 Years   (Child, Adult, Older Adult)","Phase 3","1250","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","M16-000|2016-003191-50","April 9, 2018","June 9, 2026","June 9, 2026","April 7, 2017",,"June 9, 2021","Phoenix VA Health Care System /ID# 162264, Phoenix, Arizona, United States|Digestive Disease Consultants, A Division of Arizona Digestive Health, P.C /ID# 211884, Tempe, Arizona, United States|University of Arizona /ID# 158502, Tucson, Arizona, United States|Atria Clinical Research /ID# 164505, Little Rock, Arkansas, United States|Southern California Res. Ctr. /ID# 211991, Coronado, California, United States|Care Access Research /ID# 213035, Huntington Beach, California, United States|UC San Diego Health Systems /ID# 155555, La Jolla, California, United States|United Medical Doctors /ID# 207888, Los Alamitos, California, United States|TLC Clinical Research Inc /ID# 212719, Los Angeles, California, United States|Gastrointestinal Biosciences Clinical Trials, LLC /ID# 162657, Los Angeles, California, United States|United Medical Doctors - Murrieta /ID# 158300, Murrieta, California, United States|University of California, San Francisco - 16th St /ID# 157127, San Francisco, California, United States|Cedars-Sinai Medical Center-West Hollywood /ID# 163839, West Hollywood, California, United States|Peak Gastroenterology Associat /ID# 165843, Colorado Springs, Colorado, United States|Rocky Mountain Pediatric Gastroenterology /ID# 207170, Lone Tree, Colorado, United States|Western Connecticut Medical Group /ID# 165879, Danbury, Connecticut, United States|Brandon Premier Health Care, PA/Gulf Coast Research Group, LLC /ID# 162262, Brandon, Florida, United States|Clinical Research of West Florida - Clearwater /ID# 205865, Clearwater, Florida, United States|Clinical Research of West Florida - Clearwater /ID# 208125, Clearwater, Florida, United States|South Lake Pain Institute, Inc /ID# 162808, Clermont, Florida, United States|Omega Research Maitland, LLC /ID# 171082, DeBary, Florida, United States|Universal Axon Clinical Research /ID# 165428, Doral, Florida, United States|Nature Coast Clinical Research - Inverness /ID# 159408, Inverness, Florida, United States|SIH Research Mumtaz, Inc /ID# 163083, Kissimmee, Florida, United States|Alliance Medical Research /ID# 163837, Lighthouse Point, Florida, United States|Cfagi Llc /Id# 202479, Maitland, Florida, United States|University of Miami /ID# 155007, Miami, Florida, United States|Coral Research Clinic /ID# 158456, Miami, Florida, United States|South Florida Research Ph I-IV /ID# 161832, Miami, Florida, United States|Gastroenterology Group Naples /ID# 165204, Naples, Florida, United States|Advanced Research Institute, Inc /ID# 161966, New Port Richey, Florida, United States|Endoscopic Research, Inc. /ID# 205906, Orlando, Florida, United States|IMIC Inc. Medical Research /ID# 154942, Palmetto Bay, Florida, United States|Atlanta Gastro Assoc /ID# 154724, Atlanta, Georgia, United States|Gastroenterology Associates of Central Georgia, LLC /ID# 154850, Macon, Georgia, United States|Northwestern University Division of GI/Hepatology /ID# 158261, Chicago, Illinois, United States|The University of Chicago Medical Center /ID# 157124, Chicago, Illinois, United States|NorthShore University HealthSystem - Evanston Hospital /ID# 158265, Evanston, Illinois, United States|Southwest Gastroenterology /ID# 164781, Oak Lawn, Illinois, United States|Cotton-O'Neil Clinical Res Ctr /ID# 154722, Topeka, Kansas, United States|University of Kentucky Chandler Medical Center /ID# 157120, Lexington, Kentucky, United States|University of Louisville /ID# 210525, Louisville, Kentucky, United States|Gastroenterology Associates LLC - Jefferson Hwy /ID# 161963, Baton Rouge, Louisiana, United States|Houma Digestive Health Special /ID# 158264, Houma, Louisiana, United States|Delricht Research /ID# 206644, New Orleans, Louisiana, United States|Nola Research Works, LLC /ID# 161317, New Orleans, Louisiana, United States|Louisana Research Center, LLC /ID# 162237, Shreveport, Louisiana, United States|MGG Group Co, Inc.Chevy Chase Clinical Research /ID# 154832, Chevy Chase, Maryland, United States|Gastro Center of Maryland /ID# 165001, Columbia, Maryland, United States|University of Michigan Health Systems /ID# 157126, Ann Arbor, Michigan, United States|Clin Res Inst of Michigan, LLC /ID# 169179, Chesterfield, Michigan, United States|Center for Digestive Health /ID# 154683, Troy, Michigan, United States|Gastroenterology Associates of Western Michigan, PLC /ID# 161313, Wyoming, Michigan, United States|Mayo Clinic /ID# 163086, Rochester, Minnesota, United States|Saint Louis University School of Medicine /ID# 161883, Saint Louis, Missouri, United States|University of Nebraska Med Ctr /ID# 210058, Omaha, Nebraska, United States|Las Vegas Medical Research /ID# 160170, Las Vegas, Nevada, United States|Revival Research Institute, Inc /ID# 210985, Las Vegas, Nevada, United States|NY Scientific /ID# 158294, Brooklyn, New York, United States|Saratoga Schenectady Gastroenterology Associates - Burnt Hills /ID# 213447, Burnt Hills, New York, United States|Intercity Advanced Gastroentertology Center /ID# 215205, Fresh Meadows, New York, United States|Long Island Clinical Research /ID# 154829, Great Neck, New York, United States|Digestive Disease Care /ID# 211777, New Hyde Park, New York, United States|North Shore University Hospital /ID# 168738, New Hyde Park, New York, United States|NYU Langone Medical Center /ID# 160169, New York, New York, United States|Weill Cornell Medicine /ID# 165878, New York, New York, United States|The Mount Sinai Hospital /ID# 165612, New York, New York, United States|Columbia Univ Medical Center /ID# 161899, New York, New York, United States|Lenox Hill Hospital /ID# 168467, New York, New York, United States|DiGiovanna Institute for Medical Education & Research /ID# 171126, North Massapequa, New York, United States|Univ NC Chapel Hill /ID# 154833, Chapel Hill, North Carolina, United States|Atrium Health Carolinas Medical Center /ID# 158428, Charlotte, North Carolina, United States|Wake Radiology UNC REX Healthcare - Raleigh Office /ID# 154873, Raleigh, North Carolina, United States|Plains Clinical Research Center, LLC /ID# 169718, Fargo, North Dakota, United States|Tri-State Endoscopy /ID# 154927, Cincinnati, Ohio, United States|Cleveland Clinic Main Campus /ID# 209226, Cleveland, Ohio, United States|The Ohio State University /ID# 164708, Columbus, Ohio, United States|Optimed Research, Ltd. /ID# 167887, Columbus, Ohio, United States|Hometown Urgent Care and Resea /ID# 170464, Dayton, Ohio, United States|Great Lakes Gastroenterology Research LLC /ID# 201770, Mentor, Ohio, United States|Hightower Clinical /ID# 211993, Oklahoma City, Oklahoma, United States|Digestive Disease Specialists /ID# 170775, Oklahoma City, Oklahoma, United States|Adult Gastroenterology Associates - Main /ID# 208864, Tulsa, Oklahoma, United States|Children's Hospital of Pittsburgh of UPMC /ID# 212544, Pittsburgh, Pennsylvania, United States|Digestive Disease Associates, LTD /ID# 208297, Wyomissing, Pennsylvania, United States|Medical University of South Carolina /ID# 212858, Charleston, South Carolina, United States|Gastroenterology Associates, P.A. of Greenville /ID# 154904, Greenville, South Carolina, United States|Rapid City Medical Center /ID# 163838, Rapid City, South Dakota, United States|Gastro One /ID# 154726, Germantown, Tennessee, United States|East Tennessee Research Institute /ID# 168739, Johnson City, Tennessee, United States|Clinical Neuroscience /ID# 164180, Memphis, Tennessee, United States|Vanderbilt University Medical Center /ID# 157121, Nashville, Tennessee, United States|TX Clinical Research Institute /ID# 159404, Arlington, Texas, United States|Quest Clinical Research /ID# 165694, Baytown, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209797, Cedar Park, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209946, Cedar Park, Texas, United States|Baylor Scott & White Research Institute /ID# 159406, Dallas, Texas, United States|DHAT Research Institute /ID# 158208, Garland, Texas, United States|Vilo Research Group Inc /ID# 207655, Houston, Texas, United States|Baylor College of Medicine /ID# 158203, Houston, Texas, United States|Centex Studies, Inc. - Houston /ID# 201219, Houston, Texas, United States|Clinical Associates in Researc /ID# 161323, San Antonio, Texas, United States|Southern Star Research Institute, LLC /ID# 168773, San Antonio, Texas, United States|Baylor Scott & White Center for Diagnostic Medicine /ID# 204131, Temple, Texas, United States|Tyler Research Institute, LLC /ID# 166797, Tyler, Texas, United States|Gastro Health & Nutrition - Victoria /ID# 164290, Victoria, Texas, United States|Advanced Research Institute /ID# 154907, Ogden, Utah, United States|Velocity Clinical Research - Salt Lake City /ID# 161778, West Jordan, Utah, United States|Hunter Holmes McGuire VA Medical Center /ID# 159988, Richmond, Virginia, United States|Virginia Mason - Seattle Orthapedics /ID# 155556, Seattle, Washington, United States|Harborview Medical Center /ID# 228544, Seattle, Washington, United States|West Virginia University /ID# 167941, Morgantown, West Virginia, United States|Hospital Britanico de Buenos /ID# 168077, Ciudad Autonomade, Buenos Aires, Argentina|CINME Centro de Investigaciones Metabolicas /ID# 221680, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina|Gedyt /ID# 225143, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina|Cemic /Id# 168078, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina|Hospital Centenario /Id# 170886, Rosario, Santa Fe, Argentina|Sanatorio 9 de Julio /ID# 230088, San Miguel de Tucuman, Tucuman, Argentina|Hospital Privado Univesitario /ID# 168076, Cordoba, Argentina|Mater Hospital /ID# 167220, South Brisbane, Queensland, Australia|Griffith University /ID# 212635, Southport, Queensland, Australia|Lyell McEwin Hospital /ID# 212215, Elizabeth Vale, South Australia, Australia|Emeritus Research /ID# 213512, Camberwell, Victoria, Australia|Universitaetsklinikum St.Poelten /ID# 166424, St. Poelten, Niederoesterreich, Austria|LKH-Univ. Klinikum Graz /ID# 158140, Graz, Steiermark, Austria|Krankenhaus der Barmherzigen Brueder Wien /ID# 212060, Vienna, Wien, Austria|Medical University of Vienna /ID# 158141, Vienna, Wien, Austria|Gomel Regional Clinical Hospital /ID# 205112, Gomel, Belarus|Grodno city clinical hospital #2 /ID# 205113, Grodno, Belarus|Vitebsk Regional Advanced Clin /ID# 206778, Vitebsk, Belarus|AZ Sint-Maarten /ID# 212876, Mechelen, Antwerpen, Belgium|UCL Saint-Luc /ID# 157406, Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium|UZ Gent /ID# 157405, Gent, Oost-Vlaanderen, Belgium|Universitair Ziekenhuis Leuven /ID# 157407, Leuven, Vlaams-Brabant, Belgium|Imelda Ziekenhuis /ID# 157403, Bonheiden, Belgium|ULB Erasme /ID# 157408, Brussels, Belgium|AZ Maria Middelares /ID# 213532, Gent, Belgium|AZ Groeninge /ID# 211513, Kortrijk, Belgium|CHU de Liege /ID# 157409, Liege, Belgium|Groupe Sante CHC - Clinique du MontLegia /ID# 157404, Liege, Belgium|ZNA - Jan Palfijn /ID# 212877, Merksem, Belgium|AZ-Delta /ID# 157402, Roeselare, Belgium|CHU Dinant Godinne - UCL Namur /ID# 157412, Yvoir, Belgium|University Clinical Centre of the Republic of Srpska /ID# 164513, Banja Luka, Republika Srpska, Bosnia and Herzegovina|Clinical Center University of Sarajevo /ID# 165139, Sarajevo, Bosnia and Herzegovina|UMHAT Dr Georgi Stranski EAD /ID# 203976, Pleven, Bulgaria|University Multiprofile Hospit /ID# 165700, Plovdiv, Bulgaria|Second Multiprofile Hospital f /ID# 165702, Sofia, Bulgaria|Tokuda Hospital Sofia /ID# 165701, Sofia, Bulgaria|UMHAT Tsaritsa Joanna - ISUL /ID# 211242, Sofia, Bulgaria|UMHAT Sveti Ivan Rilski /ID# 204815, Sofia, Bulgaria|MHAT Trakia /ID# 201668, Stara Zagora, Bulgaria|University of Calgary - Cumming School of Medicine - Adult Cystic Fibrosis Clini /ID# 157155, Calgary, Alberta, Canada|Allen Whey Khye Lim Professional Corporation /ID# 169763, Edmonton, Alberta, Canada|University of Alberta - Zeidler Ledcor Centre /ID# 157099, Edmonton, Alberta, Canada|Covenant Health /ID# 161632, Edmonton, Alberta, Canada|Fraser Clinical Trials Inc /ID# 159055, New Westminster, British Columbia, Canada|GIRI Gastrointestinal Research Institute /ID# 157096, Vancouver, British Columbia, Canada|Percuro Clinical Research, Ltd /ID# 161631, Victoria, British Columbia, Canada|QEII - Victoria Building /ID# 157088, Halifax, Nova Scotia, Canada|IWK Health Center /ID# 165905, Halifax, Nova Scotia, Canada|McMaster University Med Cent /ID# 157184, Hamilton, Ontario, Canada|London Health Sciences Centre - University Hospital /ID# 157161, London, Ontario, Canada|Scott Shulman Medicine Professional Corporation /ID# 165906, North Bay, Ontario, Canada|Medicor Research Inc /ID# 157150, Sudbury, Ontario, Canada|Mount Sinai Hospital /ID# 169764, Toronto, Ontario, Canada|Toronto Digestive Disease Asso /ID# 157158, Vaughan, Ontario, Canada|CISSS de la Monteregie /ID# 161630, Greenfield Park, Quebec, Canada|CHAU- Hotel-Dieu de Levis /ID# 214377, Levis, Quebec, Canada|Hospital Maisonneuve-Rosemont /ID# 159056, Montreal, Quebec, Canada|Centre Recherche luniver Montr /ID# 167068, Montreal, Quebec, Canada|Montreal General Hospital - McGill University Health Center /ID# 157085, Montreal, Quebec, Canada|Complejo Asistencial Dr. Sotero del Rio /ID# 169384, Santiago, Region Metropolitana De Santiago, Chile|Servicio de Salud Occidente Hospital San Juan de Dios /ID# 171122, Santiago, Region Metropolitana De Santiago, Chile|Hospital Guillermo Grant Benavente de Concepción /ID# 210760, Concepción, Chile|Hospital Las Higueras /ID# 167092, Talcahuano, Chile|Guangdong Provincial People's Hospital /ID# 212949, Guangzhou, Guangdong, China|The Sixth Affiliated Hosp Sun /ID# 210784, Guangzhou, Guangdong, China|The Second Hospital of Hebei Medical University /ID# 212738, Shijiazhuang, Hebei, China|Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 211039, Wuhan, Hubei, China|Renmin Hospital of Wuhan University /ID# 214874, Wuhan, Hubei, China|The Second Xiangya Hospital of Central South University /ID# 211700, Changsha, Hunan, China|The First Affiliated Hospital of Nanchang University /ID# 211036, Nanchang, Jiangxi, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 210840, Shanghai, Shanghai, China|Renji Hospital, Shanghai Jiaotong University School of Medicine /ID# 210705, Shanghai, Shanghai, China|Shanghai East Hospital /ID# 212684, Shanghai, Shanghai, China|The second Affiliated hospital of Zhejiang University school of Medicine /ID# 210724, Hangzhou, Zhejiang, China|Jinhua Municipal Central Hospital /ID# 215628, Jinhua, Zhejiang, China|West China Hospital, Sichuan University /ID# 210890, Chengdu, China|Tianjin Med Univ General Hosp /ID# 210926, Tianjin, China|Tongji Hospital Tongji Medical College Huazhong University of Science and Techno /ID# 210858, Wuhan, China|Sir Run Run Shaw Hospital of Zhejiang University School of Medicine /ID# 210625, Zhejiang, China|Instituto de Coloproctologia /ID# 158743, Medellin, Antioquia, Colombia|Hospital Pablo Tobon Uribe /ID# 158730, Medellín, Antioquia, Colombia|Hospital Univ San Ignacio /ID# 158734, Bogota, Cundinamarca, Colombia|Hospital Universitario San Vic /ID# 171486, Medellin, Colombia|Klinicka bolnica Dubrava Zagreb /ID# 157560, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Sestre milosrdnice /ID# 157728, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Zagreb /ID# 157561, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Osijek /ID# 157559, Osijek, Osjecko-baranjska Zupanija, Croatia|Klinicki bolnicki centar Split /ID# 157562, Split, Croatia|Zadar General Hospital /ID# 157563, Zadar, Croatia|Ikem /Id# 165465, Prague 4, Praha 4, Czechia|Hepato-Gastroenterologie HK, s.r.o. /ID# 163225, Hradec Kralove, Czechia|Nemocnice Pardubickeho kraje, a.s. /ID# 163226, Pardubice, Czechia|Nemocnice Milosrdnych sester sv. Karla Boromejskeho v Praze /ID# 211306, Praha, Czechia|Axon Clinical, s.r.o. /ID# 163223, Praha, Czechia|Thomayerova nemocnice /ID# 162941, Praha, Czechia|ResTrial s.r.o. /ID# 211078, Praha, Czechia|NH Hospital a.s. /ID# 211077, Praha, Czechia|ISCARE a.s. /ID# 225794, Praha, Czechia|Aarhus University Hospital /ID# 155664, Aarhus N, Midtjylland, Denmark|Sjaellands Universitets Hospit /ID# 155532, Roskilde, Sjælland, Denmark|Svendborg Sygehus, Sygehusenhe /ID# 161525, Nyborg, Syddanmark, Denmark|Hvidovre Hospital /ID# 155530, Hvidovre, Denmark|Odense Universitets Hospital /ID# 155531, Odense C, Denmark|Zagazig University Hospitals /ID# 164539, Al Sharqia, Egypt|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 157187, Alexandria, Egypt|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 164540, Alexandria, Egypt|Clinical Research Center, Faculty of Medicine, Cairo university /ID# 157175, Cairo, Egypt|National Hepatology and Tropical Medicine Research Institute /ID# 157874, Cairo, Egypt|Internal Medicine Department, Faculty of Medicine, AinShams University /ID# 157506, Cairo, Egypt|East Tallinn Central Hospital /ID# 157074, Tallinn, Harjumaa, Estonia|West Tallinn Central Hospital /ID# 157075, Tallinn, Estonia|North Estonia Medical Centre /ID# 164326, Tallinn, Estonia|Hopital Saint Eloi /ID# 215147, Montpellier CEDEX 5, Herault, France|Hopital Beaujon /ID# 166284, Clichy, Ile-de-France, France|CHU NANCY - Hopital Brabois Adultes /ID# 162561, Vandoeuvre les Nancy CEDEX, Meurthe-et-Moselle, France|CHU Amiens-Picardie Site Sud /ID# 165058, Amiens CEDEX 1, Somme, France|CHU Grenoble Alpes - Hopital /ID# 212834, Grenoble, France|Chu Lille /Id# 162559, Lille, France|Hopital l'Archet 2 /ID# 162557, Nice, France|CHU Bordeaux /ID# 162558, Pessac, France|Chu Lyon Sud /Id# 162560, Pierre Benite, France|Hospital Pontchaillou /ID# 213209, Rennes, France|CHU de Saint-Etienne, Hopital Nord /ID# 162562, SAINT-ETIENNE Cedex 1, France|Praxis fuer Gastroenterologie /ID# 166150, Heidelberg, Baden-Wuerttemberg, Germany|Universitatsklinikum Mannheim /ID# 162031, Mannheim, Baden-Wuerttemberg, Germany|Universitaetsklinikum Erlangen /ID# 159343, Erlangen, Bayern, Germany|Universitatsklinikum Munster /ID# 159344, Munster, Niedersachsen, Germany|Evangelisches Krankenhaus Kalk /ID# 212726, Cologne, Nordrhein-Westfalen, Germany|Praxiszentrum fuer Gastroenterologie /ID# 211966, Grevenbroich, Nordrhein-Westfalen, Germany|Uniklinik Koeln /ID# 164989, Köln, Nordrhein-Westfalen, Germany|Zentrum für Gastroenterologie Saar MVZ GmbH /ID# 210528, Saarbrücken, Saarland, Germany|Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 159349, Kiel, Schleswig-Holstein, Germany|Universitaetsklinikum Ulm /ID# 164990, Ulm, Thueringen, Germany|Krankenhaus Waldfriede /ID# 212727, Berlin-Zehlendorf, Germany|Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 212220, Berlin, Germany|Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 212894, Berlin, Germany|Gastroenterologische Spezialpraxis am Wittenbergplatz /ID# 211974, Berlin, Germany|Praxis am Bayrischen Platz /ID# 159350, Berlin, Germany|DRK Kliniken Berlin /ID# 166151, Berlin, Germany|Stadtisches Klinikum Braunschweig /ID# 163680, Braunschweig, Germany|Medizinisches Versorgunszentrum Dachau /ID# 211555, Dachau, Germany|Agaplesion Markus Krankenhaus /ID# 159345, Frankfurt, Germany|Universitaetsklinikum Frankfurt /ID# 212979, Frankfurt, Germany|Universitaetsklinikum Freiburg /ID# 162030, Freiburg, Germany|Medizinische Hochschule Hannover /ID# 162032, Hannover, Germany|Universitaetsklinikum Jena /ID# 159351, Jena, Germany|EUGASTRO GmbH /ID# 212078, Leipzig, Germany|Klinikum Lueneburg /ID# 163678, Lueneburg, Germany|Universitaetsklinikum Magdeburg /ID# 211843, Magdeburg, Germany|Gastroenterologische Gemeinschaftspraxis Minden /ID# 162029, Minden, Germany|Universitaetsklinikum Regensburg /ID# 163813, Regensburg, Germany|General Hospital of Chest Diseases of Athens SOTIRIA /ID# 170914, Athens, Attiki, Greece|Tzaneio general hospital of Piraeus /ID# 206443, Piraeus, Attiki, Greece|General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 157423, Athens, Greece|University General Hospital of Heraklion PA.G.N.I /ID# 157422, Heraklion, Greece|University General Hospital of Ioannina /ID# 157420, Ioannina, Greece|General Hospital of Nikaia-Piraeus ""Agios Panteleimon""- general hospital dytikis /ID# 157424, Pireaus, Greece|Theageneio Anticancer Hospital /ID# 163897, Thessaloniki, Greece|Queen Mary Hospital /ID# 163923, Hong Kong, Hong Kong|Tuen Mun Hospital /ID# 163905, Tuen Mun, Hong Kong|St Vincent's University Hospit /ID# 157540, Dublin, Ireland|Beaumont Hospital /ID# 157543, Dublin, Ireland|University Hospital Galway /ID# 157541, Galway, Ireland|Soroka Medical Center /ID# 157794, Be'er Sheva, HaDarom, Israel|Tel Aviv Sourasky Medical Center /ID# 157792, Tel Aviv-Yafo, Tel-Aviv, Israel|Hadassah Medical Center-Hebrew University /ID# 165914, Jerusalem, Yerushalayim, Israel|Rambam Medical Center /ID# 171067, Haifa, Israel|The Edith Wolfson Medical Center /ID# 217331, Holon, Israel|Shaare Zedek Medical Center /ID# 163541, Jerusalem, Israel|Shaare Zedek Medical Center /ID# 171068, Jerusalem, Israel|Sheba Medical Center /ID# 157793, Ramat Gan, Israel|Sheba Medical Center /ID# 171069, Ramat Gan, Israel|Universita di Catanzaro Magna Graecia /ID# 212016, Catanzaro, Calabria, Italy|AOU Policlinico S. Orsola Malpighi /ID# 155643, Bologna, Emilia-Romagna, Italy|Azienda Ospedaliero-Universitaria Policlinico di Modena /ID# 212028, Modena, Emilia-Romagna, Italy|Policlinico Universitario Campus Bio-Medico /ID# 162438, Rome, Lazio, Italy|Azienda Ospedaliera San Camillo Forlanini /ID# 155644, Rome, Lazio, Italy|Azienda Policlinico Universitario Umberto I /ID# 166912, Rome, Lazio, Italy|Ospedale Policlinico San Martino/ Università Degli Studi Di Genova /ID# 162439, Genoa, Liguria, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 155641, Milan, Lombardia, Italy|ASST Rhodense /ID# 212227, Rho, Lombardia, Italy|IBD Center - IRCCS Istituto Clinico Humanitas /ID# 155642, Rozzano, Milano, Italy|Presidio Columbus, Fondazione Policlinico Gemelli Universita Cattolica S. Cuore /ID# 155640, Rome, Roma, Italy|A.O. Per L'Emergenza Cannizzaro /ID# 161300, Catania, Sicilia, Italy|A.O. Ospedali Riuniti Villa Sofia - Cervello /ID# 155645, Palermo, Sicilia, Italy|Azienda Ospedaliera Univ. Meyer /ID# 167992, Florence, Toscana, Italy|Ospedale Classificato Equiparato Sacro Cuore-Don Calabria /ID# 161299, Negrar, Verona, Italy|Ospedali Riuniti Universita /ID# 162436, Ancona, Italy|ASST Fatebenefratelli Sacco /ID# 155639, Milan, Lombardia, Italy|IRCCS Policlinico S. Matteo /ID# 212031, Pavia, Italy|Policlinico Tor Vergata /ID# 158022, Rome, Italy|Aichi Medical University Hospital /ID# 160097, Nagakute-shi, Aichi, Japan|Nagoya City University Hospital /ID# 160100, Nagoya shi, Aichi, Japan|Daido Clinic /ID# 211476, Nagoya-shi, Aichi, Japan|Nagoya University Hospital /ID# 160116, Nagoya-shi, Aichi, Japan|Fujita Health University Hospital /ID# 163234, Toyoake-shi, Aichi, Japan|Tokatsutsujinaka Hospital /ID# 163352, Abiko-shi, Chiba, Japan|Chiba University Hospital /ID# 217533, Chiba-shi, Chiba, Japan|Tsujinaka Hospital Kashiwanoha /ID# 213848, Kashiwa-shi, Chiba, Japan|The Jikei University Kashiwa Hospital /ID# 200030, Kashiwa-shi, Chiba, Japan|Toho University Medical Center Sakura Hospital /ID# 160099, Sakura-shi, Chiba, Japan|Fukuoka University Hospital /ID# 217793, Fukuoka-shi, Fukuoka, Japan|Kurume University Hospital /ID# 160106, Kurume-shi, Fukuoka, Japan|NHO Fukuyama Medical Center /ID# 163577, Fukuyama-shi, Hiroshima, Japan|Hiroshima University Hospital /ID# 160109, Hiroshima-shi, Hiroshima, Japan|Asahikawa Medical University Hospital /ID# 162848, Midorigaokahiga-shi, Hokkaido, Japan|Sapporo Tokushukai Hospital /ID# 213492, Sapporo-shi, Hokkaido, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital /ID# 160096, Sapporo-shi, Hokkaido, Japan|Sapporo Medical University Hospital /ID# 163056, Sapporo-shi, Hokkaido, Japan|Nishinomiya Munic Central Hospital /ID# 210103, Nishinomiya-shi, Hyogo, Japan|Hyogo College of Medicine Hospital /ID# 160107, Nishinomiya-shi, Hyogo, Japan|National Hospital Organization Mito Medical Center /ID# 160092, Higashi Ibaraki-gun, Ibaraki, Japan|Kanazawa University Hospital /ID# 202258, Kanazawa-shi, Ishikawa, Japan|Gokeikai Ofuna Chuo Hospital /ID# 171066, Kamakura-shi, Kanagawa, Japan|Kitasato University Hospital /ID# 171065, Sagamihara-shi, Kanagawa, Japan|Yokohama City University Medical Center /ID# 163907, Yokohama shi, Kanagawa, Japan|Yokohama Municipal Citizen's Hospital /ID# 207161, Yokohama-shi, Kanagawa, Japan|Mie University Hospital /ID# 203640, Tsu-shi, Mie, Japan|Yokkaichi Hazu Medical Center /ID# 163764, Yokkaichi-shi, Mie, Japan|Tohoku University Hospital /ID# 162847, Sendai-shi, Miyagi, Japan|Tohoku Rosai Hospital /ID# 163229, Sendai-shi, Miyagi, Japan|Osaka City University Hospital /ID# 160117, Osaka-shi, Osaka, Japan|Saitama Medical Center /ID# 160093, Kawagoe-shi, Saitama, Japan|Tokitokai Tokito clinic /ID# 160110, Saitama-shi, Saitama, Japan|Shiga University of Medical Science Hospital /ID# 164025, Otsu-shi, Shiga, Japan|Hamamatsu University Hospital /ID# 205690, Hamamatsu-shi, Shizuoka, Japan|NHO Shizuoka Medical Center /ID# 163057, Sunto-gun, Shizuoka, Japan|Tokyo Medical And Dental University, Medical Hospital /ID# 160095, Bunkyo-ku, Tokyo, Japan|Tokai University Hachioji Hospital /ID# 160098, Hachioji-shi, Tokyo, Japan|The Jikei University Hospital /ID# 163209, Minato-ku, Tokyo, Japan|Kitasato University Kitasato Institute Hospital /ID# 160105, Minato-ku, Tokyo, Japan|Kyorin University Hospital /ID# 160114, Mitaka-shi, Tokyo, Japan|Tokyo Women's Medical University Hospital /ID# 205974, Shinjuku-ku, Tokyo, Japan|Wakayama Medical University /ID# 202561, Wakayama-shi, Wakayama, Japan|Yamagata University Hospital /ID# 200159, Yamagata-shi, Yamagata, Japan|Yamanashi Prefectural Central Hospital /ID# 160094, Kofu-shi, Yamanashi, Japan|Hanyang University Guri Hospital /ID# 158690, Guri, Gyeonggido, Korea, Republic of|CHA Bundang Medical center CHA University /ID# 158698, Seongnam si, Gyeonggido, Korea, Republic of|Kangbuk Samsung Hospital /ID# 158694, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Severance Hospital /ID# 158689, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Inje University Haeundae Hospital /ID# 202518, Busan, Korea, Republic of|Dong-A University Hospital /ID# 158699, Busan, Korea, Republic of|Pusan National University Hospital /ID# 158695, Busan, Korea, Republic of|Yeungnam University Medical Center /ID# 158691, Daegu, Korea, Republic of|The Catholic University of Korea, Daejeon St.Mary's Hospital /ID# 213554, Daejeon, Korea, Republic of|The Catholic Univ. of Korea /ID# 158693, Gyeonggi-do, Korea, Republic of|Asan Medical Center /ID# 158696, Seoul, Korea, Republic of|Samsung Medical Center /ID# 158692, Seoul, Korea, Republic of|Riga East Clinical Univ Hosp /ID# 159611, Riga, Latvia|P. Stradins Clinical Univ Hosp /ID# 159612, Riga, Latvia|Digestive Diseases Ctr Gastro /ID# 163107, Riga, Latvia|Hospital of lithuanian university of Health Science Kauno Klinikos /ID# 162583, Kaunas, Lithuania|Vilnius University Hospital /ID# 162514, Vilnius, Lithuania|Universiti Kebangsaan Malaysia (UKM) Medical Centre /ID# 201363, Kuala Lumpur, Selangor, Malaysia|Universiti Sains Malaysia /ID# 160666, Kelantan, Malaysia|Queen Elizabeth Hospital /ID# 160664, Kota Kinabalu, Malaysia|Investigacion Biomedica para el Desarrollo de Farmacos, S.A. de C.V. /ID# 170734, Zapopan, Jalisco, Mexico|JM Research SC /ID# 170729, Cuernavaca, Morelos, Mexico|Unidad de Atencion Medica e Investigacion en Salud /ID# 170732, Merida, Yucatan, Mexico|Health Pharma Professional Research S.A de C.V /ID# 170730, Del. Benito Juárez, Mexico|Academisch Medisch Centrum /ID# 157956, Amsterdam, Noord-Holland, Netherlands|Elisabeth Tweesteden Ziekenhuis /ID# 163632, Tilburg, Netherlands|Christchurch Hospital /ID# 167224, Christchurch, Canterbury, New Zealand|Middlemore Clinical Trials /ID# 167226, Auckland, New Zealand|Dunedin Hospital /ID# 167227, Dunedin, New Zealand|Wellington Hospital (Capital and Coast District Health Board) /ID# 167225, Wellington, New Zealand|Akershus universitetssykehus /ID# 169379, Nordbyhagen, Akershus, Norway|Vestre viken - Baerum Sykehus /ID# 212996, Gjettum, Norway|Sykehuset Levanger Helse NT /ID# 201669, Levanger, Norway|Helse More og Romsdal HF, Alesund sjukehus /ID# 212810, Ålesund, Norway|Planetmed Sp. z o.o. /ID# 202799, Wroclaw, Dolnoslaskie, Poland|Gastromed /Id# 212476, Torun, Kujawsko-pomorskie, Poland|Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego w Lodzi /ID# 212477, Lodz, Lodzkie, Poland|1 Wojskowy Szpital Kliniczny Z Poliklinika /Id# 210940, Lublin, Lubelskie, Poland|Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie /ID# 210941, Lublin, Lubelskie, Poland|Centrum Zdrowia MDM /ID# 163570, Warszawa, Mazowieckie, Poland|Centralny Szpital Kliniczny MSWiA w Warszawie /ID# 163582, Warszawa, Mazowieckie, Poland|Instytut Pomnik - Centrum Zdrowia Dziecka /ID# 213580, Warszawa, Mazowieckie, Poland|Centrum Medyczne Medyk /ID# 212891, Rzeszów, Podkarpackie, Poland|Centrum Medyczne LukaMed Joanna Luka-Wendrowska /ID# 212478, Chojnice, Pomorskie, Poland|H-T. Centrum Medyczne - Endoterapia /ID# 212475, Tychy, Slaskie, Poland|Wojewodzki Szpital Specjalistyczny /ID# 212474, Olsztyn, Warminsko-mazurskie, Poland|SOLUMED Sp. z o.o., Sp.k. /ID# 163569, Poznan, Poland|Niepubliczny Zakład Opieki Zdrowotnej VIVAMED Jadwiga Miecz /ID# 202800, Warsaw, Poland|Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclaw /ID# 212601, Wroclaw, Poland|Hospital Senhora da Oliveira de Guimaraes, EPE /ID# 160737, Guimaraes, Braga, Portugal|Centro Hospitalar Universitário do Algarve, EPE - Hospital de Portimão /ID# 167752, Portimão, Faro, Portugal|Hospital Garcia de Orta, E.P.E /ID# 160745, Almada, Setubal, Portugal|Hospital de Faro /ID# 160713, Faro, Portugal|Centro Hosp de Lisboa Central /ID# 160673, Lisboa, Portugal|Centro Hospitalar de Lisboa Ocidental, EPE - Hospital Egas Moniz /ID# 167751, Lisboa, Portugal|Centro Hospitalar Universitário de Lisboa Norte, EPE - Hospital de Santa Maria /ID# 160692, Lisboa, Portugal|Hospital Beatriz Angelo /ID# 207759, Loures, Portugal|Centro Hospitalar Universitario de Sao Joao, EPE /ID# 160693, Porto, Portugal|Centro Hospitalar de Entre Douro e Vouga /ID# 160672, Santa Maria Da Feira, Portugal|Centro Hosp de Tondela-Viseu /ID# 160699, Viseu, Portugal|Institutul Clinic Fundeni /ID# 170899, Bucharest, Romania|Tvm Med Serv Srl /Id# 170902, Cluj, Romania|Cabinet Particular Policlinic Algomed /ID# 170900, Timisoara, Romania|Centrul Medical Tuculanu SRL /ID# 170903, Timisoara, Romania|Kuzbass Regional Clinical Hospital /ID# 200962, Kemerovo, Kemerovskaya Oblast, Russian Federation|Perm state medical university n.a. E.A. Vagner /ID# 207439, Perm, Permskiy Kray, Russian Federation|St. Petersburg State Pediatric Medical University /ID# 211978, Saint Petersburg, Sankt-Peterburg, Russian Federation|Center for Educational and Clinical Gastroenterology, Hepatology and Pancreatolo /ID# 200970, Stavropol, Stavropol Skiy Kray, Russian Federation|Tver Regional Clinical Hospital /ID# 206858, Tver, Tverskaya Oblast, Russian Federation|Regional Clinical Hospital #1 /ID# 200973, Tyumen, Tyumenskaya Oblast, Russian Federation|Alliance Biomedical Ural Group /ID# 200972, Izhevsk, Udmurtskaya Respublika, Russian Federation|National Medical Research Center of Coloproctology n.a. A. N. Ryzhikh /ID# 204808, Moscow, Russian Federation|Novosibirski Gastrocenter /ID# 217552, Novosibirsk, Russian Federation|City Clinical Hospital No. 31 /ID# 208872, St. Petersburg, Russian Federation|Ulyanovsk State clinical hospi /ID# 200964, Ulyanovsk, Russian Federation|Clinical Hosp Center Zvezdara /ID# 157052, Belgrade, Beograd, Serbia|Military Medical Academy /ID# 157053, Belgrade, Beograd, Serbia|University Clinical Center Serbia /ID# 157047, Belgrade, Beograd, Serbia|Clin Hosp Ctr Bezanijska Kosa /ID# 157050, Belgrade, Beograd, Serbia|University Clinical Center Kragujevac /ID# 157049, Kragujevac, Sumadijski Okrug, Serbia|Clinical Center Vojvodina /ID# 157046, Novi Sad, Vojvodina, Serbia|University Children's Hospital 'Tirsova' /ID# 211482, Belgrade, Serbia|Clinical Hospital Center Dr Dragisa Misovic - Dedinje /ID# 212799, Belgrade, Serbia|General Hospital Leskovac /ID# 209575, Leskovac, Serbia|National University Hospital /ID# 160667, Singapore, Singapore|Singapore General Hospital /ID# 160668, Singapore, Singapore|KL Ling Gastroenterology and Liver Clinic /ID# 205741, Singapore, Singapore|Fakultna nemocnica s poliklinikou F.D. Roosevelta Banska Bystrica /ID# 156468, Banska Bystrica, Slovakia|KM Management s.r.o. /ID# 206764, Nitra, Slovakia|GASTRO I., s.r.o. /ID# 156469, Presov, Slovakia|Clinresco Centers /ID# 163865, Johannesburg, Gauteng, South Africa|Wits Clinical Research Site /ID# 158114, Johannesburg, Gauteng, South Africa|Spoke Research Inc /ID# 158116, Cape Town,Milnerton, Western Cape, South Africa|Mediclinic Constantiaberg /ID# 163112, Cape Town, Western Cape, South Africa|Hospital Arquitecto Marcide - Complejo Hospitalario Universitario de Ferrol /ID# 157553, Ferrol, A Coruna, Spain|Hospital Clínico Universitario de Santiago-CHUS /ID# 226574, Santiago de Compostela, A Coruna, Spain|Hospital Universitario Central de Asturias /ID# 225349, Oviedo, Asturias, Spain|Hospital Universitario Germans Trias i Pujol /ID# 225350, Badalona, Barcelona, Spain|Hospital Universitario de Bellvitge /ID# 208207, L'Hospitalet de Llobregat, Barcelona, Spain|Consorci Corporacio Sanitaria Parc Tauli Sabadell /ID# 159237, Sabadell, Barcelona, Spain|Hospital Universitario de Fuenlabrada /ID# 225351, Fuenlabrada, Madrid, Spain|Hospital Universitario Puerta de Hierro, Majadahonda /ID# 157573, Majadahonda, Madrid, Spain|Hospital Universitario Basurto /ID# 205190, Bilbao, Vizcaya, Spain|Hospital General Universitario Alicante /ID# 159236, Alicante, Spain|Hospital Clinic de Barcelona /ID# 157552, Barcelona, Spain|Hospital General Universitario Gregorio Maranon /ID# 161145, Madrid, Spain|Hospital Clinico Universitario San Carlos /ID# 225352, Madrid, Spain|Hospital Universitario La Paz /ID# 159235, Madrid, Spain|Hospital Clinico Universitario de Salamanca /ID# 157558, Salamanca, Spain|Hospital Universitario Virgen Macarena /ID# 159967, Sevilla, Spain|Hospital Universitario Virgen del Rocio /ID# 225348, Sevilla, Spain|Hospital Clinico Universitario de Valencia /ID# 209700, Valencia, Spain|Hospital Universitario y Politecnico La Fe /ID# 157556, Valencia, Spain|Hospital Clinico Universitario Lozano Blesa /ID# 212525, Zaragoza, Spain|Hospital Universitario Miguel Servet /ID# 157557, Zaragoza, Spain|Skanes Universitetssjukhus /ID# 211745, Malmö, Skane Lan, Sweden|GHP Stockholm Gastro Center /ID# 211748, Stockholm, Stockholms Lan, Sweden|Sahlgrenska US Gbg /ID# 163797, Göteborg, Vastra Gotalands Lan, Sweden|Sahlgrenska University Hosp /ID# 163792, Goteborg, Sweden|Karolinska Univ Sjukhuset /ID# 212025, Solna, Sweden|Medicinkliniken, Gastroenheten /ID# 163744, Stockholm, Sweden|Danderyd Hospital /ID# 202138, Stockholm, Sweden|Universitaetsspital Zuerich /ID# 163536, Zurich, Zuerich, Switzerland|Universitaetsspital Basel /ID# 164554, Basel, Switzerland|Inselspital, Universitaetsklinik /ID# 163535, Bern, Switzerland|China Medical University Hosp /ID# 160141, Taichung City, Taichung, Taiwan|National Cheng Kung University Hospital /ID# 160142, Tainan City, Tainan, Taiwan|National Taiwan University Hospital /ID# 162190, Taipei City, Taipei, Taiwan|Taichung Veterans General Hosp /ID# 160140, Taichung City, Taiwan|Taipei Veterans General Hosp /ID# 212712, Taipei City, Taiwan|Medical Centre OK Clinic of International Institute of Clinical Research LLC /ID# 211998, Kyiv, Kyivska Oblast, Ukraine|Kyiv Municipal Clinical Hospital #18 /ID# 162531, Kiev, Kyiv, Ukraine|Clinic of Scientific Research Institute of Invalid Rehabilitation /ID# 212000, Vinnytsia, Vinnytska Oblast, Ukraine|Volyn regional clinical hospital /ID# 206789, Lutsk, Volynska Oblast, Ukraine|Kharkiv City Clinical Hospital /ID# 165657, Kharkiv, Ukraine|Public Institution Kherson City Clinical Hospital named after le.le. Karabelesha /ID# 212399, Kherson, Ukraine|Consultative and Diagnostic Ce /ID# 165659, Kyiv, Ukraine|Medical Center of LLC Medbud-Clinic /ID# 216998, Kyiv, Ukraine|Kyiv Railway Clinical Hosp No.2 /ID# 217366, Kyiv, Ukraine|Lviv Railway Clinical Hospital /ID# 165658, Lviv, Ukraine|Transcarpathian Regional Clin. /ID# 167960, Uzhhorod, Ukraine|Vinnytsia Regional Clinical Hospital n.a. M.I.Pyrogov /ID# 216474, Vinnytsia, Ukraine|RD&E Hospital /ID# 157544, Exeter, Devon, United Kingdom|The Royal London Hospital /ID# 163713, London, London, City Of, United Kingdom|Guy's and St Thomas' NHS Found /ID# 157546, London, London, City Of, United Kingdom|Ashford and St Peter's Hospitals NHS Foundation Trust /ID# 207936, Chertsey, Surrey, United Kingdom|Barnsley Hospital NHS Foundation Trust /ID# 202773, Barnsley, United Kingdom|Univ Hospitals Birmingham NHS Foundation trust /ID# 157545, Birmingham, United Kingdom|Fairfield General Hospital /ID# 207766, Bury, United Kingdom|Addenbrookes Hospital /ID# 158034, Cambridge, United Kingdom|Western General Hospital /ID# 207448, Edinburgh, United Kingdom|Queen Elizabeth University Hos /ID# 202568, Glasgow, United Kingdom|Huddersfield Royal Infirmary /ID# 209570, Huddersfield, United Kingdom|Hull University Teaching Hospitals NHS Trust /ID# 158761, Hull, United Kingdom|St. James University Hospital /ID# 157550, Leeds, United Kingdom|Kings Healthcare NHS Trust /ID# 158760, London, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 163708, Newcastle Upon Tyne, United Kingdom|Oxford University Hospitals NHS Foundation Trust The John Radcliffe Hospital /ID# 158036, Oxford, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03105102"
635,"NCT03058679","Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease","DINE-CD","Active, not recruiting","No Results Available","Crohn Disease","Other: Diet","Symptomatic remission|Reduction in bowel inflammation|Clinical remission|Reduction in systemic inflammation","University of Pennsylvania|Patient-Centered Outcomes Research Institute|Crohn's and Colitis Foundation|University of North Carolina, Chapel Hill","All","18 Years and older   (Adult, Older Adult)","Not Applicable","194","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","825907","September 29, 2017","March 1, 2020","July 2021","February 23, 2017",,"May 12, 2020","University of Arizona, Tucson, Arizona, United States|UCSF Colitis and Crohn's Disease Center, San Francisco, California, United States|University of Colorado Denver, Denver, Colorado, United States|Emory University, Atlanta, Georgia, United States|Atlanta Gastroenterology, Atlanta, Georgia, United States|University of Chicago, Chicago, Illinois, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Northwestern University, Evanston, Illinois, United States|Indiana University Health University Hospital, Indianapolis, Indiana, United States|The University of Louisville, Louisville, Kentucky, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Clinical Research Institute of Michigan, Chesterfield, Michigan, United States|Troy Gastroenterology, Troy, Michigan, United States|The University of Minnesota, Minneapolis, Minnesota, United States|Minnesota Gastroenterology, P.A, Plymouth, Minnesota, United States|Mayo Clinic - Rochester, Rochester, Minnesota, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|NYU Langone Medical Center, New York, New York, United States|Weill Cornell - NewYork Presbyterian, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Lenox Hill Hospital, New York, New York, United States|The University of North Carolina, Chapel Hill, North Carolina, United States|Atrium Health (formerly Carolinas HealthCare System), Charlotte, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Cincinnati, Cincinnati, Ohio, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Ohio State University - Wexner Medical Center, Columbus, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Lifespan Health System, Providence, Rhode Island, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Utah, Salt Lake City, Utah, United States|Virginia Mason Medical Center, Seattle, Washington, United States|University of Wisconsin-Madison, Madison, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT03058679"
636,"NCT02968108","A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease","STELARA","Active, not recruiting","No Results Available","Crohn Disease","Drug: Ustekinumab","Serum Ustekinumab Concentrations Over Time|Clinical Response as Measured by the Pediatric Crohn's Disease Activity Index (PCDAI) Score|Clinical Remission as Measured by the Pediatric Crohn's Disease Activity Index (PCDAI) Score","Janssen Research & Development, LLC","All","2 Years to 17 Years   (Child)","Phase 1","45","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","CR108233|CNTO1275CRD1001|2016-001956-22","January 2017","September 2018","March 2023","November 18, 2016",,"May 12, 2021","Cedars-Sinai Medical Center, Los Angeles, California, United States|Connecticut Childrens Medical Center, Hartford, Connecticut, United States|Emory University, Atlanta, Georgia, United States|Children's Center For Digestive Healthcare, Llc, Atlanta, Georgia, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Mayo Clinic, Rochester, Minnesota, United States|Mount Sinai, New York, New York, United States|Childrens Hospital Of Philadelphia, Philadelphia, Pennsylvania, United States|Center For Digestive Health Systems-Greenville, Greenville, South Carolina, United States|Universitair Kinderziekenhuis Koningin Fabiola, Brussel, Belgium|Cliniques Universitaires Saint-Luc, Brussel, Belgium|UZ Gent, Gent, Belgium|UZ Brussel, Jette, Belgium|UZ Leuven, Leuven, Belgium|Stollery Children's Hospital, Edmonton, Alberta, Canada|Children's Hospital of Western Ontario, London, Ontario, Canada|Hospital For Sick Children, Toronto, Ontario, Canada|Centre Hospitalier Sainte Justine, Montreal, Quebec, Canada|British Columbia Children's Hospital, Vancouver, Canada|Hôpital Necker, Paris, France|Hôpital Robert Debré, Paris, France|Dr. von Haunersches Kinderspital, Munich, Germany|HELIOS Klinikum Wuppertal GmbH, Wuppertal, Germany|Instytut Centrum Zdrowia Matki Polki, Lodz, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw, Poland",,"https://ClinicalTrials.gov/show/NCT02968108"
637,"NCT02930564","The Challenge Study: A Dietary Personalization Protocol for Patients With Crohn's Disease and Deep Remission",,"Recruiting","No Results Available","Crohn's Disease","Other: CDED + milk fat and gluten","number of patients with calprotetctin elevation","Wolfson Medical Center","All","8 Years to 20 Years   (Child, Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","0186-16-WOMC","January 2017","December 2022","December 2022","October 12, 2016",,"February 17, 2021","Wolfson Medical Center, Holon, Israel",,"https://ClinicalTrials.gov/show/NCT02930564"
638,"NCT02914600","Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease","DIVERSITYLTE","Enrolling by invitation","No Results Available","Crohn's Disease","Drug: Filgotinib|Drug: Placebo","Overall Safety Profile of Filgotinib Evaluated by the Percentage of Participants Experiencing Adverse Events and Abnormal Clinical Laboratory Tests|Change from Baseline in PRO2 Scores|Change from Baseline in Crohn's Disease Activity Index (CDAI) Scores","Gilead Sciences|Galapagos NV","All","18 Years and older   (Adult, Older Adult)","Phase 3","1000","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","GS-US-419-3896|2016-002763-34","March 17, 2017","May 2025","June 2025","September 26, 2016",,"June 23, 2021","Digestive Health Specialists Of The Southeast, Dothan, Alabama, United States|Arizona Digestive Health - Sun City, Sun City, Arizona, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|UC San Diego Health Systems, San Diego, California, United States|Kaiser Permanente, San Francisco, California, United States|Clearview Medical Research, LLC, Santa Clarita, California, United States|University of Colorado Denver and Hospital, Aurora, Colorado, United States|South Denver Gastroenterology, PC, Lone Tree, Colorado, United States|Connecticut GI, PC - Research Division, Farmington, Connecticut, United States|Medstar Georgetown University Hospital, Washington, District of Columbia, United States|Advanced Research, LLC, Coral Springs, Florida, United States|UF Clinical Research Center, Gainesville, Florida, United States|Florida Research Institute, Lakewood Ranch, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|University of Miami Crohn's and Colitis Center, Miami, Florida, United States|Advanced Pharma CR, LLC, Miami, Florida, United States|Cordova Research Institute, Miami, Florida, United States|Vista Health Research, LLC, Miami, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|Center for Interventional Endoscopy - Florida Hospital, Orlando, Florida, United States|Gulf Region Clinical Research Institute, Pensacola, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Florida Medical Clinic, P.A, Zephyrhills, Florida, United States|Gastroenterology Associates Of Central Georgia, LLC, Macon, Georgia, United States|Gastrointestinal Specialists of Georgia, Marietta, Georgia, United States|Atlanta Gastroenterology Specialist, PC, Suwanee, Georgia, United States|Illinois Gastroenterology Group - Arlington Heights, Arlington Heights, Illinois, United States|Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States|The University of Chicago Medical Center (Clinic), Chicago, Illinois, United States|Illinois Gastroenterology Group - Gurnee, Gurnee, Illinois, United States|Indiana University, Indianapolis, Indiana, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|University of Louisville, Clinical Trials Unit, Louisville, Kentucky, United States|Delta Research Partners, LLC, Monroe, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Investigative Clinical Research, Annapolis, Maryland, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|MGG Group Co., Inc., Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Gastro Center of Maryland, Columbia, Maryland, United States|Meritus Center for Clinical Research, Hagerstown, Maryland, United States|Massachusetts General Hospital - Crohn's and Colitis Center, Boston, Massachusetts, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Kansas City Research Institute, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|AGA Clinical Research Associates, LLC, Egg Harbor Township, New Jersey, United States|NY Scientific, Brooklyn, New York, United States|NYU Langone Long Island Clinical Research Associates, Great Neck, New York, United States|New York University School of Medicine / NYU Gastroenterology Associates, New York, New York, United States|Lenox Hill Hospital, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Premier Medical Group of the Hudson Valley, Poughkeepsie, New York, United States|Charlotte Gastroenterology & Hepatology, PLLC, Charlotte, North Carolina, United States|Carolina's GI Research LLC, Raleigh, North Carolina, United States|Fargo Gastroenterology and Hepatology Clinic, Fargo, North Dakota, United States|Consultants for Clinical Research, Cincinnati, Ohio, United States|UC Health Physicians Clifton, Cincinnati, Ohio, United States|Great Lakes Gastroenterology Research, LLC, Mentor, Ohio, United States|Paramount Medical Research & Consulting, LLC, Middleburg Heights, Ohio, United States|Options Health Research LLC, Tulsa, Oklahoma, United States|Great Lakes Medical Research, LLC, Harrisburg, Pennsylvania, United States|Gastroenterology Associates of Orangeburg, Orangeburg, South Carolina, United States|WR-ClinSearch, LLC, Chattanooga, Tennessee, United States|Gastro One, Germantown, Tennessee, United States|Quality Medical Research, Nashville, Tennessee, United States|Vanderbilt University Medical Center - IBD Clinic, Nashville, Tennessee, United States|Texas Clinical Research Institute, Arlington, Texas, United States|Pinnacle Clinical Research, Austin, Texas, United States|Inquest Clinical Research, Baytown, Texas, United States|San Antonio Military Medical Center,, Fort Sam Houston, Texas, United States|DHAT Research Institute, Garland, Texas, United States|Kelsey-Seybold Clinic, Houston, Texas, United States|Baylor College of Medicine - McNair Campus, Houston, Texas, United States|The Methodist Hospital, Houston, Texas, United States|The University of Texas Health Science Center at Houston, Houston, Texas, United States|Centex Studies, Inc., Houston, Texas, United States|Gulf Coast Research Group, Houston, Texas, United States|Clinical Associates in Research Therapeutics of America, LLC, San Antonio, Texas, United States|Gastroenterology Research of San Antonio, San Antonio, Texas, United States|Pinnacle Clinical Research, San Antonio, Texas, United States|TDDC San Marcos, San Marcos, Texas, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|Spring Gastroenterology, The Woodlands, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|HP Clinical Research, Bountiful, Utah, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Charlottesville Medical Research Center, LLC, Charlottesville, Virginia, United States|Gastroenterology Associates of Tidewater, Chesapeake, Virginia, United States|McGuire DVAMC, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|University of Wisconsin Hospital & Clinics, Madison, Wisconsin, United States|Wisconsin Center for Advanced Research, a division of GI Associates, LLC, Milwaukee, Wisconsin, United States|Fundacion Estudios Clinicos CiRec, Rosario, Argentina|Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|Wollongong Hospital, Wollongong, New South Wales, Australia|Coastal Digestive Health, Mountain Creek, Queensland, Australia|Coral Sea Clinical Research Institute (Mackay), North Mackay, Queensland, Australia|Mater Misericordiae Ltd, South Brisbane, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|The Queen Elizabeth Hospital, Woodville South, South Australia, Australia|Emeritus Research, Camberwell, Victoria, Australia|Monash Medical Centre, Clayton, Victoria, Australia|Footscray Hospital, Footscray, Victoria, Australia|Austin Health, Heidelberg, Victoria, Australia|Cabrini Hospital, Malvern, Victoria, Australia|Alfred Hospital, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|Universitatsklinik Innsbruck, Innsbruck, Austria|Klinikum Klagenfurt am Wörthersee, Abt. Für Inn. Med. & Gastroenterol, (IMuG), Hepatol., Endokrinol., Rheumatol., & Nephrol., Klagenfurt am Wörthersee, Austria|AKH-Medizinische Universitat Wien, Wien, Austria|GZA Ziekenhuizen, campus Sint-Vincentius, Antwerpen, Belgium|Imelda General Hospital, Bonheiden, Belgium|CUB Hopital Erasme, Brussel, Belgium|Universitair Ziekenhuis Antwerpen, Edegem, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|Universitair Ziekenhuis Leuven, Leuven, Belgium|CHR Citadelle, Liege, Belgium|Centre Hospitalier Chretien (CHC) - Clinique Saint-Joseph, Liège, Belgium|AZ Delta, Roeselare, Belgium|Medical Center - Complete Medical Solutions OOD, Samokov, Bulgaria|Medical Center - ""Tsaritsa Yoanna"" EOOD, Sliven, Bulgaria|""MDHAT Dr. St.Cherkezov"" AD, Veliko Tarnovo, Bulgaria|MHAT ""Sveta Petka"" AD, Vidin, Bulgaria|Barrie GI Associates, Barrie, Canada|University of Calgary, Heritage Medical Research Clinic, Calgary, Canada|Hamilton Health Sciences Corporation, McMaster University Medical Centre, Hamilton, Canada|London Health Sciences Centre - University Hospital, London, Canada|TIDHI Innovation, Inc., North York, Canada|ABP Research Services, Oakville, Canada|Royal University Hospital, Saskatoon, Canada|Mount Sinai Hospital, Toronto, Canada|The Gordon and Leslie Diamond Health Care Centre, Vancouver, Canada|Toronto Digestive Disease Associates Inc., Vaughan, Canada|Percuro Clinical Research Ltd., Victoria, Canada|University Hospital Center Osijek, Osijek, Croatia|Clinical Hospital Dubrava, Zagreb, Croatia|University Hospital Center Zagreb, Zagreb, Croatia|Hepato-Gastroenterology HK, s.r.o., Hradec Kralove, Czechia|Oblastni nemocnice Mlada Boleslav, a.s., nemocnice Stredoceskeho kraje, Gastroenterologicke oddeleni, Mlada Boleslav, Czechia|G.E.P. Clinic, s r.o., Praha 3, Czechia|Thomayerova nemocnice, Interni klinika 3. LF UK a TN, Praha 4, Czechia|ISCARE a.s. (Klinicke centrum ISCARE), Klinicke a vyzkumne centrum pro strevni zancty, Praha 9, Czechia|CHU Amiens Picardie, Amiens Cedex 1, France|CHU de Caen, Caen Cedex 9, France|CHU de Clermont-Ferrand - Hopital d'Estaing, Clermont-Ferrand, France|APHP - Hopital Beaujon - Clichy - Universite Paris VII, Clichy, France|Centre Hospitalier Intercommunal de Creteil, Créteil Cedex, France|CHU de Dijon Bourgogne - Hopital Francois Mitterand, Dijon, France|CHU Grenoble Alpes, La Tronche, France|Hopital Universitaire de Bicetre, Le Kremlin Bicetre, France|Centre Hospitalier Regional Universitaire de Lille, Lille, France|Hopital Nord, Marseille, France|Hopital Saint Joseph, Marseille, France|CHU de Montpellier-Hopital Saint Eloi, Montpellier, France|CHU Hotel-Dieu, Nantes, France|Hopital de l'Archet 2, Nice, France|CHU de Bordeaux - Hopital Haut Leveque, Pessac, France|Centre Hospitalier Universitaire de Lyon Sud, Pierre-Benite, France|CH Annecy Genevois - Site d'Annecy, Pringy Cedex, France|Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes Cedex 9, France|CHU de Saint Etienne - Hopital Nord, Saint Priest en Jarez, France|Nouvel Hopital Civil, Strasbourg, France|Hopitaux Universitaires de Strasbourg - Hopital de Hautepierre, Strasbourg, France|CHU de Toulouse - Hopital Rangueil, Toulouse Cedex 9, France|CHU de Toulouse - Hopital Rangueil, Toulouse, France|CHU de Nancy - Hopital Brabois Adultes, Vandoeuvre-les-Nancy Cedex, France|Unimed Ajara LLC - Batumi Referral Hospital, Batumi, Georgia|Medi Club Georgia LLC, Tbilisi, Georgia|Ltd. Unimed Kakheti - Telavi Referral Hospital, Telavi, Georgia|Charite Universitaetsmedizin Berlin, Berlin, Germany|Medizinisches Versorgungszentrum Delitzsch, Berlin, Germany|Charite - Universitatsmedizin Berlin, Berlin, Germany|DRK Kliniken Berlin - Westend - Klinik fuer Innere Medizin, Berlin, Germany|Stadtisches Klinikum Braunschweig gGmbH, Braunschweig, Germany|Universitatsklinikum Dresden, Dresden, Germany|Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany|CED Studien UG, Interdisciplinary Crohn Colitis Center (iCCC), Frankfurt am Main, Germany|Universitatsklinikum Freiburg, Freiburg, Germany|Asklepios Westklinikum Hamburg, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitatsklinikum Heidelberg, Heidelberg, Germany|Praxis fur Gastroenterologie, Heidelberg, Germany|Gastroenterologische Gemeinschaftspraxis Herne, Herne, Germany|Universitatsklinikum Jena, Jena, Germany|Universitatsklinikum Schleswig-Holstein, Kiel, Germany|Universitaetsklinik Koln, Koln, Germany|EUGASTRO GmbH, Leipzig, Germany|Universitatsklinikum Leipzig, Leipzig, Germany|Klinikum Luneburg, Lüneburg, Germany|Gastroenterologische Gemeinschaftspraxis Minden, Minden, Germany|Klinikum der Universitat Munchen - Grosshadern, Muenchen, Germany|Universitaetsmedizin Rostock, Zentrum fuer Innere Medizin, Rostock, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Germany|Universitatsklinikum Ulm, Zentrum Fur Innere Medizin, Ulm, Germany|Hippokration Hospital of Athens, Athens, Greece|University General Hospital ""Attikon"", 2nd Propaedeutic Internal Medicine Dept. and Research Unit, Hepatogastroenterology Unit, Athens, Greece|University General Hospital of Ioannina, Gastroenterology Department, Internal Medicine Division, Ioannina, Greece|University General Hospital of Patras ""Panagia I Voithia"", Gastroenterology Department, Internal Medicine Division, Patra, Greece|Hippokratio General Hospital of Thessaloniki ""Hippokratio"" 4th Internal Medicine Department of Aristotle University of Thessaloniki, Thessaloniki, Greece|Princess Margaret Hospital, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong|Tuen Mun Hospital, Tuen Mun, Hong Kong|Bekes Megyei Kosponti Korhaz, Dr. Rethy Pal Tagkorhaz, IV. Belgyogyaszat - 2. Gasztroenterologia, Bekescsaba, Hungary|Szent Margit Korhaz, Gasztroenterológiai Osztály, Budapest, Hungary|Clinexpert Egeszsegugyi Szolgaltato es Kereskedelmi Kft., Budapest, Hungary|Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Kozponti Felnott Szakrendelo, Budapest, Hungary|Szent Janos Korhaz es Eszak-budai Egitett Korhazak, I. Belgyogyaszati - Gasztroenterologiai Osztaly, Budapest, Hungary|Debreceni Egyetem Klinikai Kozpont, II. sz. Belgyogyaszati Klinika, Gasztroenterologia, Debrecen, Hungary|Bugat Pal Korhaz, Belgyogyaszat, Gyöngyös, Hungary|Karolina Korhaz es Rendelointezet, Altalanos Belgyogyaszat-Gasztroenterologia, Mosonmagyarovar, Hungary|Landspitali University Hospital, Reykjavik, Iceland|Lakeshore Hospital and Research Centre Ltd, Kochi, Kerala, India|Kaizen Hospital, Ahmedabad, India|Victoria Hospital, Bangalore Medical College and Research Institute (BMCRI), Bangalore, India|M S Ramaiah Medical College and Hospital, Bangalore, India|Apollo Speciality Hospital, Chennai, India|VGM Hospital Institute of Gastroenterology, Coimbatore, India|Lourdes Hospital, Ernakulam, India|Fortis Memorial Research Institute, Gurgaon, India|Gleneagles Global Hospital, Hyderabad, India|Citizens Specialty Hospital, Hyderabad, India|Centre for Liver Research & Diagnostics, Hyderabad, India|SR Kalla Memorial Gastro and General Hospital, Jaipur, India|S.M.S Hospital, Jaipur, India|School of Digestive & Liver Diseases, Kolkata, India|King George's Medical University, Lucknow, India|Dayanand Medical College & Hospital, Ludhiana, India|Kasturba Medical College (KMC) Hospital, Mangaluru, India|Seth G.S. Medical College & KEM Hospital, Mumbai, India|S.L. Raheja Hospital (A Fortis Associate), Mumbai, India|Lokmanya Tilak Municipal General Hospital, Mumbai, India|Midas Multispeciality Hospital Pvt. Ltd, Nagpur, India|Suretech Hospital & Research Centre Ltd, Nagpur, India|All India Institute of Medical Sciences, New Delhi, India|Department of Surgery, B.J. Government Medical College & Sassoon General Hospital, Pune, India|Grant Medical Foundation Ruby Hall Clinic, Pune, India|Universal Hospital, Pune, India|Shree Giriraj Multispeciality Hospital, Rajkot, India|Gandhi Hospital, Secunderabad, India|Institute of Gastroenterology & Liver Disease. Sunshine Hospitals, Secunderabad, India|Surat Institute of Digestive Sciences, Surat, India|Kasturba Hospital Medical College, Udupi, India|Sterling Hospital, Vadodara, India|Samvedna Hospital, Varanasi, India|St. Vincent's University Hospital, Dublin, Ireland|Beaumont Hospital, Dublin, Ireland|Wellcome Trust HRB Clinical Research Facility, Dublin, Ireland|University Hospital Galway, Galway, Ireland|Emek Medical Center, Afula, Israel|Soroka Medical Center, Beer-Sheva, Israel|Bnai Zion Medical Center, Haifa, Israel|Rambam Medical Health Care Campus, Haifa, Israel|The Edith Wolfson Medical Center, Holon, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah Medical Center, Jerusalem, Israel|Meir MC, Kefar Sava, Israel|Rabin Medical Center, Petah Tikva, Israel|The Chaim Sheba Medical Center, Ramat Gan, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel|UOC Gastroenterologia II, Castellana Grotte, Italy|U.O. Fisiopatologia Digestiva, Catanzaro, Italy|UOC Medicina Interna, Cento, Italy|Ospedale Clinicizzato SS. Annunziata - Dipartimento di Medicina, Chieti, Italy|Gastroenterologia clinica - Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy|Endocsopia Digestiva Centralizzata, Milano, Italy|UO Gastroenterologia, Modena, Italy|UOC Gastroenterologia, Padova, Italy|Azienda Ospedaliero-Universitaria Pisana - Presidio Ospedaliero Cisanello, Pisa, Italy|UOC Gastroenterologia ed Endoscopia Digestiva, Roma, Italy|UOC di Gastroenterologia ed Endoscopia Digestiva, Roma, Italy|UOC Medicina Interna a Gastroenterologia, Roma, Italy|Istituto Clinico Humanitas, Rozzano, Italy|A.S.O. Ordine Mauriziano Di Torino S.C., Torino, Italy|Ohmori Toshihide gastro-intestinal Clinic, Ageo-shi, Japan|Medical Hospital, Tokyo Medical and Dental University, Bunkyo-ku, Japan|Hokkaido P.W.F.A.C Sapporo-Kosei General Hospital, Chuo-ku, Japan|Japanese Red Cross Fukuoka Hospital, Fukuoka-shi, Japan|Tokai University Hachioji Hospital, Hachioji, Japan|Hiroshima Prefectural Hospital, Hiroshima-shi, Japan|Hiroshima University Hospital, Hiroshima, Japan|Fukuoka University Hospital, Jonan-ku, Japan|Ofuna Chuo Hospital, Kamakura, Japan|Saitama Medical Center, Saitama Medical University, Kawagoe, Japan|Kitakyushu City Hospital Organization Kitakyushu Municipal Medical Center, Kitakyushu-shi, Japan|Yamanashi Prefectural Central Hospital, Kofu-shi, Japan|Kurume University Hospital, Kurume-shi, Japan|Hidaka Coloproctology Clinic, Kurume-shi, Japan|University Hospital, Kyoto Prefectural University of Medicine, Kyoto-shi, Japan|The Jikei University Hospital, Minato-ku, Japan|Kitasato University Kitasato Institute Hospital, Minato-ku, Japan|Kyorin University Hospital, Mitaka-shi, Japan|Iwate Medical University Hospital, Morioka-shi, Japan|Aichi Medical University Hospital, Nagakute-shi, Japan|Nagasaki University Hospital, Nagasaki-shi, Japan|Nagoya City University Hospital, Nagoya, Japan|Saiseikai Niigata Daini Hospital, Nishi-ku, Japan|Hyogo College of Medicine College Hospital, Nishinomiya, Japan|Ishida IBD Clinic, Oita-shi, Japan|Okayama University Hospital, Okayama-city, Japan|Kinshukai Infusion Clinic, Osaka-City, Japan|Osaka City University Hospital, Osaka, Japan|Wakakusa-Daiichi Hospital, Osaka, Japan|Shiga University of Medical Science Hospital, Otsu, Japan|Saga-Ken Medical Centre Koseikan, Saga-shi, Japan|Kitasato University Hospital,THE KITASATO INSTITUTE, Sagamihara, Japan|Saga University Hospital, Saga, Japan|Tokito Clinic, Saitama, Japan|Toho University Sakura Medical Center, Sakura, Japan|Sapporo Higashi Tokushukai Hospital, Sapporo-shi, Japan|Sapporo Tokushukai Hospital, Sapporo, Japan|National Hospital Organization Sendai Medical Center, Sendai, Japan|Tokyo Yamate Medical Center, Shinjuku-ku, Japan|Osaka University Hospital, Suita, Japan|Kagawa Prefectural Central Hospital, Takamatsu-shi, Japan|National Hospital Organization Takasaki General Medical Center, Takasaki-shi, Japan|Osaka Medical College Hospital, Takatsuki, Japan|Ieda Hospital, Toyota-shi, Japan|Wakayama Medical University Hospital, Wakayama-shi, Japan|Yokohama Health Medicine Association Kannai Suzuki Clinic, Yokohama-shi, Japan|Pusan National University Hospital, Busan, Korea, Republic of|Yeungnam University Hospital, Daegu, Korea, Republic of|Kyung Hee University Hospital, Guri-Si, Korea, Republic of|Hanyang University Guri Hospital, Gyeonggi-do, Korea, Republic of|CHA Bundang Medical Center, CHA University, Seongnam-si, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Seoul, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital, Suwon-si, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wonju, Korea, Republic of|Universiti Kebangsaan Malaysia Medical Center, Cheras, Malaysia|Hospital Pulau Pinang, George Town, Malaysia|Hospital Queen Elizabeth, Kota Kinabalu, Malaysia|University Malaya Medical Centre, Kuala Lumpur, Malaysia|Hospital Tengku Ampuan Afzan, Kuantan, Malaysia|NZW Alkmaar (Noordwest Ziekenhuisgroep), Alkmaar, Netherlands|VU Medisch Centrum, Amsterdam, Netherlands|Academic Medical Center (AMC), Amsterdam, Netherlands|Gelre Hospital, Apeldoorn, Netherlands|Universitair Medisch Centrum Groningen, Groningen, Netherlands|Maastricht University Medical Centre, Maastricht, Netherlands|Erasmus University Medical Center, Rotterdam, Netherlands|Elisabeth-TweeSteden Hospital, Tilburg, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands|Christchurch Hospital, Christchurch, New Zealand|Southern District Health Board - Dunedin Hospital, Dunedin, New Zealand|Auckland City Hospital, Grafton, New Zealand|Waikato Hospital, Hamilton, New Zealand|Wellington Hospital, Newtown, New Zealand|Bay of Plenty District Health Board - Tauranga Hospital, Tauranga, New Zealand|Hutt Valley District Health Board - Hutt Valley Hospital, Wellington, New Zealand|Uniwersytecki Szpital Kliniczny w Bialymstoku, Klinika Gastroenterologii i Chorob Wewnetrznych, Bialystok, Poland|VITAMED Galaj i Cichomski spólka jawna, Bydgoszcz, Poland|Szpital Uniwersytecki nr 2 im. Dr. Jana Biziela w Bydgoszczy, Centrum Endoskopii Zabiegowej, Poradnia Chorob Jelitowych, Bydgoszcz, Poland|Gabinet Lekarski Janusz Rudzinski, Bydgoszcz, Poland|NZOZ INTER-MED, Centrum Endoskopowe, Czestochowa, Poland|Niepubliczny Zaklad Opieki Zdrowotnej ALL-MEDICUS, Katowice, Poland|Gabinet Endoskopii Przewodu Pokarmowego, Krakow, Poland|Krakowskie Centrum Medyczne Sp. z o.o, Kraków, Poland|Samodzielny Publiczny Zaklad Opieki Zdrowotnej Uniwerstyeckiego Szpitala Klinicznego nr 1 im. Norberta Barlickiego, Lodz, Poland|Trialmed Crs, Piotrków Trybunalski, Poland|Clinical Research Center Sp. z o.o. Medic-R Sp.k., Poznan, Poland|Gabinet Lekarski Dr. Hab. N. Med. Bartosz Korczowski, Rzeszów, Poland|Endoskopia Sp. z o.o., Sopot, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|GASTROMED Kopon, Zmudzkinski i Wspolnicy Sp. j. Specjalistyczne Centrum Gastrologii i Endoskopii, Torun, Poland|H-T.Centrum Medyczne Spolka z Ograniczona Odpowiedzialnoscia Sp.K., Tychy, Poland|Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland|Centrum Zdrowia MDM, Warszawa, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych i Administacji w Warszawie, Warszawa, Poland|Medical Concierge Centrum Medyczne, Warszawa, Poland|Niepubliczny Zaklad Opieki Zrodotnej VIVAMED Jadwige Miecz, Warszawa, Poland|Bodyclinic, Warszawa, Poland|Centrum Medyczne Oporow, Wroclaw, Poland|Hospital de Braga, Braga, Portugal|Centro Hospitalar e Universitario de Coimbra, E.P.E., Coimbra, Portugal|Centro Hospitalar Cova de Beira, EPE, Covilhã, Portugal|Centro Hospitalar do Algarve EPE, Faro, Portugal|Hospital da Senhora da Oliveira Guimaraes, E.P.E., Guimaraes, Portugal|Hospital Beatriz Angelo, Loures, Portugal|Centro Hospitalar de Sao Joao, EPE, Porto, Portugal|Unidade Local de Saúde do Alto Minho, Viana do Castelo, Portugal|S.C. Centrul Medical Sana S.R.L., Gastroenterologie, Bucharest, Romania|Spitalul Universitar de Urgenta Bucuresti - Sectia Medicina Interna II, Bucharest, Romania|MedLife, Gastroenterologie, Bucuresti, Romania|Spitalul Universitar de Urgenta Militar Central Dr. Carol Davila - Sectia Clinica de Gastroenterologie, Bucuresti, Romania|Delta Health Care/ Ponderas Academic Hospital, Bucuresti, Romania|Spitalul Clinic Colentina - Sectia de Spitulal Clinic Colentina, Gastroenterologie, Bucuresti, Romania|MedLife, Gastroenterologie, Bucuresti, Romania|Gastromedica SRL, Gastroenterologie, Iasi, Romania|Cabinet Particular Policlinic Algomed SRL, Timisoara, Romania|Centrul Medical Tuculanu, Gastroenterologie, Timisoara, Romania|S.C. Policlinica Dr. Citu S.R.L.- Gastroenterologie, Timisoara, Romania|State Budgetary Healthcare Institution ""Chelyabinski Regional Clinical Hospital"", Chelyabinsk, Russian Federation|State Budgetary Institution of Health Irkustsk Order ""Badge of Honor"" Regional Clinical Hospital, Irkutsk, Russian Federation|State Budgetary Healthcare Institution of Moscow Region ""Moscow Regional Clinical Research Institute n.a. M.F. Vladimirskiy"", Moscow, Russian Federation|State Budgetary Healthcare Institution of Nizhny Novgorod Region ""Nizhny Novgorod Regional Clinical Hospital n.a. N.A., Nizhniy Novgorod, Russian Federation|State Budgetary Healthcare Institution of the Novosibirsk Region ""State Novosibirsk Regional Clinical Hospital"", Novosibirsk, Russian Federation|State Budgetary Institution of Health of Novosibirsk Region ""City Clinical Hospital #12"", Novosibirsk, Russian Federation|Saint Petersburg State Budgetary Healthcare Institution ""City Polyclinic #38"", Saint-Petersburg, Russian Federation|""Scientific Research Centre ECO-safety"" LLC, Saint-Petersburg, Russian Federation|""PolyClinic EXPERT"" LLC, Saint-Petersburg, Russian Federation|State Healthcare Institution ""Regional Clinical Hospital"", Saratov, Russian Federation|Clinical Hospital Center Zemun, Belgrade, Serbia|University Hospital Medical Center Bezanijska kosa, Belgrade, Serbia|Clinical Center of Serbia, Belgrade, Serbia|Zvezdara University Medical Center, Belgrade, Serbia|Clinical Center of Vojvodina, Novi Sad, Serbia|National University Hospital, Singapore, Singapore|Singapore General Hospital, Singapore, Singapore|Tan Tock Seng Hospital, Singapore, Singapore|Changi General Hospital, Singapore, Singapore|Cliniq s. r. o., Gastroenterologicke centrum Ruzinov, Bratislava, Slovakia|KM Management, s.r.o., Gastroenterologicke a hepatologicke centrum Nitra, Nitra, Slovakia|Gastro I., s.r.o., Presov, Slovakia|Dr MJ Prins, Cape Town, South Africa|Dr John P Wright, Cape Town, South Africa|Peermed Clinical Trial Centre, Johannesburg, South Africa|Hospital Universitari Germans Trias i Pujol, Badalona, Spain|Centro Medico Teknon, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain|Hospital Universitario de Gran Canaria ""Dr. Negrin"", Las Palmas de Gran Canaria, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Universitario de Fuenlabrada, Madrid, Spain|Hospital Universitario Central de Asturias, Oviedo, Spain|Hospital de Montecelo, Pontevedra, Spain|Hospital de Sagunto, Sagunto, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Hospital de Galdakao-Usandolo, Usansolo, Spain|National Hospital of Sri Lanka, Colombo, Sri Lanka|Karapitiya Teaching Hospital, Galle, Sri Lanka|Kandy Teaching Hospital, Kandy, Sri Lanka|Colombo North Teaching Hospital, Ragama, Sri Lanka|Danderyds Sjukhus AB, Danderyd, Sweden|Akademiska Sjukhuset, Uppsala, Sweden|Gastroenterologische Praxis Balsiger, Seibold und Partner, Bern, Switzerland|Universitätsspital Zürich, Zurich, Switzerland|Changhua Christian Hospital, Changhua, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan|Far Eastern Memorial Hospital, New Taipei City, Taiwan|Chang Shan Medical University Hospital, Taichung, Taiwan|China Medical University Hospital, Taichung, Taiwan|National Cheng Kung University Hospital, Tainan City, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Mackay Memorial Hospital, Taipei, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Tri-Service General Hospital, Taipei, Taiwan|Chang Gung Medical Foundation, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan|Municipal City Clinical Hospital of the Emergency Medical Care, 1 st Therapy Department. Danylo Halytsky Lviv National Medical, Chernivtsi, Ukraine|Regional Municipal Institution ""Chernivtsi Regional Clinical Hospital"", Surgical Department, Chernivtsi, Ukraine|State Institution ""Institute of Gastroenterology of National Academy of Medical Sciences of Ukraine"", Dnipropetrovsk, Ukraine|Ivanto-Frankivsk Central City Clinic Hospital, Therapy Department #1. State Higher Education Institution Ivano-Frankivsk National, Ivano-Frankivsk, Ukraine|Municipal Health Care Institution ""Kharkiv City Clinical Hospital #2 named after prof. O. O. Shalimov"", Proctology Department, Kharkiv, Ukraine|Municipal Institution of Health Care ""Regional Hospital of War Veterans"", Therapeutic Department No1, Kharkiv, Ukraine|Treatment and Diagnostic Center of Private Enterprise of Private Production Company ""Acinus"", Kropyvnytskyi, Ukraine|Kyiv City Clinical Hospital No. 18, Proctology Department, Kyiv, Ukraine|Municipal Non-profit Enterprise ""Consultative and Diagnostic Center"" of Pechersk District of Kyiv, Therapy Department, Kyiv, Ukraine|Municipal Institution ""Odesa Regional Clinical Hospital"", Regional Gastroenterology Center based on Surgery Department, Odessa, Ukraine|Ternopil University Hospital, Regional Center of Gastroenterology with Hepatology, Ternopil, Ukraine|Municipal Institution ""Uzhgorod District Hospital"", Therapy Department, Uzhgorod, Ukraine|Vinnytsia Regional Clinical Hospital of War Veterans, Therapy Department #1, Vinnytsia, Ukraine|M.I. Pyrogov Vinnytsia Regional Clinical Hospital, Gastroenterology Department, Vinnytsia, Ukraine|Medical Center LLC ""Health Clinic"", Vinnytsia, Ukraine|Municipal Institution ""Zaporizhzhya Regional Clinical Hospital"" of Zaporizhzhya Regional Council, Zaporizhzhya, Ukraine|Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, Norfolk, United Kingdom|Queen Elizabeth Hospital, Birmingham, United Kingdom|The Pennine Acute Hospitals NHS Trust, Bury, United Kingdom|Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom|NHS Lothian, Edinburgh, United Kingdom|Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom|Glasgow Clinical Research Facility - Queen Elizabeth University Hospital, Glasgow, United Kingdom|NHS Greater Glasgow and Clyde, Glasgow, United Kingdom|Wycombe Hospital, High Wycombe, United Kingdom|St George's University Hospitals NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, St Mary's Hospital, London, United Kingdom|Oxford University Hospitals NHS Trust, Oxford, United Kingdom|St Helens and Knowsley Teaching Hospitals NHS Trust, Prescot, United Kingdom|Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility, Southampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02914600"
639,"NCT02914561","Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease","DIVERSITY1","Recruiting","No Results Available","Crohn's Disease","Drug: Filgotinib|Drug: Placebo to match filgotinib","Induction Study: Proportion of Participants Achieving Clinical Remission by Crohn's Disease Activity Index (CDAI) at Week 10|Induction Study: Proportion of Participants Achieving Endoscopic Response at Week 10|Maintenance Study: Proportion of Participants Achieving Clinical Remission by CDAI at Week 58|Maintenance Study: Proportion of Participants Achieving Endoscopic Response at Week 58|Induction Study: Proportion of Participants Achieving Clinical Remission by Patient Reported Outcomes (PRO2) at Week 10|Induction Study: Proportion of Participants Achieving Clinical Response by CDAI at Week 10|Induction Study: Pharmacokinetic Concentrations of Filgotinib and its Metabolite GS-829845|Maintenance Study: Proportion of Participants Achieving Clinical Remission by PRO2 at Week 58|Maintenance Study: Proportion of Participants Achieving Clinical Response by CDAI at Week 58|Maintenance Study: Proportion of Participants Achieving Sustained Clinical Remission by CDAI|Maintenance Study: Proportion of Participants Achieving 6 Month Corticosteroid-Free Remission by CDAI at Week 58|Maintenance Study: Proportion of Participants Achieving Sustained Clinical Remission by PRO2|Maintenance Study: Proportion of Participants Achieving 6 Month Corticosteroid-Free Remission by PRO2 at Week 58|Maintenance Study: Pharmacokinetic Plasma Concentrations of Filgotinib and its Metabolite GS-829845","Gilead Sciences|Galapagos NV","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 3","1320","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","GS-US-419-3895|2016-001367-36","October 31, 2016","November 2022","December 2022","September 26, 2016",,"June 23, 2021","Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|Mayo Clinic Arizona, Scottsdale, Arizona, United States|Arizona Digestive Health - Sun City, Sun City, Arizona, United States|VVCRD Research, Garden Grove, California, United States|UC San Diego Health System, La Jolla, California, United States|VA Long Beach Healthcare System, Long Beach, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Naval Medical Center San Diego, San Diego, California, United States|Kaiser Permanente, San Francisco, California, United States|Clearview Medical Research, LLC, Santa Clarita, California, United States|University of Colorado Denver and Hospital, Aurora, Colorado, United States|South Denver Gastroenterology, PC, Lone Tree, Colorado, United States|Connecticut GI, PC-Research Division, Farmington, Connecticut, United States|Medstar Georgetown University Hospital (Patient Exams), Washington, District of Columbia, United States|Advanced Research, LLC, Coral Springs, Florida, United States|UF Clinical Research Center, Gainesville, Florida, United States|Florida Research Institute, Lakewood Ranch, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|Ocean Blue Medical Research Center, Inc.,, Miami Springs, Florida, United States|University of Miami Crohn's and Colitis Center, Miami, Florida, United States|Advanced Pharma CR, Miami, Florida, United States|Cordova Research Institute, Miami, Florida, United States|Vista Health Research, LLC, Miami, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|Center for Interventional Endoscopy - AdventHealth Orlando, Orlando, Florida, United States|Gulf Region Clinical Research Institute, Pensacola, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Shafran Gastroenterology Center, Winter Park, Florida, United States|Florida Medical Clinic, P.A., Zephyrhills, Florida, United States|Gastroenterology Associates of Central Georgia, LLC, Macon, Georgia, United States|Gastrointestinal Specialists of Georgia, Marietta, Georgia, United States|Atlanta Gastroenterology Specialist, PC, Suwanee, Georgia, United States|Illinois Gastroenterology Group - Arlington Heights, Arlington Heights, Illinois, United States|Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States|University of Chicago Medical Center, Chicago, Illinois, United States|Illinois Gastroenterology Group - Gurnee, Gurnee, Illinois, United States|Indiana University Health University Hospital, Indianapolis, Indiana, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|University of Louisville, School of Medicine, Louisville, Kentucky, United States|Delta Research Partners, LLC, Monroe, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Investigative Clinical Research, Annapolis, Maryland, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|MGG Group Co., Inc., Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Gastro Center of Maryland, Columbia, Maryland, United States|Meritus Center for Clinical Research, Hagerstown, Maryland, United States|Massachusetts General Hospital - Crohn's and Colitis Center, Boston, Massachusetts, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Center for Digestive Health, Troy, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Kansas City Research Institute, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|AGA Clinical Research Associates, LLC, Egg Harbor Township, New Jersey, United States|NY Scientific, Brooklyn, New York, United States|North Shore University Hospital, Great Neck, New York, United States|NYU Langone Long Island Clinical Research Associates, Great Neck, New York, United States|New York University School of Medicine/NYU Gastroenterology Associates, New York, New York, United States|Lenox Hill Hospital, New York, New York, United States|Premier Medical Group of the Hudson Valley, Poughkeepsie, New York, United States|Charlotte Gastroenterology & Hepatology, PLLC, Charlotte, North Carolina, United States|Carolina's GI Research, LLC, Raleigh, North Carolina, United States|Fargo Gastroenterology and Hepatology Clinic, Fargo, North Dakota, United States|Consultants for Clinical Research, Cincinnati, Ohio, United States|UC Health Physicians Clifton, Cincinnati, Ohio, United States|Great Lakes Gastroenterology Research, LLC,, Mentor, Ohio, United States|Paramount Medical Research & Consulting, LLC, Middleburg Heights, Ohio, United States|Options Health Research LLC, Tulsa, Oklahoma, United States|Great Lakes Medical Research, LLC, Harrisburg, Pennsylvania, United States|Gastroenterology Associates of Orangeburg, Orangeburg, South Carolina, United States|WR-ClinSearch, LLC, Chattanooga, Tennessee, United States|Gastro One, Germantown, Tennessee, United States|Quality Medical Research, Nashville, Tennessee, United States|Vanderbilt University Medical Center - IBD Clinic, Nashville, Tennessee, United States|Texas Clinical Research Institute, Arlington, Texas, United States|Pinnacle Clinical Research, Austin, Texas, United States|Austin Diagnostic Clinic, Austin, Texas, United States|Inquest Clinical Research, Baytown, Texas, United States|San Antonio Military Medical Center, Fort Sam Houston, Texas, United States|DHAT Research Institute, Garland, Texas, United States|Kelsey-Seybold Clinic, Houston, Texas, United States|Baylor College of Medicine- Baylor Medical Center, Houston, Texas, United States|The Methodist Hospital, Houston, Texas, United States|The University of Texas Health Science Center at Houston, Houston, Texas, United States|Centex Studies, Inc., Houston, Texas, United States|Gulf Coast Research Group, Houston, Texas, United States|Clinical Associates in Research Therapeutics of America, LLC, San Antonio, Texas, United States|Gastroenterology Research of San Antonio, San Antonio, Texas, United States|Pinnacle Clinical Research, San Antonio, Texas, United States|TDDC San Marcos, San Marcos, Texas, United States|Texas Digestive Disease Consultants (IP Shipment), Southlake, Texas, United States|Spring Gastroenterology, The Woodlands, Texas, United States|HP Clinical Research, Bountiful, Utah, United States|Synexus Clinical Research US, Inc./Wasatch Peak Family Practice, Layton, Utah, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Charlottesville Medical Research Center, LLC, Charlottesville, Virginia, United States|Gastroenterology Associates of Tidewater, Chesapeake, Virginia, United States|Emeritas Research Group LLC, Leesburg, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|McGuire DVAMC, GI (111N), Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|University of Wisconsin Hospital & Clinics, Madison, Wisconsin, United States|Wisconsin Center for Advanced Research, a division of GI Associates, LLC, Milwaukee, Wisconsin, United States|Fundacion Estudios Clinicos CiRec, Rosario, Argentina|The Canberra Hospital, Garran, Australian Capital Territory, Australia|Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|Monash Medical Centre, Clayton, New South Wales, Australia|St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|Wollongong Hospital, Wollongong, New South Wales, Australia|Coastal Digestive Health, Mountain Creek, Queensland, Australia|Coral Sea Clinical Research Institute (Mackay), North Mackay, Queensland, Australia|Coral Sea Clinical Research Institute (Mackay), North Mackay, Queensland, Australia|Mater Misericordiae Ltd, South Brisbane, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|The Queen Elizabeth Hospital, Woodville South, South Australia, Australia|Emeritus Research, Camberwell, Victoria, Australia|Footscray Hospital, Footscray, Victoria, Australia|Austin Health, Heidelberg, Victoria, Australia|Cabrini Hospital, Malvern, Victoria, Australia|Alfred Hospital, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|Universitatsklinik Innsbruck, Innsbruck, Austria|AKH-Medizinische Universitat Wien, Wien, Austria|GZA Ziekenhuizen campus Sint-Vincentius, Antwerpen, Belgium|Imelda General Hospital, Bonheiden, Belgium|CUB Hopital Erasme, Brussel, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|Universitair Ziekenhuis Leuven, Leuven, Belgium|CHR Citadelle, Liege, Belgium|Centre Hospitalier Chretien (CHC) - Clinique Saint-Joseph, Liège, Belgium|AZ Delta Campus Wilgenstraat, Roeselare, Belgium|Medical Center - Complete Medical Solutions OOD, Samokov, Bulgaria|Medical Center - ""Tsaritsa Yoanna"" EOOD, Sliven, Bulgaria|""MDHAT Dr. St.Cherkezov"" AD, Veliko Tarnovo, Bulgaria|MHAT ""Sveta Petka"" AD, Vidin, Bulgaria|Barrie GI Associates, Barrie, Canada|University of Calgary, Heritage Medical Research Clinic, Calgary, Canada|Hamilton Health Sciences Corporation, McMaster University Medical Centre, Hamilton, Canada|London Health Sciences Centre - University Hospital, London, Canada|TIDHI Innovation Inc., North York, Canada|ABP Research Services, Oakville, Canada|Royal University Hospital, Saskatoon, Canada|The Gordon and Leslie Diamond Health Care Centre, Vancouver, Canada|Toronto Digestive Disease Associates Inc., Vaughan, Canada|Percuro Clinical Research Ltd., Victoria, Canada|University Hospital Center Osijek, Osijek, Croatia|Clinical Hospital Dubrava, Zagreb, Croatia|Clinical Hospital Merkur, Zagreb, Croatia|University Hospital Center Zagreb, Zagreb, Croatia|Hepato-Gastroenterologie HK, s.r.o., Hradec Kralove, Czechia|Oblastni nemocnice Mlada Boleslav, a.s., nemocnice Stredoceskeho kraje, Gastroenterologicke oddeleni, Mlada Boleslav, Czechia|G.E.P. Clinic, s r.o., Praha 3, Czechia|Thomayerova nemocnice, Interni klinika 3. LF UK a TN (Interni Oddeleni), Praha 4, Czechia|ISCARE a.s. (Klinicke centrum ISCARE), Klinicke a vyzkumne centrum pro strevni zanety, Praha 9, Czechia|CHU Amiens Picardie, Amiens Cedex 1, France|CHU de Caen, Caen Cedex 9, France|CHU de Clermont-Ferrand - Hopital d'Estaing, Clermont-Ferrand, France|APHP - Hopital Beaujon - Clichy - Universite Paris VII, Clichy, France|Centre Hospitalier Intercommunal de Creteil, Créteil, France|CHU de Dijon Bourgogne - Hopital Francois Mitterand, Dijon, France|CHU Grenoble Alpes, La Tronche, France|Hopital Universitaire de Bicetre, Le Kremlin Bicetre, France|Centre Hospitalier Regional Universitaire de Lille, Lille, France|Hopital Nord, Marseille, France|Hopital Saint Joseph, Marseille, France|CHU de Montpellier-Hopital Saint Eloi, Montpellier, France|Centre d'Investigation Clinique - CHU Hotel-Dieu, Nantes, France|Hopital de l'Archet 2, Nice, France|CHU de Bordeaux - Hopital Haut Leveque, Pessac, France|Centre Hospitalier Universitaire de Lyon Sud, Pierre-Benite, France|CH Annecy Genevois - Site d'Annecy, Pringy Cedex, France|Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes Cedex 9, France|CHU de Saint-Etienne - Hopital Nord, Saint Priest en Jarez, France|Nouvel Hopital Civil, Strasbourg, France|Hopitaux Universitaires de Strasbourg - Hopital de Hautepierre, Strasbourg, France|CHU de Toulouse - Hopital Rangueil, Toulouse Cedex 9, France|CHU de Toulouse - Hopital Rangueil, Toulouse, France|CHU de Nancy - Hopital Brabois Adultes, Vandoeuvre-les-Nancy Cedex, France|Unimed Ajara LLC - Batumi Referral Hospital, Batumi, Georgia|Medi Club Georgia LLC, Tbilisi, Georgia|Ltd. Unimed Kakheti - Telavi Referral Hospital, Telavi, Georgia|Charite Universitaetsmedizin Berlin, Berlin, Germany|Gastro-Studien, Berlin, Germany|Charite - Universitatsmedizin Berlin, Berlin, Germany|DRK Kliniken Berlin - Westend - Klinik fuer Innere Medizin, Berlin, Germany|Stadtisches Klinikum Braunschweig gGmbH, Braunschweig, Germany|Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany|CED Studien UG, Interdisciplinary Crohn Colitis Center (iCCC) Rhein-Main, Frankfurt am Main, Germany|Universitatsklinikum Freiburg, Freiburg, Germany|Asklepios Westklinikum Hamburg, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitatsklinikum Heidelberg, Heidelberg, Germany|Praxis fur Gastroenterologie, Heidelberg, Germany|Gastroenterologische Gemeinschaftspraxis Herne, Herne, Germany|Universitatsklinikum Jena, Jena, Germany|Universitatsklinikum Schleswig-Holstein, Kiel, Germany|Universitatsklinik Koln, Koln, Germany|EUGASTRO GmbH, Leipzig, Germany|Universitatsklinikum Leipzig, Leipzig, Germany|Klinikum Luneburg, Lüneburg, Germany|Gastroenterologische Gemeinschaftspraxis, Mainz, Germany|Gastroenterologische Gemeinschaftspraxis Minden, Minden, Germany|Klinikum der Universitat Munchen - Grosshadern, Muenchen, Germany|Megan-Darm-Zentrum Remscheid, Praxis fuer Gastroenterologie und Hepatologie, Remscheid, Germany|Universitaetsmedizin Rostock, Zentrum fuer Innere Medizin, Rostock, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Germany|Universitatsklinikum Ulm, Zentrum Fur Innere Medizin, Ulm, Germany|General Hospital of Athens ""Hippokratio"", 2nd Internal Medicine Clinic of Athens University, Hepato-gastroenterology Unit, Athens, Greece|University General Hospital ""Attikon"", 2nd Propaedeutic Internal Medicine Dept. and Research Unit, Hepatogastroenterology Unit, Athens, Greece|University General Hospital of Ioannina, Gastroenterology Department, Internal Medicine Division, Ioannina, Greece|University General Hospital of Patras ""Panagia I Voithia"", Gastroenterology Department, Internal Medicine Division, Patras, Greece|General Hospital of Thessaloniki ""Hippokratio"", 4th Internal Medicine Department of Aristotle University of Thessaloniki, Thessaloniki, Greece|Princess Margaret Hospital, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong|Tuen Mun Hospital, Tuen Mun, Hong Kong|Bekes Megyei Kosponti Korhaz, Dr. Rethy Pal Tagkorhaz, IV. Belgyogyaszat - 2. Gasztroenterologia, Bekescsaba, Hungary|Szent Margit Korhaz, Gasztroenterológiai Osztály, Budapest, Hungary|Clinexpert Egeszsegugyi Szolgaltato es Kereskedelmi Kft., Budapest, Hungary|Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Kozponti Felnott Szakrendelo, Budapest, Hungary|Szent Janos Korhaz es Eszak-budai Egitett Korhazak, I. Belgyogyaszati - Gasztroenterologiai Osztaly, Budapest, Hungary|Debreceni Egyetem Klinikai Kozpont, II. sz. Belgyogyaszati Klinika, Gasztroenterologia, Debrecen, Hungary|Bugat Pal Korhaz, Belgyogyaszat, Gyöngyös, Hungary|Karolina Korhaz es Rendelointezet, Altalanos Belgyogyaszat-Gasztroenterologia, Mosonmagyarovar, Hungary|Landspitali University Hospital, Reykjavik, Iceland|Kaizen Hospital, Ahmedabad, India|Gastroplus Digestive Disease Centre Pvt Ltd, Ahmedabad, India|Sal Hospital and Medical Institute, Ahmedabad, India|Victoria Hospital, Bangalore Medical College and Research Institute, Bangalore, India|M S Ramaiah Medical College and Hospital, Bangalore, India|KLES Dr. Prabhakar Kore Hospital & MRC, Belgaum, India|Apollo Speciality Hospital, Chennai, India|VGM Hospital Institute of Gastroenterology, Coimbatore, India|Maharaja Agrasen Hospital, Delhi, India|Lourdes Hospital, Ernakulam, India|PVS Memorial Hospital Private Limited, Ernakulam, India|Fortis Medical Research Institute, Gurgaon, India|Institute of Digestive & Liver Diseases, Guwahati, India|Gleneagles Global Hospitals, Hyderabad, India|Citizens Specialty Hospital, Hyderabad, India|Aware Gleneagles Global Hospitals, Hyderabad, India|Centre for Liver Research & Diagnostics, Hyderabad, India|Asian Institute of Gastroenterology Pvt Ltd, Hyderabad, India|S.R.Kalla Memorial Gastro.&General Hospital, Jaipur, India|S.M.S Medical College & Hospitals, Jaipur, India|GSVM Medical College, Kanpur, India|BGS Global Hospital, Kengeri Bengaluru, India|Lakeshore Hospital and Research Centre Ltd., Kochi, India|Amrita Institute of Medical Sciences and Research Centre, Kochi, India|School of Digestive & Liver Diseases, Kolkata, India|Apollo Gleneagles Hospitals, Kolkata, India|King George's Medical University, Lucknow, India|Dayanand Medical College & Hospital, Ludhiana, India|Kasturba Medical College (KMC) Hospital, Mangaluru, India|Seth G.S Medical College & KEM Hospital, Mumbai, India|Lokmanya Tilak Municipal General Hospital, Mumbai, India|Midas Multispeciality Hospital Pvt. Ltd, Nagpur, India|Suretech Hospital & Research Centre Ltd, Nagpur, India|Max Smart Super Speciality Hospital, New Delhi, India|All India Institute of Medical Sciences, New Delhi, India|Dr. B.L. Kapur Memorial Hospital, New Delhi, India|Fortis Flt. Lt. Rajan Dhall Hospital, New Delhi, India|S.L Raheja Hospital, Parel, India|Department of Surgery, B.J. Government Medical College & Sassoon General Hospital, Pune, India|Grant Medical Foundation Ruby Hall Clinic, Pune, India|Universal Hospital, Pune, India|S.P. Medical College & AG of Hospitals, Rajasthan, India|Shree Giriraj Multispeciality Hospital, Rajkot, India|Gandhi Hospital, Secunderabad, India|Institute of Gastroenterology & Liver Disease. Sunshine Hospitals, Secunderabad, India|Surat Institute of Digestive Sciences, Surat, India|BAPS Pramukh Swami Hospital, Surat, India|Kasturba Hospital Medical College, Udupi, India|Sterling Hospital, Vadodara, India|Samvedna Hospital, Varanasi, India|St. Vincent's University Hospital, Dublin, Ireland|Clinical Research Centre, Mater Misericordiae University Hospital, Dublin, Ireland|Beaumont Hospital, Dublin, Ireland|Wellcome Trust HRB Clinical Research Facility, Dublin, Ireland|University Hospital Galway, Galway, Ireland|Emek Medical Center, Afula, Israel|Soroka Medical Center, Be'er Sheva, Israel|Bnai Zion Medical Center, Haifa, Israel|Rambam Health Care Campus, Haifa, Israel|The Lady Davis Carmel Medical Center, Haifa, Israel|The Edith Wolfson Medical Center, Holon, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah Medical Center, Jerusalem, Israel|Meir Medical Center, Kefar Sava, Israel|Rabin Medical Center, Petah Tikva, Israel|The Chaim Sheba Medical Center, Ramat Gan, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel|UOC Gastroenterologia II, Castellana Grotte, Italy|U.O. Fisiopatologia Digestiva, Catanzaro, Italy|UOC Medicina Interna, Cento, Italy|Ospedale Clinicizzato SS. Annunziata - Dipartimento di Medicina, Chieti, Italy|Gastroenterologia clinica - Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy|Endoscopia Digestiva Centralizzata, Milano, Italy|UO Gastroenterologia, Modena, Italy|UOC Gastroenterologia, Padova, Italy|Azienda Ospedaliero-Universitaria Pisana - Presidio Ospedaliero Cisanello, Pisa, Italy|UOC di Gastroenterologia ed Endoscopia Digestiva, Roma, Italy|UOC Gastroenterologia ed Endoscopia Digestiva, Roma, Italy|Istituto Clinico Humanitas, Rozzano, Italy|A.O. Ordine Mauriziano di Torino, Torino, Italy|Ohmori Toshihide gastro-intestinal Clinic, Ageo-shi, Japan|Medical Hospital, Tokyo Medical and Dental University, Bunkyo-ku, Japan|Hokkaido P.W.F.A.C Sapporo-Kosei General Hospital, Chuo-ku, Japan|Japanese Red Cross Fukuoka Hospital, Fukuoka-shi, Japan|Tokai University Hachioji Hospital, Hachioji, Japan|Medical corporation Ryowakai, Hamamatsu South Hospital, Hamamatsu-shi, Japan|Hiroshima Prefectural Hospital, Hiroshima-shi, Japan|Hiroshima University Hospital, Hiroshima, Japan|Fukuoka University Hospital, Jonan-ku, Japan|Nanpuh Hospital, Kagoshima-shi, Japan|Ofuna Chuo Hospital, Kamakura, Japan|Tsujinaka Hospital, Kashiwa-city, Japan|Saitama Medical Center, Saitama Medical University, Kawagoe, Japan|Kitakyushu City Hospital Organization Kitakyushu Municipal Medical Center, Kitakyushu-shi, Japan|Yamanashi Prefectural Central Hospital, Kofu-shi, Japan|Kurume University Hospital, Kurume-shi, Japan|Hidaka Coloproctology Clinic, Kurume-shi, Japan|University Hospital, Kyoto Prefectural University of Medicine, Kyoto-shi, Japan|The Jikei University Hospital, Minato-ku, Japan|Kitasato University Kitasato Institute Hospital, Minato-ku, Japan|Kyorin University Hospital, Mitaka-shi, Japan|Iwate Medical University Hospital, Morioka-shi, Japan|Aichi Medical University Hospital, Nagakute-shi, Japan|Nagasaki University Hospital, Nagasaki-shi, Japan|Nagoya City University Hospital, Nagoya, Japan|Saiseikai Niigata Daini Hospital, Nishi-ku, Japan|Hyogo College of Medicine College Hospital, Nishinomiya, Japan|Ishida IBD Clinic, Oita-shi, Japan|Okayama University Hospital, Okayama-city, Japan|Kinshukai Infusion Clinic, Osaka-City, Japan|Osaka City University Hospital, Osaka, Japan|Wakakusa-Daiichi Hospital, Osaka, Japan|Shiga University of Medical Science Hospital, Otsu, Japan|Saga-Ken Medical Centre Koseikan, Saga-shi, Japan|Kitasato University Hospital, THE KITASATO INSTITUTE, Sagamihara, Japan|Saga University Hospital, Saga, Japan|Tokito Clinic, Saitama, Japan|Toho University Sakura Medical Center, Sakura, Japan|Sapporo Higashi Tokushukai Hospital, Sapporo-shi, Japan|Sapporo Tokushukai Hospital, Sapporo, Japan|National Hospital Organization Sendai Medical Center, Sendai, Japan|NTT Medical Center Tokyo, Shinagawa, Japan|Tokyo Yamate Medical Center, Shinjuku-ku, Japan|Osaka University Hospital, Suita, Japan|Kagawa Prefectural Central Hospital, Takamatsu-shi, Japan|National Hospital Organization Takasaki General Medical Center, Takasaki-shi, Japan|Osaka Medical College Hospital, Takatsuki, Japan|Ieda Hospital, Toyota-shi, Japan|Wakayama Medical University Hospital, Wakayama-shi, Japan|Yokohama Health Medicine Association Kannai Suzuki Clinic, Yokohama-shi, Japan|Pusan National University Hospital, Busan, Korea, Republic of|Yeungnam University Hospital, Daegu, Korea, Republic of|Kyung Hee University Hospital, Guri-Si, Korea, Republic of|Hanyang University Guri Hospital, Gyeonggi-do, Korea, Republic of|CHA Bundang Medical Center, CHA University, Seongnam-si, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Seoul, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital, Suwon-si, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wonju, Korea, Republic of|Hospital Selayang, Batu Caves, Malaysia|Universiti Kebangsaan Malaysia Medical Center, Cheras, Malaysia|Hospital Pulau Pinang, George Town, Malaysia|Hospital Sultanah Aminah, Johor Bahru, Malaysia|Hospital Queen Elizabeth, Kota Kinabalu, Malaysia|University Malaya Medical Centre, Kuala Lumpur, Malaysia|Hospital Tengku Ampuan Afzan, Kuantan, Malaysia|PCR-Phylasis Clinicas Research S. de R.L. de C.V., Cuautitlán Izcalli, Mexico|NZW Alkmaar (Noordwest Ziekenhuisgroep), Alkmaar, Netherlands|VU University Medical Centre, Amsterdam, Netherlands|Academic Medical Center (AMC), Amsterdam, Netherlands|Gelre Hospital, Apeldoorn, Netherlands|University Medical Center Groningen (UMCG), Groningen, Netherlands|Maastricht University Medical Centre, Maastricht, Netherlands|Erasmus University Medical Center, Rotterdam, Netherlands|Elisabeth-TweeSteden Hospital, Tilburg, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands|Christchurch Hospital, Christchurch, New Zealand|Southern District Health Board - Dunedin Hospital, Dunedin, New Zealand|Auckland City Hospital, Grafton, New Zealand|Waikato Hospital, Hamilton, New Zealand|Wellington Hospital, Newtown, New Zealand|Bay of Plenty District Health Board - Tauranga Hospital, Tauranga, New Zealand|Hutt Valley District Health Board - Hutt Valley Hospital, Wellington, New Zealand|Vestre Viken Hospital Trust, Baerum Hospital, Gjettum, Norway|Uniwersytecki Szpital Kliniczny w Bialymstoku, Klinika Gastroenterologii i Chorob Wewnetrznych, Bialystok, Poland|VITAMED Galaj i Cichomski spolka jawna, Bydgoszcz, Poland|Szpital Uniwersytecki nr 2 im. Dr. Jana Biziela w Bydgoszczy, Centrum Endoskopii Zabiegowej, Poradnia Chorob Jelitowych, Bydgoszcz, Poland|Gabinet Lekarski Janusz Rudzinski, Bydgoszcz, Poland|NZOZ INTER-MED, Centrum Endoskopowe, Czestochowa, Poland|Niepubliczny Zaklad Opieki Zdrowotnej ALL-MEDICUS, Katowice, Poland|Uniwersyteckie Centrum Kliniczne im. prof. Gibinskiego Slaskiego Uniwestytetu Medyznego w Katowicach, Katowice, Poland|Gabinet Endoskopii Przewodu Pokarmowego, Krakow, Poland|Centrum Medyczno-Diagnostyczne Prima-Med, Kraków, Poland|Krakowskie Centrum Medyczne Sp. z o.o., Kraków, Poland|Samodzielny Publiczny Zaklad Opieki Zdrowotnej Uniwerstyeckiego Szpitala Klinicznego nr 1 im. Norbert Barlickiego, Lodz, Poland|Trialmed Crs, Piotrków Trybunalski, Poland|Clinical Research Center Spolka z ograniczna odpowiedzialnoscia Medic-R Sp. k., Poznan, Poland|Gabinet Lekarski Dr. Hab. N. Med. Bartosz Korczowski, Rzeszów, Poland|Endoskopia Sp. Z o.o., Sopot, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|GASTROMED Kopon, Zmudzkinski i Wspolnicy Sp. j. Specjalistyczne Centrum Gastrologii i Endoskopii, Torun, Poland|H-T.Centrum Medyczne Spolka z Ograniczona Odpowiedzialnoscia Sp.K., Tychy, Poland|Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland|Centrum Zdrowia MDM, Warszawa, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych i Administacji w Warszawie, Warszawa, Poland|Medical Concierge Centrum Medyczne, Warszawa, Poland|Niepubliczny Zaklad Opieki Zrodotnej VIVAMED Jadwige Miecz, Warszawa, Poland|Bodyclinic, Warszawa, Poland|Centrum Medyczne Oporow, Wroclaw, Poland|Centrum Medyczne, Wroclaw, Poland|Hospital de Braga, Braga, Portugal|Centro Hospitalar e Universitario de Coimbra, E.P.E., Coimbra, Portugal|Centro Hospitalar Cova de Beira, EPE, Covilhã, Portugal|Centro Hospitalar do Algarve EPE, Faro, Portugal|Hospital da Senhora da Oliveira Guimaraes, E.P.E., Guimaraes, Portugal|Hospital Beatriz Angelo, Loures, Portugal|Centro Hospitalar de Sao Joao, EPE, Porto, Portugal|Unidade Local de Saude do Alto Minho, EPE, Viana do Castelo, Portugal|S.C. Centrul Medical Sana S.R.L., Gastroenterologie, Bucharest, Romania|Spitalul Universitar de Urgenta Bucuresti - Sectia Medicina Interna II, Bucharest, Romania|SC MedLife SA, Gastroenterologie, Bucuresti, Romania|Spitalul Universitar de Urgenta Militar Central Dr. Carol Davila - Sectia Clinica de Gastroenterologie, Bucuresti, Romania|Delta Health Care/ Ponderas Academic Hospital, Bucuresti, Romania|Spitalul Clinic Colentina, Gastroenterologie, Bucuresti, Romania|MedLife, Gastroenterologie, Bucuresti, Romania|Gastromedica SRL, Gastroenterologie, Iasi, Romania|Cabinet Particular Policlinic Algomed SRL, Timisoara, Romania|Centrul Medical Tuculanu, Gastroenterologie, Timisoara, Romania|S.C. Policlinica Dr. Citu S.R.L.- Gastroenterologie, Timisoara, Romania|State Budgetary Healthcare Institute ""Chelyabinsk Regional Clinical Hospital"", Chelyabinsk, Russian Federation|State Budgetary Institution of Health Irkustsk Order ""Badge of Honor"" Regional Clinical Hospital, Irkutsk, Russian Federation|State Autonomous Institution of Health ""Republican Clinical Hospital"" of Ministry of Health of the Tatarstan Republic, Kazan, Russian Federation|Federal State Budgetary Healthcare Institution Central Clinical Hospital of the Russian Academy of Sciences, Moscow, Russian Federation|State Budgetary Healthcare Institution of Moscow ""City Clinical Hospital # 24 of Healthcare Department of Moscow"", Moscow, Russian Federation|State Budgetary Healthcare Institution of Moscow Region ""Moscow Regional Clinical Research Institute n.a. M.F. Vladimirskiy"", Moscow, Russian Federation|State Budgetary Healthcare Institution of Nizhny Novgorod Region ""Nizhny Novgorod Regional Clinical Hospital n.a. N.A., Nizhniy Novgorod, Russian Federation|State Budgetary Healthcare Institution of the Novosibirsk Region ""State Novosibirsk Regional Clinical Hospital"", Novosibirsk, Russian Federation|State Budgetary Institution of Health of Novosibirsk Region ""City Clinical Hospital #12"", Novosibirsk, Russian Federation|Saint Petersburg State Budgetary Healthcare Institution ""City Polyclinic #38"", Saint-Petersburg, Russian Federation|""Scientific Research Centre ECO-safety"" LLC, Saint-Petersburg, Russian Federation|""PolyClinic EXPERT"" LLC, Saint-Petersburg, Russian Federation|State Healthcare Institution ""Regional Clinical Hospital"", Saratov, Russian Federation|Saint Petersburg State Budget Healthcare Institution ""City Hospital #26"", St. Petersburg, Russian Federation|Clinical Center of Serbia, Belgrade, Serbia|Clinical Hospital Center Zemun, Belgrade, Serbia|University Hospital Medical Center Bezanijska kosa, Belgrade, Serbia|Zvezdara University Medical Center, Belgrade, Serbia|Clinical Center of Vojvodina, Novi Sad, Serbia|National University Hospital, Singapore, Singapore|Singapore General Hospital, Singapore, Singapore|Tan Tock Seng Hospital, Singapore, Singapore|Changi General Hospital, Singapore, Singapore|Khoo Teck Puat Hospital, Singapore, Singapore|IBDcentrum, s.r.o., Bratislava, Slovakia|Cliniq s. r. o., Gastroenterologicke centrum Ruzinov, Bratislava, Slovakia|Cliniq s. r. o., Gastroenterologicke centrum Ruzinov, Bratislava, Slovakia|KM Management, s.r.o., Gastroenterologicke a hepatologicke centrum Nitra, Nitra, Slovakia|Gastro I., s.r.o., Presov, Slovakia|Dr MJ Prins, Cape Town, South Africa|Dr John P Wright, Cape Town, South Africa|Peermed Clinical Trial Centre, Johannesburg, South Africa|Hospital Universitari Germans Trias i Pujol, Badalona, Spain|Centro Medico Teknon, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain|Hospital Universitario de Gran Canaria ""Dr. Negrin"", Las Palmas de Gran Canaria, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Universitario de Fuenlabrada, Madrid, Spain|Hospital Universitario Central de Asturias, Oviedo, Spain|Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain|Hospital de Sagunto, Sagunto, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital de Galdakao-Usandolo, Usansolo, Spain|Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain|National Hospital of Sri Lanka, Colombo, Sri Lanka|Teaching hospital Karapitiya, Galle, Sri Lanka|Kandy Teaching Hospital, Kandy, Sri Lanka|Colombo North Teaching Hospital, Ragama, Sri Lanka|Danderyds Sjukhus AB, Danderyd, Sweden|Akademiska Sjukhuset, Uppsala, Sweden|Gastroenterologische Praxis Balsiger, Seibold und Partner, Bern, Switzerland|Universitatsspital Zurich, Zurich, Switzerland|Changhua Christian Hospital, Changhua, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan|Far Eastern Memorial Hospital, New Taipei City, Taiwan|Chang Shan Medical University Hospital, Taichung, Taiwan|China Medical University Hospital, Taichung, Taiwan|National Cheng Kung University Hospital, Tainan City, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Mackay Memorial Hospital, Taipei, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Tri-Service General Hospital, Taipei, Taiwan|Chang Gung Medical Foundation, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan|Municipal Institution ""Cherkasy Regional Hospital of Cherkasy Regional Council"", Gastroenterology Department, Cherkasy, Ukraine|Bukovinian State Medical University, Chernivtsi, Ukraine|Municipal City Clinical Hospital of the Emergency Medical Care, 1 st Therapy Department. Danylo Halytsky Lviv National Medical, Chernivtsi, Ukraine|State Institution ""Institute of Gastroenterology of National Academy of Medical Sciences of Ukraine"", Dnipropetrovsk, Ukraine|Ivanto-Frankivsk Central City Clinic Hospital, Therapy Department #1. State Higher Education Institution Ivano-Frankivsk National, Ivano-Frankivsk, Ukraine|Municipal Health Care Institution ""Kharkiv City Clinical Hospital #2 named after prof. O. O. Shalimov"", Proctology Department, Kharkiv, Ukraine|Municipal Institution of Health Care ""Regional Hospital of War Veterans"", Therapeutic Department No1, Kharkiv, Ukraine|Treatment and Diagnostic Center of Private Enterprise of Private Production Company ""Acinus"", Kropyvnytskyi, Ukraine|Kyiv City Clinical Hospital No. 18, Proctology Department, Kyiv, Ukraine|Municipal Non-profit Enterprise ""Consultative and Diagnostic Center"" of Pechersk District of Kyiv, Therapy Department, Kyiv, Ukraine|Municipal Institution ""Odesa Regional Clinical Hospital"", Regional Gastroenterology Center based on Surgery Department, Odessa, Ukraine|Ternopil University Hospital, Regional Center of Gastroenterology with Hepatology, Ternopil, Ukraine|Municipal Institution ""Uzhgorod District Hospital"", Therapy Department, Uzhgorod, Ukraine|Vinnytsia Regional Clinical Hospital of War Veterans, Therapy Department #1, Vinnytsia, Ukraine|Medical Center LLC ""Health Clinic"", Vinnytsia, Ukraine|M.I. Pyrogov Vinnytsia Regional Clinical Hospital, Gastroenterology Department, Vinnytsia, Ukraine|Municipal Institution ""Zaporizhzhya Regional Clinical Hospital"" of Zaporizhzhya Regional Council, Zaporizhzhya, Ukraine|Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, Norfolk, United Kingdom|Queen Elizabeth Hospital, Birmingham, United Kingdom|The Pennine Acute Hospitals NHS Trust, Bury, United Kingdom|Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom|University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom|Royal Derby Hospital, Derby, United Kingdom|NHS Lothian, Edinburgh, United Kingdom|Medical Outpatient Department, Exeter, United Kingdom|Glasgow Clinical Research Facility - Queen Elizabeth University Hospital, Glasgow, United Kingdom|NHS Greater Glasgow and Clyde, Glasgow, United Kingdom|Wycombe Hospital, High Wycombe, United Kingdom|Hull Royal Infirmary, Hull, United Kingdom|Imperial College Healthcare NHS Trust, St Mary's Hospital, London, United Kingdom|Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom|St Helens and Knowsley Teaching Hospitals NHS Trust, Prescot, United Kingdom|Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility, Southampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02914561"
640,"NCT02897661","Washed Microbiota Transplantation Improves Nutritional Status of Patients With Crohn's Disease",,"Recruiting","No Results Available","Crohn's Diseases","Procedure: WMT|Dietary Supplement: EEN","changes in hemoglobin|changes in albumin and prealbumin in g/L|changes in lymphocyte count in 10^9/L|rate of clinical remission","The Second Hospital of Nanjing Medical University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","NEU-CN-160814","August 2016","August 2020","December 2020","September 13, 2016",,"July 23, 2020","Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China",,"https://ClinicalTrials.gov/show/NCT02897661"
641,"NCT02877134","Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease","TRIDENT","Active, not recruiting","No Results Available","Crohn Disease","Drug: JNJ-64304500|Drug: Placebo|Drug: Ustekinumab","Part I: Change From Baseline in the Crohn's Disease Activity Index (CDAI) Score at Week 8|Part II: Change From Baseline in the Crohn's Disease Activity Index (CDAI) Score at Week 12|Part II: Clinical Remission at Week 12 as Measured by Crohn's Disease Activity Index (CDAI <150)|Part II: Clinical Response at Week 12 as Measured by CDAI (>=100-point reduction from baseline in CDAI or CDAI <150)|Part II: Change in Patient-Reported Outcome (PRO)-2 from baseline at Week 12|Part II: Clinical remission at Week 12 as measured by PRO-2 (PRO-2 <75)|Part II: Clinical response at Week 12 as measured by PRO-2 (>=50-point reduction from baseline in PRO-2 or PRO-2 <75)|Part II: Change in Simple Endoscopic Score for Crohn's Disease (SES-CD) from baseline at Week 12","Janssen Research & Development, LLC","All","18 Years and older   (Adult, Older Adult)","Phase 2","388","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","CR108136|64304500CRD2001|2016-000634-21","August 25, 2016","December 10, 2020","September 10, 2022","August 24, 2016",,"June 9, 2021","Lone Tree, Colorado, United States|Coral Gables, Florida, United States|Kissimmee, Florida, United States|Miami, Florida, United States|Miramar, Florida, United States|Orlando, Florida, United States|Winter Park, Florida, United States|Marietta, Georgia, United States|Chicago, Illinois, United States|Evanston, Illinois, United States|Indianapolis, Indiana, United States|Houma, Louisiana, United States|Lake Charles, Louisiana, United States|Shreveport, Louisiana, United States|Columbia, Maryland, United States|Morristown, New Jersey, United States|Brooklyn, New York, United States|Great Neck, New York, United States|New York, New York, United States|Rochester, New York, United States|Charlotte, North Carolina, United States|Raleigh, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Doylestown, Pennsylvania, United States|Columbia, South Carolina, United States|Greenville, South Carolina, United States|Nashville, Tennessee, United States|Dallas, Texas, United States|Houston, Texas, United States|Richardson, Texas, United States|San Antonio, Texas, United States|Southlake, Texas, United States|Tyler, Texas, United States|Salt Lake City, Utah, United States|Fairfax, Virginia, United States|Richmond, Virginia, United States|Seattle, Washington, United States|Bruxelles, Belgium|Gent, Belgium|Liège, Belgium|Sofia, Bulgaria|Brandon, Manitoba, Canada|London, Ontario, Canada|Amiens, France|Lille, France|Marseille, France|Paris, France|Pierre-Bénite, France|Saint-Etienne, France|Toulouse, France|Berlin, Germany|Essen, Germany|Hamburg, Germany|Hannover, Germany|Heidelberg, Germany|Kiel, Germany|Leipzig, Germany|Ludwigshafen, Germany|Luebeck, Germany|Lüneburg, Germany|Ulm, Germany|Budapest, Hungary|Debrecen, Hungary|Szekszárd, Hungary|Szombathely, Hungary|Asahikawa, Japan|Chikushino-shi, Japan|Fukushima, Japan|Gunma, Japan|Hamamatsu-Shi, Japan|Hirosaki, Japan|Hitachi, Japan|Hyôgo, Japan|Isehara, Japan|Kagoshima, Japan|Kahoku-gun, Japan|Kamakura, Japan|Kanagawa, Japan|Kanazawa, Japan|Kashiwa, Japan|Midori-ku, Japan|Minato-ku, Japan|Niigata, Japan|Okinawa, Japan|Osaka-Sayama, Japan|Osaka, Japan|Saga, Japan|Sakura, Japan|Sapporo, Japan|Sendai, Japan|Shimotsuga-gun, Japan|Shimotsuke, Japan|Shinjuku-ku, Japan|Sunto-gun, Japan|Tokyo, Japan|Ansan-si, Korea, Republic of|Bundang, Korea, Republic of|Busan, Korea, Republic of|Daegu, Korea, Republic of|Guri-si, Korea, Republic of|Seoul, Korea, Republic of|Suwon-si, Korea, Republic of|Bydgoszcz, Poland|Chorzow, Poland|Krakow, Poland|Ksawerów, Poland|Lodz, Poland|Oswiecim, Poland|Poznan, Poland|Sopot, Poland|Szczecin, Poland|Warszawa, Poland|Wloclawek, Poland|Wroclaw, Poland|Bucuresti, Romania|Oradea, Romania|Timisoara, Romania|Ekaterinburg, Russian Federation|Irkutsk, Russian Federation|Kazan, Russian Federation|Krasnoyarsk, Russian Federation|Moscov, Russian Federation|Moscow, Russian Federation|Nizhny Novgorod, Russian Federation|Novosibirsk, Russian Federation|Omsk, Russian Federation|Rostov-on-Don, Russian Federation|Saint-Petersburg, Russian Federation|Samara, Russian Federation|Sankt-Peterburg, Russian Federation|Sankt-Petersburg, Russian Federation|St Petersburg, Russian Federation|St. Petersburg, Russian Federation|Tosno, Russian Federation|Chernivtsi, Ukraine|Dnipropetrovsk, Ukraine|Ivano-Frankivsk, Ukraine|Kharkiv, Ukraine|Kiyv, Ukraine|Kropyvnytskyi, Ukraine|Kyiv, Ukraine|Lviv, Ukraine|Sumy, Ukraine|Ternopil, Ukraine|Uzhgorod, Ukraine|Zaporizhzhia, Ukraine|Zhaporozhia, Ukraine|Cambridge, United Kingdom|Nottingham, United Kingdom|Sheffield, United Kingdom|Sutton In Ashfield, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02877134"
642,"NCT02852694","Reduce Risk for Crohn's Disease Patients","RCT","Recruiting","No Results Available","Crohn's Disease","Drug: Methotrexate|Drug: Adalimumab|Drug: Azathioprine / 6 Mercaptopurine","Rate of sustained steroid/EEN-free remission at Month 12|Time to first relapse|Remission at 12 weeks (measured by wPCDAI</=12.5 and normal CRP and being off steroids/exclusive enteral nutrition)|Linear height velocity|Steroid sparing effect of the regimens|Comparison of toxicity of the different protocol drugs|Questionnaire : health-related life of quality (IMPACT 3) between the different treatment arms|Clinical predictors for response, including genomic and serological markers|Predictive value of fecal calprotectin levels, CRP and other serum tests|Questionnaire : TUMMY-CD (patient reported outcome) at month 12|Questionnaire : WPAI:CD Caregiver (patient reported outcome) at month 12|Questionnaire : School Attendance (patient reported outcome) at month 12|DNA pharmacogenetics (multiplex genotyping of polymorphism in drug metabolism) in relation to toxicity and response to therapy|Concentration of protocol drug (ADA or MTX) monitoring in relation to adherence, toxicity and response|6 Mercaptopurine and azathioprine metabolites monitoring : concentration of metabolites in relation to adherence, toxicity and response|Anti-adalimumab antibodies monitoring : concentration of anti-adalimumab antibodies in relation to adherence, toxicity and response","PIBD-Net|European Commission","All","6 Years to 17 Years   (Child)","Phase 4","312","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2016-01","February 28, 2017","October 2021","July 2022","August 2, 2016",,"April 16, 2020","Hôpital Necker -Enfants Malades (Service de gastro-enterologie), Paris, France",,"https://ClinicalTrials.gov/show/NCT02852694"
643,"NCT02843100","Diet for Induction and Maintenance of Remission and Re-biosis in Crohn's Disease","DIETOMICS-CD","Recruiting","No Results Available","Crohn's Disease","Other: Modified Exclusive Enteral Nutrition|Other: Crohn's Disease Exclusion Diet|Other: Partial Enteral Nutrition|Other: Standard Exclusive Enteral Nutrition","ITT, steroid free Clinical remission (defined as Pediatric Crohn's Disease Activity Index (PCDAI)<10) at week 14|ITT steroid free remission at week 8|Microbiome composition difference between groups at week 14|3. Reduction of at least 50% from baseline in fecal calprotectin at week 24 for patients on original treatment|Steroid and biologic free sustained remission at week 24.|Need for additional treatment to achieve remission by week 14|Mucosal healing as assessed by MRE in dietary responsive disease at week 52","Prof. Arie Levine|Wolfson Medical Center","All","8 Years to 18 Years   (Child, Adult)","Not Applicable","76","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","0075-16 WOMC","April 10, 2018","December 2021","December 2021","July 25, 2016",,"September 10, 2020","Dr. Eytan Wine,, Edmonton, Canada|Johan Van Limbergen, Halifax, Canada|Dr Sally Lawrence, Vancouver, Canada|Dr. Séamus Hussey, Dublin, Ireland|The E. Wolfson.Medical Center, Holon, Israel|Dr. Francisco Javier Martin Carpi, Barcelona, Spain|Dr. Víctor Manuel Navas López, Málaga, Spain",,"https://ClinicalTrials.gov/show/NCT02843100"
644,"NCT02839317","COmparison of MicroBiota AccordIng to Age in Crohn's Disease (COMeBACk)","COMeBACk","Recruiting","No Results Available","Crohn's Disease","Biological: Biological","Analysis of microbiota|Specific bacteria|Association between bacterial dysbiosis and different genetic backgrounds|Presence of bacteria with invasive properties (E. coli, including adherent-invasive E.coli, Shigella, Salmonella, Yersinia, Campylobacter), and fecal fungal flora (Candida albicans, in particular)|Environmental risk factors","University Hospital, Lille|National Research Agency, France","All","8 Years to 80 Years   (Child, Adult, Older Adult)",,"300","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","2013_71|2014-A01225-42","May 9, 2016","May 2021","May 2021","July 20, 2016",,"August 25, 2020","Amiens University & Hospital, Amiens, France|Lille Hôpital Huriez, Lille, France|Lille Jean de Flandre Hospital, Lille, France|Lille University Hospital & EPIMAD Registry, Lille, France|Rouen University & Hospital, Rouen, France",,"https://ClinicalTrials.gov/show/NCT02839317"
645,"NCT02782663","A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease",,"Active, not recruiting","No Results Available","Crohn's Disease (CD)","Drug: ABT-494","Percentage of Participants Achieving Remission|Percentage of Participants in Remission at Week 0 Who Maintain Remission|Percentage of Participants Achieving Response|Percentage of Participants Achieving Clinical Remission|Percentage of Participants Achieving Modified Clinical Remission|Percentage of Participants Achieving Enhanced Clinical Response|Percentage of Participants Achieving Clinical Response|Percentage of Participants Achieving Endoscopic Remission|Percentage of Participants in Endoscopic Remission at Week 0 Who Maintain Endoscopic Remission|Percentage of Participants Achieving Endoscopic Improvement|Percentage of Participants Achieving Endoscopic Response|Percentage of Participants Achieving Crohn's Disease Activity Index (CDAI) Remission|Percentage of Participants Achieving Crohn's Disease Activity Index (CDAI) Response|Percentage of Participants Achieving Enhanced CDAI Response|Percentage of Participants Achieving Inflammatory Bowel Disease Questionnaire (IBDQ) Remission|Percentage of Participants Achieving IBDQ Response|Percentage of Participants Taking Steroids at Baseline (of Study M13-740) Who Are Steroid-Free|Percentage of Participants Taking Steroids at Baseline (of Study M13-740) Who Are Steroid-Free for At Least 90 Days and Achieve Remission|Percentage of Participants Achieving Remission and Normal C-Reactive Protein","AbbVie","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","107","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","M14-327|2015-003759-23","May 18, 2016","September 17, 2025","September 17, 2025","May 25, 2016",,"January 5, 2021","Moore UC San Diego Cancer Center /ID# 150041, La Jolla, California, United States|Univ California, San Francisco /ID# 149987, San Francisco, California, United States|University of Florida - Archer /ID# 150033, Gainesville, Florida, United States|The Ctr for Gastro Disorders /ID# 150012, Hollywood, Florida, United States|Nature Coast Clinical Research - Inverness /ID# 149975, Inverness, Florida, United States|Gastroenterology Associates of Central Georgia, LLC /ID# 149870, Macon, Georgia, United States|Gastrointestinal Specialists /ID# 150015, Marietta, Georgia, United States|Cotton-O'Neil Clinical Res Ctr /ID# 149900, Topeka, Kansas, United States|University of Louisville /ID# 149884, Louisville, Kentucky, United States|Investigative Clinical Research /ID# 149886, Annapolis, Maryland, United States|Charm City Research Group /ID# 150040, Towson, Maryland, United States|Center for Digestive Health /ID# 150008, Troy, Michigan, United States|Mayo Clinic /ID# 149894, Rochester, Minnesota, United States|Kansas City Research Institute /ID# 149888, Kansas City, Missouri, United States|Washington University-School of Medicine /ID# 149899, Saint Louis, Missouri, United States|NYU Langone Long Island Clinical Research Associates /ID# 149976, Great Neck, New York, United States|Columbia Univ Medical Center /ID# 149895, New York, New York, United States|Univ NC Chapel Hill /ID# 149982, Chapel Hill, North Carolina, United States|University of Cincinnati /ID# 149977, Cincinnati, Ohio, United States|Options Health Research, LLC /ID# 150010, Tulsa, Oklahoma, United States|Texas Digestive Disease Consultants - Southlake /ID# 149869, Southlake, Texas, United States|Texas Digestive Disease Consultants - Southlake /ID# 149989, Southlake, Texas, United States|Aspen Clinical Research /ID# 150020, Orem, Utah, United States|University of Virginia /ID# 149881, Charlottesville, Virginia, United States|Virginia Mason Medical Center /ID# 150042, Seattle, Washington, United States|University of Washington /ID# 149988, Seattle, Washington, United States|Wisconsin Center for Advanced Research, a division of GI Associates, LLC /ID# 149863, Milwaukee, Wisconsin, United States|CHU de Liege /ID# 149912, Liege, Belgium|The University of Alberta /ID# 149873, Calgary, Alberta, Canada|Univ British Columbia /ID# 149876, Vancouver, British Columbia, Canada|GIRI Gastrointestinal Research Institute /ID# 149878, Vancouver, British Columbia, Canada|Toronto Digestive Disease Asso /ID# 149877, Vaughan, Ontario, Canada|Montreal General Hospital - McGill University Health Center /ID# 149871, Montreal, Quebec, Canada|Hepato-Gastroenterologie HK s.r.o. /ID# 149882, Hradec Kralove, Czechia|Aarhus University Hospital /ID# 149919, Aarhus N, Midtjylland, Denmark|Hvidovre Hospital /ID# 149890, Hvidovre, Denmark|CHRU Lille - Hopital Claude Huriez /ID# 149897, Lille CEDEX, Hauts-de-France, France|CHU NANCY - Hopital Brabois Adultes /ID# 149896, Vandoeuvre les Nancy CEDEX, Meurthe-et-Moselle, France|CHU Amiens-Picardie Site Sud /ID# 149921, Amiens CEDEX 1, Somme, France|Universitaetsklinikum Schleswig-Holstein /ID# 149936, Kiel, Schleswig-Holstein, Germany|DRK-Kliniken Westend /ID# 149905, Berlin, Germany|Medizinisches Versorgungszentrum Portal 10 /ID# 149930, Munster, Germany|Magyar Elhizastudomanyi KKft. /ID# 149907, Budapest, Hungary|Rabin Medical Center /ID# 149942, Petakh Tikva, Tel-Aviv, Israel|Assaf Harofeh Medical Center /ID# 149943, Be'er Ya'akov, Israel|Sheba Medical Center /ID# 149945, Ramat Gan, Israel|Universita di Catanzaro Magna Graecia /ID# 149927, Catanzaro, Calabria, Italy|A.O.U. Policlinico S.Orsola-Malpighi /ID# 149958, Bologna, Emilia-Romagna, Italy|Academisch Medical center Amsterdam /ID# 149932, Amsterdam, Noord-Holland, Netherlands|Universitair Medisch Centrum Utrecht /ID# 149933, Utrecht, Netherlands|Dunedin Hospital /ID# 149964, Dunedin, New Zealand|Lovisenberg Diakonale Sykehus /ID# 149967, Oslo, Norway|Centrum.Medyczne. Szpital Swietej Rodziny /ID# 149979, Lodz, Lodzkie, Poland|Centralny Szpital Kliniczny MSWiA w Warszawie /ID# 149978, Warszawa, Mazowieckie, Poland|Cabinet Particular Policlinic Algomed /ID# 149993, Timisoara, Romania|KM Management s.r.o, Nitra, SK /ID# 149949, Nitra, Slovakia|Gastro I.S.R.O. /ID# 149948, Presov, Slovakia|Hospital Arquitecto Marcide - Complejo Hospitalario Universitario de Ferrol /ID# 149996, Ferrol, A Coruna, Spain|Hospital Universitario La Paz /ID# 149997, Madrid, Spain|Manchester Royal Infirmary, Ma /ID# 150006, Manchester, United Kingdom|Oxford University Hospitals NHS Foundation Trust The John Radcliffe Hospital /ID# 149963, Oxford, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02782663"
646,"NCT02772965","Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy","COMBINE","Recruiting","No Results Available","Pediatric Crohn's Disease","Drug: Methotrexate|Other: Sugar pill (placebo)","Time to treatment failure|Mean PROMIS (Patient Reported Outcome Measurement and Information System) Pain Interference T score by treatment arm|Mean PROMIS (Patient Reported Outcome Measurement and Information System) Fatigue T score by treatment arm|Proportion of patients with positive anti-TNF antibody status","University of North Carolina, Chapel Hill|Patient-Centered Outcomes Research Institute|ImproveCareNow (ICN)|The Leona M. and Harry B. Helmsley Charitable Trust|Children's Hospital Medical Center, Cincinnati|Grifols Diagnostics Solutions, Inc|National Institutes of Health (NIH)|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","All","up to 20 Years   (Child, Adult)","Phase 3","425","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","16-0476|PCS-1406-18643|1U19AR069525-01|PCD-MTX-001","October 2016","October 2021","December 2021","May 16, 2016",,"April 21, 2020","Children's of Alabama, Birmingham, Alabama, United States|Stanford Children's Health, Alto, California, United States|Yale-New Haven Children's Hospital, New Haven, Connecticut, United States|Nemours Children's Health System - Wilmington, Wilmington, Delaware, United States|Nemours Children's Health System - Jacksonville, Jacksonville, Florida, United States|Nicklaus Children's Hospital, Miami, Florida, United States|Nemours Children's Health System - Orlando, Orlando, Florida, United States|Children's Healthcare of Atlanta at Egleston/Emory University, Atlanta, Georgia, United States|Children's Healthcare of Atlanta at Scottish Rite-GI Care for Kids, Atlanta, Georgia, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|University of Iowa Children's Hospital, Iowa City, Iowa, United States|MassGeneral Hospital for Children, Boston, Massachusetts, United States|Boston Children's Hospital, Boston, Massachusetts, United States|University of Michigan   CS Mott Children's Hospital, Ann Arbor, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Children's Mercy Hospital, Kansas City, Missouri, United States|Cardinal Glennon Children's Medical Center, Saint Louis, Missouri, United States|St. Louis Children's Hospital   Washington University, Saint Louis, Missouri, United States|Children's Hospital and Medical Center Omaha, Omaha, Nebraska, United States|Mount Sinai Kravis Children's Hospital, New York, New York, United States|Upstate Golisano Children's Hospital, Syracuse, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Levine Children's Hospital, Charlotte, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Rainbow Babies & Children's Hospital, Cleveland, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Dayton Children's Hospital, Dayton, Ohio, United States|Oklahoma University Medical Center, Oklahoma City, Oklahoma, United States|Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States|The University of Vermont Children's Hospital, Burlington, Vermont, United States|Pediatric Specialists of Virginia, Fairfax, Virginia, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT02772965"
647,"NCT02768532","Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease","VEDO-PREDIRESP","Recruiting","No Results Available","Crohn Disease","Drug: Vedolizumab","Vedolizumab concentration at week 6|Vedolizumab concentration at week 14|Concentration of Vedolizumab at week 2|Presence of specific antibodies (anti-integrins) at week 2|Concentration of Vedolizumab at week 14|Presence of specific antibodies (anti-integrins) at week 14|Vedolizumab and calprotectin levels at week 2|Vedolizumab and calprotectin levels at week 14|Intra and inter-individual heterogeneity of Vedolizumab levels|Proportion of loss of clinical response|Vedolizumab serum levels|Concentration of Vedolizumab at week 54|Specific antibodies (anti-integrins) level at week 54","Centre Hospitalier Universitaire de Saint Etienne|Theradiag|Takeda","All","18 Years and older   (Adult, Older Adult)","Phase 4","93","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","1608051|2016-001587-11","July 1, 2016","July 2021","June 2022","May 11, 2016",,"August 20, 2020","CHU Kremlin Bicetre, Paris, Le Kremlin-Bicêtre, France|CHU d'Amiens, Amiens, France|CHU L'Archet, Nice, France|CHU Lyon-Sud, Hospices Civils de Lyon, PIERRE-BENITE, Pierre Bénite, France|Chu Saint Etienne, Saint Etienne, France",,"https://ClinicalTrials.gov/show/NCT02768532"
648,"NCT02764762","Triple Combination Therapy in High Risk Crohn's Disease (CD)",,"Active, not recruiting","No Results Available","Crohn Disease","Drug: Vedolizumab|Drug: Adalimumab|Drug: Methotrexate","Percentage of Participants Achieving Endoscopic Remission at Week 26|Percentage of Participants Achieving Endoscopic Healing at Week 26|Percentage of Participants Achieving Endoscopic Response at Week 26|Change From Baseline in SES-CD Score at Week 26|Percentage of Participants Achieving Deep Remission at Week 26|Percentage of Participants Achieving Clinical Remission and Endoscopic Response as a Measure of Mucosal Healing at Week 26|Percentage of Participants Achieving Clinical Remission at Weeks 10 and 26|Percentage of Participants Achieving Clinical Response at Weeks 10 and 26|Change From Baseline in C-reactive Protein (CRP) Levels at Weeks 10 and 26|Change From Baseline in Fecal Calprotectin Concentrations at Weeks 10, 14, 26, 52, 78, and 102|Percentage of Participants Achieving Clinical Remission and CRP <5 Milligram per Liter (mg/L) at Weeks 26, 52, 78, and 102|Percentage of Participants Using Oral Corticosteroids at Baseline who Have Discontinued Corticosteroids and are in Clinical Remission at Weeks 10, 26, and 102|Percentage of Participants Maintaining Clinical Remission at Weeks 52, 78, and 102|Percentage of Participants Maintaining Endoscopic Remission at Week 102|Percentage of Participants Maintaining Deep Remission at Week 102|Percentage of Participants Maintaining Endoscopic Healing at Week 102|Percentage of Participants Maintaining Endoscopic Response at Week 102|Percentage of Participants Maintaining Clinical Remission and Endoscopic Response as a Measure of Mucosal Healing at Week 102|Percentage of Participants with First Exacerbation of CD","Takeda","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 4","55","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Vedolizumab-4006|U1111-1175-9094","June 12, 2017","September 22, 2020","July 14, 2022","May 6, 2016",,"February 10, 2021","Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|Gastro Florida, Clearwater, Florida, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|Northshore University HealthSystem, Evanston, Illinois, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Cotton O'Neil Clinical Research, Topeka, Kansas, United States|Texas Digestive Disease Consultants Baton Rouge, Baton Rouge, Louisiana, United States|Louisana Research Center, LLC, Shreveport, Louisiana, United States|Center for Digestive Health, Troy, Michigan, United States|Huron Gastroenterology Associates, Ypsilanti, Michigan, United States|Minnesota Gastroenterology, PA - Plymouth, Plymouth, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|Icahn School of Medicine at Mt. Sinai, New York, New York, United States|Digestive Health Partners, PS, Asheville, North Carolina, United States|Carolinas HealthCare System Digestive Health, Charlotte, North Carolina, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Digestive Disease Specialists, Inc., Oklahoma City, Oklahoma, United States|Options Health Research, LLC, Tulsa, Oklahoma, United States|Baylor College of Medicine, Houston, Texas, United States|Pinnacle Clinical Research, San Antonio, Texas, United States|Texas Digestive Disease Consultants Southlake, Southlake, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Texas Digestive Disease Consultants, Webster, Webster, Texas, United States|University of Utah Health Sciences Center, Salt Lake City, Utah, United States|Digestive Health Specialists, Tacoma, Washington, United States|Covenant Health, Edmonton, Alberta, Canada|PerCuro Clinical Research Ltd, Victoria, British Columbia, Canada|LHSC - Victoria Hospital, London, Ontario, Canada|Toronto Digestive Disease Associates Inc, Vaughan, Ontario, Canada|CIUSSS de I'Estrie-CHUS, Sherbrooke, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT02764762"
649,"NCT02760836","Predictive Model of Clinical Outcomes Using Web-based Self-reporting Symptom Diary for Crohn's Disease","PICASSO","Recruiting","No Results Available","Crohn's Disease",,"Hospitalization|Unscheduled visit|Bowel resection surgery","Kyungpook National University Hospital","All","18 Years to 80 Years   (Adult, Older Adult)",,"250","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","KNUH2016-03-030","April 2016","April 2020","December 2020","May 4, 2016",,"August 13, 2019","Kyungpook National University Hospital, Daegu, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT02760836"
650,"NCT02716454","Early Surgery Versus Conservative Treatment in Patients With Ileocaecal Crohn's Disease","ESPRIT","Not yet recruiting","No Results Available","Crohn's Disease","Procedure: Ileocaecal resection","Endoscopic remission|QoL|Clinical remission|Drug consumption","Ondrej Ryska|Czech Surgical Society","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IBDchirCZ-01","May 2016","May 2021","December 2021","March 23, 2016",,"April 28, 2016","The University Hospital Brno, Brno, Czech Republic|Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic|Horovice Hospital, Horovice, Czech Republic|Universitiy Hospital Hradec Kralove, Hradec Kralove, Czech Republic|Hospital Jihlava, Jihlava, Czech Republic|Hospital Liberec, Liberec, Czech Republic|Vitkovice Hospital, Ostrava - Vitkovice, Czech Republic|University Hospital in Pilsen, Pilsen, Czech Republic|Royal Vinohrady University Hospital, Prague, Czech Republic|Institute for Clinical and Experimental Medicine, Prague, Czech Republic|Na Homolce Hospital, Prague, Czech Republic|ISCARE, Prague, Czech Republic",,"https://ClinicalTrials.gov/show/NCT02716454"
651,"NCT02646683","A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study","LOVE-CD","Recruiting","No Results Available","Crohn Disease","Drug: vedolizumab","The proportion of patients with clinical and endoscopic remission at Week 26|Proportion of patients with endoscopic response at Weeks 26 and 52|Proportion of patients with 25% and 75% reduction of SES-CD at Weeks 26 and 52|Proportion of patients with clinical response|Proportion of patients with clinical remission|Proportion of patients with corticosteroid- free clinical remission|Proportion of patients with normalized serum C-reactive protein (CRP) at all time points|Proportion of patients with no granulocytes in the biopsies at Weeks 26 and 52.|Proportion of patients with 25%, 50% and 75% reduction in the Geboes histology score at Weeks 26 and 52|Proportion of patients with sustained clinical response (response at all time points after week 10)|Proportion of patients with sustained clinical remission|Proportion of patients with draining fistulas|Proportion of patients that need to be hospitalized|Quality of life measured by Inflammatory Bowel Disease Questionnaire ( IBDQ)|Work productivity Index|Serum concentrations of vedolizumab and antibodies to vedolizumab before every infusion|Quality of life measured by Euroqol (EQ-5D)","Geert D'Haens|Takeda|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 4","260","Other|Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2014-100757","July 2015","December 2022","December 2023","January 6, 2016",,"October 8, 2020","UZ Antwerpen, Antwerpen, Belgium|Imeldahospital, Bonheiden, Belgium|AZ Sint-Lucas, Brugge, Belgium|ULB Erasme, Brussels, Belgium|Ziekenhuis Oost-Limburg, Genk, Belgium|AZ Sint Lucas, Gent, Belgium|UZ Gent, Gent, Belgium|AZ Groeninge, Kortrijk, Belgium|UZ Leuven, Leuven, Belgium|CHC Clinique Saint-Joseph, Liege, Belgium|CHU de Liège, Liege, Belgium|ZNA Jan Palfijn, Merksem, Belgium|AZ Damiaan, Oostende, Belgium|AZ Delta Roeselare, Roeselare, Belgium|St Vincentius, Wilrijk, Belgium|Semmelweis University, Budapest, Hungary|University of Debrecen, Debrecen, Hungary|Universtiy of Szeged, Szeged, Hungary|Academisch Medisch Centrum, Amsterdam, Netherlands|Ziekenhuis Gelderse Vallei, Ede, Netherlands|Catharina ziekenhuis, Eindhoven, Netherlands|LUMC, Leiden, Netherlands|OLVG, Leiden, Netherlands|Radboud Universitair Medisch Centrum, Nijmegen, Netherlands|Erasmus MC, Rotterdam, Netherlands",,"https://ClinicalTrials.gov/show/NCT02646683"
652,"NCT02631967","Surgical Prevention of Anastomotic Recurrence by Excluding Mesentery in Crohn's Disease","SuPREMeCD","Recruiting","No Results Available","Crohn Disease","Procedure: Kono anastomosis|Procedure: Stapled side-to-side anastomosis","Grade of endoscopic recurrence|Surgical recurrence|Endoscopic recurrence|Clinical recurrence|Operating time|Anastomosis time|Anastomotic leak|Surgical re-intervention|Postoperative morbidity rate|Recovery times","Federico II University","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","132","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","211/15","November 2015","November 2017","November 2022","December 16, 2015",,"February 15, 2017","UOC Colonproctologia Chirurgica - Dipartimento di Medicina Clinica e Chirurgia - Università degli Studi di Napoli Federico II, Napoli, Italy",,"https://ClinicalTrials.gov/show/NCT02631967"
653,"NCT02624414","Capsule Colonoscopy in Crohn's Disease and Its Correlation With Conventional Colonoscopy and Faecal Calprotectin",,"Recruiting","No Results Available","Crohn's Disease","Device: PillCam® COLON 2 Capsule Endoscopy","Assess bowel cleanness based on the % of mucosal surface visualized by the Capsule colonoscopy|Simple Endoscopic Score for Crohn's Disease from Conventional colonoscopy|Levels of Faecal calprotectin","Melbourne Health|Medtronic","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","34","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","2014.214","February 6, 2015","December 2022","December 2022","December 8, 2015",,"October 5, 2020","Royal Melbourne Hospital, Parkville, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT02624414"
654,"NCT02580617","A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease",,"Recruiting","No Results Available","Crohn's Disease","Biological: ALLO-ASC","Safety (Clinically measured abnormality of laboratory tests and adverse events)|CDAI value|The ratio of patients applicable to CDAI <150","Anterogen Co., Ltd.","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1","9","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","ALLO-ASC-CD-101","April 2015","June 2021","June 2021","October 20, 2015",,"January 22, 2021","Yonsei University College of Medicine, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT02580617"
655,"NCT02517684","Top-down Infliximab Study in Kids With Crohn's Disease","TISKids","Active, not recruiting","No Results Available","Crohn's Disease","Drug: Infliximab|Drug: Prednisolone|Other: Exclusive enteral nutrition|Drug: Azathioprine","Clinical remission without need for additional CD related therapy or surgery|Clinical response rates|Clinical remission rates|Mucosal healing|Change in height Z-scores|Change in BMI Z-scores|Change bone age|Change in Tanner stage|Therapy failure rates over time|Adverse events rates|Cumulative therapy use|Long-term yearly remission rates without need for additional CD related therapy or surgery|Long-term yearly number of flares|Long-term yearly clinical remission rates|Long-term yearly mucosal healing (calprotectin) rates","Erasmus Medical Center|ZonMw: The Netherlands Organisation for Health Research and Development|Hospira, now a wholly owned subsidiary of Pfizer",,"3 Years to 17 Years   (Child)","Phase 4","100","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","NL52030.078.15|2014-005702-37|MEC-2015-080","April 2015","December 2019","December 2023","August 7, 2015",,"July 22, 2020","University Hospital Brussels, Brussels, Belgium|University Hospitals Leuven, Leuven, Belgium|Helsinki University Central Hospital, Helsinki, Finland|Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands|Academic Medical Center, Amsterdam, Netherlands|VU University Medical Center, Amsterdam, Netherlands|Amphia Hospital, Breda, Netherlands|Medisch Spectrum Twente, Enschede, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Radboud University Medical Center, Nijmegen, Netherlands|Maasstad Hospital, Rotterdam, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands|Isala hospital, Zwolle, Netherlands",,"https://ClinicalTrials.gov/show/NCT02517684"
656,"NCT02412553","Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative Colitis",,"Recruiting","No Results Available","Crohn's Disease","Other: Specific carbohydrate diet|Other: Elemental diet","Clinical remission|Clinical response|Biochemical response - CRP|Biochemical response - fecal calprotectin","Massachusetts General Hospital","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2014P001134","October 2014","October 2021","October 2021","April 9, 2015",,"February 23, 2021","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02412553"
657,"NCT02403323","Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144","JUNIPER","Recruiting","No Results Available","Crohn Disease","Drug: Etrolizumab","Part 1: Number of Participants with Crohn's Disease Activity Index (CDAI) Remission Over Time|Part 1: Number of Participants with Clinical Remission Over Time|Part 1: Simple Endoscopic Score for Crohn's Disease (SES-CD) Score at Week 108|Part 1: Overall Number of Participants who Experienced at Least One Adverse Event by Severity, According to National Cancer Institute Common Terminology Criteria for Adverse Events, Version 4.0 (NCI-CTCAE v4.0)|Part 1: Overall Number of Participants with Adverse Events Leading to Etrolizumab Discontinuation|Part 1: Overall Number of Participants who Experienced at Least One Infection-Related Adverse Event by Severity, According to NCI-CTCAE v4.0|Part 1: Number of Infection-Related Adverse Events per Patient-Year|Part 1: Overall Number of Participants who Experienced at Least One Infection-Related Serious Adverse Event|Part 1: Overall Number of Participants who Experienced at Least One Injection-Site Reaction by Severity, According to NCI-CTCAE v4.0|Part 1: Overall Number of Participants who Develop Malignancies|Part 1: Number of Malignancies per Patient-Year|Part 1: Overall Number of Participants who Experienced at Least One Hypersensitivity Reaction by Severity, According to NCI-CTCAE v4.0|Part 1: Number of Participants with Anti-Therapeutic Antibodies (ATAs) to Etrolizumab|Part 2: Number of Participants who Experienced at Least One Suspected or Confirmed Event of Progressive Multifocal Leukoencephalopathy (PML)","Hoffmann-La Roche","All","18 Years and older   (Adult, Older Adult)","Phase 3","900","Industry","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","GA29145|2014-003855-76","June 8, 2015","May 21, 2026","May 21, 2026","March 31, 2015",,"June 3, 2021","Moore Clinical Trials, LLC, Sherwood, Arkansas, United States|Valley Gastroenterology Consultants, Arcadia, California, United States|Ventura County Gastroenterology, Camarillo, California, United States|Valley View Internal Medicine, Garden Grove, California, United States|Valley Gastroenterology Cnslts, Glendora, California, United States|University of California San Diego Medical Center, La Jolla, California, United States|Therapeutic Research Institute of Orange County, Laguna Hills, California, United States|VA Long Beach Healthcare System, Long Beach, California, United States|California Medical Research Associates, Inc., Northridge, California, United States|University of California, Irvine Medical Center, Orange, California, United States|Digestive Care Associates, A Medical Corporation, San Carlos, California, United States|Clinical Applications Laboratories, Inc., San Diego, California, United States|Uni. of California at San Francisco; Dept Pediatric, Div. of Gastroenterology, Hepatology & Nutri, San Francisco, California, United States|United Gastroenterologists, Inc, Temecula, California, United States|Ventura Clinical Trials, Ventura, California, United States|ABS Health, LLC, Whittier, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Rocky Mountain Gastroenterology Associates, Denver, Colorado, United States|Rocky Mountain Gastroenterology Associates, P.L.L.C.; Gastroenterology, Lakewood, Colorado, United States|Medical Research Center of Connecticut, LLC, Hamden, Connecticut, United States|Innovative Medical Research of South Florida, Aventura, Florida, United States|West Central Gastroenterology d/b/a Gastro Florida, Clearwater, Florida, United States|GastroCare; Digestive Care Research, Coral Springs, Florida, United States|Jesscan Medical Research, Doral, Florida, United States|University of Florida College of Medicine, Gainesville, Florida, United States|The Center for Gastrointestinal Disorders, Hollywood, Florida, United States|Borland-Groover Clinic, Jacksonville, Florida, United States|Borland-Groover Clinic, Jacksonville, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|Center for Advanced Gastroenterology, Maitland, Florida, United States|IMIC, Inc, Miami Beach, Florida, United States|City Medical Group, Miami, Florida, United States|Advanced Clinical Research of Miami, Miami, Florida, United States|Regenerate Clinical Trials, Miami, Florida, United States|FQL Research, LLC, Miramar, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|Advanced Research Institute, New Port Richey, Florida, United States|Med-Care Research, North Miami Beach, Florida, United States|Medical Research Group of Central Florida, Orange City, Florida, United States|Internal Medicine Specialists, Orlando, Florida, United States|International Clinical Research, Sanford, Florida, United States|University of South Florida, Tampa, Florida, United States|Advanced Research Institute, Inc., Trinity, Florida, United States|Cleveland Clinic Florida - Weston; Department of Gastroenterology, Weston, Florida, United States|Shafran Gastroenterology Center, Winter Park, Florida, United States|Emory University Hospital, Atlanta, Georgia, United States|Agile Clinical Research Trials, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Columbus Regional Research Institute, Columbus, Georgia, United States|Atlanta Center for Gastroenterology, PC, Decatur, Georgia, United States|Gastroenterology Associates of Central Georgia, Macon, Georgia, United States|Gastrointestinal Specialists of Georgia, PC, Marietta, Georgia, United States|Atlanta Gastroenterology Specialists, PC, Suwanee, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|Advanced Clinical Research, Meridian, Idaho, United States|Northwestern Uni-Feinberg School of Medicine, Chicago, Illinois, United States|University of Chicago Medical Center, Chicago, Illinois, United States|NorthShore University HealthSystem; Evanston Hospital, Evanston, Illinois, United States|Southwest Gastroenterology, Oak Lawn, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|Investigators Research Group, LLC, Brownsburg, Indiana, United States|Indiana University, Indianapolis, Indiana, United States|Aquiant Research, New Albany, Indiana, United States|Iowa Digestive Disease Center, Des Moines, Iowa, United States|Cotton-O'Neil Clinical Research Center, Digestive Health, Topeka, Kansas, United States|University of Louisville, Elizabethtown, Kentucky, United States|University of Kentucky Medical Center, Lexington, Kentucky, United States|Gastroenterology Associates, LLC, Baton Rouge, Louisiana, United States|Houma Digestive Health, Houma, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Gastro Associates, Elkridge, Maryland, United States|Gastroenterology Associates, Elkridge, Maryland, United States|Charm City Research - Prn, Towson, Maryland, United States|Massachusetts General Hospital; Crohn's & Colitis Center, Boston, Massachusetts, United States|Commonwealth Clinical Studies, Brockton, Massachusetts, United States|Community Clinical Research Network, Marlborough, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Clin. Rsrch Inst. of Michigan, Chesterfield, Michigan, United States|Gastroenterology Associates of Western Michigan, P.L.C., Grand Rapids, Michigan, United States|The iResearch Group, LLC, Southfield, Michigan, United States|Center for Digestive Health, Troy, Michigan, United States|Henry Ford Health System, West Bloomfield, Michigan, United States|Mayo Clinic - Rochester, Rochester, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Ehrhardt Clinical Research, LLC, Belton, Missouri, United States|Quality Clinical Research, Omaha, Nebraska, United States|Gastroenterology Associates of New Jersey, Clifton, New Jersey, United States|Atlantic Digestive Health Institute at Morristown, Morristown, New Jersey, United States|AGA Clinical Research Associates, LLC, Twp, New Jersey, United States|Gastroenterology Group of South Jersey, Vineland, New Jersey, United States|Allied Gastrointestinal Associates, PA, Voorhees, New Jersey, United States|Long Island Clin Rsch Asc, LLP, Great Neck, New York, United States|North Shore/Long Island Jewish PRIME; Pediatric Hematology/Oncology & Stem Cell Transplantation, New Hyde Park, New York, United States|Concorde Medical Group, New York, New York, United States|Concorde Medical Group, New York, New York, United States|Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York, United States|Westside Internal Medicine, New York, New York, United States|M.D. Gastroenterology, New York, New York, United States|Mount Sinai - PRIME, New York, New York, United States|Lenox Hill Hospital, New York, New York, United States|Premier Medical Group of the Hudson Valley PC, Poughkeepsie, New York, United States|Asheville Gastroenterology Associates, P.A.; Gastroenterology, Asheville, North Carolina, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Charlotte Gastroenterology and Hepatology, P.L.L.C, Charlotte, North Carolina, United States|Cumberland Research Associates, Llc, Fayetteville, North Carolina, United States|Clinical Research of Gastonia, Gastonia, North Carolina, United States|Atlantic Medical Group, Kinston, North Carolina, United States|Kinston Medical Specialists, Kinston, North Carolina, United States|Consultants for Clinical Research Inc., Cincinnati, Ohio, United States|UC Health Clinical Trials Office, Cincinnati, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Advanced Medical Research, Maumee, Ohio, United States|Great Lakes Gastroenterology Research, LLC, Mentor, Ohio, United States|Central Sooner Research, Norman, Oklahoma, United States|University of Oklahoma Health Sciences Center; Stephenson Cancer Center, Oklahoma City, Oklahoma, United States|Digestive Disease Specialists, Inc., Oklahoma City, Oklahoma, United States|Jackson Siegelbaum Gastroenterology, Harrisburg, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Innovative Clinical Research, Greenville, South Carolina, United States|Clinical Trials of South Carolina, North Charleston, South Carolina, United States|Clinical Research of Rock Hill, Rock Hill, South Carolina, United States|Gastro One, Germantown, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Physicians Medical Research Group, LLC, Arlington, Texas, United States|Texas Digestive Disease Consultants - Dallas, Dallas, Texas, United States|University of Texas Southwestern Medical Center; Internal Medicne, Dallas, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Methodist Hospital Research Institute, Houston, Texas, United States|Gastroenterology Research of San Antonio, LLC, San Antonio, Texas, United States|Wellness Clinical Research Center, San Antonio, Texas, United States|Texas Digestive Disease Consultants - Southlake, Southlake, Texas, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|Digestive Health Specialists of Tyler, Tyler, Texas, United States|Ericksen Research and Development, Clinton, Utah, United States|Advanced Research Institute, Ogden, Utah, United States|University of Utah School of Medicine, Salt Lake City, Utah, United States|Granger Medical Clinic, West Valley City, Utah, United States|University of Virginia; Gastroenterology and Hepatology, Charlottesville, Virginia, United States|Digestive and Liver Disease Specialists, Ltd., Norfolk, Virginia, United States|McGuire Research Institute; Gastroenterology, Richmond, Virginia, United States|Virginia Commonwealth Uni Health Center, Richmond, Virginia, United States|Gastroenterology Consultants and Endoscopy Center of Southwest Virginia; Office of Doctor Weiserbs, Roanoke, Virginia, United States|Digestive Disease Institute; Virginia Mason Medical Center, Seattle, Washington, United States|University of Washington School of Medicine, Seattle, Washington, United States|Swedish Medical Center, Seattle, Washington, United States|University of Wisconsin, Madison, Wisconsin, United States|Hospital Italiano, Caba, Argentina|Instituto DAMIC - Fundación Rusculleda, Cordoba, Argentina|Hospital Italiano de La Plata, La Plata, Argentina|Asociacion Civil para la Investigacion Gastroenterologica, Lomas de Zamora, Argentina|Hospital Privado de Comunidad; Cardiology, Mar Del Plata, Argentina|Instituto Medico CER, Quilmes, Argentina|Hospital Provincial del Centenario, Rosario, Argentina|Instituto Medico de la Fundacion Estudios Clinicos, Rosario, Argentina|The Canberra Hospital, Garran, Australian Capital Territory, Australia|Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, Australia|University of the Sunshine Coast, Sippy Downs, Queensland, Australia|Mater Adult Hospital, South Brisbane, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|Launceston General Hospital; Gastroenterology Research, Launceston, Tasmania, Australia|Monash Medical Centre Clayton, Clayton, Victoria, Australia|St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|Footscray Hospital, Footscray, Victoria, Australia|Austin Hospital, Heidelberg, Victoria, Australia|Emeritus Research, Malvern East, Victoria, Australia|St Frances Xavier Cabrini Hospital, Malvern, Victoria, Australia|Royal Melbourne Hospital; Department of Colorectal Medicine and Genetics, Parkville, Victoria, Australia|The Alfred Hospital, Prahan, Victoria, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, Australia|Medizinische Universität Innsbruck, Innsbruck, Austria|Klinikum Klagenfurt am Wörtersee; Abt.Gastroenterologie&Hepatologie,Endokrinologie, Klagenfurt, Austria|LKH - Universitätsklinikum der PMU Salzburg, Salzburg, Austria|Medizinische Universität Wien, Wien, Austria|UZ Brussel, Brussel, Belgium|CHU St Pierre (César de Paepe) X, Bruxelles, Belgium|ULB Hopital Erasme; Service de Néphrologie, Bruxelles, Belgium|Cliniques Universitaires St-Luc, Bruxelles, Belgium|UZ Antwerpen, Edegem, Belgium|AZ Maria Middelares, Gent, Belgium|AZ Sint Lucas (Sint Lucas), Gent, Belgium|AZ Sint Elisabeth Herentals, Herentals, Belgium|AZ Groeninge, Kortrijk, Belgium|UZ Leuven; Maag, -darm en leverziekten/endoscopie - Endoscopy, Leuven, Belgium|AZ Delta (Stedelijk Ziekenhuis), Roeselare, Belgium|Hospital Universitario Walter Cantidio - UFC, Fortaleza, CE, Brazil|CCBR - Brasilia, Brasilia, DF, Brazil|CEDOES - Diagnóstico e Pesquisa, Vitoria, ES, Brazil|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Ltda, Goiânia, GO, Brazil|Hospital Felicio Rocho, Belo Horizonte, MG, Brazil|Centro Mineiro de Pesquisa - CMIP, Juiz de Fora, MG, Brazil|Eurolatino Pesquisas Médicas Ltda., Uberlandia, MG, Brazil|Centro Digestivo de Curitiba, Curitiba, PR, Brazil|Hospital Universitario Gaffree e Guinle, Rio de Janeiro, RJ, Brazil|Hospital Universitario Clementino Fraga Filho - UFRJ, Rio de Janeiro, RJ, Brazil|Hospital Sao Vicente de Paulo, Passo Fundo, RS, Brazil|Hospital das Clinicas - UFRGS, Porto Alegre, RS, Brazil|Hospital Ernesto Dornelles, Porto Alegre, RS, Brazil|Centro de Pesquisa Clinica Maimonides - Maimonides Day Hospital, Porto Alegre, RS, Brazil|Hospital Sao Lucas da PUCRS*X, Porto Alegre, RS, Brazil|Clinica de Neoplasias Litoral, Itajai, SC, Brazil|Oncoeste Pesquisa Clinica - HUST - Hospital Universitario Santa Terezinha, Joacaba, SC, Brazil|UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu, Botucatu, SP, Brazil|Allergisa Pesquisa Dermato-Cosmética Ltda, Campinas, SP, Brazil|CAEP - Centro Avancado de Estudos e Pesquisas Ltda., Campinas, SP, Brazil|Pesquisare Saúde Sociedade Simples, Santo Andre, SP, Brazil|Praxis Pesquisa Médica, Santo Andre, SP, Brazil|Hospital Estadual Mario Covas, Santo Andre, SP, Brazil|Irmandade da Santa Casa da Misericórdia de Santos, Santos, SP, Brazil|Hospital de Base de Sao Jose do Rio Preto, Sao Jose do Rio Preto, SP, Brazil|Hospital Sírio-Libanês, Sao Paulo, SP, Brazil|Universidade Federal de Sao Paulo - UNIFES, Sao Paulo, SP, Brazil|Hospital do Servidor Público Estadual/HSPE-SP, São Paulo, SP, Brazil|Medical Centre ""Asklepii"", OOD, Dupnitsa, Bulgaria|MHAT ""Lyulin"", EAD, Sofia, Bulgaria|""City Clinic UMHAC"" EOOD, Sofia, Bulgaria|DCC ""Sarce i Zdrave"", OOD, Sofia, Bulgaria|MHAT Tokuda Hospital Sofia, AD, Sofia, Bulgaria|UMHAT ""Sv. Ivan Rilski"", EAD, Sofia, Bulgaria|UMHAT Tsaritsa Yoanna - ISUL, EAD, Sofia, Bulgaria|Military Medical Academy - MHAT - Sofia, Sofia, Bulgaria|MC ""Health BG"", EOOD, Sofia, Bulgaria|MHAT SofiaMed; OOD, Sofia, Bulgaria|Medical Center ""Nov Rehabilitatsionen Tsentar"", EOOD, Stara Zagora, Bulgaria|UMHAT Sv. Marina EAD, Varna, Bulgaria|MHAT 'Hristo Botev' AD, Vratsa, Bulgaria|University of Calgary, Calgary, Alberta, Canada|Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology, Edmonton, Alberta, Canada|Pacific Gastroenterology Associates, Vancouver, British Columbia, Canada|Winnipeg Regional Health Authority; Neurosurgery Department, Winnipeg, Manitoba, Canada|Queen Elizabeth II Health Sciences Centre; Gastroenterology Research, Halifax, Nova Scotia, Canada|McMaster University Health Sciences Center, Hamilton, Ontario, Canada|Hotel Dieu Hospital; Gastroenterology, Kingston, Ontario, Canada|University Hospital - London Health Sciences Centre, London, Ontario, Canada|Taunton Health Centre, Oshawa, Ontario, Canada|The Ottawa Hospital - Riverside Campus; Gastrointestinal Clinical Research Unit, Ottawa, Ontario, Canada|Northeastern Ontario Medical Offices, Sudbury, Ontario, Canada|Humber River Hospital, Toronto, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|Toronto Liver Centre, Toronto, Ontario, Canada|Toronto Digestive Disease Associates, Vaughan, Ontario, Canada|Hotel Dieu de Levis, Levis, Quebec, Canada|Hôpital Maisonneuve - Rosemont, Montreal, Quebec, Canada|Jewish General Hospital; Endoscopy Department, Montreal, Quebec, Canada|McGill University Health Centre - Glen Site, Montreal, Quebec, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada|Clinical Hospital Centre Osijek, Osijek, Croatia|General Hospital Pula, Pula, Croatia|General Hospital Zadar, Zadar, Croatia|Clinical Hospital Merkur; Coronary Care Unite, Zagreb, Croatia|Clinical Hospital Center Sestre Milosrdnice, Zagreb, Croatia|Clinical Hospital Centre Zagreb, Zagreb, Croatia|Clinical Hospital Sveti Duh, Zagreb, Croatia|Vojenska nemocnice Brno, Brno, Czechia|Fakultni nemocnice u sv. Anny v Brne; I.Interni kardioangiologicka klinika, Brno, Czechia|Nemocnice Ceske Budejovice a.s., Ceske Budejovice, Czechia|Gastroenterologie s.r.o., Hradec Kralove, Czechia|Fakultni nemocnice Hradec Kralove, Hradec Kralove, Czechia|Hepato-Gastroenterologie HK, s.r.o., Hradec Kralove, Czechia|PreventaMed, s.r.o., Olomouc, Czechia|Fakultni nemocnice Ostrava, Ostrava - Poruba, Czechia|Pardubicka krajska nemocnice, a.s., Pardubice, Czechia|Fakultni nemocnice v Motole, Praha 5, Czechia|ISCARE a.s., Praha 7, Czechia|Fakultni nemocnice Kralovske Vinohrady, Praha, Czechia|Orlickoustecka nemocnice, a.s., Usi Nad Orlici, Czechia|West Tallinn Central Hospital, Tallinn, Estonia|North Estonia Medical Centre Foundation, Tallinn, Estonia|Tartu University Hospital, Tartu, Estonia|CHU Amiens - Hopital Sud, Amiens, France|CHU de Caen - Hopital Cote de Nacre, Caen, France|CHU Tours - Hôpital Trousseau, Chambray les Tours, France|CHU Clermont Ferrand - Hôpital d'Estaing, Clermont Ferrand cedex 1, France|Hôpital Beaujon, Clichy cedex, France|CHU de Grenoble - Hôpital Nord, Grenoble, France|Centre Hospitalier Départemental Les Oudairies, La Roche sur Yon, France|Hopital Claude Huriez - CHU Lille, Lille, France|Hôpital Nord - CHU Marseille; Service d'Oncologie Multidisciplinaire, Marseille Cedex 20, France|CHU NANTES - Hôtel Dieu; Pharmacy, Nantes, France|CHU Nice - Hopital de l'Archet 2, Nice, France|Hôpital Saint-Louis, Paris, France|Groupe Hospitalier Sud - Hôpital Haut-Lévêque - USN, Pessac, France|Centre Hospitalier Lyon Sud; Service de Gastro-Enterologie, Pierre-Benite, France|CHU du Reims - Hopital Robert Debré, Reims, France|CHU Rennes - Hopital Pontchaillou, Rennes cedex 09, France|CHU de Rouen - Hôpital Charles Nicolle; Neurologie, Rouen, France|CHU Saint Etienne - Hôpital Nord, Saint Etienne, France|Höpital Hautepierre; Pediatrie1, Strasbourg, France|CHU de Toulouse - Hôpital Rangueil, Toulouse Cedex 09, France|Hôpital de Brabois Adultes, Vandoeuvre-les-nancy, France|Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany|Charite-Campus Virchow Klinikum; Hepatologie und Gastroenterologie, Berlin, Germany|Charité Campus Virchow-Klinikum; Department of Cardiology, Berlin, Germany|DRK Kliniken Berlin Westend, Berlin, Germany|Krankenhaus Waldfriede e. V., Berlin, Germany|Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH, Bochum, Germany|Staedisches Klinikum Brandenburg, Brandenburg an der Havel, Germany|Medizinisches Versorgungszentrum Dachau, Dachau, Germany|Universitätsklinikum ""Carl Gustav Carus"" der Technischen Universität Dresden, Dresden, Germany|Universitaetsklinikum Erlangen, Erlangen, Germany|Kliniken Essen-Mitte, Essen, Germany|Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt, Germany|Krankenhaus Martha-Maria Halle-Doelau, Halle (Saale), Germany|Universitaetsklinikum Halle (Saale), Halle, Germany|Hamburgisches Forschungsinstitut fuer CED, Hamburg, Germany|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Gastroenterologie, Hamburg, Germany|Asklepios Klinik Hamburg, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Praxis fuer Gastroenterologie, Drs. Ehehalt/ Helmstaedter, Heidelberg, Germany|Universitaetsklinikum Jena; Apotheke des Uniersitätsklinikums Jena, Jena, Germany|Universitaetsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany|Universitätsklinikum Koeln, Koeln, Germany|Medizinisches Zentrum Klinikum Lueneburg, Lueneburg, Germany|Universitätsklinikum Schleswig-Holstein; Campus Lübeck, Lübeck, Germany|Universitätsklinikum Magdeburg A.ö.R., Magdeburg, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, Germany|Klinikum Mannheim GmbH Universitätsklinikum, Mannheim, Germany|Gastroenterologische Praxis Minden, Minden, Germany|Universitaetsklinikum Muenster, Muenster, Germany|Gastro Campus Research; Praxis am Germania Campus, Muenster, Germany|Klinikum rechts der Isar der Technischen Universität München, Munchen, Germany|Isar Klinik GmbH, München, Germany|LMU - Campus Grosshadern; Medizinische Klinik und Poliklinik II, München, Germany|Gemeinschaftspraxis, Offenburg, Germany|Gemeinschaftspraxis Mohl, Juenglin, Hasenstein, Saarbrücken, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Germany|Universitaetsklinikum Ulm, Ulm, Germany|Internistische Praxisgemeinschaft, Weyhe, Germany|Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaza, Bekescsaba, Hungary|Szent Margit Hospital, Budapest, Hungary|Obudai Egeszsegugyi Centrum Kft., Budapest, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Magyar Elhizastudomanyi Kozp. Kft., Budapest, Hungary|Szt Janos Korhaz es EbudaiEgyesitettKorhazak, Budapest, Hungary|Pannonia Maganorvosi Centrum, Budapest, Hungary|Debreceni Egyetem Klinikai Központ; Bőrgyógyászati Klinika, Debrecen, Hungary|Vasutegeszsegugyi Nonprofit KiemeltenKozhasznu Kft, Debrecen, Hungary|Markhot Ferenc Oktato Korhaz es Rendelointezet, Eger, Hungary|Petz Aladar Megyei Oktato Korhaz, Gyor, Hungary|Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaza, Gyula, Hungary|Pest Megyei Flor Ferenc Korhaz, Kistarcsa, Hungary|Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz; II. Belgyogyaszat, Miskolc, Hungary|Pecsi Tudomanyegyetem, Pecs, Hungary|Csongrad Megyei Dr. Bugyi Istvan Korhaz, Szentes, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Székesfehérvár, Hungary|Haemek Medical Center, Afula, Israel|Soroka University Medical Centre, Beer Sheva, Israel|Assaf Harofeh Medical Center, Beer Yaacov, Israel|Bnai Zion Medical Center; Department of Internal Medicine B, Haifa, Israel|Wolfson Medical Center, Holon, Israel|Hadassah University Hospital - Ein Kerem; Oncology, Jerusaelm, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Clalit Health Services-Lev Talpiyot, Jerusalem, Israel|Holy Family Hospital, Nazareth, Israel|Rabin Medical Center-Beilinson Campus, Petach Tikva, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Kaplan Medical Center; Allergy and clinical immunology, Rechovot, Israel|Tel Aviv Sourasky Medical Center; Pharmacy, Tel Aviv, Israel|Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpigh, Bologna, Emilia-Romagna, Italy|A.O.U. Policlinico di Modena, Modena, Emilia-Romagna, Italy|Azienda Ospedaliero Universitaria di Parma; Clinica Pediatrica, Parma, Emilia-Romagna, Italy|Azienda Ospedaliera San Camillo Forlanini, Roma, Lazio, Italy|Policlinico Universitario Agostino Gemelli; Farmacia, Roma, Lazio, Italy|Azienda Ospedaliero Universitaria San Martino, Genova, Liguria, Italy|Asst Fatebenefratelli Sacco (Fatebenefratelli), Milano, Lombardia, Italy|Azienda Socio Sanitaria Territoriale Fatebenefratelli (Presidio Ospedale Sacco), Milano, Lombardia, Italy|Azienda Socio Sanitaria Territoriale Niguarda (Ospedale Niguarda Ca' Granda), Milano, Lombardia, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy|Ospedale di Circolo, Rho, Lombardia, Italy|Istituto Clinico Humanitas, Rozzano (MI), Lombardia, Italy|I.R.C.C.S Policlinico San Donato, San Donato Milanese (MI), Lombardia, Italy|Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milano, Molise, Italy|Ospedale Umberto I di Torino, Torino, Piemonte, Italy|Azienda Ospedaliera Universitaria Policlinico G. Martino; Dip. sperimentale Medicina e Farmacologia, Messina, Sicilia, Italy|Azienda Ospedaliera Vincenzo Cervello, Palermo, Sicilia, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, Toscana, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, Toscana, Italy|Azienda Ospedaliera di Padova, Padova, Veneto, Italy|Inje University Busan Paik Hospital, Busan, Korea, Republic of|Dong-A University Hospital, Busan, Korea, Republic of|Pusan National University Hospital, Busan, Korea, Republic of|Keimyung University Dongsan Hospital, Daegu, Korea, Republic of|Kyungpook National University Hospital, Daegu, Korea, Republic of|Yeungnam Univ. Hospital, Daegu, Korea, Republic of|Hanyang University Guri Hospital, Gyeonggi-do, Korea, Republic of|Korea University Ansan Hospital, Gyeonggi-do, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of|CHA Bundang Medical Centre; CHA university, Seongnam, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Korea, Republic of|The Catholic University of Korea St. Vincent's Hospital, Suwon-si,, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wonju-Si, Korea, Republic of|Riga East Clinical University Hospital, clinic ""Gailezers""; Department of Endoscopy, Riga, Latvia|Pauls Stradins Clinical University Hospital, Rīga, Latvia|Digestive Diseases Center ""Gastro"", Rīga, Latvia|Hospital of Lithuanian University of Health. Sciences Kaunas Clinics, Kaunas, Lithuania|Vilnius University Hospital Santariskiu Clinics, Public Inst; Department of Clinical Pharmacology, Vilnius, Lithuania|Hopitaux Robert Schuman, Luxembourg, Luxembourg|Gastro Medical, Mexicali, BAJA California, Mexico|Clinical Research Institute, Tlalnepantla de Baz, Mexico CITY (federal District), Mexico|Centro Regiomontano de Estudios Clínicos Roma S.C., Monterrey, Nuevo LEON, Mexico|Medical Care & Research SA de CV, Mérida, Yucatan, Mexico|Hospital Angeles Chihuahua, Chihuahua, Mexico|Hospital Angeles Lindavista, Mexico, Mexico|Universidad Autonoma De Nuevo Leon, Hospital Universitario Doctor Jose Eleuterio Gonzalez, Monterrey, Mexico|Sanatorio la Luz, Morelia, Mexico|Centro de Investigacion Torre Medica Sanatorio Toluca, Toluca de Lerdo, Mexico|Amsterdam UMC, Locatie VUMC; Gastroenterology, Amsterdam, Netherlands|Amsterdam UMC Location AMC, Amsterdam, Netherlands|Amphia Ziekenhuis, Breda, Netherlands|Leids Universitair Medisch Centrum; Cardiology, Leiden, Netherlands|Maastricht University Medical Center, Maastricht, Netherlands|Erasmus Medisch Centrum, Rotterdam, Netherlands|Zuyderland Medisch Centrum - Sittard Geleen, Sittard-Geleen, Netherlands|ETZ TweeSteden, Tilburg, Netherlands|UMC Utrecht, Utrecht, Netherlands|North Shore Hospital, Auckland, New Zealand|Christchurch Hospital NZ, Christchurch, New Zealand|Dunedin Public Hospital, Dunedin, New Zealand|Waikato Hospital, Hamilton, New Zealand|Hutt Hospital, Lower Hutt, New Zealand|Shakespeare Specialist Group, Takapuna, New Zealand|Tauranga Hospital, Tauranga, New Zealand|Wellington Hospital, Wellington, New Zealand|SP ZOZ Wojewodzki Szpital Zespolony im. J. Sniadeckiego, Białystok, Poland|Nasz Lekarz Osrodek Badan Klinicznych, Bydgoszcz, Poland|Centrum Medyczne LUKA MED.Joanna Łuka, Chojnice, Poland|Elblaski Szpital Specjalistyczny z Przychodnia SP ZOZ, Elblag, Poland|7 Szpital Marynarki Wojennej z Przychodnia SPZOZ im. W. Lasinskiego, Gdansk, Poland|Pro Familia Altera Sp z o.o., Katowice, Poland|ETG Kielce, Kielce, Poland|Centrum Opieki Zdrowotnej Orkan-Med, Ksawerow, Poland|NZOZ Centrum Medyczne Szpital Sw. Rodziny, Lodz, Poland|Indywidualna Specjalistyczna Praktyka Lekarska, Lublin, Poland|Allmedica Badania Kliniczne Sp z o.o. Sp K., Nowy Targ, Poland|SOLUMED Centrum Medyczne, Poznań, Poland|Centrum Medyczne ""MEDYK"", Rzeszow, Poland|Centrum Medyczne Medyk, Rzeszow, Poland|Gabinet Lekarski, Bartosz Korczowski, Rzeszów, Poland|Specjalistyczna Praktyka Lekarska Dr med. Marek Horynski; endoskopia, Sopot, Poland|Niepubliczny Zaklad Opieki Zdrowotnej SONOMED, Szczecin, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Gastromed Kopon Zmudzinski i Wspolnicy Sp.j.Specjalistyczne Centrum Gastrologii i Endoskopii Specj, Toruń, Poland|Specjalistyczne Gabinety Lekarskie Body Clinic, Warszawa, Poland|Centrum Zdrowia MDM, Warszawa, Poland|Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Zespó Przychodni Specjalistycznych PRIMA, Warszawa, Poland|Centrum Onkologii-Instytut im. M. Sklodowskiej Curie, Warszawa, Poland|Nzoz Vivamed, Warszawa, Poland|LexMedica Osrodek Badan Klinicznych, Wroclaw, Poland|Ars-Medica S.C Rybak Maria, Rybak Zbigniew, Wroclaw, Poland|EMC Instytut Medyczny S.A., Wrocław, Poland|AppleTreeClinics Sp. z o.o., Łódź, Poland|Institutul Clinic Fundeni Bucuresti, Bucharest, Romania|S.C MedLife S.A, Bucuresti, Romania|Spitalul Clinic Colentina, Sector 2, Romania|Centrul de Gastroenterologie Dr. Goldis, Timisoara, Romania|Baltic Medicine, St.Petersburg, Leningrad, Russian Federation|LLC Medinet, Sankt-peterburg, Sankt Petersburg, Russian Federation|North-Western Medical University n.a. I.I. Mechnikov; Rheumatology, Sankt-peterburg, Sankt Petersburg, Russian Federation|SBIH City Clinical Hospital #31, Sankt-peterburg, Sankt Petersburg, Russian Federation|SBEI HPE Altai StateMedicalUniversityofMoH andSD, Barnaul, Russian Federation|Irkutsk State Medical Academy of Continuing Education, Irkutsk, Russian Federation|SBI HPE KSMU MoH and SD of RF; Chair of Hospital Therapy, Kazan, Russian Federation|FSBI ""State Scientific Centre of Coloproctology"" of the MoH of RF, Moscow,, Russian Federation|FSBIH Central Clinical Hospital of RAS, Moscow, Russian Federation|LEC at SBIH of Moscow ""City Clinical Hospital # 24""; Gastroenterology, Moscow, Russian Federation|SBEIHPE Novosibirsk State Medical University, Novosibirsk, Russian Federation|FSBSI ""Scientific and Research Institute of Physiology and Basic Medicine"", Novosibirsk, Russian Federation|BHI of Omsk region Clinical Oncology Dispensary, Omsk, Russian Federation|Evromedservis LCC, Pushkin, Russian Federation|SEIH Prof. Education Rostov SMUH and social development, Rostov-on-Don, Russian Federation|SEIHPE ""Rostov SMU of MoH of RF"", Rostov-on-Don, Russian Federation|Federal State Military Educational Inst. of High Prof. Edu Military Medical Acad; Therapy department, Saint-Petersburg, Russian Federation|NonState Healthcare Institution Central Clinical Hospital, Samara station JSC ""Russian Railways"", Samara, Russian Federation|Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russian Federation|SPb SHI ""City Hospital #9"", St. Petersburg, Russian Federation|Stavropol Regional Clinical Diagnostic Consultative Center, Stavropol, Russian Federation|Stavropol Regional Clinical Diagnostic Centre, Stavropol, Russian Federation|SHI Ulyanovsk Reg Clinical Hospital, Ulyanovsk, Russian Federation|SBHI of Yaroslavl region Clinical hospital #10; Vascular surgery, Yaroslavl, Russian Federation|Clinical Center of Serbia, Belgrade, Serbia|Clinical Center Zvezdara, Belgrade, Serbia|Military Medical Academy, Belgrade, Serbia|Clinical Center Zemun, Belgrade, Serbia|Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia|Clinical Center Nis, NIS, Serbia|Clinical Center of Vojvodina, Novi Sad, Serbia|General Hospital Djordje Joanovic, Zrenjanin, Serbia|Cliniq s.r.o., Bratislava, Slovakia|Univerzitna nemocnica Bratislava, Nemocnica Ruzinov, Bratislava, Slovakia|IBDcentrum s.r.o., Bratislava, Slovakia|MEDAK s.r.o., Bratislava, Slovakia|KM Management spol. s r.o., Nitra, Slovakia|Poliklinika Libris, Nove Mesto nad Vahom, Slovakia|Frantisek Horvath- GEA, Sahy, Slovakia|Endomed, s.r.o., Vranov nad Topľou, Slovakia|Netcare Universitas Private Hospital, Bloemfontein, South Africa|Dr D Epstein Practice, Cape Town, South Africa|Tiervlei Trial Centre; Karl Bremer Hospital, Cape Town, South Africa|Dr JP Wright Practice, Cape Town, South Africa|Dr N Aboo Practice, Durban, South Africa|Dr HR Schneider Practice, Johannesburg, South Africa|Emmed Research, Pretoria, South Africa|CCM Ziady Practice, Pretoria, South Africa|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Clínic i Provincial; Servicio de Farmacia, Barcelona, Spain|Centro Médico Teknon, Barcelona, Spain|Hospital Reina Sofia; Medical Oncology, Cordoba, Spain|Hospital Universitari de Girona Dr Josep Trueta, Girona, Spain|Hospital Juan Ramón Jiménez, Huelva, Spain|Hospital Universitario de la Princesa, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario de Fuenlabrada, Madrid, Spain|Hospital Clinico Universitario Virgen de la Victoria, Malaga, Spain|Complejo Hospitalario de Pontevedra, Pontevedra, Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Universitario Nuestra Señora de Valme, Sevilla, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain|Skånes Universitetssjukhus, Lund, Sweden|Karolinska Universitetssjukhuset, Solna, Stockholm, Sweden|Danderyds Sjukhus AB, Stockholm, Sweden|Akademiska Sjukhuset, Uppsala, Sweden|Inselspital-Universitaetsspital Bern, Bern, Switzerland|Crohn-Colitis Zentrum Bern - Gemeinschaftspraxis Balsiger, Seibold und Partner, Bern, Switzerland|Kantonsspital St.Gallen, St. Gallen, Switzerland|Universitätsspital Zürich, Zürich, Switzerland|Ankara University Medical Faculty, Ankara, Turkey|Hacettepe University Medical Faculty; Gastroenterology, Ankara, Turkey|Ankara Diskapi Yildirim Beyazit Training and Research Hospital; Gastroenterology, Ankara, Turkey|Gazi University Medical Faculty, Ankara, Turkey|Firat University Medical Faculty; Infectious Diseases, Elazig, Turkey|Gaziantep University Medical Faculty Sahinbey Educational Research Hospital; Cocuk Kardiyolojisi, Gaziantep, Turkey|Bezmialem Foundation University, Istanbul, Turkey|Acibadem Fulya Hospital; Neurology, Istanbul, Turkey|Haydarpasa Numune Training and Research Hospital; Gastroenterology, Istanbul, Turkey|Marmara University Pendik Training and Research Hospital; Gastroenterelogy, Istanbul, Turkey|Ege University Medical Faculty, Izmir, Turkey|Medeniyet University Goztepe Training and Research Hospital., Kadiköy, Turkey|Kocaeli Universitesi Tip Fakultesi; Infectious Diseases, Kocaeli, Turkey|Acibadem Kozyatagi Hospital; Gastroenterology, Kozyataği, Turkey|Medical Center Dopomoga Plus, Kyiv, Chernihiv Governorate, Ukraine|Municipal Noncommercial Enterprise City Clinical Hospital, Lviv, Chernihiv Governorate, Ukraine|CNE Prof. O.O. Shalimov Kharkiv City Clinical Hospital #2 of KCC, Kharkiv, Kharkiv Governorate, Ukraine|CI of Healthcare Kharkiv Reg Clin Hosp-Center of Med Emergency & Accident Medicine, Kharkiv, Kharkiv Governorate, Ukraine|Kyiv Clinical Hospital on Railway Station of Healthcare Center branch of JSC, Kyiv, Kharkiv Governorate, Ukraine|Kyiv Railway Clinical Hospital#2 of Branch Health Center of the PJSC, Kyiv, Kharkiv Governorate, Ukraine|Medical Center of Limited Liability Company Medical Center Concilium Medical, Kyiv, Kharkiv Governorate, Ukraine|CI of SRC Sumy RCH Dept of Gasroenterology Sumy SU MI, Sumy, Kharkiv Governorate, Ukraine|Medical Center of Limited Liability Company Medical Clinic Blagomed, Kyiv, KIEV Governorate, Ukraine|Med Center of International Institute of Clinical Trials LLC; Medical Center ""OK!Clinic+"", Kyiv, KIEV Governorate, Ukraine|CI of Kyiv RC Regional Clinical Hospital #2, Kyiv, KIEV Governorate, Ukraine|Salutas Medical Centre, Lviv, KIEV Governorate, Ukraine|Lviv Regional Clinical Hospital, Lviv, KIEV Governorate, Ukraine|Lviv Municipal City Clinical Hospital Dept of Gastroenterology; Internal diseases, Lviv, KIEV Governorate, Ukraine|Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, Kuban People's Republica, Ukraine|Khmelnytska Regional Hospital, Khmelnytskyi, Podolia Governorate, Ukraine|Transcarpathian Regional Clinical Hospital n a Andriy Novak; Gastroenterology department, Uzhgorod, Polissya Okruha, Ukraine|Kremenchuk first city hospital n.a. O.T. Bohaievskyi; Gastroenterology department, Kremenchuk, Poltava Governorate, Ukraine|CI City Hospital #1, Zaporizhzhia, Tavria Okruha, Ukraine|Communal Enterprise Volyn Regional Clinical Hospital of Volyn Regional Council, Lutsk, Volhynian Governorate, Ukraine|RCI Chernivtsi RCH Dep of Surgery Bukovinian SMU, Chernivtsi, Ukraine|RCI Chernivtsi RCH Gastroenterology Bukovinsky SMU, Chernivtsi, Ukraine|GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine, Kharkiv, Ukraine|CHI Kharkiv City Clinical Hospital #13, Kharkiv, Ukraine|Kyiv CCH #18 Dept of Proctology O. O. Bogomolets NMU, Kyiv, Ukraine|Order of the Red Star MMMCC MMCH Clinic of Gastroenterology, Kyiv, Ukraine|CNI Consultative and Diagnostic Center of Desnianskyi District of Kyiv, Kyiv, Ukraine|City Hospital #1, Mykolaiv, Ukraine|Railway Transport Odesa CH of Healthcare Ctr Branch of PJSC Ukrainian Railway Dept of Therapy #2, Odesa, Ukraine|Private Small Enterprise Medical Center Pulse, Vinnytsia, Ukraine|M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU, Vinnytsia, Ukraine|MCIC MC LLC Health Clinic, Vinnytsia, Ukraine|CI Zapor City Multifunctional CH#9 City Center of Gastroenterology SI Zapor MA of PGE of MOHU, Zaporizhzhia, Ukraine|LLC Diaservis, Zaporizhzhia, Ukraine|Royal Victoria Hospital, Belfast, United Kingdom|The Royal Bournemouth Hospital, Bournemouth, United Kingdom|Addenbrooke's Hospital, Cambridge, United Kingdom|University Hospital Coventry, Coventry, United Kingdom|Western General Hospital, Edinburgh, United Kingdom|Royal Devon and Exeter Hospital (Wonford), Exeter, United Kingdom|Glasgow Royal Infirmary, Glasgow, United Kingdom|St Mark's Hospital, Harrow, United Kingdom|Queen Elizabeth Hospital, Kings Lynn, United Kingdom|St James University Hospital, Leeds, United Kingdom|Royal Liverpool University Hospital, Liverpool, United Kingdom|Whipps Cross Hospital, London, United Kingdom|University College London Hospital, London, United Kingdom|Chelsea & Westminster Hospital, London, United Kingdom|Fairfield General Hospital, Manchester, United Kingdom|James Cook Uni Hospital, Middlesborough, United Kingdom|Royal Victoria Infirmary; Stroke unit, Newcastle Upon Tyne, United Kingdom|Daisy Hill Hospital, Newry, United Kingdom|Norfolk and Norwich University Hospital, Norwich, United Kingdom|Nottingham University Hospitals Queen's Medical Centre, Nottingham, United Kingdom|Royal Berkshire Hospital, Reading, United Kingdom|Salford Royal, Salford, United Kingdom|Southampton General Hospital, Southampton, United Kingdom|Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom|The Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02403323"
658,"NCT02394028","A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease","BERGAMOT","Recruiting","No Results Available","Crohn Disease","Drug: Etrolizumab|Drug: Placebo","Induction Phase: Percentage of Participants with Clinical Remission at Week 14|Induction Phase: Percentage of Participants with Endoscopic Improvement at Week 14|Maintenance Phase: Percentage of Participants with Clinical Remission at Week 66|Maintenance Phase: Percentage of Participants with Endoscopic Improvement at Week 66|Induction Phase: Percentage of Participants with Clinical Remission at Week 6|Induction Phase: Percentage of Participants with SES-CD Score ≤4 (≤2 for Ileal Participants), with No Segment Having a Subcategory Score Greater than (>)1, at Week 14|Induction Phase: Change from Baseline in Crohn's Disease-Patient-Reported Outcome Signs and Symptoms (CD-PRO/SS) Score at Week 14|Maintenance Phase: Percentage of Participants with Clinical Remission at Week 66, Among Those who Achieved Clinical Remission at Week 14|Maintenance Phase: Percentage of Participants with Corticosteroid-Free Clinical Remission at Week 66, Among Those who Were Receiving Corticosteroids at Baseline|Maintenance Phase: Percentage of Participants with Endoscopic Improvement at Week 66 Among Participants who Achieved Endoscopic Improvement at Week 14|Maintenance Phase: Percentage of Participants with SES-CD Score ≤4 (≤2 for Ileal Participants), with No Segment Having a Subcategory Score >1, at Week 66|Maintenance Phase: Percentage of Participants with Durable Clinical Remission|Maintenance Phase: Percentage of Participants with Corticosteroid-Free Clinical Remission for at Least 24 Weeks at Week 66, Among Those who Were Receiving Corticosteroids at Baseline|Maintenance Phase: Change from Baseline in CD-PRO/SS Score at Week 66|Overall Number of Participants who Experienced at Least One Adverse Event by Severity, According to National Cancer Institute Common Terminology Criteria for Adverse Events, Version 4.0 (NCI-CTCAE v4.0)|Overall Number of Participants with Adverse Events Leading to Study Drug Discontinuation|Overall Number of Participants who Experienced at Least One Infection-Related Adverse Event by Severity, According to NCI-CTCAE v4.0|Overall Number of Participants who Experienced at Least One Infection-Related Serious Adverse Event|Overall Number of Participants who Experienced at Least One Injection-Site Reaction by Severity, According to NCI-CTCAE v4.0|Overall Number of Participants who Experienced at Least One Hypersensitivity Reaction by Severity, According to NCI-CTCAE v4.0|Overall Number of Participants who Develop Malignancies|Percentage of Participants With Anti-Therapeutic Antibodies (ATAs) to Etrolizumab|Observed Trough Serum Concentration (Cmin) of Etrolizumab","Hoffmann-La Roche","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 3","1150","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","GA29144|2014-003824-36","March 20, 2015","July 31, 2021","November 27, 2021","March 20, 2015",,"June 4, 2021","Moore Clinical Trials, LLC, Sherwood, Arkansas, United States|Valley Gastroenterology Consultants, Arcadia, California, United States|Ventura County Gastroenterology, Camarillo, California, United States|Valley View Internal Medicine, Garden Grove, California, United States|Valley Gastroenterology Cnslts, Glendora, California, United States|University of California San Diego Medical Center, La Jolla, California, United States|Therapeutic Research Institute of Orange County, Laguna Hills, California, United States|VA Long Beach Healthcare System, Long Beach, California, United States|United Medical Doctors, Los Alamitos, California, United States|California Medical Research Associates, Inc., Northridge, California, United States|University of California, Irvine Medical Center, Orange, California, United States|Digestive Care Associates, A Medical Corporation, San Carlos, California, United States|Clinical Applications Laboratories, Inc., San Diego, California, United States|University of California at San Francisco (PARENT); Gastroenterology, Hepatology & Nutrition, San Francisco, California, United States|Ventura Clinical Trials, Ventura, California, United States|ABS Health, LLC, Whittier, California, United States|Peak Gastroenterology Associates; Gastroenterology, Colorado Springs, Colorado, United States|Rocky Mountain Gastroenterology Associates, Denver, Colorado, United States|Rocky Mountain Gastroenterology Associates, P.L.L.C.; Gastroenterology, Lakewood, Colorado, United States|Medical Research Center of Connecticut, LLC, Hamden, Connecticut, United States|Innovative Medical Research of South Florida, Aventura, Florida, United States|West Central Gastroenterology d/b/a Gastro Florida, Clearwater, Florida, United States|GastroCare; Digestive Care Research, Coral Springs, Florida, United States|Jesscan Medical Research, Doral, Florida, United States|University of Florida College of Medicine, Gainesville, Florida, United States|The Center for Gastrointestinal Disorders, Hollywood, Florida, United States|Borland-Groover Clinic, Jacksonville, Florida, United States|Borland-Groover Clinic, Jacksonville, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|Center for Advanced Gastroenterology, Maitland, Florida, United States|IMIC, Inc, Miami Beach, Florida, United States|City Medical Group, Miami, Florida, United States|Advanced Clinical Research of Miami, Miami, Florida, United States|Regenerate Clinical Trials, Miami, Florida, United States|FQL Research, LLC, Miramar, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|Advanced Research Institute, New Port Richey, Florida, United States|Med-Care Research, North Miami Beach, Florida, United States|Medical Research Group of Central Florida, Orange City, Florida, United States|Internal Medicine Specialists, Orlando, Florida, United States|International Clinical Research, Sanford, Florida, United States|University of South Florida, Tampa, Florida, United States|Advanced Research Institute, Inc., Trinity, Florida, United States|Cleveland Clinic Florida - Weston; Department of Gastroenterology, Weston, Florida, United States|Shafran Gastroenterology Center, Winter Park, Florida, United States|Emory University Hospital, Atlanta, Georgia, United States|Agile Clinical Research Trials, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Gastrointestinal Diseases Research, Columbus, Georgia, United States|Atlanta Center for Gastroenterology, PC, Decatur, Georgia, United States|Gastroenterology Associates of Central Georgia, Macon, Georgia, United States|Gastrointestinal Specialists of Georgia, PC, Marietta, Georgia, United States|Atlanta Gastroenterology Specialists, PC, Suwanee, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|Advanced Clinical Research, Meridian, Idaho, United States|Northwestern University-Feinberg School of Medicine; Division of Gastroenterology and Hepatology, Chicago, Illinois, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|NorthShore University HealthSystem; Evanston Hospital, Evanston, Illinois, United States|Southwest Gastroenterology; DM Clinical Research, Oak Lawn, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|Investigators Research Group, LLC, Brownsburg, Indiana, United States|Indiana University, Indianapolis, Indiana, United States|Aquiant Research, New Albany, Indiana, United States|Iowa Digestive Disease Center, Des Moines, Iowa, United States|Cotton-O'Neil Clinical Research Center, Digestive Health, Topeka, Kansas, United States|University of Louisville, Elizabethtown, Kentucky, United States|University of Kentucky Medical Center, Lexington, Kentucky, United States|Gastroenterology Associates, LLC, Baton Rouge, Louisiana, United States|Houma Digestive Health, Houma, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Gastro Associates, Elkridge, Maryland, United States|Gastroenterology Associates, Elkridge, Maryland, United States|Charm City Research - Prn, Towson, Maryland, United States|Massachusetts General Hospital; Crohn's & Colitis Center, Boston, Massachusetts, United States|Commonwealth Clinical Studies, Brockton, Massachusetts, United States|Community Clinical Research Network, Marlborough, Massachusetts, United States|University of Michigan Health System, Ann Arbor, Michigan, United States|Clin. Rsrch Inst. of Michigan, Chesterfield, Michigan, United States|Gastroenterology Associates of Western Michigan, P.L.C., Grand Rapids, Michigan, United States|The iResearch Group, LLC, Southfield, Michigan, United States|Center for Digestive Health, Troy, Michigan, United States|Henry Ford Health System, West Bloomfield, Michigan, United States|Mayo Clinic - Rochester; Gastrology, Rochester, Minnesota, United States|University of Mississippi Medical Center; Division of Gastroenterology, Jackson, Mississippi, United States|Ehrhardt Clinical Research, LLC, Belton, Missouri, United States|Quality Clinical Research, Omaha, Nebraska, United States|Gastroenterology Associates of New Jersey, Clifton, New Jersey, United States|Atlantic Digestive Health Institute at Morristown, Morristown, New Jersey, United States|AGA Clinical Research Associates, LLC, Twp, New Jersey, United States|Gastroenterology Group of South Jersey, Vineland, New Jersey, United States|Allied Gastrointestinal Associates, PA, Voorhees, New Jersey, United States|Long Island Clin Rsch Asc, LLP, Great Neck, New York, United States|North Shore/Long Island Jewish PRIME, Great Neck, New York, United States|Concorde Medical Group, New York, New York, United States|Concorde Medical Group, New York, New York, United States|Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York, New York, United States|Westside Internal Medicine, New York, New York, United States|M.D. Gastroenterology, New York, New York, United States|Mount Sinai - PRIME, New York, New York, United States|Lenox Hill Hospital, New York, New York, United States|Premier Medical Group of the Hudson Valley PC, Poughkeepsie, New York, United States|Asheville Gastroenterology Associates, P.A.; Gastroenterology, Asheville, North Carolina, United States|University of North Carolina At Chapel Hill, Chapel Hill, North Carolina, United States|Charlotte Gastroenterology and Hepatology, P.L.L.C, Charlotte, North Carolina, United States|Cumberland Research Associates, Llc, Fayetteville, North Carolina, United States|Clinical Research of Gastonia, Gastonia, North Carolina, United States|Atlantic Medical Group, Kinston, North Carolina, United States|Kinston Medical Specialists, Kinston, North Carolina, United States|Consultants for Clinical Research Inc., Cincinnati, Ohio, United States|UC Health Clinical Trials Office, Cincinnati, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|Advanced Medical Research, Maumee, Ohio, United States|Great Lakes Gastroenterology Research, LLC, Mentor, Ohio, United States|Central Sooner Research, Norman, Oklahoma, United States|Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, United States|Digestive Disease Specialists, Inc., Oklahoma City, Oklahoma, United States|Jackson Siegelbaum Gastroenterology, Harrisburg, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Innovative Clinical Research, Greenville, South Carolina, United States|Clinical Trials of South Carolina, North Charleston, South Carolina, United States|Clinical Research of Rock Hill, Rock Hill, South Carolina, United States|Gastroenterology Center of the MidSouth PC, Germantown, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Physicians Medical Research Group, LLC, Arlington, Texas, United States|Texas Digestive Disease Consultants - Dallas, Dallas, Texas, United States|University of Texas Southwestern Medical Center; Internal Medicne, Dallas, Texas, United States|Baylor College of Medicine; Gastroenterology, Houston, Texas, United States|Methodist Hospital Research Institute, Houston, Texas, United States|Gastroenterology Research of San Antonio, LLC, San Antonio, Texas, United States|Wellness Clinical Research Center, San Antonio, Texas, United States|Texas Digestive Disease Consultants - Southlake, Southlake, Texas, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Ericksen Research and Development, Clinton, Utah, United States|University of Utah School of Medicine, Salt Lake City, Utah, United States|Granger Medical Clinic, West Valley City, Utah, United States|University of Virginia; Gastroenterology and Hepatology, Charlottesville, Virginia, United States|Digestive and Liver Disease Specialists, Ltd., Norfolk, Virginia, United States|McGuire Research Institute; Gastroenterology, Richmond, Virginia, United States|Virginia Commonwealth Uni Health Center, Richmond, Virginia, United States|Gastroenterology Consultants and Endoscopy Center of Southwest Virginia, Roanoke, Virginia, United States|Digestive Disease Institute; Virginia Mason Medical Center, Seattle, Washington, United States|University of Washington School of Medicine, Seattle, Washington, United States|Swedish Medical Center, Seattle, Washington, United States|University of Wisconsin, Madison, Wisconsin, United States|Hospital Italiano, Buenos Aires, Argentina|Instituto Medico DAMIC, Cordoba, Argentina|Hospital Italiano de La Plata, La Plata, Argentina|Asociacion Civil para la Investigacion Gastroenterologica, Lomas de Zamora, Argentina|Hospital Privado de Comunidad; Cardiology, Mar Del Plata, Argentina|Instituto Medico CER, Quilmes, Argentina|Hospital Provincial del Centenario, Rosario, Argentina|Instituto Medico de la Fundacion Estudios Clinicos, Rosario, Argentina|The Canberra Hospital, Garran, Australian Capital Territory, Australia|Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, Australia|University of the Sunshine Coast, Sippy Downs, Queensland, Australia|Mater Adult Hospital, South Brisbane, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|Launceston General Hospital; Gastroenterology Research, Launceston, Tasmania, Australia|Monash Medical Centre Clayton, Clayton, Victoria, Australia|St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|Footscray Hospital; Gastroenterology, Footscray, Victoria, Australia|Austin Hospital, Heidelberg, Victoria, Australia|Emeritus Research, Malvern East, Victoria, Australia|St Frances Xavier Cabrini Hospital, Malvern, Victoria, Australia|Alfred Hospital, Melbourne, Victoria, Australia|Royal Melbourne Hospital; Department of Colorectal Medicine and Genetics, Parkville, Victoria, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, Australia|Medizinische Universität Innsbruck, Innsbruck, Austria|Klinikum Klagenfurt am Wörtersee; Abt.Gastroenterologie&Hepatologie,Endokrinologie, Klagenfurt, Austria|LKH - Universitätsklinikum der PMU Salzburg, Salzburg, Austria|Medizinische Universität Wien, Wien, Austria|CHU St Pierre (St Pierre), Brussels, Belgium|UZ Brussel, Brussel, Belgium|Hospital Erasme, Bruxelles, Belgium|Cliniques Universitaires St-Luc, Bruxelles, Belgium|UZ Antwerpen, Edegem, Belgium|AZ Maria Middelares, Gent, Belgium|AZ Sint Lucas (Sint Lucas), Gent, Belgium|AZ Sint Elisabeth Herentals, Herentals, Belgium|AZ Groeninge, Kortrijk, Belgium|UZ Leuven; Maag, -darm en leverziekten/endoscopie - Endoscopy, Leuven, Belgium|AZ Delta (Campus Rumbeke), Roeselare, Belgium|Hospital Universitario Walter Cantidio - UFC, Fortaleza, CE, Brazil|CCBR - Brasilia, Brasilia, DF, Brazil|CEDOES - Diagnóstico e Pesquisa, Vitoria, ES, Brazil|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Ltda, Goiânia, GO, Brazil|Hospital Felicio Rocho, Belo Horizonte, MG, Brazil|Centro Mineiro de Pesquisa - CMIP, Juiz de Fora, MG, Brazil|Eurolatino Pesquisas Médicas Ltda., Uberlandia, MG, Brazil|Eurolatino Pesquisas Médicas Ltda., Uberlandia, MG, Brazil|Centro Digestivo de Curitiba, Curitiba, PR, Brazil|Hospital Universitario Gaffree e Guinle, Rio de Janeiro, RJ, Brazil|Hospital Universitario Clementino Fraga Filho - UFRJ; Gastroenterologia, Rio de Janeiro, RJ, Brazil|Hospital São Vicente de Paulo; Institute of Education and Reseach / Cardiovascular Research Unit, Passo Fundo, RS, Brazil|Hospital das Clinicas - UFRGS, Porto Alegre, RS, Brazil|Hospital Ernesto Dornelles, Porto Alegre, RS, Brazil|Centro de Pesquisa Clinica Maimonides - Maimonides Day Hospital, Porto Alegre, RS, Brazil|Hospital Sao Lucas da PUCRS*X, Porto Alegre, RS, Brazil|Clinica de Neoplasias Litoral, Itajai, SC, Brazil|Oncoeste Pesquisa Clinica - HUST - Hospital Universitario Santa Terezinha, Joacaba, SC, Brazil|UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu, Botucatu, SP, Brazil|Allergisa Pesquisa Dermato-Cosmética Ltda, Campinas, SP, Brazil|CAEP - Centro Avancado de Estudos e Pesquisas Ltda., Campinas, SP, Brazil|Pesquisare Saúde Sociedade Simples, Santo Andre, SP, Brazil|Praxis Pesquisa Médica, Santo Andre, SP, Brazil|Hospital Estadual Mario Covas, Santo Andre, SP, Brazil|Irmandade da Santa Casa da Misericórdia de Santos, Santos, SP, Brazil|Hospital de Base de Sao Jose do Rio Preto, Sao Jose do Rio Preto, SP, Brazil|Hospital Sírio-Libanês, Sao Paulo, SP, Brazil|Universidade Federal de Sao Paulo - UNIFES, Sao Paulo, SP, Brazil|Hospital do Servidor Público Estadual/HSPE-SP, São Paulo, SP, Brazil|Medical Centre ""Asklepii"", OOD, Dupnitsa, Bulgaria|MHAT ""Lyulin"", EAD, Sofia, Bulgaria|""City Clinic UMHAC"" EOOD, Sofia, Bulgaria|DCC ""Sarce i Zdrave"", OOD, Sofia, Bulgaria|MHAT Tokuda Hospital Sofia, AD, Sofia, Bulgaria|UMHAT ""Sv. Ivan Rilski"", EAD, Sofia, Bulgaria|UMHAT Tsaritsa Yoanna - ISUL, EAD, Sofia, Bulgaria|Military Medical Academy - MHAT - Sofia, Sofia, Bulgaria|MC ""Health BG"", EOOD, Sofia, Bulgaria|MHAT SofiaMed; OOD, Sofia, Bulgaria|Medical Center ""Nov Rehabilitatsionen Tsentar"", EOOD, Stara Zagora, Bulgaria|MHAT 'Sv. Marina', EAD, Varna, Bulgaria|MHAT 'Hristo Botev' AD, Vratsa, Bulgaria|University of Calgary, Calgary, Alberta, Canada|Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology, Edmonton, Alberta, Canada|Pacific Gastroenterology Associates, Vancouver, British Columbia, Canada|Winnipeg Regional Health Authority, Winnipeg, Manitoba, Canada|Queen Elizabeth II Health Sciences Centre; Gastroenterology Research, Halifax, Nova Scotia, Canada|Surrey GI Research Inc., Guelph, Ontario, Canada|McMaster University Health Sciences Center; Medicine, Hamilton, Ontario, Canada|Hotel Dieu Hospital; Gastroenterology, Kingston, Ontario, Canada|University Hospital - London Health Sciences Centre, London, Ontario, Canada|Taunton Health Centre, Oshawa, Ontario, Canada|The Ottawa Hospital - Riverside Campus; Gastrointestinal Clinical Research Unit, Ottawa, Ontario, Canada|Northeastern Ontario Medical Offices, Sudbury, Ontario, Canada|Humber River Hospital, Toronto, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Toronto Liver Centre, Toronto, Ontario, Canada|Toronto Digestive Disease Associates, Vaughan, Ontario, Canada|Hotel Dieu de Levis, Levis, Quebec, Canada|Hôpital Maisonneuve - Rosemont, Montreal, Quebec, Canada|Jewish General Hospital, Montreal, Quebec, Canada|McGill University Health Centre - Glen Site, Montreal, Quebec, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada|Clinical Hospital Centre Osijek, Osijek, Croatia|General Hospital Pula, Pula, Croatia|Clinical Hospital Merkur, Varazdin, Croatia|General Hospital Zadar, Zadar, Croatia|Clinical Hospital Center Sestre Milosrdnice, Zagreb, Croatia|Clinical Hospital Sveti Duh, Zagreb, Croatia|University Hospital Center Zagreb, Zagreb, Croatia|Vojenska nemocnice Brno, Brno, Czechia|Fakultni nemocnice u sv. Anny v Brne, Brno, Czechia|Nemocnice Ceske Budejovice a.s., Ceske Budejovice, Czechia|Gastroenterologie s.r.o., Hradec Kralove, Czechia|Fakultni nemocnice Hradec Kralove, Hradec Kralove, Czechia|Hepato-Gastroenterologie HK, s.r.o., Hradec Kralove, Czechia|PreventaMed, s.r.o., Olomouc, Czechia|Fakultni nemocnice Ostrava, Ostrava - Poruba, Czechia|Pardubicka krajska nemocnice, a.s., Pardubice, Czechia|Fakultni nemocnice v Motole, Praha 5, Czechia|Klinicke centrum ISCARE Lighthouse, Praha 7, Czechia|Fakultni nemocnice Kralovske Vinohrady, Praha, Czechia|Orlickoustecka nemocnice, a.s., Usi Nad Orlici, Czechia|West Tallinn Central Hospital, Tallinn, Estonia|North Estonia Medical Centre Foundation, Tallinn, Estonia|Tartu University Hospital, Tartu, Estonia|CHU Amiens - Hopital Sud, Amiens, France|CHU de Caen - Hopital Cote de Nacre, Caen, France|CHU Tours - Hôpital Trousseau, Chambray les Tours, France|CHU Clermont Ferrand - Hôpital d'Estaing, Clermont Ferrand cedex 1, France|Hôpital Beaujon, Clichy cedex, France|CHU de Grenoble - Hôpital Nord, Grenoble, France|Centre Hospitalier Départemental Les Oudairies, La Roche sur Yon, France|Hopital Claude Huriez - CHU Lille, Lille, France|Hôpital Nord - CHU Marseille; Gastroenterology and Hepatology, Marseille cedex 20, France|CHU NANTES - Hôtel Dieu; Pharmacy, Nantes, France|CHU Nice - Hopital de l'Archet 2, Nice, France|Hôpital Saint-Louis, Paris, France|Groupe Hospitalier Sud - Hôpital Haut-Lévêque - USN, Pessac, France|Centre Hospitalier Lyon Sud; Service de Gastro-Enterologie, Pierre-Benite, France|CHU du Reims - Hopital Robert Debré, Reims, France|CHU Rennes - Hopital Pontchaillou, Rennes cedex 09, France|CHU de Rouen - Hôpital Charles Nicolle; Neurologie, Rouen, France|CHU Saint Etienne - Hôpital Nord, Saint Etienne, France|Höpital Hautepierre; Pediatrie1, Strasbourg, France|CHU de Toulouse - Hôpital Rangueil, Toulouse Cedex 09, France|Hôpital de Brabois Adultes, Vandoeuvre-les-nancy, France|Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany|Charite-Campus Virchow Klinikum; Hepatologie und Gastroenterologie, Berlin, Germany|Charité Campus Virchow-Klinikum; Department of Cardiology, Berlin, Germany|DRK Kliniken Berlin Westend, Berlin, Germany|Krankenhaus Waldfriede e. V., Berlin, Germany|Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH, Bochum, Germany|Staedisches Klinikum Brandenburg, Brandenburg an der Havel, Germany|Medizinisches Versorgungszentrum Dachau, Dachau, Germany|Universitätsklinikum ""Carl Gustav Carus"" der Technischen Universität Dresden, Dresden, Germany|Universitaetsklinikum Erlangen, Erlangen, Germany|Kliniken Essen-Mitte, Essen, Germany|Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt, Germany|Krankenhaus Martha-Maria Halle-Doelau, Halle (Saale), Germany|Universitaetsklinikum Halle (Saale), Halle, Germany|Hamburgisches Forschungsinstitut fuer CED, Hamburg, Germany|Universitaetsklinikum Hamburg-Eppendorf; I. Medizinische Klinik - Gastroenterologie, Hamburg, Germany|Gastroenterologie, Hamburg, Germany|Asklepios Klinik Hamburg, Hamburg, Germany|Medizinische Hochschule Hannover; Gastroenterology and Hepatology dept, Hannover, Germany|Universitaetsklinikum Jena; Apotheke des Uniersitätsklinikums Jena, Jena, Germany|Universitaetsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany|Universitätsklinikum Koeln, Koeln, Germany|Medizinisches Zentrum Klinikum Lueneburg, Lueneburg, Germany|Universitätsklinikum Schleswig-Holstein; Campus Lübeck, Lübeck, Germany|Universitaetsklinikum Magdeburg A.oe.R; Division of Cardiology, Magdeburg, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, Germany|Klinikum Mannheim GmbH Universitätsklinikum, Mannheim, Germany|Gastroenterologische Praxis Minden, Minden, Germany|Universitaetsklinikum Muenster, Muenster, Germany|Gastro Campus Research; Praxis am Germania Campus, Muenster, Germany|Klinikum rechts der Isar der Technischen Universität München, Munchen, Germany|Isar Klinik GmbH, München, Germany|LMU - Campus Grosshadern; Medizinische Klinik und Poliklinik II, München, Germany|Praxis Dr. med. Volker Aldinger UG, Neustadt, Germany|Gemeinschaftspraxis, Offenburg, Germany|Gemeinschaftspraxis Mohl, Juenglin, Hasenstein, Saarbrücken, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Germany|Universitaetsklinikum Ulm, Ulm, Germany|Internistische Praxisgemeinschaft, Weyhe, Germany|Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaza, Bekescsaba, Hungary|Szent Margit Hospital, Budapest, Hungary|Obudai Egeszsegugyi Centrum Kft., Budapest, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Magyar Elhizastudomanyi Kozp. Kft., Budapest, Hungary|Eszak-Kozep-budai Centrum, Uj Szent Janos Korhaz es Szakrendelo, Budapest, Hungary|Pannonia Maganorvosi Centrum, Budapest, Hungary|Vasutegeszsegugyi Nonprofit KiemeltenKozhasznu Kft, Debrecen, Hungary|Debreceni Egyetem, Debrecen, Hungary|Markhot Ferenc Oktato Korhaz es Rendelointezet, Eger, Hungary|Petz Aladar Megyei Oktato Korhaz, Gyor, Hungary|Békés Megyei Pándy Kálmán Kórház; Onkologiai tanszek, Gyula, Hungary|Pest Megyei Flor Ferenc Korhaz, Kistarcsa, Hungary|Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz; II. Belgyogyaszat, Miskolc, Hungary|Pecsi Tudomanyegyetem, Pecs, Hungary|Csongrad Megyei Dr. Bugyi Istvan Korhaz, Szentes, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Székesfehérvár, Hungary|Haemek Medical Center, Afula, Israel|Soroka University Medical Centre, Beer Sheva, Israel|Assaf Harofeh Medical Center, Beer Yaacov, Israel|Bnai Zion Medical Center; Department of Internal Medicine B, Haifa, Israel|Wolfson Medical Center; Obstetrics and Gynecology, Holon, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah University Hospital - Ein Kerem, Jerusalem, Israel|Clalit Health Services-Lev Talpiyot, Jerusalem, Israel|Holy Family Hospital, Nazareth, Israel|Rabin Medical Center-Beilinson Campus, Petach Tikva, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Kaplan Medical Center; Allergy and clinical immunology, Rechovot, Israel|Tel Aviv Sourasky Medical Center; Pharmacy, Tel Aviv, Israel|Azienda Ospedaliera S. Orsola-Malpighi, Bologna, Emilia-Romagna, Italy|A.O.U. Policlinico di Modena, Modena, Emilia-Romagna, Italy|A.O. Universitaria Di Parma, Parma, Emilia-Romagna, Italy|Azienda Ospedaliera San Camillo Forlanini, Roma, Lazio, Italy|Policlinico Universitario Agostino Gemelli; Farmacia, Roma, Lazio, Italy|Azienda Ospedaliero Universitaria San Martino, Genova, Liguria, Italy|Asst Fatebenefratelli Sacco (Fatebenefratelli), Milano, Lombardia, Italy|ASST FATEBENEFRATELLI SACCO (Sacco), Milano, Lombardia, Italy|Azienda Socio Sanitaria Territoriale Niguarda (Grande Ospedale Metropolitano Niguarda), Milano, Lombardia, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy|Ospedale di Circolo, Rho, Lombardia, Italy|Istituto Clinico Humanitas, Rozzano (MI), Lombardia, Italy|I.R.C.C.S Policlinico San Donato, San Donato Milanese (MI), Lombardia, Italy|Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milano, Molise, Italy|Ospedale Umberto I di Torino, Torino, Piemonte, Italy|Azienda Ospedaliera Universitaria Policlinico G. Martino; Dip. sperimentale Medicina e Farmacologia, Messina, Sicilia, Italy|Azienda Ospedaliera Vincenzo Cervello, Palermo, Sicilia, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, Toscana, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, Toscana, Italy|Azienda Ospedaliera di Padova, Padova, Veneto, Italy|Inje University Busan Paik Hospital, Busan, Korea, Republic of|Dong-A University Hospital, Busan, Korea, Republic of|Pusan National University Hospital, Busan, Korea, Republic of|Keimyung University Dongsan Hospital, Daegu, Korea, Republic of|Kyungpook National University Hospital, Daegu, Korea, Republic of|Yeungnam Univ. Hospital, Daegu, Korea, Republic of|Hanyang University Guri Hospital, Gyeonggi-do, Korea, Republic of|Korea University Ansan Hospital, Gyeonggi-do, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of|CHA Bundang Medical Centre; CHA university, Seongnam, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Korea, Republic of|The Catholic University of Korea St. Vincent's Hospital, Suwon-si,, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wonju-Si, Korea, Republic of|Riga East Clinical University Hospital; Clinic Gailezers, Riga, Latvia|Pauls Stradins Clinical University Hospital, Rīga, Latvia|Digestive Diseases Center ""Gastro"", Rīga, Latvia|Hospital of Lithuanian University of Health. Sciences Kaunas Clinics, Kaunas, Lithuania|Vilnius University Hospital Santariskiu Clinic, Public Institution; Cardiology, Vilnius, Lithuania|Hopitaux Robert Schuman, Luxembourg, Luxembourg|Gastro Medical, Mexicali, BAJA California, Mexico|Clinical Research Institute, Tlalnepantla de Baz, Mexico CITY (federal District), Mexico|Centro Regiomontano de Estudios Clínicos Roma S.C., Monterrey, Nuevo LEON, Mexico|Medical Care & Research SA de CV, Mérida, Yucatan, Mexico|Hospital Angeles Chihuahua, Chihuahua, Mexico|Hospital Angeles Lindavista, Mexico, Mexico|Universidad Autonoma De Nuevo Leon, Hospital Universitario Doctor Jose Eleuterio Gonzalez, Monterrey, Mexico|Centro de Investigacion Clinica Chapultepec S. A. de C. V., Morelia, Mexico|Centro de Investigacion Torre Medica Sanatorio Toluca, Toluca de Lerdo, Mexico|Amsterdam UMC, Locatie VUMC; Neurology, Amsterdam, Netherlands|Amsterdam UMC Location AMC, Amsterdam, Netherlands|Amphia Ziekenhuis, Breda, Netherlands|Leids Universitair Medisch Centrum, Leiden, Netherlands|Maastricht University Medical Center, Maastricht, Netherlands|Erasmus Medisch Centrum, Rotterdam, Netherlands|Zuyderland Medisch Centrum - Sittard Geleen, Sittard-Geleen, Netherlands|ETZ TweeSteden, Tilburg, Netherlands|UMC Utrecht, Utrecht, Netherlands|North Shore Hospital, Auckland, New Zealand|Christchurch Hospital NZ, Christchurch, New Zealand|Dunedin Public Hospital, Dunedin, New Zealand|Waikato Hospital, Hamilton, New Zealand|Hutt Hospital, Lower Hutt, New Zealand|Shakespeare Specialist Group, Takapuna, New Zealand|Tauranga Hospital, Tauranga, New Zealand|Wellington Hospital; Endocrine, Diabetes & Research Centre, Wellington, New Zealand|SP ZOZ Wojewodzki Szpital Zespolony im. J. Sniadeckiego, Białystok, Poland|Nasz Lekarz Osrodek Badan Klinicznych, Bydgoszcz, Poland|Centrum Medyczne LUKA MED.Joanna Łuka, Chojnice, Poland|Elblaski Szpital Specjalistyczny z Przychodnia SP ZOZ, Elblag, Poland|7 Szpital Marynarki Wojennej z Przychodnia SPZOZ im. W. Lasinskiego, Gdansk, Poland|Pro Familia Altera Sp z o.o., Katowice, Poland|ETG Kielce, Kielce, Poland|Centrum Opieki Zdrowotnej Orkan-Med, Ksawerow, Poland|NZOZ Centrum Medyczne Szpital Sw. Rodziny, Lodz, Poland|Indywidualna Specjalistyczna Praktyka Lekarska, Lublin, Poland|Allmedica Badania Kliniczne Sp z o.o. Sp K., Nowy Targ, Poland|SOLUMED Centrum Medyczne, Poznań, Poland|Centrum Medyczne ""MEDYK"", Rzeszow, Poland|Centrum Medyczne Medyk, Rzeszow, Poland|Gabinet Lekarski, Bartosz Korczowski, Rzeszów, Poland|Specjalistyczna Praktyka Lekarska Dr med. Marek Horynski; endoskopia, Sopot, Poland|Niepubliczny Zaklad Opieki Zdrowotnej SONOMED, Szczecin, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Gastromed Kopon Zmudzinski i Wspolnicy Sp.j.Specjalistyczne Centrum Gastrologii i Endoskopii Specj, Toruń, Poland|Specjalistyczne Gabinety Lekarskie Body Clinic, Warszawa, Poland|Centrum Zdrowia MDM, Warszawa, Poland|Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Zespó Przychodni Specjalistycznych PRIMA, Warszawa, Poland|Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Warszawa, Poland|Nzoz Vivamed, Warszawa, Poland|LexMedica Osrodek Badan Klinicznych, Wroclaw, Poland|Ars-Medica S.C Rybak Maria, Rybak Zbigniew, Wroclaw, Poland|EuroMediCare Szpital Specjalistyczny z Przychodnią we Wrocławiu, Wroclaw, Poland|AppleTreeClinics Sp. z o.o., Łódź, Poland|Institutul Clinic Fundeni Bucuresti, Bucharest, Romania|Spitalul Clinic Colentina, Bucharest, Romania|S.C MedLife S.A, Bucuresti, Romania|Centrul de Gastroenterologie Dr. Goldis, Timisoara, Romania|Yusupov Hospital, Moskva, Adygeja, Russian Federation|Baltic Medicine, St.Petersburg, Leningrad, Russian Federation|LLC Medinet, Sankt-peterburg, Sankt Petersburg, Russian Federation|North-Western Medical University n.a. I.I. Mechnikov; Rheumatology, Sankt-peterburg, Sankt Petersburg, Russian Federation|SBIH City Clinical Hospital #31, Sankt-peterburg, Sankt Petersburg, Russian Federation|SBEI HPE Altai StateMedicalUniversityofMoH andSD, Barnaul, Russian Federation|Irkutsk State Medical Academy of Continuing Education, Irkutsk, Russian Federation|SBI HPE KSMU MoH and SD of RF; Chair of Hospital Therapy, Kazan, Russian Federation|FSBIH Central Clinical Hospital of RAS, Moscow, Russian Federation|FSBI ""State Scientific Centre of Coloproctology"" of the MoH of RF; Gastroenterology, Moscow, Russian Federation|SBEIHPE Novosibirsk State Medical University, Novosibirsk, Russian Federation|FSBI ""Scientific Research Institute of Physyology and Basic Medicine"" under the SB of RAMS, Novosibirsk, Russian Federation|BHI of Omsk region Clinical Oncology Dispensary, Omsk, Russian Federation|Evromedservis LCC, Pushkin, Russian Federation|SEIH Prof. Education Rostov SMUH and social development, Rostov-on-Don, Russian Federation|SEIHPE ""Rostov SMU of MoH of RF"", Rostov-on-Don, Russian Federation|Samara Railway Clinical Hospital of OAO RZhD, Samara, Russian Federation|Federal State Military Educational Institution; High Professional Education Military Medical Acad, St. Petersburg, Russian Federation|Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russian Federation|SPb SHI ""City Hospital #9"", St. Petersburg, Russian Federation|Stavropol Regional Clinical Diagnostic Centre, Stavropol, Russian Federation|SHI Ulyanovsk Reg Clinical Hospital, Ulyanovsk, Russian Federation|SBHI of Yaroslavl region Clinical hospital #10; Vascular surgery, Yaroslavl, Russian Federation|Clinical Center of Serbia, Belgrade, Serbia|Clinical Helth Centre Zvezdara, Belgrade, Serbia|Military Medical Academy, Belgrade, Serbia|Clinical Center Zemun, Belgrade, Serbia|Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia|Clinical Center Nis, NIS, Serbia|Clinical Center of Vojvodina, Novi Sad, Serbia|General Hospital Djordje Joanovic, Zrenjanin, Serbia|Cliniq s.r.o., Bratislava, Slovakia|Univerzitna nemocnica Bratislava, Nemocnica Ruzinov, Bratislava, Slovakia|IBDcentrum s.r.o., Bratislava, Slovakia|MEDAK s.r.o., Bratislava, Slovakia|KM Management spol. s r.o., Nitra, Slovakia|Poliklinika MarMedico, Nové Mesto nad Váhom, Slovakia|Frantisek Horvath- GEA, Sahy, Slovakia|Endomed, s.r.o., Vranov nad Topľou, Slovakia|Netcare Universitas Private Hospital, Bloemfontein, South Africa|Dr D Epstein Practice, Cape Town, South Africa|Tiervlei Trial Centre; Karl Bremer Hospital, Cape Town, South Africa|Dr JP Wright Practice, Cape Town, South Africa|Dr N Aboo Practice, Durban, South Africa|Dr HR Schneider Practice, Johannesburg, South Africa|Emmed Research, Pretoria, South Africa|CCM Ziady Practice, Pretoria, South Africa|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario Puerta de Hierro Majadahonda; Hepatology studies, Majadahonda, Madrid, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Clínic i Provincial; Servicio de Farmacia, Barcelona, Spain|Centro Médico Teknon, Barcelona, Spain|Hospital Reina Sofia; Medical Oncology, Cordoba, Spain|Hospital Universitari de Girona Dr Josep Trueta, Girona, Spain|Hospital Juan Ramón Jiménez, Huelva, Spain|Hospital Universitario de la Princesa, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario de Fuenlabrada, Madrid, Spain|Hospital Clinico Universitario Virgen de la Victoria, Malaga, Spain|Complejo Hospitalario de Pontevedra, Pontevedra, Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Universitario Nuestra Señora de Valme, Sevilla, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain|Skånes Universitetssjukhus, Lund, Sweden|Karolinska Universitetssjukhuset, Solna, Stockholm, Sweden|Danderyds Sjukhus AB, Stockholm, Sweden|Akademiska Sjukhuset, Uppsala, Sweden|Inselspital-Universitaetsspital Bern, Bern, Switzerland|Crohn-Colitis Zentrum Bern - Gemeinschaftspraxis Balsiger, Seibold und Partner, Bern, Switzerland|Kantonsspital St.Gallen, St. Gallen, Switzerland|Universitätsspital Zürich, Zürich, Switzerland|Ankara University Medical Faculty, Ankara, Turkey|Hacettepe University Medical Faculty; Gastroenterology, Ankara, Turkey|Ankara Diskapi Yildirim Beyazit Training and Research Hospital; Gastroenterology, Ankara, Turkey|Gazi University Medical Faculty, Ankara, Turkey|Firat University Medical Faculty, Elazig, Turkey|Gaziantep University Medical Faculty Sahinbey Educational Research Hospital; Cocuk Kardiyolojisi, Gaziantep, Turkey|Bezmialem Foundation University, Istanbul, Turkey|Acibadem Fulya Hospital; Neurology, Istanbul, Turkey|Haydarpasa Numune Training and Research Hospital; Medical Oncology, Istanbul, Turkey|Medeniyet University Goztepe Training and Research Hospital; Chest Diseases, Istanbul, Turkey|Marmara University Pendik Training and Research Hospital, Istanbul, Turkey|Ege University Medical Faculty, Izmir, Turkey|Kocaeli Universitesi Tip Fakultesi; Infectious Diseases, Kocaeli, Turkey|Acibadem Kozyatagi Hospital; Gastroenterology, Kozyataği, Turkey|Medical Center Dopomoga Plus, Kyiv, Chernihiv Governorate, Ukraine|Municipal Noncommercial Enterprise City Clinical Hospital, Lviv, Chernihiv Governorate, Ukraine|CHI Prof.O.O.Shalimov Kharkiv City Clinical Hospital #2, Kharkiv, Kharkiv Governorate, Ukraine|CI of Healthcare Kharkiv Reg Clin Hosp-Center of Med Emergency & Accident Medicine, Kharkiv, Kharkiv Governorate, Ukraine|Kyiv Clinical Hospital on Railway Station of Healthcare Center branch of JSC, Kyiv, Kharkiv Governorate, Ukraine|Kyiv Railway Clinical Hospital#2 of Branch Health Center of the PJSC, Kyiv, Kharkiv Governorate, Ukraine|Medical Center of Limited Liability Company Medical Center Concilium Medical, Kyiv, Kharkiv Governorate, Ukraine|CI of SRC Sumy RCH Dept of Gasroenterology Sumy SU MI, Sumy, Kharkiv Governorate, Ukraine|LLC Gastroenterology Center IBD Team, Zaporizhzhia, Kharkiv Governorate, Ukraine|Medical Center of Limited Liability Company Medical Clinic Blagomed, Kyiv, KIEV Governorate, Ukraine|Med Center of International Institute of Clinical Trials LLC; Medical Center ""OK!Clinic+"", Kyiv, KIEV Governorate, Ukraine|CI of Kyiv RC Regional Clinical Hospital #2, Kyiv, KIEV Governorate, Ukraine|Salutas Medical Centre, Lviv, KIEV Governorate, Ukraine|Lviv Regional Clinical Hospital, Lviv, KIEV Governorate, Ukraine|Lviv Municipal City Clinical Hospital Dept of Gastroenterology; Internal diseases, Lviv, KIEV Governorate, Ukraine|Clinical Treatment and Diagnostic Center of Limited Liability Company, Ivano Frankivsk, Kuban People's Republica, Ukraine|Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, Kuban People's Republica, Ukraine|RCNECRCH Dept of Surgery, SHEI Ukr BSMU, Chernivtsi, Podolia Governorate, Ukraine|Khmelnytska Regional Hospital, Khmelnytskyi, Podolia Governorate, Ukraine|Transcarpathian Regional Clinical Hospital n a Andriy Novak; Gastroenterology department, Uzhgorod, Polissya Okruha, Ukraine|Kremenchuk first city hospital n.a. O.T. Bohaievskyi; Gastroenterology department, Kremenchuk, Poltava Governorate, Ukraine|CI City Hospital #1, Zaporizhzhia, Tavria Okruha, Ukraine|CI City Hospital #1, Zaporizhzhia, Tavria Okruha, Ukraine|Communal Enterprise Volyn Regional Clinical Hospital of Volyn Regional Council, Lutsk, Volhynian Governorate, Ukraine|RCI Chernivtsi Regional Clinical Hospital Dept of Gastroenterology Bukovinsky SMU, Chernivtsi, Ukraine|GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine, Kharkiv, Ukraine|CHI Kharkiv City Clinical Hospital #13, Kharkiv, Ukraine|Kyiv CCH #18 Dept of Proctology O. O. Bogomolets NMU, Kyiv, Ukraine|Order of the Red Star MMMCC MMCH Clinic of Gastroenterology, Kyiv, Ukraine|CNI Consultative and Diagnostic Center of Desnianskyi District of Kyiv, Kyiv, Ukraine|City Hospital #1, Mykolaiv, Ukraine|Railway Transport Odesa CH of Healthcare Ctr Branch of PJSC Ukrainian Railway Dept of Therapy #2, Odesa, Ukraine|Private Small Enterprise Medical Center Pulse, Vinnytsia, Ukraine|M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU, Vinnytsia, Ukraine|MCIC MC LLC Health Clinic, Vinnytsia, Ukraine|CI Zapor City Multifunctional CH#9 City Center of Gastroenterology SI Zapor MA of PGE of MOHU, Zaporizhzhia, Ukraine|LLC Diaservis, Zaporizhzhia, Ukraine|Royal Victoria Hospital, Belfast, United Kingdom|The Royal Bournemouth Hospital, Bournemouth, United Kingdom|Addenbrooke's Hospital, Cambridge, United Kingdom|University Hospital Coventry, Coventry, United Kingdom|Western General Hospital, Edinburgh, United Kingdom|Royal Devon and Exeter Hospital (Wonford), Exeter, United Kingdom|Glasgow Royal Infirmary, Glasgow, United Kingdom|St Mark's Hospital, Harrow, United Kingdom|Queen Elizabeth Hospital, Kings Lynn, United Kingdom|St James University Hospital, Leeds, United Kingdom|Royal Liverpool University Hospital, Liverpool, United Kingdom|The Royal London Hospital, London, United Kingdom|Whipps Cross Hospital, London, United Kingdom|University College London Hospital, London, United Kingdom|Chelsea & Westminster Hospital, London, United Kingdom|Fairfield General Hospital, Manchester, United Kingdom|James Cook Uni Hospital, Middlesborough, United Kingdom|Royal Victoria Infirmary; Stroke unit, Newcastle Upon Tyne, United Kingdom|Daisy Hill Hospital, Newry, United Kingdom|Norfolk and Norwich University Hospital, Norwich, United Kingdom|Nottingham University Hospitals Queen's Medical Centre, Nottingham, United Kingdom|Royal Berkshire Hospital, Reading, United Kingdom|Salford Royal, Salford, United Kingdom|Southampton General Hospital, Southampton, United Kingdom|Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom|Royal Wolverhampton hospital; McHale Building, Wolverhampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02394028"
659,"NCT02193802","Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease","CHANCE","Recruiting","No Results Available","Crohn's Disease","Device: PillCam® COLON 2 and PillCam Crohn's capsules","Evaluate the agreement between capsule and ileocolonoscopy in the change of physician global assessment (PGA) as visualized in the TI in patients under treatment.|Lewis score|Segmental ileal and global CDEIS score","Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives","All","18 Years and older   (Adult, Older Adult)","Not Applicable","42","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","GETAID 2012-3|2013-A00034-41","May 2014","December 30, 2021","March 2022","July 18, 2014",,"January 20, 2021","CHU Amiens, Amiens, France|CHU CAEN, Caen, France|CHU Clermont Ferrand, Clermont-Ferrand, France|Hôpital Beaujon, Clichy, France|CHU Kremlin Bicêtre, Le Kremlin-Bicêtre, France|Hôpital Huriez, Lille, France|Hôpital Brabois, Nancy, France|Hôpital Hôtel Dieu, Nantes, France|Hôpital Archet 2, Nice, France|Hôpital St Louis, Paris, France|Hospital Clinic, Barcelona, Spain",,"https://ClinicalTrials.gov/show/NCT02193802"
660,"NCT02193048","Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease","PROGNOS","Recruiting","No Results Available","Crohn's Disease","Other: This study will evaluate a new clinical scoring system in patients receiving routine treatment","Evaluation of a Crohn's scoring system","Ferring Pharmaceuticals","All","18 Years and older   (Adult, Older Adult)",,"500","Industry","Observational","Observational Model: Case-Only|Time Perspective: Prospective","000150","September 2014","August 2024","August 2024","July 17, 2014",,"April 13, 2021","Investigational site (there may be other sites in this country), Altenholz, Germany",,"https://ClinicalTrials.gov/show/NCT02193048"
661,"NCT02177071","A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy","SPARE","Active, not recruiting","No Results Available","Crohn's Disease","Drug: INFLIXIMAB|Drug: AZATHIOPRINE|Drug: MERCAPTOPURINE|Drug: Methotrexate","co-primary efficacy end points|relapse in each arm.|Sustained clinical remission|Treatment failure|Tissue damage progression|Endoscopic remission","Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives|Saint-Louis Hospital, Paris, France","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 4","211","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","GETAID 2014-03","October 9, 2015","March 2021","September 2021","June 27, 2014",,"January 20, 2021","St Vincent Hospital, Melbourne, Australia|CHU LIEGE - Sart Tilman, Liege, Province De Liège, Belgium|Gent University Hospital, Gent, Belgium|Chu Clermont-Ferrand, Clermont-ferrand, Auvergne Rhone Alpes, France|CHU LYON, Pierre Benite, Auvergne Rhone Alpes, France|Chu Saint Etienne, St Etienne, Auvergne Rhone Alpes, France|Chu Besancon, Besancon, Bourgogne-Franche-Comte, France|Chu Rennes, Rennes, Bretagne, France|Chu Tours, Tours, Centre Val De Loire, France|Chu Reims, Reims, Grand Est, France|Chu Nancy, Vandoeuvre Les Nancy, Grand Est, France|Chu Amiens, Amiens, Hauts De France, France|Chu Lille, Lille, Hauts De France, France|Chr Valencienne, Valenciennes, Hauts De France, France|Hopital Beaujon, Clichy, Ile De France, France|Hopital Bicetre, Le Kremlin Bicetre, Ile De France, France|Chu Kremlin Bicetre, Le Kremlin-Bicêtre, Ile De France, France|Hopital Saint Louis, Paris, Ile De France, France|Hopital St Antoine, Paris, Ile De France, France|Montsouris Mutualist Institute, Paris, Ile De France, France|Caen Unversity Hospital, Caen, Normandie, France|CHU Bordeaux - Pessac, Pessac, Nouvelle-aquitaine, France|Chu Montpellier, Montpellier, Occitanie, France|Chu Toulouse, Toulouse, Occitanie, France|Chu Nantes, Nantes, Pays De La Loire, France|CHU NICE, Nice, Provences Alpes Cote d'Azur, France|Hopital Saint Joseph, Paris, France",,"https://ClinicalTrials.gov/show/NCT02177071"
662,"NCT00692939","Autologous Stem Cell Transplantation for Crohn's Disease",,"Recruiting","No Results Available","Crohn's Disease","Biological: autologous CD34-selected peripheral blood stem cells transplant|Drug: Alemtuzumab|Drug: ATG|Drug: Melphalan|Drug: Thiotepa|Drug: Rituximab|Drug: Cyclophosphamide|Drug: G-CSF|Drug: Mesna","Number of participants with regimen-related toxicities.|Number of participants with life-threatening infections.|Change and duration in the Harvey Bradshaw Index (HBI).|Change and duration in the Crohn's Disease Activity Index (CDAI).|Change and duration in the Pediatric Crohn's Disease Activity Index (PCDAI).|Number of days it takes for Absolute Neutrophil Count (ANC) to reach greater than 500.|Number of days it takes for Platelet count to reach greater than 20,000/mm3|Number of days it takes for T cell Recovery|Number of participants who have long term cardiac complications|Number of participants who have long term endocrine complications|Number of participants with active advanced Crohn's disease who have immune dysregulation evolution and correction.|Biomarker identification for relapse","Paul Szabolcs|University of Pittsburgh","All","10 Years to 60 Years   (Child, Adult)","Phase 1|Phase 2","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","PRO11090340","June 26, 2012","December 2025","December 2026","June 6, 2008",,"February 5, 2021","UPMC Prebyterian- Adult Gastroenterology, Pittsburgh, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC-Bone Marrow Team, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT00692939"
663,"NCT04944797","Crohn and Anal Incontinence","CRIA","Not yet recruiting","No Results Available","Crohn Disease",,"Determine the prevalence of anal incontinence in patients with Crohn's disease at expert gastroenterology and proctology centers in France. Anal incontinence is defined by a Cleveland or Jorge and Wexner score ≥ 5|Compare the prevalence of anal incontinence in patients followed for Crohn's disease on gastroenterology services versus patients followed for ano-perineal involvement in Crohn's disease on a proctology service.|Determine independent risk factors for anal incontinence in Crohn's disease regardless of Crohn's disease location|Compare the quality of life of patients with anal incontinence vs. patients without anal incontinence with Crohn's disease|Compare the quality of life of patients followed for Crohn's disease on gastroenterology services with anal incontinence versus patients followed for ano-perineal involvement of Crohn's disease on a proctology service with anal incontinence|Compare the quality of life of patients with anoperineal involvement in Crohn's disease and anal incontinence versus patients with exclusive luminal involvement in Crohn's disease and anal incontinence","Groupe Hospitalier Paris Saint Joseph|Hôpital Louis Mourier","All","18 Years and older   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CRIA","September 15, 2021","June 15, 2022","September 15, 2022","June 30, 2021",,"June 30, 2021","Groupe Hospitalier Paris Saint Joseph, Paris, Ile-de-France, France",,"https://ClinicalTrials.gov/show/NCT04944797"
664,"NCT04939337","A Study of TH-SC01 for Treating Complex Perianal Fistula in Perianal Crohn's Disease.",,"Enrolling by invitation","No Results Available","Crohn's Disease","Drug: TH-SC01","Percentage of Participants who Achieve Combined Remission|Percentage of Participants who Achieve Clinical Remission|Percentage of Participants who Achieve Clinical Response|Percentage of Participants who decrease in PDAI|Percentage of Participants who decrease in IBDQ|Percentage of Participants who decrease in VAS scale|Percentage of Participants who decrease in Wexner incontinence score","Jinling Hospital, China|Jiangsu Topcel-KH Pharmaceutical Co., Ltd","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 1","24","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","20181231","November 12, 2020","January 2024","August 2024","June 25, 2021",,"June 25, 2021","Jinling hospital, Nanjing, Jiangsu, China",,"https://ClinicalTrials.gov/show/NCT04939337"
665,"NCT04519684","Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease","IPAAF","Recruiting","No Results Available","Ileal Pouch|Crohn Disease","Drug: Mesenchymal stem cells|Other: Placebo","Treatment related adverse events|Complete clinical healing|Partial healing|Lack of response|Worsening disease","Amy Lightner|The Cleveland Clinic","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1|Phase 2","40","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","CCF-Stem Cells IBD-002","October 28, 2020","October 2022","October 2022","August 20, 2020",,"March 19, 2021","Cleveland Clinic, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT04519684"
666,"NCT04519671","Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease","PFCD","Recruiting","No Results Available","Perianal Crohn Disease|Perianal Fistula|Crohn Disease","Drug: Mesenchymal Stem Cells|Other: Placebo","Treatment related adverse events|Complete clinical healing","Amy Lightner|The Cleveland Clinic","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1|Phase 2","40","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","CCF-Stem Cells IBD-001","November 19, 2020","November 2022","November 2022","August 20, 2020",,"March 19, 2021","Cleveland Clinic, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT04519671"
667,"NCT04398836","Preoperative Nutrition for Crohn's Disease Patients",,"Not yet recruiting","No Results Available","Malnutrition|Crohn Disease","Dietary Supplement: Exclusive Enteral Nutrition|Other: High energy / protein diet.|Other: Standard nutrition","Changes in Compliance to diet|Changes in adherence to therapy|Changes in tolerability to the diet|The rate of post-operative complications in malnourished CD patients receiving pre-operative 4 weeks EEN, is changed during the 4 weeks post-surgery, compared to CD patients receiving high energy and protein diet without EEN one month after surgery.","Tel-Aviv Sourasky Medical Center","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 3","144","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","0825-18TLV","September 2020","July 2023","December 2027","May 21, 2020",,"May 21, 2020","Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT04398836"
668,"NCT04118088","Postauthorization Safety Study of Darvadstrocel Repeat Administration",,"Recruiting","No Results Available","Crohn's Disease|Complex Perianal Fistula","Biological: Darvadstrocel","Percentage of Participants with at Least 1 Treatment-Emergent Adverse Event (TEAE)|Percentage of Participants with at Least 1 Treatment Emergent Serious Adverse Event (TESAE)|Percentage of Participants with Special Situation Reports (SSRs)|Percentage of Participants with Adverse Event of Special Interest (AESI)|Percentage of Participants who Achieve Combined Remission of Perianal Fistula(s)|Percentage of Participants who Achieve Clinical Remission|Percentage of Participants who Achieve Clinical Response|Percentage of Participants with Relapse From Week 24 Combined Remission|Time to Relapse|Percentage of Participants with New Perianal Abscess in Treated Fistula|Change From Baseline in Score of Discharge and Pain Items of Perianal Disease Activity Index (PDAI) Score","Millennium Pharmaceuticals, Inc.|Takeda","All","18 Years and older   (Adult, Older Adult)","Phase 4","50","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Alofisel-4001|2017-002491-10|EUPAS31439","December 22, 2020","August 31, 2024","August 31, 2024","October 8, 2019",,"June 9, 2021","Akh Wien, Wien, Austria|NH Hospital a.s., Horovice, Beroun, Czechia|CHU de Nice - Hopital de l'Archet II - Gastro-Enterologie, Hepatologi, Nice cedex 03, Alpes-Maritimes, France|CHRU Hopital de Pontchaillou - Maladies De L'Appareil Digesti, Rennes, Ille-et-Vilaine, France|CHRU de Lille - Hopital Claude Huriez - Gastroenterologie, Lille, Nord, France|CHU Amiens Picardie, AMIENS cedex 1, Picardie, France|Centre Hospitalier Lyon Sud - Gastroenterology, Pierre-Benite, Rhone, France|Paris St. Joseph Hospital, Paris, France|Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, France|Klinikum Dresden, University Hospital Dresden, Dresden, Sachsen, Germany|Charite - Campus Benjamin Franklin, Berlin, Germany|Krankenhaus Waldfriede, Berlin, Germany|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah Medical Organization, Hadassah Medical Center, Ein-Karem, Jerusalem, Israel|Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Chaim sheba Medical Center, Tel Hashomer, Israel|Hospital Universitario Son Espases, Palma de Mallorca, Baleares, Spain|Hospital Universitario Nuestra Senora de la Candelaria, Santa Cruz de Tenerife,, Canarias,, Spain|H. Donostia, San Sebastian, Gipuzcoa, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario de Bellvitge, Barcelona, Spain|Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|C.H.U. de Pontevedra, Pontevedra, Spain|H.C.U. de Valencia, Valencia, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Spain",,"https://ClinicalTrials.gov/show/NCT04118088"
669,"NCT04010526","Evaluation of Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN's Fistulas.","ADICROHN2","Not yet recruiting","No Results Available","Crohn Disease","Combination Product: local co-administration of autologous ADIpose|Other: placebo","clinically evaluated|Magnetic resonance imaging (MRI)|a complete cessation of suppuration|closure of all the external openings|Index PDAI (Perianal Disease Activity )|improvement of Quality of Life Short Inflammatory Bowel Disease Questionnaire (SIBDQ) (QoL)|Crohn's Disease Activity Index (CDAI)|Reduction of anal incontinence severity (Wexner score)","Assistance Publique Hopitaux De Marseille","All","18 Years and older   (Adult, Older Adult)","Phase 2","84","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","RCAPHM18_0013","March 2020","July 2022","October 2023","July 8, 2019",,"March 18, 2020","Assistance Publique Des Hopitaux de Marseille, Marseille, Paca, France",,"https://ClinicalTrials.gov/show/NCT04010526"
670,"NCT03915262","Exocrine Pancreatic Insufficiency's Prevalence in Active Crohn's Disease","IPEC","Recruiting","No Results Available","Crohn Disease","Biological: Search for exocrine pancreatic insufficiency at week 0 and 12","Exocrine pancreatic insufficiency's prevalence","Hospices Civils de Lyon","All","18 Years and older   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","69HCL19_0294","December 2, 2019","December 2, 2020","April 2021","April 16, 2019",,"December 4, 2019","Service d'Hépato-Gastroentérologie, Centre Hospitalier Lyon-Sud, HCL, Pierre Benite, France",,"https://ClinicalTrials.gov/show/NCT03915262"
671,"NCT03913572","Treatment of Perianal Disease Using Adipose-derived Stem Cells",,"Recruiting","No Results Available","Perianal Fistula|Crohn Disease","Procedure: Injection of adipose-derived stem cells into perianal fistula","Improvement in perianal disease after the procedure","University of California, San Diego","All","18 Years and older   (Adult, Older Adult)",,"25","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","180652","September 27, 2018","June 26, 2021","July 26, 2021","April 12, 2019",,"April 27, 2021","University of California San Diego, San Diego, California, United States",,"https://ClinicalTrials.gov/show/NCT03913572"
672,"NCT03871634","Assessment of Nutritional Status of Patients With Crohn's Disease",,"Active, not recruiting","No Results Available","Crohn Disease|Malnutrition",,"Prevalence of malnutrition phenotypes|Validity test of available tools","Harokopio University|Evangelismos Hospital|Sotiria General Hospital|General Hospital of Nikaia ""Saint Panteleimon""","All","18 Years and older   (Adult, Older Adult)",,"250","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","122","December 18, 2018","December 31, 2020","December 31, 2021","March 12, 2019",,"February 3, 2021","Harokopio University, Athens, Kallithea, Greece",,"https://ClinicalTrials.gov/show/NCT03871634"
673,"NCT03815851","Relationship Between Prophylactic Drainage and Postoperative Complications in Crohn's Patients After Surgery","RBPD","Recruiting","No Results Available","Crohn Disease","Device: prophylactic drainage","postoperative complications|recurrence","Jinling Hospital, China","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","jinlingH201608","September 1, 2016","August 31, 2020","August 31, 2021","January 24, 2019",,"January 24, 2019","Jinling Hospital, Nanjing, Jiangsu, China",,"https://ClinicalTrials.gov/show/NCT03815851"
674,"NCT03776825","Permacol Paste in Perianal Crohn's Disease","UPpCro","Recruiting","No Results Available","Crohn Disease|Perianal Fistula","Device: Permacol Paste","Perianal fistula closure rate|Patients quality of life|Patients continence","Istituto Clinico Humanitas|Medtronic","All","18 Years and older   (Adult, Older Adult)",,"20","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","2134","February 7, 2019","July 1, 2021","October 1, 2021","December 17, 2018",,"February 3, 2021","Istituto Clinico Humanitas, Rozzano, MI, Italy",,"https://ClinicalTrials.gov/show/NCT03776825"
675,"NCT03706456","Phase 3 Study of Cx601 in Subjects With Complex Perianal Fistulising Crohn's Disease",,"Active, not recruiting","No Results Available","Complex Perianal Fistulas in Adult Patients With Crohn's Disease","Biological: Darvadstrocel","Percentage of Participants with Combined Remission at Week 24|Percentage of Participants with Clinical Remission at Week 24|Percentage of Participants with Response at Week 24|Time to Clinical Remission by Week 24|Time to Response by Week 24|Percentage of Participants with Relapse at Week 24 in Participants with Clinical Remission at Previous Visit|Time to Relapse by Week 24 in Participants with Clinical Remission at Previous Visit|Perianal Disease Activity Index (PDAI): Total Score at Week 24|PDAI: Discharge Sub-Score at Week 24|PDAI: Pain Sub-Score at Week 24|Crohn's Disease Activity Index (CDAI): Total Score at Week 24|Van Assche Score at Week 24|Percentage of Participants with Combined Remission at Week 52|Percentage of Participants with Clinical Remission at Week 52|Percentage of Participants with Response at Week 52|Time to Combined Remission by Week 52|Time to Clinical Remission by Week 52|Time to Response by Week 52|Percentage of Participants with Relapse at Week 52 in Participants with Clinical Remission at Week 24|Time to Relapse by Week 52 in Participants with Clinical Remission at Week 24|PDAI: Total Score at Week 52|PDAI: Discharge Sub-Score at Week 52|PDAI: Pain Sub-Score at Week 52|CDAI: Total Score at Week 52|Van Assche Score at Week 52","Takeda","All","18 Years and older   (Adult, Older Adult)","Phase 3","22","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Darvadstrocel-3002|U1111-1218-8079|JapicCTI-184145","March 6, 2019","July 20, 2020","January 31, 2023","October 16, 2018",,"October 5, 2020","Ieda Hospital, Toyota, Aichi, Japan|Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan|Sapporo Higashi Tokushukai Hospital, Sapporo, Hokkaido, Japan|Hyogo College of Medicine, Nishinomiya, Hyogo, Japan|Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan|Mie University Hospital, Tsu, Mie, Japan|Tohoku Rosai Hospital, Sendai, Miyagi, Japan|Tohoku University Hospital, Sendai, Miyagi, Japan|Osaka University Hospital, Suita, Osaka, Japan|JCHO Tokyo Yamate Medical Center, Shinjuku, Tokyo, Japan|Coloproctology Center Takano Hospital, Kumamoto, Japan",,"https://ClinicalTrials.gov/show/NCT03706456"
676,"NCT03449069","Pediatric MSC-AFP Sub-study for Crohn's Fistula",,"Recruiting","No Results Available","Fistula in Ano|Crohn Disease","Drug: MSC-AFP","Number of participants with treatment-related adverse events (safety and toxicity)|Number of participants with response to the treatment regarding cessation of drainage from the treated fistula.|Number of participants with radiographic response to the treatment regarding the treated fistula.","Mayo Clinic","All","12 Years to 17 Years   (Child)","Phase 1","5","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","17-010539","July 23, 2018","February 28, 2022","February 28, 2022","February 28, 2018",,"April 1, 2021","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03449069"
677,"NCT03288961","Self Screening Tool for Crohn's Perianal Fistula",,"Recruiting","No Results Available","Crohn Disease",,"Perianal fistula","Kyungpook National University Hospital","All","10 Years to 80 Years   (Child, Adult, Older Adult)",,"146","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","KNUH14","May 1, 2017","December 1, 2019","December 1, 2019","September 20, 2017",,"August 13, 2019","Kyungpook National University Hospital, Daegu, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT03288961"
678,"NCT03279081","Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)","ADMIRE-CD-II","Recruiting","No Results Available","Crohn's Disease","Drug: Cx601|Other: Placebo","Percentage of Participants with Combined Remission at Week 24|Percentage of Participants with Clinical Remission at Week 24|Time to Clinical Remission up to Week 24|Percentage of Participants with Clinical Response at Week 24|Time to Clinical Response up to Week 24|Percentage of Participants with Combined Remission at Week 52|Percentage of Participants with Clinical Remission at Week 52|Percentage of Participants with Clinical Response at Week 52|Time to Clinical Remission up to Week 52|Time to Clinical Response up to Week 52|Percentage of Participants with Relapse from Week 24 Combined Remission|Percentage of Participants With Treatment-emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs), Adverse Events of Special Interest (AESIs)|Number of Participants With TEAEs Related to Vital Sign Parameters|Number of Participants With TEAEs Related to Clinical Laboratory Parameters","Tigenix S.A.U.|Takeda","All","18 Years and older   (Adult, Older Adult)","Phase 3","554","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Cx601-0303|2017-000725-12","September 15, 2017","August 31, 2022","February 28, 2023","September 12, 2017",,"May 20, 2021","Scottsdale Mayo Clinic, Scottsdale, Arizona, United States|UC San Diego Health Systems, La Jolla, California, United States|University of Southern California (USC) Norris Comprehensive Cancer Center, Los Angeles, California, United States|UC Irvine Medical Center - Chao Family Comprehensive Cancer, Orange, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Kaiser Permamente, San Francisco, California, United States|University of California San Francisco, San Francisco, California, United States|Vallejo Hospital and Medical Offices, Vallejo, California, United States|Cedar-Sinai Medical Center, West Hollywood, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|Hartford Hospital - Gastroenterology, Farmington, Connecticut, United States|Yale University School of Medicine, New Haven, Connecticut, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Mayo Clinic - Gastroenterology, Jacksonville, Florida, United States|University of Miami Hospital, Miami, Florida, United States|Florida Hospital Orlando, Orlando, Florida, United States|USF Health South Tampa Center for Advanced Healthcare, Tampa, Florida, United States|Florida Hospital Tampa, Tampa, Florida, United States|Cleveland Clinic Florida, Weston, Florida, United States|Emory University, Atlanta, Georgia, United States|Northwestern University, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|The University of Chicago Medicine - Colon & Rectal Surgery, Chicago, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|Indiana University - Colon and Rectal, Indianapolis, Indiana, United States|University of Kansas Sxchool of Medicine, Kansas City, Kansas, United States|University of Louisville, Louisville, Kentucky, United States|Digestive Health Center of Louisiana, Baton Rouge, Louisiana, United States|Colon and Rectal Surgery Associates, Metairie, Louisiana, United States|University Medical Center - New Orleans, New Orleans, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|Johns Hopkins Medicine - The Johns Hopkins Hospital, Baltimore, Maryland, United States|Massachussetts General Hospital, Boston, Massachusetts, United States|Boston Medical Center, Boston, Massachusetts, United States|Lahey Hospital & Medical Center, Burlington, Massachusetts, United States|University of Massachusetts - colon & rectal surgery, Worcester, Massachusetts, United States|Mayo Clinic College of Medicine - Division of Colon and Rectal Surgery - Division of Colon and Rectal Surgery, Rochester, Minnesota, United States|Barnes-Jewish Hospital - Gastroenterology, Saint Louis, Missouri, United States|University of Nevada School of Medicine, Las Vegas, Nevada, United States|Dartmouth Hitchcock Medical Center - Cancer Center, Lebanon, New Hampshire, United States|Morristown Medical Center - Gastroenterology, Morristown, New Jersey, United States|Albany Medical Center, Albany, New York, United States|North Shore University Hospital - Gastroenterology, Manhasset, New York, United States|NYU Langone Medical Center, New York, New York, United States|Stony Brook University Medical Center, New York, New York, United States|Weill Medical College of Cornell University, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|Lenox Hill Hospital, New York, New York, United States|Cleveland Clinic, Cleveland, Ohio, United States|OHSU Digestive Health Center, Portland, Oregon, United States|Harvard Medical School-Beth Israel Deaconess Medical Center, Hershey, Pennsylvania, United States|Penn State Hershey Medical Center - Surgery, Hershey, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|University Surgical Associates-Rhode Island Hospital, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Rapid City Medical Center, Rapid City, South Dakota, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|UT Southwestern Medical Center - Gastroenterology - Gastroenterology, Dallas, Texas, United States|Baylor College of Medicine (BCM) - Gastroenterology, Houston, Texas, United States|University of Utah, Salt Lake City, Utah, United States|University of Virginia, Charlottesville, Virginia, United States|Carilion Clinic, Roanoke, Virginia, United States|Virginia Mason Medical Center - Gastroenterology, Seattle, Washington, United States|Swedish Medical Center, Seattle, Washington, United States|Aurora St. Luke's Medical Center, Milwaukee, Wisconsin, United States|Medical College of Wisconsin Hub for Collaborative Medicine - Gastroenterology and Hepatology, Milwaukee, Wisconsin, United States|UZ Leuven - Campus Gasthuisberg, Leuven, Vlaams Brabant, Belgium|AZ Groeninge - Campus Kennedylaan - Gastro-enterology, Kortrijk, West-Vlaanderen, Belgium|AZ Delta vzw - Maag-darm-leverziekten, Roeselare, West-Vlaanderen, Belgium|GZA ziekenhuizen - Campus Sint-Vincentius - Gastro-enterology, Antwerpen, Belgium|Imelda Ziekenhuis, Antwerpen, Belgium|UZ Gent - Gastroenterology, Gent, Belgium|CHU de Liege - Domaine Universitaire du Sart Tilman, Liege, Belgium|Clinique Saint-Joseph (CHC), Liege, Belgium|CHU Dinant Godinne UCL Namur, Namur, Belgium|University of Alberta, Edmonton, Alberta, Canada|(G.I.R.I.) GI Research Institute, Vancouver, British Columbia, Canada|Ottawa Hospital, Ottawa, Ontario, Canada|Mount Sinai Hospital - Toronto - Gastroenterology, Toronto, Ontario, Canada|Kensington Screening Clinic - Gastroenterology, Toronto, Ontario, Canada|Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada|McGill University Health Centre - Montreal General Hospital, Montreal, Quebec, Canada|NH Hospital a.s., Horovice, Beroun, Czechia|FN Hradec Kralove, Hradec Kralove, Czechia|Bispebjerg Hospital, Kobenhavn, Copenhague, Denmark|Aarhus University Hospital - Department of Hepatology and Gastroenterology, Lever-Mave- og Tarmsygdomme Klinik, krydspunkt C216, Aarhus, Denmark|Odense Universitetshospital, Odense, Denmark|CHU de Nice, Nice Cedex 03, Alpes-Maritimes, France|CHU de Clermont-Ferrand - Estaing, Clermont-Ferrand cedex 1, Auvergne, France|Centre Hospitalier Universitaire De Toulouse - Hopital De Ra, Toulouse cedex 09, Haute-Garonne, France|Hopital Beaujon, Clichy, Ile-de-France, France|Hopital Saint Louis - Gastro-hepatoenterologie, Paris, Ile-de-France, France|CHRU Hopital De Pontchaillou, Rennes, Ille-et-Vilaine, France|CHU Saint Etienne, St Priest en Jarez, Loire, France|CHRU de Nancy -Hopital Brabois Adultes - Service d'Hepato- Gastroenterologie, Vandoeuvre-les-Nancy, Lorraine, France|CHRU De Lille - Hopital Claude Huriez - Hepato-Gastro-Enterologie, Lille, Nord, France|CHU Amiens-Picardie, AMIENS cedex 1, Picardie, France|Centre Hospitalier Lyon Sud, Pierre-Benite, Rhone, France|Paris St. Joseph Hospital, Paris, France|Universitatsklinikum Erlangen, Erlangen, Bayern, Germany|Klinikum der Universitat Munchen - Campus Grosshadern, Munchen, Bayern, Germany|Klinikum der Johann Wolfgang Goethe-Universitat, Frankfurt/Main, Hessen, Germany|Universitatsklinikum Dresden, Dresden, Sachsen, Germany|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont - I. sz. Belgyogyaszati Klinika, Szeged, Csongrad, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hajdu-Bihar, Hungary|MH Egeszsegugyi Kozpont - Gasztroenterologiai Osztaly, Budapest, Pest, Hungary|Semmelweis Egyetem, Budapest, Pest, Hungary|Rabin Med Ctr Beilinson Hosp, Petah Tikva, HaMerkaz, Israel|Rambam Medical Centre, Haifa, HaZafon, Israel|Chaim sheba Medical Center, Tel Hashomer, Tel-Aviv, Israel|Shaare Zedek Medical Center - Gastroenterology, Jerusalem, Yerushalayim, Israel|Hadassah Medical Organization, Hadassah Medical Center, Ein-, Jerusalem, Yerushalayim, Israel|Ospedale Santissima Annunziata, Cento, Ferrara, Italy|Istituto Clinico Humanitas Rozzano, IRCCS - IBD Center, Rozzano, Milano, Italy|Policlinico S. Orsola Malpighi, AOU di Bologna-U.O. di Medicina Interna., Bologna, Italy|AOU Policlinico di Modena - Gastroenterologia, Modena, Italy|II Universita degli Studi di Napoli, Napoli, Italy|Gastroenterology Section, Palermo, Italy|Universita degli studi di Pisa, Pisa, Italy|Policlinico Universitario Campus Biomedico - UOC di Gastroenterologia, Roma, Italy|A.O. San Camillo Forlanini, Roma, Italy|Complesso Integrato Columbus, Roma, Italy|Policlinico Universitario Agostino Gemelli, Roma, Italy|Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia, Udine, Italy|Azienda Ospedaliera Universitaria Integrata Verona (AOUI) -, Verona, Italy|Centrum Medyczne Melita Medical, Wroclaw, Dolnoslaskie, Poland|Uniwersytecki Szpital Kliniczny im. Wojskowej Akademii Medycznej Centralny Szpital Weteranow, Lodz, Lodzkie, Poland|Centrum Medyczne PROMED, Krakow, Malopolskie, Poland|Wielospecjalistyczny Szpital Medicover, Warszawa, Mazowieckie, Poland|Endoskopia Sp z o.o., Sopot, Pomorskie, Poland|COPERNICUS Podmiot Leczniczy Sp. z o.o., Gdansk, Poland|Centralny Szpital Kliniczny MSWiA w Warszawie, Warszawa, Poland|University of Puerto Rico School of Medicine, San Juan, Puerto Rico|Hospital Universitario Son Espases, Palma de Mallorca, Baleares, Spain|H.U. G.Trias i Pujol, Badalona, Barcelona, Spain|Corporacio Sanitaria Parc Tauli, Sabadell, Barcelona, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain|Hospital de Sagunto, Sagunto, Valencia, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|C.H.U. de Pontevedra, Pontevedra, Spain|H.U.V. del Rocio, Sevilla, Spain|Linkoping University Hospital - Department of Surgery, Linkoping, Ostergotlands Lan [se-05], Sweden|Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom|NHS Greater Glasgow and Clyde - Glasgow Royal Infirmary (GRI), Glasgow, Glasgow City, United Kingdom|St. Mark's Hospital, Harrow, London, City Of, United Kingdom|Guys & St Thomas, London, London, City Of, United Kingdom|Nottingham University Hospitals NHS Trust - Surgery, Nottingham, Nottinghamshire, United Kingdom|University Colleague London Hospital (UCLH), London, United Kingdom|Wythenshawe Hospital - Gastroenterology, Manchester, United Kingdom|Northern General Hospital, Sheffield, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03279081"
679,"NCT02675153","To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related Stricture",,"Recruiting","No Results Available","Crohn's Diseases","Drug: Rapamycin","Response rate|Adverse events|The rate of surgery or ED after rapamycin","The Second Hospital of Nanjing Medical University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","15","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","RAPA-CN-160122","April 1, 2015","October 2020","October 2020","February 5, 2016",,"October 8, 2020","Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China",,"https://ClinicalTrials.gov/show/NCT02675153"
680,"NCT04467580","Development of Inflammation and Fibrosis Index, Combining MRI and PET 18F-FDG, in Patient's With Crohn's Disease","FILM","Not yet recruiting","No Results Available","Crohn Disease","Diagnostic Test: abdominal [18F]FDG PET/CT","Index FILM-i|Index FILM-f|Contribution of [18F]FDG PET/CT with index NET (Net Reclassification Index)|To compare the performance of the inflammation index (FILM-i) with that of a baseline MRI score, the Nancy score, for the detection of significant colonic inflammation (moderate to severe in histopathology).|Inter- and intra-observer reproducibility|Degree of correlation between FILM-i and FILM-f index and the modified histological activity score of the Global Histologic Activity Score (GHAS).","Central Hospital, Nancy, France","All","18 Years and older   (Adult, Older Adult)","Not Applicable","59","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","2020_003067-26","September 1, 2020","September 1, 2022","May 2, 2023","July 13, 2020",,"July 13, 2020",,,"https://ClinicalTrials.gov/show/NCT04467580"
681,"NCT02859675","Olfactogustatory Perception, Eating Behaviour and Inflammation in Crohn's Disease","Smell&Crohn","Recruiting","No Results Available","Crohn's Disease|Olfactogustatory Perception","Other: triangular test|Biological: blood sampling|Other: Questionnaires","Modification of sweet taste","Centre Hospitalier Universitaire Dijon","Female","18 Years to 60 Years   (Adult)",,"75","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","BRONDEL Ass INRA 2011","October 7, 2013","July 2023","December 2023","August 9, 2016",,"August 15, 2019","Centre Hospitalier Universitaire, Dijon, France",,"https://ClinicalTrials.gov/show/NCT02859675"
682,"NCT04548583","Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis",,"Recruiting","No Results Available","Crohn Colitis","Drug: Remestemcel-L|Other: Placebo","Treatment related adverse events|Complete clinical healing|Clinical response|Partial clinical response|Lack of response|Crohn's disease activity index|Inflammatory bowel disease questionnaire|EuroQol 5 Dimensions survey|Inflammatory bowel disease patient reported treatment impact survey|Short Form 36 health survey","The Cleveland Clinic|Mesoblast, Inc.","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1|Phase 2","24","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","CCF-Stem Cells IBD-004","November 4, 2020","October 2023","October 2023","September 14, 2020",,"February 10, 2021","Cleveland Clinic, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT04548583"
683,"NCT02425852","A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis","ACTIVE","Recruiting","No Results Available","Ulcerative Colitis","Drug: Azathioprine|Drug: Infliximab|Drug: Prednisolone|Drug: Hydrocortisone","Percentage of patients with treatment failure at week 52.|Percentage of patients in clinical response at day 7","Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives","All","18 Years and older   (Adult, Older Adult)","Phase 4","146","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","GETAID 2015-02","December 2016","December 2022","December 2023","April 24, 2015",,"January 20, 2021","Chu Besancon, Besancon, France|CHU de CLERMONT FERRAND- Hopital Estain, Clermont-Ferrand, France|APHP- Hopital BEAUJON, Clichy, France|Hopital Louis Mourrier, Colombes, France|Henri Mondor Hospital, Creteil, France|Chu Kremlin Bicetre, Le Kremlin-Bicêtre, France|CHRU Lille, Lille, France|Chu Montpellier, Montpellier, France|CHU de NICE- Hopital Archet 2, Nice, France|Hopital Saint Louis, Paris, France|Hopital St Antoine, Paris, France|Hopital Saint Joseph, Paris, France|CHU RENNES - Hopital Pontchaillou, Rennes, France|Chu Rouen, Rouen, France|Chu Saint Etienne, St Etienne, France|CHU NANCY - Hopital Brabois, Vandoeuvre Les Nancy, France",,"https://ClinicalTrials.gov/show/NCT02425852"
684,"NCT00001456","Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome",,"Recruiting","No Results Available","Hermansky-Pudlak Syndrome (HPS)",,"Natural History","National Human Genome Research Institute (NHGRI)|National Institutes of Health Clinical Center (CC)","All","1 Year to 80 Years   (Child, Adult, Older Adult)",,"600","NIH","Observational","Observational Model: Cohort|Time Perspective: Prospective","950193|95-HG-0193","November 6, 1995",,,"November 4, 1999",,"June 24, 2021","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT00001456"
685,"NCT04927403","Integrative Therapy of Chronic Diseases","InteChron","Recruiting","No Results Available","Chronic Disease",,"Generic quality of life|anxiety and depression|wellbeing/flourishing|Perceived stress|disease activity and diseasespecific quality of life (irritable bowel syndrome)|disease activity and diseasespecific quality of life (ulcerative colitis)|disease activity and diseasespecific quality of life (Crohn's disease)|disease activity and diseasespecific quality of life (pain patients)|disease activity and diseasespecific quality of life (rheumatism)|disease activity and diseasespecific quality of life (fibromyalgia syndrome)|Lactoferrin (chronic gastroenterological)|Calprotectin (chronic gastroenterological)|PMN-Elastase (chronic gastroenterological)|Humanes Beta-Defensin (hBD-2) (chronic gastroenterological)|Zonulin (chronic gastroenterological)|Alpha-Antitrypsin (chronic gastroenterological)|CRP (C-reactive protein)|BKS (blood cell sedimentation rate)|age|sex|Educational level|job|Course of the disease (questionnaire)|Use of complementary medicine/natural remedies (questionnaire)|Expectation of the treatment (questionnaire)","Universität Duisburg-Essen|Sozialstiftung Bamberg","All","18 Years and older   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","20068","January 4, 2021","December 31, 2023","December 31, 2023","June 16, 2021",,"June 16, 2021","Sozialstiftung Bamberg, Klinik für Intergrative Medizin, Bamberg, Bayern, Germany",,"https://ClinicalTrials.gov/show/NCT04927403"
686,"NCT04940611","A Study of Surgical Interventions in Fistulizing Conditions",,"Not yet recruiting","No Results Available","Crohns Disease|Fistula|Rectovaginal Fistula|Complex Perianal Fistula|Complex Cryptoglandular Fistula",,"Percentage of Participants who Achieve Clinical Remission of Fistula|Percentage of Participants With Post-surgical Complications|Percentage of Participants who Achieve Combined Remission|Percentage of Participants who Achieve Cessation of Drainage in Treated Fistula|Percentage of Participants With Relapse of Fistula in Clinical Remission|Percentage of Participants With New Perianal Abscess","Takeda","All","18 Years and older   (Adult, Older Adult)",,"750","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","Alofisel-5007","July 13, 2021","May 2, 2026","May 2, 2026","June 25, 2021",,"June 25, 2021",,,"https://ClinicalTrials.gov/show/NCT04940611"
687,"NCT04876690","A Study of the Quality of Life in Adults With Crohn's Disease With Complex Perianal Fistulas","CONFLICT","Not yet recruiting","No Results Available","Crohn Disease|Rectal Fistula",,"Number of Participants Based on General Quality of Life (QoL) as Measured by the Short Form Health Survey (SF-12)|Number of Participants Based on QOL as Measured by Short Inflammatory Bowel Disease Questionnaire (SIBDQ)|Number of Male Participants Characterized Based on Sexual Quality of Life-Male (SQOL-M)|Number of Female Participants Characterized Based on Sexual Quality of Life-Female (SQOL-F)|Number of Participants With Fecal Incontinence Assessed by Wexner Score|Number of Participants Based on Impact on Social/Work Activities and Work Productivity Assessed by Work Productivity and Activity Impairment (WPAI)|Number of Participants Characterized Based on Healthcare Resource Utilization (HCRU) Within Previous 3 Years|Number of Participants Characterized by Sociodemographic and Anthropometric Characteristics|Number of Participants With Moderate to Severe Crohn's disease (CD) Stratified by Clinical Characteristics|Number of Participants Characterized Based on Pharmacological Treatments and Surgeries for CPF|Correlation Between General QoL (PCS-12 and MCS-12) and the Participants Socio-demographic, Anthropometric and Clinical Characteristics","Takeda","All","18 Years and older   (Adult, Older Adult)",,"80","Industry","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","IBD-5007","July 1, 2021","January 31, 2022","January 31, 2022","May 6, 2021",,"June 3, 2021",,,"https://ClinicalTrials.gov/show/NCT04876690"
688,"NCT04872491","A Study of Vedolizumab in Adults in Real-World Practice",,"Not yet recruiting","No Results Available","Colitis, Ulcerative|Crohn Disease",,"Percentage of Participants With Adverse Events (AEs)|Percentage of Participants With Serious Adverse Events (SAEs)|Percentage of Participants With Adverse Events of Special Interests (AESIs)|Percentage of Participants With Adverse Drug Reactions (ADRs)|Percentage of Participants With Ulcerative Colitis (UC) Achieving Clinical Response Based on Partial Mayo Score|Percentage of Participants With Crohn's Disease (CD) Achieving Clinical Response Based on Harvey-Bradshaw Index (HBI)|Percentage of Participants With UC Achieving Clinical Remission Based on Partial Mayo Score|Percentage of Participants With CD Achieving Clinical Remission Based on HBI|Percentage of Participants With UC Achieving Endoscopic Remission|Percentage of Participants With CD Achieving Endoscopic Remission","Takeda","All","18 Years and older   (Adult, Older Adult)",,"750","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","Vedolizumab-5064","October 31, 2021","May 31, 2024","May 31, 2024","May 4, 2021",,"May 10, 2021",,,"https://ClinicalTrials.gov/show/NCT04872491"
689,"NCT04847739","Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas",,"Not yet recruiting","No Results Available","Perianal Fistula|Crohn's Disease","Procedure: Seton Placement|Drug: AVB-114","Change in proportions of subjects with combined remission of treated perianal fistula between the AVB-114 and standard of care groups.|Change in proportions of subjects with fistula clinical remission between the AVB-114 and standard of care groups.|Change in the means of durability of clinical remission between the AVB-114 and standard of care groups.|Change in means of time to clinical remission between the AVB-114 and standard of care groups.|Change in proportions of subjects with fistula relapse between the AVB-114 and standard of care groups.|Change in means of time to fistula relapse between the AVB-114 and standard of care groups.|Change in proportions of radiologic response of treated fistula between the AVB-114 and standard of care groups.|Change in means of disease activity index scores using the Perianal Disease Activity Index (PDAI) between the AVB-114 and standard of care groups.|Change in means of disease activity index scores using the short Crohn's Disease Activity Index (sCDAI) between the AVB-114 and standard of care groups.|Change in means of patient quality of life assessment scores using the Euroqol 5 Diumention 5, level measure of health status (Eq-5Q-5L) between the AVB-114 and standard of care groups.|Change in means of patient quality of life assessment scores using the Inflammatory Bowel Disease Questionnaire (IBDQ) between the AVB-114 and standard of care groups.|Change in patient assessment of impact to daily functionality related to treated fistula between the AVB-114 and standard of care groups.|Change in the evaluations of patient care trajectory related to treated fistula between the AVB-114 and standard of care groups.|Change in number of adverse events between the AVB-114 and standard of care groups.|Change in number of serious adverse events between the AVB-114 and standard of care groups.","Avobis Bio, LLC|Alimentiv Inc.","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 2","60","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","STOMP-II","May 2021","August 2023","January 2025","April 19, 2021",,"April 19, 2021",,,"https://ClinicalTrials.gov/show/NCT04847739"
690,"NCT04844593","A Study Using Artificial Intelligence to Identify Adults With Complex Perianal Fistulas Associated With Crohn's Disease","INTUITION-CPF","Not yet recruiting","No Results Available","Crohn Disease|Rectal Fistula",,"Percentage of Participants With CD and CPF Accurately Identified With the use of NLP and Medical Language (MEL)|Number of Participants With CD and CPF Characterized Using NLP and Machine Learning Techniques","Takeda","All","18 Years and older   (Adult, Older Adult)",,"100","Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","Darvadstrocel-5001","July 15, 2021","March 1, 2023","March 1, 2023","April 14, 2021",,"June 1, 2021",,,"https://ClinicalTrials.gov/show/NCT04844593"
691,"NCT04804540","A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease",,"Not yet recruiting","No Results Available","Ulcerative Colitis|Crohn Disease","Drug: Vedolizumab IV","Number of Participants with Adverse Events (AEs), Serious Adverse events (SAEs), Adverse Events of Special Interest (AESIs), Adverse Drug Reactions (ADRs) and Unexpected ADRs|Percentage of Participants with Ulcerative Colitis (UC) and Crohn's Disease (CD) Who Achieved Clinical Response|Percentage of Participants with UC and CD Who Achieved Clinical Remission|Percentage of Participants with UC and CD Who Had Vedolizumab Discontinuation|Percentage of Participants with UC and CD Who Achieved Mucosal Healing|Percentage of Participants with UC and CD Who Achieved Endoscopic Response|Change From Baseline in Patient-reported Quality of Life (Short Inflammatory Bowel Disease Questionnaire [SIBDQ])","Takeda","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 4","150","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Vedolizumab-4020","August 31, 2021","July 31, 2023","October 31, 2023","March 18, 2021",,"April 29, 2021",,,"https://ClinicalTrials.gov/show/NCT04804540"
692,"NCT04791878","Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease",,"Recruiting","No Results Available","Perianal Fistula Due to Crohn's Disease (Disorder)","Drug: Mesenchymal stem cells","Treatment related adverse events|Complete clinical healing|Partial clinical healing|Lack of response|Worsening of disease","Amy Lightner|The Cleveland Clinic","All","13 Years to 17 Years   (Child)","Phase 1","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Peds-PF","April 1, 2021","April 1, 2023","April 1, 2023","March 10, 2021",,"April 19, 2021","Cleveland Clinic, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT04791878"
693,"NCT04738942","A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease",,"Recruiting","No Results Available","Ulcerative Colitis|Crohn's Disease","Drug: Vedolizumab","Percentage of Participants with Clinical Response at Week 12 Based on Modified Mayo Score in UC Cohort|Percentage of Participants with Clinical Response at Week 12 in CD Cohort|Percentage of Participants with Clinical Remission at Week 12 Based on Modified Mayo Score in UC Cohort|Percentage of Participants with Mucosal Healing at Week 12 in UC Cohort|Percentage of Participants with Corticosteroid-Free Remission Based on Partial Mayo Score in UC Cohort|Percentage of Participants with Clinical Remission at Week 12 in CD Cohort|Percentage of Participants with Enhanced Clinical Response at Week 12 in CD Cohort|Percentage of Participants with Corticosteroid-Free Remission in CD Cohort","Takeda","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 3","158","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Vedolizumab-3039|U1111-1262-7325|jRCT2031200371","June 4, 2021","September 18, 2024","September 18, 2024","February 4, 2021",,"June 30, 2021","Ieda Hospital, Toyota, Aichi, Japan|Hirosaki University Hospital, Hirosaki, Aomori, Japan|Toho University Sakura Medical Center, Sakura, Chiba, Japan|Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan|Hyogo College of Medicine Hospital, Nishinomiya, Hyogo, Japan|Ofuna Chuo Hospital, Kamakura, Kanagawa, Japan|Kitasato University Hospital, Sagamihara, Kanagawa, Japan|Yokohama City University Medical Center, Yokohama, Kanagawa, Japan|Tohoku University Hospital, Sendai, Miyagi, Japan|Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan|Tokyo Medical and Dental University Medical Hospital, Bunkyo-ku, Tokyo, Japan|Kitasato University Kitasato Institute Hospital, Minato-ku, Tokyo, Japan|Tokyo Yamate Medical Center, Shinjuku-ku, Tokyo, Japan|Infusion Clinic., Osaka, Japan|Osaka City University Hospital, Osaka, Japan",,"https://ClinicalTrials.gov/show/NCT04738942"
694,"NCT04709445","Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses",,"Recruiting","No Results Available","Bowel Obstruction|Bowel Ischemia|Diverticulitis|Abnormality of the Gastrointestinal Tract|Symptomatic Disorders of the Gastrointestinal Tract|Stoma Ileostomy|Cancer of the Gastrointestinal Tract|Crohn Disease|Ulcerative Colitis|Familial Adenomatous Polyposis|Pancreatic Neoplasms|Hepatobiliary Neoplasm","Diagnostic Test: ICG-NIRF Imaging plus ingress and egress analysis","anastomotic leak|Operative and post-operative complications|Length of hospital stay","Charite University, Berlin, Germany","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","EA1/087/20","March 1, 2020","December 2021","December 2021","January 14, 2021",,"January 14, 2021","Charité Campus Benjamin Franklin, Berlin, Germany",,"https://ClinicalTrials.gov/show/NCT04709445"
695,"NCT04701411","A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's Disease",,"Not yet recruiting","No Results Available","Crohn's Disease|Complex Perianal Fistula","Biological: Darvadstrocel","Percentage of Participants who Achieve Combined Remission|Percentage of Participants who Achieve Clinical Remission|Percentage of Participants who Achieve Clinical Response|Time to Clinical Remission|Time to Clinical Response|Percentage of Participants with Relapse in Participants with Combined Remission at Week 24|Percentage of Participants with At Least One Adverse Event (AE)|Percentage of Participants with At Least One Serious Adverse Event (SAE)|Percentage of Participants with At Least One Adverse Event of Special Interest (AESI)|Percentage of Participants with Potentially Clinically Significant Vital Sign Values|Percentage of Participants with Potentially Clinically Significant Laboratory Values","Takeda|Takeda Development Center Americas, Inc.","All","4 Years to 17 Years   (Child)","Phase 3","20","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Darvadstrocel-3004|2020-003193-48|EMEA-001561-PIP01-13-M02","June 30, 2021","July 15, 2023","January 15, 2024","January 8, 2021",,"June 8, 2021",,,"https://ClinicalTrials.gov/show/NCT04701411"
696,"NCT04539665","Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease.",,"Recruiting","No Results Available","Crohn Disease|Recurrence|Crohn's Ileocolitis","Procedure: Extended mesenteric resection.","Number of participants with endoscopic recurrence at 6 months|Number of participants with endoscopic recurrence at 18 months|Rates of recurrence requiring surgery by 2 years|Rates of post-operative complications compared between study groups","Montreal General Hospital|Jewish General Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","crohn's mesentery","September 27, 2019","September 30, 2021","December 30, 2021","September 7, 2020",,"March 19, 2021","Montreal General Hospital, Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT04539665"
697,"NCT04538638","Mesenteric SParIng Versus Central mesenterectomY in Ileocolic Resection for Terminal Ileitis in Crohn's Disease","SPICY","Recruiting","No Results Available","Crohn's Disease","Procedure: Mesenteric sparing ileocolic resection|Procedure: Central mesenterectomy ileocolic resection","The post-operative endoscopic recurrence of Crohn's disease at six months following ileocolic resection|Postoperative morbidity|Histologic and clinical recurrence rate at 6 months following ileocolic resection|The need for restarting immunosuppressive medication within the first year postoperatively for endoscopic or clinical recurrence|The 5 year reoperation rate for recurrence of disease at the anastomotic site.","Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","All","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","138","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","NL61632.018.18","March 1, 2020","September 1, 2022","September 1, 2022","September 4, 2020",,"September 4, 2020","Amsterdam UMC - Location AMC, Amsterdam, Meibergdreef 9, Netherlands",,"https://ClinicalTrials.gov/show/NCT04538638"
698,"NCT04519697","Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease","RVF","Recruiting","No Results Available","Rectovaginal Fistula|Crohn Disease|Crohn Disease of Vulva|Rectolabial; Fistula","Drug: Mesenchymal Stem Cells|Other: Placebo","Treatment related adverse events|Complete clinical healing|Partial healing|Lack of response|Worsening disease","Amy Lightner|The Cleveland Clinic","Female","18 Years to 75 Years   (Adult, Older Adult)","Phase 1|Phase 2","40","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","CCF-Stem Cells IBD-003","October 28, 2020","October 2022","October 2022","August 20, 2020",,"March 19, 2021","Cleveland Clinic, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT04519697"
699,"NCT04327219","Prospective Dietary Therapy Using Crohn's Disease Exclusion Diet for Ileal Pouch Anal Anastomosis Patients",,"Recruiting","No Results Available","Pouchitis|Crhon's Disease Like of the Pouch","Other: CDED diet","steroid free clinical remission|Steroid free clinical remission|Maintanence of clinical remission|Clinical response|Pouchitis remission|Clinically significant change in mean CRP|Clinically significant change in mean fecal calprotectin","Tel-Aviv Sourasky Medical Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","62","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","TASMC-0637-19-CTIL","April 1, 2020","April 1, 2022","April 1, 2023","March 31, 2020",,"May 27, 2021","Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT04327219"
700,"NCT04308850","Exploring the Effects of Vitamin D Supplementation on the Chronic Course of Patients With Crohn's Disease With Vitamin D Deficiency",,"Not yet recruiting","No Results Available","Crohn's Disease|Vitamin D Deficiency|Vitamin D Supplement","Drug: Vitamin D drops","Genotype frequency of vitamin D receptor single nucleotide polymorphisms in participants|Serum 25 (OH) D level|Blood calcium and phosphorus level|erythrocyte sedimentation rate|Concentration of C-reactive protein in participants","Second Affiliated Hospital of Wenzhou Medical University","All","Child, Adult, Older Adult","Early Phase 1","60","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","SAHoWMU-CR2020-01-104","October 2020","April 2021","April 2021","March 16, 2020",,"October 14, 2020","SAHWenzhouMU, Wenzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04308850"
701,"NCT04276636","Exploring the Effects of Caltrate Supplement on the Chronic Course of Crohn's Disease Patients With Vitamin D Deficiency",,"Not yet recruiting","No Results Available","Crohn's Disease|Vitamin D Deficiency|Vitamin D Supplement","Drug: Caltrate Pill","Serum 25 (OH) D level|White blood cell count|erythrocyte sedimentation rate|C-reactive protein.","Second Affiliated Hospital of Wenzhou Medical University","All","Child, Adult, Older Adult","Early Phase 1","60","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","SAHoWMU-CR2020-01-102","October 2020","March 2021","March 2021","February 19, 2020",,"October 14, 2020","SAHWenzhouMU, Wenzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04276636"
702,"NCT04266600","Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease|Recurrence|Crohn's Ileocolitis","Procedure: Extensive mesentery resection","Endoscopic recurrence at 6 months|Endoscopic recurrence at 18 months|Rates of recurrence requiring surgery by 2 years|Post-operative complications","Jewish General Hospital|Montreal General Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","29","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research","MUHC-2020-5789","September 27, 2019","September 27, 2023","September 27, 2024","February 12, 2020",,"May 19, 2021","Montreal General Hospital, Montreal, Quebec, Canada|Jewish General Hospital, Montreal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT04266600"
703,"NCT04254783","A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease",,"Recruiting","No Results Available","Ulcerative Colitis (UC)|Crohn's Disease","Drug: Risankizumab|Drug: Cytochrome P450 (CYP) Substrates","Maximum Observed Plasma Concentration (Cmax) of Midazolam|Time to Maximum Observed Plasma Concentration (Tmax) of Midazolam|Area Under the Plasma Concentration-Time Curve (AUC) From Time 0 to Time of the Last Measurable Concentration (AUCt) of Midazolam|AUC From Time 0 to Infinity (AUCinf) of Midazolam|Terminal Phase Elimination Rate Constant (β) of Midazolam|Terminal Phase Elimination Half-Life (t1/2) of Midazolam|Maximum Observed Plasma Concentration (Cmax) of Caffeine|Time to Maximum Observed Plasma Concentration (Tmax) of Caffeine|Area Under the Plasma Concentration-Time Curve (AUC) From Time 0 to Time of the Last Measurable Concentration (AUCt) of Caffeine|AUC From Time 0 to Infinity (AUCinf) of Caffeine|Terminal Phase Elimination Rate Constant (β) of Caffeine|Terminal Phase Elimination Half-Life (t1/2) of Caffeine|Maximum Observed Plasma Concentration (Cmax) of Warfarin|Time to Maximum Observed Plasma Concentration (Tmax) of Warfarin|Area Under the Plasma Concentration-Time Curve (AUC) From Time 0 to Time of the Last Measurable Concentration (AUCt) of Warfarin|AUC From Time 0 to Infinity (AUCinf) of Warfarin|Terminal Phase Elimination Rate Constant (β) of Warfarin|Terminal Phase Elimination Half-Life (t1/2) of Warfarin|Maximum Observed Plasma Concentration (Cmax) of Omeprazole|Time to Maximum Observed Plasma Concentration (Tmax) of Omeprazole|Area Under the Plasma Concentration-Time Curve (AUC) From Time 0 to Time of the Last Measurable Concentration (AUCt) of Omeprazole|AUC From Time 0 to Infinity (AUCinf) of Omeprazole|Terminal Phase Elimination Rate Constant (β) of Omeprazole|Terminal Phase Elimination Half-Life (t1/2) of Omeprazole|Maximum Observed Plasma Concentration (Cmax) of Metoprolol|Time to Maximum Observed Plasma Concentration (Tmax) of Metoprolol|Area Under the Plasma Concentration-Time Curve (AUC) From Time 0 to Time of the Last Measurable Concentration (AUCt) of Metoprolol|AUC From Time 0 to Infinity (AUCinf) of Metoprolol|Terminal Phase Elimination Rate Constant (β) of Metoprolol|Terminal Phase Elimination Half-Life (t1/2) of Metoprolol","AbbVie","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 1","20","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","M19-974|2019-003684-22","February 16, 2020","November 5, 2021","November 5, 2021","February 5, 2020",,"December 14, 2020","Southern California Res. Ctr. /ID# 216257, Coronado, California, United States|University Clinical Research /ID# 216823, DeLand, Florida, United States|Clinical Trials of Texas,Inc. /ID# 216277, San Antonio, Texas, United States|Charite Research Organisation GmbH /ID# 218646, Berlin, Germany|Sheba Medical Center /ID# 223959, Ramat Gan, Israel",,"https://ClinicalTrials.gov/show/NCT04254783"
704,"NCT04254549","Rifaximin in Patients With Diabetic Gastroparesis",,"Recruiting","No Results Available","Crohn Disease|Diabetic Gastroparesis","Drug: Rifaximin|Drug: Placebo","Improvement in bloating","Mayo Clinic","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","19-002908","June 14, 2019","September 14, 2021","September 14, 2021","February 5, 2020",,"November 27, 2020","Mayo Clinic in Florida, Jacksonville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT04254549"
705,"NCT04192825","Analysis of Therapeutic Management Strategies for Anal Suppurations of Crohn's Disease","3T-LAP","Not yet recruiting","No Results Available","Crohn Disease|Anal Suppurations|Drainage Procedure","Procedure: surgical treatment","Clinical and anatomical healing","Rennes University Hospital","All","18 Years and older   (Adult, Older Adult)",,"440","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","35RC18_8808_3T-LAP","December 10, 2019","December 10, 2023","December 10, 2025","December 10, 2019",,"December 10, 2019","Centre Hospitalier de Rennes, Rennes, France",,"https://ClinicalTrials.gov/show/NCT04192825"
706,"NCT04134065","the Effect of Vitamin D in Crohn's Disease",,"Not yet recruiting","No Results Available","Vitamin D Deficiency|Crohn Disease","Drug: Vitamin D|Drug: Placebo oral capsule","Clinical disease activity|Fecal calprotectin|C-reactive protein|Discomportant complaint|24-hour urinary calcium","Nanjing University School of Medicine|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","All","20 Years to 60 Years   (Adult)","Early Phase 1","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","SJUSM","December 1, 2019","October 31, 2020","December 31, 2020","October 21, 2019",,"October 21, 2019",,,"https://ClinicalTrials.gov/show/NCT04134065"
707,"NCT04100005","A Pilot Study to Explore the Role of Gut Flora in Crohn's Disease",,"Recruiting","No Results Available","Crohn Disease|Crohn Colitis|Crohn's Ileocolitis|Crohn Ileitis|Crohn Disease of Ileum|Crohn's Disease Relapse|Crohn's Gastritis|Crohns Disease Aggravated|Crohn Disease in Remission|Crohn's Jejunitis|Crohn's Duodenitis|Crohn's Disease of Pylorus|Crohn's Esophagitis|Crohn's","Other: No intervention","Correlation of Microbiome to Crohn's Disease via Relative Abundance Found in Microbiome Sequencing|Validation of Sequencing Methods","ProgenaBiome","All","18 Years and older   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","ProgenaBiome-008","March 2, 2020","March 2023","July 2023","September 23, 2019",,"April 8, 2021","ProgenaBiome, Ventura, California, United States",,"https://ClinicalTrials.gov/show/NCT04100005"
708,"NCT04075825","Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula",,"Recruiting","No Results Available","Crohn's Disease|Complex Perianal Fistula","Biological: Darvadstrocel","Number of Participants With Adverse Events (AEs)|Number of Participants With Serious Adverse Events (SAEs)|Number of Participants With Specific Adverse Events of Special Interest (AESIs)|Percentage of Participants who Achieve Clinical Remission at Weeks 104 and 156 (After IMP Administration in ADMIRE-CD II Study)|Percentage of Participants who Achieve Clinical Response at Weeks 104 and 156 (After IMP Administration in ADMIRE-CD II Study)|Percentage of Participants With Relapse|Percentage of Participants who Achieve Combined Clinical Remission at Week 156 (After IMP Administration in ADMIRE-CD II Study)|Percentage of Participants With New Anal Abscess in Treated Fistula|Change from Baseline in Scores of Discharge Items of Perianal Disease Activity Index (PDAI) Score at Weeks 104 and 156 (After IMP Administration in ADMIRE-CD II Study)|Change from Baseline in Scores of Pain Items of Perianal Disease Activity Index (PDAI) Score at Weeks 104 and 156 (After IMP Administration in ADMIRE-CD II Study)","Millennium Pharmaceuticals, Inc.|Takeda","All","18 Years and older   (Adult, Older Adult)","Phase 3","150","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","Darvadstrocel-3003|2019-000333-39","November 4, 2019","February 28, 2024","February 28, 2024","September 3, 2019",,"May 19, 2021","Cedar-Sinai Medical Center, West Hollywood, California, United States|Hartford Hospital - Gastroenterology, Farmington, Connecticut, United States|Florida Hospital Tampa, Tampa, Florida, United States|Indiana University - Colon and Rectal, Indianapolis, Indiana, United States|University of Kansas Sxchool of Medicine, Kansas City, Kansas, United States|Colon and Rectal Surgery Associates, Metairie, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|University of Massachusetts - colon & rectal surgery, Worcester, Massachusetts, United States|Mayo Clinic College of Medicine - Division of Colon and Rectal Surgery - Division of Colon and Rectal Surgery, Rochester, Minnesota, United States|Barnes-Jewish Hospital - Gastroenterology, Saint Louis, Missouri, United States|Dartmouth Hitchcock Medical Center - Cancer Center, Lebanon, New Hampshire, United States|Morristown Medical Center - Gastroenterology, Morristown, New Jersey, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Lenox Hill Hospital, New York, New York, United States|Cleveland Clinic, Cleveland, Ohio, United States|Penn State Hershey Medical Center - Surgery, Hershey, Pennsylvania, United States|University Surgical Associates-Rhode Island Hospital, Providence, Rhode Island, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Utah, Salt Lake City, Utah, United States|Virginia Mason Medical Center - Gastroenterology, Seattle, Washington, United States|Swedish Medical Center, Seattle, Washington, United States|Medical College of Wisconsin Hub for Collaborative Medicine - Gastroenterology and Hepatology, Milwaukee, Wisconsin, United States|UZ Leuven - Campus Gasthuisberg, Leuven, Vlaams Brabant, Belgium|AZ Delta vzw - Maag-darm-leverziekten, Roeselare, West-Vlaanderen, Belgium|GZA ziekenhuizen - Campus Sint-Vincentius - Gastro-enterology, Antwerpen, Belgium|UZ Gent - Gastroenterology, Gent, Belgium|NH Hospital a.s., Horovice, Beroun, Czechia|FN Hradec Kralove, Hradec Kralove, Czechia|CHU de Nice, Nice Cedex 03, Alpes-Maritimes, France|CHU de Clermont-Ferrand - Estaing, Clermont-Ferrand cedex 1, Auvergne, France|Hopital Saint Louis - Gastro-hepatoenterologie, Paris, Ile-de-France, France|CHRU Hopital De Pontchaillou, Rennes, Ille-et-Vilaine, France|CHRU de Nancy -Hopital Brabois Adultes - Service d'Hepato- Gastroenterologie, Vandoeuvre-les-Nancy, Lorraine, France|CHRU De Lille - Hopital Claude Huriez - Hepato-Gastro-Enterologie, Lille, Nord, France|CHU Amiens-Picardie, AMIENS cedex 1, Picardie, France|Centre Hospitalier Lyon Sud, Pierre-Benite, Rhone, France|Paris St. Joseph Hospital, Paris, France|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont - I. sz. Belgyogyaszati Klinika, Szeged, Csongrad, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hajdu-Bihar, Hungary|MH Egeszsegugyi Kozpont - Gasztroenterologiai Osztaly, Budapest, Pest, Hungary|Semmelweis Egyetem, Budapest, Pest, Hungary|Rabin Med Ctr Beilinson Hosp, Petah Tikva, HaMerkaz, Israel|Rambam Medical Centre, Haifa, HaZafon, Israel|Chaim sheba Medical Center, Tel Hashomer, Tel-Aviv, Israel|Shaare Zedek Medical Center - Gastroenterology, Jerusalem, Yerushalayim, Israel|Hadassah Medical Organization, Hadassah Medical Center, Ein-, Jerusalem, Yerushalayim, Israel|Istituto Clinico Humanitas Rozzano, IRCCS - IBD Center, Rozzano, Milano, Italy|AOU Policlinico di Modena - Gastroenterologia, Modena, Italy|Complesso Integrato Columbus, Roma, Italy|Policlinico Universitario Agostino Gemelli, Roma, Italy|Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia, Udine, Italy|Centrum Medyczne Melita Medical, Wroclaw, Dolnoslaskie, Poland|Wielospecjalistyczny Szpital Medicover, Warszawa, Mazowieckie, Poland|Endoskopia Sp z o.o., Sopot, Pomorskie, Poland|Hospital Universitario Son Espases, Palma de Mallorca, Baleares, Spain|H.U. G.Trias i Pujol, Badalona, Barcelona, Spain|Corporacio Sanitaria Parc Tauli, Sabadell, Barcelona, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|C.H.U. de Pontevedra, Pontevedra, Spain|H.U.V. del Rocio, Sevilla, Spain",,"https://ClinicalTrials.gov/show/NCT04075825"
709,"NCT04073472","Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's","IPAAF","Not yet recruiting","No Results Available","Crohn's Disease|Fistula|Anal Fistula|Pouch, Ileal|Pouches, Ileoanal","Drug: mesenchymal stem cells (MSCs)","Safety and Feasibility: Number Of Adverse Events|Radiographic Healing|Clinical Healing","The Cleveland Clinic","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1","15","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IPAAF IND# IRB# are pending","June 1, 2021","June 1, 2022","June 1, 2023","August 29, 2019",,"April 19, 2021","Cleveland Clinic, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT04073472"
710,"NCT03943446","TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD)",,"Recruiting","No Results Available","Crohn Disease","Drug: TAK-018|Drug: TAK-018 Placebo","Percentage of Participants With Endoscopic Recurrence of CD as Assessed by Rutgeerts Grading Scale at Week 26|Percentage of Participants With Fecal Calprotectin (FCP) >135 Microgram per Gram (mcg/g) at Weeks 3, 6, 12, 18, 26 and 30|Ctrough: Observed Plasma Trough Concentrations of TAK-018","Millennium Pharmaceuticals, Inc.|Takeda","All","18 Years and older   (Adult, Older Adult)","Phase 2","96","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","TAK-018-2001|2019-000886-19|U1111-1225-5064|NR266345|NL71098.018.19","August 4, 2020","September 29, 2022","October 31, 2022","May 9, 2019",,"June 9, 2021","University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Hoag Memorial Hospital Presbyterian, Los Angeles, California, United States|University of Colorado Hospital Anschutz Cancer Pavilion, Aurora, Colorado, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|University of Miami Leonard M. Miller School of Medicine, Miami, Florida, United States|University of South Florida/USF Health, Tampa, Florida, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Northwestern University, Chicago, Illinois, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States|Johns Hopkins University, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|NYU Langone Inflammatory Bowel Disease Center, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Columbia University Irving Medical Center, New York, New York, United States|University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States|Cleveland Clinic, Cleveland, Ohio, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Vanderbilt Inflammatory Bowel Disease Clinic, Nashville, Tennessee, United States|Houston Methodist Hospital, Houston, Texas, United States|Medizinische Universitat Innsbruck, Innsbruck, Tyrol, Austria|Allgemeines Krankenhaus Wien, Wien, Vienna, Austria|Les Hopitaux Universitaires de Strasbourg - Hopital Hautepierre, Strasbourg Cedex, Alsace, France|Centre Hospitalier Universitaire Estaing, Clermont-Ferrand Cedex, Auvergne, France|Hopital Pontchaillou, Rennes Cedex 9, Bretagne, France|Hopital Saint-Louis, Paris Cedex 10, Il-de-France, France|Hopital Rangueil, Toulouse Cedex 9, Midi-pyrenees, France|Centre Hospitalier Universitaire de Nice Hopital l'Archet, Nice Cedex 3, Provence Alpes Cote D'Azur, France|Universitatsklinikum Freiburg, Freiburg, Baden-Wuerttemberg, Germany|Universitatsmedizin Mannheim, Mannheim, Baden-Wuerttemberg, Germany|Klinikum Luneburg, Luneburg, Niedersachsen, Germany|Klinikum St. George, Leipzig, Sachsen, Germany|London North West Healthcare NHS Trust, Harrow, England, United Kingdom|University College London Hospitals NHS Foundation Trust, London, England, United Kingdom|Saint Helens and Knowsley Teaching Hospitals NHS Trust, Prescot, England, United Kingdom|NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03943446"
711,"NCT03904212","Adipose Tissue Injection in Perianal Fistulas in Crohn´s Disease",,"Recruiting","No Results Available","Crohn Disease|Perianal Fistulas|Cell- and Tissue-Based Therapy|Treatment","Procedure: Adipose tissue injection|Procedure: saline","Complete clinical healing 6 months after treatment|Clinical healing 3 months after treatment|Partial healing 6 months after treatment|Reduction in symptoms 3 months after treatment|Reduction in symptoms 6 months after treatment|Changes in inconsistency 6 months after treatment","University of Aarhus","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 2|Phase 3","140","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","Adiposetissue_CD_Fistula_RCT","March 27, 2019","March 1, 2022","March 1, 2024","April 5, 2019",,"April 5, 2019","Aarhus University Hospital, Aarhus N, Denmark","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/12/NCT03904212/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03904212"
712,"NCT03884439","Infliximab Biosimilar ""Pfizer"" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)",,"Recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis","Drug: Infliximab [infliximab biosimilar 3]","Incidence of adverse drug reactions|Percentage of Participants With Remission (Clinical Disease Activity Index (CDAI)) for Crohn's disease|Percentage of Participants With Improvement (Clinical Disease Activity Index (CDAI)) for Crohn's disease|Percentage of Participants With Remission (Mayo) score for ulcerative colitis|Percentage of Participants With Improvement (Mayo) score for ulcerative colitis|Partial mayo Score","Pfizer","All","Child, Adult, Older Adult",,"300","Industry","Observational","Observational Model: Case-Only|Time Perspective: Other","B5371008","March 18, 2019","March 13, 2023","March 13, 2023","March 21, 2019",,"December 21, 2020","Pfizer Local Country Office, Tokyo, Japan",,"https://ClinicalTrials.gov/show/NCT03884439"
713,"NCT03773237","Intralipid Versus SMOFlipid in HPN Patients",,"Recruiting","No Results Available","Short Bowel Syndrome|Intestinal Fistula|Crohn Disease|Intestinal Obstruction","Dietary Supplement: SMOFLipid|Dietary Supplement: Intralipid","Direct Bilirubin Change is assessed","Mayo Clinic","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","17-001403","December 31, 2018","November 30, 2021","May 1, 2022","December 12, 2018",,"February 8, 2021","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03773237"
714,"NCT03769922","Postoperative Progression of the Disease Following Extensive Versus Limited Mesenteric Excision for Crohn's Disease",,"Recruiting","No Results Available","Postoperative Surgical Recurrence","Procedure: Extensive mesenteric resection|Procedure: Limited mesenteric excision","Accumulated 5-year postoperative surgical recurrence|Accumulated 5-year endoscopic recurrence|Accumulated 5-year clinical recurrence","Jinling Hospital, China|University Hospital of Limerick|The Cleveland Clinic|Sixth Affiliated Hospital, Sun Yat-sen University|Sir Run Run Shaw Hospital","All","16 Years to 65 Years   (Child, Adult, Older Adult)","Not Applicable","116","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","2018NZKY-025-02","February 18, 2019","January 2024","January 2025","December 10, 2018",,"February 27, 2019","General Hospital of Eastern Theater Command, Nanjing, Jiangsu, China",,"https://ClinicalTrials.gov/show/NCT03769922"
715,"NCT03710486","A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants","EVOLVE-IBERIA","Recruiting","No Results Available","Colitis, Ulcerative|Crohn Disease",,"Number of Participants With Change in Dose and Frequency of Dose Intervals|Number of Participants With Treatment Modifications|Number of Participants With Non-biological Concomitant Drug Treatment|Number of Participants who Discontinued Index Therapy|Number of Participants who Discontinued Index Therapy With Subsequent Implementation of Another Biologic Therapy|Time to Switching|Time to Discontinuation|Change From Baseline in Mayo Score at Month 6|Change From Baseline in Simple Endoscopic Index for Crohn's Disease (SES-CD) at Month 6|Change From Baseline in Harvey Bradshaw Index (HBI) Score at Month 6|Change From Baseline in Crohn's disease active index (CDAI) Score at Month 6|Number of Participants With Change From baseline in C-reactive Protein (CRP) Level|Number of Participants With Change From Baseline in Erythrocyte Sedimentation Rate (ESR) Level|Number of Participants With Change From Baseline in Fecal Calprotectin (FCP) Level|Number of Participants With Change From Baseline in Endoscopic Findings|Change From Baseline in Mayo Score at Month 12|Change From Baseline in SES-CD at Month 12|Change From Baseline in HBI Score at Month 12|Change From Baseline in CDAI Score at Month 12|Number of Participants with Change from Baseline in CRP Level, ESR Level, and FCP Level at Month 12|Number of Participants with Change From Baseline in Endoscopic Findings|Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Non-Treatment Related Events|Number of Participants With Non-serious Adverse Events and Serious Adverse Events (SAEs) Related to Treatment|Number of Participants With Treatment Alterations due to AEs|AE Duration|Number of Participants with AE Outcome","Takeda","All","18 Years and older   (Adult, Older Adult)",,"400","Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","Vedolizumab-5047|U1111-1218-0768|TAK-VDZ-2018-01","February 19, 2019","September 30, 2021","November 30, 2021","October 18, 2018",,"July 21, 2020","Hospital de Oviedo HUCA, Oviedo, Asturias, Spain|Hospital de Leon, Leon, Castilla Y Leon, Spain|Hospital de Salamanca, Salamanca, Castilla Y Leon, Spain|Hospital Vall d'Hebron, Barcelona, Cataluna, Spain|Hospital de Sant Pau, Barcelona, Cataluna, Spain|Hospital Moises Broggi, Barcelona, Cataluna, Spain|Hospital Josep Trueta, Girona, Cataluna, Spain|Hospital Parc Tauli, Sabadell, Cataluna, Spain|Hospital General de Alicante, Alicante, Comunidad Valenciana, Spain|H. Clinico de Valencia, Valencia, Comunidad Valenciana, Spain|H. Universitario y Politecnico de La Fe, Valencia, Comunidad Valenciana, Spain|H. de Manises, Valencia, Comunidad Valenciana, Spain|Hospital Son Espases, Palma de Mallorca, Islas Baleares, Spain|Hospital Universitario de Canarias, Santa Cruz de Tenerife, Islas Canarias, Spain|Hospital de Navarra, Pamplona, Navarra, Spain|Hospital La Princesa, Madrid, Spain|H. Gregorio Maranon, Madrid, Spain|Hospital Cinico San Carlos, Madrid, Spain|H. 12 de Octubre, Madrid, Spain|Hospital de la Paz, Madrid, Spain|H. Puerta de Hierro, Madrid, Spain",,"https://ClinicalTrials.gov/show/NCT03710486"
716,"NCT03650413","An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease",,"Recruiting","No Results Available","Ulcerative Colitis|Crohn's Disease","Drug: UTTR1147A","Number of Participants with Adverse Events, Severity Determined According to National Cancer Institute Common Terminology Criteria for Adverse Events Version 4.0 Scale (NCI CTCAE v4.0)|Number of Participants with Adverse Events of Clinically Significant Changes From Baseline in Targeted Vital Signs|Number of Participants with Adverse Events of Clinically Significant Changes From Baseline in Physical Examination Findings|Number of Participants with Adverse Events of Clinically Significant Changes From Baseline in Laboratory Test Results","Genentech, Inc.","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","320","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","GA40209|2017-004997-32","January 14, 2019","February 25, 2025","February 25, 2025","August 28, 2018",,"June 18, 2021","QWay Research, Hialeah, Florida, United States|University of Miami, Miami, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|University of Chicago Medical Center, Chicago, Illinois, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Atlantic Health System, Morristown, New Jersey, United States|NYU Langone Long Island Clinical Research Associates, Great Neck, New York, United States|Weill Cornell Medical College, New York, New York, United States|Southtowns Gastroenterology, PLLC, Orchard Park, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Syracuse VA Medical Center - NAVREF; Pharmacy, Syracuse, New York, United States|Carolina Digestive Diseases, Greenville, North Carolina, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Gastro One, Germantown, Tennessee, United States|Vanderbilt University Medical Center; IBD Clinic, Nashville, Tennessee, United States|Vilo Research Group, Houston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Biopharma Informatic Inc.; Research Center, Houston, Texas, United States|BI Research Center, Houston, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Texas Digestive Disease Consultants - PPDS, Webster, Texas, United States|University of Utah; Division of Gastroenterology/Hepatology, Salt Lake City, Utah, United States|The Medical College of Wisconsin Inc., Milwaukee, Wisconsin, United States|MHAT Saint Karidad EAD, Plovdiv, Bulgaria|Multiprofile Hospital for Active Treatment Hadji Dimitar OOD, Sliven, Bulgaria|Diagnostic and Consulting Center Aleksandrovska EOOD, Sofia, Bulgaria|Medical center CONVEX EOOD, Sofia, Bulgaria|Synexus - Medical Center Synexus Sofia EOOD, Sofia, Bulgaria|Synexus - Medical Centre Synexus Sofia EOOD (branch - Stara Zagora), Stara Zagora, Bulgaria|Medical Center Medica Plus OOD, Veliko Tarnovo, Bulgaria|LLC ARENSIA Exploratory Medicine, Tbilisi, Georgia|Charite Campus Mitte, Berlin, Germany|Gastroenterologische Spezialpraxis-Berlin-Karlshorst, Berlin, Germany|Synexus - Berlin, Berlin, Germany|Universitätsklinikum ""Carl Gustav Carus"" der Technischen Universität Dresden, Dresden, Germany|AES - DRS - Synexus Frankfurt Research Centre, Frankfurt, Germany|Asklepios Westklinikum Hamburg Ggmbh; Gastroenterologie, Hamburg, Germany|KRH Klinikum Siloah, Hannover, Germany|Universitätsklinikum Jena; Klinik und Poliklinik für Frauenheilkunde und Fortpflanzungsmedizin, Jena, Germany|Universitatsklinikum Schleswig Holstein; Klinik fur Allgemeine Innere Medizin, Kiel, Germany|Synexus - Leipzig, Leipzig, Germany|St. Marien Krankenhaus; Med. Klinik, Ludwigshafen, Germany|Klinikum Mannheim GmbH Universitätsklinikum, Mannheim, Germany|Universitatsklinikum Munster, Münster, Germany|Klinikum der Universität Regensburg, Regensburg, Germany|Universitätsklinikum Ulm; Klinik für Innere Medizin II, Ulm, Germany|University General Hospital of Heraklion; Department of Ophthalmology, Heraklon, Greece|University General Hospital of Larissa; University Gastroenterology Clinic, Larissa, Greece|Iatriko Palaiou Falirou; Gastrointestinal Department, Palaio Faliro, Greece|EUROMEDICA General Clinic of Thessaloniki; Gastroenterology Department, Thessaloniki, Greece|CMC Déli Klinika, Budapest, Hungary|Szent Margit Korhaz; IV.sz. Belgyogyaszati Osztaly, Budapest, Hungary|Synexus (DRS) - Synexus Magyarország Kft. Budapest, Budapest, Hungary|Magyar Honvédség Egészségügyi Központ; Országos Haemophilia Központ, Budapest, Hungary|Szent Pantaleon Korhaz-Rendelointezet; Gastroenterologiai Osztaly, Dunaújváros, Hungary|AES - DRS - Synexus Gyula - Magyarország Egészségügyi Szolgáltató Kft, Gyula, Hungary|Csongrad Megyei Dr. Bugyi Istvan Korhaz; Belgyogyaszati Osztaly, Szentes, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz; I. sz. Belgyogyaszati Osztaly, Székesfehérvár, Hungary|Csolnoky Ferenc Kórház, Veszprém, Hungary|Portiuncula Hospital, Ballinasloe, Co Galway, Ireland|Our Lady of Lourdes Hospital, Louth, County Louth, Ireland|Connolly Hospital, Dublin, Ireland|Beaumont Hospital, Dublin, Ireland|St Vincents University Hospital, Dublin, Ireland|Soroka University Medical Centre, Beer Sheva, Israel|Shaare Zedek Medical Center; Bait Vagan, Jerusalem, Israel|Meir Medical Center, Kfar- Saba, Israel|The Galilli Medical Center, Nahariyya, Israel|Rabin Medical Center; PPDS; Pharmacy, Petach Tiqwa, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Kaplan Medical Center, Rehovot, Israel|Azienda Ospedaliero Universitaria Di Bologna - Policlinico S.Orsola Malpighi; UO Farmacia Clinica, Bologna, Emilia-Romagna, Italy|Azienda Sanitaria Universitaria Integrata di Udine - PO Universitario Santa Maria della, Udine, Friuli-Venezia Giulia, Italy|Policlinico Universitario Campus Biomedico Di Roma, Roma, Lazio, Italy|Complesso Integrato Columbus, Roma, Lazio, Italy|ASST FATEBENEFRATELLI SACCO (Sacco), Milano, Lombardia, Italy|ASST di Monza - Azienda Ospedaliera San Gerardo; U.O. Farmacia -Settore A - Corpo Posteriore, Monza, Lombardia, Italy|ASST Rhodense - Ospedale di Rho, Rho, Lombardia, Italy|Istituto Clinico Humanitas, Rozzano (MI), Lombardia, Italy|Azienda Ospedaliera Ordine Mauriziano di Torino, Torino, Piemonte, Italy|Azienda Ospedaliera Di Padova, Padova, Veneto, Italy|ICS ARENSIA Exploratory Medicine, Chisinau, Moldova, Republic of|Szpital Uniwersytecki Nr 2 im. Dr Jana Biziela w Bydgoszczy; Centrum Endoskopii Zabiegowej, Bydgoszcz, Poland|Centrum Medyczne Lukamed Joanna Luka-Wendrowska, Chojnice, Poland|AES - DRS - Synexus Polska Sp. z o.o. Oddzial w Czestochowie, Częstochowa, Poland|AES - DRS - Synexus Polska Sp. z o.o. Oddzial w Gdansku, Gdańsk, Poland|Synexus Polska Sp. z o.o. Oddzial w Gdyni, Gdynia, Poland|Centrum Medycyny i Stomatologii SILESIA MED Sp. z o.o., Katowice, Poland|Economicus - NZOZ ALL-MEDICUS; Zaklad Gastroenterologii, Katowice, Poland|NZOZ Linia Centrum Leczenia Zaburzen Metabolicznych, Katowice, Poland|ETG Kielce, Kielce, Poland|Gastromed SPK Niepubliczny Zaklad Opieki Zdrowotnej, Lublin, Poland|Allmedica Badania Kliniczne Sp z o.o. Sp K., Nowy Targ, Poland|Klimed Marek Klimkiewicz, Piotrków Trybunalski, Poland|Synexus - Poznan, Poznan, Poland|SOLUMED Centrum Medyczne, Poznań, Poland|Clinical Research Center Sp. z o.o. MEDIC-R Spółka Komandytowa, Poznań, Poland|Endoskopia Sp. z o.o., Sopot, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Sonomed Sp. z o.o., Szczecin, Poland|Gastromed Kopon Zmudzinski i Wspolnicy Sp.j.Specjalistyczne Centrum Gastrologii i Endoskopii Specj, Toruń, Poland|Centrum Zdrowia MDM, Warszawa, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Synexus Polska Sp. z o.o. Oddzial w Warszawie, Warszawa, Poland|AES - BS - AS - SOMED CR Sp. z o.o. Sp. Komandytowa - Warszawa, Warszawa, Poland|BioVirtus Research Site, Warszawa, Poland|Niepubliczny Zaklad Opieki Zdrowotnej VIVAMED, Warszawa, Poland|Centrum Diagnostyczno - Lecznicze Barska sp. z o.o., Wloclawek, Poland|Synexus - Wroclaw, Wroclaw, Poland|EMC Instytut Medyczny S.A., Wrocław, Poland|Melita Medical, Wrocław, Poland|PlanetMed, Wrocław, Poland|ETG Zamosc, Zamosc, Poland|Synexus Polska Sp. Z o.o. Oddzial w Lodzi, Łódź, Poland|SPZOZ Uniwersytecki SK nr 1 im N. Barlickiego UM w Lodzi; Oddz. Klin. Gastroenter. Og. i Onk., Łódź, Poland|Osrodek Badan Klinicznych Appletreeclinics, Łódź, Poland|SOMED - Lodzkie Centrum Osteoporozy, Łódź, Poland|Medical Center Stolitsa-Medikl, Moscow, Moskovskaja Oblast, Russian Federation|Saint Martyr Elizabeth City Hospital, Sankt-peterburg, Sankt Petersburg, Russian Federation|Irkutsk Research Centre Hospital of Siberian department of Russian Academy of Science, Irkutsk, Russian Federation|Kuban State Medical University, Krasnodar, Russian Federation|Rostov State Medical University; Cardiorheumatology Department, Rostov-na-Donu, Russian Federation|Medical University Reaviz, Samara, Russian Federation|North-West State Medical University n.a. I.I. Mechnikov, St. Petersburg, Russian Federation|Russian Medical Military Academy n.a. S.M. Kirov, St. Petersburg, Russian Federation|Tomsk Regional Clinical Hospital, Tomsk, Russian Federation|Clinical Center of Serbia, Belgrade, Serbia|Clinical Hospital Center Zvezdara, Belgrade, Serbia|KBC Dr Dragisa Misovic Dedinje, Belgrade, Serbia|Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia|Clinical Center Kragujevac; Clinic Of Psychiatry, Kragujevac, Serbia|Clinical Center Nis, NIS, Serbia|General Hospital Vrsac, Vrsac, Serbia|Clinical Hospital Centre Zemun, Zemun, Serbia|General Hospital Djordje Joanovic - Zrenjanin, Zrenjanin, Serbia|Hospital de Gran Canaria Dr. Negrin; Servicio de Aparato Digestivo, Las Palmas de Gran Canaria, LAS Palmas, Spain|Hospital Universitario de Torrejon, Torrejon de Ardoz, Madrid, Spain|Centro Medico Teknon; Servicio de Farmacia, Barcelona, Spain|Hospital Universitari de Girona Dr Josep Trueta, Girona, Spain|Hospital Universitario de La Princesa; Aparato Digestivo, Madrid, Spain|Complejo Asistencial Universitario de Salamanca - H. Clinico, Salamanca, Spain|Hospital Clinico Universitario de Valencia; Servicio de Neurologia, Valencia, Spain|Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain|Regional Municipal Institution Chernivtsi Regional Clinical Hospital, Chernivtsi, Chernihiv Governorate, Ukraine|Medical Centre of PE First Private Clinic, Zhytomir, Crimean Regional Governmenta, Ukraine|Ternopil University Hospital; Regional Center of Gastroenterology with Hepatology, Ternopil, Katerynoslav Governorate, Ukraine|Zaporizhia City Multispecialty Clinical Hospital #9, Zaporizhzhye, Katerynoslav Governorate, Ukraine|Municipal Nonprofit Enterprise CCH #2 n.a. prof. O.O. Shalimov of Kharkiv City Council, Kharkiv, Kharkiv Governorate, Ukraine|Medical Centre of LLC CARDIOCOM, Kozyn, Kharkiv Governorate, Ukraine|City Clinical Hospital #1; Department of Gastroenterology, Vinnytsia, Kharkiv Governorate, Ukraine|Municipal Institution Zaporizhzhia Regional Clinical Hospital of Zaporizhzhia Regional Council, Zaporizhzhia, Kharkiv Governorate, Ukraine|ME Dnipropetrovsk Regional Clinical Hospital n.a. I.I Mechnykov Dnipropetrovsk Regional Council, Dnipro, KIEV Governorate, Ukraine|Treatment and Diagnostic Center of LLC MRT Elit, Kropyvnytskyi, KIEV Governorate, Ukraine|Medical Center of LLC Medical Clinic Blagomed, Kyiv, KIEV Governorate, Ukraine|Medical Center of Limited Liability Company ""Harmoniya krasy"", Kyiv, KIEV Governorate, Ukraine|Medical Center of LLC Medical Center Dopomoga Plus, Kyiv, KIEV Governorate, Ukraine|Medical Center of Edelweiss Medics LLC, Kyiv, KIEV Governorate, Ukraine|Synexus Affiliate - MC of LLC Medbud-Clinic, Kyiv, KIEV Governorate, Ukraine|Kyiv Railway Clinical Hospital No2 of Branch Health Center of the JSC Ukrainian Rail, Kyiv, KIEV Governorate, Ukraine|Med Center of International Institute of Clinical Trials LLC; Medical Center ""OK!Clinic+"", Kyiv, KIEV Governorate, Ukraine|Communal Non-profit Enterprise of Kyiv Regional Council Kyiv Regional Hospital, Kyiv, KIEV Governorate, Ukraine|Communal Nonprofit Enterprise Vinnytsia Regional Clinical Hospital named after N.I. Pirogov VRC, Vinnyts, KIEV Governorate, Ukraine|Medical Center of LLC Diaservis, Zaporizhzhia, KIEV Governorate, Ukraine|Municipal Nonprofit Enterprise City Hospital #1 of Zaporizhzhia City Council, Zaporizhzhia, KIEV Governorate, Ukraine|Clinic of SRI of Invalid Rehab. (ESTC) of VNMU n.a. M.I.Pyrohov, Vinnytsia, Podolia Governorate, Ukraine|Municipal Nonprofit Enterprise Lviv Clinical Emergency Care Hospital, Lviv, Polissya Okruha, Ukraine|Transcarpathian Regional Clinical Hospital n.a. A. Novak; Rheumatology Department, Uzhgorod, Ukraine|Medical Center of Diaservice LLC; Division of clinical trials conduct, Department #3, Zaporizhzhia, Ukraine|Non-Commercial Enterprise City Clinical Hospital 1 of Zaporizhzhia City Council, Zaporizhzhia, Ukraine|Synexus Midlands Clinical Research Centre, Birmingham, United Kingdom|Synexus - Wales Clinical Research Centre, Cardiff, United Kingdom|Kings College Hospital, London, United Kingdom|Synexus - Manchester Clinical Research Centre, Manchester, United Kingdom|Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03650413"
717,"NCT03537157","A Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention","STOP-PER","Active, not recruiting","No Results Available","Crohn Disease","Drug: Rifaximin delayed release tablets|Other: Placebo","Rutgeerts score","Alfasigma S.p.A.|Cromsource","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","43","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","RETIPC/01/17","November 16, 2017","August 1, 2020","August 15, 2020","May 25, 2018",,"January 23, 2020","Humanitas Clinical Research Center, Rozzano, Italy",,"https://ClinicalTrials.gov/show/NCT03537157"
718,"NCT03478956","A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Disease","FENNEL","Active, not recruiting","Has Results","Ulcerative Colitis|Crohn's Disease","Drug: Etrolizumab","Maximum Serum Concentration (Cmax) of Etrolizumab After First and Last Dose During the Randomized Treatment Phase|Time to Maximum Serum Concentration (Tmax) of Etrolizumab After First and Last Dose During the Randomized Treatment Phase|Area Under the Concentration-Time Curve Within the Last Dosing Interval (AUC-tau) of Etrolizumab During the Randomized Treatment Phase|Elimination Half-Life (t1/2) of Etrolizumab After Last Dose During the Randomized Treatment Phase|Serum Trough Concentration (Ctrough) of Etrolizumab at the End of Each Dosing Interval During the Randomized Treatment Phase|Percentage of Baseline Absolute Numbers of Beta7 Receptor-Expressing Gut Homing CD3, CD4, and CD8 T Cells and CD19 B Cells With Unoccupied Beta7 Receptors in Peripheral Blood, Assessed by Flow Cytometry, During the Randomized Treatment Phase|Number of Participants With Adverse Events by Highest Severity Grade, Assessed According to National Cancer Institute Common Terminology Criteria for Adverse Events, Version 4.0 (NCI-CTCAE v4.0), During the Randomized Treatment Phase|Number of Participants With Serious Infection-Related Adverse Events by Highest Severity Grade, Assessed According to NCI-CTCAE v4.0, During the Randomized Treatment Phase|Number of Participants With Hypersensitivity Reactions by Highest Severity Grade, Assessed According to NCI-CTCAE v4.0, During the Randomized Treatment Phase|Number of Participants With Malignancies by Highest Severity Grade, Assessed According to NCI-CTCAE v4.0, During the Randomized Treatment Phase|Number of Participants With Anti-Drug Antibodies (ADAs) to Etrolizumab at Baseline and Post-Baseline During the Randomized Treatment Phase|Long-Term Safety of Etrolizumab: Number of Participants With Adverse Events by Highest Severity Grade, Assessed According to NCI-CTCAE v4.0|Long-Term Safety of Etrolizumab: Number of Participants With Serious Infection-Related Adverse Events by Highest Severity Grade, Assessed According to NCI-CTCAE v4.0|Long-Term Safety of Etrolizumab: Number of Participants With Hypersensitivity Reactions by Highest Severity Grade, Assessed According to NCI-CTCAE v4.0|Long-Term Safety of Etrolizumab: Number of Participants With Malignancies by Highest Severity Grade, Assessed According to NCI-CTCAE v4.0|Long-Term Safety of Etrolizumab: Number of Participants With Anti-Drug Antibodies (ADAs) to Etrolizumab at Baseline and Post-Baseline|Number of Participants With Confirmed Progressive Multifocal Leukoencephalopathy (PML) During the Post-Treatment PML Monitoring Phase","Hoffmann-La Roche","All","4 Years to 17 Years   (Child)","Phase 1","24","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CA40192|2017-003649-10","March 27, 2018","December 2, 2019","December 18, 2027","March 27, 2018","August 5, 2020","April 14, 2021","Hôpital Enfants Reine Fabiola, Bruxelles, Belgium|Gabinet Lekarski, Bartosz Korczowski, Rzeszów, Poland|Centrum Zdrowia MDM, Warszawa, Poland|Hospital Niño Jesus; Servicio de Pediatria - Gastrenterologia y Nutricion, Madrid, Spain|Royal Manchester Childrens Hospital, Manchester, United Kingdom","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/56/NCT03478956/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03478956"
719,"NCT03358706","A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis",,"Recruiting","No Results Available","Crohn Disease|Ulcerative Colitis","Drug: Ustekinumab IV Infusion|Drug: Ustekinumab SC Injection|Drug: Midazolam 2 mg|Drug: Warfarin 10 mg|Drug: Vitamin K 10 mg|Drug: Omeprazole 20 mg|Drug: Dextromethorphan 30 mg|Drug: Caffeine 100 mg","For Crohn's disease (CD) or Ulcerative Colitis (UC) Participants: Geometric Mean Ratio (Day 22/ Day 1) of the Maximum Plasma Concentration (Cmax) of Cytochrome P450 Probe Substrates (Midazolam, Omeprazole, Dextromethorphan, S-warfarin and Caffeine)|For CD or UC Participants: Geometric Mean Ratio (Day 113/ Day 1) of the Cmax of Cytochrome P450 Probe Substrates (Midazolam, Omeprazole, Dextromethorphan, S-warfarin and Caffeine)|For CD or UC Participants: Geometric Mean Ratio (Day 22/ Day 1) of the Area Under the Plasma Concentration-time Curve From 0 to Infinity (AUC [0-inf]) of Cytochrome P450 Probe Substrates (Midazolam, Omeprazole, Dextromethorphan, S-warfarin and Caffeine)|For CD or UC Participants: Geometric Mean Ratio (Day 113/ Day 1) of AUC (0-inf) of Cytochrome P450 Probe Substrates (Midazolam, Omeprazole, Dextromethorphan, S-warfarin and Caffeine)|For CD or UC Participants: Geometric Mean Ratio (Day 22/ Day 1) of Area Under the Plasma Concentration-time Curve From 0 to Last Time (AUC [0-last]) of Cytochrome P450 Probe Substrates (Midazolam, Omeprazole, Dextromethorphan, S-warfarin and Caffeine)|For CD or UC Participants: Geometric Mean Ratio (Day 113/ Day 1) of AUC (0-last) of Cytochrome P450 Probe Substrates (Midazolam, Omeprazole, Dextromethorphan, S-warfarin and Caffeine)|For CD or UC Participants: Geometric Mean Ratio (Day 22/ Day 1) of the Area Under the Plasma Concentration-time Curve From 0 to 24 Hours (AUC [0-24]) of Cytochrome P450 Probe Substrates (Midazolam, Omeprazole, Dextromethorphan, and Caffeine)|For CD or UC Participants: Geometric Mean Ratio (Day 113/ Day 1) of the Area Under the Plasma Concentration-time Curve From 0 to 24 Hours (AUC [0-24]) of Cytochrome P450 Probe Substrates (Midazolam, Omeprazole, Dextromethorphan, and Caffeine)|For CD or UC Participants: Geometric Mean Ratio (Day 22/ Day 1) of the Area Under the Plasma Concentration-time Curve From 0 to 96 Hours (AUC [0-96]) of Cytochrome P450 Probe Substrate (S-warfarin)|For CD or UC Participants: Geometric Mean Ratio (Day 113/ Day 1) of the Area Under the Plasma Concentration-time Curve From 0 to 96 Hours (AUC [0-96]) of Cytochrome P450 Probe Substrate (S-warfarin)|CD and UC Participants: Time to Reach the Maximum Observed Plasma Concentration (Tmax) of Cytochrome P450 Probe Substrates (Midazolam, Omeprazole, Dextromethorphan, S-warfarin and Caffeine)|CD and UC Participants: Terminal Half-Life (T1/2) of Cytochrome P450 Probe Substrates (Midazolam, Omeprazole, Dextromethorphan, S-warfarin and Caffeine)|CD and UC Participants: Apparent Total Systemic Clearance (CL/F) of Cytochrome P450 Probe Substrates (Midazolam, Omeprazole, Dextromethorphan, S-warfarin and Caffeine)|CD and UC Participants: Apparent Volume of Distribution (Vz/F) of Cytochrome P450 Probe Substrates (Midazolam, Omeprazole, Dextromethorphan, S-warfarin and Caffeine)|CD and UC Participants: Twelve Hour Urine Dextromethorphan to Dextrorphan Ratio|Number of Participants With Treatment-Emergent Adverse Events (TEAEs)","Janssen Research & Development, LLC","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1","57","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","CR108352|2017-000831-16|CNTO1275CRD1003","February 2, 2018","May 17, 2022","August 1, 2024","December 2, 2017",,"June 9, 2021","WCCT Global, LLC, Cypress, California, United States|Accel Research Sites, DeLand, Florida, United States|Ocean Blue Medical Research Center Inc., Miami Springs, Florida, United States|Advanced Pharma CR, LLC, Miami, Florida, United States|University Of Minnesota, Minneapolis, Minnesota, United States|Duke University, Durham, North Carolina, United States|University of Washington, Seattle, Washington, United States|Ghent University Hospital, Gent, Belgium|Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman, Liege, Belgium|Az Sint-Maarten, Mechelen, Belgium|Clinical Pharmacology Unit, Merksem, Belgium|Universitatsklinikum Bonn, Bonn, Germany|Universitatsklinikum Essen, Essen, Germany|Universitatsklinikum Freiburg, Freiburg, Germany|CTC North GmbH & Co. KG, Am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Clinical Research Center Hannover, Hannover, Germany|University Hospital Heidelberg, Heidelberg, Germany|Danderyd Hospital, Stockholm, Sweden|Wythenshawe Hospital, Greater Manchester, United Kingdom|Royal Liverpool University Hospital, Liverpool, United Kingdom|Guy's Hospital, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03358706"
720,"NCT03283085","A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)",,"Recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis","Drug: 25 mg Ontamalimab|Drug: 75 mg Ontamalimab","Number of Participants With Treatment Emergent Adverse Events (TEAEs)|Number of Participants With Serious Infections|Number of Participants With Clinically Significant Change in Clinical Laboratory Tests Reported as an Adverse Event|Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Reported as an Adverse Event|Number of Participants With Clinically Significant Change in Vital Signs Reported as an Adverse Event|Number of Participants with Ulcerative Colitis with Treatment Response Over Time|Number of Participants with Crohn's Disease with Treatment Response Over Time","Shire|Takeda","All","16 Years to 80 Years   (Child, Adult, Older Adult)","Phase 3","451","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","SHP647-304|2017-000574-11","February 27, 2018","December 31, 2023","December 31, 2023","September 14, 2017",,"June 8, 2021","Arizona Digestive Health Mesa - East, Mesa, Arizona, United States|Elite Clinical Studies - Phoenix - Clinedge - PPDS, Phoenix, Arizona, United States|Arizona Digestive Health, Sun City, Arizona, United States|Del Sol Research Management, Tucson, Arizona, United States|CATS Research Center - University of Arizona, Tucson, Arizona, United States|Atria Clinical Research - Clinedge - PPDS, Little Rock, Arkansas, United States|Advanced Research Center, Anaheim, California, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, United States|United Medical Doctors, Encinitas, California, United States|University of California San Diego, La Jolla, California, United States|OM Research LLC - Lancaster - ClinEdge - PPDS, Lancaster, California, United States|Tibor Rubin VA Medical Center - NAVREF, Long Beach, California, United States|VA Long Beach Healthcare System - NAVREF - PPDS, Long Beach, California, United States|Facey Medical Foundation, Mission Hills, California, United States|United Medical Doctors, Murrieta, California, United States|Alliance Clinical Research-(Vestavia Hills), Poway, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|University of California San Francisco, San Francisco, California, United States|Care Access Research, San Pablo, San Pablo, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Asthma and Allergy Associates PC - CRN - PPDS, Colorado Springs, Colorado, United States|Renaissance Research Medical Group, INC, Cape Coral, Florida, United States|Gastro Florida, Clearwater, Florida, United States|Advanced Clinical Research Network, Coral Gables, Florida, United States|Alliance Medical Research LLC, Coral Springs, Florida, United States|ENCORE Borland-Groover Clinical Research - ERN - PPDS, Jacksonville, Florida, United States|SIH Research, Kissimmee, Florida, United States|Crystal Biomedical Research, Miami Lakes, Florida, United States|Hi Tech and Global Research, LLc, Miami, Florida, United States|University of Miami Miller School of Medicine, Miami, Florida, United States|Nuren Medical and Research Center, Miami, Florida, United States|Sanchez Clinical Research, Inc, Miami, Florida, United States|Advanced Clinical Research Network, Miami, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|Pharma Research International Inc, Naples, Florida, United States|Bayside Clinical Research - New Port Richey, New Port Richey, Florida, United States|Clinical Neuroscience Solutions Inc, Orlando, Florida, United States|Omega Research Consultants LLC - Clinedge - PPDS, Orlando, Florida, United States|Accel Research Sites - St. Petersburg - ERN - PPDS, Pinellas Park, Florida, United States|BRCR Medical Center, Inc, Plantation, Florida, United States|East Coast Institute for Research, LLC, Saint Augustine, Florida, United States|DBC Research, Tamarac, Florida, United States|Infinite Clinical Trials, Atlanta, Georgia, United States|Columbus Regional Research Institute, Columbus, Georgia, United States|Gastrointestinal Diseases, Inc Research - IACT- HyperCore - PPDS, Columbus, Georgia, United States|Atlanta Center For Gastroenterology PC, Decatur, Georgia, United States|Atlanta Gastroenterology Specialists, PC, Suwanee, Georgia, United States|Northwestern University, Chicago, Illinois, United States|University of Chicago Medical Center, Chicago, Illinois, United States|Loretto Hospital, Chicago, Illinois, United States|IL Gastroenterology Group, Gurnee, Illinois, United States|Edward Hines Jr VA Hospital - NAVREF - PPDS, Hines, Illinois, United States|Dupage Medical Group, Oakbrook Terrace, Illinois, United States|Medisphere Medical Research Center LLC, Evansville, Indiana, United States|Laporte County Institute For Clinical Research, Michigan City, Indiana, United States|Cotton O'Neil Clinical Research Center, Topeka, Kansas, United States|Tri-State Gastroentrology Associates, Florence, Kentucky, United States|Gastroenterology Associates of Hazard, Hazard, Kentucky, United States|CroNOLA, LLC., Houma, Louisiana, United States|Clinical Trials of SWLA LLC, Lake Charles, Louisiana, United States|DelRicht Clinical Research, LLC - ClinEdge - PPDS, New Orleans, Louisiana, United States|Louisiana Research Center LLC, Shreveport, Louisiana, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Tri County Endoscopy, Hollywood, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Commonwealth Clinical Studies LLC, Brockton, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|UMass Memorial Medical Center, Worcester, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Clinical Research Institute of Michigan, Chesterfield, Michigan, United States|National Clinical, LLC, Hamtramck, Michigan, United States|Gastroenterology Associates of Western Michigan, PLC, Wyoming, Michigan, United States|Mayo Clinic Health System - PPDS, Duluth, Minnesota, United States|Minnesota Gastroenterology PA, Saint Paul, Minnesota, United States|Digestive Health Center PA, Ocean Springs, Mississippi, United States|Midwest Biomedical Research Foundation - NAVREF, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|St Louis Center For Clinical Research, Saint Louis, Missouri, United States|Advanced Biomedical Research of America, Las Vegas, Nevada, United States|Encompass Care, North Las Vegas, Nevada, United States|Friedrich, Rubin, Panella, Sapienza, and Kaplounov, LLP, Englewood, New Jersey, United States|New York Total Medical Care PC, Brooklyn, New York, United States|NYU Langone Long Island Clinical Research Associates, Great Neck, New York, United States|Weill Cornell Medical College, New York, New York, United States|Southtowns Gastroenterology, PLLC, Orchard Park, New York, United States|East Carolina Gastroenterology, Jacksonville, North Carolina, United States|Piedmont Healthcare, Statesville, North Carolina, United States|Consultants For Clinical Research Inc, Cincinnati, Ohio, United States|Consultants For Clinical Research Inc, Cincinnati, Ohio, United States|Consultants For Clinical Research Inc, Fairfield, Ohio, United States|Prestige Clinical Research, Franklin, Ohio, United States|Ohio Clinical Research Partners LLC, Mentor, Ohio, United States|Veteran's Research and Education Foundation - NAVREF - PPDS, Oklahoma City, Oklahoma, United States|Allegheny Center For Digestive Health, Pittsburgh, Pennsylvania, United States|Veterans Research Foundation of Pittsburgh - NAVREF - PPDS, Pittsburgh, Pennsylvania, United States|Penn State Hershey Medical Group, State College, Pennsylvania, United States|Digestive Disease Associates, Wyomissing, Pennsylvania, United States|Gastro One, Germantown, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Advanced Gastroenterology-Union City, Union City, Tennessee, United States|Northside Gastroenterology, Cypress, Texas, United States|Digestive Health Associates of Texas, P.A.dba DHAT Research Institute, Garland, Texas, United States|Kelsey Seybold Clinic, Houston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Precision Research Institute, LLC, Houston, Texas, United States|Biopharma Informatic Inc., Houston, Texas, United States|Northwest Med Care, Houston, Texas, United States|Southwest Clinical Trials, Houston, Texas, United States|Aztec Medical Research, Houston, Texas, United States|BI Research Center, Houston, Texas, United States|Southern Star Research Institute LLC, San Antonio, Texas, United States|DM Clinical Research - ERN - PPDS, Tomball, Texas, United States|Inquest Clinical Research/Coastal Gastroenterology Associates, PA - TDDC - PPDS, Webster, Texas, United States|HP Clinical Research, Bountiful, Utah, United States|University of Vermont, Burlington, Vermont, United States|Mid Atlantic Health Specialists, Galax, Virginia, United States|Winchester Gastroenterology Associates, Winchester, Virginia, United States|Digestive Health Center at UWMC, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States|CHI Franciscan Digestive Care Associates, Tacoma, Washington, United States|Exemplar Research, Inc. - Elkins, Elkins, West Virginia, United States|West Virginia University Hospital, Morgantown, West Virginia, United States|Fundación Favaloro, Buenos Aires, Argentina|Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina|Sanatorio 9 de Julio SA, San Miguel de Tucumán, Argentina|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Liverpool Hospital, Liverpool, New South Wales, Australia|Royal Brisbane & Women's Hospital, Herston, Queensland, Australia|Mater Hospital Brisbane, South Brisbane, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|The Alfred Hospital, Box Hill, Victoria, Australia|St Vincents Hospital Melbourne - PPDS, Melbourne, Victoria, Australia|A.ö. Krankenhaus der Barmherzigen Brüder, St. Veit an der Glan, Kärnten, Austria|LKH-Universitätsklinikum Klinikum Graz, Graz, Steiermark, Austria|Klinikum Klagenfurt Am Woerthersee, Klagenfurt am Wörthersee, Austria|Salzburger Landeskliniken, Salzburg, Austria|Universitätsklinikum St. Pölten, St. Pölten, Austria|Klinikum Wels-Grieskirchen GmbH, Wels, Austria|Medizinische Universitat Wien (Medical University of Vienna), Wien, Austria|UZ Gent, Gent, Oost-Vlaanderen, Belgium|UZ Gasthuisberg, Leuven, Vlaams Brabant, Belgium|AZ Groeninge, Kortrijk, West-Vlaanderen, Belgium|CHU Mouscron, Mouscron, Belgium|Clinical Center Banja Luka, Banja Luka, Bosnia and Herzegovina|Clinical Center Banja Luka, Banja Luka, Bosnia and Herzegovina|Acibadem City Clinic University Multiprofile Hospital for Active Treatment EOOD, Sofia, Sofia-Grad, Bulgaria|University Multiprofile Hospital for Active Treatment - Dr. Georgi Stranski EAD, Pleven, Bulgaria|Multiprofile Hospital for Active Treatment Eurohospital, Plovdiv, Bulgaria|Specialized Hospital for Active Treatment of Pneumophthisiatric Diseases Dr.D.Gramatikov- Ruse- PPDS, Ruse, Bulgaria|Medical Center-1-Sevlievo EOOD, Sevlievo, Bulgaria|Medical Center Excelsior OOD - PPDS, Sofia, Bulgaria|Second Multiprofile Hospital for Active Treatment Sofia, Sofia, Bulgaria|Diagnostic and Consulting Center Aleksandrovska EOOD, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Sv Ivan Rilski EAD, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna - ISUL EAD, Sofia, Bulgaria|Medical Center Convex EOOD, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Sveta Anna, Sofia, Bulgaria|Diagnostic Consultative Centre Mladost - M OOD, Varna, Bulgaria|Percuro Clinical Research LTD, Victoria, British Columbia, Canada|Toronto Digestive Disease Associates Inc, Toronto, Ontario, Canada|Montreal General Hospital, Montreal, Quebec, Canada|Hospital Pablo Tobón Uribe, Medellin, Antioquia, Colombia|Hospital Universitario San Ignacio, Bogotá, Cundinamarca, Colombia|Servimed S.A.S, Bucaramanga, Santander, Colombia|Fundación Valle Del Lili, Cali, Valle Del Cauca, Colombia|Fundación Clínica Shaio, Bogota, Colombia|Fundación Cardioinfantil Instituto Cardiológico, Bogotá, Colombia|IPS Centro Médico Julián Coronel S.A.S. - PPDS, Cali, Colombia|University Hospital Center Zagreb, Zagreb, Grad Zagreb, Croatia|Opca Bolnica Karlovac, Karlovac, Karlovacka Županija, Croatia|Opca bolnica Bjelovar, Bjelovar, Croatia|Clinical Hospital Centre Osijek, Osijek, Croatia|University Hospital Centre Split, Split, Croatia|General Hospital Virovitica, Virovitica, Croatia|General County Hospital Vukovar and Croatian Veterans Hospital, Vukovar, Croatia|General Hospital Zadar, Zadar, Croatia|Hepato-Gastroenterologie HK, s. r. o., Hradec Králové, Královéhradecký Kraj, Czechia|PreventaMed s.r.o., Olomouc, Olomoucký Kraj, Czechia|Institut Klinicke A Experimentalni Mediciny, Praha 4, Czechia|ISCARE I.V.F. a.s., Praha 7, Czechia|Krajska zdravotni, a.s. - Masarykova nemocnice v Usti nad Labem, o.z., Usti nad Labem, Czechia|Nemocnice Pardubickeho kraje, a.s. Orlickoustecka nemocnice, Usti nad Orlici, Czechia|OÜ LV Venter, Pärnu, Pärnumaa, Estonia|East Viru Central Hospital, Kohta-Järve, Estonia|West Tallinn Central Hospital, Tallinn, Estonia|CHU Estaing, Clermont Ferrand, France|CHRU Lille, Lille cedex, France|Marienhospital Stuttgart, Stuttgart, Baden-Württemberg, Germany|Universitätsklinikum Ulm, Ulm, Baden-Württemberg, Germany|Städtisches Klinikum Lüneburg, Lüneburg, Niedersachsen, Germany|Universitätsklinikum der RWTH Aachen, Aachen, Nordrhein-Westfalen, Germany|Uniklinik Köln, Köln, Nordrhein-Westfalen, Germany|Gastroenterologische Gemeinschaftspraxis Minden, Minden, Nordrhein-Westfalen, Germany|Gastro Campus Research GbR, Münster, Nordrhein-Westfalen, Germany|Universitatsklinikum Schleswig-Holstein, Kiel, Schleswig-Holstein, Germany|Universitatsklinikum Jena, Jena, Thüringen, Germany|Gastroenterologische Facharztpraxis am Mexikoplatz, Berlin-Zehlendorf, Germany|Charité - Universitätsmedizin Berlin, Berlin, Germany|Sana Klinikum Biberach, Biberach an der Riss, Germany|Universitätsklinikum Frankfurt, Frankfurt, Germany|Asklepios Westklinikum Hamburg Ggmbh, Hamburg, Germany|Klinikum rechts der Isa der Technischen Universitaet Muenchen, Munich, Germany|Gemeinschaftspraxis Dres. Zimber/Brendel/Hoesl/Maintz, Nürnberg, Germany|Ippokrateio General Hospital of Athens, Athens, Attiki, Greece|University General Hospital of Heraklion, Heraklion, Greece|University General Hospital of Ioannina, Ioannina, Greece|Iatriko Palaiou Falirou, Paliao Faliro, Greece|University General Hospital of Patras, Patras, Greece|Theageneio Anticancer Oncology Hospital of Thessaloniki, Thessaloniki, Greece|Euromedica - PPDS, Thessaloniki, Greece|Magyar Honvédség Egészségügyi Központ, Budapest, Hungary|Pannónia Magánorvosi Centrum Kft, Budapest, Hungary|ENDOMEDIX Kft., Budapest, Hungary|Bekes Megyei Kozponti Korhaz, Békéscsaba, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Bekes Megyei Kozponti Korhaz, Gyula, Hungary|Mohacsi Korhaz, Mohacs, Hungary|Tolna Megyei Balassa János Kórház, Szekszard, Hungary|Csongrad Megyei Dr. Bugyi Istvan Korhaz, Szentes, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Székesfehérvár, Hungary|Csolnoky Ferenc Korhaz, Veszprém, Hungary|Jávorszky Ödön Kórház, Vác, Hungary|St Vincent's University Hospital, Dublin, Ireland|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah Medical Center - PPDS, Jerusalem, Israel|Galilee Medical Center, Nahariya, Israel|Nazareth EMMS Hospital, Nazareth, Israel|Tel Aviv Sourasky Medical Center PPDS, Tel Aviv, Israel|Baruch Padeh Poriya Medical Center, Tiberias, Israel|Azienda Ospedaliera Mater Domini Di Catanzaro, Catanzaro, Calabria, Italy|Azienda Ospedaliero Universitaria Di Bologna - Policlinico S Orsola Malpighi, Bologna, Emilia-Romagna, Italy|Azienda Ospedaliero Universitaria Di Modena Policlinico, Modena, Emilia-Romagna, Italy|Azienda Ospedaliera San Camillo Forlanini, Roma, Lazio, Italy|Ospedale Casa Sollievo Della Sofferenza IRCCS, San Giovanni Rotondo (FG), Puglia, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, Toscana, Italy|IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Veneto, Italy|Azienda Ospedale Università Padova - Dipartimento Salute della Donna e del Bambino, Padova, Veneto, Italy|A.O.U. Maggiore della Carità, Novara, Italy|Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia, Italy|La Sapienza-Università di Roma-Policlinico Umberto I, Roma, Italy|Fondazione Policlinico Universitario A Gemelli, Roma, Italy|Istituto Clinico Humanitas, Rozzano (MI), Italy|Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy|Azienda Ospedaliera Ordine Mauriziano di Torino, Torino, Italy|Sapporo Tokushukai Hospital, Sapporo-shi, Hokkaidô, Japan|Sapporo Medical University Hospital, Sapporo, Hokkaidô, Japan|Medical Corporation Aoyama Clinic, Kobe-shi, Hyôgo, Japan|Hyogo College of Medicine, Nishinomiya-shi, Hyôgo, Japan|Sagamihara Kyodo Hospital, Sagamihara, Kanagawa, Japan|Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama, Japan|Nihonbashi Egawa Clinic, Chuo-Ku, Tokyo, Japan|Jikei University Hospital, Minato-ku, Tokyo, Japan|Kitasato University Kitasato Institute Hospital, Minato-ku, Tokyo, Japan|Ome Municipal General Hospital, Ome, Tokyo, Japan|Tokatsu Tsujinaka Hospital, Abiko, Japan|Kunimoto Hospital, Asahikawa, Japan|Fukuoka University Chikushi Hospital, Chikushino, Japan|Hakodate Koseiin Hakodate Goryoukaku Hospital, Hakodate, Japan|Kawabe Clinic, Koganei, Japan|Yuai Memorial Hospital, Koga, Japan|Hidaka Coloproctology Clinic, Kurume-shi, Japan|Aizawa Hospital, Matsumoto-shi, Japan|Aichi Medical University Hospital, Nagakute, Japan|Nishinomiya Municipal Central Hospital, Nishinomiya, Japan|Onomichi General Hospital, Onomichi, Japan|Kinshukai Infusion Clinic, Osaka-shi, Japan|Chiinkai Dojima General & Gastroenterology Clinic, Osaka, Japan|Shiga University of Medical Science Hospital, Otsu-Shi, Japan|Bellland General Hospital, Sakai, Japan|Toho University Sakura Medical Center, Sakura, Japan|Sapporo Higashi Tokushukai Hospital, Sapporo, Japan|Tohoku Rosai Hospital, Sendai, Japan|Dokkyo Medical University Hospital, Shimotsuga-gun, Japan|Medical Corporation Shoyu-kai Fujita Gastroenterology Hospital, Takatsuki, Japan|Koukokukai Ebisu Clinic, Tokyo, Japan|Colo-Proctology Center Matsushima Clinic, Yokohama, Japan|Shinbeppu Hospital, Beppu, Ôita, Japan|Ishida Clinic of IBD and Gastroenterology, Oita-city, Ôita, Japan|Yodogawa Christian Hospital, Osaka, Ôsaka, Japan|Kyungpook National University Hospital, Daegu, Daegu Gwang'yeogsi, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wonju, Gang'weondo, Korea, Republic of|CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggido, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital, Suwon, Gyeonggido, Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Pusan National University Hospital, Busan, Korea, Republic of|Yeungnam University Hospital, Daegu, Korea, Republic of|Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of|Gachon University Gil Medical Center, Incheon, Korea, Republic of|Kyung Hee University Hospital, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Severance Hospital Yonsei University Health System, Seoul, Korea, Republic of|Inje University Seoul Paik Hospital, Seoul, Korea, Republic of|Asan Medical Center - PPDS, Seoul, Korea, Republic of|Samsung Medical Center PPDS, Seoul, Korea, Republic of|Al Zahraa University Hospital, Beirut, Lebanon|Rafik Hariri University Hospital, Beirut, Lebanon|Hammoud Hospital University Medical Center, Saida, Lebanon|Hammoud Hospital University Medical Center, Saida, Lebanon|Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania|Klaipeda University Hospital, Klaipeda, Lithuania|Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania|Vilnius City Clinical Hospital, Vilnius, Lithuania|Health Pharma Professional Research S.A de C.V., Ciudad de Mexico, Distrito Federal, Mexico|Clinica de Higado y Gastroenterologia Integral, S.C., Cuernavaca, Morelos, Mexico|JM Research S.C, Cuernavaca, Morelos, Mexico|Accelerium, S. de R.L. de C.V., Monterrey, Nuevo León, Mexico|Unidad de Atencion Medica e Investigacion en Salud, Merida, Yucatán, Mexico|Centro de Investigación Médica Aguascalientes, Aguascalientes, Mexico|Phylasis Clinicas Research S. de R.L. de C.V., Cuautitlán Izcalli, Mexico|Centro de Investigacion Clinica Acelerada, S.C., Distrito Federal, Mexico|Instituto de Investigaciones Aplicadas a la Neurociencia A.C., Durango, Mexico|Accelerium, S. de R.L. de C.V., Monterrey, Mexico|Clinical Research Institute, Tlalnepantla De Baz, Mexico|Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V., Zapopan, Jalisco, Mexico|ETZ-Elisabeth, Tilburg, Noord-Brabant, Netherlands|NWZ, location Alkmaar, Alkmaar, Noord-Holland, Netherlands|Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, Netherlands|VU Medisch Centrum, Amsterdam, Netherlands|Academisch Medisch Centrum Amsterdam, Amsterdam, Netherlands|Auckland City Hospital, Grafton, Auckland, New Zealand|Dunedin Hospital, Dunedin, South Island, New Zealand|Wellington Hospital, Newtown, Wellington, New Zealand|Waikato Hospital, Hamilton, New Zealand|Melita Medical, Wroclaw, Dolnoslaskie, Poland|Lexmedica, Wroclaw, Dolnoslaskie, Poland|Vitamed Galaj i Cichomski sp.j., Bydgoszcz, Kujawsko-pomorskie, Poland|Gastromed Kopon Zmudzinski i Wspolnicy Sp.j.Specjalistyczne Centrum Gastrologii i Endoskopii Specj, Torun, Kujawsko-pomorskie, Poland|Centrum Diagnostyczno - Lecznicze Barska sp. z o.o., Wloclawek, Kujawsko-pomorskie, Poland|Niepubliczny Zaklad Opieki Zdrowotnej CENTRUM MEDYCZNE Szpital Swietej Rodziny, Lódz, Lódzkie, Poland|Uniwersytecki Szpital Kliniczny im. Wojskowej Akademii Medycznej Centralny Szpital Weteranow, Lódz, Lódzkie, Poland|Instytut Centrum Zdrowia Matki Polki, Lódz, Lódzkie, Poland|Krakowskie Centrum Medyczne, Krakow, Malopolskie, Poland|BioVirtus Centrum Medyczne, Jozefow, Mazowieckie, Poland|Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Warszawa, Mazowieckie, Poland|Niepubliczny Zakład Opieki Zdrowotnej VIVAMED, Warszawa, Mazowieckie, Poland|Miedzyleski Szpital Specjalistyczny w Warszawie, Warszawa, Mazowieckie, Poland|Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok, Podlaskie, Poland|Endoskopia Sp. z o.o., Sopot, Pomorskie, Poland|Szpital Zakonu Bonifratrow pw. Aniolow Strozow w Katowicach, Katowice, Slaskie, Poland|Szpital Specjalistyczny sw Lukasza - Oddzial Gastroenterologii, Konskie, Swietokrzyskie, Poland|Twoja Przychodnia - Szczecińskie Centrum Medyczne, Szczecin, Zachodniopomorskie, Poland|Szpital Uniwersytecki Nr 2 im. Dr Jana Biziela w Bydgoszczy, Bydgoszcz, Poland|Centrum Medyczne Pratia Bydgoszcz, Bydgoszcz, Poland|Centrum Medyczne Czestochowa - PRATIA - PPDS, Czestochowa, Poland|Centrum Medyczne Gdynia - PRATIA - PPDS, Gdynia, Poland|NZOZ All Medicus, Katowice, Poland|Centrum Medyczne A-Z Clinic Mateusz Sidor, Piotr Puc-Lekarze Spolka Partnerska, Krakow, Poland|Centrum Opieki Zdrowotnej Orkan-Med Stec-Michalska Sp. J., Ksawerow, Poland|Med Gastr Sp.z.o.o Sp.k, Lodz, Poland|Twoja Przychodnia - Centrum Medyczne Nowa Sol, Nowa Sól, Poland|Centrum Innowacyjnych Terapii, Piaseczno, Poland|Clinical Research Center Spółka z Ograniczoną Odpowiedzialnością, Medic-R Spółka Komandytowa, Poznan, Poland|Korczowski Bartosz, Gabinet Lekarski, Rzeszow, Poland|Sonomed Sp. z o.o., Szczecin, Poland|Sonomed Sp. z o.o., Szczecin, Poland|H-T. Centrum Medyczne Endoterapia, Tychy, Poland|Centrum Zdrowia MDM, Warszawa, Poland|Centrum Medyczne Warszawa - PRATIA - PPDS, Warszawa, Poland|Centralny Szpital Kliniczny MSW, Warszawa, Poland|Samodzielny Publiczny Szpital Wojewodzki im. Papieza Jana Pawla II, Zamosc, Poland|Hospital de Braga, Braga, Portugal|Centro Hospitalar do Algarve - Hospital de Portimao, Faro, Portugal|Hospital Senhora da Oliveira - Guimaraes, E.P.E, Guimarães, Portugal|Hospital da Luz, Lisboa, Portugal|Hospital de São Bernardo, Setubal, Portugal|Cluj Clinical County Hospital, Cluj-Napoca, Cluj, Romania|Dr.Carol Davila Emergency University Central Military Hospital, Bucharest, Romania|Sana Monitoring SRL, Bucharest, Romania|Colentina Clinical Hospital, Bucharest, Romania|Prof. Dr. Matei Bals Institute of Infectious Diseases, Bucharest, Romania|Fundeni Clinical Institute, Bucharest, Romania|Emergency University Hospital, Bucharest, Romania|SC Centrul Medical MEDICUM S.R.L., Bucuresti, Romania|Cluj-Napoca Emergency Clinical County Hospital, Cluj-Napoca, Romania|Affidea Romania SRL, Constanta, Romania|Gastromedica SRL, Iasi, Romania|Dr. Tirnaveanu Amelita Private Practice, Oradea, Romania|Dr. Goldis Gastroenterology Center SRL, Timisoara, Romania|Kazan State Medical University, Kazan, Russian Federation|Moscow Clinical Scientific Center, Moscow, Russian Federation|Moscow Regional Research Clinical Institute Na Mfvladimirskiy, Moscow, Russian Federation|Nizhegorodskaya Regional Clinical Hospital n.a. Semashko, Nizhny Novgorod, Russian Federation|Research Institute of Physiology and Basic Medicine, Novosibirsk, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|Union Clinic, LLC, Saint Petersburg, Russian Federation|Russian Medical Military Academy n.a. S.M. Kirov, Saint Petersburg, Russian Federation|Medical University Reaviz, Samara, Russian Federation|Private Healthcare Institution Clinical Hospital RZD-Medicina of Samara city, Samara, Russian Federation|Medical Company Hepatolog, LLC, Samara, Russian Federation|SHI Regional Clinical Hospital, Saratov, Russian Federation|Smolensk Regional Clinical Hospital, Smoensk, Russian Federation|St. Elizabeth Municipal Clinical Hospital, St. Petersburg, Russian Federation|First St. Petersburg State Medical University n.a. I.P Pavlov, St. Petersburg, Russian Federation|Stavropol State Medical University, Stavropol, Russian Federation|Regional Consulting and Diagnostics Centre, Tyumen, Russian Federation|Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia|University Clinical Center Nis, Nis, Serbia|General Hospital Vrsac, Vrsac, Serbia|Clinical Hospital Center Zemun, Zemun, Serbia|University Clinical Center Kragujevac, Kragujevac, Šumadijski Okrug, Serbia|Fakultna nemocnica s poliklinikou F. D. Roosevelta, Banska Bystrica, Slovakia|Univerzitna nemocnica Bratislava, Bratislava, Slovakia|KM Management, spol. s r.o., Nitra, Slovakia|Gastro LM, s.r.o., Presov, Slovakia|CLINRESCO, ARWYP Medical Suites, Johannesburg, Gauteng, South Africa|Dr. J Breedt, Pretoria, Gauteng, South Africa|Dr JP Wright, Claremont, Western Cape, South Africa|C.H. Regional Reina Sofia - PPDS, Cordoba, Córdoba, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Madrid, Communidad Delaware, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|CHUVI - H.U. Alvaro Cunqueiro, Vigo, Pontevedra, Spain|Centro Medico Teknon - Grupo Quironsalud, Barcelona, Spain|Hospital Universitario Juan Ramon Jimenez, Huelva, Spain|Hospital Universitario de La Princesa, Madrid, Spain|Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain|Hospital Universitario La Paz - PPDS, Madrid, Spain|Hospital Universitario Virgen del Rocio - PPDS, Sevilla, Spain|Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain|Hospital Universitario del Rio Hortega, Valladolid, Spain|Spital Bülach AG, Bülach, Nordrhein-Westfalen, Switzerland|Universität Zürich, Zürich, Zürich (de), Switzerland|Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul, Turkey|Mersin University Medical Faculty, Mersin, Turkey|Regional Municipal Non-profit Enterprise ""Chernivtsi Regional Clinical Hospital"", Chernivtsi, Chernivets'ka Oblast, Ukraine|Municipal Nonprofit Enterprise CCH #2 n.a. prof. O.O. Shalimov of Kharkiv City Council, Kharkiv, Kharkivs'ka Oblast, Ukraine|Communal Nonprofit Enterprise Vinnytsia Regional Clinical Hospital named after N.I. Pirogov VR, Vinnytsia, Vinnyts'ka Oblast, Ukraine|Municipal Non-profit Enterprise City Emergency Care Hospital of Zaporizhzhia Regional Council, Zaporizhzhia, Zaporiz'ka Oblast, Ukraine|SI ""Dept. Clin. Hospital of Zaporizhzhia-2 Railway Station"" of SE ""Prydniprovska Zaliznytsia"", Zaporizhzhia, Zaporiz'ka Oblast, Ukraine|ME Dnipropetrovsk Regional Clinical Hospital n.a. I.I Mechnykov Dnipropetrovsk Regional Council, Dnipro, Ukraine|ME Dnipropetrovsk Regional Clinical Hospital n.a. I.I Mechnykov Dnipropetrovsk Regional Council, Dnipro, Ukraine|LLC Medical Center Family Medicine Clinic, Dnipro, Ukraine|State Institution ""Institute of Gastroenterology of National Academy of Medical Sciences of Ukraine"", Dnipro, Ukraine|Clinic of SI National Institute of Therapy n.a. L.T. Mala of NAMS of Ukraine, Kharkiv, Ukraine|Municipal Nonprofit Enterprise of Kharkiv Regional Council Regional Clinical Hospital, Kharkiv, Ukraine|MNPE of Kharkiv Regional Council Regional Clinical Specialised Dispensary of Radiation Protection, Kharkiv, Ukraine|Municipal Non-profit Enterprise Kherson City Clinical Hospital named after Ye.Ye. Karabelesh, Kherson, Ukraine|Municipal Enterprise Kryvyi Rih City Clinical Hospital #2 of Kryvyi Rih City Council, Kryvyi Rih, Ukraine|Medical Center of LLC Medical Clinic Blagomed, Kyiv, Ukraine|Kyiv City Clinical Hospital #18, Kyiv, Ukraine|Treatment and Diagnostic Center ""Healthy and Happy"" of LLC ""Healthy and Happy"", Kyiv, Ukraine|Medical Center OK!Clinic+LLC International Institute of Clinical Research, Kyiv, Ukraine|Medical Center of LLC Medical Center Dopomoga-Plus, Kyiv, Ukraine|Communal Non-profit Enterprise of Kyiv Regional Council Kyiv Regional Hospital, Kyiv, Ukraine|Municipal Non-profit Enterprise of Kyiv Regional Council Kyiv Regional Clinical Hospital, Kyiv, Ukraine|Lviv Railway Clinical Hospital of branch Health Center of Joint Stock Co. Ukrainian Railway, Lviv, Ukraine|Municipal Nonprofit Enterprise Lviv Clinical Emergency Care Hospital, Lviv, Ukraine|Municipal Non-profit Enterprise Odessa Regional Clinical Hospital of Odessa Regional Council, Odesa, Ukraine|MNPE Central City Clinical Hospital of Uzhhorod City Council, Uzhhorod, Ukraine|Medical Clinical Research Center of Medical Center LLC Health Clinic, Vinnytsia, Ukraine|Communal Nonprofit Enterprise Vinnytsia Regional Clinical Hospital named after N.I. Pirogov VRC, Vinnytsia, Ukraine|Communal Non-Commercial Enterprise Vinnytsia City Clinical Hospital 1, Vinnytsia, Ukraine|MNPE City Hospital No. 6 of Zaporizhzhia City Council, Zaporizhzhia, Ukraine|Fairfield General Hospital - PPDS, Lancashire, Bury, United Kingdom|Pennine Acute Hospitals Trust, Lancashire, Bury, United Kingdom|Whipps Cross University Hospital, London, London, City Of, United Kingdom|North Tyneside General Hospital, North Shields, Northumberland, United Kingdom|Royal Shrewsbury Hospital, Shrewsbury, Shropshire, United Kingdom|Aberdeen Royal Infirmary - PPDS, Aberdeen, United Kingdom|Western General Hospital Edinburgh - PPDS, Edinburh, United Kingdom|Royal Gwent Hospital - PPDS, Newport, United Kingdom|New Cross Hospital, Wolverhampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03283085"
721,"NCT03196427","Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)",,"Active, not recruiting","No Results Available","Ulcerative Colitis|Crohn's Disease","Drug: Vedolizumab","Percentage of Participants with Treatment-emergent Adverse Events (TEAEs)|Time to Major Inflammatory Bowel Disease (IBD) - Related Events|Change from Baseline in IMPACT-III Total and Subscale Scores at Week 24 and Every 24 weeks, Thereafter up to 5 years|Height Velocity at Week 48 and Every 48 weeks, Thereafter up to 5 years|Change from Baseline in Height at Week 24 and Every 24 Weeks, Thereafter up to 5 years|Change from Baseline in Weight at Week 24 and Every 24 Weeks, Thereafter up to 5 years|Change from Baseline in Body Mass Index (BMI) at Week 24 and Every 24 Weeks, Thereafter up to 5 years|Percentage of Participants Achieving Tanner Stage V Scale|Percentage of Participants With UC Meeting Complete Mayo Score Response at Week 32|Percentage of Participants With CD Meeting 50 Percent (%) Reduction in Simple Endoscopic Score for Crohn's Disease (SES-CD) Score at Week 32","Takeda|Takeda Development Center Americas, Inc.","All","2 Years to 17 Years   (Child)","Phase 2","80","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","Vedolizumab-2005|2017-002182-21|U1111-1176-5741|17/NE/0258|MOH_2017-09-18_000649","July 30, 2018","May 25, 2025","May 25, 2025","June 22, 2017",,"January 8, 2021","Cedars-Sinai Medical Center, Los Angeles, California, United States|University of California San Francisco, San Francisco, California, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Nemours Childrens Specialty Care - Jacksonville, Jacksonville, Florida, United States|Children's Center for Digestive Healthcare, Atlanta, Georgia, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Indiana University School of Medicine - Indianapolis, Indianapolis, Indiana, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Northwell Health, Lake Success, New York, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Texas Children's Hospital, Houston, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States|Universitair Ziekenhuis Leuven, Leuven, Flemish Brabant, Belgium|Universitair Ziekenhuis Brussel, Berchem, Provence Alpes COTE D'azur, Belgium|Cliniques Universitaires Saint-Luc, Brussels, Belgium|Alberta Children's Hospital, Calgary, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|London Health Sciences Centre University Hospital, London, Ontario, Canada|Toronto Hospital for Sick Children, Toronto, Ontario, Canada|Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada|Hopital Necker-Enfants Malades, Paris Cedex 15, Ile-de-france, France|Hopital Robert Debre, Paris Cedex 19, Ile-de-france, France|Hopital de la Timone, Marseille Cedex 5, Provence Alpes COTE D'azur, France|Hopital Jeanne de Flandre, Petach Tikvah, France|BAZ Megyei Korhaz es Egyetemi Oktatokorhaz, Miskolc, Borsod-abauj-zemplen, Hungary|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged, Csongrad, Hungary|Soproni Erzsebet Oktato Korhaz es Rehabilitacios Intezet, Sopron, Gyor-moson-sopron, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hajdu-bihar, Hungary|Semmelweis Egyetem, Budapest, Hungary|Assaf Harofeh Medical Center, Zerifin, Rehoboth, Israel|The Edmond and Lily Safra Children's Hospital - Sheba Medical Center, Ramat Gan, Tel Aviv, Israel|Rambam Health Care Campus - Rambam Medical Center, Haifa, Israel|Carmel Medical Center, Haifa, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Schneider Children's Medical Center of Israel, Petach Tikvah, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Radboud Universitair Medisch Centrum, Nijmegen, GA, Netherlands|Erasmus University Medical Center, Rotterdam, Zuid-holland, Netherlands|Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw, Dolnoslaskie, Poland|Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi Osrodek Pediatryczny im Marii Konopnic, Lodz, Lodzkie, Poland|Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow, Malopolskie, Poland|Gabinet Lekarski Dr. Hab. N. Med. Bartosz Korczowski, Rzeszow, Podkarpackie, Poland|Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa w Bialymstoku, Bialystok, Podlaskie, Poland|Kharkiv Regional Clinical Children's Hospital, Kharkiv, Ukraine|Birmingham Women's and Children's NHS Foundation Trust, Birmingham, England, United Kingdom|Cambridge University Hospitals NHS Foundation Trust, Cambridge, England, United Kingdom|Barts and The London NHS Trust, London, England, United Kingdom|Central Manchester University Hospitals NHS Foundation Trust, Manchester, England, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, England, United Kingdom|NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03196427"
722,"NCT03072836","Study of Gut Microbiota in Crohn's Disease Patients Suffering From Spondylarthritis","FLORACROHN","Recruiting","No Results Available","Crohn Disease|Spondyloarthritis","Other: analysing microbiota","Microbiota analysis","Central Hospital, Nancy, France","All","18 Years and older   (Adult, Older Adult)","Not Applicable","108","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2016-A01720-51","March 6, 2017","May 15, 2020","December 15, 2020","March 7, 2017",,"January 23, 2020","CHRU de Nancy, Vandoeuvre les Nancy, France",,"https://ClinicalTrials.gov/show/NCT03072836"
723,"NCT02743806","Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease",,"Active, not recruiting","No Results Available","Colitis, Ulcerative|Crohn Disease","Drug: Vedolizumab","Percentage of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)|Percentage of Participants With Adverse Events of Special Interest (AESIs)","Takeda","All","18 Years to 90 Years   (Adult, Older Adult)","Phase 4","331","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Vedolizumab-4013|2016-000678-40|U1111-1180-9339","August 1, 2016","February 15, 2022","February 15, 2022","April 19, 2016",,"September 30, 2020","The Canberra Hospital, Garran, Australian Capital Territory, Australia|Western Hospital, Footscray, Victoria, Australia|Cabrini Medical Centre, Malvern, Victoria, Australia|Box Hill Hospital, Box Hill, Australia|Royal Brisbane & Women's Hospital, Herston, Australia|Fiona Stanley Hospital, Murdoch, Australia|Multiprofile Hospital For Active Treatment Ruse, Ruse, Bulgaria|City Clinic University Multiprofile Hospital for Active Treatment EOOD, Sofia, Bulgaria|Karlovarska krajska nemocnice a.s., Karlovy Vary, Karlovarsk Kraj, Czechia|Hepato-Gastroenterologie HK, s. r. o., Hradec Kralove, Czechia|Oblastni nemocnice Kladno, a.s., Kladno, Czechia|Nemocnice Pardubickeho kraje, a.s. Pardubicka nemocnice, Pardubice, Czechia|Fakultni nemocnice Kralovske Vinohrady, Praha 10, Czechia|Institut klinicke a experimentalni mediciny, Praha 4, Czechia|ISCARE I.V.F. a.s., Praha 7, Czechia|Nemocnice Strakonice, a.s., Strakonice, Czechia|Nemocnice Tabor, a.s., Tabor, Czechia|Krajska zdravotni, a.s. Masarykova nemocnice v Usti nad Labem, o.z., Usti Nad Labem, Czechia|West Tallinn Central Hospital, Tallinn, Estonia|East Tallinn Central Hospital, Tallinn, Estonia|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged, Csongrad, Hungary|Bekes Megyei Kozponti Korhaz, Bekescsaba, Hungary|Peterfy Sandor utcai Korhaz-Rendelintezet es Baleseti Kozpont, Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Szent Janos Korhaz es Eszak-Budai Egyesitett Korhazak, Budapest, Hungary|Szent Pantaleon Korhaz-Rendelointezet, Dunaujvaros, Hungary|Bugat Pal Korhaz, Gyongyos, Hungary|Bekes Megyei Kozponti Korhaz, Gyula, Hungary|Somogy Megyei Kaposi Mor Oktato Korhaz, Kaposvar, Hungary|Karolina Korhaz Rendelointezet, Mosonmagyarovar, Hungary|Kanizsai Dorottya Korhaz, Nagykanizsa, Hungary|Pecsi Tudomanyegyetem, Pecs, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Szekesfehervar, Hungary|Tolna Megyei Balassa Janos Korhaz, Szekszard, Hungary|Owaisi Hospital and Research Centre, Hyderabad, Andhra Pradesh, India|All India Institute of Medical Sciences, New Delhi, Delhi, India|Lakeshore Hospital, Kochi, Kerala, India|KEM Hospital Research Centre, Pune, Maharashtra, India|VGM Hospital Institute of Gastroenterology, Coimbatore, Tamil Nadu, India|Policlinico San Donato, San Donato Milanese, Milano, Italy|Istituto Clinico Humanitas, Rozzano, Italy|Yeungnam University Hospital, Daegu, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Severance Hospital Yonsei University Health System - PPDS, Seoul, Korea, Republic of|Kyung Hee University Hospital, Seoul, Korea, Republic of|Samsung Medical Center - PPDS, Seoul, Korea, Republic of|Asan Medical Center - PPDS, Seoul, Korea, Republic of|Pauls Stradins Clinical University Hospital, Riga, Latvia|University Malaya Medical Centre, Kuala Lumpur, Malaysia|Christchurch Hospital, Christchurch, Canterbury, New Zealand|Waikato Hospital, Hamilton, Waikato, New Zealand|Shakespeare Specialist Group, Auckland, New Zealand|Ars Medica, Wroclaw, Dolnoslaskie, Poland|SP ZOZ Szpital Uniwersytecki w Krakowie, Krakow, Malopolskie, Poland|Wojewodzki Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie, Krakow, Malopolskie, Poland|Centrum Medyczne sw. Lukasza, Czestochowa, Slaskie, Poland|SPZOZ Wojewodzki Szpital Zespolony im J Sniadeckiego, Bialystok, Poland|10 Wojskowy Szpital Kliniczny z Poliklinika, Bydgoszcz, Poland|Corpora-Med, Gliwice, Poland|Centrum Zdrowia Matki, Dziecka i Mlodziezy, Warsaw, Poland|Centralny Szpital Kliniczny MSW, Warszawa, Poland|Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu, Wroclaw, Poland|Fundeni Clinical Institute, Bucharest, Romania|Colentina Clinical Hospital, Bucuresti, Romania|City Clinical Hospital #24, Moscow, Russian Federation|Nizhegorodskaya Regional Clinical Hospital n.a. Semashko, Nizhniy Novgorod, Russian Federation|Russian Medical Military Academy n.a. S.M. Kirov, Saint Petersburg, Russian Federation|Medical Company Hepatolog, LLC, Samara, Russian Federation|Union Clinic, LLC, St. Petersburg, Russian Federation|St.Petersburg Multi Field City Hospital #2, St. Petersburg, Russian Federation|Military Medical Academy, Belgrade, Serbia|CLINRESCO, ARWYP Medical Suites, Johannesburg, Gauteng, South Africa|St Augustines Medical Centre, Durban, Kwazulu - Natal, South Africa|Kingsbury Hospital, Claremont, Western Cape, South Africa|Universitas Hospital, Bloemfontein, South Africa|Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul, Turkey|Medical Clinical Research Center of Medical Center LLC Health Clinic, Vinnytsia, Vinnyts'ka Oblast, Ukraine|Poltava Regional Clinical Hospital n.a. M.V. Skliphosovskyi, Poltava, Ukraine",,"https://ClinicalTrials.gov/show/NCT02743806"
724,"NCT02709694","Imaging Biomarkers in Crohn's Associated Spondyloarthritis","MaRCH-on","Active, not recruiting","No Results Available","Crohn's Disease|Spondyloarthritis","Other: No intervention","MRI evidence of axial inflammation in patients with Crohn's Disease. This is a cross -sectional study with all outcomes measured at a single point in time|Association of MRI evidence of inflammation to symptoms of Inflammatory Back Pain|Association of MRI evidence of inflammation to patient reported outcome- ASDAS-CRP|Association of MRI evidence of inflammation to patient reported outcome- BASDAI|Association of MRI evidence of inflammation to severity of Crohn's disease, i.e. Harvey Bradshaw Index|Association of MRI evidence of inflammation to item banks of SF-12 questionnaires|Association of MRI evidence of inflammation to item banks of PROMIS 29 questionnaires|Association of MRI evidence of inflammation with pattern of intestinal dysbiosis","Hospital for Special Surgery, New York|Weill Medical College of Cornell University","All","18 Years and older   (Adult, Older Adult)",,"30","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","2015-491","March 2016","January 2023","January 2023","March 16, 2016",,"February 8, 2021","Hospital for Special Surgery, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT02709694"
725,"NCT02704624","Effects of Supplementation of Vitamin D in Patients With Crohn's Disease",,"Enrolling by invitation","No Results Available","Crohn Disease|Vitamin D Deficiency|Fatigue|Sarcopenia|Muscle Weakness|Disorder of Bone Density and Structure, Unspecified","Dietary Supplement: Vitamin D|Other: Placebo","Increase in the grip strength in patients with Crohn under vitamin D supplementation|Increase in mineral bone density (MBD)|Decrease in fecal Calprotectin levels|Global reduction in laboratorial inflammatory biomarkers (TNF-α)|Increase in exercise capacity assessed by Shuttle Walk Test (SWT)|Increase in lean body mass in patients with Crohn under vitamin D supplementation|Reduction in fatigue perception in patients with Crohn under vitamin D supplementation|Global reduction in laboratorial inflammatory biomarkers (IL 6)|Global reduction in laboratorial inflammatory biomarkers (IL 17)|Global reduction in laboratorial inflammatory biomarkers (CRP)","Federal University of Juiz de Fora|Fundação de Amparo à Pesquisa do estado de Minas Gerais","All","18 Years to 50 Years   (Adult)","Phase 4","110","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","CAAE41674814500005147","December 2016","August 2020","February 2022","March 10, 2016",,"June 29, 2018","Universidade Federal de Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil",,"https://ClinicalTrials.gov/show/NCT02704624"
726,"NCT02678052","OTIS Vedolizumab Pregnancy Exposure Registry",,"Active, not recruiting","No Results Available","Colitis, Ulcerative|Crohn's Disease","Drug: Vedolizumab|Biological: Other Biological Agent","Major Structural Birth Defects Identified in Infants After Birth|Minor Structural Birth Defects Identified in Infants After Birth","Takeda","Female","18 Years to 44 Years   (Adult)",,"300","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","Vedolizumab-5001","December 1, 2015","November 30, 2022","August 31, 2023","February 9, 2016",,"November 16, 2020","San Diego, California, United States|Multiple Locations, Canada",,"https://ClinicalTrials.gov/show/NCT02678052"
727,"NCT02674308","Entyvio (Vedolizumab) Long Term Safety Study","Entyvio PASS","Active, not recruiting","No Results Available","Ulcerative Colitis and Crohn's Disease","Drug: Vedolizumab|Other: Other Biologic Agents","Percentage of Participants with Adverse Events of Special Interest|Disease Severity in Ulcerative Colitis (UC) Participants|Disease Severity in Crohn's Disease (CD) Participants|Participant Reported Quality of Life Assessment Using Short Inflammatory Bowel Disease Questionnaire (SIBDQ)|Participant Reported Quality of Life Assessment Using 12-Item Short Form Health Survey (SF-12)|Time to Treatment Discontinuation|Reasons for Treatment Discontinuation","Takeda","All","18 Years and older   (Adult, Older Adult)",,"5302","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","MLN-0002_401","March 24, 2015","July 30, 2021","July 30, 2021","February 4, 2016",,"April 14, 2021","University of Alabama, Birmingham, Alabama, United States|University of South Alabama, Mobile, Alabama, United States|University of Arizona Medical Center, Tucson, Arizona, United States|Scripps Clinic, La Jolla, California, United States|Stanford University, Palo Alto, California, United States|South Bay Gastroenterology Medical Group, Torrance, California, United States|Gastroenterology Center of Connecticut P.C., Hamden, Connecticut, United States|Middlesex Gastroenterology Associates, Llc, Middletown, Connecticut, United States|Gastroenterology Group of Naples, Naples, Florida, United States|Florida Hospital Orlando, Orlando, Florida, United States|Gulf Region Clinical Research Institute, Pensacola, Florida, United States|Emory University Hospital, the Emory Clinic, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Georgia Regents University, Augusta, Georgia, United States|Atlanta Gastroenterology Associates, Suwanee, Georgia, United States|Illinois Gastroenterology Groupllc Northwest Gastroenterologists, Arlington Heights, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago Medical Center, Chicago, Illinois, United States|Northshore University Health Systems, Evanston, Illinois, United States|Loyola University, Maywood, Illinois, United States|Southwest Gastroenterology, Oak Lawn, Illinois, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|The University of Kansas Medical Center, Kansas City, Kansas, United States|Cotton O'Neil Digestive Health Center, Topeka, Kansas, United States|Kansas Gastroenterology, Wichita, Kansas, United States|University of Louisville, Louisville, Kentucky, United States|New Orleans Research Institute, Metairie, Louisiana, United States|Louisiana Research Center, Llc, Shreveport, Louisiana, United States|Crohn'S and Colitis Center, Boston, Massachusetts, United States|Boston University Moakley Building Center For Digestive Disorders, Boston, Massachusetts, United States|Umass Memorial Medical Center, Worcester, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Infusion Associates, Grand Rapids, Grand Rapids, Michigan, United States|Mayo Clinic - Rochester, Rochester, Minnesota, United States|Digestive Health Center, Pa, Ocean Spring, Mississippi, United States|St. Louis University, Saint Louis, Missouri, United States|Washington University, Saint Louis, Missouri, United States|Chi Health Alegent Creighton Clinic, Omaha, Nebraska, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Englewood Endoscopic Associates, Englewood, New Jersey, United States|Morristown Medical Center, Morristown, New Jersey, United States|Saratoga-Schenectady Gastroenterology Associates, Burnt Hills, New York, United States|Digestive Disease Center, Fishkill, New York, United States|Northwell Health, Great Neck, New York, United States|Nyu Langone Long Island Clinical Research Associates, Great Neck, New York, United States|Nyu Langone Medical Center, New York, New York, United States|Icahn School of Medicine At Mount Sinai, New York, New York, United States|Lenox Hill Hospital, New York, New York, United States|Gastroenterology Group of Rochester, Rochester, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Carolina Research, Greenville, North Carolina, United States|Wake Research Associates, Raleigh, North Carolina, United States|Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States|Trihealth Digestive Institute, Cincinnati, Ohio, United States|Mark Osterman, Philadelphia, Pennsylvania, United States|Philadelphia Va Medical Center, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Consultants in Gastroenterology - Columbia, Columbia, South Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Fort Sam Houston, Texas, United States|Baylor University Medical Center, Houston, Texas, United States|Ut Health Science Center, Houston, Texas, United States|Spring Gastroenterology, Humble, Texas, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Krankenhaus Der Elisabethinen Linz Gmbh, Oberosterreich, Austria|Kh Der Barmherzigen Schwestern, Ried Im Innkreis, Austria|Ordination Dr. Thomas Haas Darmpraxis Salzburg, Salzburg, Austria|Salk Salzburg, Salzburg, Austria|Landesklinikum St. Poelten, St. Poelten, Austria|KH WELS, Wels, Austria|Medizinischen Universitat Wien - Allgemeines Krankenhaus (Akh) - Universitaetsklinik Fuer Innere Medizin Iii, Wien, Austria|Loha For Life, Wien, Austria|Olv Aalst - Gastro-Enterologie, Aalst, Belgium|Imelda - Gastro-Enterologie, Bonheiden, Belgium|Chu Saint Pierre - Service de Gastroenterologie, Brussels, Belgium|Cub Hopital Erasme, Brussels, Belgium|Uz Brussel - Gastro-Enterologie, Brussels, Belgium|HIS-IZZ, Bruxelles, Belgium|Uz Antwerpen - Gastro-Enterologie, Edegem, Belgium|Ziekenhuis Oost Limburg - Gastro-Enterologie, Genk, Belgium|Az Maria Middelares - Gastro-Enterologie, Gent, Belgium|Az St Lucas - Gastro-Enterologie, Gent, Belgium|Uz Gent - Gastro-Enterologie, Gent, Belgium|Jessa Ziekenhus - Gastro-Enterologie, Hasselt, Belgium|Az Groeninge - Campus Kennedylaan - Gastro-Enterologie, Kortrijk, Belgium|Universitaire Ziekenhuizen (Uz) Leuven - Gasthuisberg, Leuven, Flemish Brabant, Belgium|Centre Hospitalier Chretien (Chc) - Clinique Saint-Joseph (Hopital St-Joseph) - Gastro-Enterologie, Liege, Belgium|Chr de La Citadelle, Liege, Belgium|Chu Liege - Gastro-Enterologie, Liege, Belgium|Az Sint Maarten, Campus Rooienberg, Mechelen, Belgium|Chu Ambroise-Pare, Mons, Belgium|Clinique Et Maternite Sainte-Elisabeth, Namur, Belgium|Clinique St Pierre Asbl, Ottignies, Belgium|Az Delta - Gastro-Enterologie, Roeselare, Belgium|Centre Hospitalier de Wallonie Picardie, Site Notre Dame, Tournai, Belgium|Okanagan Clinical Trials Ltd., Kelowna, British Columbia, Canada|Nova Scotia Health Authority, Halifax, Nova Scotia, Canada|McMasters University, Hamilton, Ontario, Canada|Scott Shulman Medical Prof. Corp, North Bay, Ontario, Canada|Taunton Surgical Centre-Oshawa Clinic, Oshawa, Ontario, Canada|University of Toronto - St. Michaels Hospital, Toronto, Ontario, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada|University Hospital Center Osijek, Osijek, Croatia|Clinical Hospital Centre Split, Split, Croatia|Kbc Split, Split, Croatia|University Hospital Dubrava, Zagreb, Croatia|University Hospital, Aalborg, Aalborg, Denmark|Bispebjerg Univarsity Hospital, Copenhagen Nv, Denmark|Rigshospitalet, Abdominal Centre, Copenhagen, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Nykobing Falster Sygehus, Nykobing Falster, Denmark|Silkeborg Hospital, Silkeborg, Denmark|West-Tallinn Central Hospital (Ltkh), Tallinn, Estonia|North Estonian Regional Hospital, Tallinn, Estonia|Tartu University Hospital, Tartu, Estonia|Chu Amiens Picardie - Service Hepato-Gastro-Enterologie, Amiens, France|C H U Angers, Angers, France|Hopital Avicenne, Bobigny, France|Centre Hospitalier Universitaire (Chu) de Caen - Service D'Hepatogastroenterologie, Caen Cedex, France|C.H.U de Tours - Hopital Trousseau, Chambray-les-tours, France|Chu de Clermont Ferrand - Hopital Estaing, Clermont Ferrand, France|Hopitaux Civils de Colmar, Colmar Cedex, France|Centre Hospitalier Regional Universitaire (Chru) de Lille - Hopital Claude Huriez, Lille, France|Hospices Civils de Lyon (Hcl) - Hopital Edouard Herriot, Lyon, France|Chu Hopital Nord, Marseille - Service D'Hepato-Gastro-Enterologie, Marseille, France|University Hospital St Eloi, Montpellier, France|Centre Hospitalier Universitaire (Chu) de Nice - Hopital L'Archet 2 - Pole Digestif, Nice, France|Chu Nimes - Hopital Caremeau, Nimes, France|Institut Mutualiste Montsouris, Paris Cedex 14, France|Centre Hospitalo Universitaire (Chu) - Hopital Saint-Antoine, Paris, France|Hopital Du Haut Leveque - Service D'Hepato-Gastro-Enterologie Et Nutritution, Unite de Soin Normalise, Pessac Cedex, France|Hospices Civils de Lyon (Hcl) - Centre Hospitalier Lyon-Sud - Hepatogastroenterologie, Pierre Benite, France|Centre Hospitalier Annecy Genevois, Pringy, France|Chu de Reims - Hopital Robert Debre, Reims, France|Centre Hospitalier Universitaire (Chu) de Rouen, Rouen, France|Service Gastro-Enterologie Hopital Nord - Chu de Saint Etienne, Saint-etienne, France|Hopital Rangueil - Service de Gastroenterologie, Toulouse Cedex 9, France|Ch Gustave Dron - Hopital de Tourcoing, Tourcoing Cedex, France|Ch Valenciennes - Hopital Jean Bernard - Service Maladies de L'Appareil Digestif Et de La Nutrition, Valenciennes, France|Praxis Dr. Med. Eberhard Meier, Amberg, Germany|Charite Campus Campus Mitte, Berlin, Germany|Praxis Dr. Mross, Berlin, Germany|Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin (Cbf) - Medizinische Klinik I, Berlin, Germany|Charite Campus Virchow Klinikum - Medizinische Klinik Mit Schwerpunkt Hepatologie Und Gastroenterologie, Berlin, Germany|Praxis Fur Gastroenterologie Am Bayerischen Platz, Berlin, Germany|Sana Klinik Biberach, Biberach, Germany|Medizinisches Versorgungszentrum (Mvz) Dachau, Dachau, Germany|Stadtisches Klinikum Dessau, DESSAU-ROsLAU, Germany|Technische Universitaet Dresden - Universitaetklinikum Carl Gustav Carus - Medizinische Klinik Und Poliklinik I, Dresden, Germany|Universitatsklinikum Erlangen Medizinische Klinik I - Studien Ambulanz Ced, Erlangen, Germany|St. Josef Krankenhaus Essen-Werden / Abteilung Fur Gastroenterologie, Essen, Germany|Crohn-Colitis Centrum Rhein-Main, Frankfurt Am Main, Germany|Agaplesion Markus Krankenhaus, Medizinische Klinik 1, Frankfurt, Germany|Praxis Dr. Med. Thomas Zeisler, Halle (saale), Germany|Krankenhaus Martha-Maria Halle Dolau Ggmbii, Klinik Fur Innere Medizin I, Halle, Germany|Universitatsklinik Und Poliklinik Fur Innere Medizin I, Halle, Germany|Hafced E.K., Hamburg Eppendorf, Germany|Asklepios Westklinikum Hamburg, Hamburg, Germany|Universitatsklinikum Heidelberg, Heidelberg, Germany|Praxis Fur Gastroenterologie, Heidelberg, Germany|Gastroenterologische Gemeinschaftspraxis Dr. Felten, Herne, Germany|Praxis Group, Jerichow, Germany|PRAXIS, Kothen, Germany|Eugastro Gmbh, Leipzig, Germany|Universitat Leipzig, Medizinische Fakultat, Leipzig, Germany|Gesellschaft Fuer Klinische Studien, Leipzig, Germany|St. Marien Krankenhauses - Medizinischen Klinik I, Ludwigshafen Am Rhein, Germany|Staedtisches Klinikum Luneburg, Luneburg, Germany|Universitatsklinikum Magdeburg A. O. R. - Klinik Fur Gastroenterologie, Magdeburg, Germany|Universitaetsmedizin Mainz, I.Med.Klinik, Geb.605, Eg, Zi.0240, Mainz, Germany|Gastroenterologische Schwerpunkt Praxis, Mannheim, Germany|Praxis Dr. Krammer, Mannheim, Germany|Universitaetsklinikum Mannheim (Umm) - Ii Medizinische Klinik, Mannheim, Germany|Gastroenterologische Gemeinschaftspraxis Minden, Minden, Germany|Klinikum Der Universitat Munchen, Munchen, Germany|Medizinische Versorgungszentrum Portal 10, Munster, Germany|Gastroenterologische Fachpraxis Am Germania Campus, Munster, Germany|Praxis Group, Nurnberg, Germany|Praxiszentrum Alte Malzerei, Regensburg, Germany|Eric Norgaard Jorgensen, Remscheid, Germany|Gpr Mvz Gastroenterologie, Russelsheim, Germany|Gemeinschaftspraxis - Endoskopiezentrum M. Hasenstein, Saarbrucken, Germany|Gastroenterologische Gemeinschaftspraxis - Stade, Stade, Germany|Uni-Klinik Tubingen, Tubingen, Germany|Gastro Data Gbr, Wiesbaden, Germany|University and General Hospital of Alexandroupoli, Alexandroupoli, Greece|General Hospital of Athens 'Evangelismos', Athens, Greece|General and University Hospital of Western Athens 'Attiko', Athens, Greece|St. Panteleimon General Hospital of Nikaia, Athens, Greece|University and General Hospital of Heraklion, Heraklion, Greece|University Hospital of Ioannina - Division of Gastroenterology, Ioannina, Greece|Theagenio Hospital of Thessaloniki, Thessaloniki, Greece|Mercy University Hospital Cork, Cork, Ireland|St. Vincent'S University Hospital, Dublin 4, Ireland|Mater Misericordiae University Hospital, Dublin 7, Ireland|St James Hospital, Dublin 8, Ireland|Beaumont Hospital, Dublin, Ireland|National University of Ireland Galway, Galway, Ireland|Haemek Medical Center, Afula, Israel|Soroka University Medical Center (Sumc), Beer Sheva, Israel|Rambam Health Care Campus (Rhcc) - Institute of Gastroenterology, Haifa, Israel|Bnai Zion Mc, Haifa, Israel|Clalit Health Services - Lev Talpiot, Jerusalem, Israel|Meir Medical Center, Kfar Saba, Israel|Tel Aviv University - Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel|Clalit Medical Services - Migdal Hamea, Tel Aviv, Israel|Maccabi Healthcare Services, Tel Aviv, Israel|Tel Aviv Medical Center, Tel Aviv, Israel|Assaf Harofeh Medical Center (Ahmc) - Institute of Gastroenterology, Zrifin, Israel|Ospedale Civile Giuseppe Moscati, Avellino Campania, Italy|Spedali Civili Gastroenterology Unit University of Brescia, Brescia, Italy|Fondazione Poliambulanza, Brescia, Italy|Azienda Ospedaliera Per Lemergenza Cannizzaro, Catania, Italy|Azienda Ospedaliero-Universitaria Careggi (Aouc), Firenze, Italy|Casa Sollievo Della Sofferenza, Foggia 0301, Puglia, Italy|Ospedale Morgagni Pierantoni Forli U.O. Gastroenterologia Ed Endoscopia, Forli, Italy|Policlinico G Martino, Messina, Italy|Asst Fatebenefratelli Sacco, Milano 3901, Lombardia, Italy|A.O. Guido Salvini Di Garbagnate Milanese, Milano, Italy|Fondazione Irccs Ca' Granda Osp Magg Policlinico, Milano, Italy|Universita Federico Ii, Napoli 2007, Campania, Italy|Ospedale Maggiore Della Carita, Novara, Italy|Policlicnico Universita Paolo Giaccone, Palermo, Italy|Ospedale Nuovo Regina Margherita, Roma, Lazio, Italy|Ospedale San Filippo Neri, Roma, Lazio, Italy|Ao San Camillo Forlanini, Roma, Italy|Ospedale Sandro Pertini, Roma, Italy|Fondazione Policlinico Universitario A. Gemelli, Roma, Italy|Universita Campus Bio-Medico, Rome, Italy|Policlinico Tor Vergata, Rome, Italy|Universita Di Salerno Aou San Giovanni Di Dio E Ruggi D'Aragona, Salerno, Italy|Ao Ordine Mauriziano Di Torino, Torino, Italy|Osp Di Circolo Fondazione Macchi, Varese, Italy|VUMC, Amsterdam, Netherlands|Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands|Academisch Medisch Centrum - Mdl, Amsterdam, Netherlands|Amphia Ziekenhuis, Breda, Netherlands|Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands|Erasmus Mc, Rotterdam, Netherlands|Zuyderland, Sittard, Netherlands|Nordlandssykehuset Hf Bodo, Bodo, Norway|Sykehuset Innlandet Hf Hamar, Hamar, Norway|Akershus University Hospital, Nordbyhagen, Norway|Oslo Univeristy Hospital Ulleval Hospital, Oslo, Norway|Instituto Portugues de Oncologia de Lisboa Francisco Gentil, Epe, Lisboa, Portugal|General Hospital Celje, Celje, Slovenia|University Medical Center Maribor, Maribor, Slovenia|Hospital Univ. Germans Trias I Pujol, Badalona, Spain|Hospital de Bellvitge, Hospitalet, Spain|Hospital Universitario La Paz, Madrid, Spain|Complexo H. Pontevedra-Hospital de Montecelo, Pontevedra, Spain|Consorci Sanitari de Terrassa, Terrasa, Barcelona, Spain|H. Alvaro Cunqueiro, Vigo, Spain|Medical Dept, Gastroenterology Unit, Stockholm, Sweden|Karolinska Universitetssjukhuset Huddinge, Stockholm, Sweden|Danderyds Sjukhus Ab, Stockholm, Sweden|Universitaetsspital Bern - Inselspital - Universitaetsklinik Fuer Viszerale Chirurgie Und Medizin (Uvcm) - Klinik Und Poliklinik Fuer Gastroenterologie, Bern, Switzerland|Gastroenterologische Praxis Balsiger, Seibold & Partner Crohn-Colitis-Zentrum Hochhaus Lindenhofspital, Bern, Switzerland|Kantonsspital St. Gallen - Gastroenterologie, St. Gallen, Switzerland|Universitatspital Zurich, Zurich, Switzerland|Nevill Hall Hospital - Aneurin Bevan Health Board, Abergavenny, United Kingdom|Blackpool Victoria Hospital (Bvh) - Gastroenterology Department, Blackpool, United Kingdom|Bradford Teaching Hospitals, Bradford, United Kingdom|Frimley Park Hospital, Camberley, Surrey, United Kingdom|University Hospitals Coventry and Warwickshire Nhs Trust - University Hospital (Walsgrave Hospital), Coventry, United Kingdom|Derby Hospitals Nhs Foundation Trust - Royal Derby Hospital (Derby City General Hospital), Derby, United Kingdom|The North West London Hospitals Nhs Trust (Nwlh) - St Mark'S Hospital, Harrow, Middlesex, United Kingdom|Hull and East Yorkshire Nhs Trust, Hull, United Kingdom|Airedale Nhs Foundation Trust, Keighley, United Kingdom|Forth Valley Royal Hospital, Larbert, United Kingdom|Royal Liverpool University Hospital, Liverpool, United Kingdom|Barts Health Nhs Trust, London, United Kingdom|Nhs Foundation Trust - Homerton University Hospital (Huh), London, United Kingdom|King'S College Hospital (Kch) Nhs Foundation Trust, London, United Kingdom|Manchester Royal Infirmary, Manchester, United Kingdom|Royal Gwent Hospital, Newport, United Kingdom|The University of Nottingham - Nottingham Digestive Diseases Centre (Nddc) (Wolfson Digestive Diseases Centre), Nottingham, United Kingdom|Salford Royal Nhs Foundation Trust, Salford, United Kingdom|University of Sheffield - Sheffield Teaching Hospitals Nhs Foundation Trust - Royal Hallamshire Hospital (Rhh), Sheffield, United Kingdom|The Shrewsbury and Telford Hospital Nhs Trust - Royal Shrewsbury Hospital, Shrewsbury, United Kingdom|University Hospital Southampton Nhs Foundation Trust, Southampton, Hampshire, United Kingdom|Pinderfields Hospital - Mid Yorkshire Hospital Trust, Wakefield, United Kingdom|Nhs Trust - Weston Area Health - Weston General Hospital, Weston-super-mare, AVON, United Kingdom|The Royal Wolverhampton Hospitals Nhs Trust - New Cross Hospital, Wolverhampton, United Kingdom|Western Sussex Hospitals Nhs Trust - Worthing Hospital, Worthing, WEST Sussex, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02674308"
728,"NCT04803916","Pre-stenotic Inflammation Following Endoscopic Balloon Dilatation in Crohn's Disease: A Prospective Study",,"Recruiting","No Results Available","Crohn Disease",,"Endoscopic response|Endoscopic healing|Wall thickness|Limberg score US|Luminal diameter|Inflammed length|Obstructive score reduction|Clinical remission|Stool calprotectin|No treatment escalation|Comparison of imaging and calprotectin","Shaare Zedek Medical Center|Sheffield Children's NHS Foundation Trust|Bambino Gesù Hospital|University of Roma La Sapienza|Robert Debré Hospital","All","Child, Adult, Older Adult",,"24","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Inflammation following EBD","November 1, 2020","September 2023","March 2024","March 18, 2021",,"March 18, 2021","Shaare Zedek, Jerusalem, Israel",,"https://ClinicalTrials.gov/show/NCT04803916"
729,"NCT02620046","A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease",,"Active, not recruiting","No Results Available","Colitis, Ulcerative|Crohn's Disease","Drug: Vedolizumab SC","Number of Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) Adjusted by Duration of Participant's Exposure to Long-term Vedolizumab Treatment|Number of Adverse Events of Special Interest (AESIs) Adjusted by Duration of Participant's Exposure to Long-term Vedolizumab Treatment|Percentage of Participants with Ulcerative Colitis Achieving Partial Mayo Scoring Clinical Response|Percentage of Participants with Crohn's Disease Achieving Clinical Response|Percentage of Participants with Ulcerative Colitis Achieving Clinical Remission|Percentage of Participants with Crohn's Disease (CD) Achieving Clinical Remission","Takeda","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 3","746","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","MLN0002SC-3030|U1111-1168-0921|2015-000482-31|JapicCTI-163220|MLN0002SC-3030CTIL|16/LO/0110|NL55765.056.16|189751|163300410A0052|MOH_2017-01-05_000040","April 15, 2016","May 6, 2023","May 6, 2023","December 2, 2015",,"May 28, 2021","Arizona Arthritis & Rheumatology Research, PLLC, Phoenix, Arizona, United States|Arkansas Primary Care Clinic, PA, Little Rock, Arkansas, United States|Rocky Mountain Clinical Research, LLC, Wheat Ridge, Colorado, United States|Medical Research Center of Connecticut, LLC, Hamden, Connecticut, United States|Middlesex Gastroenterology Associates, Middletown, Connecticut, United States|Nature Coast Clinical Research, LLC, Inverness, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|L & L Research Choices, Inc., Miami, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|BRCR Medical Center, Inc., Pembroke Pines, Florida, United States|Shafran Gastroenterology Center, Winter Park, Florida, United States|Florida Medical Clinic, P.A., Zephyrhills, Florida, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Gastroenterology Associates of Central Georgia, Macon, Georgia, United States|Atlanta Gastroenterology Specialists, PC, Suwanee, Georgia, United States|Grand Teton Research Group, PLL, Idaho Falls, Idaho, United States|Rush University Medical Center, Chicago, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|Cotton-O'Neil Clinical Research Center, Digestive Health, Topeka, Kansas, United States|Tri-State Gastroenterology Associates, Crestview Hills, Kentucky, United States|Research Concierge, LLC, Owensboro, Kentucky, United States|Gastroenterology Associates, LLC, Baton Rouge, Louisiana, United States|Lafayette General Medical Center, Lafayette, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Metropolitan Gastroenterology Group, PC, Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Gastroenterology Associates of Western Michigan, P.L.C., Wyoming, Michigan, United States|Huron Gastroenterology Associates, Ypsilanti, Michigan, United States|Mayo Clinic - Rochester, Rochester, Minnesota, United States|Digestive Health Center PA, Ocean Springs, Mississippi, United States|Ehrhardt Clinical Research, LLC, Belton, Missouri, United States|AGA Clinical Research Associates, LLC, Egg Harbor Township, New Jersey, United States|Long Island Clinical Research Associates, Great Neck, New York, United States|Premier Medical Group of the Hudson Valley, PC, Poughkeepsie, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Dayton Gastroenterology, Inc, Dayton, Ohio, United States|Gastro-Enterology Research of Lima, Lima, Ohio, United States|Options Health Research, Tulsa, Oklahoma, United States|Main Line Gastroenterology Associates, Perkasie, Pennsylvania, United States|Medical University of South Carolina (MUSC), Charleston, South Carolina, United States|Gastroenterology Center of the MidSouth PC, Germantown, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|San Antonio Gastroenterology, San Antonio, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Gastroenterology Associates of Tidewater, Chesapeake, Virginia, United States|Virginia Mason Seattle Main Clinic, Seattle, Washington, United States|Allegiance Research Specialists, LLC, Milwaukee, Wisconsin, United States|Hospital Italiano, Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina|Centro de Investigaciones Medicas Mar del Plata, Mar del Plata, Buenos Aires, Argentina|Centro Medico Viamonte SRL, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|Mater Hospital Brisbane, South Brisbane, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Tennyson Centre Day Hospital, Kurralta Park, South Australia, Australia|Ballarat Base Hospital, Ballarat, Victoria, Australia|Monash Medical Centre Clayton, Bentleigh East, Victoria, Australia|St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|St Frances Xavier Cabrini Hospital, Malvern, Victoria, Australia|Royal Melbourne Hospital, Melbourne, Victoria, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, Australia|St John of God Subiaco Hospital, Subiaco, Western Australia, Australia|Imeldaziekenhuis, Bonheiden, Belgium|AZ Sint-Lucas, Brugge, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|AZ Groeninge - Kennedylaan, Kortrijk, Belgium|ZNA Jan Palfijn, Merksem, Belgium|Clinique Saint-Pierre, Ottignies, Belgium|AZ Delta, Roeselare, Belgium|University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina|University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Ltda, Goiania, Goias, Brazil|HUGG - Hospital Universitario Gaffree e Guinle, Rio de Janeiro, Rio Do Janeiro, Brazil|HUCFF-UFRJ - Hospital Universitario Clementino Fraga Filho - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio Do Janeiro, Brazil|Hospital Sao Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu, Botucatu, Sao Paulo, Brazil|Faculdade de Medicina do ABC, Santo Andre, Sao Paulo, Brazil|Irmandade da Santa Casa da Misericordia de Santos, Santos, Sao Paulo, Brazil|Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto, Sao Jose do Rio Preto, Sao Paulo, Brazil|""MHAT Avis - Medica"" OOD, Pleven, Bulgaria|UMHAT 'Dr. Georgi Stranski', EAD, Pleven, Bulgaria|MHAT - Silistra AD, Silistra, Bulgaria|MC ""Tsaritsa Yoanna' EOOD, Sliven, Bulgaria|MHAT ""Hadzhi Dimitar"", OOD, Sliven, Bulgaria|Second MHAT - Sofia AD, Sofia, Bulgaria|""City Clinic UMHAC"" EOOD, Sofia, Bulgaria|Medical Center ""Excelsior"", OOD, Sofia, Bulgaria|UMHAT ""Sv. Ivan Rilski"", EAD, Sofia, Bulgaria|UMHAT 'Tsaritsa Yoanna - ISUL', EAD, Sofia, Bulgaria|Fourth MHAT - Sofia EAD, Sofia, Bulgaria|Military Medical Academy - MHAT - Sofia, Sofia, Bulgaria|UMHAT 'Sveta Anna' AD, Sofia, Bulgaria|Medical Center ""Nov Rehabilitatsionen Tsentar"", EOOD, Stara Zagora, Bulgaria|Zeidler Ledcor Centre - University of Alberta, Edmonton, Alberta, Canada|PerCuro Clinical Research Ltd., Victoria, British Columbia, Canada|LHSC - University Hospital, London, Ontario, Canada|LHSC - Victoria Hospital, London, Ontario, Canada|Toronto Digestive Disease Associates, Inc., Vaughan, Ontario, Canada|Clinical Hospital Centre Osijek, Osijek, Croatia|Clinical Hospital Centre Rijeka, Rijeka, Croatia|Special Hospital Medico, Rijeka, Croatia|Clinical Hospital Dubrava, Zagreb, Croatia|University hospital centre Zagreb, Zagreb, Croatia|CCBR - Czech Brno, s.r.o.., Brno, Czechia|Hepato-Gastroenterologie HK s.r.o., Hradec Kralove, Czechia|A-SHINE s.r.o., Plzen, Czechia|CLINTRIAL s.r.o., Praha 10, Czechia|CCBR Czech Prague, s.r.o., Praha 3, Czechia|Axon Clinical s.r.o., Praha 5, Czechia|Nemocnice Tabor a.s., Tabor, Czechia|Odense Universitetshospital, Odense C, Denmark|Regionshospitalet Silkeborg, Silkeborg, Denmark|West Tallinn Central Hospital, Tallinn, Estonia|North Estonia Medical Centre Foundation, Tallinn, Estonia|Tartu University Hospital, Tartu, Estonia|LMU - Campus Grosshadern, Muenchen, Bayern, Germany|Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt, Hessen, Germany|Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany|Universitaetsklinikum Koeln, Koeln, Nordrhein Westfalen, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, Rheinland Pfalz, Germany|Universitaetsklinikum Magdeburg A.oe.R, Magdeburg, Sachsen Anhalt, Germany|EUGASTRO GmbH, Leipzig, Sachsen, Germany|Universitaetsklinikum Schleswig-Holstein - Campus Kiel, Kiel, Schleswig Holstein, Germany|Universitaetsklinikum Schleswig-Holstein - Campus Luebeck, Lubeck, Schleswig Holstein, Germany|Charite - Campus Virchow-Klinikum, Berlin, Germany|DRK Kliniken Berlin Westend, Berlin, Germany|Krankenhaus Waldfriede e. V., Berlin, Germany|Obudai Egeszsegugyi Centrum Kft., Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak, Budapest, Hungary|Pannonia Maganorvosi Centrum, Budapest, Hungary|Markhot Ferenc Oktatokorhaz es Rendelointezet, Eger, Hungary|Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaza, Gyula, Hungary|Pest Megyei Flor Ferenc Korhaz, Kistarcsa, Hungary|Borsod-Abauj-Zemplen Megyei Kozponti Korhaz es Egyetemi Oktatokorhaz, Miskolc, Hungary|Karolina Korhaz-Rendelointezet, Mosonmagyarovar, Hungary|Pecsi Tudomanyegyetem, Pecs, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Szekesfehervar, Hungary|Tolna Megyei Balassa Janos Korhaz, Szekszard, Hungary|HaEmek Medical Center, Afula, Israel|Barzilai Medical Center, Ashkelon, Israel|Soroka University Medical Center, Beer Sheva, Israel|Rambam Health Care Campus, Haifa, Israel|Wolfson Medical Center, Holon, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Galilee Medical Center, Nahariya, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Kaplan Medical Center, Rechovot, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy|Istituto Clinico Humanitas, Rozzano, Milano, Italy|I.R.C.C.S Policlinico San Donato, San Donato Milanese, Milano, Italy|Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi, Bologna, Italy|Azienda Ospedaliera Ospedale Cannizzaro, Catania, Italy|Azienda Ospedaliera Universitaria Policlinico G. Martino, Messina, Italy|Azienda Socio Sanitaria Territoriale Fatebenefratelli (Presidio Ospedale Sacco), Milano, Italy|A.O.U. Policlinico di Modena, Modena, Italy|Azienda Ospedaliera Universitaria ""Federico II"", Napoli, Italy|Azienda Ospedaliera di Padova, Padova, Italy|Azienda Ospedaliera Vincenzo Cervello, Palermo, Italy|Azienda Ospedaliera San Camillo Forlanini, Roma, Italy|Policlinico Universitario Agostino Gemelli, Roma, Italy|Yokoyama IBD Clinic, Nagoya-shi, Aichi-Ken, Japan|Toho University Sakura Medical Center, Sakura-shi, Chiba-Ken, Japan|Ehime Prefectural Central Hospital, Matsuyama-shi, Ehime-Ken, Japan|Fukuoka University Chikushi Hospital, Chikushino-shi, Fukuoka-Ken, Japan|Fukuoka University Hospital, Fukuoka-shi, Fukuoka-Ken, Japan|Kurume University Hospital, Kurume-shi, Fukuoka-Ken, Japan|Hiroshima University Hospital, Hiroshima-shi, Hiroshima-Ken, Japan|Tokushukai Sapporo Tokushukai Hospital, Sapporo-shi, Hokkaido, Japan|Sapporo-Kosei General Hospital, Sapporo-shi, Hokkaido, Japan|Tokushukai Sapporo Higashi Tokushukai Hospital, Sapporo-shi, Hokkaido, Japan|Hyogo College of Medicine Hospital, Nishinomiya-shi, Hyogo-Ken, Japan|Iwate Medical University Hospital, Morioka-shi, Iwate-Ken, Japan|Kagawa Prefectural Central Hospital, Takamatsu-shi, Kagawa-Ken, Japan|Gokeikai Ofuna Chuo Hospital, Kamakura-shi, Kanagawa-Ken, Japan|Okayama University Hospital, Okayama-shi, Okayama-Ken, Japan|Kinshukai Infusion Clinic, Osaka-shi, Osaka-Fu, Japan|Osaka City General Hospital, Osaka-shi, Osaka-Fu, Japan|Saga University Hospital, Saga-shi, Saga-Ken, Japan|Shiga University of Medical Science Hospital, Otsu-shi, Shiga-Ken, Japan|Hamamatsu South Hospital, Hamamatsu-shi, Shizuoka-Ken, Japan|Medical Hospital, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo-To, Japan|Jikei University Hospital, Minato-ku, Tokyo-To, Japan|Kitasato University Kitasato Institute Hospital, Minato-ku, Tokyo-To, Japan|Kyorin University Hospital, Mitaka-shi, Tokyo-To, Japan|Keio University Hospital, Shinjuku-ku, Tokyo-To, Japan|JCHO Tokyo Yamate Medical Center, Shinjuku-ku, Tokyo-To, Japan|Wakayama Medical University Hospital, Wakayama-shi, Wakayama-Ken, Japan|Kyungpook National University Hospital, Daegu, Gyeongsangbuk-do, Korea, Republic of|Yeungnam University Hospital, Daegu, Korea, Republic of|Kyung Hee University Hospital, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Severance Hospital, Yonsei University, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania|Klaipeda Republican Hospital, Public Institution, Klaipeda, Lithuania|Klaipeda University Hospital, Public Institution, Klaipeda, Lithuania|Vilnius University Hospital Santariskiu Clinics, Public Institution, Vilnius, Lithuania|Morales Vargas Centro de Investigacion, S.C., Leon, Guanajuato, Mexico|Centro de Investigacion Farmacologica del Bajio, S.C., Leon, Guanajuato, Mexico|iBiomed Guadalajara, Zapopan, Jalisco, Mexico|Universidad Autonoma de Nuevo Leon, Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico|Christus Muguerza Sur S.A. de C.V., Monterrey, Nuevo Leon, Mexico|Instituto de Investigaciones Aplicadas a la Neurociencia A.C., Durango, Mexico|Sociedad de Metabolismo y Corazon S.C, Veracruz, Mexico|Academisch Medisch Centrum, Amsterdam, Netherlands|Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands|Universitair Medisch Centrum Groningen (UMCG), Groningen, Netherlands|Maastricht University Medical Center, Maastricht, Netherlands|Erasmus Medisch Centrum, Rotterdam, Netherlands|SP ZOZ Wojewodzki Szpital Zespolony im. J. Sniadeckiego, Bialystok, Poland|NZOZ Vitamed, Bydgoszcz, Poland|SP CSK im. prof. K. Gibinskiego SUM, Katowice, Poland|Gabinet Endoskopii Przewodu Pokarmowego, Krakow, Poland|SPZOZ Uniwersytecki Szpital Klin. nr 1 im.N.Barlickiego UM, Lodz, Poland|Santa Familia Centrum Badan, Profilaktyki i Leczenia, Lodz, Poland|GASTROMED Sp. z o.o., Lublin, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Centrum Zdrowia MDM, Warszawa, Poland|Centralny Szpital Kliniczny MSW w Warszawie, Warszawa, Poland|Centrum Onkologii-Instytut im. M. Sklodowskiej Curie, Warszawa, Poland|Nzoz Vivamed, Warszawa, Poland|LexMedica Osrodek Badan Klinicznych, Wroclaw, Poland|Ars-Medica S.C Rybak Maria, Rybak Zbigniew, Wroclaw, Poland|Spitalul Clinic Colentina, Bucuresti, Romania|Institutul Clinic Fundeni, Bucuresti, Romania|S.C Centrul de Gastroenterologie Dr. Goldis S.R.L, Timisoara, Romania|Kazan State Medical University, Kazan, Russian Federation|TSBIH ""Territorial Clinical Hospital"", Krasnoyarsk, Russian Federation|FSBIH ""Central Clinical Hospital of Russian Academy of Sciences"", Moscow, Russian Federation|SBEI HPE ""Moscow State Medical and Dentistry University n.a. A. I. Evdokimov"" of the MoH of the RF, Moscow, Russian Federation|SBEIHPE Novosibirsk State Medical University, Novosibirsk, Russian Federation|FSBSI ""Scientific and Research Institute of Physiology and Basic Medicine"", Novosibirsk, Russian Federation|BHI of Omsk region Clinical Oncology Dispensary, Omsk, Russian Federation|SBEI of HPE ""Omsk SMA"" SBEI HPE ""Omsk State Medical University"" of the MoH of the RF, Omsk, Russian Federation|SBEI HPE ""Rostov State Medical University"" of the MoH of the RF, Rostov-on-Don, Russian Federation|LLC ""RIAT SPb"", Saint-Petersburg, Russian Federation|SIH ""Regional Clinical Hospital "", Saratov, Russian Federation|SPb SBIH ""City Hospital # 40 of Kurortnyi region"", Sestroretsk, Russian Federation|SPb SBIH ""City Hospital of Saint Martyr Elizaveta"", St. Petersburg, Russian Federation|SBIH of Yaroslavl region "" Regional Clinical Hospital "", Yaroslavl, Russian Federation|Clinical Center of Serbia, Belgrade, Serbia|Clinical Helth Centre Zvezdara, Belgrade, Serbia|Military Medical Academy, Belgrade, Serbia|Clinical Center Bezanijska Kosa, Belgrade, Serbia|Clinical Center Zemun, Belgrade, Serbia|Clinical Center Kragujevac, Kragujevac, Serbia|Clinical Center Nis, Nis, Serbia|Clinical Center of Vojvodina, Novi Sad, Serbia|Fakultna nemocnica s poliklinikou F.D. Roosevelta, Banska Bystrica, Slovakia|Univerzitna nemocnica Bratislava, Nemocnica Ruzinov, Bratislava, Slovakia|Gastroped s.r.o., Kosice, Slovakia|KM Management spol. s r.o., Nitra, Slovakia|Gastro I, s.r.o., Presov, Slovakia|Dr CCM Ziady Practice, Pretoria, Gauteng, South Africa|Dr MJ Prins Practice, Cape Town, Western Cape, South Africa|Dr JP Wright Practice, Cape Town, Western Cape, South Africa|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain|Hospital General Universitario de Alicante, Alicante, Spain|Hospital Universitari de Girona Dr Josep Trueta, Girona, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Complejo Hospitalario de Pontevedra, Pontevedra, Spain|Karolinska Universitetssjukhuset - Solna, Stockholm, Sweden|Danderyds Sjukhus, Stockholm, Sweden|National Taiwan University Hospital, Taipei, Taiwan|Mackay Memorial Hospital, Taipei, Taiwan|Tri-Service General Hospital, Taipei, Taiwan|Ankara University Medical Faculty, Ankara, Turkey|Gazi University Medical Faculty, Ankara, Turkey|Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty, Istanbul, Turkey|Acibadem Fulya Hospital, Istanbul, Turkey|Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey|Marmara University Pendik Research and Training Hospital, Istanbul, Turkey|Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey|Mersin University Medical Faculty, Mersin, Turkey|RCI Chernivtsi RCH Dep of Surgery HSEI of Ukr Bukovinian SMU, Chernivtsi, Ukraine|SI Institute of Gastroenterology of NAMSU Dept of Stomach & Duodenum Diseases, D&ThN SI DMA of MoHU, Dnipro, Ukraine|Regional CH Dep of Gastroenterology SHEI Ivano-Frankivsk NMU, Ivano-Frankivsk, Ukraine|CNE Prof. O.O. Shalimov Kharkiv City Clinical Hospital #2 of KCC, Kharkiv, Ukraine|GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine, Kharkiv, Ukraine|CI A.and O. Tropiny City Clinical Hospital, Kherson, Ukraine|CI of Kyiv RC Kyiv Regional Clinical Hospital, Kyiv, Ukraine|MI of Healthcare Kyiv RCH P.L. Shupyk NMA of PGE, Kyiv, Ukraine|Kyiv CCH #12 Dept of Therapy O.O.Bogomolets NMU, Kyiv, Ukraine|Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU, Lviv, Ukraine|CI Odesa Regional Clinical Hospital, Odesa, Ukraine|Ternopil University Hospital, Ternopil, Ukraine|CI UDH Dept of Ther SHEI Fac of PGE&Pre-Univ Training, Uzhgorod, Ukraine|Private Small Enterprise Medical Center Pulse, Vinnytsia, Ukraine|Vinnytsia RCH of Veterans of War Dept of Therapy#1 Vinnytsia M.I.Pyrogov NMU, Vinnytsia, Ukraine|MCIC MC LLC Health Clinic, Vinnytsia, Ukraine|CI City Hospital #1, Zaporizhzhia, Ukraine|Royal Devon and Exeter Hospital (Wonford), Exeter, Devon, United Kingdom|Whipps Cross University Hospital, London, Greater London, United Kingdom|Royal Free Hospital, London, Greater London, United Kingdom|St George's Hospital, London, Greater London, United Kingdom|Norfolk and Norwich University Hospital, Norwich, Norfolk, United Kingdom|Royal Shrewsbury Hospital, Shrewsbury, Shropshire, United Kingdom|University Hospital Coventry, Coventry, West Midlands, United Kingdom|Royal Wolverhampton hospital, Wolverhampton, West Midlands, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02620046"
730,"NCT04305535","Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease",,"Recruiting","No Results Available","Crohn Disease|Absorption; Disorder, Protein|Absorption; Disorder|Absorption; Disorder, Fat|Absorption; Disorder, Carbohydrate|Malnutrition","Dietary Supplement: Peptidic+Probiotic|Dietary Supplement: Peptidic+Placebo|Dietary Supplement: Polymeric+Placebo","Malabsorption|Changes in the consistency of the stools according to Bristol scale.|Fat malabsorption","Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz|Adventia Pharma, S.L.|Biopolis S.L.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","162","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","EC032-19_FJD","February 13, 2020","February 2021","June 2021","March 12, 2020",,"March 12, 2020","Miguel Aganzo Yeves, Madrid, Spain",,"https://ClinicalTrials.gov/show/NCT04305535"
731,"NCT02326155","To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)",,"Recruiting","No Results Available","Crohn's Disease|Ulcerative Colitis",,"Detection of events of special interest in IBD patients","Celltrion","All","6 Years and older   (Child, Adult, Older Adult)",,"500","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","CT-P13 4.3","April 2014","June 2020","June 2026","December 25, 2014",,"July 24, 2018","Dr. Pavel Svoboda, Ostrava, Morvskoslezsky Kraj, Czechia",,"https://ClinicalTrials.gov/show/NCT02326155"
732,"NCT04013152","Clinical Database of Colorectal Robotic Surgery","ROBOT CR","Recruiting","No Results Available","Crohn Disease|Polyposis|Ulcerative Colitis|Diverticulitis|Colorectal Tumor|Rectal Prolapse|Benign Colorectal Tumor","Other: Clinical database","Collection of clinical data following surgery with robotic assistance in colorectal pathologies|Time of learning for each surgical technique by determining a learning curve for each of them|The conversion rate of surgical technique|Operating time|Intraoperative complications rate|Duration of hospital stay|local relapse-free survival|overall survival|Digestive functionality assessment by using the Low Anterior Resection Syndrome score (LARS)|The Erectile Function of patient by using the II-EF-5 score (The International Index of Erectile Function)|The dysfunction of female Sexual Function by using the Index FSFI (The Female Sexual Function Index) score|Urinary functionality by using the questionnaire of urinary function|Objective surgeon performance metrics using a novel recorder (dVLogger) to directly capture surgeon manipulations on the da Vinci Surgical System|Number of lymph node resected|Quality of the mesorectum by using Quirke classification","Institut du Cancer de Montpellier - Val d'Aurelle","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1800","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","PROICM 2017-05 ROB","June 13, 2018","January 2022","January 2026","July 9, 2019",,"June 18, 2021","CHU de Bordeaux, Bordeaux, Gironde, France|Institut régional du cancer de Montpellier, Montpellier, Hérault, France|CHU de Clermont-Ferrand, Clermont-Ferrand, Puy De Dôme, France|CHU de Lyon, Lyon, Rhône, France",,"https://ClinicalTrials.gov/show/NCT04013152"
733,"NCT01735461","Calcium Supplements Strategy for Kidney Stones Prevention in Crohn's Patients",,"Recruiting","No Results Available","Kidney Calculi|Crohn's Disease","Dietary Supplement: Calcium Carbonate","Molar ratio of urinary calcium:oxalate in relation to the supersaturation product of calcium oxalate|Optimal level of Ca supplementation for prevention of stones in Crohn's patients","University of British Columbia|University of Texas Southwestern Medical Center","All","19 Years and older   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","H11-02525","December 2012","December 2022","December 2022","November 28, 2012",,"April 29, 2021","Vancouver General Hospital, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT01735461"
734,"NCT04089514","A Real-world Study of Imraldi® Use","PROPER","Active, not recruiting","No Results Available","Arthritis, Rheumatoid (RA)|Axial Spondyloarthritis (axSpA)|Arthritis, Psoriatic (PsA)|Crohn's Disease (CD)|Colitis, Ulcerative (UC)","Drug: Adalimumab","Candidate Predictors of Persistence on Adalimumab|Number of Participants by Baseline Clinical Characteristic Categories|Number of Participants by Utilization of Adalimumab Categories|Change from Baseline in Disease Scores as Applicable by Indication|Patient Satisfaction with Biologic Administration|Number of Participants with Clinically Significant Laboratory Values and Clinical Evaluation Measurements|Number of Participants by Utilization of Relevant Concomitant Medication Categories|Number of Participants with Anti-drug Antibodies|Number of Participants with Serious Adverse Events (SAEs) and Causally-related Non-serious Adverse Events (AEs)","Biogen","All","18 Years and older   (Adult, Older Adult)",,"1000","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","EUR-BIO-18-11391","June 30, 2019","November 6, 2021","November 6, 2021","September 13, 2019",,"April 19, 2021","Research Site, Brugge, Belgium|Research Site, Bruxelles, Belgium|Research Site, Genk, Belgium|Research Site, Gent, Belgium|Research Site, Herentals, Belgium|Research Site, Kortrijk, Belgium|Research Site, Liège, Belgium|Research Site, Sijsele, Belgium|Research Site, Turnhout, Belgium|Research Site, Berlin, Germany|Research Site, Bruchhausen-Vilsen, Germany|Research Site, Burghausen, Germany|Research Site, Dresden, Germany|Research Site, Elmshorn, Germany|Research Site, Erfurt, Germany|Research Site, Halle, Germany|Research Site, Hamburg, Germany|Research Site, Hamm, Germany|Research Site, Heidelberg, Germany|Research Site, Magdeburg, Germany|Research Site, Munchen, Germany|Research Site, Munich, Germany|Research Site, Münster, Germany|Research Site, Oldenburg, Germany|Research Site, Ratingen, Germany|Research Site, Dublin, Ireland|Research Site, Ancona, Italy|Research Site, Bari, Italy|Research Site, Firenze, Italy|Research Site, Foggia, Italy|Research Site, Milano, Italy|Research Site, Modena, Italy|Research Site, Pavia, Italy|Research Site, San Giovanni Rotondo, Italy|Research Site, Siena, Italy|Research Site, Varese, Italy|Research Site, Almeria, Spain|Research Site, Badajoz, Spain|Research Site, Donostia, Spain|Research Site, Granada, Spain|Research Site, Mérida, Spain|Research Site, Sant Joan Despi, Spain|Research Site, Sevilla, Spain|Research Site, Terrassa, Spain|Research Site, Valladolid, Spain|Research Site, Ashford, United Kingdom|Research Site, Bath, United Kingdom|Research Site, Belfast, United Kingdom|Research Site, Cambridge, United Kingdom|Research Site, Kettering, United Kingdom|Research Site, Luton, United Kingdom|Research Site, Norwich, United Kingdom|Research Site, Nottingham, United Kingdom|Research Site, Sussex, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04089514"
735,"NCT03662919","One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study","PERFUSE","Recruiting","No Results Available","Arthritis, Rheumatoid|Spondylitis, Ankylosing|Arthritis, Psoriatic|Crohn's Disease|Colitis, Ulcerative","Drug: Infliximab|Drug: Adalimumab","Percentage of Participants who are Still Treated with Either Flixabi or Imraldi at 12 Months","Biogen","All","6 Years and older   (Child, Adult, Older Adult)",,"3000","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","FRA-FLX-17-11226|2017-A03220-53","July 2, 2018","June 30, 2022","June 30, 2022","September 10, 2018",,"March 30, 2020","Research Site, Bobigny, France|Research Site, Clichy, France|Research Site, Creteil, France|Research Site, Paris, France|Research Site 1, Paris, France|Research Site 2, Paris, France|Research Site 3, Paris, France|Research Site 4, Paris, France|Research Site 5, Paris, France|Research Site 6, Paris, France",,"https://ClinicalTrials.gov/show/NCT03662919"
736,"NCT04939025","Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC","MIRACLE","Not yet recruiting","No Results Available","Ulcerative Colitis","Procedure: Multi-interventional program","Leak rate|Cumulative anastomotic dehiscence rate|QOL|Protocol compliance|ICG|CRP|EVAC|Stoma rate|Temporary ileostomy rate and duration|Complications|Death|Hospital stay|Reintervention rate|Readmission|Cost analysis of EVAC","London North West Healthcare NHS Trust","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","271078","July 1, 2021","July 1, 2022","August 1, 2025","June 25, 2021",,"June 25, 2021",,,"https://ClinicalTrials.gov/show/NCT04939025"
737,"NCT04933162","UC Cohort - The Influence of Diet on Gut Microbiotas",,"Not yet recruiting","No Results Available","Ulcerative Colitis","Dietary Supplement: High Protein and Low Fiber Diet|Dietary Supplement: Low Protein and High Fiber Diet","Decrease in endoscopic Mayo score for ulcerative colitis inflammation|Clinical remission derived from patient reported outcomes|Intestinal inflammation determined from blood and stool samples|Urinary excretion of lactulose and 13C-Mannitol","Mayo Clinic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","70","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Supportive Care","20-012389","July 1, 2021","July 1, 2023","July 1, 2024","June 21, 2021",,"June 21, 2021","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT04933162"
738,"NCT04926103","Screening Donors, Fecal Microbiota Transplant Program in Ulcerative Colitis","FUEL","Not yet recruiting","No Results Available","Ulcerative Colitis Flare","Other: Fecal Microbiota transplant (FMT)","Efficacy of FMT donors at inducing UC remission|Efficacy of FMT at maintaining remission in UC|Efficacy of FMT at in inducing histological remission in active UC|Efficacy of FMT at relieving PRO2 symptoms|Efficacy of FMT at improving Quality of life|Adverse effects of FMT|Stool microbiota predicting FMT success|Mucosal microbiota predicting FMT success","Hamilton Health Sciences Corporation|Canadian Institutes of Health Research (CIHR)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","FUEL001","October 1, 2021","October 1, 2028","May 1, 2029","June 14, 2021",,"June 14, 2021","Hamilton Health Sciences / McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04926103"
739,"NCT04925973","Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management","TRIUMPH","Recruiting","No Results Available","Ulcerative Colitis Acute","Drug: Tofacitinib 10 MG [Xeljanz]","Clinical response at day 7|1. Percentage of patients who achieve clinical remission at day 7, and weeks 12, 26, and 52 (Partial Mayo score < 2, with no subscore >1)|Number of colectomies (emergency and planned) during the 52 weeks|Number of patients requiring switch in therapy (i.e. initiation of another biological medication, start of a different clinical trial with another active drug, etc) during the 52 weeks|Percentage of patients who achieve clinical response at weeks 12, 26, and 52 (MTWSI reduction 3 or more points and MTWSI < 10)|For patients who have response, to determine the mean number of days before detection of clinically significant response (MTWSI reduction of 3 or more points) population.|To determine the rate of corticosteroid-free clinical remission based on Number of patients with initial Mayo 2/3 disease at flexible sigmoidoscopy that achieve endoscopic improvement (Mayo score 0 or 1) at week 26|Comparison of absolute change from baseline endoscopic Mayo score at week 26|Comparison of number of patients with severe colitis based on histology who are able to achieve histological improvement (mild or inactive colitis) at week 26|Proportion of individuals who experience a severe adverse event over the course of treatment","McMaster University|University of Manitoba|University of British Columbia|McGill University|University of Alberta","All","18 Years and older   (Adult, Older Adult)","Phase 2","26","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","11428","June 1, 2021","June 2022","June 2023","June 14, 2021",,"June 14, 2021","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04925973"
740,"NCT04924270","Safety and Efficacy of Faecal Microbiota Transplantation in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases","FRONT","Not yet recruiting","No Results Available","Rheumatoid Arthritis|Reactive Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis|Gouty Arthritis|Psoriasis|Hidradenitis Suppurativa|Pulmonary Sarcoidosis|Crohn Disease|Ulcerative Colitis","Biological: Faecal microbiota transplantation|Other: Placebo","Change from baseline in the physical component score (PCS) of the 36-Item Short Form Health Survey (SF-36)|Change from baseline in the mental component score (MCS) of the 36-Item Short Form Health Survey (SF-36)|Change from baseline in patient global assessment (VAS 0-100 mm)|Change from baseline in patient fatigue (VAS 0-100 mm)|Change from baseline in patient pain (VAS 0-100 mm)|Change from baseline in physician's global assessment (VAS 0-100 mm)|Change from baseline in C-reactive protein|Change from baseline in the mental component score (MCS) of the 36-Item Short Form Health Survey","Torkell Ellingsen|Region of Southern Denmark|University of Southern Denmark|Odense University Hospital","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 2","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","20/3106","January 2022","December 2024","December 2024","June 11, 2021",,"June 11, 2021",,,"https://ClinicalTrials.gov/show/NCT04924270"
741,"NCT04924114","A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002)",,"Not yet recruiting","No Results Available","Ulcerative Colitis","Drug: MK-6194|Drug: MK-6194-matching placebo","Percentage of Participants Experiencing Adverse Events (AEs)|Percentage of Participants Discontinuing Study Treatment Due to an AE|Maximum Concentration (Cmax) of MK-6194|Time to Cmax (Tmax) of MK-6194|Area Under the Concentration Time-curve From Time 0 to the Last Quantifiable Concentration (AUC0-t)|Minimum Concentration (Cmin) of MK-6194|Area Under the Curve From Time 0 to Infinity (AUC0-inf) of MK-6194|Apparent Half-life (t1/2) of MK-6194|Apparent Clearance (CL/F) of MK-6194|Apparent Volume of Distribution (Vd/F) of MK-6194|Change in Number of Peripheral Regulatory T-cells (Tregs) in Whole Blood|Change in Number of Natural Killer (NK) Cells in Whole Blood|Change in Number of Conventional T Cells (Tcons) in Whole Blood|Titer of anti-drug antibody (ADA) of MK-6194","Merck Sharp & Dohme Corp.","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 1","30","Industry","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","6194-002|PT101-201|2021-000093-28","July 12, 2021","October 27, 2022","October 27, 2022","June 11, 2021",,"July 2, 2021",,,"https://ClinicalTrials.gov/show/NCT04924114"
742,"NCT04908644","MS-20 on Patients With Ulcerative Colitis(UC)",,"Not yet recruiting","No Results Available","Ulcerative Colitis","Drug: MS-20 oral solution|Other: Placebo","Change from baseline structural of gut microbiota at 16 weeks|Change from baseline in the abundance and variability of gut microbiota at 16 weeks|Change from baseline of Partial Mayo Score at 12 weeks|Change from baseline of IL-6 level in blood at 12 weeks|Change from baseline of TNF-α level in blood at 12 weeks|Change from baseline of IL-1β level in blood at 12 weeks|Change from baseline of IL-23 level in blood at 12 weeks|Change from baseline of IL-33 level in blood at 12 weeks|Change from baseline of C-reactive protein(CRP) level in blood at 12 weeks|Change from baseline of erythrocyte sedimentation rate(ESR) at 12 weeks|Change from baseline of fecal calprotectin result at 12 weeks|Change from baseline of fecal occult blood result at 12 weeks|Adverse events","National Taiwan University Hospital|Microbio Co Ltd","All","20 Years to 65 Years   (Adult, Older Adult)","Not Applicable","40","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Supportive Care","202006118MIPB|MB103CLAS07","June 2021","February 2022","June 2022","June 1, 2021",,"June 1, 2021",,,"https://ClinicalTrials.gov/show/NCT04908644"
743,"NCT04897282","Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients.",,"Recruiting","No Results Available","Ulcerative Colitis","Diagnostic Test: UCRI","UCRI panel validation|fCal comparison analysis","Glycominds, LLC|University of California, Davis|University of California, Irvine|University of Chicago|Weill Medical College of Cornell University|Crohn's and Colitis Foundation","All","18 Years to 65 Years   (Adult, Older Adult)",,"100","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","UCRI-1020","May 24, 2021","November 30, 2022","December 31, 2022","May 21, 2021",,"May 21, 2021","UC Davis Inflammatory Bowel Disease Center, Sacramento, California, United States",,"https://ClinicalTrials.gov/show/NCT04897282"
744,"NCT04883840","Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis","ReMiDy","Recruiting","No Results Available","Ulcerative Colitis","Drug: Rosuvastatin 10mg","UC Mayo Score|Systemic inflammatory measures|Local inflammatory measures|Significant change in gastrointestinal microbiome composition","Universitaire Ziekenhuizen Leuven|Vlaams Instituut Biotechnologie (VIB)","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 2|Phase 3","220","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","S63190","October 22, 2020","April 22, 2022","December 22, 2022","May 12, 2021",,"May 12, 2021","Imelda Ziekenhuis, Bonheiden, Antwerp, Belgium|UZ Leuven, Leuven, Vlaams-Brabant, Belgium",,"https://ClinicalTrials.gov/show/NCT04883840"
745,"NCT04882683","Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Prednisone|Drug: Azathioprine|Drug: Adalimumab|Biological: umbilical cord blood mononuclear cells","Clinical efficacy rate|Clinical response rate|Clinical symptom score|Endoscopic response rate|Mucosal healing rate","Shandong Qilu Stem Cells Engineering Co., Ltd.","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","50","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","UCB-MNCs-UC-2021","June 1, 2021","June 1, 2022","December 31, 2022","May 12, 2021",,"May 12, 2021","The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shandong, Shandong, China",,"https://ClinicalTrials.gov/show/NCT04882683"
746,"NCT04879966","A Cohort Study Comparing IFX to CS for Moderate to Severe UC","INSURE","Recruiting","No Results Available","Moderate to Severe Ulcerative Colitis","Drug: Infliximab|Drug: Corticosteroid","clinical remission|clinical response in induction phase|mucosal healing in induction phase|histological healing in induction phase|clinical response in maintenance phase|mucosal healing in maintenance phase|histological healing in maintenance phase|quality of life in induction phase|quality of life in maintenance phase|adverse events","Sixth Affiliated Hospital, Sun Yat-sen University","All","18 Years to 70 Years   (Adult, Older Adult)",,"342","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2021ZSLYEC-102","May 17, 2021","December 31, 2022","December 31, 2023","May 10, 2021",,"May 27, 2021","The Sixth Affiliated Hospital, Sun Yat-sen University, Guandong, China",,"https://ClinicalTrials.gov/show/NCT04879966"
747,"NCT04862741","Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: NX-13 250mg IR|Drug: NX-13 500mg IR|Drug: NX-13 500mg MR|Drug: Placebo","Incidence of Treatment-Emergent Adverse Events after multiple oral dose administration of NX-13 in subjects with active ulcerative colitis (UC)|PK profile of NX-13 after multiple oral dose administration in subjects with active UC|PK Parameters - Time to maximum concentration (tmax);|PK Parameters- Maximum concentration (Cmax)|PK Parameters- Area under the concentration-time curve from time 0 to last measurable time-point (AUC0-tlast);|PK Parameters-Terminal half-life (t1/2)|PK Parameters- clearance (CL);|PK Parameters- Vz, apparent volume of distribution during terminal phase.","Landos Biopharma Inc.","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1","40","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","NX-13-1b","May 5, 2021","August 2021","October 2021","April 28, 2021",,"June 30, 2021","I.H.S Health LLC, Kissimmee, Florida, United States",,"https://ClinicalTrials.gov/show/NCT04862741"
748,"NCT04857112","Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Low Dose MT-1303|Drug: High Dose MT-1303|Drug: Placebo","Change from Baseline in the modified Mayo Score at Day 85|The proportion of subjects with endoscopic improvement at Day 85|The change from Baseline in the 2-component Mayo Score at Day 85.|The proportion of subjects with clinical remission at Day 85 based on the modified Mayo Score","Bausch Health Americas, Inc.","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","336","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","AMUC-2023","May 2021","October 2023","October 2023","April 23, 2021",,"May 12, 2021","Salix Site 003, Los Angeles, California, United States|Salix Site 006, San Bernardino, California, United States|Salix Site 005, Ventura, California, United States|Salix Site 004, Fort Lauderdale, Florida, United States|Salix Site 009, Marietta, Georgia, United States|Salix Site 008, Snellville, Georgia, United States|Salix Site 001, Shreveport, Louisiana, United States|Salix Site 002, West Long Branch, New Jersey, United States|Salix Site 007, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT04857112"
749,"NCT04855799","GI Permeability Change in Response to Aquamin®",,"Recruiting","No Results Available","Healthy|Ulcerative Colitis","Drug: Aquamin","Change in the lactulose:mannitol ratio in urine by comparing values at 90-days (post-intervention) to baseline (pre-intervention) levels.","James Varani|University of Michigan","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","HUM00156676 sub-study 1","July 2021","December 2022","May 2023","April 22, 2021",,"May 25, 2021","University of Michigan Hospital, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT04855799"
750,"NCT04818788","Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis",,"Not yet recruiting","No Results Available","Ulcerative Colitis","Drug: Biological Drug","Histological remission in ulcerative colitis patients receiving biological therapy|Assessment of fecal calprotectin level in ulcerative colitis patients receiving biological therapy|Assessment of the level of PLR, NLR , MLR in ulcerative colitis patients receiving biological therapy|Ability of hematological indices and fecal calprotectin to predict histological remission","Assiut University","All","18 Years to 55 Years   (Adult)",,"24","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","ulcerative colitis","April 1, 2021","April 20, 2022","June 1, 2022","March 26, 2021",,"March 29, 2021",,,"https://ClinicalTrials.gov/show/NCT04818788"
751,"NCT04798625","Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication","Nor-vaC","Recruiting","No Results Available","Rheumatoid Arthritis|Psoriatic Arthritis|Spondyloarthritis|Crohn Disease|Ulcerative Colitis|Autoimmune Hepatitis|Liver Transplant; Complications",,"Serological response|Cellular response|Adverse events|BASDAI|Partial Mayo score|Harvey-Bradshaw index (HBI)|DAS28","Diakonhjemmet Hospital|University Hospital, Akershus","All","18 Years and older   (Adult, Older Adult)",,"1600","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","DIA2021-1","February 15, 2021","February 15, 2026","February 15, 2027","March 15, 2021",,"March 15, 2021","Akershus University Hospital, Lørenskog, Norway|Diakonhjemmet Hospital, Oslo, Norway",,"https://ClinicalTrials.gov/show/NCT04798625"
752,"NCT04779307","A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis",,"Not yet recruiting","No Results Available","Colitis, Ulcerative","Drug: Vedolizumab","Percentage of Participants with Clinical Remission at Week 54 Based on Modified Mayo Score|Percentage of Participants with Clinical Remission at Week 14 Based on Modified Mayo Score|Percentage of Participants with Sustained Clinical Remission at Week 54|Percentage of Participants with Corticosteroid-free Clinical Remission at Week 54|Percentage of Participants with Clinical Remission at Week 54 Based on Complete Mayo Score|Percentage of Participants with Clinical Remission at Week 54 Based on Pediatric Ulcerative Colitis Activity Index (PUCAI) Score|Serum Trough Concentrations of Vedolizumab over Time|Percentage of Participants with Positive Anti-vedolizumab Antibodies (AVA)|Percentage of Participants with Positive Neutralizing AVA|Percentage of Participants with Clinical Response at Weeks 14 and 54 Based on Complete Mayo Score|Percentage of Participants with Clinical Response up to Week 54 Based on Partial Mayo Score|• Percentage of Participants with at least One Adverse Event (AE), Serious Adverse Event (SAE), and Adverse Event of Special Interest (AESI)|Change from Baseline in Weight|Change from Baseline in Linear Growth Z-score|Percentage of Participants Achieving Tanner Stage V","Takeda","All","2 Years to 17 Years   (Child)","Phase 3","120","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","MLN0002-3024|2020-004300-34","May 5, 2021","May 30, 2024","May 30, 2024","March 3, 2021",,"April 29, 2021",,,"https://ClinicalTrials.gov/show/NCT04779307"
753,"NCT04767984","Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis",,"Not yet recruiting","No Results Available","Colorectal Carcinoma|Ulcerative Colitis","Drug: Atorvastatin Calcium|Procedure: Biospecimen Collection|Drug: Placebo Administration","Reduction in mutant p53 staining in biopsy samples obtained during colonoscopies done before and after intervention|Levels of biomarkers of Ki-67 (cell proliferation), Waf1p21 (wild type p53 allele reactivated signal), and cleaved caspase-3 (wild type p53-induced cell apoptosis)|Analysis of spectrum, hotspot and load of TP53 gene mutations|Histological analysis for grading the severity of histologic inflammation in colorectal biopsies|Plasma concentration of cholesterol, high density lipoprotein (HDL) and low density lipoprotein (LDL)|Clinical efficacy on UC related symptoms|Banking of colorectal specimens","National Cancer Institute (NCI)","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 2","70","NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","NCI-2021-01261|NCI20-02-02|NWU20-02-02|P30CA060553|UG1CA242643","August 8, 2021","March 31, 2023","March 31, 2023","February 24, 2021",,"June 23, 2021","Northwestern University, Chicago, Illinois, United States|National Cancer Institute, Rockville, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT04767984"
754,"NCT04743518","Impact of Anti-TNF, Vedolizumab and Tofacitinib on Aortic Stiffness, Carotid Intima-media Thickness and Cardiovascular Risk of Patients With Ulcerative Colitis","VASC-UC","Recruiting","No Results Available","Ulcerative Colitis","Other: Aortic pulse wave velocity|Other: carotid intima media thickness (CIMT)","variation of carotid intima media thickness (CIMT) between the 3 patient groups","Centre Hospitalier Universitaire, Amiens","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","PI2020_843_0114","February 2, 2021","February 2023","February 2024","February 8, 2021",,"February 8, 2021","CHU Amiens, Amiens, France",,"https://ClinicalTrials.gov/show/NCT04743518"
755,"NCT04200690","Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory Diseases","NCAS-1","Recruiting","No Results Available","Psoriasis|Psoriatic Arthritis|Axial Spondyloarthritis|Hidradenitis Suppurativa|Crohn Disease|Ulcerative Colitis","Other: Interdisciplinary management|Other: Usual-care management","Change From Baseline on the Short-Form Health Survey (SF-36) Physical Component Summary (PCS)|Proportion of subjects achieving Minimal Clinical Important Difference (MCID) on the Short-Form Health Survey (SF-36) Physical Component Summary (PCS)|Change From Baseline on the Short-Form Health Survey (SF-36) Mental Component Summary (MCS)|Change From Baseline in the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) Score|Change from baseline in the Work Productivity and Activity Impairment Questionnaire (WPAI:GH) Percentage of Overall Work Impairment|Change in mean General Self-Efficacy scale scores|Change in the mean Hospital Anxiety and Depression Scale - Anxiety (HADS-A)|Change in the mean Hospital Anxiety and Depression Scale - Anxiety (HADS-D)","University of Aarhus|Aarhus University Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","300","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","NCAS-1","January 14, 2020","August 2022","January 2023","December 16, 2019",,"March 23, 2021","National Center for Autoimmune Diseases, Aarhus University Hospital, Aarhus, Denmark",,"https://ClinicalTrials.gov/show/NCT04200690"
756,"NCT04721873","Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients",,"Recruiting","No Results Available","Colitis, Ulcerative|Obesity","Drug: Phentermine-Topiramate|Drug: Placebo","Weight loss - 5%|Weight loss - 10%|Absolute weight loss|Discontinuation|Corticosteroid-free clinical remission|Biochemical remission","University of California, San Diego","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","190419|623346","December 18, 2020","June 30, 2022","September 30, 2022","January 25, 2021",,"January 27, 2021","University of California San Diego, La Jolla, California, United States",,"https://ClinicalTrials.gov/show/NCT04721873"
757,"NCT04712032","Anastomotic Leakage and Value Of Indocyanine Green in Decreasing Leakage Rates","AVOID","Recruiting","No Results Available","Colo-rectal Cancer|Crohn Disease|Resectable Colorectal Carcinoma","Drug: ICG-guided bowel perfusion assessment","90-days Anastomotic Leakage (AL) rate|30-days Anastomotic Leakage ( AL) rate|complication rate|mortality|days in hospital stay","Leiden University Medical Center|Medical Center Haaglanden|Catharina Ziekenhuis Eindhoven|Haga Hospital|Jeroen Bosch Ziekenhuis|Amphia Hospital|Alrijne Hospital|IJsselland","All","18 Years and older   (Adult, Older Adult)","Phase 3","978","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","P19.079","July 1, 2020","July 1, 2022","October 1, 2022","January 15, 2021",,"January 15, 2021","Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands",,"https://ClinicalTrials.gov/show/NCT04712032"
758,"NCT04706793","Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Etrasimod|Drug: Placebo","Proportion of Participants Achieving Clinical Remission|Proportion of Participants Achieving Endoscopic Improvement|Proportion of Participants Achieving Symptomatic Remission|Proportion of Participants, Who had not been Receiving Corticosteroids for ≥ 12 Weeks, Achieving Clinical Remission at Week 52 among Participants Receiving Corticosteroids at APD334-302 Study Entry|Proportion of Participants with Mucosal Healing|Number and Severity of Adverse Events","Arena Pharmaceuticals","All","16 Years to 80 Years   (Child, Adult, Older Adult)","Phase 3","35","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","APD334-308","December 25, 2020","December 2022","December 2022","January 13, 2021",,"June 11, 2021","Koujunkai Daido Clinic, Nagoya, Aichi, Japan|Toyohashi Municipal Hospital, Toyohashi, Aichi, Japan|Tsujinaka Hospital Kashiwanoha, Kashiwa-city, Chiba, Japan|Gifu University Hospital, Gifu-shi, Gifu, Japan|NHO Kanazawa Medical Center, Kanazawa, Ishikawa, Japan|Takamatsu Red Cross Hospital, Takamatsu-shi, Kagawa-Ken, Japan|Jiaikai Izuro Imamura Hospital, Kagoshima-shi, Kagoshima, Japan|Sameshima Hospital, Kagoshima-shi, Kagoshima, Japan|Mie University Hospital, Tsu-shi, Mie-Ken, Japan|Local Independent Administrative Institution Mie Prefectural General Medical Center, Yokkaichi-shi, Mie, Japan|Sendai City Hospital, Sendai-shi, Miyagi, Japan|Japan Community Health care Organization Osaka Hospital, Fukushima, Osaka, Japan|JCHO Tokyo Yamate Medical Center, Shinjuku-ku, Tokyo, Japan|Wakayama Medical University Hospital, Wakayama-shi, Wakayama-ken, Japan",,"https://ClinicalTrials.gov/show/NCT04706793"
759,"NCT04700449","A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)",,"Recruiting","No Results Available","Moderate to Severe Ulcerative Colitis","Drug: CBP-307|Drug: Placebo","Adapted Mayo score|Change in complete Mayo score|Comparison of clinical response rate by adapted Mayo score|Comparison of clinical response rate by complete Mayo score|Comparison of clinical remission rate by adapted Mayo score|Comparison of clinical remission rate by complete Mayo score|Mucosal healing rate|Incidence, type and severity of Treatment Emergent Adverse Event (TEAE)|Incidence, type and severity of Serious Adverse Event (SAE)|Incidence, type and severity of Adverse Events (AE)","Suzhou Connect Biopharmaceuticals, Ltd.","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","134","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","CBP-307CN002","February 27, 2019","December 2021","September 2022","January 7, 2021",,"May 12, 2021","Connect Investigative Site 2316, Phoenix, Arizona, United States|Connect Investigative Site 2308, Mission Hills, California, United States|Connect Investigative Site 2314, Hialeah, Florida, United States|Connect Investigative Site 2309, Homestead, Florida, United States|Connect Investigative Site 2320, Kissimmee, Florida, United States|Connect Investigative Site 2318, Miami, Florida, United States|Connect Investigative Site 2302, Orlando, Florida, United States|Connect Investigative Site 2304, Orlando, Florida, United States|Connect Investigative Site 2306, Orlando, Florida, United States|Connect Investigative Site 2307, Atlanta, Georgia, United States|Connect Investigative Site 2315, Cincinnati, Ohio, United States|Connect Investigative Site 2321, Oklahoma City, Oklahoma, United States|Connect Investigative Site 2311, Cypress, Texas, United States|Connect Investigative Site 2319, San Antonio, Texas, United States|Connect Investigative Site 2018, Hefei, Anhui, China|Connect Investigative Site 2004, Hefei, Anhui, China|Connect Investigative Site 2008, Beijing, Beijing, China|Connect Investigative Site 2001, Beijing, Beijing, China|Connect Investigative Site 2015, Jilin, Changchun, China|Connect Investigative Site 2006, Fuzhou, Fujian, China|Connect Investigative Site 2012, Xiamen, Fujian, China|Connect Investigative Site 2003, Guangzhou, Guangdong, China|Connect Investigative Site 2009, Guangzhou, Guangdong, China|Connect Investigative Site 2017, Shenzhen, Guangdong, China|Connect Investigative Site 2021, Shenzhen, Guangdong, China|Connect Investigative Site 2030, Nanning, Guangxi, China|Connect Investigative Site 2034, Haikou, Hainan, China|Connect Investigative Site 2026, Shijiazhuang, Hebei, China|Connect Investigative Site 2041, Shijiazhuang, Hebei, China|Connect Investigative Site 2022, Zhengzhou, Henan, China|Connect Investigative Site 2016, Wuhan, Hubei, China|Connect Investigative Site 2005, Wuhan, Hubei, China|Connect Investigative Site 2027, Nanjing, Jiangsu, China|Connect Investigative Site 2031, Nanjing, Jiangsu, China|Connect Investigative Site 2023, Nanjing, Jiangsu, China|Connect Investigative Site 2033, Suzhou, Jiangsu, China|Connect Investigative Site 2046, Nanchang, Jiangxi, China|Connect Investigative Site 2025, Dalian, Liaoning, China|Connect Investigative Site 2040, Shenyang, Liaoning, China|Connect Investigative Site 2028, Jinan, Shandong, China|Connect Investigative Site 2024, Qingdao, Shandong, China|Connect Investigative Site 2011, Shanghai, Shanghai, China|Connect Investigative Site 2007, Shanghai, Shanghai, China|Connect Investigative Site 2019, Shanghai, Shanghai, China|Connect Investigative Site 2035, Shanghai, Shanghai, China|Connect Investigative Site 2038, Shanghai, Shanghai, China|Connect Investigative Site 2020, Taiyuan, Shanxi, China|Connect Investigative Site 2013, Chengdu, Sichuan, China|Connect Investigative Site 2043, Chongqing, Sichuan, China|Connect Investigative Site 2047, Hangzhou, Zhejiang, China|Connect Investigative Site 2032, Hangzhou, Zhejiang, China|Connect Investigative Site 2045, Wenzhou, Zhejiang, China|Connect Investigative Site 2151, Karachi, Sindh Province, Pakistan|Connect Investigative Site 2152, Karachi, Sindh Province, Pakistan|Connect Investigative Site 2211, Dnipro, Ukraine|Connect Investigative Site 2217, Ivano-Frankivsk, Ukraine|Connect Investigative Site 2202, Kharkiv, Ukraine|Connect Investigative Site 2208, Kharkiv, Ukraine|Connect Investigative Site 2205, Kyiv, Ukraine|Connect Investigative Site 2220, Kyiv, Ukraine|Connect Investigative Site 2215, Lviv, Ukraine|Connect Investigative Site 2216, Lviv, Ukraine|Connect Investigative Site 2218, Uzhhorod, Ukraine|Connect Investigative Site 2209, Vinnytsia, Ukraine|Connect Investigative Site 2214, Zaporizhzhia, Ukraine",,"https://ClinicalTrials.gov/show/NCT04700449"
760,"NCT04695964","Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis",,"Recruiting","No Results Available","Ulcerative Colitis|Colorectal Cancer|Crohn Disease|Familial Adenomatous Polyposis|Ulcerative Colitis in Remission|Ulcerative Colitis Chronic|Crohn Colitis|Ileal Pouch","Diagnostic Test: ICG-NIRF Imaging plus ingress and egress analysis","anastomotic leak|Operative and post-operative complications|Length of post-operative hospital stay","Charite University, Berlin, Germany","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","EA4/116/19/2","February 1, 2019","January 2021","January 2021","January 6, 2021",,"January 15, 2021","Charité Campus Benjamin Franklin, Berlin, Germany",,"https://ClinicalTrials.gov/show/NCT04695964"
761,"NCT04695184","Subjective Near-infrared Fluorescence Guidance in Perfusion Assessment of Ileal Pouch Formation and Ileal-pouch-anal Anastomosis",,"Recruiting","No Results Available","Ulcerative Colitis|Colorectal Cancer|Crohn Disease|Familial Adenomatous Polyposis|Crohn Colitis|Ileal Pouch","Diagnostic Test: ICG-NIRF Imaging","anastomotic leak|Operative and post-operative complications|Length of post-operative hospital stay","Charite University, Berlin, Germany","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","EA4/116/19/1","February 1, 2019","January 2021","January 2021","January 5, 2021",,"January 15, 2021","Charité Campus Benjamin Franklin, Berlin, Germany",,"https://ClinicalTrials.gov/show/NCT04695184"
762,"NCT04691232","Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis|Autoimmune Diseases","Biological: Regulatory T cells","Dose-finding|Assessment of safety of one single Infusion of regulatory T cells","University of Erlangen-Nürnberg Medical School","All","18 Years to 18 Years   (Adult)","Phase 1","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","ER-TREG 01","February 22, 2021","February 1, 2022","August 1, 2023","December 31, 2020",,"May 18, 2021","University of Erlangen-Nürnberg Medical School, Erlangen, Bayern, Germany",,"https://ClinicalTrials.gov/show/NCT04691232"
763,"NCT04687150","Fecal Microbiota Transplantation and Newly Diagnosed Ulcerative Colitis (UC)","FinUC","Not yet recruiting","No Results Available","Ulcerative Colitis","Other: Fecal microbiota transplantation|Other: Colored water","Modified gut microbiota composition","Turku University Hospital|Helsinki University Central Hospital|Päijänne Tavastia Central Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","T298/2020","January 2021","January 2022","January 2023","December 29, 2020",,"December 29, 2020",,,"https://ClinicalTrials.gov/show/NCT04687150"
764,"NCT04677179","A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)","INSTRUCT-UC","Recruiting","No Results Available","Colitis, Ulcerative","Drug: LY3471851|Drug: Placebo","Percentage of Participants in Clinical Remission|Percentage of Participants Who Achieved Clinical Response|Percentage of Participants Who Achieved Endoscopic Remission|Percentage of Participants Who Achieved Endoscopic Response|Percentage of Participants Who Achieved Symptomatic Response|Percentage of Participants Who Achieved Symptomatic Remission|Percentage of Participants Who Achieved Histologic Remission|Percentage of Participants Who Achieved Histologic-Endoscopic Mucosal Healing|Mean Change from Baseline in Inflammatory Bowel Disease Questionnaire (IBDQ)|Pharmacokinetics (PK) of LY3471851 Trough Concentration","Eli Lilly and Company","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","200","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","17287|J1P-MC-KFAH|2020-003017-35","March 22, 2021","July 30, 2023","July 7, 2024","December 21, 2020",,"June 18, 2021","Dedicated Clinical Research, Litchfield Park, Arizona, United States|University of California - San Diego, La Jolla, California, United States|I.H.S. Health, LLC, Kissimmee, Florida, United States|Gastroenterology Associates of Pensacola, PA, Pensacola, Florida, United States|Atlantic Digestive Health Institute, Morristown, New Jersey, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Biopharma Informatic, Inc., Houston, Texas, United States|Southern Star Research Institute, LLC, San Antonio, Texas, United States|Care Access Research - Ogden, Ogden, Utah, United States|The Gastroenterology Group, P.C., Reston, Virginia, United States|DOM- Centro de Reumatologia, Caba, Buenos Aires, Argentina|Centro de Educación Médica e Investigaciones Clínicas ""Norberto Quirno"" CEMIC, Caba, Buenos Aires, Argentina|Mautalen Salud e Investigacion-Centro de Osteopatías Médicas, Ciudad Autonoma De Buenos Air, Buenos Aires, Argentina|Centro Médico Privado de Reumatología, Tucumán, Argentina|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Paratus Clinical Research Brisbane, Albion, Queensland, Australia|Mater Adult Hospital Brisbane, South Brisbane, Queensland, Australia|St Vincents Hospital Melbourne, Fitzroy, Victoria, Australia|Université Libre de Bruxelles - Hôpital Erasme, Brussels, Belgium|AZ Maria Middelares, Gent, Belgium|Centre Hospitalier de Wallonie picarde - CHwapi A.S.B.L., Tournai, Belgium|Chronos Pesquisa Clínica, Brasília, Distrito Federal, Brazil|Eurolatino Pesquisas Medicas Ltda., Uberlandia, Minas Gerais, Brazil|Nucleo de Pesquisa Clínica do Rio Grande do Sul-NPCRS, Porto Alegre, Rio Grande Do Sul, Brazil|HMCP - Hospital e Maternidade Celso Pierro - PUC-Campinas, Campinas, Sao Paulo, Brazil|Pesquisare, Santo Andre, Sao Paulo, Brazil|Instituto de Assistencia Medica ao Servidor Publico Estudo Estadual, Sao Paulo, SP, Brazil|Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP, Botucatu, São Paulo, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clinicos EPP Ltda, São Bernardo do Campo, São Paulo, Brazil|Hepatogastro, Sao Paulo, Brazil|Gastroenterology Research, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada|London Health Science Centre - Victoria Hospital, London, Ontario, Canada|TIDHI Innovation Inc., North York, Ontario, Canada|CISSS de la Montérégie - Centre Hôpital Charles-Le Moyne, Greenfield Park, Quebec, Canada|McGill University, Montreal, Quebec, Canada|The First Affiliated Hospital of Anhui Medical University, HefeiCity, Anhui, China|First affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China|The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China|Tongji Hosp Tongji Med Col Huazhong Univ of Sci & Tech, Wu Han, Hubei, China|Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China|Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China|Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China|Gregar s.r.o., Olomouc, Czechia|PreventaMed, s.r.o., Olomouc, Czechia|I. Interni klinika FN Plzen, Plzen-Lochotin, Czechia|A-Shine s.r.o., Plzen, Czechia|Nemocnice Slaný, Slany, Czechia|CHU De Grenoble Hopital Albert Michallon, Grenoble Cedex 09, France|Acad. F. Todua Medical Center - Research Institute of Clinical Medicine, Tbilisi, Georgia|Medical Center: Medinvestment, Tbilisi, Georgia|Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt am Main, Hessen, Germany|Medizinische Hochschule Hanover, Hannover, Niedersachsen, Germany|Studiengesellschaft BSF Unternehmergesellschaft haftungsbeschraenkt, Halle (Saale),, Sachsen Anhalt, Germany|Gastroenterologische Spezialpraxis, Berlin, Germany|Hamburgisches Forschungsinstitut fuer Chronisch Entzuendliche Darmerkrankungen, Hamburg, Germany|Clinexpert SMO, Budapest, Hungary|Obudai Egeszsegugyi Centrum Kft, Budapest, Hungary|Bugát Pál Kórház, Gyöngyös, Hungary|Clinfan Szolgaltato Kft., Szekszard, Hungary|Shree Giriraj Hospital, Rajkot, Gujarat, India|Midas Multispecilaity Hopsital Pvt Ltd, Ramdaspeth, Nagpur, India|S.R. Kalla Hospital, Jaipur, Rajasthan, India|Post Graduate Institute of Medical Education & Research, Chandigarh, India|Apollo Speciality Hospital, Chennai, India|Gujarat Hospital - Gastro and Vascular Centre, Gujarat, India|Gandhi Hospital, Telangana, India|Soroka Medical Center, Beer Sheva, Israel|Galilee Medical Center - Internal A, Nahariya, Israel|Kaplan Medical Center, Rehovot, Israel|Fukuoka University Chikushi Hospital, Chikushino-shi, Fukuoka-Ken, Japan|Tokushukai Sapporo Tokushukai Hospital, Sapporo-shi, Hokkaido, Japan|Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan|Sameshima Hospital, Kagoshima-shi, Kagoshima, Japan|Shinseikai Sai Gastroenterology, proctology, Fujiidera-shi, Osaka Fu, Japan|Kinshukai Infusion Clinic, Osaka-shi, Osaka-Fu, Japan|Matsuaikai Matsuda Hospital, Hamamatsu-shi, Shizuoka-Ken, Japan|Center Hospital of the National Center for Global Health and Medicine, Shinjuku-ku, Tokyo-To, Japan|Showa University Koto Toyosu Hospital, Koto-ku, Tokyo, Japan|Toyama Prefectural Central Hospital, Toyama-Shi, Toyama, Japan|Fukuoka University Hospital, Fukuoka, Japan|Yamagata University Hospital, Yamagata, Japan|Ajou University Hospital, Suwon-si, Gyeonggi-do, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Korea, Republic of|Seoul St. Mary's Hospital, Seoul, Korea, Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Gangwon-do, Korea, Republic of|Pauls Stradins Kliniska Universitates Slimnica, Riga, Latvia|Pauls Stradins Kliniska Universitates Slimnica, Riga, Latvia|Health Center 4, Affiliate Diagnostic Center, Riga, Latvia|Szpital Miejski Sw. Jana Pawla II, Elblag, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Vivamed, Warszawa, Poland|ETG Zamosc, Zamosc, Poland|SC Pelican SRL, Oradea, Bihor, Romania|SC Med Life SA, Bucuresti, Romania|SC Centrul Medical Sana SRL, Bucuresti, Romania|Spital Clinic Colentina, Bucuresti, Romania|Spitalul Clinic Judetean de Urgenta Cluj, Cluj-Napoca, Romania|S.C. Materna Care S.R.L., Timisoara, Romania|LLC Olla-Med, Moscow, Russian Federation|First Moscow State Medical University, Moscow, Russian Federation|Open Joint Stock Company Clinical and Diagnostic Center Euromedservice, Moscow, Russian Federation|LLC Novosibirsk GastroCenter, Novosibirsk, Russian Federation|The University Clinic of OSMU, Omsk, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|SPb SBIH ""City Mariinskaya Hospital"", Saint-Petersburg, Russian Federation|GOU VPO St-Petersburg SMA n/a Mechnikov Fed. Agen of Health, St. Petersburg, Russian Federation|FNsP FDRoosevelta Banska Bystrica, Banska Bystrica, Slovakia|ENDOMED s.r.o., Kosice, Slovakia|Medical Center of LLC Medical Center Clinic of Family Medicine, Dnipro, Ukraine|International Institute of Clinical Trials LLC, Kyiv, Ukraine|Medical Centre CONSILIUM MEDICAL, Kyiv, Ukraine|Communal Non-Commercial Enterprise of Lviv Regional Council Lviv Regional Clinical Hospital, Liviv, Ukraine|Lviv Clinical Hospital at Railway Transport of Division Healthcare Center PJSC Ukrainian Railway Sta, Lviv, Ukraine|Communal Enterprise ""Odesa Regional Clinical Hospital"", Odesa, Ukraine|A. Novak Transcarpathian Regional Clinical Hospital, Uzhgorod, Ukraine|CCH #1 Vinnytsia M.I. Pyrogov NMU Ch of Propaedeutics of IM, Vinnytsia, Ukraine|Vinnytsia War Veterans Regional Clinical Hospital, Vinnytsia, Ukraine|Diacenter LLC, Zaporizhzhia, Ukraine|Royal Derby Hospital, Derby, Derbyshire, United Kingdom|Whipps Cross University Hospital, Leytonstone, London, United Kingdom|York Hospital, York, North Yorkshire, United Kingdom|Guys/St. Thomas Hospital, London, Surrey, United Kingdom|St. George's University Hospitals NHS Foundation Trust, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04677179"
765,"NCT04659148","Surgical and Oncological Outcomes in Patients With Ulcerative Colitis-associated Rectal Cancer","UC-RectalK","Recruiting","No Results Available","Ulcerative Colitis|Rectal Cancer","Procedure: Total proctocolectomy","Surgical outcome|Oncological outcome","Istituto Clinico Humanitas","All","18 Years and older   (Adult, Older Adult)",,"40","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","2712-2020","October 1, 2020","January 30, 2021","April 1, 2021","December 9, 2020",,"December 9, 2020","Humanitas Research Hospital, Rozzano, MI, Italy|St. Mark's Hospital, Harrow, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04659148"
766,"NCT04630028","A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)","UNIFI Jr","Recruiting","No Results Available","Colitis, Ulcerative","Drug: Ustekinumab Dose Based on BSA and Body Weight|Drug: Matching Placebo","Global: Number of Participants with Clinical Remission at Induction Week 8 (I-8) Visit|Number of Participants with Adverse Events (AEs) as a Measure of Safety and Tolerability|Number of Participants with Serious Adverse Events (SAEs) as a Measure of Safety and Tolerability|Number of Participants with AEs Leading to Discontinuation of Study Intervention|Number of Participants with AEs of Special Interest (AESI) as a Measure of Safety and Tolerability|Number of Participants with Laboratory Abnormalities|Reactions Temporally Associated with an Intravenous (IV) Infusion and Subcutaneous (SC) Injection-site Reactions|Serum Concentration of Ustekinumab|US Specific: Clinical Remission at M-44 for Participants who are in Clinical Response at I-8|Number of Participants With Clinical Response at I-8 Visit|Number of Participants with Symptomatic Remission at I-8 Visit|Clinical Remission at I-8 as Assessed by the Pediatric Ulcerative Colitis Activity Index Score (PUCAI) Score|Endoscopic Improvement at I-8 Visit|Number of Participants with Clinical Remission at Week 44 (M-44) Visit|Number of Participants with Symptomatic Remission at M-44 Visit|Clinical Remission at M-44 as Assessed by the PUCAI Score|Endoscopic Improvement at M-44 Visit|Clinical Remission at M-44 and not Receiving Corticosteroids for at Least 90 Days Prior to M-44 Among Participants who Received Corticosteroids at M-0|Clinical Remission at M-44 for Participants who are in Clinical Remission at I-8|US Specific: Number of Participants with Clinical Remission at I-8 Visit","Janssen Research & Development, LLC","All","2 Years to 17 Years   (Child)","Phase 3","90","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","CR108865|2019-004224-38|CNTO1275PUC3001","March 15, 2021","July 24, 2025","July 24, 2025","November 16, 2020",,"June 18, 2021","Nemours DuPont Hospital for Children, Wilmington, Delaware, United States|Children's Center for Digestive Health Care, Atlanta, Georgia, United States|Mayo Clinic, Rochester, Minnesota, United States|Morristown Memorial Hospital, Morristown, New Jersey, United States|Cohen Children's Medical Center, Lake Success, New York, United States|Levine Children's at Atrium Health, Charlotte, North Carolina, United States|University Hospitals Case Medical Center Rainbow Babies and Childrens Hospital, Cleveland, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|Penn State Hershey Children's Hospital, Hershey, Pennsylvania, United States|Center For Digestive Health Systems-Greenville, Greenville, South Carolina, United States|Children's Medical Center of Dallas, Dallas, Texas, United States|Pediatric Specialists Of Virginia, Fairfax, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Universitair Kinderziekenhuis Koningin Fabiola, Brussel, Belgium|Cliniques Universitaires Saint-Luc, Brussel, Belgium|UZ Gent, Gent, Belgium|UZ Brussel, Jette, Belgium|UZ Leuven, Leuven, Belgium|Universitätsklinikum Aachen, Aachen, Germany|Charite-Universitätsmedizin Berlin - Berlin, Berlin, Germany|Universitatsklinikum Essen, Essen, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Dr. von Haunersches Kinderspital, Munich, Germany|KUNO Klinik St. Hedwig, Regensburg, Germany|Universitätsklinikum Ulm, Ulm, Germany|Semmelweis Egyetem, Budapest, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz, Miskolc, Hungary|Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz, Josa Andras Oktatokorhaz, Nyiregyhaza, Hungary|Szegedi Tudományegyetem, Gyermekgyógyászati Klinika és Gyermekegészségügyi Centrum, Szeged, Hungary|Juntendo University Hospital, Bunkyo-Ku, Japan|Gunma University Hospital, Gunma, Japan|Kindai University Nara Hospital, Ikoma, Japan|Kurume University Hospital, Kurume, Japan|Saitama Children's Medical Center, Saitama-shi, Japan|Miyagi Children'S Hospital, Sendai-shi, Japan|National Center for Child Health and Development, Setagaya-ku, Japan|Jichi Medical University Hospital, Shimotsuke, Japan|Mie University Hospital, Tsu, Japan|Szpital im. M. Kopernika, Gdansk, Poland|Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow, Poland|Gabinet Lekarski Bartosz Korczowski, Rzeszow, Poland|Szpital Pomnik Centrum Zdrowia Dziecka, Warszawa, Poland|Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw, Poland|Kazan State Medical University, Kazan, Russian Federation|Kemerovo Regional Clinical Hospital, Kemerovo, Russian Federation|Russian National Research Medical University named after N.I.Pirogov, Moscow, Russian Federation|FSBI 'Scientific Centre of Children Health' of the Russian Academy of Medical Sciences, Moscow, Russian Federation|Privolzhsky Research Medical University of Ministry of Health of Russian Federation, Nizhny Novgorod, Russian Federation|Saratov State Medical University, Saratov, Russian Federation|Yaroslavl Regional Children's Clinical Hospital, Yaroslavl, Russian Federation|Birmingham Children's Hospital, Birmingham, United Kingdom|Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom|Royal Hospital for Children and Young People, Edinburgh, United Kingdom|Royal London Hospital, London, United Kingdom|King's College Hospital, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04630028"
767,"NCT04624230","Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: tofacitinib","Remission by central read Mayo score following 44 weeks in the maintenance phase.|Response by Mayo score|Remission by Mayo score|Change from baseline in Mayo score.|Response measured by Partial Mayo Score|Change from baseline in Partial Mayo score|Response by PUCAI score|Change from baseline in PUCAI score|Percentage of Participants Achieving Endoscopic Improvement at Week 8, 16, and 44|Time to flare|Change from baseline in fecal calprotectin levels|Change from baseline in serum high sensitivity C-Reactive Protein (hsCRP) levels|Corticosteroid free remission by Partial Mayo Score|Average plasma concentration of tofacitinib (Cavg)|Evaluation of taste acceptability of tofacitinib oral solution, and acceptability of film coated tablet by choosing one of 5 choices|Peak (maximum) plasma concentration of tofacitinib (Cmax)|Percentage of Participants Achieving Endoscopic Remission at Week 8, 16, and 44|Remission by PUCAI score","Pfizer","All","2 Years to 17 Years   (Child)","Phase 3","120","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","A3921210|2018-002378-30|OVATION","June 18, 2021","July 14, 2026","October 3, 2028","November 10, 2020",,"June 4, 2021","Children's Hospital Los Angeles, Los Angeles, California, United States|University of California, San Francisco (Admin Only), San Francisco, California, United States|University of California, San Francisco Benioff Children's Hospital, San Francisco, California, United States|University of California, San Francisco Pediatric Clinical Research Center (PCRC), San Francisco, California, United States|Connecticut Children's Infusion Center, Farmington, Connecticut, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Nicklaus Children's Hospital, Miami, Florida, United States|Northwell Health - Cohen Children's Medical Center, Lake Success, New York, United States|Northwell Health - Cohen Children's Medical Center, New Hyde Park, New York, United States|Mount Sinai Hospital (Investigational Drug Pharmacy), New York, New York, United States|Mount Sinai Hospital Endoscopy Center (Endoscopy Only), New York, New York, United States|Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at Mount Sinai, New York, New York, United States|Texas Children's Hospital - Clinical Research Center, Houston, Texas, United States|Texas Children's Hospital - Wallace Tower, Houston, Texas, United States|Texas Children's Hospital - West Tower, Houston, Texas, United States|IWK Health Centre, Halifax, Nova Scotia, Canada|Aichi Children's Health and Medical Center, Obu-shi, Aichi, Japan|Kurume University Hospital, Kurume-shi, Fukuoka, Japan|Gunma University Hospital, Maebashi, Gunma, Japan|Miyagi Children's Hospital, Sendai-shi, Miyagi, Japan|Osaka Women's and Children's Hospital, Izumi, Osaka, Japan|Osaka Medical and Pharmaceutical University Hospital, Takatsuki-shi, Osaka, Japan|Saitama Children's Medical Center, Saitama-shi, Saitama, Japan|Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan|National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan|Osaka City University Hospital, Osaka, Japan",,"https://ClinicalTrials.gov/show/NCT04624230"
768,"NCT04613518","A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis",,"Recruiting","No Results Available","Colitis, Ulcerative","Drug: BMS-986165 Dose 1|Drug: BMS-986165 Dose 2|Other: Placebo Comparator","Proportion of participants in clinical response","Bristol-Myers Squibb","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","50","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","IM011-127|2019-004878-26|U1111-1245-2970","March 15, 2021","June 1, 2022","April 6, 2023","November 3, 2020",,"June 15, 2021","Local Institution, San Diego, California, United States|Local Institution, Shreveport, Louisiana, United States|Local Institution, New York, New York, United States|Cleveland Clinic-Gastroenterology, Cleveland, Ohio, United States|Local Institution, Oklahoma City, Oklahoma, United States|St Vincent's Hospital-Gastroenterology, Darlinghurst, New South Wales, Australia|Emeritus Research, Camberwell, Victoria, Australia|Local Institution, Edmonton, Alberta, Canada|Local Institution, Vaughan, Ontario, Canada|Charite Universitätsmedizin Berlin Campus Benjamin Franklin-Medizinische Klinik I für Gastroenterolo, Berlin, Brandenburg, Germany|Universitaetsklinikum Schleswig-Holstein Campus Kiel-Allgemeine Innere Medizin I, Kiel, Schleswig-Holstein, Germany|Local Institution, Dresden, Germany|Academisch Medisch Centrum-Inflammatory Bowel Disease, Amsterdam, Netherlands|UPR Medical Sciences Campus-UPR GI Research Unit, San Juan, Puerto Rico|Local Institution, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04613518"
769,"NCT04607837","Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis","GLADIATOR UC","Recruiting","No Results Available","Ulcerative Colitis","Drug: Etrasimod|Drug: Placebo","Proportion of Participants Achieving Clinical Remission as Assessed by Total Mayo Clinic Score|Proportion of Participants With Reduction From Baseline in Both Endoscopic Score and Rectal Bleeding or in Both Endoscopic Score and Stool Frequency|Proportion of Participants With Endoscopic Improvement|Proportion of Participants With Histologic Response as Assessed by Robarts Histopathology Index Score|Proportion of Participants With a Clinical Response as Assessed by Total Mayo Clinic Score|Proportion of Participants With Symptomatic Remission|Number and Severity of Adverse Events","Arena Pharmaceuticals","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","162","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","APD334-210|2020-003507-34","April 19, 2021","May 2023","May 2023","October 29, 2020",,"June 25, 2021","Gut P.C., dba Digestive Health Specialists, Dothan, Alabama, United States|Arizona Digestive Health, Sun City, Arizona, United States|Om Research LLC, Lancaster, California, United States|Gastrointestinal Biosciences Clinical Trials, LLC, Los Angeles, California, United States|United Medical Doctors, Murrieta, California, United States|ACRC Studies, San Diego, California, United States|Gastro Florida, Clearwater, Florida, United States|Gastro Florida, Clearwater, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|NSB Research, New Smyrna Beach, Florida, United States|Pediatric & Adult Research Center, Orlando, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|GCP Clinical Research, Tampa, Florida, United States|Guardian Angel Research Center, Tampa, Florida, United States|Florida Medical Clinic LLC, Zephyrhills, Florida, United States|Illinois Gastroenterology Group-Gurnee, Gurnee, Illinois, United States|Texas Digestive Disease Consultants d/b/a GI Alliance, Baton Rouge, Louisiana, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Great Lakes Medical Research, LLC, Mentor, Ohio, United States|Susquehanna Research Group, Harrisburg, Pennsylvania, United States|Rio Grande Gastroenterology, McAllen, Texas, United States|Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance, Southlake, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Gastro Health & Nutrition - Victoria, Victoria, Texas, United States|Blue Ridge Medical Research, Lynchburg, Virginia, United States|Washington Gastroenterology, Bellevue, Washington, United States|Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States|Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, United States|AZ Delta Roeselare Menen vzw, Roeselare, Belgium|Diagnostic-Consultative Center I - Sliven, EOOD, Sliven, Bulgaria|DCC ""Alexandrovska"", EOOD, Sofia, Bulgaria|Medical Centre MEDICA Plus OOD, Veliko Tarnovo, Bulgaria|Hepato-Gastroenterologie HK s.r.o., Hradec, Kralov, Czechia|Fakultni nemocnice Ostrava, Ostrava - Poruba, Czechia|ISCARE a.s., Praha 9, Czechia|Nemocnice Slany, Slany, Czechia|Centre Hospitalier Universitaire de Nantes - Hotel-Dieu, Nantes Cedex 1, France|Bugat Pal Korhaz, Gyongyos, Heves, Hungary|Endoexpert Egészségügyi Szolgáltató Kft., Budapest, Hungary|Ospedale San Bortolo di Vicenza, Vicenza, Italy|Yonsei University Wonju Severance Christian Hospital, Wonju, Gangwon-do, Korea, Republic of|Kyungpook National University Chilgok Hospital, Daegu, Gyeongsangbuk-do, Korea, Republic of|EuroMediCare Szpital Specjalistyczny z Przychodnia we Wroclawiu, Wroclaw, Dolnoslaskie, Poland|Amicare Sp. z o.o. Sp.k, Lodz, Lodzkie, Poland|IP Clinic, Lodz, Lodzkie, Poland|Allmedica Badania Kliniczne Sp. z.o.o. Sp.k., Nowy Targ, Malopolskie, Poland|Medicome Sp. z o.o, Oświęcim, Malopolskie, Poland|Centrum Medyczne Grunwald, Poznan, Weilkopolski, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Zachodnipomorskie, Poland|Hospital General Universitario de Alicante, Alicante, Spain|Hospital Universitario La Paz, Madrid, Spain",,"https://ClinicalTrials.gov/show/NCT04607837"
770,"NCT04596293","Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis",,"Not yet recruiting","No Results Available","Ulcerative Colitis","Drug: BBT-401-1S|Drug: Placebo","Clinical response rate|Clinical remission rate|Endoscopic remission rate","Bridge Biotherapeutics, Inc.|Covance","All","18 Years to 60 Years   (Adult)","Phase 2","36","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","BBT401-UC-005","January 31, 2021","December 31, 2021","February 28, 2022","October 22, 2020",,"November 6, 2020",,,"https://ClinicalTrials.gov/show/NCT04596293"
771,"NCT04576000","Identification of Biomarkers of Tofacitinib Therapy in Patients With Ulcerative Colitis","PROPHETIC","Recruiting","No Results Available","Ulcerative Colitis","Drug: Tofacitinib","Identify predictive fecal biomarkers that are associated with a change from baseline in UC-100 score|Identify predictive blood biomarkers that are associated with a change from baseline in UC-100 score|Identify predictive tissue biomarkers that are associated with a change from baseline in UC-100 score|Identify pharmacodynamic fecal biomarkers that are associated with a change from baseline in UC-100 score|Identify pharmacodynamic blood biomarkers that are associated with a change from baseline in UC-100 score|Identify pharmacodynamic tissue biomarkers that are associated with a change from baseline in UC-100 score|Identify a fecal biomarker signature as a surrogate measure for change from baseline in UC-100 score|Identify a blood biomarker signature as a surrogate measure for change from baseline in UC-100 score|Identify a tissue biomarker signature as a surrogate measure for change from baseline in UC-100 score|Identify whether colonic tissue pSTAT3 at week 8 and/or 16 correlates with change from baseline in UC-100 score|Evaluate long-term hospitalization rates, surgery rates, and corticosteroid use up to 2 years after initiation of tofacitinib therapy and identify baseline or early biomarker signatures associated with these long-term healthcare resource use outcomes|Measure adverse drug reactions, clinical, endoscopic, and histologic response and remission rates to tofacitinib in a ""real-world"" population","Alimentiv Inc.","All","18 Years and older   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","RP1907","August 25, 2020","March 2023","March 2023","October 5, 2020",,"October 5, 2020","UCSD, La Jolla, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Mayo Clinic, Rochester, Minnesota, United States|KU Leuven, Campus Gasthuisberg-IBD Studies, Leuven, Flemish Brabant, Belgium|Mount Sinai Hospital, Toronto, Ontario, Canada|Humanitas University, Hamanitas Research Hospital, Rozzano, Milan, Italy|Amsterdam Medical Center, IBD Center, Amsterdam, North Halland, Netherlands|IDIBAPS, Barcelona, Spain",,"https://ClinicalTrials.gov/show/NCT04576000"
772,"NCT04550130","Dose-Evaluation Study of the Efficacy and Safety of TLA Gut™ Leukapheresis Treatment in Patients With Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis (UC)","Device: TLA Gut™","Evaluate whether the intervention of TLA Gut™ reduces Human Leukocyte Antigen DR isotype (HLADRhi)|Evaluate the effect of intervention of TLA Gut™ on clinical, histopathology and laboratory criteria and variables|Evaluate the effect of intervention of TLA Gut™ on clinical variables|Evaluate the effect of intervention of TLA Gut™ on laboratory criteria","TLA, Targeted Immunotherapies AB","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","12","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","TLA002","April 2021","September 2021","March 2022","September 16, 2020",,"April 30, 2021","Ersta Sjukhus, Medicinkliniken, Stockholm, Sweden",,"https://ClinicalTrials.gov/show/NCT04550130"
773,"NCT04543994","Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)","UC","Recruiting","No Results Available","Ulcerative Colitis","Drug: Remestemcel-L|Other: Placebo","Treatment related adverse events|Clinical and endoscopic remission|Clinical and endoscopic response|Partial clinical and endoscopic response|Lack of response|Mayo clinic score","The Cleveland Clinic|Mesoblast, Inc.","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1|Phase 2","24","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","CCF-Stem Cells IBD-005","November 10, 2020","November 2023","November 2023","September 10, 2020",,"February 10, 2021","Cleveland Clinic, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT04543994"
774,"NCT04522843","Analysis of Intestinal Defensin Expression in Acute GVHD",,"Active, not recruiting","No Results Available","GVHD,Acute|Ulcerative Colitis|Morbus Crohn",,"Defensin Expression (mRNA)|Defensin Expression (peptide)","University of Freiburg","All","18 Years and older   (Adult, Older Adult)",,"80","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","GVHD_Def","September 1, 2018","September 1, 2021","September 1, 2021","August 21, 2020",,"August 25, 2020","Medical Center University of Freiburg, Freiburg, Baden-Württemberg, Germany",,"https://ClinicalTrials.gov/show/NCT04522843"
775,"NCT04508413","A Clinical Study to Assess the Affects of KB295 in Patients With Ulcerative Colitis (UC) on Gut Microbiota Structure and Function",,"Recruiting","No Results Available","Ulcerative Colitis","Other: KB295","Number of patients experiencing any treatment-emergent adverse events (TEAEs)|Number of patients experiencing discontinuations due to adverse events (AEs)","Kaleido Biosciences","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","30","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","K030-120","August 12, 2020","January 2021","April 2021","August 11, 2020",,"January 22, 2021","Atlantia Food Clinical Trials, Chicago, Illinois, United States|Atlantia Food Clinical Trials, Cork, Ireland",,"https://ClinicalTrials.gov/show/NCT04508413"
776,"NCT04505410","Xeljanz and Healthy Diet",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Tofacitinib|Other: Fast Mimicking Diet","Percentage of patients who achieved clinical response|Change in Fecal Calprotectin levels|Change in CRP levels","University of Miami|Pfizer","All","18 Years and older   (Adult, Older Adult)","Phase 3","76","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","20200436","November 18, 2020","October 15, 2023","October 15, 2023","August 10, 2020",,"February 9, 2021","The University of Miami, Miami, Florida, United States|Gastro Health, Miami, Florida, United States",,"https://ClinicalTrials.gov/show/NCT04505410"
777,"NCT04499495","Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea",,"Not yet recruiting","No Results Available","Ulcerative Colitis","Other: PENTASA (mesalamine/ 5-Aminosalicylic acid (5-ASA)","Changes in initial 3-months average daily dose of 5-ASA|Prescription patterns of 5-ASA|Non-response to 5-ASA by the average daily dose of 5-ASA|Ulcerative Colitis Related hospitalization by the average daily dose of 5-ASA|Ulcerative Colitis related surgery by the average daily dose of 5-ASA","Ferring Pharmaceuticals","All","15 Years and older   (Child, Adult, Older Adult)",,"15000","Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","000388","September 30, 2021","December 31, 2021","January 31, 2022","August 5, 2020",,"June 4, 2021",,,"https://ClinicalTrials.gov/show/NCT04499495"
778,"NCT04478825","Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: BBT-401-1S","Endoscopic remission rate|Endoscopic response rate","Bridge Biotherapeutics, Inc.|Covance","All","18 Years to 60 Years   (Adult)","Phase 1","6","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","BBT401-UC-004","October 30, 2020","April 30, 2021","June 30, 2021","July 21, 2020",,"November 5, 2020","P3 Research, Tauranga, New Zealand|P3 Research, Wellington, New Zealand",,"https://ClinicalTrials.gov/show/NCT04478825"
779,"NCT04457960","A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis",,"Recruiting","No Results Available","Healthy|Colitis, Ulcerative","Drug: JNJ-66525433|Drug: Placebo","Part 1, 2 and 3: Number of Participants with Treatment-emergent Adverse Events (TEAEs) as a Measure of Safety and Tolerability|Part 1, 2 and 3: Number of Participants with Vital Sign Abnormalities|Part 1, 2 and 3: Number of Participants with Physical Examination Abnormalities|Part 1, 2 and 3: Number of Participants with Hematology Laboratory Abnormalities|Part 1, 2 and 3: Number of Participants with Chemistry Laboratory Abnormalities|Part 1, 2 and 3: Number of Participants with Urinalysis Laboratory Abnormalities|Part 2 and 3: Number of Participants with Abnormalities in High Sensitivity C- Reactive Protein (hs-CRP)|Part 2 and 3: Number of Participants with Abnormalities in Fecal Calprotectin|Part 2 and 3: Incidence of Enteric Pathogens in Stool Samples|Part 1, 2 and 3: Number of Participants with Electrocardiogram (ECG) Abnormalities|Part 1, 2 and 3: Plasma Concentrations of JNJ-66525433|Part 1: Plasma Concentrations of JNJ-66525433 After Fasted or Fed Dosing|Part 3: Mayo Score|Part 3: Partial Mayo Score|Part 3: Endoscopic Subscore|Part 3: Inflammatory Bowel Disease Questionnaire (IBDQ) Total Score|Part 2 and 3: Target Engagement of Messenger Ribonucleic Acid (mRNA) Levels|Part 2 and 3: Tissue Biopsy JNJ-66525433 Concentrations|Plasma Concentrations of JNJ-66525433 After Two Meal Timing Conditions|Faecal Concentrations of JNJ-66525433 After Two Meal Timing Conditions","Janssen Research & Development, LLC","All","18 Years to 60 Years   (Adult)","Phase 1","140","Industry","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","CR108764|2018-003743-29|66525433IBD1001","July 1, 2020","April 20, 2022","June 11, 2023","July 7, 2020",,"May 4, 2021","Arensia Exploratory Medicine, Tbilisi, Georgia|Charité Research Organisation GmbH, Berlin, Germany|Arensia Exploratory Medicine - Clinical Republican Hospital, Chisinau, Moldova, Republic of",,"https://ClinicalTrials.gov/show/NCT04457960"
780,"NCT04424303","Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis","TOFAST","Recruiting","No Results Available","Ulcerative Colitis","Drug: Tofacitinib","Proportion of patients with clinical benefit 2 years after initiation of tofacitinib treatment.|Proportion of patients with clinical benefit of tofacitinib at 2 years, for those still receiving tofacitinib at 2 years.|Predictors of the clinical benefit at 2 years identified from the available baseline data|Proportion of patients in clinical remission and still receiving tofacitinib|Proportion of patients in clinical remission without corticosteroids (oral or topical with systemic effects for UC) at 1 year|Proportion of patients with short-term clinical response for patients still treated with tofacitinib|Proportion of patients with biological response during the observation period|Proportion of patients with mucosal healing during the observation period|Proportion of patients in sustained clinical remission|Time to loss of response to tofacitinib treatment in patients after dose reduction to 5 mg BID at the end of induction|Proportion of patients with extraintestinal manifestations at each visit|Proportion of patients with a colectomy during study follow-up and time of occurrence|Characteristics of patients and UC, on the basis of all the data collected at baseline|Description of the changes in the rectal bleeding and stool frequency subscores during the first 2 weeks after initiation of tofacitinib therapy|Change in patient quality-of-life evaluated from the SIBDQ questionnaire between baseline and 1 year, baseline and 2 years, and between 1 and 2 years|Change in adherence to tofacitinib treatment during each visit|Proportion of patients with serious and non-serious adverse events.","Pfizer","All","18 Years and older   (Adult, Older Adult)",,"280","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","A3921360|TOFAst study","December 7, 2020","June 30, 2024","November 30, 2024","June 9, 2020",,"April 19, 2021","Hopital Sud, Amiens, France|Infirmerie Protestante de Lyon, Caluire, France|Hopital Trousseau, Chambray Les Tours, France|Ch Emile Roux, Le Puy En Velay, France|Hopital Claude Huriez, Lille, France|Ch Saint Joseph Saint Luc, Lyon, France|Hopital Saint Eloi, Montpellier Cedex 5, France|Hopital de L'Archet, Nice, France|Hopital Caremeau, Nimes, France|Chu de Bordeaux - Hopital Haut Leveque, Pessac, France|CHU LYON, Pierre Benite, France|Ch Annecy Genevois, Pringy, France|Hopital Nord, St Priest En Jarez Cedex, France|Clinique Pasteur, Toulouse, France|Ch Valence, Valence, France|Ch Valenciennes, Valenciennes, France",,"https://ClinicalTrials.gov/show/NCT04424303"
781,"NCT04398550","SCD vs. Mediterranean Diet Therapy in Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Other: Specific Carbohydrate Diet|Other: Mediterranean Diet","Partial Mayo Clinic Score|Inflammatory Bowel Disease Questionnaire (IBDQ10)|Short Form (12) Health Survey (SF-12)|Simple Clinical Colitis Activity Index (SCCAI)|stool microbiome|fecal calprotectin|C-reactive protein","Massachusetts General Hospital","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","2020P000298","September 3, 2020","December 31, 2021","December 31, 2021","May 21, 2020",,"May 17, 2021","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04398550"
782,"NCT04373473","Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis",,"Recruiting","No Results Available","Adults With Ulcerative Colitis","Drug: PRIM-DJ2727|Drug: Placebos","Patients in remission after administering 12 weeks of PRIM-DJ2727 capsules will be measured by partial Mayo score ≤ 3|Quality of life will be characterized by health-related quality of life score.|Subject-reported score in Hospital Anxiety and Depression Scale","The University of Texas Health Science Center, Houston","All","18 Years and older   (Adult, Older Adult)","Phase 2","58","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","HSC-MS-20-0316","September 14, 2020","July 31, 2022","January 30, 2023","May 4, 2020",,"January 25, 2021","The University of Texas Health Science Center at Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT04373473"
783,"NCT04353791","Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis Chronic Moderate|Ulcerative Colitis Chronic Severe","Drug: OST-122|Drug: Placebo","Evaluate the safety of OST-122 administered for 28 days in subjects with active UC by assessing the number, severity, and type of adverse events|Study the incidence of clinically significant abnormalities in vital signs, electrocardiograms, (ECGs) and laboratory values during the treatment period|Cmax: Maximum plasma concentration for OST-122|Ctrough: Minimum plasma concentration for OST-122|Tmax: Time to reach maximum plasma concentration (Cmax) for OST-122|AUC: Area under the plasma-concentration time-curve|Percentage of subjects with improvement in Endoscopic Mayo Score|Percentage of subjects with improvement in PRO-2|Study the effect of OST-122 or placebo on faecal calprotectin levels|Effect of OST-122 or placebo on serum C-reactive protein levels|Study the change relative to baseline in JAK/STAT pathway activation in rectal/sigmoidal biopsies","Oncostellae S.L","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1|Phase 2","32","Industry","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","CT-OST-122-02","September 16, 2020","February 2022","April 2022","April 20, 2020",,"February 24, 2021","Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, A Coruña, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Universitari Doctor Josep Trueta, Girona, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Central de Asturias, Oviedo, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain",,"https://ClinicalTrials.gov/show/NCT04353791"
784,"NCT04340895","Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study)","OPTIMISE","Recruiting","No Results Available","Mild-to-moderate Ulcerative Colitis","Other: Faecal Calprotectin Home Test|Other: PRO-2 Scoring","Percentage of Participants with Mayo Endoscopic Sub-score = 0|Percentage of Participants with Rectal Bleeding = 0|Percentage of Participants with Stool Frequency <=1|Percentage of Participants with Mayo Endoscopic Sub-score <=1|Change in Short Inflammatory Bowel Disease Questionnaire (SIBDQ)|Change in Short Form Questionnaire-36 (SF-36)|Percentage of Participants Escalated to Rescue Therapy|Change in Work Productivity and Activity Impairment: Ulcerative Colitis (WPAI: UC) Questionnaire|Number of Hospitalization Days|Number of Outpatients Visits and Calls (Outside of Study Schedule)|Number of Ulcerative Colitis Related Procedures and/or Surgeries|Faecal Calprotectin Value Changes at the Defined Study Time Points (Interventional Arm Only)","Ferring Pharmaceuticals","All","18 Years and older   (Adult, Older Adult)","Not Applicable","240","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","7002661","October 14, 2019","April 2023","April 2023","April 10, 2020",,"April 14, 2021","Vojenska nemocnice Brno p.o., Brno, Czechia|Hepato-Gastroenterologie HK, s.r.o., Hradec Králové, Czechia|EGK s.r.o. - Sanatorium sv. Anny, Praha, Czechia|ISCARE IVF a.s., Praha, Czechia|Mediendo s.r.o., Praha, Czechia|KZ a.s. - Masaryk Hospital, Usti nad Labem, Czechia|Azienda Ospedaliero - Universitaria Pisana, Pisa, Italy|Jeroen Bosch Ziekenhuis, Den Bosch, Netherlands|Catharina Ziekenhuis, Eindhoven, Netherlands|Franciscus Gasthuis & Vlietland, Rotterdam, Netherlands|NZOZ Vitamed, Bydgoszcz, Poland|Szpital Uniwersytecki, Bydgoszcz, Poland|Osrodek Sadan Klinicznych CLINSANTE, Bydgoszcz, Poland|Centrum Medyczne LukaMed, Chojnice, Poland|Karkonoskie Centrum Bada Klinicznych - Lexmedica SP Z O O, Jelenia Góra, Poland|Korczowski Bartosz, Gabinet Lekarski, Rzeszow, Poland|H-T. Centrum Medyczne sp. z o.o., Tychy, Poland|Centralny Szpital Kliniczny Ministerstwa Spraw, Warszawa, Poland|Centrum Diagnostyczno Lecznicze Barska, Wloclawek, Poland|NZOZ Centrum Gastroenterologii w Wodzislawiu Slaskim, Wodzislaw Slaski, Poland|Melita Medical, Wrocław, Poland|SANTA FAMILIA Centrum Badan Profilaktyki i Leczenia, Łódź, Poland",,"https://ClinicalTrials.gov/show/NCT04340895"
785,"NCT04338204","Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden","ODEN","Recruiting","No Results Available","Ulcerative Colitis","Drug: tofacitinib","Proportion of Participants in Remission as Measured by Partial Mayo Score|Proportion of Participants who are taking tofacitinib|Proportion of Participants in Clinical Remission Based on Total Mayo Score|Proportion of Participants in Clinical Response Based on Total Mayo Score|Proportion of Participants in Clinical Remission Based on Partial Mayo Score|Proportion of Participants in Clinical Response Based on Partial Mayo Score|Proportion of Participants in Steroid-Free Clinical Remission|Change from Baseline in Total Mayo Score|Change From Baseline In Partial Mayo Score|Change From Baseline In Level of Fecal Calprotectin (f-calprotectin)|Proportion of Responders defined by a Fecal Calprotectin (f-calprotectin) Reduction of ≥50%, ≥75% or ≥90%|Change from Baseline of C-Reactive Protein (CRP)|Proportion of Participants In Sustained Remission (Partial Mayo score)|Proportion of Participants in Sustained Steroid Free Remission (Partial Mayo Score) (for all patients and for those treated with corticosteroids at baseline)|Proportion of Participants in Endoscopic Remission, Mucosal Healing or Endoscopic Response|Proportion of Participants in Sustained Endoscopic Remission, Mucosal Healing or Endoscopic Response|Proportion of Participants in Sustained Steroid Free Remission (Partial Mayo Score) (For All Participants and for Those Treated With Corticosteroids at Baseline) and Endoscopic Remission, Mucosal Healing or Endoscopic Response|Change From Baseline In Inflammatory Bowel Disease Fatigue (IBD-F) Score|Change From Baseline In EuroQol 5 Dimensions 5 Levels (EQ5D-5L)|Change From Baseline In Short Health Scale (SHS)|Proportion of Participants Who Had a Colectomy|Comparison of Response and Remission (Partial Mayo Score) Based on the Extent of Ulcerative Colitis According To the Montreal Classification|Proportion of Participants In Sustained Remission (Total Mayo score)|Proportion of Participants in Sustained Steroid Free Remission (Total Mayo Score) (For All Participants and for Those Treated With Corticosteroids at Baseline) and Endoscopic Remission, Mucosal Healing or Endoscopic Response|Proportion of Participants in Sustained Steroid Free Remission (Total Mayo Score) (for all patients and for those treated with corticosteroids at baseline)|Comparison of Response and Remission (Total Mayo Score) Based on the Extent of Ulcerative Colitis According To the Montreal Classification","Pfizer","All","18 Years to 99 Years   (Adult, Older Adult)",,"120","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","A3921366|ODEN","September 14, 2020","August 14, 2025","August 14, 2025","April 8, 2020",,"June 1, 2021","Medicinkliniken, Södra Älvsborgs Sjukhus Borås, Brämhultsvägen 53, Borås, Sweden|SU/Sahlgrenska, Gastroenterologi & Hepatologi, Göteborg, Sweden|Medicinkliniken, Länssjukhuset Ryhov, Sjukhusgatan, Jönköping, Sweden|Mag-Tarmmedicinska kliniken, Universitetssjukhuset i Linköping, Linköping, Sweden|Region skåne, Skånes Universitetssjukhus, Malmö, Sweden|Stockholm Gastro Center, Stockholm, Sweden|Ersta Sjukhus, Medicinkliniken, Fjällgatan 44, Stockholm, Sweden|Danderyds Hospital, Stockholm, Sweden|Medicinkliniken, Umeås Universitetssjukhus, Umeå, Sweden|Medicinmottagningen gastroenterologi, Västmanlands sjukhus, Västerås, Sweden",,"https://ClinicalTrials.gov/show/NCT04338204"
786,"NCT04332328","Study of Demographic and Dietary Profile in Patients With Ulcerative Colitis in Upper Egypt",,"Not yet recruiting","No Results Available","Diet in Ulcerative Colitis Patients","Dietary Supplement: Diet","Study of demographic and dietary profile in patients with ulcerative colitis in upper Egypt","Assiut University","All","Child, Adult, Older Adult",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","3032020","April 1, 2020","November 1, 2020","April 30, 2021","April 2, 2020",,"April 2, 2020",,,"https://ClinicalTrials.gov/show/NCT04332328"
787,"NCT04314375","Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis",,"Not yet recruiting","No Results Available","Ulcerative Colitis","Drug: Low Dose Budesonide|Drug: High Dose Budesonide|Drug: Placebo","The primary efficacy endpoint is the proportion of subjects who achieve clinical remission at Day 56, defined as a total Mayo score of ≤ 1 with subscores of 0 for both rectal bleeding and stool frequency, and a subscore of ≤ 1 for endoscopy.|Proportion of subjects who achieve a Mayo rectal bleeding subscale score of 0 at Day 56.|Proportion of subjects who achieve a Mayo stool frequency subscale score of 0 at Day 56.|Proportion of subjects who achieve a Mayo endoscopy subscale score of 0 or 1 at Day 56.","Bausch Health Americas, Inc.","All","5 Years to 17 Years   (Child)","Phase 4","70","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","BUUC4991","April 2021","June 2023","June 2023","March 19, 2020",,"September 16, 2020",,,"https://ClinicalTrials.gov/show/NCT04314375"
788,"NCT04312113","Angiographic Delivery of AD-MSC for Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Adipose derived, autologous mesenchymal stem cells","Number of participants with treatment-related adverse events|Number of participants with mucosal healing|Number of participants with clinical symptom response|Number of participants with improved healing on pathology","Mayo Clinic","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","19-000826","November 16, 2020","December 31, 2022","December 31, 2022","March 18, 2020",,"November 24, 2020","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT04312113"
789,"NCT04309058","Observation of the Effect of Vitamin D Supplementation on Chronic Course of Patients With Ulcerative Colitis Based on Vitamin D Receptor Fok I Gene Polymorphism",,"Not yet recruiting","No Results Available","Ulcerative Colitis|Vitamin D Deficiency|Vitamin D Supplement","Drug: Vitamin D drops","Genotype frequency of vitamin D receptor single nucleotide polymorphisms in participants|Serum 25 (OH) D level|Blood calcium and phosphorus|erythrocyte sedimentation rate|Concentration of C-reactive protein in participants","Second Affiliated Hospital of Wenzhou Medical University","All","Child, Adult, Older Adult","Early Phase 1","100","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","SAHoWMU-CR2017-01-121","March 2020","March 2021","March 2021","March 16, 2020",,"March 16, 2020","SAHWenzhouMU, Wenzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04309058"
790,"NCT04277546","Open-label Extension Study of Brazikumab in Ulcerative Colitis","Expedition","Enrolling by invitation","No Results Available","Ulcerative Colitis","Biological: Brazikumab","Percentage of participants with potentially clinically significant adverse events|Percentage of participants with potentially clinically significant Clinical Laboratory Values|Percentage of participants with potentially clinically significant physical examinations|Percentage of participants with potentially clinically significant vital signs|Percentage of participants with potentially clinically significant electrocardiograms|Percentage of participants with potentially clinically significant partial Mayo Score (pMS) assessments","AstraZeneca","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","150","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","D5272C00002|2019-004174-26","March 3, 2020","February 18, 2025","February 18, 2025","February 20, 2020",,"April 20, 2021","Research Site, Tucson, Arizona, United States|Research Site, Little Rock, Arkansas, United States|Research Site, Chula Vista, California, United States|Research Site, Lancaster, California, United States|Research Site, Los Angeles, California, United States|Research Site, Poway, California, United States|Research Site, Colorado Springs, Colorado, United States|Research Site, Clearwater, Florida, United States|Research Site, Kissimmee, Florida, United States|Research Site, Lakeland, Florida, United States|Research Site, Miami Lakes, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, New Port Richey, Florida, United States|Research Site, Tampa, Florida, United States|Research Site, Evansville, Indiana, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Beachwood, Ohio, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Uniontown, Pennsylvania, United States|Research Site, Houston, Texas, United States|Research Site, Bruges, Belgium|Research Site, Edegem, Belgium|Research Site, Kortrijk, Belgium|Research Site, Sofia, Bulgaria|Research Site, Gyöngyös, Hungary|Research Site, Szeged, Hungary|Research Site, Mysłowice, Poland|Research Site, San Juan, Puerto Rico|Research Site, Móstoles, Spain|Research Site, Salamanca, Spain",,"https://ClinicalTrials.gov/show/NCT04277546"
791,"NCT04276740","MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis","MARVEL","Not yet recruiting","No Results Available","Ulcerative Colitis Flare","Dietary Supplement: MitoQ|Other: Placebo","The proportions of subjects achieving clinical response at Week12|Clinical remission at week 12|Clinical response and remission based on Partial Mayo Score at Week 24|Longitudinal Analysis of Mucosal healing|Normalization of faecal calprotectin|Normalization of faecal haemoglobin|Proportions of participants with primary treatment failure with 24 week study period requiring change in medical treatment as below:","University of Edinburgh|JP Moulton Charitable Foundation|MitoQ","All","18 Years and older   (Adult, Older Adult)","Phase 2","206","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","AC19100","April 1, 2020","October 2, 2023","October 2, 2023","February 19, 2020",,"February 19, 2020",,,"https://ClinicalTrials.gov/show/NCT04276740"
792,"NCT04276649","Exploring the Effects of Caltrate Supplement on the Chronic Course of Ulcerative Colitis Patients With Vitamin D Deficiency",,"Not yet recruiting","No Results Available","Ulcerative Colitis|Vitamin D Deficiency|Vitamin D Supplement","Drug: Caltrate Pill","Serum 25 (OH) D level|White blood cell count|erythrocyte sedimentation rate|C-reactive protein","Second Affiliated Hospital of Wenzhou Medical University","All","Child, Adult, Older Adult","Early Phase 1","60","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","SAHoWMU-CR2020-01-103","October 2020","March 2021","March 2021","February 19, 2020",,"October 14, 2020","SAHWenzhouMU, Wenzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04276649"
793,"NCT04259138","Determination of the Optimal Treatment Target in Ulcerative Colitis","VERDICT","Recruiting","No Results Available","Colitis, Ulcerative","Biological: Treatment Algorithm A|Biological: Treatment Algorithm B|Biological: Treatment Algorithm C","Difference in Time to UC-related Complication Between Treatment Target Groups 1 and 3|Difference in Time to UC-related Complication Compared Between Treatment Target Groups 1 and 2.|Difference in Time to UC-related Complication Compared Between Treatment Target Groups 2 and 3.|Difference in Time to UC-related Complication Compared Between Treatment Target Groups (fast responder sub-group)|Difference in Time to Achieve Treatment Target|Fecal Calprotectin Levels|C-Reactive Protein Concentration","Alimentiv Inc.|Takeda Development Center Americas, Inc.","All","18 Years and older   (Adult, Older Adult)","Phase 4","660","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","RP1706|2019-002485-12","September 17, 2020","November 2024","November 2024","February 6, 2020",,"November 20, 2020","Asheville Gastroenterology Associates, PA, Asheville, North Carolina, United States|University of Calgary, Calgary, Alberta, Canada|GIRI (GI Research Institute), Vancouver, British Columbia, Canada|London Health Sciences Centre - University Campus, London, Ontario, Canada|Taunton Surgical Centre, Oshawa, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04259138"
794,"NCT04257084","Surveillance in Ulcerative Colitis: Narrow Band Image Versus Chromoendoscopy for High-risk Groups","SUNRISE-High","Not yet recruiting","No Results Available","Ulcerative Colitis|Dysplasia","Diagnostic Test: chromoendoscopy with target biopsy; NBI with target biopsy","Dysplasia detection rate at first surveillance|Neoplasia detection rate at first surveillance|Dysplasia detection rate at second surveillance|Neoplasia detection rate at second surveillance|SSL detection rate|Total procedure time|Withdrawal time|Endoscopic features of target-biopsied lesions|Procedure-related adverse events","Asan Medical Center|Yonsei University|Samsung Medical Center|Sungkyunkwan University|Ewha Womans University|The Catholic University of Korea|Soonchunhyang University Hospital","All","19 Years to 79 Years   (Adult, Older Adult)","Not Applicable","188","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Diagnostic","SUNRISE-High","December 2020","August 2022","January 2023","February 5, 2020",,"November 24, 2020",,,"https://ClinicalTrials.gov/show/NCT04257084"
795,"NCT04239521","The Epidemiology, Management, and the Associated Burden of Mental Health, Atopic and Autoimmune Conditions in Alopecia Areata",,"Not yet recruiting","No Results Available","Alopecia Areata|Depressive Episode|Recurrent Depressive Disorder|Anxiety Disorders|Atopic Dermatitis|Allergic Rhinitis|Asthma|Crohn Disease|Ulcerative Colitis|Pernicious Anemia|Type 1 Diabetes|Hashimoto Thyroiditis|Graves Disease|Rheumatoid Arthritis|Psoriatic Arthritis|Ankylosing Spondylitis|Systemic Lupus Erythematosus|Polymyalgia Rheumatica|Sjogren's Syndrome|Psoriasis|Vitiligo|Multiple Sclerosis|Celiac Disease","Other: Exposure of interest (studies 2 & 3).","Study 1: The incidence of Alopecia Areata|Study 1: The incidence of Alopecia Areata stratified by sociodemographic factors|Study 1:The annual rate of primary care visits for people with Alopecia Areata.|Study 1: The percent of people reviewed in secondary care dermatology services within one year of diagnosis of Alopecia Areata|Study 2: The prevalence of common mental health conditions in adult patients diagnosed with Alopecia Areata at the time of diagnosis|Study 2: Describe the incidence of common mental health conditions in adult patients with Alopecia Areata|Study 2: Describe the mental health medication treatment burden of adult patients diagnosed with Alopecia Areata.|Study 2: Number of patients diagnosed with Alopecia Areata receiving mental health psychological intervention.|Study 3: Describe the prevalence of atopic and autoimmune conditions in adult patients diagnosed with Alopecia Areata at the time of diagnosis|Study 3: Describe the incidence of atopic and autoimmune conditions in adult patients with Alopecia Areata.|Study 1: Adjusted incidence rate ratios of Alopecia Areata within England by geographic region.|Study 2: Prevalence (percentage) of common mental health conditions (depressive episodes, recurrent depressive disorder and anxiety disorder), by socio-demographic factors, in adult patients diagnosed with Alopecia Areata.|Study 2: Describe the burden of 'sick days' in adult patients diagnosed with Alopecia Areata relating to mental health conditions.|Study 2: Describe the prevalence of unemployment in adult patients diagnosed with Alopecia Areata.","Momentum Data|Pfizer|University of Surrey","All","Child, Adult, Older Adult",,"4000","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","P005","March 2020","March 2020","March 2020","January 27, 2020",,"January 28, 2020","Momentum Data Ltd, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04239521"
796,"NCT04231110","Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Ulcerative Colitis",,"Not yet recruiting","No Results Available","Ulcerative Colitis","Biological: Fecal microbiota transplantation","Clinical remission|Compliance|Clinical response|Endoscopic improvement|Fecal microbiome|Mucosal microbiome|Adverse events","McMaster University","All","18 Years and older   (Adult, Older Adult)","Phase 4","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","1001","May 1, 2021","March 30, 2022","June 30, 2022","January 18, 2020",,"February 24, 2021",,,"https://ClinicalTrials.gov/show/NCT04231110"
797,"NCT04223479","Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Probiotic Formula Capsule|Drug: Placebos","The level of Immunoglobulin (Ig) A|The level of Immunoglobulin (Ig) G|The level of Immunoglobulin (Ig) M|The Level of Interleukin (IL)-6|The Level of Interleukin (IL)-1|The Level of Interleukin (IL)-10|The Level of Tumor Necrosis Factor (TNF)-α|The Level of C-reactive protein (CRP)|Quality of Life of patients","University of Jordan","All","35 Years to 65 Years   (Adult, Older Adult)","Phase 2|Phase 3","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","2019/385","January 15, 2020","November 30, 2021","December 30, 2021","January 10, 2020",,"April 13, 2021","Jordan University Hospital, Amman, Jordan",,"https://ClinicalTrials.gov/show/NCT04223479"
798,"NCT04205643","CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Biological: CT-P13 SC (Infliximab)|Other: Placebo SC","Clinical remission","Celltrion","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 3","615","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","CT-P13 3.7|2019-003849-15","September 2, 2020","January 2022","January 2023","December 19, 2019",,"May 4, 2021","Centrum Zdrowia MDM, Warszawa, Poland",,"https://ClinicalTrials.gov/show/NCT04205643"
799,"NCT04197973","Association Between Self-reported Web-based SCCAI and Health-related Quality of Life Index in UC Patients","UC","Recruiting","No Results Available","Quality of Life|Ulcerative Colitis",,"Correlation between SCCAI and health-related quality of life (IBD-Q 32) in patient with UC|Correlation between self-administered SCCAI and SCCAI assessed by physician","YooJin Lee|Inje University|Gangnam Severance Hospital|Jeju National University Hospital|Soonchunhyang University Hospital|Keimyung University Dongsan Medical Center","All","18 Years to 65 Years   (Adult, Older Adult)",,"225","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2018-05-056","December 18, 2019","December 20, 2020","December 30, 2020","December 13, 2019",,"September 3, 2020","KeimyungUniversity, Daegu, Dalseo-gu, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT04197973"
800,"NCT04176588","A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis",,"Recruiting","No Results Available","Moderately to Severely Active Ulcerative Colitis","Drug: Etrasimod|Drug: Placebo","Proportion of Subjects With Clinical Remission Assessed by modified Mayo score(mMS)|Proportion of Subjects Achieving Endoscopic Improvement Assessed by endoscopic subscore|Proportion of Subjects with Clinical Response Assessed by modified Mayo score(mMS)|Proportion of Subjects who achieve symptomatic response over time|Proportion of Subjects who achieve Symptomatic Remission over time","Everstar Therapeutics Limited","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 3","333","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","ES101002","September 10, 2019","October 2022","November 2022","November 25, 2019",,"November 27, 2019","The First Affiliated Hospital of Fourth Military Medical University, PLA, Xi'an, Shanxi, China",,"https://ClinicalTrials.gov/show/NCT04176588"
801,"NCT04163016","A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)","CHERISH","Recruiting","No Results Available","Rheumatoid Arthritis|Psoriatic Arthritis|Crohn's Disease|Axial Spondyloarthritis|Plaque Psoriasis","Drug: Pharmacokinetics of certolizumab pegol","Predose and postdose plasma certolizumab pegol (CZP) concentrations in women during pregnancy, relative to postpartum|Plasma levels of anti-certolizumab pegol (CZP) antibodies throughout the study period|Adverse events from time of informed consent through Safety Follow-up (SFU)|Pregnancy outcome","UCB Biopharma S.P.R.L.|UCB Pharma","Female","18 Years and older   (Adult, Older Adult)","Phase 1","20","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","UP0085|2019-003410-13","June 19, 2020","August 2022","August 2022","November 14, 2019",,"May 21, 2021","Up0085 104, Minneapolis, Minnesota, United States|Up0085 103, Durham, North Carolina, United States|Up0085 101, Oklahoma City, Oklahoma, United States|Up0085 102, Houston, Texas, United States|Up0085 600, Toronto, Canada|Up0085 500, Paris, France|Up0085 202, Freiburg, Germany|Up0085 201, Hamburg, Germany|Up0085 800, Barcelona, Spain|Up0085 300, Bern, Switzerland",,"https://ClinicalTrials.gov/show/NCT04163016"
802,"NCT04148274","A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis|Ulcerative Colitis Chronic","Other: No intervention","Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing|Validation of Sequencing Methods","ProgenaBiome","All","Child, Adult, Older Adult",,"100","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","ProgenaBiome-016","March 2, 2020","March 2023","July 2023","November 1, 2019",,"April 8, 2021","ProgenaBiome, Ventura, California, United States",,"https://ClinicalTrials.gov/show/NCT04148274"
803,"NCT04133194","Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis","EASI","Recruiting","No Results Available","Ulcerative Colitis","Drug: Mesalazine","Medical Adherence|Assessment of disease activity by Mayo Score|Assessment of disease activity by the Simple clinical colitis activity index (SCCAI)|Assessment of endoscopic severity by the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)|Assessment of endoscopic severity by the Mayo endoscopic score|Assessment of histological severity by the Geboes score|Assessment of histological severity by the Nancy Index|Assessment of histological severity by the Robarts Histopathology Index (RHI)|Correlation between the different clinical scores|Remission - days|Relapse - days|Remission and relapse - episodes|Changes in quality of life|Changes in disease specific quality of life|Changes in disability among ulcerative colitis patients|Changes in sleep quality|Changes in resilience","Copenhagen University Hospital, Hvidovre","All","18 Years to 60 Years   (Adult)","Phase 4","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","1337-EASI-trial","November 28, 2019","September 2022","May 2023","October 21, 2019",,"February 5, 2020","Copenhagen University Hospital Hvidovre, Hvidovre, Denmark",,"https://ClinicalTrials.gov/show/NCT04133194"
804,"NCT04131530","Automatic Evaluation of Inflammation Activity in Ulcerative Colitis Using pCLE With Artificial Intelligence",,"Recruiting","No Results Available","Ulcerative Colitis|Artificial Intelligence|Confocal Laser Endomicroscopy","Diagnostic Test: The diagnosis of Artificial Intelligence and endoscopist","The diagnosis efficiency of Artificial Intelligence|Contrast the diagnosis efficiency of Artificial Intelligence with endoscopists","Shandong University","All","18 Years to 80 Years   (Adult, Older Adult)",,"60","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2019SDU-QILU-10","October 2019","December 2019","December 2019","October 18, 2019",,"October 18, 2019","Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China",,"https://ClinicalTrials.gov/show/NCT04131530"
805,"NCT04130919","Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis","Falcon","Active, not recruiting","No Results Available","Ulcerative Colitis","Drug: Tilpisertib|Drug: Placebo","Percentage of Participants who Achieve Clinical Remission per Modified MCS at Week 10|Percentage of Participants who Achieve Endoscopic Response at Week 10|Percentage of Participants who Achieve MCS Response at Week 10|Percentage of Participants who Achieve MCS Remission at Week 10|Percentage of Participants who Achieve Histologic Remission Based Upon the Geboes Scale at Week 10|Percentage of Participants Experiencing Adverse Events|Percentage of Participants Experiencing Laboratory Abnormalities","Gilead Sciences","All","18 Years and older   (Adult, Older Adult)","Phase 2","19","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","GS-US-365-4237|2019-001430-33","December 20, 2019","February 18, 2021","February 2022","October 18, 2019",,"May 4, 2021","Gut P.C., dba Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|Om Research LLC, Lancaster, California, United States|United Medical Doctors, Murrieta, California, United States|Alliance Clinical Research, Poway, California, United States|Alliance Medical Research, Coral Springs, Florida, United States|Encore Borland-Groover Clinical Research, Jacksonville, Florida, United States|A Plus Research, Inc, Miami, Florida, United States|BRCR Medical Center Inc., Plantation, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Gastrointestinal Specialists of Georgia, Marietta, Georgia, United States|Atlanta Gastroenterology Specialists, PC, Suwanee, Georgia, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Kansas City Research Institute, Kansas City, Missouri, United States|Advanced Biomedical Research of America, Las Vegas, Nevada, United States|Consultants for Clinical Research, Cincinnati, Ohio, United States|Gastroenterology Associates of Orangeburg, Orangeburg, South Carolina, United States|Vanderbilt University Medical Center - IBD Clinic, Nashville, Tennessee, United States|Allied Digestive Disease Center, Cypress, Texas, United States|Southwest Clinical Trials, Houston, Texas, United States|Clinical Associates in Research Therapeutics of America, LLC, San Antonio, Texas, United States|Texas Digestive Disease Consultants, San Marcos, Texas, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|Allegiance Research Specialists, LLC, Wauwatosa, Wisconsin, United States|Coastal Digestive Health, Maroochydore, Queensland, Australia|The Queen Elizabeth Hospital, Woodville, South Australia, Australia|St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|Emeritus Research, Melbourne, Victoria, Australia|Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin I, Innsbruck, Austria|Medizinische Universitat Wien Klinik fur Innere Medizin III/Abt. fur Gastroenterologie and Hepatologie, Vienna, Austria|Vancouver General Hospital - The Gordon and Leslie Diamond Health Care Centre, Vancouver, British Columbia, Canada|Hopital Beaujon, Clichy, France|CHU de Dijon Bourgogne, Dijon, France|Centre Hospitalier Universitaire de Grenoble Alpes, Grenoble, France|CHRU de Lille - Hôpital Claude Huriez, Lille, France|CHU de Lyon Sud, Pierre-Benite, France|CHRU Pontchaillou, Rennes, France|CHU de Saint Etienne, Saint-Etienne, France|Hopital Rangueil, Toulouse, France|CHRU de Nancy, Vandoeuvre-les-Nancy Cedex, France|Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik fur Innere Medizin I, Haus C, Haus K3, Kiel, Germany|Eugastro GmbH, Leipzig, Germany|Gastroenterologische Gemeinschaftspraxis Minden, Minden, Germany|Istituto Clinico Humanitas, Rozzano, Italy|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, Poland|""GASTROMED"" Kopon, Zmudzinski i Wsp. Sp. J. Spec. Centrum Gastrologii i Endoskopii, Spec. Gabinety Lekarskie, Torun, Poland|Centrum Medyczne Melita Medical, Wroclaw, Poland|Gastroenterologische Praxis Balsiger, Seibold & Partner/Crohn-Colitis-Zentrum, Bern, Switzerland|Inselspital Bern/Klinik fur Viszerale Chirurgie und Medizin/Bauchzentrum, Bern, Switzerland|Universitätsspital Zürich/Klinik für Gastroenterologie und Hepatologie, Zurich, Switzerland",,"https://ClinicalTrials.gov/show/NCT04130919"
806,"NCT04121806","Diet Intervention Treatment for Active Ulcerative Colitis",,"Recruiting","No Results Available","Colitis, Ulcerative","Other: UC intervention diet","Change in microbiome composition|Change in microbiome function|Decrease in endoscopic disease activity|Decrease in clinical disease activity","Mount Sinai Hospital, Canada|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","20","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","19-0112-A|3U01DK062423-18S1","March 1, 2021","September 30, 2022","September 30, 2022","October 10, 2019",,"May 13, 2021","Mount Sinai Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04121806"
807,"NCT04114292","TUDCA as a Therapy for Ulcerative Colitis (UC)","TUDCA","Recruiting","No Results Available","Ulcerative Colitis","Drug: Tauroursoursodeoxycholic acid, brand name Tudcabil","Determine the effect of TUDCA treatment on ER stress in colon biopsy tissues from subjects with symptomatic ulcerative colitis|Monitoring of UC patients for TUDCA safety and tolerability: Adverse events|Change ulcerative colitis disease activity based on Total Mayo Score|Change in inflammation on histology by Goebes index","Washington University School of Medicine|Crohn's and Colitis Foundation","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1","13","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","201812101","January 17, 2019","July 31, 2021","July 31, 2021","October 3, 2019",,"November 27, 2020","Barnes-Jewish West County Hospital, Creve Coeur, Missouri, United States|Barnes-Jewish Hospital, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/92/NCT04114292/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT04114292"
808,"NCT04102852","Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients","LGGinUC","Recruiting","No Results Available","Ulcerative Colitis Chronic Mild|Ulcerative Colitis Chronic Moderate","Dietary Supplement: Lactobacillus rhamnosus GG ATCC 53103","Change from baseline Clinical Mayo Score after treatment [Efficacy]|Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]|Mucosal Adhesion of LGG to Colonic Mucosa|Quality of Life Improvement","San Giovanni Addolorata Hospital|Onlus S. Andrea","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1|Phase 2","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","LGG/UC/001","September 30, 2019","September 2021","September 2021","September 25, 2019",,"April 19, 2021","S. Giovanni Addolorata Hospital, Roma, Italy",,"https://ClinicalTrials.gov/show/NCT04102852"
809,"NCT04096573","Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis",,"Not yet recruiting","No Results Available","Ulcerative Colitis","Drug: LC51-0255|Drug: Placebo","Clinical remission|Clinical response|Endoscopic improvement and remission","LG Chem","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","240","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","LG-SGCL002","April 2020","November 2021","August 2022","September 20, 2019",,"September 20, 2019",,,"https://ClinicalTrials.gov/show/NCT04096573"
810,"NCT04090411","A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Ulcerative Colitis",,"Recruiting","No Results Available","Moderate to Severe Ulcerative Colitis","Drug: 50 mg|Drug: 450 mg|Drug: 150 mg|Other: 0 mg","Proportion of participants achieving clinical remission (defined as a Total Mayo Score ≤2, with no individual subscore >1) at Week 14. Safety and tolerability will also be assessed|Incidence and severity of treatment emergent adverse events (TEAEs) during the induction period.|Incidence of serious adverse events (SAEs) during the induction period.|Incidence of AEs or SAEs leading to discontinuation during the induction period.|Incidence of clinically significant abnormalities in vital signs, electrocaridograms, (ECGs) and laboratory values during the induction period.|Proportion of participants achieving remission Food and Drug Administration, ((FDA) definition 1 - defined as endoscopic subscore = 0 or 1, stool frequency subscore = 0, and rectal bleeding subscore = 0) at Week 14.|Proportion of participants achieving remission (FDA definition 2 - defined as endoscopic subscore = 0 or 1, ≥1 point decrease from baseline to achieve a stool frequency subscore = 0 or 1, and rectal bleeding subscore = 0) at Week 14.|Proportion of participants achieving endoscopic improvement (defined as endoscopic subscore = 0 or 1) at Week 14.|Proportion of participants achieving endoscopic remission (defined as endoscopic subscore = 0) at Week 14.|PF 06480605 trough concentrations during the induction period through Week 14.|Change from baseline in fecal calprotectin during the induction period through Week 14.|Change from baseline in hsCRP during the induction period through Week 14.|Change from baseline in serum sTL1A during the induction period through Week 14.|Incidence of development of anti drug antibodies (ADAs) and neutralizing antibodies (NAbs) during the induction period through Week 14.","Pfizer","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","240","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","B7541007|TL1A|Tuscany 2|2019-002698-74","December 19, 2019","February 5, 2023","February 5, 2023","September 16, 2019",,"July 2, 2021","Dothan Surgery Center, Dothan, Alabama, United States|Flowers Hospital, Dothan, Alabama, United States|Gut P.C., dba Digestive Health Specialists, Dothan, Alabama, United States|Lynn Institute of the Ozarks, Little Rock, Arkansas, United States|Southern California Research Institute Medical Group, Inc., Los Angeles, California, United States|Surinder Saini, M.D., Inc., Newport Beach, California, United States|Front Range Endoscopy Center, Colorado Springs, Colorado, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Endoscopy Center of Connecticut, LLC, Guilford, Connecticut, United States|Endoscopy Center of Connecticut, LLC, Hamden, Connecticut, United States|Medical Research Center Of Connecticut, LLC, Hamden, Connecticut, United States|PACT Gastroenterology Center, Hamden, Connecticut, United States|Whitney Imaging, Hamden, Connecticut, United States|Medycal Research Inc., Brooksville, Florida, United States|Safety Harbor Surgery, Clearwater, Florida, United States|Trident Care, Clearwater, Florida, United States|Tower Radiology Center, Oldsmar, Florida, United States|Akumin, Tampa, Florida, United States|Tampa Bay Endoscopy Center, Tampa, Florida, United States|Alliance Clinical Research of Tampa, Tampa, Florida, United States|Atlanta Center for Gastroenterology, P.C., Decatur, Georgia, United States|Atlanta Endoscopy Center, LTD, Decatur, Georgia, United States|Gastroenterology Consultants P.C., Roswell, Georgia, United States|The University of Chicago Medical Center (clinic address), Chicago, Illinois, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Kentucky Good Samaritan Hospital, Lexington, Kentucky, United States|University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States|Brigham & Women's Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital - Office, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Michigan Endoscopy Center, Farmington Hills, Michigan, United States|Valley View Surgery Center, Las Vegas, Nevada, United States|Sierra Clinical Research, Las Vegas, Nevada, United States|Weill Cornell Medical College - New York Presbyterian Hospital, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|New York Presbyterian Hospital - Weill Cornell Medical Center, New York, New York, United States|Weill Cornell Medical College - New York Presbyterian Hospital, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Digestive Specialist, Inc. Digestive Endoscopy Center, LLC, Dayton, Ohio, United States|Dayton Outpatient Center, Dayton, Ohio, United States|META Medical Research Institute, Dayton, Ohio, United States|Digestive Specialists, Inc., Dayton, Ohio, United States|Digestive Specialist, INC. Digestive Endoscopy Center, LLC, Huber Heights, Ohio, United States|Digestive Specialist, Inc Digestive Endoscopy Center, LLC, Springboro, Ohio, United States|Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States|Greenville Endoscopy Center Patewood, Greenville, South Carolina, United States|Gastroenterology Associates, PA of Greenville, Greenville, South Carolina, United States|Vanderbilt Inflammatory Bowel Disease Clinic, Nashville, Tennessee, United States|Vanderbilt University Medical Center - GI Research Office, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Vanderbilt University Med. Center, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|PrimeCare Medical Group, Houston, Texas, United States|Elite Health Services, Houston, Texas, United States|Memorial Endoscopy Center, Houston, Texas, United States|Rio Grande Gastroenterology CNS, McAllen, Texas, United States|Victorium Clinical Research, San Antonio, Texas, United States|Gastroenterology Associates of Northern VA, Fairfax, Virginia, United States|Gastroenterology Associates of Northern Virginia, Fairfax, Virginia, United States|Verity Research, Inc., Fairfax, Virginia, United States|Medical Diagnostic Imaging, Wauwatosa, Wisconsin, United States|Allegiance Internal Medicine and Allegiance Research Specialists, Wauwatosa, Wisconsin, United States|GI Associates, Wauwatosa, Wisconsin, United States|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Mater Misericordiae Ltd., South Brisbane, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, Australia|University Hospitals Leuven/Department of Gastroenterology, Leuven, Belgium|AZ Nikolaas, Sint-Niklaas, Belgium|MC Vitadar Consult OOD, Ruse, Bulgaria|""Medical Center Hera"" EOOD, Sofia, Bulgaria|UMHAT ""Tsaritsa Ioanna-ISUL"" EAD, Sofia, Bulgaria|""MHAT - Doverie"" AD, Sofia, Bulgaria|""ACIBADEM City Clinic Diagnostic-Consultative Center"" EOOD, Sofia, Bulgaria|Asociacion IPS Medicos Internistas de Caldas, Manizales, Caldas, Colombia|Fundacion Santa Fe de Bogota, Bogota, Cundinamarca, Colombia|Hospital Universitario San Ignacio, Bogotá, Cundinamarca, Colombia|CHU d'Amiens-Picardie - SITE SUD, Amiens Cedex 1, France|Centre Hospitalier Regional Universitaire (CHU) de Lille - CIC, Lille Cedex, France|Centre Hospitalier Regional Universitaire (CHU) de Lille - Hopital Claude Huriez, Lille Cedex, France|Centre Hospitalier Regional Universitaire (CHU) de Lille, Lille Cedex, France|CHU Hôtel-Dieu, Nantes Cedex 1, France|Centre Hospitalier Lyon Sud, Pierre-Benite Cedex, France|Centre Hospitalier Universitaire de Lyon Sud, Pierre-Bénite Cedex, France|Deutsches Rotes Kreuz Schwesternschaft Berlin Gemeinnützige Krankenhaus GmbH, Berlin, Germany|Studiengesellschaft BSF UG (haftungsbeschränkt), Halle/Saale, Germany|DRC Gyogyszervizsgalo Kozpont Kft., Balatonfured, Veszprem, Hungary|Magyar Imre Kórház, Ajka, Hungary|Clinexpert Egészségügyi Szolgáltató és Kereskedelmi Kft., Budapest, Hungary|Clinfan Kft., Szekszard, Hungary|Life Egészségcentrum, Székesfehérvár, Hungary|Deák Jenő Kórház, Tapolca, Hungary|Clinexpert Tatabanya, Szent Borbala Hospital, Tatabanya, Hungary|Javorszky Odon Korhaz Gasztroenterologiai osztaly, Vac, Hungary|Shree Giriraj Multispeciality Hospital, Rajkot, Gujarat, India|Surat Institute of Digestive Sciences, Surat, Gujarat, India|Gujarat Hospital - Gastro and Vascular Centre, Surat, Gujarat, India|M.S. Ramaiah Medical College and Hospitals, Bangalore, Karnataka, India|Grant Medical Foundation, Ruby Hall Clinic, Pune, Maharashtra, India|Sahyadri Super Speciality Hospital, Pune, Maharashtra, India|S.R. Kalla Memorial Gastro & General Hospital, Jaipur, Rajasthan, India|S.M.S. Medical College & Hospital, Jaipur, Rajasthan, India|All India Institute of Medical Sciences (AIIMS), New Delhi, India|IRCCS ""Saverio de Bellis"", UOC Gastroenterologia, Castellana Grotte, Bari, Italy|Istituto Clinico Humanitas Centro per le Malattie Infiammatorie Croniche dell'Intestino - IBD Cent, Rozzano, Milan, Italy|Policlinico Universitario Campus Bio-Medico di Roma, Roma, RM, Italy|UO Malattie retto-Intestinali Ospedale ""Sacro Cuore-don Calabria"", Negrar Di Valpolicella, Verona, Italy|A.O.U. dell'Università degli Studi della Campania ""Luigi Vanvitelli"", Napoli, Italy|Azienda Ospedaliera di Padova - U.O.C. di Gastroenterologia, Padova, Italy|Aichi Medical University Hospital, Nagakute, Aichi, Japan|National Hospital Organization Hirosaki National Hospital, Hirosaki, Aomori, Japan|Toho University Sakura Medical Center, Sakura, Chiba, Japan|Kurume University Hospital, Kurume, Fukuoka, Japan|Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan|Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan|Iwate Medical University Uchimaru Medical Center, Morioka, Iwate, Japan|National Hospital Organization Sendai Medical Center, Sendai, Miyagi, Japan|Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Osaka, Japan|Tokyo Medical And Dental University, Medical Hospital, Bunkyo-ku, Tokyo, Japan|Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan|National Hospital Organization Tokyo Medical Center, Meguro-Ku, Tokyo, Japan|The Jikei University Hospital, Minato-ku, Tokyo, Japan|Keio University Hospital, Shinjuku-ku, Tokyo, Japan|Fukuoka University Hospital, Fukuoka, Japan|BRCR Global Mexico, Guadalajara, Jalisco, Mexico|Centro Multidisciplinario para el Desarrollo Especializado de la Investigacion, Merida, Yucatan, Mexico|Karla Adriana Espinosa Bautista, Ciudad de Mexico, Mexico|Smiq S. de R.L. de C.V., Queretaro, Mexico|LEXMEDICA Hanna Durbajlo-Gradziel, Wroclaw, Dolnoslaskie, Poland|KLIMED Marek Klimkiewicz, Bialystok, Poland|Szpital Uniwersytecki nr 2 im. J. Biziela, Centrum Endoskopii Zabiegowej, Poradnia Chorob Jelitowych, Bydgoszcz, Poland|Indywidualna Specjalistyczna Praktyka Lekarska Maciej Zymla, Knurow, Poland|ENDOSKOPIA Sp. z o. o., Sopot, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|NZOZ Vivamed Jadwiga Miecz, Warszawa, Poland|Centrum Diagnostyczno-Lecznicze Barska Sp. z o. o., Wloclawek, Poland|Centrum Medyczne Melita Medical, Wroclaw, Poland|EMC Instytut Medyczny Spolka Akcyjna EuroMediCare Szpital Specjalistyczny z Przychodnia, Wroclaw, Poland|Institutul Regional de Gastroenterologie - Hepatologie ""Prof. Dr. Octavian Fodor"" Cluj - Napoca, Cluj-Napoca, Jud Cluj, Romania|S.C. Cabinet Particular Policlinic Algomed SRL, Gastroenterologie, Timisoara, Timis, Romania|Medlife S.A., Bucuresti, Romania|Spitalul Clinic Colentina, Bucuresti, Romania|Spitalul Clinic ""Dr. I. Cantacuzino"", Medicina Interna II, Bucuresti, Romania|Institutul Clinic Fundeni, Centrul de Gastroenterologie si Hepatologie, Bucuresti, Romania|Pyatigorsk City Clinical Hospital, Pyatigorsk, Stavropol Region, Russian Federation|KDC ""Evromedservis"", OJSC, Moscow, Russian Federation|Limited Liability Company ""Medsanchast #14"" (LLC ""MSCh 14), Moscow, Russian Federation|Limited Liability Company ""Medicinsky Center SibNovoMed"", Novosibirsk, Russian Federation|LLC Novosibirskiy Gastrocenter, Novosibirsk, Russian Federation|Clinic of OSMU, Omsk, Russian Federation|Perm Clinical Centre of the Federal Medical-Biological Agency, Perm, Russian Federation|Private Healthcare Institution ""Clinical Hospital"" Russian Railways-Medicine ""Samara city"", Samara, Russian Federation|Clinical Hospital named after S.R. Mirotvortsev, Saratov, Russian Federation|Research Institute of Antimicrobial Chemotherapy, Smolensk, Russian Federation|Tomsk Regional Clinical Hospital, Tomsk, Russian Federation|City Hospital JSC ""Medical centre"", Tyumen, Russian Federation|SAHI TR ''Multidisciplinary consultative and diagnostic center"", Tyumen, Russian Federation|SBHI YaR ""Regional Clinical Hospital"", Yaroslavl, Russian Federation|Klinicko Bolnicki Centar Zvezdara, Klinika za Interne bolesti,, Beograd, Serbia|Klinicki Centar Kragujevac, Kragujevac, Serbia|Klinicki Centar Nis, Nis, Serbia|Opsta bolnica Subotica, Subotica, Serbia|Opsta Bolnica ""Djordje Joanovic"", Odeljenje Interno, Odsek Gastroenterologija, Zrenjanin, Serbia|Medak s.r.o., Bratislava, Slovakia|KM Management spol. s.r.o., Nitra, Slovakia|Gastro LM s.r.o, Presov, Slovakia|Endomed, s.r.o., Vranov nad Toplou, Slovakia|Dr van Dyk & Partners Inc, Bloemfontein, FREE State, South Africa|Iatros International, Bloemfontein, FREE State, South Africa|Universitas Private Hospital, Bloemfontein, FREE State, South Africa|Ahmed Kathrada Private Hospital, Johannesburg, Gauteng, South Africa|Lenasia Clinical Trial Centre, Johannesburg, Gauteng, South Africa|Arwyp Medical Centre, Kempton Park, Gauteng, South Africa|Clinresco Centres (Pty) Ltd, Kempton Park, Gauteng, South Africa|Emmed Research, Pretoria, Gauteng, South Africa|Radiology24 Jakaranda Hospital, Pretoria, Gauteng, South Africa|Mediclinic Kloof Hospital, Pretoria, Gauteng, South Africa|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Patumwan, Bangkok, Thailand|Songklanagarind Hospital, Prince of Songkla University, Hat Yai, Songkhla, Thailand|Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkoknoi, Thailand|Phramongkutklao Hospital, Bangkok, Thailand|Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand|Chiang Mai University, Chiang Mai, Thailand|Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand|Hacettepe Universitesi Tip Fakultesi, Ankara, Turkey|Bezmialem Vakif Universitesi Tip Fakultesi Hastanesi, Istanbul, Turkey|Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul, Turkey|Kocaeli Universitesi Tip Fakultesi, Ic Hastaliklari Anabilim Dali, Kocaeli, Turkey|Mersin Universitesi Tip Fakultesi Hastanesi, Mersin, Turkey|Bulent Ecevit Universitesi Tip Fakultesi, Zonguldak, Turkey|Municipal non-profit enterprise of Kharkiv regional council ""Regional clinical hospital"", Kharkiv, Ukraine|Municipal non-profit enterprise ""City clinical hospital #2 named after O.O.Shalimov"", Kharkiv, Ukraine|Medical Centre Medical Clinic Blagomed LLC, Kyiv, Ukraine|Municipal Non-profit Enterprise ""Kyiv City Clinical Hospital #1"", Kyiv, Ukraine|Municipal Non-profit enterprise of Kyiv Regional Council ""Kyiv regional hospital"", Kyiv, Ukraine|Municipal non-profit enterprise of Kyiv regional council ""Kyiv regional clinical hospital"", Kyiv, Ukraine|Medical center of Limited Liability Company ""Health Clinic"", medical clinical research center, Vinnytsia, Ukraine|Medical Centre ""DIACENTER"" LLC, Zaporizhzhia, Ukraine|University Hospitals Plymouth NHS Trust, Plymouth, Devon, United Kingdom|MeDiNova North London Quality Research Site, Northwood, Middlesex, United Kingdom|MeDiNova Northamptonshire Quality Research Site, Corby, United Kingdom|Egin Research Ltd, High Wycombe, United Kingdom|Chest X-ray Facility - BMI Bishops Wood Hospital, Northwood, United Kingdom|Spire Nottingham Hospital, Nottingham, United Kingdom|Endoscopy Facility - Orpington Endoscopy Centre, Orpington, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04090411"
811,"NCT04074590","Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis",,"Recruiting","No Results Available","Colitis, Ulcerative","Drug: LYS006|Drug: Placebo","Clinical remission rate at the end of Week 8|Number and severity of adverse events","Novartis Pharmaceuticals|Novartis","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","45","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","CLYS006X2202","February 3, 2020","August 18, 2023","August 18, 2023","August 30, 2019",,"June 30, 2021","Novartis Investigative Site, Downers Grove, Illinois, United States|Novartis Investigative Site, Brooklyn, New York, United States|Novartis Investigative Site, Sofia, Bulgaria|Novartis Investigative Site, Praha 19, Czech Republic, Czechia|Novartis Investigative Site, Zlin, Czech Republic, Czechia|Novartis Investigative Site, Havirov, Czechia|Novartis Investigative Site, Kiel, Schleswig- Holstein, Germany|Novartis Investigative Site, Berlin, Germany|Novartis Investigative Site, Budapest, Hungary|Novartis Investigative Site, Lorenskog, Oslo, Norway|Novartis Investigative Site, Nowy Targ, Malopolskie, Poland|Novartis Investigative Site, Piotrkow Trybunalski, Poland|Novartis Investigative Site, Poznan, Poland|Novartis Investigative Site, Novosibirsk, Russian Federation|Novartis Investigative Site, St Petersburg, Russian Federation|Novartis Investigative Site, Tomsk, Russian Federation|Novartis Investigative Site, Yekaterinburg, Russian Federation",,"https://ClinicalTrials.gov/show/NCT04074590"
812,"NCT04071405","Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients",,"Recruiting","No Results Available","Ulcerative Colitis","Other: Non-intervention","Incidence of Adverse Events|General efficacy by the investigator|Mayo or partial Mayo Score","Pfizer","All","18 Years and older   (Adult, Older Adult)",,"290","Industry","Observational","Observational Model: Case-Only|Time Perspective: Other","A3921343","May 12, 2020","September 19, 2022","September 19, 2022","August 28, 2019",,"June 16, 2021","Kyung Hee University Medical Center, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Severance Hospital Sinchon, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT04071405"
813,"NCT04064697","Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy","CYTOVEDO","Recruiting","No Results Available","Ulcerative Colitis, Unspecified","Drug: Valganciclovir","Clinical response|Clinical remission|Mucosal healing|Viral load CytoMegaloVirus (CMV)|clinical remission|Rate of colectomy|Adverse effects|viral load of the Torque teno virus","Centre Hospitalier Universitaire de Saint Etienne|Ministry of Health, France","All","18 Years and older   (Adult, Older Adult)","Phase 3","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","18PH192|2019-001032-54","April 22, 2021","July 2022","July 2023","August 22, 2019",,"May 4, 2021","CH d'Annecy, Annecy, France|CHU de Clermont-Ferrand, Clermont-Ferrand, France|CHU de Grenoble, Grenoble, France|CHU de Lyon Sud, Lyon, France|CHU de Montpellier, Montpellier, France|CHU de Nice, Nice, France|APHP - Hôpital Saint-Antoine, Paris, France|CHU de Saint Etienne, Saint-Étienne, France",,"https://ClinicalTrials.gov/show/NCT04064697"
814,"NCT04057547","Efficacy and Safety of Modified Gegen Qinlian Decoction for Ulcerative Colitis With Damp-heat Syndrome",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Modified Gegen Qinlian Decoction","Improved Mayo scale|The Clinical Global Impression of severity Scale ( CGI-S)|Improved Baron endoscopic scale of UC activity|Improved Truelove ＆ Witts scale|The Montreal classification of inflammatory bowel disease|The short form 36 (SF-36) health survey questionnaire|The scores of TCM(Traditional Chinese Medicine) syndrome","Xiyuan Hospital of China Academy of Chinese Medical Sciences","All","18 Years to 75 Years   (Adult, Older Adult)","Early Phase 1","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","81830018","April 1, 2019","July 1, 2019","December 31, 2023","August 15, 2019",,"October 15, 2019","Xiyuanhospital, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT04057547"
815,"NCT04034758","Safety and Efficacy of Heterologous FMT by SQIMC-md Capsule in Mild-moderate Ulcerative Colitis Patients","SQIMC-md","Not yet recruiting","No Results Available","Ulcerative Colitis","Procedure: Standardized Quantitative multi-donor Intestinal Microbiota Capsule (SQIMC-md)|Procedure: placebo capsule","Clinical response rate at week 8 after SQIMC-md treatment.|Incidence of Treatment-Emergent Adverse Events|clinical response rate at week4 and week12|the remission rate at week12|Mean (or median) decrease of fecal calprotectin|Mean (or median) change from baseline in Inflammatory Bowel Disease Questionnaire （IBDQ） total score and subscore at week 12","Tongji Hospital","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","99","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","2019CR209","August 30, 2019","December 31, 2023","December 31, 2023","July 26, 2019",,"August 13, 2019",,,"https://ClinicalTrials.gov/show/NCT04034758"
816,"NCT04033445","A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis","QUASAR","Recruiting","No Results Available","Ulcerative Colitis","Drug: Placebo|Drug: Guselkumab","Induction Study 1: Clinical Response at Week 12|Induction Study 2: Clinical Remission at Week 12|Maintenance Study: Clinical Remission at Week 44|Induction Study 1: Clinical Remission at Week 12|Induction Study 1: Symptomatic Remission at Week 12|Induction Study 1: Endoscopic Healing at Week 12|Induction Study 1: Histo-Endoscopic Mucosal Healing at Week 12|Induction Study 1: Endoscopic Normalization at Week 12|Induction Study 2: Symptomatic Remission at Week 12|Induction Study 2: Endoscopic Healing at Week 12|Induction Study 2: Clinical Response at Week 12|Induction Study 2: Histo-Endoscopic Mucosal Healing at Week 12|Induction Study 2: Symptomatic Remission at Week 4|Induction Study 2: Symptomatic Remission at Week 2|Induction Study 2: Endoscopic Normalization at Week 12|Maintenance Study: Symptomatic Remission at Week 44|Maintenance Study: Endoscopic Healing at Week 44|Maintenance Study: Corticosteroid-free Clinical Remission at Week 44|Maintenance Study: Clinical Response at Week 44|Maintenance Study: Histo-Endoscopic Mucosal Healing at Week 44|Maintenance Study: Clinical Remission at Week 44 Among the Participants Who had Achieved Clinical Remission at Maintenance Baseline|Maintenance Study: Endoscopic Normalization at Week 44","Janssen Research & Development, LLC","All","18 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","950","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","CR108657|2018-004002-25|CNTO1959UCO3001","September 26, 2019","June 29, 2022","December 29, 2025","July 26, 2019",,"June 9, 2021","Alabama Medical Group, Mobile, Alabama, United States|University of Arizona, Tucson, Arizona, United States|UC San Diego, La Jolla, California, United States|Om Research LLC, Lancaster, California, United States|UCLA, Los Angeles, California, United States|San Francisco Research Institute, San Francisco, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Florida Research Network, LLC, Gainesville, Florida, United States|University of Florida, Gainesville, Florida, United States|Harmony Medical Research Institute, Inc., Hialeah, Florida, United States|River City Clinical Research, Jacksonville, Florida, United States|UF Health Jacksonville Gastroenterology- Emerson, Jacksonville, Florida, United States|I.H.S. Health. LLC, Kissimmee, Florida, United States|San Marcus Research Clinic, Inc., Miami Lakes, Florida, United States|Columbus Clinical Services LLC, Miami, Florida, United States|Orlando Health, Orlando, Florida, United States|Synexus Clinical Research US, Inc, Pinellas Park, Florida, United States|Univ. of South Florida Med. Group, Tampa, Florida, United States|GCP Clinical Research, Tampa, Florida, United States|Alliance Clinical Research, Tampa, Florida, United States|Emory Clinic, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Atlanta Center For Gastroenterology, Decatur, Georgia, United States|Gastroenterolgy Associates of Central GA, Macon, Georgia, United States|University of Chicago, Chicago, Illinois, United States|Illinois Gastroenterology Institute, S.C., Peoria, Illinois, United States|Community Clinical Research Center, Anderson, Indiana, United States|IU Health University Hospital, Indianapolis, Indiana, United States|University of Iowa Health Care, Iowa City, Iowa, United States|Health Science Research Center, Pratt, Kansas, United States|Tri-State Gastroenterology Assoc, Crestview Hills, Kentucky, United States|CroNOLA, LLC, Houma, Louisiana, United States|Gastroenterologist Lafayette - Jacque F. Noel III MD, Lafayette, Louisiana, United States|Louisiana Research Center, Shreveport, Louisiana, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Capitol Research, Rockville, Maryland, United States|Lahey Hospital & Medical Center, Burlington, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Revive Research Institute, Farmington Hills, Michigan, United States|Minnesota Gastroenterology, P.A, Minneapolis, Minnesota, United States|Mid-America Gastro-Intestinal Consultants, Kansas City, Missouri, United States|Barnes-jewish Hospital, Saint Louis, Missouri, United States|Somnos Clinical Research, Lincoln, Nebraska, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|United Health Services Hospitals Office of Clinical Trials, Johnson City, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Duke University Hospital Medical Center, Raleigh, North Carolina, United States|Ohio State University Hospital, Columbus, Ohio, United States|Synexus Clinical Research US, Inc, Columbus, Ohio, United States|Great Lakes Medical Research, LLC, Westlake, Ohio, United States|Digestive Disease Specialists Inc, Oklahoma City, Oklahoma, United States|Synexus Clinical Research US, Inc, Anderson, South Carolina, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Gastroenterology Associates of Orangeburg, SC, Orangeburg, South Carolina, United States|Erlanger Health System, Chattanooga, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|The University of Texas at Austin, Austin, Texas, United States|Pinnacle Clinical Resesrch, Austin, Texas, United States|Inquest Clinical Research, Baytown, Texas, United States|Crescent Health Clinical, DeSoto, Texas, United States|El Paso Integrated Physicians Group, P.A., El Paso, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|GI Specialists of Houston, Houston, Texas, United States|Caprock Gastro Research, Lubbock, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Gastroenterology Associates of Tidewater, Chesapeake, Virginia, United States|Medical College Of Virginia Hospital, Richmond, Virginia, United States|UW-Harborview Medical Center, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States|Velocity Clinical Research Spokane, Spokane, Washington, United States|Providence Medical Group, Spokane, Washington, United States|Hospital de Clínicas José de San Martín, Buenos Aires, Argentina|CEMIC (Centro de Educación Médica e Investigaciones Clínicas), Buenos Aires, Argentina|Cer Instituto Medico, Buenos Aires, Argentina|Cinme - Centro De Investigaciones Metabolicas, Buenos Aires, Argentina|Hospital General de Agudos José Maria Ramos Mejía, Buenos Aires, Argentina|Expertia S.A, Caba, Argentina|Centro Médico Dra. De Salvo, Caba, Argentina|Clínica Adventista Belgrano, Ciudad De Buenos Aires, Argentina|Instituto Médico Elsa Pérez I.M.E.P, Ciudadela, Argentina|Sanatorio Duarte Quiroz, Cordoba, Argentina|Hospital de Alta Complejidad en Red 'El Cruce', Florencio Varela, Argentina|HIGA San Martin, La Plata, Argentina|Centro de Investigaciones Medicas Mar Del Plata, Mar Del Plata, Argentina|Fundación de Estudios Clínicos, Rosario, Argentina|Hospital Provincial del Centenario, Rosario, Argentina|CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica, San Juan, Argentina|Sanatorio 9 de Julio, San Miguel de Tucuman, Argentina|Centro Medico Privado de Reumatologia, San Miguel De Tucuman, Argentina|Sanatorio Vicente Lopez - La Torre, Vicente Lopez, Argentina|Southern Adelaide Health Network, Bedfford Park, Australia|Emeritus Research, Camberwell, Australia|Monash Health, Clayton, Australia|St Vincent's hospital, Darlinghurst, Australia|Western Health, Footscray, Australia|Frankston Gastrointestinal and Liver Specialists, Frankston, Australia|Austin Health, Heidelberg, Australia|Fiona Stanley Hospital, Murdoch, Australia|Royal Perth Hospital, Perth, Australia|Mater Hospital, South Brisbane, Australia|St John of God Subiaco Hospital, Subiaco, Australia|Princess Alexandra Hospital, Woolloongabba, Australia|Medizinische Universität Innsbruck, Innsbruck, Austria|Universitätsklinikum Salzburg - Landeskrankenhaus, Salzburg, Austria|Akh Wien, Vienna, Austria|AZ Sint-Lucas, Brugge, Belgium|Hopital Erasme, Brussels, Belgium|CHU Saint-Pierre, Bruxelles, Belgium|AZ Maria Middelares, Gent, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|Algemeen Ziekenhuis Jan Palfijn Merksem, Merksem, Belgium|Centre Hospitalier De Mouscron, Mouscron, Belgium|Algemeen Ziekenhuis Delta, Roeselare, Belgium|Hospital e Maternidade Celso Pierro, Campinas, Brazil|CDC - Centro Digestivo de Curitiba, Curitiba, Brazil|Eurolatino Pesquisas Medicas Ltda, Juiz de Fora, Brazil|Instituto Méderi de Pesquisa e Saúde, Passo Fundo, Brazil|Hospital de Clínicas de Porto Alegre/ HCPA / UFRGS, Porto Alegre, Brazil|NPCRS - Nucleo de Pesquisa Clinica do Rio Grande do Sul, Porto Alegre, Brazil|UFRJ-Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil|CLIAGEN - Clinica de Atencao em Gastroenterologia Especializada e Nutricao, Salvador, Brazil|Onco Star SP Oncologia Ltda, Sao Paulo, Brazil|CPQuali Pesquisa Clinica LTDA ME, São Paulo, Brazil|BR Trials, São Paulo, Brazil|Universidade Federal Do Piaui - Campos Universitario, Teresina, Brazil|Eurolatino Pesquisas Médicas, Uberlândia, Brazil|Medical Centre Asklepii OOD, Dupnitsa, Bulgaria|Medical Center-1-Sevlievo EOOD, Sevlievo, Bulgaria|2-nd MHAT, Sofia, Bulgaria|4th MHAT - Sofia, Sofia, Bulgaria|DCC Convex EOOD, Sofia, Bulgaria|Acibadem City Clinic - Oncology Center, Sofia, Bulgaria|MHAT 'St. Marina' EAD, Varna, Bulgaria|MHAT Dr Stefan Cherkezov, Veliko Tarnovo, Bulgaria|GIRI Gastrointestinal Research Institute, Vancouver, British Columbia, Canada|Health Sciences Centre, Winnipeg, Manitoba, Canada|Nova Scotia Health Authority, Halifax, Nova Scotia, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Toronto Immune & Digestive Health Institute Inc., Toronto, Ontario, Canada|Hopital Maisonneuve-Rosemont, Montréal, Quebec, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada|Capital Medical University, Beijing Friendship Hospital, Beijing, China|Peking University Third Hospital, Beijing, China|China-Japan Union Hospital of Jilin University, Changchun, China|The second Xiangya Hospital of Central South University, Changsha, China|The Third Xiangya Hospital of Central Sourth University, Changsha, China|West China Hospital of Sichuan University, Chengdu, China|Daping Hospital, Chongqing, China|The Second Hospital To Dalian Medical University, Dalian, China|First Affiliated Hospital of Gannan Medical University, Ganzhou, China|The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China|Sun Yat-sen University - The Sixth Affiliated Hospital Guangdong Gastrointestinal Hospital, Guangzhou, China|The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China|The Second Affiliated Hospital of Zhejiang University, Hangzhou, China|Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China|The 1st affiliated hospital of Anhui Medical University, Hefei, China|First Affiliated Hospital of Kunming Medical Unversity, Kunming, China|The First Affiliated Hospital of NanChang University, Nanchang, China|Nanjing Drum Tower Hospital, Nanjing, China|Zhongda Hospital,Southeast University, Nanjing, China|Jiangsu Province Hospital, Nanjing, China|Ruijing Hospital Affiliated To Shanghai Jiaotong University School Of Medicine, Shanghai, China|Shengjing Hospital of China Medical University, Shenyang, China|The Second Hospital Affiliated To Suzhou University, Suzhou, China|The first affiliated hospital of suzhou University, Suzhou, China|Tianjin Medical University General Hospital, Tianjin, China|Wuhan Union Hospital, Wuhan, China|Tongji Hospital, Tongji Medical College of HUST, Wuhan, China|Wuxi People's Hospital, Wuxi, China|Nemocnice Ceske Budejovice, a.s., Ceske Budejovice, Czechia|Asclepiades - interna a gastroenterologie s.r.o, Havirov, Czechia|MUDr. Gregar s.r.o., Olomouc, Czechia|Vitkovicka nemocnice a.s., Ostrava, Czechia|Artroscan s.r.o., Ostrava, Czechia|AXON Clinical s.r.o., Prague, Czechia|ResTrial GastroEndo, s.r.o, Praha 4, Czechia|Nemocnice na Homolce, Praha 5, Czechia|Klinicke centrum ISCARE, Praha 9, Czechia|Nemocnice Strakonice, a.s., Strakonice, Czechia|CHU caen, Caen, France|Hôpital Beaujon, Clichy, France|CHRU de Lille - Hôpital Claude Huriez, Lille, France|Hopital Saint Eloi, Montpellier, France|CHU Hotel Dieu, CIC IMAD, Nantes, France|CHU de Nice Hopital de l Archet, Nice Cedex 3, France|Hopital Saint Antoine, Paris, France|Hopital Haut-Leveque, CMC Magellan, Pessac, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, France|CHU Reims, Reims, France|CHU Saint-Etienne - Hôpital Nord, Saint-Priest en Jarez, France|CHRU Hôpital de Hautepierre, Strasbourg Cedex, France|CHU Rangueil, Toulouse, France|CHRU Nancy-Brabois, Vandoeuvre-les-Nancy, France|Universitaetsklinikum Charite, Campus Virchow Klinikum, Berlin, Germany|Universitätsklinikum Carl-Gustav-Carus Dresden, Dresden, Germany|BSF Studiengesellschaft, Halle, Germany|Hamburgisches Forschungsinstitut fuer CED, HaFCED e.K., Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitaetsklinikum Heidelberg, Heidelberg, Germany|Praxisgemeinschaft Jerichow, Jerichow, Germany|Evangelisches Krankenhaus Kalk, Köln, Germany|Städtisches Klinikum Lüneburg, Lueneburg, Germany|Zentrum für Gastroenterologie Saar MVZ GmbH, Saarbrücken, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Germany|Universitaetsklinikum Ulm, Ulm, Germany|Synexus Magyarorszag Kft., Budapest, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Semmelweis Egyetem, Ii. Belgyogyaszati Klinika, Budapest, Hungary|Vasutegeszsegugyi Nonprofit Kozhasznu Kft Debreceni Kozpont, Debrecen, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Bugat Pal Korhaz, Gyongyos, Hungary|Synexus Magyarorszag Kft, Gyula, Hungary|Szegedi Tud.Egyetem Szent-Gyorgyi Albert Klin. Közp., Szeged, Hungary|St Vincent's University Hospital, Dublin 4, Ireland|Beaumont Hospital, Dublin, Ireland|University Hospital Galway - Ireland, Galway, Ireland|Haemek Medical Center - Afula, Afula, Israel|Rambam Medical Center, Haifa, Israel|Bnai Zion Medical Center, Haifa, Israel|Wolfson Medical Center, Holon, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah Hebrew University Medical Center, Jerusalem, Israel|Lev Talpiot Clinic, Jerusalem, Israel|Galilee Medical Center, Naharia, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Policlinico Sant'Orsola Malpighi, Bologna, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy|Ospedale Classificato Equiparato Sacro Cuore Don Calabria di Negrar, Negrar ( Ve), Italy|Azienda Ospedaliera di Padova, Padova, Italy|Ospedale Villa Sofia-Cervello, Palermo, Italy|Azienda Ospedaliera G.Salvini Ospedale di Rho, RHO, Italy|Università Campus Biomedico di Roma, Roma, Italy|Fondazione Policlinico Gemelli Università Cattolica, Roma, Italy|Istituto Clinico Humanitas Rozzano, IRCCS, Rozzano, Italy|Casa Sollievo della Sofferenza, IRCCS, San Giovanni Rotondo, Italy|AO Ordine Mauriziano, Torino, Italy|Tokyo Medical and Dental University Medical Hospital, Bunkyo-Ku, Japan|The Jikei University Kashiwa Hospital, Chiba, Japan|Juntendo University Hospital Urayasu, Chiba, Japan|Fukuoka University Chikushi Hospital, Chikushino, Japan|Ehime Prefectural Central Hospital, Ehime, Japan|Sai Clinic, Gastrointestinal and Protology Divisions, Fujiidera-shi, Japan|Kitakyushu Municipal Medical Center, Fukuoka-ken, Japan|Fukuoka University Hospital, Fukuoka, Japan|Fukushima Medical University Hospital, Fukushima, Japan|Gifu University Hospital, Gifu, Japan|Hachinohe City Hospital, Hachinohe, Japan|Tokai University Hachioji Hospital, Hachioji, Japan|Hakodate Goryokaku Hospital, Hakodate, Japan|Hirosaki National Hospital, Hirosaki, Japan|Hirosaki University Hospital, Hirosaki, Japan|Kure Kyosai Hospital, Hiroshima, Japan|Asahikawa Medical University Hospital, Hokkaido, Japan|Mito Saiseikai General Hospital, Ibaraki, Japan|Shimane University Hospital, Izumo, Japan|Kagawa Prefectural Central Hospital, Kagawa, Japan|Kagoshima University Hospital, Kagoshima City, Japan|Imamura General Hospital, Kagoshima, Japan|Izuro Imamura Hospital, Kagoshima, Japan|Sameshima Hospital, Kagoshima, Japan|St.Marianna University School of Medicine, Kanagawa, Japan|Matsushima Clinic, Kanagawa, Japan|Kanazawa University Hospital, Kanazawa, Japan|National Hospital Organization Kanazawa Medical Center, Kanazawa, Japan|Nara Medical University Hospital, Kashihara, Japan|Medical corporation Kokikai Tsujinaka Hospital Kashiwanoha, Kashiwa, Japan|Kyushu Rosai Hospital, Kitakyushu, Japan|Aoyama Naika Clinic, Kobe, Japan|Kobe University Hospital, Kobe, Japan|Kochi National Hospital, Kochi, Japan|Yamanashi Prefectural Central Hospital, Kofu, Japan|National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan|University Hospital Kyoto Perfectural University of Medicine, Kyoto, Japan|National Hospital Organization Matsumoto Medical Center, Matsumoto, Japan|Kitasato University Kitasato Institute Hospital, Minato-ku, Japan|Kyorin University Hospital, Mitaka, Japan|Takagi Clinic, Miyagi, Japan|Osaki Citizen Hospital, Miyagi, Japan|Iwate Medical University Hospital, Morioka, Japan|Nagoya University Hospital, Nagoya, Japan|Nagoya City University Hospital, Nagoya, Japan|Nagaoka Chuo General Hospital, Niigata, Japan|The Hospital of Hyogo College of Medicine, Nishinomiya, Japan|Oita Red Cross Hospital, Oita, Japan|Shinbeppu Hospital, Oita, Japan|Nakagami Hospital, Okinawa, Japan|Kindai University Hospital, Osaka-Sayama, Japan|Japanese Red Cross Osaka Hospital, Osaka, Japan|Osaka City University Hospital, Osaka, Japan|Higashiosaka City Medical Center, Osaka, Japan|Izumiotsu Municipal Hospital, Osaka, Japan|Japan Community Health Care Organization Saitama Medical Center, Saitama, Japan|Toho University Sakura Medical Center, Sakura, Japan|Sapporo Tokushukai Hospital, Sapporo, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital, Sapporo, Japan|Sapporo Medical University Hospital, Sapporo, Japan|Sapporo Higashi Tokushukai Hospital, Sapporo, Japan|National Hospital Organization Higashi Ohmi General Medical Center, Shiga, Japan|Tokyo Yamate Medical Center, Shinjuku-ku, Japan|Matsuda Hospital, Shizuoka, Japan|Tokushima University Hospital, Tokushima, Japan|The Jikei University Hospital, Tokyo, Japan|Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan|National Hospital Organization Tokyo Medical Center, Tokyo, Japan|Mie University Hospital, Tsu, Japan|Yokkaichi Hazu Medical Center, Yokkaichi, Japan|Yokohama Municipal Citizen&#39;s Hospital, Yokohama, Japan|University of Fukui Hospital, Yoshida, Japan|Prince Hamza Hospital, Amman- Tareq, Jordan|Jordan University Hospital, Amman, Jordan|Istishari Hospital, Amman, Jordan|Khalidi Hospital and Medical Center, Amman, Jordan|King Abdullah University Hospital, Irbid, Jordan|Korea University Ansan Hospital, Ansan-si, Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Yeungnam University Medical Center, Daegu, Korea, Republic of|Gachon University Gil Medical Center, Incheon, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of|Kyung Hee University Medical Center, Seoul, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of|Chung-Ang University Hospital, Seoul, Korea, Republic of|The Catholic University of Korea St. Vincent's Hospital, Suwon-si, Korea, Republic of|Ajou University Hospital, Suwon, Korea, Republic of|Pauls Stradins Clinical University Hospital, Riga, Latvia|Pauls Stradins Clinical University Hospital, Riga, Latvia|Health Centre 4 Centre of Diagnostics, Riga, Latvia|Digestive Diseases Centre GASTRO, Riga, Latvia|Hospital Serdang, Kajang, Malaysia|Hospital University Sains Malaysia, Kelantan, Malaysia|Pusat Perubatan Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia|University Malaya Medical Centre, Kuala Lumpur, Malaysia|Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands|Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands|Radboudumc, Nijmegen, Netherlands|Jeroen Bosch Ziekenhuis, S-Hertogenbosch, Netherlands|Auckland City Hospital, Auckland, New Zealand|Christchurch Hospital, Christchurch, New Zealand|Dunedin Hospital, Dunedin, New Zealand|Waikato Hospital, Hamilton, New Zealand|Gastromed Kralisz Romatowski Stachurska Sp. j., Bialystok, Poland|Szpital Uniwersytecki nr 2 im. dr. Jana Biziela w Bydgoszczy, Bydgoszcz, Poland|Centrum medyczne plejady, Krakow, Poland|Centrum Medyczne Promed, Krakow, Poland|Centrum Medyczne Szpital św. Rodziny, Lodz, Poland|Gastromed ZOZ, Lublin, Poland|Medicome Sp z o.o., Oswiecim, Poland|Centrum Medyczne Medyk, Rzeszow, Poland|Endoskopia Sp z o.o., Sopot, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, Poland|GASTROMED Kopon, Zmudzinski i wspolnicy SP.j., Specjalistyczne Centrum Gastrologii i Endoskopii, Torun, Poland|H-T Centrum Medyczne Endoterapia, Tychy, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Centralny Szpital Kliniczny Mswia, Warszawa, Poland|NZOZ Vivamed, Warszawa, Poland|Wojskowy Instytut Medyczny, Warszawa, Poland|Melita Medical Sp. z o.o., Wroclaw, Poland|Centrum Zdrowia WroMedica, Wroclaw, Poland|ETG Zamosc, Zamosc, Poland|Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal|Centro Hospitalar do Porto, EPE, Porto, Portugal|Centro Hospitalar de São João, EPE, Porto, Portugal|Centro Hospitalar de Entre o Douro e Vouga, E.P.E, Santa Maria da Feira, Portugal|Centro Hospitalar de Tondela Viseu, EPE, Viseu, Portugal|LLC Evimed, Chelyabinsk, Russian Federation|Chelyabinck Regional Clinical Hospital, Chelyabinsk, Russian Federation|Medical Center Meditsinskie Tekhnologii, Ekaterinburg, Russian Federation|OOO MO New Hospital, Ekaterinburg, Russian Federation|Irkutsk State Medical Academy of Postgraduate Education, Irkutsk, Russian Federation|Immanuel Kant Baltic Federal University, Kaliningrad, Russian Federation|Kazan State Medical University, Kazan, Russian Federation|Kemerovo Regional Clinical Hospital, Kemerovo, Russian Federation|GUZ of Moscow City Clinical Hospital #24, Moscow, Russian Federation|Road Clinical Hospital at the Nizhny Novgorod Station of the Russian Railways, Nizhniy Novgorod, Russian Federation|Medical Center SibNovoMed LLC, Novosibirsk, Russian Federation|LLC 'Novosibirsk Gastrocentr', Novosibirsk, Russian Federation|Budgetary Healthcare Intitution of Omsk Region, Omsk, Russian Federation|City Clinical Hospital #2, Perm, Russian Federation|Rostov State Medical University, Rostov-On-Don, Russian Federation|Rostov State Medical University, Rostov-On-Don, Russian Federation|Elizavetinskaya hospital, Saint Petersburg, Russian Federation|All-Russian Center of Emergency and Radiation Medicine MCRS, Saint-Petersburg, Russian Federation|Eco-safety Ltd, Saint-Petersburg, Russian Federation|Medical University Reaviz, Samara, Russian Federation|NUZ 'Railway Clinical Hospital on Samara station of LLC 'Russian Railways', Samara, Russian Federation|Regional Hospital of War Veterans, Saratov, Russian Federation|International Medical Centre SOGAZ, St-Petersburg, Russian Federation|Regional Clinical Hospital, Tver, Russian Federation|GBUZ Respublican Clinical Hospital n.a. GG Kuvatova, Ufa, Russian Federation|City Clinical Hospital # 21, Ufa, Russian Federation|Ulyanovsk Regional Clinical Hospital, Ulyanovsk, Russian Federation|Regional Clinical Hospital, Yaroslavl, Russian Federation|University Clinical Hospital Center Dr Dragisa Misovic- Dedi, Belgrade, Serbia|Zvezdara University Medical Center, Belgrade, Serbia|General Hospital Sombor, Sombor, Serbia|General Hospital Dr Djordje Joanovic, Zrenjanin, Serbia|FNsP F.D.R. Banska Bystrica, Banska Bystrica, Slovakia|Gastroenterology Department GASTROMART s.r.o., Bardejov, Slovakia|Gastroenterology Center ASSIDUO, Bratislava, Slovakia|University Hospital in Bratislava, Ruzinov Hospital, Bratislava, Slovakia|University Hospital in Bratislava, St. Cyril and Method Hospital, Bratislava, Slovakia|ENDOMED s.r.o, Kosice, Slovakia|GASTRO I. s.r.o., Presov, Slovakia|Accout Center, s.r.o., Gastroenterologická ambulancia, Sahy, Slovakia|Hosp. Univ. Germans Trias I Pujol, Badalona, Spain|Hosp. Clinic I Provincial de Barcelona, Barcelona, Spain|Hosp. Univ. Dr. Josep Trueta, Girona, Spain|Hosp. Univ. La Paz, Madrid, Spain|Hosp. Univ. Marques de Valdecilla, Santander, Spain|Hosp. Virgen Del Rocio, Sevilla, Spain|Hosp. Ntra. Sra. de Valme, Sevilla, Spain|Hosp. Univ. Miguel Servet, Zaragoza, Spain|Södra Älvsborgs Sjukhus, Kirurgkliniken, Borås, Boras, Sweden|Karolinska Universitetssjukhuset, Stockholm, Sweden|Uppsala University, Uppsala, Sweden|Chang-Hua Christian Hospital, Changhua, Taiwan|Taichung Veterans General Hospital, Taichung, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Chang-Gung Memorial Hospital, LinKou Branch, Taoyuan, Taiwan|Ankara Gulhane Training and Research Hospital, Ankara, Turkey|Ankara University, Ankara, Turkey|Dışkapı Yıldırım Beyazıd Training and Research Hospital, Ankara, Turkey|Hacettepe University Hospital, Ankara, Turkey|Gazi University Hospital, Ankara, Turkey|Ankara Sehir Hastanesi, Ankara, Turkey|Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey|Acibadem Kozyatagi Hospital, Istanbul, Turkey|BAU Medical Park Goztepe Hospital, Istanbul, Turkey|Dokuz Eylul University Medical Faculty, Izmir, Turkey|Kocaeli University Medical Faculty, Kocaeli, Turkey|Mersin University Medical Faculty Hospital, Mersin, Turkey|Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, Ukraine|Communal Nonprofit Enterprise 'City Clinical Hospital # 2 N.A. Prof. O.O. Shalimov', Kharkiv, Ukraine|SI 'L.T. Maloyi National Institute of Therapy of National Academy of Medical Sciences of Ukraine', Kharkiv, Ukraine|Municipal Institution 'Kherson City Clinical Hospital n.a. Y.Y.Karabelesh', Kherson, Ukraine|Kyiv City Clinical Hospital #18, Kyiv, Ukraine|Medical Center 'Ok Clinic' of LLC 'International Institute of Clinical Studies', Kyiv, Ukraine|Lviv Clinical Hospital on Railway Transport of Affiliate Healthcare center of JSC Ukrainian Railway, Lviv, Ukraine|Communal Nonprofit Enterprise of Lviv Regional Council 'Lviv Regional Clinical Hospital', Lviv, Ukraine|Municipal Non-profit Enterprise 'Odesa Regional Clinical Hospital' Odesa Regional Council, Odesa, Ukraine|Sumy State University, Sumy Regional Clinical Hospital, Sumy, Ukraine|Municipal institution of Tepnopil Regional Council 'Ternopil University Hospital', Ternopil, Ukraine|MNCE Zakarpatska Regional Clinical Hospital named after A Novak of Zakarpatska Regional Council, Uzhgorod, Ukraine|Medical Center Ltd 'Health Clinic', Department Of General Therapy, Vinnytsya, Ukraine|Vinnitsia Regional Clinical Hospital n.a. M. I. Pyrogov, Vinnytsya, Ukraine|Addenbrooke's Hospital, Cambridge, United Kingdom|Glasgow Royal Infirmary, Glasgow, United Kingdom|Royal Free Hospital, London, United Kingdom|Guy's and St Thomas' Hospital, London, United Kingdom|Chelsea And Westminster Hospital, London, United Kingdom|St George's Hospital, London, United Kingdom|Whiston Hospital, Prescot, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04033445"
817,"NCT04030676","QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis","RECOHFERRON","Recruiting","No Results Available","Cytomegalovirus Infections","Procedure: Biopsies|Biological: Blood samples","Quantification of CytoMegaloVirus (CMV) DeoxyriboNucleic Acid (DNA) load (quantitative PolymeraseChainReaction (qPCR) analysis) in the inflammatory tissue - UI/100 000 cells|QuantiFERON-CytoMegaloVirus (QF-CMV) test result (UI/ml) in blood|Total number of cells infected by CMV (/mm2) by ImmunoHistoChemistry (IHC) in the inflammatory tissue|Concordance of the results between quantitative PolymeraseChainReaction (qPCR) and ImmunoHistoChemistry (IHC)","Centre Hospitalier Universitaire de Saint Etienne","All","18 Years and older   (Adult, Older Adult)","Not Applicable","196","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","18CH053|2018-A01622-53","July 17, 2019","January 2022","April 2022","July 24, 2019",,"October 19, 2020","HCL-Hôpital Lyon Sud, Lyon, France|Chu Saint-Etienne, Saint-Étienne, France",,"https://ClinicalTrials.gov/show/NCT04030676"
818,"NCT04023396","Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: ABX464","Proportion of patients with clinical remission at week 48 compared to baseline of induction study (ABX464-103)|Change in Modified Mayo Score and in partial Modified Mayo Score|Endoscopic changes at week 48|Sustained endoscopic changes at week 48|Glucocorticoid-free clinical remission|Rectal bleeding|Fecal calprotectin and C-Reactive Proteine|Clinical response at week 48|miRNA-124 expression|Inflammatory Bowel Disease Questionnaire|Histopathological evaluation of the effect of ABX464 50 mg on the rectal/sigmoidal infiltrate based on Gebeos score|Histopathological evaluation of the effect of ABX464 50 mg on the rectal/sigmoidal infiltrate based on Nancy index scoring system|Histopathological evaluation of the effect of ABX464 50 mg on the rectal/sigmoidal infiltrate based on the Robarts Histological index|Incidence and description of Adverse Events","Abivax S.A.","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","210","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","ABX464-104","January 13, 2020","December 2022","March 2023","July 17, 2019",,"January 28, 2021","Medizinische Universität Innsbruck, Innsbruck, Austria|Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria|Ordensklinikum Linz GmbH - Barmherzige Schwestern, Linz, Austria|AKH - Medizinische Universität Wien, Vienna, Austria|Gomel Regional Clinical Hospital, Gomel, Belarus|Minsk city diagnostic center, Minsk, Belarus|Regional Clinical Hospital, Minsk, Belarus|Vitebsk Regional Clinical Hospital, Vitebsk, Belarus|Vitebsk regoinal clinical specialized center, Vitebsk, Belarus|AZ Sint-Lucas, Brugge, Belgium|C. H. U. St-Pierre, Brussels, Belgium|University Hospitals Leuven - campus Gasthuisberg, Leuven, Belgium|Brandon Medical Arts Clinic, Brandon, Canada|South Edmonton Gastroenterology, Edmonton, Canada|LHSC - Victoria Hospital, London, Canada|The Ottawa Hospital - General Campus, Ottawa, Canada|Mount Sinai Hospital, Toronto, Canada|Fakultni nemocnice u sv. Anny v Brne, Brno, Czechia|Hepato-Gastroenterologie HK s.r.o., Hradec Kralove, Czechia|MUDr. GREGAR s.r.o., Olomouc, Czechia|Fakultni nemocnice Ostrava, Ostrava-Kunčice, Czechia|Nemocnice Na Bulovce, Praha, Czechia|Thomayerova nemocnice, Praha, Czechia|Nemocnice Slany, Slany, Czechia|CHU Amiens - Hopital Sud, Amiens, France|CHU Besançon - Hôpital Jean Minjoz, Besançon, France|CHU Clermont Ferrand - Hôpital d'Estaing, Clermont-Ferrand, France|Hôpital Beaujon, Clichy, France|CHU de Grenoble - Hôpital Nord, Grenoble, France|Centre Hospitalier Départemental Les Oudairies, La Roche-sur-Yon, France|CHU Lille - Hôpital Claude Huriez, Lille, France|Hôpital Nord - CHU Marseille, Marseille, France|Hopital Saint Eloi, Montpellier, France|CHU Nantes - Hôtel Dieu, Nantes, France|CHU Nice - Hôpital de l'Archet 2, Nice, France|CHU Reims - Hôpital Robert Debré, Reims, France|CHU Rennes - Hôpital Pontchaillou, Rennes, France|CHU de Rouen - Hôpital Charles Nicolle, Rouen, France|CHU Saint Etienne - Hôpital Nord, Saint-Étienne, France|CHU Strasbourg - Hôpital Hautepierre, Strasbourg, France|Hopital Rangueil, Toulouse, France|Hôpital de Brabois Adultes, Vandœuvre-lès-Nancy, France|Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany|Florence-Nightingale-Krankenhaus-Diakonie Kaiserswerth, Düsseldorf, Germany|Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt, Germany|Studiengesellschaft BSF Unternehmergesellschaft haftungsbeschraenkt, Halle, Germany|Universitaetsklinikum Halle (Saale), Halle, Germany|Medizinische Hochschule Hannover, Hanover, Germany|Johanna-Etienne-Krankenhaus, Neuss, Germany|Tumorzentrum Nordthueringen MVZ GmbH, Nordhausen, Germany|Dr. Tasso Bieler, Riesa, Germany|Universitaetsklinikum Ulm, Ulm, Germany|DRC Gyogyszervizsgalo Kozpont Kft., Balatonfured, Hungary|Obudai Egeszsegugyi Centrum Kft., Budapest, Hungary|Pannonia Maganorvosi Centrum, Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Debreceni Egyetem, Debrecen, Hungary|Vasutegeszsegugyi Kft. - Debreceni Egeszsegugyi Kozpont, Debrecen, Hungary|Petz Aladar Megyei Oktato Korhaz, Győr, Hungary|Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi, Bologna, Italy|Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy|Azienda Ospedaliero Universitaria Mater Domini, Catanzaro, Italy|I.R.C.C.S Policlinico San Donato, Milano, Italy|Ospedale Sacro Cuore Don Calabria, Negrar, Italy|Azienda Ospedaliera di Padova, Padova, Italy|Azienda Ospedaliero Universitaria Policlinico Paolo Giaccone, Palermo, Italy|Azienda Ospedaliero Universitaria Pisana (Presidio di Cisanello), Pisa, Italy|Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy|Istituto Clinico Humanitas, Rozzano, Italy|Szpital Uniwersytecki nr 2 im.dr J. Biziela, Bydgoszcz, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, Poland|Centrum Medyczne Plejady, Kraków, Poland|Santa Familia Centrum Badan, Profilaktyki i Leczenia, Lodz, Poland|Wojskowy Szpital Kliniczny w Lublinie, Lublin, Poland|Trialmed CRS, Piotrkow Trybunalski, Poland|Centrum Medyczne Grunwald, Poznan, Poland|KO-MED Centra Kliniczne Pulawy, Pulawy, Poland|Gabinet Lekarski Bartosz Korczowski, Rzeszow, Poland|Centrum Zdrowia MDM, Warszawa, Poland|Nzoz Vivamed, Warszawa, Poland|Centrum Zdrowia Tuchow Sp. z o.o., Wierzchosławice, Poland|Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska, Wroclaw, Poland|Centrum Medyczne Oporow, Wroclaw, Poland|LexMedica, Wroclaw, Poland|Clinical Center "" Dr Dragisa Misovic Dedinje"", Belgrad, Serbia|Clinical Center Bezanijska Kosa, Belgrad, Serbia|General Hospital Uzice, Užice, Serbia|Alian s.r.o., Bardejov, Slovakia|Gastromedic, s.r.o., Nové Zámky, Slovakia|Gastro I, s.r.o., Prešov, Slovakia|Endomed, s.r.o., Vranov Nad Topľou, Slovakia|Accout Center s.r.o., Šahy, Slovakia|General Hospital Celje, Celje, Slovenia|University Medical Centre Maribor, Maribor, Slovenia|General Hospital Murska Sobota, Murska Sobota, Slovenia|Centro Médico Teknon, Barcelona, Spain|Hospital Universitario Reina Sofia, Córdoba, Spain|Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria, Spain|Hospital Quironsalud Malaga, Málaga, Spain|CNE Cherkasy Regional Hospital of Cherkasy Regional Council, Cherkasy, Ukraine|I.I.Mechnykov Dnipropetrovsk Regional Clinical Hospital, Dnipro, Ukraine|Central City Clinical Hospital Dept of Theraphy No. 2 SHEI Ivano-Frankivsk NMU, Ivano-Frankivs'k, Ukraine|CHI Kharkiv City Clinical Hospital #13, Kharkiv, Ukraine|CNE Prof. O.O. Shalimov Kharkiv City Clinical Hospital #2 of KCC, Kharkiv, Ukraine|Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital, Kharkiv, Ukraine|CI Kherson CCH, Kherson, Ukraine|Khmelnytska Regional Hospital, Khmelnytskyi, Ukraine|Communal Institution of Kyiv Regional Council Kyiv Regional Clinical Hospital, Kyiv, Ukraine|Lviv Regional Clinical Hospital D.Halytskyi Lviv NMU, Lviv, Ukraine|Ternopil University Hospital, Ternopil', Ukraine|CCH #1 Vinnytsia M.I. Pyrogov NMU Ch of Propaedeutics of IM, Vinnytsia, Ukraine|M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU, Vinnytsia, Ukraine|MCIC MC LLC Health Clinic, Vinnytsia, Ukraine|CI City Clinical Hospital #6 Dept of Gastroenterology, Zaporizhzhia, Ukraine|CNCE ""City Hospital 9"" Zaporizhzhia CC, Zaporizhzhia, Ukraine|A. Novak Transcarpathian Regional Clinical Hospital, Úzhgorod, Ukraine|Fairfield General Hospital, Bury, United Kingdom|Guy's Hospital, London, United Kingdom|University College London Hospitals, London, United Kingdom|Nottingham University Hospitals Queen's Medical Centre, Nottingham, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04023396"
819,"NCT04018040","Vegetarian Diet in Ulcerative Colitis","LOVUC","Recruiting","No Results Available","Ulcerative Colitis","Other: Lacto-ovo vegetarian diet","Number of participants with a clinical response at week 8|Number of participants achieving clinical remission at week 8|Number of participants with changes to IBDQ score at week 8|Participants Food related quality of life in IBD (Fr-QoL 29) score at week 8|Participants SF-36 quality of life score at week 8|Number of participants achieving mucosal healing at week 8|Number of participants achieving a change in gut microbiome diversity at week 8|Number of participants with a change in beneficial gut metabolome profile at week 8","Edith Cowan University|St John of God Subiaco Hospital, Subiaco|Liverpool Hospital, South Western Sydney Local Health District|Fiona Stanley Fremantle Hospitals Group","All","18 Years to 79 Years   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment","EdithCowanU","May 6, 2019","December 2021","November 2022","July 12, 2019",,"February 15, 2021","St John of God Subiaco Hospital, Perth, Western Australia, Australia","""Study Protocol, Statistical Analysis Plan, and Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/40/NCT04018040/Prot_SAP_ICF_001.pdf","https://ClinicalTrials.gov/show/NCT04018040"
820,"NCT04006977","Multistrain Probiotics Reduces UC Depression and Anxiety Scores",,"Not yet recruiting","No Results Available","Ulcerative Colitis","Dietary Supplement: a multistrain probiotic product (DSF)|Dietary Supplement: Placebo","reduction of anxiety and depression scores|Clinical response|Clinical remission|Endoscopic remission/response|Changes in fecal-associated microbiota following probiotic therapy|Identification of potential stressors|Adverse events","Xijing Hospital of Digestive Diseases|MENDES SA","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","XijingHDD-UC-Probiotics","October 2019","February 2020","May 2020","July 5, 2019",,"September 12, 2019","Xijing Digestive Disease, Xi'an, Shaanxi, China",,"https://ClinicalTrials.gov/show/NCT04006977"
821,"NCT04004611","A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)","SHINE1","Recruiting","No Results Available","Ulcerative Colitis","Drug: Mirikizumab","Pharmacokinetics (PK): Clearance of Mirikizumab|Percentage of Participants in Clinical Remission|Percentage of Participants in Clinical Response|Percentage of Participants who Entered the Study on Corticosteroids and who are in MMS Clinical Remission without the use of Corticosteroids|Percentage of Participants in Clinical Remission Based on the Pediatric Ulcerative Colitis Activity Index (PUCAI)|Percentage of Participants in Clinical Response Based on the PUCAI|Percentage of Participants in Endoscopic Remission|Percentage of Participants in Symptomatic Remission|Height Velocity (in Centimeters/Year)|Change from Baseline in Body Weight|Percentage of Participants with Histologic-Endoscopic Mucosal Remission|Change from baseline in 7-day average of Abdominal Pain Numeric Rating Scale (NRS) score at Week 12","Eli Lilly and Company","All","2 Years to 17 Years   (Child)","Phase 2","30","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","17410|I6T-MC-AMBU","May 18, 2020","December 31, 2022","December 31, 2022","July 2, 2019",,"June 9, 2021","Childrens Hospital of Orange County, Orange, California, United States|UCSF Medical Center at Mission Bay, San Francisco, California, United States|Children's Hospital of Colorado, Denver, Colorado, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Emory University, Atlanta, Georgia, United States|University of Chicago Hospital, Chicago, Illinois, United States|Riley Hospital for Children, Carmel, Indiana, United States|Boston Children's Hospital, Boston, Massachusetts, United States|MGH for Children - Waltham, Waltham, Massachusetts, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Goryeb Children's Hospital / Atlantic Health System, Morristown, New Jersey, United States|Icahn Sch of Med at Mt. Sinai, New York, New York, United States|Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States|The Abbigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Cook Children's Hospital, Fort Worth, Texas, United States|Texas Childrens Hospital, Houston, Texas, United States|Pediatrics Specialists of Virginia, Fairfax, Virginia, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, United States|Seattle Children's Hospital Research Foundation, Seattle, Washington, United States|University of Alberta Hospital, Edmonton, Alberta, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada|Rambam Medical Center, Haifa, Israel|The Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition; Shaare Zedek Medical Center, Jerusalem, Israel|Schneider Children's Medical Center, Petah Tiqva, Israel|Kurume University Hospital, Kurume, Fukuoka, Japan|Saitama Children's Medical Center, Saitama-shi, Saitama, Japan|Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan|Tokyo Medical And Dental University Medical Hospital, Bunkyō, Tokyo, Japan|National Center For Child Health And Development, Setagaya-ku, Tokyo, Japan|Kyungpook National University Medical Center Chilgok Hospital, Daegu, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT04004611"
822,"NCT03996369","Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis","ELEVATE UC 12","Recruiting","No Results Available","Ulcerative Colitis","Drug: Etrasimod|Drug: Placebo","Proportion of Participants Achieving Clinical Remission Assessed by Mayo Component Sub-scores|Proportion of Participants Achieving Endoscopic Improvement Assessed by Mayo Component Sub-scores|Proportion of Participants Achieving Symptomatic Remission Assessed by Mayo Component Sub-scores|Proportion of Participants With Mucosal Healing Assessed by Geboes Index Scores","Arena Pharmaceuticals","All","16 Years to 80 Years   (Child, Adult, Older Adult)","Phase 3","330","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","APD334-302|2018-003986-33","September 15, 2020","November 2021","November 2021","June 24, 2019",,"June 21, 2021","Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|East View Medical Research, LLC, Mobile, Alabama, United States|Arizona Digestive Health, Sun City, Arizona, United States|Om Research, LLC, Lancaster, California, United States|Entertainment Medical Group, Inc., Los Angeles, California, United States|United Medical Doctors, Murrieta, California, United States|ACRC Studies,LLC, San Diego, California, United States|Paradigm Clinical Research Institute, Torrance, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Gastro Florida, Clearwater, Florida, United States|Gastro Florida, Clearwater, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|Life Medical Center & Research, Inc, Miami Lakes, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|NSB Research, New Smyrna Beach, Florida, United States|Pediatric & Adult Research Center, Orlando, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Theia Clinical Research, LLC, Saint Petersburg, Florida, United States|Lenus Research & Medical Group, LLC, Sweetwater, Florida, United States|USF Department of Surgery, Tampa, Florida, United States|GCP Clinical Research, Tampa, Florida, United States|Guardian Angel Research Center, Tampa, Florida, United States|Florida Medical Clinic, P.A., Zephyrhills, Florida, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Children's Center for Digestive Health Care, LLC, Atlanta, Georgia, United States|Atlanta Center for Gastroenterology, P.C., Decatur, Georgia, United States|Treasure Valley Medical Research, Boise, Idaho, United States|University of Chicago, Chicago, Illinois, United States|Illinois Gastroenterology Group, Gurnee, Illinois, United States|The Iowa Clinic, West Des Moines, Iowa, United States|Texas Digestive Disease Consultants, Baton Rouge, Louisiana, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Gastro Center of Maryland, Columbia, Maryland, United States|West Michigan Clinical Research Center, Wyoming, Michigan, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Sierra Clinical Research, Las Vegas, Nevada, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|Duke University Medical Center, Durham, North Carolina, United States|Great Lakes Medical Research, LLC - Mentor, Mentor, Ohio, United States|Care Access Research, Poland, Ohio, United States|Great Lakes Medical Research, LLC - Harrisburg, Harrisburg, Pennsylvania, United States|Tri-Cities Gastroenterology, Kingsport, Tennessee, United States|GI for Kids, Knoxville, Tennessee, United States|Texas Clinical Research Institute, LLC, Arlington, Texas, United States|The University of Texas at Austin Dell Medical School, Austin, Texas, United States|Texas Gastroenterology Associates, PA, Cypress, Texas, United States|Texas Digestive Disease Consultants - Dallas, Dallas, Texas, United States|DHAT Research Institute, Garland, Texas, United States|Rio Grande Gastroenterology, McAllen, Texas, United States|Texas Digestive Disease Consultants - San Marcos, San Marcos, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Victoria Gastroenterology, Victoria, Texas, United States|Care Access Research LLC, Ogden, Utah, United States|Blue Ridge Medical Research, Lynchburg, Virginia, United States|Washington Gastroenterology, Bellevue, Washington, United States|Virginia Mason, Seattle, Washington, United States|Marshall University Department of Clinical Research, Huntington, West Virginia, United States|Medical College of Wisconsin Clinical Trials Office, Milwaukee, Wisconsin, United States|Clinica Adventista Belgrano, Caba, Buenos Aires, Argentina|Mautalen Salud e Investigacion, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina|Fundación Respirar- Centro Médico Dra. De Salvo, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina|Instituto de Investigaciones Clínicas Quilmes SRL, Quilmes, Buenos Aires, Argentina|CICE Sanatorio 9 de Julio, San Miguel de Tucuman, Tucuman, Argentina|Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|Coastal Digestive Health, Maroochydore, Queensland, Australia|Coral Sea Clinical Research Institute, North Mackay, Queensland, Australia|Footscray Hospital, Footscray, Victoria, Australia|Austin Health, Heidelberg, Victoria, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|Lkh Univ. Klinikum Graz, Graz, Austria|KH der Barmherzigen Brüder Linz, Interne Abteilung, Linz, Austria|AKH - Medizinische Universität Wien, Wien, Austria|Institution ""Gomel Regional Clinical Hospital"", Gomel, Belarus|Grodno City Clinical Hospital #4, Grodno, Belarus|Vitebsk Regional Clinical Hospital, Vitebsk, Belarus|Vitebsk Regional Clinical Specialized Center, Vitebsk, Belarus|University Hospital Antwerp Gastroenterology and Hepatology Department, Edegem, Antwerp, Belgium|Dr. Peter Bossuyt - GI Clinical Research Center, Bonheiden, Belgium|AZ Sint-Lucas & Volkskliniek, Gent, Belgium|UZ Gent - Gastroenterology, Gent, Belgium|UZ Leuven Campus Gasthuisberg, Leuven, Belgium|AZ Sint-Maarten, Mechelen, Belgium|ZNA Jan Palfijn, Merksem, Belgium|AZ Delta, Roeselare, Belgium|UMHAT ""Sv. Georgi"", EAD, Plovdiv, Bulgaria|UMHAT Kanev AD, Ruse, Ruse, Bulgaria|Diagnostic-Consultative Center I - Sliven, EOOD, Sliven, Bulgaria|ACIBADEM CITY CLINIC TOKUDA HOSPITAL EAD,Clinical Research Center, Sofia, Bulgaria|DCC ""Alexandrovska"", EOOD, Sofia, Bulgaria|UMHAT ""Tsaritsa Yoanna-ISUL"" EAD, Sofia, Bulgaria|UMHATEM ""N.I.Pirogov"" EAD, Gastroenterology Department/Clinical Research center, Sofia, Bulgaria|Diagnostic Consultation Center CONVEX EOOD, Sofia, Bulgaria|Acibadem City Clinic University Hospital EOOD, Sofia, Bulgaria|Medical center ""Nov Rehabilitatsionen Tsentar"" EOOD, Stara Zagora, Bulgaria|Medical Centre MEDICA Plus OOD, Veliko Tarnovo, Bulgaria|Heritage Medical Research Clinic, Calgary, Alberta, Canada|LHSC - University Hospital, London, Ontario, Canada|Enroll SpA, Santiago, Chile|Biomedica Research Group, Santiago, Chile|Hospital Sotero del Rio, Santiago, Chile|Centro de Investigación del Maule SPA, Talca, Chile|Clinical Research Chile SpA, Valdivia, Chile|Clínica de la Costa Ltda., Barranquilla, Atlantico, Colombia|Clinica de la Mujer Centro de Investigaciones, Bogota, Cundinamarca, Colombia|Hospital San Juan de Dios Fundacion Cardiomet-Cequin, Armenia, Quindio, Colombia|Clinica farallones centro de investigaciones clinicas CIC, Cali, Valle Del Cauca, Colombia|General Hospital ""Dr. Tomislav Bardek"" Koprivnica, Koprivnica, Croatia|Clinical Hospital Centre Osijek, Osijek, Croatia|General Hospital Zadar, Zadar, Croatia|Clinical Hospital Sveti Duh, Zagreb, Croatia|University hospital centre Zagreb, Zagreb, Croatia|Fakultni nemocnice u svate Anny v Brne, Brno, Czechia|Hepato Gastroenterologie HK s.r.o., Hradec Kralove, Czechia|GASTRO JeKa s.r.o., Klatovy, Czechia|PreventaMed s.r.o., Olomouc, Czechia|Fakultni nemocnice Ostrava, Ostrava-Poruba, Czechia|Axon Clinical s. r. o., Praha, Czechia|ISCARE I.V.F. a.s., Praha, Czechia|Nemocnice Na Bulovce, Praha, Czechia|Oblastni nemocnice Pribram a.s., Pribram, Czechia|Nemocnice Slany, Slany, Czechia|Aalborg University Hospital, department of medical gastroenterology, Aalborg, Nordjylland, Denmark|Herlev Hospital, Gastroenheden, 54Q2, Herlev, Denmark|Innomedica OÜ, Tallinn, Estonia|West Tallinn Central Hospital, Tallinn, Estonia|North Estonia Medical Centre Foundation, Tallinn, Estonia|Tartu University Hospital, Tartu, Estonia|CHU Nice - Hôpital de l'Archet 2, Nice Cedex 3, Alpes Maritimes, France|CHU Dijon - Hôpital Bocage Central, Dijon, Côte-d'Or, France|Hôpital Rangueil Service Gastro-entérologie et pancreatologie, Toulouse cedex 9, Haute Garonne, France|Hopital Saint Eloi, Montpellier cedex 5, Herault, France|Chu Pontchaillou Rennes, Rennes, Ille Et Vilaine, France|CHU Nantes Hôtel-Dieu, Nantes, Loire Atlantique, France|CHRU-Nancy Brabois, Vandoeuvre les Nancy, Meurthe Et Moselle, France|CHU Lille - Hôpital Claude Huriez, Lille cedex, Nord, France|CHU Clermont Ferrand - Hôpital d'Estaing, Clermont-Ferrand, Puy De Dome, France|Unite de Recherche Clinique-Urc, Montfermeil, Seine Saint Denis, France|Chu Amiens Picardie-Sit Sud, AMIENS cedex 1, Somme, France|Groupement Hospitalier Sud - Hôpital Bicêtre, Le Kremlin Bicêtre, Val De Marne, France|CHU Grenoble Alpes - Hôpital Michallon, Grenoble, France|LTD Acad. F. Todua Medical Centre, LTD. Research Institution of Clinical Medicine, Tbilisi, Georgia|LTD Israeli-Georgian medical research clinic Helsicore, Tbilisi, Georgia|LLC Vivamedi, Tbilisi, Georgia|LTD Institute of Clinical Cardiology, Tbilisi, Georgia|JSC Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia|LTD Aversi Clinic, Tbilisi, Georgia|LTD Central University Clinic After Academic N. Kipshidze, Tbilisi, Georgia|Malkhaz Katsiashvili Multiprofile Emergency Medicine Center, Tbilisi, Georgia|Praxis Dr. Joergensen, Remscheid, Nordrhein Westfalen, Germany|Schwerpunktpraxis Bonn, Bonn, Rheinland Pfalz, Germany|Clinic for Internal Medicine I, University hospital Schleswig-Holstein, Campus Kiel, Kiel, Schleswig Holstein, Germany|Charité Universitätsmedizin Berlin - Campus Charité Mitte, Berlin, Germany|Krankenhaus Waldfriede, Berlin, Germany|Florence-Nightingale-Krankenhaus, Düsseldorf, Germany|Johanna Etienne Krankenhaus, Neuss, Germany|Klinische Forschung Schwerin GmbH, Schwerin, Germany|DRC Gyogyszervizsgalo Kozpont Kft., Balatonfured, Hungary|Bekes Megyei Kozpont Korhaz Dr Rethy Pal Tagkorhaz, 4. Belgyogyaszat es 2. Gasztroenterologia, Bekescsaba, Hungary|Obudai Egeszsegugyi Centrum Kft., Budapest, Hungary|Endoexpert Egeszsegugyi Szolgaltato Kft, Budapest, Hungary|Semmelweis Egyetem, II.sz. Belgyogyaszati Klinika, Budapest, Hungary|Pannonia Maganorvosi Centrum, Budapest, Hungary|Bugat Pal Korhaz, Gyongyos, Hungary|Dept of Gastroenterology, Szent Gyorgy Hospital, Szekesfehervar, Hungary|Clinfan Ltd. Outpatient Clinic, Szekszard, Hungary|Szent Borbala Korhaz, Tatabanya, Hungary|Nirmal Hospitals Pvt Ltd, Surat, Gujarat, India|Surat Institute of Digestive Sciences, Surat, Gujarat, India|Fortis Memorial Research Institute, Gurgaon, Haryana, India|All India Institute of Medical Sciences, Kochi, Kerala, India|Aster Medcity,Aster DM healthcare Ltd, Kochi, Kerala, India|Superspeciality hospital and government medical college, Nagpur, Maharashtra, India|Midas Multispeciality Hospital Pvt.Ltd., Nagpur, Maharashtra, India|Ruby Hall Clinic, Pune, Maharashtra, India|Shweta Paliwal/Vipin Kumar Jain, Jaipur, Rajasthan, India|Postgraduate department of Medicine, GSVM Medical college, Kanpur, Uttar Pradesh, India|HaEmek Medical Center, Afula, Israel|Bnei Zion Medical Center, Haifa, Israel|Wolfson Medical Center, Holon, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah University Hospital - Ein Kerem, Jerusalem, Israel|Galilee Medical Center, Nahariya, Israel|Rabin Medical Center-Beilinson Campus, Petach Tikva, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Kaplan Medical Center, Rehovot, Israel|Azienda Ospedaliera Saverio De Bellis, Castellana Grotte, Bari, Italy|Ospedale di Circolo, Rho, Milano, Italy|Istituto Clinico Humanitas, Rozzano, Milano, Italy|I.R.C.C.S Policlinico San Donato, San Donato Milanese, Milano, Italy|Ospedale Sacro Cuore Don Calabria, Negrar, Verona, Italy|Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi, Bologna, Italy|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili), Brescia, Italy|Azienda Ospedaliera Ospedale Cannizzaro, Catania, Italy|Azienda Ospedaliero Universitaria Mater Domini, Catanzaro, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, Italy|A.O.U. Policlinico di Modena, Modena, Italy|Fondazione Policlinico Universitario Agostino Gemelli IRCCS - CEMAD, Roma, Italy|Centro Ricerche Cliniche di Verona, Verona, Italy|Ospedale San Bortolo di Vicenza, Vicenza, Italy|Nagoya City University Hospital, Nagoya-shi, Aichi, Japan|Koujunkai Daido Clinic, Nagoya, Aichi, Japan|Toyohashi Municipal Hospital, Toyohashi-shi, Aichi, Japan|Hirosaki University Hospital, Hirosaki-shi, Aomori-ken, Japan|NHO Hirosaki National Hospital, Hirosaki-shi, Aomori, Japan|Tsujinaka Hospital Kashiwanoha, Kashiwa-city, Chiba, Japan|Saiseikai Matsuyama Hospital, Matsuyama-shi, Ehime, Japan|Fukuoka Tokushukai Hospital, Kasuga, Fukuoka, Japan|JCHO Kyushu Hospital, Kitakyushu-shi, Fukuoka, Japan|Kurume University Hospital, Kurume-shi, Fukuoka, Japan|Fukushima Medical University Hospital, Fukushima-shi, Fukushima, Japan|Gifu University Hospital, Gifu-shi, Gifu, Japan|Ogaki Municipal Hospital, Ogaki-shi, Gifu, Japan|SUBARU Health Insurance Society Ota Memorial Hospital, Ota-shi, Gunma, Japan|NHO Fukuyama Medical Center, Fukuyama-shi, Hiroshima-Ken, Japan|Hiroshima City Hiroshima Citizens Hospital, Hiroshima-shi, Hiroshima, Japan|Hiroshima University Hospital, Hiroshima-shi, Hiroshima, Japan|Asahikawa City Hospital, Asahikawa-shi, Hokkaido, Japan|Tokushukai Sapporo Tokushukai Hospital, Sapporo-shi, Hokkaido, Japan|Sapporo-Kosei General Hospital, Sapporo-shi, Hokkaido, Japan|NHO Mito Medical Center, Higashi, Ibaraki, Japan|Yuai Memorial Hospital, Koga-shi, Ibaraki, Japan|Tsuchiura Kyodo General Hospital, Tsuchiura-shi, Ibaraki, Japan|NHO Kanazawa Medical Center, Kanazawa, Ishikawa, Japan|Iwate Medical University Uchimaru Medical Center, Morioka-shi, Iwate, Japan|Takamatsu Red Cross Hospital, Takamatsu-shi, Kagawa-Ken, Japan|Kagawa Prefectural Central Hospital, Takamatsu-shi, Kagawa, Japan|Jiaikai Izuro Imamura Hospital, Kagoshima-shi, Kagoshima, Japan|Sameshima Hospital, Kagoshima-shi, Kagoshima, Japan|Gokeikai Ofuna Chuo Hospital, Kamakura-shi, Kanagawa-Ken, Japan|Sagamihara Kyodo Hospital, Sagamihara-shi, Kanagawa, Japan|NHO Yokohama Medical Center, Yokohama-shi, Kanagawa, Japan|Japanese Red Cross Kumamoto Hospital, Kumamoto-shi, Kumamoto, Japan|NHO Kyoto Medical Center, Kyoto-shi, Kyoto, Japan|Mie University Hospital, Tsu-shi, Mie-Ken, Japan|Mie Prefectural General Medical Center, Yokkaichi-City, Mie, Japan|Tohoku University Hospital, Sendai-shi, Miyagi, Japan|JOHAS Tohoku Rosai Hospital, Sendai-shi, Miyagi, Japan|Sendai City Hospital, Sendai-shi, Miyagi, Japan|Nara Medical University Hospital, Kashihara-city, Nara, Japan|Saiseikai Niigata Hospital, Niigata-shi, Niigata, Japan|Tokushukai Kishiwada Tokushukai Hospital, Kishiwada-shi, Osaka, Japan|Osaka City University Hospital, Osaka-shi, Osaka, Japan|Japan Community Health care Organization Osaka Hospital, Osaka-shi, Osaka, Japan|Saga University Hospital, Saga-shi, Saga-ken, Japan|JCHO Saitama Medical Center, Saitama-shi, Saitama-Ken, Japan|Shiga University of Medical Science Hospital, Otsu-shi, Shiga-ken, Japan|St. Luke's International Hospital, Chuo -ku, Tokyo, Japan|Teikyo University Hospital, Itabashi-ku, Tokyo, Japan|Showa General Hospital, Kodaira-shi, Tokyo, Japan|Jikei University Hospital, Minato-ku, Tokyo, Japan|NTT Medical Center Tokyo, Shinagawa-ku, Tokyo, Japan|JCHO Tokyo Yamate Medical Center, Shinjuku-ku, Tokyo, Japan|Toyama Prefectural Central Hospital, Toyama-shi, Toyama, Japan|Wakayama Medical University Hospital, Wakayama-shi, Wakayama-ken, Japan|Fukuoka University Hospital, Fukuoka, Japan|Kyungpook National University Hospital, Junggu, Daegu, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wonju, Gangwon-do, Korea, Republic of|The Catholic University of Korea St. Vincent's Hospital, Suwon-si, Gyeonggi-do, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Seodaemun-gu, Korea, Republic of|Dong-A University Hospital, Busan, Korea, Republic of|Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of|Saint George Hospital University Medical Center, Beirut, Lebanon|American University of Beirut Medical Center, Beirut, Lebanon|Hotel Dieu de France Hospital, Beirut, Lebanon|UAB ""Inlita"", Santaros Clinical Trials Centre, Vilnius, Lithuania|Vilnius University Hospital Santaros Clinics, Center of Hepatology, Gastroenterology and Dietology, Vilnius, Lithuania|Consultorio Medico, InvesclinicMX, Irapuato, Guanajuato, Mexico|Centro de Investigacion Medico Biologica y Terapia Avanzada s.c., Guadalajara, Jalisco, Mexico|InspirePharma S. de R. L. de C.V., Monterrey, Nuevo León, Mexico|Scientia Investigación Clínica S.C., Chihuahua, Mexico|Hospital Angeles Chihuahua, Chihuahua, Mexico|Faicic S. de R.L. de Cv, Veracruz, Mexico|Republican Clinical Hospital, ARENSIA Exploratory Medicine, Chisinau, Moldova, Republic of|Rtl Sm Srl, Chisinau, Moldova, Republic of|Timofei Mosneaga Republican Clinical Hospital, Department of Gastroenterology, Chisinau, Moldova, Republic of|RTL SM SRL, Institutia Medico- Sanitara Publica Spitalul Clinic, Sectia Proctologie, Chisinau, Moldova, Republic of|Zuyderland Medisch Centrum - Sittard-Geleen, Geleen, Netherlands|Radboudumc, Nijmegen, Netherlands|ETZ Elisabeth, Tilburg, Netherlands|Centrum Dentystyczno-Lekarskie Promedica Joanna Markiewicz, Bedzin, Poland|Gastromed Kralisz, Romatowski, Stachurska sp.j, Białystok, Poland|Centrum Medyczne Pratia Czestochowa, Czestochowa, Poland|Karkonoskie Centrum Badan Klinicznych Lexmedica, Jelenia Gora, Poland|Centrum Medyczne Plejady, Kraków, Poland|Topolowa Medicenter Mrozek & Wspolnicy Spolka Jawna, Kraków, Poland|AmiCare Sp. z O.O. Sp.K., Lodz, Poland|IP Clinic, Lodz, Poland|Allmedica Badania Kliniczne Sp. z o.o. Sp.k., Nowy Targ, Poland|Medicome Sp. Zo.O., Oswiecim, Poland|Centrum Medyczne Grunwald, Poznan, Poland|SOLUMED Centrum Medyczne, Poznan, Poland|Korczowski Bartosz, Gabinet Lekarski, Rzeszow, Poland|Centrum Medyczne Medyk, Rzeszow, Poland|ENDOSKOPIA Sp.zo.o, Sopot, Poland|DC-MED, Swidnica, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Centrum Zdrowia MDM, Warsaw, Poland|Centralny Szpital Kliniczny MSW w Warszawie, Warsaw, Poland|EMC INSTYTUT MEDYCZNY SA, EuroMediCare Szpital Specjalistyczny z Przychodnia - Dzial Farmacji, Wroclaw, Poland|Centrum Medyczne Oporow, Wroclaw, Poland|Hospital de Braga, Braga, Portugal|Centro Hospitalar e Universitário de Coimbra Serviço Gastrenterologia, Coimbra, Portugal|Hospital da Senhora da Oliveira Guimarães, Guimarães, Portugal|Centro Hospitalar de São João, EPE, Porto, Portugal|Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E, Vila Nova de Gaia, Portugal|S.C. Centrul Medical Unirea SRL, Bucharest, Romania|S.C MedLife SA, Bucuresti, Romania|S.C Delta Health Care S.R.L, Ponderas Academic Hospital, Bucuresti, Romania|S.C Euroclinic Hospital S.A, Bucuresti, Romania|Spitalul Clinic Colentina, Bucuresti, Romania|Institutul Clinic Fundeni, Bucuresti, Romania|S.C Policlinica CCBR S.R.L, Bucuresti, Romania|Spitalul Clinic Judetean de Urgenta Cluj Napoca, Cluj-Napoca, Romania|Spitalul Clinic Judetean de Urgenta Craiova, Craiova, Romania|S.C Pelican Impex S.R.L, Oradea, Romania|LLC ""Multidisciplinary Medical Clinic ""Anthurium"", Barnaul, Russian Federation|LLC ""Alyans Biomedical- Ural Group"", Izhevsk, Russian Federation|Kazan State Medical University, Kazan, Russian Federation|SAIH ""Kemerovo Regional Clinical Hospital"", Kemerovo, Russian Federation|SBIH of Nizhniy Novgorod region ""Nizhniy Novgorod Regional Clinical Hospital n.a. N.A. Semashko"", Nizhniy Novgorod, Russian Federation|LLC Medicine Center SibNovoMed, Novosibirsk, Russian Federation|CDC ""Ultramed"", Omsk, Russian Federation|State Budgetary Healthcare Institution ""Penza Region Clinical Hospital n.a. N.N. Burdenko"", Penza, Russian Federation|LLC SM-Clinic, Saint-Peterburg, Russian Federation|Federal state Budgetary Educational Institution of Higher Education ""North-Western Medical University"", Saint-Petersburg, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""First Saint Petersburg State University, Saint-Petersburg, Russian Federation|LLC ""Gastroenterological centre Expert"", Saint-Petersburg, Russian Federation|Irkutsk State Medical Academy of Continuing Education, Samara, Russian Federation|Private Educational Institution of Higher Education ""Medical University ""REAVIZ"", Samara, Russian Federation|LLC Medical Company ""Hepatologist"", Samara, Russian Federation|SPb SBIH ""City Hospital # 40 of Kurortnyi region"", Sestroretsk, Russian Federation|LLC Uromed, Smolensk, Russian Federation|Stavropol Regional Clinical Diagnostic Centre, Stavropol, Russian Federation|LLC ""Polyclinic of ultrasonography 4D"", Stavropol, Russian Federation|City Clinical Hospital #8, Yaroslavl, Russian Federation|Clinical Center "" Dr Dragisa Misovic Dedinje"", Belgrade, Serbia|Clinical Center of Serbia, Belgrade, Serbia|Clinical Health Center Zvezdara, Belgrade, Serbia|Clinical Center Bezanijska Kosa, Belgrade, Serbia|Clinical Center Kragujevac, Kragujevac, Serbia|General Hospital Sremska Mitrovica, Sremska Mitrovica, Serbia|Endomed, S.R.O, Vranov nad Toplou, Presov, Slovakia|Fakultna nemocnica s poliklinikou F.D. Roosevelta, Banska Bystrica, Slovakia|Alian S.R.O, Bardejov, Slovakia|KM Management spol. s r.o., Nitra, Slovakia|Fakultna nemocnica Nitra, Nitra, Slovakia|Gastro I, s.r.o., Presov, Slovakia|Accout Center s.r.o., Sahy, Slovakia|BeneDig s.r.o., Zilina, Slovakia|Johese Clinical Research: Unitas, Lyttelton, Centurion, South Africa|Johese Clinical Research, Midstream, Centurion, South Africa|Lenasia Clinical Trial Centre, Lenasia, Gauteng, South Africa|Dr JP Wright Practice, Cape Town, Western Cape, South Africa|Hospital General Universitario de Alicante, Alicante, Spain|Centro Médico Teknon, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas, Spain|Hospital Universitario La Paz, Madrid, Spain|Kantonsspital Baden, Baden, Switzerland|Berner IBD study group c/o Gastroenterologische Praxis Balsiger, Seibold &Partner, Bern, Switzerland|Siriraj Hospital, Bangkoknoi, Bangkok, Thailand|King Chulalongkorn Memorial Hospital, Pathum wan, Bangkok, Thailand|Phramongkutklao Hospital, Ratchathewi, Bangkok, Thailand|Bumrungrad hospital, Watthana, Bangkok, Thailand|Uludag University Medical Faculty, Beşevler, Yenimahalle/Ankara, Turkey|Hacettepe University Medical Faculty, Ankara, Turkey|Gazi University Medical Faculty, Ankara, Turkey|Antalya Training and Research Hospital, Antalya, Turkey|Kocaeli University Research and Training Hospital, Kocaeli, Turkey|Karadeniz Tecnical Uni. Med. Fac., Trabzon, Turkey|I.I.Mechnykov Dnipropetrovsk Regional Clinical Hospital, Dnipro, Ukraine|Department of Propaedeutics of Internal Medicine Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine|Municipal non-profit enterprise Regional Clinical Hospital of Ivano-Frankivsk Regional Council, Ga, Ivano-Frankivsk, Ukraine|CNE Prof. O.O. Shalimov Kharkiv City Clinical Hospital #2 of KCC, Kharkiv, Ukraine|Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital, Kharkiv, Ukraine|Communal Non-Commercial Enterprise City Clinical Hospital #13 of Kharkiv City Council, Kharkiv, Ukraine|Communal Noncommercial Enterprise Ye.Ye. Karabelesh Kherson City Clinical Hospital of Kherson City, Kherson, Ukraine|Kremenchuk first city hospital n.a. O.T. Bohaievskyi, Kremenchuk, Ukraine|Kyiv CCH #18 Dept of Proctology O. O. Bogomolets NMU, Kyiv, Ukraine|Kyiv City Clinical Hospital N 1, Kyiv, Ukraine|Communal Non-Commercial Enterprise Lviv Clinical Hospital of Emergency Medical Care, Lviv, Ukraine|Odesa regional clinical hospital, regional center of gastroenterology, surgical department, Odesa, Ukraine|A. Novak Transcarpathian Regional Clinical Hospital, Uzhgorod, Ukraine|Medical Clinical Investigational Center of Medical Center Health Clinic LLC, Vinnytsia, Ukraine|M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU, Vinnytsia, Ukraine|SRI of Invalid Rehabilitation (EST Complex) of Vinnytsia M.I.Pyrogov NMU MOHU, Vinnytsia, Ukraine|Guy's and Saint Thomas NHS Foundation Trust, London, Greater London, United Kingdom|Norfolk and Norwich University Hospital, Norwich, Norfolk, United Kingdom|Yeovil District Hospital, Yeovil, Somerset, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03996369"
823,"NCT03986996","Antimicrobial Therapy for Ulcerative Colitis (UC)","UC","Recruiting","No Results Available","Ulcerative Colitis","Drug: amoxicillin, metronidazole and doxycycline|Drug: amoxicillin and doxycyclin","Efficacy - Clinical Response in group 1 and 2 or Clinical Remission|Efficacy - Clinical Response in group 1 and 2|EFFICACY - Remission|EFFICACY - PGA|EFFICACY - Corticosteroid free remission|EFFICACY - Decrease in endoscopic disease activity","Wolfson Medical Center","All","13 Years to 60 Years   (Child, Adult)","Phase 2","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","AntimicrobialUC","July 25, 2019","July 30, 2021","July 30, 2022","June 14, 2019",,"April 23, 2021","The E.Wolfson Medical Center, Holon, Israel",,"https://ClinicalTrials.gov/show/NCT03986996"
824,"NCT03980405","Combination of Diet and 5ASA ( 5-aminosalicylic Acid) for Ulcerative Colitis","INDUCT","Recruiting","No Results Available","Ulcerative Colitis","Dietary Supplement: Group 1- Control Diet|Dietary Supplement: Group 2- UCD Diet","PUCAI< 10 at week 6|A drop of PUCAI at least 10 points or remission|Mean/median change in Calprotectin at week 6|Sustained remission week 12|Need for topical therapy by week 12|Change in UCEIS at week 12 ( optional)|Tolerance to diet","Prof. Arie Levine|Wolfson Medical Center","All","10 Years to 19 Years   (Child, Adult)","Not Applicable","62","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","0001-19-WOMC","April 1, 2020","September 30, 2022","September 30, 2022","June 10, 2019",,"January 7, 2021","Wolfson MC, Holon, Israel",,"https://ClinicalTrials.gov/show/NCT03980405"
825,"NCT03977480","Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Hemay007|Drug: Placebo","clinical response","Tianjin Hemay Pharmaceutical Co.,Ltd","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 2","70","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","HM007UC2S01","August 13, 2019","December 31, 2021","December 31, 2021","June 6, 2019",,"June 23, 2021","The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China|Peking University International Hospital, Beijing, Beijing, China|Peking University People's Hospital, Beijing, Beijing, China|Army Special Medical Center, Chongqing, Chongqing, China|The First Affiliated Hospital of Army Military Medical University, Chongqing, Chongqing, China|The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China|The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China|First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China|Zhengzhou People's Hospital, Zhengzhou, Henan, China|Tongji hospital, tongji medical college, huazhong university of science and technology, Wuhan, Hubei, China|XiangYa Hospital CentralSouth University, Changsha, Hunan, China|Gulou Hospital Affiliated to Nanjing University School of Medicine, Nankín, Jiangsu, China|The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China|Shengjing Hospital Affiliated to China Medical University, Shenyang, Liaoning, China|The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China|Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Neimenggu, China|Inner Mongolia Autonomous Region People's Hospital, Hohhot, Neimenggu, China|Affiliated Hospital of Qinghai University, Xining, Qinghai, China|Shandong Provincial Hospital, Jinan, Shandong, China|Shanghai Sixth People's Hospital, Shanghai, Shanghai, China|Zhongshan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China|Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China|Tianjin Medical University General Hospital, Tianjin, Tianjin, China|The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China|The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT03977480"
826,"NCT03950232","An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis","ELEVATE UC OLE","Recruiting","No Results Available","Ulcerative Colitis","Drug: Etrasimod","Number and Severity of Safety Measures|Proportion of Participants Achieving Clinical Remission Assessed by Mayo Component Sub-scores|Proportion of Participants Achieving Clinical Response Assessed by Mayo Component Sub-scores|Proportion of Participants Achieving Symptomatic Remission Assessed by Mayo Component Sub-scores|Proportion of Participants Achieving Non-invasive Response Assessed by Mayo Component Sub-scores|Proportion of Participants Remaining in Clinical Remission Assessed by Mayo Component Sub-scores|Proportion of Participants Achieving Symptomatic Response Assessed by Mayo Component Sub-scores|Longitudinal change from both Open-Label Extension and Parent Study in Mayo Component Sub-scores|Proportion of Participants With Remission and Response Using Total Mayo Clinic Score|Percentage of Participants With Histologic Improvement at Each Visit With Endoscopy Assessed by the Geboes, Robarts, and Nancy Histopathology Scores|Percentage of Participants With Histologic Remission at Each Visit With Endoscopy Assessed by the Geboes, Robarts, and Nancy Histopathology Scores|Time to Loss of Response Assessed by Mayo Component Sub-scores|Proportion of Participants With Improvement in Extraintestinal Manifestations (EIMs) in Participants With EIMs at Baseline","Arena Pharmaceuticals","All","16 Years to 80 Years   (Child, Adult, Older Adult)","Phase 3","702","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","APD334-303|2018-003987-29","September 20, 2019","August 2027","August 2027","May 15, 2019",,"June 1, 2021","Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|Downey Medical Center, Downey, California, United States|Valley View Internal Medicine, Garden Grove, California, United States|University of California San Diego Medical Center, La Jolla, California, United States|Om Research, LLC, Lancaster, California, United States|Entertainment Medical Group, Inc., Los Angeles, California, United States|United Medical Doctors, Murrieta, California, United States|Odyssey Clinical Research, LLC, Orange, California, United States|San Diego Gastroenterology Medical Associates, San Diego, California, United States|Kaiser Permanente - San Diego, San Diego, California, United States|Naugatuck Valley Gastroenterology Consultants, Prospect, Connecticut, United States|Xera Med Research, Boca Raton, Florida, United States|Gastro Florida, Clearwater, Florida, United States|Gastro Florida, Clearwater, Florida, United States|Florida Center for Gastroenterology, Clearwater, Florida, United States|UF Health Jacksonville Gastroenterology-Emerson, Jacksonville, Florida, United States|Life Medical Center & Research, INC, Miami Lakes, Florida, United States|Javier Sobrado, MD, Miami, Florida, United States|Vista Health Research, LLC, Miami, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|Office of Dr Meckstroth, Naples, Florida, United States|NSB Research, New Smyrna Beach, Florida, United States|Sarkis Clinical Trials, Ocala, Florida, United States|Pediatric & Adult Research Center, Orlando, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Advanced Research Institute, Inc., Saint Petersburg, Florida, United States|Lenus Research & Medical Group, LLC, Sweetwater, Florida, United States|USF Deparment of Surgery, Tampa, Florida, United States|GCP Clinical Research, Tampa, Florida, United States|Guardian Angel Research Center, Tampa, Florida, United States|ASCLEPES Research Centers, P.C., Weeki Wachee, Florida, United States|Florida Medical Clinic, P.A., Zephyrhills, Florida, United States|Atlanta Gastroenterology Associates LLC, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Children's Center for Digestive Health Care, LLC, Atlanta, Georgia, United States|Atlanta Center for Gastroenterology, P.C., Decatur, Georgia, United States|Treasure Valley Medical Research, Boise, Idaho, United States|Illinois Gastroenterology Group, Gurnee, Illinois, United States|Endoscopy Center of the North Shore - Gen1 Research, Wilmette, Illinois, United States|The Iowa Clinic, West Des Moines, Iowa, United States|Texas Digestive Disease Consultants, Baton Rouge, Louisiana, United States|CroNOLA, Houma, Louisiana, United States|Clinical Trials of SW Louisiana, LLC, Lake Charles, Louisiana, United States|Clinical Trials Management, LLC, Metairie, Louisiana, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|NECCR Primacare Research, LLC, Fall River, Massachusetts, United States|Flint Clinical Research, Flint, Michigan, United States|Robert Ferguson, MD PC, West Bloomfield, Michigan, United States|NDORI - Gen1 Research, Biloxi, Mississippi, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Jubilee Clinical Research, Inc., Las Vegas, Nevada, United States|Sierra Clinical Research, Las Vegas, Nevada, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Oleg Katcher, MD - Gen1 Research, Brooklyn, New York, United States|Lake Success Gastroenterology, a Division of Pro Healthcare, Lake Success, New York, United States|DiGiovanna Institute for Medical Education & Research, North Massapequa, New York, United States|Premier Medical Group of the Hudson Valley, PC, Poughkeepsie, New York, United States|Duke University Medical Center GI Clinical Research Unit, Durham, North Carolina, United States|Clinical Research of Gastonia, Gastonia, North Carolina, United States|Great Lakes Medical Research, LLC - Beachwood, Beachwood, Ohio, United States|Great Lakes Medical Research, LLC - Mentor, Mentor, Ohio, United States|Care Access Research, Poland, Ohio, United States|Great Lakes Medical Research, LLC - Warren, Warren, Ohio, United States|Digestive Disease Specialists, Inc., Oklahoma City, Oklahoma, United States|St. Luke's University Health Network, Bethlehem, Pennsylvania, United States|Great Lakes Medical Research, LLC - Harrisburg, Harrisburg, Pennsylvania, United States|Care Access Research LLC, Pottsville, Pennsylvania, United States|Clinical Research of Rock Hill, Rock Hill, South Carolina, United States|GI for Kids, Knoxville, Tennessee, United States|Texas Clinical Research Institute, LLC, Arlington, Texas, United States|Coastal Medical Group, Baytown, Texas, United States|Texas Gastroenterology Associates, PA, Cypress, Texas, United States|Texas Digestive Disease Consultants - Dallas, Dallas, Texas, United States|DHAT Research Institute, Garland, Texas, United States|Spring Gastroenterology, Houston, Texas, United States|CliniCore International, Houston, Texas, United States|Baylor Gastroenterology Assoc, Houston, Texas, United States|Biopharma Informatic, Inc. Research Center, Houston, Texas, United States|Houston Gastroenterology Associates, Katy, Texas, United States|Rio Grande Gastroenterology, McAllen, Texas, United States|Digestive System Health Care, Pasadena, Texas, United States|Texas Digestive Disease Consultants - San Marcos, San Marcos, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Victoria Gastroenterology, Victoria, Texas, United States|Care Access Research LLC, Ogden, Utah, United States|Gastroenterology Associates of Tidewater, Chesapeake, Virginia, United States|Blue Ridge Medical Research, Lynchburg, Virginia, United States|Washington Gastroenterology, Bellevue, Washington, United States|Virginia Mason, Seattle, Washington, United States|Marshall University Department of Clinical Research, Huntington, West Virginia, United States|Medical College of Wisconsin Clinical Trials Office, Milwaukee, Wisconsin, United States|CICE Sanatorio 9 de Julio, San Miguel de Tucuman, Tucuman, Argentina|Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia|Coastal Digestive Health, Maroochydore, Queensland, Australia|Coral Sea Clinical Research Institute, North Mackay, Queensland, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|AKH - Medizinische Universität Wien, Wien, Austria|Institution ""Gomel Regional Clinical Hospital"", Gomel, Belarus|Grodno City Clinical Hospital #4, Grodno, Belarus|Health Care Institution ""10th City Clinical Hospital"", Minsk, Belarus|Vitebsk Regional Clinical Hospital, Vitebsk, Belarus|Vitebsk Regional Clinical Specialized Center, Vitebsk, Belarus|University Hospital Antwerp Gastroenterology and Hepatology Department, Edegem, Antwerp, Belgium|Dr. Peter Bossuyt - GI Clinical Research Center, Bonheiden, Belgium|AZ Sint-Lucas & Volkskliniek, Gent, Belgium|UZ Gent- Gastroenterology, Gent, Belgium|UZ Leuven Campus Gasthuisberg, Leuven, Belgium|ZNA Jan Palfijn, Merksem, Belgium|AZ Delta, Roeselare, Belgium|Medical center Medconsult Pleven OOD, Pleven, Bulgaria|UMHAT ""Sv. Georgi"", EAD, Plovdiv, Bulgaria|UMHAT Kanev AD Ruse, Ruse, Bulgaria|Diagnostic-Consultative Center I - Sliven, EOOD, Sliven, Bulgaria|Acibadem City Clinic Tokuda Hospital Ead, Sofia, Bulgaria|DCC ""Alexandrovska"", EOOD, Sofia, Bulgaria|UMHAT ""Sv. Ivan Rilski"", EAD,Clinic of gastroenterology, Sofia, Bulgaria|UMHAT 'Tsaritsa Yoanna - ISUL', EAD, Sofia, Bulgaria|Diagnostic Consultation Center CONVEX EOOD, Sofia, Bulgaria|UMHATEM 'N.I. Pirogov', EAD, Sofia, Bulgaria|Acibadem City Clinic University Hospital EOOD, Sofia, Bulgaria|MC ""Nov Rehabilitatsionen Tsentar""EOOD, Stara Zagora, Bulgaria|MC Medica Plus, Veliko Tarnovo, Bulgaria|Heritage Medical Research Clinic, Calgary, Alberta, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Enroll SpA, Santiago, Chile|Centro de Investigación del Maule SPA, Talca, Chile|Clinical Research Chile SpA, Valdivia, Chile|General Hospital ""Dr.Tomislav Bardek"" Koprivnica, Koprivnica, Croatia|General Hospital Zadar, Zadar, Croatia|University hospital centre Zagreb, Zagreb, Croatia|Fakultni nemocnice u svate Anny v Brne, Brno, Czechia|Hepato-Gastroenterologie HK, s.r.o.,, Hradec Kralove, Czechia|GASTRO JeKa, s.r.o., Klatovy, Czechia|PreventaMed s.r.o., Olomouc, Czechia|Fakultni nemocnice Ostrava, Ostrava-Poruba, Czechia|Axon Clinical s.r.o., Praha, Czechia|ISCARE I.V.F. a.s., Praha, Czechia|Nemocnice Na Bulovce, Praha, Czechia|Nemocnice Slany, Slany, Czechia|Aalborg University Hospital, department of medical gastroenterology, Aalborg, Nordjylland, Denmark|Herlev Hospital, Gastroenheden, 54Q2, Herlev, Denmark|Ou Innomedica, Tallinn, Estonia|West Tallinn Central Hospital, Tallinn, Estonia|North Estonia Medical Centre Foundation, Tallinn, Estonia|Tartu University Hospital, Tartu, Estonia|CHU Nice - Hôpital de l'Archet 2, Nice Cedex 3, Alpes Maritimes, France|CHU Nantes Hôtel - Dieu, Nantes, Loire Atlantique, France|CHU Amiens Picardie Site Sud, AMIENS cedex 1, Somme, France|CHU Grenoble Alpes - Hôpital Michallon, Grenoble, France|Hopital Saint Eloi, Montpellier cedex 5, France|LTD Acad. F. Todua Medical Center - LTD Research Institute of Clinical Medicine, Tbilisi, Georgia|LTD Israeli-Georgian Medical Research clinic Helsicore, Tbilisi, Georgia|LLC Vivamedi, Tbilisi, Georgia|LTD Institute of Clinical Cardiology, Tbilisi, Georgia|JSC Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia|LTD Aversi Clinic, Tbilisi, Georgia|LTD Central University Clinic After Academic N. Kipshidze, Tbilisi, Georgia|Malkhaz Katsiashvili Multiprofile Emergency Medicine Center, Tbilisi, Georgia|Praxis Dr. Joergensen, Remscheid, Nordrhein Westfalen, Germany|Schwerpunktpraxis Bonn, Bonn, Rheinland Pfalz, Germany|Charité Universitätsmedizin Berlin - Campus Charité Mitte, Berlin, Germany|Krankenhaus Waldfriede e. V., Berlin, Germany|Johanna Etienne Krankenhaus, Neuss, Germany|Klinische Forschung Schwerin GmbH, Schwerin, Germany|DRC Gyogyszervizsgalo Kozpont Kft., Balatonfured, Hungary|Pannonia Maganorvosi Centrum, Budapest, Hungary|Bugat Pal Korhaz, Gyongyos, Hungary|Somogy Megyei Kaposi Mor Oktato Korhaz, Kaposvar, Hungary|Clinfan Szolgaltato Kft., Szekszard, Hungary|Dept of Gastroenterology, Szent Gyorgy Hospital, Székesfehérvár, Hungary|Szent Borbala Korhaz, Tatabanya, Hungary|Nirmal Hospitals Pvt Ltd, Surat, Gujarat, India|Fortis Memorial Research Institute, Gurgaon, Haryana, India|Midas Multispeciality Hospital Pvt.Ltd., Nagpur, Maharashtra, India|Ruby Hall Clinic, Pune, Maharashtra, India|Shweta Paliwal/Vipin Kumar Jain, Jaipur, Rajasthan, India|HaEmek Medical Center, Afula, Israel|Bnei Zion Medical Center, Haifa, Israel|Wolfson Medical Center, Holon, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah University Hospital - Ein Kerem, Jerusalem, Israel|Galilee Medical Center, Nahariya, Israel|Rabin Medical Center-Beilinson Campus, Petach Tikva, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Kaplan Medical Center, Rehovot, Israel|Azienda Ospedaliera Saverio De Bellis, Castellana Grotte, Bari, Italy|Ospedale di Circolo, Rho, Milano, Italy|Ospedale Sacro Cuore Don Calabria, Negrar, Verona, Italy|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili), Brescia, Italy|Azienda Ospedaliera Ospedale Cannizzaro, Catania, Italy|Azienda Ospedaliero Universitaria Mater Domini, Catanzaro, Italy|A.O.U. Policlinico di Modena, Modena, Italy|Ospedale Sandro Pertini, Roma, Italy|Fondazione Policlinico Universitario Agostino Gemelli IRCCS - CEMAD, Roma, Italy|Ospedale San Bortolo di Vicenza, Vicenza, Italy|Koujunkai Daido Clinic, Nagoya, Aichi, Japan|Toyohashi Municipal Hospital, Toyohashi-shi, Aichi, Japan|Tsujinaka Hospital Kashiwanoha, Kashiwa-city, Chiba, Japan|Gifu University Hospital, Gifu-shi, Gifu, Japan|NHO Kanazawa Medical Center, Kanazawa, Ishikawa, Japan|Takamatsu Red Cross Hospital, Takamatsu-shi, Kagawa, Japan|Jiaikai Izuro Imamura Hospital, Kagoshima-shi, Kagoshima, Japan|Sameshima Hospital, Kagoshima-shi, Kagoshima, Japan|Mie University Hospital, Tsu-shi, Mie-Ken, Japan|Sendai City Hospital, Sendai-shi, Miyagi, Japan|Japan Community Health care Organization Osaka Hospital, Osaka-shi, Osaka, Japan|JCHO Tokyo Yamate Medical Center, Shinjuku-ku, Tokyo, Japan|Wakayama Medical University Hospital, Wakayama-shi, Wakayama-ken, Japan|Kyungpook National University Hospital, Junggu, Daegu, Korea, Republic of|Wonju Severance Christian Hospital, Wonju, Gangwon-do, Korea, Republic of|Dong-A University Hospital, Busan, Korea, Republic of|Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of|P. Stradins Clinical University Hospital, Riga, Latvia|American University of Beirut Medical Center, Beirut, Lebanon|Vilnius University Hospital Santaros Clinics, Center of Hepatology, Gastroenterology and Dietology, Vilnius, Lithuania|Centro de Investigacion Medico Biologica y Terapia Avanzada s.c., Guadalajara, Jalisco, Mexico|Scientia Investigación Clínica S.C., Chihuahua, Mexico|Faicic S. de R.L. de Cv, Veracruz, Mexico|Clinical Hospital of the Ministry of Health, Labor and Social Protection, Chisinau, Moldova, Republic of|Rtl Sm Srl, Chisinau, Moldova, Republic of|Timofei Mosneaga Republican Clinical Hospital, Department of Gastroenterology, Chisinau, Moldova, Republic of|Zuyderland Medisch Centrum - Sittard-Geleen, Geleen, Netherlands|Radboudumc, Nijmegen, Netherlands|ETZ Elisabeth, Tilburg, Netherlands|Centrum Dentystyczno-Lekarskie Promedica Joanna Markiewicz, Bedzin, Poland|Gastromed Kralisz, Romatowski, Stachurska sp.j, Białystok, Poland|Centrum Medyczne Pratia Czestochowa, Czestochowa, Poland|Karkonoskie Centrum Badan Klinicznych - Lexmedica, Jelenia Gora, Poland|ETG Kielce Zagorska, Kielce, Poland|Centrum Medyczne Plejady, Kraków, Poland|Topolowa Medicenter Mrozek & Wspolnicy Spolka Jawna, Kraków, Poland|AmiCare Sp. z O.O. Sp.K., Lodz, Poland|IP Clinic, Lodz, Poland|Allmedica Badania Kliniczne Sp. z o.o. Sp.k., Nowy Targ, Poland|Medicenter Nowy Targ, Nowy Targ, Poland|Medicome Sp.Zo.O., Oswiecim, Poland|Centrum Medyczne Grunwald, Poznan, Poland|SOLUMED Centrum Medyczne, Poznan, Poland|Korczowski Bartosz, Gabinet Lekarski, Rzeszow, Poland|Centrum Medyczne Medyk, Rzeszow, Poland|ENDOSKOPIA Sp.zo.o, Sopot, Poland|DC-MED, Swidnica, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Centrum Zdrowia MDM, Warsaw, Poland|Centralny Szpital Kliniczny MSW w Warszawie, Warsaw, Poland|EMC INSTYTUT MEDYCZNY SA, EuroMediCare Szpital Specjalistyczny z Przychodnia, Wroclaw, Poland|Centrum Medyczne Oporow, Wroclaw, Poland|LexMedica Osrodek Badan Klinicznych, Wroclaw, Poland|Centro Hospitalar e Universitário de Coimbra E.P.E, Coimbra, Portugal|Centro Hospitalar Vila Nova de Gaia/Espinho, E.P.E, Vila Nova de Gaia, Portugal|S.C MedLife S.A, Bucuresti, Romania|S.C Euroclinic Hospital S.A, Bucuresti, Romania|Spitalul Clinic Colentina, Bucuresti, Romania|Institutul Clinic Fundeni, Bucuresti, Romania|Hifu Terramed Conformal SRL, Bucuresti, Romania|Spitalul Clinic Judetean de Urgenta Cluj Napoca, Cluj-Napoca, Romania|Spitalul Clinic Judetean de Urgenta, Craiova, Romania|S.C Pelican Impex S.R.L, Oradea, Romania|Clinic of Plastic and Laser Surgery ""Anturium"" LLC, Barnaul, Russian Federation|LLC ""Alyans Biomedical- Ural Group"", Izhevsk, Russian Federation|Kazan State Medical University, Kazan, Russian Federation|SAIH ""Kemerovo Regional Clinical Hospital, Kemerovo, Russian Federation|SBIH of Nizhniy Novgorod region ""Nizhniy Novgorod Regional Clinical Hospital n.a. N.A. Semashko"", Nizhniy Novgorod, Russian Federation|LLC ""Medicine Center SibNovoMed, Novosibirsk, Russian Federation|CDC Ultramed, Omsk, Russian Federation|State Budgetary Healthcare Institution ""Penza Region Clinical Hospital n.a. N.N. Burdenko"", Penza, Russian Federation|LLC ""Gastroenterological centre Expert"",, Saint Petersburg, Russian Federation|LLC SM-Clinic, Saint-Peterburg, Russian Federation|Federal state Budgetary Educational Institution of Higher Education ""North-Western Medical University"", Saint-Petersburg, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""First Saint Petersburg State Medical University"", Saint-Petersburg, Russian Federation|Irkutsk State Medical Academy of Continuing Education, Samara, Russian Federation|Private Educational Institution of Higher Education ""Medical University ""REAVIZ"", Samara, Russian Federation|LLC Medical Company ""Hepatologist"", Samara, Russian Federation|SPb SBIH ""City Hospital # 40 of Kurortnyi region"", Sestroretsk, Russian Federation|LLC ""Uromed"", Smolensk, Russian Federation|Stavropol Regional Clinical Diagnostic Centre, Stavropol, Russian Federation|LLC ""Polyclinic of ultrasonography 4D"",, Stavropol, Russian Federation|City Clinical Hospital #8, Yaroslavl, Russian Federation|Clinical Center "" Dr Dragisa Misovic Dedinje"", Belgrade, Serbia|Clinical Center of Serbia, Belgrade, Serbia|Clinical Health Center Zvezdara, Belgrade, Serbia|Clinical Center Kragujevac, Kragujevac, Serbia|General Hospital Sremska Mitrovica, Sremska Mitrovica, Serbia|ENDOMED, s.r.o., Vranov nad Toplou, Presov, Slovakia|Fakultna nemocnica s poliklinikou F.D. Roosevelta, Banska Bystrica, Slovakia|Alian S.R.O., Bardejov, Slovakia|KM Management spol. s r.o., Nitra, Slovakia|Fakultna nemocnica Nitra, Nitra, Slovakia|GASTROENTEROLOG, s.r.o., Nove Zamky, Slovakia|Gastromedic, s.r.o., Nove Zamky, Slovakia|Gastro I, s.r.o., Presov, Slovakia|Accout Center s.r.o., Sahy, Slovakia|BeneDig s.r.o., Zilina, Slovakia|Johese Clinical Research: Unitas, Lyttelton, Centurion, South Africa|Johese Clinical Research, Midstream, Centurion, South Africa|Lenasia Clinical Trial Centre, Johannesburg, Gauteng, South Africa|Dr JP Wright Practice, Cape Town, Western Cape, South Africa|Hospital General Universitario de Alicante, Alicante, Spain|Hospital Universitario La Paz, Madrid, Spain|Siriraj Hospital, Bangkok noi, Bangkok, Thailand|King Chulalongkorn Memorial Hospital, Pathum wan, Bangkok, Thailand|Phramongkutklao Hospital, Ratchathewi, Bangkok, Thailand|Piyapath Boonsamrej, Watthana, Bangkok, Thailand|Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand|Uludag University Medical Faculty, Beşevler, Yenimahalle/ANKARA, Turkey|Hacettepe University Medical Faculty, Ankara, Turkey|Gazi University Medical Faculty, Ankara, Turkey|Antalya Training and Research Hospital, Antalya, Turkey|Kocaeli University Research and Training Hospital, Kocaeli, Turkey|Karadeniz Tecnical Uni. Med. Fac., Trabzon, Turkey|I.I.Mechnykov Dnipropetrovsk Regional Clinical Hospital, Dnipro, Ukraine|Department of Propaedeutics of Internal Medicine Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine|Municipal non-profit enterprise ""Regional Clinical Hospital of Ivano-Frankivsk Regional Council"", Ga, Ivano-Frankivsk, Ukraine|CNE Prof. O.O. Shalimov Kharkiv City Clinical Hospital #2 of KCC, Kharkiv, Ukraine|Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital, Kharkiv, Ukraine|Communal Non-Commercial Enterprise City Clinical Hospital #13 of Kharkiv City Council, Kharkiv, Ukraine|Communal Noncommercial Enterprise Ye.Ye. Karabelesh Kherson City Clinical Hospital of Kherson City, Kherson, Ukraine|Kremenchuk first city hospital n.a. O.T. Bohaievskyi, Kremenchuk, Ukraine|National Military Medical Clinical Center Main Military Clinical Hospital, Kyiv, Ukraine|Kyiv City Clinical Hospital N 1, Kyiv, Ukraine|Communal Non-Commercial Enterprise Lviv Clinical Hospital of Emergency Medical Care, Lviv, Ukraine|Odesa regional clinical hospital, regional center of gastroenterology, surgical department, Odesa, Ukraine|A. Novak Transcarpathian Regional Clinical Hospital, Uzhgorod, Ukraine|Medical Clinical Investigational Center Medical Center LLC Health Clinic, Vinnytsia, Ukraine|M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU, Vinnytsia, Ukraine|SRI of Invalid Rehabilitation (EST Complex) of Vinnytsia M.I.Pyrogov NMU MOHU, Vinnytsia, Ukraine|CI City Clinical Hospital #6 Dept of Gastroenterology, Zaporizhzhia, Ukraine|Barts Health NHS Trust - Whipps Cross University Hospital, London, Greater London, United Kingdom|Norfolk and Norwich University Hospital, Norwich, Norfolk, United Kingdom|Yeovil District Hospital, Yeovil, Somerset, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03950232"
827,"NCT03948919","Low Sulfur Fecal Transplant for Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Fecal microbiota|Other: Placebo","Engraftment of low sulfate reducing microbiota|Rate of change of sulfate reducing microbiota|Clinical efficacy of FMT versus placebo|Clinical efficacy of low sulfate reducing microbiota|Serious adverse events","University of Minnesota","All","18 Years to 89 Years   (Adult, Older Adult)","Phase 1","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","GI-2019-27285","July 31, 2019","December 31, 2020","December 31, 2021","May 14, 2019",,"July 17, 2020","University of Minnesota, Minneapolis, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03948919"
828,"NCT03945188","Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis","ELEVATE UC 52","Active, not recruiting","No Results Available","Ulcerative Colitis","Drug: Etrasimod|Drug: Placebo","Proportion of Participants Achieving Clinical Remission Assessed by Mayo Component Sub-scores|Proportion of Participants Achieving Endoscopic Improvement Assessed by Mayo Component Sub-scores|Proportion of Participants Achieving Symptomatic Remission Assessed by Mayo Component Sub-scores|Proportion of Participants in Clinical Remission at Week 52 and who had not Been Receiving Corticosteroids for ≥ 12 Weeks Prior to Week 52|Proportion of Participants With Mucosal Healing Assessed by Geboes Index Score and Mayo Component Sub-scores","Arena Pharmaceuticals","All","16 Years to 80 Years   (Child, Adult, Older Adult)","Phase 3","433","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","APD334-301|2018-003985-15","June 13, 2019","January 2022","February 2022","May 10, 2019",,"May 28, 2021","Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|Arizona Digestive Health, Sun City, Arizona, United States|Kaiser Permanente, Downey Medical Center, Downey, California, United States|University of California San Diego Medical Center, La Jolla, California, United States|Om Research, LLC, Lancaster, California, United States|Entertainment Medical Group, Inc., Los Angeles, California, United States|United Medical Doctors, Murrieta, California, United States|Odyssey Clinical Research, LLC, Orange, California, United States|San Diego Gastroenterology Medical Associates, San Diego, California, United States|ACRC Studies, LLC, San Diego, California, United States|Kaiser Permanente - San Diego, San Diego, California, United States|Paradigm Clinical Research Institute, Torrance, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Xera Med Research, Boca Raton, Florida, United States|Gastro Florida, Clearwater, Florida, United States|West Central Gastroenterology d/b/a Gastro Florida, Clearwater, Florida, United States|Florida Center for Gastroenterology, Clearwater, Florida, United States|University of Florida at Shands Jacksonville, Jacksonville, Florida, United States|Life Medical Center & Research, INC, Miami Lakes, Florida, United States|Javier Sobrado, MD, Miami, Florida, United States|Vista Health Research, LLC, Miami, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|Office of Dr Meckstroth, Naples, Florida, United States|NSB Research, New Smyrna Beach, Florida, United States|Sarkis Clinical Trials - Parent, Ocala, Florida, United States|Pediatric & Adult Research Center, Orlando, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Theia Clinical Research, LLC, Saint Petersburg, Florida, United States|Advanced Research Institute, Inc., Saint Petersburg, Florida, United States|Lenus Research & Medical Group, Sweetwater, Florida, United States|USF Physicians Group, Tampa, Florida, United States|GCP Clinical Research, Tampa, Florida, United States|Guardian Angel Research Center, Tampa, Florida, United States|ASCLEPES Research Centers, P.C., Weeki Wachee, Florida, United States|Florida Medical Clinic, P.A., Zephyrhills, Florida, United States|Atlanta Gastroenterology Associates LLC, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Children's Center for Digestive Health Care, LLC, Atlanta, Georgia, United States|Atlanta Center for Gastroenterology, P.C., Decatur, Georgia, United States|Treasure Valley Medical Research, Boise, Idaho, United States|Northwestern University-Feinberg School of Medicine, Chicago, Illinois, United States|Illinois Gastroenterology Group, Gurnee, Illinois, United States|Gen1 Research, Moline, Illinois, United States|The Iowa Clinic, West Des Moines, Iowa, United States|Texas Digestive Disease Consultants, Baton Rouge, Louisiana, United States|CroNOLA, Houma, Louisiana, United States|Clinical Trials of SW Louisiana, LLC, Lake Charles, Louisiana, United States|Clinical Trials Management, LLC, Metairie, Louisiana, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Flint Clinical Research, Flint, Michigan, United States|Robert Ferguson MD, West Bloomfield, Michigan, United States|Gastrointestinal Associates, Flowood, Mississippi, United States|Jubilee Clinical Research, Inc., Las Vegas, Nevada, United States|Sierra Clinical Research, Las Vegas, Nevada, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Pro Healthcare Associates, Lake Success, New York, United States|Duke University Medical Center GI Clinical Research Unit, Durham, North Carolina, United States|Clinical Research of Gastonia, Gastonia, North Carolina, United States|Great Lakes Medical Research, LLC, Beachwood, Ohio, United States|University of Cincinnati, Cincinnati, Ohio, United States|Great Lakes Medical Research, LLC, Mentor, Ohio, United States|Care Access Research, Poland, Ohio, United States|Digestive Disease Specialists, Inc., Oklahoma City, Oklahoma, United States|St. Luke's Gastroenterology Specialists, Bethlehem, Pennsylvania, United States|Great Lakes Medical Research, LLC, Harrisburg, Pennsylvania, United States|Care Access Research LLC, Pottsville, Pennsylvania, United States|Clinical Research of Rock Hill, Rock Hill, South Carolina, United States|Tri-Cities Gastroenterology, Kingsport, Tennessee, United States|GI for Kids, Knoxville, Tennessee, United States|Texas Clinical Research Institute, LLC, Arlington, Texas, United States|The University of Texas at Austin Dell Medical School, Austin, Texas, United States|Coastal Medical Group, Baytown, Texas, United States|Texas Gastroenterology Associates, PA, Cypress, Texas, United States|Texas Digestive Disease Consultants, Dallas, Texas, United States|Digestive Health Associates of Texas, Garland, Texas, United States|Spring Gastroenterology, Houston, Texas, United States|CliniCore Texas, Houston, Texas, United States|Baylor Gastroenterology Assoc, Houston, Texas, United States|Biopharma Informatic, Inc. Research Center, Houston, Texas, United States|Houston Gastroenterology Associates, Katy, Texas, United States|Rio Grande Gastroenterology, McAllen, Texas, United States|Biopharma Informatic, Inc. Research Center, Pasadena, Texas, United States|Texas Digestive Disease Consultants - San Marcos, San Marcos, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Victoria Gastroenterology, Victoria, Texas, United States|Care Access Research LLC, Ogden, Utah, United States|Blue Ridge Medical Research, Lynchburg, Virginia, United States|Washington Gastroenterology, Bellevue, Washington, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Marshall University Department of Clinical Research, Huntington, West Virginia, United States|Medical College of Wisconsin Clinical Trials Office, Milwaukee, Wisconsin, United States|Clinica Adventista Belgrano, Caba, Buenos Aires, Argentina|Mautalen Salud e Investigacion, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina|Fundación Respirar- Centro Médico Dra. De Salvo, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina|CICE Sanatorio 9 de Julio, San Miguel de Tucuman, Tucuman, Argentina|Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|Coastal Digestive Health Pty Ltd, Maroochydore, Queensland, Australia|Coral Sea Clinical Research Institute, North Mackay, Queensland, Australia|Austin Health Gastroenterology Department, Heidelberg, Victoria, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|KH der Barmherzigen Brüder Linz, Linz, Austria|AKH - Medizinische Universität Wien, Wien, Austria|Wilhelminenspital der Stadt Wien, Wien, Austria|Institution ""Gomel Regional Clinical Hospital"", Gomel, Belarus|Grodno City Clinical Hospital #4, Grodno, Belarus|Health Care Institution ""10th City Clinical Hospital"", Minsk, Belarus|Vitebsk Regional Clinical Hospital, Vitebsk, Belarus|Vitebsk Regional Clinical Specialized Center, Vitebsk, Belarus|AZ Sint-Lucas & Volkskliniek, Gent, Belgium|UZ Gent Gastroenterology, Gent, Belgium|ZNA Jan Palfijn, Merksem, Belgium|AZ Delta, Roeselare, Belgium|Medical center Medconsult Pleven OOD, Pleven, Bulgaria|UMHAT ""Sv. Georgi"", EAD, Plovdiv, Bulgaria|UMHAT Kanev AD, Ruse, Ruse, Bulgaria|Diagnostic-Consultative Center I - Sliven, EOOD, Sliven, Bulgaria|ACIBADEM CITY CLINIC TOKUDA HOSPITAL EAD,Clinical Research Center, 7th Floor, Sofia, Bulgaria|DCC ""Alexandrovska"", EOOD, Sofia, Bulgaria|UMHAT ""Sv. Ivan Rilski"", EAD,Clinic of gastroenterology, Sofia, Bulgaria|UMHAT Tsaritsa Yoanna-ISUL EAD, Sofia, Bulgaria|UMHATEM ""N.I.Pirogov"" EAD, Gastroenterology Department/Clinical Research center, next to the chimney, Sofia, Bulgaria|Diagnostic Consultation Center CONVEX EOOD, Sofia, Bulgaria|Acibadem City Clinic University Hospital EOOD, Sofia, Bulgaria|Medical Center Nov Rehabilitatsionen Tsentar EOOD, Stara Zagora, Bulgaria|Medical Centre MEDICA Plus OOD, Veliko Tarnovo, Bulgaria|Heritage Medical Research Clinic, Calgary, Alberta, Canada|The Gordon and Leslie Diamond Health Care Centre, Vancouver, British Columbia, Canada|LHSC - University Hospital, London, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Enroll SpA, Santiago, Chile|Biomedica Research Group, Santiago, Chile|Hospital Sotero del Rio, Santiago, Chile|Centro de Investigación del Maule SPA, Talca, Chile|Clinical Research Chile SpA, Valdivia, Chile|General Hospital ""Dr.Tomislav Bardek"" Koprivnica, Koprivnica, Croatia|Clinical Hospital Centre Osijek, Osijek, Croatia|Clinical Hospital Centre Rijeka, Rijeka, Croatia|General Hospital Zadar, Zadar, Croatia|Clinical Hospital Dubrava, Zagreb, Croatia|Clinical Hospital Sveti Duh, Zagreb, Croatia|Polyclinic Bonifarm, Zagreb, Croatia|University hospital centre Zagreb, Zagreb, Croatia|Fakultni nemocnice u svate Anny v Brne, Brno, Czechia|Hepato-Gastroenterologie HK, s.r.o.,, Hradec Kralove, Czechia|GASTRO JeKa, s.r.o., Klatovy, Czechia|PreventaMed s.r.o., Olomouc, Czechia|Fakultni nemocnice Ostrava, Ostrava-Poruba, Czechia|ISCARE I.V.F. a.s., Praha, Czechia|Nemocnice Na Bulovce, Praha, Czechia|Oblastni nemocnice Pribram a.s., Pribram, Czechia|Nemocnice Slany, Slany, Czechia|Aalborg University Hospital, department of medical gastroenterology, Aalborg, Nordjylland, Denmark|Herlev Hospital, Herlev, Denmark|Innomedica OÜ, Tallinn, Estonia|West Tallinn Central Hospital, Tallinn, Estonia|North Estonia Medical Centre Foundation, Tallinn, Estonia|CHU Nice - Hôpital de l'Archet 2, Nice Cedex 3, Alpes Maritimes, France|CHU Dijon - Hôpital Bocage Central, Dijon, Côte-d'Or, France|Hôpital Rangueil Service Gastro-entérologie et pancreatologie, Toulouse cedex 9, Haute Garonne, France|Hopital Saint-Eloi, Montpellier cedex 5, Herault, France|Chu Pontchaillou Rennes, Rennes, Ille Et Vilaine, France|CHU Nantes Hôtel-Dieu, Nantes, Loire Atlantique, France|CHU Lille - Hôpital Claude Huriez, Lille cedex, Nord, France|CHU Clermont Ferrand - Hôpital d'Estaing- Service d'Hépato-Gastro-Entérologie, Clermont-Ferrand, Puy De Dome, France|Unite de Recherche Clinique, Montfermeil, Seine Saint Denis, France|Chu Amiens Picardie-Sit Sud, AMIENS cedex 1, Somme, France|CHU Grenoble Alpes - Hôpital Michallon, Grenoble, France|CHRU-Nancy Brabois, Vandoeuvre-lès-Nancy, France|LTD Acad. F. Todua Medical Center - LTD Research Institute of Clinical Medicine, Tbilisi, Georgia|LTD Israeli-Georgian Medical Research clinic Helsicore, Tbilisi, Georgia|LLC Vivamedi, Tbilisi, Georgia|LTD Institute of Clinical Cardiology, Tbilisi, Georgia|JSC Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia|LTD Aversi Clinic, Tbilisi, Georgia|LTD Central University Clinic After Academic N. Kipshidze, Tbilisi, Georgia|Malkhaz Katsiashvili Multiprofile Emergency Medicine Center, Tbilisi, Georgia|Praxis Dr. Joergensen, Remscheid, Nordrhein Westfalen, Germany|Schwerpunktpraxis Bonn, Bonn, Rheinland Pfalz, Germany|Clinic for Internal Medicine I, University hospital Schleswig-Holstein, Campus Kiel, Kiel, Schleswig Holstein, Germany|Krankenhaus Waldfriede, Berlin, Germany|Florence-Nightingale-Krankenhaus, Düsseldorf, Germany|Johanna Etienne Krankenhaus, Neuss, Germany|Klinische Forschung Schwerin GmbH, Schwerin, Germany|DRC Gyogyszervizsgalo Kozpont Kft., Balatonfured, Hungary|Bekes Megyei Kozpont Korhaz Dr Rethy Pal Tagkorhaz, 4. Belgyogyaszat es 2. Gasztroenterologia, Bekescsaba, Hungary|Obudai Egeszsegugyi Centrum Kft., Budapest, Hungary|Pannonia Maganorvosi Centrum, Budapest, Hungary|Bugat Pal Korhaz, Gyongyos, Hungary|SZTE AOK I.st dept. of Internal Medicine., Szeged, Hungary|1th Dept of Gastroenterology, Szent Gyorgy Hospital, Szekesfehervar, Hungary|Clinfan Ltd. Outpatient Clinic, Szekszard, Hungary|Szent Borbala Korhaz, Tatabanya, Hungary|Asian Institute of Gastroenterology, Hyderabad, Andhra Pradesh, India|Nirmal Hospitals Pvt Ltd, Surat, Gujarat, India|Surat Institute of Digestive Sciences, Surat, Gujarat, India|Fortis Memorial Research Institute, Gurgaon, Haryana, India|Aster Medcity,Aster DM healthcare Ltd, Kochi, Kerala, India|Midas Multispeciality Hospital-Nagpur, Nagpur, Maharashtra, India|Ruby Hall Clinic, Pune, Maharashtra, India|Shweta Paliwal/Vipin Kumar Jain, Jaipur, Rajasthan, India|Postgraduate department of Medicine, GSVM Medical college, Kanpur, Uttar Pradesh, India|HaEmek Medical Center, Afula, Israel|Bnei Zion Medical Center, Haifa, Israel|Wolfson Medical Center, Holon, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah University Hospital - Ein Kerem, Jerusalem, Israel|Galilee Medical Center, Nahariya, Israel|Rabin Medical Center, Petach Tikva, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Kaplan Medical Center, Rehovot, Israel|Azienda Ospedaliera Saverio De Bellis, Castellana Grotte, Bari, Italy|Ospedale di Circolo, Rho, Milano, Italy|Istituto Clinico Humanitas, U.O. Sezione Autonoma di Malattie Infiammatorie Croniche Intestinali, Rozzano, Milano, Italy|I.R.C.C.S Policlinico San Donato, San Donato Milanese, Milano, Italy|Ospedale Sacro Cuore Don Calabria, Negrar, Verona, Italy|Azienda Ospedaliera Universitaria Policlinico Sant Orsola Malpighi SSD Malattie Infiammatorie Cronic, Bologna, Italy|Spedali Civili di Brescia, U.O. Gastroenterologia, Brescia, Italy|Azienda Ospedaliera Ospedale Cannizzaro, Catania, Italy|Magna Graecia University, Catanzaro, Italy|A.O.U. Policlinico di Modena, Modena, Italy|Ospedale Sandro Pertini, Roma, Italy|Fondazione Policlinico Universitario Agostino Gemelli IRCCS - CEMAD, Roma, Italy|Centro Ricerche Cliniche di Verona, Verona, Italy|Ospedale San Bortolo di Vicenza, Vicenza, Italy|Kyungpook National University Hospital, Junggu, Daegu, Korea, Republic of|Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of|Wonju Severance Christian Hospital, Wonju, Gangwon-do, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital, Suwon-si, Gyeonggi-do, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Seodaemun-gu, Korea, Republic of|Dong-A University Hospital, Busan, Korea, Republic of|Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|The Catholic University of Korea, Seoul St. Marys Hospital, Seoul, Korea, Republic of|P. Stradins Clinical University Hospital, Riga, Latvia|Kaunas Clinical Hospital, Kaunas, Lithuania|Klaipeda University Hospital, Department of Gastroenterology, Klaipeda, Lithuania|Republican Panevezys Hospital, Department of Gastroenterology, Panevezys, Lithuania|UAB ""Inlita"", Santaros Clinical Trials Centre, Vilnius, Lithuania|Vilnius University Hospital Santaros Clinics, Center of Hepatology, Gastroenterology and Dietology, Vilnius, Lithuania|Centro de Investigacion Medico Biologica y Terapia Avanzada s.c., Guadalajara, Jalisco, Mexico|InspirePharma S. de R. L. de C.V., Monterrey, Nuevo León, Mexico|Scientia Investigación Clínica S.C., Chihuahua, Mexico|Hospital Angeles Chihuahua, Chihuahua, Mexico|Faicic S. de R.L. de Cv, Veracruz, Mexico|Clinical Hospital of the Ministry of Health, Labor and Social Protection, Chisinau, Moldova, Republic of|Rtl Sm Srl, Chisinau, Moldova, Republic of|Timofei Mosneaga Republican Clinical Hospital, Department of Gastroenterology, Chisinau, Moldova, Republic of|RTL SM SRL, Institutia Medico-Sanitara Publica Spitalul Clinic, Sectia Proctologie, Chisinau, Moldova, Republic of|Zuyderland Medisch Centrum - Sittard-Geleen, Geleen, Netherlands|Radboudumc, Nijmegen, Netherlands|ETZ Elisabeth, Tilburg, Netherlands|Centrum Dentystyczno-Lekarskie Promedica Joanna Markiewicz, Bedzin, Poland|Gastromed Kralisz, Romatowski, Stachurska sp.j, Białystok, Poland|Centrum Medyczne Pratia Czestochowa, Czestochowa, Poland|Karkonoskie Centrum Badan Klinicznych Lexmedica, Jelenia Gora, Poland|Topolowa Medicenter Mrozek & Wspolnicy Spolka Jawna, Kraków, Poland|Centrum Opieki Zdrowotnej Orkan-med, Ksawerow, Poland|AmiCare Sp. z O.O. Sp.K., Lodz, Poland|IP Clinic, Lodz, Poland|Med-Gastr Przychodnia Specjalistyczna, Lodz, Poland|Allmedica Badania Kliniczne Sp. z o.o. Sp.k., Nowy Targ, Poland|Medicenter Nowy Targ, Nowy Targ, Poland|Medicome Sp. Zo.O., Oswiecim, Poland|Centrum Medyczne Grunwald, Poznan, Poland|SOLUMED Centrum Medyczne, Poznan, Poland|Centrum Medyczne Medyk, Rzeszow, Poland|ENDOSKOPIA Sp.zo.o, Sopot, Poland|DC-MED, Swidnica, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Centrum Zdrowia MDM, Warsaw, Poland|Centralny Szpital Kliniczny MSW w Warszawie, Warsaw, Poland|EMC INSTYTUT MEDYCZNY SA, EuroMediCare Szpital Specjalistyczny z Przychodnia - Dzial Farmacji, Wroclaw, Poland|Centrum Medyczne Oporow, Wroclaw, Poland|Jerzy Rozciecha- Lexmedica, Wroclaw, Poland|Hospital de Braga, Braga, Portugal|Centro Hospitalar e Universitário de Coimbra Serviço Gastrenterologia, Coimbra, Portugal|Hospital da Senhora da Oliveira Guimarães, Guimarães, Portugal|Centro Hospitalar de São João, EPE, Porto, Portugal|Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E., Vila Nova de Gaia, Portugal|Dr. Carol Davila Central University Emergency Military Hospital, Bucharest, Romania|Centrul Medical Unirea srl, Bucharest, Romania|S.C Policlinica CCBR S.R.L, Bucuresti, Romania|S.C MedLife SA, Bucuresti, Romania|Delta Health Care srl, Bucuresti, Romania|S.C Euroclinic Hospital S.A, Bucuresti, Romania|Spitalul Clinic Colentina, Bucuresti, Romania|Institutul Clinic Fundeni, Bucuresti, Romania|Spitalul Clinic Judetean de Urgenta Cluj Napoca, Cluj-Napoca, Romania|Spitalul Clinic Judetean de Urgenta, Craiova, Romania|Cabinet Medical Dr. Fratila S.R.L, Oradea, Romania|S.C Pelican Impex S.R.L, Oradea, Romania|LLC ""Multidisciplinary Medical Clinic ""Anthurium"", Barnaul, Russian Federation|LLC ""Alyans Biomedical- Ural Group"", Irkutsk, Russian Federation|Kazan State Medical University, Kazan, Russian Federation|SAIH ""Kemerovo Regional Clinical Hospital, Kemerovo, Russian Federation|SBIH of Nizhniy Novgorod region ""Nizhniy Novgorod Regional Clinical Hospital n.a. N.A. Semashko"", Nizhniy Novgorod, Russian Federation|LLC Medicine Center SibNovoMed, Novosibirsk, Russian Federation|CDC Ultramed, Omsk, Russian Federation|State Budgetary Healthcare Institution ""Penza Region Clinical Hospital n.a. N.N. Burdenko"", Penza, Russian Federation|LLC ""Medinet"", Saint Petersburg, Russian Federation|LLC ""Gastroenterological centre Expert"", Saint Petersburg, Russian Federation|LLC SM-Clinic, Saint-Peterburg, Russian Federation|Federal state Budgetary Educational Institution of Higher Education ""North-Western Medical University"", Saint. Petersburg, Russian Federation|Irkutsk State Medical Academy of Continuing Education, Samara, Russian Federation|Private Educational Institution of Higher Education ""Medical University REAVIZ"", Samara, Russian Federation|LLC Medical Company ""Hepatologist"", Samara, Russian Federation|SPb SBIH ""City Hospital # 40 of Kurortnyi region"", Sestroretsk, Russian Federation|LLC Uromed, Smolensk, Russian Federation|Stavropol Regional Clinical Diagnostic Centre, Stavropol, Russian Federation|LLC ""Polyclinic of ultrasonography 4D"", Stavropol, Russian Federation|Clinical Center "" Dr Dragisa Misovic Dedinje"", Belgrade, Serbia|Clinical Center of Serbia, Belgrade, Serbia|Clinical Health Center Zvezdara, Belgrade, Serbia|Clinical Center Kragujevac, Kragujevac, Serbia|General Hospital Sremska Mitrovica, Sremska Mitrovica, Serbia|ENDOMED, s.r.o., Vranov nad Toplou, Presov, Slovakia|Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica, Banska Bystrica, Slovakia|Alian S.R.O, Bardejov, Slovakia|KM Management spol. s r.o., Nitra, Slovakia|Fakultna nemocnica Nitra, Nitra, Slovakia|GASTROENTEROLOG, s.r.o., Nove Zamky, Slovakia|Gastromedic, s.r.o., Nove Zamky, Slovakia|Gastro I, s.r.o., Presov, Slovakia|Accout Center s.r.o., Sahy, Slovakia|Johese Clinical Research: Unitas, Lyttelton, Centurion, South Africa|Johese Clinical Research, Midstream, Centurion, South Africa|Lenasia Clinical Trial Centre, Johannesburg, Gauteng, South Africa|Dr JP Wright Practice, Cape Town, Western Cape, South Africa|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Las Palmas, Spain|Hospital General Universitario de Alicante, Alicante, Spain|Centro Médico Teknon, Barcelona, Spain|Hospital Universitario La Paz, Madrid, Spain|Taichung Veterans General Hospital, Taichung, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Faculty of Medicine Siriraj Hospital, Bangkoknoi, Bangkok, Thailand|Supaporn Lertkawinanan, Pathum Wan, Bangkok, Thailand|Phramongkutklao Hospital, Ratchathewi, Bangkok, Thailand|Ms. Arawan Larplertsakul, Chiang Mai, Thailand|Uludag University Medical Faculty, Beşevler, Yenimahalle / Ankara, Turkey|Gazi University Medical Faculty, Ankara, Turkey|Antalya Training and Research Hospital, Antalya, Turkey|Kocaeli University Research and Training Hospital, Kocaeli, Turkey|I.I.Mechnykov Dnipropetrovsk Regional Clinical Hospital, Dnipro, Ukraine|Department of Propaedeutics of Internal Medicine Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine|Municipal non-profit enterprise ""Regional Clinical Hospital of Ivano-Frankivsk Regional Council"", Ga, Ivano-Frankivsk, Ukraine|CNE Prof. O.O. Shalimov Kharkiv City Clinical Hospital #2 of KCC, Kharkiv, Ukraine|Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital, Kharkiv, Ukraine|Communal Non-Commercial Enterprise City Clinical Hospital #13 of Kharkiv City Council, Kharkiv, Ukraine|Communal Noncommercial Enterprise Ye.Ye. Karabelesh Kherson City Clinical Hospital of Kherson City, Kherson, Ukraine|Kremenchuk first city hospital n.a. O.T. Bohaievskyi, Kremenchuk, Ukraine|National Military Medical Clinical Center Main Military Clinical Hospital, Kyiv, Ukraine|Kyiv City Clinical Hospital N 1, Kyiv, Ukraine|Communal Non-Commercial Enterprise Lviv Clinical Hospital of Emergency Medical Care, Lviv, Ukraine|Odesa regional clinical hospital, regional center of gastroenterology, surgical department, Odesa, Ukraine|A. Novak Transcarpathian Regional Clinical Hospital, Uzhgorod, Ukraine|Medical Clinical Investigational Center of Medical Center Health Clinic LLC, Vinnytsia, Ukraine|M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU, Vinnytsia, Ukraine|SRI of Invalid Rehabilitation (EST Complex) of Vinnytsia M.I.Pyrogov NMU MOHU, Vinnytsia, Ukraine|Communal Institution City Clinical Hospital #6, Department of Gastroenterology, Zaporizhzhia, Ukraine|Barts Health NHS Trust - Whipps Cross University Hospital, London, Greater London, United Kingdom|Guys and St Thomas NHS Foundation Trust, London, Greater London, United Kingdom|Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, United Kingdom|Yeovil Hospital NHS Foundation Trust, Yeovil, Somerset, United Kingdom|Belfast Health and Social Care Trust Royal Victoria Hospital, Belfast, United Kingdom|West Hertfordshire Hospitals NHS Trust Hemel Hempstead General Hospital, Hemel Hempstead, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03945188"
829,"NCT03943550","Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Patients With Ulcerative Colitis (UC)",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: RO7049665|Drug: Placebo","Percentage of Participants with Adverse Events|Time to Maximum Concentration (Tmax) of RO7049665|Maximum Serum Concentration Observed (Cmax) of RO7049665|AUC from Time 0 to infinity (AUCinf) of RO7049665|AUC from Time 0 to Time tau (AUC0-t) of RO7049665|Apparent Clearance (CL/F) of RO7049665|Apparent Volume of Distribution (V/F) of RO7049665|Half-life (t1/2) of RO7049665|Change from Baseline in the Endoscopy Subscore of the Mayo Clinic Score (MCS-ES)|Change from Baseline in the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)|Change from Baseline in Histology Score of Sigmoid Colon Biopsies|Change from Baseline in the Mayo Clinic Score (MCS)|Percentage of Participants with Anti-Drug Antibodies|Change from Baseline in White Blood Cells","Hoffmann-La Roche","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 1","65","Industry","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","WP40161|2017-004599-74","May 14, 2019","April 7, 2022","April 7, 2022","May 9, 2019",,"June 21, 2021","Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|University of Washington Medical Center, Seattle, Washington, United States|The Research Institute of Clinical Medicine, Tbilisi, Georgia|Drug Research Centre Gyogyszervizsgalo Kozpontot Kft., Balatonfüred, Hungary|Budai Irgalmasrendi Kórház, Budapest, Hungary|SE ÁOK I. sz. Belgyógyászati Klinika, Budapest, Hungary|ARENSIA Phase 1 Unit- Spitalul Clinic Republican Location, Chisinau, Moldova, Republic of|Medical Center ""Adonis"" LLC, Kapitanovka Village, KIEV Governorate, Ukraine",,"https://ClinicalTrials.gov/show/NCT03943550"
830,"NCT03937609","TITRATE (inducTIon for acuTe ulceRATivE Colitis)","TITRATE","Recruiting","No Results Available","Colitis, Ulcerative","Drug: Infliximab","Increased treatment success|Endoscopic Remission|Endoscopic Reponse|Clinical Remission|Corticosteroid-free remission","Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Pfizer","All","18 Years and older   (Adult, Older Adult)","Phase 4","120","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","6746101818","September 4, 2019","December 31, 2023","December 31, 2024","May 6, 2019",,"February 6, 2020","Academic Medical Center, Amsterdam, Netherlands",,"https://ClinicalTrials.gov/show/NCT03937609"
831,"NCT03934216","Safety and Efficacy of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: BMS-986165|Other: Placebo","Proportion of participants who achieve clinical remission (modified Mayo score)|Proportion of participants who achieve clinical response (modified Mayo score)|Proportion of Participants with Endoscopic Remission|Proportion of Participants with Endoscopic Response","Bristol-Myers Squibb","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","120","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","IM011-024|2018-004694-27","July 1, 2019","September 21, 2021","July 26, 2023","May 1, 2019",,"February 2, 2021","Local Institution, Bristol, Connecticut, United States|University of Florida, Gainesville, Florida, United States|Local Institution, Gainesville, Florida, United States|Advanced Research Institute - New Port Richey, New Port Richey, Florida, United States|Lenus Research, Sweetwater, Florida, United States|Atlanta Gastroenterology Associates, Suwanee, Georgia, United States|Texas Digestive Disease Consultants - Gastroenterology Associates - Baton Rouge, Baton Rouge, Louisiana, United States|Louisiana Research Center, Shreveport, Louisiana, United States|Local Institution, Annapolis, Maryland, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Local Institution, Grand Rapids, Michigan, United States|Mayo Clinic - Rochester, Rochester, Minnesota, United States|Advanced Biomedical Research of America, Las Vegas, Nevada, United States|New York Langone Long Island Clinical Research Associates, Lake Success, New York, United States|New York University Langone Medical Center, New York, New York, United States|Consultants for Clinical Research, Cincinnati, Ohio, United States|Local Institution, Hershey, Pennsylvania, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Rapid City Medical Center, Rapid City, South Dakota, United States|Gastro One, Germantown, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Local Institution, Garland, Texas, United States|Local Institution, Houston, Texas, United States|Spring Gastroenterology Associates - Houston, Houston, Texas, United States|Gastroenterology Research of San Antonio, San Antonio, Texas, United States|Southern Star Research Institute - Medical Center Office, San Antonio, Texas, United States|Local Institution, Southlake, Texas, United States|Tyler Research Institute, Tyler, Texas, United States|Local Institution, Seattle, Washington, United States|Swedish First Hill Campus, Seattle, Washington, United States|Local Institution, Seattle, Washington, United States|Local Institution, Spokane, Washington, United States|The Vancouver Clinic, Vancouver, Washington, United States|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|Local Institution, Ballarat, Victoria, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|Fiona Stanley Hospital, Murdoch, Australia|GZA Ziekenhuizen campus Sint-Vincentius, Antwerpen, Belgium|Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium|Clinique du MontLegia - CHC, Liege, Belgium|Local Institution, New Westminister, British Columbia, Canada|Local Institution, Vancouver, British Columbia, Canada|Local Institution, Etobicoke, Ontario, Canada|Hepato-Gastroenterology HK, Hradec Kralove, Czechia|Nemocnice Slany, Slany, Czechia|Local Institution, Clichy Cedex, France|Local Institution, Montpellier cedex 5, France|Local Institution, Pierre Benite, France|Local Institution, Rennes Cedex 9, France|Local Institution, Saint-Etienne, France|Local Institution, Toulouse cedex 9, France|Charite Universitatsmedizin Berlin - Campus Virchow-Klinikum, Berlin, Germany|Universitatsklinikum Dresden, Dresden, Germany|Local Institution, Hannover, Germany|Local Institution, Jena, Germany|Universitaetsklinikum Schleswig-Holstein - Campus Kiel, Kiel, Germany|EUGASTRO, Leipzig, Germany|Local Institution, Munchen, Germany|Local Institution, Ulm, Germany|Local Institution, Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Budapest, Hungary|Local Institution, Debrecen, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Bugat Pal Korhaz, Gy?gy?, Hungary|Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna, Italy|Azienda Ospedaliero-Universitaria Mater Domini, Catanzaro, Italy|Clinica Medica Azienda Ospedaliera Universitaria, Messina, Italy|Local Institution, Milano, Italy|Local Institution, Milan, Italy|Local Institution, Padova, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|Local Institution, Roma, Italy|Fondazione Policlinico Tor Vergata, Roma, Italy|Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy|Istituto Clinico Humanitas, Rozzano, Italy|National Hospital Organization Hirosaki National Hospital, Hirosaki, Aomori, Japan|Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan|Kurume University Hospital, Kurume-shi, Fukuoka, Japan|National Hospital Organization Takasaki General Medical Center, Takasaki, Gunma, Japan|Hyogo College of Medicine Hospital, Nishinomiya, Hyogo, Japan|Kitasato University Hospital, Sagamihara-shi, Kanagawa, Japan|Shiga University of Medical Science Hospital, Otsu, Shiga, Japan|Tokyo Medical and Dental University, Medical Hospital, Bunkyo-ku, Tokyo, Japan|The Jikei University Hospital, Minato-ku, Tokyo, Japan|Saga University Hospital, Saga, Japan|Local Institution, Daegu, Korea, Republic of|Local Institution, Daegu, Korea, Republic of|Local Institution, Daegu, Korea, Republic of|Local Institution, Incheon, Korea, Republic of|Local Institution, Seoul, Korea, Republic of|Local Institution, Seoul, Korea, Republic of|NZOZ Centrum Medyczne KERmed, Bydgoszcz, Poland|Osrodek Badan Klinicznych CLINSANTE Ewa Galczak-Nowak Malgorzata Trzaska, Bydgoszcz, Poland|Uniwersytecki Szpital Kliniczny Nr 1 Im. Norberta Barlickiego Uniwersytetu Medycznego W Lodzi, Lodz, Poland|Santa Familia - Centrum Badan Profilaktyki i Leczenia, Lodz, Poland|Local Institution, Nowy Targ, Poland|TRIALMED CRS Piotrkow Trybunalski, Piotrkow Trybunalski, Poland|Endoskopia, Sopot, Poland|Twoja Przychodnia Szczecinskie Centrum Medyczne, Szczecin, Poland|H-T. Centrum Medyczne Spolka z Ograniczona Odpowiedzialnoscia, Tychy, Poland|Bodyclinic, Warszawa, Poland|Centrum Zdrowia Matki Dziecka i Mlodziezy, Warszawa, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Medical Concierge Centrum Medyczne, Warszawa, Poland|Niepubliczny Zaklad Opieki Zdrowotnej VIVAMED Jadwiga Miecz, Warszawa, Poland|LexMedica, Wroc?aw, Poland|Centrum Medyczne Oporow, Wroclaw, Poland|Nizhniy Novgorod Regional Clinical Hospital N.A. Semashko, Nizhniy Novgorod, Russian Federation|Medical Center SibNovoMed, Novosibirsk, Russian Federation|Novosibirsk State Regional Clinical Hospital, Novosibirsk, Russian Federation|Medical Center Healthy Family, Novosibirsk, Russian Federation|Saratov Regional Clinical Hospital, Saratov, Russian Federation|Local Institution, Tyumen, Russian Federation|Barnsley Hospital NHS Foundation Trust, Barnsley, United Kingdom|Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom|NHS Greater Glasgow and Clyde, Glasgow, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03934216"
832,"NCT03915769","To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis",,"Recruiting","No Results Available","Colitis, Ulcerative","Drug: Ozanimod|Other: Placebo","Proportion of subjects with clinical response|Proportion of subjects with clinical remission|Proportion of subjects in clinical remission measured at week 12- Rectal Bleeding|Proportion of subjects with endoscopic improvement|Proportion of subjects with mucosal healing|Proportion of subjects with a clinical response|Change in the EuroQol-5 Dimension (EQ-5D) from baseline|Proportion of subjects in clinical remission measured at week 52 - Mayo Score|Proportion of subject with clinical response|Proportion of subjects in remission while off corticosteroids for any length of time|Change in partial Mayo score from Baseline|Adverse Event (AE)|Proportion of subjects in clinical remission measured at week 52- Rectal Bleeding|Proportion of subject with clinical response at week 52","Celgene","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 3","195","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","RPC01-3103|U1111-1230-3228","June 3, 2019","May 20, 2024","May 20, 2024","April 16, 2019",,"January 22, 2021","Kokikai Tokatsu-Tsujinaka Hospital, Abiko, Japan|Mazda Hospital of Mazda Motor Corporation, Aki-gun, Japan|Medical Hospital of Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan|Fukuoka University Chikushi Hospital, Chikushino, Japan|Sai Clinic, Fujiidera, Japan|Fukui Prefectural Hospital, Fukui, Japan|Fukui-ken Saiseikai Hospital, Fukui, Japan|Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan|Gifu Prefectural General Medical Center, Gifu, Japan|Hakodate Goryokaku Hospital, Hakodate, Japan|Hirosaki University Hospital, Hirosaki, Japan|Hiroshima University Hospital, Hiroshima, Japan|Hitachi General Hospital, Hitachi, Ibaraki, Japan|Saitama Medical University Hospital, Iruma-gun, Japan|Tokai University Hospital, Isehara City, Kanagawa, Japan|Kanazawa Medical University Hospital, Kahoku-gun, Japan|Mitoyo General Hospital, Kannonji, Japan|Nara Medical University Hospital, Kashihara, Japan|Kobe University Hospital, Kobe, Japan|Komatsu Municipal Hospital, Komatsu, Japan|Hoshi General Hospital, Koriyama, Japan|Kurume University Hospital, Kurume, Fukuoka, Japan|Our Lady of the Snow Social Medical Corporation St. Mary's Hospital, Kurume, Japan|University Hospital, Kyoto Prefectural University of Medicine, Kyoto-city, Japan|Ehime Prefectural Central Hospital, Matsuyama, Japan|Jikei University Hospital, Minato-ku, Japan|Kitasato University Kitasato Institute Hospital, Minato-ku, Japan|Kyorin University Hospital, Mitaka, Japan|Iwate Medical University Uchimaru Medical Center, Morioka, Japan|Nagaoka Chuo General Hospital, Nagaoka, Japan|Hyogo College of Medicine Hospital, Nishinomiya, Japan|Ogaki Municipal Hospital, Ogaki, Japan|Okayama Saiseikai Outpatient Center Hospital, Okayama, Japan|Iseikai Hospital, Osaka, Japan|Osaka City University Hospital, Osaka, Japan|Osaki Citizen Hospital, Osaki-shi, Japan|Shiga University of Medical Science Hospital, Otsu, Japan|Saga University Hospital, Saga, Japan|Tokitokai Tokito Clinic, Saitama, Japan|Osaka Rosai Hospital, Sakai, Japan|Toho University Medical Center Sakura Hospital, Sakura, Japan|Sapporo Medical University Hospital, Sapporo, Hokkaidô, Japan|JA Sapporo Kosei General Hospital, Sapporo, Japan|Japan Community Health care Organization Hokkaido Hospital, Sapporo, Japan|IMS Meirikai Sendai General Hospital, Sendai, Japan|NTT Medical Center Tokyo, Shinagawa-ku, Tokyo, Japan|Tokyo Yamate Medical Center, Shinju-ku, Japan|Shizuoka City Shizuoka Hospital, Shizuoka-shi, Japan|National Hospital Organization Shizuoka Medical Center, Sunto-gun, Japan|Kagawa Prefectural Central Hospital, Takamatsu, Japan|Medical Corporation Shoyu-Kai Fujita Gastroenterology Hospital, Takatsuki, Japan|Takatsuki Red Cross Hospital, Takatsuki, Japan|Toyama City Hospital, Toyama, Japan|Mie University hospital, Tsu, Japan|Kanke Gastrointestinal Clinic, Utsunomiya, Japan",,"https://ClinicalTrials.gov/show/NCT03915769"
833,"NCT03907631","Multi-centre Acute Severe Ulcerative Colitis Prospective Cohort Study (Elevate ASUC)","ELEVATE-ASUC","Recruiting","No Results Available","Severe Ulcerative Colitis","Other: Standard of care","In Hospital Outcomes|Colectomy rates|Long-term response to medical management|Risk factors for need for rescue","Hull University Teaching Hospitals NHS Trust","All","18 Years to 80 Years   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","259837","October 18, 2019","September 1, 2020","September 1, 2021","April 9, 2019",,"February 5, 2020","Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust, Hull, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03907631"
834,"NCT03872271","Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL Trial","IDEAL","Not yet recruiting","No Results Available","Ulcerative Colitis|Ileostomy - Stoma","Procedure: ileal pouch-anal anastomosis with diverting loop ileastomy","6-month global postoperative morbidity","Assistance Publique Hopitaux De Marseille","All","18 Years and older   (Adult, Older Adult)","Not Applicable","194","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","2019-04|2019-A00687-50","September 1, 2019","August 31, 2023","December 31, 2023","March 13, 2019",,"March 13, 2019","Assistance Publique Hôpitaux de Marseille, Marseille, France",,"https://ClinicalTrials.gov/show/NCT03872271"
835,"NCT03869905","Aquamin® as an Adjuvant Intervention for Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Aquamin®|Drug: Placebo first then Aquamin®","Change in ulcerative colitis clinical features / presentation as measured by the Inflammatory Bowel Disease Questionnaire (IBDQ) score|Change in clinical assessment /gastroenterologist's endoscopic findings based on Ulcerative Colitis Disease Activity Index (UCDAI)/Mayo Scoring|Change in Cytokine levels of the colon tissue as measured by Interleukin 8 (IL-8) levels assessed by enzyme-linked immunosorbent assay (ELISA)|Change in serum C-reactive protein (CRP) levels as measured in a blood sample.|Change in fecal calprotectin levels measured in a stool sample|Changes in serum liver function tests","James Varani|University of Michigan","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","HUM00156676","August 8, 2019","May 2023","December 2023","March 11, 2019",,"April 8, 2021","The University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT03869905"
836,"NCT03861143","Efficacy and Safety of Oral BT-11 in Mild to Moderate Ulcerative Colitis",,"Active, not recruiting","No Results Available","Ulcerative Colitis","Drug: BT-11 (500 mg)|Drug: BT-11 (1000 mg)|Drug: Placebo","Clinical remission rate|Endoscopic remission rate|Mucosal healing rate|Mean change in fecal calprotectin from baseline|Concentration of BT-11 in feces|Number of participants with treatment-related adverse events","Landos Biopharma Inc.","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","198","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","BT-11-201","August 14, 2019","July 2021","July 2021","March 4, 2019",,"June 29, 2021","Axis Clinical Trials, Los Angeles, California, United States|Ventura Clinical Trials, Ventura, California, United States|Clinical Research of California, Walnut Creek, California, United States|Medycal Research Inc., Brooksville, Florida, United States|Invesclinic.U.S,LLC.FL, Fort Lauderdale, Florida, United States|I.H.S Health LLC, Kissimmee, Florida, United States|Smart Medical Research, Richmond Hill, New York, United States|Invesclinic.U.S,LLC., McAllen, Texas, United States|Texas Gastroenterology Associates, Spring, Texas, United States|Polyclinic and Daily hospital ""Dr Al Tawil"", Sarajevo, Federation BiH, Bosnia and Herzegovina|Cantonal Hospital Zenica, Gastroenterology, Zenica, Bosnia and Herzegovina|Polyclinic Duvnjak, Zagreb, Croatia|Centrum Badan Klinicznych PI-House Sp. z o.o., Gdańsk, Pomorskie, Poland|RIVERM E D Sp. zo.o., Poznań, Wielkopolskie, Poland|Municipal Non-profit Enterprise ""City Outpatient Clinic No 9 of Kharkiv City Council, Surgery department, Kharkiv, Kharkiv, Ukraine|Multidisciplinary Medical Center of Odesa National Medical University, First Surgery Department ,Odesa National Medical University , Chair of General and Military Surgeon, Odesa, Ukraine",,"https://ClinicalTrials.gov/show/NCT03861143"
837,"NCT03840928","AR-Power Patient Powered Research Network","GHLF","Recruiting","No Results Available","Rheumatoid Arthritis|Ankylosing Spondylitis|Fibromyalgia|Gout|Crohn Disease|Juvenile Idiopathic Arthritis|Lupus Erythematosus|Myositis|Osteoarthritis|Osteoporosis|Psoriasis|Psoriatic Arthritis|Scleroderma",,"Pain Interference (PROMIS)|Fatigue (PROMIS)|Sleep Disturbance (PROMIS)|Physical Function (PROMIS)|RAPID-3 (MD-HAQ with visual analogue scale for pain and patient global measure for overall health)","Global Healthy Living Foundation|University of Alabama at Birmingham","All","19 Years and older   (Adult, Older Adult)",,"9867","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","GlobalHealthyLivingF","April 1, 2015","March 1, 2025","March 1, 2025","February 15, 2019",,"February 2, 2021","Global Healthy Living Foundation, Upper Nyack, New York, United States",,"https://ClinicalTrials.gov/show/NCT03840928"
838,"NCT03824561","Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Vedolizumab","Number of Participants who have One or More Adverse Events|Number of Participants who have One or More Adverse Drug Reactions|Number of Participants who have a Presence or Absence of Therapeutic Response After 3 Doses of Vedolizumab|Number of Participants who continue the Therapy After 3 Doses of Vedolizumab|Change from Baseline in Complete Mayo Scores|Change from Baseline in Partial Mayo Scores|Change from Baseline in Quality of Life (QOL) Assessment using Short Inflammatory Bowel Disease Questionnaire (SIBDQ)|Change from Baseline in Fecal Calprotectin","Takeda","All","Child, Adult, Older Adult",,"1000","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","Vedolizumab-5033|JapicCTI-194603","February 1, 2019","October 31, 2023","October 31, 2023","January 31, 2019",,"April 19, 2021","Takeda Selected Site, Tokyo, Japan",,"https://ClinicalTrials.gov/show/NCT03824561"
839,"NCT03808506","Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Diagnostic Test: Fecal calprotectin","Baseline fecal calprotectin concentration|Post Induction fecal calprotectin concentration|Baseline Mayo Endoscopic Score|Baseline bowel ultrasound inflammatory score","Lawson Health Research Institute","All","18 Years and older   (Adult, Older Adult)",,"29","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","113446","September 1, 2019","June 30, 2021","June 30, 2021","January 17, 2019",,"February 25, 2020","London Health Sciences Center, London, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03808506"
840,"NCT03804931","Fecal Microbiota Transplantation for Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis|Fecal Microbiota Transplantation","Procedure: Fecal microbiota transplantation|Procedure: Infusion of Saline|Drug: 5-Aminosalicylic acid(5-ASA) and/or Prednisone","Clinical remission in patient as assessed using Mayo score|Clinical improvement in patient as assessed using Mayo score|Intestinal microbiota changing","Guangzhou First People's Hospital","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2|Phase 3","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","K-2017-103-01","January 20, 2019","December 31, 2028","December 31, 2030","January 15, 2019",,"January 15, 2019","Guangzhou First People's Hospital, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03804931"
841,"NCT03773952","Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients","ADENOIBD","Recruiting","No Results Available","Ulcerative Colitis","Drug: PBF-677|Drug: Placebo oral capsule","Number of subjects with treatment-related adverse events as assessed by CTCAE v4.03""|Effect of PBF-677 on Faecal calprotectin levels|Effect of PBF-677 on Ulcerative Colitis activity|Pharmacokinetic PBF-677 peak concentration in plasma|Pharmacokinetic Time to PBF-677 peak concentration in plasma ""Tmax""|Pharmacokinetic Area under curve (AUC) of PBF-677 in plasma|Pharmacokinetic Ctrough plasma concentration of PBF-677","Palobiofarma SL|Qualitecfarma","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","50","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","PBF-677-3","July 1, 2018","August 31, 2021","October 30, 2021","December 12, 2018",,"September 21, 2020","Unidad de Enfermedad Inflamatoria Intestinal / IBD Unit. Servicio de Gastroenterología y Hepatología / Gastroenterology and Hepatology Dpt. Study Medical Coordinator Hospital Universitario Puerta de Hierro, Madrid, Spain",,"https://ClinicalTrials.gov/show/NCT03773952"
842,"NCT03765450","Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis","PROTOS","Recruiting","No Results Available","Ulcerative Colitis","Drug: Infliximab","Inter-compartmental Difference in Infliximab Concentration|Change in Proteome|Change in Transcriptome|Change in Robarts Histopathologic Index|Change in Mayo Clinic Endoscopic Score","Alimentiv Inc.","All","18 Years and older   (Adult, Older Adult)",,"30","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","RP1713","December 21, 2018","December 2021","December 2021","December 5, 2018",,"December 2, 2020","UCSD, San Diego, California, United States|Cornell University, New York, New York, United States|London Health Sciences Center, London, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03765450"
843,"NCT03760003","Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis",,"Active, not recruiting","No Results Available","Ulcerative Colitis","Drug: ABX464 25mg|Drug: ABX464 50mg|Drug: ABX464 100mg|Drug: Placebo","Modified Mayo Score|Clinical remission|Endoscopic Improvement|fecal calprotectin|C Reactive Protein|miR-124 expression|Inflammatory Infiltrate","Abivax S.A.","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","254","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","ABX464-103","June 11, 2019","May 15, 2021","June 30, 2021","November 30, 2018",,"January 28, 2021","UCSD Health System, San Diego, California, United States|Atlanta Center for Gastroenterology, P.C, Decatur, Georgia, United States|Central Texas Clinical Research, LLC, Austin, Texas, United States|Southern Star Research Institute, LLC, San Antonio, Texas, United States|Medizinische Universität Innsbruck, Innsbruck, Austria|Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria|Ordensklinikum Linz GmbH - Barmherzige Schwestern, Linz, Austria|AKH - Medizinische Universität Wien, Vienna, Austria|Gomel Regional Clinical Hospital, Gomel, Belarus|Minsk city diagnostic center, Minsk, Belarus|Regional Clinical Hospital, Minsk, Belarus|Vitebsk Regional Clinical Hospital, Vitebsk, Belarus|Vitebsk regoinal clinical specialized center, Vitebsk, Belarus|AZ Sint-Lucas, Brugge, Belgium|C. H. U. St-Pierre, Brussels, Belgium|UZA, Edegem, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|UZ Leuven, Leuven, Belgium|Brandon Medical Arts Clinic, Brandon, Canada|South Edmonton Gastroenterology, Edmonton, Canada|LHSC - Victoria Hospital, London, Canada|The Ottawa Hospital - General Campus, Ottawa, Canada|Allen Whey Khye Lim Professional Corporation, Saskatoon, Canada|Mount Sinai Hospital, Toronto, Canada|Fakultni nemocnice u sv. Anny v Brne, Brno, Czechia|Hepato-Gastroenterologie HK s.r.o., Hradec Kralove, Czechia|MUDr. GREGAR s.r.o., Olomouc, Czechia|Fakultni nemocnice Ostrava, Ostrava-Kunčice, Czechia|Nemocnice Na Bulovce, Praha, Czechia|Thomayerova nemocnice, Praha, Czechia|Nemocnice Slany, Slany, Czechia|CHU Amiens - Hopital Sud, Amiens, France|CHU Besançon - Hôpital Jean Minjoz, Besançon, France|CHU Clermont Ferrand - Hôpital d'Estaing, Clermont-Ferrand, France|Hôpital Beaujon, Clichy, France|CHU de Grenoble - Hôpital Nord, Grenoble, France|Centre Hospitalier Départemental Les Oudairies, La Roche-sur-Yon, France|CHU Lille - Hôpital Claude Huriez, Lille, France|Hôpital Nord - CHU Marseille, Marseille, France|Hopital Saint Eloi, Montpellier, France|CHU Nantes - Hôtel Dieu, Nantes, France|CHU Nice - Hôpital de l'Archet 2, Nice, France|CHU Reims - Hôpital Robert Debré, Reims, France|CHU Rennes - Hôpital Pontchaillou, Rennes, France|CHU de Rouen - Hôpital Charles Nicolle, Rouen, France|CHU Saint Etienne - Hôpital Nord, Saint-Étienne, France|CHU Strasbourg - Hôpital Hautepierre, Strasbourg, France|Hopital Rangueil, Toulouse, France|Hôpital de Brabois Adultes, Vandœuvre-lès-Nancy, France|Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany|Florence-Nightingale-Krankenhaus-Diakonie Kaiserswerth, Düsseldorf, Germany|Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt, Germany|Studiengesellschaft BSF Unternehmergesellschaft haftungsbeschraenkt, Halle, Germany|Universitaetsklinikum Halle (Saale), Halle, Germany|Medizinische Hochschule Hannover, Hanover, Germany|Johanna-Etienne-Krankenhaus, Neuss, Germany|Tumorzentrum Nordthueringen MVZ GmbH, Nordhausen, Germany|Dr. Tasso Bieler, Riesa, Germany|Universitaetsklinikum Ulm, Ulm, Germany|DRC Gyogyszervizsgalo Kozpont Kft., Balatonfured, Hungary|Obudai Egeszsegugyi Centrum Kft., Budapest, Hungary|Pannonia Maganorvosi Centrum, Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Debreceni Egyetem, Debrecen, Hungary|Vasutegeszsegugyi Kft. - Debreceni Egeszsegugyi Kozpont, Debrecen, Hungary|Petz Aladar Megyei Oktato Korhaz, Győr, Hungary|Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi, Bologna, Italy|Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy|Azienda Ospedaliero Universitaria Mater Domini, Catanzaro, Italy|I.R.C.C.S Policlinico San Donato, Milano, Italy|Ospedale Sacro Cuore Don Calabria, Negrar, Italy|Azienda Ospedaliera di Padova, Padova, Italy|Azienda Ospedaliero Universitaria Policlinico Paolo Giaccone, Palermo, Italy|Azienda Ospedaliero Universitaria Pisana (Presidio di Cisanello), Pisa, Italy|Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy|Istituto Clinico Humanitas, Rozzano, Italy|Szpital Uniwersytecki nr 2 im.dr J. Biziela, Bydgoszcz, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, Poland|Centrum Medyczne Plejady, Kraków, Poland|Santa Familia Centrum Badan, Profilaktyki i Leczenia, Lodz, Poland|Wojskowy Szpital Kliniczny w Lublinie, Lublin, Poland|Trialmed CRS, Piotrkow Trybunalski, Poland|Centrum Medyczne Grunwald, Poznan, Poland|KO-MED Centra Kliniczne Pulawy, Pulawy, Poland|Gabinet Lekarski Bartosz Korczowski, Rzeszow, Poland|Centrum Zdrowia MDM, Warszawa, Poland|Nzoz Vivamed, Warszawa, Poland|Centrum Zdrowia Tuchow Sp. z o.o., Wierzchosławice, Poland|Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska, Wroclaw, Poland|Centrum Medyczne Oporow, Wroclaw, Poland|LexMedica, Wroclaw, Poland|Clinical Center Zvezdara, Belgrade, Serbia|Clinical Center "" Dr Dragisa Misovic Dedinje"", Belgrad, Serbia|Clinical Center Bezanijska Kosa, Belgrad, Serbia|General Hospital Uzice, Užice, Serbia|General Hospital ""Djordje Joanovic"", Zrenjanin, Serbia|Alian s.r.o., Bardejov, Slovakia|Cliniq s.r.o., Bratislava, Slovakia|Gastromedic, s.r.o., Nové Zámky, Slovakia|Gastro I, s.r.o., Prešov, Slovakia|Endomed, s.r.o., Vranov Nad Topľou, Slovakia|Accout Center s.r.o., Šahy, Slovakia|General Hospital Celje, Celje, Slovenia|University Medical Centre Maribor, Maribor, Slovenia|General Hospital Murska Sobota, Murska Sobota, Slovenia|Centro Médico Teknon, Barcelona, Spain|Hospital Universitario Reina Sofia, Córdoba, Spain|Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria, Spain|Hospital Quironsalud Malaga, Málaga, Spain|CNE Cherkasy Regional Hospital of Cherkasy Regional Council, Cherkasy, Ukraine|I.I.Mechnykov Dnipropetrovsk Regional Clinical Hospital, Dnipro, Ukraine|Central City Clinical Hospital Dept of Theraphy No. 2 SHEI Ivano-Frankivsk NMU, Ivano-Frankivs'k, Ukraine|CHI Kharkiv City Clinical Hospital #13, Kharkiv, Ukraine|CNE Prof. O.O. Shalimov Kharkiv City Clinical Hospital #2 of KCC, Kharkiv, Ukraine|Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital, Kharkiv, Ukraine|CI Kherson CCH, Kherson, Ukraine|Khmelnytska Regional Hospital, Khmelnytskyi, Ukraine|Communal Institution of Kyiv Regional Council Kyiv Regional Clinical Hospital, Kyiv, Ukraine|Lviv Regional Clinical Hospital D.Halytskyi Lviv NMU, Lviv, Ukraine|Ternopil University Hospital, Ternopil', Ukraine|CCH #1 Vinnytsia M.I. Pyrogov NMU Ch of Propaedeutics of IM, Vinnytsia, Ukraine|M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU, Vinnytsia, Ukraine|MCIC MC LLC Health Clinic, Vinnytsia, Ukraine|CI City Clinical Hospital #6 Dept of Gastroenterology, Zaporizhzhia, Ukraine|CNCE ""City Hospital 9"" Zaporizhzhia CC, Zaporizhzhia, Ukraine|A. Novak Transcarpathian Regional Clinical Hospital, Úzhgorod, Ukraine|Fairfield General Hospital, Bury, United Kingdom|Guy's Hospital, London, United Kingdom|University College London Hospitals, London, United Kingdom|Nottingham University Hospitals Queen's Medical Centre, Nottingham, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03760003"
844,"NCT03759041","A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis","ECO-RESET","Active, not recruiting","No Results Available","Ulcerative Colitis","Drug: Vancomycin Pre-Treatment|Drug: Placebo for Vancomycin Pre-Treatment|Drug: SER-287|Drug: Placebo for SER-287","Clinical Remission|Endoscopic Improvement","Seres Therapeutics, Inc.","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","201","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","SERES-201","December 19, 2018","June 2021","July 2022","November 29, 2018",,"March 17, 2021","(Investigator site), Phoenix, Arizona, United States|(Investigator site), North Little Rock, Arkansas, United States|(Investigator site), La Jolla, California, United States|(Investigator site), Lancaster, California, United States|(Investigator site), Los Angeles, California, United States|(Investigator site), Mountain View, California, United States|(Investigator site), San Diego, California, United States|(Investigator site), San Diego, California, United States|(Investigator site), Wheat Ridge, Colorado, United States|(Investigator site), Danbury, Connecticut, United States|(Investigator site), Hamden, Connecticut, United States|(Investigator site), Boca Raton, Florida, United States|(Investigator site), Clearwater, Florida, United States|(Investigator site), Crystal River, Florida, United States|(Investigator site), Fort Lauderdale, Florida, United States|(Investigator site), Hialeah, Florida, United States|(Investigator site), Jacksonville, Florida, United States|(Investigator site), Miami, Florida, United States|(Investigator site), Miami, Florida, United States|(Investigator site), Naples, Florida, United States|(Investigator site), Ocala, Florida, United States|(Investigator site), Orlando, Florida, United States|(Investigator site), Pompano Beach, Florida, United States|(Investigator site), Port Orange, Florida, United States|(Investigator site), Tampa, Florida, United States|(Investigator site), Athens, Georgia, United States|(Investigator site), Atlanta, Georgia, United States|(Investigator site), Marietta, Georgia, United States|(Investigator site), Chicago, Illinois, United States|(Investigator site), Chicago, Illinois, United States|(Investigator site), Chicago, Illinois, United States|(Investigator site), Indianapolis, Indiana, United States|(Investigator site), Lexington, Kentucky, United States|(Investigator site), Lake Charles, Louisiana, United States|(Investigator site), Metairie, Louisiana, United States|(Investigator site), Monroe, Louisiana, United States|(Investigator site), New Orleans, Louisiana, United States|(Investigator site), Shreveport, Louisiana, United States|(Investigator site), Baltimore, Maryland, United States|(Investigator site), Glen Burnie, Maryland, United States|(Investigator site), Ann Arbor, Michigan, United States|(Investigator site), Farmington Hills, Michigan, United States|(Investigator site), Rochester, Minnesota, United States|(Investigator site), Bridgeton, Missouri, United States|(Investigator site), Creve Coeur, Missouri, United States|(Investigator site), Las Vegas, Nevada, United States|(Investigator site), Reno, Nevada, United States|(Investigator site), Lebanon, New Hampshire, United States|(Investigator site), Great Neck, New York, United States|(Investigator site), Hartsdale, New York, United States|(Investigator site), New York, New York, United States|(Investigator site), New York, New York, United States|(Investigator site), Asheville, North Carolina, United States|(Investigator site), Chapel Hill, North Carolina, United States|(Investigator site), Durham, North Carolina, United States|(Investigator site), Raleigh, North Carolina, United States|(Investigator site), Winston-Salem, North Carolina, United States|(Investigator site), Winston-Salem, North Carolina, United States|(Investigator site), Cincinnati, Ohio, United States|(Investigator site), Oklahoma City, Oklahoma, United States|(Investigator site), Columbia, South Carolina, United States|(Investigator site), Greenville, South Carolina, United States|(Investigator site), Memphis, Tennessee, United States|(Investigator site), Nashville, Tennessee, United States|(Investigator site), Bedford, Texas, United States|(Investigator site), Fort Sam Houston, Texas, United States|(Investigator site), Houston, Texas, United States|(Investigator site), Houston, Texas, United States|(Investigator site), Houston, Texas, United States|(Investigator site), McAllen, Texas, United States|(Investigator site), San Antonio, Texas, United States|(Investigator site), Temple, Texas, United States|(Investigator site), Ogden, Utah, United States|(Investigator site), Salt Lake City, Utah, United States|(Investigator site), Leesburg, Virginia, United States|(Investigator site), Lynchburg, Virginia, United States|(Investigator site), Reston, Virginia, United States|(Investigator site), Richmond, Virginia, United States|(Investigator site), Spokane, Washington, United States|(Investigator site), Madison, Wisconsin, United States|(Investigator site), Milwaukee, Wisconsin, United States|(Investigator site), Edmonton, Alberta, Canada|(Investigator site), Edmonton, Alberta, Canada|(Investigator site), New Westminster, British Columbia, Canada|(Investigator site), Bridgewater, Ontario, Canada|(Investigator site), Lindsay, Ontario, Canada|(Investigator site), London, Ontario, Canada|(Investigator site), London, Ontario, Canada|(Investigator site), Sudbury, Ontario, Canada|(Investigator site), Toronto, Ontario, Canada|(Investigator site), Vaughan, Ontario, Canada|(Investigator site), Greenfield Park, Quebec, Canada|(Investigator site), Saskatoon, Saskatchewan, Canada",,"https://ClinicalTrials.gov/show/NCT03759041"
845,"NCT02538341","Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)",,"Active, not recruiting","No Results Available","Rheumatoid Arthritis|Inflammatory Arthritis|Arthritis|Psoriatic Arthritis|Psoriasis|Ankylosing Spondylitis|Enteropathic Arthritis|Crohn's Disease","Biological: Herpes Zoster Vaccine|Drug: Placebo","Immunogenicity measured at 6 weeks.|The clinical effectiveness of the HZ vaccine in reducing longer-term HZ risk|Estimate vaccine safety|Vaccine tolerability|Evaluate RA disease activity","University of Alabama at Birmingham|Oregon Health and Science University","All","50 Years and older   (Adult, Older Adult)","Phase 2","617","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","VERVE-UM1","May 2016","December 2019","December 2020","September 2, 2015",,"July 20, 2020","Rheumatology Associates, PC, Birmingham, Alabama, United States|Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, United States|University of Alabama at Birmingham, Birmingham, Alabama, United States|Rheumatology Associates of North Alabama, PC, Huntsville, Alabama, United States|Clinical and Translational Research Center of Alabama, PC, Tuscaloosa, Alabama, United States|SunValley Arthritis Center, Ltd, Peoria, Arizona, United States|Arthritis Association of Southern California, Los Angeles, California, United States|The Regents of the University of California Los Angeles, Los Angeles, California, United States|Rheumatology Consultants of Delaware dba Delaware Arthritis, Lewes, Delaware, United States|Center for Arthritis and Rheumatic Diseases, Miami, Florida, United States|Coral Research Clinic Corp, Miami, Florida, United States|Arthritis Research of Florida, Inc, Palm Harbor, Florida, United States|Sarasota Arthritis Research Center, Sarasota, Florida, United States|West Broward Rheumatology Associates, Inc, Tamarac, Florida, United States|North Georgia Rheumatology Group, Lawrenceville, Georgia, United States|Arthritis Research Center Foundation, NDB, Wichita, Kansas, United States|Ochsner Clinic Baton Rouge, Baton Rouge, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, New Orleans, Louisiana, United States|Rheumatology & Osteoporosis Specialists, Shreveport, Louisiana, United States|Boston Medical Center, Boston, Massachusetts, United States|Pine Hollow Partners, East Lansing, Michigan, United States|St. Paul Rheumatology, Eagan, Minnesota, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|The Center for Rheumatology, LLP, Albany, New York, United States|Mary Imogene Bassett Hospital, Bassett Research Institute, Cooperstown, New York, United States|The Ohio State University, Columbus, Ohio, United States|Oregon Health & Science University, Portland, Oregon, United States|Altoona Center for Clinical Research, Duncansville, Pennsylvania, United States|Carolina Health Specialists, Myrtle Beach, South Carolina, United States|Arthritis Associates, PLLC, Hixson, Tennessee, United States|West Tennessee Research Institute, Jackson, Tennessee, United States|Southwest Rheumatology Research, LLC, Mesquite, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|West Virginia Research Institute, PLLC, South Charleston, West Virginia, United States",,"https://ClinicalTrials.gov/show/NCT02538341"
846,"NCT03724929","Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis","PREDIRESPUC","Recruiting","No Results Available","Ulcerative Colitis","Procedure: Blood sample|Device: Rectosigmoidoscopy","Vedolizumab concentration at week 6|Vedolizumab concentration at week 14|vedolizumab concentration and anti-vedolizumab antibodies concentrations at week 2|vedolizumab concentration and anti-vedolizumab antibodies concentrations at week 14|Vedolizumab concentration at week 6 and mucosal healing|Vedolizumab concentration at week 14 and mucosal healing|intra and inter-individual heterogeneity of VDZ levels|Proportion of loss of clinical response|Variation of serum VDZ|vedolizumab concentration and anti-vedolizumab antibodies concentrations","Centre Hospitalier Universitaire de Saint Etienne|Takeda|Theradiag","All","18 Years and older   (Adult, Older Adult)","Not Applicable","125","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","1708213|2018-001051-12","March 4, 2019","September 2023","September 2024","October 30, 2018",,"May 21, 2021","CHU Amiens, Amiens, France|CHU Kremlin Bicêtre, Le Kremlin-Bicêtre, France|Chu L'Archet, Nice, France|Ch Lyon Sud, Pierre-Bénite, France|CHU Saint-Etienne, Saint-Étienne, France",,"https://ClinicalTrials.gov/show/NCT03724929"
847,"NCT03724175","The Role of Secondary Bile Acids in Intestinal Inflammation",,"Recruiting","No Results Available","Ulcerative Colitis|Pouchitis","Drug: ursodiol (ursodeoxycholic acid, UDCA)","Proportion of subjects who achieve clinical response at week 10.|Proportion of subjects who achieve remission at week 10.|Proportion of subjects who achieve endoscopic response at week 10.|Proportion of subjects who achieve endoscopic remission at week 10.|Proportion of subjects with a stool frequency represented by a Mayo subscore of <1 at Week 10.|Mean change in Cleveland Global Quality of Life (CGQL)|Mean change in erythrocyte sedimentation rate (ESR)|Mean change in C-reactive protein (CRP)|Mean change in fecal calprotectin","Stanford University","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 2|Phase 3","15","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB-47198","August 26, 2019","December 2025","December 2050","October 30, 2018",,"May 4, 2021","Stanford University, Stanford, California, United States",,"https://ClinicalTrials.gov/show/NCT03724175"
848,"NCT03720002","HF2 Therapy in the Treatment of Active Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Dietary Supplement: HF2","Clinical remission","Sheba Medical Center","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 1|Phase 2","34","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","SHEBA-17-4232-UK-CTIL","May 29, 2019","January 1, 2023","January 1, 2023","October 25, 2018",,"February 5, 2021","Sheba Medical Center, Ramat Gan, Israel",,"https://ClinicalTrials.gov/show/NCT03720002"
849,"NCT03698812","A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis",,"Recruiting","No Results Available","Prospective Study|Ulcerative Colitis in Remission","Combination Product: Colonoscope","relapse rate|surgery rate|Rehospitalization rate|requirement for escalation of drugs|complication rate","Nanfang Hospital of Southern Medical University","All","14 Years to 75 Years   (Child, Adult, Older Adult)",,"9","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","LC2016PY007","January 1, 2017","September 30, 2020","September 30, 2021","October 9, 2018",,"October 17, 2018","Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03698812"
850,"NCT03695185","A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy",,"Active, not recruiting","No Results Available","Ulcerative Colitis (UC)","Drug: ABBV-323 Dose A|Drug: ABBV-323 Dose B","Percentage of Participants with Endoscopic Improvement|Percentage of Participants with Clinical Remission per Adapted Mayo Score|Percentage of Participants with Clinical Response per Adapted Mayo Score|Percentage of Participants with Clinical Response per Partial Adapted Mayo Score|Percentage of Participants with Clinical Remission per Full Mayo Score in Participants with a Full Mayo Score of 6 to 12 at Baseline|Percentage of Participants with Endoscopic Remission","AbbVie","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 2","42","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","M15-722|2018-000930-37","March 26, 2019","December 27, 2021","May 18, 2023","October 4, 2018",,"February 11, 2021","Banner University Medical Cent /ID# 208392, Tucson, Arizona, United States|Meridian Investigator Network /ID# 204646, Huntington Beach, California, United States|Meridian Investigator Network /ID# 218568, Lakewood, California, United States|TLC Clinical Research Inc /ID# 206626, Los Angeles, California, United States|Orange County Institute of Gastroenterology and Endoscopy /ID# 207405, Mission Viejo, California, United States|UC Davis Medical Center /ID# 209402, Sacramento, California, United States|University of Chicago /ID# 207086, Chicago, Illinois, United States|Affinity Clinical Research /ID# 206211, Oak Brook, Illinois, United States|Univ New Mexico /ID# 208817, Albuquerque, New Mexico, United States|Penn Presbyterian Medical Center /ID# 206826, Philadelphia, Pennsylvania, United States|Vanderbilt Univ Med Ctr /ID# 204670, Nashville, Tennessee, United States|Clinical Associates in Researc /ID# 204689, San Antonio, Texas, United States|Mount Sinai Hosp.-Toronto /ID# 206180, Toronto, Ontario, Canada|Chu de Nice-Hopital L'Archet Ii /Id# 208131, Nice CEDEX 3, Alpes-Maritimes, France|Hopital Beaujon /ID# 208129, Clichy, Ile-de-France, France|CHU NANCY - Hopital Brabois Adultes /ID# 208133, Vandoeuvre les Nancy CEDEX, Meurthe-et-Moselle, France|Universitaetsklinikum Schleswig-Holstein /ID# 207571, Kiel, Schleswig-Holstein, Germany|Charite Universitaetsmedizin Berlin /ID# 207570, Berlin, Germany|Universitaetsklinikum Frankfurt /ID# 207569, Frankfurt, Germany|Debreceni Egyetem Klinikai Kozpont /ID# 221952, Debrecen, Hungary|University of Szeged /ID# 221576, Szeged, Hungary|Universita di Catanzaro Magna Graecia /ID# 204546, Catanzaro, Calabria, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 208504, Milan, Lombardia, Italy|Complesso integrato Columbus /ID# 204549, Rome, Italy|Kyungpook National Univ Hosp /ID# 209912, Daegu, Daegu Gwang Yeogsi, Korea, Republic of|Yeungnam University Med Ctr /ID# 210447, Daegu, Daegu Gwang Yeogsi, Korea, Republic of|Maastricht Universitair Medisch Centrum /ID# 204428, Maastricht, Netherlands|Sint Franciscus Gasthuis /ID# 206976, Rotterdam, Netherlands|Elisabeth Tweesteden Ziekenhuis /ID# 206272, Tilburg, Netherlands|Hospital Santa Creu i Sant Pau /ID# 213259, Barcelona, Spain|Hospital General Universitario Gregorio Maranon /ID# 204504, Madrid, Spain|Hospital Universitario La Paz /ID# 210065, Madrid, Spain|Queen Elizabeth University Hos /ID# 206574, Glasgow, Glasgow City, United Kingdom|Royal Victoria Hospital /ID# 206744, Belfast, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03695185"
851,"NCT03679546","EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis","EFFICACI","Recruiting","No Results Available","Ulcerative Colitis","Drug: Infliximab|Drug: Vedolizumab Injection","Remission|Mayo score|Faecal calprotectin level|Colectomy or hospitalization for disease flare|Endoscopic subscore of the mayo Score|Partial Mayo score|Inflammatory Bowel Disease Questionnaire (IBDQ) index|Inflammatory Bowel Disease-Disk (IBD-Disk)|Inflammatory Bowel Disease-Disability Index (IBD-DI)|Adverse events|Last trough concentration of the first subcutaneous agent|anti-drug antibodies concentration|Blood trough concentration of infliximab or vedolizumab|Fecal trough concentration of infliximab or vedolizumab","Rennes University Hospital","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 4","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","35RC17_8841_EFFICACI|2018-002673-21|2018-66-PP","January 4, 2019","January 4, 2023","January 4, 2024","September 20, 2018",,"January 6, 2021","Centre Hospitalier Bretagne Atlantique, Vannes, Bretagne, France|Centre Hospitalier Universitaire d'Amiens-Picardie, Amiens, France|Centre Hospitalier Universitaire de Besançon, Besançon, France|Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France|Centre Hospitalier Universitaire de Caen, Caen, France|Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France|Assistance Publique des Hôpitaux de Paris - Hôpital Beaujon, Clichy, France|Assistance Publique des Hôpitaux de Paris - Hôpital Henri Mondor, Créteil, France|Centre Hospitalier Universitaire de Lille, Lille, France|Centre Hospitalier de Bretagne Sud, Lorient, France|Hospices Civils de Lyon, Lyon, France|Centre Hospitalier Universitaire de Montpellier, Montpellier, France|Centre Hospitalier Universitaire de Nancy, Nancy, France|Centre Hospitalier Universitaire de Nantes, Nantes, France|Centre Hospitalier Universitaire de Nice, Nice, France|Assistance Publique des Hôpitaux de Paris - Hôpital Saint-Louis, Paris, France|Centre Hospitalier de Saint-Brieuc, Saint-Brieuc, France|Centre Hospitalier de Saint-Malo, Saint-Malo, France|Centre Hospitalier Universitaire de Saint-Etienne, Saint-Étienne, France|Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France",,"https://ClinicalTrials.gov/show/NCT03679546"
852,"NCT03663400","Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples",,"Recruiting","No Results Available","Ulcerative Colitis","Diagnostic Test: GWAS analysis by Illumina BeadChip","GWAS analysis pretreatment","NYU Langone Health","All","18 Years to 70 Years   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","18-00630","December 4, 2018","March 15, 2021","March 15, 2021","September 10, 2018",,"December 16, 2020","New York University School of Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03663400"
853,"NCT03662542","A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis","VEGA","Active, not recruiting","No Results Available","Colitis, Ulcerative","Drug: Guselkumab Dose 1|Drug: Guselkumab Dose 2|Drug: Golimumab Dose 1|Drug: Golimumab Dose 2|Drug: Placebo","Clinical Response at Week 12|Clinical Remission at Week 12","Janssen Research & Development, LLC","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","214","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","CR108527|2018-001510-15|CNTO1959UCO2002","November 20, 2018","December 1, 2020","November 7, 2022","September 7, 2018",,"June 9, 2021","Precision Research Institute, San Diego, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|GCP Clinical Research, Tampa, Florida, United States|Gastrointestinal Specialists of Georgia, Marietta, Georgia, United States|Indiana University, Indianapolis, Indiana, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Woodholme Gastroenterology, Glen Burnie, Maryland, United States|Sierra Clinical Research, Las Vegas, Nevada, United States|The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Fargo Gastroenterology Clinic, PC, Fargo, North Dakota, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|Gastroenterology Associates of Tidewater, Chesapeake, Virginia, United States|Virginia Mason, Seattle, Washington, United States|Washington Gastroenterology, PLLC, Tacoma, Washington, United States|CEMIC (Centro de Educación Médica e Investigaciones Clínicas), Buenos Aires, Argentina|Expertia S.A, Caba, Argentina|Centro Médico Dra. De Salvo, Caba, Argentina|Hospital Britanico de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina|Clínica Adventista Belgrano, Ciudad De Buenos Aires, Argentina|Hospital de Alta Complejidad en Red 'El Cruce', Florencio Varela, Argentina|Fundación de Estudios Clínicos, Rosario, Argentina|Sanatorio 9 de Julio, San Miguel de Tucuman, Argentina|Princess Alexandra Hospital, Brisbane, Australia|Saint Vincent's Hospital - Melbourne, Fitzroy, Australia|Nepean Hospital, Kingswood, Australia|Royal Adelaide Hospital, North Terrace, Australia|Macquarie University Hospital, NSW, Australia|Royal Melbourne Hospital, Parkville, Australia|Mater Hospital Brisbane (Inflammatory Bowel Diseases), South Brisbane, Australia|Hospital Das Clinicas Da Ufmg, Belo Horizonte, Brazil|Universidade Estadual Paulista 'Julio De Mesquita Filho', Botucatu, Brazil|Clinica De Gastroenterologia, Goiania, Brazil|Hospital de Clínicas de Porto Alegre/ HCPA / UFRGS, Porto Alegre, Brazil|Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo, Ribeirão Preto, Brazil|UFRJ-Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil|Instituto Brasil de Pesquisa Clinica, Rio de Janeiro, Brazil|Faculdade de Medicina Do Abc, Santo Andre, Brazil|Kaiser Hospta, São José Do Rio Preto, Brazil|Eurolatino Pesquisas Médicas, Uberlândia, Brazil|Charite Berlin, Berlin, Germany|Universitätsklinikum Frankfurt/ Medizinische Klinik 1, Frankfurt, Germany|Universitätsklinikum Jena, Jena, Germany|Universitaetsklinikum Ulm, Ulm, Germany|Clínica Saluz, Boca del Rio, Mexico|Clinicos Asociados BOCM, SC, Mexico City, Mexico|Centro Regiomontano de Estudios Clínicos Roma S.C., Monterrey, Mexico|Capital Humano para la Investigacion clinica, Queretaro, Mexico|Centro Medico Zambrano Hellion, San Pedro Garza Garcia, Mexico|Synexus Polska Sp. z o.o. Oddzial w Gdansku, Gdansk, Poland|Pratia MCM Krakow, Krakow, Poland|Endoskopia Sp. z o.o. z siedzibą w Sopocie, Sopot, Poland|Centralny Szpital Kliniczny MSWiA w Warszawie, Warsaw, Poland|Centrum Zdrowia MDM, Warszawa, Poland|WIP Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Niepubliczny Zakład Opieki Zdrowotnej Vivamed Jadwiga Miecz, Warszawa, Poland|Melita Medical Sp. z o.o., Wroclaw, Poland|Medical Association 'New Hospital', Ekaterinburg, Russian Federation|Kazan State Medical University, Kazan, Russian Federation|City Clinical Hospital # 24, Moscow, Russian Federation|Medical Center SibNovoMed LLC, Novosibirsk, Russian Federation|Rostov State Medical University, Rostov-On-Don, Russian Federation|Elizavetinskaya hospital, Saint Petersburg, Russian Federation|City Clinical Hospital #31, Saint Petersburg, Russian Federation|Eco-safety Ltd, Saint-Petersburg, Russian Federation|Medical University Reaviz, Samara, Russian Federation|International Medical Centre SOGAZ, St-Petersburg, Russian Federation|Tver Regional Clinical Hospital, Tver, Russian Federation|GBUZ Respublican Clinical Hospital n.a. GG Kuvatova, Ufa, Russian Federation|City Clinical Hospital #2, Yaroslavl, Russian Federation|Regional Clinical Hospital, Yaroslavl, Russian Federation|Communal Nonprofit Enterprise 'City Clinical Hospital # 2 N.A. Prof. O.O. Shalimov', Kharkiv, Ukraine|SI 'L.T. Maloyi National Institute of Therapy of National Academy of Medical Sciences of Ukraine', Kharkiv, Ukraine|Municipal Institution 'Kherson City Clinical Hospital n.a. Y.Y.Karabelesh', Kherson, Ukraine|Kyiv City Clinical Hospital #18, Kyiv, Ukraine|Medical Center 'Ok Clinic' of LLC 'International Institute of Clinical Studies', Kyiv, Ukraine|Lviv Clinical Hospital on Railway Transport of Affiliate Healthcare center of JSC Ukrainian Railway, Lviv, Ukraine|Communal Nonprofit Enterprise of Lviv Regional Council 'Lviv Regional Clinical Hospital', Lviv, Ukraine|Municipal Non-profit Enterprise 'Odesa Regional Clinical Hospital' Odesa Regional Council, Odessa, Ukraine|Sumy State University, Sumy Regional Clinical Hospital, Sumy, Ukraine|Municipal institution of Tepnopil Regional Council 'Ternopil University Hospital', Ternopil, Ukraine|Medical Center Ltd 'Health Clinic', Department Of General Therapy, Vinnytsya, Ukraine|Vinnitsia Regional Clinical Hospital n.a. M. I. Pyrogov, Vinnytsya, Ukraine",,"https://ClinicalTrials.gov/show/NCT03662542"
854,"NCT03656627","Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease",,"Active, not recruiting","No Results Available","Autoimmune Diseases|Non-small Cell Lung Cancer|Rheumatoid Arthritis|Psoriasis|Giant Cell Arteritis|Polymyalgia Rheumatica|Systemic Lupus Erythematosus|Crohn Disease|Multiple Sclerosis|Ulcerative Colitis","Drug: Nivolumab","Dose-Limiting Toxicity (DLT)|Overall Response Rate|Progression-Free Survival|Overall Survival","Alliance Foundation Trials, LLC.|Bristol-Myers Squibb","All","18 Years and older   (Adult, Older Adult)","Phase 1","7","Other|Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","AFT-42","June 27, 2019","October 31, 2022","October 31, 2022","September 4, 2018",,"June 18, 2021","University of Chicago Medical Center, Chicago, Illinois, United States|Marlene and Stewart Greenebaum Comprehensive Cancer Center/University of Maryland School of Medicine, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|St. Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States|Dartmouth Hitchcock Norris Cotton Cancer Center, Lebanon, New Hampshire, United States|Atlantic Health System/Morristown Medical Center, Morristown, New Jersey, United States|The Ohio State University Wexner Medical Center - Thoracic Oncology Clinic, Columbus, Ohio, United States|Providence Cancer Institute Franz Clinic, Portland, Oregon, United States|UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States|University of Wisconsin Clinical Science Center, Madison, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT03656627"
855,"NCT03648541","BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis",,"Active, not recruiting","No Results Available","Colitis, Ulcerative","Drug: Spesolimab IV infusion|Drug: Spesolimab SC solution for injection","The exposure adjusted rate of patients reporting a treatment emergent adverse event (TEAE)|Proportion of patients with clinical remission","Boehringer Ingelheim","All","18 Years and older   (Adult, Older Adult)","Phase 2","79","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","1368-0017|2018-000334-35","October 29, 2018","May 18, 2027","May 18, 2027","August 27, 2018",,"July 1, 2021","Medical Research Center of Connecticut, LLC, Hamden, Connecticut, United States|Emory University, Atlanta, Georgia, United States|University of Chicago, Chicago, Illinois, United States|Columbia University Medical Center-New York Presbyterian Hospital, New York, New York, United States|Digestive Disease Specialists Inc, Oklahoma City, Oklahoma, United States|Southern Star Research Institute, LLC, San Antonio, Texas, United States|Texas Digestive Disease Consultants - Southlake, Southlake, Texas, United States|Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States|Ordensklinikum Linz GmbH - Barmherzige Schwestern, Linz, Austria|AKH - Medical University of Vienna, Wien, Austria|UZ Leuven, Leuven, Belgium|Centre Hospitalier Universitaire de Liège, Liège, Belgium|Victoria Hospital (LHSC), London, Ontario, Canada|Universitätsklinikum Erlangen, Erlangen, Germany|Klinikum Esslingen GmbH, Esslingen, Germany|Asklepios Kliniken Westklinikum Hamburg, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany|Universitätsklinikum Ulm, Ulm, Germany|Azienda Ospedaliera Universitaria di Padova, Padova, Italy|Istituto Clinico Humanitas, Rozzano (MI), Italy|Sapporo Tokushukai Hospital, Hokkaido, Sapporo, Japan|Sapporo Higashi Tokushukai Hospital, Hokkaido, Sapporo, Japan|Hyogo College of Medicine Hospital, Hyogo, Nishinomiya, Japan|Ofuna Chuo Hospital, Kanagawa, Kamakura, Japan|Tokyo Medical and Dental University, Tokyo, Bunkyo-ku, Japan|Tokyo Yamate Medical Center, Tokyo, Shinjuku, Japan|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Yeungnam University Medical Center, Daegu, Korea, Republic of|Central Clinical Hospital MSWiA, Internal Diseases, Warsaw, Warsaw, Poland|FSB Instit. HC Irkutsk Scient.Cent. Sibirian Branch of Russ. Acad. Scien., Irkutsk, Russian Federation|Federal State Budgetary Institution "" State Scientific Center of Coloproctology"" MOH Russia, Moscow, Russian Federation|Military Medical Academy n.a. C. M. Kirov, St. Petersburg, St. Petersburg, Russian Federation|Hospital Virgen del Rocío, Sevilla, Spain|Hospital Politècnic La Fe, Valencia, Spain|Doncaster Royal Infirmary, Doncaster, United Kingdom|Guy's Hospital, London, United Kingdom|Whiston Hospital, Prescot, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03648541"
856,"NCT03643211","Xeljanz Special Investigation for Long-term Use in UC Patients",,"Active, not recruiting","No Results Available","Ulcerative Colitis",,"The incident condition of major adverse drug reactions (adverse events for which the causal relationship with Xejanz cannot be ruled out)","Pfizer","All","Child, Adult, Older Adult",,"1","Industry","Observational","Observational Model: Case-Only|Time Perspective: Prospective","A3921248","June 8, 2018","January 11, 2022","January 11, 2022","August 22, 2018",,"April 6, 2021","Pfizer Local Country Office, Tokyo, Japan",,"https://ClinicalTrials.gov/show/NCT03643211"
857,"NCT03609905","Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis","AMSC_UC","Recruiting","No Results Available","Ulcerative Colitis (UC)","Biological: Adipose-cord mesenchymal stromal cells (A-MSCs)|Other: Conventional drugs","Change From Baseline in Endoscopic Score (as Measured by Ulcerative Colitis Endoscopic Index of Severity)|Change from Baseline in clinical response (CDAI points)|To evaluate the quality of life index, Short Inflammatory Bowel Disease Questionnaire (SIBDQ)|Histologic Evaluation of Ulcerative Colitis|Immune response in ulcerative colitis.|Incidence of Treatment Adverse.","Liaocheng People's Hospital","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1|Phase 2","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","lcsrmyy-yp1","July 1, 2018","June 1, 2021","December 1, 2021","August 1, 2018",,"September 2, 2020","Liaocheng city people's hospital, Liaocheng, Shandong, China",,"https://ClinicalTrials.gov/show/NCT03609905"
858,"NCT03596645","A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis","PURSUIT 2","Recruiting","No Results Available","Colitis, Ulcerative","Drug: Golimumab|Drug: Infliximab","Clinical Remission at Week 6 as Assessed by the Mayo Score|Symptomatic Remission at Week 54|Clinical Remission at Week 54 as Assessed by the Mayo score|Clinical Remission at Week 54 as Assessed by the Pediatric Ulcerative Colitis Activity Index Score (PUCAI) Score|Clinical Remission at Week 6 as Assessed by the PUCAI Score|Clinical Response at Week 6 as Assessed by the Mayo Score|Endoscopic Healing at Week 6|Endoscopic Healing at Week 54","Janssen Research & Development, LLC","All","2 Years to 17 Years   (Child)","Phase 3","100","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CR108499|2017-004496-31|CNTO148UCO3003","October 29, 2018","December 22, 2021","December 11, 2024","July 24, 2018",,"May 12, 2021","University of California San Francisco, San Francisco, California, United States|Children's Hospital Colorado and University of Colorado, Aurora, Colorado, United States|Rocky Mountain Pediatric Gastroenterology, Lone Tree, Colorado, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Nemours DuPont Hospital for Children, Wilmington, Delaware, United States|Children's Center for Digestive Health Care, Atlanta, Georgia, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Mayo Clinic, Rochester, Minnesota, United States|Columbia University Medical Center, New York, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Digestive Disease Specialists Inc, Oklahoma City, Oklahoma, United States|Medical University of South Carolina, Charleston, South Carolina, United States|GI For Kids, Knoxville, Tennessee, United States|Children's Medical Center of Dallas, Dallas, Texas, United States|Cook Childrens Medical Center, Fort Worth, Texas, United States|DHAT Research Institute, Garland, Texas, United States|Universitair Kinderziekenhuis Koningin Fabiola, Brussel, Belgium|Cliniques Universitaires Saint-Luc, Brussel, Belgium|UZ Brussel, Jette, Belgium|MK Blumenau Pesquisa Clínica, Blumenau, Brazil|Hospital Pequeno Principe, Curitiba, Brazil|Hospital da Crianca Santo Antonio de Porto Alegre, Porto Alegre, Brazil|Hôpital Pellegrin CHU Bordeaux, Bordeaux, France|Hopital Femme Mère Enfant, Bron, France|Hôpital Necker, Paris, France|Rambam Medical Center, Haifa, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Sheba Medical Center, Ramat Gan, Israel|Assaf Harofeh Medical Center, Rishon-Le-Zion, Israel|Sourasky Medical Center, Tel-Aviv, Israel|Azienda USL di Bologna - Ospedale Maggiore, Bologna, Italy|AOU Policlinico G.Martino, Messina, Italy|AOU Policlinico Umberto I, Roma, Italy|IRCCS Ospedale Pediatrico Bambino Gesu, Roma, Italy|IRCCS Materno Infantile Burlo Garofolo, Trieste, Italy|Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Emma Children's Hospital Academic Medical Center, Amsterdam, Netherlands|Radboudumc Amalia Children's Hospital, Nijmegen, Netherlands|Isala Kliniek, Zwolle, Netherlands|Szpital Uniwersytecki NR 1 IM. Dr. Antoniego Jurasza, Bydgoszcz, Poland|Szpital im. M. Kopernika, Gdansk, Poland|Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow, Poland|Wojewodzki Specjalistyczny Szpital Dziecięcy im. Prof. Stanislawa Popowskiego, Olsztyn, Poland|Gabinet Lekarski Bartosz Korczowski, Rzeszow, Poland|Centrum Zdrowia Matki, Dziecka i Młodzieży, Warszawa, Poland|Szpital Pomnik Centrum Zdrowia Dziecka, Warszawa, Poland|Hosp. Univ. de Cruces, Barakaldo, Spain|Hosp. Sant Joan de Deu, Barcelona, Spain|Hosp. Infantil Univ. Niño Jesus, Madrid, Spain|Hosp. Gral. Univ. Gregorio Marañon, Madrid, Spain|Hosp. Univ. 12 de Octubre, Madrid, Spain|Hosp. Regional Univ. de Malaga, Málaga, Spain|Hosp. Virgen Del Rocio, Sevilla, Spain|National Taiwan University Hospital, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Chang Gung Memorial Hospital- Linkou, Taoyuan City, Taiwan",,"https://ClinicalTrials.gov/show/NCT03596645"
859,"NCT03581149","Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis Patients",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Sodium Picosulfate/Magnesium Citrate Laxative|Drug: 2L polyethylene glycol/ascorbic acid","Tolerability of the preparation as assessed by a Likert-type scale|Quality of the preparation as assessed by the Modified Aronchick scale.|Quality of the preparation as assessed by the Boston Bowel Preparation Scale.|Assessment of adherence to protocol","American University of Beirut Medical Center","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 4","68","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Diagnostic","BIO-2017-0434","March 26, 2018","July 26, 2020","July 26, 2020","July 10, 2018",,"September 19, 2019","American University of Beirut, Beirut, Lebanon",,"https://ClinicalTrials.gov/show/NCT03581149"
860,"NCT03561532","Fecal Transplantation in Ulcerative Colitis","FMT-CU","Active, not recruiting","No Results Available","Ulcerative Colitis","Other: Fecal microbiota transplantation (FMT)|Other: Placebo","Maintenance of remission of ulcerative colitis","Joint Authority for Päijät-Häme Social and Health Care|Helsinki University Central Hospital|University of Helsinki","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","48","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","HUS / 1652/2016","October 1, 2016","May 31, 2020","May 31, 2020","June 19, 2018",,"August 15, 2019","Helsinki University Hospital, Helsinki, Finland|Päijät-Häme Central Hospital, Lahti, Finland",,"https://ClinicalTrials.gov/show/NCT03561532"
861,"NCT03558152","A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)",,"Active, not recruiting","No Results Available","Ulcerative Colitis","Drug: UTTR1147A|Drug: UTTR1147A Placebo|Drug: Vedolizumab|Drug: Vedolizumab Placebo","Percentage of Participants with Clinical Remission at Week 8|Percentage of Participants with Sustained Remission|Percentage of Participants with Clinical Response at Weeks 8 and 30|Percentage of Participants with Endoscopic Healing at Weeks 8 and 30|Percentage of Participants with Endoscopic Remission at Weeks 8 and 30|Change From Baseline in UC Bowel Movement Signs and Symptoms at Weeks 8 and 30, as Assessed by Ulcerative Colitis Patient-Reported Outcome Signs and Symptoms (UC-PRO/SS) Score|Change From Baseline in UC Abdominal Signs and Symptoms at Weeks 8 and 30, as Assessed by Ulcerative Colitis Patient-Reported Outcome Signs and Symptoms (UC-PRO/SS) Score|Change From Baseline in Patient-Reported Inflammatory Bowel Disease Questionnaire (IBDQ) Score at Weeks 8 and 30|Percentage of Participants with Adverse Events|Percentage of Participants with Presence of Anti-Drug Antibodies (ADA) at Baseline and After Drug Administration|Maximum Serum Concentration (Cmax) of UTTR1147A|Minimum Serum Concentration (Cmin) of UTTR1147A","Genentech, Inc.","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","195","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","GA39925|2017-002350-36","October 26, 2018","July 28, 2022","December 29, 2022","June 15, 2018",,"June 21, 2021","QWay Research, Hialeah, Florida, United States|University of Miami, Miami, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|University of Chicago Medical Center; Cancer Research Center, Chicago, Illinois, United States|University of Minnesota Medical Center, Minneapolis, Minnesota, United States|Atlantic Health System, Morristown, New Jersey, United States|NYU Langone Long Island Clinical Research Associates, Great Neck, New York, United States|Weill Cornell Medical College, New York, New York, United States|Southtowns Gastroenterology, PLLC, Orchard Park, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Carolina Digestive Diseases, Greenville, North Carolina, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Vilo Research Group, Houston, Texas, United States|Baylor College of Medicine; Gastroenterology, Houston, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Texas Digestive Disease Consultants - PPDS, Webster, Texas, United States|University of Utah School of Medicine; Gastroenterology Division, Salt Lake City, Utah, United States|University of Washington Medical Center, Seattle, Washington, United States|Velocity Clinical Research - Spokane - ERN - PPDS, Spokane, Washington, United States|The Medical College of Wisconsin Inc., Milwaukee, Wisconsin, United States|MHAT Saint Karidad EAD, Plovdiv, Bulgaria|Multiprofile Hospital for Active Treatment Hadji Dimitar OOD, Sliven, Bulgaria|Diagnostic and Consulting Center Aleksandrovska EOOD, Sofia, Bulgaria|Medical center CONVEX EOOD, Sofia, Bulgaria|Synexus - Medical Center Synexus Sofia EOOD, Sofia, Bulgaria|Synexus - Medical Centre Synexus Sofia EOOD (branch - Stara Zagora), Stara Zagora, Bulgaria|LLC ARENSIA Exploratory Medicine, Tbilisi, Georgia|Charite Universitaetsmedizin Berlin - Campus Charite Mitte, Berlin, Germany|Gastroenterologische Spezialpraxis-Berlin-Karlshorst, Berlin, Germany|Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden, Germany|AES - DRS - Synexus Frankfurt Research Centre, Frankfurt, Germany|KRH Klinikum Siloah, Hannover, Germany|Synexus - Leipzig, Leipzig, Germany|Universitatsklinikum Schleswig-Holstein, Lubeck, Germany|St. Marien Krankenhaus; Med. Klinik, Ludwigshafen, Germany|Klinikum Mannheim GmbH Universitätsklinikum, Mannheim, Germany|Universitatsklinikum Munster, Münster, Germany|Klinikum der Universität Regensburg; Klinik und Poliklinik für Innere Medizin I, Regensburg, Germany|Universitätsklinikum Ulm; Klinik für Innere Medizin II, Ulm, Germany|University General Hospital of Heraklion; Department of Ophthalmology, Heraklon, Greece|Iatriko Palaiou Falirou; Gastrointestinal Department, Palaio Faliro, Greece|EUROMEDICA General Clinic of Thessaloniki; Gastroenterology Department, Thessaloniki, Greece|CMC Déli Klinika, Budapest, Hungary|Synexus (DRS) - Synexus Magyarország Kft. Budapest, Budapest, Hungary|Magyar Honvédség Egészségügyi Központ; Országos Haemophilia Központ, Budapest, Hungary|Szent Pantaleon Korhaz; I. Belgyogyaszat, Dunaujvaros, Hungary|AES - DRS - Synexus Gyula - Magyarország Egészségügyi Szolgáltató Kft, Gyula, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz; I. sz. Belgyogyaszati Osztaly, Székesfehérvár, Hungary|Portiuncula Hospital, Ballinasloe, Co Galway, Ireland|Our Lady of Lourdes Hospital, Louth, County Louth, Ireland|St Vincents University Hospital, Dublin 4, Ireland|Connolly Hospital, Dublin, Ireland|Beaumont Hospital, Dublin, Ireland|Soroka University Medical Centre, Beer Sheva, Israel|Shaare Zedek Medical Center; Bait Vagan, Jerusalem, Israel|Meir Medical Center, Kfar- Saba, Israel|Galilee Medical Center, Nahariya, Israel|Rabin Medical Center; PPDS; Pharmacy, Petach Tiqwa, Israel|Chaim Sheba Medical Center; Allergy and Clinical Immunology Unit, Ramat Gan, Israel|Azienda Ospedaliero Universitaria Di Bologna - Policlinico S.Orsola Malpighi; UO Farmacia Clinica, Bologna, Emilia-Romagna, Italy|La Sapienza-Università di Roma-Policlinico Umberto I, Roma, Emilia-Romagna, Italy|Azienda Sanitaria Universitaria Integrata di Udine - PO Universitario Santa Maria della, Udine, Friuli-Venezia Giulia, Italy|Policlinico Universitario Campus Biomedico Di Roma, Roma, Lazio, Italy|Complesso Integrato Columbus, Roma, Lazio, Italy|ASST FATEBENEFRATELLI SACCO (Sacco), Milano, Lombardia, Italy|ASST di Monza - Azienda Ospedaliera San Gerardo; U.O. Farmacia -Settore A - Corpo Posteriore, Monza, Lombardia, Italy|ASST Rhodense - Ospedale di Rho, Rho, Lombardia, Italy|Istituto Clinico Humanitas, Rozzano (MI), Lombardia, Italy|Azienda Ospedaliera Ordine Mauriziano di Torino, Torino, Piemonte, Italy|Azienda Ospedaliera Di Padova, Padova, Veneto, Italy|ICS ARENSIA Exploratory Medicine, Chisinau, Moldova, Republic of|ETZ TweeSteden, Tilburg, Netherlands|Szpital Uniwersytecki Nr 2 im. Dr Jana Biziela w Bydgoszczy; Centrum Endoskopii Zabiegowej, Bydgoszcz, Poland|Centrum Medyczne Lukamed Joanna Luka-Wendrowska, Chojnice, Poland|Synexus Polska Sp. z o.o. Oddzial w Czestochowie, Częstochowa, Poland|Synexus Polska Sp. z o.o. Oddzial w Gdansku, Gdańsk, Poland|Synexus Polska Sp. z o.o. Oddzial w Gdyni, Gdynia, Poland|Synexus - Katowice, Katowice, Poland|Economicus - NZOZ ALL-MEDICUS; Zaklad Gastroenterologii, Katowice, Poland|ETG Kielce, Kielce, Poland|Gastromed SPK Niepubliczny Zaklad Opieki Zdrowotnej, Lublin, Poland|Allmedica Badania Kliniczne Sp z o.o. Sp K., Nowy Targ, Poland|Klimed Marek Klimkiewicz, Piotrków Trybunalski, Poland|SOLUMED Centrum Medyczne, Poznań, Poland|Synexus Polska Sp. z o.o. Oddzial w Poznaniu, Poznań, Poland|Clinical Research Center Sp. z o.o. MEDIC-R Spółka Komandytowa, Poznań, Poland|Gabinet Lekarski, Bartosz Korczowski, Rzeszów, Poland|Endoskopia Sp. z o.o., Sopot, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Sonomed Sp. z o.o., Szczecin, Poland|Gastromed Kopon Zmudzinski i, Toruń, Poland|Centrum Zdrowia MDM, Warszawa, Poland|Jaroslaw Kierkus Prywatna Prakyka Lekarska, Warszawa, Poland|Synexus Polska Sp. z o.o. Oddzial w Warszawie, Warszawa, Poland|AES - BS - AS - SOMED CR Sp. z o.o. Sp. Komandytowa - Warszawa, Warszawa, Poland|Niepubliczny Zaklad Opieki Zdrowotnej VIVAMED, Warszawa, Poland|Centrum Diagnostyczno - Lecznicze Barska sp. z o.o., Wloclawek, Poland|EMC Instytut Medyczny S.A., Wrocław, Poland|Synexus Polska Sp. z o.o. Oddzial we Wroclawiu, Wrocław, Poland|Melita Medical, Wrocław, Poland|PlanetMed, Wrocław, Poland|ETG Zamosc, Zamosc, Poland|Synexus - Lodz, Łódź, Poland|SPZOZ Uniwersytecki SK nr 1 im N. Barlickiego UM w Lodzi; Oddz. Klin. Gastroenter. Og. i Onk., Łódź, Poland|Osrodek Badan Klinicznych Appletreeclinics, Łódź, Poland|SOMED - Lodzkie Centrum Osteoporozy, Łódź, Poland|Medical Center Stolitsa-Medikl, Moscow, Moskovskaja Oblast, Russian Federation|Saint Martyr Elizabeth City Hospital, Sankt-peterburg, Sankt Petersburg, Russian Federation|Irkutsk Research Centre Hospital of Siberian department of Russian Academy of Science, Irkutsk, Russian Federation|Kuban State Medical University, Krasnodar, Russian Federation|Rostov State Medical University; Cardiorheumatology Department, Rostov-na-Donu, Russian Federation|Medical University Reaviz, Samara, Russian Federation|North-West State Medical University n.a. I.I. Mechnikov, St. Petersburg, Russian Federation|Russian Medical Military Academy n.a. S.M. Kirov, St. Petersburg, Russian Federation|Tomsk Regional Clinical Hospital, Tomsk, Russian Federation|Clinical Center of Serbia; Clinic of Gastroenterology, Belgraade, Serbia|Clinical Hospital Center Zvezdara, Belgrade, Serbia|KBC Dr Dragisa Misovic Dedinje, Belgrade, Serbia|Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia|Clinical Center Kragujevac; Clinic Of Psychiatry, Kragujevac, Serbia|Clinical Center Nis, NIS, Serbia|General Hospital Vrsac, Vrsac, Serbia|Clinical Hospital Centre Zemun, Zemun, Serbia|General Hospital Djordje Joanovic - Zrenjanin, Zrenjanin, Serbia|Hospital de Gran Canaria Dr. Negrin; Servicio de Aparato Digestivo, Las Palmas de Gran Canaria, LAS Palmas, Spain|Hospital Universitario de Torrejon, Torrejon de Ardoz, Madrid, Spain|Centro Medico Teknon; Servicio de Farmacia, Barcelona, Spain|Hospital Universitari de Girona Dr Josep Trueta, Girona, Spain|Hospital Universitario de La Princesa; Aparato Digestivo, Madrid, Spain|Hospital Clinico Universitario de Valencia, Valencia, Spain|Regional Municipal Institution Chernivtsi Regional Clinical Hospital; Gastroenterology department, Chernivtsi, Chernihiv Governorate, Ukraine|Medical Centre of PE First Private Clinic, Zhytomir, Crimean Regional Governmenta, Ukraine|Ternopil University Hospital; Regional Center of Gastroenterology with Hepatology, Ternopil, Katerynoslav Governorate, Ukraine|Zaporizhia City Multispecialty Clinical Hospital #9, Zaporizhzhye, Katerynoslav Governorate, Ukraine|Medical Centre of LLC CARDIOCOM, Kozyn, Kharkiv Governorate, Ukraine|City Clinical Hospital #1; Department of Gastroenterology, Vinnytsia, Kharkiv Governorate, Ukraine|Municipal Institution Zaporizhzhia Regional Clinical Hospital of Zaporizhzhia Regional Council, Zaporizhzhia, Kharkiv Governorate, Ukraine|ME Dnipropetrovsk Regional Clinical Hospital n.a. I.I Mechnykov Dnipropetrovsk Regional Council, Dnipro, KIEV Governorate, Ukraine|Treatment and Diagnostic Center of LLC MRT Elit, Kropyvnytskyi, KIEV Governorate, Ukraine|Medical Center of LLC Medical Clinic Blagomed, Kyiv, KIEV Governorate, Ukraine|Medical Center of Limited Liability Company ""Harmoniya krasy"", Kyiv, KIEV Governorate, Ukraine|Medical Center of LLC Medical Center Dopomoga Plus, Kyiv, KIEV Governorate, Ukraine|Medical Center of Edelweiss Medics LLC, Kyiv, KIEV Governorate, Ukraine|Synexus Affiliate - MC of LLC Medbud-Clinic, Kyiv, KIEV Governorate, Ukraine|Kyiv Railway Clinical Hospital No2 of Branch Health Center of the JSC Ukrainian Rail, Kyiv, KIEV Governorate, Ukraine|Med Center of International Institute of Clinical Trials LLC; Medical Center ""OK!Clinic+"", Kyiv, KIEV Governorate, Ukraine|Communal Non-profit Enterprise of Kyiv Regional Council Kyiv Regional Hospital, Kyiv, KIEV Governorate, Ukraine|Medical Center of LLC Diaservis, Zaporizhzhia, KIEV Governorate, Ukraine|Clinic of SRI of Invalid Rehab. (ESTC) of VNMU n.a. M.I.Pyrohov, Vinnytsia, Podolia Governorate, Ukraine|Medical Center of LLC Medical Center Family Medicine Clinic; Endoscopy & Gastroenterology, Dnipr, Polissya Okruha, Ukraine|Transcarpathian Regional Clinical Hospital n.a. A. Novak; Rheumatology Department, Uzhgorod, Ukraine|Medical Center of Diaservice LLC; Division of clinical trials conduct, Department #3, Zaporizhzhia, Ukraine|Synexus Midlands Clinical Research Centre, Birmingham, United Kingdom|Synexus - Wales Clinical Research Centre, Cardiff, United Kingdom|Kings College Hospital, London, United Kingdom|Synexus - Manchester Clinical Research Centre, Manchester, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03558152"
862,"NCT03549988","Pro-active Fecal Calprotectin Monitoring PROMOTE-UC",,"Recruiting","No Results Available","Ulcerative Colitis","Other: Fecal Calprotectin (FC) measurements with IBDocTM","The time to a symptomatic flare, defined as an increase in modified partial Mayo score > 2 points from baseline or a rectal bleeding score > 1|Hospitalization, surgery, steroid or biologic use|Proportion of subjects who underwent an escalation of therapy|Quality of life measured by SIBDQ questionnaire|Quality of life measured by EQ-5D 5L questionnaire|Number of physician visits|Time lost from work or school|Correlation of fecal calprotectin with endoscopic activity|Correlation of fecal calprotectin with histologic disease activity|Successful use of IBDoc","University of British Columbia","All","19 Years and older   (Adult, Older Adult)",,"654","Other","Observational","Observational Model: Other|Time Perspective: Prospective","H18-00647","December 1, 2018","January 30, 2023","December 31, 2023","June 8, 2018",,"August 11, 2020","Pacific Gastroenterology Associates, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT03549988"
863,"NCT03521232","A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis",,"Recruiting","No Results Available","Ulcerative Colitis|Ulcerative Proctitis|Ulcerative Proctosigmoiditis","Drug: Niclosamide","Safety and tolerability of Niclosamide enemas 150 mg/60 ml and 450 mg/60 ml graded according to Common Terminology Criteria for Adverse Events (CTCAE) v4.0.|Number of subjects with clinical remission defined as MMS* ≤ 2 with no individual subscore >1 after 6 weeks of treatment","First Wave Bio, Inc.","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","51","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","FW-UC-2017","May 15, 2018","December 2021","December 2021","May 11, 2018",,"September 7, 2020","Fondazione IRCCS Policlinico San Matteo - Phase I Clinical Trial Unit And Experimental Therapy, Pavia, Italy|U.O.C. Gastroenterologia ed Endoscopia Digestiva - Azienda Ospedaliera Universitaria PTV - Policlinico, Roma, Italy|Centro Ricerche Cliniche di Verona, Verona, Italy",,"https://ClinicalTrials.gov/show/NCT03521232"
864,"NCT03518086","An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)",,"Recruiting","No Results Available","Ulcerative Colitis","Drug: Mirikizumab|Drug: Placebo","Percentage of Participants in Clinical Remission|Percentage of Participants in Clinical Response|Percentage of Participants in Endoscopic Remission|Percentage of Participants in Symptomatic Remission|Percentage of Participants in Symptomatic Response|Percentage of Participants with Histologic Remission|Percentage of Participants in Endoscopic Response|Change from Baseline to Week 12 in UC Symptoms: Numeric Rating Scale (NRS)|Change from Baseline to Week 12 in Health Related Quality of Life: Inflammatory Bowel Disease Questionnaire (IBDQ)|Change from Baseline to Week 12 in Fecal Calprotectin|Pharmacokinetics (PK): Clearance of Mirikizumab","Eli Lilly and Company","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 3","1160","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","16591|I6T-MC-AMAN|2017-003229-14","March 15, 2018","January 21, 2021","October 8, 2022","May 8, 2018",,"June 18, 2021","Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|Dcr-Pi, Pc, Litchfield Park, Arizona, United States|Maricopa Integrated Health System, Phoenix, Arizona, United States|Physicians Research Group, Tempe, Arizona, United States|University of Arizona, CATS Research Center, Tucson, Arizona, United States|Yuma Gastro LLC, Yuma, Arizona, United States|Valley Gastroenterology Cnslts, Arcadia, California, United States|Care Access Research, Berkeley, California, United States|Citrus Valley Health Partners, Covina, California, United States|Valley View Internal Medicine, Garden Grove, California, United States|University of California - San Diego, La Jolla, California, United States|Om Research, LLC, Lancaster, California, United States|Catalina Research Institute, LLC, Montclair, California, United States|California Medical Research Group, Northridge, California, United States|Gastroenterology Associates, Pasadena, California, United States|Clinical Applications Laboratories, Inc., San Diego, California, United States|UCSF Medical Center at Mission Bay, San Francisco, California, United States|University of Colorado, Aurora, Colorado, United States|Delta Waves Sleep Disorders and Research Center, Colorado Springs, Colorado, United States|Gastro Florida, Clearwater, Florida, United States|West Central Gastroenterology d/b/a Gastro Florida, Clearwater, Florida, United States|Clinical Research of West Florida, Inc. (Clearwater), Clearwater, Florida, United States|Pioneer Clinical Research, Coral Springs, Florida, United States|Doral Research Center, Doral, Florida, United States|Direct Helpers Medical Center, Hialeah, Florida, United States|Wellness Clinical Research, Hialeah, Florida, United States|The Center for Gastrointestinal Disorders, Hollywood, Florida, United States|Nature Coast Clinical Research, LLC, Inverness, Florida, United States|SIH Research, LLC, Kissimmee, Florida, United States|Center for Advanced Gastroenterology, PLLC, Maitland, Florida, United States|Inpatient Research Clinic, LLC, Miami Lakes, Florida, United States|Life Medical Center & Research, Inc, Miami Lakes, Florida, United States|Columbus Clinical Services, LLC, Miami, Florida, United States|Research Associates of South Florida, LLC, Miami, Florida, United States|Coral Research Clinic Corp, Miami, Florida, United States|Pharma Research International, Inc., Naples, Florida, United States|Center for Interventional Endoscopy, Orlando, Florida, United States|Clintheory Healthcare, Orlando, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Gastroenterology Associates of Pensacola, PA, Pensacola, Florida, United States|Florida Digestive Specialist, Saint Petersburg, Florida, United States|Florida Medical Clinic LLC, Zephyrhills, Florida, United States|Digestive Healthcare of Georgia, Atlanta, Georgia, United States|Gastrointestinal Diseases Research, Columbus, Georgia, United States|Atlanta Gastroenterology Specialists, PC, Suwanee, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Lemah Creek Clinical Research, Oakbrook Terrace, Illinois, United States|Indiana University School of Medicine, Indianapolis, Indiana, United States|Iowa Digestive Disease Center, Clive, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|WestGlen GI Consultants, Shawnee Mission, Kansas, United States|Cotton-O'Neil Clinical Research Center, Digestive Health, Topeka, Kansas, United States|Texas Digestive Disease Consultants, Baton Rouge, Louisiana, United States|Clinical Trials of SWLA, LLC, Lake Charles, Louisiana, United States|Delta Research Partners LLC, Monroe, Louisiana, United States|Tulane Univ School of Med, New Orleans, Louisiana, United States|Nola Research Works, LLC, New Orleans, Louisiana, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|University of Massachusetts Medical Center, Worcester, Massachusetts, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Henry Ford Health System, Novi, Michigan, United States|Gastroenterology Associates of Western Michigan, P.L.C., Wyoming, Michigan, United States|Huron Gastroenterology Associates, Ypsilanti, Michigan, United States|Minnesota Gastroenterology, P.A., Plymouth, Minnesota, United States|Washington University Medical School, Saint Louis, Missouri, United States|Bozeman Health Deaconess Hospital, Bozeman, Montana, United States|Capital Health Medical Center Hopewell, Pennington, New Jersey, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|Northwell Health, Great Neck, New York, United States|NYU Langone Long Island Clinical Research Associates, Lake Success, New York, United States|Weill Cornell Medical College, New York, New York, United States|Mount Sinai - PRIME, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Carolina Digestive Diseases, Greenville, North Carolina, United States|Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States|Mid Dakota Clinic, Bismarck, North Dakota, United States|Trinity Health Center Medical Arts, Minot, North Dakota, United States|META Medical Research Institute, LLC, Dayton, Ohio, United States|Paramount Medical Research, Middleburg Heights, Ohio, United States|Care Access Research - Youngstown, Poland, Ohio, United States|Great Lakes Medical Research, LLC, Westlake, Ohio, United States|Central Sooner Research, Norman, Oklahoma, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Care Access Research LLC, Pottsville, Pennsylvania, United States|Digestive Disease Associates, Ltd., Wyomissing, Pennsylvania, United States|Ocean State Clinical Research Partners, Lincoln, Rhode Island, United States|Invocare Clinical Research Center, Mauldin, South Carolina, United States|Invocare Clinical Research Center, West Columbia, South Carolina, United States|Midwest Medical Care, Sioux Falls, South Dakota, United States|Gastro One, Germantown, Tennessee, United States|Galen Medical Group, Hixson, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Doctors Hospital at Renaissance Research Institute, Edinburg, Texas, United States|University of Texas Medical Branch at Galveston, Galveston, Texas, United States|Digestive Health Associates of Texas, Garland, Texas, United States|Houston Methodist Research Ins, Houston, Texas, United States|Biopharma Informatic, Inc., Houston, Texas, United States|Gastroenterology Research of San Antonio, San Antonio, Texas, United States|Southern Star Research Institute, LLC, San Antonio, Texas, United States|BFHC Research, San Antonio, Texas, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|GI and Liver Research, LLC, Webster, Texas, United States|Care Access Research LLC - Salt Lake City, Ogden, Utah, United States|Care Access Research LLC - Salt Lake City, Salt Lake City, Utah, United States|Emeritas Research Group, Leesburg, Virginia, United States|Blue Ridge Medical Research, Lynchburg, Virginia, United States|Gastroenterology Associates, PC, Manassas, Virginia, United States|The Gastroenterology Group, P.C., Reston, Virginia, United States|Carilion Clinic, Roanoke, Virginia, United States|University of Washington Medical Center, Seattle, Washington, United States|Digestive Health Specialists, Tacoma, Washington, United States|Wisconsin Center for Advanced Research, Milwaukee, Wisconsin, United States|Allegiance Research Specialists, LLC, Milwaukee, Wisconsin, United States|Centro de Investigaciones Metabólicas (CINME), Caba, Buenos Aires, Argentina|Mautalen Salud e Investigacion-Centro de Osteopatías Médicas, Ciudad Autonoma De Buenos Air, Buenos Aires, Argentina|CER Instituto Medico, Quilmes, Buenos Aires, Argentina|Instituto de Investigaciones Clinicas Quilmes, Quilmes, Buenos Aires, Argentina|Fundación de Estudios Clínicos, Rosario, Santa Fe, Argentina|Sanatorio 9 de Julio SA, San Miguel de Tucuman, Tucuman, Argentina|Centro Medico Privado de Reumatologia, SAN M. DE Tucuman, Tucumán, Argentina|Hospital Privado Centro Medico de Cordoba SA, Cordoba, Argentina|John Hunter Hospital, Newcastle, New South Wales, Australia|Princess Alexandra Hospital, Brisbane, Queensland, Australia|Coastal Digestive Health, Maroochydore, Queensland, Australia|Mater University Hospital, South Brisbane, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Box Hill Hospital, Box Hill, Victoria, Australia|The Northern Hospital, Epping, Victoria, Australia|Melbourne Gastrointestinal Investigation Unit (MGIU), Malvern, Victoria, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|The Royal Melbourne Hospital, Parkville, Victoria, Australia|Medizinische Universität Innsbruck, Innsbruck, Austria|Universitätsklinikum Salzburg, Salzburg, Austria|Medical University of Vienna, Vienna, Austria|Krankenhaus der Barmherzigen Schwestern, Wien, Austria|Universitair Ziekenhuis Gent, Gent, Oost-Vlaanderen, Belgium|AZ Klina, Brasschaat, Belgium|AZ Groeninge, Kortrijk, Belgium|Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium|Centre Hospitalier de Wallonie picarde - CHwapi A.S.B.L., Tournai, Belgium|Allen Whey Khye Lim Professional Corporation, Edmonton, Alberta, Canada|The Gordon and Leslie Diamond Health Care Centre, Vancouver, British Columbia, Canada|GI Research Institute, Vancouver, British Columbia, Canada|PerCuro Clinical Research Ltd., Victoria, British Columbia, Canada|Victoria Hospital, London, Ontario, Canada|University of Western Ontario, London, Ontario, Canada|Centre de santé et de services sociaux Champlain-Charles-Le Moyne, Greenfield Park, Quebec, Canada|Hopital Maisonneure-Rosemount, Montreal, Quebec, Canada|Inflammatory Bowel Disease Centre Montreal General Hospital - MUHC, Montreal, Quebec, Canada|Anhui Provincial Hospital, Hefei City, Anhui, China|The First Affiliated Hospital of Anhui Medical University, HefeiCity, Anhui, China|Beijing Friendship Hospital, Beijing, Beijing, China|Xiangya Hospital Central South University, Kaifu District, Changsha City, China|The Affiliated 2nd Hosp. of Third Military Med. Univ. of PLA, Chongqing, Chongqing, China|The First Hospital Affiliated to AMU (Southwest Hospital), Chongqing, Chongqing, China|Fujian Province Hospital, Fuzhou, Fujian, China|The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China|The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China|Hainan General Hospital, Haikou, Hainan, China|Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China|The Affiliated Drum Tower Hospital of Nanjing University, Nanjing, Jiangsu, China|Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China|Jiangsu Province Hospital, Nanjing, Jiangsu, China|Zhongda Hospital Southeast University, Nanjing, Jiangsu, China|Nanjing Medical University - Nanjing Jiangning Hospital, Nanjing, Jiangsu, China|Jiangxi Pingxiang People's Hospital, Pingxiang, Jiangxi, China|Jilin Central General Hospital, Jilin, Jilin, China|The Second Hospital of Dalian Medical University, Dalian, Lianing, China|Qilu Hospital of Shandong University, Jinan, Shandong, China|Liaocheng People's hospital, Liaocheng, Shandong, China|Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China|Renji Hospital Affliated to Shanghai Jiaotong University, Shanghai, Shanghai, China|West China Hospital Sichuan University, Chengdu, Sichuan, China|No.1 Hospital Affiliated to Xinjiang Medical University, Urumchi, Urumchi, China|Kunming Medical College Affiliated First Hospital, Kunming, Yunnan, China|The First People's Hospital of Yunnan Province, Kunming, Yunnan, China|The Second Affiliated Hospital of Zhejiang University School of Med, Hangzhou, Zhejiang, China|First Affiliated Hosp of College of Med, Zhejiang University, Hangzhou, Zhejiang, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China|The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou, Zhejiang, China|Tongji Hospital of Tongji University, Wuhan, China|University Hospital Center Osijek, Osijek, Croatia|CHC Zagreb, Zagreb, Croatia|Polyclinic Bonifarm, Zagreb, Croatia|Fakultni nemocnice Kralovske Vinohrady, Praha 10, Hl. M. Praha, Czechia|Klinika ResTrial, Praha, Modrany, Czechia|Vojenska nemocnice Brno, Brno, Czechia|Fakultni nemocnice u sv. Anny v Brne, Brno, Czechia|Hepato-gastroenterologie HK, s.r.o., Hradec Kralove, Czechia|Gregar s.r.o., Olomouc, Czechia|PreventaMed, s.r.o., Olomouc, Czechia|A-Shine s.r.o., Plzen, Czechia|Mediendo s.r.o., Praha 8 - Karlin, Czechia|ISCARE Clinical Centre, Praha 9, Czechia|Sydvestjysk Sygehus Esbjerg, Esbjerg, Denmark|Herlev and Gentofte Hospital, Herlev, Denmark|Zealand University Hospital Køge, Køge, Denmark|Hopital de Hautepierre - Service d'Hépatogastroentérolgie, Strasbourg Cedex, Bas Rhin, France|Hopital Saint-Louis, Paris, Cedex 10, France|CHU Lille - Hôpital Claude Huriez, Lille cedex, Nord, France|Hospices Civils de Lyon - Centre Hospitalier Lyon Sud -, Pierre Benite cedex, Rhone, France|CHU Amiens Picardie-Site Sud - RDC Service Hépato gastro, Amiens Cedex, Somme, France|CHU Tours - Hôpital Trousseau, Chambray les Tours, France|Hopital Beaujon, Clichy, France|Hopital Nord de Marseille, Marseille Cedex 20, France|Hopital Saint Eloi, Montpellier, France|Hopital L'Archet 2, Nice Cedex, France|Centre Hospitalier de Pau, Pau CEDEX, France|CHU Bordeaux - Hôpital Haut-Lévêque, Pessac Cedex, France|CHU de Poitiers- Service d'Hépato-gastro-entérologie,, Poitiers Cedex, France|Robert Debre Hospital, Reims, France|CHU de Saint Etienne Hopital Nord, Saint Priest en Jarez, France|CHRU Nancy Brabois - Hôpital d'Enfants, Vandoeuvre les Nancy, France|Staedisches Klinikum Brandenburg, Brandenburg an der Havel, Brandenburg, Germany|Medizinische Hochschule Hanover, Hannover, Niedersachsen, Germany|Gastro Campus Research GbR, Muenster, Nordrhein Westfalen, Germany|Studiengesellschaft BSF Unternehmergesellschaft haftungsbeschraenkt, Halle (Saale),, Sachsen Anhalt, Germany|Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Sachsen-Anhalt, Germany|Charité Universitätsmedizin Berlin Campus Buch, Berlin, Germany|Charité Universitätsmedizin Berlin Campus Buch, Berlin, Germany|Krankenhaus Waldfriede e. V., Berlin, Germany|Hamburgisches Forschungsinstitut fuer Chronisch Entzuendliche Darmerkrankungen, Hamburg, Germany|INLUGA im Haus der Gesundheit, Ludwigshafen, Germany|Praxiszentrum Alte Maelzerei, Regensburg, Germany|Internistische Praxisgemeinschaft, Weyhe, Germany|DRC Gyogyszervizsgalo Rendelointezet Kft, Balatonfüred, EU, Hungary|Obudai Egeszsegugyi Centrum Kft, Budapest, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Endomedix Diagnosztikai Kozpont, Miskolc, Hungary|Karolina Korhaz-Rendelointezet, Mosonmagyarovar, Hungary|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont I. Belgyogyaszati Klinika, Szeged, Hungary|Clinfan Szolgaltato Kft., Szekszard, Hungary|Javorszky Odon Hospital, Vac, Hungary|Osmania Medical College & Hospital, Hyderabad, Andhra Pradesh, India|Centre for Liver Research & Diagnostics, Deccan College of Medical Sciences, Owaisi Hospital & Research Centre, Hyderabad, Andhra Pradesh, India|Yashoda Hospital, Secunderabad, Andhra Pradesh, India|Institute of Digestive and Liver Diseases, Guwahati, Assam, India|Escorts Heart Institute and Research Centre Ltd, New Delhi, Delhi, India|Sir Ganga Ram Hospital, New Delhi, Delhi, India|Apollo Research and Innovations, Apollo Hospitals International Ltd, Gandhinagar, Gujarat, India|Shree Giriraj Hospital, Rajkot, Gujarat, India|Nirmal Hospital Private Limited, Surat, Gujarat, India|Bangalore Medical College and Research Institute, Bangalore, Karnataka, India|M S Ramaiah Medical College Hospital, Bangalore, Karnataka, India|Lokmanya Hospital, Mumbai, Maharashtra, India|Fortis Hospital, Mumbai, Maharashtra, India|Poona Medical Foundation. Ruby Hall Clinic, Pune, Maharashtra, India|K E M Hospital and Research Centre, Pune, Maharashtra, India|Datta Meghe Institute of Medical Sciences (DU), Acharya Vinoba Bhave Rural Hospital, Wardha, Maharashtra, India|Midas Multispecilaity Hopsital Pvt Ltd, Ramdaspeth, Nagpur, India|Dayanand Medical College, Ludhiana, Punjab, India|S.R. Kalla Hospital, Jaipur, Rajasthan, India|King George Medical University, Lucknow, Uttar Pradesh, India|Fortis Hospital, Noida, Uttar Pradesh, India|SSKM Post Graduate Hospital, Kolkata, West Bengal, India|Nil Ratan Sircar Medical College, Kolkata, West Bengal, India|Asian Institute of Gastroenterology, Hyderabad, India|Gandhi Hospital, Telangana, India|Beaumont Hospital, Dublin, Ireland|Shaare Zedek Medical Center, Bait Vagan, Jerusalem, Israel|Soroka Medical Center - Pediatric Outpatient Clinic, Beer-Sheva, Israel|Meir Medical Center, Kfar Saba, Israel|Galilee Medical Center Department of Internal Medicine A, Nahariya, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Kaplan Medical Center, Rehovot, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Assaf Harofeh Medical Center, Zerifin, Israel|Presidio di Rho, Rho, Milano, Italy|Istituto Clinico Humanitas, Rozzano, Milano, Italy|Ospedale Sandro Pertini, Roma, RM, Italy|Azienda Ospedaliera Universitaria Policlinico Tor Vergata, Torre, Roma, Italy|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili), Brescia, Italy|Azienda ospedaliero-universitaria Mater Domini, Catanzaro, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, Italy|Azienda Ospedaliero Universitaria San Martino, Genova, Italy|Gastroenterology and Endoscopy Unit IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation, Milano, Italy|Azienda Ospedaliera Universitaria Policlinico de Modena, Modena, Italy|Azienda Ospedaliera Universitaria Pisana, Pisa, Italy|Policlinico Univ. Agostino Gemelli, Roma, Italy|Azienda Ospedaliera Universitaria OO. RR. S. Giovanni di Dio e Ruggi D'Aragona Medicina Interna, Salerno, Italy|I.R.C.C.S Policlinico San Donato, San Donato Milanese (MI), Italy|Ospedale Mauriziano Umberto I, Torino, Italy|Azienda Ospedaliero-Universitaria Santa Maria della Misericordia Gastroenterologia, Udine, Italy|Aichi Medical University Hospital, Nagakute-shi, Aichi-ken, Japan|Fujita Health University Hospital, Toyoake-shi, Aichi-ken, Japan|NHO Hirosaki National Hospital, Hirosaki-shi, Aomori-Ken, Japan|Toho University School of Medicine, Sakura Hospital, Sakura, Chiba, Japan|Kitakyushu Municipal Medical Center, Kitakyusyu-shi, Fukoka, Japan|Fukuoka University Chikushi Hospital, Chikushino-shi, Fukuoka-Ken, Japan|Yukinoseibokai St. Mary's Hospital, Kurume-shi, Fukuoka-Ken, Japan|Hidaka Coloproctology Clinic, Kurume-shi, Fukuoka-Ken, Japan|Gunma University Hosptial, Maebashi, Gunma, Japan|Takasaki General Medical Center, Takasaki, Gunma, Japan|NHO Mito Medical Center, Ibaraki-machi, HigaShiibaraki-Gun, Japan|Hiroshima University Hospital, Hiroshima-shi, Hiroshima-ken, Japan|Asahikawa City Hospital, Asahikawa, Hokkaido, Japan|Tokushukai Sapporo Tokushukai Hospital, Sapporo-shi, Hokkaido, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital, Sapporo-shi, Hokkaido, Japan|Tokushukai Sapporo Higashi Tokushukai Hospital, Sapporo-shi, Hokkaido, Japan|Aoyama Clinic GI Endoscopy & IBD Center, Kobe-shi, Hyogo-Ken, Japan|Takamatsu Red Cross Hospital, Takamatsu, Kagawa, Japan|Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan|Sameshima Hospital, Kagoshima-shi, Kagoshima, Japan|Kitasato University Hospital, Sagamihara-shi, Kanagawa-ken, Japan|Sankikai Yokohama Shin midori General Hospital, Yokohama-shi, Kanagawa-Ken, Japan|Gokeikai Ofuna Chuo Hospital, Kamakura-shi, Kanagawa, Japan|Kawasaki Municipal Kawasaki Hospital, Kawasaki, Kanagawa, Japan|Showa University Northern Yokohama Hospital, Yokohama, Kanagawa, Japan|Yokohama City University Medical Center, Yokohama, Kanagawa, Japan|Kumamoto University Hospital, Kumamoto-shi, Kumamoto, Japan|NHO Kyoto Medical Center, Kyoto-shi, Kyoto, Japan|Mie University Hospital, Tsu, Mie, Japan|Takagi Clinic, Sendai-shi, Miyagi-Ken, Japan|Nagaoka Chuo General Hospital, Nagaoka-shi, Niigata, Japan|Ishida Clinic of IBD and Gastroenterology, Oita-shi, Oita-Ken, Japan|Shinseikai Sai Gastroenterology, proctology, Fujiidera-shi, Osaka Fu, Japan|Kinshukai Infusion Clinic, Osaka-City, Osaka-fu, Japan|NHO Osaka National Hospital, Osaka-shi, Osaka, Japan|Osaka University Hospital, Suita-shi, Osaka, Japan|Saga-Ken Medical Center Koseikan, Saga-Shi, Saga-Ken, Japan|Kumagaya General Hospital, Kumagaya-shi, Saitama-Ken, Japan|Tokitokai Tokito Clinic, Saitama-shi, Saitama-Ken, Japan|Matsuaikai Matsuda Hospital, Hamamatsu-shi, Shizuoka-Ken, Japan|Jichi Medical University Hospital, Shimotsuke-shi, Tochigi-Ken, Japan|Mitsui Memorial Hospital, Chiyoda-ku, Tokyo-To, Japan|Center Hospital of the National Center for Global Health and Medicine, Shinjuku-ku, Tokyo-To, Japan|Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan|Tokyo Medical And Dental University Medical Hospital, Bunkyō, Tokyo, Japan|Showa University Koto Toyosu Hospital, Koto-ku, Tokyo, Japan|Kitasato University Kitasato Institute Hospital, Minato-Ku, Tokyo, Japan|Kyorin University Hospital, Mitaka, Tokyo, Japan|JHCO Tokyo Yamate Medical Center, Shinjuku-ku, Tokyo, Japan|Toyama Prefectural Central Hospital, Toyama-Shi, Toyama, Japan|Fukuoka University Hospital, Fukuoka, Japan|Okayama University Hospital, Okayama, Japan|The Catholic University of Daejeon St. Mary's Hospital, Jung-gu, Daejeon, Korea, Republic of|Severance Hospital, Wonju-si, Gangwon-do, Korea, Republic of|Korea University Ansan Hospital, Ansan-si, Gyeonggi-do, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital, Suwon-si, Gyeonggi-do, Korea, Republic of|Ajou University Hospital, Suwon, Gyeonggi-do, Korea, Republic of|Hanyang University Guri Hospital, Guri-si, Gyeonggido, Korea, Republic of|Kyung Hee University Hospital, Seoul, Korea, Korea, Republic of|Asan Medical Center, Seoul, Korea, Korea, Republic of|Dong-A University Hospital, Busan, Pusan-Kwangyǒkshi, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of|Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Kyungpook National University Medical Center Chilgok Hospital, Daegu, Korea, Republic of|Yeungnam Univeristy Medical Center, Daegu, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of|Digestive Diseases Center ""Gastro"", Riga, Latvia|Pauls Stradins Kliniska Universitates Slimnica, Riga, Latvia|Riga Eastern Clinical University Hospital, Riga, Latvia|Hospital of Lithuanian University of Health Sciences Kaunas, Kaunas, Lithuania|Republic Hospital of Klaipeda, Klaipeda, Lithuania|Klaipeda Seamen's Hospital, Klaipeda, Lithuania|Respublikine Panevezio Ligonine, Panevezys, Lithuania|Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania|Hospital Sultanah Bahiyah, Alor Star, Kedah, Malaysia|Pusat Penyelidikan Klinikal (CRC), Hospital Raja Perempuan Zainab II, Kota Bharu, Kelantan, Malaysia|Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia|University Malaya Medical Centre, Lembah Pantai, Kuala Lumpur, Malaysia|Hospital Pulau Pinang, Georgetown, Penang, Malaysia|Hospital Ampang, Ampang, Selangor, Malaysia|Pusat Perubatan University Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia|Clinicos Asociados BOCM, S.C., Mexico, DF, Mexico|Centro de Investigación Clínica Acelerada, Mexico City, Distrito Federal, Mexico|Clinical Research Institute S C, Tlalnepantla, Edo De Mex, Mexico|Investigación Biomédica para el Desarrollo de Fármacos S.A. de C.V., Zapopan, Jalisco, Mexico|Christus Muguerza Sur S.A. de C.V., Monterrey, Nuevo León, Mexico|Centro Para el Desarrollo de la Medicina y de Asistencia Med, Culiacan, Sinaloa, Mexico|Clinical Medical Research S.C., Orizaba, Veracruz, Mexico|Scientia Investigacion Clinica S.C., Chihuahua, Mexico|Sociedad de Metabolismo y Corazon S.C., Veracruz, Mexico|St Elisabeth Ziekenhuis, Tilburg, Noord Brabant, Netherlands|Academisch Medisch Centrum, Amsterdam, Noord-Holland, Netherlands|Amphia Ziekenhuis, Breda, Netherlands|Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands|Bernhoven Ziekenhuis, Uden, Netherlands|UMC Utrecht, Dept. of Internal Medicine, MDL, Utrecht, Netherlands|Szpital Uniwersytecki Nr 2 w Bydgoszczy, Klinika Reumatologii i Ukladowych Chorob Tkanki Lacznej, Bydgoszcz, Kujawsko-pomorskie, Poland|Promedica S.C, Bedzin, Poland|Centrum Medyczne Pratia Bydgoszcz, Bydgoszcz, Poland|NZOZ ALL-MEDICUS, Zaklad Gastroenterologii, Katowice, Poland|Indywidualna Specjalistyczna Praktyka Lekarska, Knurow, Poland|Topolowa Medicenter, Krakow, Poland|GASTROMED Zakład Opieki Zdrowotnej, Lublin, Poland|Samodzielny Publiczny Szpital Kliniczny nr 4, Lublin, Poland|Medicenter Nowy Targ, Nowy Targ, Poland|Wojewodzki Specjalistyczny Szpital w Olsztynie, Olsztyn, Poland|Endoskopia sp z o. o, Sopot, Poland|KO-MED Centra Kliniczne Staszow, Staszow, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Niepubliczny Zaklad Opieki Zdrowotnej SONOMED, Szczecin, Poland|Gastromed Kopoń Zmudziński I Wspólnicy Spółka Jawna Specjalistyczne Centrum Gastrologii I Endoskopii, Torun, Poland|Nzoz Formed, Wadowice, Poland|Warsaw IBD Point Profesor Kierkus, Warszawa, Poland|Centrum Zdrowia Matki, Dziecka i Młodzieży (CZMDM) Przychodnie, Warszawa, Poland|Centrum Medyczne NeuroProtect, Warszawa, Poland|Centralny Szpital Kliniczny MSWiA, Warszawa, Poland|Vivamed, Warszawa, Poland|PlanetMed Sp.z o.o., Wroclaw, Poland|LexMedica Osrodek Badan Klinicznych, Wroclaw, Poland|ETG Zamosc, Zamosc, Poland|CCBR Clinical Research, Bucharest, București, Romania|MedLife Grivita, Bucuresti, Romania|Spitalul Clinic Colentina, Bucuresti, Romania|Institutul Clinic Fundeni, Bucuresti, Romania|Institutul Clinic Fundeni, Bucuresti, Romania|Hifu Terramed Conformal SRL, Bucuresti, Romania|Centrul Medical Unirea SRL, Bucuresti, Romania|Spital Pelican Oradea, Oradea, Romania|Multidisciplinary Medical Clinic ""Anthurium"", Barnaul, Russian Federation|Medical and Sanitary Division of Severstal, Cherepovets, Russian Federation|LLC MA New Hospital, Ekaterinburg, Russian Federation|Irkutsk State Medical Academy of Continuing Education, Irkutsk, Russian Federation|LLC Alliance Biomedical - Ural Group, Izhevsk, Russian Federation|Clinical Trials Center of Medical Institute, Kaliningrad, Russian Federation|State Autonomous Institution of Healthcare ""Republican Clinical Hospital of the Ministry of Healthcare of Republic Tatarstan"", Kazan, Russian Federation|SIH Kemerovo Regional Clinical Hosptial, Kemerovo, Russian Federation|SBHI Regional Clinical Hospital #2 MoH of Krasnodar region, Krasnodar, Russian Federation|Medical rehabilitation center, Moscow, Russian Federation|Moscow Budgetary State Healthcare Institution City Clinical Hospital 24, Moscow, Russian Federation|Nizhegorodskiy Regional Clinical Hospital N.A.Semashko, Nizhniy Novgorod, Russian Federation|Private Healthcare Institution Clinical Hospital Russian Railways - Medicine of Nizhniy Novgorod, Nizhniy Novgorod, Russian Federation|LLC ""Medicine Center SibNovoMed"", Novosibirsk, Russian Federation|LLC Novosibirsk GastroCenter, Novosibirsk, Russian Federation|Clinical Diagnostic Center Ultramed, Omsk, Russian Federation|Karelia Republican Hospital V.A. Baranova, Petrozavodsk, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|Saint Petersburg State Medical University n.a. Pavlov I.P., Saint Petersburg, Russian Federation|Pokrovskaya Municipal Hospital, Saint-Petersburg, Russian Federation|Non-state Healthcare Institution ""Roadway Clinical Hospital of OJSC Russian Railways"", Saint-Petersburg, Russian Federation|LLC Gastroenterology Centre Expert, Saint-Petersburg, Russian Federation|SBIH City Clinical Hospital #31, Saint-Petersburg, Russian Federation|Medical Institute REAVIZ, Samara, Russian Federation|City Mariinskaya Hospital, St. Petersburg, Russian Federation|Saint-Petersburg City Hospital of Saint Elizabeth, St. Petersburg, Russian Federation|LLC Scientific Research Centre EKO-Bezopasnost, St. Petersburg, Russian Federation|OOO ""OrKli"", St. Petersburg, Russian Federation|Stavropol State Medical Academy, Stavropol, Russian Federation|SBI of Healthcare of Leningrad region ""Clinical Interregional Hospital of Tosno"", Tosno, Russian Federation|Yaroslavl Municipal HI Clinical Hospital #8, Yaroslavl, Russian Federation|King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia|King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia|Clinical Center Bezanijska Kosa, Belgrade, NAP, Serbia|Clinical Center Zvezdara, Belgrade, Serbia|Clinical Center Kragujevac Gastroenterohepatology Clinic, Kragujevac, Serbia|Clinical Hospital Center Kragujevac, Kragujevac, Serbia|General Hospital Dr Radivoj Simonovic, Sombor, Serbia|General Hospital Sremska Mitrovica, Sremska Mitrovica, Serbia|General Hospital Uzice, Uzice, Serbia|Clinical Center Zemun, Zemun, Serbia|General Hospital ""Djordje Joanovic"", Zrenjanin, Serbia|Fakultna nemocnica s poliklinikou Roosevelta Banska Bystrica, Banska Bystrica, Slovakia|Alian, s.r.o., Bardejov, Slovakia|Univerzitna nemocnica Bratislava-Nemocnica Stare Mesteo, Bratislava, Slovakia|Univerzitna nemocnica Bratislava, Bratislava, Slovakia|KM Management spol. s r.o. Gastroenterologicke a hepatologicke centrum, Nitra, Slovakia|Gastro I s.r.o., Gastroenterologická ambulancia, Prešov, Slovakia|Endomed, s.r.o.- Gastroenterologicka ambulancia, Vranov N. Toplou, Slovakia|Hospital Universitario Virgen Del Rocio, Sevilla, Andalucía, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Universitari Son Espases, Palma de Mallorca, Baleares Islands, Spain|Hospital Universitario Marques De Valdecilla, Santander, Cantabria, Spain|Hospital De Fuenlabrada, Fuenlabrada, Madrid, Spain|Complejo Hospitalario De Navarra, Pamplona, Navarra, Spain|Hospital de Sagunto, Port De Sagunto, Valencia, Spain|Instituto de Ciencias Médicas, Alicante, Spain|Hospital San Pedro de Alcantara, Caceres, Spain|Hospital Universitario Reina Sofia Comite Etico, Cordoba, Spain|Hospital Universitari de Girona, Girona, Spain|Hospital General Juan Ramón Jiménez, Huelva, Spain|Complexo Hospitalario Universitario A Coruña, CHUAC, La Coruña, Spain|Hospital De Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Rio Hortega, Valladolid, Spain|Inselspital Bern, Bern, Switzerland|Praxis Balsiger, Seibold & Partner und Crohn-Colitis-Zentrum, Bern, Switzerland|Kantonsspital St.Gallen, St.Gallen, Switzerland|Universitätsspital Zürich USZ Zürich, Zürich, Switzerland|Changhua Christian Hospital, Changhua, Taiwan|China Medical University Hospital, Taichung City, Taiwan|Health management center, Taipei, Taiwan|Gazi University Faculty of Medicine, Besevler, Ankara, Turkey|Hacettepe University Faculty of Medicine, Sihhiye, Ankara, Turkey|Antalya Training and Research Hospital, Muratpasa, Antayla, Turkey|Istanbul University Cerrahpasa Medical Faculty, Istanbul, Faith, Turkey|Acibadem Universitesi - Acibadem Kozyatagi Hastanesi, Kadıkoy, Istanbul, Turkey|Kocaeli University Medical Faculty Hospital, Izmit, Kocaeli, Turkey|Mersin University Medical Faculty, Yenişehir, Mersin, Turkey|Gaziantep University Medical Faculty, Gaziantep, Turkey|Acibadem Fulya Hospital, Istanbuk, Turkey|Ege University Medicine of Faculty, Izmir, Turkey|Dokuz Eylul University Hospital, Izmir, Turkey|Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, Ivano-Frankivsk Region, Ukraine|Medical Center of Limited Liability Company Medical Center Clinic of Family Medicine, Dnipro, Ukraine|Kharkiv City Student Hospital, Kharkiv, Ukraine|CHI Prof.O.O.Shalimov Kharkiv City Clinical Hospital #2, Kharkiv, Ukraine|GI L.T. Malaya TI Namsu, Kharkiv, Ukraine|CI Kherson CCH, Kherson, Ukraine|Treatment-Diagnostic Center of Private Enterprise of PPC Atsynus, Kropyvnytskyi, Ukraine|Kyiv Municipal Clinical Hospital #1, Kyiv, Ukraine|Medical Centre CONSILIUM MEDICAL, Kyiv, Ukraine|Communal institution of the Kyiv Regional Council ""Kyiv Regional Clinical Oncology Dispensary"", Kyiv, Ukraine|Communal institution of the Kyiv Regional Council ""Kyiv Regional Clinical Oncology Dispensary"", Kyiv, Ukraine|Communal Non-Commercial Enterprise of Lviv Regional Council Lviv Regional Clinical Hospital, Liviv, Ukraine|Lviv Clinical Hospital at Railway Transport of Division Healthcare Center PJSC Ukrainian Railway Sta, Lviv, Ukraine|Communal City Clinical Hospital of Ambulance, Lviv, Ukraine|Communal Enterprise ""Odesa Regional Clinical Hospital"", Odesa, Ukraine|Communal Institution ""Poltava Reg.Cl.H. n.a.M.V.Sklifosovskogo"", Poltava, Ukraine|A. Novak Transcarpathian Regional Clinical Hospital, Uzhgorod, Ukraine|Vinnytsia RCH of Veterans of War Dept of Therapy#1 Vinnytsia M.I.Pyrogov NMU, Vinnytsia, Ukraine|MCIC MC LLC Health Clinic, Vinnytsia, Ukraine|CCH #1 Vinnytsia M.I. Pyrogov NMU Ch of Propaedeutics of IM, Vinnytsia, Ukraine|Private Small Enterprise, Medical Center Pulse, Vinnytsia, Ukraine|M.I. Pyrogov Regional Clinical Hospital, Vinnytsya, Ukraine|Diaservis Ltd, Zaporizhzhia, Ukraine|Communal Institution of Kyiv Regional Council Kyiv Regional Hospital #2, Zaporizhzhia, Ukraine|Queens Hospital, Romford, Essex, United Kingdom|Royal Hampshire County Hospital, Winchester, Hants, United Kingdom|Fairfield General Hospital, Bury, Lancashire, United Kingdom|St Thomas' Hospital, Great Maze Pond, London, United Kingdom|Ninewells Hospital, Dundee, Scotland, United Kingdom|Whipps Cross University Hospital, London, Surrey, United Kingdom|St James's University Hospital, Leeds, Vinnytsia, United Kingdom|Morriston Hospital, Swansea, Wales, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03518086"
865,"NCT03504930","COLISURG Prospective, Multicentric Cohort","COLISURG","Not yet recruiting","No Results Available","Ulcerative Colitis","Other: Impact of biotherapy on postoperative morbidity in ulcerative colitis","Infectious complications at D30 postoperative","Hospices Civils de Lyon","All","18 Years and older   (Adult, Older Adult)",,"330","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","69HCL18_0178","June 2018","June 2021","December 2021","April 20, 2018",,"April 20, 2018","Centre Hospitalier Universitaire de Besançon, Besançon, France|Centre Hospitalier Universitaire de Caen, Caen, France|Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France|APHP - Hôpital Beaujon, Clichy, France|Centre Hospitalier Universitaire de Grenoble, La Tronche, France|APHP - Hôpital Kremlin-Bicêtre, Le Kremlin-Bicêtre, France|Centre Hospitalier Universitaire de Lille, Lille, France|APHM - Hôpital Nord, Marseille, France|Centre Hospitalier Universitaire de Nice - Hôpital L'Archet II, Nice, France|APHP - Hôpital Cochin, Paris, France|APHP - Hôpital Européen Georges Pompidou, Paris, France|APHP - Hôpital St Antoine, Paris, France|APHP - Hôpital St Louis, Paris, France|Institut Mutualiste Montsouris, Paris, France|Hôpital Haut-Lévêque, Pessac, France|Centre Hospitalier Lyon SUD, Pierre-Bénite, France|Centre Hospitalier Universitaire de Rennes, Rennes, France|Centre Hospitalier Universitaire de Rouen, Rouen, France|Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, France|Centre Hospitalier Universitaire de Tours, Tours, France|Centre Hospitalier Universitaire de Nancy, Vandœuvre-lès-Nancy, France",,"https://ClinicalTrials.gov/show/NCT03504930"
866,"NCT03501758","Predicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound","PRELAPSE","Recruiting","No Results Available","Ulcerative Colitis in Remission|Ultrasound|Relapse/Recurrence","Diagnostic Test: Ultrasound|Diagnostic Test: Analysis of prouroguanyline and uroguanyline in full blood","Endoscopic relapse|Clinical relapse|Interobserver variation","Haukeland University Hospital|Alesund Hospital","All","18 Years and older   (Adult, Older Adult)",,"40","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2017/1769","January 17, 2017","December 30, 2023","December 30, 2023","April 18, 2018",,"September 18, 2019","Department of Medicine, Haukeland University Hospital, Bergen, Hordaland, Norway|Ålesund Hospital, Ålesund, Møre Og Romsdal, Norway",,"https://ClinicalTrials.gov/show/NCT03501758"
867,"NCT03460847","Fecal Microbiota Alterations in Steroid Refractory Active Colitis Ulcerosa",,"Recruiting","No Results Available","Colitis, Ulcerative","Drug: Steroids","Microbiota alterations","Medical University of Graz","All","18 Years and older   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","29-316 ex 16/17","March 1, 2018","January 2021","January 2021","March 9, 2018",,"August 11, 2020","LKH Graz, Graz, Styria, Austria",,"https://ClinicalTrials.gov/show/NCT03460847"
868,"NCT03441893","Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis",,"Active, not recruiting","No Results Available","Ulcerative Colitis|Ulcerative Colitis Exacerbation|Protozoan Infections|Helminth Infection","Diagnostic Test: parasitological diagnostics (coproscopy)|Drug: Nitazoxanide 500Mg Oral Tablet|Drug: Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet|Drug: Mesalazine 250Mg","Prevalence of intestinal helminths in patients with ulcerative colitis and association with pathogenesis.|Prevalence of Lamblia intestinalis and Cryptosporidium parvum in patients with ulcerative colitis and association with pathogenesis|Prevalence of intestinal protozoa (commensals) in patients with ulcerative colitis and association with pathogenesis|Efficiency of antiparasitic therapy with nitazoxanide in ulcerative colitis patients infected with B. hominis|Efficiency of combination therapy with nitazoxanide and mesalazine in ulcerative colitis patients infected with B. hominis|Efficiency of monotherapy with mesalazine in ulcerative colitis patients infected with B. hominis|Clinical efficiency of antiparasitic therapy with nitazoxanide in ulcerative colitis patients infected with B. hominis|Clinical efficiency of combination therapy with nitazoxanide and mesalazine in ulcerative colitis patients infected with B. hominis|Clinical efficiency of monotherapy with mesalazine in ulcerative colitis patients infected with B. hominis","Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan","All","18 Years to 90 Years   (Adult, Older Adult)","Phase 1|Phase 2","300","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","#15.21.2","January 1, 2015","July 1, 2025","December 31, 2025","February 22, 2018",,"March 10, 2020",,,"https://ClinicalTrials.gov/show/NCT03441893"
869,"NCT03398148","A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis (UC)","Drug: risankizumab IV|Drug: placebo for risankizumab|Drug: risankizumab SC","Sub-Study 1 and Sub-Study 2: Percentage of Participants with Clinical Remission per Adapted Mayo Score|Sub-Study 1: Percentage of Participants with Endoscopic Improvement|Sub-Study 1: Percentage of Participants Achieving Clinical Remission per Full Mayo Score in Participants with a Full Mayo Score of 6 to 12 at Baseline|Sub-Study 1: Percentage of Participants Achieving Clinical Response per Adapted Mayo Score|Sub-Study 1: Percentage of Participants Achieving Clinical Response per Partial Adapted Mayo Score|Sub-Study 1: Percentage of Participants with Endoscopic Remission|Sub-Study 1: Percentage of Participants with Hospitalization|Sub-Study 1: Percentage of Participants with Mucosal Healing|Sub-Study 1: Change in Ulcerative Colitis Symptom Questionnaire (UC-SQ)|Sub-Study 1: Change in Inflammatory Bowel Disease Questionnaire (IBDQ)|Sub-Study 1: Change in Short Form-36 (SF-36)|Sub-Study 1: Change in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue)|Sub-Study 1: Percentage of Participants with Ulcerative Colitis (UC)-related Surgeries|Sub-Study 2: Percentage of Participants Achieving Clinical Remission per Full Mayo Score in Participants with a Full Mayo Score of 6 to 12 at Baseline|Sub-Study 2: Percentage of Participants Achieving Clinical Response per Adapted Mayo Score|Sub-Study 2: Percentage of Participants who Reported No Abdominal Pain|Sub-Study 2: Percentage of Participants who Reported No Bowel Urgency|Sub-Study 2: Percentage of Participants with Endoscopic Remission|Sub-Study 2: Percentage of Participants with Endoscopic Improvement|Sub-Study 2: Change in Inflammatory Bowel Disease Questionnaire (IBDQ)|Sub-Study 2: Change in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue)|Sub-Study 2: Percentage of Participants with Histological Endoscopic Improvement of the Mucosa|Sub-Study 2: Percentage of Participants who Reported No Nocturnal Bowel Movements|Sub-Study 2: Percentage of Participants who Reported No Tenesmus|Sub-Study 2: Change in Number of Fecal Incontinence Episodes per Week|Sub-Study 2: Change in Number of Days per Week with Sleep Interrupted due to UC Symptoms|Sub-Study 2: Percentage of Participants Achieving Clinical Response per Partial Adapted Mayo Score in Participants with Pancolitis at Baseline|Sub-Study 2: Percentage of Participants with Ulcerative Colitis (UC)-related Hospitalization|Sub-Study 2: Change in Short Form-36 (SF-36)","AbbVie","All","16 Years to 80 Years   (Child, Adult, Older Adult)","Phase 2|Phase 3","1547","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","M16-067|2016-004677-40","March 7, 2018","September 23, 2022","April 20, 2023","January 12, 2018",,"June 30, 2021","Southern California Res. Ctr. /ID# 169660, Coronado, California, United States|Hoag Memorial Hosp Presbyterian /ID# 218348, Irvine, California, United States|Moore UC San Diego Cancer Center /ID# 160452, La Jolla, California, United States|United Medical Doctors /ID# 158528, Los Alamitos, California, United States|Gastrointestinal Biosciences Clinical Trials, LLC /ID# 200931, Los Angeles, California, United States|UCSF Center for Colitis and Crohn's Disease /ID# 201210, San Francisco, California, United States|Kaiser Permanente - San Francisco /ID# 211627, San Francisco, California, United States|Cedars-Sinai Medical Center-West Hollywood /ID# 163851, West Hollywood, California, United States|Peak Gastroenterology Associates, PC /ID# 165841, Colorado Springs, Colorado, United States|Rocky Mountain Pediatric Gastroenterology /ID# 207174, Lone Tree, Colorado, United States|Medical Research Center of CT /ID# 160311, Hamden, Connecticut, United States|Yale Univ Digestive Diseases /ID# 213179, New Haven, Connecticut, United States|South Lake Pain Institute, Inc /ID# 162878, Clermont, Florida, United States|Ctr for Advanced Gastroenterol /ID# 202811, Maitland, Florida, United States|University of Miami /ID# 160471, Miami, Florida, United States|Coral Research Clinic /ID# 158584, Miami, Florida, United States|South Florida Research Ph I-IV, Inc. /ID# 161848, Miami, Florida, United States|Gastroenterology Group Naples /ID# 165212, Naples, Florida, United States|Advanced Research Institute, Inc /ID# 161938, New Port Richey, Florida, United States|Advent Health /ID# 160433, Orlando, Florida, United States|Endoscopic Research, Inc. /ID# 206711, Orlando, Florida, United States|Omega Research Maitland, LLC /ID# 203059, Orlando, Florida, United States|Lenus Research & Medical Group /ID# 169730, Sweetwater, Florida, United States|Clinical Research Trials of Florida, Inc. /ID# 201783, Tampa, Florida, United States|AdventHealth Tampa /ID# 170503, Tampa, Florida, United States|Gastroenterology Associates of Central Georgia, LLC /ID# 160523, Macon, Georgia, United States|Atlanta Gastroenterology Spec /ID# 161372, Suwanee, Georgia, United States|The University of Chicago Medical Center /ID# 160521, Chicago, Illinois, United States|DM Clinical Research/Southwest /ID# 165012, Oak Lawn, Illinois, United States|Indiana University /ID# 167252, Indianapolis, Indiana, United States|University of Kansas Medical Center - Main /ID# 226602, Kansas City, Kansas, United States|Cotton-O'Neil Clinical Res Ctr /ID# 160412, Topeka, Kansas, United States|Robely Rex VA Medical Center /ID# 218648, Louisville, Kentucky, United States|Gastroenterology Associates LLC - Jefferson Hwy /ID# 161935, Baton Rouge, Louisiana, United States|Houma Digestive Health Special /ID# 158317, Houma, Louisiana, United States|Delricht Research /ID# 206815, New Orleans, Louisiana, United States|Nola Research Works, LLC /ID# 161368, New Orleans, Louisiana, United States|Louisana Research Center, LLC /ID# 201204, Shreveport, Louisiana, United States|Johns Hopkins University School of Medicine /ID# 211793, Baltimore, Maryland, United States|MGH Digestive Health Center /ID# 164255, Boston, Massachusetts, United States|University of Michigan Health Systems /ID# 158524, Ann Arbor, Michigan, United States|Center for Digestive Health /ID# 160327, Troy, Michigan, United States|Mayo Clinic /ID# 200458, Rochester, Minnesota, United States|Quality Clinical Research Inc. /ID# 167313, Omaha, Nebraska, United States|Manhattan Clinical Research, LLC /ID# 211805, New York, New York, United States|Weill Cornell Medicine /ID# 165887, New York, New York, United States|Columbia Univ Medical Center /ID# 161934, New York, New York, United States|Lenox Hill Hospital /ID# 168470, New York, New York, United States|DiGiovanna Institute for Medical Education & Research /ID# 171129, North Massapequa, New York, United States|Univ Rochester Med Ctr /ID# 161664, Rochester, New York, United States|Atrium Health Carolinas Medical Center /ID# 158512, Charlotte, North Carolina, United States|Carolina Research /ID# 201090, Greenville, North Carolina, United States|Plains Clinical Research Center, LLC /ID# 169732, Fargo, North Dakota, United States|Cleveland Clinic Main Campus /ID# 209232, Cleveland, Ohio, United States|The Ohio State University /ID# 164714, Columbus, Ohio, United States|Optimed Research, Ltd. /ID# 167113, Columbus, Ohio, United States|Great Lakes Gastroenterology Research LLC /ID# 201777, Mentor, Ohio, United States|ProMedica Physicians Digestive Healthcare /ID# 215623, Sylvania, Ohio, United States|Digestive Disease Specialists /ID# 170779, Oklahoma City, Oklahoma, United States|Adult Gastroenterology Associates - Gen 1 Research /ID# 208867, Tulsa, Oklahoma, United States|Penn State Milton S. Hershey Medical Center /ID# 223563, Hershey, Pennsylvania, United States|University of Pennsylvania /ID# 166266, Philadelphia, Pennsylvania, United States|Digestive Disease Associates, LTD /ID# 232407, Wyomissing, Pennsylvania, United States|Gastroenterology Associates, P.A. of Greenville /ID# 160472, Greenville, South Carolina, United States|Gastro One /ID# 160418, Germantown, Tennessee, United States|East Tennessee Research Institute /ID# 168747, Johnson City, Tennessee, United States|Vanderbilt University Medical Center /ID# 160580, Nashville, Tennessee, United States|Quest Clinical Research /ID# 165685, Baytown, Texas, United States|Texas Digestive Disease Consultants /ID# 209798, Cedar Park, Texas, United States|Texas Digestive Disease Consultants /ID# 209950, Cedar Park, Texas, United States|DHAT Research Institute /ID# 158226, Garland, Texas, United States|Vilo Research Group Inc /ID# 207656, Houston, Texas, United States|CliniCore International, LLC /ID# 158218, Houston, Texas, United States|Baylor College of Medicine - Baylor Medical Center /ID# 158221, Houston, Texas, United States|Precision Research Institute, LLC /ID# 201351, Houston, Texas, United States|Centex Studies, Inc. - Houston /ID# 201222, Houston, Texas, United States|Caprock Gastro Research /ID# 215432, Lubbock, Texas, United States|Clinical Associates in Research Therapeutics of America, LLC /ID# 161376, San Antonio, Texas, United States|Southern Star Research Institute, LLC /ID# 168776, San Antonio, Texas, United States|Baylor Scott & White Center for Diagnostic Medicine /ID# 204130, Temple, Texas, United States|Tyler Research Institute, LLC /ID# 166800, Tyler, Texas, United States|Gastro Health & Nutrition - Victoria /ID# 164321, Victoria, Texas, United States|Advanced Research Institute /ID# 160480, Ogden, Utah, United States|Gastroenterology Consultants of Southwest Virginia /ID# 218143, Roanoke, Virginia, United States|Virginia Mason - Seattle Orthapedics /ID# 160466, Seattle, Washington, United States|Cemic /Id# 167782, Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina|Hospital Centenario /Id# 170898, Rosario, Santa Fe, Argentina|Sanatorio 9 de Julio /ID# 167780, San Miguel de Tucuman, Tucuman, Argentina|Hospital Privado Univesitario /ID# 167779, Cordoba, Argentina|Duplicate_Universitaetsklinikum St.Poelten /ID# 169048, St. Poelten, Niederoesterreich, Austria|Ordensklinikum Linz GmbH Barmherzige Schwestern /ID# 215320, Linz, Oberoesterreich, Austria|Medizinische Universität Graz /ID# 169053, Graz, Steiermark, Austria|Medical University of Vienna /ID# 169050, Vienna, Wien, Austria|LKH Salzburg and Paracelsus /ID# 200685, Salzburg, Austria|ULB Hospital Erasme /ID# 200252, Brussels, Bruxelles-Capitale, Belgium|UCL Saint-Luc /ID# 200039, Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium|CHU UCL Namur - site Godinne /ID# 200254, Godinne, Namur, Belgium|Universitair Ziekenhuis Leuven /ID# 170812, Leuven, Vlaams-Brabant, Belgium|Imelda Ziekenhuis /ID# 211100, Bonheiden, Belgium|CHU de Liege /ID# 200253, Liege, Belgium|Groupe Sante CHC - Clinique du MontLegia /ID# 200250, Liege, Belgium|AZ-Delta /ID# 200040, Roeselare, Belgium|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva /ID# 157679, Goiania, Goias, Brazil|Hospital Nossa Senhora das Graças /ID# 157671, Curitiba, Parana, Brazil|Hospital de Clinicas de Porto Alegre /ID# 157662, Porto Alegre, Rio Grande Do Sul, Brazil|Upeclin Fmb - Unesp /Id# 157690, Botucatu, Sao Paulo, Brazil|Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP /ID# 157660, Ribeirão Preto, Sao Paulo, Brazil|Faculdade de Medicina do ABC /ID# 163995, Santo André, Sao Paulo, Brazil|Kaiser Clinica e Hospital Dia /ID# 157680, Sao Jose Do Rio Preto, Sao Paulo, Brazil|MHAT Hadzhi Dimitar /ID# 207945, Sliven, Bulgaria|Second MHAT Sofia /ID# 200799, Sofia, Bulgaria|UMHAT Sveti Ivan Rilski /ID# 210797, Sofia, Bulgaria|UMHAT Tsaritsa Joanna - ISUL /ID# 209977, Sofia, Bulgaria|University of Calgary - Heritage Medical Research Clinic /ID# 169111, Calgary, Alberta, Canada|Allen Whey Khye Lim Professional Corporation /ID# 169767, Edmonton, Alberta, Canada|Covenant Health /ID# 169114, Edmonton, Alberta, Canada|Fraser Clinical Trials Inc /ID# 169102, New Westminster, British Columbia, Canada|Percuro Clinical Research, Ltd /ID# 169109, Victoria, British Columbia, Canada|London Health Sciences Center /ID# 169103, London, Ontario, Canada|Scott Shulman Medicine Professional Corporation /ID# 169113, North Bay, Ontario, Canada|Toronto Digestive Disease Asso /ID# 169106, Vaughan, Ontario, Canada|CHAU- Hotel-Dieu de Levis /ID# 214378, Levis, Quebec, Canada|CIUSSS de l'est de l'Ile-de-Montreal - Hopital Maisonneuve-Rosemont /ID# 169108, Montreal, Quebec, Canada|Montreal General Hospital - McGill University Health Center /ID# 169104, Montreal, Quebec, Canada|Servicio de Salud Araucanía Norte Hospital Victoria /ID# 213151, Victoria, Araucania, Chile|Complejo Asistencial Dr. Sotero del Rio /ID# 169385, Santiago, Region Metropolitana De Santiago, Chile|Servicio de Salud Occidente Hospital San Juan de Dios /ID# 171125, Santiago, Region Metropolitana De Santiago, Chile|Hospital Guillermo Grant Benavente de Concepción /ID# 210761, Concepción, Chile|Hospital Las Higueras /ID# 167093, Talcahuano, Chile|The First Affiliated Hospital of Anhui Medical University /ID# 211228, Hefei, Anhui, China|The Sixth Affiliated Hosp Sun /ID# 211231, Guangzhou, Guangdong, China|The Second Hospital of Hebei Medical University /ID# 213018, Shijiazhuang, Hebei, China|Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 211071, Wuhan, Hubei, China|Renmin Hospital of Wuhan University /ID# 212868, Wuhan, Hubei, China|Jiangsu Province Hospital /ID# 211232, Nanjing, Jiangsu, China|Wuxi People's Hospital /ID# 218798, Wuxi, Jiangsu, China|The First Affiliated Hospital of Nanchang University /ID# 212183, Nanchang, Jiangxi, China|The First Hospital of Jilin University /ID# 212278, Changchun, Jilin, China|General Hospital of Ningxia Medical University /ID# 213911, Yinchuan, Ningxia, China|Tangdu Hospital of The Fourth Military Medical University, PLA /ID# 215504, Xi'an, Shaanxi, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 210962, Shanghai, Shanghai, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 211233, Shanghai, Shanghai, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 218791, Shanghai, Shanghai, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 226190, Shanghai, Shanghai, China|Xijing Hospital /ID# 211639, Xian, Shanxi, China|The second Affiliated hospital of Zhejiang University school of Medicine /ID# 211025, Hangzhou, Zhejiang, China|Sir Run Run Shaw Hospital /ID# 211064, Hangzhou, Zhejiang, China|Beijing Friendship Hospital /ID# 211066, Beijing, China|The Second Hospital Central South University /ID# 211198, Changsha, China|West China Hospital, Sichuan University /ID# 211276, Chengdu, China|Nanjing Drum Tower Hospital /ID# 227439, Nanjing Jiangsu, China|Shengjing Hospital of China Medical University /ID# 211646, Shenyang, China|Tongji Hospital Tongji Medical College Huazhong University of Science and Techno /ID# 211072, Wuhan, China|Instituto Medico de Alta Tecnologia Oncomédica S.A /ID# 206937, Monteria, Cordoba, Colombia|Corporacion Hospitalaria Juan Cuidad Sede Denominada Hospital Universitario Mayo /ID# 158717, Bogota DC, Cundinamarca, Colombia|Hospital Universitario San Vic /ID# 171490, Medellin, Colombia|Klinicka bolnica Dubrava Zagreb /ID# 157475, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Zagreb /ID# 157471, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Zagreb /ID# 201917, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Osijek /ID# 157472, Osijek, Osjecko-baranjska Zupanija, Croatia|Klinicki bolnicki centar Split /ID# 157473, Split, Croatia|Nemocnice Ceske Budejovice a.s. /ID# 225226, Ceske Budejovice, Czechia|Hepato-Gastroenterologie HK, s.r.o. /ID# 163395, Hradec Kralove, Czechia|Fakultni nemocnice Ostrava /ID# 225567, Ostrava, Czechia|Fakultni nemocnice Plzen /ID# 225565, Plzen, Czechia|Bispebjerg Hospital /ID# 208945, Copenhagen NV, Hovedstaden, Denmark|Sjaellands Universitets Hospital /ID# 200033, Roskilde, Sjælland, Denmark|Odense Universitets Hospital /ID# 205602, Odense C, Syddanmark, Denmark|Hvidovre Hospital /ID# 202266, Hvidovre, Denmark|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 200848, Alexandria, Egypt|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 226793, Alexandria, Egypt|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 226794, Alexandria, Egypt|Air Force Specialized Hospital /ID# 170986, Cairo, Egypt|National Liver Institute /ID# 171040, Menoufiya, Egypt|Hopital Haut-Leveque /ID# 171579, Pessac CEDEX, Gironde, France|Hopital Saint Eloi /ID# 223779, Montpellier CEDEX 5, Herault, France|Hopital Beaujon /ID# 200092, Clichy, Ile-de-France, France|CHU de SAINT ETIENNE - Hopital Nord /ID# 171580, St. Priest En Jarez, Loire, France|Hopitaux de Brabois Adultes /ID# 200095, Vandoeuvre les Nancy, Lorraine, France|Assis.Publique-Hopital Nord /ID# 225825, Marseille, Provence-Alpes-Cote-d Azur, France|CHU Amiens Picardie - Site Sud /ID# 171576, Amiens Cedex 1, France|Universitaetsklinikum Freiburg /ID# 162034, Freiburg, Baden-Wuerttemberg, Germany|Praxis fuer Gastroenterologie /ID# 166152, Heidelberg, Baden-Wuerttemberg, Germany|Universitatsklinikum Mannheim /ID# 162035, Mannheim, Baden-Wuerttemberg, Germany|Universitaetsklinikum Ulm /ID# 164992, Ulm, Baden-Wuerttemberg, Germany|Universitaetsklinikum Erlangen /ID# 159354, Erlangen, Bayern, Germany|Praxiszentrum fuer Gastroenterologie /ID# 219069, Grevenbroich, Nordrhein-Westfalen, Germany|Universitaetsklinikum Koeln /ID# 164991, Köln, Nordrhein-Westfalen, Germany|Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 159360, Kiel, Schleswig-Holstein, Germany|Gastroenterologische Spezialpraxis am Wittenbergplatz /ID# 219145, Berlin, Germany|MVZ fuer Gastroenterlogie am Bayerischen Platz /ID# 159361, Berlin, Germany|Charite; Campus Benjamin Frank /ID# 210510, Berlin, Germany|DRK Kliniken Berlin Westend /ID# 166153, Berlin, Germany|Stadtisches Klinikum Braunschweig /ID# 163687, Braunschweig, Germany|Agaplesion Markus Krankenhaus /ID# 159356, Frankfurt am Main, Germany|Gastroenterologie Opernstrasse /ID# 163683, Kassel, Germany|EUGASTRO GmbH /ID# 219070, Leipzig, Germany|Klinikum Lueneburg /ID# 163685, Lueneburg, Germany|Gastroenterologische Gemeinschaftspraxis Minden /ID# 162033, Minden, Germany|LMU Klinikum Campus Grosshadern /ID# 210481, Muenchen, Germany|Universitaetsklinikum Regensburg /ID# 163686, Regensburg, Germany|General Hospital of Athens Ippokratio /ID# 229189, Athens, Attiki, Greece|General Hospital of Athens Laiko /ID# 206440, Athens, Attiki, Greece|General Hospital of Chest Diseases of Athens SOTIRIA /ID# 170915, Athens, Attiki, Greece|Tzaneio general hospital of Piraeus /ID# 206439, Piraeus, Attiki, Greece|University General Hospital of Heraklion PA.G.N.I /ID# 165216, Heraklion, Kriti, Greece|General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 217480, Athens, Greece|General Hospital of Nikaia-Piraeus ""Agios Panteleimon""- general hospital dytikis /ID# 165218, Pireaus, Greece|Theageneio Anticancer Hospital /ID# 165217, Thessaloniki, Greece|Soroka Medical Center /ID# 171100, Be'er Sheva, HaDarom, Israel|Hadassah Medical Center-Hebrew University /ID# 171099, Jerusalem, Yerushalayim, Israel|Rambam Medical Center /ID# 171101, Haifa, Israel|Rambam Medical Center /ID# 171103, Haifa, Israel|Shaare Zedek Medical Center /ID# 163544, Jerusalem, Israel|Rabin Medical Center /ID# 167403, Petakh Tikva, Israel|Sheba Medical Center /ID# 211278, Ramat Gan, Israel|University of Catanzaro /ID# 200125, Catanzaro, Calabria, Italy|Ospedale Sant Orsola Malpighi /ID# 155611, Bologna, Emilia-Romagna, Italy|Policlinico Universitario Campus Bio-Medico /ID# 163992, Rome, Lazio, Italy|Azienda Ospedaliera San Camillo Forlanini /ID# 155612, Rome, Lazio, Italy|Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 171226, Rome, Lazio, Italy|ASST Rhodense/Presidio Ospedaliero di Rho /ID# 211449, Rho, Milano, Italy|Istituto Clinico Humanitas /ID# 155610, Rozzano, Milano, Italy|Fondazione PTV Policlinico Tor Vergata /ID# 158018, Rome, Roma, Italy|IRCCS Ospedale Sacro Cuore Don Calabria /ID# 164041, Negrar, Verona, Italy|A.O. Per L'Emergenza Cannizzaro /ID# 164036, Catania, Italy|Ospedale Policlinico San Martino - IRCCS /ID# 164031, Genoa, Italy|ASST Grande Ospedale Metropolitano Niguarda /ID# 170947, Milano, Italy|Azienda Ospedaliera Luigi Sacc /ID# 155607, Milan, Italy|Azienda Ospedaliero-Universitaria di Modena /ID# 201819, Modena, Italy|UOC Medicina Interna e Gastroe /ID# 155608, Rome, Italy|Aichi Medical University Hospital /ID# 164332, Nagakute-shi, Aichi, Japan|Nagoya City University Hospital /ID# 164331, Nagoya shi, Aichi, Japan|Japanese Red Cross Nagoya Daiichi Hospital /ID# 164271, Nagoya-shi, Aichi, Japan|Fujita Health University Hospital /ID# 164261, Toyoake-shi, Aichi, Japan|Fukui Clinic /ID# 211479, Toyohashi-shi, Aichi, Japan|Hirosaki National Hospital /ID# 164252, Hirosaki-shi, Aomori, Japan|Tokatsu Tsujinaka Hospital /ID# 164438, Abiko-shi, Chiba, Japan|Chiba Children's Hospital /ID# 209632, Chiba-shi, Chiba, Japan|National Cancer Center Hospital East /ID# 208964, Kashiwa-shi, Chiba, Japan|Toho University Medical Center Sakura Hospital /ID# 164254, Sakura-shi, Chiba, Japan|Kyushu University Hospital /ID# 226189, Fukuoka-shi, Fukuoka, Japan|Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers /ID# 225639, Fukuoka-shi, Fukuoka, Japan|Kurume University Hospital /ID# 164427, Kurume-shi, Fukuoka, Japan|Gifu Municipal Hospital /ID# 208081, Gifu-shi, Gifu, Japan|Ogaki Municipal Hospital /ID# 226010, Ogaki-shi, Gifu, Japan|National Hospital Organization Takasaki General Medical Center /ID# 164437, Takasaki-shi, Gunma, Japan|NHO Fukuyama Medical Center /ID# 164439, Fukuyama-shi, Hiroshima, Japan|Duplicate_Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital /ID# 164426, Hiroshima-shi, Hiroshima, Japan|Asahikawa Medical University Hospital /ID# 164433, Midorigaokahiga-shi, Hokkaido, Japan|Sapporo IBD Clinic /ID# 225923, Sapporo-shi, Hokkaido, Japan|Duplicate_Sapporo Higashi Tokushukai Hospital /ID# 164251, Sapporo-shi, Hokkaido, Japan|Duplicate_Sapporo Higashi Tokushukai Hospital /ID# 164432, Sapporo-shi, Hokkaido, Japan|Duplicate_Keiyukai Daini Hospital /ID# 208488, Sapporo-shi, Hokkaido, Japan|Kobe Home Clinic of Neurology /ID# 164425, Kobe-shi, Hyogo, Japan|Hyogo College of Medicine College Hospital /Id# 164424, Nishinomiya-shi, Hyogo, Japan|Kanazawa University Hospital /ID# 169224, Kanazawa-shi, Ishikawa, Japan|Sameshima Hospital /ID# 211181, Kagoshima-shi, Kagoshima, Japan|Tokai University Hospital /ID# 209204, Isehara-shi, Kanagawa, Japan|Gokeikai Ofuna Chuo Hospital /ID# 169300, Kamakura-shi, Kanagawa, Japan|St. Marianna University School of Medicine Hospital /ID# 226728, Kawasaki-shi, Kanagawa, Japan|Showa University Fujigaoka Hospital /ID# 209555, Yokohama-shi, Kanagawa, Japan|Kannai-Suzuki Clinic /ID# 225914, Yokohama-shi, Kanagawa, Japan|Kumamoto University Hospital /ID# 169226, Kumamoto shi, Kumamoto, Japan|Mie University Hospital /ID# 203633, Tsu-shi, Mie, Japan|Yokkaichi Hazu Medical Center /ID# 164441, Yokkaichi-shi, Mie, Japan|Tohoku Rosai Hospital /ID# 164430, Sendai-shi, Miyagi, Japan|Nagasaki University Hospital /ID# 202674, Nagasaki-shi, Nagasaki, Japan|Nara Medical University Hospital /ID# 169225, Kashihara-shi, Nara, Japan|National Hospital Organization Osaka Minami Medical Center /ID# 226035, Kawachinagano Shi, Osaka, Japan|Shimizu-Clinic /ID# 226747, Osaka-shi, Osaka, Japan|Saga University Hospital /ID# 209396, Saga-shi, Saga, Japan|Tokitokai Tokito clinic /ID# 164253, Saitama-shi, Saitama, Japan|Shiga University of Medical Science Hospital /ID# 164440, Otsu-shi, Shiga, Japan|Hamamatsu University Hospital /ID# 226727, Hamamatsu-shi, Shizuoka, Japan|Matsuda Hospital /ID# 226616, Hamamatsu-shi, Shizuoka, Japan|Shizuoka Medical Centre /ID# 164435, Sunto-shi, Shizuoka, Japan|St.Luke's International Hospital /ID# 225822, Chuo-ku, Tokyo, Japan|Duplicate_Tokai University Hachioji Hospital /ID# 226899, Hachioji-shi, Tokyo, Japan|Teikyo University Hospital /ID# 225588, Itabashi-ku, Tokyo, Japan|Duplicate_Kitasato University Kitasato Institute Hospital /ID# 164256, Minato-ku, Tokyo, Japan|Kyorin University Hospital /ID# 164259, Mitaka-shi, Tokyo, Japan|NTT Medical Center Tokyo /ID# 225587, Shinagawa-ku, Tokyo, Japan|Tokyo Medical University Hospital /ID# 164258, Shinjuku-ku, Tokyo, Japan|Tokyo Medical University Hospital /ID# 164434, Shinjuku-ku, Tokyo, Japan|Keio University Hospital /ID# 203629, Shinjuku-ku, Tokyo, Japan|Japanese Red Cross Wakayama Medical Center /ID# 171195, Wakayama-shi, Wakayama, Japan|Wakayama Medical University Hospital /ID# 169487, Wakayama-shi, Wakayama, Japan|Yamagata University Hospital /ID# 171474, Yamagata-shi, Yamagata, Japan|Shunan Memorial Hospital /ID# 209055, Kudamatsu-shi, Yamaguchi, Japan|Tokuyama Central Hospital /ID# 226011, Shunan-shi, Yamaguchi, Japan|Hanyang University Guri Hospital /ID# 158702, Guri, Gyeonggido, Korea, Republic of|CHA Bundang Medical center CHA University /ID# 158710, Seongnam si, Gyeonggido, Korea, Republic of|The Catholic University of Korea, ST. Vincent's Hospital /ID# 158706, Suwon, Gyeonggido, Korea, Republic of|Kangbuk Samsung Hospital /ID# 158707, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Severance Hospital /ID# 158701, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Inje University Haeundae Hospital /ID# 203028, Busan, Korea, Republic of|Dong-A University Hospital /ID# 158705, Busan, Korea, Republic of|Pusan National University Hospital /ID# 158711, Busan, Korea, Republic of|Yeungnam University Medical Center /ID# 158703, Daegu, Korea, Republic of|Samsung Medical Center /ID# 158704, Seoul, Korea, Republic of|Riga East Clinical Univ Hosp /ID# 163802, Riga, Latvia|P. Stradins Clinical Univ Hosp /ID# 163803, Riga, Latvia|Hospital of Lithuanian Univers /ID# 170714, Kovno, Kaunas, Lithuania|Vilnius University Hospital /ID# 170614, Vilnius, Lithuania|Universiti Kebangsaan Malaysia (UKM) Medical Centre /ID# 200635, Kuala Lumpur, Selangor, Malaysia|Universiti Sains Malaysia /ID# 221971, Kelantan, Malaysia|JM Research SC /ID# 203593, Cuernavaca, Morelos, Mexico|Unidad de Atencion Medica e Investigacion en Salud /ID# 203595, Merida, Yucatan, Mexico|Health Pharma Professional Research S.A de C.V /ID# 203597, Del. Benito Juárez, Mexico|Academisch Medisch Centrum /ID# 157959, Amsterdam, Noord-Holland, Netherlands|Elisabeth Tweesteden Ziekenhuis /ID# 163767, Tilburg, Netherlands|Tauranga Hospital /ID# 212792, Tauranga, Bay Of Plenty, New Zealand|Christchurch Hospital /ID# 205342, Christchurch, Canterbury, New Zealand|Dunedin Hospital /ID# 212790, Dunedin, Otago, New Zealand|Waikato Hospital /ID# 212789, Hamilton, Waikato, New Zealand|Wellington Regional Hospital /ID# 205343, Newtown Wellington, Wellington, New Zealand|Hutt Hospital /ID# 212786, Lower Hutt, New Zealand|Vistamed /ID# 210105, Wroclaw, Dolnoslaskie, Poland|Gastromed /Id# 230978, Torun, Kujawsko-pomorskie, Poland|Centrum Medyczne Plejady /ID# 170633, Krakow, Malopolskie, Poland|WIP Warsaw IBD Point Profesor Kierkus /ID# 216102, Warsaw, Mazowieckie, Poland|Centrum Zdrowia MDM /ID# 170597, Warszawa, Mazowieckie, Poland|Centralny Szpital Kliniczny MSWiA w Warszawie /ID# 170601, Warszawa, Mazowieckie, Poland|Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Panstwowy Instytut Bada /ID# 170600, Warszawa, Mazowieckie, Poland|NZOZ Vivamed /ID# 216307, Warszawa, Mazowieckie, Poland|NZOZ Vitamed /ID# 213283, Bydgoszcz, Podlaskie, Poland|Endoskopia Sp. z o.o. /ID# 170598, Sopot, Pomorskie, Poland|NZOZ All-Medicus /ID# 170596, Katowice, Slaskie, Poland|H-T. Centrum Medyczne - Endoterapia /ID# 230979, Tychy, Slaskie, Poland|Hospital da Senhora da Oliveira Guimaraes, EPE /ID# 165580, Guimaraes, Braga, Portugal|Centro Hospitalar Universitário do Algarve, EPE - Hospital de Portimão /ID# 166551, Portimão, Faro, Portugal|Centro Hospitalar de Entre Douro e Vouga /ID# 166052, Santa Maria Da Feira, Porto, Portugal|Hospital Garcia de Orta, EPE /ID# 165583, Almada, Portugal|Centro Hospitalar e Universitario de Coimbra, EPE /ID# 166054, Coimbra, Portugal|Centro Hospitalar Universitario Lisboa Central, EPE - Hospital dos Capuchos /ID# 165582, Lisboa, Portugal|Centro Hospitalar Universitario de Sao Joao, EPE /ID# 165581, Porto, Portugal|Centro Hosp de Tondela-Viseu /ID# 166053, Viseu, Portugal|Ponce Medical School Foundation /ID# 221244, Ponce, Puerto Rico|San Jorge Children Hospital /ID# 166954, San Juan, Puerto Rico|VA Caribbean Healthcare System /ID# 221245, San Juan, Puerto Rico|Clinica GASTRO MED SRL /ID# 224169, Cluj-Napoca, Cluj, Romania|Strada dr. Sergiu Dumitru Nr 5 /ID# 224166, Bucharest, Romania|Institutul Clinic Fundeni /ID# 171264, Bucharest, Romania|Institutul Clinic Fundeni /ID# 224168, Bucharest, Romania|Cabinet Particular Policlinic Algomed /ID# 171266, Timisoara, Romania|Centrul Medical Tuculanu SRL /ID# 171268, Timisoara, Romania|Interdisctrict Multidisciplinary Hospital /ID# 203335, Anzorey, Kabardino-Balkarskaya Respublika, Russian Federation|Immanuel Kant Baltic Federal University /ID# 204888, Kaliningrad, Kaliningradskaya Oblast, Russian Federation|Kuzbass Regional Clinical Hospital /ID# 165750, Kemerovo, Kemerovskaya Oblast, Russian Federation|Uninova Medical Center /ID# 229216, Saint Petersburg, Leningradskaya Oblast, Russian Federation|Arsvita Clinic /ID# 208946, Korolev, Moskovskaya Oblast, Russian Federation|Perm Clinical Center of the Federal Medical and Biological Agency /ID# 227457, Perm, Permskiy Kray, Russian Federation|Regional Clinical Hospital #1 /ID# 165754, Tyumen, Tyumenskaya Oblast, Russian Federation|Clinic of New Technologies of Medicine /ID# 203369, Dzerzhinskiy, Russian Federation|Sechenov First Moscow Medical /ID# 204978, Moscow, Russian Federation|National Medical Research Center of Coloproctology n.a. A. N. Ryzhikh /ID# 203512, Moscow, Russian Federation|Central Clinical Hospital RZHD Medicine /ID# 204917, Moscow, Russian Federation|Novosibirski Gastrocenter /ID# 229855, Novosibirsk, Russian Federation|Euromedservice /ID# 204892, Pushkin, Russian Federation|International Medical Center SOGAZ /ID# 206727, St. Petersburg, Russian Federation|City Clinical Hospital #40 /ID# 203370, St. Petersburg, Russian Federation|State financed health instit /ID# 226928, Ufa, Russian Federation|Ulyanovsk Regional Clinical Hospital /ID# 203368, Ulyanovsk, Russian Federation|Clinical Hosp Center Zvezdara /ID# 200151, Belgrade, Beograd, Serbia|Military Medical Academy /ID# 202057, Belgrade, Beograd, Serbia|University Clinical Center Serbia /ID# 200152, Belgrade, Beograd, Serbia|Clin Hosp Ctr Bezanijska Kosa /ID# 202059, Belgrade, Beograd, Serbia|Clinical Center Vojvodina /ID# 156910, Novi Sad, Vojvodina, Serbia|Clinical Hospital Center Dr Dragisa Misovic - Dedinje /ID# 224926, Belgrade, Serbia|General Hospital Leskovac /ID# 207226, Leskovac, Serbia|Singapore General Hospital /ID# 204227, Singapore, Singapore|KL Ling Gastroenterology and Liver Clinic /ID# 205738, Singapore, Singapore|Fakultna nemocnica s poliklinikou F.D. Roosevelta Banska Bystrica /ID# 164347, Banska Bystrica, Slovakia|KM Management, spol. s.r.o. /ID# 206602, Nitra, Slovakia|Fakultna nemocnica s poliklini /ID# 224099, Nove Zamky, Slovakia|GASTRO I., s.r.o. /ID# 164346, Presov, Slovakia|Univ Medical Ctr Ljubljana /ID# 210627, Ljubljana, Slovenia|Farmovs (Pty) Ltd /Id# 207537, Bloemfontein, Free State, South Africa|Spoke Research Inc /ID# 229905, Cape Town,Milnerton, Western Cape, South Africa|Allergy & Immunology (AIU) /ID# 171441, Cape Town, Western Cape, South Africa|Dr JP Wright /ID# 171138, Cape Town, Western Cape, South Africa|Private Practice Dr MN Rajabally /ID# 171137, Cape Town, Western Cape, South Africa|Hospital Arquitecto Marcide - Complejo Hospitalario Universitario de Ferrol /ID# 159440, Ferrol, A Coruna, Spain|Hospital de Cabuenes /ID# 170748, Gijon, Asturias, Spain|Consorci Corporacio Sanitaria Parc Tauli Sabadell /ID# 159461, Sabadell, Barcelona, Spain|Hospital Universitario Puerta de Hierro, Majadahonda /ID# 159443, Majadahonda, Madrid, Spain|Hospital Alvaro Cunqueiro CHUVI /ID# 167360, Vigo, Pontevedra, Spain|Hospital Clinic de Barcelona /ID# 159439, Barcelona, Spain|Hospital Universitario Reina Sofia /ID# 167058, Cordoba, Spain|Hospital Universitario de Girona Doctor Josep Trueta /ID# 225584, Girona, Spain|Hospital Universitario La Paz /ID# 159459, Madrid, Spain|Complejo Hospitalario Universitario de Pontevedra /ID# 216182, Pontevedra, Spain|Hospital Clinico Universitario de Salamanca /ID# 159446, Salamanca, Spain|Hospital Universitario Virgen Macarena /ID# 159968, Sevilla, Spain|Hospital Universitario Miguel Servet /ID# 159445, Zaragoza, Spain|Alingsås lasarett /ID# 202074, Alingsås, Vastra Gotalands Lan, Sweden|SU Molndal. /ID# 202843, Molndal, Sweden|Danderyds sjukhus AB /ID# 202035, Stockholm, Sweden|Universitätsspital Zürich /ID# 202910, Zürich, Zuerich, Switzerland|Inselspital, Universitätsspital Bern /ID# 202911, Bern, Switzerland|China Medical University Hosp /ID# 160189, Taichung City, Taichung, Taiwan|National Taiwan University Hospital /ID# 162187, Taipei City, Taipei, Taiwan|Chung Shan Medical University /ID# 163651, Taichung City, Taiwan|Taichung Veterans General Hosp /ID# 163649, Taichung City, Taiwan|Taipei Veterans General Hosp /ID# 163650, Taipei City, Taiwan|Linkou Chang Gung Memorial Hos /ID# 222877, Taoyuan County, Taiwan|Acibadem Kozyatagi Hospital /ID# 213276, Kadikoy, Istanbul, Turkey|Erciyes University Medical Fac /ID# 171291, Melikgazi, Kayseri, Turkey|Ankara Univ Medical Faculty /ID# 167210, Ankara, Turkey|Inonu Universitesi Turgut Ozal /ID# 203981, Battalgazi/malatya, Turkey|Uludag University Medical Faculty /ID# 204182, Bursa, Turkey|Fırat University Medical Facul /ID# 171292, Elazig, Turkey|Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty /ID# 167207, Istanbul, Turkey|Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi /ID# 171293, Istanbul, Turkey|Sisli Etfal Train & Res Hosp /ID# 171409, Sisli, Turkey|Medical Centre OK Clinic of International Institute of Clinical Research LLC /ID# 205482, Kyiv, Kyivska Oblast, Ukraine|Kyiv Regional Hospital /ID# 224343, Kyiv, Kyivska Oblast, Ukraine|Kyiv Municipal Clinical Hospital #18 /ID# 224348, Kiev, Kyiv, Ukraine|Volyn regional clinical hospital /ID# 229848, Lutsk, Volynska Oblast, Ukraine|CNE Regional Clinical Hospital of Ivano-Frankivsk RC /ID# 203367, Ivano-frankivsk, Ukraine|Municipal Nonprofit Enterprise Kherson city clinical hospital n.a. Y.Y. Karabel /ID# 224350, Kherson, Ukraine|RD&E Hospital /ID# 157587, Exeter, Devon, United Kingdom|Barnsley Hospital NHS Foundation Trust /ID# 202770, Barnsley, United Kingdom|Addenbrookes Hospital /ID# 158040, Cambridge, United Kingdom|Western General Hospital /ID# 208802, Edinburgh, United Kingdom|Royal Liverpool and Broadgreen /ID# 203858, Liverpool, United Kingdom|Barts and the London NHS Trust /ID# 157590, London, United Kingdom|King's College Hospital NHS Foundation Trust /ID# 158766, London, United Kingdom|St. George's Healthcare NHS /ID# 208378, London, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 158041, Newcastle Upon Tyne, United Kingdom|Univ Hosp Southampton NHS /ID# 210813, Southampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03398148"
870,"NCT03398135","A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis",,"Enrolling by invitation","No Results Available","Ulcerative Colitis (UC)","Drug: risankizumab|Drug: placebo for risankizumab","Sub-Study 1: Percentage of Participants with Clinical Remission per Adapted Mayo Score|Sub-Study 3: Percentage of Participants with Adverse Events (AE)|Sub-Study 1: Percentage of Participants with Endoscopic Improvement|Sub-Study 1: Percentage of Participants with Clinical Remission per Full Mayo Score in Participants with a Full Mayo Score of 6 to 12 at Baseline (of Induction)|Sub-Study 1: Percentage of Participants who Discontinued Corticosteroid Use, in Participants Taking Steroids at Baseline (of induction).|Sub-Study 1: Percentage of Participants with Clinical Remission per Adapted Mayo Score in Participants with a Clinical Remission at Week 0|Sub-Study 1: Percentage of Participants who Discontinued Corticosteroid Use, Remained Corticosteroid Free for 90 days and Achieved Clinical Remission in Participants who were Taking Steroids at Baseline (of induction)|Sub-Study 1: Percentage of Participants with Clinical Response per Adapted Mayo Score|Sub-Study 1: Percentage of Participants Achieving Histologic-Endoscopic Mucosal Improvement|Sub-Study 1: Percentage of Participants with Endoscopic Remission|Sub-Study 1: Percentage of Participants with Endoscopic Improvement in Participants with Endoscopic Improvement at Week 0|Sub-Study 1: Percentage of Participants with Ulcerative Colitis (UC) Related Hospitalization|Sub-Study 1: Percentage of Participants with Histologic Remission|Sub-Study 1: Percentage of Participants who Reported No Abdominal Pain|Sub-Study 1: Percentage of Participants who Reported No Bowel Urgency|Sub-Study 1: Percentage of Participants with Mucosal Healing|Sub-Study 1: Change in Inflammatory Bowel Disease Questionnaire (IBDQ)|Sub-Study 1: Percentage of Participants with Ulcerative Colitis (UC)-Related Surgeries|Sub-Study 1: Change in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue)|Sub-Study 1: Percentage of Participants who Reported No Nocturnal Bowel Movements|Sub-Study 1: Percentage of Participants who Reported No Tenesmus|Sub-Study 1: Change in Number of Fecal Incontinence Episodes per Week|Sub-Study 1: Change in Number of Days per Week with Sleep Interrupted due to UC Symptoms|Sub-Study 1: Change in 36-Item Short Form Health Status Survey (SF-36)","AbbVie","All","16 Years to 80 Years   (Child, Adult, Older Adult)","Phase 3","942","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","M16-066|2016-004676-22","August 28, 2018","December 15, 2023","May 23, 2024","January 12, 2018",,"June 10, 2021","Southern California Res. Ctr. /ID# 169659, Coronado, California, United States|Moore UC San Diego Cancer Center /ID# 160430, La Jolla, California, United States|United Medical Doctors /ID# 158574, Los Alamitos, California, United States|Gastrointestinal Biosciences Clinical Trials, LLC /ID# 200934, Los Angeles, California, United States|Hoag Memorial Hosp Presbyterian /ID# 218347, Newport Beach, California, United States|UCSF Center for Colitis and Crohn's Disease /ID# 201209, San Francisco, California, United States|Kaiser Permanente - San Francisco /ID# 212087, San Francisco, California, United States|Cedars-Sinai Medical Center-West Hollywood /ID# 163848, West Hollywood, California, United States|Peak Gastroenterology Associat /ID# 165838, Colorado Springs, Colorado, United States|Rocky Mountain Pediatric Gastroenterology /ID# 207173, Lone Tree, Colorado, United States|Medical Research Ctr CT /ID# 160287, Hamden, Connecticut, United States|Yale Univ Digestive Diseases /ID# 213265, New Haven, Connecticut, United States|South Lake Pain Institute, Inc /ID# 162859, Clermont, Florida, United States|Ctr for Advanced Gastroenterol /ID# 202820, Maitland, Florida, United States|University of Miami /ID# 160456, Miami, Florida, United States|Coral Research Clinic /ID# 158608, Miami, Florida, United States|South Florida Research Ph I-IV /ID# 161844, Miami, Florida, United States|Gastroenterology Group Naples /ID# 165210, Naples, Florida, United States|Advanced Research Institute, Inc /ID# 161945, New Port Richey, Florida, United States|Advent Health /ID# 160393, Orlando, Florida, United States|Endoscopic Research, Inc. /ID# 206709, Orlando, Florida, United States|Omega Research Maitland, LLC /ID# 203105, Orlando, Florida, United States|Lenus Research & Medical Group /ID# 169727, Sweetwater, Florida, United States|Clinical Research Trials of Florida, Inc. /ID# 201794, Tampa, Florida, United States|AdventHealth Tampa /ID# 170482, Tampa, Florida, United States|Gastroenterology Associates of Central Georgia, LLC /ID# 160513, Macon, Georgia, United States|The University of Chicago Medical Center /ID# 160511, Chicago, Illinois, United States|DM Clinical Research/Southwest /ID# 165009, Oak Lawn, Illinois, United States|Indiana University /ID# 167250, Indianapolis, Indiana, United States|Cotton-O'Neil Clinical Res Ctr /ID# 160367, Topeka, Kansas, United States|Robely Rex VA Medical Center /ID# 218647, Louisville, Kentucky, United States|Houma Digestive Health Special /ID# 158377, Houma, Louisiana, United States|Delricht Research /ID# 206817, New Orleans, Louisiana, United States|Nola Research Works, LLC /ID# 161356, New Orleans, Louisiana, United States|Louisana Research Center, LLC /ID# 201205, Shreveport, Louisiana, United States|Johns Hopkins University School of Medicine /ID# 211792, Baltimore, Maryland, United States|MGH Digestive Health Center /ID# 164257, Boston, Massachusetts, United States|University of Michigan Health Systems /ID# 159430, Ann Arbor, Michigan, United States|Center for Digestive Health /ID# 160300, Troy, Michigan, United States|Mayo Clinic /ID# 200455, Rochester, Minnesota, United States|Quality Clinical Research Inc. /ID# 167312, Omaha, Nebraska, United States|Manhattan Clinical Research, LLC /ID# 211803, New York, New York, United States|Weill Cornell Medicine /ID# 165884, New York, New York, United States|Columbia Univ Medical Center /ID# 161929, New York, New York, United States|Lenox Hill Hospital /ID# 168469, New York, New York, United States|DiGiovanna Institute for Medical Education & Research /ID# 171128, North Massapequa, New York, United States|Univ Rochester Med Ctr /ID# 161660, Rochester, New York, United States|Atrium Health Carolinas Medical Center /ID# 158543, Charlotte, North Carolina, United States|Plains Clinical Research Center, LLC /ID# 169729, Fargo, North Dakota, United States|Cleveland Clinic Main Campus /ID# 209235, Cleveland, Ohio, United States|The Ohio State University /ID# 164713, Columbus, Ohio, United States|Optimed Research, Ltd. /ID# 167112, Columbus, Ohio, United States|Great Lakes Gastroenterology Research LLC /ID# 201778, Mentor, Ohio, United States|ProMedica Physicians Digestive Healthcare /ID# 215622, Sylvania, Ohio, United States|Digestive Disease Specialists /ID# 170777, Oklahoma City, Oklahoma, United States|Adult Gastroenterology Associates - Main /ID# 208873, Tulsa, Oklahoma, United States|Penn State Milton S. Hershey Medical Center /ID# 230474, Hershey, Pennsylvania, United States|University of Pennsylvania /ID# 166262, Philadelphia, Pennsylvania, United States|Gastroenterology Associates, P.A. of Greenville /ID# 160457, Greenville, South Carolina, United States|Gastro One /ID# 160373, Germantown, Tennessee, United States|East Tennessee Research Institute /ID# 168744, Johnson City, Tennessee, United States|Vanderbilt University Medical Center /ID# 160567, Nashville, Tennessee, United States|Quest Clinical Research /ID# 165686, Baytown, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209799, Cedar Park, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209951, Cedar Park, Texas, United States|DHAT Research Institute /ID# 158235, Garland, Texas, United States|Vilo Research Group Inc /ID# 207657, Houston, Texas, United States|Baylor College of Medicine /ID# 158230, Houston, Texas, United States|Centex Studies, Inc. - Houston /ID# 201221, Houston, Texas, United States|Caprock Gastro Research /ID# 215433, Lubbock, Texas, United States|Clinical Associates in Researc /ID# 161364, San Antonio, Texas, United States|Southern Star Research Institute, LLC /ID# 168774, San Antonio, Texas, United States|Baylor Scott & White Center for Diagnostic Medicine /ID# 204132, Temple, Texas, United States|Tyler Research Institute, LLC /ID# 166799, Tyler, Texas, United States|Gastro Health & Nutrition - Victoria /ID# 164308, Victoria, Texas, United States|Advanced Research Institute /ID# 160465, Ogden, Utah, United States|Gastroenterology Consultants of Southwest Virginia /ID# 218142, Roanoke, Virginia, United States|Virginia Mason - Seattle Orthapedics /ID# 160432, Seattle, Washington, United States|Cemic /Id# 167805, Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina|Hospital Centenario /Id# 170896, Rosario, Santa Fe, Argentina|Sanatorio 9 de Julio /ID# 167803, San Miguel de Tucuman, Tucuman, Argentina|Hospital Privado Univesitario /ID# 167802, Cordoba, Argentina|Universitaetsklinikum St.Poelten /ID# 169049, St. Poelten, Niederoesterreich, Austria|Ordensklinikum Linz GmbH Barmherzige Schwestern /ID# 216043, Linz, Oberoesterreich, Austria|Medizinische Universität Graz /ID# 169052, Graz, Steiermark, Austria|Medical University of Vienna /ID# 169051, Vienna, Wien, Austria|LKH Salzburg and Paracelsus /ID# 200686, Salzburg, Austria|ULB Hospital Erasme /ID# 200256, Brussels, Bruxelles-Capitale, Belgium|UCL Saint-Luc /ID# 200260, Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium|CHU UCL Namur - site Godinne /ID# 200259, Godinne, Namur, Belgium|Universitair Ziekenhuis Leuven /ID# 170829, Leuven, Vlaams-Brabant, Belgium|Imelda Ziekenhuis /ID# 211101, Bonheiden, Belgium|CHU de Liege /ID# 200257, Liege, Belgium|Groupe Sante CHC - Clinique du MontLegia /ID# 200255, Liege, Belgium|AZ-Delta /ID# 200258, Roeselare, Belgium|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva /ID# 157683, Goiania, Goias, Brazil|Hospital Nossa Senhora das Graças /ID# 157677, Curitiba, Parana, Brazil|Hospital de Clinicas de Porto Alegre /ID# 157670, Porto Alegre, Rio Grande Do Sul, Brazil|Upeclin Fmb - Unesp /Id# 157691, Botucatu, Sao Paulo, Brazil|Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP /ID# 157668, Ribeirão Preto, Sao Paulo, Brazil|Faculdade de Medicina do ABC /ID# 163993, Santo André, Sao Paulo, Brazil|Kaiser Clinica e Hospital Dia /ID# 157686, Sao Jose Do Rio Preto, Sao Paulo, Brazil|MHAT Hadzhi Dimitar /ID# 207947, Sliven, Bulgaria|Second MHAT Sofia /ID# 200794, Sofia, Bulgaria|UMHAT Tsaritsa Joanna - ISUL /ID# 209978, Sofia, Bulgaria|UMHAT Sveti Ivan Rilski /ID# 210798, Sofia, Bulgaria|University of Calgary - Cumming School of Medicine - Adult Cystic Fibrosis Clini /ID# 169125, Calgary, Alberta, Canada|Allen Whey Khye Lim Professional Corporation /ID# 169770, Edmonton, Alberta, Canada|Covenant Health /ID# 169128, Edmonton, Alberta, Canada|Fraser Clinical Trials Inc /ID# 169116, New Westminster, British Columbia, Canada|Percuro Clinical Research, Ltd /ID# 169123, Victoria, British Columbia, Canada|IWK Health Center /ID# 169124, Halifax, Nova Scotia, Canada|London Health Sciences Center /ID# 169117, London, Ontario, Canada|Scott Shulman Medicine Professional Corporation /ID# 169127, North Bay, Ontario, Canada|Toronto Digestive Disease Asso /ID# 169120, Vaughan, Ontario, Canada|CHAU- Hotel-Dieu de Levis /ID# 214379, Levis, Quebec, Canada|CIUSSS de l'est de l'Ile-de-Montreal - Hopital Maisonneuve-Rosemont /ID# 169122, Montreal, Quebec, Canada|Montreal General Hospital /ID# 169118, Montréal, Quebec, Canada|Servicio de Salud Araucanía Norte Hospital Victoria /ID# 213152, Victoria, Araucania, Chile|Complejo Asistencial Dr. Sotero del Rio /ID# 169386, Santiago, Region Metropolitana De Santiago, Chile|Hospital Guillermo Grant Benavente de Concepción /ID# 210762, Concepción, Chile|Hospital Las Higueras /ID# 167094, Talcahuano, Chile|The First Affiliated Hospital of Anhui Medical University /ID# 211227, Hefei, Anhui, China|The Sixty Affiliated Hospital Sun Yat-Sen University /ID# 211229, Guangzhou, Guangdong, China|The Second Hospital of Hebei Medical University /ID# 213019, Shijiazhuang, Hebei, China|Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 211070, Wuhan, Hubei, China|Renmin Hospital of Wuhan University /ID# 212867, Wuhan, Hubei, China|The Second Xiangya Hospital of Central South University /ID# 211196, Changsha, Hunan, China|Jiangsu Province Hospital /ID# 211234, Nanjing, Jiangsu, China|Wuxi People's Hospital /ID# 218797, Wuxi, Jiangsu, China|The First Affiliated Hospital of Nanchang University /ID# 212182, Nanchang, Jiangxi, China|The First Hospital of Jilin University /ID# 212277, Changchun, Jilin, China|General Hospital of Ningxia Medical University /ID# 213912, Yinchuan, Ningxia, China|Tangdu Hospital of The Fourth Military Medical University, PLA /ID# 215505, Xi'an, Shaanxi, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 210960, Shanghai, Shanghai, China|Renji Hospital, Shanghai Jiaotong University School of Medicine /ID# 211230, Shanghai, Shanghai, China|Shanghai East Hospital /ID# 218796, Shanghai, Shanghai, China|Shanghai General Hospital /ID# 226652, Shanghai, Shanghai, China|Xijing Hospital /ID# 210708, Xian, Shanxi, China|West China Hospital, Sichuan University /ID# 211275, Chengdu, Sichuan, China|The second Affiliated hospital of Zhejiang University school of Medicine /ID# 211024, Hangzhou, Zhejiang, China|Sir Run Run Shaw Hospital /ID# 211062, Hangzhou, Zhejiang, China|Beijing Friendship Hospital /ID# 211061, Beijing, China|Peking University Third Hospital /ID# 221022, Beijing, China|Nanjing Drum Tower Hospital /ID# 227438, Nanjing Jiangsu, China|Shengjing Hospital of China Medical University /ID# 211643, Shenyang, China|Tongji Hospital Tongji Medical College Huazhong University of Science and Techno /ID# 211069, Wuhan, China|Instituto Medico de Alta Tecnologia Oncomédica S.A /ID# 207041, Monteria, Cordoba, Colombia|Corporacion Hospitalaria Juan Cuidad Sede Denominada Hospital Universitario Mayo /ID# 158736, Bogota DC, Cundinamarca, Colombia|Hospital Universitario San Vic /ID# 171488, Medellin, Colombia|Klinicka bolnica Dubrava Zagreb /ID# 157598, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Zagreb /ID# 157594, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Zagreb /ID# 201915, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Osijek /ID# 157595, Osijek, Osjecko-baranjska Zupanija, Croatia|Klinicki bolnicki centar Split /ID# 157596, Split, Croatia|Nemocnice Ceske Budejovice a.s. /ID# 225228, Ceske Budejovice, Czechia|Hepato-Gastroenterologie HK, s.r.o. /ID# 163389, Hradec Kralove, Czechia|Fakultni nemocnice Ostrava /ID# 225568, Ostrava, Czechia|Fakultni nemocnice Plzen /ID# 225566, Plzen, Czechia|Bispebjerg Hospital /ID# 208953, Copenhagen NV, Hovedstaden, Denmark|Sjaellands Universitets Hospit /ID# 200073, Roskilde, Sjælland, Denmark|Hvidovre Hospital /ID# 205093, Hvidovre, Denmark|Odense University Hospital /ID# 209502, Odense, Denmark|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 201824, Alexandria, Egypt|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 226795, Alexandria, Egypt|Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 226796, Alexandria, Egypt|Air Force Specialized Hospital /ID# 170984, Cairo, Egypt|National Liver Institute /ID# 171042, Menoufiya, Egypt|Hopital Haut-Leveque /ID# 207883, Pessac CEDEX, Gironde, France|Hopital Saint Eloi /ID# 223781, Montpellier CEDEX 5, Herault, France|Hopital Beaujon /ID# 207876, Clichy, Ile-de-France, France|CHU de SAINT ETIENNE - Hopital Nord /ID# 207882, St. Priest En Jarez, Loire, France|Hopitaux de Brabois Adultes /ID# 207877, Vandoeuvre les Nancy, Lorraine, France|Assis.Publique-Hopital Nord /ID# 225826, Marseille, Provence-Alpes-Cote-d Azur, France|CHU Amiens Picardie - Site Sud /ID# 207880, Amiens Cedex 1, France|Praxis fuer Gastroenterologie /ID# 166154, Heidelberg, Baden-Wuerttemberg, Germany|Universitatsklinikum Mannheim /ID# 162039, Mannheim, Baden-Wuerttemberg, Germany|Universitaetsklinikum Erlangen /ID# 159373, Erlangen, Bayern, Germany|Praxiszentrum fuer Gastroenterologie /ID# 219072, Grevenbroich, Nordrhein-Westfalen, Germany|Uniklinik Koeln /ID# 164993, Köln, Nordrhein-Westfalen, Germany|Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 159379, Kiel, Schleswig-Holstein, Germany|Universitaetsklinikum Ulm /ID# 164994, Ulm, Thueringen, Germany|Gastroenterologische Spezialpraxis am Wittenbergplatz /ID# 219146, Berlin, Germany|Praxis am Bayrischen Platz /ID# 159380, Berlin, Germany|Charite; Campus Benjamin Frank /ID# 210508, Berlin, Germany|DRK Kliniken Berlin /ID# 166155, Berlin, Germany|Stadtisches Klinikum Braunschweig /ID# 163694, Braunschweig, Germany|Agaplesion Markus Krankenhaus /ID# 159375, Frankfurt, Germany|Universitaetsklinikum Freiburg /ID# 162038, Freiburg, Germany|Gastroenterologie Opernstrasse /ID# 163690, Kassel, Germany|EUGASTRO GmbH /ID# 219071, Leipzig, Germany|Klinikum Lueneburg /ID# 163692, Lueneburg, Germany|Gastroenterologische Gemeinschaftspraxis Minden /ID# 162037, Minden, Germany|LMU Klinikum Campus Grosshadern /ID# 210484, Muenchen, Germany|Universitaetsklinikum Regensburg /ID# 163693, Regensburg, Germany|General Hospital of Athens Laiko /ID# 206438, Athens, Attiki, Greece|General Hospital of Chest Diseases of Athens SOTIRIA /ID# 170910, Athens, Attiki, Greece|Tzaneio general hospital of Piraeus /ID# 206437, Piraeus, Attiki, Greece|General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 217479, Athens, Greece|General Hospital of Athens Ippokratio /ID# 229190, Athens, Greece|University General Hospital of Heraklion PA.G.N.I /ID# 165327, Heraklion, Greece|General Hospital of Nikaia-Piraeus ""Agios Panteleimon""- general hospital dytikis /ID# 165313, Pireaus, Greece|Theageneio Anticancer Hospital /ID# 165329, Thessaloniki, Greece|Soroka Medical Center /ID# 171093, Be'er Sheva, HaDarom, Israel|Hadassah Medical Center-Hebrew University /ID# 171092, Jerusalem, Yerushalayim, Israel|Rambam Medical Center /ID# 171094, Haifa, Israel|Rambam Medical Center /ID# 171096, Haifa, Israel|Shaare Zedek Medical Center /ID# 163543, Jerusalem, Israel|Rabin Medical Center /ID# 167402, Petakh Tikva, Israel|Sheba Medical Center /ID# 211279, Ramat Gan, Israel|University of Catanzaro /ID# 200124, Catanzaro, Calabria, Italy|Ospedale Sant Orsola Malpighi /ID# 155627, Bologna, Emilia-Romagna, Italy|Azienda Ospedaliero-Universitaria Policlinico di Modena /ID# 201818, Modena, Emilia-Romagna, Italy|Policlinico Universitario Campus Bio-Medico /ID# 163994, Rome, Lazio, Italy|Azienda Ospedaliera San Camillo Forlanini /ID# 155628, Rome, Lazio, Italy|Azienda Policlinico Universitario Umberto I /ID# 171223, Rome, Lazio, Italy|ASST Rhodense /ID# 211450, Rho, Lombardia, Italy|IBD Center - IRCCS Istituto Clinico Humanitas /ID# 155626, Rozzano, Milano, Italy|A.O. Per L'Emergenza Cannizzaro /ID# 164039, Catania, Sicilia, Italy|Ospedale Classificato Equiparato Sacro Cuore-Don Calabria /ID# 164029, Negrar, Verona, Italy|Ospedale Policlinico San Martino - IRCCS /ID# 164030, Genoa, Italy|Azienda Ospedaliera Ospedale N /ID# 170959, Milano, Italy|Azienda Ospedaliera Luigi Sacc /ID# 155623, Milan, Italy|Policlinico Tor Vergata /ID# 158020, Rome, Italy|UOC Medicina Interna e Gastroe /ID# 155624, Rome, Italy|Aichi Medical University Hospital /ID# 164227, Nagakute-shi, Aichi, Japan|Nagoya City University Hospital /ID# 164229, Nagoya shi, Aichi, Japan|Daido Clinic /ID# 211478, Nagoya-shi, Aichi, Japan|Nagoya University Hospital /ID# 164230, Nagoya-shi, Aichi, Japan|Fujita Health University Hospital /ID# 164313, Toyoake-shi, Aichi, Japan|Hirosaki National Hospital /ID# 164216, Hirosaki-shi, Aomori, Japan|Tokatsutsujinaka Hospital /ID# 164310, Abiko-shi, Chiba, Japan|Chiba University Hospital /ID# 209633, Chiba-shi, Chiba, Japan|Tsujinaka Hospital Kashiwanoha /ID# 225968, Kashiwa-shi, Chiba, Japan|Toho University Medical Center Sakura Hospital /ID# 164219, Sakura-shi, Chiba, Japan|Fukuoka University Chikushi Hospital /ID# 209056, Chikushino shi, Fukuoka, Japan|Saiseikai Fukuoka Genaral Hospital /ID# 225640, Fukuoka-shi, Fukuoka, Japan|Fukuoka University Hospital /ID# 226723, Fukuoka-shi, Fukuoka, Japan|Kurume University Hospital /ID# 164237, Kurume-shi, Fukuoka, Japan|Gifu University Hospital /ID# 208490, Gifu-shi, Gifu, Japan|Ogaki Municipal Hospital /ID# 226009, Ogaki-shi, Gifu, Japan|National Hospital Organization Takasaki General Medical Center /ID# 164312, Takasaki-shi, Gunma, Japan|NHO Fukuyama Medical Center /ID# 164315, Fukuyama-shi, Hiroshima, Japan|Hiroshima University Hospital /ID# 164240, Hiroshima-shi, Hiroshima, Japan|Asahikawa Medical University Hospital /ID# 164324, Midorigaokahiga-shi, Hokkaido, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital /ID# 164215, Sapporo-shi, Hokkaido, Japan|Sapporo Medical University Hospital /ID# 164278, Sapporo-shi, Hokkaido, Japan|Sapporo IBD Clinic /ID# 225967, Sapporo-shi, Hokkaido, Japan|Sapporo Higashi Tokushukai Hospital /ID# 208493, Sapporo-shi, Hokkaido, Japan|Aoyama Clinic /ID# 164236, Kobe-shi, Hyogo, Japan|Hyogo College of Medicine Hospital /ID# 164238, Nishinomiya-shi, Hyogo, Japan|Kanazawa University Hospital /ID# 169221, Kanazawa-shi, Ishikawa, Japan|Sameshima Hospital /ID# 211182, Kagoshima-shi, Kagoshima, Japan|Tokai University Hospital /ID# 209207, Isehara-shi, Kanagawa, Japan|Gokeikai Ofuna Chuo Hospital /ID# 169296, Kamakura-shi, Kanagawa, Japan|St. Marianna University School of Medicine Hospital /ID# 226730, Kawasaki-shi, Kanagawa, Japan|Kitasato University Hospital /ID# 169223, Sagamihara-shi, Kanagawa, Japan|Colo-proctology Center Matsushima Clinic /ID# 225915, Yokohama-shi, Kanagawa, Japan|Showa University Fujigaoka Hospital /ID# 209606, Yokohama-shi, Kanagawa, Japan|Mie University Hospital /ID# 203635, Tsu-shi, Mie, Japan|Yokkaichi Hazu Medical Center /ID# 164316, Yokkaichi-shi, Mie, Japan|Tohoku University Hospital /ID# 164276, Sendai-shi, Miyagi, Japan|Nagasaki University Hospital /ID# 205326, Nagasaki-shi, Nagasaki, Japan|Nara Medical University Hospital /ID# 169222, Kashihara-shi, Nara, Japan|Kinshukai Infusion Clinic /ID# 226992, Osaka-shi, Osaka, Japan|Osaka Medical and Pharmaceutical University Hospital /ID# 226036, Takatsuki-shi, Osaka, Japan|Saga University Hospital /ID# 209273, Saga-shi, Saga, Japan|Tokitokai Tokito clinic /ID# 164218, Saitama-shi, Saitama, Japan|Shiga University of Medical Science Hospital /ID# 164323, Otsu-shi, Shiga, Japan|Hamamatsu University Hospital /ID# 226729, Hamamatsu-shi, Shizuoka, Japan|Matsuda Hospital /ID# 226831, Hamamatsu-shi, Shizuoka, Japan|NHO Shizuoka Medical Center /ID# 164314, Sunto-gun, Shizuoka, Japan|Tokyo Medical And Dental University, Medical Hospital /ID# 164225, Bunkyo-ku, Tokyo, Japan|St.Luke's International Hospital /ID# 225969, Chuo-ku, Tokyo, Japan|Tokai University Hachioji Hospital /ID# 227102, Hachioji-shi, Tokyo, Japan|Teikyo University Hospital /ID# 225594, Itabashi-ku, Tokyo, Japan|The Jikei University Hospital /ID# 164279, Minato-ku, Tokyo, Japan|Kitasato University Kitasato Institute Hospital /ID# 164222, Minato-ku, Tokyo, Japan|Kyorin University Hospital /ID# 164226, Mitaka-shi, Tokyo, Japan|NTT Medical Center Tokyo /ID# 225595, Shinagawa-ku, Tokyo, Japan|Keio University Hospital /ID# 203630, Shinjuku-ku, Tokyo, Japan|Japanese Red Cross Wakayama Medical Center /ID# 171196, Wakayama-shi, Wakayama, Japan|Wakayama Medical University /ID# 169485, Wakayama-shi, Wakayama, Japan|Yamagata University Hospital /ID# 171481, Yamagata-shi, Yamagata, Japan|Tokuyama Central Hospital /ID# 226857, Shunan-shi, Yamaguchi, Japan|Hanyang University Guri Hospital /ID# 158661, Guri, Gyeonggido, Korea, Republic of|CHA bundang medical center CHA University /ID# 158669, Seongnam-si, Gyeonggido, Korea, Republic of|The Catholic University of Korea, ST. Vincent's Hospital /ID# 158664, Suwon, Gyeonggido, Korea, Republic of|Kangbuk Samsung Hospital /ID# 158666, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Severance Hospital /ID# 158660, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Inje University Haeundae Hospital /ID# 203027, Busan, Korea, Republic of|Dong-A University Hospital /ID# 158665, Busan, Korea, Republic of|Pusan National University Hospital /ID# 158670, Busan, Korea, Republic of|Yeungnam University Medical Center /ID# 158662, Daegu, Korea, Republic of|Samsung Medical Center /ID# 158663, Seoul, Korea, Republic of|Riga East Clinical Univ Hosp /ID# 160204, Riga, Latvia|P. Stradins Clinical Univ Hosp /ID# 160205, Riga, Latvia|Hospital of Lithuanian Univers /ID# 201142, Kovno, Kaunas, Lithuania|Vilnius University Hospital /ID# 201144, Vilnius, Lithuania|Universiti Kebangsaan Malaysia (UKM) Medical Centre /ID# 200634, Kuala Lumpur, Selangor, Malaysia|Universiti Sains Malaysia /ID# 200633, Kelantan, Malaysia|JM Research SC /ID# 206518, Cuernavaca, Morelos, Mexico|Unidad de Atencion Medica e Investigacion en Salud /ID# 206515, Merida, Yucatan, Mexico|Health Pharma Professional Research S.A de C.V /ID# 206516, Del. Benito Juárez, Mexico|Academisch Medisch Centrum /ID# 157965, Amsterdam, Noord-Holland, Netherlands|Elisabeth Tweesteden Ziekenhuis /ID# 163738, Tilburg, Netherlands|Tauranga Hospital /ID# 212793, Tauranga, Bay Of Plenty, New Zealand|Christchurch Hospital /ID# 205337, Christchurch, Canterbury, New Zealand|Waikato Hospital /ID# 212788, Hamilton, Waikato, New Zealand|Dunedin Hospital /ID# 212791, Dunedin, New Zealand|Hutt Valley Dist Health Board /ID# 212787, Lower Hutt, New Zealand|Wellington Hospital (Capital and Coast District Health Board) /ID# 205338, Wellington, New Zealand|Vistamed /ID# 210106, Wroclaw, Dolnoslaskie, Poland|Gastromed /Id# 231065, Torun, Kujawsko-pomorskie, Poland|Centrum Medyczne Plejady /ID# 170635, Krakow, Malopolskie, Poland|WIP Warsaw IBD Point Profesor Kierkus /ID# 216103, Warsaw, Mazowieckie, Poland|Centrum Zdrowia MDM /ID# 170283, Warszawa, Mazowieckie, Poland|Centralny Szpital Kliniczny MSWiA w Warszawie /ID# 170286, Warszawa, Mazowieckie, Poland|Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Panstwowy Instytut Bada /ID# 170285, Warszawa, Mazowieckie, Poland|NZOZ Vivamed /ID# 216308, Warszawa, Mazowieckie, Poland|NZOZ Vitamed /ID# 213358, Bydgoszcz, Podlaskie, Poland|Endoskopia Sp. z o.o. /ID# 170284, Sopot, Pomorskie, Poland|NZOZ All-Medicus /ID# 170282, Katowice, Slaskie, Poland|H-T. Centrum Medyczne - Endoterapia /ID# 231501, Tychy, Slaskie, Poland|Centro Hospitalar Universitário do Algarve, EPE - Hospital de Portimão /ID# 166563, Portimão, Faro, Portugal|Hospital Garcia de Orta, E.P.E /ID# 165579, Almada, Setubal, Portugal|Centro Hospitalar e Universitário de Coimbra, EPE /ID# 166050, Coimbra, Portugal|Hospital da Senhora da Oliveira Guimarães, EPE /ID# 165576, Guimarães, Portugal|Centro Hosp de Lisboa Central /ID# 165578, Lisboa, Portugal|Centro Hospitalar Universitario de Sao Joao, EPE /ID# 165577, Porto, Portugal|Centro Hospitalar de Entre Douro e Vouga /ID# 166048, Santa Maria Da Feira, Portugal|Centro Hosp de Tondela-Viseu /ID# 166049, Viseu, Portugal|Ponce Medical School Foundation /ID# 222825, Ponce, Puerto Rico|VA Caribbean Healthcare System /ID# 222779, San Juan, Puerto Rico|Clinica GASTRO MED SRL /ID# 224156, Cluj-Napoca, Cluj, Romania|Strada dr. Sergiu Dumitru Nr 5 /ID# 224154, Bucharest, Romania|Institutul Clinic Fundeni /ID# 171259, Bucharest, Romania|Institutul Clinic Fundeni /ID# 224155, Bucharest, Romania|Cabinet Particular Policlinic Algomed /ID# 171260, Timisoara, Romania|Centrul Medical Tuculanu SRL /ID# 171263, Timisoara, Romania|Interdisctrict Multidisciplinary Hospital /ID# 204921, Anzorey, Kabardino-Balkarskaya Respublika, Russian Federation|Immanuel Kant Baltic Federal University /ID# 204920, Kaliningrad, Kaliningradskaya Oblast, Russian Federation|Kuzbass Regional Clinical Hospital /ID# 165759, Kemerovo, Kemerovskaya Oblast, Russian Federation|Uninova Medical Center /ID# 229786, Saint Petersburg, Leningradskaya Oblast, Russian Federation|Arsvita Clinic /ID# 208947, Korolev, Moskovskaya Oblast, Russian Federation|Perm Clinical Center of the Federal Medical and Biological Agency /ID# 227456, Perm, Permskiy Kray, Russian Federation|Regional Clinical Hospital #1 /ID# 165763, Tyumen, Tyumenskaya Oblast, Russian Federation|Clinic of New Technologies of Medicine /ID# 204926, Dzerzhinskiy, Russian Federation|Sechenov First Moscow Medical /ID# 204981, Moscow, Russian Federation|National Medical Research Center of Coloproctology n.a. A. N. Ryzhikh /ID# 203513, Moscow, Russian Federation|Central Clinical Hospital RZHD Medicine /ID# 204922, Moscow, Russian Federation|Euromedservice /ID# 204918, Pushkin, Russian Federation|International Medical Center SOGAZ /ID# 206832, St. Petersburg, Russian Federation|City Clinical Hospital #40 /ID# 204927, St. Petersburg, Russian Federation|Ulyanovsk State clinical hospi /ID# 204923, Ulyanovsk, Russian Federation|Clinical Hosp Center Zvezdara /ID# 200150, Belgrade, Beograd, Serbia|Military Medical Academy /ID# 202058, Belgrade, Beograd, Serbia|University Clinical Center Serbia /ID# 200153, Belgrade, Beograd, Serbia|Clin Hosp Ctr Bezanijska Kosa /ID# 202060, Belgrade, Beograd, Serbia|Clinical Center Vojvodina /ID# 156876, Novi Sad, Vojvodina, Serbia|Clinical Hospital Center Dr Dragisa Misovic - Dedinje /ID# 224927, Belgrade, Serbia|General Hospital Leskovac /ID# 224198, Leskovac, Serbia|Singapore General Hospital /ID# 204225, Singapore, Singapore|KL Ling Gastroenterology and Liver Clinic /ID# 206563, Singapore, Singapore|Fakultna nemocnica s poliklinikou F.D. Roosevelta Banska Bystrica /ID# 164348, Banska Bystrica, Slovakia|KM Management, spol. s.r.o. /ID# 206603, Nitra, Slovakia|Fakultna nemocnica s poliklini /ID# 224100, Nove Zamky, Slovakia|GASTRO I., s.r.o. /ID# 164345, Presov, Slovakia|Univ Medical Ctr Ljubljana /ID# 210628, Ljubljana, Slovenia|Farmovs (Pty) Ltd /Id# 207538, Bloemfontein, Free State, South Africa|Spoke Research Inc /ID# 229906, Cape Town,Milnerton, Western Cape, South Africa|Allergy & Immunology (AIU) /ID# 171439, Cape Town, Western Cape, South Africa|Dr JP Wright /ID# 171142, Cape Town, Western Cape, South Africa|Mediclinic Constantiaberg /ID# 171141, Cape Town, Western Cape, South Africa|Hospital Arquitecto Marcide - Complejo Hospitalario Universitario de Ferrol /ID# 159463, Ferrol, A Coruna, Spain|Hospital de Cabuenes /ID# 170745, Gijon, Asturias, Spain|Consorci Corporacio Sanitaria Parc Tauli Sabadell /ID# 159473, Sabadell, Barcelona, Spain|Hospital Universitario Puerta de Hierro, Majadahonda /ID# 159466, Majadahonda, Madrid, Spain|Hospital Alvaro Cunqueiro CHUVI /ID# 167359, Vigo, Pontevedra, Spain|Hospital Clinic de Barcelona /ID# 159462, Barcelona, Spain|Hospital Universitario Reina Sofia /ID# 167062, Cordoba, Spain|Hospital Universitario de Girona Doctor Josep Trueta /ID# 205678, Girona, Spain|Hospital Universitario La Paz /ID# 159471, Madrid, Spain|Complejo Hospitalario Universitario de Pontevedra /ID# 216183, Pontevedra, Spain|Hospital Clinico Universitario de Salamanca /ID# 159469, Salamanca, Spain|Hospital Universitario Virgen Macarena /ID# 159969, Sevilla, Spain|Hospital Universitario Miguel Servet /ID# 159468, Zaragoza, Spain|Alingsås lasarett /ID# 202075, Alingsås, Vastra Gotalands Lan, Sweden|SU Molndal. /ID# 202841, Molndal, Sweden|Danderyds sjukhus AB /ID# 202036, Stockholm, Sweden|Universitaetsspital Zuerich /ID# 202908, Zurich, Zuerich, Switzerland|Inselspital, Universitaetsklinik /ID# 202909, Bern, Switzerland|China Medical University Hosp /ID# 160194, Taichung City, Taichung, Taiwan|National Taiwan University Hospital /ID# 162188, Taipei City, Taipei, Taiwan|Chung Shan Medical University /ID# 171426, Taichung City, Taiwan|Taichung Veterans General Hosp /ID# 171433, Taichung City, Taiwan|Taipei Veterans General Hosp /ID# 171436, Taipei City, Taiwan|Linkou Chang Gung Memorial Hos /ID# 222878, Taoyuan County, Taiwan|Acibadem Kozyatagi Hospital /ID# 213277, Kadikoy, Istanbul, Turkey|Erciyes University Medical Fac /ID# 171283, Melikgazi, Kayseri, Turkey|Ankara Univ Medical Faculty /ID# 167205, Ankara, Turkey|Inonu Universitesi Turgut Ozal /ID# 203980, Battalgazi/malatya, Turkey|Uludag University Medical Faculty /ID# 204179, Bursa, Turkey|Fırat University Medical Facul /ID# 171285, Elazig, Turkey|Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty /ID# 167202, Istanbul, Turkey|Marmara University Medical Fac /ID# 171290, Istanbul, Turkey|Sisli Etfal Train & Res Hosp /ID# 171415, Sisli, Turkey|Medical Centre OK Clinic of International Institute of Clinical Research LLC /ID# 205484, Kyiv, Kyivska Oblast, Ukraine|Kyiv Regional Hospital /ID# 224344, Kyiv, Kyivska Oblast, Ukraine|Kyiv Municipal Clinical Hospital #18 /ID# 224347, Kiev, Kyiv, Ukraine|Volyn regional clinical hospital /ID# 229849, Lutsk, Volynska Oblast, Ukraine|CNE Regional Clinical Hospital of Ivano-Frankivsk RC /ID# 203366, Ivano-frankivsk, Ukraine|Public Institution Kherson City Clinical Hospital named after le.le. Karabelesha /ID# 224349, Kherson, Ukraine|RD&E Hospital /ID# 157614, Exeter, Devon, United Kingdom|Barnsley Hospital NHS Foundation Trust /ID# 202771, Barnsley, United Kingdom|Addenbrookes Hospital /ID# 158046, Cambridge, United Kingdom|Western General Hospital /ID# 208801, Edinburgh, United Kingdom|Royal Liverpool and Broadgreen /ID# 203860, Liverpool, United Kingdom|Barts and the London NHS Trust /ID# 157617, London, United Kingdom|King's College Hospital NHS Foundation Trust /ID# 158762, London, United Kingdom|St. George's Healthcare NHS /ID# 208379, London, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 158047, Newcastle Upon Tyne, United Kingdom|Univ Hosp Southampton NHS /ID# 210814, Southampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03398135"
871,"NCT03368118","Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis",,"Active, not recruiting","No Results Available","Ulcerative Colitis","Drug: ABX464","Number of incidences of treatment-emergent adverse events|Total Mayo Score|Partial Mayo Score|UC worsening|Fecal calprotectin|CRP levels and ESR|Incidence of treatment-emergent serious adverse events|Incidence of treatment-emergent adverse events of special interest|Incidence of adverse events leading to investigational product discontinuation|Incidence of specific laboratory abnormalities|SF-36 Quality of Life questionnaire","Abivax S.A.|Orion Corporation, Orion Pharma","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 2","22","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","ABX464-102","January 20, 2018","March 8, 2019","October 2022","December 11, 2017",,"January 19, 2021","Department of Gastroenterology - University hospitals Leuven, Leuven, Belgium",,"https://ClinicalTrials.gov/show/NCT03368118"
872,"NCT03341962","Phase 2 Dose-finding IMU-838 for Ulcerative Colitis","CALDOSE-1","Recruiting","No Results Available","Ulcerative Colitis","Drug: IMU-838|Drug: Placebo","Symptomatic remission and endoscopic healing|Symptomatic remission and endoscopic healing at different doses|Symptomatic remission during induction|Time to achieving symptomatic remission|Proportion of patients with clinical response|Proportion of patients with endoscopic healing|Proportion of patients with symptomatic response|Full Mayo Score|Partial Mayo Score|Patient Reported Outcome (PRO)-2 Mayo Score|Fecal calprotectin (fCP)|C-reactive protein (CRP)|Safety: Adverse Events|Safety: Number of participants with clinically significant findings during physical examination|Safety: body weight|Safety: blood pressure|Safety: heart rate|Safety: 12-lead electrocardiogram (ECG)|Safety: Hematology|Safety: Blood Chemistry|Safety: Coagulation|Safety: Urinalysis|Safety: Micro ribonucleic acid expression|PK: IMU-838 trough level|PK: IMU-838 plasma level|PK: area under the drug concentration-time curve (AUC) from time zero to 24 hours (AUC0-24h)|PK: AUC time zero to last measurable concentration (AUC0-t)|PK: AUC time zero to infinity (AUC0-inf)|PK: maximum plasma concentration (Cmax)|PK: time to Cmax (Tmax)|Maintenance Phase: Proportion of patients with symptomatic response|Maintenance Phase: Mayo PRO-2 score|Maintenance Phase: Time to relapse|Maintenance Phase: Proportion of patients without relapse|Maintenance Phase: fCP|Maintenance Phase: CRP|Maintenance Phase: Proportion of patients with endoscopic healing|Maintenance Phase: Proportion of patients with microscopic healing|Maintenance Phase: corticosteroid-free remission|Open-label Phase: symptom control|Open-label Phase: fCP|Open-label Phase: CRP","Immunic AG","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","240","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","P2-IMU-838-UC|2017-003703-22","March 15, 2018","July 10, 2022","June 30, 2029","November 14, 2017",,"July 2, 2021","Del Sol Research Management, LLC, Tucson, Arizona, United States|Axis Clinical Trials, Los Angeles, California, United States|Ventura Clinical Trials, Ventura, California, United States|Eastern Research, Inc., Hialeah, Florida, United States|Alliance Medical Research, LLC, Lighthouse Point, Florida, United States|Medley Research Associates, Medley, Florida, United States|Global Life Research LLC, Miami, Florida, United States|Family Clinical Trials, Pembroke Pines, Florida, United States|Clinical Research Trials of Florida, Inc., Tampa, Florida, United States|Atlanta Gastroenterology Associates, LLC, Atlanta, Georgia, United States|McFarland Clinic, P.C., Ames, Iowa, United States|Commonwealth Clinical Studies, Brockton, Massachusetts, United States|PMG Research of Salisbury, LLC, Salisbury, North Carolina, United States|Clinical Trials of South Carolina, Charleston, South Carolina, United States|First Street Surgical Hospital, Bellaire, Texas, United States|Digestive Health Specialists, Tacoma, Washington, United States|Durres Regional Hospital, Durres, Albania|Regional Hospital of Shkoder, Shkoder, Albania|American Hospital 2, Tirana, Albania|University Hospital Center Mother Teresa, Tirana, Albania|University Hospital of Trauma, Tirana, Albania|American Hospital 1, Tirana, Albania|Gomel Regional Clinical Hospital, Gomel, Belarus|Republican Scientific and Practical Center for Radiation Medicine and Human Ecology, Gomel, Belarus|Vitiebsk State Order of Peoples' Friendship Medical University, Vitebsk, Belarus|University Clinical Centre of the Republic of Srpska, Internal Medicine Clinic, Department of Gastroenterology and Hepatology, Banja Luka, Bosnia and Herzegovina|University Clinical Hospital Mostar, Internal Medicine Clinic, Department of Gastroenterology, Mostar, Bosnia and Herzegovina|Multiprofile Hospital for Active Treatment Blagoevgrad AD, Blagoevgrad, Bulgaria|Mhat Byala, Byala, Bulgaria|Multiprofile Hospital for Active Treatment ""Dr. Hristo Stambolski"" EOOD, Kazanlak, Bulgaria|Medical Center ""Medconsult Pleven"" OOD, Pleven, Bulgaria|Medical Center Exacta Medica, Pleven, Bulgaria|University Multiprofile Hospital for Active Treatment ""Sveti Georgi"" EAD, Plovdiv, Gastroenterology clinic, Plovdiv, Bulgaria|Medical Center ""Hera"" EOOD, Sofia, Bulgaria|Diagnostic-Consulting Center ""Convex"" EOOD, Sofia, Bulgaria|General Hospital Bjelovar, Bjelovar, Croatia|Clinical Hospital Center Osijek, Osijek, Croatia|Clinical Hospital Center Rijeka, Rijeka, Croatia|Clinical Hospital Center Split, Split, Croatia|General Hospital Vukovar, Vukovar, Croatia|Clinical Hospital Center Zagreb, Zagreb, Croatia|Clinical Hospital Dubrava, Zagreb, Croatia|Polyclinic Solmed Zagreb, Zagreb, Croatia|Clinical Hospital Center Split, Zagreb, Croatia|Asclepiades - Interna a gastroenterologie s.r.o. - Havířov, Havířov, Czechia|Hepato-Gastroenterologie HK, s.r.o. Poliklinika III, Hradec Králové, Czechia|Artroscan s.r.o., Ostrava - Třebovice, Czechia|FaraCol s.r.o. - Prague, Praha, Czechia|MEDICON a.s. - Poliklinika Budějovická Gastroenterologie, Praha, Czechia|Klinika ResTrial, Praha, Czechia|ISCARE I.V.F., a.s. Lighthouse, Praha, Czechia|Všeobecná fakultní nemocnice v Praze IV. interní klinika VFN a 1. LF UK, Praha, Czechia|Mediendo s.r.o., Praha, Czechia|Academician Z.Tskhakaia West Georgia National Center of Interventional Medicine, Kutaisi, Georgia|LTD Unimedi Kakheti - Caraps Medline, Tbilisi, Georgia|Medison Medical Holding - Saburtalo, Tbilisi, Georgia|Amsterdam UMC, locatie AMC, Amsterdam, Netherlands|Albert Schweitzer Hospital, Dordrecht, Netherlands|Maastricht UMC+, Maastricht, Netherlands|Elisabeth-TweeSteden Hospital, Tilburg, Netherlands|City General Hospita 8th September, Skopje, North Macedonia|University Clinic for Hematology - Skopje - Macedonian Hematology Association, Skopje, North Macedonia|Samodzielny Szpital Miejski im. PCK w Białymstoku Oddział Chorób Wewnętrznych i Gastroenterologii, Białystok, Poland|Centrum Usług Medycznych MaxMed, Bochnia, Poland|Centrum Medyczne Pratia Gdynia, Gdynia, Poland|Centrum Medyczne Endo-med Sp. z o.o., Karczew, Poland|Vita Longa Sp. z o.o., Katowice, Poland|GLOBE Badania Kliniczne Sp. z o.o., Kłodzko, Poland|Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie Oddział Gastroenterologii, Lublin, Poland|Zakład leczniczy ALLMEDICA BADANIA KLINICZNE Sp. z o.o. Sp. K., Nowy Targ, Poland|Etyka Ośrodek Badań Klinicznych, Olsztyn, Poland|Ars Medical - Szpital, Ars Medical - Ambulatorium, Piła, Poland|SOLUMED Centrum Medyczne, Poznań, Poland|Niepubliczny Zakład Opieki Zdrowotnej Centrum Medyczne HCP - Lecznictwo Stacjonarne, Poznań, Poland|Endoskopia Sp. z o.o., Sopot, Poland|Twoja Przychodnia Szczecińskie Centrum Medyczne, Szczecin, Poland|Klinika Medifem, Warszawa, Poland|Centrum Badawcze Współczesnej Terapii, Prywatny Gabinet Lekarski dr Anna Bochenek-Mularczyk, Warszawa, Poland|Przychodnia Vistamed, Wroclaw, Poland|Centrum Medyczne OMNI Clinic Sp. z o.o. Spółka Komandytowa, Wrocław, Poland|Centrum Medyczne Med-Gastr Sp. z o.o. Spółka Komandytowa, Łódz, Poland|Salve Medica Sp. z o.o. Spółka Komandytowa, Łódź, Poland|Centro Hospitalar e Universitário de Coimbra, EPE - Hospitais da Universidade de Coimbra, Coimbra, Portugal|Hospital da Senhora da Oliveira - Guimarães, EPE, Guimarães, Portugal|Centro Hospitalar de Entre o Douro e Vouga, EPE - Hospital São Sebastião, Santa Maria da Feira, Portugal|S.C. MEDLIFE S.A., Sectia Gastroenterologie, Bucharest, Romania|Spitalul Clinic Colentina, Sectia Gastroenterologie, Bucharest, Romania|Institutul Clinic Fundeni, Sectia Clinica Gastroenterologie III, Bucharest, Romania|S.C. Cabinet Particular Policlinic Algomed SRL, Specialitatea Gastroenterologie, Timisoara, Romania|Kazan State Medical University, Kazan, Russian Federation|SEI HPE ""Kuban State Medical University"" of MoH and SD, CBHS Regional Clinical Hospital No.2, Krasnodar, Russian Federation|Central Clinical Hospital of the Russian Academy of Sciences, Moscow, Russian Federation|Federal Medical Biophysical Center n.a. Burnazyan, Moscow, Russian Federation|Clinical Research Institution of Moscow Region named after M. F. Vladimirsky, Moscow, Russian Federation|Novosibirskiy Gastrocenter, LLC, Novosibirsk, Russian Federation|FSBEI HE ""Military Medical Academy n.a. S.M. Kirov"" under the Ministry of Defence of Russian Federation, Saint Petersburg, Russian Federation|Hospital of Saint Martyr Elizaveta, Saint Petersburg, Russian Federation|Research Center Eco-Safety, LLC, Saint Petersburg, Russian Federation|Gastroenterological Center ""Expert"" LLC, Saint Petersburg, Russian Federation|Saint Petersburg State Medical University named after I.P. Pavlov, Saint Petersburg, Russian Federation|City Clinical Hospital No. 31, Saint Petersburg, Russian Federation|City Hospital No. 5 - Sochi, Sochi, Russian Federation|Siberian State Medical University, Tomsk, Russian Federation|Regional State Autonomous Healthcare Institution ""Tomsk Regional Clinical Hospital"", Tomsk, Russian Federation|Clinic for gastroenterohepatology, Belgrade, Serbia|Clinical Hospital Center Zemun, Belgrade, Serbia|University Hospital Center Bezaniska Kosa, Belgrade, Serbia|Clinical Center Kragujevac, Kragujevac, Serbia|General Hospital Leskovac, Leskovac, Serbia|Clinical Center Nis, Nis, Serbia|General Hospital Djordje Joanovic, Internal Deases Department, Gastroenterology, Zrenjanin, Serbia|Department of Internal medicine, Granada, Spain|Hospital Universitario Virgen de la Nieves, Granada, Spain|Hospital Juan Ramón Jimenez, Huelva, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Bezmiâlem Vakıf Üniversitesi, Fatih, Turkey|Istanbul Universitesi Istanbul Tip Fakultesi Gastroenteroloji Bilim Dali, Fatih, Turkey|Istanbul Universitesi Cerrahpasa Tip Fakultesi Hastanesi, Fatih, Turkey|Karadeniz Teknik Üniversitesi Tip Fakultesi, Trabzon, Turkey|Koç University Hospital, Zeytinburnu, Turkey|Public Enterprise ""Dnipropetrovsk regional clinical hospital named after I.I. Mechnikova"", Department of Gastroenterology (Hepatology), Dnipro, Ukraine|MNPE ""Regional Clinical Hospital of Ivano-Frankivsk Regional Council"", Gastroenterology Department, SHEI ""Ivano-Frankivsk National Medical University"", Chair of Internal Medicine #1, Ivano-Frankivs'k, Ukraine|Ivano-Frankivsk City Clinical Hospital No. 1, Ivano-Frankivs'k, Ukraine|Municipal Non-profit Enterprise ""City Clinical Hospital #2 named after prof. O.O. Shalimova"", of Kharkiv City Council, Proctology Department, Kharkiv, Ukraine|Municipal Non-profit Enterprise of Kharkiv Regional Council ""Regional Clinical Hospital"", Gastroenterology Department, Kharkiv, Ukraine|Private Enterprise Private Manufacturing Firm ""Acinus"", Treatment and diagnostic Centre, Kropyvnytskyi, Ukraine|Medical Center Medical Clinic Blagomed LLC, Kyiv, Ukraine|Kyiv City Clinical Hospital #18, Proctology Department, National Medical University named after O.O.Bogomolets, Chair of Surgery #1, Kyiv, Ukraine|Kyiv City Clinical Hospital #1, Therapeutics Department #2, Kyiv, Ukraine|Medical Centre of Limited Liability Company ""Medical Centre ""Dopomoga plus"""", Kyiv, Ukraine|Communal Non-profit Enterprise ""Consultative and Diagnostic Centre"" of Desnianskyi District of Kyiv, Surgery Department, Kyiv, Ukraine|Shalimov's National Institute of surgery and transplantation, Kyiv, Ukraine|Medical Centre of Limited Liability Company ""Medical Centre ""Consilium Medical"", clinico-consultation department, Kyiv, Ukraine|Kyiv Regional Clinical Hospital No 2, Kyiv, Ukraine|Communal Institution of the Kyiv Regional Council ""Kyiv Regional Clinical Hospital"", Gastroenterology Department, Kyiv, Ukraine|Volyn Regional Clinical Hospital, Lutsk, Ukraine|Municipal Non-profit Enterprise of Lviv Regional Council ""Lviv Regional Clinical Hospital"", proctology department, Danylo Galytsky Lviv National Medical University, Chair of Surgery #1, Lviv, Ukraine|KARDIOKOM Ltd., Mykolaiv, Ukraine|Transcarpathian Regional Clinical Hospital named after Andriy Novaka, gastroenterology department, Uzhhorod, Ukraine|Municipal Non-profit Enterprise ""Vinnytsia Regional Clinical Hospital named after M.I. Pyrogova of Vinnytsia Regional Council, Regional Specialized Clinical Gastroenterological Center,, Vinnytsia, Ukraine|Municipal Non-profit Enterprise ""Vinnytsia City Clinical Hospital #1, Gastroenterology Department, Vinnytsia National Medical University named after M.I.Pyrogova, Chair of Propaedeutics of Internal Medicine, Vinnytsia, Ukraine|Municipal Institution ""Zaporizhzhska Regional Clinical Hospital"" of Zaporizhzha Regional Council, gastroenterology department, Zaporizhzhya, Ukraine|London North West University Healthcare NHS Trust (LNWH), St Mark's Hospital, R&D Department, Northwick Park Hospital, Harrow, United Kingdom|Barts Health NHS Trust, of Royal London Hospital, London, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom|St Helens & Knowsley Teaching Hospitals NHS Trust, Whiston Hospital, Prescot, United Kingdom|University Hospitals Coventry and Warwickshire NHS Trust, University Hospital, Shrewsbury, United Kingdom|Shrewsbury and Telford Hospitals NHS Trust, Royal Shrewsbury Hospital, Shrewsbury, United Kingdom|The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03341962"
873,"NCT03290781","An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis","FIGARO UC 303","Active, not recruiting","No Results Available","Ulcerative Colitis","Drug: Ontamalimab|Other: Placebo","Number of Participants With Remission at Week 52|Number of Participants With Endoscopic Remission at Week 52|Number of Participants With Clinical Remission at Week 52|Number of Participants With Sustained Remission at Week 52|Number of Participants With Clinical Response Based on Composite Score at Week 52|Number of Participants With Mucosal Healing Based on Endoscopic and Histologic Assessment at Week 52|Number of Participants With Glucocorticoid-free Clinical Remission at Week 52|Number of Participants With Glucocorticoid-free Remission at Week 52|Number of Participants With Remission Based on Total Mayo Score at Week 52|Number of Participants With Clinical Remission Over Time With Both Rectal Bleeding and Stool Frequency Subscores of 0|Number of Participants With Sustained Endoscopic Remission at Week 52|Number of Participants With Treatment Emergent Adverse Events (TEAEs)|Number of Participants With Clinically Significant Change in Clinical Laboratory Results Reported as Adverse Event|Number of Participants With Clinically Significant Findings in Physical Examinations Reported as Adverse Event|Number of Participants With Clinically Significant Change in Vital Signs Reported as Adverse Event|Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Reported as Adverse Event|Number of Participants who Develop Antidrug Antibodies to Ontamalimab","Shire|Takeda","All","16 Years to 81 Years   (Child, Adult, Older Adult)","Phase 3","366","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","SHP647-303|2017-000573-37","April 4, 2018","August 24, 2021","August 24, 2021","September 25, 2017",,"June 8, 2021","Arizona Digestive Health Mesa - East, Mesa, Arizona, United States|Elite Clinical Studies - Phoenix - Clinedge - PPDS, Phoenix, Arizona, United States|Atria Clinical Research - Clinedge - PPDS, Little Rock, Arkansas, United States|Advanced Research Center, Anaheim, California, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, United States|United Medical Doctors, Encinitas, California, United States|University of California San Diego, La Jolla, California, United States|OM Research LLC - Lancaster - ClinEdge - PPDS, Lancaster, California, United States|Tibor Rubin VA Medical Center - NAVREF, Long Beach, California, United States|VA Long Beach Healthcare System - NAVREF - PPDS, Long Beach, California, United States|Facey Medical Foundation, Mission Hills, California, United States|United Medical Doctors, Murrieta, California, United States|Alliance Clinical Research-(Vestavia Hills), Poway, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|University of California San Francisco, San Francisco, California, United States|Care Access Research, San Pablo, San Pablo, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Asthma and Allergy Associates PC - CRN - PPDS, Colorado Springs, Colorado, United States|Renaissance Research Medical Group, INC, Cape Coral, Florida, United States|Gastro Florida, Clearwater, Florida, United States|Advanced Clinical Research Network, Coral Gables, Florida, United States|Alliance Medical Research LLC, Coral Springs, Florida, United States|ENCORE Borland-Groover Clinical Research - ERN - PPDS, Jacksonville, Florida, United States|SIH Research, Kissimmee, Florida, United States|Crystal Biomedical Research, Miami Lakes, Florida, United States|Hi Tech and Global Research, LLc, Miami, Florida, United States|Nuren Medical and Research Center, Miami, Florida, United States|Sanchez Clinical Research, Inc, Miami, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|Pharma Research International Inc, Naples, Florida, United States|Omega Research Consultants LLC - Clinedge - PPDS, Orlando, Florida, United States|Accel Research Sites - St. Petersburg - ERN - PPDS, Pinellas Park, Florida, United States|BRCR Medical Center, Inc, Plantation, Florida, United States|East Coast Institute for Research, LLC, Saint Augustine, Florida, United States|DBC Research, Tamarac, Florida, United States|Bayside Clinical Research - New Port Richey, Tampa, Florida, United States|Atlanta Gastroenterology Specialists, PC, Atlanta, Georgia, United States|Infinite Clinical Trials, Atlanta, Georgia, United States|Gastrointestinal Diseases, Inc Research - IACT- HyperCore - PPDS, Columbus, Georgia, United States|Atlanta Center For Gastroenterology PC, Decatur, Georgia, United States|Northwestern University, Chicago, Illinois, United States|University of Chicago Medical Center, Chicago, Illinois, United States|Loretto Hospital, Chicago, Illinois, United States|IL Gastroenterology Group, Gurnee, Illinois, United States|Edward Hines Jr VA Hospital - NAVREF - PPDS, Hines, Illinois, United States|Dupage Medical Group, Oakbrook Terrace, Illinois, United States|Medisphere Medical Research Center LLC, Evansville, Indiana, United States|Laporte County Institute For Clinical Research, Michigan City, Indiana, United States|Gastroenterology Associates of Hazard, Hazard, Kentucky, United States|CroNOLA, LLC., Houma, Louisiana, United States|Clinical Trials of SWLA, LLC, Lake Charles, Louisiana, United States|Louisiana Research Center LLC, Shreveport, Louisiana, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Commonwealth Clinical Studies LLC, Brockton, Massachusetts, United States|UMass Memorial Medical Center, Worcester, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Clinical Research Institute of Michigan, Chesterfield, Michigan, United States|National Clinical, LLC, Hamtramck, Michigan, United States|Mayo Clinic Health System - PPDS, Duluth, Minnesota, United States|Digestive Health Center PA, Ocean Springs, Mississippi, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|St Louis Center For Clinical Research, Saint Louis, Missouri, United States|Advanced Biomedical Research of America, Las Vegas, Nevada, United States|Encompass Care, North Las Vegas, Nevada, United States|New York Total Medical Care PC, Brooklyn, New York, United States|NYU Langone Long Island Clinical Research Associates, Lake Success, New York, United States|Weill Cornell Medical College, New York, New York, United States|Southtowns Gastroenterology, PLLC, Orchard Park, New York, United States|East Carolina Gastroenterology, Jacksonville, North Carolina, United States|Piedmont Healthcare, Statesville, North Carolina, United States|Consultants For Clinical Research Inc, Cincinnati, Ohio, United States|Consultants For Clinical Research Inc, Cincinnati, Ohio, United States|Consultants For Clinical Research Inc, Fairfield, Ohio, United States|Prestige Clinical Research, Franklin, Ohio, United States|Ohio Clinical Research Partners LLC, Mentor, Ohio, United States|Veteran's Research and Education Foundation - NAVREF - PPDS, Oklahoma City, Oklahoma, United States|Veterans Research Foundation of Pittsburgh - NAVREF - PPDS, Pittsburgh, Pennsylvania, United States|Digestive Disease Associates, Wyomissing, Pennsylvania, United States|Gastro One, Germantown, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Advanced Gastroenterology-Union City, Union City, Tennessee, United States|Inquest Clinical Research/Coastal Gastroenterology Associates, PA, Baytown, Texas, United States|Northside Gastroenterology, Cypress, Texas, United States|Digestive Health Associates of Texas, P.A.dba DHAT Research Institute, Garland, Texas, United States|Precision Research Institute, LLC, Houston, Texas, United States|Biopharma Informatic Inc., Houston, Texas, United States|Southwest Clinical Trials, Houston, Texas, United States|Aztec Medical Research, Houston, Texas, United States|BI Research Center, Houston, Texas, United States|Southern Star Research Institute LLC, San Antonio, Texas, United States|DM Clinical Research - ERN - PPDS, Tomball, Texas, United States|HP Clinical Research, Bountiful, Utah, United States|Mid Atlantic Health Specialists, Galax, Virginia, United States|Winchester Gastroenterology Associates, Winchester, Virginia, United States|Digestive Health Center at UWMC, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States|CHI Franciscan Digestive Care Associates, Tacoma, Washington, United States|Exemplar Research, Inc. - Elkins, Elkins, West Virginia, United States|West Virginia University Hospital, Morgantown, West Virginia, United States|Fundación Favaloro, Buenos Aires, Argentina|Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina|Sanatorio 9 de Julio SA, San Miguel De Tucumán, Argentina|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Liverpool Hospital, Liverpool, New South Wales, Australia|Royal Brisbane & Women's Hospital, Herston, Queensland, Australia|Mater Hospital Brisbane, South Brisbane, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|The Alfred Hospital, Box Hill, Victoria, Australia|St Vincents Hospital Melbourne - PPDS, Melbourne, Victoria, Australia|A.ö. Krankenhaus der Barmherzigen Brüder, St. Veit an der Glan, Kärnten, Austria|Universitätsklinikum St. Pölten, St. Pölten, Saint Pölten, Austria|LKH-Universitätsklinikum Klinikum Graz, Graz, Steiermark, Austria|Klinikum Klagenfurt Am Woerthersee, Klagenfurt am Wörthersee, Austria|Salzburger Landeskliniken, Salzburg, Austria|Klinikum Wels-Grieskirchen GmbH, Wels, Austria|Medizinische Universitat Wien (Medical University of Vienna), Wien, Austria|UZ Gent, Gent, Oost-Vlaanderen, Belgium|UZ Gasthuisberg, Leuven, Vlaams Brabant, Belgium|AZ Groeninge, Kortrijk, West-Vlaanderen, Belgium|CHU Mouscron, Mouscron, Belgium|Clinical Center Banja Luka, Banja Luka, Bosnia and Herzegovina|University Multiprofile Hospital for Active Treatment Sveta Anna, Sofia, Sofia-Grad, Bulgaria|Acibadem City Clinic University Multiprofile Hospital for Active Treatment EOOD, Sofia, Sofia-Grad, Bulgaria|University Multiprofile Hospital for Active Treatment - Dr. Georgi Stranski EAD, Pleven, Bulgaria|Multiprofile Hospital for Active Treatment Eurohospital, Plovdiv, Bulgaria|Specialized Hospital for Active Treatment of Pneumophthisiatric Diseases Dr.D.Gramatikov- Ruse- PPDS, Ruse, Bulgaria|Medical Center-1-Sevlievo EOOD, Sevlievo, Bulgaria|Second Multiprofile Hospital for Active Treatment Sofia, Sofia, Bulgaria|Medical Center Excelsior OOD - PPDS, Sofia, Bulgaria|Diagnostic and Consulting Center Aleksandrovska EOOD, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Sv Ivan Rilski EAD, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna - ISUL EAD, Sofia, Bulgaria|Medical Center Convex EOOD, Sofia, Bulgaria|Diagnostic Consultative Centre Mladost - M OOD, Varna, Bulgaria|Percuro Clinical Research LTD, Victoria, British Columbia, Canada|Toronto Digestive Disease Associates Inc, Toronto, Ontario, Canada|Hospital Pablo Tobón Uribe, Medellin, Antioquia, Colombia|Servimed S.A.S, Bucaramanga, Santander, Colombia|Fundación Clínica Shaio, Bogota, Colombia|Fundación Cardioinfantil Instituto Cardiológico, Bogotá, Colombia|IPS Centro Médico Julián Coronel S.A.S. - PPDS, Cali, Colombia|University Hospital Center Zagreb, Zagreb, Grad Zagreb, Croatia|Opca Bolnica Karlovac, Karlovac, Karlovacka Županija, Croatia|Opca bolnica Bjelovar, Bjelovar, Croatia|Clinical Hospital Centre Osijek, Osijek, Croatia|University Hospital Centre Split, Split, Croatia|General Hospital Virovitica, Virovitica, Croatia|General County Hospital Vukovar and Croatian Veterans Hospital, Vukovar, Croatia|General Hospital Zadar, Zadar, Croatia|Hepato-Gastroenterologie HK, s. r. o., Hradec Králové, Královéhradecký Kraj, Czechia|PreventaMed s.r.o., Olomouc, Olomoucký Kraj, Czechia|Institut Klinicke A Experimentalni Mediciny, Praha 4, Czechia|ISCARE I.V.F. a.s., Praha 7, Czechia|Krajska zdravotni, a.s. - Masarykova nemocnice v Usti nad Labem, o.z., Usti nad Labem, Czechia|Nemocnice Pardubickeho kraje, a.s. Orlickoustecka nemocnice, Ústi Nad Orlici, Czechia|East Viru Central Hospital, Kohta-Järve, Estonia|OÜ LV Venter, Parnu, Estonia|West Tallinn Central Hospital, Tallinn, Estonia|Universitätsklinikum Ulm, Ulm, Baden-Württemberg, Germany|Universitätsklinikum der RWTH Aachen, Aachen, Nordrhein-Westfalen, Germany|Uniklinik Köln, Köln, Nordrhein-Westfalen, Germany|Gastro Campus Research GbR, Münster, Nordrhein-Westfalen, Germany|Universitatsklinikum Schleswig-Holstein, Kiel, Schleswig-Holstein, Germany|Universitatsklinikum Jena, Jena, Thüringen, Germany|Gastroenterologische Facharztpraxis am Mexikoplatz, Berlin-Zehlendorf, Germany|Charité - Universitätsmedizin Berlin, Berlin, Germany|Sana Klinikum Biberach, Biberach an der Riss, Germany|Universitätsklinikum Frankfurt, Frankfurt, Germany|Asklepios Westklinikum Hamburg Ggmbh, Hamburg, Germany|Klinikum rechts der Isa der Technischen Universitaet Muenchen, Munich, Germany|Ippokrateio General Hospital of Athens, Athens, Attiki, Greece|University General Hospital of Ioannina, Ioannina, Greece|University General Hospital of Patras, Patras, Greece|Theageneio Anticancer Oncology Hospital of Thessaloniki, Thessaloniki, Greece|Euromedica - PPDS, Thessaloniki, Greece|Magyar Honvédség Egészségügyi Központ, Budapest, Hungary|Pannónia Magánorvosi Centrum Kft, Budapest, Hungary|ENDOMEDIX Kft., Budapest, Hungary|Bekes Megyei Kozponti Korhaz, Békéscsaba, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Bekes Megyei Kozponti Korhaz, Gyula, Hungary|Mohacsi Korhaz, Mohacs, Hungary|Tolna Megyei Balassa János Kórház, Szekszard, Hungary|Csongrad Megyei Dr. Bugyi Istvan Korhaz, Szentes, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Székesfehérvár, Hungary|Csolnoky Ferenc Korhaz, Veszprém, Hungary|Jávorszky Ödön Kórház, Vác, Hungary|St Vincent's University Hospital, Dublin, Ireland|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah Medical Center - PPDS, Jerusalem, Israel|Galilee Medical Center, Nahariya, Israel|Nazareth EMMS Hospital, Nazareth, Israel|Tel Aviv Sourasky Medical Center PPDS, Tel Aviv, Israel|Baruch Padeh Poriya Medical Center, Tiberias, Israel|Azienda Ospedaliera Mater Domini Di Catanzaro, Catanzaro, Calabria, Italy|Azienda Ospedaliero Universitaria Di Bologna - Policlinico S Orsola Malpighi, Bologna, Emilia-Romagna, Italy|Azienda Ospedaliero Universitaria Di Modena Policlinico, Modena, Emilia-Romagna, Italy|Azienda Ospedaliera San Camillo Forlanini, Roma, Lazio, Italy|Ospedale Casa Sollievo Della Sofferenza IRCCS, San Giovanni Rotondo (FG), Puglia, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, Toscana, Italy|IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Veneto, Italy|Azienda Ospedale Università Padova - Dipartimento Salute della Donna e del Bambino, Padova, Veneto, Italy|A.O.U. Maggiore della Carità, Novara, Italy|Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia, Italy|La Sapienza-Università di Roma-Policlinico Umberto I, Roma, Italy|Fondazione Policlinico Universitario A Gemelli, Roma, Italy|Istituto Clinico Humanitas, Rozzano (MI), Italy|Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy|Azienda Ospedaliera Ordine Mauriziano di Torino, Torino, Italy|Sapporo Medical University Hospital, Sapporo, Hokkaidô, Japan|Medical Corporation Aoyama Clinic, Kobe-shi, Hyôgo, Japan|Hyogo College of Medicine, Nishinomiya-shi, Hyôgo, Japan|Sagamihara Kyodo Hospital, Sagamihara, Kanagawa, Japan|Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama, Japan|Nihonbashi Egawa Clinic, Chuo-Ku, Tokyo, Japan|Jikei University Hospital, Minato-ku, Tokyo, Japan|Kitasato University Kitasato Institute Hospital, Minato-ku, Tokyo, Japan|Ome Municipal General Hospital, Ome, Tokyo, Japan|Tokatsu Tsujinaka Hospital, Abiko, Japan|Kunimoto Hospital, Asahikawa, Japan|Fukuoka University Chikushi Hospital, Chikushino, Japan|Hakodate Koseiin Hakodate Goryoukaku Hospital, Hakodate, Japan|Kawabe Clinic, Koganei, Japan|Yuai Memorial Hospital, Koga, Japan|Hidaka Coloproctology Clinic, Kurume-shi, Japan|Aizawa Hospital, Matsumoto-shi, Japan|Aichi Medical University Hospital, Nagakute, Japan|Nishinomiya Municipal Central Hospital, Nishinomiya, Japan|Ishida Clinic of IBD and Gastroenterology, Oita, Japan|Onomichi General Hospital, Onomichi, Japan|Kinshukai Infusion Clinic, Osaka-shi, Japan|Chiinkai Dojima General & Gastroenterology Clinic, Osaka, Japan|Shiga University of Medical Science Hospital, Otsu-Shi, Japan|Bellland General Hospital, Sakai, Japan|Toho University Sakura Medical Center, Sakura, Japan|Sapporo Tokushukai Hospital, Sapporo-shi, Japan|Sapporo Higashi Tokushukai Hospital, Sapporo, Japan|Tohoku Rosai Hospital, Sendai, Japan|Dokkyo Medical University Hospital, Shimotsuga-gun, Japan|Medical Corporation Shoyu-kai Fujita Gastroenterology Hospital, Takatsuki, Japan|Koukokukai Ebisu Clinic, Tokyo, Japan|Shinbeppu Hospital, Beppu, Ôita, Japan|Yodogawa Christian Hospital, Osaka, Ôsaka, Japan|Kyungpook National University Hospital, Daegu, Daegu Gwang'yeogsi, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wonju, Gang'weondo, Korea, Republic of|CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggido, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital, Suwon, Gyeonggido, Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Pusan National University Hospital, Busan, Korea, Republic of|Yeungnam University Hospital, Daegu, Korea, Republic of|Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of|Gachon University Gil Medical Center, Incheon, Korea, Republic of|Kyung Hee University Hospital, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Severance Hospital Yonsei University Health System, Seoul, Korea, Republic of|Asan Medical Center - PPDS, Seoul, Korea, Republic of|Samsung Medical Center PPDS, Seoul, Korea, Republic of|Inje University Seoul Paik Hospital, Seoul, Korea, Republic of|Rafik Hariri University Hospital, Beirut, Lebanon|Hammoud Hospital University Medical Center, Saida, Lebanon|Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania|Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania|Vilnius City Clinical Hospital, Vilnius, Lithuania|Clinica de Higado y Gastroenterologia Integral, S.C., Cuernavaca, Morelos, Mexico|JM Research S.C, Cuernavaca, Morelos, Mexico|Unidad de Atencion Medica e Investigacion en Salud, Merida, Yucatán, Mexico|Centro de Investigación Médica Aguascalientes, Aguascalientes, Mexico|Phylasis Clinicas Research S. de R.L. de C.V., Cuautitlán Izcalli, Mexico|Centro de Investigacion Clinica Acelerada, S.C., Distrito Federal, Mexico|Instituto de Investigaciones Aplicadas a la Neurociencia A.C., Durango, Mexico|Accelerium, S. de R.L. de C.V., Monterrey, Mexico|Clinical Research Institute, Tlalnepantla De Baz, Mexico|Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V., Zapopan, Jalisco, Mexico|ETZ-Elisabeth, Tilburg, Noord-Brabant, Netherlands|NWZ, location Alkmaar, Alkmaar, Noord-Holland, Netherlands|Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, Netherlands|VU Medisch Centrum, Amsterdam, Netherlands|Academisch Medisch Centrum Amsterdam, Amsterdam, Netherlands|Auckland City Hospital, Grafton, Auckland, New Zealand|Dunedin Hospital, Dunedin, South Island, New Zealand|Wellington Hospital, Newtown, Wellington, New Zealand|Waikato Hospital, Hamilton, New Zealand|Melita Medical, Wroclaw, Dolnoslaskie, Poland|Lexmedica, Wroclaw, Dolnoslaskie, Poland|Vitamed Galaj i Cichomski sp.j., Bydgoszcz, Kujawsko-pomorskie, Poland|Gastromed Kopon Zmudzinski i Wspolnicy Sp.j.Specjalistyczne Centrum Gastrologii i Endoskopii Specj, Torun, Kujawsko-pomorskie, Poland|Centrum Diagnostyczno - Lecznicze Barska sp. z o.o., Wloclawek, Kujawsko-pomorskie, Poland|Niepubliczny Zaklad Opieki Zdrowotnej CENTRUM MEDYCZNE Szpital Swietej Rodziny, Lódz, Lódzkie, Poland|Uniwersytecki Szpital Kliniczny im. Wojskowej Akademii Medycznej Centralny Szpital Weteranow, Lódz, Lódzkie, Poland|Instytut Centrum Zdrowia Matki Polki, Lódz, Lódzkie, Poland|Krakowskie Centrum Medyczne, Krakow, Malopolskie, Poland|BioVirtus Centrum Medyczne, Jozefow, Mazowieckie, Poland|Niepubliczny Zakład Opieki Zdrowotnej VIVAMED, Warszawa, Mazowieckie, Poland|Miedzyleski Szpital Specjalistyczny w Warszawie, Warszawa, Mazowieckie, Poland|Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok, Podlaskie, Poland|Endoskopia Sp. z o.o., Sopot, Pomorskie, Poland|Szpital Zakonu Bonifratrow pw. Aniolow Strozow w Katowicach, Katowice, Slaskie, Poland|Szpital Specjalistyczny sw Lukasza - Oddzial Gastroenterologii, Konskie, Swietokrzyskie, Poland|Twoja Przychodnia - Szczecińskie Centrum Medyczne, Szczecin, Zachodniopomorskie, Poland|Szpital Uniwersytecki Nr 2 im. Dr Jana Biziela w Bydgoszczy, Bydgoszcz, Poland|Centrum Medyczne Pratia Bydgoszcz, Bydgoszcz, Poland|Centrum Medyczne Czestochowa - PRATIA - PPDS, Czestochowa, Poland|Centrum Medyczne Gdynia - PRATIA - PPDS, Gdynia, Poland|NZOZ All Medicus, Katowice, Poland|Centrum Medyczne A-Z Clinic Mateusz Sidor, Piotr Puc-Lekarze Spolka Partnerska, Krakow, Poland|Centrum Opieki Zdrowotnej Orkan-Med Stec-Michalska Sp. J., Ksawerow, Poland|Med Gastr Sp.z.o.o Sp.k, Lodz, Poland|Twoja Przychodnia - Centrum Medyczne Nowa Sol, Nowa Sól, Poland|Centrum Innowacyjnych Terapii, Piaseczno, Poland|Clinical Research Center Spółka z Ograniczoną Odpowiedzialnością, Medic-R Spółka Komandytowa, Poznan, Poland|Korczowski Bartosz, Gabinet Lekarski, Rzeszow, Poland|Bandurskiego 98/U12, Szczecin, Poland|Sonomed Sp. z o.o., Szczecin, Poland|H-T. Centrum Medyczne Endoterapia, Tychy, Poland|Centrum Zdrowia MDM, Warszawa, Poland|Centrum Medyczne Warszawa - PRATIA - PPDS, Warszawa, Poland|Centralny Szpital Kliniczny MSW, Warszawa, Poland|Samodzielny Publiczny Szpital Wojewodzki im. Papieza Jana Pawla II, Zamosc, Poland|Hospital da Luz, Lisbon, Lisboa, Portugal|Hospital de Braga, Braga, Portugal|Centro Hospitalar do Algarve - Hospital de Portimao, Faro, Portugal|Hospital Senhora da Oliveira - Guimaraes, E.P.E, Guimarães, Portugal|Hospital de São Bernardo, Setubal, Portugal|Cluj-Napoca Emergency Clinical County Hospital, Cluj-Napoca, Cluj, Romania|Dr.Carol Davila Emergency University Central Military Hospital, Bucharest, Romania|Sana Monitoring SRL, Bucharest, Romania|Colentina Clinical Hospital, Bucharest, Romania|Prof. Dr. Matei Bals Institute of Infectious Diseases, Bucharest, Romania|Fundeni Clinical Institute, Bucharest, Romania|Centrul Medical Hifu Terramed Conformal S.R.L., Bucuresti, Romania|Affidea Romania SRL, Constanta, Romania|Gastromedica SRL, Iasi, Romania|Dr. Tirnaveanu Amelita Private Practice, Oradea, Romania|Dr. Goldis Gastroenterology Center SRL, Timisoara, Romania|Kazan State Medical University, Kazan, Russian Federation|Moscow Clinical Scientific Center, Moscow, Russian Federation|Moscow Regional Research Clinical Institute Na Mfvladimirskiy, Moscow, Russian Federation|Nizhegorodskaya Regional Clinical Hospital n.a. Semashko, Nizhny Novgorod, Russian Federation|Research Institute of Physiology and Basic Medicine, Novosibirsk, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|Union Clinic, LLC, Saint Petersburg, Russian Federation|Russian Medical Military Academy n.a. S.M. Kirov, Saint Petersburg, Russian Federation|Medical University Reaviz, Samara, Russian Federation|Private Healthcare Institution Clinical Hospital RZD-Medicina of Samara city, Samara, Russian Federation|Medical Company Hepatolog, LLC, Samara, Russian Federation|SHI Regional Clinical Hospital, Saratov, Russian Federation|Smolensk Regional Clinical Hospital, Smolensk, Russian Federation|St. Elizabeth Municipal Clinical Hospital, St. Petersburg, Russian Federation|First St. Petersburg State Medical University n.a. I.P Pavlov, St. Petersburg, Russian Federation|Stavropol State Medical University, Stavropol, Russian Federation|Regional Consulting and Diagnostics Centre, Tyumen, Russian Federation|Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia|University Clinical Center Nis, Nis, Serbia|General Hospital Vrsac, Vrsac, Serbia|University Clinical Center Kragujevac, Kragujevac, Šumadijski Okrug, Serbia|Fakultna nemocnica s poliklinikou F. D. Roosevelta, Banska Bystrica, Slovakia|Univerzitna nemocnica Bratislava, Bratislava, Slovakia|KM Management, spol. s r.o., Nitra, Slovakia|Gastro LM, s.r.o., Presov, Slovakia|CLINRESCO, ARWYP Medical Suites, Johannesburg, Gauteng, South Africa|Dr. J Breedt, Pretoria, Gauteng, South Africa|Dr JP Wright, Claremont, Western Cape, South Africa|C.H. Regional Reina Sofia - PPDS, Cordoba, Córdoba, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|CHUVI - H.U. Alvaro Cunqueiro, Vigo, Pontevedra, Spain|Centro Medico Teknon - Grupo Quironsalud, Barcelona, Spain|Hospital Universitario Juan Ramon Jimenez, Huelva, Spain|Hospital Universitario de La Princesa, Madrid, Spain|Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain|Hospital Universitario La Paz - PPDS, Madrid, Spain|Hospital Universitario Virgen del Rocio - PPDS, Sevilla, Spain|Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain|Universität Zürich, Zürich, Zürich (de), Switzerland|Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul, Turkey|Mersin University Medical Faculty, Mersin, Turkey|Regional Municipal Non-profit Enterprise ""Chernivtsi Regional Clinical Hospital"", Chernivtsi, Chernivets'ka Oblast, Ukraine|Municipal Nonprofit Enterprise CCH #2 n.a. prof. O.O. Shalimov of Kharkiv City Council, Kharkiv, Kharkivs'ka Oblast, Ukraine|Municipal Non-profit Enterprise of Kyiv Regional Council Kyiv Regional Clinical Hospital, Kyiv, Kyïv, Ukraine|Communal Nonprofit Enterprise Vinnytsia Regional Clinical Hospital named after N.I. Pirogov VRC, Vinnytsia, Vinnyts'ka Oblast, Ukraine|Municipal Non-profit Enterprise City Emergency Care Hospital of Zaporizhzhia Regional Council, Zaporizhzhia, Zaporiz'ka Oblast, Ukraine|ME Dnipropetrovsk Regional Clinical Hospital n.a. I.I Mechnykov Dnipropetrovsk Regional Council, Dnipro, Ukraine|LLC Medical Center Family Medicine Clinic, Dnipro, Ukraine|State Institution ""Institute of Gastroenterology of National Academy of Medical Sciences of Ukraine"", Dnipro, Ukraine|Clinic of SI National Institute of Therapy n.a. L.T. Mala of NAMS of Ukraine, Kharkiv, Ukraine|Communal Non-Commercial Enterprize of Kharkiv Regional Council Regional Clinical Hospital, Kharkiv, Ukraine|MNPE of Kharkiv Regional Council Regional Clinical Specialized Dispensary of Radiation Protection, Kharkiv, Ukraine|Municipal Non-profit Enterprise Kherson City Clinical Hospital named after Ye.Ye. Karabelesh, Kherson, Ukraine|Municipal Enterprise Kryvyi Rih City Clinical Hospital #2 of Kryvyi Rih City Council, Kryvyi Rih, Ukraine|Medical Center of LLC Medical Clinic Blagomed, Kyiv, Ukraine|Kyiv City Clinical Hospital #18, Kyiv, Ukraine|Treatment and Diagnostic Center ""Healthy and Happy"" of LLC ""Healthy and Happy"", Kyiv, Ukraine|Municipal Institution of KRC Kyiv Regional Hospital #2, Kyiv, Ukraine|Lviv Railway Clinical Hospital of branch Health Center of Joint Stock Co. Ukrainian Railway, Lviv, Ukraine|Municipal Nonprofit Enterprise Lviv Clinical Emergency Care Hospital, Lviv, Ukraine|Municipal Non-profit Enterprise Odessa Regional Clinical Hospital of Odessa Regional Council, Odesa, Ukraine|MNPE Central City Clinical Hospital of Uzhhorod City Council, Uzhhorod, Ukraine|Medical Clinical Research Center of Medical Center LLC Health Clinic, Vinnytsia, Ukraine|Communal Nonprofit Enterprise Vinnytsia Regional Clinical Hospital named after N.I. Pirogov VRC, Vinnytsia, Ukraine|Communal Non-Commercial Enterprise Vinnytsia City Clinical Hospital 1, Vinnytsia, Ukraine|MNPE City Hospital No. 6 of Zaporizhzhia City Council, Zaporizhzhia, Ukraine|Aberdeen Royal Infirmary - PPDS, Aberdeen, Aberdeen City, United Kingdom|Fairfield General Hospital - PPDS, Lancashire, Bury, United Kingdom|Whipps Cross University Hospital, London, London, City Of, United Kingdom|North Tyneside General Hospital, North Shields, Northumberland, United Kingdom|Royal Shrewsbury Hospital, Shrewsbury, Shropshire, United Kingdom|Western General Hospital Edinburgh - PPDS, Edinburh, United Kingdom|Royal Gwent Hospital - PPDS, Newport, United Kingdom|New Cross Hospital, Wolverhampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03290781"
874,"NCT03268213","Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis","FMT","Active, not recruiting","No Results Available","Clostridium Difficile Infection|Ulcerative Colitis|Indeterminate Colitis","Biological: Fecal Microbial Transplantation","Number of participants with treatment-related adverse events as assessed by CTCAE v4.0|To measure the effect of fecal microbial transplantation on microbial diversity in healthy donor stools compared to pre-FMT, 1 week post FMT, and 12 weeks post-FMT recipient stools.|To measure the effect of fecal microbial transplantation on microbial composition in healthy donor stools compared to pre-FMT, 1 week post FMT, and 12 weeks post-FMT recipient stools.|To measure the effect of fecal microbial transplantation on microbial function using shotgun DNA metagenomic in healthy donor stools compared to pre-FMT, 1 week post FMT, and 12 weeks post-FMT recipient stools.|To measure the effect of fecal microbial transplantation on microbial function using bacterial metatranscriptomic sequencing|To measure the effect of fecal microbial transplantation on microbial function using targeted metabolomic assays.|Determine if FMT causes a statistically significant change in recipient fecal calprotectin levels|Determine number of C. difficile recipients who have recurrent C. difficile within a year after fecal microbial transplant","Stony Brook University","All","7 Years and older   (Child, Adult, Older Adult)","Early Phase 1","12","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","479696","November 2013","June 30, 2022","June 30, 2023","August 31, 2017",,"March 18, 2021","Stony Brook University Hospital, Stony Brook, New York, United States","""Study Protocol and Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/13/NCT03268213/Prot_ICF_002.pdf","https://ClinicalTrials.gov/show/NCT03268213"
875,"NCT03221036","Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis",,"Recruiting","No Results Available","Moderately to Severely Active Ulcerative Colitis","Drug: Vedolizumab IV|Drug: Placebo","Percentage of Participants with Clinical Response at Week 10|Percentage of Participants with Clinical Remission at Week 60|Percentage of Participants with Clinical Remission at Week 10|Percentage of Participants with Mucosal Healing at Weeks 10 and 60|Percentage of Participants with Durable Clinical Response at Weeks 10 and 60|Percentage of Participants with Durable Clinical Remission at Weeks 10 and 60|Percentage of Participants Using Oral Corticosteroids at Baseline who have Discontinued Corticosteroids and are in Clinical Remission at Week 60","Takeda","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 3","302","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Vedolizumab-3033|U1111-1195-3994","August 3, 2017","August 14, 2023","October 9, 2023","July 18, 2017",,"May 19, 2021","Gastroenterology, Hefei, Anhui, China|Gastroenterology, Beijing, Beijing, China|Gastroenterology, Beijing, Beijing, China|Gastroenterology, Chongqing, Chongqing, China|Gastroenterology, Chongqing, Chongqing, China|Gastroenterology, Fuzhou, Fujian, China|Gastroenterology, Xiamen, Fujian, China|Gastroenterology, Zhangzhou, Fujian, China|Gastroenterology, Guangzhou, Guangdong, China|Gastroenterology, Guangzhou, Guangdong, China|Gastroenterology, Guangzhou, Guangdong, China|Gastroenterology, Guangzhou, Guangdong, China|Gastroenterology, Shantou, Guangdong, China|Gastroenterology, Wuhan, Hubei, China|Gastroenterology, Wuhan, Hubei, China|Gastroenterology, Wuhan, Hubei, China|Gastroenterology, Changsha, Hunan, China|Gastroenterology, Changsha, Hunan, China|Gastroenterology, Changsha, Hunan, China|Gastroenterology, Nanjing, Jiangsu, China|Gastroenterology, Nanjing, Jiangsu, China|Gastroenterology, Wuxi, Jiangsu, China|Gastroenterology, Nanchang, Jiangxi, China|Gastroenterology, Changchun, Jilin, China|Gastroenterology, Shenyang, Liaoning, China|Gastroenterology, Yinchuan, Ningxia, China|Gastroenterology, Shanghai, Shanghai, China|Gastroenterology, Shanghai, Shanghai, China|Gastroenterology, Shanghai, Shanghai, China|Gastroenterology, Shanghai, Shanghai, China|Gastroenterology, Chengdu, Sichuan, China|Gastroenterology, Kunming, Yunnan, China|Gastroenterology, Hangzhou, Zhejiang, China|Gastroenterology, Hangzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT03221036"
876,"NCT03209232","Infliximab Accelerated Induction in Moderate to Severe Pediatric UC","INDUCE","Recruiting","No Results Available","Ulcerative Colitis","Drug: Infliximab","Clinical remission on infliximab|Colectomy free rate|Drug levels prior to last study infusion|Calprotectin level|Adverse events","Schneider Children's Medical Center, Israel","All","6 Years to 18 Years   (Child, Adult)","Not Applicable","84","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","INDUCE","April 16, 2018","December 2021","April 2022","July 6, 2017",,"October 20, 2020","Schenider Children's Medical Center, Petaẖ Tiqwa, Israel",,"https://ClinicalTrials.gov/show/NCT03209232"
877,"NCT03182166","Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization","GOLILOR","Recruiting","No Results Available","Ulcerative Colitis","Drug: Golimumab (Optimization)|Diagnostic Test: Rectosigmoidoscopy|Biological: Blood samples","correlation between concentration of golimumab and clinical response according to treatment|Number of patient with antibodies to golimumab|correlation between concentration of antibodies to golimumab and clinical response according to treatment|Number of patients with Infectious diseases or Neuropathies or Injection site pain or fever","Centre Hospitalier Universitaire de Saint Etienne|Merck Sharp & Dohme Corp.","All","18 Years and older   (Adult, Older Adult)","Phase 2","80","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","1608162|2016-004245-85","November 21, 2017","October 30, 2021","May 30, 2022","June 9, 2017",,"January 6, 2021","CHU Amiens-Picardie, Amiens, France|CHU Lyon Sud, Lyon, France|CHU Montpellier - St Eloi, Montpellier, France|CHU Nice, Nice, France|Chu Saint Etienne, Saint Etienne, France",,"https://ClinicalTrials.gov/show/NCT03182166"
878,"NCT02103361","Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project",,"Recruiting","No Results Available","Psoriasis|Pregnancy|Psoriatic Arthritis|Crohn Disease","Drug: Ustekinumab|Drug: Guselkumab","Major structural malformations|Minor Congenital Structural Malformations","University of California, San Diego|The Organization of Teratology Information Specialists|Janssen Biotech, Inc.","Female","Child, Adult, Older Adult",,"200","Other|Industry","Observational","Observational Model: Case-Only|Time Perspective: Other","CNTO1275PSO4037","November 2013","December 2024","December 2025","April 3, 2014",,"April 5, 2021","University of California, San Diego, La Jolla, California, United States",,"https://ClinicalTrials.gov/show/NCT02103361"
879,"NCT03172195","Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-up","VIRCH","Recruiting","No Results Available","Colitis, Ulcerative","Procedure: rectosigmoidoscopy|Biological: biopsies|Biological: blood sample","Number of patients with different viral load in the colonic mucosa|Correlation of the different viral loads with the Mayo endoscopic score|Correlation of the different viral loads with the steroid treatment response|Correlation of the different viral loads with the anti-TNF treatment response","Centre Hospitalier Universitaire de Saint Etienne","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","1708033|ANSM","October 11, 2017","June 2022","June 2023","June 1, 2017",,"October 19, 2020","CHU Saint-Etienne, Saint-Etienne, France",,"https://ClinicalTrials.gov/show/NCT03172195"
880,"NCT03104036","Faecal Bacteriotherapy for Ulcerative Colitis","FACTU","Active, not recruiting","No Results Available","Ulcerative Colitis","Other: Faecal bacterial transplantation|Drug: Mesalazine 4G Enema","Clinical remission|Endoscopic remission|Clinical response","Institute for Clinical and Experimental Medicine|Institute of Animal Physiology and Genetics Academy of Science Czech Republic","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 2","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","F16-27449A","June 19, 2017","January 30, 2021","June 30, 2021","April 7, 2017",,"January 25, 2021","Gastroenterology departement Hospital České Budějovice, Ceske Budejovice, Jihočeský Kraj, Czechia|Centrum péče o zažívací trakt Vítkovická nemocnice, Ostrava - Vitkovice, Moravskoslezský Kraj, Czechia|Second department of internal medicine of University Hospital Olomouc, Olomouc, Olomoucký Kraj, Czechia|IV. Department of Internal Medicine, General University Hospital in Prague, Prague, Prague 2, Czechia|Internal departement of Thomayer Hospital, Prague, Prague 4, Czechia|ISCARE, Prague, Prague 7, Czechia|II. Department of Internal Medicine University Hospital Vinohrady, Prague, Czechia|Institute of clinical and experimental medicine, Prague, Czechia|Internal departement Hospital Na Bulovce, Prague, Czechia",,"https://ClinicalTrials.gov/show/NCT03104036"
881,"NCT03011268","Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?","BIOSTOP","Recruiting","No Results Available","Colitis,Ulcerative","Other: Discontinuation of anti-TNF treatment|Other: Continuation of anti-TNF treatment","Proportion of patients in sustained clinical remission|Time from randomization to relapse|Proportion of patients who are no longer in remission, but who do not need to restart anti-tumor necrosis factor (TNF) therapy|Proportion of relapse patients achieving remission after anti-TNF restart|Adverse events and serious adverse events frequency and severity","Helse Møre og Romsdal HF|Oslo University Hospital|University of Oslo","All","18 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","HMR2016-0.6|2016-001409-18","June 9, 2017","December 31, 2022","December 31, 2024","January 5, 2017",,"December 22, 2020","Helse Møre og Romsdal, Ålesund Sjukehus, Alesund, Norway|Haraldsplass Diakonale sykehus, Bergen, Norway|Haukeland Universitetssykehus Helse Bergen HF, Bergen, Norway|Helse Førde, Førde Sentralsjukehus, Forde, Norway|Sykehuset Østfold HF Kalnes, Fredrikstad, Norway|Sykehuset Innlandet, Hamar Sykehus, Hamar, Norway|Universitetssykehuset i Nord-Norge, Harstad, Harstad, Norway|Sørlandet Sykehus HF, Kristiansand, Kristiansand, Norway|Helse Møre og Romsdal, Kristiansund Sjukehus, Kristiansund, Norway|Helse Nord Trøndelag, Levanger Sykehus, Levanger, Norway|Akershus Universitetssykehus, Lørenskog, Lørenskog, Norway|Oslo Universitetssykehus, Rikshospitalet, Oslo, Norway|Oslo Universitetssykehus, Ullevål, Oslo, Norway|Vestre Viken HF, Bærum Sykehus, Sandvika, Norway|Sykehuset Telemark, Skien, Skien, Norway|Stavanger Universitetssykehus, Stavanger, Norway|Sykehuset Vestfold, Tønsberg, Tonsberg, Norway|Helse Møre og Romsdal, Volda Sjukehus, Volda, Norway|Helse Bergen HF Voss Sjukehus, Voss, Norway",,"https://ClinicalTrials.gov/show/NCT03011268"
882,"NCT03006068","A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)",,"Enrolling by invitation","No Results Available","Ulcerative Colitis (UC)","Drug: Upadacitinib (ABT-494)|Drug: Placebo","Assessing Treatment-Emergent Adverse Events","AbbVie","All","16 Years to 75 Years   (Child, Adult, Older Adult)","Phase 3","950","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","M14-533|2016-000674-38","January 31, 2017","August 28, 2024","August 28, 2024","December 30, 2016",,"January 6, 2021","East View Medical Research, LLC /ID# 171184, Mobile, Alabama, United States|CB Flock Research Corporation /ID# 165986, Mobile, Alabama, United States|Delsol Research Management, Ll /Id# 170130, Chandler, Arizona, United States|Arizona Arthritis & Rheumatolo /ID# 169823, Phoenix, Arizona, United States|Physician's Research Group /ID# 211886, Tempe, Arizona, United States|Adobe Clinical Research LLC /ID# 155249, Tucson, Arizona, United States|University of Arizona /ID# 150568, Tucson, Arizona, United States|Citrus Valley Gastroenterology /ID# 151915, Covina, California, United States|Newport Huntington Medical Group /ID# 217006, Huntington Beach, California, United States|UC San Diego Health System /ID# 155187, La Jolla, California, United States|United Gastroenterologists /ID# 207467, Los Alamitos, California, United States|TLC Clinical Research Inc /ID# 216830, Los Angeles, California, United States|Gastrointestinal Biosciences /ID# 157082, Los Angeles, California, United States|Facey Medical Foundation /ID# 203135, Mission Hills, California, United States|United Gastroenterologists - Murrieta /ID# 151213, Murrieta, California, United States|Ventura County Gastroenterology /ID# 163417, Oxnard, California, United States|Inland Empire Liver Foundation /ID# 216163, Rialto, California, United States|San Diego Clinical Trials /ID# 212121, San Diego, California, United States|Medical Assoc Research Grp /ID# 169149, San Diego, California, United States|Univ of California San Francis /ID# 164583, San Francisco, California, United States|Delta Waves, Inc. /ID# 151727, Colorado Springs, Colorado, United States|South Denver Gastroenterology /ID# 151224, Lone Tree, Colorado, United States|Duplicate_Western States Clinical Res /ID# 158078, Wheat Ridge, Colorado, United States|Western Connecticut Medical Group /ID# 169211, Danbury, Connecticut, United States|Medical Research Ctr CT /ID# 150534, Hamden, Connecticut, United States|West Central Gastroenterology /ID# 155242, Clearwater, Florida, United States|Moonshine Research Center, Inc /ID# 152534, Doral, Florida, United States|Universal Axon Clinical Resear /ID# 213463, Doral, Florida, United States|Palmetto Research, LLC /ID# 151724, Hialeah, Florida, United States|Nature Coast Clinical Research - Inverness /ID# 154070, Inverness, Florida, United States|Borland-Groover Clinic /ID# 170913, Jacksonville, Florida, United States|SIH Research Mumtaz, Inc /ID# 163199, Kissimmee, Florida, United States|Ctr for Advanced Gastroenterol /ID# 202018, Maitland, Florida, United States|University of Miami /ID# 215443, Miami, Florida, United States|Advanced Pharma CR, LLC /ID# 151723, Miami, Florida, United States|Crystal Pharmacology Research /ID# 151848, Miami, Florida, United States|New Horizon Research Center /ID# 152475, Miami, Florida, United States|Coral Research Clinic /ID# 150524, Miami, Florida, United States|Advanced Research Institute /ID# 163093, New Port Richey, Florida, United States|Endoscopic Research, Inc. /ID# 151725, Orlando, Florida, United States|Omega Research Consultants /ID# 200271, Orlando, Florida, United States|Clinical Research Trials of Florida, Inc. /ID# 201791, Tampa, Florida, United States|University of South Florida /ID# 214494, Tampa, Florida, United States|Florida Hospital Tampa /ID# 200274, Tampa, Florida, United States|Gastroenterology Associates of Central Georgia, LLC /ID# 165783, Macon, Georgia, United States|Infinite Clinical Trials /ID# 215342, Riverdale, Georgia, United States|Atlanta Gastroenterology Spec /ID# 150565, Suwanee, Georgia, United States|Next Innovative Clinical Research - Chicago /ID# 217323, Chicago, Illinois, United States|University of Chicago /ID# 150564, Chicago, Illinois, United States|NorthShore University HealthSystem - Evanston Hospital /ID# 150570, Evanston, Illinois, United States|Northwest Health Care Associat /ID# 151591, Hoffman Estates, Illinois, United States|Carle Foundation Hospital /ID# 151155, Urbana, Illinois, United States|MediSphere Medical Research Center /ID# 152080, Evansville, Indiana, United States|Indianapolis Gastroenterology /ID# 162914, Indianapolis, Indiana, United States|University of Iowa Hospitals and Clinics /ID# 157059, Iowa City, Iowa, United States|Cotton-O'Neil Clinical Res Ctr /ID# 167183, Topeka, Kansas, United States|Tri-State Gastroenterology /ID# 169812, Crestview Hills, Kentucky, United States|Houma Digestive Health Special /ID# 151851, Houma, Louisiana, United States|Nola Research Works, LLC /ID# 153365, New Orleans, Louisiana, United States|Louisana Research Center, LLC /ID# 150526, Shreveport, Louisiana, United States|University of Maryland Med Ctr /ID# 150529, Baltimore, Maryland, United States|Gastro Center of Maryland /ID# 200024, Columbia, Maryland, United States|Massachusetts General Hospital /ID# 165678, Boston, Massachusetts, United States|University of Michigan Health Systems /ID# 151158, Ann Arbor, Michigan, United States|Huron Gastroenterology Assoc /ID# 152712, Ann Arbor, Michigan, United States|Clin Res Inst of Michigan, LLC /ID# 153031, Chesterfield, Michigan, United States|Revival Research Institute, LLC /ID# 207281, Southfield, Michigan, United States|Center for Digestive Health /ID# 161983, Troy, Michigan, United States|Gastroenterology Associates of Western Michigan, PLC /ID# 157487, Wyoming, Michigan, United States|Mayo Clinic /ID# 151681, Rochester, Minnesota, United States|Minnesota Gastroenterology P.A /ID# 151682, Saint Paul, Minnesota, United States|Univ of Mississippi Med Ctr /ID# 213140, Jackson, Mississippi, United States|Southern Therapy and Advanced Research (STAR) LLC /ID# 170713, Jackson, Mississippi, United States|Washington University-School of Medicine /ID# 150537, Saint Louis, Missouri, United States|Las Vegas Medical Research /ID# 153052, Las Vegas, Nevada, United States|Dartmouth-Hitchcock Medical Center /ID# 150566, Lebanon, New Hampshire, United States|AGA Clinical Research Associates, LLC /ID# 153048, Egg Harbor Township, New Jersey, United States|Atlantic Digestive Health Inst /ID# 150527, Morristown, New Jersey, United States|Rutgers Robert Wood Johnson /ID# 155247, New Brunswick, New Jersey, United States|Univ New Mexico /ID# 214399, Albuquerque, New Mexico, United States|Montefiore Medical Center - Moses Campus /ID# 150559, Bronx, New York, United States|Advantage Clinical Trials /ID# 163940, Bronx, New York, United States|NY Scientific /ID# 152708, Brooklyn, New York, United States|NYU Langone Long Island Clin. Res. Assoc. /ID# 155271, Great Neck, New York, United States|Columbia Univ Medical Center /ID# 163409, New York, New York, United States|DiGiovanna Institute for Medical Education & Research /ID# 201534, North Massapequa, New York, United States|Premier Medical Group /ID# 153366, Poughkeepsie, New York, United States|Gastro Group of Rochester /ID# 151080, Rochester, New York, United States|Richmond University Medical Center /ID# 201860, Staten Island, New York, United States|Digestive Health Partners, P.A /ID# 167238, Asheville, North Carolina, United States|Atrium Health Carolinas Medical Center /ID# 157060, Charlotte, North Carolina, United States|Charlotte Gastroenterology and Hepatology, PLLC /ID# 150561, Charlotte, North Carolina, United States|AG Clinical Research, PLLC /ID# 151901, Greenville, North Carolina, United States|Clinical Trials of America /ID# 153453, Winston-Salem, North Carolina, United States|Wake Forest Baptist Medical Center /ID# 150528, Winston-Salem, North Carolina, United States|Plains Clinical Research Center, LLC /ID# 170291, Fargo, North Dakota, United States|Consultants for Clinical Res /ID# 151683, Cincinnati, Ohio, United States|University of Cincinnati /ID# 164584, Cincinnati, Ohio, United States|The Ohio State University /ID# 169417, Columbus, Ohio, United States|Optimed Research, Ltd. /ID# 169697, Columbus, Ohio, United States|Hometown Urgent Care and Resea /ID# 200066, Dayton, Ohio, United States|Dayton Gastroenterology, Inc. /ID# 167632, Englewood, Ohio, United States|Great Lakes Gastroenterology Research LLC /ID# 201773, Mentor, Ohio, United States|Ohio Clinical Research Partner /ID# 154074, Mentor, Ohio, United States|Hightower Clinical /ID# 216338, Oklahoma City, Oklahoma, United States|Digestive Disease Specialists /ID# 201057, Oklahoma City, Oklahoma, United States|Options Health Research, LLC /ID# 150569, Tulsa, Oklahoma, United States|Healthcare Research Consultant /ID# 163096, Tulsa, Oklahoma, United States|Northwest Gastroenterology Cli /ID# 152528, Portland, Oregon, United States|Guthrie Medical Group, PC /ID# 150533, Sayre, Pennsylvania, United States|Penn State Health Colonnade /ID# 150267, State College, Pennsylvania, United States|Pharmacorp Clinical Trials /ID# 153363, Charleston, South Carolina, United States|Gastroenterology Associates, P.A. /ID# 150557, Greenville, South Carolina, United States|Gastro One /ID# 151154, Germantown, Tennessee, United States|East Tennessee Research Instit /ID# 203611, Johnson City, Tennessee, United States|Quality Medical Research, PLLC /ID# 203427, Nashville, Tennessee, United States|Vanderbilt Univ Med Ctr /ID# 153364, Nashville, Tennessee, United States|TX Clinical Research Institute /ID# 151528, Arlington, Texas, United States|Inquest Clinical Research /ID# 164636, Baytown, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209806, Cedar Park, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209949, Cedar Park, Texas, United States|Baylor Scott & White Research /ID# 200771, Dallas, Texas, United States|DHAT Research Institute /ID# 151221, Garland, Texas, United States|Vilo Research Group Inc /ID# 212626, Houston, Texas, United States|CliniCore International, LLC /ID# 152078, Houston, Texas, United States|Baylor College of Medicine /ID# 150538, Houston, Texas, United States|Centex Studies, Inc. - Houston /ID# 201217, Houston, Texas, United States|GI Specialists of Houston /ID# 202337, Houston, Texas, United States|Caprock Gastro Research /ID# 215116, Lubbock, Texas, United States|Clinical Associates in Researc /ID# 167954, San Antonio, Texas, United States|Southern Star Research Institute, LLC /ID# 169397, San Antonio, Texas, United States|Carl R. Meisner Medical Clinic /ID# 171270, Sugar Land, Texas, United States|Baylor Scott & White Health - Temple /ID# 204777, Temple, Texas, United States|Tyler Research Institute, LLC /ID# 169147, Tyler, Texas, United States|Victoria gastroenterology /ID# 167764, Victoria, Texas, United States|HP Clinical Research /ID# 163941, Bountiful, Utah, United States|Advanced Research Institute /ID# 162640, Ogden, Utah, United States|Utah Gastroenterology /ID# 163097, Salt Lake City, Utah, United States|Advanced Clinical Research (ACR) - Salt Lake City /ID# 163180, West Jordan, Utah, United States|Ctr for Gastrointestinal Healt /ID# 153369, Franklin, Virginia, United States|Washington Gastroenterology /ID# 163630, Bellevue, Washington, United States|Virginia Mason Medical Center /ID# 153030, Seattle, Washington, United States|The Polyclinic /ID# 165117, Seattle, Washington, United States|The Vancouver Clinic, INC. PS /ID# 162334, Vancouver, Washington, United States|Aurora Medical Center - Grafto /ID# 151726, Grafton, Wisconsin, United States|Wisconsin Center for Advanced Research, a division of GI Associates, LLC /ID# 151845, Milwaukee, Wisconsin, United States|Medical College of Wisconsin /ID# 151850, Milwaukee, Wisconsin, United States|Cardio Alem /ID# 211281, San Isidro, Buenos Aires, Argentina|Mautalen Salud e Investigacion /ID# 171174, Buenos Aires, Argentina|Hospital Britanico de Bs As /ID# 209496, Caba, Argentina|Gedyt /ID# 210016, Ciudad Autonoma Buenos Aires, Argentina|Hospital Privado Univesitario /ID# 164186, Cordoba, Argentina|Sanatorio 9 de Julio S.A. /ID# 150215, San Miguel de Tucuman, Argentina|Macquarie University /ID# 211953, Macquarie Park, New South Wales, Australia|Mater Misericordiae /ID# 212686, South Brisbane, Queensland, Australia|Griffith University /ID# 211954, Southport, Queensland, Australia|Monash Health /ID# 150218, Clayton, Victoria, Australia|St. Vincents Hosp Melbourne /ID# 152503, Fitzroy, Victoria, Australia|Fiona Stanley Hospital /ID# 211641, Murdoch, Western Australia, Australia|Ordensklinikum Linz GmbH, Barmherzige Schwestern /ID# 150462, Linz, Oberoesterreich, Austria|Krankenanstalt Rudolfstiftung /ID# 162867, Vienna, Wien, Austria|Medizinische Universitat Wien /ID# 150616, Vienna, Wien, Austria|LKH Salzburg and Paracelsus /ID# 150463, Salzburg, Austria|Vitebsk Regional Advanced Clin /ID# 169592, Vitebsk, Belarus|AZ Maria Middelares /ID# 150466, Ghent, Belgium|UZ Leuven /ID# 150468, Leuven, Belgium|AZ-Delta /ID# 150467, Roeselare, Belgium|University Clinical Centre of the Republic of Srpska /ID# 150223, Banja Luka, Republika Srpska, Bosnia and Herzegovina|University Clinical Centre of the Republic of Srpska /ID# 150712, Banja Luka, Republika Srpska, Bosnia and Herzegovina|University Clinical Center Tuzla /ID# 150224, Tuzla, Tuzlanski, Bosnia and Herzegovina|University Clinical Hospital Mostar /ID# 150711, Mostar, Bosnia and Herzegovina|Clinical Center University of Sarajevo /ID# 150222, Sarajevo, Bosnia and Herzegovina|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Ltda /ID# 153744, Goiania, Goias, Brazil|Hospital Nossa Senhora das Graças /ID# 152488, Curitiba, Parana, Brazil|Hospital de Clinicas de Porto Alegre /ID# 153745, Porto Alegre, Rio Grande Do Sul, Brazil|Upeclin Fmb - Unesp /Id# 152493, Botucatu, Sao Paulo, Brazil|Hospital das Clinicas da Faculdade de Medicina de Ribeirão Preto - USP /ID# 152492, Ribeirão Preto, Sao Paulo, Brazil|Faculdade de Medicina do ABC /ID# 152489, Santo André, Sao Paulo, Brazil|Kaiser Clinica e Hospital Dia /ID# 152491, Sao Jose Do Rio Preto, Sao Paulo, Brazil|University of Calgary Cumming School of Medicine Adult Cystic Fibrosis Clinic /ID# 151818, Calgary, Alberta, Canada|Allen Whey Khye Lim Professional Corporation /ID# 211169, Edmonton, Alberta, Canada|University of Alberta /ID# 151824, Edmonton, Alberta, Canada|Covenant Health /ID# 158931, Edmonton, Alberta, Canada|Okanagan Clinical Trials /ID# 153179, Kelowna, British Columbia, Canada|Percuro Clinical Research, Ltd /ID# 150479, Victoria, British Columbia, Canada|McMaster University Med Cent /ID# 150477, Hamilton, Ontario, Canada|The Ottawa Hospital /ID# 151817, Ottawa, Ontario, Canada|Medicor Research Inc /ID# 151825, Sudbury, Ontario, Canada|Toronto Digestive Disease Asso /ID# 150475, Vaughan, Ontario, Canada|CISSS de la Monteregie /ID# 159271, Greenfield Park, Quebec, Canada|Hopital Hotel-Dieu de Levis /ID# 150473, Levis, Quebec, Canada|Recherche GCP Research /ID# 151819, Montreal, Quebec, Canada|Crchum /Id# 167170, Montreal, Quebec, Canada|Montreal General Hospital - McGill University Health Centre /ID# 170013, Montréal, Quebec, Canada|CRCHUS Hotel-Dieu /ID# 150478, Sherbrooke, Quebec, Canada|Research Group Ltda /ID# 203177, Santiago, Region Metropolitana De Santiago, Chile|M y F Estudios Clínicos Ltda. /ID# 200112, Ñuñoa, Region Metropolitana De Santiago, Chile|Centro de Investigaciones Clínicas Viña del Mar /ID# 150226, Viña del Mar, Valparaíso, Chile|Hospital Guillermo Grant Benavente de Concepción /ID# 212425, Concepción, Chile|CTR Estudios SpA /ID# 200111, Providencia, Chile|Hospital Clinico Universidad De Los Andes /ID# 207427, Santiago, Chile|The First Affiliated Hosp, Sun /ID# 150517, Guangzhou, Anhui, China|Shanghai Tenth People's Hosp /ID# 150522, Shanghai, Anhui, China|The Sixth Affiliated Hosp Sun /ID# 150518, Guangzhou, Guangdong, China|Affiliated Taihe Hospital of Hubei University of Medicine /ID# 216407, Shiyan, Hubei, China|Tongji Hospital Tongji Medical College Huazhong University of Science and Techno /ID# 167089, Wuhan, Hubei, Hubei, China|Xiangya Hospital Central South University /ID# 167230, Changsha, Hunan, China|The First Affiliated Hospital of Soochow University /ID# 217981, Suzhou, Jiangsu, China|The First Affiliated Hospital of Nanchang University /ID# 212185, Nanchang, Jiangxi, China|The First Hosp of Jilin Univ /ID# 210087, Changchun, Jilin, China|Ruijin Hospital, Shanghai Jiaotong /ID# 150523, Shanghai, Shanghai, China|Renji Hospital, Shanghai Jiaotong University School of Medicine /ID# 165826, Shanghai, Shanghai, China|The second affiliated hospital of Zhejiang University school of medicine /ID# 165813, Hangzhou, Zhejiang, China|Sir Run Run Shaw Hospital /ID# 150516, Jianggan Hangzhou, Zhejiang, China|The 2nd Affiliated Hospital and Yuying Children's Hospital of WMU /ID# 217557, Wenzhou, Zhejiang, China|West China Hospital, Sichuan University /ID# 167041, Chengdu, China|Shengjing Hospital of China Medical University /ID# 166921, Shenyang, China|Tianjin Med Univ General Hosp /ID# 170605, Tianjin, China|Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 167079, Wuhan, China|Corporacion Hospitalaria Juan Ciudad sede Denominada Hospital Universitario Mayo /ID# 152811, Bogota DC, Cundinamarca, Colombia|Hospital Universitario de San /ID# 155388, Medellin, Colombia|Inst Med Alta Tec Onc (IMAT) /ID# 207052, Montería, Colombia|Klinicka bolnica Dubrava Zagreb /ID# 150228, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Zagreb /ID# 150262, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Zagreb /ID# 150715, Zagreb, Grad Zagreb, Croatia|Poliklinika Solmed /ID# 211567, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Osijek /ID# 150229, Osijek, Osjecko-baranjska Zupanija, Croatia|Klinicki bolnicki centar Rijeka /ID# 150714, Rijeka, Primorsko-goranska Zupanija, Croatia|Klinicki bolnicki centar Split /ID# 213989, Split, Croatia|Zadar General Hospital /ID# 150261, Zadar, Croatia|CTCenter MaVe, s.r.o. /ID# 150903, Olomouc, Olomoucky Kraj, Czechia|Axon Clinical, s.r.o. /ID# 152477, Praha, Praha 5, Czechia|Hepato-Gastroenterologie HK s.r.o. /ID# 150946, Hradec Kralove, Czechia|Artroscan s.r.o. /ID# 150502, Ostrava, Czechia|Nemocnice Pardubickeho kraje, a.s. /ID# 213541, Pardubice, Czechia|Nemocnice Milosrdnych sester sv. Karla Boromejskeho v Praze /ID# 216224, Praha 1, Czechia|ISCARE a.s. /ID# 209279, Praha 9, Czechia|East Tallinn Central Hospital /ID# 150488, Tallinn, Estonia|West Tallinn Central Hospital /ID# 150490, Tallinn, Estonia|North Estonian Medical Centre /ID# 160871, Tallinn, Estonia|Tartu University Hospital /ID# 150489, Tartu, Estonia|Tampere University Hospital /ID# 150376, Tampere, Pirkanmaa, Finland|Helsinki Univ Central Hospital /ID# 154283, Helsinki, Finland|Keski-Suomen Keskussairaala /ID# 155665, Jyvaskyla, Finland|Laakarikeskus Ikioma /ID# 150377, Mikkeli, Finland|Tyks /Id# 169895, Turku, Finland|Centre Hospitalier Lyon Sud /ID# 152540, Pierre Benite CEDEX, Auvergne-Rhone-Alpes, France|CHRU Lille - Hopital Claude Huriez /ID# 152609, Lille CEDEX, Hauts-de-France, France|Hopital Saint Eloi /ID# 200088, Montpellier CEDEX 5, Herault, France|CHD Vendee /ID# 165749, La Roche Sur Yon, France|Centre Hospitalier Universitaire de Nice - Hopital l'Archet 2 /ID# 152608, Nice, France|CHU de Saint-Etienne, Hopital Nord /ID# 165756, SAINT-ETIENNE Cedex 1, France|Universitatsklinikum Mannheim /ID# 150405, Mannheim, Baden-Wuerttemberg, Germany|Universitaetsklinikum Tuebingen /ID# 151698, Tübingen, Baden-Wuerttemberg, Germany|Universitatsklinikum Munster /ID# 150402, Munster, Niedersachsen, Germany|Gastroenterologische Gemeinschaftspraxis Herne /ID# 214575, Herne, Nordrhein-Westfalen, Germany|Zentrum für Gastroenterologie Saar MVZ GmbH /ID# 215812, Saarbrücken, Saarland, Germany|Universitaetsklinikum Schleswig-Holstein /ID# 161871, Kiel, Schleswig-Holstein, Germany|Praxis am Bayerischen Platz /ID# 151697, Berlin, Germany|Agaplesion Markus Krankenhaus /ID# 161870, Frankfurt, Germany|Medizinisches Versorgungszentrum Portal 10 /ID# 207136, Munster, Germany|Gastro Data Wiesbaden /ID# 150404, Wiesbaden, Germany|General Hospital of Athens Laiko /ID# 208672, Athens, Attiki, Greece|General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 150406, Athens, Greece|General Hospital of Chest Diseases of Athens SOTIRIA /ID# 202101, Athens, Greece|University General Hospital of Heraklion PA.G.N.I /ID# 150236, Heraklion, Greece|University General Hospital of Ioannina /ID# 164247, Ioannina, Greece|Theageneio Anticancer Hospital /ID# 164187, Thessaloniki, Greece|General Hospital of Thessaloniki Hippokrateio /ID# 209522, Thessaloniki, Greece|Markusovszky Egyetemi Oktatokorhaz /ID# 150410, Szombathely, Vas, Hungary|Bekes Megyei Kozponti Korhaz /ID# 151601, Bekescsaba, Hungary|Semmelweis Egyetem /ID# 150409, Budapest, Hungary|Meditres Kft. /ID# 151597, Kecskemet, Hungary|Soproni Erzsebet Oktato Korhaz es Rehabilitacios Intezet /ID# 151599, Sopron, Hungary|Mentahaz Maganorvosi Kozpont /ID# 206977, Szekesfehervar, Hungary|Mercy University Hospital /ID# 153794, Cork, Ireland|Trinity College Dublin - St. J /ID# 150413, Dublin, Ireland|St Vincent's University Hosp /ID# 150411, Dublin, Ireland|Beaumont Hospital /ID# 150414, Dublin, Ireland|Galway University Hospital /ID# 150412, Galway, Ireland|Hadassah Medical Center-Hebrew University /ID# 165119, Jerusalem, Yerushalayim, Israel|Soroka University Medical Center /ID# 156562, Be'er Sheva, Israel|Rambam Health Care Campus /ID# 150416, Haifa, Israel|Shaare Zedek Medical Center /ID# 163139, Jerusalem, Israel|A.O.U. Policlinico S.Orsola-Malpighi /ID# 150424, Bologna, Emilia-Romagna, Italy|UOSD - Azienda Ospedaliera San Camillo Forlanini /ID# 151362, Rome, Lazio, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 150421, Milan, Lombardia, Italy|ASST Rhodense /ID# 216673, Rho, Lombardia, Italy|IBD Center - IRCCS Istituto Clinico Humanitas /ID# 151363, Rozzano, Milano, Italy|A.O. Ospedali Riuniti Villa Sofia - Cervello /ID# 150263, Palermo, Sicilia, Italy|Ospedale Classificato Equiparato Sacro Cuore-Don Calabria /ID# 201726, Negrar, Verona, Italy|ASST Fatebenefratelli Sacco - Ospedale Fatebenefratelli e Oftalmico /ID# 150605, Milano, Italy|Policlinico Tor Vergata /ID# 150425, Rome, Italy|Complesso integrato Columbus /ID# 150420, Rome, Italy|Aichi Medical University Hospital /ID# 151994, Nagakute-shi, Aichi, Japan|Nagoya University Hospital /ID# 152728, Nagoya-shi, Aichi, Japan|Nagoya City University Hospital /ID# 151949, Nagoya-shi, Aichi, Japan|Toyohashi Municipal Hospital /ID# 171470, Toyohashi-shi, Aichi, Japan|Ieda Hospital /ID# 157782, Toyota-shi, Aichi, Japan|Hirosaki National Hospital /ID# 152761, Hirosaki-shi, Aomori, Japan|Tokatsutsujinaka Hospital /ID# 214964, Abiko-shi, Chiba, Japan|Toho University Sakura Medical Center /ID# 151935, Sakura-shi, Chiba, Japan|Juntendo University Urayasu Hospital /ID# 208783, Urayasu-shi, Chiba, Japan|Fukui Prefectural Hospital /ID# 210450, Fukui-shi, Fukui, Japan|Fukuoka University Chikushi Hospital /ID# 152627, Chikushino-shi, Fukuoka, Japan|Saiseikai Fukuoka Genaral Hospital /ID# 209481, Fukuoka-shi, Fukuoka, Japan|Kyushu University Hospital /ID# 152525, Fukuoka-shi, Fukuoka, Japan|Kurume University Hospital /ID# 151977, Kurume-shi, Fukuoka, Japan|Ogaki Municipal Hospital /ID# 208226, Ogaki-shi, Gifu, Japan|NHO Fukuyama Medical Center /ID# 206294, Fukuyama-shi, Hiroshima, Japan|Hiroshima University Hospital /ID# 151952, Hiroshima-shi, Hiroshima, Japan|Asahikawa Medical University Hospital /ID# 170281, Asahikawa-shi, Hokkaido, Japan|Obihiro kosei Hospital /ID# 210425, Obihiro-shi, Hokkaido, Japan|Sapporo Tokushukai Hospital /ID# 209449, Sapporo-shi, Hokkaido, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital /ID# 151705, Sapporo-shi, Hokkaido, Japan|Sapporo Medical University Hospital /ID# 206493, Sapporo-shi, Hokkaido, Japan|Sapporo Higashi Tokushukai Hospital /ID# 208495, Sapporo-shi, Hokkaido, Japan|Aoyama Clinic /ID# 152048, Kobe-shi, Hyogo, Japan|Hyogo College of Medicine College Hospital /Id# 152433, Nishinomiya-shi, Hyogo, Japan|National Hospital Organization Mito Medical Center /ID# 152626, Higashi Ibaraki-gun, Ibaraki, Japan|Kanazawa University Hospital /ID# 207810, Kanazawa-shi, Ishikawa, Japan|Iwate Medical University Uchimaru Medical Center /ID# 203412, Morioka-shi, Iwate, Japan|Idzuro Imamura Hospital /ID# 207640, Kagoshima-shi, Kagoshima, Japan|Sameshima Hospital /ID# 206673, Kagoshima-shi, Kagoshima, Japan|St. Marianna University School of Medicine Hospital /ID# 209452, Kawasaki-shi, Kanagawa, Japan|Showa University Fujigaoka Hospital /ID# 208223, Yokohama-shi, Kanagawa, Japan|Yokohama City University Medical Center /ID# 169900, Yokohama-shi, Kanagawa, Japan|Japanese Red Cross Kyoto Daiichi Hosital /ID# 152358, Kyoto-shi, Kyoto, Japan|Kyoto University Hospital /ID# 211808, Kyoto-shi, Kyoto, Japan|Mie University Hospital /ID# 207253, Tsu-shi, Mie, Japan|Yokkaichi Hazu Hazu Medical Center /ID# 214349, Yokkaichi-shi, Mie, Japan|National Hospital Organization Sendai Medical Center /ID# 209529, Sendai-shi, Miyagi, Japan|NHO Nagasaki Medical Center /ID# 210821, Omura-shi, Nagasaki, Japan|Kenseikai Dongo Hospital /ID# 208102, Yamatotakada-shi, Nara, Japan|Saiseikai Niigata Hospital /ID# 209923, Niigata-shi, Niigata, Japan|Niigata University Medical & Dental Hospital /ID# 218050, Niigata-shi, Niigata, Japan|Ishida Clinic of IBD and Gastroenterology /ID# 210118, Oita-shi, Oita, Japan|Chikuba Hospital for Proctological and Gastrointestinal Diseases /ID# 157820, Kurashiki-shi, Okayama, Japan|Okayama University Hospital /ID# 217924, Okayama-shi, Okayama, Japan|Kinshukai Infusion Clinic /ID# 207866, Osaka-shi, Osaka, Japan|Osaka City General Hospital /ID# 152703, Osaka-shi, Osaka, Japan|Japanese Red Cross Osaka Hospital /ID# 209477, Osaka-shi, Osaka, Japan|Osaka City University Hospital /ID# 152681, Osaka-shi, Osaka, Japan|Toyonaka Municipal Hospital /ID# 217083, Toyonaka-shi, Osaka, Japan|Saga University Hospital /ID# 209272, Saga-shi, Saga, Japan|Saitama Medical Center /ID# 152019, Kawagoe-shi, Saitama, Japan|Tokitokai Tokito clinic /ID# 152676, Saitama-shi, Saitama, Japan|National Hospital Organization Higashi-Ohmi General Medical Center /ID# 210711, Higashi-ohmi-shi, Shiga, Japan|Hamamatsu University Hospital /ID# 205709, Hamamatsu-shi, Shizuoka, Japan|NHO Shizuoka Medical Center /ID# 163571, Sunto-gun, Shizuoka, Japan|Tokyo Medical And Dental University, Medical Hospital /ID# 152017, Bunkyo-ku, Tokyo, Japan|St.Luke's International Hospital /ID# 208075, Chuo-ku, Tokyo, Japan|Tokai University Hachioji Hospital /ID# 152584, Hachioji-shi, Tokyo, Japan|Teikyo University Hospital /ID# 209865, Itabashi-ku, Tokyo, Japan|Kitasato University Kitasato Institute Hospital /ID# 152687, Minato-ku, Tokyo, Japan|Kyorin University Hospital /ID# 153195, Mitaka-shi, Tokyo, Japan|Center Hospital of the National Center for Global Health and Medicine /ID# 209533, Shinjuku-ku, Tokyo, Japan|Tokyo Women's Medical University Hospital /ID# 205978, Shinjuku-ku, Tokyo, Japan|Yamagata University Hospital /ID# 171468, Yamagata-shi, Yamagata, Japan|Tokuyama Central Hospital /ID# 216995, Shunan-shi, Yamaguchi, Japan|Yamanashi Prefectural Central Hospital /ID# 151909, Kofu-shi, Yamanashi, Japan|Shimane University School of Medicine /ID# 208906, Izumo, Japan|Tsujinaka Hospital Kashiwanoha /ID# 209572, Kashiwa, Japan|Kitakyushu Municipal Med Ctr /ID# 152589, Kitakyushu, Japan|Kitano Hospital /ID# 210396, Osaka, Japan|Fujita Gastroenterological Hos /ID# 216494, Takatsuki-shi, Japan|Dong-A University Hospital /ID# 161568, Busan, Busan Gwang Yeogsi, Korea, Republic of|Pusan National University Hosp /ID# 161569, Busan, Busan Gwang Yeogsi, Korea, Republic of|Yeungnam University Med Ctr /ID# 150432, Daegu, Daegu Gwang Yeogsi, Korea, Republic of|The Catholic University of Korea St. Vincent's Hospital /ID# 150434, Suwon, Gyeonggido, Korea, Republic of|Kangbuk Samsung Hospital /ID# 150435, Jongno-Gu, Seoul Teugbyeolsi, Korea, Republic of|Severance Hospital /ID# 161566, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Samsung Medical Center /ID# 150433, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Hanyang University Guri Hosp /ID# 150431, Guri-si, Korea, Republic of|CHA Bundang Medical Center /ID# 161567, Seongnam, Korea, Republic of|Asan Medical Center /ID# 159155, Seoul, Korea, Republic of|Riga East Clinical Univ Hosp /ID# 150436, Riga, Latvia|P. Stradins Clinical Univ Hosp /ID# 153183, Riga, Latvia|Hospital of Lithuanian University of Health Sciences Kaunas Clinics /ID# 150439, Kovno, Kaunas, Lithuania|Klaipeda University Hospital /ID# 163719, Klaipeda, Lithuania|Klaipeda Seamens Hospital /ID# 163501, Klaipeda, Lithuania|Vilnius University Hospital /ID# 164172, Vilnius, Lithuania|Hospital Sultanah Bahiyah /ID# 152310, Alor Setar, Kedah, Malaysia|UKM Medical Centre /ID# 152313, Kuala Lumpur, Selangor, Malaysia|Hospital Ampang /ID# 152311, Ampang, Selangor, Malaysia|Uni Malaya MC /ID# 150440, Kuala Lumpur, Malaysia|Morales Vargas Centro de Investigacion S.C. /ID# 211327, Leon, Guanajuato, Mexico|Clinica de Investigacion en Reumatologia y Obesidad S.C. /ID# 202334, Guadalajara, Jalisco, Mexico|Centro Regiomontano de Estudios Clínicos ROMA S.C /ID# 150265, Monterrey, Nuevo Leon, Mexico|Radboud Universitair Medisch Centrum /ID# 151701, Nijmegen, Gelderland, Netherlands|Academisch Medical center Amsterdam /ID# 150617, Amsterdam, Noord-Holland, Netherlands|Leids Universitair Medisch Centrum /ID# 152625, Leiden, Netherlands|Erasmus Medisch Centrum /ID# 150619, Rotterdam, Netherlands|Universitair Medisch Centrum Utrecht /ID# 152776, Utrecht, Netherlands|Akershus Universitetssykehus_MAIN /ID# 150622, Lorenskog, Akershus, Norway|Universitetssykehuset Nord-Norge /ID# 152836, Tromsø, Troms, Norway|Centrum Zdrowia MDM /ID# 150626, Warsaw, Mazowieckie, Poland|Instytut Pomnik - Centrum Zdrowia Dziecka /ID# 215733, Warsaw, Mazowieckie, Poland|Centralny Szpital Kliniczny MSWiA w Warszawie /ID# 150627, Warszawa, Mazowieckie, Poland|Endoskopia Sp. z o.o. /ID# 152940, Sopot, Pomorskie, Poland|Gastromed /Id# 216198, Toruń, Poland|Reumatika - Centrum Reumatologii NZOZ /ID# 150624, Warsaw, Poland|NZOZ Vivamed /ID# 216743, Warsaw, Poland|Hospital Senhora da Oliveira de Guimaraes, EPE /ID# 151616, Guimaraes, Braga, Portugal|Centro Hosp de Lisboa Central /ID# 151620, Lisbon, Lisboa, Portugal|Hospital Garcia de Orta, E.P.E /ID# 151622, Almada, Setubal, Portugal|CCA Braga - Hospital de Braga /ID# 151617, Braga, Portugal|Centro Hospitalar Lisboa Norte, EPE /ID# 151615, Lisboa, Portugal|Centro Hospitalar de Sao Joao, EPE /ID# 151619, Porto, Portugal|Centro Hospitalar de Entre o D /ID# 152336, Santa Maria Da Feira, Portugal|Unidade Local De Saude Do Alto Minho /ID# 151618, Viana Do Castelo, Portugal|School of Medicine University of Puerto Rico-Medical Science Campus /ID# 150629, San Juan, Puerto Rico|Immanuel Kant Baltic Federal University /ID# 202129, Kaliningrad, Kaliningradskaya Oblast, Russian Federation|NW State Medical Univ na Mechn /ID# 169332, St. Petersburg, Leningradskaya Oblast, Russian Federation|Perm Clinical Center of FMBA /ID# 150634, Perm, Permskiy Kray, Russian Federation|LLC Medical Company Hepatolog /ID# 200208, Samara, Samarskaya Oblast, Russian Federation|LLC Novaya Klinika /ID# 208106, Pyatigorsk, Stavropol Skiy Kray, Russian Federation|Kazan State Medical University /ID# 166040, Kazan, Tatarstan, Respublika, Russian Federation|Llc Olla-Med /Id# 215334, Moscow, Russian Federation|City Clinical Hospital 24 /ID# 150638, Moscow, Russian Federation|Republican Clin Hos n.a. Baran /ID# 206508, Petrozavodsk, Russian Federation|PMI Euromedservice /ID# 208968, Pushkin, Russian Federation|Stavropol State Medical Univ /ID# 150635, Stavropol, Russian Federation|Clinical Center Serbia /ID# 150642, Belgrade, Beograd, Serbia|Clinical Hosp Center Zvezdara /ID# 150641, Belgrade, Beograd, Serbia|Military Medical Academy /ID# 150643, Belgrade, Beograd, Serbia|Clin Hosp Ctr Bezanijska Kosa /ID# 150640, Belgrade, Beograd, Serbia|Clinical Center of Nis /ID# 151902, NIS, Nisavski Okrug, Serbia|Clinical Center Kragujevac /ID# 150644, Kragujevac, Sumadijski Okrug, Serbia|Clinical Center Vojvodina /ID# 150759, Novi Sad, Vojvodina, Serbia|General Hospital Leskovac /ID# 217882, Leskovac, Serbia|National University Hospital /ID# 150583, Singapore, Singapore|Gleneagles Medical Centre /ID# 206020, Singapore, Singapore|Tan Tock Seng Hospital /ID# 150646, Singapore, Singapore|Medak s.r.o., gastroenterologi /ID# 150550, Bratislava, Bratislavsky Kraj, Slovakia|Fakultna nemocnica s poliklinikou F.D. Roosevelta Banska Bystrica /ID# 150869, Banska Bystrica, Slovakia|Slovak Research Center Team Me /ID# 150240, Ilava, Slovakia|B and B MED s.r.o. /ID# 150584, Kosice, Slovakia|Fakultna nemocnica s poliklini /ID# 211371, Nove Zamky, Slovakia|Gastro I.S.R.O. /ID# 150585, Presov, Slovakia|Clinresco Centres /ID# 163625, Johannesburg, Gauteng, South Africa|Lenasia Clinical Trial Centre /ID# 214361, Johannesburg, Gauteng, South Africa|Wits Health Consortium (Pty) Ltd /ID# 157730, Johannesburg, Gauteng, South Africa|Wits Clinical Research Site /ID# 150586, Johannesburg, Gauteng, South Africa|Mediclinic Milnerton /ID# 162203, CAPE TOWN,Milnerton, Western Cape, South Africa|Kingsbury Hospital /ID# 150587, Cape Town, Western Cape, South Africa|Mediclinic Constantiaberg /ID# 155145, Cape Town, Western Cape, South Africa|MD Search /ID# 157524, Boksburg North, South Africa|Hospital Universitario A Coruña - CHUAC /ID# 203912, A Coruña, A Coruna, Spain|Hospital Clínico Universitario de Santiago-CHUS /ID# 171492, Santiago de Compostela, A Coruna, Spain|Hospital Unversitario Marques de Valdecilla /ID# 216621, Santander, Cantabria, Spain|Hospital Clinic /ID# 150598, Barcelona, Spain|Hospital Universitario Reina Sofia /ID# 154031, Cordoba, Spain|Hospital Universitario Dr. Negrin /ID# 203965, Las Palmas de Gran Canaria, Spain|Hospital Universitario Ramon y Cajal /ID# 171491, Madrid, Spain|Hospital Universitario La Paz /ID# 214541, Madrid, Spain|Hospital Clinico Universitario de Salamanca /ID# 150590, Salamanca, Spain|Hospital Universitario y Politecnico La Fe /ID# 150591, Valencia, Spain|Sahlgrenska University Hosp /ID# 152326, Goteborg, Sweden|Kantonsspital St. Gallen /ID# 152601, St. Gallen, Sankt Gallen, Switzerland|Universitaetsspital Zuerich /ID# 152603, Zurich, Zuerich, Switzerland|Universitaetsspital Basel /ID# 161732, Basel, Switzerland|Inselspital, Universitaetsklinik /ID# 152602, Bern, Switzerland|China Medical University Hosp /ID# 150600, Taichung City, Taichung, Taiwan|National Cheng Kung University Hospital /ID# 151751, Tainan City, Tainan, Taiwan|National Taiwan University Hospital /ID# 150604, Taipei City, Taipei, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 150606, Kaohsiung, Taiwan|Chung Shan Medical University /ID# 150603, Taichung City, Taiwan|Taipei Veterans General Hosp /ID# 151750, Taipei City, Taiwan|Erciyes University Medical Fac /ID# 150495, Melikgazi, Kayseri, Turkey|Gazi Universitesi Tip Fakultes /ID# 150493, Ankara, Turkey|Istanbul University Cerrahpasa Faculty of Medicine /ID# 150491, Cerrahpasa, Turkey|Umraniye Training and Res Hosp /ID# 163136, Istanbul, Turkey|Marmara University Medical Fac /ID# 214573, Istanbul, Turkey|Mersin University Medical /ID# 163135, Mersin, Turkey|Communal Non-Commercial Enterprize of Kharkiv Regional Council Regional Clinical /ID# 206941, Kharkiv, Kharkivska Oblast, Ukraine|Kyiv Regional Hospital /ID# 217374, Київ, Kyivska Oblast, Ukraine|Kyiv Municipal Clinical Hospital #18 /ID# 150505, Kiev, Kyiv, Ukraine|Medical Center of the ""Health /ID# 162501, Vinnytsya, Vinnytska Oblast, Ukraine|Regional Clin Hosp Mechnykov /ID# 207731, Dnipro, Ukraine|PE PMC Acinus, Medical and Diagnostic Center /ID# 217219, Kropyvnytskyi, Ukraine|Medical centre of CONSILIUM MEDICAL LLC /ID# 217448, Kyiv, Ukraine|Lviv Regional Clinical Hospita /ID# 150508, Lviv, Ukraine|MNI Odesa Regional Clinical Hospital of ORC /ID# 162502, Odesa, Ukraine|Vinnytsia Regional Clinical Hospital n.a. M.I.Pyrogov /ID# 216302, Vinnytsia, Ukraine|RD&E Hospital /ID# 150510, Exeter, Devon, United Kingdom|Queen Elizabeth University Hos /ID# 163788, Glasgow, Glasgow City, United Kingdom|The Royal London Hospital /ID# 150515, London, London, City Of, United Kingdom|Basingstoke & North Hampshire /ID# 150511, Basingstoke, United Kingdom|Royal United Hospitals Bath /ID# 154211, Bath, United Kingdom|Univ Hospitals Birmingham NHS Foundation trust /ID# 150513, Birmingham, United Kingdom|Huddersfield Royal Infirmary /ID# 217659, Huddersfield, United Kingdom|St. George's Healthcare NHS /ID# 208376, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03006068"
883,"NCT02925338","National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life","ReFLECT","Recruiting","No Results Available","Crohn Desease|Ulcerative Colitis|Rheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis","Other: QOL questionaire","Percent of patients without treatment failure during the 2 year follow-up period|Average time between diagnosis and inclusion.|• Average Duration of previous biotherapies|Mean weight of patients enrolled|Mean age of patients enrolled|Average time between diagnosis and 1st Inflectra infusion|Mean dose administered (in mg)|Cumulative dose (mg)|Mean infusion time (minutes)|Mean post-infusion monitoring time at hospital (minutes)|Mean time between infusions (weeks)|Absolute variation of mean global disease assessment compared with baseline|Absolute variation of mean fatigue score compared with baseline|Absolute variation of mean of each activity index score compared with baseline|Absolute variation of endoscopic score compared with baseline","Pfizer","All","6 Years and older   (Child, Adult, Older Adult)",,"1200","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","C1231004|REFLECT","October 19, 2016","September 1, 2021","September 1, 2021","October 5, 2016",,"November 25, 2020","Hopitaux Universitaires de Strasbourg - Hopital de Hautepierre, Strasbourg, Alsace, France|Service de rhumatologie - CHU Nantes, Hopital Hotel Dieu, Nantes cedex 1, Loire-atlantique, France|Centre Hospitalier Universitaire Gabriel Montpied, Clermont Ferrand Cedex, Puy-de-dôme, France|Centre Hospitalier du Pays d'Aix, Aix En Provence, France|Chi Aix Pertuis, Aix-En-Provence, France|Centre Hospitalier de la Cote Basque, Bayonne, France|Centre Hospitalier Regional de Besancon, Service de Gastrologie, Besancon, France|CHU Jean Minjoz, Besancon, France|Centre Hospitalier Universitaire de Bordeaux - Hopital Pellegrin, Bordeaux Cedex, France|Hopital Saint Andre - Chu Bordeaux, Bordeaux, France|CHU - Hôpital Pellegrin-tripode, Bordeaux, France|Clinique Jean Vila, Bruges, France|Polyclinique Jean Vilar, Bruges, France|Clinique Jean Vilar, Bruges, France|Centre Hospitalier Universitaire (CHU) de Caen - Hopital Cote de Nacre, Caen, France|Ch de Cannes Hopital Pierre Nouveau, Cannes Cedex, France|Centre Hospitalier de Cannes Hopital Pierre Nouveau, Cannes, France|Centre Hospitalier de Cannes, Cannes, France|Centre Hospitalier Carcassonne, Service de Rhumatologie, Carcassonne, France|Centre Hospitalier de Cholet Service d'Hépato-Gastro-Entérologie, Cholet, France|Centre Hospitalier de Cholet, Cholet, France|Hopital d'Estaing, Clermont Ferrand Cedex, France|Centre Hospitalier Estaing, Service de Medicine Interne, Clermont Ferrand, France|Hopital Beaujon, Clichy, France|Hopital Beaujon, Clichy, France|Hopital Louis Mourier, Service d'Hepato-Gastroenterologie, Colombes Cedex, France|Centre Hospitalier, Contamine Sur Avre, France|Chu Henri Mondor, Creteil, France|Hôpital Henri Mondor, Créteil, France|CHU de Grenoble - Hopital Sud, Echirolles, France|Hopital Nord, GRENOBLE Cedex 9, France|CHU De Grenoble, Grenoble, France|CHD Vendee, La Roche Sur Yon, France|CHD Vendee, La Roche Sur Yon, France|Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, France|CHU Grenoble Alpes, La Tronche, France|CHU Grenoble Alpes, La Tronche, France|Centre Hospitalier de Lille Hopital Roger Salengro, Lille, France|CHU Limoges - Hôpital Dupuytren, Limoges, France|Hospital Huriez, CHRU de Lille, Little Cedex, France|Hopital Saint Philibert, Lomme, France|Centre Hospitalier Saint Philibert, Lomme, France|Hôpital Edouard HERRIOT- Hospices Civils de Lyon, Lyon Cedex 03, France|Hopital Edouard Herriot Pav H, Lyon, France|Centre Hospitalier, Metz Tessy, France|CHG Montauban, Montauban Cedex, France|Groupe Hospitalier du Havre, Montivilliers, France|Centre Hospitalier de Montpellier Hopital Saint Eloi, Montpellier, France|CHU de Montpellier - Saint Eloi, Montpellier, France|CHU de MONTPELLIER HOPITAL LAPEYRONIE, Montpellier, France|CHU, Montpellier, France|Hopital Lapeyronie, Montpellier, France|CHU Nice-Hopital Archet I, Nice Cedex 3, France|Hopital de l'Archet, NICE Cedex 3, France|CHU Nimes, Nimes, France|Hopital Claude Bichat, Paris Cedex 18, France|Hopital Cochin, Paris, France|Hôpital Cochin, Paris, France|Hôpital Haut-Lévêque, Pessac Cedex, France|Hopital Lyon Sud, Pierre Benite Cedex, France|Centre Hospitalier Lyon-Sud, Pierre Benite, France|Hopital Robert Debre, Service d'Hepato-gastro-enterologie et de Cancerologie Digestive, Reims cedex, France|Hopital Robert Debre, Service D'Hepato-gastro-enterolo, Reims CEDEX, France|CHU de Rouen, Rouen, France|CHRU Charles Nicolle, Rouen, France|Hopital Charles Nicolle, Rouen, France|Service Rhumatologie, Saint Etienne, France|Centre Hospitalier Universitaire (CHU) de Saint-Etienne - Hopital Nord, St. Priest En Jarez, France|Hopital de Hautepierre, Strasbourg, France|Fondation Maison Sante Bagatelle, Gastro Enterologie, Talence Cedex, France|Centre Hospitalier de la Gespe, Tarbes, France|Hopital du Leman, Thonon les Bains, France|Hopitaux du Leman, Thonon Les Bains, France|Hopital Rangueil, Toulouse cedex 04, France|Hopital Purpan, Toulouse Cedex 09, France|CHU de Rangueil, Toulouse, France|Hopital Purpan, Toulouse, France|Hopital des Hauts Clos, Troyes, France|Chu Brabois, Vandoeuvre Les Nancy, France|Hopital Saint Nicolas, Vitre, France",,"https://ClinicalTrials.gov/show/NCT02925338"
884,"NCT02922881","Microbiota-targeted Diet for Pediatric UC","UCD","Recruiting","No Results Available","Ulcerative Colitis","Other: Ulcerative Colitis Diet (UCD)","Clinical Remission|Dietary Compliance|Change in C-reactive protein (CRP) between baseline and week 12|Change in erythrocyte sedimentation rate (ESR) between baseline and week 12|Change in fecal calprotectin (FCP) between baseline and week 12|Microbial composition of the gastrointestinal tract","Children's Hospital of Philadelphia|Wolfson Medical Center|IWK Health Centre|National Institutes of Health (NIH)","All","8 Years to 19 Years   (Child, Adult)","Not Applicable","15","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","16-013075","March 8, 2017","November 2021","November 2021","October 4, 2016",,"January 6, 2021","The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT02922881"
885,"NCT02921555","Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis","CECUM","Recruiting","No Results Available","Ulcerative Colitis","Drug: Methylprednisolone|Drug: Prednisone","Clinical Remission|Clinical response|Biological response|Rate of adverse events|Rate of serious adverse events|Proportion of patients with clinical recurrence|Time to clinical relapse|Risk of hospitalization|Time to corticodependency|Number of participants with surgery events|Proportion of patients with corticodependency criteria","Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa","All","18 Years and older   (Adult, Older Adult)","Phase 4","148","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","CECUM","October 11, 2018","January 31, 2022","October 31, 2023","October 3, 2016",,"November 5, 2020","Complejo Hospitalario Universitario Santiago de Compostela, Santiago de Compostela, A Coruña, Spain|Hospital Universitario Central de Asturias, Oviedo, Astúrias, Spain|Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain|Althaia, xarxa assistencial universitaria de Manresa, Manresa, Barcelona, Spain|Consorci Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain|Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain|Consorci Hospitalari de Terrassa, Terrassa, Barcelona, Spain|Hospital de Galdakao, Galdakao, Bilbao, Spain|Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain|hospital Puerta de Hierro-Majadahonda, Majadahonda, Madrid, Spain|Hospital Universitario de Ourense, Orense, Ourense, Spain|Hospital Álvaro Cunqueiro, Vigo, Pontevedra, Spain|Hospital Universitario Cruces, Baracaldo, Vizcaya, Spain|Hospital General Universitario de Alicante, Alicante, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Universitario Reina Sofia, Córdoba, Spain|Hospital Universitari Dr. Josep Trueta, Girona, Spain|Hospital De La Princesa, Madrid, Spain|Hospital Gregorio Marañon, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Mútua de Terrassa, Terrassa, Spain|Hospital Clínico de Valencia, Valencia, Spain|Hospital Universitario General de Valencia, Valencia, Spain|Hospital de Manises, Valencia, Spain|Hospital Universitari La Fe, Valencia, Spain|Hospital Universitario Clinico de Valladolid, Valladolid, Spain|Hospital Universitario Río Hortega, Valladolid, Spain|Hospital clínico Universitario Lozano Blesa, Zaragoza, Spain",,"https://ClinicalTrials.gov/show/NCT02921555"
886,"NCT02914535","Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis","SELECTIONLTE","Active, not recruiting","No Results Available","Ulcerative Colitis","Drug: Filgotinib|Drug: Placebo","Overall Safety Profile of Filgotinib Evaluated by Proportion of Participants Experiencing Adverse Events and Abnormal Clinical Laboratory Tests|Change From Baseline in Components of Mayo Clinic Score (MCS)","Gilead Sciences|Galapagos NV","All","18 Years and older   (Adult, Older Adult)","Phase 3","1173","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","GS-US-418-3899|2016-002765-58","February 23, 2017","November 2023","December 2023","September 26, 2016",,"May 13, 2021","Digestive Health Specialists Of The Southeast, Dothan, Alabama, United States|Mayo Clinic Arizona, Scottsdale, Arizona, United States|VA Long Beach Healthcare System, Long Beach, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|South Denver Gastroenterology, PC, Lone Tree, Colorado, United States|Connecticut GI PC-Research Division, Farmington, Connecticut, United States|UF Clinical Research Center, Gainesville, Florida, United States|Florida Research Institute, Lakewood Ranch, Florida, United States|University of Miami Crohn's and Colitis Center, Miami, Florida, United States|Cordova Research Institute, Miami, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Florida Medical Clinic, P.A, Zephyrhills, Florida, United States|Gastroenterology Associates Of Central Georgia, LLC, Macon, Georgia, United States|Gastrointestinal Specialists of Georgia, Marietta, Georgia, United States|Atlanta Gastroenterology Specialist, PC, Suwanee, Georgia, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Louisville, Clinical Trials Unit, Louisville, Kentucky, United States|Delta Research Partners, LLC, Monroe, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Investigative Clinical Research, Annapolis, Maryland, United States|MGG Group Co., Inc., Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Gastro Center of Maryland, Columbia, Maryland, United States|Meritus Center for Clinical Research, Hagerstown, Maryland, United States|Massachusetts General Hospital - Crohn's and Colitis Center, Boston, Massachusetts, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, United States|Center for Digestive Health Research, Troy, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Kansas City Research Institute, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|NY Scientific, Brooklyn, New York, United States|NYU Langone Long Island Clinical Research Associates, Great Neck, New York, United States|Carolina's GI Research LLC, Raleigh, North Carolina, United States|Fargo Gastroenterology and Hepatology Clinic, Fargo, North Dakota, United States|Consultants for Clinical Research, Cincinnati, Ohio, United States|UC Health Physicians Clifton, Cincinnati, Ohio, United States|Great Lakes Gastroenterology Research, LLC, Mentor, Ohio, United States|Gastroenterology Associates of Orangeburg, Orangeburg, South Carolina, United States|Rapid City Medical Center, Rapid City, South Dakota, United States|Gastro One, Germantown, Tennessee, United States|Quality Medical Research, Nashville, Tennessee, United States|Vanderbilt University Medical Center - IBD Clinic, Nashville, Tennessee, United States|San Antonio Military Medical Center, Fort Sam Houston, Texas, United States|DHAT Research Institute, Garland, Texas, United States|Baylor College of Medicine - Baylor Medical Center, Houston, Texas, United States|The University of Texas Health Science Center at Houston, Houston, Texas, United States|Clinical Associates in Research Therapeutics of America, LLC, San Antonio, Texas, United States|Gastroenterology Research of San Antonio, San Antonio, Texas, United States|TDDC San Marcos, San Marcos, Texas, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|Spring Gastroenterology, The Woodlands, Texas, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Gastroenterology Associates of Tidewater, Chesapeake, Virginia, United States|McGuire DVAMC, Richmond, Virginia, United States|University of Wisconsin Hospital & Clinics, Madison, Wisconsin, United States|Allegiance Research Specialists, LLC, Wauwatosa, Wisconsin, United States|Instituto de Investigaciones Clinicas Mar del Plata, Mar del Plata, Argentina|Instituto Médico Cer, Quilmes, Argentina|Monash Medical Centre, Clayton, New South Wales, Australia|St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|Coastal Digestive Health, Mountain Creek, Queensland, Australia|Mater Misericordiae Ltd, South Brisbane, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|The Queen Elizabeth Hospital, Woodville South, South Australia, Australia|Footscray Hospital, Footscray, Victoria, Australia|Cabrini Hospital, Malvern, Victoria, Australia|Alfred Hospital, Melbourne, Victoria, Australia|Universitatsklinik Innsbruck, Innsbruck, Austria|AKH-Medizinische Universitat Wien, Wien, Austria|GZA Ziekenhuizen, campus Sint-Vincentius, Antwerpen, Belgium|CUB Hopital Erasme, Brussel, Belgium|Universitair Ziekenhuis Leuven, Leuven, Belgium|Centre Hospitalier Chretien (CHC) - Clinique Saint-Joseph, Liège, Belgium|MHAT Sveti Pantaleymon- Pleven OOD, Pleven, Bulgaria|""MDHAT Dr. St.Cherkezov"" AD, Veliko Tarnovo, Bulgaria|MHAT ""Sveta Petka"" AD, Vidin, Bulgaria|University of Calgary, Heritage Medical Research Clinic, Calgary, Alberta, Canada|The Gordon and Leslie Diamond Health Care Centre, Vancouver, British Columbia, Canada|Hamilton Health Sciences Corporation, McMaster University Medical Centre, Hamilton, Ontario, Canada|Toronto Digestive Disease Associates Inc., Vaughan, Ontario, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada|Clinical Hospital Dubrava, Zagreb, Croatia|University Hospital Center Zagreb, Zagreb, Croatia|Hepato-Gastroenterology HK, s.r.o., Hradec Kralove, Czechia|Oblastni nemocnice Mlada Boleslav, a.s., nemocnice Stredoceskeho kraje, Gastroenterologicke oddeleni, Mlada Boleslav, Czechia|G.E.P. Clinic, s r.o., Praha 3, Czechia|ISCARE a.s. (Klinicke centrum ISCARE), Klinicke a vyzkumne centrum pro strevni zanety, Praha 9, Czechia|CHU Amiens Picardie, Amiens Cedex 1, France|CHU de Caen, Caen Cedex 9, France|CHU de Clermont-Ferrand - Hopital d'Estaing, Clermont-Ferrand, France|APHP - Hopital Beaujon - Clichy - Universite Paris VII, Clichy, France|CHU de Dijon Bourgogne - Hopital Francois Mitterand, Dijon, France|CHU Grenoble Alpes, La Tronche, France|Hopital Universitaire de Bicetre, Le Kremlin Bicetre, France|Centre Hospitalier Regional Universitaire de Lille, Lille, France|Hopital Nord, Marseille, France|CHU de Montpellier-Hopital Saint Eloi, Montpellier, France|CHU Hotel-Dieu, Nantes, France|Hopital de l'Archet 2, Nice, France|CHU de Bordeaux - Hopital Haut Leveque, Pessac, France|Centre Hospitalier Universitaire de Lyon Sud, Pierre-Benite, France|Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes Cedex 9, France|CHU de Saint Etienne - Hopital Nord, Saint Priest en Jarez, France|CHU de Toulouse - Hopital Rangueil, Toulouse, France|CHU de Nancy - Hopital Brabois Adultes, Vandoeuvre Les Nancy, France|Unimed Ajara LLC - Batumi Referral Hospital, Batumi, Georgia|Medi Club Georgia LLC, Tbilisi, Georgia|Universitatsklinikum Schleswig-Holstein, Kiel, Schleswig Holstein, Germany|Charite Universitaetsmedizin Berlin, Berlin, Germany|Charite - Universitatsmedizin Berlin, Berlin, Germany|DRK Kliniken Berlin - Westend - Klinik fuer Innere Medizin, Berlin, Germany|Stadtisches Klinikum Braunschweig gGmbH, Braunschweig, Germany|Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany|Universitatsklinikum Freiburg, Freiburg, Germany|Asklepios Westklinikum Hamburg, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Gastroenterologische Gemeinschaftspraxis Herne, Herne, Germany|Universitatsklinikum Jena, Jena, Germany|Universitaetsklinik Koln, Koln, Germany|EUGASTRO GmbH, Leipzig, Germany|Klinikum Luneburg, Lüneburg, Germany|Gastroenterologische Gemeinschaftspraxis Minden, Minden, Germany|Klinikum der Universitat Munchen - Grosshadern, Muenchen, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Germany|Universitatsklinikum Ulm, Zentrum Fur Innere Medizin, Ulm, Germany|General Hospital of Athens ""Hippokratio"", 2nd Internal Medicine Clinic of Athens University, Hepato-gastroenterology Unit, Athens, Greece|Princess Margaret Hospital, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong|Bekes Megyei Kosponti Korhaz, Dr. Rethy Pal Tagkorhaz, IV. Belgyogyaszat - 2. Gasztroenterologia, Bekescsaba, Hungary|Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Kozponti Felnott Szakrendelo, Budapest, Hungary|Szent Janos Korhaz es Eszak-budai Egitett Korhazak, I. Belgyogyaszati - Gasztroenterologiai Osztaly, Budapest, Hungary|Debreceni Egyetem Klinikai Kozpont, II. sz. Belgyogyaszati Klinika, Gasztroenterologia, Debrecen, Hungary|Bugat Pal Korhaz, Belgyogyaszat, Gyöngyös, Hungary|Karolina Korhaz es Rendelointezet, Altalanos Belgyogyaszat-Gasztroenterologia, Mosonmagyarovar, Hungary|Kaizen Hospital, Ahmedabad, India|M S Ramaiah Medical College and Hospital, Bangalore, India|Apollo Speciality Hospital, Chennai, India|VGM Hospital Institute of Gastroenterology, Coimbatore, India|Gleneagles Global Hospitals, Hyderabad, India|Citizens Specialty Hospital, Hyderabad, India|Centre for Liver Research & Diagnostics, Hyderabad, India|SR Kalla Memorial Gastro and General Hospital, Jaipur, India|S.M.S Medical College & Hospitals, Jaipur, India|Dayanand Medical College & Hospital, Ludhiana, India|Kasturba Medical College (KMC) Hospital, Mangaluru, India|Lokmanya Tilak Municipal General Hospital, Mumbai, India|Midas Multispeciality Hospital Pvt. Ltd, Nagpur, India|Suretech Hospital & Research Centre Ltd, Nagpur, India|Grant Medical Foundation Ruby Hall Clinic, Pune, India|Shree Giriraj Multispeciality Hospital, Rajkot, India|Gandhi Hospital, Secunderabad, India|Surat Institute of Digestive Sciences, Surat, India|Kasturba Hospital Medical College, Udupi, India|Sterling Hospital, Vadodara, India|Samvedna Hospital, Varanasi, India|Beaumont Hospital, Dublin, Ireland|Bnai Zion Medical Center, Haifa, Israel|Rambam Medical Health Care Campus, Haifa, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah Medical Center, Jerusalem, Israel|Rabin Medical Center, Petah Tikva, Israel|UOC Gastroenterologia II, Castellana Grotte, Italy|U.O. Fisiopatologia Digestiva, Catanzaro, Italy|Ospedale Clinicizzato SS. Annunziata - Dipartimento di Medicina, Chieti, Italy|Endocsopia Digestiva Centralizzata - ASST Fatebenefratelli Sacco, Ospedale Fatebenefratelli e Oftalmico, Milano, Italy|UOC Gastroenterologia, Padova, Italy|Azienda Ospedaliero-Universitaria Pisana - Presidio Ospedaliero Cisanello, Pisa, Italy|UOC Gastroenterologia ed Endoscopia Digestiva, Roma, Italy|Istituto Clinico Humanitas, Rozzano, Italy|Nagasaki University Hospital, Nagasaki-shi, Nagasaki, Japan|Osaka University Hospital, Suita, Osaka, Japan|Medical Hospital, Tokyo Medical and Dental University, Bunkyo-ku, Japan|Fukuoka University Chikushi Hospital, Chikushino-shi, Japan|Hokkaido P.W.F.A.C Sapporo-Kosei General Hospital, Chuo-ku, Japan|Japanese Red Cross Fukuoka Hospital, Fukuoka-shi, Japan|Tokai University Hachioji Hospital, Hachioji, Japan|Hiroshima University Hospital, Hiroshima, Japan|Fukuoka University Hospital, Jonan-ku, Japan|Ofuna Chuo Hospital, Kamakura, Japan|Kitakyushu City Hospital Organization Kitakyushu Municipal Medical Center, Kitakyushu-shi, Japan|Yamanashi Prefectural Central Hospital, Kofu-shi, Japan|Kurume University Hospital, Kurume-shi, Japan|Hidaka Coloproctology Clinic, Kurume-shi, Japan|University Hospital, Kyoto Prefectural University of Medicine, Kyoto-shi, Japan|The Jikei University Hospital, Minato-Ku, Japan|Kitasato University Kitasato Institute Hospital, Minato-ku, Japan|Kyorin University Hospital, Mitaka-shi, Japan|Iwate Medical University Hospital, Morioka-shi, Japan|Aichi Medical University Hospital, Nagakute-shi, Japan|Saiseikai Niigata Daini Hospital, Nishi-ku, Japan|Hyogo College of Medicine College Hospital, Nishinomiya, Japan|Ishida IBD Clinic, Oita-shi, Japan|Okayama University Hospital, Okayama-city, Japan|Kinshukai Infusion Clinic, Osaka, Japan|Osaka City University Hospital, Osaka, Japan|Wakakusa-Daiichi Hospital, Osaka, Japan|Shiga University of Medical Science Hospital, Otsu, Japan|Saga-Ken Medical Centre Koseikan, Saga-shi, Japan|Kitasato University Hospital,THE KITASATO INSTITUTE, Sagamihara, Japan|Saga University Hospital, Saga, Japan|Tokito Clinic, Saitama, Japan|Toho University Sakura Medical Center, Sakura, Japan|Sapporo Higashi Tokushukai Hospital, Sapporo-shi, Japan|National Hospital Organization Sendai Medical Center, Sendai, Japan|Tokyo Yamate Medical Center, Shinjuku-ku, Japan|Kagawa Prefectural Central Hospital, Takamatsu-shi, Japan|National Hospital Organization Takasaki General Medical Center, Takasaki-shi, Japan|Osaka Medical College Hospital, Takatsuki, Japan|Ieda Hospital, Toyota-shi, Japan|Wakayama Medical University Hospital, Wakayama-shi, Japan|Colo-proctology Center Matsushima Clinic, Yokohama-shi, Japan|The Catholic University of Korea, St. Vincent's Hospital, Suwon-si, Gyeonggi-do, Korea, Republic of|Pusan National University Hospital, Busan, Korea, Republic of|Yeungnam University Hospital, Daegu, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Seoul, Korea, Republic of|Kyung Hee University Hospital, Seoul, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wonju, Korea, Republic of|Hospital Pulau Pinang, George Town, Malaysia|Hospital Queen Elizabeth, Kota Kinabalu, Malaysia|PCR-Phylasis Clinicas Research S. de R.L. de C.V., Cuautitlán Izcalli, Mexico|Academic Medical Center (AMC), Amsterdam, Netherlands|Gelre Hospital, Apeldoorn, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands|Christchurch Hospital, Christchurch, New Zealand|Auckland City Hospital, Grafton, New Zealand|Wellington Hospital, Newtown, New Zealand|Bay of Plenty District Health Board - Tauranga Hospital, Tauranga, New Zealand|Uniwersytecki Szpital Kliniczny w Bialymstoku, Klinika Gastroenterologii i Chorob Wewnetrznych, Bialystok, Poland|VITAMED Galaj i Cichomski spólka jawna, Bydgoszcz, Poland|Gabinet Lekarski Janusz Rudzinski, Bydgoszcz, Poland|NZOZ INTER-MED, Centrum Endoskopowe, Czestochowa, Poland|Niepubliczny Zaklad Opieki Zdrowotnej ALL-MEDICUS, Katowice, Poland|Gabinet Endoskopii Przewodu Pokarmowego, Krakow, Poland|Krakowskie Centrum Medyczne Sp. z o.o, Kraków, Poland|Centrum Opieki Zdrowotnej Orkan-Med Stec-Michalska Sp. J., Ksawerów, Poland|Santa Familia, Centrum Badan, Profilaktyki i Leczenia, Lodz, Poland|Centrum Innowacyjnych Terapii Sp. z o.o., Piaseczno, Poland|Clinical Research Center Spolka z ograniczna odpowiedzialnoscia Medic-R Sp. k., Poznan, Poland|Gabinet Lekarski Dr. Hab. N. Med. Bartosz Korczowski, Rzeszów, Poland|Endoskopia Sp. z o.o., Sopot, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|GASTROMED Kopon, Zmudzinski i Wspolnicy Sp. j. Specjalistyczne Centrum Gastrologii i Endoskopii, Torun, Poland|H-T.Centrum Medyczne Spolka z Ograniczona Odpowiedzialnoscia Sp.K., Tychy, Poland|Centrum Zdrowia MDM, Warszawa, Poland|Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych i Administacji w Warszawie, Warszawa, Poland|Niepubliczny Zaklad Opieki Zrodotnej VIVAMED Jadwige Miecz, Warszawa, Poland|Bodyclinic, Warszawa, Poland|Centrum Medyczne Oporow, Wroclaw, Poland|Hospital da Senhora da Oliveira Guimaraes, E.P.E., Guimaraes, Portugal|Centro Hospitalar de Sao Joao, EPE, Porto, Portugal|MedLife, Gastroenterologie, Bucuresti, Romania|Spitalul Clinic Colentina - Sectia de Spitulal Clinic Colentina, Gastroenterologie, Bucuresti, Romania|Cabinet Medical Individual Dr Tirnaveanue Amelita, Gastroenterologie, Oradea, Romania|Cabinet Particular Policlinic Algomed SRL, Timisoara, Romania|State Budgetary Healthcare Institution ""Chelyabinski Regional Clinical Hospital"", Chelyabinsk, Russian Federation|State Budgetary Institution of Health Irkustsk Order ""Badge of Honor"" Regional Clinical Hospital, Irkutsk, Russian Federation|Federal State Budgetary Institution of Science Federal Research Center of Nutrition, Biotechnology and Food Safety, Moscow, Russian Federation|State Budgetary Healthcare Institution of Moscow ""City Clinical Hospital # 24 of Healthcare Department of Moscow"", Moscow, Russian Federation|State Budgetary Healthcare Institution of Moscow Region ""Moscow Regional Clinical Research Institute n.a. M.F. Vladimirskiy"", Moscow, Russian Federation|State Budgetary Healthcare Institution of Nizhny Novgorod Region ""Nizhny Novgorod Regional Clinical Hospital n.a. N.A., Nizhniy Novgorod, Russian Federation|State Budgetary Institution of Health of Novosibirsk Region ""City Clinical Hospital #12"", Novosibirsk, Russian Federation|State Budgetary Healthcare Institution of the Novosibirsk Region ""State Novosibirsk Regional Clinical Hospital"", Novosibirsk, Russian Federation|""Riat"" LLC, Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Healthcare Institution ""City Polyclinic #38"", Saint-Petersburg, Russian Federation|""Scientific Research Centre ECO-safety"" LLC, Saint-Petersburg, Russian Federation|State Healthcare Institution ""Regional Clinical Hospital"", Saratov, Russian Federation|Treatment and Prevention Interdistrict Institution ""Smolenskie kliniki"" LLC, Smolensk, Russian Federation|Tyumen Regional State Autonomous Healthcare Institution << Consulting and Diagnostic Centre <<Endos>>, Tyumen, Russian Federation|Zvezdara University Medical Center, Belgrade, Serbia|Singapore General Hospital, Singapore, Singapore|KM Management, s.r.o., Gastroenterologicke a hepatologicke centrum Nitra, Nitra, Slovakia|Dr MJ Prins, Cape Town, South Africa|Peermed Clinical Trial Centre, Johannesburg, South Africa|Centro Medico Teknon, Barcelona, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Universitario de Fuenlabrada, Madrid, Spain|Hospital Universitario Central de Asturias, Oviedo, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Skane University Hospital, Malmo, Sweden|Danderyd University Hospital Corp, Stockholm, Sweden|Akademiska Sjukhuset, Uppsala, Sweden|Gastroenterologische Praxis Balsiger, Seibold und Partner, Bern, Switzerland|Universitätsspital Zürich, Zurich, Switzerland|Changhua Christian Hospital, Changhua, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Mackay Memorial Hospital, Taipei, Taipei, Taiwan|Chang Gung Medical Foundation, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan|Municipal Institution ""Cherkasy Regional Hospital of Cherkasy Regional Council"", Gastroenterology Department, Cherkasy, Ukraine|Municipal City Clinical Hospital of the Emergency Medical Care, 1 st Therapy Department. Danylo Halytsky Lviv National Medical, Chernivtsi, Ukraine|Regional Municipal Institution ""Chernivtsi Regional Clinical Hospital"", Surgical Department, Chernivtsi, Ukraine|State Institution ""Institute of Gastroenterology of National Academy of Medical Sciences of Ukraine"", Dnipropetrovsk, Ukraine|Ivanto-Frankivsk Central City Clinic Hospital, Therapy Department #1. State Higher Education Institution Ivano-Frankivsk National, Ivano-Frankivsk, Ukraine|Municipal Health Care Institution ""Kharkiv City Clinical Hospital #2 named after prof. O. O. Shalimov"", Proctology Department, Kharkiv, Ukraine|L.T. Mala State Institution ""National Institute of Therapy of National Academy of Medical Sciences of Ukraine"", Kharkiv, Ukraine|Municipal Institution of Health Care ""Regional Hospital of War Veterans"", Therapeutic Department No1, Kharkiv, Ukraine|Kyiv City Clinical Hospital No. 18, Proctology Department, Kyiv, Ukraine|Municipal Non-profit Enterprise ""Consultative and Diagnostic Center"" of Pechersk District of Kyiv, Therapy Department, Kyiv, Ukraine|Odesa Clinical Railway Hospital Branch of ""Healthcare Center"" of Public joint stock company ""Ukrainian Railway"", Odessa, Ukraine|Municipal Institution ""Odesa Regional Clinical Hospital"", Regional Gastroenterology Center based on Surgery Department, Odessa, Ukraine|Ternopil University Hospital, Regional Center of Gastroenterology with Hepatology, Ternopil, Ukraine|Vinnytsia Regional Clinical Hospital of War Veterans, Therapy Department #1, Vinnytsia, Ukraine|M.I. Pyrogov Vinnytsia Regional Clinical Hospital, Gastroenterology Department, Vinnytsia, Ukraine|Medical Center LLC ""Health Clinic"", Vinnytsia, Ukraine|Municipal Institution ""Zaporizhzhya Regional Clinical Hospital"" of Zaporizhzhya Regional Council, Zaporizhzhya, Ukraine|Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, Norfolk, United Kingdom|The Pennine Acute Hospitals NHS Trust, Bury, United Kingdom|Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom|Royal Derby Hospital, Derby, United Kingdom|NHS Lothian, Edinburgh, United Kingdom|Glasgow Clinical Research Facility - Queen Elizabeth University Hospital, Glasgow, United Kingdom|NHS Greater Glasgow and Clyde, Glasgow, United Kingdom|Wycombe Hospital, High Wycombe, United Kingdom|Imperial College Healthcare NHS Trust, St Mary's Hospital, London, United Kingdom|Biomedical Research Unit, Nottingham, United Kingdom|Oxford University Hospitals NHS Trust, Oxford, United Kingdom|St Helens and Knowsley Teaching Hospitals NHS Trust, Prescot, United Kingdom|Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility, Southampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02914535"
887,"NCT02910245","Mercaptopurine Therapy in Ulcerative Colitis","OPTIC","Recruiting","No Results Available","Colitis, Ulcerative","Drug: Mercaptopurine (Purinethol)|Drug: Placebo|Drug: Mesalamine|Drug: Prednisone","Clinical and endoscopic remission|(Serious) Adverse Events|Leukocyte counts|Liver function tests|Occurrence of subjective thiopurine intolerance|6-TGN levels|6-MMP levels|Occurrence of treatment failure|Occurrence of upscaling treatment|Treatment costs","Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|ZonMw: The Netherlands Organisation for Health Research and Development","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 3","136","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","SA652012","November 2016","April 30, 2022","April 30, 2022","September 22, 2016",,"January 7, 2020","Noordwest Ziekenhuisgroep, Alkmaar, Netherlands|Flevoziekenhuis, Almere, Netherlands|Meander MC, Amersfoort, Netherlands|Amsterdam UMC, location VUMC, Amsterdam, Netherlands|OLVG Oost, Amsterdam, Netherlands|Amsterdam UMC, location AMC, Amsterdam, Netherlands|Amstelland Hospital, Amsterdam, Netherlands|MC Haaglanden, Den Haag, Netherlands|Tergooi Hospital, Hilversum, Netherlands|Westfriesgasthuis, Hoorn, Netherlands|St. Antonius Hospital, Nieuwegein, Netherlands|Sint Franciscus Gasthuis, Rotterdam, Netherlands",,"https://ClinicalTrials.gov/show/NCT02910245"
888,"NCT02819635","A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)",,"Active, not recruiting","No Results Available","Ulcerative Colitis (UC)","Drug: Placebo|Drug: Updacitinib (ABT-494)","Substudy 1/Substudy 2: Percentage Of Participants Who Achieve Clinical Remission Per Adapted Mayo Score|Substudy 3: Percentage Of Participants Who Achieve Clinical Remission Per Adapted Mayo Score|Substudy 1: Percentage Of Participants With Endoscopic Improvement|Substudy 1: Percentage Of Participants Achieving Clinical Remission Per Full Mayo Score|Substudy 1: Percentage Of Participants Achieving Clinical Response Per Adapted Mayo Score|Substudy 1: Percentage Of Participants Achieving Clinical Response Per Partial Mayo Score|Substudy 1: Change in Full Mayo Score|Substudy 1: Percentage Of Participants With Endoscopic Remission|Substudy 1: Percentage Of Participants Who Achieved Histologic Improvement|Substudy 2: Percentage Of Participants With Endoscopic Improvement|Substudy 2: Percentage Of Participants With Endoscopic Remission|Substudy 2: Percentage Of Participants Achieving Clinical Response Per Adapted Mayo Score|Substudy 2: Percentage Of Participants Achieving Clinical Response Per Partial Mayo Score|Substudy 2: Percentage Of Participants Who Achieved Histologic-Endoscopic Mucosal Improvement|Substudy 2: Percentage Of Participants Who Report No Bowel Urgency|Substudy 2: Percentage Of Participants Who Reported No Abdominal Pain|Substudy 2: Percentage Of Participants Who Achieved Histologic Improvement|Substudy 2: Change in Inflammatory Bowel Disease Questionnaire (IBDQ) Total Score|Substudy 2: Percentage Of Participants With Mucosal Healing|Substudy 2: Change in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Questionnaire Score|Substudy 3: Percentage Of Participants With Endoscopic Improvement|Substudy 3: Percentage Of Participants Who Maintain Clinical Remission Per Adapted Mayo Score Among Participants Who Received Clinical Remission Per Adapted Mayo Score in Study M14-234 (Substudy 1 or 2) Or M14-675|Substudy 3: Percentage Of Participants Who Achieved Clinical Remission Per Adapted Mayo score And Were Corticosteroid Free ≥ 90 days|Substudy 3: Percentage Of Participants With Endoscopic Improvement Among Participants Who Had Endoscopic Improvement In Study M14-234 (Substudy 1 or 2) Or Study M14-675|Substudy 3: Percentage Of Participants With Endoscopic Remission|Substudy 3: Percentage Of Participants Who Maintain Clinical Response Per Adapted Mayo Score|Substudy 3: Percentage Of Participants Who Achieved Histologic-Endoscopic Mucosal Improvement|Substudy 3: Change in Inflammatory Bowel Disease Questionnaire (IBDQ) Total Score|Substudy 3: Percentage Of Participants With Mucosal Healing|Substudy 3: Percentage Of Participants Who Reported No Bowel Urgency|Substudy 3: Percentage Of Participants Who Reported No Abdominal Pain|Substudy 3: Change in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Score","AbbVie","All","16 Years to 75 Years   (Child, Adult, Older Adult)","Phase 3","844","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","M14-234|2016-000641-31","September 26, 2016","December 14, 2021","January 13, 2022","June 30, 2016",,"June 30, 2021","Birmingham Gastroenterology Associates O.C /ID# 151276, Birmingham, Alabama, United States|East View Medical Research, LLC /ID# 171183, Mobile, Alabama, United States|CB Flock Research Corporation /ID# 165980, Mobile, Alabama, United States|Delsol Research Management, Ll /Id# 170131, Chandler, Arizona, United States|Arizona Arthritis & Rheumatology Research, PLLC /ID# 169822, Sun City, Arizona, United States|Digestive Disease Consultants, A Division of Arizona Digestive Health, P.C /ID# 211885, Tempe, Arizona, United States|Adobe Clinical Research LLC /ID# 155250, Tucson, Arizona, United States|University of Arizona /ID# 150553, Tucson, Arizona, United States|Citrus Valley Gastroenterology /ID# 151914, Covina, California, United States|Newport Huntington Medical Group /ID# 217005, Huntington Beach, California, United States|UC San Diego Health System /ID# 155185, La Jolla, California, United States|United Medical Doctors /ID# 207464, Los Alamitos, California, United States|TLC Clinical Research Inc /ID# 216829, Los Angeles, California, United States|Gastrointestinal Biosciences Clinical Trials, LLC /ID# 157080, Los Angeles, California, United States|Facey Medical Foundation /ID# 203133, Mission Hills, California, United States|United Medical Doctors - Murrieta /ID# 151211, Murrieta, California, United States|InSite Digestive Health Care - Oxnard /ID# 163414, Oxnard, California, United States|Inland Empire Clinical Trials, LLC /ID# 216038, Rialto, California, United States|San Diego Clinical Trials /ID# 212120, San Diego, California, United States|Medical Assoc Research Grp /ID# 169148, San Diego, California, United States|Univ of California San Francis /ID# 164581, San Francisco, California, United States|Delta Waves, Inc. /ID# 151721, Colorado Springs, Colorado, United States|South Denver Gastroenterology /ID# 151223, Lone Tree, Colorado, United States|Western States Clinical Res /ID# 158076, Wheat Ridge, Colorado, United States|Western Connecticut Medical Group /ID# 169210, Danbury, Connecticut, United States|Medical Research Center of CT /ID# 150482, Hamden, Connecticut, United States|Gastro Florida /ID# 155245, Clearwater, Florida, United States|Moonshine Research Center, Inc /ID# 152533, Doral, Florida, United States|Universal Axon Clinical Research /ID# 213461, Doral, Florida, United States|Palmetto Research, LLC /ID# 151716, Hialeah, Florida, United States|Nature Coast Clinical Research - Inverness /ID# 154064, Inverness, Florida, United States|Encore Borland-Groover Clinical Research /Id# 170912, Jacksonville, Florida, United States|SIH Research Mumtaz, Inc /ID# 163319, Kissimmee, Florida, United States|Cfagi Llc /Id# 202017, Maitland, Florida, United States|University of Miami /ID# 215441, Miami, Florida, United States|Advanced Pharma /ID# 151719, Miami, Florida, United States|New Horizon Research Center /ID# 152474, Miami, Florida, United States|Crystal Pharmacology Research /ID# 151841, Miami, Florida, United States|Coral Research Clinic /ID# 150444, Miami, Florida, United States|Advanced Research Institute, Inc /ID# 163098, New Port Richey, Florida, United States|Endoscopic Research, Inc. /ID# 151720, Orlando, Florida, United States|Omega Research Consultants /ID# 200269, Orlando, Florida, United States|Clinical Research Trials of Florida, Inc. /ID# 201790, Tampa, Florida, United States|University of South Florida /ID# 214493, Tampa, Florida, United States|AdventHealth Tampa /ID# 200272, Tampa, Florida, United States|Gastroenterology Associates of Central Georgia, LLC /ID# 165782, Macon, Georgia, United States|Infinite Clinical Trials /ID# 215340, Riverdale, Georgia, United States|Atlanta Gastroenterology Spec /ID# 150548, Suwanee, Georgia, United States|Next Innovative Clinical Research - Chicago /ID# 216060, Chicago, Illinois, United States|University of Chicago /ID# 150547, Chicago, Illinois, United States|NorthShore University HealthSystem /ID# 150555, Evanston, Illinois, United States|Northwest Health Care Associates /ID# 151590, Hoffman Estates, Illinois, United States|Carle Foundation Hospital /ID# 151137, Urbana, Illinois, United States|MediSphere Medical Research Center /ID# 152064, Evansville, Indiana, United States|Indianapolis Gastroenterology /ID# 162901, Indianapolis, Indiana, United States|University of Iowa Hospitals and Clinics /ID# 157058, Iowa City, Iowa, United States|Cotton-O'Neil Clinical Res Ctr /ID# 167182, Topeka, Kansas, United States|Tri-State Gastroenterology /ID# 169811, Crestview Hills, Kentucky, United States|Houma Digestive Health Special /ID# 151844, Houma, Louisiana, United States|Nola Research Works, LLC /ID# 153356, New Orleans, Louisiana, United States|Louisana Research Center, LLC /ID# 150446, Shreveport, Louisiana, United States|University of Maryland Med Ctr /ID# 150449, Baltimore, Maryland, United States|Gastro Center of Maryland /ID# 200022, Columbia, Maryland, United States|Massachusetts General Hospital /ID# 165676, Boston, Massachusetts, United States|University of Michigan Health Systems /ID# 151140, Ann Arbor, Michigan, United States|Huron Gastroenterology Assoc /ID# 152710, Ann Arbor, Michigan, United States|Clin Res Inst of Michigan, LLC /ID# 153027, Chesterfield, Michigan, United States|Revival Research Institute, LLC /ID# 207280, Southfield, Michigan, United States|Center for Digestive Health /ID# 161984, Troy, Michigan, United States|Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinic /ID# 157484, Wyoming, Michigan, United States|Mayo Clinic /ID# 151677, Rochester, Minnesota, United States|Minnesota Gastroenterology PA /ID# 151678, Saint Paul, Minnesota, United States|University of Mississippi Medical Center /ID# 213139, Jackson, Mississippi, United States|Southern Therapy and Advanced Research (STAR) LLC /ID# 170712, Jackson, Mississippi, United States|Washington University-School of Medicine /ID# 150485, Saint Louis, Missouri, United States|Las Vegas Medical Research /ID# 153044, Las Vegas, Nevada, United States|Dartmouth-Hitchcock Medical Center /ID# 150549, Lebanon, New Hampshire, United States|AGA Clinical Research Associates, LLC /ID# 153040, Egg Harbor Township, New Jersey, United States|Atlantic Digestive Health Inst /ID# 150447, Morristown, New Jersey, United States|Rutgers Robert Wood Johnson /ID# 155248, New Brunswick, New Jersey, United States|University of New Mexico Department of Internal Medicine /ID# 214396, Albuquerque, New Mexico, United States|Montefiore Medical Center - Moses Campus /ID# 150543, Bronx, New York, United States|Advantage Clinical Trials /ID# 163938, Bronx, New York, United States|NY Scientific /ID# 152707, Brooklyn, New York, United States|NYU Langone Long Island Clinical Research Association /ID# 155272, Great Neck, New York, United States|Columbia Univ Medical Center /ID# 163410, New York, New York, United States|DiGiovanna Institute for Medical Education & Research /ID# 201533, North Massapequa, New York, United States|Premier Medical Group - GI Division /ID# 153357, Poughkeepsie, New York, United States|Gastro Group of Rochester /ID# 151079, Rochester, New York, United States|Richmond University Medical Center /ID# 201859, Staten Island, New York, United States|Digestive Health Partners, P.A /ID# 167237, Asheville, North Carolina, United States|Atrium Health Carolinas Medical Center /ID# 156971, Charlotte, North Carolina, United States|Charlotte Gastroenterology and Hepatology, PLLC /ID# 150545, Charlotte, North Carolina, United States|Atlantic Gastroenterology Clinical Research /ID# 151899, Greenville, North Carolina, United States|Clinical Trials of America /ID# 153448, Winston-Salem, North Carolina, United States|Wake Forest Baptist Medical Center /ID# 150448, Winston-Salem, North Carolina, United States|Plains Clinical Research Center, LLC /ID# 170290, Fargo, North Dakota, United States|Consultants for Clinical Res /ID# 151679, Cincinnati, Ohio, United States|University of Cincinnati /ID# 164582, Cincinnati, Ohio, United States|The Ohio State University /ID# 169416, Columbus, Ohio, United States|Optimed Research, Ltd. /ID# 169696, Columbus, Ohio, United States|Hometown Urgent Care and Resea /ID# 200065, Dayton, Ohio, United States|Dayton Gastroenterology, Inc. /ID# 167631, Englewood, Ohio, United States|Great Lakes Gastroenterology Research LLC /ID# 201772, Mentor, Ohio, United States|Ohio Clinical Research Partner /ID# 154068, Mentor, Ohio, United States|Hightower Clinical /ID# 216337, Oklahoma City, Oklahoma, United States|Digestive Disease Specialists /ID# 201056, Oklahoma City, Oklahoma, United States|Options Health Research, LLC /ID# 150554, Tulsa, Oklahoma, United States|Healthcare Research Consultant /ID# 163100, Tulsa, Oklahoma, United States|Northwest Gastroenterology Clinic /ID# 152527, Portland, Oregon, United States|Guthrie Medical Group, PC /ID# 150481, Sayre, Pennsylvania, United States|Penn State Health Colonnade /ID# 150259, State College, Pennsylvania, United States|Pharmacorp Clinical Trials /ID# 153354, Charleston, South Carolina, United States|Gastroenterology Associates, P.A. of Greenville /ID# 150541, Greenville, South Carolina, United States|Gastro One /ID# 151144, Germantown, Tennessee, United States|East Tennessee Research Institute /ID# 203610, Johnson City, Tennessee, United States|Quality Medical Research /ID# 203426, Nashville, Tennessee, United States|Vanderbilt University Medical Center /ID# 153355, Nashville, Tennessee, United States|TX Clinical Research Institute /ID# 151526, Arlington, Texas, United States|Quest Clinical Research /ID# 164635, Baytown, Texas, United States|Texas Digestive Disease Consultants /ID# 209804, Cedar Park, Texas, United States|Texas Digestive Disease Consultants /ID# 209947, Cedar Park, Texas, United States|Baylor Scott & White Center for Inflammatory Bowel Diseases /ID# 200770, Dallas, Texas, United States|DHAT Research Institute /ID# 151218, Garland, Texas, United States|Vilo Research Group Inc /ID# 212624, Houston, Texas, United States|CliniCore International, LLC /ID# 152062, Houston, Texas, United States|Baylor College of Medicine - Baylor Medical Center /ID# 150486, Houston, Texas, United States|Centex Studies, Inc. - Houston /ID# 201216, Houston, Texas, United States|GI Specialists of Houston /ID# 202327, Houston, Texas, United States|Caprock Gastro Research /ID# 214754, Lubbock, Texas, United States|Clinical Associates in Research Therapeutics of America, LLC /ID# 201260, San Antonio, Texas, United States|Southern Star Research Institute, LLC /ID# 169396, San Antonio, Texas, United States|Carl R. Meisner Medical Clinic /ID# 171061, Sugar Land, Texas, United States|Baylor Scott & White Center for Diagnostic Medicine /ID# 204499, Temple, Texas, United States|Tyler Research Institute, LLC /ID# 169146, Tyler, Texas, United States|Gastro Health & Nutrition - Victoria /ID# 167761, Victoria, Texas, United States|HP Clinical Research /ID# 163939, Bountiful, Utah, United States|Advanced Research Institute /ID# 162624, Ogden, Utah, United States|Utah Gastroenternology - St. Mark's Office /ID# 163101, Salt Lake City, Utah, United States|Velocity Clinical Research/ Gut Whisperer /ID# 163181, West Jordan, Utah, United States|Ctr for Gastrointestinal Healt /ID# 153360, Franklin, Virginia, United States|Emeritas Research Group, LLC /ID# 150258, Leesburg, Virginia, United States|Washington Gastroenterology Associates /ID# 163629, Bellevue, Washington, United States|Virginia Mason - Seattle Orthapedics /ID# 153026, Seattle, Washington, United States|The Polyclinic /ID# 164369, Seattle, Washington, United States|The Vancouver Clinic, INC. PS /ID# 162333, Vancouver, Washington, United States|Aurora Medical Center - Grafto /ID# 151717, Grafton, Wisconsin, United States|Wisconsin Center for Advanced Research, a division of GI Associates, LLC /ID# 151838, Milwaukee, Wisconsin, United States|Medical College of Wisconsin /ID# 151843, Milwaukee, Wisconsin, United States|Cardio Alem /ID# 211280, San Isidro, Buenos Aires, Argentina|Mautalen Salud e Investigacion /ID# 171173, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina|Hospital Britanico de Buenos Aires /ID# 209495, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina|Gedyt /ID# 210015, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina|Sanatorio 9 de Julio /ID# 150189, San Miguel de Tucuman, Tucuman, Argentina|Hospital Privado Univesitario /ID# 164185, Cordoba, Argentina|Macquarie University Hospital /ID# 211951, Macquarie University, New South Wales, Australia|Mater Misericordiae Limited /ID# 212685, South Brisbane, Queensland, Australia|Griffith University /ID# 211952, Southport, Queensland, Australia|Monash Medical Centre /ID# 150206, Clayton, Victoria, Australia|St Vincent's Hospital Melbourne /ID# 152472, Fitzroy, Victoria, Australia|Fiona Stanley Hospital /ID# 211640, Murdoch, Western Australia, Australia|Ordensklinikum Linz GmbH Barmherzige Schwestern /ID# 150305, Linz, Oberoesterreich, Austria|Klinik Landstrasse /ID# 162866, Vienna, Wien, Austria|Medical University of Vienna /ID# 150614, Vienna, Wien, Austria|LKH Salzburg and Paracelsus /ID# 150306, Salzburg, Austria|Vitebsk Regional Advanced Clin /ID# 169612, Vitebsk, Belarus|Universitair Ziekenhuis Leuven /ID# 150332, Leuven, Vlaams-Brabant, Belgium|AZ Maria Middelares /ID# 150331, Gent, Belgium|AZ-Delta /ID# 150330, Roeselare, Belgium|University Clinical Centre of the Republic of Srpska /ID# 150209, Banja Luka, Republika Srpska, Bosnia and Herzegovina|University Clinical Centre of the Republic of Srpska /ID# 150706, Banja Luka, Republika Srpska, Bosnia and Herzegovina|University Clinical Center Tuzla /ID# 150211, Tuzla, Tuzlanski, Bosnia and Herzegovina|University Clinical Hospital Mostar /ID# 150705, Mostar, Bosnia and Herzegovina|Clinical Center University of Sarajevo /ID# 150208, Sarajevo, Bosnia and Herzegovina|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva /ID# 153742, Goiania, Goias, Brazil|Hospital Nossa Senhora das Graças /ID# 152480, Curitiba, Parana, Brazil|Hospital de Clinicas de Porto Alegre /ID# 153743, Porto Alegre, Rio Grande Do Sul, Brazil|Upeclin Fmb - Unesp /Id# 152485, Botucatu, Sao Paulo, Brazil|Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP /ID# 152484, Ribeirão Preto, Sao Paulo, Brazil|Faculdade de Medicina do ABC /ID# 152481, Santo André, Sao Paulo, Brazil|Kaiser Clinica e Hospital Dia /ID# 152483, Sao Jose Do Rio Preto, Sao Paulo, Brazil|University of Calgary - Cumming School of Medicine - Adult Cystic Fibrosis Clini /ID# 151821, Calgary, Alberta, Canada|Allen Whey Khye Lim Professional Corporation /ID# 211168, Edmonton, Alberta, Canada|University of Alberta - Zeidler Ledcor Centre /ID# 151100, Edmonton, Alberta, Canada|Covenant Health /ID# 158930, Edmonton, Alberta, Canada|Okanagan Clinical Trials /ID# 153178, Kelowna, British Columbia, Canada|Percuro Clinical Research, Ltd /ID# 150367, Victoria, British Columbia, Canada|Hamilton Health Sciences - McMaster University Medical Centre /ID# 150365, Hamilton, Ontario, Canada|The Ottawa Hospital /ID# 151820, Ottawa, Ontario, Canada|Medicor Research Inc /ID# 151101, Sudbury, Ontario, Canada|Toronto Digestive Disease Asso /ID# 150363, Vaughan, Ontario, Canada|CISSS de la Monteregie /ID# 159215, Greenfield Park, Quebec, Canada|CHAU- Hotel-Dieu de Levis /ID# 150361, Levis, Quebec, Canada|Recherche GCP Research /ID# 151822, Montreal, Quebec, Canada|Crchum /Id# 167169, Montreal, Quebec, Canada|Montreal General Hospital - McGill University Health Centre /ID# 170012, Montréal, Quebec, Canada|CIUSSS de l'Estrie - CHUS /ID# 150366, Sherbrooke, Quebec, Canada|Research Group /ID# 203176, Santiago, Region Metropolitana De Santiago, Chile|M y F Estudios Clínicos Ltda. /ID# 200107, Santiago, Region Metropolitana De Santiago, Chile|Centro de Investigaciones Clínicas Viña del Mar /ID# 150212, Viña del Mar, Valparaíso, Chile|Hospital Guillermo Grant Benavente de Concepción /ID# 212424, Concepción, Chile|CTR Estudios Clinicos /ID# 200110, Providencia, Chile|Hospital Clinico Universidad De Los Andes /ID# 207422, Santiago, Chile|Sun Yat-sen Memorial Hospital of Sun Yat-sen University /ID# 150455, Guangzhou, Guangdong, China|The Sixth Affiliated Hosp Sun /ID# 150456, Guangzhou, Guangdong, China|Affiliated Taihe Hospital of Hubei University of Medicine /ID# 216405, Shiyan, Hubei, China|Tongji Hospital Tongji Medical College Huazhong University of Science and Techno /ID# 167088, Wuhan, Hubei, China|Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 167078, Wuhan, Hubei, China|The First Affiliated Hospital of Nanchang University /ID# 211750, Nanchang, Jiangxi, China|The First Hospital of Jilin University /ID# 209986, Changchun, Jilin, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 150461, Shanghai, Shanghai, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 165815, Shanghai, Shanghai, China|Duplicate_Shanghai Tenth People's Hospital /ID# 150460, Shanghai, Shanghai, China|The second Affiliated hospital of Zhejiang University school of Medicine /ID# 165807, Hangzhou, Zhejiang, China|Sir Run Run Shaw Hospital /ID# 150454, Hangzhou, Zhejiang, China|Xiangya Hospital Central South University /ID# 167229, Changsha, China|West China Hospital, Sichuan University /ID# 167040, Chengdu, China|Shengjing Hospital of China Medical University /ID# 166920, Shenyang, China|Tianjin Medical University General Hospital /ID# 170604, Tianjin, China|Instituto Medico de Alta Tecnologia Oncomédica S.A /ID# 207042, Monteria, Cordoba, Colombia|Corporacion Hospitalaria Juan Cuidad Sede Denominada Hospital Universitario Mayo /ID# 151564, Bogota DC, Cundinamarca, Colombia|Hospital Universitario de San /ID# 155387, Medellin, Colombia|Klinicki bolnicki centar Zagreb /ID# 150225, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Zagreb /ID# 150709, Zagreb, Grad Zagreb, Croatia|Poliklinika Solmed /ID# 211483, Zagreb, Grad Zagreb, Croatia|Klinicki bolnicki centar Osijek /ID# 150216, Osijek, Osjecko-baranjska Zupanija, Croatia|Klinicki bolnicki centar Rijeka /ID# 150708, Rijeka, Primorsko-goranska Zupanija, Croatia|Klinicki bolnicki centar Split /ID# 213988, Split, Croatia|Zadar General Hospital /ID# 150221, Zadar, Croatia|Clinical Hospital Dubrava /ID# 150213, Zagreb, Croatia|Hepato-Gastroenterologie HK, s.r.o. /ID# 150912, Hradec Kralove, Czechia|CTCenter MaVe s.r.o. /ID# 150904, Olomouc, Czechia|Artroscan s.r.o. /ID# 150401, Ostrava, Czechia|Nemocnice Pardubickeho kraje, a.s. /ID# 213539, Pardubice, Czechia|Nemocnice Milosrdnych sester sv. Karla Boromejskeho v Praze /ID# 216221, Praha, Czechia|Axon Clinical, s.r.o. /ID# 152479, Praha, Czechia|ISCARE a.s. /ID# 209278, Praha, Czechia|East Tallinn Central Hospital /ID# 150417, Tallinn, Harjumaa, Estonia|West Tallinn Central Hospital /ID# 150419, Tallinn, Estonia|North Estonia Medical Centre /ID# 160870, Tallinn, Estonia|Tartu University Hospital /ID# 150418, Tartu, Estonia|Helsinki Univ Central Hospital /ID# 150407, Helsinki, Finland|Keski-Suomen Sairaala Nova /ID# 155666, Jyvaskyla, Finland|Laakarikeskus Ikioma /ID# 150121, Mikkeli, Finland|Tampere University Hospital /ID# 150114, Tampere, Finland|Tyks /Id# 168301, Turku, Finland|Chu de Nice-Hopital L'Archet Ii /Id# 152606, Nice CEDEX 3, Alpes-Maritimes, France|HCL - Hôpital Lyon Sud /ID# 152539, Pierre Benite CEDEX, Auvergne-Rhone-Alpes, France|CHU Hopital Nord /ID# 163508, Marseille, Bouches-du-Rhone, France|CHRU Lille - Hopital Claude Huriez /ID# 152607, Lille CEDEX, Hauts-de-France, France|Hopital Saint Eloi /ID# 200006, Montpellier CEDEX 5, Herault, France|CHU Amiens-Picardie Site Sud /ID# 163456, Amiens CEDEX 1, Somme, France|CHD Vendée- La Roche-sur-Yon - Les Oudairies /ID# 154452, La Roche Sur Yon, France|CHU de Saint-Etienne, Hopital Nord /ID# 154453, SAINT-ETIENNE Cedex 1, France|Universitatsklinikum Mannheim /ID# 150173, Mannheim, Baden-Wuerttemberg, Germany|Universitaetsklinikum Tuebingen /ID# 150767, Tübingen, Baden-Wuerttemberg, Germany|Universitatsklinikum Munster /ID# 150158, Munster, Niedersachsen, Germany|Gastroenterologische Gemeinschaftspraxis Herne /ID# 214574, Herne, Nordrhein-Westfalen, Germany|Zentrum für Gastroenterologie Saar MVZ GmbH /ID# 215811, Saarbrücken, Saarland, Germany|Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 161981, Kiel, Schleswig-Holstein, Germany|MVZ fuer Gastroenterlogie am Bayerischen Platz /ID# 150766, Berlin, Germany|Agaplesion Markus Krankenhaus /ID# 161982, Frankfurt am Main, Germany|Medizinisches Versorgungszentrum Portal 10 /ID# 207135, Muenster, Germany|Praxis medicum /ID# 150166, Wiesbaden, Germany|General Hospital of Athens Laiko /ID# 208669, Athens, Attiki, Greece|General Hospital of Chest Diseases of Athens SOTIRIA /ID# 202100, Athens, Attiki, Greece|University General Hospital of Heraklion PA.G.N.I /ID# 150250, Heraklion, Kriti, Greece|General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 150309, Athens, Greece|University General Hospital of Ioannina /ID# 164248, Ioannina, Greece|Theageneio Anticancer Hospital /ID# 163896, Thessaloniki, Greece|Genl Hosp Thess Ippokrateio /ID# 209521, Thessaloniki, Greece|Markusovszky Egyetemi Oktatokorhaz /ID# 150313, Szombathely, Vas, Hungary|Bekes Megyei Kozponti Korhaz /ID# 151572, Bekescsaba, Hungary|Semmelweis Egyetem /ID# 150312, Budapest, Hungary|Meditres Kft. /ID# 151521, Kecskemet, Hungary|Soproni Erzsebet Oktato Korhaz es Rehabilitacios Intezet /ID# 151523, Sopron, Hungary|Mentahaz Maganorvosi Kozpont /ID# 205884, Szekesfehervar, Hungary|Mercy University Hospital /ID# 151529, Cork, Ireland|Trinity College Dublin - St. J /ID# 150320, Dublin, Ireland|St Vincent's University Hosp /ID# 150318, Dublin, Ireland|Beaumont Hospital /ID# 150321, Dublin, Ireland|Galway University Hospital /ID# 150319, Galway, Ireland|Soroka Medical Center /ID# 156561, Be'er Sheva, HaDarom, Israel|Hadassah Medical Center-Hebrew University /ID# 165118, Jerusalem, Yerushalayim, Israel|Rambam Health Care Campus /ID# 150325, Haifa, Israel|Shaare Zedek Medical Center /ID# 161677, Jerusalem, Israel|A.O.U. Policlinico S.Orsola-Malpighi /ID# 150337, Bologna, Emilia-Romagna, Italy|Azienda Ospedaliera San Camillo Forlanini /ID# 151360, Rome, Lazio, Italy|ASST Rhodense/Presidio Ospedaliero di Rho /ID# 216610, Rho, Milano, Italy|Istituto Clinico Humanitas /ID# 151361, Rozzano, Milano, Italy|Fondazione PTV Policlinico Tor Vergata /ID# 150338, Rome, Roma, Italy|IRCCS Ospedale Sacro Cuore Don Calabria /ID# 201725, Negrar, Verona, Italy|ASST Fatebenefratelli Sacco - Ospedale Fatebenefratelli e Oftalmico /ID# 150602, Milano, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 150334, Milan, Italy|A.O. Ospedali Riuniti Villa Sofia - Cervello /ID# 150253, Palermo, Italy|Complesso integrato Columbus /ID# 150333, Rome, Italy|Aichi Medical University Hospital /ID# 151993, Nagakute-shi, Aichi, Japan|Nagoya City University Hospital /ID# 151950, Nagoya shi, Aichi, Japan|Nagoya University Hospital /ID# 152709, Nagoyashi, Aichi, Japan|Toyohashi Municipal Hospital /ID# 171457, Toyohashi-shi, Aichi, Japan|Ieda Hospital /ID# 157781, Toyota-shi, Aichi, Japan|Hirosaki National Hospital /ID# 152763, Hirosaki-shi, Aomori, Japan|Tokatsu Tsujinaka Hospital /ID# 214962, Abiko-shi, Chiba, Japan|Tsujinaka Hospital Kashiwanoha /ID# 209130, Kashiwa-shi, Chiba, Japan|Toho University Medical Center Sakura Hospital /ID# 151936, Sakura-shi, Chiba, Japan|Juntendo University Urayasu Hospital /ID# 208781, Urayasu-shi, Chiba, Japan|Fukui Prefectural Hospital /ID# 210448, Fukui-shi, Fukui, Japan|Fukuoka University Chikushi Hospital /ID# 152628, Chikushino-shi, Fukuoka, Japan|Kyushu University Hospital /ID# 152526, Fukuoka-shi, Fukuoka, Japan|Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers /ID# 209479, Fukuoka-shi, Fukuoka, Japan|Kurume University Hospital /ID# 151976, Kurume-shi, Fukuoka, Japan|Ogaki Municipal Hospital /ID# 208225, Ogaki-shi, Gifu, Japan|NHO Fukuyama Medical Center /ID# 206293, Fukuyama-shi, Hiroshima, Japan|Hiroshima University Hospital /ID# 151951, Hiroshima-shi, Hiroshima, Japan|Asahikawa Medical University Hospital /ID# 170289, Midorigaokahiga-shi, Hokkaido, Japan|Obihiro kosei Hospital /ID# 210412, Obihiro-shi, Hokkaido, Japan|Sapporo Tokushukai Hospital /ID# 209397, Sapporo-shi, Hokkaido, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital /ID# 151506, Sapporo-shi, Hokkaido, Japan|Sapporo Medical University Hospital /ID# 206492, Sapporo-shi, Hokkaido, Japan|Sapporo Higashi Tokushukai Hospital /ID# 208487, Sapporo-shi, Hokkaido, Japan|Kobe Home Clinic of Neurology /ID# 152049, Kobe-shi, Hyogo, Japan|Hyogo College of Medicine Hospital /ID# 152434, Nishinomiya-shi, Hyogo, Japan|National Hospital Organization Mito Medical Center /ID# 152631, Higashi Ibaraki-gun, Ibaraki, Japan|Kanazawa University Hospital /ID# 205099, Kanazawa-shi, Ishikawa, Japan|Iwate Medical University Uchimaru Medical Center /ID# 203411, Morioka-shi, Iwate, Japan|Sameshima Hospital /ID# 206672, Kagoshima-shi, Kagoshima, Japan|Shin-Yurigaoka General Hospital /ID# 206024, Kawasaki City, Kanagawa, Japan|Shin-Yurigaoka General Hospital /ID# 227134, Kawasaki City, Kanagawa, Japan|St. Marianna University School of Medicine Hospital /ID# 208654, Kawasaki-shi, Kanagawa, Japan|Yokohama City University Medical Center /ID# 169899, Yokohama shi, Kanagawa, Japan|Showa University Fujigaoka Hospital /ID# 208222, Yokohama-shi, Kanagawa, Japan|Japanese Red Cross Kyoto Daiichi Hosital /ID# 152359, Kyoto-shi, Kyoto, Japan|Kyoto University Hospital /ID# 211758, Kyoto-shi, Kyoto, Japan|Mie University Hospital /ID# 205362, Tsu-shi, Mie, Japan|Yokkaichi Hazu Medical Center /ID# 214347, Yokkaichi-shi, Mie, Japan|National Hospital Organization Sendai Medical Center /ID# 209527, Sendai-shi, Miyagi, Japan|NHO Nagasaki Medical Center /ID# 209531, Omura-shi, Nagasaki, Japan|Kenseikai Dongo Hospital /ID# 208100, Yamatotakada-shi, Nara, Japan|Saiseikai Niigata Hospital /ID# 209916, Niigata-shi, Niigata, Japan|Niigata University Medical & Dental Hospital /ID# 218048, Niigata-shi, Niigata, Japan|Ishida Clinic of IBD and Gastroenterology /ID# 210117, Oita-shi, Oita, Japan|Chikuba Hospital for Proctological and Gastrointestinal Diseases /ID# 157821, Kurashiki-shi, Okayama, Japan|Okayama University Hospital /ID# 217923, Okayama-shi, Okayama, Japan|Kinshukai Infusion Clinic /ID# 207864, Osaka-shi, Osaka, Japan|Kitano Hospital /ID# 210395, Osaka-shi, Osaka, Japan|Osaka City General Hospital /ID# 152704, Osaka-shi, Osaka, Japan|Japanese Red Cross Osaka Hospital /ID# 209476, Osaka-shi, Osaka, Japan|Osaka City University Hospital /ID# 152682, Osaka-shi, Osaka, Japan|Toyonaka Municipal Hospital /ID# 217079, Toyonaka-shi, Osaka, Japan|Saga University Hospital /ID# 209268, Saga-shi, Saga, Japan|Saitama Medical Center /ID# 152031, Kawagoe-shi, Saitama, Japan|Tokitokai Tokito clinic /ID# 152677, Saitama-shi, Saitama, Japan|National Hospital Organization Higashi-Ohmi General Medical Center /ID# 210709, Higashi-ohmi-shi, Shiga, Japan|Shimane University School of Medicine /ID# 208899, Izumo-shi, Shimane, Japan|Hamamatsu University Hospital /ID# 205708, Hamamatsu-shi, Shizuoka, Japan|NHO Shizuoka Medical Center /ID# 163572, Sunto-gun, Shizuoka, Japan|Tokyo Medical And Dental University, Medical Hospital /ID# 152016, Bunkyo-ku, Tokyo, Japan|St.Luke's International Hospital /ID# 208074, Chuo-ku, Tokyo, Japan|Tokai University Hachioji Hospital /ID# 152587, Hachioji-shi, Tokyo, Japan|Teikyo University Hospital /ID# 208897, Itabashi-ku, Tokyo, Japan|Kitasato University Kitasato Institute Hospital /ID# 152686, Minato-ku, Tokyo, Japan|Kyorin University Hospital /ID# 153194, Mitaka-shi, Tokyo, Japan|Center Hospital of the National Center for Global Health and Medicine /ID# 209267, Shinjuku-ku, Tokyo, Japan|Tokyo Women's Medical University Hospital /ID# 205977, Shinjuku-ku, Tokyo, Japan|Yamagata University Hospital /ID# 171454, Yamagata-shi, Yamagata, Japan|Tokuyama Central Hospital /ID# 216993, Shunan-shi, Yamaguchi, Japan|Yamanashi Prefectural Central Hospital /ID# 151908, Kofu-shi, Yamanashi, Japan|Kitakyushu Municipal Med Ctr /ID# 152588, Kitakyushu, Japan|Shoyukai Fujita Gastroenterological Hospital /ID# 216492, Takatsuki-shi, Japan|Hanyang University Guri Hospital /ID# 150344, Guri, Gyeonggido, Korea, Republic of|CHA Bundang Medical center CHA University /ID# 159479, Seongnam si, Gyeonggido, Korea, Republic of|The Catholic University of Korea, ST. Vincent's Hospital /ID# 150347, Suwon, Gyeonggido, Korea, Republic of|Kangbuk Samsung Hospital /ID# 150348, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Severance Hospital /ID# 159478, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Dong-A University Hospital /ID# 159480, Busan, Korea, Republic of|Pusan National University Hospital /ID# 159481, Busan, Korea, Republic of|Yeungnam University Medical Center /ID# 150345, Daegu, Korea, Republic of|Asan Medical Center /ID# 150900, Seoul, Korea, Republic of|Samsung Medical Center /ID# 150346, Seoul, Korea, Republic of|Riga East Clinical Univ Hosp /ID# 150354, Riga, Latvia|P. Stradins Clinical Univ Hosp /ID# 151409, Riga, Latvia|Hospital of Lithuanian University of Health Sciences Kaunas Clinics /ID# 150357, Kaunas, Lithuania|Klaipeda Seamens Hospital /ID# 154319, Klaipeda, Lithuania|Klaipeda University Hospital /ID# 158862, Klaipeda, Lithuania|Vilnius University Hospital /ID# 154318, Vilnius, Lithuania|Hospital Sultanah Bahiyah /ID# 151687, Alor Setar, Kedah, Malaysia|Universiti Kebangsaan Malaysia (UKM) Medical Centre /ID# 151689, Kuala Lumpur, Selangor, Malaysia|Hospital Ampang /ID# 151298, Ampang, Malaysia|University Malaya Med Ctr /ID# 150359, Kuala Lumpur, Malaysia|Morales Vargas Centro de Investigacion S.C. /ID# 211325, Leon, Guanajuato, Mexico|Clinica de Investigacion en Reumatologia y Obesidad S.C. /ID# 150710, Guadalajara, Jalisco, Mexico|Centro Regiomontano de Estudios Clínicos ROMA S.C /ID# 150256, Monterrey, Nuevo Leon, Mexico|Radboud Universitair Medisch Centrum /ID# 151700, Nijmegen, Gelderland, Netherlands|Academisch Medisch Centrum /ID# 150647, Amsterdam, Noord-Holland, Netherlands|Leids Universitair Medisch Centrum /ID# 152624, Leiden, Netherlands|Erasmus Medisch Centrum /ID# 150308, Rotterdam, Netherlands|Universitair Medisch Centrum Utrecht /ID# 152775, Utrecht, Netherlands|Akershus universitetssykehus /ID# 150317, Nordbyhagen, Akershus, Norway|Universitetssykehuset Nord-Norge /ID# 152835, Tromsø, Troms, Norway|Gastromed /Id# 216197, Torun, Kujawsko-pomorskie, Poland|Centrum Medyczne Reuma Park w Warszawie /ID# 150349, Warsaw, Mazowieckie, Poland|Centrum Zdrowia MDM /ID# 150351, Warszawa, Mazowieckie, Poland|Centralny Szpital Kliniczny MSWiA w Warszawie /ID# 150580, Warszawa, Mazowieckie, Poland|NZOZ Vivamed /ID# 216742, Warszawa, Mazowieckie, Poland|Instytut Pomnik - Centrum Zdrowia Dziecka /ID# 215732, Warszawa, Mazowieckie, Poland|Endoskopia Sp. z o.o. /ID# 150765, Sopot, Pomorskie, Poland|Hospital da Senhora da Oliveira Guimaraes, EPE /ID# 151607, Guimaraes, Braga, Portugal|Centro Hospitalar de Entre Douro e Vouga /ID# 152335, Santa Maria Da Feira, Porto, Portugal|Unidade Local de Saúde do Alto Minho, EPE - Hospital Conde de Bertiandos /ID# 151609, Ponte de Lima, Viana Do Castelo, Portugal|Hospital Garcia de Orta, EPE /ID# 151613, Almada, Portugal|CCA Braga - Hospital de Braga /ID# 151608, Braga, Portugal|Centro Hospitalar Universitario Lisboa Central, EPE - Hospital dos Capuchos /ID# 151611, Lisboa, Portugal|Centro Hospitalar Universitário de Lisboa Norte, EPE - Hospital de Santa Maria /ID# 151606, Lisboa, Portugal|Centro Hospitalar Universitario de Sao Joao, EPE /ID# 151610, Porto, Portugal|School of Medicine University of Puerto Rico-Medical Science Campus /ID# 150358, San Juan, Puerto Rico|Immanuel Kant Baltic Federal University /ID# 200719, Kaliningrad, Kaliningradskaya Oblast, Russian Federation|NW State Medical Univ na Mechn /ID# 169322, St. Petersburg, Leningradskaya Oblast, Russian Federation|Perm Clinical Center of the Federal Medical and Biological Agency /ID# 150386, Perm, Permskiy Kray, Russian Federation|Medical Company Hepatolog /ID# 200197, Samara, Samarskaya Oblast, Russian Federation|LLC Novaya Klinika /ID# 208107, Pyatigorsk, Stavropol Skiy Kray, Russian Federation|Kazan State Medical University /ID# 166042, Kazan, Tatarstan, Respublika, Russian Federation|Olla-Med Clinic /ID# 215332, Moscow, Russian Federation|City Clinical Hospital #24 /ID# 150395, Moscow, Russian Federation|Republican hospital named after V.A. Baranov /ID# 206506, Petrozavodsk, Russian Federation|Euromedservice /ID# 203800, Pushkin, Russian Federation|Duplicate_Stavropol State Medical Univ /ID# 150387, Stavropol, Russian Federation|Clinical Hosp Center Zvezdara /ID# 150427, Belgrade, Beograd, Serbia|Military Medical Academy /ID# 150429, Belgrade, Beograd, Serbia|University Clinical Center Serbia /ID# 150428, Belgrade, Beograd, Serbia|Clin Hosp Ctr Bezanijska Kosa /ID# 150426, Belgrade, Beograd, Serbia|University Clinical Center of Nis /ID# 151903, NIS, Nisavski Okrug, Serbia|University Clinical Center Kragujevac /ID# 150430, Kragujevac, Sumadijski Okrug, Serbia|Clinical Center Vojvodina /ID# 150764, Novi Sad, Vojvodina, Serbia|General Hospital Leskovac /ID# 217880, Leskovac, Serbia|National University Hospital /ID# 150453, Singapore, Singapore|Gleneagles Medical Centre /ID# 206018, Singapore, Singapore|Tan Tock Seng Hospital /ID# 150443, Singapore, Singapore|Medak s.r.o. /ID# 150480, Bratislava, Bratislavsky Kraj, Slovakia|Fakultna nemocnica s poliklinikou F.D. Roosevelta Banska Bystrica /ID# 150868, Banska Bystrica, Slovakia|Slovak Research Center Team Me /ID# 150257, Ilava, Slovakia|B+B MED, s.r.o. /ID# 150471, Kosice, Slovakia|Fakultna nemocnica s poliklini /ID# 211370, Nove Zamky, Slovakia|GASTRO I., s.r.o. /ID# 150472, Presov, Slovakia|MD Search /ID# 167293, Boksburg North, Gauteng, South Africa|Clinresco Centers /ID# 163622, Johannesburg, Gauteng, South Africa|Lenasia Clinical Trial Centre /ID# 214344, Johannesburg, Gauteng, South Africa|Wits Clinical Research , Wits Health Consortium (PTY) Ltd /ID# 150785, Johannesburg, Gauteng, South Africa|Wits Clinical Research Site /ID# 150496, Johannesburg, Gauteng, South Africa|Mediclinic Milnerton /ID# 162202, CAPE TOWN Milnerton, Western Cape, South Africa|Kingsbury Hospital /ID# 150497, Cape Town, Western Cape, South Africa|Private Practice Dr MN Rajabally /ID# 155144, Cape Town, Western Cape, South Africa|Hospital Clínico Universitario de Santiago-CHUS /ID# 151065, Santiago de Compostela, A Coruna, Spain|Hospital Unversitario Marques de Valdecilla /ID# 216620, Santander, Cantabria, Spain|Hospital Universitario Dr. Negrin /ID# 203937, Las Palmas de Gran Canaria, Las Palmas, Spain|Hospital Universitario A Coruna - CHUAC /ID# 203911, A Coruna, Spain|Hospital Clinic de Barcelona /ID# 150612, Barcelona, Spain|Hospital Universitario Reina Sofia /ID# 151066, Cordoba, Spain|Hospital Universitario Ramon y Cajal /ID# 151067, Madrid, Spain|Hospital Universitario La Paz /ID# 214539, Madrid, Spain|Hospital Clinico Universitario de Salamanca /ID# 150509, Salamanca, Spain|Hospital Universitario y Politecnico La Fe /ID# 150611, Valencia, Spain|Sahlgrenska University Hosp /ID# 151496, Goteborg, Sweden|Universitätsspital Basel /ID# 161731, Basel, Basel-Stadt, Switzerland|Kantonsspital St. Gallen /ID# 152599, St. Gallen, Sankt Gallen, Switzerland|Universitätsspital Zürich /ID# 152591, Zürich, Zuerich, Switzerland|Inselspital, Universitätsspital Bern /ID# 152590, Bern, Switzerland|China Medical University Hosp /ID# 150571, Taichung City, Taichung, Taiwan|National Cheng Kung University Hospital /ID# 151749, Tainan City, Tainan, Taiwan|National Taiwan University Hospital /ID# 150574, Taipei City, Taipei, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 150575, Kaohsiung, Taiwan|Chung Shan Medical University /ID# 150573, Taichung City, Taiwan|Taipei Veterans General Hosp /ID# 151748, Taipei City, Taiwan|Erciyes University Medical Fac /ID# 150129, Melikgazi, Kayseri, Turkey|Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty /ID# 150125, Istanbul, Turkey|Umraniye Training and Res Hosp /ID# 162659, Istanbul, Turkey|Duplicate_Marmara University Medical Fac /ID# 213969, Istanbul, Turkey|Mersin University Medical /ID# 157849, Mersin, Turkey|Gazi Universitesi Tip Fakultes /ID# 150127, Yenimahalle, Turkey|Communal Non-Commercial Enterprize of Kharkiv Regional Council Regional Clinical /ID# 206940, Kharkiv, Kharkivska Oblast, Ukraine|Kyiv Regional Hospital /ID# 217372, Kyiv, Kyivska Oblast, Ukraine|Kyiv Municipal Clinical Hospital #18 /ID# 150372, Kiev, Kyiv, Ukraine|Medical Center of the ""Health /ID# 151274, Vinnytsya, Vinnytska Oblast, Ukraine|Municipal Enterprise ""I.I. Mechnikov Dnipropetrovsk Regional Clinical Hospital"" /ID# 207723, Dnipro, Ukraine|PE PMC Acinus, Medical and Diagnostic Center /ID# 217216, Kropyvnytskyi, Ukraine|Medical centre of CONSILIUM MEDICAL LLC /ID# 217446, Kyiv, Ukraine|Lviv Regional Clinical Hospital /ID# 150375, Lviv, Ukraine|Municipal Non-Commercial Enterprise Odesa Regional Clinical Hospital of the Od /ID# 151275, Odesa, Ukraine|Vinnytsia Regional Clinical Hospital n.a. M.I.Pyrogov /ID# 216297, Vinnytsia, Ukraine|RD&E Hospital /ID# 150379, Exeter, Devon, United Kingdom|Queen Elizabeth University Hos /ID# 163787, Glasgow, Glasgow City, United Kingdom|The Royal London Hospital /ID# 150384, London, London, City Of, United Kingdom|Basingstoke & North Hampshire /ID# 150380, Basingstoke, United Kingdom|Royal United Hospitals Bath /ID# 151532, Bath, United Kingdom|Univ Hospitals Birmingham NHS Foundation trust /ID# 150382, Birmingham, United Kingdom|Huddersfield Royal Infirmary /ID# 217658, Huddersfield, United Kingdom|St. George's Healthcare NHS /ID# 208374, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02819635"
889,"NCT02808780","An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis","OPAL","Recruiting","No Results Available","Ulcerative Colitis",,"Incidence of Lymphoma|Relative Risk of Lymphoma (ratio of the rate of lymphoma events in participants in each cohort)|Long-term Safety: Participants with Adverse Events of Interest (AEIs) and Serious AEs including malignancies other than lymphoma|Clinical Disease Status as assessed by Partial Mayo Score|Short Inflammatory Bowel Disease Questionnaire (SIBDQ) Score|EuroQoL-5 Dimensions-5 Levels (EQ-5D-5L) Score|Work Productivity and Activity Impairment Questionnaire - Ulcerative Colitis (WPAI-UC)|Treatment Satisfaction Questionnaire for Medication (TSQM) Score|Health Care Utilization: Evaluate the Number of each Hospitalizations in participants in each cohort|Health Care Utilization: Evaluate the Reasons for Hospitalization in participants in each cohort","Janssen Biotech, Inc.","All","18 Years and older   (Adult, Older Adult)",,"6000","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","CR105891|CNTO148UCO4001","December 16, 2016","July 30, 2031","July 30, 2031","June 22, 2016",,"September 30, 2020","UCLA, Los Angeles, California, United States|United Gastroenterologists, Murrieta, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Ventura Clinical Trials, Ventura, California, United States|Coral Gables Clinical Research, Inc, Coral Gables, Florida, United States|West Coast Clinical Research, LLC, Fort Myers, Florida, United States|C & R Research Services, Lake Worth, Florida, United States|Precision Clinical Research, Lauderdale Lakes, Florida, United States|City Medical Group, RC, Miami, Florida, United States|Medsearch Professional Group, Miami, Florida, United States|Sanitas Research, Miami, Florida, United States|The Core Research Associates, Miami, Florida, United States|Guardian Angel Health Center, Tampa, Florida, United States|Atlanta Gastroenterology Specialists, PC, Suwanee, Georgia, United States|Northwestern University Hospital, Chicago, Illinois, United States|The University Of Chicago Medicine, Chicago, Illinois, United States|Gastrointestinal Associates LLP, Flowood, Mississippi, United States|Chi Health Research Center, Omaha, Nebraska, United States|Promedica Physicians Digestive Healthcare, Sylvania, Ohio, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Houston Methodist Hospital, Houston, Texas, United States|Gastroenterology Research of America, LLC, San Antonio, Texas, United States|Gastroenterology Clinic Of San Antonio P A, San Antonio, Texas, United States|Emeritas Research Group, Lansdowne Town Center, Virginia, United States|KH.D Barmherzige Bruder Salzburg, Salzburg, Austria|LKH Salzburg Medizin I, Salzburg, Austria|Allg. Krankenhaus der Landeshauptstadt St. Poelten, Sankt Poelten Noe, Austria|Medical University Vienna, Vienna, Austria|Zeidler Ledcor Centre, Edmonton, Alberta, Canada|Columbia Gastroenterology, New Westminster, British Columbia, Canada|GIRI Gastrointestinal Research Institute, Vancouver, British Columbia, Canada|Taunton Surgical Centre, Oshawa, Ontario, Canada|Ottawa Hospital, Ottawa, Ontario, Canada|RESEARCH SITE s.r.o., Plzen, Czechia|FN Motol, Prageu, Czechia|CHRU de Tours - Hopital Trousseau, Chambray Les Tours Centre, France|CHU Estaing, Clermont-Ferrand, France|Hôpital Beaujon, Clichy, France|CHU Henri Mondor, Creteil, France|CHU Grenoble, Grenoble, France|Hopital Saint Eloi, Montpellier, France|CHU de Nice Hopital de l Archet, Nice, France|Hospices Civils de Lyon HCL, Pierre Bénite, France|CHU Saint-etienne, Saint Priest en jarez, France|CHRU Hôpital de Hautepierre, Strasbourg Cedex, France|Gastroenterologische Spezialpraxis - Berlin-Karlshorst, Berlin-Karlshorst, Germany|Charité Universitatsmedizin Berlin, Campus Mitte Zentrum 13, Berlin, Germany|Praxis Für Gastroenteroligie, Berlin, Germany|Charite Universitastmedizin Berlin, Berlin, Germany|Städtisches Klinikum Dessau-Klinik Für Innere Medizin, Dessau-Roßlau, Germany|Praxis Dr Zeisler, Halle, Germany|Städtisches Krankenhaus Martha-Maria Halle-Dölau gGmbH, Halle, Germany|ifi-Institut für interdisziplinäre Medizin, Hamburg, Germany|Hamburgisches Forschungsinstitut fuer CED, HaFCED e.K., Hamburg, Germany|Hannover Medical School, Hannover, Germany|University Hospital Heidelberg, Heidelberg, Germany|Gemeinschaftspraxis Dr Lars Helmstadter & Prof Dr Robert Ehehalt, Heidelberg, Germany|Universitätsklinikum Schlesw.-H., Campus Kiel/ Sektion für Stammzelll- und Immuntherapie - Germany, Kiel, Germany|Universitatsklinikum Leipzig, Leipzig, Germany|Internistische Gemeinschaftspraxis Für Verdauungs- Und Stoffwechselkrankheiten, Leipzig, Germany|St Marien-Und St Annastiftskrankenhaus, Ludwigshafen, Germany|Städtisches Klinikum Lüneburg, Lyneburg, Lower Saxony, Germany|Herbert Kellner, Muenchen, Germany|Gemeinschaftspraxis, Saarbrucken, Germany|Kreiskrankenhaus Sigmaringen, Sigmaringen, Germany|Universitaetsklinik Tuebingen, Tübingen, Germany|Medical School, University of Athens., Athens, Greece|Hippokration Hospital, Athens, Greece|University Hospital of Heraklion, Heraklion, Greece|Division Of Gastroenterology Medical School University Of Ioannina, Ioannina, Greece|Hippokration Hospital, Thessaloniki, Greece|A.O. Per L' Emergenza Cannizzaro - U.O. Chirurgia Generale, Catania, Italy|Ospedale Santissima Annunziata, Cento, Italy|Ospedale S. Maria Del Prato, Feltre, Italy|Azienda Ospedaliera di Padova, Padova, Italy|UOC Gastroenterologia Ed Epatologia, Dibimis, Policlinico Palermo, Palermo, Italy|Gastroenterology And Endoscopy Unit, University Hospital Of Parma, Parma, Italy|Fondazione Policlinico Universitario Al gemeli, Rome, Italy|TOR Vergata University - U.O.C. Gastroenterologia Dipartimento Di Medicina, Rome, Italy|Istituto Clinico Humanitas Rozzano, IRCCS, Rozzano, Italy|Gastroenterology Unit, Sardinia, Italy|A.O.Citta della Salute e della Scienza di Torino, Torino, Italy|A.O. Ordine Mauriziano Di Torino - Ospedale Mauriziano Umberto, Torino, Italy|Pusan National University Hospital., Busan, Korea, Republic of|HanYang Univ. Guri Hospital, Gyeonggi-Do, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-Si, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Hosp. Univ. A Coruña, A Coruna, Spain|Corporacio Sanitari Parc Tauli, Barcelona, Spain|Hosp. Univ. de Bellvitge, Barcelona, Spain|Hosp. Reina Sofia, Córdoba, Spain|Hosp. Univ. Fuenlabrada, Fuenlabrada, Spain|Hosp. Gral. Juan Ramon Jimenez, Huelva, Spain|Hosp. Univ. de La Princesa, Madrid, Spain|Hosp. Gral. Univ. Gregorio Marañon, Madrid, Spain|Hosp. Univ. La Paz, Madrid, Spain|Hosp. Univ. Fundacion Alcorcon, Madrid, Spain|Hosp. Clinico San Carlos, Madrid, Spain|Hosp. Univ. Pta. de Hierro Majadahonda, Majadahonda, Spain|Fund. Hosp. de Manacor, Mallorca, Spain|Hosp. Univ. Infanta Sofia, San Sebastian De Los Reyes, Spain|Hosp. Virgen de La Salud, Toledo, Spain|Hosp. Clinico Univ. de Valencia, Valencia, Spain|Hosp. Clinico Univ. de Valencia, Valencia, Spain|Hosp. Univ. I Politecni La Fe-, Valencia, Spain|Hosp. Alvaro Cunqueiro, Vigo, Spain|Hosp. Univ. Miguel Servet, Zaragoza, Spain|Hosp. Clinico Univ. Lozano Blesa, Zaragoza, Spain",,"https://ClinicalTrials.gov/show/NCT02808780"
890,"NCT02770040","Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis","PREDICT-UC","Recruiting","No Results Available","Ulcerative Colitis","Drug: Infliximab","Colectomy free survival|Clinical response|Treatment failure|Differences in daily Lichtiger score|Steroid free remission|Endoscopic remission rate","Austin Health|University of Melbourne","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 4","138","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","HREC/14/Austin/595","July 2016","June 2021","July 2022","May 12, 2016",,"September 2, 2020","Austin Health, Melbourne, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT02770040"
891,"NCT02738125","Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions","SOTHIS","Active, not recruiting","No Results Available","Ulcerative Colitis (UC)",,"Time to loss of clinical benefit|Change from Baseline (Month 0) in Steroid-free remission|Change from Baseline (Month 0) in Clinical Remission|Change from Baseline (Month 0) in Clinical Response","AbbVie",,"18 Years to 99 Years   (Adult, Older Adult)",,"265","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","P15-681","April 29, 2016","February 7, 2024","February 7, 2024","April 14, 2016",,"March 23, 2021","Centre Hospitalier Lyon Sud /ID# 165859, Pierre Benite CEDEX, Auvergne-Rhone-Alpes, France|Hopital Saint Joseph /ID# 164405, Marseille CEDEX 08, Bouches-du-Rhone, France|CHU Hopital Nord /ID# 152620, Marseille, Bouches-du-Rhone, France|Hopital Purpan /ID# 167179, TOULOUSE Cedex 9, Haute-Garonne, France|CH Annecy Genevois Site Annecy /ID# 151131, Epagny Metz Tessy, Haute-Savoie, France|CHRU Lille - Hopital Claude Huriez /ID# 151514, Lille CEDEX, Hauts-de-France, France|Hopital Beaujon /ID# 151498, Clichy, Ile-de-France, France|Hopitaux de Brabois Adultes /ID# 151147, Vandoeuvre les Nancy, Lorraine, France|Centre Hosp Intercommunal de Creteil /ID# 152361, Creteil, Val-de-Marne, France|Centre Medical Alexandre Dumas /Id# 165857, Amiens, France|Hopital Robert Ballanger /ID# 151382, Aulnay Sous Bois Cedex, France|CH Henri Duffaut /ID# 151383, Avignon, France|CH Henri Duffaut /ID# 151499, Avignon, France|Cabinet Medical /ID# 155460, BAIE Mahault, France|Centre Hospitalier Cote Basque /ID# 163714, Bayonne, France|Clinique du Tondu /ID# 161977, Bordeaux, France|Centre Endo Nord Isere /ID# 151390, Bourgoin Jallieu, France|Geier, Cabinet Medical /ID# 149652, Brest, France|Hopital de la Cavale Blanche /ID# 152618, Brest, France|Hopital de la Cavale Blanche /ID# 153608, Brest, France|Cabinet Medical /ID# 151391, Caen, France|Pole Sante Leonard de Vinci /ID# 151384, Chambray Les Tours, France|CH Heut Anjou de Chateau Gonti /ID# 151151, Chateau Gontier, France|CH de Chauny /ID# 151149, Chauny, France|CHU Estaing /ID# 153527, Clermont Ferrand, France|Hopital Louis Mourier,Colombes /ID# 152650, Colombe, France|GHPSO CH Creil /ID# 151117, Creil, France|Cabinet Medical /ID# 150978, Douarnenez, France|Cabinet Medical /ID# 150845, Erstein, France|Centre Gastro Loire /ID# 151387, Gien, France|Clinique du Palais /ID# 151175, Grasse, France|Centre Hospitalier Universitaire de Grenoble - Hopital Michallon /ID# 151508, Grenoble, France|Hopital Saint Louis /ID# 151182, La Roche Sur Yon, France|Hopital Dupuytren /Id# 157889, Limoges, France|CH Des Deux Vallees Longumeau /ID# 150977, Longjumeau, France|Ctr Consultations La Sauvegard /ID# 151515, Lyon, France|Hopital Edouard Herriot /ID# 151513, Lyon, France|Centre Medical Les Sources /ID# 151174, Montigny Les Cormeilles, France|Centre Hospitalier Universitaire de Nice - Hopital l'Archet 2 /ID# 151132, Nice, France|Centre Hospitalier Universitaire de Nice - Hopital l'Archet 2 /ID# 151181, Nice, France|CHU Nimes /ID# 169178, Nimes Cedex 9, France|Hopital Saint-Louis /ID# 151509, Paris, France|Hopital Saint Joseph /ID# 153526, Paris, France|Cabinet Medical /ID# 151118, Paris, France|Cabinet Medical /ID# 152362, Paris, France|Hopital Bichat Claude Bernard /ID# 151176, Paris, France|Chu Lyon Sud /Id# 151146, Pierre Benite, France|Chu Lyon Sud /Id# 151505, Pierre Benite, France|Chu Lyon Sud /Id# 153801, Pierre Benite, France|Cabinet Medical /ID# 151092, Plerin, France|Cabinet Medical /ID# 151093, Plerin, France|Cabinet Medical /ID# 151094, Plerin, France|Cabinet Medical /ID# 151148, Poissy, France|Cabinet Medical /ID# 151555, Prades-le-lez, France|Hospital Pontchaillou /ID# 166806, Rennes, France|CHU de Saint-Etienne, Hopital Nord /ID# 166807, SAINT-ETIENNE Cedex 1, France|CHU d'Amiens /ID# 152651, Salouel, France|Cabinet Medical /ID# 151558, Saverne, France|CHU la Reunion Site St. Denis /ID# 151556, St Denis, France|Centre de Consultations /ID# 151128, St Nazaire, France|Centre de Consultations /ID# 151164, St Nazaire, France|Centre de Consultations /ID# 155458, St Nazaire, France|Cabinet Medical /ID# 151559, St Quentin, France|Cabinet Medical /ID# 151162, Strasbourg, France|Centre Medical du Clos de Pacy /ID# 151129, Sucy En Brie, France|Fondation Maison Sante Bagatel /ID# 151497, Talence, France|Cabinet Medical, Dr. Constant, /ID# 151119, Toulon, France|Clinique Pasteur /ID# 151088, Toulouse, France|Hopital Rangueil /ID# 157890, Toulouse, France|Clinique /Id# 155792, Toulouse, France|Clinique Amroise Pare /ID# 161978, Toulouse, France|Cabinet Medical /ID# 170136, Toulouse, France|Cabinet Medical /ID# 152841, Toulouse, France|Hopital Trousseau /ID# 150168, Tours, France|Hopital Trousseau /ID# 163503, Tours, France|Cabinet Medical /ID# 151557, Troyes, France|GH Mutualiste Les Port Du Sud /ID# 152374, Venissieux, France|GH Mutualiste Les Port Du Sud /ID# 159231, Venissieux, France|Ceentre Hepatologie Biliaire /ID# 151152, Villejuif, France|Cabinet Medical /ID# 152617, Voiron, France",,"https://ClinicalTrials.gov/show/NCT02738125"
892,"NCT02665845","Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).","COMBOMESA","Recruiting","No Results Available","Ulcerative Colitis","Drug: 5-ASA|Drug: Corticosteroids","Percentage of patients who respond to the treatment by day 7.","Centre Hospitalier Universitaire de Saint Etienne","All","18 Years and older   (Adult, Older Adult)","Phase 3","160","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","1508090|2015-002671-21","June 13, 2016","September 2021","January 2022","January 28, 2016",,"April 9, 2021","Chu Saint Etienne, Saint Etienne, France|Department of Gastroenterology Venizeleio General Hospital, Leoforos Knosou, Heraklion, Greece|Sheba Medical Center, Tel HaShomer, Ramat-Gan, Israel|Università di Roma Sapienza, Rome, Italy|Institute of Gastroenterology and Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of|Zvezdara University Clinical Center, Gastroenterology Department, Belgrade, Serbia",,"https://ClinicalTrials.gov/show/NCT02665845"
893,"NCT02632175","Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis",,"Active, not recruiting","No Results Available","Ulcerative Colitis","Biological: Adalimumab","Proportion of subjects who achieve clinical remission as measured by PMS|Proportion of subjects who achieve PUCAI response|Proportion of subjects who achieve clinical response as measured by Partial Mayo Score (PMS)|Proportion of subjects who achieve Pediatric Ulcerative Colitis Activity Index (PUCAI) remission|Assessing impact on children who have inflammatory bowel disease (ulcerative colitis) using IMPACT III questionnaire|Assessing activity impairment using the Work Productivity and Activity Impairment Questionnaire: Ulcerative Colitis (WPAI: UC)|Proportion of subjects who achieve remission/response based on Full Mayo score","AbbVie","All","4 Years to 17 Years   (Child)","Phase 3","101","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","M10-870|2015-001346-29","November 26, 2015","May 14, 2025","May 14, 2025","December 16, 2015",,"February 16, 2021","Arnold Palmer Hosp Children /ID# 147295, Orlando, Florida, United States|MNGI Digestive Health, P. A. /ID# 147294, Minneapolis, Minnesota, United States|Mayo Clinic /ID# 147304, Rochester, Minnesota, United States|MultiCare Institute Health Sys /ID# 169005, Tacoma, Washington, United States|Kurume University Hospital /ID# 145710, Kurume-shi, Fukuoka, Japan|Juntendo University Hospital /ID# 147315, Bunkyo-ku, Tokyo, Japan|National Center for Child Health and Development /ID# 147312, Setagaya-ku, Tokyo, Japan|Instytut Centrum Zdrowia Matki /ID# 169017, Lodz, Lodzkie, Poland|Uni Szpital Dzieciecy w Krakowie /ID# 147279, Cracow, Malopolskie, Poland|Centrum Zdrowia MDM /ID# 147280, Warsaw, Mazowieckie, Poland|Gabinet Lekarski Bartosz Korcz /ID# 147281, Rzeszow, Poland|Samodzielny Publiczny Szpital /ID# 147310, Wroclaw, Poland|Univerzitna nemocnica Martin /ID# 147283, Martin, Zilinsky Kraj, Slovakia|Hospital Universitario Vall d'Hebron /ID# 147288, Barcelona, Spain|The Royal London Hospital /ID# 147290, London, London, City Of, United Kingdom|The Royal Free Hospital /ID# 147292, London, London, City Of, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02632175"
894,"NCT02537210","Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis",,"Recruiting","No Results Available","Colitis, Ulcerative|Aminosalicylic Acid","Drug: Mesalazine|Drug: Placebo oral capsule","The differences of relapse rates between the two arms|Patients' drug compliance","Chinese University of Hong Kong|Queen Elizabeth Hospital, Hong Kong|Alice Ho Miu Ling Nethersole Hospital|Tseung Kwan O Hospital, Hong Kong","All","18 Years and older   (Adult, Older Adult)","Not Applicable","194","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","ASA withdrawal study","September 2015","September 2021","August 2022","September 1, 2015",,"April 29, 2020","Prince of Wales Hospital, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT02537210"
895,"NCT02531126","Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis",,"Active, not recruiting","No Results Available","Ulcerative Colitis","Drug: RPC1063","Number of Participants With Treatment Emergent Adverse Events (TEAEs)|Number of Participants With Adverse Events (AEs)|Number of Participants With Serious Adverse Events (SAEs)|Number of Participants With TEAEs leading to discontinuation of investigational drug|Number of Participants With adverse events of special interest|Proportion of participants with clinical remission|Proportion of participants with a clinical response|Proportion of participants with endoscopic improvement|Proportion of participants with mucosal healing|Proportion of participants with corticosteroid-free remission|Change from Baseline in complete Mayo score|Change from Baseline in partial Mayo score|Change from Baseline in 9-point Mayo score|Proportion of participants with histologic remission|Proportion of patients with clinical response in participants who had previously received anti-TNF therapy|Proportion of patients with clinical remission in participants who had previously received anti-TNF therapy|Proportion of patients with endoscopic improvement in participants who had previously received anti-TNF therapy|Assessment of absolute lymphocyte count (ALC)|Assessment of Plasma protein biomarkers change from baseline|Assessment of Fecal calprotectin change from baseline","Celgene","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 3","871","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","RPC01-3102|2015-001600-64|U1111-1218-0284","December 2, 2015","February 28, 2022","February 28, 2022","August 24, 2015",,"May 18, 2021","Adobe Clinical Research LLC, Tucson, Arizona, United States|Arkansas Gastroenterology, P.A., North Little Rock, Arkansas, United States|Anaheim Clinical Trials, Anaheim, California, United States|Aurora Care Clinic, Costa Mesa, California, United States|University of California San Diego Medical Center, La Jolla, California, United States|OM Research, Lancaster, California, United States|Facey Medical Foundation (Parent), Mission Hills, California, United States|Alliance Clinical Research, LLC, Oceanside, California, United States|Medical Associates Research Group, Inc., San Diego, California, United States|University of California at San Francisco (PARENT), San Francisco, California, United States|West Central Gastroenterology d/b/a Gastro Florida, Clearwater, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|Regenerate Clinical Trials, Miami, Florida, United States|NSB Research, New Smyrna Beach, Florida, United States|Harmony Clinical Research, North Miami Beach, Florida, United States|Center For Digestive Health, Orlando, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Theia Clinical Research, LLC, Pinellas Park, Florida, United States|Florida Medical Clinic, P.A., Zephyrhills, Florida, United States|Atlanta Gastroenterology Associates LLC, Atlanta, Georgia, United States|Gastrointestinal Specialists of Georgia, PC, Marietta, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|Southwest Gastroenterology, Oak Lawn, Illinois, United States|University of Kentucky Medical Center, Lexington, Kentucky, United States|Gastroenterology Associates, LLC, Baton Rouge, Louisiana, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Woodholme Gastroenterology, Baltimore, Maryland, United States|Johns Hopkins Clinical Research Network, Baltimore, Maryland, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Charm City Research Group, Towson, Maryland, United States|Boston Medical Center Boston Univ School of Medicine, Boston, Massachusetts, United States|Mayo Clinic, Rochester, Minnesota, United States|Ehrhardt Clinical Research, LLC, Belton, Missouri, United States|Clinical Research Professionals, LLC - De Paul Medical Dr, Bridgeton, Missouri, United States|Clinical Research Professionals, LLC - Olde Cabin Rd, Saint Louis, Missouri, United States|Mary Hitchcock Memorial Hospital, Lebanon, New Hampshire, United States|Centex Studies-Webster, Brooklyn, New York, United States|Long Island Clinical Research Associates, Great Neck, New York, United States|Concord Medical Group PRIME, New York, New York, United States|New York University School of Medicine, New York, New York, United States|Mount Sinai - PRIME, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Carolinas HealthCare System Digestive Health, Charlotte, North Carolina, United States|East Carolina Gastroenterology, PA, Jacksonville, North Carolina, United States|PMG Research of Rocky Mount, LLC, Rocky Mount, North Carolina, United States|Clinical Inquest Center Ltd, Beavercreek, Ohio, United States|Consultants for Clinical Research Inc., Cincinnati, Ohio, United States|UC Health Clinical Trials Office, Cincinnati, Ohio, United States|Ohio State University Clinical Trials Management Office, Columbus, Ohio, United States|University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City, Oklahoma, United States|Digestive Disease Specialists, Oklahoma City, Oklahoma, United States|Oregon Health & Science University, Portland, Oregon, United States|Consultants in Gastroenterology, PA, Columbia, South Carolina, United States|Gastroenterology Associates of Orangeburg, Orangeburg, South Carolina, United States|Gastro One, Germantown, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Digestive Disease Consultants Dallas, Dallas, Texas, United States|Baylor Research Institute - Dallas Clinical Trials Office, Dallas, Texas, United States|Brooke Army Medical Center Francis Street Medical Center, Fort Sam Houston, Texas, United States|Ventavia Research Group, LLC, Fort Worth, Texas, United States|The Methodist Hospital Research Institute, Houston, Texas, United States|Houston Endoscopy and Research Center, Houston, Texas, United States|Gulf Coast Research Group LLC, Houston, Texas, United States|San Antonio Gastroenterology, San Antonio, Texas, United States|Digestive Health Specialists of Tyler, Tyler, Texas, United States|University of Utah, Salt Lake City, Utah, United States|University of Virginia, Charlottesville, Virginia, United States|Gastroenterology, LTD, Virginia Beach, Virginia, United States|University of Washington School of Medicine, Seattle, Washington, United States|Hospital Italiano, Buenos Aires, Argentina|Instituto Medico CER, Quilmes, Argentina|Instituto Medico de la Fundacion Estudios Clinicos, Rosario, Argentina|Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|Medical University Vienna, Vienna, Austria|Gomel Regional Clinical Hospital, Gomel, Belarus|City Clinical Hospital No 10, Minsk, Belarus|Vitebsk Regional Clinical Hospital, Vitebsk, Belarus|Imeldaziekenhuis, Bonheiden, Belgium|AZ Maria Middelares, Gent, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|UZ Leuven, Leuven, Belgium|CHC - Clinique St-Jospeh, Liege, Belgium|MC Rusemed ltd., Ruse, Bulgaria|NMTH ""Tsar Boris III"", Sofia, Bulgaria|MHAT ""Lyulin"", EAD, Sofia, Bulgaria|""City Clinic UMHAC"" EOOD, Sofia, Bulgaria|MHAT 'Tokuda Hospital Sofia', EAD, Sofia, Bulgaria|UMHAT ""Sv. Ivan Rilski"", EAD, Sofia, Bulgaria|UMHAT 'Tsaritsa Yoanna - ISUL', EAD, Sofia, Bulgaria|Fourth MHAT - Sofia EAD, Sofia, Bulgaria|Medical Center ""Nov Rehabilitatsionen Tsentar"", EOOD, Stara Zagora, Bulgaria|MHAT 'Sv. Marina', EAD, Varna, Bulgaria|MC Medica Plus, Veliko Tarnovo, Bulgaria|Vancouver General Hospital, Vancouver, British Columbia, Canada|Viable Clinical Research - Lindsay, Lindsay, Ontario, Canada|LHSC - University Hospital, London, Ontario, Canada|LHSC - Victoria Hospital, London, Ontario, Canada|Humber River Hospital, Toronto, Ontario, Canada|Toronto Liver Centre, Toronto, Ontario, Canada|Toronto Digestive Disease Associates, Inc., Vaughan, Ontario, Canada|The Ottawa Hospital - General Campus, Ottawa, Quebec, Canada|Clinical Hospital Centre Osijek, Osijek, Croatia|Clinical Hospital Centre Rijeka, Rijeka, Croatia|Vojenska nemocnice Brno, Brno, Czechia|Hepato-Gastroenterologie HK, s.r.o., Hradec Kralove, Czechia|GASTRO JeKa s.r.o., Klatovy, Czechia|Gregar s.r.o., Olomouc, Czechia|PreventaMed, Olomouc, Czechia|ISCARE, a.s., Prague 9, Czechia|Institut klinicke a experimentalni mediciny, Praha 4, Czechia|Nemocnice Slany, Slany, Czechia|LTD Research Institute of Clinical Medicine, Tbilisi, Georgia|LLC Vivamedi, Tbilisi, Georgia|LTD Academician N.Kipshidze Central University Clinic, Tbilisi, Georgia|LTD Coloproctological Center, Tbilisi, Georgia|Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany|Charite - Campus Virchow-Klinikum, Berlin, Germany|DRK Kliniken Berlin Westend, Berlin, Germany|Medizinisches Versorgungszentrum Dachau, Dachau, Germany|Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden, Germany|Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt, Germany|Crohn Colitis Centrum Rhein Main, Frankfurt, Germany|Asklepios Klinik Hamburg, Hamburg, Germany|Universitaetsklinikum Koeln, Koeln, Germany|EUGASTRO GmbH, Leipzig, Germany|Universitaetsklinikum Schleswig-Holstein - Campus Luebeck, Luebeck, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, Germany|General Hospital of Athens Evangelismos, Athens, Greece|DRC Gyogyszervizsgalo Kozpont Kft, Balatonfured, Hungary|Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaz, Bekescsaba, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary|Semmelweis Egyetem, Budapest, Hungary|Pannonia Maganorvosi Centrum, Budapest, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaza, Gyula, Hungary|Vasutegeszsegugyi Kft. - Debreceni Egeszsegugyi Kozpont, Letavertes, Hungary|Mohacsi Korhaz, Mohacs, Hungary|Clinfan Szolgaltato Kft, Szekszard, Hungary|Shaare Zedek Medical Center, Jerusalem, Israel|Meir Medical Center, Kfar-Saba, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Kaplan Medical Center, Rechovot, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Azienda Ospedaliera Universitaria Policlinico Sant Orsola Malpighi, Bologna, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, Italy|Azienda Ospedaliero Universitaria San Martino, Genova, Italy|Azienda Socio Sanitaria Territoriale Fatebenefratelli (Presidio Ospedale Sacco), Milano, Italy|A.O.U. Policlinico di Modena, Modena, Italy|Azienda Socio Sanitaria Territoriale di Monza (Presidio San Gerardo), Monza, Italy|Azienda Ospedaliera Universitaria ""Federico II"", Napoli, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, Italy|Complesso Integrato Columbus, Roma, Italy|Istituto Clinico Humanitas, Rozzano, Italy|IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Yeungnam University Hospital, Daegu, Korea, Republic of|Hanyang Univerisy Guri Hospital, Guri-si, Korea, Republic of|CHA Bundang Medical Center CHA University, Seongnam-si,, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of|Kyung Hee University Hospital, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Korea University Anam Hospital, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital, Suwon-si, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wonju-si, Korea, Republic of|P. Stradins Clinical University Hospital, Riga, Latvia|""Sfanta Treime"" Clinical Municipal Hospital, Chisinau, Moldova, Republic of|Clinical Hospital of the Ministry of Health, Department of Endoscopic Surgery, Chisinau, Moldova, Republic of|""Sf. Arhanghel Mihail"" Municipal Clinical Hospital, Chisinau, Moldova, Republic of|Republican Clinical Hospital, Chisinau, Moldova, Republic of|Vrije Universiteit Medisch Centrum (VUMC), Amsterdam, Netherlands|Academisch Medisch Centrum, Amsterdam, Netherlands|Universitair Medisch Centrum Groningen (UMCG), Groningen, Netherlands|Zuyderland Medisch Centrum - Sittard-Geleen, Sittard-Geleen, Netherlands|ETZ Elisabeth, Tilburg, Netherlands|Dunedin Public Hospital, Dunedin, New Zealand|Clinsante S.C. Osrodek Badan Klinicznych, Bydgoszcz, Poland|Specjalistyczna Przychodnia Lekarska Medicus, Chorzow, Poland|Niepubliczny Zaklad Opieki Zdrowotnej Inter-Med, Czestochowa, Poland|GLOBE Clinical Research Sp. z o.o. LLC, Klodzko, Poland|PLEJADY Sp. z o.o. (LLC) Medical Centre, Krakow, Poland|Healthcare Center Orkan Med Stec Michalska Spolka Jawna, Ksawerow, Poland|Santa Familia Centrum Badan, Profilaktyki i Leczenia, Lodz, Poland|KO-MED Centra Kliniczne Lublin II, Lublin, Poland|Trialmed Llc, Piotrkow Trybunalski, Poland|Specjalistyczna Praktyka Lekarska dr med. Marek Horynski, Sopot, Poland|KO-MED Centra Kliniczne Staszow, Staszow, Poland|GASTROMED Kopon, Zmudzinski and Partners Specialist Centre for Gastroenterology and Endoscopy, Spe, Torun, Poland|MDM Healthcare Centre, Warsaw, Poland|Health Centre Metabolic Diseases Outpatient Clinic in Wierzchoslawice, Wierzchoslawice, Poland|LexMedica Osrodek Badan Klinicznych, Wroclaw, Poland|Bacau County Emergency Hospital, Department of Gastroenterology, Bacau, Romania|Hyperclinica MedLife Grivita, Bucharest, Romania|Bucharest University Emergency Hospital, Department of Internal Medicine II, Bucharest, Romania|TVM MED SERV SRL, Medical Center for Gastroenterology, Hepatology and Digestive Endoscopy, Cluj-Napoca, Romania|Craiova County Emergency Clinical Hospital, Craiova, Romania|""Pius Brinzeu"" County Emergency Clinical Hospital, Department of Gastroenterology and Hepatology, Timisoara, Romania|Multidisciplinary Medical Clinic ""Anthurium"", Barnaul, Russian Federation|Irkutsk State Medical Academy of Continuing Education, Irkutsk, Russian Federation|SBEI HPE ""Kazan State Medical University"" of the MoH of the RF, Kazan, Russian Federation|SBIH of Nizhniy Novgorod region "" Nizhniy Novgorod Regional Clinical Hospital n.a. N.A. Semashko"", Nizhniy Novgorod, Russian Federation|SBEIHPE Novosibirsk State Medical University, Novosibirsk, Russian Federation|FSBI ""Scientific Research Institute of Physyology and Basic Medicine"" under the SB of RAMS, Novosibirsk, Russian Federation|BHI of Omsk region ""Clinical Oncology Dispensary"", Omsk, Russian Federation|SBEI HPE Rostov State Medical University of the MoH of the RF, Rostov-on-Don, Russian Federation|City Clinical Hospital No 31 - St. Petersburg, Saint Petersburg, Russian Federation|FSMEI HPE ""Military Medical Academy n.a. S.M.Kirov""of Ministry of Defense of Russia, Saint-Petersburg, Russian Federation|SPb SBIH City Hospital # 26, Saint-Petersburg, Russian Federation|Pavlov First Saint Petersburg State Medical University, Saint-Petersburg, Russian Federation|Private Educational Institution of Higher Education ""Medical University ""REAVIZ"", Samara, Russian Federation|LLC Medical Company Hepatologist, Samara, Russian Federation|FFSBI ""The Nikiforov Russian Center of Emergency and Radiation Medicine"", St. Petersburg, Russian Federation|SPb SBIH Alexandrovskaya City Hospital, St.Petersburg, Russian Federation|SBEI HPE ""Stavropol State Medical Academy"" MoH of RF, Stavropol, Russian Federation|Clinical Hospital Center Zvezdara Clinic of Internal Diseases, Belgrade, Serbia|Military Medical Academy, Belgrade, Serbia|Clinical Center Bezanijska Kosa, Belgrade, Serbia|Clinical Hospital Center Zemun Department of Gastroenterology, Belgrade, Serbia|Clinical Center Kragujevac, Kragujevac, Serbia|General Hospital Djordje Jovanovic Zrenjanin, Zrenjanin, Serbia|Fakultna nemocnica s poliklinikou F.D. Roosevelta, Banska Bystrica, Slovakia|Alian s.r.o., Bardejov, Slovakia|Gastromedic s.r.o., Nove Zamky, Slovakia|GASTRO I., s.r.o., Presov, Slovakia|Dr MJ Prins Practice, Cape Town, South Africa|Endocare Research, Cape Town, South Africa|Emmed Research, Pretoria, South Africa|RCI Chernivtsi Regional Clinical Hospital Dept of Gastroenterology Bukovinsky SMU, Chernivtsi, Ukraine|Dnipropetrovsk I.I. Mechnykov Regional Clinical Hospital, Dnipropetrovsk, Ukraine|Si Institute Of Gastroenterology Of Namsu Dept Of Stomach And Duodenum Diseases, Dnipropetrovsk, Ukraine|Central City Clinical Hospital Dept of Theraphy No. 2 SHEI Ivano-Frankivsk NMU, Ivano-Frankivsk, Ukraine|CI of PH Kharkiv CCH #2, Kharkiv, Ukraine|GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine, Kharkiv, Ukraine|Ok Clinic Medical Center within International Institute of Clinical Trials, LLC, Kyiv, Ukraine|Kyiv Regional Hospital #2, Kyiv, Ukraine|SI Republican Clinical Hospital of the MOHU Dept of Gastroenterology O.O.Bogomolets NMU, Kyiv, Ukraine|Kyiv CCH #8 Dept of Gastroenterology P.L. Shupyk NMA of PGE, Kyiv, Ukraine|Kyiv CCH #18 Dept of Proctology O. O. Bogomolets NMU, Kyiv, Ukraine|Lviv Regional Clinical Hospital D Halytskyi Lviv NMU, Lviv, Ukraine|Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU, Lviv, Ukraine|CI Sumy City Clinical Hospital #1 Dept of Therapy Sumy SU, Sumy, Ukraine|Sumy Regional Clinical Hospital, Sumy, Ukraine|Vinnytsia Regional Clinical Hospital for Invalids of the Great Patriotic War, Vinnytsia, Ukraine|M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU, Vinnytsia, Ukraine|Vinnytsia M.I. Pyrohov National Medical University, Vinnytsia, Ukraine|City Clinical Hospital of Emergency and Urgent Care of Zaporizhzhya, Zaporizhia, Ukraine|CI City Hospital #1, Zaporizhia, Ukraine|CI Zapor City Multifunctional CH#9 City Center of Gastroenterology SI Zapor MA of PGE of MOHU, Zaporizhzhia, Ukraine|Zaporizhia Regional Clinical Hospital, Zaporizhzhia, Ukraine|Central District Hospital under Zhytomyr District Council, Zhytomyr, Ukraine|Royal Devon and Exeter Hospital (Wonford), Exeter, United Kingdom|Whipps Cross University Hospital, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital, London, United Kingdom|Royal Shrewsbury Hospital, Shrewsbury, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02531126"
896,"NCT02469220","Diet Treatment of Patients With Ulcerative Colitis in Remission",,"Active, not recruiting","No Results Available","Ulcerative Colitis","Dietary Supplement: Low FODMAP|Dietary Supplement: Standardized FODMAP","Gastrointestinal symptoms|Change in Quality of life|Pain diary","Vendsyssel Hospital","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","19","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","RHN_ALK_01","July 1, 2018","August 31, 2020","July 31, 2021","June 11, 2015",,"October 8, 2020","North Denmark Regional Hospital, Hjørring, Nordjylland, Denmark",,"https://ClinicalTrials.gov/show/NCT02469220"
897,"NCT02466217","Phenomics in Autoimmune and Inflammatory Diseases","TRANSIMMUNOM","Recruiting","No Results Available","Healthy Volunteer|Rheumatoid Arthritis|Ankylosing Spondylitis|Systemic Lupus Erythematosus/Antiphospholipid Syndrome|FMF|Cryopyrin-Associated Periodic Syndromes /TNF-receptor Associated Periodic Syndrome|Vasculitis|Uveitis|Myositis|Crohn's Disease|Ulcerative Rectocolitis|Type 1 Diabetes|Unclassified IAD Knee and/or Hip Arthritis, Muscular Dystrophy","Other: 1: AID groups|Other: 2: Control groups","Total peripheral blood gene expression between patients, expressed as fluorescence intensity|Tregs and Tconvs T cell receptor repertoire, expressed as the % of unique TCR sequences|HLA type and SNPs expressed as the occurrence events across patients|Microbiote species identification expressed as the % of species per family and genus|Cytokines and chemokines expressed as fluorescence intensity|Immune cells phenotyping expressed as the each cell type % within total PBMCs|Changes in gene expression intensity between patients and healthy controls - for each Disease cohorts|Changes in Tregs and Tconvs TCR sequence frequencies between patients and healthy controls - for each Disease cohorts|Characterization of HLA and SNP profiles in patients and healthy controls - for each Disease cohorts|Changes in Microbiote composition between patients and healthy controls - for each Disease cohorts|Changes in cytokines and chemokines expression levels between patients and healthy controls - for each Disease cohorts|Changes in immune cells frequencies between patients and healthy controls - for each Disease cohorts|Identification of specific and common gene expression levels between patients - between Disease cohorts|Identification of specific and common Tregs and Tconvs TCR sequence frequencies between patients - between Disease cohorts|Characterization of specific and common HLA and SNP profiles in patients - between Disease cohorts|Identification of specific and common microbiote composition between patients - between Disease cohorts|Identification of specific and common cytokines and chemokines expression levels between patients - between Disease cohorts|Characterization specific and common variations in immune cells frequencies between patients - between Disease cohorts","Assistance Publique - Hôpitaux de Paris|National Research Agency, France","All","18 Years and older   (Adult, Older Adult)",,"1300","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","P141006|2015-A00558-41","July 2015","July 2022","July 2025","June 9, 2015",,"May 14, 2020","Rhumatologie - Hôpital Saint-Antoine, Paris, France|CIC Paris-Est, Hôpital PITIE SALPETRIERE, Paris, France",,"https://ClinicalTrials.gov/show/NCT02466217"
898,"NCT02345733","Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis (UC)","Other: Ulcerative Colitis Diet|Drug: Antibiotic cocktail","Remission rate, defined as a PUCAI less than 10 at week 6.|Mean PUCAI week 6|Mean Calprotectin at week 6|Physicians Global Assessment week 6|Remission week 12, defined as a PUCAI less than 10|Mean PUCAI week 12","Prof. Arie Levine|Wolfson Medical Center","All","8 Years to 19 Years   (Child, Adult)","Phase 4","20","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","0009-15-WOMC","September 2015","December 2021","December 2021","January 26, 2015",,"February 17, 2021","The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|IWK Health Centre, Dalhousie University, Halifax, Nova Scotia, Canada|The E. Wolfson.Medical Center, Holon, Israel",,"https://ClinicalTrials.gov/show/NCT02345733"
899,"NCT02291523","The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis","FMT_UC","Recruiting","No Results Available","Ulcerative Colitis","Biological: Fecal Microbial Transplant","The primary endpoint is disease remission based on PUCAI scores (<10).|Secondary endpoints will include change in mucosal inflammation reflected on laboratory studies.","Children's Hospital Los Angeles","All","7 Years to 21 Years   (Child, Adult)","Phase 1","101","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","CHLA-16-00050","November 2016","November 2021","November 2023","November 14, 2014",,"January 27, 2020","Children's Hospital Los Angeles, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT02291523"
900,"NCT02277223","Curcumin in Pediatric Ulcerative Colitis",,"Recruiting","No Results Available","Ulcerative Colitis","Dietary Supplement: Curcumin|Drug: Placebo","A change in disease activity, defined by PUCAI at 2 weeks and 6 months|Sustained clinical remission, 2 weeks and 6 months|Medication associated adverse events|Time to relapse|The need for further medical interventions (e.g topical 5-ASA) during the maintenance phase","Schneider Children's Medical Center, Israel","All","6 Years to 18 Years   (Child, Adult)","Phase 3","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","PUCC 1","March 1, 2020","July 31, 2022","December 31, 2022","October 28, 2014",,"March 19, 2020","Schneider Medical Center, Petach Tikva, Israel",,"https://ClinicalTrials.gov/show/NCT02277223"
901,"NCT02229344","Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea","MOSAIK","Active, not recruiting","No Results Available","Colitis, Ulcerative","Other: No Intervention","Total Number of Relapses in Year 1|Total Number of Relapses in Year 3|Total Number of Relapses in Year 5|Percentage of Participants With Sustained Remission in Year 1|Percentage of Participants With Sustained Remission in Year 3|Percentage of Participants With Sustained Remission in Year 5|Mean Time to Relapse|Percentage of Participants With Sustained Clinical Response|Total Number of Ulcerative Colitis-Related Hospitalizations|Total Days of Ulcerative Colitis-Related Hospitalizations|Percentage of Participants With Colectomy|Percentage of Participants With Death|Mean Change From Baseline in Disease Extent at Year 1, 3 and 5|Mean Change From Baseline in Inflammatory Bowel Disease Questionnaire (IBDQ) Score at Year 1, 3 and 5|Mean Change From Baseline in Short Form Survey (SF 12) Score at Year 1, 3 and 5|Change From Baseline in Hospital Anxiety and Depression Scale (HADS) Score at Year 1, 3 and 5|Percentage of Participants Treated With Immune Modulators, Systemic Steroids and Biologics|Mean Time to First Treatment With Immune Modulators, Systemic Steroids and Biologics From Baseline|Number of Participants With Complementary and Alternative Medicine (CAM) use and Satisfaction","Janssen Korea, Ltd., Korea","All","7 Years and older   (Child, Adult, Older Adult)",,"368","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","CR103116|REMICADECRD4016|INF-KOR-5005","July 1, 2014","February 22, 2022","February 28, 2022","September 1, 2014",,"March 17, 2021","Ansan-si, Korea, Republic of|Busan, Korea, Republic of|Cheonan, Korea, Republic of|Cheongju-si, Korea, Republic of|Daegu, Korea, Republic of|Daejeon, Korea, Republic of|Guri-Si, Korea, Republic of|Gwangju, Korea, Republic of|Iksan, Korea, Republic of|Incheon, Korea, Republic of|Kwanju, Korea, Republic of|Seongnam-Si, Korea, Republic of|Seoul, Korea, Republic of|Suwon, Korea, Republic of|Wonju, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT02229344"
902,"NCT02118584","Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies","COTTONWOOD","Active, not recruiting","No Results Available","Ulcerative Colitis","Drug: Etrolizumab","Percentage of Participants With Clinical Remission as Determined by the Partial Mayo Clinic Score (pMCS) - Part 1|Percentage of Participants With Remission as Determined by the Mayo Clinic Score (MCS) - Part 1|Percentage of Participants With Endoscopic Remission|Percentage of Participants With Anti-therapeutic Antibodies to Etrolizumab - Part 1|Percentage of Participants With Adverse Events - Part 1|Percentage of Participants With Progressive Multifocal Leukoencephalopathy (PML) - Part 2|Change From Baseline in pMCS at Year 9","Hoffmann-La Roche","All","18 Years and older   (Adult, Older Adult)","Phase 3","1822","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","GA28951|2013-004435-72","September 15, 2014","August 16, 2025","August 16, 2025","April 21, 2014",,"April 13, 2021","University of Alabama Medical Center, Birmingham, Alabama, United States|University of California San Diego Medical Center, La Jolla, California, United States|University of California, Irvine Medical Center, Orange, California, United States|Clinical Applications Laboratories, Inc., San Diego, California, United States|University of California at San Francisco, San Francisco, California, United States|Ventura Clinical Trials, Ventura, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Rocky Mountain Gastroenterology Associates, Denver, Colorado, United States|Clinical Research of the Rockies, Lafayette, Colorado, United States|Innovative Medical Research of South Florida, Inc., Aventura, Florida, United States|West Central Gastroenterology d/b/a Gastro Florida, Clearwater, Florida, United States|IMIC, Inc, Miami Beach, Florida, United States|Regenerate Clinical Trials, Miami, Florida, United States|FQL Research, LLC, Miramar, Florida, United States|Gastroenterology Group of Naples, Naples, Florida, United States|Internal Medicine Specialists, Orlando, Florida, United States|Advanced Research Institute, Inc., Trinity, Florida, United States|Shafran Gastroenterology Center, Winter Park, Florida, United States|Atlanta Gastroenterology Associates, Atlanta, Georgia, United States|Gastroenterology Associates of Central Georgia, Macon, Georgia, United States|Gastrointestinal Specialists of Georgia, PC, Marietta, Georgia, United States|Atlanta Gastroenterology Specialists, PC, Suwanee, Georgia, United States|Northwestern University Feinberg School Of Medicine, Chicago, Illinois, United States|University of Chicago Medical Center; Medicine, Section of Pulmonary, Chicago, Illinois, United States|Southwest Gastroenterology, Oak Lawn, Illinois, United States|Aquiant Research, New Albany, Indiana, United States|Cotton-O'Neil Clinical Research Center, Digestive Health, Topeka, Kansas, United States|Gastroenterology Associates, LLC, Baton Rouge, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Massachusetts General Hospital; Crohn's & Colitis Center, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Center for Digestive Health, Troy, Michigan, United States|Huron Gastroenterology Associates, Ypsilanti, Michigan, United States|Regents of the University of Minnesota, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Ehrhardt Clinical Research, LLC, Belton, Missouri, United States|Kansas City Research Institute, LLC, Kansas City, Missouri, United States|Clinica Peruano Americana S.A., Great Neck, New York, United States|NYU Langone Medical Center IRB, New York, New York, United States|Concorde Medical Group, New York, New York, United States|Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York, New York, United States|Asheville Gastroenterology Associates, P.A., Asheville, North Carolina, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Kinston Medical Specialists, Kinston, North Carolina, United States|Consultants for Clin. Rsrch, Cincinnati, Ohio, United States|UC Health Clinical Trials Office; Division of Digestive Diseases, Cincinnati, Ohio, United States|Great Lakes Gastroenterology Research, LLC, Mentor, Ohio, United States|Gastroenterology Center of the Midsouth, P.C., Memphis, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Digestive Disease Consultants - Dallas, Dallas, Texas, United States|Wellness Clinical Research Center, San Antonio, Texas, United States|Texas Digestive Disease Consultants - Southlake, Southlake, Texas, United States|Tyler Research Institute, LLC, Tyler, Texas, United States|Ericksen Research and Development, Clinton, Utah, United States|University of Utah School of Medicine, Salt Lake City, Utah, United States|McGuire Research Institute; Gastroenterology, Richmond, Virginia, United States|Washington Gastroenterology, Bellevue, Washington, United States|Instituto Medico DAMIC, Cordoba, Argentina|Hospital Provincial del Centenario, Rosario, Argentina|Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, Australia|Mater Adult Hospital, Mackay, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|Launceston General Hospital; Gastroenterology Research, Launceston, Tasmania, Australia|Monash Medical Centre, Clayton, Victoria, Australia|St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|Footscray Hospital, Footscray, Victoria, Australia|St Frances Xavier Cabrini Hospital, Malvern, Victoria, Australia|Royal Melbourne Hospital; Department of Colorectal Medicine and Genetics, Parkville, Victoria, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, Australia|Klinikum Klagenfurt am Wörtersee, Klagenfurt am Worthersee, Austria|LKH - Universitätsklinikum der PMU Salzburg, Salzburg, Austria|Medizinische Universität Wien, Wien, Austria|GZA Ziekenhuizen - Campus Sint-Vincentius, Antwerpen, Belgium|Imeldaziekenhuis, Bonheiden, Belgium|CHU St Pierre (St Pierre), Brussels, Belgium|UZ Brussel, Brussel, Belgium|Cliniques Universitaires Saint-Luc; Pharmacy, Bruxelles, Belgium|UZ Gent, Gent, Belgium|AZ Sint Elisabeth Herentals, Herentals, Belgium|UZ Leuven; Neurology, Leuven, Belgium|AZ Delta (Campus Rumbeke), Roeselare, Belgium|Hospital Universitario Prof Edgar Santos-Ufba; Ambulatorio Magalhaes Neto 3Andar- Dermatologia, Salvador, BA, Brazil|Hospital Universitario Walter Cantidio - UFC, Fortaleza, CE, Brazil|CCBR - Brasilia, Brasilia, DF, Brazil|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Ltda, Goiânia, GO, Brazil|Hospital Felicio Rocho, Belo Horizonte, MG, Brazil|Centro Digestivo de Curitiba, Curitiba, PR, Brazil|Hospital Universitario Clementino Fraga Filho - UFRJ, Rio de Janeiro, RJ, Brazil|Hospital Moinhos de Vento, Porto Alegre, RS, Brazil|Hospital das Clinicas - UFRGS, Porto Alegre, RS, Brazil|Hospital Ernesto Dornelles, Porto Alegre, RS, Brazil|UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu, Botucatu, SP, Brazil|CAEP - Centro Avancado de Estudos e Pesquisas Ltda., Campinas, SP, Brazil|CECIP - Centro de Estudos Clínicos do Interior Paulista, Jaú, SP, Brazil|Pesquisare Saúde Sociedade Simples, Santo Andre, SP, Brazil|Hospital Estadual Mario Covas, Santo Andre, SP, Brazil|Hospital Sírio-Libanês, Sao Paulo, SP, Brazil|Hospital do Servidor Público Estadual/HSPE-SP, São Paulo, SP, Brazil|Medical Centre ""Asklepii"", OOD, Dupnitsa, Bulgaria|DCC Sv. Pantaleymon OOD; II-nd Clinic of Neurology, Pleven, Bulgaria|Medical center Medconsult Pleven OOD, Pleven, Bulgaria|MHAT - Ruse, AD, Ruse, Bulgaria|MHAT ""Hadzhi Dimitar"", OOD, Sliven, Bulgaria|""City Clinic UMHAC"" EOOD, Sofia, Bulgaria|UMHAT ""Sv. Ivan Rilski"", EAD, Sofia, Bulgaria|UMHAT Tsaritsa Yoanna - ISUL, EAD, Sofia, Bulgaria|Diagnostic Consultation Center CONVEX EOOD, Sofia, Bulgaria|Medical Center ""Nov Rehabilitatsionen Tsentar"", EOOD, Stara Zagora, Bulgaria|MHAT 'Sv. Marina', EAD; First Children's Clinic, Varna, Bulgaria|MC Medica Plus, Veliko Tarnovo, Bulgaria|University of Calgary, Calgary, Alberta, Canada|Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology, Edmonton, Alberta, Canada|Pacific Gastroenterology Associates, Vancouver, British Columbia, Canada|Queen Elizabeth II Health Sciences Centre; Gastroenterology Research, Halifax, Nova Scotia, Canada|Guelph GI & Surgery Clinic, Guelph, Ontario, Canada|University Hospital - London Health Sciences Centre, London, Ontario, Canada|Taunton Health Centre, Oshawa, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Toronto Liver Centre, Toronto, Ontario, Canada|Toronto Digestive Disease Associates, Vaughan, Ontario, Canada|Centre de santé et de services sociaux Champlain-Charles-Le Moyne, Greenfield Park, Quebec, Canada|Hotel Dieu de Levis, Levis, Quebec, Canada|Hôpital Maisonneuve - Rosemont, Montreal, Quebec, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada|RTS - Fundación Valle de Lili, Cali, Colombia|Instituto de Coloproctologia ICO S.A.S., Medellin, Colombia|Clinical Hospital Centre Osijek, Osijek, Croatia|Clinical Hospital Sveti Duh; Department of Neurology, Zagreb, Croatia|Vojenska nemocnice Brno, Brno, Czechia|Fakultni nemocnice u sv. Anny v Brne; I.Interni kardioangiologicka klinika, Brno, Czechia|Fakultni nemocnice Hradec Kralove, Hradec Kralove, Czechia|Hepato-Gastroenterologie HK, s.r.o., Hradec Kralove, Czechia|Oblastni nemocnice Kladno, a.s., nemocnice Stredoces. kraje; Endoskopicke centrum, Kladno, Czechia|PreventaMed, s.r.o., Olomouc, Czechia|Mestska Nemocnice Ostrava, Ostrava, Czechia|Pardubicka krajska nemocnice, a.s., Pardubice, Czechia|Nemocnice Na Bulovce, Prague, Czechia|ISCARE a.s., Praha 7, Czechia|Krajska zdravotni, a.s. - Masarykova nemocnice v Usti nad Labem, o.z., Ocni oddeleni, Usti Nad Labem, Czechia|Krajska nemocnice T. Bati, a.s., Zlin, Czechia|Herlev og Gentofte Hospital, Herlev, Denmark|Rigshospitalet; Medicinsk gastroenterologisk klinik, København Ø, Denmark|Ålborg Universitets Hospital; Gastromedicinsk, Ålborg, Denmark|OÜ Innomedica, Tallinn, Estonia|East Tallinn Central Hospital, Tallinn, Estonia|West Tallinn Central Hospital, Tallinn, Estonia|North Estonia Medical Centre Foundation, Tallinn, Estonia|Tartu University Hospital, Tartu, Estonia|CHU Amiens - Hopital Sud, Amiens, France|CHU de Caen - Hopital Cote de Nacre, Caen, France|CHU Tours - Hôpital Trousseau, Chambray les Tours, France|CHU Clermont Ferrand - Hôtel Dieu, Clermont-Ferrand, France|Hôpital Beaujon, Clichy cedex, France|Hopital Claude Huriez - CHU Lille, Lille, France|CHU Hopital Saint Eloi, Montpellier, France|CHU Nice - Hopital de l'Archet 2, Nice, France|Hôpital Saint-Louis, Paris, France|CHU Bordeaux - Hôpital Haut-Lévêque, Pessac, France|Centre Hospitalier Lyon Sud; Service de Gastro-Enterologie, Pierre-Benite, France|CHU Saint Etienne - Hôpital Nord, Saint Etienne, France|Höpital Hautepierre; Pediatrie1, Strasbourg, France|CHU de Toulouse - Hôpital Rangueil, Toulouse Cedex 09, France|Hôpital de Brabois Adultes, Vandoeuvre-les-nancy, France|Charite Universitaetsmedizin Berlin - Campus Charite Mitte, Berlin, Germany|Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany|DRK Kliniken Berlin Westend, Berlin, Germany|Krankenhaus Waldfriede e. V., Berlin, Germany|Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH, Bochum, Germany|Universitaetsklinikum Erlangen, Erlangen, Germany|Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt, Germany|Universitaetsklinikum Freiburg; Urology, Freiburg, Germany|Universitaetsklinikum Halle (Saale), Halle, Germany|Hamburgisches Forschungsinstitut fuer CED, Hamburg, Germany|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Gastroenterologie Eppendorfer Baum, Hamburg, Germany|Medizinische Hochschule Hannover; Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Hannover, Germany|Universitaetsklinikum Jena; Apotheke des Uniersitätsklinikums Jena, Jena, Germany|Universitaetsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany|Universitätsklinikum Koeln, Koeln, Germany|Medizinisches Zentrum Klinikum Lueneburg, Lueneburg, Germany|Klinikum Mannheim GmbH Universitätsklinikum, Mannheim, Germany|Universitaetsklinikum Muenster, Muenster, Germany|Gemeinschaftspraxis Dres. Joachim Mueller und Steffi Appelt, Schweinfurt, Germany|Universitaetsklinikum Ulm, Ulm, Germany|University General Hospital of Heraklion, Herakleion, Greece|University of Hong Kong, Hong Kong, Hong Kong|DRC Gyogyszervizsgalo Kozpont Kft, Balatonfured, Hungary|Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaza, Bekescsaba, Hungary|Semmelweis Egyetem, Budapest, Hungary|Eszak-Kozep-budai Centrum, Uj Szent Janos Korhaz es Szakrendelo, Budapest, Hungary|Pannónia Klinika Magánorvosi, Budapest, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont; Fázis I-es Klinikai Farmakológiai Vizsgálóhely, Budapest, Hungary|Endomedix Diagnosztikai Kozpont, Budapest, Hungary|Vasutegeszsegugyi Kft. - Debreceni Egeszsegugyi Kozpont, Debrecen, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Markhot Ferenc Oktato Korhaz es Rendelointezet, Eger, Hungary|Petz Aladar Megyei Oktato Korhaz, Gyor, Hungary|Pest Megyei Flor Ferenc Korhaz, Kistarcsa, Hungary|Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz, Miskolc, Hungary|Pecsi Tudomanyegyetem, Pecs, Hungary|Csongrad Megyei Dr. Bugyi Istvan Korhaz, Szentes, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Székesfehérvár, Hungary|Osmania General Hospital, Hyderabad, Andhra Pradesh, India|Deccan College of Medical Sciences and Allied Hospitals; Department of Gastroenterology, Hyderabad, Andhra Pradesh, India|Nirmal Hospital, Surat, Gujarat, India|K.L.E. Society's Dr. Prabhakar Kore Hospital and Medical Research Centre, Belgaum, Karnataka, India|M. S. Ramaiah Medical College and Hospital, Bengaluru, Karnataka, India|Midas institute of Gastroenterology, Nagpur, Maharashtra, India|Dayanand Medical College and Hospital, Ludhiana, Punjab, India|S. R. Kalla Memorial Gastro & General Hospital, Jaipur, Rajasthan, India|Kasturba Medical College & Hospital, Mangalore, India|Ruby Hall Clinic, Pune, India|King Edward Memorial Hospital Research Centre, Pune, India|Bnai Zion Medical Center; Internal Medicine, Haifa, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah University Hospital - Ein Kerem, Jerusalem, Israel|Holy Family Hospital, Nazareth, Israel|Rabin Medical Center-Beilinson Campus; Gaucher Clinic, Genetics Institute, Petach Tiqwa, Israel|Kaplan Medical Center, Rehovot, Israel|Assaf Harofeh, Rishon Lezion, Israel|Chaim Sheba Medical Center; Pediatrics B North and Pediatric Endocrinology Unit, Tel Hashomer, Israel|Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpigh, Bologna, Emilia-Romagna, Italy|A.O.U. Policlinico di Modena, Modena, Emilia-Romagna, Italy|Azienda Ospedaliero Universitaria di Parma, Parma, Emilia-Romagna, Italy|Azienda Ospedaliera Universitaria Policlinico Tor Vergata, Roma, Lazio, Italy|Azienda Ospedaliera San Camillo Forlanini, Roma, Lazio, Italy|Ospedale Sandro Pertini, Roma, Lazio, Italy|Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Lazio, Italy|Azienda Ospedaliero Universitaria San Martino, Genova, Liguria, Italy|Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Lombardia, Italy|Azienda Ospedaliera Fatebenefratelli e Oftalmico, Milano, Lombardia, Italy|Azienda Socio Sanitaria Territoriale Niguarda (Grande Ospedale Metropolitano Niguarda), Milano, Lombardia, Italy|Azienda Socio Sanitaria Territoriale Fatebenefratelli (Presidio Ospedale Sacco), Milano, Lombardia, Italy|Ospedale di Circolo; Neuropsichiatria Infantile, Rho, Lombardia, Italy|Istituto Clinico Humanitas, Rozzano (MI), Lombardia, Italy|I.R.C.C.S Policlinico San Donato, San Donato Milanese (MI), Lombardia, Italy|IRCCS Ospedale Casa Sollievo della Soffenza; Stru Comp di Gastroenterologia ed Endoscopia digest, San Giovanni Rotondo, Lombardia, Italy|Ospedale Mauriziano Umberto I, Torino, Piemonte, Italy|Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo, Sicilia, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, Toscana, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, Toscana, Italy|Azienda Ospedaliera di Padova, Padova, Veneto, Italy|Dong-A University Hospital, Busan, Korea, Republic of|Pusan National University Hospital, Busan, Korea, Republic of|Kyungpook National University Medical Center, Daegu, Korea, Republic of|Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of|Kyungpook National University Hospital, Daegu, Korea, Republic of|Yeungnam Univ. Hospital, Daegu, Korea, Republic of|Korea University Ansan Hospital, Gyeonggi-do, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of|CHA Bundang Medical Centre; CHA university, Seongnam, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of|Asan Medical Center., Seoul, Korea, Republic of|Ajou University Hospital, Suwon City, Korea, Republic of|The Catholic University of Korea St. Vincent's Hospital, Suwon-si,, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wonju-Si, Korea, Republic of|Daugavpils Regional Hospital, Daugavpils, Latvia|Pauls Stradins Clinical University Hospital, Rīga, Latvia|Digestive Diseases Center ""Gastro"", Rīga, Latvia|Hospital of Lithuanian University of Health. Sciences Kaunas Clinics, Kaunas, Lithuania|Klaipeda Seamen's Hospital, Public Institution, Klaipeda, Lithuania|Vilnius University Hospital Santariskiu Clinic, Public Institution; Cardiology, Vilnius, Lithuania|Hospital Raja Perempuan Zainab II; Department of Medicine, Kota Bahru, Malaysia|Pusat Perubatan Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia|University Malaya Medical Center, Kuala Lumpur, Malaysia|Hospital Tengku Ampuan Afzan, Pahang, Malaysia|Centro Integral en Reumatología S.A. de C.V. (CIRSA), Guadalajara, Jalisco, Mexico|Centro Regiomontano de Estudios Clínicos Roma S.C., Monterrey, Nuevo LEON, Mexico|Phylasis Clinicas Research S de RL de CV, Estado de México, Mexico|Accelerium S. de R.L. de C.V., Monterrey, Mexico|Hospital Universitario Dr Jose Eleuterio Gonzalez; Universidad Autónoma de Nuevo León, Monterrey, Mexico|Amsterdam UMC Location VUMC, Amsterdam, Netherlands|Amsterdam UMC Location AMC, Amsterdam, Netherlands|Radboudumc, NL -nijmegen, Netherlands|North Shore Hospital, Auckland, New Zealand|Middlemore Hospital, Auckland, New Zealand|Dunedin Hospital, Dunedin, New Zealand|Waikato Hospital, Hamilton, New Zealand|Shakespeare Specialist Group, Takapuna, New Zealand|Tauranga Hospital, Tauranga, New Zealand|Akershus universitetssykehus HF, Lørenskog, Norway|Nasz Lekarz Osrodek Badan Klinicznych, Bydgoszcz, Poland|Centrum Medyczne LUKA MED.Joanna Łuka, Chojnice, Poland|Centrum Medyczne Sw. Lukasza, Częstochowa, Poland|7 Szpital Marynarki Wojennej z Przychodnia SPZOZ im. W. Lasinskiego, Gdansk, Poland|Pro Familia Altera Sp z o.o., Katowice, Poland|Nzoz All-Medicus, Katowice, Poland|Uniwersyteckie Centrum Kliniczne im. prof. K. Gibinskiego SUM, Katowice, Poland|NZOZ Centrum Medyczne ProMiMed, Krakow, Poland|Centrum Opieki Zdrowotnej Orkan-Med, Ksawerow, Poland|Indywidualna Specjalistyczna Praktyka Lekarska, Lublin, Poland|GASTROMED Sp. z o.o., Lublin, Poland|Allmedica Badania Kliniczne Sp z o.o. Sp K., Nowy Targ, Poland|Wojewodzki Specjalistyczny Szpital w Olsztynie, Olsztyn, Poland|SOLUMED Centrum Medyczne, Poznań, Poland|Centrum Medyczne Medyk, Rzeszow, Poland|Gabinet Lekarski, Bartosz Korczowski, Rzeszów, Poland|Specjalistyczna Praktyka Lekarska Dr med. Marek Horynski; endoskopia, Sopot, Poland|Niepubliczny Zaklad Opieki Zdrowotnej SONOMED, Szczecin, Poland|Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland|Centrum Zdrowia MDM, Warszawa, Poland|Zespó Przychodni Specjalistycznych PRIMA, Warszawa, Poland|Endoterapia PFG Sp. z o.o., Warszawa, Poland|Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Warszawa, Poland|Nzoz Vivamed, Warszawa, Poland|LexMedica Osrodek Badan Klinicznych, Wroclaw, Poland|EMC Instytut Medyczny S.A., Wrocław, Poland|PlanetMed, Wrocław, Poland|AppleTreeClinics Sp. z o.o., Łódź, Poland|Hospital de Braga, Braga, Portugal|Hospital da Senhora da Oliveira Guimarães, Guimarães, Portugal|Spitalul Clinic Colentina, Bucharest, Romania|S.C MedLife S.A, Bucuresti, Romania|Centrul Medical Unirea SRL, Bucuresti, Romania|Centrul de Gastroenterologie Dr. Goldis, Timisoara, Romania|Yusupov Hospital, Moskva, Adygeja, Russian Federation|Baltic Medicine, St.Petersburg, Leningrad, Russian Federation|CJSC Nasledniki, Moscow, Moskovskaja Oblast, Russian Federation|FFSBI ""The Nikiforov Russian Center of Emergency and Radiation Medicine""; Pulmonology, Sankt-peterburg, Sankt Petersburg, Russian Federation|SPb SBIH ""City Multy-field Hospital # 2""; Intensive Pulmonology and Thoracal Surgery, Sankt-peterburg, Sankt Petersburg, Russian Federation|SBIH City Clinical Hospital #31, Sankt-peterburg, Sankt Petersburg, Russian Federation|FSBMEI HPE ""Military Medical Academy n.a. S.M. Kirov"" of the MoD of the RF; Therapy, St. Petersburg, Sankt Petersburg, Russian Federation|Medical and Sanitary Division of Severstal, Cherepovets, Vologda, Russian Federation|SBEI HPE ""Voronezh State Medical University n.a. N.N. Burdenko"" of the MoH of the RF, Voronezh, Voronez, Russian Federation|SBEI HPE Altai StateMedicalUniversityofMoH andSD, Barnaul, Russian Federation|Irkutsk State Medical Academy of Continuing Education, Irkutsk, Russian Federation|FSBIH Central Clinical Hospital of RAS, Moscow, Russian Federation|FSBI ""State Scientific Centre of Coloproctology"" of the MoH of RF; Gastroenterology, Moscow, Russian Federation|SBHI of NN region ""RCH of NN n.a. N.A.Semashko"", Nizhny Novgorod, Russian Federation|FSBI ""Scientific Research Institute of Physyology and Basic Medicine"" under the SB of RAMS, Novosibirsk, Russian Federation|BHI of Omsk region Clinical Oncology Dispensary, Omsk, Russian Federation|SBEI of HPE ""Omsk SMA"" Ministry of healthcare of RF"", Omsk, Russian Federation|SEIHPE ""Rostov SMU of MoH of RF"", Rostov-on-Don, Russian Federation|City Hospital #26, St Petersburg, Russian Federation|LLC International Medical Centre ""SOGAZ"", St-Petersburg, Russian Federation|Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russian Federation|SPb SHI ""City Hospital #9"", St. Petersburg, Russian Federation|Stavropol Regional Clinical Diagnostic Consultative Center, Stavropol, Russian Federation|FSBEI HE ""Stavropol State Medical University"" of Ministry of Healthcare of Russian Federation, Stavropol, Russian Federation|Clinical Center Zvezdara, Belgrade, Serbia|Military Medical Academy, Belgrade, Serbia|Clinical Center Bezanijska Kosa, Belgrade, Serbia|Clinical Center Zemun, Belgrade, Serbia|Clinical Center Kragujevac, Kragujevac, Serbia|General Hospital Djordje Joanovic, Zrenjanin, Serbia|Singapore General Hospital, Singapore, Singapore|Fakultna nemocnica s poliklinikou F.D. Roosevelta, Banska Bystrica, Slovakia|Nemocnica A.Lena Humenne, n.o., Humenné, Slovakia|KM Management spol. s r.o., Nitra, Slovakia|Fakultna nemocnica Nitra, Nitra, Slovakia|Gastro I, s.r.o., Prešov, Slovakia|Svet zdravia a.s., Rimavská Sobota, Slovakia|Endomed, s.r.o., Vranov nad Topľou, Slovakia|Accout Center s.r.o., Šahy, Slovakia|Netcare Universitas Private Hospital, Bloemfontein, South Africa|Dr MJ Prins Practice, Cape Town, South Africa|Dr JP Wright Practice, Cape Town, South Africa|Emmed Research, Pretoria, South Africa|Corporacio Sanitaria Parc Tauli, Sabadell, Barcelona, Spain|Fundacion Hospital de Alcorcon; Servicio de Digestivo, Alcorcon, Madrid, Spain|Centro Médico Teknon, Barcelona, Spain|Hospital Universitari de Girona Dr Josep Trueta, Girona, Spain|Hospital Universitario de la Princesa, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario de Fuenlabrada, Madrid, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain|Inselspital-Universitaetsspital Bern, Bern, Switzerland|Crohn-Colitis Zentrum Bern - Gemeinschaftspraxis Balsiger, Seibold und Partner, Bern, Switzerland|Gazi University Medical Faculty; Gastroenterology, Ankara, Turkey|Haydarpasa Numune Training and Research Hospital; Medical Oncology, Istanbul, Turkey|Kocaeli Universitesi Tip Fakultesi; Infectious Diseases, Kocaeli, Turkey|CNE Prof. O.O. Shalimov Kharkiv City Clinical Hospital #2 of KCC, Kharkiv, Kharkiv Governorate, Ukraine|Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital, Kharkiv, Kharkiv Governorate, Ukraine|Communal Institution of Kyiv Regional Council Kyiv Regional Clinical Hospital, Kyiv, Kharkiv Governorate, Ukraine|CI of SRC Sumy RCH Dept of Gasroenterology Sumy SU MI, Sumy, Kharkiv Governorate, Ukraine|CNE Kyiv CCH #18, Kyiv, KIEV Governorate, Ukraine|CI of Kyiv RC Kyiv Regional Clinical Hospital, Kyiv, KIEV Governorate, Ukraine|Medical Center of Limited Liability Company Medical Clinic Blagomed, Kyiv, KIEV Governorate, Ukraine|Med Center of International Institute of Clinical Trials LLC; Medical Center ""OK!Clinic+"", Kyiv, KIEV Governorate, Ukraine|CI of Kyiv RC Regional Clinical Hospital #2, Kyiv, KIEV Governorate, Ukraine|Lviv Regional Clinical Hospital, Lviv, KIEV Governorate, Ukraine|CI UDH Dept of Ther SHEI Fac of PGE&Pre-Univ Training, Uzhgorod, KIEV Governorate, Ukraine|A.Novak Transcarpathian Regional Clinical Hospital, Uzhgorod, KIEV Governorate, Ukraine|RCNECRCH Dept of Surgery, SHEI Ukr BSMU, Chernivtsi, Podolia Governorate, Ukraine|CI City Hospital #1, Zaporizhzhia, Tavria Okruha, Ukraine|RCI Chernivtsi RCH Gastroenterology Bukovinsky SMU, Chernivtsi, Ukraine|SI Dnipropetrovsk MA of MOHU SI Institute of gastroenterology of AMSU, Dnipropetrovsk, Ukraine|GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine, Kharkiv, Ukraine|CI of Healthcare Kharkiv CCH #13, Kharkiv, Ukraine|CI Kherson Afanasii and Olha Tropiny City Clinical Hospital, Kherson, Ukraine|CNI Consultative and Diagnostic Center of Desnianskyi District of Kyiv, Kyiv, Ukraine|City Hospital #1, Mykolaiv, Ukraine|Odessa regional clinical Hospital, Odessa, Ukraine|M.V. Sklifosovskyi Poltava RCH Dept of Gastroenterology HSEIU UMSA, Poltava, Ukraine|M.V. Sklifosovskyi Poltava RCH Outpatient UMSA HSEIU Ukrainian Medical Stomatological Academy, Poltava, Ukraine|Private Small Enterprise Medical Center Pulse, Vinnytsia, Ukraine|M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU, Vinnytsia, Ukraine|MCIC Health Clinic BO LTD TPC Slaomed, Vinnytsia, Ukraine|Co Ltd. Diaservice, Zaporizhzhia, Ukraine|CI City Hospital #7, Zaporizhzhia, Ukraine|Addenbrooke's Hospital, Cambridge, United Kingdom|University Hospital Coventry, Coventry, United Kingdom|Royal Devon and Exeter Hospital (Wonford), Exeter, United Kingdom|St James University Hospital, Leeds, United Kingdom|The Royal London Hospital, London, United Kingdom|University College London Hospital, London, United Kingdom|St Thomas Hospital, London, United Kingdom|King's College London, London, United Kingdom|Fairfield General Hospital, Manchester, United Kingdom|Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom|Nottingham University Hospitals; QMC Campus, Nottingham, United Kingdom|Southampton General Hospital, Southampton, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02118584"
903,"NCT01797224","OTIS Autoimmune Diseases in Pregnancy Project",,"Recruiting","No Results Available","Crohn's Disease|Rheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis|Psoriasis",,"Major malformations|Minor malformations|Pregnancy Outcome|Infant follow-up","University of California, San Diego|The Organization of Teratology Information Specialists|UCB Pharma","Female","Child, Adult, Older Adult",,"925","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","RA0023","March 2012","September 2023","October 2026","February 22, 2013",,"April 5, 2021","University of California, San Diego, San Diego, California, United States",,"https://ClinicalTrials.gov/show/NCT01797224"
904,"NCT01988506","Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases","TRANSREG","Active, not recruiting","No Results Available","Rheumatoid Arthritis|Ankylosing Spondylitis|Systemic Lupus Erythematosus|Psoriasis|Behcet's Disease|Wegener's Granulomatosis|Takayasu's Disease|Crohn's Disease|Ulcerative Colitis|Autoimmune Hepatitis|Sclerosing Cholangitis|Gougerot-sjögren|Idiopathic Thrombocytopenic Purpura|Systemic Sclerosis","Drug: Interleukin 2","Percentages of Tregs|inflammation markers (CRP and CRP ultra sensible)|markers of inflammatory anemia (Hemoglobin, serum iron level, transferrin) ferritin|Number of relapses|CGI-sev, CGI-activity and CGI-eff scales|EuroQL-5 scale|Evolution of clinical, biological or radiological criteria specific to each disease|Safety Assessment","Assistance Publique - Hôpitaux de Paris|Iltoo Pharma","All","18 Years and older   (Adult, Older Adult)","Phase 2","81","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","P130101|2013-001232-22","January 6, 2014","October 16, 2019","March 31, 2021","November 20, 2013",,"November 9, 2020","Service d' Hépato Gastro Entérologie - Hôpital SAINT-ANTOINE, Paris, Ile De France, France|Service de Gastro Entérologie - Hôpital SAINT-ANTOINE, Paris, Ile De France, France|Service de Rhumatologie - Hôpital SAINT-ANTOINE, Paris, Ile De France, France|CIC - Hôpital PITIE SALPETRIERE, Paris, Ile De France, France|Service de Médecine Interne - Hôpital PITIE SALPETRIERE, Paris, Ile De France, France|Service de Rhumatologie - Hôpital PITIE SALPETRIERE, Paris, Ile De France, France|Service de Dermatologie - Hôpital COCHIN, Paris, Ile De France, France|Centre Hépato-Biliaire - Hôpital Paul Brousse, Villejuif, Ile De France, France|Henri Mondor - Médecine Interne, Créteil, France|Médecine interne - Hôpital Saint-Antoine, Paris, France|Service de médecine vasculaire - HEGP, Paris, France",,"https://ClinicalTrials.gov/show/NCT01988506"
905,"NCT01931644","At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions",,"Recruiting","No Results Available","All Diagnosed Health Conditions|ADD/ADHD|Alopecia Areata|Ankylosing Spondylitis|Asthma|Atopic Dermatitis Eczema|Beta Thalassemia|Bipolar Disorder|Breast Cancer|Celiac Disease|Cervical Cancer|Chronic Inflammatory Demyelinating Polyneuropathy|Chronic Kidney Diseases|Chronic Obstructive Pulmonary Disease|Colon Cancer|Colorectal Cancer|Crohn's Disease|Cystic Fibrosis|Depression|Diabetes Mellitus|Duchenne Muscular Dystrophy|Endometriosis|Epilepsy|Facioscapulohumeral Muscular Dystrophy|G6PD Deficiency|General Anxiety Disorder|Hepatitis B|Hereditary Hemorrhagic Telangiectasia|HIV/AIDS|Human Papilloma Virus|Huntington's Disease|Idiopathic Thrombocytopenic Purpura|Insomnia|Kidney Cancer|Leukemia|Lung Cancer|Lupus Nephritis|Lymphoma|Melanoma|Multiple Myeloma|Multiple Sclerosis|Myositis|Myotonic Dystrophy|Ovarian Cancer|Pancreatic Cancer|Parkinson's Disease|Polycystic Kidney Diseases|Prostate Cancer|Psoriasis|Psoriatic Arthritis|Rosacea|Scleroderma|Sickle Cell Anemia|Sickle Cell Trait|Sjogren's Syndrome|Skin Cancer|Spinal Muscular Atrophy|Systemic Lupus Erythematosus|Thrombotic Thrombocytopenic Purpura|Trisomy 21|Ulcerative Colitis",,"Biospecimen & Clinical Data Collection","Sanguine Biosciences","All","18 Years to 100 Years   (Adult, Older Adult)",,"20000","Industry","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","SAN-BB-01","July 2013","August 2025","December 2040","August 29, 2013",,"October 8, 2019","Sanguine Biosciences, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT01931644"
906,"NCT01900574","A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis",,"Active, not recruiting","No Results Available","Colitis, Ulcerative","Drug: Golimumab","Serum golimumab concentrations at Week 6|Area under the curve for serum golimumab concentration from Week 0 through Week 6|Number of participants with adverse events as a measure of safety|Number of participants who will achieve clinical response at Week 6|Number of participants who will achieve clinical remission at Week 6 measured by the Mayo score|Number of participants who will achieve clinical remission at Week 6 measured by Pediatric Ulcerative Colitis Activity Index (PUCAI) score|Number of participants with mucosal healing at Week 6|Number of participants who will achieve clinical remission at Week 54 and Week 110 measured by Pediatric Ulcerative Colitis Activity Index (PUCAI) score","Janssen Research & Development, LLC","All","2 Years to 17 Years   (Child)","Phase 1","35","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CR101676|CNTO148UCO1001|2012-004366-18","August 9, 2013","February 18, 2015","January 8, 2024","July 16, 2013",,"March 15, 2021","Phoenix, Arizona, United States|Los Angeles, California, United States|San Francisco, California, United States|Hartford, Connecticut, United States|Atlanta, Georgia, United States|Chicago, Illinois, United States|Rochester, Minnesota, United States|Morristown, New Jersey, United States|Seattle, Washington, United States|Graz, Austria|Wien, Austria|Brussels, Belgium|Brussel, Belgium|Edmonton, Alberta, Canada|Halifax, Nova Scotia, Canada|Toronto, Ontario, Canada|Aarhus, Denmark|Hvidovre, Denmark|Paris, France|Aachen, Germany|Muenchen, Germany|Beer Sheva, Israel|Haifa, Israel|Jerusalem, Israel|Nijmegen, Netherlands|Rotterdam, Netherlands|Rzeszow Poland, Poland|Warszawa, Poland",,"https://ClinicalTrials.gov/show/NCT01900574"
907,"NCT01604564","Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients","KOPOF","Active, not recruiting","No Results Available","Colitis,Ulcerative|Adenomatous Polyposis Coli|Reservoir, Ileoanal",,"Evaluation of postoperatieve recovery","Universitaire Ziekenhuizen Leuven","All","Child, Adult, Older Adult",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","S-54228","May 2012","December 2019","December 2021","May 23, 2012",,"October 16, 2018","University Clinics Gasthuisberg, Leuven, Flemish Brabant, Belgium",,"https://ClinicalTrials.gov/show/NCT01604564"
908,"NCT04352231","Luxembourgish Fiber Cohort","Lux-FiCo","Recruiting","No Results Available","Dietary Fiber|Gastrointestinal Microbiome|Healthy Volunteers","Dietary Supplement: High Fiber Diet Intervention|Dietary Supplement: Low Fiber Diet Intervention","Change in gut microbiota composition across study periods|Change in gut microbiota CAZyme abundance across study periods|Change in gut microbiota mucolytic enzyme activity across study periods","Luxembourg Institute of Health|Centre Hospitalier du Luxembourg|Integrated Biobank of Luxembourg|Luxembourg Centre for Systems Biomedicine","All","18 Years to 55 Years   (Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","LUX-FICO","February 22, 2021","December 2021","January 2025","April 20, 2020",,"March 3, 2021","Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg|Luxembourg Institute of Health, Strassen, Luxembourg",,"https://ClinicalTrials.gov/show/NCT04352231"
909,"NCT04528355","Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC","PRO-RIC","Recruiting","No Results Available","Primary Immunodeficiency (PID)|Congenital Bone Marrow Failure Syndromes|Inherited Metabolic Disorders (IMD)|Hereditary Anemias|Inflammatory Conditions","Drug: data collection","incidence of acute graft versus host disease (GVHD)|overall survival after HSCT|Describe degree of engraftment, based upon chimerism data|Describe probability to discontinue systemic immunosuppression medications|Describe the tempo of immune reconstitution|Describe the use of donor leukocyte infusion (DLI)","Paul Szabolcs|University of Pittsburgh","All","2 Months to 60 Years   (Child, Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","STUDY20070105","August 20, 2020","December 31, 2025","June 30, 2026","August 27, 2020",,"October 8, 2020","UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT04528355"
910,"NCT04741841","Effect of Probiotics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)",,"Recruiting","No Results Available","Myalgic Encephalomyelitis|Chronic Fatigue Syndrome","Dietary Supplement: GutMagnific™ H.|Dietary Supplement: GutMagnific™ L.|Dietary Supplement: Placebo","Changes in ME/CFS symptoms|Changes in Irritable Bowel Syndrome (IBS) symptoms|Changes in the gastrointestinal symptoms based on Rome III criteria|Changes in health related quality of life (RAND 36-Item Health Survey)|Changes in Hospital Anxiety and Depression Scale (HADS)|Changes in gut microbiota composition","ImmuneBiotech Medical Sweden AB|Karolinska Institutet","All","18 Years and older   (Adult, Older Adult)","Not Applicable","90","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","GM_ME/CFS_2020SE","March 30, 2020","March 30, 2021","March 30, 2022","February 5, 2021",,"February 9, 2021","Neurological Rehabilitation Clinic in Stora Sköndal, Stockholm, Sweden",,"https://ClinicalTrials.gov/show/NCT04741841"
911,"NCT01962415","Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT","HSCT+RIC","Recruiting","No Results Available","Primary Immunodeficiency (PID)|Congenital Bone Marrow Failure Syndromes|Inherited Metabolic Disorders (IMD)|Hereditary Anemias|Inflammatory Conditions","Drug: Hydroxyurea|Drug: Alemtuzumab|Drug: Fludarabine|Drug: Melphalan|Drug: Thiotepa","Post-transplant treatment-related mortality (TRM)|Neurodevelopmental milestones|Immune Reconstitution|Severe opportunistic infections|GVHD occurrence|Donor cell engraftment|Normal enzyme level|Neutrophil recovery|Platelet recovery|Grade 3-4 organ toxicity|Long-term complications|Late graft failure","Paul Szabolcs|University of Pittsburgh","All","2 Months to 55 Years   (Child, Adult)","Phase 2","100","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","PRO13100018","February 4, 2014","November 2021","November 2022","October 14, 2013",,"May 5, 2021","UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT01962415"
912,"NCT03058003","Correlation Between Central Sensitization Inventory and Posturographic Data",,"Active, not recruiting","No Results Available","Central Nervous System Sensitization","Diagnostic Test: Posturography Evaluation|Other: Central Sensitization Inventory","Stability Score|CSI|CSI-SS","Caps Research Network","All","18 Years to 65 Years   (Adult, Older Adult)",,"180","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","CI-IRB-20170124001","May 2016","January 2018","April 2021","February 20, 2017",,"July 16, 2020","Innova Brain Rehabilitation, Marietta, Georgia, United States|Small Street Clinic, Hampton, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT03058003"
